PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cali, T; Fedrizzi, L; Ottolini, D; Gomez-Villafuertes, R; Mellstrom, B; Naranjo, JR; Carafoli, E; Brini, M				Cali, Tito; Fedrizzi, Laura; Ottolini, Denis; Gomez-Villafuertes, Rosa; Mellstroem, Britt; Naranjo, Jose R.; Carafoli, Ernesto; Brini, Marisa			Ca2+-activated Nucleotidase 1, a Novel Target Gene for the Transcriptional Repressor DREAM (Downstream Regulatory Element Antagonist Modulator), Is Involved in Protein Folding and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; NUCLEOSIDE DIPHOSPHATASE; MISFOLDED GLYCOPROTEINS; DESBUQUOIS DYSPLASIA; CA2+ CONCENTRATION; CALCIUM-BINDING; QUALITY-CONTROL; EXPRESSION; MUTATION; APYRASE	DREAM is a Ca2+-dependent transcriptional repressor highly expressed in neuronal cells. A number of genes have already been identified as the target of its regulation. Targeted analysis performed on cerebella from transgenic mice expressing a dominant active DREAM mutant (daDREAM) showed a drastic reduction of the amount of transcript of Ca2+-activated nucleotidase 1 (CANT1), an endoplasmic reticulum (ER)-Golgi resident Ca2+-dependent nucleoside diphosphatase that has been suggested to have a role in glucosylation reactions related to the quality control of proteins in the ER and the Golgi apparatus. CANT1 down-regulation was also found in neuroblastoma SH-SY5Y cells stably overexpressing wild type (wt) DREAM or daDREAM, thus providing a simple cell model to investigate the protein maturation pathway. Pulse-chase experiments demonstrated that the down-regulation of CANT1 is associated with reduced protein secretion and increased degradation rates. Importantly, overexpression of wtDREAM or daDREAM augmented the expression of the EDEM1 gene, which encodes a key component of the ER-associated degradation pathway, suggesting an alternative pathway to enhanced protein degradation. Restoring CANT1 levels in neuroblastoma clones recovered the phenotype, thus confirming a key role of CANT1, and of the regulation of its gene by DREAM, in the control of protein synthesis and degradation.	[Carafoli, Ernesto] VIMM, I-35129 Padua, Italy; [Cali, Tito; Fedrizzi, Laura; Brini, Marisa] Univ Padua, Dept Comparat Biomed & Food Sci, I-35131 Padua, Italy; [Ottolini, Denis] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Gomez-Villafuertes, Rosa; Mellstroem, Britt; Naranjo, Jose R.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Gomez-Villafuertes, Rosa; Mellstroem, Britt; Naranjo, Jose R.] CNB CIBERNED, Madrid, Spain	Veneto Institute Molecular Medicine; University of Padua; University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBERNED	Carafoli, E (corresponding author), VIMM, Via G Orus 2, I-35129 Padua, Italy.	ernesto.carafoli@unipd.it; marisa.brini@unipd.it	Gomez-Villafuertes, Rosa/L-7181-2014; Brini, Marisa/K-5189-2016; NARANJO, Jose R/K-1950-2014; Carafoli, Ernesto/K-5192-2016; Calì, Tito/K-5064-2016	Gomez-Villafuertes, Rosa/0000-0002-7064-0906; NARANJO, Jose R/0000-0002-0270-3469; Carafoli, Ernesto/0000-0002-7826-0094; Calì, Tito/0000-0002-8901-1659; NEGRO, ALESSANDRO/0000-0003-3142-7632; Brini, Marisa/0000-0001-5141-0243	Italian Ministry of University and Research; University of Padova; Fondazione Cariparo; ERA-Net Neuron [nEUROsyn 2008]; Ministerio Ciencia e Innovacion [SAF2007-62449, SAF2005-04682, SAF2008-03469]; CIBERNED; EU	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Fondazione Cariparo(Fondazione Cariparo); ERA-Net Neuron; Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERNED(Instituto de Salud Carlos III); EU(European Commission)	This work was supported by grants from the Italian Ministry of University and Research [PRIN 2008] and the University of Padova (Progetto di Ateneo 2008) (to M. B.), from Fondazione Cariparo [Progetti di Eccellenza 2008-2009] (to E. C.), from ERA-Net Neuron (grant nEUROsyn 2008) ( to E. C. and J. R. N.), from Ministerio Ciencia e Innovacion (SAF2007-62449 (to J. R. N.), SAF2005-04682 and SAF2008-03469, to B. M.), from CIBERNED (to B. M. and J. R. N.), and from the EU 6th Framework Program (NeuroNE) (to E. C. and J. R. N.).	ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; ALLEN JM, 1961, J HISTOCHEM CYTOCHEM, V9, P418, DOI 10.1177/9.4.418; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castro O, 1999, MOL BIOL CELL, V10, P1019, DOI 10.1091/mbc.10.4.1019; Dai J, 2011, J HUM GENET, V56, P398, DOI 10.1038/jhg.2011.28; Devader C, 2006, GENE, V367, P135, DOI 10.1016/j.gene.2005.10.014; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Eriksson KK, 2004, J BIOL CHEM, V279, P44600, DOI 10.1074/jbc.M407972200; Faden M, 2010, AM J MED GENET A, V152A, P1157, DOI 10.1002/ajmg.a.33404; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Fedrizzi L, 2008, J BIOL CHEM, V283, P27494, DOI 10.1074/jbc.M804152200; Furuichi T, 2011, J MED GENET, V48, P32, DOI 10.1136/jmg.2010.080226; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; KUHN NJ, 1977, BIOCHEM J, V168, P423, DOI 10.1042/bj1680423; Laccone F, 2011, EUR J HUM GENET, V19, P1133, DOI 10.1038/ejhg.2011.101; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Murphy DM, 2003, BIOCHEMISTRY-US, V42, P2412, DOI 10.1021/bi026763b; NOVIKOFF AB, 1961, P NATL ACAD SCI USA, V47, P802, DOI 10.1073/pnas.47.6.802; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rivas M, 2009, MOL ENDOCRINOL, V23, P862, DOI 10.1210/me.2008-0466; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Savignac M, 2010, J IMMUNOL, V185, P7527, DOI 10.4049/jimmunol.1000152; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Smith TM, 2002, ARCH BIOCHEM BIOPHYS, V406, P105, DOI 10.1016/S0003-9861(02)00420-4; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Wu LJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-3; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010; Zuber C, 2001, P NATL ACAD SCI USA, V98, P10710, DOI 10.1073/pnas.191359198	59	210	218	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18478	18491		10.1074/jbc.M111.304733	http://dx.doi.org/10.1074/jbc.M111.304733			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22453917	Green Published, hybrid			2022-12-28	WOS:000306411600054
J	Cali, T; Ottolini, D; Negro, A; Brini, M				Cali, Tito; Ottolini, Denis; Negro, Alessandro; Brini, Marisa			alpha-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; COMPLEX-I; OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; CELL-DEATH; CA2+; INHIBITION; DEGENERATION; CHAPERONE; PROTEIN	alpha-Synuclein has a central role in Parkinson disease, but its physiological function and the mechanism leading to neuronal degeneration remain unknown. Because recent studies have highlighted a role for alpha-synuclein in regulating mitochondrial morphology and autophagic clearance, we investigated the effect of alpha-synuclein in HeLa cells on mitochondrial signaling properties focusing on Ca2+ homeostasis, which controls essential bioenergetic functions. By using organelle-targeted Ca2+-sensitive aequorin probes, we demonstrated that alpha-synuclein positively affects Ca2+ transfer from the endoplasmic reticulum to the mitochondria, augmenting the mitochondrial Ca2+ transients elicited by agonists that induce endoplasmic reticulum Ca2+ release. This effect is not dependent on the intrinsic Ca2+ uptake capacity of mitochondria, as measured in permeabilized cells, but correlates with an increase in the number of endoplasmic reticulum-mitochondria interactions. This action specifically requires the presence of the C-terminal alpha-synuclein domain. Conversely, alpha-synuclein siRNA silencing markedly reduces mitochondrial Ca2+ uptake, causing profound alterations in organelle morphology. The enhanced accumulation of alpha-synuclein into the cells causes the redistribution of alpha-synuclein to localized foci and, similarly to the silencing of alpha-synuclein, reduces the ability of mitochondria to accumulate Ca2+. The absence of efficient Ca2+ transfer from endoplasmic reticulum to mitochondria results in augmented autophagy that, in the long range, could compromise cellular bio-energetics. Overall, these findings demonstrate a key role for alpha-synuclein in the regulation of mitochondrial homeostasis in physiological conditions. Elevated alpha-synuclein expression and/or eventually alteration of the aggregation properties cause the redistribution of the protein within the cell and the loss of modulation on mitochondrial function.	[Cali, Tito; Brini, Marisa] Univ Padua, Dept Comparat Biomed & Food Sci, I-35131 Padua, Italy; [Ottolini, Denis; Negro, Alessandro] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Brini, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Viale G Colombo 3, I-35131 Padua, Italy.	marisa.brini@unipd.it	Gomez-Villafuertes, Rosa/L-7181-2014; Brini, Marisa/K-5189-2016; NARANJO, Jose R/K-1950-2014; Carafoli, Ernesto/K-5192-2016; Calì, Tito/K-5064-2016	Gomez-Villafuertes, Rosa/0000-0002-7064-0906; NARANJO, Jose R/0000-0002-0270-3469; Carafoli, Ernesto/0000-0002-7826-0094; Calì, Tito/0000-0002-8901-1659; NEGRO, ALESSANDRO/0000-0003-3142-7632; Brini, Marisa/0000-0001-5141-0243	Italian Ministry of University and Research; University of Padova	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova	The work was supported by the Italian Ministry of University and Research (PRIN 2008) and the local founding of the University of Padova (Progetto di Ateneo 2008).	Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Arduino DM, 2009, NEUROCHEM INT, V55, P341, DOI 10.1016/j.neuint.2009.04.004; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cali T, 2011, BIOFACTORS, V37, P228, DOI 10.1002/biof.159; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Hettiarachchi NT, 2009, J NEUROCHEM, V111, P1192, DOI 10.1111/j.1471-4159.2009.06411.x; Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rizzuto R, 1995, METHOD ENZYMOL, V260, P417, DOI 10.1016/0076-6879(95)60155-4; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Ulrih NP, 2008, BBA-MOL BASIS DIS, V1782, P581, DOI 10.1016/j.bbadis.2008.07.004; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122	53	210	218	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17914	17929		10.1074/jbc.M111.302794	http://dx.doi.org/10.1074/jbc.M111.302794			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22453917	hybrid, Green Published			2022-12-28	WOS:000306411600002
J	Farnham, PJ				Farnham, Peggy J.			Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Farnham, PJ (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	pfarnham@usc.edu		Farnham, Peggy/0000-0003-4469-7914				Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; ENCODE Consortium, 2012, NATURE IN PRESS; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012	6	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30885	30887		10.1074/jbc.R112.365940	http://dx.doi.org/10.1074/jbc.R112.365940			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22451669	Green Published, hybrid			2022-12-28	WOS:000308791300001
J	Trauner, A; Lougheed, KEA; Bennett, MH; Hingley-Wilson, SM; Williams, HD				Trauner, Andrej; Lougheed, Kathryn E. A.; Bennett, Mark H.; Hingley-Wilson, Suzanne M.; Williams, Huw D.			The Dormancy Regulator DosR Controls Ribosome Stability in Hypoxic Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIBERNATION PROMOTING FACTOR; MODULATION FACTOR; ESCHERICHIA-COLI; STATIONARY-PHASE; PROTEIN EXPRESSION; GENE-EXPRESSION; TUBERCULOSIS; STARVATION; SENSOR; DEVS	It is thought that during latent infection, Mycobacterium tuberculosis bacilli are retained within granulomas in a low-oxygen environment. The dormancy survival (Dos) regulon, regulated by the response regulator DosR, appears to be essential for hypoxic survival in M. tuberculosis, but it is not known how the regulon promotes survival. Here we report that mycobacteria, in contrast to enteric bacteria, do not form higher-order structures (e.g. ribosomal dimers) upon entry into stasis. Instead, ribosomes are stabilized in the associated form (70S). Using a strategy incorporating microfluidic, proteomic, and ribosomal profiling techniques to elucidate the fate of mycobacterial ribosomes during hypoxic stasis, we show that the dormancy regulator DosR is required for optimal ribosome stabilization. We present evidence that the majority of this effect is mediated by the DosR-regulated protein MSMEG_3935 (a S30AE domain protein), which is associated with the ribosome under hypoxic conditions. A Delta 3935 mutant phenocopies the Delta dosR mutant during hypoxia, and complementation of Delta dosR with the MSMEG_3935 gene leads to complete recovery of dosR mutant phenotypes during hypoxia. We suggest that this protein is named ribosome-associated factor under hypoxia (RafH) and that it is the major factor responsible for DosR-mediated hypoxic survival in mycobacteria.	[Trauner, Andrej; Lougheed, Kathryn E. A.; Bennett, Mark H.; Hingley-Wilson, Suzanne M.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Williams, HD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Trauner, Andrej/0000-0002-6260-9829; Hingley-Wilson, Suzie/0000-0002-6514-1424	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Agafonov DE, 2001, EMBO REP, V2, P399; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; El-Sharoud WM, 2007, MICROBIOL-SGM, V153, P247, DOI 10.1099/mic.0.2006/001552-0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Hingley-Wilson SM, 2010, TUBERCULOSIS, V90, P236, DOI 10.1016/j.tube.2010.03.013; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keer J, 2001, MICROBIOL-SGM, V147, P473, DOI 10.1099/00221287-147-2-473; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Niven GW, 2004, ARCH MICROBIOL, V182, P60, DOI 10.1007/s00203-004-0698-9; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAN XL, 1994, J BIOL CHEM, V269, P20905; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Trauner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016273; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Ueta M, 2010, GENES CELLS, V15, P43, DOI 10.1111/j.1365-2443.2009.01364.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; WADA A, 1995, BIOCHEM BIOPH RES CO, V214, P410, DOI 10.1006/bbrc.1995.2302; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wilson DN, 2004, NAT STRUCT MOL BIOL, V11, P1026, DOI 10.1038/nsmb1104-1026; Yoshida H, 2002, J BIOCHEM, V132, P983, DOI 10.1093/oxfordjournals.jbchem.a003313; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	63	47	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24053	24063		10.1074/jbc.M112.364851	http://dx.doi.org/10.1074/jbc.M112.364851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22544737	Green Published, hybrid			2022-12-28	WOS:000306511300073
J	Xu, J; Kurup, P; Bartos, JA; Patriarchi, T; Hell, JW; Lombroso, PJ				Xu, Jian; Kurup, Pradeep; Bartos, Jason A.; Patriarchi, Tommaso; Hell, Johannes W.; Lombroso, Paul J.			Striatal-enriched Protein-tyrosine Phosphatase (STEP) Regulates Pyk2 Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; D-ASPARTATE RECEPTOR; NMDA RECEPTORS; HIPPOCAMPAL SLICES; CEREBRAL-ISCHEMIA; MOLECULAR CHARACTERIZATION; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; RAT HIPPOCAMPUS; NERVOUS-SYSTEM	Proline-rich tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family and is highly expressed in brain and hematopoietic cells. Pyk2 plays diverse functions in cells, including the regulation of cell adhesion, migration, and cytoskeletal reorganization. In the brain, it is involved in the induction of long term potentiation through regulation of N-methyl-D-aspartate receptor trafficking. This occurs through the phosphorylation and activation of Src family tyrosine kinase members, such as Fyn, that phosphorylate GluN2B at Tyr(1472). Phosphorylation at this site leads to exocytosis of GluN1-GluN2B receptors to synaptic membranes. Pyk2 activity is modulated by phosphorylation at several critical tyrosine sites, including Tyr(402). In this study, we report that Pyk2 is a substrate of striatal-enriched protein-tyrosine phosphatase (STEP). STEP binds to and dephosphorylates Pyk2 at Tyr(402). STEP KO mice showed enhanced phosphorylation of Pyk2 at Tyr(402) and of the Pyk2 substrates paxillin and ASAP1. Functional studies indicated that STEP opposes Pyk2 activation after KCl depolarization of cortical slices and blocks Pyk2 translocation to postsynaptic densities, a key step required for Pyk2 activation and function. This is the first study to identify Pyk2 as a substrate for STEP.	[Xu, Jian; Kurup, Pradeep; Hell, Johannes W.; Lombroso, Paul J.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Lombroso, Paul J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Lombroso, Paul J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Bartos, Jason A.; Patriarchi, Tommaso; Hell, Johannes W.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95615 USA	Yale University; Yale University; Yale University; University of Iowa; University of California System; University of California Davis	Xu, J (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd,SHMI 269, New Haven, CT 06519 USA.	jian.xu@yale.edu; jwhell@ucdavis.edu	Hell, Johannes W./P-5085-2019; Patriarchi, Tommaso/AAK-8653-2020; Kurup, Pradeep/F-1291-2010; XU, JIAN/E-6915-2010	Patriarchi, Tommaso/0000-0001-9351-3734; Bartos, Jason/0000-0003-0113-5305	National Institutes of Health [MH052711, MH091037, AG017502]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052711, R01MH091037, R29MH052711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants MH052711 and MH091037 (to P. J. L.) and AG017502 (to J. W. H.).	ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; Baum Matthew L, 2010, Commun Integr Biol, V3, P419, DOI 10.4161/cib.3.5.12692; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, TRENDS NEUROSCI, V29, P452, DOI 10.1016/j.tins.2006.06.007; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Corvol JC, 2005, J BIOL CHEM, V280, P660, DOI 10.1074/jbc.M411312200; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Derkinderen P, 1998, EUR J NEUROSCI, V10, P1667, DOI 10.1046/j.1460-9568.1998.00174.x; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Du QS, 2001, J CELL SCI, V114, P2977; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Kumar S, 1999, J BIOL CHEM, V274, P30657, DOI 10.1074/jbc.274.43.30657; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lu WY, 2000, J NEUROSCI, V20, P4452, DOI 10.1523/JNEUROSCI.20-12-04452.2000; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Ma J, 2004, NEUROSCI RES, V49, P357, DOI 10.1016/j.neures.2004.04.004; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; OYAMA T, 1995, NEUROSCIENCE, V69, P869, DOI 10.1016/0306-4522(95)00278-Q; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sabri A, 1998, CIRC RES, V83, P841, DOI 10.1161/01.RES.83.8.841; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schaller Michael D, 2008, Biochem J, V410, pe3, DOI 10.1042/BJ20080133; Schauwienold D, 2008, J BIOL CHEM, V283, P27748, DOI 10.1074/jbc.M801431200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; SHIOZUKA K, 1995, GENE, V162, P279, DOI 10.1016/0378-1119(95)00306-Q; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107	67	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20942	20956		10.1074/jbc.M112.368654	http://dx.doi.org/10.1074/jbc.M112.368654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544749	hybrid, Green Published			2022-12-28	WOS:000306416800016
J	Zhang, J; Ying, ZZ; Tang, ZL; Long, LQ; Li, K				Zhang, Jing; Ying, Zheng-zhou; Tang, Zhong-lin; Long, Liang-qi; Li, Kui			MicroRNA-148a Promotes Myogenic Differentiation by Targeting the ROCK1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; BINDING PROTEIN RHO; MYOBLAST DIFFERENTIATION; C2C12 MYOBLASTS; OBLIGATORY ROLE; DOWN-REGULATION; CELL-CYCLE; EXPRESSION; KINASE; MIR-148A	MicroRNAs are evolutionarily conserved small RNAs that post-transcriptionally regulate gene expression and have emerged as critical regulators of skeletal muscle development. Here, we identified miR-148a as a novel myogenic microRNA that mediated myogenic differentiation. The expression levels of miR-148a increased during C2C12 myoblast differentiation. Overexpression of miR-148a significantly promoted myogenic differentiation of both C2C12 myoblast and primary muscle cells. Blocking the function of miR-148a with a 2'-O-methylated antisense oligonucleotide inhibitor repressed C2C12 myoblast differentiation. Using a bioinformatics approach, we identified Rho-associated coiled-coil containing protein kinase 1 (ROCK1), a known inhibitor of myogenesis, as a target of miR-148a. A dual-luciferase reporter assay was used to demonstrate that miR-148a directly targeted the 3'-UTR of ROCK1. In addition, the overexpression of miR-148a decreased the protein expression of ROCK1 in C2C12 myoblast and primary muscle cells. Furthermore, ROCK1 inhibition with specific siRNA leaded to accelerated myogenic differentiation progression, underscoring a negative regulatory function of ROCK1 in myogenesis. Therefore, our results revealed a novel mechanism in which miR-148a positively regulates myogenic differentiation via ROCK1 down-regulation.	[Tang, Zhong-lin] Chinese Acad Agr Sci, Dept Gene & Cell Engn, State Key Lab Anim Nutr,Minist Agr China,Inst Ani, IAS,Key Lab Domest Anim Genet Resources & Breedin, Beijing 100193, Peoples R China; [Zhang, Jing; Long, Liang-qi] Huazhong Agr Univ, Sch Anim Vet Med, Wuhan 430070, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Tang, ZL (corresponding author), Chinese Acad Agr Sci, Dept Gene & Cell Engn, State Key Lab Anim Nutr,Minist Agr China,Inst Ani, IAS,Key Lab Domest Anim Genet Resources & Breedin, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; wulong491024@mail.hzau.edu.cn	Ying, ZZ/ABF-7816-2021	Tang, Zhonglin/0000-0002-4538-4349	National Natural Science Foundation of China [30830080, 31171192]; National Basic Research Program of China [2009CB941604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 30830080, No. 31171192) and National Basic Research Program of China (No. 2009CB941604).	Beqaj S, 2002, J CELL BIOL, V156, P893, DOI 10.1083/jcb.200107049; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Cloutier M, 2010, PEDIATR PULM, V45, P966, DOI 10.1002/ppul.21266; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Hummel R, 2011, J GASTROINTEST SURG, V15, P429, DOI 10.1007/s11605-011-1418-9; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lim MJ, 2007, MOL ENDOCRINOL, V21, P2282, DOI 10.1210/me.2007-0114; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; Merlie J P, 1977, Curr Top Dev Biol, V11, P61, DOI 10.1016/S0070-2153(08)60743-7; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wei L, 2001, DEVELOPMENT, V128, P2953; Wei L, 2000, AM J PHYSIOL-HEART C, V278, pH1736, DOI 10.1152/ajpheart.2000.278.6.H1736; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	58	105	120	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21093	21101		10.1074/jbc.M111.330381	http://dx.doi.org/10.1074/jbc.M111.330381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547064	Green Published, hybrid			2022-12-28	WOS:000306416800030
J	Lay, FT; Mills, GD; Poon, IKH; Cowieson, NP; Kirby, N; Baxter, AA; van der Weerden, NL; Dogovski, C; Perugini, MA; Anderson, MA; Kvansakul, M; Hulett, MD				Lay, Fung T.; Mills, Grant D.; Poon, Ivan K. H.; Cowieson, Nathan P.; Kirby, Nigel; Baxter, Amy A.; van der Weerden, Nicole L.; Dogovski, Con; Perugini, Matthew A.; Anderson, Marilyn A.; Kvansakul, Marc; Hulett, Mark D.			Dimerization of Plant Defensin NaD1 Enhances Its Antifungal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; SIZE-DISTRIBUTION ANALYSIS; ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; PROTEIN-SYNTHESIS; SCORPION TOXINS; ALPHA-DEFENSINS; GAMMA-THIONIN; CDNA CLONING; RABBIT NP-2	The plant defensin, NaD1, from the flowers of Nicotiana alata, is a member of a family of cationic peptides that displays growth inhibitory activity against several filamentous fungi, including Fusarium oxysporum. The antifungal activity of NaD1 has been attributed to its ability to permeabilize membranes; however, the molecular basis of this function remains poorly defined. In this study, we have solved the structure of NaD1 from two crystal forms to high resolution (1.4 and 1.58 angstrom, respectively), both of which contain NaD1 in a dimeric configuration. Using protein cross-linking experiments as well as small angle x-ray scattering analysis and analytical ultracentrifugation, we show that NaD1 forms dimers in solution. The structural studies identified Lys(4) as critical in formation of the NaD1 dimer. This was confirmed by site-directed mutagenesis of Lys(4) that resulted in substantially reduced dimer formation. Significantly, the reduced ability of the Lys(4) mutant to dimerize correlated with diminished antifungal activity. These data demonstrate the importance of dimerization in NaD1 function and have implications for the use of defensins in agribiotechnology applications such as enhancing plant crop protection against fungal pathogens.	[Lay, Fung T.; Mills, Grant D.; Poon, Ivan K. H.; Baxter, Amy A.; van der Weerden, Nicole L.; Dogovski, Con; Perugini, Matthew A.; Anderson, Marilyn A.; Kvansakul, Marc; Hulett, Mark D.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Lay, Fung T.; Mills, Grant D.; Baxter, Amy A.; van der Weerden, Nicole L.; Anderson, Marilyn A.; Hulett, Mark D.] Hexima Ltd, Melbourne, Vic 3000, Australia; [Cowieson, Nathan P.; Kirby, Nigel] Australian Synchrotron, Clayton, Vic 3168, Australia	La Trobe University	Kvansakul, M (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au; m.hulett@latrobe.edu.au	Lay, Fung T/A-9043-2010; van der Weerden, Nicole L/C-3705-2014; Anderson, Marilyn A/A-4259-2012; Kirby, Nigel/AAC-3846-2021; Kvansakul, Marc/AAF-2453-2019	Lay, Fung T/0000-0002-3101-3782; Anderson, Marilyn A/0000-0002-8257-5128; Kvansakul, Marc/0000-0003-2639-2498; Kirby, Nigel/0000-0002-2791-4684; Baxter, Amy/0000-0001-9843-1914; Poon, Ivan/0000-0002-9119-7173; Hulett, Mark/0000-0003-2072-5968	Balmoral Australia Pty Ltd.; Hexima Ltd.; Australian Research Council [DP0881732]; National Health and Medical Research Council of Australia [637372]	Balmoral Australia Pty Ltd.; Hexima Ltd.; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Balmoral Australia Pty Ltd., Hexima Ltd., Australian Research Council Project Grant DP0881732 (to M. A. A.), and the National Health and Medical Research Council of Australia Fellowship 637372 (to M. K).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; BACH AC, 1987, BIOCHEMISTRY-US, V26, P4389, DOI 10.1021/bi00388a030; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Bloch C, 1998, PROTEINS, V32, P334, DOI 10.1002/(SICI)1097-0134(19980815)32:3<334::AID-PROT9>3.0.CO;2-H; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041; BRUIX M, 1995, BIOPOLYMERS, V36, P751, DOI 10.1002/bip.360360608; Cabral KMS, 2003, PROTEIN EXPRES PURIF, V31, P115, DOI 10.1016/S1046-5928(03)00136-0; Chang T, 2005, MOL BIOL CELL, V16, P4941, DOI 10.1091/mbc.E05-02-0143; Chen GH, 2005, J AGR FOOD CHEM, V53, P982, DOI 10.1021/jf0402227; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011; De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; Franco OL, 2006, FEBS J, V273, P3489, DOI 10.1111/j.1742-4658.2006.05349.x; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GARRILL A, 1993, EUR J CELL BIOL, V60, P358; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koike M, 2002, BIOCHEM BIOPH RES CO, V298, P46, DOI 10.1016/S0006-291X(02)02391-4; Komori T., 1997, PLANT PHYSIOL, V115, P314; Kushmerick C, 1998, FEBS LETT, V440, P302, DOI 10.1016/S0014-5793(98)01480-X; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lay FT, 2012, ACTA CRYSTALLOGR F, V68, P85, DOI 10.1107/S1744309111049530; Lehrer RI, 1996, ANN NY ACAD SCI, V797, P228, DOI 10.1111/j.1749-6632.1996.tb52963.x; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lin KF, 2007, PROTEINS, V68, P530, DOI 10.1002/prot.21378; Liu YJ, 2006, PROTEINS, V63, P777, DOI 10.1002/prot.20962; Melo FR, 2002, PROTEINS, V48, P311, DOI 10.1002/prot.10142; Mendez E, 1996, EUR J BIOCHEM, V239, P67, DOI 10.1111/j.1432-1033.1996.0067u.x; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; PARDI A, 1988, J MOL BIOL, V201, P625, DOI 10.1016/0022-2836(88)90643-2; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Pelegrini PB, 2008, PROTEINS, V73, P719, DOI 10.1002/prot.22086; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; ROBSON GD, 1991, EXP MYCOL, V15, P263, DOI 10.1016/0147-5975(91)90028-C; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segura A, 1998, FEBS LETT, V435, P159, DOI 10.1016/S0014-5793(98)01060-6; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Song XM, 2011, FEBS LETT, V585, P300, DOI 10.1016/j.febslet.2010.12.039; Song XM, 2005, PLANT MOL BIOL, V57, P13, DOI 10.1007/s11103-004-6637-y; Song XM, 2004, ACTA CRYSTALLOGR D, V60, P1121, DOI 10.1107/S0907444904007395; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; Thomma Bart P. H. J., 2003, Current Drug Targets - Infectious Disorders, V3, P1, DOI 10.2174/1568005033342000; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wijaya R, 2000, PLANT SCI, V159, P243, DOI 10.1016/S0168-9452(00)00348-4; Yamada S., 1997, PLANT PHYSIOL, V115, P314; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012; Zhang Y, 1997, FEMS MICROBIOL LETT, V149, P59, DOI 10.1111/j.1574-6968.1997.tb10308.x; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	91	60	66	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19961	19972		10.1074/jbc.M111.331009	http://dx.doi.org/10.1074/jbc.M111.331009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511788	Green Published, hybrid			2022-12-28	WOS:000306414500018
J	van der Woude, AD; Sarkar, D; Bhatt, A; Sparrius, M; Raadsen, SA; Boon, L; Geurtsen, J; van der Sar, AM; Luirink, J; Houben, ENG; Besra, GS; Bitter, W				van der Woude, Aniek D.; Sarkar, Debasmita; Bhatt, Apoorva; Sparrius, Marion; Raadsen, Susanne A.; Boon, Louis; Geurtsen, Jeroen; van der Sar, Astrid M.; Luirink, Joen; Houben, Edith N. G.; Besra, Gurdyal S.; Bitter, Wilbert			Unexpected Link between Lipooligosaccharide Biosynthesis and Surface Protein Release in Mycobacterium marinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOMA-FORMATION; GENE-EXPRESSION; OUTER-MEMBRANE; VII SECRETION; TUBERCULOSIS; IDENTIFICATION; MODEL; VISUALIZATION; ANTIGENS; SEQUENCE	The mycobacterial cell envelope is characterized by the presence of a highly impermeable second membrane, which is composed of mycolic acids intercalated with different unusual free lipids, such as lipooligosaccharides (LOS). Transport across this cell envelope requires a dedicated secretion system for extracellular proteins, such as PE_PGRS proteins, which are specific mycobacterial proteins with polymorphic (G) under barC-(r) under bar ich (s) under arc equence (PGRS). In this study, we set out to identify novel components involved in the secretion of PE_ PGRS proteins by screening Mycobacterium marinum transposon mutants for secretion defects. Interestingly, most mutants were not affected in secretion but in the release of PE_ PGRS proteins from the cell surface. These mutants had insertions in a gene cluster associated with LOS biosynthesis. Lipid analysis of these mutants revealed a role at different stages of LOS biosynthesis for 10 novel genes. Furthermore, we show that regulatory protein WhiB4 is involved in LOS biosynthesis. The absence of the most extended LOS molecule, i.e. LOS-IV, and a concomitant accumulation of LOS-III was already sufficient to reduce the release of PE_ PGRS proteins from the mycobacterial cell surface. A similar effect was observed for major surface protein EspE. These results show that the attachment of surface proteins is strongly influenced by the glycolipid composition of the mycobacterial cell envelope. Finally, we tested the virulence of a LOS-IV-deficient mutant in our zebrafish embryo infection model. This mutant showed a marked increase in virulence as compared with the wild-type strain, suggesting that LOS-IV plays a role in the modulation of mycobacterial virulence.	[van der Woude, Aniek D.; Sparrius, Marion; Raadsen, Susanne A.; Geurtsen, Jeroen; van der Sar, Astrid M.; Houben, Edith N. G.; Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 HV Amsterdam, Netherlands; [van der Woude, Aniek D.; Luirink, Joen; Bitter, Wilbert] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 BT Amsterdam, Netherlands; [Sarkar, Debasmita; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Boon, Louis; Besra, Gurdyal S.] Bioceros BV, NL-3584 Utrecht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Birmingham; Bioceros B.V.	Bitter, W (corresponding author), Vrije Univ Amsterdam, Dept Mol Microbiol, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	w.bitter@vumc.nl	Boon, Laurence/HCI-3629-2022; Bitter, Wilbert/ABG-3726-2020; Luirink, Joen/AAB-8658-2021; Houben, Edith N.G./B-2110-2015; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; van der Sar, Astrid M/A-3698-2008	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; van der Sar, Astrid M/0000-0001-5790-5036; Besra, Gurdyal/0000-0002-5605-0395; Boon, Louis/0000-0002-0937-9171; van der Woude, Aniek/0000-0002-7786-9893; Luirink, J./0000-0001-8431-0804	Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research-VENI grant; MRC [G0600105] Funding Source: UKRI; Medical Research Council [G0600105] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research-VENI grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an ECHO project grant from the Netherlands Organization for Scientific Research (to A. D. v. d. W.) and a Netherlands Organization for Scientific Research-VENI grant (to E. N. G. H.).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; ALLEN MM, 1984, ANNU REV MICROBIOL, V38, P1, DOI 10.1146/annurev.mi.38.100184.000245; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fuser G, 2007, MACROMOL BIOSCI, V7, P278, DOI 10.1002/mabi.200600207; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; GILLERON M, 1993, J BIOL CHEM, V268, P3168; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; LEMASSU A, 1992, J GEN MICROBIOL, V138, P1535, DOI 10.1099/00221287-138-7-1535; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Parish T, 1998, METH MOL B, V101, P1, DOI 10.1385/0-89603-471-2:1; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; WHO, 2011, 2011 2012 TUB GLOB F; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	51	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20417	20429		10.1074/jbc.M111.336461	http://dx.doi.org/10.1074/jbc.M111.336461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22505711	hybrid, Green Published			2022-12-28	WOS:000306414500060
J	Ma, XJ; Zhao, Y; Daaka, YH; Nie, ZZ				Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen			Acute Activation of beta(2)-Adrenergic Receptor Regulates Focal Adhesions through beta Arrestin2-and p115RhoGEF Protein-mediated Activation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS FIBER FORMATION; KINASE ACTIVATION; COUPLED RECEPTORS; CELL-MIGRATION; GROWTH-FACTOR; P115 RHOGEF; CYCLIC-AMP; GTPASE; ARRESTIN; PHOSPHORYLATION	beta(2)-Adrenergic receptors (beta(2)ARs) regulate cellular functions through G protein-transduced and beta Arrestin-transduced signals. beta(2)ARs have been shown to regulate cancer cell migration, but the underlying mechanisms are not well understood. Here, we report that beta(2)AR regulates formation of focal adhesions, whose dynamic remodeling is critical for directed cell migration. beta(2)ARs induce activation of RhoA, which is dependent on beta Arrestin2 but not G(s). beta Arrestin2 forms a complex with p115RhoGEF, a guanine nucleotide exchange factor for RhoA that is well known to be activated by G(12/13)-coupled receptors. Our results show that beta Arrestin2 forms a complex with p115RhoGEF in the cytosol in resting cells. Upon beta(2)AR activation, both beta Arrestin2 and p115RhoGEF translocate to the plasma membrane, with concomitant activation of RhoA and formation of focal adhesions and stress fibers. Activation of RhoA and focal adhesion remodeling may explain, at least in part, the role of beta(2)ARs in cell migration. These results suggest that beta Arrestin2 may serve as a convergence point for non-G(12/13) and non-G(q) protein-coupled receptors to activate RhoA.	[Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Dept Urol, Gainesville, FL 32610 USA; [Ma, Xiaojie; Zhao, Yu; Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Prostate Dis Ctr, Gainesville, FL 32610 USA; [Daaka, Yehia; Nie, Zhongzhen] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nie, ZZ (corresponding author), 2033 Mowry Rd,CGRC Rm 460, Gainesville, FL 32610 USA.	niez@ufl.edu		Zhao, Yu/0000-0002-4919-1341	National Institutes of Health [K22CA124578, R01CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155, K22CA124578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA124578 (to Z. N.) and R01CA129155 (to Y. D.).	Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Lodewyks C, 2011, HEPATOL RES, V41, P1000, DOI 10.1111/j.1872-034X.2011.00854.x; Luthy IA, 2009, CURR MED CHEM, V16, P1850, DOI 10.2174/092986709788186048; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malchinkhuu E, 2009, MOL BIOL CELL, V20, P5156, DOI 10.1091/mbc.E09-08-0692; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sun M, 2010, NAT REV UROL, V7, P327, DOI 10.1038/nrurol.2010.57; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Wu JJ, 2011, J BIOL CHEM, V286, P33954, DOI 10.1074/jbc.M110.187344; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	65	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18925	18936		10.1074/jbc.M112.352260	http://dx.doi.org/10.1074/jbc.M112.352260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500016	hybrid, Green Published			2022-12-28	WOS:000306411900005
J	Rubinstein, JD; Elagib, KE; Goldfarb, AN				Rubinstein, Jeremy D.; Elagib, Kamaleldin E.; Goldfarb, Adam N.			Cyclic AMP Signaling Inhibits Megakaryocytic Differentiation by Targeting Transcription Factor 3 (E2A) Cyclin-dependent Kinase Inhibitor 1A (CDKN1A) Transcriptional Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; PROTEIN-KINASE; LEUKEMIA-CELLS; ID PROTEINS; EXPRESSION; SCL; MATURATION; MEGAKARYOPOIESIS; ERYTHROPOIESIS; ACTIVATION	Signaling via the intracellular second messenger cyclic AMP (cAMP) has long been implicated in the repression of megakaryocytic differentiation. However, the mechanisms by which cAMP signaling impairs megakaryopoiesis have never been elucidated. In a human CD34(+) cell culture model, we show that the adenylyl cyclase agonist forskolin inhibits megakaryocytic differentiation in a protein kinase A-dependent manner. Using this system to screen for downstream effectors, we identified the transcription factor E2A as a key target in a novel repressive signaling pathway. Specifically, forskolin acting through protein kinase A-induced E2A down-regulation and enforced expression of E2A overrode the inhibitory effects of forskolin on megakaryopoiesis. The dependence of megakaryopoiesis on critical thresholds of E2A expression was confirmed in vivo in haploinsufficient mice and ex vivo using shRNA knockdown in human progenitors. Using a variety of approaches, we further identified p21 (encoded by CDKN1A) as a functionally important megakaryopoietic regulator residing downstream of E2A. These results thus implicate the E2A-CDKN1A transcriptional axis in the control of megakaryopoiesis and reveal the lineage-selective inhibition of this axis as a likely mechanistic basis for the inhibitory effects of cAMP signaling.	[Rubinstein, Jeremy D.; Elagib, Kamaleldin E.; Goldfarb, Adam N.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia	Goldfarb, AN (corresponding author), Univ Virginia, Sch Med, POB 800904, Charlottesville, VA 22908 USA.	ang3x@virginia.edu			National Institutes of Health [DK090926, DK079924, 2T32GM007267-33, T32 CA009109-35]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079924, R01DK090926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK090926 (to A. N. G) and DK079924 (to A. N. G.).; Supported by National Institutes of Health Training Grants 2T32GM007267-33 (Medical Scientist Training Program) and T32 CA009109-35 (Cancer Research Training in Molecular Biology) awarded to the University of Virginia.	Baccini V, 2001, BLOOD, V98, P3274, DOI 10.1182/blood.V98.12.3274; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chagraoui H, 2011, BLOOD, V118, P723, DOI 10.1182/blood-2011-01-328765; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delehanty LL, 2003, BLOOD, V101, P1744, DOI 10.1182/blood-2002-04-1278; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Freson K, 2008, BLOOD, V111, P1885, DOI 10.1182/blood-2007-06-098558; Goldfarb AN, 2007, ONCOGENE, V26, P6795, DOI 10.1038/sj.onc.1210762; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hamlett I, 2008, BLOOD, V112, P2738, DOI 10.1182/blood-2008-03-146605; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Jackers P, 2004, J BIOL CHEM, V279, P52183, DOI 10.1074/jbc.M407489200; Katayama Y, 2009, BLOOD, V114, P1768, DOI 10.1182/blood-2009-03-213371; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Keefer JR, 2006, EXP HEMATOL, V34, P1151, DOI 10.1016/j.exphem.2006.03.018; Kikuchi J, 1997, BLOOD, V89, P3980, DOI 10.1182/blood.V89.11.3980; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Mathur Anthony, 2004, Methods Mol Biol, V272, P309; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; McCormack MP, 2006, BLOOD, V108, P2248, DOI 10.1182/blood-2006-02-002188; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Roscioni SS, 2011, BRIT J PHARMACOL, V162, P193, DOI 10.1111/j.1476-5381.2010.01011.x; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; SEILER S, 1987, J PHARMACOL EXP THER, V243, P767; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; SILVERSTEIN MN, 1988, NEW ENGL J MED, V318, P1292, DOI 10.1056/NEJM198805193182002; Solberg LA, 1997, BRIT J HAEMATOL, V99, P174, DOI 10.1046/j.1365-2141.1997.3503164.x; Stankiewicz MJ, 2009, BLOOD, V113, P3337, DOI 10.1182/blood-2008-08-174813; Taniguchi T, 1999, BLOOD, V93, P4167, DOI 10.1182/blood.V93.12.4167.412k05_4167_4178; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; VITTET D, 1995, J CELL PHYSIOL, V163, P645, DOI 10.1002/jcp.1041630327; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689	48	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19207	19215		10.1074/jbc.M112.366476	http://dx.doi.org/10.1074/jbc.M112.366476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22514271	hybrid, Green Published			2022-12-28	WOS:000306411900031
J	Gao, XJ; Zhao, XJ; Zhu, Y; He, JY; Shao, J; Su, C; Zhang, Y; Zhang, W; Saarikettu, J; Silvennoinen, O; Yao, Z; Yang, J				Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Saarikettu, Juha; Silvennoinen, Olli; Yao, Zhi; Yang, Jie			Tudor Staphylococcal Nuclease (Tudor-SN) Participates in Small Ribonucleoprotein (snRNP) Assembly via Interacting with Symmetrically Dimethylated Sm Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLTRANSFERASE; PROTEOMIC ANALYSIS; STRUCTURAL BASIS; BINDING PROTEIN; CAJAL BODIES; RNA; DOMAIN; P100; COACTIVATOR; METHYLATION	Human Tudor staphylococcal nuclease (Tudor-SN) is composed of four tandem repeats of staphylococcal nuclease (SN)-like domains, followed by a tudor and SN-like domain (TSN) consisting of a central tudor flanked by two partial SN-like sequences. The crystal structure of the tudor domain displays a conserved aromatic cage, which is predicted to hook methyl groups. Here, we demonstrated that the TSN domain of Tudor-SN binds to symmetrically dimethylarginine (sDMA)-modified SmB/B' and SmD1/D3 core proteins of the spliceosome. We demonstrated that this interaction ability is reduced by the methyltransferase inhibitor 5-deoxy-5-(methylthio)adenosine. Mutagenesis experiments indicated that the conserved amino acids (Phe-715, Tyr-721, Tyr-738, and Tyr-741) in the methyl-binding cage of the TSN domain are required for Tudor-SN-SmB interaction. Furthermore, depletion of Tudor-SN affects the association of Sm protein with snRNAs and, as a result, inhibits the assembly of uridine-rich small ribonucleoprotein mediated by the Sm core complex in vivo. Our results reveal the molecular basis for the involvement of Tudor-SN in regulating small nuclear ribonucleoprotein biogenesis, which provides novel insight related to the biological activity of Tudor-SN.	[Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Immunol, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Biochem, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 30070, Peoples R China; [Gao, Xingjie; Zhao, Xiujuan; Zhu, Yu; He, Jinyan; Shao, Jie; Su, Chao; Zhang, Yi; Zhang, Wei; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Key Lab Educ Minist China, Tianjin 30070, Peoples R China; [Gao, Xingjie; Su, Chao; Zhang, Yi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Lab Mol Immunol, Tianjin 30070, Peoples R China; [Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tampere University; Tampere University Hospital	Yao, Z (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Sch Basic Med Sci, Dept Immunol, Tianjin 30070, Peoples R China.	yaozhi@tijmu.edu.cn; yangj@tijmu.edu.cn	Zhang, Yi/N-2069-2018	Zhang, Yi/0000-0002-2500-680X	Project 863 of the Ministry of Science and Technology of China [2007AA02Z115]; 973 Program [2009CB918903]; Specialized Fund for the Doctoral Program of Higher Education [20091202110001]; China Postdoctoral Science Foundation [2011M500529]; Tianjin Educational Committee Foundation [2008ZD01]; Tianjin Municipal Science and Technology Commission [08ZCGHHZ01900]; NSFC [31125012, 90919032, 30970582, 30670441, 31100967, 31170830]	Project 863 of the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); Specialized Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Educational Committee Foundation; Tianjin Municipal Science and Technology Commission; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by Project 863 of the Ministry of Science and Technology of China Grants 2007AA02Z115, NSFC 31125012, 90919032, 30970582, 30670441, 31100967, and 31170830, 973 Program Grant 2009CB918903, Specialized Fund for the Doctoral Program of Higher Education Grant 20091202110001, China Postdoctoral Science Foundation Grant 2011M500529, Tianjin Educational Committee Foundation Grant 2008ZD01, and Tianjin Municipal Science and Technology Commission Grant 08ZCGHHZ01900.	Abe S, 2003, J EXP BOT, V54, P971, DOI 10.1093/jxb/erg096; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; ANDERSEN J, 1991, BIOESSAYS, V13, P57, DOI 10.1002/bies.950130203; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brenner TJ, 2006, RNA, V12, P862, DOI 10.1261/rna.2319806; Broadhurst MK, 2005, BBA-GENE STRUCT EXPR, V1681, P126, DOI 10.1016/j.bbaexp.2004.10.009; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dong LJ, 2011, J BIOL CHEM, V286, P3451, DOI 10.1074/jbc.M110.168377; Friberg A, 2009, J MOL BIOL, V387, P921, DOI 10.1016/j.jmb.2009.02.018; Frilander MJ, 2005, MOL CELL BIOL, V25, P4813, DOI 10.1128/MCB.25.12.4813-4825.2005; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Guthrie C, 2010, J BIOL CHEM, V285, P1, DOI 10.1074/jbc.X109.080580; Howard-Till RA, 2007, EUKARYOT CELL, V6, P1795, DOI 10.1128/EC.00192-07; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kotani T, 2007, J NEUROL, V254, P624, DOI 10.1007/s00415-006-0410-x; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Paukku K, 2008, NUCLEIC ACIDS RES, V36, P4474, DOI 10.1093/nar/gkn411; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Rodriguez L, 2007, BIOCHEM BIOPH RES CO, V356, P226, DOI 10.1016/j.bbrc.2007.02.110; Sami-Subbu R, 2001, PLANT MOL BIOL, V46, P79, DOI 10.1023/A:1010643209402; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sleeman JE, 2001, J CELL SCI, V114, P4407; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; SUROWY CS, 1989, MOL CELL BIOL, V9, P4179, DOI 10.1128/MCB.9.10.4179; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhao CT, 2003, FEBS LETT, V543, P190, DOI 10.1016/S0014-5793(03)00445-9; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	56	42	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18130	18141		10.1074/jbc.M111.311852	http://dx.doi.org/10.1074/jbc.M111.311852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493508	Green Published, hybrid			2022-12-28	WOS:000306411600021
J	Lange, A; Castaneda, C; Hoeller, D; Lancelin, JM; Fushman, D; Walker, O				Lange, Anja; Castaneda, Carlos; Hoeller, Daniela; Lancelin, Jean-Marc; Fushman, David; Walker, Olivier			Evidence for Cooperative and Domain-specific Binding of the Signal Transducing Adaptor Molecule 2 (STAM2) to Lys(63)-linked Diubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INTERACTING MOTIF; POLYUBIQUITIN CHAINS; BIOLOGICAL MACROMOLECULES; RECEPTOR ENDOCYTOSIS; NMR-SPECTROSCOPY; ESCRT COMPLEXES; PROTEIN; RECOGNITION; DYNAMICS; CONFORMATION	As the upstream component of the ESCRT (endosomal sorting complexes required for transport) machinery, the ESCRT-0 complex is responsible for directing ubiquitinated membrane proteins to the multivesicular body pathway. ESCRT-0 is formed by two subunits known as Hrs (hepatocyte growth factor-regulated substrate) and STAM (signal transducing adaptor molecule), both of which harbor multiple ubiquitin-binding domains (UBDs). In particular, STAM2 possesses two UBDs, the VHS (Vps27/Hrs/Stam) and UIM (ubiquitin interacting motif) domains, connected by a 20-amino acid flexible linker. In the present study, we report the interactions of the UIM domain and VHS-UIM construct of STAM2 with monoubiquitin (Ub), Lys(48)- and Lys(63)-linked diubiquitins. Our results demonstrate that the UIM domain alone binds monoubiquitin, Lys(48)- and Lys(63)-linked diubiquitins with the same affinity and in the same binding mode. Interestingly, binding of VHS-UIM to Lys(63)-linked diubiquitin is not only avid, but also cooperative. We also show that the distal domain of Lys(63)-linked diubiquitin stabilizes the helical structure of the UIM domain and that the corresponding complex adopts a specific structural organization responsible for its greater affinity. In contrast, binding of VHS-UIM to Lys(48)-linked diubiquitin and monoubiquitin is not cooperative and does not show any avidity. These results may explain the better sorting efficiency of some cargoes polyubiquitinated with Lys(63)-linked chains over monoubiquitinated cargoes or those tagged with Lys(48)-linked chains.	[Lange, Anja; Lancelin, Jean-Marc; Walker, Olivier] Univ Lyon, CNRS, UMR 5280, Inst Sci Analyt, F-69622 Villeurbanne, France; [Castaneda, Carlos; Fushman, David] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20910 USA; [Hoeller, Daniela] Innsbruck Med Univ, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University System of Maryland; University of Maryland College Park; Medical University of Innsbruck	Walker, O (corresponding author), 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.	olivier.walker@univ-lyon1.fr	Lancelin, Jean-marc/AAC-5686-2019; WALKER, Olivier/B-2580-2016; Hoeller, Daniela/GVT-8953-2022	WALKER, Olivier/0000-0001-7284-2555; Castaneda, Carlos/0000-0001-9634-0867	National Institutes of Health [GM065334]; National Science Foundation [DBI-0905967]; French MENRT; French Rhone Alpes region for the ExploraDoc; eNMR project (European FP7 e-Infrastructure grant) [213010]; national GRID Initiatives of Italy, Germany; Dutch BiG Grid project (Netherlands Organization for Scientific Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); French MENRT; French Rhone Alpes region for the ExploraDoc(Region Auvergne-Rhone-Alpes); eNMR project (European FP7 e-Infrastructure grant); national GRID Initiatives of Italy, Germany; Dutch BiG Grid project (Netherlands Organization for Scientific Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065334 (to D. F.) and National Science Foundation Postdoctoral Fellowship DBI-0905967 (to C. A. C.).; Recipient of fellowships from the French MENRT and a French Rhone Alpes region for the ExploraDoc.; The eNMR project (European FP7 e-Infrastructure grant, contract no. 213010), supported by the national GRID Initiatives of Italy, Germany, and the Dutch BiG Grid project (Netherlands Organization for Scientific Research) are acknowledged for the use of web portals, computing, and storage facilities.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goddard T. D., 2001, SPARKY 3; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, COMPUTER AIDED RESON, V1; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lim J, 2011, BIOCHEM BIOPH RES CO, V405, P24, DOI 10.1016/j.bbrc.2010.12.103; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, METHOD ENZYMOL, V399, P177, DOI 10.1016/S0076-6879(05)99012-5; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhou HX, 2009, CHEM REV, V109, P4092, DOI 10.1021/cr800551w; Zhou HX, 2001, J PHYS CHEM B, V105, P6763, DOI 10.1021/jp011355n	64	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18687	18699		10.1074/jbc.M111.324954	http://dx.doi.org/10.1074/jbc.M111.324954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493438	hybrid, Green Published			2022-12-28	WOS:000306411600077
J	Liu, CI; Jeng, WY; Chang, WJ; Ko, TP; Wang, AHJ				Liu, Chia-I; Jeng, Wen-Yih; Chang, Wei-Jung; Ko, Tzu-Ping; Wang, Andrew H. -J.			Binding Modes of Zaragozic Acid A to Human Squalene Synthase and Staphylococcal Dehydrosqualene Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-INHIBITORY ACTIVITIES; IN-VIVO EVALUATION; POTENT INHIBITORS; NATURAL-PRODUCTS; SQUALESTATINS; BIOSYNTHESIS; AUREUS; MECHANISM; DISCOVERY; VIRULENCE	Zaragozic acids (ZAs) belong to a family of fungal metabolites with nanomolar inhibitory activity toward squalene synthase (SQS). The enzyme catalyzes the committed step of sterol synthesis and has attracted attention as a potential target for anti-lipogenic and anti-lipogenic therapies. Here, we have determined the structure of ZA-A complexed with human SQS. ZA-A binding induces a local conformational change in the substrate binding site, and its C-6 acyl group also extends over to the cofactor binding cavity. In addition, ZA-A effectively inhibits a homologous bacterial enzyme, dehydrosqualene synthase (CrtM), which synthesizes the precursor of staphyloxanthin in Staphylococcus aureus to cope with oxidative stress. Size reduction at Tyr(248) in CrtM further increases the ZA-A binding affinity, and it reveals a similar overall inhibitor binding mode to that of human SQS/ZA-A except for the C-6 acyl group. These structures pave the way for further improving selectivity and development of a new generation of anticholesterolemic and antimicrobial inhibitors.	[Liu, Chia-I; Jeng, Wen-Yih; Chang, Wei-Jung; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 701, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University	Wang, AHJ (corresponding author), 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ahjwang@gate.sinica.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Academia Sinica and National Science Council, Taiwan [NSC97-3112-B-001-017, NSC98-3112-B-001-024, NSC99-3112-B-001-026]	Academia Sinica and National Science Council, Taiwan	This work was supported by Academia Sinica and National Science Council, Taiwan Grants NSC97-3112-B-001-017, NSC98-3112-B-001-024, and NSC99-3112-B-001-026 (to A. H.-J. W.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2007, NEUROPHARMACOLOGY, V53, P222, DOI 10.1016/j.neuropharm.2007.05.003; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; BIFTU T, 1994, J MED CHEM, V37, P421, DOI 10.1021/jm00029a015; Chan C, 1996, J MED CHEM, V39, P207, DOI 10.1021/jm9504969; Charlton-Menys V, 2007, DRUGS, V67, P11, DOI 10.2165/00003495-200767010-00002; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x; DUFRESNE C, 1993, J NAT PROD, V56, P1923, DOI 10.1021/np50101a009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairlamb IJS, 2002, BIOORGAN MED CHEM, V10, P2641, DOI 10.1016/S0968-0896(02)00090-1; GIBLIN GMP, 1993, BIOORG MED CHEM LETT, V3, P2605, DOI 10.1016/S0960-894X(01)80724-1; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; KOERT U, 1995, ANGEW CHEM INT EDIT, V34, P773, DOI 10.1002/anie.199507731; Lin FY, 2010, P NATL ACAD SCI USA, V107, P21337, DOI 10.1073/pnas.1010907107; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mandala SM, 1997, J ANTIBIOT, V50, P339, DOI 10.7164/antibiotics.50.339; Naito S, 2002, J ORG CHEM, V67, P4200, DOI 10.1021/jo011157s; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; PONPIPOM MM, 1994, J MED CHEM, V37, P4031, DOI 10.1021/jm00049a022; PROCOPIOU PA, 1994, J MED CHEM, V37, P3274, DOI 10.1021/jm00046a011; Procopiou PA, 1996, J MED CHEM, V39, P1413, DOI 10.1021/jm950893j; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Song YC, 2009, J MED CHEM, V52, P3869, DOI 10.1021/jm9001764; Song YC, 2009, J MED CHEM, V52, P976, DOI 10.1021/jm801023u; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Thompson JF, 1998, ARCH BIOCHEM BIOPHYS, V350, P283, DOI 10.1006/abbi.1997.0502; Toutouzas K, 2010, EXPERT OPIN PHARMACO, V11, P1659, DOI 10.1517/14656561003774080; Wang YZ, 2011, CHEM-EUR J, V17, P3335, DOI 10.1002/chem.201003399; Watson N S, 1996, Prog Med Chem, V33, P331, DOI 10.1016/S0079-6468(08)70308-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	38	30	32	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18750	18757		10.1074/jbc.M112.351254	http://dx.doi.org/10.1074/jbc.M112.351254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474324	hybrid, Green Published			2022-12-28	WOS:000306411600083
J	Ohgo, K; Niemczura, WP; Seacat, BC; Wise, SG; Weiss, AS; Kumashiro, KK				Ohgo, Kosuke; Niemczura, Walter P.; Seacat, Brian C.; Wise, Steven G.; Weiss, Anthony S.; Kumashiro, Kristin K.			Resolving Nitrogen-15 and Proton Chemical Shifts for Mobile Segments of Elastin with Two-dimensional NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SOLID-STATE NMR; PROTEIN SECONDARY STRUCTURE; HUMAN TROPOELASTIN; POLARIZATION TRANSFER; TEMPERATURE-DEPENDENCE; MOLECULAR-MODEL; C-13; ENHANCEMENT; INEPT	In this study, one- and two-dimensional NMR experiments are applied to uniformly N-15-enriched synthetic elastin, a recombinant human tropoelastin that has been cross-linked to form an elastic hydrogel. Hydrated elastin is characterized by large segments that undergo "liquid-like" motions that limit the efficiency of cross-polarization. The refocused insensitive nuclei enhanced by polarization transfer experiment is used to target these extensive, mobile regions of this protein. Numerous peaks are detected in the backbone amide region of the protein, and their chemical shifts indicate the completely unstructured, "random coil" model for elastin is unlikely. Instead, more evidence is gathered that supports a characteristic ensemble of conformations in this rubber-like protein.	[Ohgo, Kosuke; Niemczura, Walter P.; Seacat, Brian C.; Kumashiro, Kristin K.] Univ Hawaii, Dept Chem, Honolulu, HI 96822 USA; [Wise, Steven G.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Hawaii System; University of Sydney	Kumashiro, KK (corresponding author), Univ Hawaii, Dept Chem, 2545 McCarthy Mall, Honolulu, HI 96822 USA.	kumashir@hawaii.edu	Weiss, Anthony S/F-8103-2010; Wise, Steven G/G-2630-2018; Weiss, Anthony S/GYV-0157-2022; Wise, Steven/AAB-8170-2021; Wise, Steven G/B-1858-2009	Weiss, Anthony S/0000-0002-8106-4836; Wise, Steven G/0000-0001-7964-819X	National Science Foundation [MCB-0344975, MCB-1022526]; Australian Research Council; Div Of Molecular and Cellular Bioscience [1022526] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partially supported by National Science Foundation Grants MCB-0344975 and MCB-1022526 ( to K.K.K.).; Supported by the Australian Research Council.	Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215, DOI 10.1006/jmra.1995.0010; BURUM DP, 1980, J MAGN RESON, V39, P163, DOI 10.1016/0022-2364(80)90168-7; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; DEBELLE L, 1995, J MOL STRUCT, V348, P321, DOI 10.1016/0022-2860(95)08653-D; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Elena B, 2005, J AM CHEM SOC, V127, P17296, DOI 10.1021/ja054411x; Golotvin S, 2000, J MAGN RESON, V146, P122, DOI 10.1006/jmre.2000.2121; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Holland GP, 2010, J MAGN RESON, V202, P64, DOI 10.1016/j.jmr.2009.09.024; Kumashiro KK, 2003, BIOPOLYMERS, V70, P221, DOI 10.1002/bip.10470; Kumashiro KK, 2008, BIOPOLYMERS, V89, P668, DOI 10.1002/bip.20984; Kurkova D, 2003, BIOMACROMOLECULES, V4, P589, DOI 10.1021/bm025618a; Mackay JP, 2005, J STRUCT BIOL, V150, P154, DOI 10.1016/j.jsb.2005.02.005; Martin RW, 2003, REV SCI INSTRUM, V74, P3045, DOI 10.1063/1.1571951; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091; Mifsud N, 2006, PHYS CHEM CHEM PHYS, V8, P3418, DOI 10.1039/b605227d; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; MORRIS GA, 1980, J AM CHEM SOC, V102, P428, DOI 10.1021/ja00521a097; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Ohgo K, 2005, MACROMOLECULES, V38, P6038, DOI 10.1021/ma050052e; Ohgo K, 2009, MACROMOLECULES, V42, P8899, DOI 10.1021/ma901604m; Ohgo K, 2009, MACROMOLECULES, V42, P7024, DOI 10.1021/ma900816k; Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4; Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VENKATACHALAM CM, 1981, MACROMOLECULES, V14, P1225, DOI 10.1021/ma50006a017; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Xu JD, 2010, J AM CHEM SOC, V132, P9944, DOI 10.1021/ja103983f; Yao XL, 2004, J AM CHEM SOC, V126, P4199, DOI 10.1021/ja036686n; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	47	16	16	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18201	18209		10.1074/jbc.M111.285163	http://dx.doi.org/10.1074/jbc.M111.285163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474297	Green Published, hybrid			2022-12-28	WOS:000306411600028
J	Celic, AS; Petri, ET; Benbow, J; Hodsdon, ME; Ehrlich, BE; Boggon, TJ				Celic, Andjelka S.; Petri, Edward T.; Benbow, Jennifer; Hodsdon, Michael E.; Ehrlich, Barbara E.; Boggon, Titus J.			Calcium-induced Conformational Changes in C-terminal Tail of Polycystin-2 Are Necessary for Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; X-RAY SOLUTION; KIDNEY-DISEASE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CHEMICAL-SHIFT; PROTEIN; RESOLUTION; MECHANISM; PKD2	Polycystin-2 (PC2) is a Ca2+-permeable transient receptor potential channel activated and regulated by changes in cytoplasmic Ca2+. PC2 mutations are responsible for similar to 15% of autosomal dominant polycystic kidney disease. Although the C-terminal cytoplasmic tail of PC2 has been shown to contain a Ca2+-binding EF-hand domain, the molecular basis of PC2 channel gating by Ca2+ remains unknown. We propose that the PC2 EF-hand is a Ca2+ sensor required for channel gating. Consistent with this, Ca2+ binding causes a dramatic decrease in the radius of gyration (R-g) of the PC2 EF-hand by small angle x-ray scattering and significant conformational changes by NMR. Furthermore, increasing Ca2+ concentrations cause the C-terminal cytoplasmic tail to transition from a mixture of extended oligomers to a single compact dimer by analytical ultracentrifugation, coupled with a >30 angstrom decrease in maximum interatomic distance (D-max) by small angle x-ray scattering. Mutant PC2 channels unable to bind Ca2+ via the EF-hand are inactive in single-channel planar lipid bilayers and inhibit Ca2+ release from ER stores upon overexpression in cells, suggesting dominant negative properties. Our results support a model where PC2 channels are gated by discrete conformational changes in the C-terminal cytoplasmic tail in response to changes in cytoplasmic Ca2+ levels. These properties of PC2 are lost in autosomal dominant polycystic kidney disease, emphasizing the importance of PC2 to kidney cell function. We speculate that PC2 and the Ca2+-dependent transient receptor potential channels in general are regulated by similar conformational changes in their cytoplasmic domains that are propagated to the channel pore.	[Celic, Andjelka S.; Petri, Edward T.; Benbow, Jennifer; Hodsdon, Michael E.; Ehrlich, Barbara E.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Celic, Andjelka S.; Benbow, Jennifer; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	/AAX-8408-2021; Celic, Andjeka S/AAC-1865-2022	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Petri, Edward/0000-0002-3650-1523	National Institutes of Health [R01DK087844, R01DK61747, P50DK057328, RR19895, 5T32DK007356-32]; Ministry of Education and Science, Republic of Serbia [173014, 172021]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, T32DK007356, R01DK087844, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education and Science, Republic of Serbia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK087844, R01DK61747, P50DK057328, and RR19895. This work was also supported by National Institutes of Health Training Grant 5T32DK007356-32 administered by the Department of Digestive Diseases at Yale University. This work was also supported in part by Projects 173014 and 172021 from the Ministry of Education and Science, Republic of Serbia (to E. T. P. and A. S. C.).	Anyatonwu GI, 2004, BIOCHEM BIOPH RES CO, V322, P1364, DOI 10.1016/j.bbrc.2004.08.043; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Brookes E., 2006, SC 06 P 2006 ACM IEE; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Casuscelli J, 2009, AM J PHYSIOL-RENAL, V297, pF1310, DOI 10.1152/ajprenal.00412.2009; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2005, ULTRASCAN COMPREHENS; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Molland KL, 2012, BBA-PROTEINS PROTEOM, V1824, P413, DOI 10.1016/j.bbapap.2011.12.002; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	37	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17232	17240		10.1074/jbc.M112.354613	http://dx.doi.org/10.1074/jbc.M112.354613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474326	Green Published, hybrid			2022-12-28	WOS:000306373000023
J	Li, N; Zhong, XM; Lin, XJ; Guo, JY; Zou, L; Tanyi, JL; Shao, ZJ; Liang, S; Wang, LP; Hwang, WT; Katsaros, D; Montone, K; Zhao, X; Zhang, L				Li, Ning; Zhong, Xiaomin; Lin, Xiaojuan; Guo, Jinyi; Zou, Lian; Tanyi, Janos L.; Shao, Zhongjun; Liang, Shun; Wang, Li-Ping; Hwang, Wei-Ting; Katsaros, Dionyssios; Montone, Kathleen; Zhao, Xia; Zhang, Lin			Lin-28 Homologue A (LIN28A) Promotes Cell Cycle Progression via Regulation of Cyclin-dependent Kinase 2 (CDK2), Cyclin D1 (CCND1), and Cell Division Cycle 25 Homolog A (CDC25A) Expression in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; BINDING PROTEIN LIN28; PLURIPOTENCY FACTORS LIN28; REPROGRAMMING FACTOR LIN28; LET-7 MICRORNA; POSTTRANSCRIPTIONAL REGULATION; MESSENGER-RNA; FEEDBACK LOOP; IDENTIFICATION; TRANSFORMATION	The RNA-binding protein LIN28A regulates the translation and stability of a large number of mRNAs as well as the biogenesis of certain miRNAs in embryonic stem cells and developing tissues. Increasing evidence indicates that LIN28A functions as an oncogene promoting cancer cell growth. However, little is known about its molecular mechanism of cell cycle regulation in cancer. Using tissue microarrays, we found that strong LIN28A expression was reactivated in about 10% (7.1-17.1%) of epithelial tumors (six tumor types, n = 369). Both in vitro and in vivo experiments demonstrate that LIN28A promotes cell cycle progression in cancer cells. Genome-wide RNA-IP-chip experiments indicate that LIN28A binds to thousands of mRNAs, including a large group of cell cycle regulatory mRNAs in cancer and embryonic stem cells. Furthermore, the ability of LIN28A to stimulate translation of LIN28A-binding mRNAs, such as CDK2, was validated in vitro and in vivo. Finally, using a combined gene expression microarray and bioinformatics approach, we found that LIN28A also regulates CCND1 and CDC25A expression and that this is mediated by inhibiting the biogenesis of let-7 miRNA. Taken together, these results demonstrate that LIN28A is reactivated in about 10% of epithelial tumors and promotes cell cycle progression by regulation of both mRNA translation (let-7-independent) and miRNA biogenesis (let-7-dependent).	[Zhang, Lin] Univ Penn, Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Li, Ning; Zhong, Xiaomin; Lin, Xiaojuan; Guo, Jinyi; Zou, Lian; Tanyi, Janos L.; Shao, Zhongjun; Liang, Shun; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Hwang, Wei-Ting] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Wang, Li-Ping; Montone, Kathleen] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lin, Xiaojuan; Zou, Lian; Zhao, Xia] Sichuan Univ, W China Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, I-10124 Turin, Italy	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Sichuan University; University of Turin	Zhang, L (corresponding author), Univ Penn, Sch Med, Ovarian Canc Res Ctr, Rm 1209,BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Zhang, Lin/K-8478-2012		National Institutes of Health, NCI [R01-CA142776]; Ovarian Cancer SPORE [P50-CA83638-7951]; Department of Defense [W81XWH-10-1-0082]; Ovarian Cancer Research Fund Tilberis Scholar Award; China Scholarship Council; National Institutes of Health [5K12HD000849-23]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142776, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer SPORE; Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund Tilberis Scholar Award; China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01-CA142776 (to L. Z.) and Ovarian Cancer SPORE P50-CA83638-7951 Project 3 (to L. Z.). This work was also supported by Department of Defense Grant W81XWH-10-1-0082 (to L. Z.) and the Ovarian Cancer Research Fund Tilberis Scholar Award (to L. Z.).; Supported by the China Scholarship Council.; Supported by National Institutes of Health Grant 5K12HD000849-23.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Desjardins A, 2012, NUCLEIC ACIDS RES, V40, P1767, DOI 10.1093/nar/gkr808; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lightfoot HL, 2011, BIOCHEMISTRY-US, V50, P7514, DOI 10.1021/bi200851d; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Qiu J. L., 2012, CHIN J CANC IN PRESS; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	69	51	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17386	17397		10.1074/jbc.M111.321158	http://dx.doi.org/10.1074/jbc.M111.321158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467868	hybrid, Green Published			2022-12-28	WOS:000306373000038
J	Ni, SW; Hong, F; Haldeman, BD; Baker, JE; Facemyer, KC; Cremo, CR				Ni, Shaowei; Hong, Feng; Haldeman, Brian D.; Baker, Josh E.; Facemyer, Kevin C.; Cremo, Christine R.			Modification of Interface between Regulatory and Essential Light Chains Hampers Phosphorylation-dependent Activation of Smooth Muscle Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-MEROMYOSIN; SCALLOP MYOSIN; ANGSTROM RESOLUTION; CALCIUM-BINDING; RECOVERY STROKE; ATPASE ACTIVITY; GIZZARD MYOSIN; MOTOR DOMAIN; POWER STROKE; IN-VITRO	We examined the regulatory importance of interactions between regulatory light chain (RLC), essential light chain (ELC), and adjacent heavy chain (HC) in the regulatory domain of smooth muscle heavy meromyosin. After mutating the HC, RLC, and/or ELC to disrupt their predicted interactions (using scallop myosin coordinates), we measured basal ATPase, V-max, and K-ATPase of actin-activated ATPase, actin-sliding velocities, rigor binding to actin, and kinetics of ATP binding and ADP release. If unphosphorylated, all mutants were similar to wild type showing turned-off behaviors. In contrast, if phosphorylated, mutation of RLC residues smM129Q and smG130C in the F-G helix linker, which interact with the ELC (Ca2+ binding in scallop), was sufficient to abolish motility and diminish ATPase activity, without altering other parameters. ELC mutations within this interacting ELC loop (smR20M and smK25A) were normal, but smM129Q/G130C-R20M or -K25A showed a partially recovered phenotype suggesting that interaction between the RLC and ELC is important. A molecular dynamics study suggested that breaking the RLC/ELC interface leads to increased flexibility at the interface and ELC-binding site of the HC. We hypothesize that this leads to hampered activation by allowing a pre-existing equilibrium between activated and inhibited structural distributions (Vileno, B., Chamoun, J., Liang, H., Brewer, P., Haldeman, B. D., Facemyer, K. C., Salzameda, B., Song, L., Li, H. C., Cremo, C. R., and Fajer, P. G. (2011) Broad disorder and the allosteric mechanism of myosin II regulation by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 8218-8223) to be biased strongly toward the inhibited distribution even when the RLC is phosphorylated. We propose that an important structural function of RLC phosphorylation is to promote or assist in the maintenance of an intact RLC/ELC interface. If the RLC/ELC interface is broken, the off-state structures are no longer destabilized by phosphorylation.	[Ni, Shaowei; Hong, Feng; Haldeman, Brian D.; Baker, Josh E.; Facemyer, Kevin C.; Cremo, Christine R.] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Cremo, CR (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, 1664 N Virginia St, Reno, NV 89557 USA.	cremo@unr.edu			National Institutes of Health Grant from NIAMS [RO1 AR040917]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040917] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR040917 from NIAMS (to C. R. C. and K. C. F.).	Baumann BAJ, 2012, J MOL BIOL, V415, P274, DOI 10.1016/j.jmb.2011.10.047; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; Ellison PA, 2003, J BIOL CHEM, V278, P4410, DOI 10.1074/jbc.M211016200; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Fiske CH, 1925, J BIOL CHEM, V66, P375; GEEVES MA, 1991, BIOCHEM J, V274, P1; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Himmel DM, 2009, J MOL BIOL, V394, P496, DOI 10.1016/j.jmb.2009.09.035; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Howard J, 2001, MECH MOTOR PROTEINS; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; JANCSO A, 1994, P NATL ACAD SCI USA, V91, P8762, DOI 10.1073/pnas.91.19.8762; Katoh T, 1996, J BIOL CHEM, V271, P9992, DOI 10.1074/jbc.271.17.9992; Katoh T, 2002, J BIOCHEM, V131, P641, DOI 10.1093/oxfordjournals.jbchem.a003146; Khromov AS, 1998, J PHYSIOL-LONDON, V512, P345, DOI 10.1111/j.1469-7793.1998.345be.x; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; KWON H, 1990, P NATL ACAD SCI USA, V87, P4771, DOI 10.1073/pnas.87.12.4771; KWON H, 1992, J MUSCLE RES CELL M, V13, P315, DOI 10.1007/BF01766459; LOWEY S, 1969, J MOL BIOL, V42, P1, DOI 10.1016/0022-2836(69)90483-5; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Malnasi-Csizmadia A, 1999, EUR J BIOCHEM, V261, P452, DOI 10.1046/j.1432-1327.1999.00290.x; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; Ni SW, 2009, BBA-PROTEINS PROTEOM, V1794, P1599, DOI 10.1016/j.bbapap.2009.07.009; Onishi H, 2008, BIOCHEM BIOPH RES CO, V369, P115, DOI 10.1016/j.bbrc.2007.11.148; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; SEIDEL JC, 1980, J BIOL CHEM, V255, P4355; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Szent-Gyorgyi AG, 2007, ADV EXP MED BIOL, V592, P253; SZENTGYORGYI AG, 1994, MYOLOGY, P506; TAYLOR EW, 1979, CRC CR REV BIOCH MOL, V6, P103, DOI 10.3109/10409237909102562; TRYBUS KM, 1994, J CELL BIOL, V124, P963, DOI 10.1083/jcb.124.6.963; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; VANBUREN P, 1994, P NATL ACAD SCI USA, V91, P12403, DOI 10.1073/pnas.91.26.12403; Vileno B, 2011, P NATL ACAD SCI USA, V108, P8218, DOI 10.1073/pnas.1014137108; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; WARSHAW DM, 1991, J BIOL CHEM, V266, P24339; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	52	10	11	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22068	22079		10.1074/jbc.M112.343491	http://dx.doi.org/10.1074/jbc.M112.343491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549781	hybrid, Green Published			2022-12-28	WOS:000306418600044
J	Baron, O; Forthmann, B; Lee, YW; Terranova, C; Ratzka, A; Stachowiak, EK; Grothe, C; Claus, P; Stachowiak, MK				Baron, Olga; Foerthmann, Benjamin; Lee, Yu-Wei; Terranova, Christopher; Ratzka, Andreas; Stachowiak, Ewa K.; Grothe, Claudia; Claus, Peter; Stachowiak, Michal K.			Cooperation of Nuclear Fibroblast Growth Factor Receptor 1 and Nurr1 Offers New Interactive Mechanism in Postmitotic Development of Mesencephalic Dopaminergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE GENE; PATHWAY MEDIATES ACTIVATION; CENTRAL-NERVOUS-SYSTEM; FGFR1 SIGNALING INFS; ANGIOTENSIN-II; RETINOIC-ACID; MOUSE-BRAIN; TRANSCRIPTIONAL ACTIVITY; INDUCED DIFFERENTIATION; MOTONEURON PROTEIN	Experiments in mice deficient for Nurr1 or expressing the dominant-negative FGF receptor (FGFR) identified orphan nuclear receptor Nurr1 and FGFR1 as essential factors in development of mesencephalic dopaminergic (mDA) neurons. FGFR1 affects brain cell development by two distinct mechanisms. Activation of cell surface FGFR1 by secreted FGFs stimulates proliferation of neural progenitor cells, whereas direct integrative nuclear FGFR1 signaling (INFS) is associated with an exit from the cell cycle and neuronal differentiation. Both Nurr1 and INFS activate expression of neuronal genes, such as tyrosine hydroxylase (TH), which is the rate-limiting enzyme in dopamine synthesis. Here, we show that nuclear FGFR1 and Nurr1 are expressed in the nuclei of developing TH-positive cells in the embryonic ventral midbrain. Both nuclear receptors were effectively co-immunoprecipitated from the ventral midbrain of FGF-2-deficient embryonic mice, which previously showed an increase of mDA neurons and enhanced nuclear FGFR1 accumulation. Immunoprecipitation and co-localization experiments showed the presence of Nurr1 and FGFR1 in common nuclear protein complexes. Fluorescence recovery after photo-bleaching and chromatin immunoprecipitation experiments demonstrated the Nurr1-mediated shift of nuclear FGFR1-EGFP mobility toward a transcriptionally active population and that both Nurr1 and FGFR1 bind to a common region in the TH gene promoter. Furthermore, nuclear FGFR1 or its 23-kDa FGF-2 ligand (FGF-2(23)) enhances Nurr1-dependent activation of the TH gene promoter. Transcriptional cooperation of FGFR1 with Nurr1 was confirmed on isolated Nurr1-binding elements. The proposed INFS/Nurr1 nuclear partnership provides a novel mechanism for TH gene regulation in mDA neurons and a potential therapeutic target in neurodevelopmental and neurodegenerative disorders.	[Baron, Olga; Foerthmann, Benjamin; Ratzka, Andreas; Grothe, Claudia; Claus, Peter] Hannover Med Sch, Inst Neuroanat, D-30625 Hannover, Germany; [Baron, Olga; Foerthmann, Benjamin; Grothe, Claudia; Claus, Peter] Ctr Syst Neurosci, D-30559 Hannover, Germany; [Lee, Yu-Wei; Terranova, Christopher; Stachowiak, Ewa K.; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14214 USA	Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Claus, P (corresponding author), Hannover Med Sch, Inst Neuroanat, Carl Neuberg Str 1, D-30625 Hannover, Germany.	claus.peter@mh-hannover.de; mks4@buffalo.edu	Ratzka, Andreas/H-7917-2012; Claus, Peter/A-7978-2008; Baron, Olga/HII-8390-2022	Claus, Peter/0000-0003-3824-9445; Baron, Olga/0000-0002-0536-8678; Terranova, Christopher/0000-0002-3674-7013	New York State Stem Cell Science (NYSTEM) [N09G-271]; Deutsche Forschungsgemeinschaft	New York State Stem Cell Science (NYSTEM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by New York State Stem Cell Science (NYSTEM) Grant N09G-271 (to M. K. S.) and by a Deutsche Forschungsgemeinschaft grant (to C. G.).	ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; Backman C, 1999, BRAIN RES, V851, P125, DOI 10.1016/S0006-8993(99)02149-6; Bruns AF, 2009, P NATL ACAD SCI USA, V106, P12747, DOI 10.1073/pnas.0900122106; Calo L, 2005, J NEUROCHEM, V92, P235, DOI 10.1111/j.1471-4159.2004.02853.x; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Claus P, 2004, BIOCHEM J, V384, P559, DOI 10.1042/BJ20040801; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Ghigo D, 1998, J CELL PHYSIOL, V174, P99; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Iwawaki T, 2000, BIOCHEM BIOPH RES CO, V274, P590, DOI 10.1006/bbrc.2000.3204; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kelly BB, 2006, NEUROSCIENCE, V142, P343, DOI 10.1016/j.neuroscience.2006.06.032; Kim EL, 1996, J NEUROCHEM, V67, P26; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Murphy EP, 1996, GENE EXPRESSION, V5, P169; Nakamura S, 2000, J NEUROSCI, V20, P4112; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nobre A, 2010, CELL TISSUE RES, V340, P29, DOI 10.1007/s00441-010-0933-4; Ota S, 2010, GENESIS, V48, P707, DOI 10.1002/dvg.20682; Ozawa K, 1996, MOL BRAIN RES, V41, P279, DOI 10.1016/0169-328X(96)00108-8; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Ratzka A, 2012, CELL TRANSPLANT, V21, P749, DOI 10.3727/096368911X586774; Ratzka A, 2012, J NEUROCHEM, V122, P94, DOI 10.1111/j.1471-4159.2012.07768.x; Ratzka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023564; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; SaucedoCardenas O, 1996, J MOL NEUROSCI, V7, P51, DOI 10.1007/BF02736848; Silvagno F, 2002, FEBS LETT, V532, P153, DOI 10.1016/S0014-5793(02)03667-0; Smidt MP, 2009, ADV EXP MED BIOL, V651, P47; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak M. K., 2011, STEM CELLS MECH TECH, P87; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak MK, 1996, MOL BIOL CELL, V7, P1299, DOI 10.1091/mbc.7.8.1299; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Timmer M, 2006, NEUROBIOL DIS, V21, P587, DOI 10.1016/j.nbd.2005.09.003; Timmer M, 2007, J NEUROSCI, V27, P459, DOI 10.1523/JNEUROSCI.4493-06.2007; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; WANAKA A, 1991, DEVELOPMENT, V111, P455; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	61	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19827	19840		10.1074/jbc.M112.347831	http://dx.doi.org/10.1074/jbc.M112.347831			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22514272	Green Published, hybrid			2022-12-28	WOS:000306414500006
J	Okroj, M; Holmquist, E; Sjolander, J; Corrales, L; Saxne, T; Wisniewski, HG; Blom, AM				Okroj, Marcin; Holmquist, Emelie; Sjolander, Jonatan; Corrales, Leticia; Saxne, Tore; Wisniewski, Hans-Georg; Blom, Anna M.			Heavy Chains of Inter Alpha Inhibitor (I alpha I) Inhibit the Human Complement System at Early Stages of the Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPSIN-INHIBITOR; C4B-BINDING PROTEIN; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; NEONATAL SEPSIS; SYNOVIAL-FLUID; FACTOR-H; ACTIVATION; BIKUNIN; PLASMA	Inter alpha inhibitor (I alpha I) is an abundant serum protein consisting of three polypeptides: two heavy chains (HC1 and HC2) and bikunin, a broad-specificity Kunitz-type proteinase inhibitor. The complex is covalently held together by chondroitin sulfate but during inflammation I alpha I may interact with TNF-stimulated gene 6 protein (TSG-6), which supports transesterification of heavy chains to hyaluronan. Recently, I alpha I was shown to inhibit mouse complement in vivo and to protect from complement-mediated lung injury but the mechanism of such activity was not elucidated. Using human serum depleted from I alpha I, we found that I alpha I is not an essential human complement inhibitor as was reported for mice and that such serum has unaltered hemolytic activity. However, purified human I alpha I inhibited classical, lectin and alternative complement pathways in vitro when added in excess to human serum. The inhibitory activity was dependent on heavy chains but not bikunin and detected at the level of initiating molecules (MBL, properdin) in the lectin/alternative pathways or C4b in the classical pathway. Furthermore, I alpha I affected formation and assembly of the C1 complex and prevented assembly of the classical pathway C3-convertase. Presence and putative interactions with TSG-6 did not affect the ability of I alpha I to inhibit complement thus implicating I alpha I as a potentially important complement inhibitor once enriched onto hyaluronan moieties in the course of local inflammatory processes. In support of this, we found a correlation between I alpha I/HC-containing proteins and hemolytic activity of synovial fluid from patients suffering from rheumatoid arthritis.	[Okroj, Marcin; Holmquist, Emelie; Sjolander, Jonatan; Blom, Anna M.] Lund Univ, Dept Lab Med, S-20502 Malmo, Sweden; [Corrales, Leticia] Ctr Appl Med Res CIMA, Div Oncol, Pamplona 31008, Spain; [Saxne, Tore] Lund Univ, Dept Clin Sci, Rheumatol Sect, S-21185 Lund, Sweden; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Lund University; University of Navarra; Lund University; New York University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734	Cancerfonden, Swedish Research Council [K2009-68X-14928-06-3, K2010-80X-21514-01-4]; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; UTE-project CIMA; Spanish Ministry of Education [AP2006-02403]; University Hospital in Malmo; Region Skane	Cancerfonden, Swedish Research Council(Swedish Research Council); Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; UTE-project CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish Ministry of Education(Spanish Government); University Hospital in Malmo; Region Skane	This work was supported by Cancerfonden, Swedish Research Council (K2009-68X-14928-06-3 and K2010-80X-21514-01-4) and the Foundations of Osterlund, Greta and Johan Kock, Thelma Zoega, Tore Nilsson, King Gustav V's 80th anniversary, Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg, UTE-project CIMA, Spanish Ministry of Education (AP2006-02403) as well as grants for clinical research from the University Hospital in Malmo and the Region Skane.	BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Chaaban H, 2009, J PEDIATR-US, V154, P620, DOI 10.1016/j.jpeds.2008.10.008; CHEN L, 1994, J BIOL CHEM, V269, P28282; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Ebanks RO, 1996, MOL IMMUNOL, V33, P297, DOI 10.1016/0161-5890(95)00135-2; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; HUTADILOK N, 1988, ANN RHEUM DIS, V47, P377, DOI 10.1136/ard.47.5.377; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kida D, 1999, J RHEUMATOL, V26, P1230; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mateos J., 2012, J PROTEOMIC IN PRESS; Michlmayr A, 2010, BRIT J CANCER, V103, P1201, DOI 10.1038/sj.bjc.6605909; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Okroj M, 2009, J BIOL CHEM, V284, P505, DOI 10.1074/jbc.M806669200; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; POTEMPA J, 1989, J BIOL CHEM, V264, P15109; PROKSCH GJ, 1973, CLIN BIOCHEM, V6, P200, DOI 10.1016/S0009-9120(73)80027-X; Sanggaard K. W., BIOCH BIOPHYS ACTA, V1804, P1011; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Singh K, 2010, PEDIATR RES, V68, P242, DOI 10.1203/00006450-201011001-00474; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; SLOTA A, 1994, BIOL CHEM H-S, V375, P127; TENNER AJ, 1981, J IMMUNOL, V127, P648; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yang L, 2005, BJU INT, V96, P647, DOI 10.1111/j.1464-410X.2005.05700.x; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; ZICCARDI RJ, 1984, J BIOL CHEM, V259, P3674	41	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20100	20110		10.1074/jbc.M111.324913	http://dx.doi.org/10.1074/jbc.M111.324913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528482	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000306414500031
J	Rock, K; Meusch, M; Fuchs, N; Tigges, J; Zipper, P; Fritsche, E; Krutmann, J; Homey, B; Reifenberger, J; Fischer, JW				Roeck, Katharina; Meusch, Michael; Fuchs, Nikola; Tigges, Julia; Zipper, Petra; Fritsche, Ellen; Krutmann, Jean; Homey, Bernhard; Reifenberger, Julia; Fischer, Jens W.			Estradiol Protects Dermal Hyaluronan/Versican Matrix during Photoaging by Release of Epidermal Growth Factor from Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE REPLACEMENT THERAPY; SMOOTH-MUSCLE-CELLS; HYALURONIC-ACID; ESTROGEN-RECEPTOR; HUMAN SKIN; ACTIVATES HYALURONAN; POSTMENOPAUSAL WOMEN; PROLIFERATION; VERSICAN; FIBROBLASTS	Hyaluronan (HA) and versican are key components of the dermis and are responsive to ultraviolet (UV) B-induced remodeling. The aim of this study was to explore the molecular mechanisms mediating the effects of estrogen (E-2) on HA-rich extracellular matrix during photoaging. Hairless skh-1 mice were irradiated with UVB (three times, 1 minimal erythema dose (80 mJ/cm(2)), weekly) for 10 weeks, and endogenous sex hormone production was abrogated by ovariectomy. Subcutaneous substitution of E-2 by means of controlled-release pellets caused a strong increase in the dermal HA content in both irradiated and nonirradiated skin. The increase in dermal HA correlated with induction of HA synthase HAS3 by E-2. Expression of splice variant 2 of the HA-binding proteoglycan versican was also increased by E-2. In search of candidate mediators of these effects, it was found that E-2 strongly induced the expression of epidermal growth factor (EGF) in UVB-irradiated epidermis in vivo and in keratinocytes in vitro. EGF in turn up-regulated the expression of HAS3 and versican V2 in dermal fibroblasts. HAS3 knockdown by shRNA caused inhibition of fibroblast proliferation. Furthermore, HAS3 and versican V2 induction by E-2 correlated positively with proliferation in vivo. In addition, the accumulation of inflammatory macrophages, expression of inducible cyclooxygenase 2, as well as proinflammatory monocyte chemotactic protein 1 were decreased in response to E-2 in the dermis. Collectively, these data suggest that E-2 treatment increases the amount of dermal HA and versican V2 via paracrine release of EGF, which may be implicated in the pro-proliferative and anti-inflammatory effects of E-2 during photoaging.	[Roeck, Katharina; Meusch, Michael; Fuchs, Nikola; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Tigges, Julia; Fritsche, Ellen; Krutmann, Jean] Univ Dusseldorf, IUF Leibniz Inst Environm Med, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Zipper, Petra; Homey, Bernhard; Reifenberger, Julia] Univ Dusseldorf, Dept Dermatol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de	Reifenberger, Guido/AAE-3599-2019	Tigges, Julia/0000-0002-0847-9939	Deutsche Forschungsgemeinschaft [SFB 728, TP C6, TP C1, TP C4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 728, TP C6, C1, and C4.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; BENTLEY JP, 1986, J INVEST DERMATOL, V87, P668, DOI 10.1111/1523-1747.ep12456427; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; CASTELOBRANCO C, 1992, MATURITAS, V15, P113, DOI 10.1016/0378-5122(92)90245-Y; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Gehm BD, 2000, MOL CELL ENDOCRINOL, V159, P53, DOI 10.1016/S0303-7207(99)00195-1; GHERSETICH I, 1994, INT J DERMATOL, V33, P119, DOI 10.1111/j.1365-4362.1994.tb01540.x; GROSMAN N, 1971, ACTA PHARMACOL TOX, V30, P458; Haczynski J, 2002, INT J MOL MED, V10, P149; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kanda N, 2005, J DERMATOL SCI, V38, P1, DOI 10.1016/j.jdermsci.2004.10.011; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Knott A, 2009, BIOGERONTOLOGY, V10, P181, DOI 10.1007/s10522-008-9165-3; Koshiishi I, 1999, BBA-GEN SUBJECTS, V1428, P327, DOI 10.1016/S0304-4165(99)00081-1; NELSON KG, 1991, P NATL ACAD SCI USA, V88, P21, DOI 10.1073/pnas.88.1.21; Oppermann M, 2011, BASIC RES CARDIOL, V106, P539, DOI 10.1007/s00395-011-0160-5; Papakonstantinou E, 1998, ATHEROSCLEROSIS, V138, P79, DOI 10.1016/S0021-9150(98)00006-9; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; REENSTRA WR, 1993, EXP CELL RES, V209, P118, DOI 10.1006/excr.1993.1291; Sator PG, 2007, CLIMACTERIC, V10, P320, DOI 10.1080/13697130701444073; Sator PG, 2001, MATURITAS, V39, P43, DOI 10.1016/S0378-5122(00)00225-5; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; SOBEL H, 1970, STEROIDS, V16, P1, DOI 10.1016/S0039-128X(70)80090-3; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Takahashi Y, 1996, J DERMATOL SCI, V11, P129, DOI 10.1016/0923-1811(95)00430-0; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; UZUKA M, 1981, BIOCHIM BIOPHYS ACTA, V673, P387, DOI 10.1016/0304-4165(81)90470-0; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Verdier-Sevain S, 2004, FASEB J, V18, P1252, DOI 10.1096/fj.03-1088fje; Verdier-Sevrain S, 2006, EXP DERMATOL, V15, P83, DOI 10.1111/j.1600-0625.2005.00377.x; Vickers MR, 2007, BMJ-BRIT MED J, V335, P239, DOI 10.1136/bmj.39266.425069.AD; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; YONEDA M, 1988, J CELL SCI, V90, P265; Zhang B, 2001, GENE THER, V8, P1745, DOI 10.1038/sj.gt.3301587	55	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20056	20069		10.1074/jbc.M112.353151	http://dx.doi.org/10.1074/jbc.M112.353151			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493503	Green Published, hybrid			2022-12-28	WOS:000306414500027
J	van Roermund, CWT; Ijlst, L; Majczak, W; Waterham, HR; Folkerts, H; Wanders, RJA; Hellingwerf, KJ				van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.; Hellingwerf, Klaas J.			Peroxisomal Fatty Acid Uptake Mechanism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; ACYL-COA SYNTHETASE; X-LINKED ADRENOLEUKODYSTROPHY; BETA-OXIDATION; ABC TRANSPORTERS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; COENZYME-A; PROTEIN; METABOLISM	Peroxisomes play a major role in human cellular lipid metabolism, including fatty acid beta-oxidation. The most frequent peroxisomal disorder is X-linked adrenoleukodystrophy, which is caused by mutations in ABCD1. The biochemical hallmark of X-linked adrenoleukodystrophy is the accumulation of very long chain fatty acids (VLCFAs) due to impaired peroxisomal beta-oxidation. Although this suggests a role of ABCD1 in VLCFA import into peroxisomes, no direct experimental evidence is available to substantiate this. To unravel the mechanism of peroxisomal VLCFA transport, we use Saccharomyces cerevisiae as a model organism. Here we provide evidence that in this organism very long chain acyl-CoA esters are hydrolyzed by the Pxa1p-Pxa2p complex prior to the actual transport of their fatty acid moiety into the peroxisomes with the CoA presumably being released into the cytoplasm. The Pxa1p-Pxa2p complex functionally interacts with the acyl-CoA synthetases Faa2p and/or Fat1p on the inner surface of the peroxisomal membrane for subsequent re-esterification of the VLCFAs. Importantly, the Pxa1p-Pxa2p complex shares this molecular mechanism with HsABCD1 and HsABCD2.	[van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Ijlst, Lodewijk; Majczak, Wiktor; Waterham, Hans R.; Folkerts, Hendrik; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Hellingwerf, Klaas J.] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	van Roermund, CWT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, Rm F0-226,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.vanroermund@amc.uva.nl			Europeon Leukodystrophies Association (ELA) Foundation [091564]	Europeon Leukodystrophies Association (ELA) Foundation	This work was supported by the Europeon Leukodystrophies Association (ELA) Foundation Research Grant 091564.	Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; Igoillo-Esteve M, 2011, INT J PARASITOL, V41, P429, DOI 10.1016/j.ijpara.2010.11.002; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Lolkema JS, 1998, CURR OPIN MICROBIOL, V1, P248, DOI 10.1016/S1369-5274(98)80018-0; Nyathi Y, 2010, J BIOL CHEM, V285, P29892, DOI 10.1074/jbc.M110.151225; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinberg SJ, 1999, ANN NEUROL, V46, P409, DOI 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Watkins PA, 2000, CELL BIOCHEM BIOPHYS, V32, P333, DOI 10.1385/CBB:32:1-3:333; Wieser T, 2003, NEUROLOGY, V60, P1351, DOI 10.1212/01.WNL.0000055901.58642.48; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	42	62	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20144	20153		10.1074/jbc.M111.332833	http://dx.doi.org/10.1074/jbc.M111.332833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493507	Green Published, hybrid			2022-12-28	WOS:000306414500035
J	Bultema, JJ; Ambrosio, AL; Burek, CL; Di Pietro, SM				Bultema, Jarred J.; Ambrosio, Andrea L.; Burek, Carolyn L.; Di Pietro, Santiago M.			BLOC-2, AP-3, and AP-1 Proteins Function in Concert with Rab38 and Rab32 Proteins to Mediate Protein Trafficking to Lysosome-related Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; MEMBRANE-PROTEINS; PUDIAK-SYNDROME; EARLY ENDOSOMES; SYNDROME GENES; MELANOSOMES; BIOGENESIS; ADAPTER; COMPLEX; TYROSINASE	Lysosome-related organelles (LROs) are synthesized in specialized cell types where they largely coexist with conventional lysosomes. Most of the known cellular transport machinery involved in biogenesis are ubiquitously expressed and shared between lysosomes and LROs. Examples of common components are the adaptor protein complex-3 (AP-3) and biogenesis of lysosome-related organelle complex (BLOC)-2. These protein complexes control sorting and transport of newly synthesized integral membrane proteins from early endosomes to both lysosomes and LROs such as the melanosome. However, it is unknown what factors cooperate with the ubiquitous transport machinery to mediate transport to LROs in specialized cells. Focusing on the melanosome, we show that the ubiquitous machinery interacts with cell type-specific Rab proteins, Rab38 and Rab32, to facilitate transport to the maturing organelle. BLOC-2, AP-3, and AP-1 coimmunoprecipitated with Rab38 and Rab32 from MNT-1 melanocytic cell extracts. BLOC-2, AP-3, AP-1, and clathrin partially colocalized with Rab38 and Rab32 by confocal immunofluorescence microscopy in MNT-1 cells. Rab38- and Rab32-deficient MNT-1 cells displayed abnormal trafficking and steady state levels of known cargoes of the BLOC-2, AP-3, and AP-1 pathways, the melanin-synthesizing enzymes tyrosinase and tyrosinase-related protein-1. These observations support the idea that Rab38 and Rab32 are the specific factors that direct the ubiquitous machinery to mediate transport from early endosomes to maturing LROs. Additionally, analysis of tyrosinase-related protein-2 and total melanin production indicates that Rab32 has unique functions that cannot be carried out by Rab38 in melanosome biogenesis.	[Bultema, Jarred J.; Ambrosio, Andrea L.; Burek, Carolyn L.; Di Pietro, Santiago M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Di Pietro, SM (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	santiago.dipietro@colostate.edu	di pietro, santiago/AAR-6899-2020		Microscope Imaging Network core infrastructure from Colorado State University; National Institutes of Health [1R01HL106186-01A1]; American Heart Association [09SDG2280525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106186] Funding Source: NIH RePORTER	Microscope Imaging Network core infrastructure from Colorado State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Andrew A. Peden, Esteban C. Dell'Angelica, and Peter K. Kim for their generous gifts of reagents and Vincent J. Hearing for guidance with the Nucleofector system for MNT-1 transfection. Microscopes used in this work are supported in part by the Microscope Imaging Network core infrastructure grant from Colorado State University.; This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HL106186-01A1 (to S. D. P.). This work was also supported by American Heart Association Award 09SDG2280525.	Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brooks BP, 2007, INVEST OPHTH VIS SCI, V48, P3905, DOI 10.1167/iovs.06-1464; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Gautam R, 2004, J BIOL CHEM, V279, P12935, DOI 10.1074/jbc.M311311200; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Helip-Wooley A, 2007, J INVEST DERMATOL, V127, P1471, DOI 10.1038/sj.jid.5700737; Huizing M, 2009, J MED GENET, V46, P803, DOI 10.1136/jmg.2008.065961; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Kobayashi T, 2007, J CELL SCI, V120, P4261, DOI 10.1242/jcs.017913; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Marks MS, 2006, J CELL BIOL, V175, P199, DOI 10.1083/jcb.200608058; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Nazarian R, 2008, MOL GENET METAB, V93, P134, DOI 10.1016/j.ymgme.2007.09.001; Ninkovic I, 2008, J THROMB HAEMOST, V6, P2143, DOI 10.1111/j.1538-7836.2008.03178.x; Oiso N, 2004, MAMM GENOME, V15, P307, DOI 10.1007/s00335-004-2337-9; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Spritz RA, 2003, CURR OPIN GENET DEV, V13, P284, DOI 10.1016/S0959-437X(03)00059-5; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	54	84	85	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19550	19563		10.1074/jbc.M112.351908	http://dx.doi.org/10.1074/jbc.M112.351908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511774	Green Published, hybrid			2022-12-28	WOS:000306411900067
J	Chan, SC; Li, YM; Dehm, SM				Chan, Siu Chiu; Li, Yingming; Dehm, Scott M.			Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-RECEPTORS; STRUCTURAL BASIS; DNA-BINDING; IN-VIVO; RESISTANT; DOMAIN; TRANSACTIVATION; IDENTIFICATION; ABIRATERONE; EXPRESSION	Synthesis of truncated androgen receptor (AR) splice variants has emerged as an important mechanism of prostate cancer (PCa) resistance to AR-targeted therapy and progression to a lethal castration-resistant phenotype. However, the precise role of these factors at this stage of the disease is not clear due to loss of multiple COOH-terminal AR protein domains, including the canonical nuclear localization signal (NLS) in the AR hinge region. Despite loss of this NLS, we show that diverse truncated AR variant species have a basal level of nuclear localization sufficient for ligand-independent transcriptional activity. Whereas full-length AR requires Hsp90 and importin-beta for active nuclear translocation, basal nuclear localization of truncated AR variants is independent of these classical signals. For a subset of truncated AR variants, this basal level of nuclear import can be augmented by unique COOH-terminal sequences that reconstitute classical AR NLS activity. However, this property is separable from ligand-independent transcriptional activity. Therefore, the AR splice variant core consisting of the AR NH2-terminal domain and DNA binding domain is sufficient for nuclear localization and androgen-independent transcriptional activation of endogenous AR target genes. Indeed, we show that truncated AR variants with nuclear as well as nuclear/cytoplasmic localization patterns can drive androgen-independent growth of PCa cells. Together, our data demonstrate that diverse truncated AR species with varying efficiencies of nuclear localization can contribute to castration-resistant PCa pathology by driving persistent ligand-independent AR transcriptional activity.	[Chan, Siu Chiu; Li, Yingming; Dehm, Scott M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dehm, SM (corresponding author), Univ Minnesota, Masonic Canc Ctr, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	dehm@umn.edu			National Institutes of Health (NCI) [CA141011]; Prostate Cancer Foundation; American Cancer Society [RSG-12-031-01]; Department of Defense [PC094384]; NATIONAL CANCER INSTITUTE [R21CA141011] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA141011 (NCI; to S. M. D.). This work was also supported by a Prostate Cancer Foundation Young Investigator Award (to S. M. D.), an American Cancer Society Research Scholar Grant (RSG-12-031-01 (to S. M. D.), and a Department of Defense Prostate Cancer Research Program New Investigator Award (PC094384 (to S. M. D.)).	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Black BE, 2004, TRENDS ENDOCRIN MET, V15, P411, DOI 10.1016/j.tem.2004.09.006; BONNEKOH B, 1989, ARCH DERMATOL RES, V281, P487, DOI 10.1007/BF00510085; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Callewaert L, 2006, CANCER RES, V66, P543, DOI 10.1158/0008-5472.CAN-05-2389; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; DELAUNOIT Y, 1991, CANCER RES, V51, P5165; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Hofman K, 2001, BIOCHEM BIOPH RES CO, V283, P97, DOI 10.1006/bbrc.2001.4738; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2012, ONCOGENE IN PRESS; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	46	169	173	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19736	19749		10.1074/jbc.M112.352930	http://dx.doi.org/10.1074/jbc.M112.352930			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22532567	Green Published, hybrid			2022-12-28	WOS:000306411900083
J	Hanna, RA; Quinsay, MN; Orogo, AM; Giang, K; Rikka, S; Gustafsson, AB				Hanna, Rita A.; Quinsay, Melissa N.; Orogo, Amabel M.; Giang, Kayla; Rikka, Shivaji; Gustafsson, Asa B.			Microtubule-associated Protein 1 Light Chain 3 (LC3) Interacts with Bnip3 Protein to Selectively Remove Endoplasmic Reticulum and Mitochondria via Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; TRANSMEMBRANE DOMAIN; UP-REGULATION; DEGRADATION; EXPRESSION; APOPTOSIS; GABARAP; BINDS; CA2+; NIX	Autophagy plays an important role in cellular quality control and is responsible for removing protein aggregates and dysfunctional organelles. Bnip3 is an atypical BH3-only protein that is known to cause mitochondrial dysfunction and cell death. Interestingly, Bnip3 can also protect against cell death by inducing mitochondrial autophagy. The mechanism for this process, however, remains poorly understood. Bnip3 contains a C-terminal transmembrane domain that is essential for homodimerization and proapoptotic function. In this study, we show that homodimerization of Bnip3 is also a requirement for induction of autophagy. Several Bnip3 mutants that do not interfere with its mitochondrial localization but disrupt homodimerization failed to induce autophagy in cells. In addition, we discovered that endogenous Bnip3 is localized to both mitochondria and the endoplasmic reticulum (ER). To investigate the effects of Bnip3 at mitochondria or the ER on autophagy, Bnip3 was targeted specifically to each organelle by substituting the Bnip3 transmembrane domain with that of Acta or cytochrome b(5). We found that Bnip3 enhanced autophagy in cells from both sites. We also discovered that Bnip3 induced removal of both ER (ERphagy) and mitochondria (mitophagy) via autophagy. The clearance of these organelles was mediated in part via binding of Bnip3 to LC3 on the autophagosome. Although ablation of the Bnip3-LC3 interaction by mutating the LC3 binding site did not impair the prodeath activity of Bnip3, it significantly reduced both mitophagy and ERphagy. Our data indicate that Bnip3 regulates the apoptotic balance as an autophagy receptor that induces removal of both mitochondria and ER.	[Hanna, Rita A.; Quinsay, Melissa N.; Orogo, Amabel M.; Giang, Kayla; Rikka, Shivaji; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asag@ucsd.edu			National Institutes of Health [R01HL087023, R01HL101217]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087023, R01HL101217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL087023 and R01HL101217. This work was also supported by a scientist development grant from the American Heart Association.	Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Jian BX, 2011, MOL MED, V17, P542, DOI 10.2119/molmed.2010.00195; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ma XC, 2012, AUTOPHAGY, V8, P297, DOI 10.4161/auto.18658; Monastyrska Iryna, 2006, Molecular Aspects of Medicine, V27, P483, DOI 10.1016/j.mam.2006.08.004; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang L, 2009, FASEB J, V23, P3405, DOI 10.1096/fj.08-124354; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129	46	452	483	5	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19094	19104		10.1074/jbc.M111.322933	http://dx.doi.org/10.1074/jbc.M111.322933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505714	Green Published, hybrid			2022-12-28	WOS:000306411900020
J	Johnson, MA; Cartmell, J; Weisser, NE; Woods, RJ; Bundle, DR				Johnson, Margaret A.; Cartmell, Jonathan; Weisser, Nina E.; Woods, Robert J.; Bundle, David R.			Molecular Recognition of Candida albicans (1 -> 2)-beta-Mannan Oligosaccharides by a Protective Monoclonal Antibody Reveals the Immunodominance of Internal Saccharide Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIH-B-792 STRAIN; NMR-SPECTROSCOPY; LIGAND-BINDING; COMBINING SITE; FORCE-FIELD; PHOSPHOMANNAN; DIFFERENCE; MANNAN; SEROTYPE; CELLS	A self-consistent model of beta-mannan oligosaccharides bound to a monoclonal antibody, C3.1, that protects mice against Candida albicans has been developed through chemical mapping, NMR spectroscopic, and computational studies. This antibody optimally binds di- and trisaccharide epitopes, whereas larger oligomers bind with affinities that markedly decrease with increasing chain length. The (1 -> 2)-beta-linked di-, tri-, and tetra-mannosides bind in helical conformations similar to the solution global minimum. Antibody recognition of the di- and trisaccharide is primarily dependent on the mannose unit at the reducing end, with the hydrophobic face of this sugar being tightly bound. Recognition of a tetrasaccharide involves a frameshift in the ligand interaction, shown by strong binding of the sugar adjacent to the reducing end. We show that frameshifting may also be deliberately induced by chemical modifications. Molecular recognition patterns similar to that of mAb C3.1, determined by saturation transfer difference-NMR, were also observed in polyclonal sera from rabbits immunized with a trisaccharide glycoconjugate. The latter observation points to the importance of internal residues as immunodominant epitopes in (1 -> 2)-beta-mannans and to the viability of a glycoconjugate vaccine composed of a minimal length oligosaccharide hapten.	[Johnson, Margaret A.; Cartmell, Jonathan; Bundle, David R.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Weisser, Nina E.; Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Alberta; Ollscoil na Gaillimhe-University of Galway; University System of Georgia; University of Georgia	Johnson, MA (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	maggie.johnson@ualberta.ca	Cartmell, Jonathan/GPS-4523-2022; Woods, Robert/F-4962-2015	Weisser, Nina/0000-0002-9903-2429; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [GM094919, RR005351]; Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada; Science Foundation of Ireland [08/IN.1/B2070]; European Union; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science Foundation of Ireland(Science Foundation Ireland); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094919 and RR005351 (to R. J. W. and N. E. W.). This work was also supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada, the Science Foundation of Ireland (08/IN.1/B2070), and the European Union (European Regional Development Fund). D. R. B. is a co-founder and shareholder in a company attempting to advance a vaccine against C. albicans.	Bundle D. R., 2008, ACS SYM SER, V989, P163; Bundle D. R., 2012, ANTICARBOHYDRATE ANT, P121; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; BUNDLE DR, 1999, BIOORGANIC CHEM CARB, P370; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Costello C., 2012, CARBOHYDR R IN PRESS; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fidel Paul L Jr, 2011, Curr Infect Dis Rep, V13, P102, DOI 10.1007/s11908-010-0143-y; Han Y, 1999, J INFECT DIS, V179, P1477, DOI 10.1086/314779; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HAN YM, 1995, INFECT IMMUN, V63, P2714, DOI 10.1128/IAI.63.7.2714-2719.1995; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Haselhorst T, 1999, BIOCHEMISTRY-US, V38, P6449, DOI 10.1021/bi982984z; HEIDELBERGER MICHAEL, 1960, FORSCHR CHEM ORG NATURSTOFFE, V18, P503; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JANN K, 1975, ANTIGENS, V3, P1; Jennings H., 2012, ANTICARBOHYDRATE ANT, P55; KABAT EA, 1960, J IMMUNOL, V84, P82; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOBAYASHI H, 1989, ARCH BIOCHEM BIOPHYS, V272, P364, DOI 10.1016/0003-9861(89)90230-0; KOBAYASHI H, 1990, ARCH BIOCHEM BIOPHYS, V278, P195, DOI 10.1016/0003-9861(90)90248-W; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacCallum D.M., 2010, PATHOGENIC YEASTS YE, P41, DOI [10.1007/978-3-642-03150-2_3, DOI 10.1007/978-3-642-03150-2_3]; MARTIN ACR, 1989, P NATL ACAD SCI USA, V86, P9268, DOI 10.1073/pnas.86.23.9268; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; NEWMAN BA, 1985, J IMMUNOL, V135, P1220; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Nitz M, 2001, J ORG CHEM, V66, P8411, DOI 10.1021/jo010570x; Nycholat C., 2008, THESIS U ALBERTA; Nycholat CM, 2009, CARBOHYD RES, V344, P1397, DOI 10.1016/j.carres.2009.07.008; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Plum M, 2011, J BIOL CHEM, V286, P43103, DOI 10.1074/jbc.M111.291823; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; SHIBATA N, 1991, ARCH BIOCHEM BIOPHYS, V290, P535, DOI 10.1016/0003-9861(91)90578-7; SHIBATA N, 1986, ARCH BIOCHEM BIOPHYS, V251, P697, DOI 10.1016/0003-9861(86)90379-6; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Stronati M, 2006, Minerva Pediatr, V58, P537; Szabo EK, 2011, FEMS MICROBIOL LETT, V320, P1, DOI 10.1111/j.1574-6968.2011.02262.x; TOJO M, 1990, CARBOHYD RES, V199, P215, DOI 10.1016/0008-6215(90)84263-T; Toscano, 1999, Curr Infect Dis Rep, V1, P347, DOI 10.1007/s11908-999-0041-3; Trinel PA, 1997, FEBS LETT, V416, P203, DOI 10.1016/S0014-5793(97)01205-2; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vincent SJF, 1996, J BIOMOL NMR, V7, P169; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wu XY, 2007, ORG BIOMOL CHEM, V5, P3477, DOI 10.1039/b709912f; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Zhang AY, 2007, DERMATOL CLIN, V25, P165, DOI 10.1016/j.det.2007.01.002	52	34	34	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18078	18090		10.1074/jbc.M112.355578	http://dx.doi.org/10.1074/jbc.M112.355578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493450	hybrid, Green Published			2022-12-28	WOS:000306411600017
J	Ryan, KE; Chiang, C				Ryan, Kaitlyn E.; Chiang, Chin			Hedgehog Secretion and Signal Transduction in Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-A; HUMAN SONIC HEDGEHOG; LONG-RANGE; CHOLESTEROL MODIFICATION; PRIMARY CILIUM; UBIQUITIN LIGASE; BETA-TRCP; ANIMAL DEVELOPMENT; GLI PROTEINS; NEURAL-TUBE	Signaling by the Hedgehog (Hh) family of secreted proteins is essential for proper embryonic patterning and development. Dysregulation of Hh signaling is associated with a variety of human diseases ranging from developmental disorders such as holoprosencephaly to certain forms of cancer, including medulloblastoma and basal cell carcinoma. Genetic studies in flies and mice have shaped our understanding of Hh signaling and revealed that nearly all core components of the pathway are highly conserved. Although many aspects of the Drosophila Hh pathway are conserved in vertebrates, mechanistic differences between the two species have begun to emerge. Perhaps the most striking divergence in vertebrate Hh signaling is its dependence on the primary cilium, a vestigial organelle that is largely absent in flies. This minireview will provide an overview of Hh signaling and present recent insights into vertebrate Hh secretion, receptor binding, and signal transduction.	[Ryan, Kaitlyn E.; Chiang, Chin] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Chiang, C (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	chin.chiang@vanderbilt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042205] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042205] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Callejo A, 2011, P NATL ACAD SCI USA, V108, P12591, DOI 10.1073/pnas.1106881108; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chen YB, 2010, GENE DEV, V24, P2054, DOI 10.1101/gad.1948710; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Day ES, 1999, BIOCHEMISTRY-US, V38, P14868, DOI 10.1021/bi9910068; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guerrero I, 2007, TRENDS CELL BIOL, V17, P1, DOI 10.1016/j.tcb.2006.11.002; Huang X, 2007, DEVELOPMENT, V134, P2095, DOI 10.1242/dev.000729; Huang YZ, 2002, J BIOL CHEM, V277, P19889, DOI 10.1074/jbc.M111412200; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Molnar C, 2007, P NATL ACAD SCI USA, V104, P7963, DOI 10.1073/pnas.0702374104; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schrader EK, 2011, J BIOL CHEM, V286, P39051, DOI 10.1074/jbc.M111.274993; Shi Q, 2011, DEVELOPMENT, V138, P4219, DOI 10.1242/dev.067959; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tokhunts R, 2010, J BIOL CHEM, V285, P2562, DOI 10.1074/jbc.M109.078626; Traiffort E, 2004, J BIOL CHEM, V279, P42889, DOI 10.1074/jbc.M405161200; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Yavan A, 2010, DEV CELL, V19, P54, DOI 10.1016/j.devcel.2010.06.007; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	99	90	98	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17905	17913		10.1074/jbc.R112.356006	http://dx.doi.org/10.1074/jbc.R112.356006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474285	Green Published, hybrid			2022-12-28	WOS:000306411600001
J	Tejero, J; Basu, S; Helms, C; Hogg, N; King, SB; Kim-Shapiro, DB; Gladwin, MT				Tejero, Jesus; Basu, Swati; Helms, Christine; Hogg, Neil; King, S. Bruce; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Low NO Concentration Dependence of Reductive Nitrosylation Reaction of Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMER-DIMER EQUILIBRIUM; OXIDE SYNTHASE ACTIVITY; NITRIC-OXIDE; INOSITOL HEXAPHOSPHATE; SUBUNIT DISSOCIATION; BETA-CHAINS; DEOXYHEMOGLOBIN; KINETICS; BINDING; OXIDATION	The reductive nitrosylation of ferric (met) hemoglobin is of considerable interest and remains incompletely explained. We have previously observed that at low NO concentrations the reaction with tetrameric hemoglobin occurs with an observed rate constant that is at least 5 times faster than that observed at higher concentrations. This was ascribed to a faster reaction of NO with a methemoglobin-nitrite complex. We now report detailed studies of this reaction of low NO with methemoglobin. Nitric oxide paradoxically reacts with ferric hemoglobin with faster observed rate constants at the lower NO concentration in a manner that is not affected by changes in nitrite concentration, suggesting that it is not a competition between NO and nitrite, as we previously hypothesized. By evaluation of the fast reaction in the presence of allosteric effectors and isolated beta- and alpha-chains of hemoglobin, it appears that NO reacts with a subpopulation of beta-subunit ferric hemes whose population is influenced by quaternary state, redox potential, and hemoglobin dimerization. To further characterize the role of nitrite, we developed a system that oxidizes nitrite to nitrate to eliminate nitrite contamination. Removal of nitrite does not alter reaction kinetics, but modulates reaction products, with a decrease in the formation of S-nitrosothiols. These results are consistent with the formation of NO2/N2O3 in the presence of nitrite. The observed fast reductive nitrosylation observed at low NO concentrations may function to preserve NO bioactivity via primary oxidation of NO to form nitrite or in the presence of nitrite to form N2O3 and S-nitrosothiols.	[Basu, Swati; Helms, Christine; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Tejero, Jesus; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hogg, Neil] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Gladwin, Mark T.] Univ Pittsburgh, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	shapiro@wfu.edu; gladwinmt@upmc.edu	Kim-Shapiro, Daniel/HGA-2682-2022; Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978	National Institutes of Health [HL058091, HL098032, HL096973, DK085852]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098032, R37HL058091, R01HL058091, R29HL058091, R01HL096973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091, HL098032, HL096973, and DK085852, and the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P110; Ascenzi P, 2007, FEBS J, V274, P551, DOI 10.1111/j.1742-4658.2006.05609.x; Ascenzi P, 2010, FEBS J, V277, P2474, DOI 10.1111/j.1742-4658.2010.07662.x; Ascenzi P, 2010, BIOCHEM BIOPH RES CO, V393, P196, DOI 10.1016/j.bbrc.2010.01.092; Basu S, 2008, METHOD ENZYMOL, V440, P137, DOI 10.1016/S0076-6879(07)00808-7; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; CHANCE B, 1952, J BIOL CHEM, V194, P471; CHIEN JCW, 1969, J AM CHEM SOC, V91, P2166, DOI 10.1021/ja01036a085; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Daff S, 2004, BIOCHEMISTRY-US, V43, P3929, DOI 10.1021/bi0360408; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; GERACI G, 1969, J BIOL CHEM, V244, P4664; GIBSON QH, 1970, BIOCHEM BIOPH RES CO, V41, P415, DOI 10.1016/0006-291X(70)90520-6; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; GRAY RD, 1974, J BIOL CHEM, V249, P2879; GRAY RD, 1980, J BIOL CHEM, V255, P1812; GRAY RD, 1971, J BIOL CHEM, V246, P7168; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; HENSLEY P, 1975, J BIOL CHEM, V250, P9391; Herold S, 2003, J BIOL CHEM, V278, P6623, DOI 10.1074/jbc.M210275200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IMAI K, 1977, BIOCHIM BIOPHYS ACTA, V490, P164, DOI 10.1016/0005-2795(77)90116-7; KEILIN D, 1958, BIOCHIM BIOPHYS ACTA, V29, P302, DOI 10.1016/0006-3002(58)90189-6; Keilin D., 1937, NATURE, V139, P548; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Lancaster JR, 2004, AM J PHYSIOL-LUNG C, V287, pL465, DOI 10.1152/ajplung.00151.2004; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lancaster JR, 1996, METHOD ENZYMOL, V268, P31; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; OLSON JS, 1976, J BIOL CHEM, V251, P441; OLSON JS, 1976, J BIOL CHEM, V251, P447; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; PHILO JS, 1988, J BIOL CHEM, V263, P682; Rifkind JM, 2011, NITRIC OXIDE-BIOL CH, V24, P102, DOI 10.1016/j.niox.2011.01.001; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; WHITE SL, 1975, J BIOL CHEM, V250, P1263; WHITE SL, 1976, J BIOL CHEM, V251, P4763; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; Zhang Y, 2002, FREE RADICAL BIO MED, V32, P1212, DOI 10.1016/S0891-5849(02)00829-8	63	35	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18262	18274		10.1074/jbc.M111.298927	http://dx.doi.org/10.1074/jbc.M111.298927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493289	Green Published, hybrid			2022-12-28	WOS:000306411600033
J	Vastagh, C; Gardoni, F; Bagetta, V; Stanic, J; Zianni, E; Giampa, C; Picconi, B; Calabresi, P; Di Luca, M				Vastagh, Csaba; Gardoni, Fabrizio; Bagetta, Vincenza; Stanic, Jennifer; Zianni, Elisa; Giampa, Carmen; Picconi, Barbara; Calabresi, Paolo; Di Luca, Monica			N-Methyl-D-aspartate (NMDA) Receptor Composition Modulates Dendritic Spine Morphology in Striatal Medium Spiny Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; NR2B SUBUNIT; DOPAMINE; TRAFFICKING; PHOSPHORYLATION; ACTIVATION; DISEASE	Dendritic spines of medium spiny neurons represent an essential site of information processing between NMDA and dopamine receptors in striatum. Even if activation of NMDA receptors in the striatum has important implications for synaptic plasticity and disease states, the contribution of specific NMDA receptor subunits still remains to be elucidated. Here, we show that treatment of corticostriatal slices with NR2A antagonist NVP-AAM077 or with NR2A blocking peptide induces a significant increase of spine head width. Sustained treatment with D1 receptor agonist (SKF38393) leads to a significant decrease of NR2A-containing NMDA receptors and to a concomitant increase of spine head width. Interestingly, co-treatment of corticostriatal slices with NR2A antagonist (NVP-AAM077) and D1 receptor agonist augmented the increase of dendritic spine head width as obtained with SKF38393. Conversely, NR2B antagonist (ifenprodil) blocked any morphological effect induced by D1 activation. These results indicate that alteration of NMDA receptor composition at the corticostriatal synapse contributes not only to the clinical features of disease states such as experimental parkinsonism but leads also to a functional and morphological outcome in dendritic spines of medium spiny neurons.	[Vastagh, Csaba; Gardoni, Fabrizio; Stanic, Jennifer; Zianni, Elisa; Di Luca, Monica] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Bagetta, Vincenza; Giampa, Carmen; Picconi, Barbara; Calabresi, Paolo] Ist Ricovero & Cura Carattere Sci, Fdn Santa Lucia, Lab Neurofisiol, I-00143 Rome, Italy; [Calabresi, Paolo] Univ Perugia, Osped S Maria della Misericordia, I-06156 Perugia, Italy	University of Milan; IRCCS Santa Lucia; Hospital Santa Maria della Misericordia; University of Perugia	Gardoni, F (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	fabrizio.gardoni@unimi.it	Bagetta, Vincenza/J-4248-2012; Gardoni, Fabrizio/A-3135-2009; Picconi, Barbara/G-8299-2011; Calabresi, Paolo/G-8496-2011; Di Luca, Monica/A-7632-2012	Gardoni, Fabrizio/0000-0003-4598-5563; Picconi, Barbara/0000-0001-6020-1021; Calabresi, Paolo/0000-0003-0326-5509; Di Luca, Monica/0000-0003-2298-615X; , Giampa/0000-0002-1763-5665; Stanic, Jennifer/0000-0003-1295-4568	European Community [222918, 217902, 238608]; Progetto Strategico; Progetto Giovani Ministero Sanita; Cariplo Foundation [2010-0661]	European Community(European Commission); Progetto Strategico; Progetto Giovani Ministero Sanita; Cariplo Foundation(Fondazione Cariplo)	This work was supported by European Community FP7 Contracts 222918 (REPLACES; to P. C. and M. D. L.), 217902 (cPADS; to M. D. L.), and 238608 (Symbad (to M. D. L.); Progetto Strategico 2007 (to P. C., B. P., and M. D. L.); Progetto Giovani Ministero Sanita 2008 (to B. P. and F. G.); and Cariplo Foundation Project 2010-0661 (to F. G. and B. P.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Albers DS, 1999, NEUROSCIENCE, V89, P209, DOI 10.1016/S0306-4522(98)00328-5; Arbuthnott GW, 2000, J ANAT, V196, P587, DOI 10.1046/j.1469-7580.2000.19640587.x; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Chapman DE, 2003, J NEUROPHYSIOL, V89, P69, DOI 10.1152/jn.00342.2002; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Dunah AW, 2003, J NEUROCHEM, V85, P935, DOI 10.1046/j.1471-4159.2003.01744.x; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Fantin M, 2007, J NEUROCHEM, V103, P2200, DOI 10.1111/j.1471-4159.2007.04966.x; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gardoni F, 2006, J NEUROSCI, V26, P2914, DOI 10.1523/JNEUROSCI.5326-05.2006; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Gardoni F., 2011, NEUROBIOL AGING; Gardoni F, 2010, PROG BRAIN RES, V183, P169, DOI 10.1016/S0079-6123(10)83009-2; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Jocoy EL, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00028; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Kruusmagi M, 2009, NEUROSCIENCE, V164, P463, DOI 10.1016/j.neuroscience.2009.08.052; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Neely MD, 2009, J NEUROSCI METH, V184, P332, DOI 10.1016/j.jneumeth.2009.08.016; Paille V, 2010, J NEUROSCI, V30, P14182, DOI 10.1523/JNEUROSCI.2149-10.2010; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Ren Z, 2010, NEUROSCIENCE, V168, P48, DOI 10.1016/j.neuroscience.2010.03.034; Schotanus SM, 2008, J NEUROCHEM, V106, P1758, DOI 10.1111/j.1471-4159.2008.05512.x; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005	44	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18103	18114		10.1074/jbc.M112.347427	http://dx.doi.org/10.1074/jbc.M112.347427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493505	Green Published, hybrid			2022-12-28	WOS:000306411600019
J	Bikman, BT; Guan, YG; Shui, GH; Siddique, MM; Holland, WL; Kim, JY; Fabrias, G; Wenk, MR; Summers, SA				Bikman, Benjamin T.; Guan, Yuguang; Shui, Guanghou; Siddique, M. Mobin; Holland, William L.; Kim, Ji Yun; Fabrias, Gemma; Wenk, Markus R.; Summers, Scott A.			Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATURATED FATTY-ACIDS; SKELETAL-MUSCLE CELLS; HEPATIC STEATOSIS; DIHYDROCERAMIDE DESATURASE; BREAST-CANCER; OBESITY; INHIBITION; PALMITATE; SYNTHASE; MICE	Fenretinide is a synthetic retinoid that is being tested in clinical trials for the treatment of breast cancer and insulin resistance, but its mechanism of action has been elusive. Recent in vitro data indicate that fenretinide inhibits dihydroceramide desaturase, an enzyme involved in the biosynthesis of lipotoxic ceramides that antagonize insulin action. Because of this finding, we assessed whether fenretinide could improve insulin sensitivity and glucose homeostasis in vitro and in vivo by controlling ceramide production. The effect of fenretinide on insulin action and the cellular lipidome was assessed in a number of lipid-challenged models including cultured myotubes and isolated muscles strips incubated with exogenous fatty acids and mice fed a high-fat diet. Insulin action was evaluated in the various models by measuring glucose uptake or disposal and the activation of Akt/PKB, a serine/threonine kinase that is obligate for insulin-stimulated anabolism. The effects of fenretinide on cellular lipid levels were assessed by LC-MS/MS. Fenretinide negated lipid-induced insulin resistance in each of the model systems assayed. Simultaneously, the drug depleted cells of ceramide, while promoting the accumulation of the precursor dihydroceramide, a substrate for the reaction catalyzed by Des1. These data suggest that fenretinide improves insulin sensitivity, at least in part, by inhibiting Des1 and suggest that therapeutics targeting this enzyme may be a viable therapeutic means for normalizing glucose homeostasis in the overweight and diabetic.	[Bikman, Benjamin T.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Bikman, Benjamin T.; Guan, Yuguang; Siddique, M. Mobin; Summers, Scott A.] Duke Natl Univ Singapore, Grad Sch Med, Program Cardiovasc & Metab Dis, Singapore 169857, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Inst Life Sci, Singapore 119077, Singapore; [Holland, William L.] Univ Texas SW Med Sch, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Ji Yun] Natl Univ Singapore, High Sch Math & Sci, Singapore 129957, Singapore; [Fabrias, Gemma] CSIC, Inst Invest Quim & Ambientals Barcelona, Dept Quim Organ Biol, Res Unit BioAct Mol RUBAM, Barcelona 08034, Spain; [Summers, Scott A.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 169857, Singapore	Brigham Young University; National University of Singapore; National University of Singapore; National University of Singapore; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore; Consejo Superior de Investigaciones Cientificas (CSIC); Duke University; National University of Singapore	Bikman, BT (corresponding author), Brigham Young Univ, 593 WIDB, Provo, UT 84604 USA.	benjamin_bikman@byu.edu	guan, yuguang/AAO-9253-2021; Wenk, Markus Rene/D-1441-2014; Bikman, Benjamin/AAT-9606-2021; /AAE-5384-2020	Fabrias, Gemma/0000-0001-7162-3772; Shui, Guanghou/0000-0002-1621-9643	National Institutes of Health [R01DK081456-01]; Singapore Ministry of Education Academic Research Fund [MOE2009-T2-2-016]; National Medical Research Council [IRG09may004]; Singapore National Research Foundation (CRP) [2007-04]; Duke-National University of Singapore (Duke-NUS); Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; Brigham Young University (BYU); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore National Research Foundation (CRP)(National Research Foundation, Singapore); Duke-National University of Singapore (Duke-NUS)(National University of Singapore); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); Brigham Young University (BYU); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081456-01 (to S. A. S.). This work was also supported by the Singapore Ministry of Education Academic Research Fund (Grant MOE2009-T2-2-016) (to S. A. S.); the National Medical Research Council (Grant IRG09may004) and the Singapore National Research Foundation (CRP Award 2007-04)(to S. A. S.); the Duke-National University of Singapore (Duke-NUS) Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore (to S. A. S.); and a Brigham Young University (BYU) Mentoring Environment grant (to B. T. B.).	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Antonoff MB, 2010, SEMIN THORAC CARDIOV, V22, P195, DOI 10.1053/j.semtcvs.2010.10.015; Bijl N, 2008, J PHARMACOL EXP THER, V326, P849, DOI 10.1124/jpet.108.139394; Bikman BT, 2011, ADV EXP MED BIOL, V721, P87, DOI 10.1007/978-1-4614-0650-1_6; Bonanni B, 2009, RECENT RES CANCER, V181, P77; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Heemskerk Jill, 2002, Trends in Neurosciences, V25, P494, DOI 10.1016/S0166-2236(02)02236-1; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Li X, 2009, CANCER LETT, V284, P175, DOI 10.1016/j.canlet.2009.04.022; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Saeed Z, 2008, J CYST FIBROS, V7, P222, DOI 10.1016/j.jcf.2007.09.001; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Valsecchi M, 2010, J LIPID RES, V51, P1832, DOI 10.1194/jlr.M004010; Vratilova J, 2004, J CHROMATOGR B, V808, P125, DOI 10.1016/j.jchromb.2004.02.031; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2003, UROLOGY, V61, P1047, DOI 10.1016/S0090-4295(02)02511-6; Wang HT, 2001, CANCER RES, V61, P5102; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970; Zheng W., 2006, THESIS GEORGIA I TEC; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	38	89	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17426	17437		10.1074/jbc.M112.359950	http://dx.doi.org/10.1074/jbc.M112.359950			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474281	Green Published, hybrid			2022-12-28	WOS:000306373000043
J	de Graaf, KL; Albert, M; Weissert, R				de Graaf, Katrien L.; Albert, Monika; Weissert, Robert			Autoantigen Conformation Influences Both B- and T-cell Responses and Encephalitogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; BASIC-PROTEIN; MICE; MOG	It has become increasingly clear that only antibodies recognizing conformation-dependent epitopes of myelin oligodendrocyte glycoprotein (MOG) have a demyelinating potential in the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). Nevertheless, for the induction of EAE, most studies to date have used MOG peptides or bacterially expressed MOG, neither of which contain the tertiary structure of the native antigen. Non-refolded recombinant human MOG does not induce EAE in DA rats. Therefore, we refolded this protein in order to assess the influence of MOG conformation on its pathogenicity in DA rats. DA rats immunized with refolded human MOG developed severe acute EAE. As expected, rats immunized with the refolded protein had a higher amount of conformational MOG antibodies present in serum. But in addition, a striking effect of MOG refolding on the generation of T-cell responses was found. Indeed, T-cell responses against the encephalitogenic MOG 91-108 epitope were greatly enhanced after refolding. Therefore, we conclude that refolding of MOG increases its pathogenicity both by generating conformation-dependent MOG antibodies and by enhancing its processing or/and presentation on MHC molecules. These data are important in regard to investigations of the pathogenic potential of many (auto)antigens.	[de Graaf, Katrien L.; Albert, Monika; Weissert, Robert] Univ Tubingen, Hertie Inst Clin Brain Res, Expt Neuroimmunol Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Weissert, R (corresponding author), Univ Regensburg, Dept Neurol, Univ Str 84, D-93053 Regensburg, Germany.	robert.weissert@klinik.uni-regensburg.de	Weissert, Robert/AAA-4791-2019; Weissert, Robert/B-2585-2009	Weissert, Robert/0000-0002-1295-1271	German Research Foundation (Deutsche Forschungsgemeinschaft)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft).	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Allamargot C, 2007, J NEUROCHEM, V101, P298, DOI 10.1111/j.1471-4159.2006.04296.x; AMOR S, 1994, J IMMUNOL, V153, P4349; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bourquin C, 2003, J IMMUNOL, V171, P455, DOI 10.4049/jimmunol.171.1.455; Brehm U, 1999, J NEUROIMMUNOL, V97, P9, DOI 10.1016/S0165-5728(99)00010-7; Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100; Breithaupt C, 2008, J IMMUNOL, V181, P1255, DOI 10.4049/jimmunol.181.2.1255; BRUNNER C, 1989, J NEUROCHEM, V52, P296, DOI 10.1111/j.1471-4159.1989.tb10930.x; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Gaertner S, 2004, NEUROLOGY, V63, P2381, DOI 10.1212/01.WNL.0000147259.34163.33; Genain CP, 1995, J CLIN INVEST, V96, P2966, DOI 10.1172/JCI118368; Herrmann MM, 2005, BLOOD, V106, P1875, DOI 10.1182/blood-2004-12-4607; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lalive PH, 2006, P NATL ACAD SCI USA, V103, P2280, DOI 10.1073/pnas.0510672103; Lampasona V, 2004, NEUROLOGY, V62, P2092, DOI 10.1212/01.WNL.0000127615.15768.AE; Linares D, 2004, PROTEIN EXPRES PURIF, V34, P249, DOI 10.1016/j.pep.2003.11.016; Lindert RB, 1999, BRAIN, V122, P2089, DOI 10.1093/brain/122.11.2089; LININGTON C, 1988, AM J PATHOL, V130, P443; LINNINGTON C, 1984, J NEUROIMMUNOL, V6, P387, DOI 10.1016/0165-5728(84)90064-X; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Lyons JA, 2002, EUR J IMMUNOL, V32, P1905, DOI 10.1002/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Mathey E, 2004, EUR J IMMUNOL, V34, P2065, DOI 10.1002/eji.200425291; McLaughlin KA, 2009, J IMMUNOL, V183, P4067, DOI 10.4049/jimmunol.0801888; O'Connor KC, 2007, NAT MED, V13, P211, DOI 10.1038/nm1488; OETTINGER HF, 1993, J NEUROIMMUNOL, V44, P157, DOI 10.1016/0165-5728(93)90037-Y; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Sakuma H, 2004, BRAIN, V127, P2201, DOI 10.1093/brain/awh260; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Weissert R, 2001, J IMMUNOL, V166, P7588, DOI 10.4049/jimmunol.166.12.7588; Zhou D, 2006, J NEUROIMMUNOL, V178, P103	39	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17206	17213		10.1074/jbc.M111.304246	http://dx.doi.org/10.1074/jbc.M111.304246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493449	Green Published, hybrid			2022-12-28	WOS:000306373000020
J	Gowda, PS; Zhou, FC; Chadwell, LV; McEwen, DG				Gowda, Pramod S.; Zhou, Fuchun; Chadwell, Linda V.; McEwen, Donald G.			p53 Binding Prevents Phosphatase-mediated Inactivation of Diphosphorylated c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROGRAMMED CELL-DEATH; SUBSTRATE RECOGNITION; ECTOPIC EXPRESSION; MAPK PHOSPHATASE; DORSAL CLOSURE; RNA-POLYMERASE; JNK; DROSOPHILA; APOPTOSIS	c-Jun N-terminal kinase (JNK) is a serine/threonine phosphotransferase whose sustained activation in response to genotoxic stress promotes apoptosis. In Drosophila, the normally rapid JNK-dependent apoptotic response to genotoxic stress is significantly delayed in Dmp53 (Drosophila p53) mutants. Likewise, the extent of JNK activity after UV irradiation is dependent on p53 in murine embryonic fibroblasts with loss of p53 resulting in diminished JNK activity. Together, these results suggest that p53 potentiates the JNK-dependent response to genotoxic stress; however, the mechanism whereby p53 stimulates JNK activity remains undefined. Here, we demonstrate that both Drosophila and human p53 can directly stimulate JNK activity independently of p53-dependent gene transcription. Furthermore, we demonstrate that both the Drosophila and human p53 orthologs form a physical complex with diphosphorylated JNK ((DP)JNK) both in vivo and in vitro, suggesting that the interaction is evolutionarily conserved. Focusing on human p53, we demonstrate that the interaction maps to the DNA binding domain (hp53(DBD)). Intriguingly, binding of p53(DBD) alone to (DP)JNK prevented its inactivation by MAPK phosphatase (MKP)-5; however, JNK was still able to phosphorylate c-Jun while in a complex with the p53(DBD). Apparent dissociation constants for the p53(DBD.DP)JNK (274 +/- 14 nM) and MKP-5 . DPJNK (55 +/- 8 nM) complexes were established; however, binding of MKP-5 and p53 to JNK was not mutually exclusive. Together, these results suggest that stress-dependent increases in p53 levels potentiate JNK activation by preventing its rapid dephosphorylation by MKPs and that the simultaneous activation of p53 and JNK may constitute a "fail-safe" switch for the JNK-dependent apoptotic response.	[Zhou, Fuchun; Chadwell, Linda V.; McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Gowda, Pramod S.; McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Zhou, Fuchun] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	McEwen, DG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	mcewen@uthscsa.edu			American Cancer Society [RSG-10-049-01-DMC]	American Cancer Society(American Cancer Society)	This work was supported in part by American Cancer Society Research Scholar Award RSG-10-049-01-DMC (to D.G.M.).	ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Behrens A, 2001, P NATL ACAD SCI USA, V98, P1769, DOI 10.1073/pnas.98.4.1769; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonafe M, 2004, CELL DEATH DIFFER, V11, P962, DOI 10.1038/sj.cdd.4401415; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Buschmann T, 2000, J MOL BIOL, V295, P1009, DOI 10.1006/jmbi.1999.3387; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jassim OW, 2003, EMBO J, V22, P5622, DOI 10.1093/emboj/cdg543; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Kojima K, 1998, J BIOL CHEM, V273, P32542, DOI 10.1074/jbc.273.49.32542; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Levrero M, 2000, J CELL SCI, V113, P1661; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Ljungman M, 1996, ONCOGENE, V13, P823; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; McEwen DG, 1998, J BIOL CHEM, V273, P5349, DOI 10.1074/jbc.273.9.5349; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Ravi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015864; RING JM, 1993, DEVELOPMENT, P251; Rinkenberger JL, 1997, CURR OPIN GENET DEV, V7, P589, DOI 10.1016/S0959-437X(97)80004-4; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Watson A, 1998, J NEUROSCI, V18, P751; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yin HR, 2007, BBA-PROTEINS PROTEOM, V1774, P493, DOI 10.1016/j.bbapap.2007.02.003; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0	75	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17554	17567		10.1074/jbc.M111.319277	http://dx.doi.org/10.1074/jbc.M111.319277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467874	Green Published, hybrid			2022-12-28	WOS:000306373000054
J	Kurita, T; Noda, Y; Yoda, K				Kurita, Tomokazu; Noda, Yoichi; Yoda, Koji			Action of Multiple Endoplasmic Reticulum Chaperon-like Proteins Is Required for Proper Folding and Polarized Localization of Kre6 Protein Essential in Yeast Cell Wall beta-1,6-Glucan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; MEMBRANE-PROTEIN; BIOSYNTHESIS; BIP/KAR2P	Saccharomyces cerevisiae Kre6 is a type II membrane protein essential for cell wall beta-1,6-glucan synthesis. Recently we reported that the majority of Kre6 is in the endoplasmic reticulum (ER), but a significant portion of Kre6 is found in the plasma membrane of buds, and this polarized appearance of Kre6 is required for beta-1,6-glucan synthesis. An essential membrane protein, Keg1, and ER chaperon Rot1 bind to Kre6. In this study we found that in mutant keg1-1 cells, accumulation of Kre6 at the buds is diminished, binding of Kre6 to Keg1 is decreased, and Kre6 becomes susceptible to ER-associated degradation (ERAD), which suggests Keg1 participates in folding and transport of Kre6. All mutants of the calnexin cycle member homologues (cwh41, rot2, kre5, and cne1) showed defects in beta-1,6-glucan synthesis, although the calnexin chaperon system is considered not functional in yeast. We found synthetic defects between them and keg1-1, and Cne1 co-immunoprecipitated with Keg1 and Kre6. A stronger binding of Cne1 to Kre6 was detected when two glucosidases (Cwh41 and Rot2) that remove glucose on N-glycan were functional. Skn1, a Kre6 homologue, was not detected by immunofluorescence in the wild type yeast, but in kre6 Delta cells it became detectable and behaved like Kre6. In conclusion, the action of multiple ER chaperon-like proteins is required for proper folding and localization of Kre6 and probably Skn1 to function in beta-1,6-glucan synthesis.	[Kurita, Tomokazu; Noda, Yoichi; Yoda, Koji] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp	Kurita, Tomokazu/E-6346-2012		Japan Society for the Promotion of Science; Noda Institute of Scientific Research; Grants-in-Aid for Scientific Research [21380058] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute of Scientific Research(Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to Y. N. and K. Y.) and a grant from the Noda Institute of Scientific Research (to Y. N.).	Abeijon C, 1998, MOL BIOL CELL, V9, P2729, DOI 10.1091/mbc.9.10.2729; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Castro O, 1999, MOL BIOL CELL, V10, P1019, DOI 10.1091/mbc.10.4.1019; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Kurita T, 2011, J BIOL CHEM, V286, P7429, DOI 10.1074/jbc.M110.174060; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Nakamata K, 2007, J BIOL CHEM, V282, P34315, DOI 10.1074/jbc.M706486200; Page N, 2003, GENETICS, V163, P875; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shahinian S, 1998, GENETICS, V149, P843; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Takeuchi M, 2006, J BIOCHEM, V139, P597, DOI 10.1093/jb/mvj063; Takeuchi M, 2008, MOL BIOL CELL, V19, P3514, DOI 10.1091/mbc.E07-12-1289; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039	24	13	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17415	17424		10.1074/jbc.M111.321018	http://dx.doi.org/10.1074/jbc.M111.321018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22447934	Green Published, hybrid			2022-12-28	WOS:000306373000041
J	Oh, P; Horner, T; Witkiewicz, H; Schnitzer, JE				Oh, Phil; Horner, Thierry; Witkiewicz, Halina; Schnitzer, Jan E.			Endothelin Induces Rapid, Dynamin-mediated Budding of Endothelial Caveolae Rich in ET-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-COUPLED RECEPTOR; GPI-ANCHORED PROTEINS; SMOOTH-MUSCLE-CELLS; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; CAPILLARY ENDOTHELIUM; VESICULAR-TRANSPORT; ENOS ACTIVATION; ET(B) RECEPTORS	Clathrin-independent trafficking pathways for internalizing G protein-coupled receptors (GPCRs) remain undefined. Clathrin-mediated endocytosis of receptors including ligand-engaged GPCRs can be very rapid and comprehensive ( < 10 min). Caveolae-mediated endocytosis of ligands and antibodies has been reported to be much slower in cell culture ( >> 10 min). Little is known about the role of physiological ligands and specific GPCRs in regulating caveolae trafficking. Here, we find that one receptor for endothelin, ET-B but not ET-A, resides on endothelial cell surfaces in both tissue and cell culture primarily concentrated within caveolae. Reconstituted cell-free budding assays show that endothelins (ETs) induce the fission of caveolae from endothelial plasma membranes purified from rat lungs. Electron microcopy of lung tissue sections and tissue subcellular fractionation both show that endothelin administered intravascularly in rats also induces a significant loss of caveolae at the luminal surface of lung vascular endothelium. Endothelial cells in culture show that ET stimulates very rapid internalization of caveolae and cargo including caveolin, caveolae-targeting antibody, and itself. The ET-B inhibitor BQ788, but not the ET-A inhibitor BQ123, blocks the ET-induced budding of caveolae. Both the pharmacological inhibitor Dynasore and the genetic dominant negative K44A mutant of dynamin prevent this induced budding and internalization of caveolae. Also shRNA lentivirus knockdown of caveolin-1 expression prevents rapid internalization of ET and ET-B. It appears that endothelin can engage ET-B already highly concentrated in caveolae of endothelial cells to induce very rapid caveolae fission and endocytosis. This transport requires active dynamin function. Caveolae trafficking may occur more rapidly than previously documented when it is stimulated by a specific ligand to signaling receptors already located in caveolae before ligand engagement.	[Oh, Phil; Horner, Thierry; Witkiewicz, Halina; Schnitzer, Jan E.] Proteogenom Res Inst Syst Med, San Diego, CA 92121 USA		Schnitzer, JE (corresponding author), Proteogenom Res Inst Syst Med, 11107 Roselle St, San Diego, CA 92121 USA.	jschnitzer@prism-sd.org			National Institutes of Health [HL52766, HL58216, HL67386]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052766, R01HL058216, R01HL067386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL52766, HL58216, and HL67386.	Agapitov AV, 2002, J RENIN-ANGIO-ALDO S, V3, P1, DOI 10.3317/jraas.2002.001; BATRA VK, 1993, AM J PHYSIOL, V264, pC479, DOI 10.1152/ajpcell.1993.264.2.C479; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; BUNDGAARD M, 1983, FED PROC, V42, P2425; Chen X, 1995, BIOCHEM BIOPH RES CO, V217, P445, DOI 10.1006/bbrc.1995.2796; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; CHUN MY, 1995, J BIOL CHEM, V270, P10855, DOI 10.1074/jbc.270.18.10855; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dessy C, 2000, EMBO J, V19, P4272, DOI 10.1093/emboj/19.16.4272; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Feron O, 1999, LIFE SCI, V64, P471, DOI 10.1016/S0024-3205(98)00590-6; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gines S, 2001, MOL PHARMACOL, V59, P1314, DOI 10.1124/mol.59.5.1314; Haasemann M, 1998, J CELL SCI, V111, P917; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; McIntosh DP, 1999, AM J PHYSIOL-HEART C, V277, pH2222, DOI 10.1152/ajpheart.1999.277.6.H2222; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Oh P, 1999, J BIOL CHEM, V274, P23144, DOI 10.1074/jbc.274.33.23144; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P., 1998, CELL BIOL LAB HDB; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; Oksche A, 2000, MOL PHARMACOL, V57, P1104; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pula G, 2004, J NEUROCHEM, V89, P1009, DOI 10.1111/j.1471-4159.2004.02387.x; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schwencke C, 1999, J CELL BIOCHEM, V75, P64, DOI 10.1002/(SICI)1097-4644(19991001)75:1<64::AID-JCB7>3.0.CO;2-L; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Yamaguchi T, 2003, EUR J BIOCHEM, V270, P1816, DOI 10.1046/j.1432-1033.2003.03544.x; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zheng YZ, 2009, J PROTEOMICS, V72, P12, DOI 10.1016/j.jprot.2008.09.003	56	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17353	17362		10.1074/jbc.M111.338897	http://dx.doi.org/10.1074/jbc.M111.338897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457360	Green Published, hybrid			2022-12-28	WOS:000306373000035
J	Tangredi, MM; Ng, FS; Jackson, FR				Tangredi, Michelle M.; Ng, Fanny S.; Jackson, F. Rob			The C-terminal Kinase and ERK-binding Domains of Drosophila S6KII (RSK) Are Required for Phosphorylation of the Protein and Modulation of Circadian Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; SIGNAL-TRANSDUCTION; DOCKING SITE; ACTIVATION; IDENTIFICATION; INHIBITION; OSCILLATOR; SEQUENCE; PP90RSK; MAPK	A detailed structure/function analysis of Drosophila p90 ribosomal S6 kinase (S6KII) or its mammalian homolog RSK has not been performed in the context of neuronal plasticity or behavior. We previously reported that S6KII is required for normal circadian periodicity. Here we report a site-directed mutagenesis of S6KII and analysis of mutants, in vivo, that identifies functional domains and phosphorylation sites critical for the regulation of circadian period. We demonstrate, for the first time, a role for the S6KII C-terminal kinase that is independent of its known role in activation of the N-terminal kinase. Both S6KII C-terminal kinase activity and its ERK-binding domain are required for wild-type circadian period and normal phosphorylation status of the protein. In contrast, the N-terminal kinase of S6KII is dispensable for modulation of circadian period and normal phosphorylation of the protein. We also show that particular sites of S6KII phosphorylation, Ser-515 and Thr-732, are essential for normal circadian behavior. Surprisingly, the phosphorylation of S6KII residues, in vivo, does not follow a strict sequential pattern, as implied by certain cell-based studies of mammalian RSK protein.	[Tangredi, Michelle M.; Ng, Fanny S.; Jackson, F. Rob] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Ctr Neurosci Res,Dept Neurosci, Boston, MA 02111 USA	Tufts University	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Ctr Neurosci Res,Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	rob.jackson@tufts.edu			National Science Foundation [DGE 0238731]; National Institutes of Health [T32 HD049341, R01 NS45817, R01 HL59873, R01 NS065900, P30 NS047243]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R01NS045817, R01NS065900] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Science Foundation Fellowship DGE 0238731 (to M. M. T.), National Institutes of Health Grant T32 HD049341 (to F. S. N.), National Institutes of Health Grant R01 NS45817 (to F. R. J.), National Institutes of Health Grant R01 HL59873 (to F. R. J.), National Institutes of Health Grant R01 NS065900 (to F. R. J.), and National Institutes of Health Grant P30 NS047243 (to F. R. J.).	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Akten B., 2005, THESIS TUFTS U BOSTO; Akten B, 2009, J NEUROSCI, V29, P466, DOI 10.1523/JNEUROSCI.4034-08.2009; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BLENIS J, 1991, CELL GROWTH DIFFER, V2, P279; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; ERIKSON E, 1985, P NATL ACAD SCI USA, V82, P742, DOI 10.1073/pnas.82.3.742; Fischer M, 2009, DEV NEUROBIOL, V69, P212, DOI 10.1002/dneu.20700; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; Tangredi M. M., 2010, THESIS TUFTS U BOSTO; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16748	16758		10.1074/jbc.M111.315929	http://dx.doi.org/10.1074/jbc.M111.315929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447936	hybrid, Green Published			2022-12-28	WOS:000304030900062
J	Becker, D; Richter, J; Tocilescu, MA; Przedborski, S; Voos, W				Becker, Dorothea; Richter, Judith; Tocilescu, Maja A.; Przedborski, Serge; Voos, Wolfgang			Pink1 Kinase and Its Membrane Potential (Delta psi)-dependent Cleavage Product Both Localize to Outer Mitochondrial Membrane by Unique Targeting Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; INTRAMEMBRANE PROTEOLYSIS; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; RECESSIVE PARKINSONISM; PROTEASE PARL; 2 LOCATIONS; IMPORT; DISEASE; MUTATIONS	The Parkinson disease-associated kinase Pink1 is targeted to mitochondria where it is thought to regulate mitochondrial quality control by promoting the selective autophagic removal of dysfunctional mitochondria. Nevertheless, the targeting mode of Pink1 and its submitochondrial localization are still not conclusively resolved. The aim of this study was to dissect the mitochondrial import pathway of Pink1 by use of a highly sensitive in vitro assay. Mutational analysis of the Pink1 sequence revealed that its N terminus acts as a genuine matrix localization sequence that mediates the initial membrane potential (Delta psi)-dependent targeting of the Pink1 precursor to the inner mitochondrial membrane, but it is dispensable for Pink1 import or processing. A hydrophobic segment downstream of the signal sequence impeded complete translocation of Pink1 across the mitochondrial inner membrane. Additionally, the C-terminal end of the protein promoted the retention of Pink1 at the outer membrane. Thus, multiple targeting signals featured by the Pink1 sequence result in the final localization of both the full-length protein and its major Delta psi-dependent cleavage product to the cytosolic face of the outer mitochondrial membrane. Full-length Pink1 and deletion constructs resembling the natural Pink1 processing product were found to assemble into membrane potential-sensitive high molecular weight protein complexes at the mitochondrial surface and displayed similar cytoprotective effects when expressed in vivo, indicating that both species are functionally relevant.	[Becker, Dorothea; Richter, Judith; Voos, Wolfgang] Univ Bonn, IBMB, D-53115 Bonn, Germany; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	University of Bonn; Columbia University; Columbia University; Columbia University; Columbia University	Voos, W (corresponding author), Univ Bonn, IBMB, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de			National Institutes of Health [NS042269, NS064191, NS38370, NS070276, NS072182]; Medical Faculty of the University of Bonn; United States Department of Defense [W81XWH-08-1-0522, W81XWH-08-1-0465, W81XWH-09-1-0245]; Parkinson's Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; Muscular Dystrophy Association; P2ALS; Deutsche Forschungsgemeinschaft [805231]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042269, R21NS064191, P50NS038370, R21NS072182, RC2NS070276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Faculty of the University of Bonn; United States Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; Muscular Dystrophy Association(Muscular Dystrophy Association); P2ALS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS042269, NS064191, NS38370, NS070276, and NS072182. This work was also supported by a grant from the BONFOR program of the Medical Faculty of the University of Bonn (to W. V.); United States Department of Defense Grants W81XWH-08-1-0522, W81XWH-08-1-0465, and W81XWH-09-1-0245; the Parkinson's Disease Foundation; the Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; the Muscular Dystrophy Association and P2ALS (to S. P.); and Deutsche Forschungsgemeinschaft Grant 805231 (to M. A. T.).	Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Ben-Menachem R, 2011, J MOL BIOL, V409, P113, DOI 10.1016/j.jmb.2011.03.045; Bentivoglio AR, 2001, MOVEMENT DISORD, V16, P999, DOI 10.1002/mds.10034; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Bomer U, 1998, EMBO J, V17, P4226, DOI 10.1093/emboj/17.15.4226; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chu CT, 2010, BBA-MOL BASIS DIS, V1802, P20, DOI 10.1016/j.bbadis.2009.06.012; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Haucke V, 1997, MOL CELL BIOL, V17, P4024, DOI 10.1128/MCB.17.7.4024; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Lin W, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-90; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Luciano P, 1998, J MOL BIOL, V280, P193, DOI 10.1006/jmbi.1998.1858; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nett JH, 1996, J BIOL CHEM, V271, P26713, DOI 10.1074/jbc.271.43.26713; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	64	59	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22969	22987		10.1074/jbc.M112.365700	http://dx.doi.org/10.1074/jbc.M112.365700			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22547060	Green Published, hybrid			2022-12-28	WOS:000306495000054
J	Hutt, DM; Roth, DM; Chalfant, MA; Youker, RT; Matteson, J; Brodsky, JL; Balch, WE				Hutt, Darren M.; Roth, Daniela Martino; Chalfant, Monica A.; Youker, Robert T.; Matteson, Jeanne; Brodsky, Jeffrey L.; Balch, William E.			FK506 Binding Protein 8 Peptidylprolyl Isomerase Activity Manages a Late Stage of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Folding and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; STEROID-RECEPTOR COMPLEXES; CALCINEURIN PHOSPHATASE-ACTIVITY; CHANNEL RYANODINE RECEPTOR; HSP90 CHAPERONE MACHINERY; CALCIUM-RELEASE CHANNEL; ENDOPLASMIC-RETICULUM; FK506-BINDING PROTEIN; CYCLOSPORINE-A	Cystic fibrosis (CF) is caused by mutations in the apical chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) with 90% of patients carrying at least one deletion of the F508 (Delta F508) allele. This mutant form of CFTR is characterized by a folding and trafficking defect that prevents exit from the endoplasmic reticulum. We previously reported that Delta F508 CFTR can be recovered in a complex with Hsp90 and its co-chaperones as an on-pathway folding intermediate, suggesting that Delta 508 CF disease arises due to a failure of the proteostasis network (PN), which manages protein folding and degradation in the cell. We have now examined the role of FK506-binding protein 8 (FKBP8), a component of the CFTR interactome, during the biogenesis of wild-type and Delta F508 CFTR. FKBP8 is a member of the peptidylprolyl isomerase family that mediates the cis/trans interconversion of peptidyl prolyl bonds. Our results suggest that FKBP8 is a key PN factor required at a post-Hsp90 step in CFTR biogenesis. In addition, changes in its expression level or alteration of its activity by a peptidylprolyl isomerase inhibitor alter CFTR stability and transport. We propose that CF is caused by the sequential failure of the prevailing PN pathway to stabilize Delta F508-CFTR for endoplasmic reticulum export, a pathway that can be therapeutically managed.	[Hutt, Darren M.; Roth, Daniela Martino; Chalfant, Monica A.; Matteson, Jeanne; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Youker, Robert T.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Youker, Robert T.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	webalch@scripps.edu	Youker, Robert/AAP-8725-2021	Youker, Robert/0000-0002-3986-1655	National Institutes of Health [HL079442, GM42336, DK785483, GM75061]; Cystic Fibrosis Foundation Therapeutics [BRODSK08XX0]; Cystic Fibrosis Foundation; Cystic Fibrosis Consortium; Canadian Cystic Fibrosis Foundation; Canadian Institutes for Health Research; Australian National Health and Medical Research Council C. J. Martin Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442, R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM075061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Consortium; Canadian Cystic Fibrosis Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council C. J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079442 (to W. E. B.), GM42336 (to W. E. B.), DK785483 (to W. E. B.), and GM75061 (to J. L. B.). This work was also supported by Grant BRODSK08XX0 (to J. L. B.) from Cystic Fibrosis Foundation Therapeutics, by fellowships from the Cystic Fibrosis Foundation, and by funding from the Cystic Fibrosis Consortium.; Supported by fellowships from the Canadian Cystic Fibrosis Foundation and the Canadian Institutes for Health Research.; Supported by an Australian National Health and Medical Research Council C. J. Martin Fellowship.	Adams A., 1997, METHODS YEAST GENETI, P178; AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Balch W. E., 2011, COLD SPRING HARBOR P, V3; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; CALLEBAUT I, 1992, P NATL ACAD SCI USA, V89, P6270, DOI 10.1073/pnas.89.14.6270; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; CHEN SRW, 1994, P NATL ACAD SCI USA, V91, P11953, DOI 10.1073/pnas.91.25.11953; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; CZAR MJ, 1994, MOL ENDOCRINOL, V8, P1731, DOI 10.1210/me.8.12.1731; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; FRUMAN DA, 1995, J IMMUNOL, V154, P1846; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Huang PB, 1996, BBA-BIOMEMBRANES, V1281, P80, DOI 10.1016/0005-2736(96)00032-6; Hutt D, 2010, SCIENCE, V329, P766, DOI 10.1126/science.1194160; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17977, DOI 10.1021/bi9819733; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; RENOIR JM, 1993, CR ACAD SCI III-VIE, V316, P1410; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid FX, 1996, BIOL CHEM, V377, P417; Schmid K, 2008, ANN NY ACAD SCI, V1126, P257, DOI 10.1196/annals.1433.062; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	82	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21914	21925		10.1074/jbc.M112.339788	http://dx.doi.org/10.1074/jbc.M112.339788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22474283	hybrid, Green Published			2022-12-28	WOS:000306418600031
J	Kim, SH; Lee, PC				Kim, Se Hyeuk; Lee, Pyung Cheon			Functional Expression and Extension of Staphylococcal Staphyloxanthin Biosynthetic Pathway in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS; VIRULENCE	The biosynthetic pathway for staphyloxanthin, a C-30 carotenoid biosynthesized by Staphylococcus aureus, has previously been proposed to consist of five enzymes (CrtO, CrtP, CrtQ, CrtM, and CrtN). Here, we report a missing sixth enzyme, 4,4'-diaponeurosporen-aldehyde dehydrogenase (AldH), in the staphyloxanthin biosynthetic pathway and describe the functional expression of the complete staphyloxanthin biosynthetic pathway in Escherichia coli. When we expressed the five known pathway enzymes through artificial synthetic operons and the wild-type operon (crtOPQMN) in E. coli, carotenoid aldehyde intermediates such as 4,4'-diaponeurosporen-4-al accumulated without being converted into staphyloxanthin or other intermediates. We identified an aldH gene located 670 kilobase pairs from the known staphyloxanthin gene cluster in the S. aureus genome and an aldH gene in the non-staphyloxanthin-producing Staphylococcus carnosus genome. These two putative enzymes catalyzed the missing oxidation reaction to convert 4,4'-diaponeurosporen-4-al into 4,4'-diaponeurosporenoic acid in E. coli. Deletion of the aldH gene in S. aureus abolished staphyloxanthin biosynthesis and caused accumulation of 4,4'-diaponeurosporen-4-al, confirming the role of AldH in staphyloxanthin biosynthesis. When the complete staphyloxanthin biosynthetic pathway was expressed using an artificial synthetic operon in E. coli, staphyloxanthin-like compounds, which contained altered fatty acid acyl chains, and novel carotenoid compounds were produced, indicating functional expression and coordination of the six staphyloxanthin pathway enzymes.	[Lee, Pyung Cheon] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; Ajou Univ, Dept Biotechnol, Suwon 443749, South Korea	Ajou University; Ajou University	Lee, PC (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.	pclee@ajou.ac.kr	Lee, Pyung Cheon/AAR-1021-2021; Kim, Hyeuk/O-9911-2015	Kim, Hyeuk/0000-0003-4543-4622; Lee, Pyung Cheon/0000-0003-2014-6587	National Research Foundation of Korea [2011-0018057, 2011-0003535]; Korean Government; Ministry of Education, Science, and Technology; Priority Research Center Program through National Research Foundation of Korea [2011-0022978]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Priority Research Center Program through National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2011-0018057 and 2011-0003535 funded by the Korean Government and by Priority Research Centers Program Grant 2011-0022978 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.	Albrecht M, 2000, NAT BIOTECHNOL, V18, P843, DOI 10.1038/78443; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Bowles B. L., 1996, J RAPID METH AUT MIC, V4, P235; Cahoon EB, 1996, J BACTERIOL, V178, P936, DOI 10.1128/jb.178.3.936-939.1996; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Daum RS, 2008, NEW ENGL J MED, V359, P85, DOI 10.1056/NEJMcibr0803278; Fischer CR, 2010, APPL MICROBIOL BIOT, V88, P265, DOI 10.1007/s00253-010-2749-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horinouchi S, 2009, CURR OPIN CHEM BIOL, V13, P197, DOI 10.1016/j.cbpa.2009.02.004; Johnson ET, 2008, TRENDS BIOTECHNOL, V26, P682, DOI 10.1016/j.tibtech.2008.09.002; Kim SH, 2010, APPL ENVIRON MICROB, V76, P5199, DOI 10.1128/AEM.00263-10; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee PC, 2003, CHEM BIOL, V10, P453, DOI 10.1016/S1074-5521(03)00103-0; Lee PC, 2010, APPL ENVIRON MICROB, V76, P7328, DOI 10.1128/AEM.01606-10; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; MARSHALL JH, 1981, J BACTERIOL, V147, P914, DOI 10.1128/JB.147.3.914-919.1981; Mijts BN, 2005, CHEM BIOL, V12, P453, DOI 10.1016/j.chembiol.2005.02.010; Mijts BN, 2004, METHOD ENZYMOL, V388, P315; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Smirnova N, 2001, J IND MICROBIOL BIOT, V27, P246, DOI 10.1038/sj.jim.7000185; Tao L, 2005, APPL ENVIRON MICROB, V71, P3294, DOI 10.1128/AEM.71.6.3294-3301.2005; Walsh CT, 2008, ANGEW CHEM INT EDIT, V47, P5700, DOI 10.1002/anie.200801801; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yadav VG, 2010, CURR OPIN MICROBIOL, V13, P371, DOI 10.1016/j.mib.2010.04.002	27	37	40	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21575	21583		10.1074/jbc.M112.343020	http://dx.doi.org/10.1074/jbc.M112.343020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22535955	hybrid, Green Published			2022-12-28	WOS:000306418600002
J	Fermani, S; Trivelli, X; Sparla, F; Thumiger, A; Calvaresi, M; Marri, L; Falini, G; Zerbetto, F; Trost, P				Fermani, Simona; Trivelli, Xavier; Sparla, Francesca; Thumiger, Anton; Calvaresi, Matteo; Marri, Lucia; Falini, Giuseppe; Zerbetto, Francesco; Trost, Paolo			Conformational Selection and Folding-upon-binding of Intrinsically Disordered Protein CP12 Regulate Photosynthetic Enzymes Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CHLAMYDOMONAS-REINHARDTII; CALVIN CYCLE; SUPRAMOLECULAR COMPLEX; UNSTRUCTURED PROTEINS; RECOGNITION; DISSOCIATION; ARABIDOPSIS; MECHANISMS; SIMULATION	Carbon assimilation in plants is regulated by the reduction of specific protein disulfides by light and their re-oxidation in the dark. The redox switch CP12 is an intrinsically disordered protein that can form two disulfide bridges. In the dark oxidized CP12 forms an inactive supramolecular complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and phosphoribulokinase, two enzymes of the carbon assimilation cycle. Here we show that binding of CP12 to GAPDH, the first step of ternary complex formation, follows an integrated mechanism that combines conformational selection with induced folding steps. Initially, a CP12 conformation characterized by a circular structural motif including the C-terminal disulfide is selected by GAPDH. Subsequently, the induced folding of the flexible C-terminal tail of CP12 in the active site of GAPDH stabilizes the binary complex. Formation of several hydrogen bonds compensates the entropic cost of CP12 fixation and terminates the interaction mechanism that contributes to carbon assimilation control.	[Sparla, Francesca; Thumiger, Anton; Marri, Lucia; Trost, Paolo] Univ Bologna, Dept Expt Evolutionary Biol, I-40126 Bologna, Italy; [Fermani, Simona; Calvaresi, Matteo; Falini, Giuseppe; Zerbetto, Francesco] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy; [Trivelli, Xavier] Univ Lille Nord France, F-59000 Lille, France; [Trivelli, Xavier] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Trivelli, Xavier] CNRS, UMR 8576, F-59655 Villeneuve Dascq, France	University of Bologna; University of Bologna; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Trost, P (corresponding author), Univ Bologna, Dept Expt Evolutionary Biol, Via Irnerio 42, I-40126 Bologna, Italy.	paolo.trost@unibo.it	Trost, Paolo/F-2425-2011; Zerbetto, Francesco/D-2503-2014; Calvaresi, Matteo/ABG-6570-2021	Zerbetto, Francesco/0000-0002-2419-057X; Calvaresi, Matteo/0000-0002-9583-2146; Trost, Paolo/0000-0002-6347-8701; Sparla, Francesca/0000-0002-2103-4870; Trivelli, Xavier/0000-0001-6775-9650	Italian Ministry of University and Research (MiUR); Tres Grand Equipement de Recherche (TGE) Resonance Magnetique Nuclear (RMN) a Tres Haut Champs (THC) [Fr3050]	Italian Ministry of University and Research (MiUR)(Ministry of Education, Universities and Research (MIUR)); Tres Grand Equipement de Recherche (TGE) Resonance Magnetique Nuclear (RMN) a Tres Haut Champs (THC)	This work was supported by the Italian Ministry of University and Research (MiUR, projects FIRB and PRIN 2008). This work was also supported by Tres Grand Equipement de Recherche (TGE) Resonance Magnetique Nuclear (RMN) a Tres Haut Champs (THC) Fr3050.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erales J, 2011, BIOCHEMISTRY-US, V50, P2881, DOI 10.1021/bi1020259; Erales J, 2009, J BIOL CHEM, V284, P12735, DOI 10.1074/jbc.M808254200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2010, ACTA CRYSTALLOGR F, V66, P621, DOI 10.1107/S1744309110013527; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Graciet E, 2004, EUR J BIOCHEM, V271, P4737, DOI 10.1111/j.1432-1033.2004.04437.x; Graciet E, 2003, BIOCHEMISTRY-US, V42, P8163, DOI 10.1021/bi034474x; Howard TP, 2008, P NATL ACAD SCI USA, V105, P4056, DOI 10.1073/pnas.0710518105; Howard TP, 2011, PLANT PHYSIOL, V157, P620, DOI 10.1104/pp.111.183806; Howard TP, 2011, J EXP BOT, V62, P3799, DOI 10.1093/jxb/err057; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Marri L, 2008, J BIOL CHEM, V283, P1831, DOI 10.1074/jbc.M705650200; Marri L, 2010, J PLANT PHYSIOL, V167, P939, DOI 10.1016/j.jplph.2010.02.008; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Matsumura H, 2011, STRUCTURE, V19, P1846, DOI 10.1016/j.str.2011.08.016; Espinoza-Fonseca LM, 2009, BIOCHEM BIOPH RES CO, V382, P479, DOI 10.1016/j.bbrc.2009.02.151; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Scheibe R, 2002, EUR J BIOCHEM, V269, P5617, DOI 10.1046/j.1432-1033.2002.03269.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XL, 2010, J BIOL CHEM, V285, P11557, DOI 10.1074/jbc.M109.027011; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	55	51	54	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21372	21383		10.1074/jbc.M112.350355	http://dx.doi.org/10.1074/jbc.M112.350355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22514274	hybrid, Green Published			2022-12-28	WOS:000306416800055
J	Kulaeva, OI; Zheng, GH; Polikanov, YS; Colasanti, AV; Clauvelin, N; Mukhopadhyay, S; Sengupta, AM; Studitsky, VM; Olson, WK				Kulaeva, Olga I.; Zheng, Guohui; Polikanov, Yury S.; Colasanti, Andrew V.; Clauvelin, Nicolas; Mukhopadhyay, Swagatam; Sengupta, Anirvan M.; Studitsky, Vasily M.; Olson, Wilma K.			Internucleosomal Interactions Mediated by Histone Tails Allow Distant Communication in Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; NUCLEOSOME CORE; ENHANCER ACTION; H4-K16 ACETYLATION; DNA FLEXIBILITY; RNA-POLYMERASES; GENE-EXPRESSION; FIBER STRUCTURE; RING-CLOSURE; MODEL	Action across long distances on chromatin is a hallmark of eukaryotic transcriptional regulation. Although chromatin structure per se can support long-range interactions, the mechanisms of efficient communication between widely spaced DNA modules in chromatin remain a mystery. The molecular simulations described herein suggest that transient binary internucleosomal interactions can mediate distant communication in chromatin. Electrostatic interactions between the N-terminal tails of the core histones and DNA enhance the computed probability of juxtaposition of sites that lie far apart along the DNA sequence. Experimental analysis of the rates of communication in chromatin constructs confirms that long-distance communication occurs efficiently and independently of distance on tail-containing, but not on tailless, chromatin. Taken together, our data suggest that internucleosomal interactions involving the histone tails are essential for highly efficient, long-range communication between regulatory elements and their targets in eukaryotic genomes.	[Kulaeva, Olga I.; Polikanov, Yury S.; Studitsky, Vasily M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Studitsky, Vasily M.] Moscow MV Lomonosov State Univ, Sch Biol, Moscow, Russia; [Zheng, Guohui; Colasanti, Andrew V.; Clauvelin, Nicolas; Olson, Wilma K.] Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Mukhopadhyay, Swagatam; Sengupta, Anirvan M.] Rutgers State Univ, Dept Phys & Astron, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Lomonosov Moscow State University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Studitsky, VM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes La W, Piscataway, NJ 08854 USA.	studitvm@umdnj.edu; wilma.olson@rutgers.edu	Clauvelin, Nicolas/B-4287-2009; Sengupta, Anirvan/G-2508-2012; Studitskaia, Olga/D-8551-2014; Polikanov, Yury/B-4322-2016	Studitskaia, Olga/0000-0001-5417-9964; Polikanov, Yury/0000-0002-5064-0327	National Institutes of Health [GM34809, HG03470, RR022375]; National Science Foundation [7046342]; Government of the Russian Federation [220]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022375] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Government of the Russian Federation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34809 (to W. K. O.) and HG03470 (to A. M. S.) and National Institutes of Health Instrumentation Award RR022375 (to A. M. S. and W. K. O.). This work was also supported by National Science Foundation Grant 7046342 and a Government of the Russian Federation (Order 220) research grant (to V. M. S.).	Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; Baneres JL, 1997, J MOL BIOL, V273, P503, DOI 10.1006/jmbi.1997.1297; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bellomy G R, 1990, Prog Nucleic Acid Res Mol Biol, V39, P81, DOI 10.1016/S0079-6603(08)60624-8; Ben-Haim E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051921; Bondarenko V, 2003, METHOD ENZYMOL, V370, P324; Bondarenko VA, 2003, BIOCHEM CELL BIOL, V81, P241, DOI 10.1139/o03-051; Bondarenko VA, 2003, EMBO J, V22, P4728, DOI 10.1093/emboj/cdg468; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Czapla L, 2008, J MOL BIOL, V382, P353, DOI 10.1016/j.jmb.2008.05.088; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Diesinger PM, 2010, BIOPHYS J, V99, P2995, DOI 10.1016/j.bpj.2010.08.039; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Katritch V, 2000, J MOL BIOL, V295, P29, DOI 10.1006/jmbi.1999.3021; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; LAYBOURN PJ, 1992, SCIENCE, V257, P1682, DOI 10.1126/science.1388287; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Liu Y, 2001, P NATL ACAD SCI USA, V98, P14883, DOI 10.1073/pnas.261477898; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mergell B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011915; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; Polikanov YS, 2007, METHODS, V41, P250, DOI 10.1016/j.ymeth.2006.11.003; Polikanov YS, 2009, METHODS MOL BIOL, V543, P563, DOI 10.1007/978-1-60327-015-1_33; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rosa A, 2010, BIOPHYS J, V98, P2410, DOI 10.1016/j.bpj.2010.01.054; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rubtsov MA, 2006, P NATL ACAD SCI USA, V103, P17690, DOI 10.1073/pnas.0603819103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Staynov DZ, 2008, CHROMOSOMA, V117, P67, DOI 10.1007/s00412-007-0127-3; Stein A, 2002, NUCLEIC ACIDS RES, V30, P5103, DOI 10.1093/nar/gkf671; TAYLOR WH, 1990, J MOL BIOL, V212, P363, DOI 10.1016/0022-2836(90)90131-5; Vologodskii A, 1996, BIOPHYS J, V70, P2548, DOI 10.1016/S0006-3495(96)79826-0; Walter W, 2004, METHOD ENZYMOL, V377, P445; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Yang Y, 2009, BIOPHYS J, V96, P2082, DOI 10.1016/j.bpj.2008.10.073; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zheng GH, 2010, PHYS CHEM CHEM PHYS, V12, P1399, DOI 10.1039/b916183j; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	60	35	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20248	20257		10.1074/jbc.M111.333104	http://dx.doi.org/10.1074/jbc.M111.333104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518845	Green Published, hybrid			2022-12-28	WOS:000306414500045
J	Liu, Y; Song, R; Gao, Y; Li, Y; Wang, S; Liu, HY; Wang, Y; Hu, YH; Shu, HB				Liu, Yu; Song, Ren; Gao, Yan; Li, Yi; Wang, Shuai; Liu, Hai-Yun; Wang, Yan; Hu, Yun-Hong; Shu, Hong-Bing			Protein Kinase C-delta Negatively Regulates T Cell Receptor-induced NF-kappa B Activation by Inhibiting the Assembly of CARMA1 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; LYMPHOCYTES; PHOSPHORYLATION; MALT1; BCL10; LYMPHOMA; PATHWAY; COMPLEX; BETA; TCR	T-cell receptor (TCR)-induced T-cell activation is a critical event in adaptive immune responses. The engagement of TCR complex by antigen along with the activation of the costimulatory receptors trigger a cascade of intracellular signaling, in which caspase recruitment domain-containing membrane-associated guanylate kinase 1 (CARMA1) is a crucial scaffold protein. Upon stimulation, CARMA1 recruits downstream molecules including B-cell CLL/lymphoma 10 (Bcl10), mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1), and TRAF6 to assemble a specific TCR-induced signalosome that triggers NF-kappa B and JNK activation. In this report, we identified protein kinase C delta (PKC delta) as a CARMA1-associated protein by a biochemical affinity purification approach. PKC delta interacted with CARMA1 in TCR stimulation-dependent manner in Jurkat T cells. Overexpression of PKC delta inhibited CARMA1-mediated NF-kappa B activation, whereas knockdown of PKC delta potentiated TCR-triggered NF-kappa B activation and IL-2 secretion in Jurkat T cells. Reconstitution experiments with PKC delta kinase-dead mutant indicated that the kinase activity of PKC delta was dispensable for its ability to inhibit TCR-triggered NF-kappa B activation. Furthermore, we found that PKC delta inhibited the interaction between MALT1 and TRAF6, but not the association of CARMA1 with PKC theta, Bcl10, or MALT1. These observations suggest that PKC delta is a negative regulator in T cell activation through inhibiting the assembly of CARMA1 signalosome.	[Liu, Yu; Song, Ren; Gao, Yan; Li, Yi; Wang, Shuai; Liu, Hai-Yun; Wang, Yan; Hu, Yun-Hong; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liu, Y (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	yuliu@whu.edu.cn; shuh@whu.edu.cn	Liu, Haiyun/T-1047-2016; Wang, Shuai/Y-6634-2019	Wang, Shuai/0000-0002-5432-4970; Song, Ren/0000-0002-0620-4958	National Natural Science Foundation of China [30700417, 30972719, 30921001]; Ministry of Science and Technology of China [2012CB910201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (30700417, 30972719, and 30921001), and the Ministry of Science and Technology of China (2012CB910201).	Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Gruber T, 2005, IMMUNOL LETT, V96, P291, DOI 10.1016/j.imlet.2004.08.011; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rueda D, 2005, IMMUNITY, V23, P551, DOI 10.1016/j.immuni.2005.11.007; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Szamel M, 1998, J IMMUNOL, V160, P2207; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; van Oers NSC, 2005, SCIENCE, V308, P65, DOI 10.1126/science.1110902; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003	31	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20081	20087		10.1074/jbc.M111.335463	http://dx.doi.org/10.1074/jbc.M111.335463			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528498	Green Published, hybrid			2022-12-28	WOS:000306414500029
J	Breitman, M; Kook, S; Gimenez, LE; Lizama, BN; Palazzo, MC; Gurevich, EV; Gurevich, VV				Breitman, Maya; Kook, Seunghyi; Gimenez, Luis E.; Lizama, Britney N.; Palazzo, Maria C.; Gurevich, Eugenia V.; Gurevich, Vsevolod V.			Silent Scaffolds INHIBITION OF c-Jun N-TERMINAL KINASE 3 ACTIVITY IN CELL BY DOMINANT-NEGATIVE ARRESTIN-3 MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTIN; CRYSTAL-STRUCTURE; NONVISUAL ARRESTINS; PHYSIOLOGICAL FUNCTIONS; CLATHRIN ADAPTER; CONE ARRESTIN; MAP KINASES; ACTIVATION	We established a new in vivo arrestin-3-JNK3 interaction assay based on bioluminescence resonance energy transfer (BRET) between JNK3-luciferase and Venus-arrestins. We tested the ability of WT arrestin-3 and its 3A mutant that readily binds beta 2-adrenergic receptors as well as two mutants impaired in receptor binding, Delta 7 and KNC, to directly bind JNK3 and to promote JNK3 phosphorylation in cells. Both receptor binding-deficient mutants interact with JNK3 significantly better than WT and 3A arrestin-3. WT arrestin-3 and Delta 7 mutant robustly promoted JNK3 activation, whereas 3A and KNC mutants did not. Thus, receptor binding, JNK3 interaction, and JNK3 activation are three distinct arrestin functions. We found that the KNC mutant, which tightly binds ASK1, MKK4, and JNK3 without facilitating JNK3 phosphorylation, has a dominant-negative effect, competitively decreasing JNK activation by WT arrestin-3. Thus, KNC is a silent scaffold, a novel type of molecular tool for the suppression of MAPK signaling in living cells.	[Breitman, Maya; Kook, Seunghyi; Gimenez, Luis E.; Lizama, Britney N.; Palazzo, Maria C.; Gurevich, Eugenia V.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Lizama, Britney/E-2260-2012; Gurevich, Vsevolod/A-3236-2008	Lizama, Britney/0000-0001-5970-3913; Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, NS065868]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R25GM062459, R01GM077561, T34GM008718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, and EY011500 (to V. V. G.) and NS065868 (to E V. G.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; WACKER WB, 1977, J IMMUNOL, V119, P1949; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	57	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19653	19664		10.1074/jbc.M112.358192	http://dx.doi.org/10.1074/jbc.M112.358192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523077	Green Published, hybrid			2022-12-28	WOS:000306411900076
J	Kim, H; Kim, A; Cunningham, KW				Kim, Hyemin; Kim, Adam; Cunningham, Kyle W.			Vacuolar H+-ATPase (V-ATPase) Promotes Vacuolar Membrane Permeabilization and Nonapoptotic Death in Stressed Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE CELLS; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; PLASMA-MEMBRANE; SIGNALING PATHWAYS; C. ELEGANS; CALCINEURIN; GENE	Stress in the endoplasmic reticulum caused by tunicamycin, dithiothreitol, and azole-class antifungal drugs can induce nonapoptotic cell death in yeasts that can be blocked by the action of calcineurin (Cn), a Ca2+-dependent serine/threonine protein phosphatase. To identify additional factors that regulate nonapoptotic cell death in yeast, a collection of gene knock-out mutants was screened for mutants exhibiting altered survival rates. The screen revealed an endocytic protein (Ede1) that can function upstream of Ca2+/calmodulin-dependent protein kinase 2 (Cmk2) to suppress cell death in parallel to Cn. The screen also revealed the vacuolar H+-ATPase (V-ATPase), which acidifies the lysosome-like vacuole. The V-ATPase performed its death-promoting functions very soon after imposition of the stress and was not required for later stages of the cell death program. Cn did not inhibit V-ATPase activities but did block vacuole membrane permeabilization (VMP), which occurred at late stages of the cell death program. All of the other nondying mutants identified in the screens blocked steps before VMP. These findings suggest that VMP is the lethal event in dying yeast cells and that fungi may employ a mechanism of cell death similar to the necrosis-like cell death of degenerating neurons.	[Kim, Hyemin; Kim, Adam; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	kwc@jhu.edu		Kim, Adam/0000-0002-3186-3912	National Institutes of Health [GM053082, NS057023, NS074072]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074072, R21NS057023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Awards GM053082, NS057023, and NS074072 (to K. W. C.).	Alby K, 2010, EUKARYOT CELL, V9, P1690, DOI 10.1128/EC.00155-10; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Blum ES, 2008, CELL DEATH DIFFER, V15, P1124, DOI 10.1038/cdd.2008.56; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Fasolo J, 2011, GENE DEV, V25, P767, DOI 10.1101/gad.1998811; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; FOOR F, 1992, NATURE, V360, P682; Gagny B, 2000, J CELL SCI, V113, P3309; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Kane PM, 2005, J BIOENERG BIOMEMBR, V37, P399, DOI 10.1007/s10863-005-9479-7; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Sherman F., 1986, METHODS YEAST GENETI; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Troulinaki K, 2012, EMBO J, V31, P654, DOI 10.1038/emboj.2011.447; van Doorn WG, 2011, J EXP BOT, V62, P4749, DOI 10.1093/jxb/err196; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	64	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19029	19039		10.1074/jbc.M112.363390	http://dx.doi.org/10.1074/jbc.M112.363390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511765	Green Published, hybrid			2022-12-28	WOS:000306411900014
J	Okayasu, M; Nakayachi, M; Hayashida, C; Ito, J; Kaneda, T; Masuhara, M; Suda, N; Sato, T; Hakeda, Y				Okayasu, Mari; Nakayachi, Mai; Hayashida, Chiyomi; Ito, Junta; Kaneda, Toshio; Masuhara, Masaaki; Suda, Naoto; Sato, Takuya; Hakeda, Yoshiyuki			Low-density Lipoprotein Receptor Deficiency Causes Impaired Osteoclastogenesis and Increased Bone Mass in Mice because of Defect in Osteoclastic Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; COLONY-STIMULATING FACTOR; POSTMENOPAUSAL WOMEN; ENDOTHELIAL-CELLS; IN-VITRO; DC-STAMP; MEVALONATE PATHWAY; SIGNALING COMPLEX; PLASMA-MEMBRANES; FAMILY-MEMBER	Osteoporosis is associated with both atherosclerosis and vascular calcification attributed to hyperlipidemia. However, the cellular and molecular mechanisms explaining the parallel progression of these diseases remain unclear. Here, we used low-density lipoprotein receptor knockout (LDLR-/-) mice to elucidate the role of LDLR in regulating the differentiation of osteoclasts, which are responsible for bone resorption. Culturing wild-type osteoclast precursors in medium containing LDL-depleted serum decreased receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast formation, and this defect was additively rescued by simultaneous treatment with native and oxidized LDLs. Osteoclast precursors constitutively expressed LDLR in a RANKL-independent manner. Osteoclast formation from LDLR-/- osteoclast precursors was delayed, and the multinucleated cells formed in culture were smaller and contained fewer nuclei than wild-type cells, implying impaired cell-cell fusion. Despite these findings, RANK signaling, including the activation of Erk and Akt, was normal in LDLR-/- preosteoclasts, and RANKL-induced expression of NFATc1 (a master regulator of osteoclastogenesis), cathepsin K, and tartrate-resistant acid phosphatase was equivalent in LDLR-null and wild-type cells. In contrast, the amounts of the osteoclast fusion-related proteins v-ATPase V-o subunit d2 and dendritic cell-specific transmembrane protein in LDLR-/- plasma membranes were reduced when compared with the wild type, suggesting a correlation with impaired cell-cell fusion, which occurs on the plasma membrane. LDLR-/- mice consistently exhibited increased bone mass in vivo. This change was accompanied by decreases in bone resorption parameters, with no changes in bone formation parameters. These findings provide a novel mechanism for osteoclast differentiation and improve the understanding of the correlation between osteoclast formation and lipids.	[Okayasu, Mari; Nakayachi, Mai; Hayashida, Chiyomi; Ito, Junta; Masuhara, Masaaki; Sato, Takuya; Hakeda, Yoshiyuki] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Oral Anat, Sakado, Saitama 3500283, Japan; [Okayasu, Mari; Nakayachi, Mai; Suda, Naoto] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Orthodont, Sakado, Saitama 3500283, Japan; [Okayasu, Mari] Tokyo Univ Hosp, Dept Sensory & Motor Syst Med, Div Oral Maxillofacial Surg Dent & Orthodont, Tokyo 1138655, Japan; [Kaneda, Toshio] Hoshi Univ, Fac Pharmaceut Sci, Tokyo 1428501, Japan; [Masuhara, Masaaki] Kagoshima Univ, Fac Dent, Dept Appl Pharmacol, Kagoshima 8908544, Japan	Meikai University; Meikai University; University of Tokyo; Hoshi University; Kagoshima University	Hakeda, Y (corresponding author), Meikai Univ, Sch Dent, Div Oral Anat, Sakado, Saitama 350283, Japan.	y-hakeda@dent.meikai.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture [19592130, 21592341]	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japanese Ministry of Education, Science, Sports, and Culture Grants-in-aid for scientific research 19592130 and 21592341 (to Y. H.).	Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Bastiaanse EML, 1997, CARDIOVASC RES, V33, P272, DOI 10.1016/S0008-6363(96)00193-9; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; BROWN MS, 1980, J LIPID RES, V21, P505; Buhagiar KA, 2004, AM J PHYSIOL-CELL PH, V286, pC398, DOI 10.1152/ajpcell.00016.2003; Chiu YH, 2012, J BONE MINER RES, V27, P79, DOI 10.1002/jbmr.531; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grasser W. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P53; Hada N, 2012, BONE, V50, P226, DOI 10.1016/j.bone.2011.10.028; Hartgers FC, 2000, EUR J IMMUNOL, V30, P3585, DOI 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.3.CO;2-P; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jobling MG, 2002, INFECT IMMUN, V70, P1260, DOI 10.1128/IAI.70.3.1260-1271.2002; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kim T, 2009, BIOCHEM BIOPH RES CO, V390, P585, DOI 10.1016/j.bbrc.2009.10.010; KURIHARA N, 1989, BLOOD, V74, P1295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto H., 2012, J BONE MINE IN PRESS; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nagao T, 2007, ARTERIOSCL THROM VAS, V27, P1596, DOI 10.1161/ATVBAHA.107.145086; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; PINALS RS, 1972, LANCET, V2, P929; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; RUDNEY H, 1986, ANNU REV NUTR, V6, P245, DOI 10.1146/annurev.nu.06.070186.001333; Sato R, 1995, CELL STRUCT FUNCT, V20, P421, DOI 10.1247/csf.20.421; Sato T, 1998, BONE, V23, P135, DOI 10.1016/S8756-3282(98)00082-9; Smith AN, 2005, J AM SOC NEPHROL, V16, P1245, DOI 10.1681/ASN.2004090761; SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Takahashi A, 1996, ATHEROSCLEROSIS, V120, P93, DOI 10.1016/0021-9150(95)05686-6; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanko LB, 2003, CALCIFIED TISSUE INT, V73, P15, DOI 10.1007/s00223-002-2070-x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; THORIN E, 1995, ATHEROSCLEROSIS, V114, P185, DOI 10.1016/0021-9150(94)05482-X; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Woo JT, 2005, BIOCHEM PHARMACOL, V69, P87, DOI 10.1016/j.bcp.2004.08.036; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	65	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19229	19241		10.1074/jbc.M111.323600	http://dx.doi.org/10.1074/jbc.M111.323600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500026	Green Published, hybrid			2022-12-28	WOS:000306411900033
J	Pauls, E; Shpiro, N; Peggie, M; Young, ER; Sorcek, RJ; Tan, L; Choi, HG; Cohen, P				Pauls, Eduardo; Shpiro, Natalia; Peggie, Mark; Young, Erick R.; Sorcek, Ronald J.; Tan, Li; Choi, Hwan Geun; Cohen, Philip			Essential Role for IKK beta in Production of Type 1 Interferons by Plasmacytoid Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B KINASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; I INTERFERON; TRANSCRIPTION FACTORS; AUTOIMMUNE-DISEASES; IMMUNE-RESPONSES; ALPHA INDUCTION; GENE INDUCTION; NUCLEIC-ACIDS	Plasmacytoid dendritic cells (pDCs) are characterized by their ability to produce high levels of type 1 interferons in response to ligands that activate TLR7 and TLR9, but the signaling pathways required for IFN production are incompletely understood. Here we exploit the human pDC cell line Gen2.2 and improved pharmacological inhibitors of protein kinases to address this issue. We demonstrate that ligands that activate TLR7 and TLR9 require the TAK1-IKK beta signaling pathway to induce the production of IFN beta via a pathway that is independent of the degradation of I kappa B alpha. We also show that IKK beta activity, as well as the subsequent IFN beta-stimulated activation of the JAK-STAT1/2 signaling pathway, are essential for the production of IFN alpha by TLR9 ligands. We further show that TLR7 ligands CL097 and R848 fail to produce significant amounts of IFN alpha because the activation of IKK beta is not sustained for a sufficient length of time. The TLR7/9-stimulated production of type 1 IFNs is inhibited by much lower concentrations of IKK beta inhibitors than those needed to suppress the production of NF kappa B-dependent proinflammatory cytokines, such as IL-6, suggesting that drugs that inhibit IKK beta may have a potential for the treatment of forms of lupus that are driven by self-RNA and self-DNA-induced activation of TLR7 and TLR9, respectively.	[Pauls, Eduardo; Shpiro, Natalia; Peggie, Mark; Cohen, Philip] Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland; [Young, Erick R.; Sorcek, Ronald J.] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA; [Tan, Li; Choi, Hwan Geun] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Tan, Li; Choi, Hwan Geun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Dundee; Boehringer Ingelheim; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Cohen, P (corresponding author), Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat Unit, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk		Tan, Li/0000-0002-1199-9046; Pauls, Eduardo/0000-0002-2511-0711	United Kingdom Medical Research Council; Medical Research Council [MC_U127084348] Funding Source: researchfish; MRC [MC_U127084348] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Campbell David G, 2002, J Biomol Tech, V13, P119; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Lui G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007111; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770	39	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19216	19228		10.1074/jbc.M112.345405	http://dx.doi.org/10.1074/jbc.M112.345405			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511786	hybrid, Green Published			2022-12-28	WOS:000306411900032
J	Zhao, L; Ericksen, B; Wu, XJ; Zhan, CY; Yuan, WR; Li, X; Pazgier, M; Lu, WY				Zhao, Le; Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Li, Xu; Pazgier, Marzena; Lu, Wuyuan			Invariant Gly Residue Is Important for alpha-Defensin Folding, Dimerization, and Function A CASE STUDY OF THE HUMAN NEUTROPHIL alpha-DEFENSIN HNP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED SALT BRIDGE; ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; MOUSE CRYPTDIN-4; HOST-DEFENSE; PANETH CELLS; BETA-BULGE; PROTEINS; TOXIN	The human alpha-defensins (HNP) are synthesized in vivo as inactive prodefensins, and contain a conserved glycine, Gly(17), which is part of a beta-bulge structure. It had previously been shown that the glycine main chain torsion angles are in a D-configuration, and that D-amino acids but not L-alanine could be substituted at that position to yield correctly folded peptides without the help of a prodomain. In this study, the glycine to L-alanine mutant defensin was synthesized in the form of a prodefensin using native chemical ligation. The ligation product folded correctly and yielded an active peptide upon CNBr cleavage. The L-Ala(17)-HNP1 crystal structure depicted a beta-bulge identical to wild-type HNP1. However, dimerization was perturbed, causing one monomer to tilt with respect to the other in a dimerization model. Inhibitory activity against the anthrax lethal factor showed a 2-fold reduction relative to wild-type HNP1 as measured by the inhibitory concentration IC50. Self-association was slightly reduced, as detected by surface plasmon resonance measurements. According to the results of the virtual colony count assay, the antibacterial activity against Escherichia coli, Staphylococcus aureus, and Bacillus cereus exhibited a less than 2-fold reduction in virtual lethal dose values. Prodefensins with two other L-amino acid substitutions, Arg and Phe, at the same position did not fold, indicating that only small side chains are tolerable. These results further elucidate the factors governing the region of the beta-bulge structure that includes Gly(17), illuminating why glycine is conserved in all mammalian alpha-defensins.	[Zhao, Le; Li, Xu; Pazgier, Marzena; Lu, Wuyuan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian, Peoples R China; [Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Ericksen, Bryan; Wu, Xueji; Zhan, Changyou; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	Xi'an Jiaotong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pazgier, M (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian, Peoples R China.	mpazgier@ihv.umaryland.edu; wlu@ihv.umaryland.edu	Zhan, Changyou/G-3667-2011; Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	DOE Office of Biological and Environmental Research; National Institutes of Health [AI072732, AI061482]; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; Xi'an Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Xi'an Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by National Institutes of Health, National Center for Research Resources, Biomedical Technology Program Grant P41RR001209, and the National Institute of General Medical Sciences.; This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).; Guanghua Scholar supported by Xi'an Jiaotong University School of Medicine.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Andersson H. S., 2012, AMINO ACIDS     0129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernard JJ, 2011, CELL MOL LIFE SCI, V68, P2189, DOI 10.1007/s00018-011-0712-8; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Min DH, 2004, NAT BIOTECHNOL, V22, P717, DOI 10.1038/nbt973; Mitchell JBO, 2003, PROTEINS, V50, P563, DOI 10.1002/prot.10320; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, PEPTIDES, V26, P2377, DOI 10.1016/j.peptides.2005.06.002; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	58	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18900	18912		10.1074/jbc.M112.355255	http://dx.doi.org/10.1074/jbc.M112.355255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496447	Green Published, hybrid			2022-12-28	WOS:000306411900003
J	Bendfeldt, H; Benary, M; Scheel, T; Frischbutter, S; Abajyan, A; Radbruch, A; Herzel, H; Baumgrass, R				Bendfeldt, Hanna; Benary, Manuela; Scheel, Tobias; Frischbutter, Stefan; Abajyan, Anna; Radbruch, Andreas; Herzel, Hanspeter; Baumgrass, Ria			Stable IL-2 Decision Making by Endogenous c-Fos Amounts in Peripheral Memory T-helper Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; PROTEIN-KINASE-C; INTERLEUKIN-2 PROMOTER; ANTIGEN RECEPTOR; GENE-EXPRESSION; MICE LACKING; ACTIVATION; LYMPHOCYTES; RESPONSES; SIGNALS	The cytokine IL-2 performs opposite functions supporting efficient immune responses and playing a key role in peripheral tolerance. Therefore, precise fine-tuning of IL-2 expression is crucial for adjusting the immune response. Combining transcription factor analysis at the single cell and the single nucleus level using flow cytometry with statistical analysis, we showed that physiological differences in the expression levels of c-Fos and NFATc2, but not of c-Jun and NF-kappa Bp65, are limiting for the decision whether IL-2 is expressed in a strongly activated human memory T-helper (Th) cell. Variation in the expression of c-Fos leads to substantial diversity of IL-2 expression in similar to 40% of the memory Th cells. The remaining cells exhibit an equally high c-Fos expression level, thereby ensuring robustness in IL-2 response within the population. These findings reveal how memory Th cells benefit from regulated variation in transcription factor expression to achieve a certain stability and variability of cytokine expression in a controlled manner.	[Bendfeldt, Hanna; Scheel, Tobias; Frischbutter, Stefan; Abajyan, Anna; Radbruch, Andreas; Baumgrass, Ria] Deutsch Rheuma Forschungszentrum Berlin, A Leibniz Inst, D-10117 Berlin, Germany; [Benary, Manuela; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Radbruch, Andreas] Charite, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Baumgrass, R (corresponding author), Deutsch Rheuma Forschungszentrum Berlin, A Leibniz Inst, Charitepl 1, D-10117 Berlin, Germany.	baumgrass@drfz.de	Frischbutter, Stefan/AAM-9487-2021	Frischbutter, Stefan/0000-0003-3971-7343; Benary, Manuela/0000-0002-3067-2030; Radbruch, Andreas/0000-0001-5753-0000; Baumgrass, Ria/0000-0002-3289-1608	German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft [SFB/TR52]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the German Federal Ministry of Education and Research (Forsys-Partner; to R. B. and H. H.) and by Deutsche Forschungsgemeinschaft Grant SFB/TR52 (to R. B. and A. R.).	Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Carson BD, 2007, ANN NY ACAD SCI, V1103, P167, DOI 10.1196/annals.1394.022; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; Chu D, 2009, J THEOR BIOL, V257, P419, DOI 10.1016/j.jtbi.2008.11.026; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Dooms H, 2004, J IMMUNOL, V172, P5973, DOI 10.4049/jimmunol.172.10.5973; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hughes CCW, 1996, J BIOL CHEM, V271, P5369, DOI 10.1074/jbc.271.10.5369; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; OCHI Y, 1994, J IMMUNOL, V153, P3485; Ohori M, 2008, DRUG NEWS PERSPECT, V21, P245, DOI 10.1358/DNP.2008.21.5.1219006; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PETRAK D, 1994, J IMMUNOL, V153, P2046; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691	44	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18386	18397		10.1074/jbc.M112.358853	http://dx.doi.org/10.1074/jbc.M112.358853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474330	Green Published, hybrid			2022-12-28	WOS:000306411600045
J	Choe, J; Oh, N; Park, S; Lee, YK; Song, OK; Locker, N; Chi, SG; Kim, YK				Choe, Junho; Oh, Nara; Park, Sungjin; Lee, Ye Kyung; Song, Ok-Kyu; Locker, Nicolas; Chi, Sung-Gil; Kim, Yoon Ki			Translation Initiation on mRNAs Bound by Nuclear Cap-binding Protein Complex CBP80/20 Requires Interaction between CBP80/20-dependent Translation Initiation Factor and Eukaryotic Translation Initiation Factor 3g	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; MAMMALIAN-CELLS; EIF3; SUBUNIT; SURVEILLANCE; REPRESSION; RECRUITS; REVEALS; OCCURS	In the cytoplasm of mammalian cells, either cap-binding proteins 80 and 20 (CBP80/20) or eukaryotic translation initiation factor (eIF) 4E can direct the initiation of translation. Although the recruitment of ribosomes to mRNAs during eIF4E-dependent translation (ET) is well characterized, the molecular mechanism for CBP80/20-dependent translation (CT) remains obscure. Here, we show that CBP80/20-dependent translation initiation factor (CTIF), which has been shown to be preferentially involved in CT but not ET, specifically interacts with eIF3g, a component of the eIF3 complex involved in ribosome recruitment. By interacting with eIF3g, CTIF serves as an adaptor protein to bridge the CBP80/20 and the eIF3 complex, leading to efficient ribosome recruitment during CT. Accordingly, down-regulation of CTIF using a small interfering RNA causes a redistribution of CBP80 from polysome fractions to subpoly-some fractions, without significant consequence to eIF4E distribution. In addition, down-regulation of eIF3g inhibits the efficiency of nonsense-mediated mRNA decay, which is tightly coupled to CT but not to ET. Moreover, the artificial tethering of CTIF to an intercistronic region of dicistronic mRNA results in translation of the downstream cistron in an eIF3-dependent manner. These findings support the idea that CT mechanistically differs from ET.	[Choe, Junho; Oh, Nara; Park, Sungjin; Chi, Sung-Gil; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Lee, Ye Kyung; Song, Ok-Kyu] Panbionet Corp, Pohang 790784, Kyungbuk, South Korea; [Locker, Nicolas] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 7HX, Surrey, England	Korea University; University of Surrey	Kim, YK (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	yk-kim@korea.ac.kr	Choe, Junho/E-3410-2019	Choe, Junho/0000-0002-2365-3755; Kim, Yoon Ki/0000-0003-1303-072X; Locker, Nicolas/0000-0002-0053-2897	Korea Science and Engineering Foundation (KOSEF) [2009-0084897, 0001197]; Korea Government (MEST); Korea Research Foundation [KRF-2008-314-C00247]; Korean Government (MOEHRD); Seoul Science Fellowship	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Seoul Science Fellowship	This work was supported in part by the Korea Science and Engineering Foundation (KOSEF) Grants 2009-0084897 and 0001197 funded by the Korea Government (MEST) and Korea Research Foundation Grant KRF-2008-314-C00247 funded by the Korean Government (MOEHRD).; Supported in part by a Seoul Science Fellowship.	Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2011, FEBS LETT, V585, P2682, DOI 10.1016/j.febslet.2011.07.047; Choe J, 2010, EMBO REP, V11, P380, DOI 10.1038/embor.2010.44; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; Durand S, 2011, CELL, V145, P324, DOI 10.1016/j.cell.2011.03.038; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Lee HC, 2010, FEBS LETT, V584, P795, DOI 10.1016/j.febslet.2010.01.003; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Locker N, 2011, NUCLEIC ACIDS RES, V39, P2367, DOI 10.1093/nar/gkq1118; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Marin-Vinader L, 2006, BBA-GENE STRUCT EXPR, V1759, P535, DOI 10.1016/J.bbaexp.2006.10.003; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Oh N, 2007, FEBS LETT, V581, P5158, DOI 10.1016/j.febslet.2007.10.002; Oh N, 2007, BIOCHEM BIOPH RES CO, V362, P145, DOI 10.1016/j.bbrc.2007.07.169; Oh YL, 1998, BIOCHEM J, V331, P169, DOI 10.1042/bj3310169; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	35	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18500	18509		10.1074/jbc.M111.327528	http://dx.doi.org/10.1074/jbc.M111.327528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493286	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000306411600056
J	Mcneil, MB; Clulow, JS; Wilf, NM; Salmond, GPC; Fineran, PC				Mcneil, Matthew B.; Clulow, James S.; Wilf, Nabil M.; Salmond, George P. C.; Fineran, Peter C.			SdhE Is a Conserved Protein Required for Flavinylation of Succinate Dehydrogenase in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GGDEF/EAL DOMAIN PROTEIN; COVALENTLY BOUND FLAVIN; ANTIBIOTIC BIOSYNTHESIS; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; SERRATIA; FAD; PRODIGIOSIN; ATTACHMENT; FLAVOPROTEIN	Conserved uncharacterized genes account for similar to 30% of genes in both eukaryotic and bacterial genomes and are predicted to encode what are often termed "conserved hypothetical proteins." Many of these proteins have a wide phylogenetic distribution and might play important roles in conserved cellular pathways. Using the bacterium Serratia as a model system, we have investigated two conserved uncharacterized proteins, YgfY (a DUF339 protein, renamed SdhE; (s) under bar uccinate (d) under bare (h) under bar ydrogenase protein (E) under bar) and YgfX (a DUF1434 protein). SdhE was required for growth on succinate as a sole carbon source and for the function, but not stability, of succinate dehydrogenase, an important component of the electron transport chain and the tricarboxylic acid cycle. SdhE interacted with the flavoprotein SdhA, directly bound the flavin adenine dinucleotide co-factor, and was required for the flavinylation of SdhA. This is the first demonstration of a protein required for FAD incorporation in bacteria. Furthermore, the loss of SdhE was highly pleiotropic, suggesting that SdhE might flavinylate other flavoproteins. Our findings are of wide importance to central metabolism because SdhE homologues are present in alpha-, beta-, and gamma-proteobacteria and multiple eukaryotes, including humans and yeast.	[Mcneil, Matthew B.; Clulow, James S.; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Wilf, Nabil M.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Otago; University of Cambridge	Fineran, PC (corresponding author), Univ Otago, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.	peter.fineran@otago.ac.nz	Fineran, Peter C/A-5766-2012	Fineran, Peter C/0000-0002-4639-6704; McNeil, Matthew/0000-0001-7747-7745	Royal Society of New Zealand; Biotechnology and Biological Sciences Research Council; Tertiary Education Commission, New Zealand; Gates Foundation	Royal Society of New Zealand(Royal Society of New Zealand); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tertiary Education Commission, New Zealand; Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a Marsden Fund, Royal Society of New Zealand grant (to P. C. F.). The C. elegans work was funded by the Biotechnology and Biological Sciences Research Council (to G.P. C. S.).; Funded by a Top Achievers Doctoral Scholarship, Tertiary Education Commission, New Zealand.; Funded by the Gates Foundation.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ANRAKU Y, 1988, ANNU REV BIOCHEM, V57, P101, DOI 10.1146/annurev.bi.57.070188.000533; Baba Tomoya, 2006, Mol Syst Biol, V2; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BRANDSCH R, 1989, EUR J BIOCHEM, V182, P125, DOI 10.1111/j.1432-1033.1989.tb14808.x; BURGER SR, 1985, APPL ENVIRON MICROB, V50, P487, DOI 10.1128/AEM.50.2.487-490.1985; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P206; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; Fineran PC, 2005, MOL MICROBIOL, V56, P1495, DOI 10.1111/j.1365-2958.2005.04660.x; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Gristwood Tamzin, 2011, J Bacteriol, V193, P1076, DOI 10.1128/JB.00352-10; Gristwood T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-112; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Haddix PL, 2008, J BACTERIOL, V190, P7453, DOI 10.1128/JB.00909-08; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; HEDERSTEDT L, 1981, MICROBIOL REV, V45, P542, DOI 10.1128/MMBR.45.4.542-555.1981; HEDERSTEDT L, 1983, EUR J BIOCHEM, V132, P589, DOI 10.1111/j.1432-1033.1983.tb07404.x; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jin J, 2008, FEBS J, V275, P5191, DOI 10.1111/j.1742-4658.2008.06649.x; Kunst HPM, 2011, CLIN CANCER RES, V17, P247, DOI 10.1158/1078-0432.CCR-10-0420; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; PARK SJ, 1995, MOL MICROBIOL, V15, P473, DOI 10.1111/j.1365-2958.1995.tb02261.x; Qiagen Inc., 2003, QIAEXPRESSIONIST; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Robinson KM, 1996, J BIOL CHEM, V271, P4055; ROBINSON KM, 1994, EUR J BIOCHEM, V222, P983, DOI 10.1111/j.1432-1033.1994.tb18949.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sousa PMF, 2011, BIOCHIMIE, V93, P418, DOI 10.1016/j.biochi.2010.10.014; Stevens JM, 2005, BIOCHEM SOC T, V33, P792, DOI 10.1042/BST0330792; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	47	49	54	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18418	18428		10.1074/jbc.M111.293803	http://dx.doi.org/10.1074/jbc.M111.293803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474332	Green Published, hybrid			2022-12-28	WOS:000306411600048
J	Pierrat, MJ; Marsaud, V; Mauviel, A; Javelaud, D				Pierrat, Marie-Jeanne; Marsaud, Veronique; Mauviel, Alain; Javelaud, Delphine			Expression of Microphthalmia-associated Transcription Factor (MITF), Which Is Critical for Melanoma Progression, Is Inhibited by Both Transcription Factor GLI2 and Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-EXPRESSION; TGF-BETA; STABLE OVEREXPRESSION; SKI ONCOPROTEIN; CELLS; VITRO; METASTASIS; PROTEINS; INVASION	The melanocyte-specific transcription factor M-MITF is involved in numerous aspects of melanoblast lineage biology including pigmentation, survival, and migration. It plays complex roles at all stages of melanoma progression and metastasis. We established previously that GLI2, a Kruppel-like transcription factor that acts downstream of Hedgehog signaling, is a direct transcriptional target of the TGF-beta/SMAD pathway and contributes to melanoma progression, exerting antagonistic activities against M-MITF to control melanoma cell invasiveness. Herein, we dissected the molecular mechanisms underlying both TGF-beta and GLI2-driven M-MITF gene repression. Using transient cell transfection experiments with M-MITF promoter constructs, chromatin immunoprecipitation, site-directed mutagenesis, and electrophoretic mobility shift assays, we identified a GLI2 binding site within the -334/-296 region of the M-MITF promoter, critical for GLI2-driven transcriptional repression. This region is, however, not needed for inhibition of M-MITF promoter activity by TGF-beta. We determined that TGF-beta rapidly repressed protein kinase A activity, thus reducing both phospho-cAMP-response element-binding protein (CREB) levels and CREB-dependent transcription of the M-MITF promoter. Increased GLI2 binding to its cognate cis-element, associated with reduced CREB-dependent transcription, allowed maximal inhibition of the M-MITF promoter via two distinct mechanisms.	[Mauviel, Alain] Inst Curie, Ctr Rech, INSERM, CNRS,U1021,UMR3347,Univ Ctr,Team TGP, F-91400 Orsay, France; Univ Paris 11, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Mauviel, A (corresponding author), Inst Curie, Ctr Rech, INSERM, CNRS,U1021,UMR3347,Univ Ctr,Team TGP, Bldg 110, F-91400 Orsay, France.	alain.mauviel@curie.fr; delphine.javelaud@curie.fr	MAUVIEL, Alain/F-6251-2013; Javelaud, Delphine/B-1129-2019	Javelaud, Delphine/0000-0002-7674-7739; Mauviel, Alain/0000-0002-0438-2793	Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE) [EL2011-AM]; INCa [PLBIO08-126]; Emile and Henriette Goutiere; Association pour la Recherche contre le Cancer; Institut Curie, INSERM; CNRS; Canceropole Ile-de-France and Fondation pour la Recherche Medicale	Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE); INCa(Institut National du Cancer (INCA) France); Emile and Henriette Goutiere; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut Curie, INSERM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Canceropole Ile-de-France and Fondation pour la Recherche Medicale	This work was supported by Ligue Nationale Contre le Cancer (Equipe Labellisee LIGUE EL2011-AM), INCa (PLBIO08-126) and a donation from Emile and Henriette Goutiere (to A. M.), Association pour la Recherche contre le Cancer (to D. J.), and institutional funding from Institut Curie, INSERM, and CNRS.; Recipient of a Ph.D. scholarship awarded by Canceropole Ile-de-France and Fondation pour la Recherche Medicale.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; DiVito KA, 2010, PIGM CELL MELANOMA R, V23, P795, DOI 10.1111/j.1755-148X.2010.00758.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Javelaud D, 2004, INT J BIOCHEM CELL B, V36, P1161, DOI 10.1016/S1357-2725(03)00255-3; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Javelaud D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-2; Kump E, 2008, ONCOGENE, V27, P3856, DOI 10.1038/onc.2008.5; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Rodeck U, 1999, CANCER RES, V59, P547; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x	35	53	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17996	18004		10.1074/jbc.M112.358341	http://dx.doi.org/10.1074/jbc.M112.358341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496449	hybrid, Green Published			2022-12-28	WOS:000306411600009
J	So, CH; Michal, AM; Mashayekhi, R; Benovic, JL				So, Christopher H.; Michal, Allison M.; Mashayekhi, Rouzbeh; Benovic, Jeffrey L.			G Protein-coupled Receptor Kinase 5 Phosphorylates Nucleophosmin and Regulates Cell Sensitivity to Polo-like Kinase 1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION; TUMOR-GROWTH; HELA-CELLS; EXPRESSION; ARRESTINS; BINDING; GRK5; ACTIVATION; MEMBRANE; CANCER	G protein-coupled receptor kinases (GRKs) phosphorylate activated G protein-coupled receptors, leading to their desensitization and endocytosis. GRKs have also been implicated in phosphorylating other classes of proteins and can localize in a variety of cellular compartments, including the nucleus. Here, we attempted to identify potential nuclear substrates for GRK5. Our studies reveal that GRK5 is able to interact with and phosphorylate nucleophosmin (NPM1) both in vitro and in intact cells. NPM1 is a nuclear protein that regulates a variety of cell functions including centrosomal duplication, cell cycle control, and apoptosis. GRK5 interaction with NPM1 is mediated by the N-terminal domain of each protein, and GRK5 primarily phosphorylates NPM1 at Ser-4, a site shared with polo-like kinase 1 (PLK1). NPM1 phosphorylation by GRK5 and PLK1 correlates with the sensitivity of cells to undergo apoptosis with cells having higher GRK5 levels being less sensitive and cells with lower GRK5 being more sensitive to PLK1 inhibitor-induced apoptosis. Taken together, our results demonstrate that GRK5 phosphorylates Ser-4 in nucleophosmin and regulates the sensitivity of cells to PLK1 inhibition.	[So, Christopher H.; Michal, Allison M.; Mashayekhi, Rouzbeh; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu			National Institutes of Health [GM44944, CA129626]; Canadian Heart and Stroke Foundation; NATIONAL CANCER INSTITUTE [R01CA129626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944 and CA129626 (to J. L. B.).; Supported in part by a research fellowship from the Canadian Heart and Stroke Foundation.	Ackermann S, 2011, CLIN CANCER RES, V17, P731, DOI 10.1158/1078-0432.CCR-10-1129; Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Bychkov ER, 2011, NEUROBIOL DIS, V44, P248, DOI 10.1016/j.nbd.2011.07.009; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carey MF, 2009, COLD SPRING HARB PRO, V2009; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; CHAN PK, 1995, BBA-GENE STRUCT EXPR, V1262, P37, DOI 10.1016/0167-4781(95)00044-H; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Garcia-Sevilla JA, 2010, EUR NEUROPSYCHOPHARM, V20, P721, DOI 10.1016/j.euroneuro.2010.04.008; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Huang Z.M., 2012, FRONT BIOSCI, V17, P3047; Ito T, 2011, INT J CANCER, V129, P2134, DOI 10.1002/ijc.25874; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; KIM CM, 1993, RECEPTOR, V3, P39; Kim JI, 2012, J UROLOGY, V187, P322, DOI 10.1016/j.juro.2011.09.049; Krause A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009849; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Matsubayashi I, 2008, J PATHOL, V216, P317, DOI 10.1002/path.2414; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ruiz-Gomez A, 2000, J BIOL CHEM, V275, P29724, DOI 10.1074/jbc.M001864200; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Tiedemann RE, 2010, BLOOD, V115, P1594, DOI 10.1182/blood-2009-09-243980; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wang LH, 2009, ONCOL REP, V22, P1333, DOI 10.3892/or_00000572; Woerner BM, 2012, MOL CANCER RES, V10, P156, DOI 10.1158/1541-7786.MCR-11-0411; Wu JH, 2012, ARTERIOSCL THROM VAS, V32, P308, DOI 10.1161/ATVBAHA.111.239608; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200; Zhang WB, 2007, MOL PHARMACOL, V72, P1310, DOI 10.1124/mol.107.037119	59	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17088	17099		10.1074/jbc.M112.353854	http://dx.doi.org/10.1074/jbc.M112.353854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467873	Green Published, hybrid			2022-12-28	WOS:000306373000009
J	Huls, D; Storchova, Z; Niessing, D				Huels, Daniela; Storchova, Zuzana; Niessing, Dierk			Post-translational Modifications Regulate Assembly of Early Spindle Orientation Complex in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-BINDING PROTEIN-1; MITOTIC SPINDLE; PLUS END; GENES; MICROTUBULES; RECRUITMENT; INSIGHTS; REVEALS; DOMAIN; KAR9P	Mitosis begins with the tethering of chromosomes to the mitotic spindle and their orientation perpendicular to the axis of cell division. In budding yeast, mitotic spindle orientation and the subsequent chromosome segregation are two independent processes. Early spindle orientation is driven by the actin-bound myosin Myo2p, which interacts with the adapter Kar9p. The latter also binds to microtubule-associated Bim1p, thereby connecting both types of cytoskeleton. This study focuses on the interaction between Kar9p and Bim1p and its regulation. We solved the crystal structure of the previously reported Kar9p-binding motif of Bim1p and identified a second, novel Kar9p interaction domain. We further show that two independent post-translational modification events regulate their interaction. Whereas Kar9p sumoylation is required for efficient complex formation with Bim1p, Aurora B/Ipl1p-dependent phosphorylation of Bim1p down-regulates their interaction. The observed effects of these modifications allow us to propose a novel regulatory framework for the assembly and disassembly of the early spindle orientation complex.	[Huels, Daniela; Niessing, Dierk] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Biol Struct, D-85764 Neuherberg, Germany; [Huels, Daniela; Niessing, Dierk] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Huels, Daniela; Niessing, Dierk] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Storchova, Zuzana] Max Planck Inst Biochem, Grp Maintenance Genome Stabil, D-82152 Martinsried, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Max Planck Society	Niessing, D (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Biol Struct, D-85764 Neuherberg, Germany.	niessing@helmholtz-muenchen.de	Niessing, Dierk/M-4619-2014; Niessing, Dierk/AAE-4936-2022	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X; Storchova, Zuzana/0000-0003-2376-7047	Helmholtz Association; Deutsche Forschungsgemeinschaft	Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Helmholtz Association (to D. N.) and the Deutsche Forschungsgemeinschaft (to Z. S. and D. N.).	Adams A, 1997, METHODS YEAST GENETI; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bricogne G., 2010, BUSTER; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Leisner C, 2008, CURR BIOL, V18, P1249, DOI 10.1016/j.cub.2008.07.091; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meednu N, 2008, GENETICS, V180, P2033, DOI 10.1534/genetics.108.095042; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	37	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16238	16245		10.1074/jbc.M112.347872	http://dx.doi.org/10.1074/jbc.M112.347872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22461628	hybrid, Green Published			2022-12-28	WOS:000304030900016
J	Lohmiller, T; Cox, N; Su, JH; Messinger, J; Lubitz, W				Lohmiller, Thomas; Cox, Nicholas; Su, Ji-Hu; Messinger, Johannes; Lubitz, Wolfgang			The Basic Properties of the Electronic Structure of the Oxygen-evolving Complex of Photosystem II Are Not Perturbed by Ca2+ Removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINACH THYLAKOID MEMBRANES; WATER-OXIDIZING COMPLEX; STATE MULTILINE SIGNAL; KDA EXTRINSIC PROTEIN; CALCIUM-BINDING SITE; MANGANESE CLUSTER; S-2 STATE; PARAMAGNETIC-RES; CRYSTAL-STRUCTURE; PULSE EPR	Ca2+ is an integral component of the Mn4O5Ca cluster of the oxygen-evolving complex in photosystem II (PS II). Its removal leads to the loss of the water oxidizing functionality. The S-2' state of the Ca2+-depleted cluster from spinach is examined by X-and Q-band EPR and Mn-55 electron nuclear double resonance (ENDOR) spectroscopy. Spectral simulations demonstrate that upon Ca2+ removal, its electronic structure remains essentially unaltered, i.e. that of a manganese tetramer. No redistribution of the manganese valence states and only minor perturbation of the exchange interactions between the manganese ions were found. Interestingly, the S-2' state in spinach PS II is very similar to the native S-2 state of Thermosynechococcus elongatus in terms of spin state energies and insensitivity to methanol addition. These results assign the Ca2+ a functional as opposed to a structural role in water splitting catalysis, such as (i) being essential for efficient proton-coupled electron transfer between Y-Z and the manganese cluster and/or (ii) providing an initial binding site for substrate water. Additionally, a novel Mn-55(2+) signal, detected by Q-band pulse EPR and ENDOR, was observed in Ca2+-depleted PS II. Mn2+ titration, monitored by Mn-55 ENDOR, revealed a specific Mn2+ binding site with a submicromolar K-D. Ca2+ titration of Mn2+-loaded, Ca2+-depleted PS II demonstrated that the site is reversibly made accessible to Mn2+ by Ca2+ depletion and reconstitution. Mn2+ is proposed to bind at one of the extrinsic subunits. This process is possibly relevant for the formation of the Mn4O5Ca cluster during photoassembly and/or D1 repair.	[Lohmiller, Thomas; Cox, Nicholas; Su, Ji-Hu; Lubitz, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Messinger, Johannes] Umea Univ, Dept Chem, Chem Biol Ctr KBC, S-90187 Umea, Sweden	Max Planck Society; Umea University	Lubitz, W (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	wolfgang.lubitz@mpi-mail.mpg.de	Cox, Nicholas/J-8047-2014; Messinger, Johannes/AAC-4221-2019	Cox, Nicholas/0000-0002-7815-6115; Messinger, Johannes/0000-0003-2790-7721; Lohmiller, Thomas/0000-0003-0373-1506	Max Planck Gesellschaft; EU/Energy Network project SOLAR-H2 (FP7) [212508]; Federal Ministry of Education and Research of Germany (BMBF) [03SF0355C]; National Natural Science Foundation of China [31070211]; Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment); K&A Wallenberg foundation (Artificial Leaf project Umea); Kempe foundation	Max Planck Gesellschaft(Max Planck Society); EU/Energy Network project SOLAR-H2 (FP7); Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment); K&A Wallenberg foundation (Artificial Leaf project Umea); Kempe foundation	This work was supported by Max Planck Gesellschaft and the EU/Energy Network project SOLAR-H2 (FP7 Contract 212508).; Supported by the Federal Ministry of Education and Research of Germany (BMBF) in the framework of the Bio-H2 project (03SF0355C).; Supported by the National Natural Science Foundation of China (31070211). Present address: Dept. of Modern Physics, University of Science and Technology of China, Hefei, Anhui 230026, China.; Supported by Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment), the K&A Wallenberg foundation (Artificial Leaf project Umea), and the Kempe foundation.	ABRAMOWICZ DA, 1984, BIOCHIM BIOPHYS ACTA, V765, P318, DOI 10.1016/0005-2728(84)90172-5; Ahrling KA, 1998, BIOCHEMISTRY-US, V37, P8115, DOI 10.1021/bi980117o; Ahrling KA, 2004, BBA-BIOENERGETICS, V1656, P66, DOI 10.1016/j.bbabio.2004.01.006; Ahrling KA, 2006, BIOCHEMISTRY-US, V45, P7069, DOI 10.1021/bi052146m; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2005, BBA-BIOENERGETICS, V1708, P63, DOI 10.1016/j.bbabio.2005.01.005; Bondarava N, 2007, BBA-BIOENERGETICS, V1767, P583, DOI 10.1016/j.bbabio.2007.01.001; Booth PJ, 1996, BBA-BIOENERGETICS, V1277, P127, DOI 10.1016/S0005-2728(96)00094-1; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; Boussac A, 1997, J BIOL INORG CHEM, V2, P580, DOI 10.1007/s007750050172; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; BOUSSAC A, 1988, FEBS LETT, V236, P432, DOI 10.1016/0014-5793(88)80071-1; BOUSSAC A, 1985, BIOCHIM BIOPHYS ACTA, V808, P231, DOI 10.1016/0005-2728(85)90004-0; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; CASEY JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P21, DOI 10.1016/0005-2728(84)90075-6; Charlot MF, 2005, BBA-BIOENERGETICS, V1708, P120, DOI 10.1016/j.bbabio.2005.01.006; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Epel B, 2005, CONCEPT MAGN RESON B, V26B, P36, DOI 10.1002/cmr.b.20037; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Force DA, 1998, J AM CHEM SOC, V120, P13321, DOI 10.1021/ja982713b; GERRITSEN HJ, 1963, PHYS REV, V132, P1507, DOI 10.1103/PhysRev.132.1507; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Grasse N, 2011, J BIOL CHEM, V286, P29548, DOI 10.1074/jbc.M111.238394; Griffith J., 2009, THEORY TRANSITION ME; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Heredia P, 2003, BIOCHEMISTRY-US, V42, P11831, DOI 10.1021/bi034582j; Hillier W, 2005, ADV PHOTO RESPIRAT, V22, P567; Hillier W, 2008, COORDIN CHEM REV, V252, P306, DOI 10.1016/j.ccr.2007.09.004; Horner O, 1998, J AM CHEM SOC, V120, P7924, DOI 10.1021/ja981330a; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Komenda J., 2011, SELF HEALING NANOSCA, P3; Kruk J, 2003, BIOCHEMISTRY-US, V42, P14862, DOI 10.1021/bi0351413; Kulik L, 2005, PHOTOSYNTH RES, V84, P347, DOI 10.1007/s11120-005-2438-7; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; KUSUNOKI M, 1992, CHEM PHYS LETT, V197, P108, DOI 10.1016/0009-2614(92)86031-C; Kusunoki M, 2007, BBA-BIOENERGETICS, V1767, P484, DOI 10.1016/j.bbabio.2007.03.012; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Lohmiller T., 2010, P 15 INT C PHOT BEIJ; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LORIGAN GA, 1994, BIOCHEMISTRY-US, V33, P12072, DOI 10.1021/bi00206a009; Lu YK, 2005, PLANT CELL PHYSIOL, V46, P1944, DOI 10.1093/pcp/pci209; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; MESSINGER J, 1995, P NATL ACAD SCI USA, V92, P3209, DOI 10.1073/pnas.92.8.3209; Messinger J., 2008, PRIMARY PROCESSES PH, P291; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Murray JW, 2006, BIOCHEMISTRY-US, V45, P4128, DOI 10.1021/bi052503t; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; ONO TA, 1989, ARCH BIOCHEM BIOPHYS, V275, P440, DOI 10.1016/0003-9861(89)90390-1; PACE RJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P161, DOI 10.1016/S0005-2728(05)80233-6; Pantazis DA, 2009, PHYS CHEM CHEM PHYS, V11, P6788, DOI 10.1039/b907038a; Pecoraro VL, 1998, PURE APPL CHEM, V70, P925, DOI 10.1351/pac199870040925; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Roberts AG, 2003, BBA-BIOENERGETICS, V1604, P23, DOI 10.1016/S0005-2728(03)00021-5; RUTHERFORD AW, 1984, BIOCHIM BIOPHYS ACTA, V767, P168, DOI 10.1016/0005-2728(84)90092-6; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Siegbahn PEM, 2009, DALTON T, P10063, DOI 10.1039/b909470a; SIVARAJA M, 1989, BIOCHEMISTRY-US, V28, P9459, DOI 10.1021/bi00450a032; Stich TA, 2011, BIOCHEMISTRY-US, V50, P7390, DOI 10.1021/bi2010703; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STURGEON BE, 1994, J PHYS CHEM-US, V98, P12871, DOI 10.1021/j100100a012; Su JH, 2011, BBA-BIOENERGETICS, V1807, P829, DOI 10.1016/j.bbabio.2011.03.002; Teutloff C, 2006, FEBS LETT, V580, P3605, DOI 10.1016/j.febslet.2006.05.039; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; TSO J, 1991, BIOCHEMISTRY-US, V30, P4734, DOI 10.1021/bi00233a014; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vrettos JS, 2001, BIOCHEMISTRY-US, V40, P7937, DOI 10.1021/bi010679z; Yachandra VK, 2011, J PHOTOCH PHOTOBIO B, V104, P51, DOI 10.1016/j.jphotobiol.2011.02.019; Yachandra VK, 2005, ADV PHOTO RESPIRAT, V22, P235; YAMAMOTO Y, 1984, FEBS LETT, V175, P429, DOI 10.1016/0014-5793(84)80782-6; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhang LX, 1996, PHOTOSYNTH RES, V48, P379, DOI 10.1007/BF00029470; Zheng M, 1996, INORG CHEM, V35, P3307, DOI 10.1021/ic9512340; ZIMMERMANN JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P160, DOI 10.1016/0005-2728(84)90091-4; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	100	53	53	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24721	24733		10.1074/jbc.M112.365288	http://dx.doi.org/10.1074/jbc.M112.365288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22549771	Green Published, hybrid			2022-12-28	WOS:000306651100065
J	Magnone, M; Bauer, I; Poggi, A; Mannino, E; Sturla, L; Brini, M; Zocchi, E; De Flora, A; Nencioni, A; Bruzzone, S				Magnone, Mirko; Bauer, Inga; Poggi, Alessandro; Mannino, Elena; Sturla, Laura; Brini, Marisa; Zocchi, Elena; De Flora, Antonio; Nencioni, Alessio; Bruzzone, Santina			NAD(+) Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CALCIUM; 2ND-MESSENGER; CD38; ACTIVATION; CELLS; BCL-2; INHIBITION; INFLUX; PROLIFERATION	Intracellular NAD(+) levels ([NAD(+)](i)) are important in regulating human T lymphocyte survival, cytokine secretion, and the capacity to respond to antigenic stimuli. NAD(+)-derived Ca2+-mobilizing second messengers, produced by CD38, play a pivotal role in T cell activation. Here we demonstrate that [NAD(+)] i modifications in T lymphocytes affect intracellular Ca2+ homeostasis both in terms of mitogen-induced [Ca2+](i) increase and of endoplasmic reticulum Ca2+ store replenishment. Lowering [NAD(+)](i) by FK866-mediated nicotinamide phosphoribosyltransferase inhibition decreased the mitogen-induced [Ca2+](i) rise in Jurkat cells and in activated T lymphocytes. Accordingly, the Ca2+ content of thapsigargin-sensitive Ca2+ stores was greatly reduced in these cells in the presence of FK866. When NAD(+) levels were increased by supplementing peripheral blood lymphocytes with the NAD(+) precursors nicotinamide, nicotinic acid, or nicotinamide mononucleotide, the Ca2+ content of thapsigargin-sensitive Ca2+ stores as well as cell responsiveness to mitogens in terms of [Ca2+](i) elevation were up-regulated. The use of specific siRNA showed that the changes of Ca2+ homeostasis induced by NAD(+) precursors are mediated by CD38 and the consequent ADPR-mediated TRPM2 gating. Finally, the presence of NAD(+) precursors up-regulated important T cell functions, such as proliferation and IL-2 release in response to mitogens.	[Bauer, Inga; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Magnone, Mirko; Mannino, Elena; Sturla, Laura; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Magnone, Mirko; Mannino, Elena; Sturla, Laura; De Flora, Antonio; Nencioni, Alessio] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Poggi, Alessandro] IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, I-16132 Genoa, Italy; [Zocchi, Elena; Bruzzone, Santina] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Brini, Marisa] Univ Padua, Dept Comparat Biomed & Food Sci, I-35131 Padua, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Padua	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy.	alessio.nencioni@unige.it; santina.bruzzone@unige.it	Nencioni, Alessio/K-3692-2018; Brini, Marisa/K-5189-2016; Poggi, Alessandro/K-6664-2016; Bruzzone, Santina/A-4264-2015	Poggi, Alessandro/0000-0002-1860-430X; Bruzzone, Santina/0000-0003-2034-3716; Brini, Marisa/0000-0001-5141-0243; NENCIONI, ALESSIO/0000-0001-5068-8884	Italian Ministry of Education, University and Scientific Research; Italian Ministry of Health; University of Genova; Fondazione CARIGE; Compagnia di S. Paolo; Regione Liguria; Fondazione Italiana Sclerosi Multipla (FISM); Associazione Italiana per la Ricerca sul Cancro (AIRC) [8761]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); University of Genova; Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo); Regione Liguria(Regione Liguria); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Education, University and Scientific Research, the Italian Ministry of Health, the University of Genova, the Fondazione CARIGE, the Compagnia di S. Paolo, the Regione Liguria, the Fondazione Italiana Sclerosi Multipla (FISM), and the Associazione Italiana per la Ricerca sul Cancro (AIRC, START-UP grant (to A. N.) and AIRC n.8761 (to A. P.)).	Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belka C, 2000, ONCOGENE, V19, P1181, DOI 10.1038/sj.onc.1203401; BERGER SJ, 1987, EXP CELL RES, V169, P149, DOI 10.1016/0014-4827(87)90233-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MOL MED, V4, P239, DOI 10.2174/1566524043360771; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Musso A, 2011, HAEMATOL-HEMATOL J, V96, P16, DOI 10.3324/haematol.2010.031633; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wosikowski K, 2002, CANCER RES, V62, P1057; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	65	43	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21067	21081		10.1074/jbc.M111.324269	http://dx.doi.org/10.1074/jbc.M111.324269			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547068	hybrid, Green Published			2022-12-28	WOS:000306416800028
J	Moshitzky, S; Asher, C; Garty, H				Moshitzky, Shiri; Asher, Carol; Garty, Haim			Intracellular Trafficking of FXYD1 (Phospholemman) and FXYD7 Proteins in Xenopus Oocytes and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC NA+/CA2+ EXCHANGER; O-GLYCOSYLATION; PLASMA-MEMBRANE; KINASE-C; FUNCTIONAL INTERACTIONS; CHANNEL ACTIVITY; ALPHA-SUBUNIT; GAMMA-SUBUNIT; ION-TRANSPORT; PUMP FUNCTION	FXYD proteins are a group of short single-span transmembrane proteins that interact with the Na+/K+ ATPase and modulate its kinetic properties. This study characterizes intracellular trafficking of two FXYD family members, FXYD1 (phospholemman (PLM)) and FXYD7. Surface expression of PLM in Xenopus oocytes requires coexpression with the Na+/K+ ATPase. On the other hand, the Na+/Ca2+ exchanger, another PLM-interacting protein could not drive it to the cell surface. The Na+/K+ ATPase-dependent surface expression of PLM could be facilitated by either a phosphorylation-mimicking mutation at Thr-69 or a truncation of three terminal arginine residues. Unlike PLM, FXYD7 could translocate to the cell surface of Xenopus oocytes independently of the coexpression of alpha 1 beta 1 Na+/K+ ATPase. The Na+/K+ ATPase-independent membrane translocation of FXYD7 requires O-glycosylation of at least two of three conserved threonines in its ectodomain. Subsequent experiments in mammalian cells confirmed the role of conserved extracellular threonine residues and demonstrated that FXYD7 protein, in which these have been mutated to alanine, is trapped in the endoplasmic reticulum and Golgi apparatus.	[Moshitzky, Shiri; Asher, Carol; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Garty, H (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	h.garty@weizmann.ac.il			Israel Science Foundation [688/11]	Israel Science Foundation(Israel Science Foundation)	This study was supported by Israel Science Foundation Research Grant 688/11.	Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Cheung JY, 2008, AM J PHYSIOL-HEART C, V294, pH584, DOI 10.1152/ajpheart.91430.2007; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Crambert G, 2003, ANN NY ACAD SCI, V986, P444, DOI 10.1111/j.1749-6632.2003.tb07227.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Fuzesi M, 2005, J BIOL CHEM, V280, P18291, DOI 10.1074/jbc.M500080200; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Guo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1203, DOI 10.1152/ajpcell.00149.2010; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hennebicq-Reig S, 1998, BIOCHEM J, V334, P283, DOI 10.1042/bj3340283; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Kanno E, 2008, J NEUROSCI RES, V86, P1036, DOI 10.1002/jnr.21568; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li CM, 2005, J BIOL CHEM, V280, P42738, DOI 10.1074/jbc.M508451200; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Lubarski I, 2011, AM J PHYSIOL-RENAL, V301, pF1270, DOI 10.1152/ajprenal.00142.2011; Madhani M, 2010, AM J PHYSIOL-HEART C, V299, pH827, DOI 10.1152/ajpheart.00129.2010; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Miller TJ, 2008, AM J PHYSIOL-LUNG C, V294, pL654, DOI 10.1152/ajplung.00430.2007; Minor NT, 1998, P NATL ACAD SCI USA, V95, P6521, DOI 10.1073/pnas.95.11.6521; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; Mounsey JP, 1999, BBA-MOL CELL RES, V1451, P305, DOI 10.1016/S0167-4889(99)00102-0; Nam JS, 2007, CANCER LETT, V255, P161, DOI 10.1016/j.canlet.2007.02.018; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2012, AM J PHYSIOL-HEART C, V302, pH770, DOI 10.1152/ajpheart.00733.2011; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Wang JF, 2006, J BIOL CHEM, V281, P32004, DOI 10.1074/jbc.M606876200; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; WILCHEK M, 1986, BIOCHEM BIOPH RES CO, V138, P872, DOI 10.1016/S0006-291X(86)80577-0; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	56	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21130	21141		10.1074/jbc.M112.347807	http://dx.doi.org/10.1074/jbc.M112.347807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535957	hybrid, Green Published			2022-12-28	WOS:000306416800034
J	Wang, JH; Sasaki, J; Tsai, AL; Spudich, JL				Wang, Jihong; Sasaki, Jun; Tsai, Ah-lim; Spudich, John L.			HAMP Domain Signal Relay Mechanism in a Sensory Rhodopsin-Transducer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; BACTERIAL CHEMORECEPTORS; II/TRANSDUCER COMPLEX; CHEMOTAXIS RECEPTORS; MEMBRANE-PROTEINS; LINKER REGION; HELICES; MODEL; PHOTOTAXIS; ASPARTATE	The phototaxis receptor complex composed of sensory rhodopsin II (SRII) and the transducer subunit HtrII mediates photorepellent responses in haloarchaea. Light-activated SRII transmits a signal through two HAMP switch domains (HAMP1 and HAMP2) in HtrII that bridge the photoreceptive membrane domain of the complex and the cytoplasmic output kinase-modulating domain. HAMP domains, widespread signal relay modules in prokaryotic sensors, consist of four-helix bundles composed of two helices, AS1 and AS2, from each of two dimerized transducer subunits. To examine their molecular motion during signal transmission, we incorporated SRII-HtrII dimeric complexes in nanodiscs to allow unrestricted probe access to the cytoplasmic side HAMP domains. Spin-spin dipolar coupling measurements confirmed that in the nanodiscs, SRII photoactivation induces helix movement in the HtrII membrane domain diagnostic of transducer activation. Labeling kinetics of a fluorescein probe in monocysteine-substituted HAMP1 mutants revealed a light-induced shift of AS2 against AS1 by one-half alpha-helix turn with minimal other changes. An opposite shift of AS2 against AS1 in HAMP2 at the corresponding positions supports the proposal from x-ray crystal structures by Airola et al. (Airola, M. V., Watts, K. J., Bilwes, A. M., and Crane, B. R. (2010) Structure 18, 436-448) that poly-HAMP chains undergo alternating opposite interconversions to relay the signal. Moreover, we found that haloarchaeal cells expressing a HAMP2-deleted SRII-HtrII exhibit attractant phototaxis, opposite from the repellent phototaxis mediated by the wild-type di-HAMP SRII-HtrII complex. The opposite conformational changes and corresponding opposite output signals of HAMP1 and HAMP2 imply a signal transmission mechanism entailing small shifts in helical register between AS1 and AS2 alternately in opposite directions in adjacent HAMPs.	[Wang, Jihong; Sasaki, Jun; Spudich, John L.] UT Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Tsai, Ah-lim] UT Med Sch, Dept Internal Med, Div Hematol, Houston, TX 77030 USA		Spudich, JL (corresponding author), UT Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu			National Institutes of Health from NIGMS [R37GM027750, RO1HL095820]; Endowed Chair from the Robert A. Welch Foundation [AU-0009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Endowed Chair from the Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37GM027750 from the NIGMS (to J. L. S.) and RO1HL095820 (A. L. T.). This work was also supported by Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.).	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Doebber M, 2008, J BIOL CHEM, V283, P28691, DOI 10.1074/jbc.M801931200; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Inoue K, 2008, J MOL BIOL, V376, P963, DOI 10.1016/j.jmb.2007.12.026; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Khursigara CM, 2008, P NATL ACAD SCI USA, V105, P16555, DOI 10.1073/pnas.0806401105; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; KIM SH, 1994, PROTEIN SCI, V3, P159; Klare JP, 2006, J MOL BIOL, V356, P1207, DOI 10.1016/j.jmb.2005.12.015; Klare JP, 2004, FEBS LETT, V564, P219, DOI 10.1016/S0014-5793(04)00193-0; Krebs MP, 1995, PROTEIN EXPRES PURIF, V6, P780, DOI 10.1006/prep.1995.0009; Kriegsmann J, 2009, BBA-BIOMEMBRANES, V1788, P522, DOI 10.1016/j.bbamem.2008.11.011; Li MS, 2011, MOL MICROBIOL, V79, P677, DOI 10.1111/j.1365-2958.2010.07478.x; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Spudich EN, 1997, P NATL ACAD SCI USA, V94, P4960, DOI 10.1073/pnas.94.10.4960; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Yang CS, 2001, BIOCHEMISTRY-US, V40, P14207, DOI 10.1021/bi010985c; YAO VJ, 1994, J BACTERIOL, V176, P6931, DOI 10.1128/JB.176.22.6931-6935.1994; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x	37	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21316	21325		10.1074/jbc.M112.344622	http://dx.doi.org/10.1074/jbc.M112.344622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22511775	hybrid, Green Published			2022-12-28	WOS:000306416800050
J	Moskovich, O; Herzog, LO; Ehrlich, M; Fishelson, Z				Moskovich, Oren; Herzog, Lee-Or; Ehrlich, Marcelo; Fishelson, Zvi			Caveolin-1 and Dynamin-2 Are Essential for Removal of the Complement C5b-9 Complex via Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; CLATHRIN-INDEPENDENT ENDOCYTOSIS; PROTEIN-KINASE-C; PLASMA-MEMBRANE; HUMAN-NEUTROPHILS; MEDIATED LYSIS; GOLGI-COMPLEX; UP-REGULATION; CELL-DEATH; RESISTANCE	The complement system, an important element of both innate and adaptive immunity, is executing complement-dependent cytotoxicity (CDC) with its C5b-9 protein complex that is assembled on cell surfaces and transmits to the cell death signals. In turn, cells, and in particular cancer cells, protect themselves from CDC in various ways. Thus, cells actively remove the C5b-9 complexes from their plasma membrane by endocytosis. Inhibition of clathrin by transfection with shRNA or of EPS-15 with a dominant negative plasmid had no effect on C5b-9 endocytosis and on cell death. In contrast, inhibition of caveolin-1 (Cav-1) by transfection with an shRNA or a dominant negative plasmid sensitized cells to CDC and inhibited C5b-9 endocytosis. Similarly, both inhibition of dynamin-2 by transfection with a dominant negative plasmid or by treatment with Dynasore reduced C5b-9 endocytosis and enhanced CDC. C5b-9 endocytosis was also disrupted by pretreatment of the cells with methyl-beta-cyclodextrin or Filipin III, hence implicating membrane cholesterol in the process. Analyses by confocal microscopy demonstrated co-localization of Cav-1-EGFP with C5b-9 at the plasma membrane, in early endosomes, at the endocytic recycling compartment and in secreted vesicles. Further investigation of the process of C5b-9 removal by exo-vesiculation demonstrated that inhibition of Cav-1 and cholesterol depletion abrogated C5b-9 exo-vesiculation, whereas, over-expression of Cav-1 increased C5b-9 exo-vesiculation. Our results show that Cav-1 and dynamin-2 (but not clathrin) support cell resistance to CDC, probably by facilitating purging of the C5b-9 complexes by endocytosis and exo-vesiculation.	[Moskovich, Oren; Herzog, Lee-Or; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Fishelson, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	lifish@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association	This research was in part supported by grants from the Israel Science Foundation and the Israel Cancer Association.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Boll W, 2004, EUR J CELL BIOL, V83, P281, DOI 10.1078/0171-9335-00373; CARNEY DF, 1985, J IMMUNOL, V134, P1804; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Gancz D, 2009, MOL IMMUNOL, V47, P310, DOI 10.1016/j.molimm.2009.09.016; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Jurianz K, 2001, INT J CANCER, V93, P848, DOI 10.1002/ijc.1406; KERJASCHKI D, 1989, J IMMUNOL, V143, P546; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kraus S, 2000, EUR J IMMUNOL, V30, P1272; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; MORGAN BP, 1986, J IMMUNOL, V136, P3402; MORGAN BP, 1987, J IMMUNOL, V138, P246; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PAPADIMITRIOU JC, 1994, VIRCHOWS ARCH, V424, P677, DOI 10.1007/BF01069750; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; REITER Y, 1992, EUR J IMMUNOL, V22, P1207, DOI 10.1002/eji.1830220515; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHLESINGER M, 1990, CLIN EXP IMMUNOL, V81, P423; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; SIMS PJ, 1986, BLOOD, V68, P556; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Tirado OM, 2010, INT J CANCER, V126, P426, DOI 10.1002/ijc.24754; TSCHOPP J, 1985, J IMMUNOL, V134, P495; Varsano S, 1996, AM J RESP CELL MOL, V15, P731, DOI 10.1165/ajrcmb.15.6.8969267; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Ziporen L, 2009, J IMMUNOL, V182, P515, DOI 10.4049/jimmunol.182.1.515	52	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19904	19915		10.1074/jbc.M111.333039	http://dx.doi.org/10.1074/jbc.M111.333039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528500	Green Published, hybrid			2022-12-28	WOS:000306414500013
J	Salamat, K; Moudjou, M; Chapuis, J; Herzog, L; Jaumain, E; Beringue, V; Rezaei, H; Pastore, A; Laude, H; Dron, M				Salamat, Khalid; Moudjou, Mohammed; Chapuis, Jerome; Herzog, Laetitia; Jaumain, Emilie; Beringue, Vincent; Rezaei, Human; Pastore, Annalisa; Laude, Hubert; Dron, Michel			Integrity of Helix 2-Helix 3 Domain of the PrP Protein Is Not Mandatory for Prion Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; SHEEP SCRAPIE; CONVERSION; SUSCEPTIBILITY; CELL; RESISTANT; GLYCOSYLATION; TRANSMISSION; EXPRESSION; PARALLEL	The process of prion conversion is not yet well understood at the molecular level. The regions critical for the conformational change of PrP remain mostly debated and the extent of sequence change acceptable for prion conversion is poorly documented. To achieve progress on these issues, we applied a reverse genetic approach using the Rov cell system. This allowed us to test the susceptibility of a number of insertion mutants to conversion into prion in the absence of wild-type PrP molecules. We were able to propagate several prions with 8 to 16 extra amino acids, including a polyglycine stretch and His or FLAG tags, inserted in the middle of the protease-resistant fragment. These results demonstrate the possibility to increase the length of the loop between helices H2 and H3 up to 4-fold, without preventing prion replication. They also indicate that this loop probably remains unstructured in PrPSc. We also showed that bona fide prions can be produced following insertion of octapeptides in the two C-terminal turns of H2. These insertions do not interfere with the overall fold of the H2-H3 domain indicating that the highly conserved sequence of the terminal part of H2 is not critical for the conversion. Altogether these data showed that the amplitude of modifications acceptable for prion conversion in the core of the globular domain of PrP is much greater than one might have assumed. These observations should help to refine structural models of PrPSc and elucidate the conformational changes underlying prions generation.	[Salamat, Khalid; Moudjou, Mohammed; Chapuis, Jerome; Herzog, Laetitia; Jaumain, Emilie; Beringue, Vincent; Rezaei, Human; Laude, Hubert; Dron, Michel] INRA, Virol Immunol Mol UR892, F-78350 Jouy En Josas, France; [Pastore, Annalisa] MRC Natl Inst Med Res, London NW7 1AA, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; MRC National Institute for Medical Research	Dron, M (corresponding author), INRA, Virol Immunol Mol UR892, F-78350 Jouy En Josas, France.	michel.dron@jouy.inra.fr	DRON, Michel/M-7093-2017		Institut National de la Recherche Agronomique (INRA); Higher Education Commission of Pakistan; INRA Animal Health division; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish	Institut National de la Recherche Agronomique (INRA); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); INRA Animal Health division; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Institut National de la Recherche Agronomique (INRA).; Supported by the Higher Education Commission of Pakistan and the INRA Animal Health division.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Geissen Markus, 2009, Infectious Disorders - Drug Targets, V9, P40; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Gong BB, 2011, BIOCHEMISTRY-US, V50, P4963, DOI 10.1021/bi102073j; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Howells LC, 2008, BIOMARKERS, V13, P393, DOI [10.1080/13547500801903719, 10.1080/13547500801903719 ]; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kunes KC, 2008, PRION, V2, P81, DOI 10.4161/pri.2.2.7059; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Moudjou M, 2007, NEUROCHEM INT, V50, P689, DOI 10.1016/j.neuint.2007.01.001; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Prigent S, 2011, PRION, V5, P69, DOI 10.4161/pri.5.2.16383; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Salamat MK, 2011, J VIROL, V85, P3077, DOI 10.1128/JVI.02257-10; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Zaidi SIA, 2005, J ALZHEIMERS DIS, V7, P159	59	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18953	18964		10.1074/jbc.M112.341677	http://dx.doi.org/10.1074/jbc.M112.341677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511770	Green Published, hybrid			2022-12-28	WOS:000306411900007
J	Erales, J; Hoyt, MA; Troll, F; Coffino, P				Erales, Jenny; Hoyt, Martin A.; Troll, Fabian; Coffino, Philip			Functional Asymmetries of Proteasome Translocase Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ORNITHINE-DECARBOXYLASE; REGULATORY PARTICLE; YEAST; DEGRADATION; ATPASES; ATP; ARCHITECTURE; MECHANISM; MUTANTS; SUBUNIT	Degradation by proteasomes involves coupled translocation and unfolding of its protein substrates. Six distinct but paralo-gous proteasome ATPase proteins, Rpt1 to -6, form a heterohexameric ring that acts on substrates. An axially positioned loop (Ar-Phi loop) moves in concert with ATP hydrolysis, engages substrate, and propels it into a proteolytic chamber. The aromatic (Ar) residue of the Ar-Phi loop in all six Rpts of S. cerevisiae is tyrosine; this amino acid is thought to have important functional contacts with substrate. Six yeast strains were constructed and characterized in which Tyr was individually mutated to Ala. The mutant cells were viable and had distinct phenotypes. rpt3, rpt4, and rpt5 Tyr/Ala mutants, which cluster on one side of the ATPase hexamer, were substantially impaired in their capacity to degrade substrates. In contrast, rpt1, rpt2, and rpt6 mutants equaled or exceeded wild type in degradation activity. However, rpt1 and rpt6 mutants had defects that limited cell growth or viability under conditions that stressed the ubiquitin proteasome system. In contrast, the rpt3 mutant grew faster than wild type and to a smaller size, a defect that has previously been associated with misregulation of G1 cyclins. This rpt3 phenotype probably results from altered degradation of cell cycle regulatory proteins. Finally, mutation of five of the Rpt subunits increased proteasome ATPase activity, implying bidirectional coupling between the Ar-Phi loop and the ATP hydrolysis site. The present observations assign specific functions to individual Rpt proteins and provide insights into the diverse roles of the axial loops of individual proteasome ATPases.	[Erales, Jenny; Hoyt, Martin A.; Troll, Fabian; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94127 USA	University of California System; University of California San Francisco	Coffino, P (corresponding author), 513 Parnassus Ave,Rm S-430, San Francisco, CA 94143 USA.	Philip.Coffino@ucsf.edu		Coffino, Philip/0000-0003-0344-5083	National Institutes of Health [GM45335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45335 (to P.C.).	Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Gerlinger UM, 1997, MOL BIOL CELL, V8, P2487, DOI 10.1091/mbc.8.12.2487; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guthrie C., 2002, GUIDE YEAST GENETICS; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HILT W, 1993, J BIOL CHEM, V268, P3479; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee SH, 2012, J BIOL CHEM, V287, P9269, DOI 10.1074/jbc.M111.316208; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pringle J R, 1975, Methods Cell Biol, V11, P131, DOI 10.1016/S0091-679X(08)60320-9; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; SUDBERY PE, 1980, NATURE, V288, P401, DOI 10.1038/288401a0; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; WETTERS TV, 1989, MOL CELL BIOL, V9, P5484, DOI 10.1128/MCB.9.12.5484; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	37	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18535	18543		10.1074/jbc.M112.357327	http://dx.doi.org/10.1074/jbc.M112.357327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493437	Green Published, hybrid			2022-12-28	WOS:000306411600059
J	Jamesdaniel, S; Coling, D; Hinduja, S; Ding, DL; Li, J; Cassidy, L; Seigel, GM; Qu, J; Salvi, R				Jamesdaniel, Samson; Coling, Donald; Hinduja, Sneha; Ding, Dalian; Li, Jun; Cassidy, Linda; Seigel, Gail M.; Qu, Jun; Salvi, Richard			Cisplatin-induced Ototoxicity Is Mediated by Nitroxidative Modification of Cochlear Proteins Characterized by Nitration of Lmo4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEARING-LOSS; TYROSINE NITRATION; INNER-EAR; PROTEOMIC ANALYSIS; SIGNAL TRANSDUCER; GUINEA-PIGS; PEROXYNITRITE; APOPTOSIS; EXPRESSION; MECHANISM	Tyrosine nitration is an important sequel of cellular signaling induced by reactive oxygen species. Cisplatin is an anti-neoplastic agent that damages the inner ear through reactive oxygen species and by the formation of DNA adducts. This study reveals a correlation between cisplatin-mediated hearing loss and nitroxidative modification of cochlear proteins and is the first to report nitration of Lmo4. Cisplatin induced a dose-dependent increase in hearing loss in Wistar rats. A 10-15-dB decrease in distortion product amplitude and massive loss of outer hair cells at the basal turn of the cochlea was observed 3 days post-treatment after a 16 mg/kg dose. Cisplatin induced nitration of cellular proteins within the organ of Corti, spiral ganglion, and stria vascularis, which are known targets of cisplatin ototoxicity. Nitration of a 76-kDa cochlear protein correlated with cisplatin dose. The nitrated protein was identified as Lmo4 (LIM domain only 4) by MALDI-TOF (matrix-assisted laser desorption/ionization time of flight) mass spectrometry and confirmed by reciprocal immunoprecipitation and immunoblotting. Co-localization of nitrotyrosine and Lmo4 was particularly high in outer hair cell nuclei after cisplatin treatment. Cochlear levels of Lmo4 were decreased in rats treated with cisplatin. In vitro studies supported the repression of Lmo4 in nitroxidative conditions and the induction of apoptosis upon repression of Lmo4. Inhibition of cochlear protein nitration prevented cisplatin-induced hearing loss. As Lmo4 is a transcriptional regulator that controls the choice between cell survival and cell death, these results support the hypothesis that nitration of Lmo4 influences cisplatin-induced ototoxicity.	[Jamesdaniel, Samson; Coling, Donald; Hinduja, Sneha; Ding, Dalian; Cassidy, Linda; Seigel, Gail M.; Salvi, Richard] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Jamesdaniel, S (corresponding author), SUNY Buffalo, Dept Commun Disorders & Sci, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	sj57@buffalo.edu	Li, Jun/N-3806-2014; Jamesdaniel, Samson/ABA-2616-2021	Li, Jun/0000-0001-9940-3421; Jamesdaniel, Samson/0000-0002-5269-9007; Coling, Donald/0000-0001-6285-5336	National Institutes of Health [1 R03 DC010225-01 (NIDCD), CA127061]; NYSTEM [C026412]; Cornell Center on the Microenvironment and Metastasis from NCI [U54CA143876]; NATIONAL CANCER INSTITUTE [R21CA127061, U54CA143876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Cornell Center on the Microenvironment and Metastasis from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R03 DC010225-01 (NIDCD).; Supported by the Cornell Center on the Microenvironment and Metastasis through Award U54CA143876 from the NCI, National Institutes of Health Grant CA127061 and NYSTEM C026412.	ANNIKO M, 1986, AM J OTOLARYNG, V7, P276, DOI 10.1016/S0196-0709(86)80050-3; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Charitidi K, 2010, NEUROSCIENCE, V165, P923, DOI 10.1016/j.neuroscience.2009.11.020; Chen HH, 2007, EXP CELL RES, V313, P3106, DOI 10.1016/j.yexcr.2007.04.026; COLING D, 2001, CURR PROTOC NEUROSCI, pCH2; Coling DE, 2007, HEARING RES, V226, P140, DOI 10.1016/j.heares.2006.12.017; Dehne N, 2001, TOXICOL APPL PHARM, V174, P27, DOI 10.1006/taap.2001.9171; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Ding D., 2001, AUDITORY PSYCHOBIOLO, P189; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Garcia-Berrocal JR, 2007, BRIT J PHARMACOL, V152, P1012, DOI 10.1038/sj.bjp.0707405; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Hofstetter P, 1997, HEARING RES, V112, P199, DOI 10.1016/S0378-5955(97)00123-8; HOGG N, 1994, ARCH BIOCHEM BIOPHYS, V314, P153, DOI 10.1006/abbi.1994.1423; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Kelly TC, 2003, HEARING RES, V186, P10, DOI 10.1016/S0378-5955(03)00303-4; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Lee JE, 2004, ACTA OTO-LARYNGOL, V124, P1131, DOI 10.1080/00016480410017521; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Maruyama J, 2008, NEUROBIOL DIS, V29, P14, DOI 10.1016/j.nbd.2007.07.026; Meech RP, 1998, HEARING RES, V124, P44, DOI 10.1016/S0378-5955(98)00116-6; Novotny-Diermayr V, 2005, J BIOL CHEM, V280, P12747, DOI 10.1074/jbc.M500175200; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; RAVI R, 1995, PHARMACOL TOXICOL, V76, P386, DOI 10.1111/j.1600-0773.1995.tb00167.x; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Schaffar G, 2008, J NEUROCHEM, V107, P418, DOI 10.1111/j.1471-4159.2008.05621.x; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Teranishi M, 2003, INT J PEDIATR OTORHI, V67, P133, DOI 10.1016/S0165-5876(02)00353-1; Tu CJ, 2011, ANAL CHEM, V83, P4802, DOI 10.1021/ac200376m; van Ruijven MWM, 2005, HEARING RES, V205, P241, DOI 10.1016/j.heares.2005.03.023; van Ruijven MWM, 2005, HEARING RES, V203, P112, DOI 10.1016/j.heares.2004.12.007; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Wang H, 2009, J AM SOC MASS SPECTR, V20, P507, DOI 10.1016/j.jasms.2008.11.008; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang Y, 2008, PROTEIN PEPTIDE LETT, V15, P1063, DOI 10.2174/092986608786071111; Xiao T, 2003, J TOXICOL ENV HEAL A, V66, P469, DOI 10.1080/15287390306449; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Yamashita D, 2005, NEUROSCIENCE, V134, P633, DOI 10.1016/j.neuroscience.2005.04.015; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	53	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18674	18686		10.1074/jbc.M111.297960	http://dx.doi.org/10.1074/jbc.M111.297960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493493	Green Published, hybrid			2022-12-28	WOS:000306411600076
J	Haddad, A; Flint-Ashtamker, G; Minzel, W; Sood, R; Rimon, G; Barki-Harrington, L				Haddad, Ariz; Flint-Ashtamker, Galit; Minzel, Waleed; Sood, Rapita; Rimon, Gilad; Barki-Harrington, Liza			Prostaglandin EP1 Receptor Down-regulates Expression of Cyclooxygenase-2 by Facilitating Its Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; ARACHIDONIC-ACID; CELLS; KINASE; E-2; UBIQUITINATION; LOCALIZATION	The enzyme cyclooxygenase-2 (COX-2) is rapidly and transiently up-regulated by a large variety of signals and implicated in pathologies such as inflammation and tumorigenesis. Although many signals cause COX-2 up-regulation, much less is known about mechanisms that actively down-regulate its expression. Here we show that the G protein-coupled receptor prostaglandin E-1 (EP1) reduces the expression of COX-2 in a concentration-dependent manner through a mechanism that does not require receptor activation. The reduction in COX-2 protein is not due to decreased protein synthesis and occurs because of enhancement of substrate-independent COX-2 proteolysis. Although EP1 does not interfere with the entry of COX-2 into the endoplasmic reticulum-associated degradation cascade, it facilitates COX-2 ubiquitination through complex formation. Blockade of proteasomal activity results in degradation of the receptor and concomitant recovery in the expression of COX-2, suggesting that EP1 may scaffold an unknown E3 ligase that ubiquitinates COX-2. These findings propose a new role for the EP1 receptor in resolving inflammation through down-regulation of COX-2.	[Haddad, Ariz; Flint-Ashtamker, Galit; Minzel, Waleed; Sood, Rapita; Barki-Harrington, Liza] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31905 Haifa, Israel; [Rimon, Gilad] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel	University of Haifa; Ben Gurion University	Barki-Harrington, L (corresponding author), Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31905 Haifa, Israel.	lbarki@psy.haifa.ac.il						Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Dipiro JT, 2010, CONCEPTS CLIN PHARMA, P19; Figueiredo-Pereira ME, 2002, J BIOL CHEM, V277, P25283, DOI 10.1074/jbc.M109145200; Giordano F, 2011, P NATL ACAD SCI USA, V108, P11906, DOI 10.1073/pnas.1103381108; HARKER LA, 1986, CIRCULATION, V73, P206, DOI 10.1161/01.CIR.73.2.206; Hinz B, 2000, BIOCHEM BIOPH RES CO, V272, P744, DOI 10.1006/bbrc.2000.2859; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Neaud V, 2004, J BIOL CHEM, V279, P5200, DOI 10.1074/jbc.M306679200; Neuss H, 2007, J MOL MED-JMM, V85, P961, DOI 10.1007/s00109-007-0197-y; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Rosch S, 2005, BIOCHEM BIOPH RES CO, V338, P1171, DOI 10.1016/j.bbrc.2005.10.051; Rosenstock M, 2001, EUR J PHARMACOL, V412, P101, DOI 10.1016/S0014-2999(00)00931-6; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sokolova E, 2005, AM J PHYSIOL-LUNG C, V288, pL793, DOI 10.1152/ajplung.00343.2004; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wen XD, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-29; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444	32	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17214	17223		10.1074/jbc.M111.304220	http://dx.doi.org/10.1074/jbc.M111.304220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474323	Green Published, hybrid			2022-12-28	WOS:000306373000021
J	Wang, YN; Lee, HH; Lee, HJ; Du, Y; Yamaguchi, H; Hung, MC				Wang, Ying-Nai; Lee, Heng-Huan; Lee, Hong-Jen; Du, Yi; Yamaguchi, Hirohito; Hung, Mien-Chie			Membrane-bound Trafficking Regulates Nuclear Transport of Integral Epidermal Growth Factor Receptor (EGFR) and ErbB-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; PROGNOSTIC VALUE; PROTEIN IMPORT; CELL-CARCINOMA; EXPRESSION; BINDING; PHOSPHORYLATION; TRANSLOCATION; FAMILY; TRANSCRIPTION	Nuclear localization of multiple receptor-tyrosine kinases (RTKs), such as EGF receptor (EGFR), ErbB-2, FGF receptor (FGFR), and many others, has been reported by several groups. We previously showed that cell surface EGFR is trafficked to the nucleus through a retrograde pathway from the Golgi to the endoplasmic reticulum (ER) and that EGFR is then translocated to the inner nuclear membrane (INM) through the INTERNET (integral trafficking from the ER to the nuclear envelope transport) pathway. However, the nuclear trafficking mechanisms of other membrane RTKs, apart from EGFR, remain unclear. The purpose of this study was to compare the nuclear transport of EGFR family proteins with that of FGFR-1. Interestingly, we found that digitonin permeabilization, which selectively releases soluble nuclear transporters from the cytoplasm and has been shown to inhibit nuclear transport of FGFR-1, had no effects on EGFR nuclear transport, raising the possibility that EGFR and FGFR-1 use different pathways to be translocated into the nucleus. Using the subnuclear fractionation assay, we further demonstrated that biotinylated cell surface ErbB-2, but not FGFR-1, is targeted to the INM, associating with Sec61 beta in the INM, similar to the nuclear trafficking of EGFR. Thus, ErbB-2, but not FGFR-1, shows a similar trafficking pathway to EGFR for translocation to the nucleus, indicating that at least two different pathways of nuclear transport exist for cell surface receptors. This finding provides a new direction for investigating the trafficking mechanisms of various nuclear RTKs.	[Wang, Ying-Nai; Lee, Heng-Huan; Lee, Hong-Jen; Du, Yi; Yamaguchi, Hirohito; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lee, Heng-Huan; Lee, Hong-Jen; Du, Yi; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA; [Wang, Ying-Nai; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Wang, Ying-Nai; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan	Hung, MC (corresponding author), 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Wang, Ying-Nai/0000-0002-5275-6729	National Institutes of Health [NIH R01 109311, NIH P01 099031]; National Breast Cancer Foundation; MD Anderson-China Medical University Hospital Sister Institution; MD Anderson's Cancer Center [CA 16672]; High Resolution Electron Microscopy Facility; Cancer Research Center of Excellence [DOH99-TD-C-111-005];  [NSC-2632-B-001-MY3]; NATIONAL CANCER INSTITUTE [P01CA099031, P30CA016672, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation; MD Anderson-China Medical University Hospital Sister Institution; MD Anderson's Cancer Center; High Resolution Electron Microscopy Facility; Cancer Research Center of Excellence; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by the National Institutes of Health through Grants NIH R01 109311 and NIH P01 099031 (to M.-C. H.). This work was also supported by the National Breast Cancer Foundation and the MD Anderson-China Medical University Hospital Sister Institution Fund (to M.-C. H.); MD Anderson's Cancer Center Support Grant (CA 16672) High Resolution Electron Microscopy Facility; the Cancer Research Center of Excellence Grant DOH99-TD-C-111-005; and NSC-2632-B-001-MY3 from Taiwan.	Adam RM, 2003, CANCER RES, V63, P484; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Dunham-Ems SM, 2006, MOL BIOL CELL, V17, P2223, DOI 10.1091/mbc.E05-08-0749; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Kiyokawa N, 1997, J BIOL CHEM, V272, P18656, DOI 10.1074/jbc.272.30.18656; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER RES, V65, P338; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Psyrri A, 2008, CANCER EPIDEM BIOMAR, V17, P1486, DOI 10.1158/1055-9965.EPI-07-2684; RAPER SE, 1987, GASTROENTEROLOGY, V92, P1243, DOI 10.1016/S0016-5085(87)91084-5; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Schausberger E, 2003, CARCINOGENESIS, V24, P835, DOI 10.1093/carcin/bgg027; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504	44	56	56	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16869	16879		10.1074/jbc.M111.314799	http://dx.doi.org/10.1074/jbc.M111.314799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451678	Green Published, hybrid			2022-12-28	WOS:000304030900073
J	Laviad, EL; Kelly, S; Merrill, AH; Futerman, AH				Laviad, Elad L.; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Modulation of Ceramide Synthase Activity via Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; SPHINGOLIPID METABOLISM; (DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; QUANTITATIVE-ANALYSIS; FAMILY-MEMBERS; CELLS; COA; ACCUMULATION; MECHANISM	Ceramide, the backbone of all sphingolipids, is synthesized by a family of ceramide synthases (CerS) that each use acyl-CoAs of defined chain length for N-acylation of the sphingoid long chain base. CerS mRNA expression and enzymatic activity do not always correlate with the sphingolipid acyl chain composition of a particular tissue, suggesting post-translational mechanism(s) of regulation of CerS activity. We now demonstrate that CerS activity can be modulated by dimer formation. Under suitable conditions, high M-r CerS complexes can be detected by Western blotting, and various CerS co-immunoprecipitate. CerS5 activity is inhibited in a dominant-negative fashion by co-expression with catalytically inactive CerS5, and CerS2 activity is enhanced by co-expression with a catalytically active form of CerS5 or CerS6. In a constitutive heterodimer comprising CerS5 and CerS2, the activity of CerS2 depends on the catalytic activity of CerS5. Finally, CerS dimers are formed upon rapid stimulation of ceramide synthesis by curcumin. Together, these data demonstrate that ceramide synthesis can be regulated by the formation of CerS dimers and suggest a novel way to generate the acyl chain composition of ceramide (and downstream sphingolipids), which may depend on the interaction of CerS with each other.	[Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by the Israel Science Foundation (1404/07) and the Minerva Foundation.	Basnakian AG, 2005, AM J PHYSIOL-RENAL, V288, pF308, DOI 10.1152/ajprenal.00204.2004; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Blazquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hilchie AL, 2010, NUTR CANCER, V62, P379, DOI 10.1080/01635580903441238; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liao WC, 1999, J BIOL CHEM, V274, P17908, DOI 10.1074/jbc.274.25.17908; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mondal MS, 2001, FEBS LETT, V489, P14, DOI 10.1016/S0014-5793(00)02428-5; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	43	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21025	21033		10.1074/jbc.M112.363580	http://dx.doi.org/10.1074/jbc.M112.363580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539345	Green Published, hybrid			2022-12-28	WOS:000306416800024
J	Tran, DT; Lim, JM; Liu, M; Stalnaker, SH; Wells, L; Ten Hagen, KG; Live, D				Tran, Duy T.; Lim, Jae-Min; Liu, Mian; Stalnaker, Stephanie H.; Wells, Lance; Ten Hagen, Kelly G.; Live, David			Glycosylation of alpha-Dystroglycan O-MANNOSYLATION INFLUENCES THE SUBSEQUENT ADDITION OF GalNAc BY UDP-GalNAc POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NEIGHBORING RESIDUE GLYCOSYLATION; ELECTRON-TRANSFER DISSOCIATION; RABBIT SKELETAL-MUSCLE; LAMININ-BINDING; DROSOPHILA-MELANOGASTER; CONSECUTIVE THREONINES; MUSCULAR-DYSTROPHY; GLYCAN STRUCTURES	O-Linked glycosylation is a functionally and structurally diverse type of protein modification present in many tissues and across many species. alpha-Dystroglycan (alpha-DG), a protein linked to the extracellular matrix, whose glycosylation status is associated with human muscular dystrophies, displays two predominant types of O-glycosylation, O-linked mannose (O-Man) and O-linked N-acetylgalactosamine (O-GalNAc), in its highly conserved mucin-like domain. The O-Man is installed by an enzyme complex present in the endoplasmic reticulum. O-GalNAc modifications are initiated subsequently in the Golgi apparatus by the UDP-GalNAc polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-T) enzymes. How the presence and position of O-Man influences the action of the ppGalNAc-Ts on alpha-DG and the distribution of the two forms of glycosylation in this domain is not known. Here, we investigated the interplay between O-Man and the addition of O-GalNAc by examining the activity of the ppGalNAc-Ts on peptides and O-Man-containing glycopeptides mimicking those found in native alpha-DG. These synthetic glycopeptides emulate intermediate structures, not otherwise readily available from natural sources. Through enzymatic and mass spectrometric methods, we demonstrate that the presence and specific location of O-Man can impact either the regional exclusion or the site of O-GalNAc addition on alpha-DG, elucidating the factors contributing to the glycosylation patterns observed in vivo. These results provide evidence that one form of glycosylation can influence another form of glycosylation in alpha-DG and suggest that in the absence of proper O-mannosylation, as is associated with certain forms of muscular dystrophy, aberrant O-GalNAc modifications may occur and could play a role in disease presentation.	[Tran, Duy T.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA; [Lim, Jae-Min; Liu, Mian; Stalnaker, Stephanie H.; Wells, Lance; Live, David] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Georgia; University of Georgia	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov; dlive@ccrc.uga.edu	Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363	National Institutes of Health [R21AR056055, R01GM066148]; Resource for Integrated Glycotechnology Grant [P41GM103390]; Integrated Technology Resource for Biomedical Glycomics Grant [P41GM103490]; NIDCR at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P41GM103490, R01GM066148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Resource for Integrated Glycotechnology Grant; Integrated Technology Resource for Biomedical Glycomics Grant; NIDCR at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR056055 and R01GM066148 and Resource for Integrated Glycotechnology Grant P41GM103390 (to D. L.), Integrated Technology Resource for Biomedical Glycomics Grant P41GM103490 (to L. W.), and by the Intramural Research Program of NIDCR at the National Institutes of Health (to K. T. H.).	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; ALBONE EF, 1994, J BIOL CHEM, V269, P16845; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Borgert A., 2012, ACS CHEM BI IN PRESS; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Kojima K, 2011, KIDNEY INT, V79, P311, DOI 10.1038/ki.2010.403; Kunz S, 2004, VIROLOGY, V325, P207, DOI 10.1016/j.virol.2004.04.044; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Moore C, 2009, GLYCOCONJUGATE J, V26, P349, DOI 10.1007/s10719-008-9182-0; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shimojo H, 2011, PROSTATE, V71, P1151, DOI 10.1002/pros.21330; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takeuchi H, 2002, EUR J BIOCHEM, V269, P6173, DOI 10.1046/j.1432-1033.2002.03334.x; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726	57	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20967	20974		10.1074/jbc.M112.370387	http://dx.doi.org/10.1074/jbc.M112.370387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549772	hybrid, Green Published			2022-12-28	WOS:000306416800018
J	Tsiang, M; Jones, GS; Niedziela-Majka, A; Kan, E; Lansdon, EB; Huang, WN; Hung, M; Samuel, D; Novikov, N; Xu, YL; Mitchell, M; Guo, HY; Babaoglu, K; Liu, XH; Geleziunas, R; Sakowicz, R				Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman			New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; SMALL-MOLECULE INHIBITORS; DNA-BINDING DOMAIN; PEPTIDE INHIBITORS; VIRAL-DNA; IN-VITRO; LEDGF/P75; DISCOVERY; REVEALS; PROTEIN	tert-Butoxy-(4-phenyl-quinolin-3-yl)-acetic acids (tBPQA) are a new class of HIV-1 integrase (IN) inhibitors that are structurally distinct from IN strand transfer inhibitors but analogous to LEDGINs. LEDGINs are a class of potent antiviral compounds that interacts with the lens epithelium-derived growth factor (LEDGF) binding pocket on IN and were identified through competition binding against LEDGF.LEDGF tethers IN to the host chromatin and enables targeted integration of viral DNA. The prevailing understanding of the antiviral mechanism of LEDGINs is that they inhibit LEDGF binding to IN, which prevents targeted integration of HIV-1. We showed that in addition to the properties already known for LEDGINs, the binding of tBPQAs to the IN dimer interface inhibits IN enzymatic activity in a LEDGF-independent manner. Using the analysis of two long terminal repeat junctions in HIV-infected cells, we showed that the inhibition by tBPQAs occurs at or prior to the viral DNA 3'-processing step. Biochemical studies revealed that this inhibition operates by compound-induced conformational changes in the IN dimer that prevent proper assembly of IN onto viral DNA. For the first time, tBPQAs were demonstrated to be allosteric inhibitors of HIV-1 IN displaying a dual mode of action: inhibition of IN-viral DNA assembly and inhibition of IN-LEDGF interaction.	[Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Tsiang, M (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	mtsiang@gilead.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Mawsawi LQ, 2008, EXPERT OPIN EMERG DR, V13, P213, DOI [10.1517/14728214.13.2.213, 10.1517/14728214.13.2.213 ]; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carayon K, 2010, NUCLEIC ACIDS RES, V38, P3692, DOI 10.1093/nar/gkq087; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cooper D.A., 2008, 15 C RETR OPP INF BO, P357; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DeJesus E., 2007, 4 INT AIDS SOC C HIV; Du L, 2008, ACTA PHARMACOL SIN, V29, P1261, DOI 10.1111/j.1745-7254.2008.00863.x; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; Du L, 2008, CHEMMEDCHEM, V3, P173, DOI 10.1002/cmdc.200700223; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; HAZUDA DJ, 1994, NUCLEIC ACIDS RES, V22, P1121, DOI 10.1093/nar/22.6.1121; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jones GS, 2009, ANTIMICROB AGENTS CH, V53, P1194, DOI 10.1128/AAC.00984-08; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Lataillade M, 2007, ANTIVIR THER, V12, P563; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Markowitz M, 2009, JAIDS-J ACQ IMM DEF, V52, P350, DOI 10.1097/QAI.0b013e3181b064b0; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Mathias A., 2009, 16 C RETR OPP INF MO, P79; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Metifiot M, 2010, VIRUSES-BASEL, V2, P1347, DOI 10.3390/v2071347; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Savarino A, 2006, EXPERT OPIN INV DRUG, V15, P1507, DOI 10.1517/13543784.15.12.1507; Shimura Kazuya, 2009, Antiviral Chemistry & Chemotherapy, V20, P79, DOI 10.3851/IMP1397; Steigbigel R., 2008, 15 C RETR OPP INF BO, P357; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Tsantrizos Y., 2009, Patent No. [WO2009/062285A1, 2009062285]; Tsantrizos Y. S., 2009, WO Patent, Patent No. [2009062289A1, 2009062289, WO 2,009,062,289 (A1)]; Tsantrizos YS, 2007, International patent, Patent No. [WO 2007/131350 A1, 2007131350, WO2007/131350A1, 2007131350 2007131350]; Tsiang M, 2011, BIOCHEMISTRY-US, V50, P1567, DOI 10.1021/bi101504w; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Wai J., 2007, 14 C RETR OPP INF LO, P96; Wang Y, 2005, J BIOMOL SCREEN, V10, P456, DOI 10.1177/1087057105275212; Williams KL, 2005, J BIOL CHEM, V280, P7949, DOI 10.1074/jbc.M413579200; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zhao L, 2003, BIOORG MED CHEM LETT, V13, P1175, DOI 10.1016/S0960-894X(03)00040-4; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	64	126	133	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21189	21203		10.1074/jbc.M112.347534	http://dx.doi.org/10.1074/jbc.M112.347534			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535962	Green Published, hybrid			2022-12-28	WOS:000306416800039
J	Villota, C; Campos, A; Vidaurre, S; Oliveira-Cruz, L; Boccardo, E; Burzio, VA; Varas, M; Villegas, J; Villa, LL; Valenzuela, PDT; Socias, M; Roberts, S; Burzio, LO				Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Boccardo, Enrique; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Villa, Luisa L.; Valenzuela, Pablo D. T.; Socias, Miguel; Roberts, Sally; Burzio, Luis O.			Expression of Mitochondrial Non-coding RNAs (ncRNAs) Is Modulated by High Risk Human Papillomavirus (HPV) Oncogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TUMOR-SUPPRESSOR; E2 PROTEIN; TRANSGENIC MICE; TYPE-16 E7; CANCER; GENES; TELOMERASE; SUFFICIENT; MICRORNA	The study of RNA and DNA oncogenic viruses has proved invaluable in the discovery of key cellular pathways that are rendered dysfunctional during cancer progression. An example is high risk human papillomavirus (HPV), the etiological agent of cervical cancer. The role of HPV oncogenes in cellular immortalization and transformation has been extensively investigated. We reported the differential expression of a family of human mitochondrial non-coding RNAs (ncRNAs) between normal and cancer cells. Normal cells express a sense mitochondrial ncRNA (SncmtRNA) that seems to be required for cell proliferation and two antisense transcripts (ASncmtRNAs). In contrast, the ASncmtRNAs are down-regulated in cancer cells. To shed some light on the mechanisms that trigger down-regulation of the ASncmtRNAs, we studied human keratinocytes (HFK) immortalized with HPV. Here we show that immortalization of HFK with HPV-16 or 18 causes down-regulation of the ASncmtRNAs and induces the expression of a new sense transcript named SncmtRNA-2. Transduction of HFK with both E6 and E7 is sufficient to induce expression of SncmtRNA-2. Moreover, E2 oncogene is involved in down-regulation of the ASncmtRNAs. Knockdown of E2 in immortalized cells reestablishes in a reversible manner the expression of the ASncmtRNAs, suggesting that endogenous cellular factors(s) could play functions analogous to E2 during non-HPV-induced oncogenesis.	[Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Valenzuela, Pablo D. T.; Burzio, Luis O.] Andes Biotechnol SA, Santiago 8370146, Chile; [Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Valenzuela, Pablo D. T.; Burzio, Luis O.] Fdn Ciencia Vida, Santiago 8370146, Chile; [Villota, Claudio; Campos, America; Vidaurre, Soledad; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Burzio, Luis O.] Univ Andres Bello, Fac Ciencias Biol, Santiago 8370146, Chile; [Boccardo, Enrique; Villa, Luisa L.] Ludwig Inst Canc Res, BR-1323903 Sao Paulo, Brazil; [Boccardo, Enrique] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil; [Socias, Miguel] Clin Alemana, Santiago 7650567, Chile; [Roberts, Sally] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Universidad Andres Bello; Ludwig Institute for Cancer Research; Universidade de Sao Paulo; Clinica Alemana; Cancer Research UK; University of Birmingham	Villota, C (corresponding author), Andes Biotechnol SA, Zanartu 1482, Santiago 8370146, Chile.	claudio.villota@gmail.com; lburzio@gmail.com	Villegas, Jaime/AAW-5938-2020; Roberts, Sally/N-6143-2014; Oliveira-Cruz, Luciana/N-7756-2014; VILLA, LUISA/AAH-4761-2019; Boccardo, Enrique/A-3960-2012	Roberts, Sally/0000-0003-4653-9442; VILLA, LUISA/0000-0003-4074-2335; Boccardo, Enrique/0000-0003-1900-0273; Varas-Godoy, Manuel/0000-0001-5857-4793; Villegas, Jaime/0000-0002-9556-4655	Fondecyt [11090060, 1085210, 1110835]; Fondef [D04I1338]; CCTE-PFB16 Program Grant; Conicyt, Chile; Universidad Andres Bello, Chile [DI-34-09/R, DI-31-09/R, DI-28-09/R4, DI-06-09/R]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondef; CCTE-PFB16 Program Grant; Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Andres Bello, Chile	This work was supported by Fondecyt Grants 11090060, 1085210, and 1110835; Fondef Grant D04I1338; CCTE-PFB16 Program Grant; Conicyt, Chile, and Universidad Andres Bello, Chile, Grants DI-34-09/R, DI-31-09/R, DI-28-09/R4, and DI-06-09/R.	Alvarez-Salas LM, 2003, ANTIVIR THER, V8, P265; BARBOSA MS, 1989, ONCOGENE, V4, P1529; Bellanger S, 2011, AM J CANCER RES, V1, P373; BERNARD BA, 1989, J VIROL, V63, P4317, DOI 10.1128/JVI.63.10.4317-4324.1989; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; Boccardo E, 2010, CARCINOGENESIS, V31, P521, DOI 10.1093/carcin/bgp333; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; D'Agostino DM, 2005, ADV CANCER RES, V94, P87, DOI 10.1016/S0065-230X(05)94003-7; DOORBAR J, 1991, NATURE, V352, P824, DOI 10.1038/352824a0; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; Gewin L, 2001, J VIROL, V75, P7198, DOI 10.1128/JVI.75.15.7198-7201.2001; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Helt AM, 2001, J VIROL, V75, P6737, DOI 10.1128/JVI.75.15.6737-6747.2001; Hufbauer M, 2010, VIROLOGY, V403, P128, DOI 10.1016/j.virol.2010.04.013; Kapushoc ST, 1999, RNA, V5, P656, DOI 10.1017/S1355838299982250; Knight GL, 2011, VIROLOGY, V412, P196, DOI 10.1016/j.virol.2011.01.007; Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589; Kruse B, 1995, Methods Mol Biol, V37, P179; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee D, 2002, J BIOL CHEM, V277, P27748, DOI 10.1074/jbc.M203706200; Lee SK, 2011, DISCOV MED, V11, P245; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Leykauf K, 2008, TRANSGENIC RES, V17, P1, DOI 10.1007/s11248-007-9130-y; Lin KY, 1996, CANCER RES, V56, P21; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McBride AA, 2006, CELL CYCLE, V5, P1499, DOI 10.4161/cc.5.14.3094; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Ramirez-Salazar E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-247; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; ROMANCZUK H, 1991, J VIROL, V65, P2739, DOI 10.1128/JVI.65.5.2739-2744.1991; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; Swindle CS, 1999, J VIROL, V73, P1001, DOI 10.1128/JVI.73.2.1001-1009.1999; Villegas J, 2002, NUCLEIC ACIDS RES, V30, P1895, DOI 10.1093/nar/30.9.1895; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Webster K, 2000, J BIOL CHEM, V275, P87, DOI 10.1074/jbc.275.1.87; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; YOUNG PG, 1975, BIOCHEM BIOPH RES CO, V65, P1201, DOI 10.1016/S0006-291X(75)80357-3; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	67	29	31	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21303	21315		10.1074/jbc.M111.326694	http://dx.doi.org/10.1074/jbc.M111.326694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539350	hybrid, Green Published			2022-12-28	WOS:000306416800049
J	Muller, A; Munch, D; Schmidt, Y; Reder-Christ, K; Schiffer, G; Bendas, G; Gross, H; Sahl, HG; Schneider, T; Brotz-Oesterhelt, H				Mueller, Anna; Muench, Daniela; Schmidt, Yvonne; Reder-Christ, Katrin; Schiffer, Guido; Bendas, Gerd; Gross, Harald; Sahl, Hans-Georg; Schneider, Tanja; Broetz-Oesterhelt, Heike			Lipodepsipeptide Empedopeptin Inhibits Cell Wall Biosynthesis through Ca2+-dependent Complex Formation with Peptidoglycan Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIPID-II; STAPHYLOCOCCUS-AUREUS; LYSOBACTER SP; UNDECAPRENYL PYROPHOSPHATE; BIOSENSOR TECHNIQUES; PEPTIDE ANTIBIOTICS; BACILLUS-SUBTILIS; MEMBRANE; IDENTIFICATION	Empedopeptin is a natural lipodepsipeptide antibiotic with potent antibacterial activity against multiresistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae in vitro and in animal models of bacterial infection. Here, we describe its so far elusive mechanism of antibacterial action. Empedopeptin selectively interferes with late stages of cell wall biosynthesis in intact bacterial cells as demonstrated by inhibition of N-acetylglucosamine incorporation into polymeric cell wall and the accumulation of the ultimate soluble peptidoglycan precursor UDP-N-acetylmuramic acid-pentapeptide in the cytoplasm. Using membrane preparations and the complete cascade of purified, recombinant late stage peptidoglycan biosynthetic enzymes and their respective purified substrates, we show that empedopeptin forms complexes with undecaprenyl pyrophosphate containing peptidoglycan precursors. The primary physiological target of empedopeptin is undecaprenyl pyrophosphate-N-acetylmuramic acid(pentapeptide)-N-acetylglucosamine (lipid II), which is readily accessible at the outside of the cell and which forms a complex with the antibiotic in a 1:2 molar stoichiometry. Lipid II is bound in a region that involves at least the pyrophosphate group, the first sugar, and the proximal parts of stem peptide and undecaprenyl chain. Undecaprenyl pyrophosphate and also teichoic acid precursors are bound with lower affinity and constitute additional targets. Calcium ions are crucial for the antibacterial activity of empedopeptin as they promote stronger interaction with its targets and with negatively charged phospholipids in the membrane. Based on the high structural similarity of empedopeptin to the tripropeptins and plusbacins, we propose this mechanism of action for the whole compound class.	[Broetz-Oesterhelt, Heike] Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, D-40225 Dusseldorf, Germany; [Mueller, Anna; Muench, Daniela; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Schmidt, Yvonne; Gross, Harald] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Reder-Christ, Katrin; Bendas, Gerd] Univ Bonn, Inst Pharmaceut Chem, D-53121 Bonn, Germany; [Schiffer, Guido] AiCuris GmbH & Co KG, D-42117 Wuppertal, Germany	Heinrich Heine University Dusseldorf; University of Bonn; University of Bonn; University of Bonn	Brotz-Oesterhelt, H (corresponding author), Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Univ Str 1,Bldg 26-23 U1-36, D-40225 Dusseldorf, Germany.	heike.broetz-oesterhelt@duesseldorf.de	Schneider, Tanja/L-8049-2013; Mueller, Anna/L-9779-2017	Mueller, Anna/0000-0001-6420-3868; Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745	German Research Organization [FOR-854, BR 3783/1-1, SA 292/15-1, SA 292/13-1, GR 2673/2-1, BE 2242/3-1]; research fund of the Medical Faculty of the University of Bonn (BONFOR); Bonn, Germany	German Research Organization(German Research Foundation (DFG)); research fund of the Medical Faculty of the University of Bonn (BONFOR); Bonn, Germany	This work was supported by the German Research Organization (Grant FOR-854, Projects BR 3783/1-1, SA 292/15-1, SA 292/13-1, GR 2673/2-1, and BE 2242/3-1) and by the research fund of the Medical Faculty of the University of Bonn (BONFOR).; We gratefully acknowledge MALDI support by Michaele Josten, Bonn, Germany.	Barry AL, 2001, ANTIMICROB AGENTS CH, V45, P1919, DOI 10.1128/AAC.45.6.1919-1922.2001; Bottiger T, 2009, APPL ENVIRON MICROB, V75, P4427, DOI 10.1128/AEM.00262-09; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Christ K, 2005, PHOTOCHEM PHOTOBIOL, V81, P1417, DOI 10.1562/2005-04-19-RA-493; Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003; Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4; Clinical and Laboratory Standards Institute, 2008, M07A8 CLIN LAB STAND; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; DAI D, 1988, J BACTERIOL, V170, P2197, DOI 10.1128/jb.170.5.2197-2201.1988; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Ha S., 2001, Current Drug Targets - Infectious Disorders, V1, P201, DOI 10.2174/1568005014606116; Hashizume H, 2004, J ANTIBIOT, V57, P394, DOI 10.7164/antibiotics.57.394; Hashizume H, 2004, J ANTIBIOT, V57, P52, DOI 10.7164/antibiotics.57.52; Hashizume H, 2001, J ANTIBIOT, V54, P1054, DOI 10.7164/antibiotics.54.1054; Hashizume H, 2011, ANTIMICROB AGENTS CH, V55, P3821, DOI 10.1128/AAC.00443-11; IKEDA M, 1991, J BACTERIOL, V173, P1021, DOI 10.1128/jb.173.3.1021-1026.1991; KOHLRAUSCH U, 1991, J BACTERIOL, V173, P3425, DOI 10.1128/jb.173.11.3425-3431.1991; KONISHI M, 1984, J ANTIBIOT, V37, P949, DOI 10.7164/antibiotics.37.949; Maki H, 2001, ANTIMICROB AGENTS CH, V45, P1823, DOI 10.1128/AAC.45.6.1823-1827.2001; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; NAGARAJAN R, 1991, ANTIMICROB AGENTS CH, V35, P605, DOI 10.1128/AAC.35.4.605; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rohrer S, 2003, ANTIMICROB AGENTS CH, V47, P837, DOI 10.1128/AAC.47.3.837-846.2003; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Rubinchik E, 2011, ANTIMICROB AGENTS CH, V55, P2743, DOI 10.1128/AAC.00170-11; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SHOJI J, 1992, J ANTIBIOT, V45, P817, DOI 10.7164/antibiotics.45.817; SHOJI J, 1992, J ANTIBIOT, V45, P824, DOI 10.7164/antibiotics.45.824; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Simonis D, 2007, BIOCHEMISTRY-US, V46, P6156, DOI 10.1021/bi602347g; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; STULKE J, 1993, J GEN MICROBIOL, V139, P2041, DOI 10.1099/00221287-139-9-2041; SUGAWARA K, 1984, J ANTIBIOT, V37, P958, DOI 10.7164/antibiotics.37.958; UMBREIT JN, 1972, J BACTERIOL, V112, P1306, DOI 10.1128/JB.112.3.1306-1309.1972; Wong KK, 1998, J AM CHEM SOC, V120, P13527, DOI 10.1021/ja983468z; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005	43	21	21	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20270	20280		10.1074/jbc.M112.369561	http://dx.doi.org/10.1074/jbc.M112.369561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22514280	Green Published, hybrid			2022-12-28	WOS:000306414500047
J	Onnerfjord, P; Khabut, A; Reinholt, FP; Svensson, O; Heinegard, D				Onnerfjord, Patrik; Khabut, Areej; Reinholt, Finn P.; Svensson, Olle; Heinegard, Dick			Quantitative Proteomic Analysis of Eight Cartilaginous Tissues Reveals Characteristic Differences as well as Similarities between Subgroups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID REPEAT POLYMORPHISM; HUMAN INTERVERTEBRAL DISC; HUMAN ARTICULAR-CARTILAGE; GROWTH-FACTOR-BETA; MATRIX PROTEIN; ASPORIN GENE; COLLAGEN-VI; OSTEOARTHRITIS; PROTEOGLYCANS; SUSCEPTIBILITY	Human synovial joints display a characteristic anatomic distribution of arthritis, e.g. rheumatoid arthritis primarily affects the metacarpophalangeal and proximal finger joints, but rarely the distal finger joints, whereas osteoarthritis occurs in the distal and proximal finger joints. Pelvospondylitis has a selective localization to the spine and sacroiliac joints. Is this tropism due to differences between the cartilages at the molecular level? To substantiate this concept the present study provides a background detailed compositional analysis by relative quantification of extracellular matrix proteins in articular cartilages, meniscus, intervertebral disc, rib, and tracheal cartilages on samples from 5-6 different individuals using an optimized approach for proteomics. Tissue extraction followed by trypsin digestion and two-dimensional LC separations coupled to tandem mass spectrometry, relative quantification with isobaric labeling, iTRAQ (TM), was used to compare the relative abundance of about 150 proteins. There were clear differences in protein patterns between different kinds of cartilages. Matrilin-1 and epiphycan were specific for rib and trachea, whereas asporin was particularly abundant in the meniscus. Interestingly, lubricin was prominent in the intervertebral disc, especially in the nucleus pulposus. Fibromodulin and lumican showed distributions that were mirror images of one other. Analyses of the insoluble residues from guanidine extraction revealed that a fraction of several proteins remained unextracted, e.g. asporin, CILP, and COMP, indicating cross-linking. Distinct differences in protein patterns may relate to different tissue mechanical properties, and to the intriguing tropism in different patterns of joint pathology.	[Onnerfjord, Patrik] Lund Univ, Rheumatol Sect, Dept Clin Sci Lund, SE-22184 Lund, Sweden; [Reinholt, Finn P.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Svensson, Olle] Umea Univ, Dept Perioperat Sci, Div Orthopaed, S-90185 Umea, Sweden	Lund University; University of Oslo; National Hospital Norway; Umea University	Onnerfjord, P (corresponding author), Lund Univ, Rheumatol Sect, Dept Clin Sci Lund, BMC-C12, SE-22184 Lund, Sweden.	patrik.onnerfjord@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937	Inga-Britt and Arne Lundberg foundation; National Institutes of Health from the NIAMS [U01 AR050926]; Swedish Research Council [52X-05668]; European Union [FP7-NMP-2008-LARGE-2]; Lund University; Alfred Osterlund Foundation; Magnus Bergvall Foundation; King Gustaf V 80-year fund; Crafoord Foundation; Anamar Medical; Greta and Johan Kock Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR050926] Funding Source: NIH RePORTER	Inga-Britt and Arne Lundberg foundation; National Institutes of Health from the NIAMS; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Lund University; Alfred Osterlund Foundation; Magnus Bergvall Foundation; King Gustaf V 80-year fund; Crafoord Foundation; Anamar Medical; Greta and Johan Kock Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Kari Ormstad is gratefully acknowledged for scientific input and providing the tissue samples. The mass spectrometers were financed by the Inga-Britt and Arne Lundberg foundation.; This work was supported, in whole or in part, by National Institutes of Health Grant U01 AR050926 from the NIAMS, Swedish Research Council Grant 52X-05668, grants from the European Union FP7-ICT project NanoDiaRA under contract FP7-NMP-2008-LARGE-2, Lund University (to ALF and TIM), Alfred Osterlund Foundation, Magnus Bergvall Foundation, King Gustaf V 80-year fund, the Crafoord Foundation, Anamar Medical, and the Greta and Johan Kock Foundation.	Aszodi A, 1996, EUR J BIOCHEM, V236, P970, DOI 10.1111/j.1432-1033.1996.00970.x; Bao JP, 2011, MOL BIOL REP, V38, P2879, DOI 10.1007/s11033-010-9949-9; BAYLISS MT, 1983, BIOCHEM J, V209, P387, DOI 10.1042/bj2090387; Belluoccio D, 2006, PROTEOMICS, V6, P6549, DOI 10.1002/pmic.200600191; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CHRISTNER JE, 1983, J BIOL CHEM, V258, P4335; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Gruber HE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2660; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Jay GD, 2000, J RHEUMATOL, V27, P594; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kou I, 2010, J BONE MINER METAB, V28, P395, DOI 10.1007/s00774-009-0145-8; Kurita K, 1996, BIOCHEM J, V318, P909, DOI 10.1042/bj3180909; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Nuka S, 2010, OSTEOARTHR CARTILAGE, V18, P88, DOI 10.1016/j.joca.2009.11.006; PAULSSON M, 1984, BIOCHEM J, V221, P623, DOI 10.1042/bj2210623; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Shine KM, 2009, J BONE JOINT SURG AM, V91A, P2205, DOI 10.2106/JBJS.H.01344; Song JH, 2008, KNEE, V15, P191, DOI 10.1016/j.knee.2007.11.005; Song YQ, 2008, AM J HUM GENET, V82, P744, DOI 10.1016/j.ajhg.2007.12.017; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; SWANN DA, 1981, J BIOL CHEM, V256, P5921; Vincourt JB, 2006, MOL CELL PROTEOMICS, V5, P1984, DOI 10.1074/mcp.T600007-MCP200; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Wilson R, 2008, METHODS, V45, P22, DOI 10.1016/j.ymeth.2008.01.008; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yu J, 2010, J ANAT, V216, P533, DOI 10.1111/j.1469-7580.2009.01207.x	47	83	84	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18913	18924		10.1074/jbc.M111.298968	http://dx.doi.org/10.1074/jbc.M111.298968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493511	hybrid, Green Published			2022-12-28	WOS:000306411900004
J	Yoon, CH; Kim, MJ; Lee, H; Kim, RK; Lim, EJ; Yoo, KC; Lee, GH; Cui, YH; Oh, YS; Gye, MC; Lee, YY; Park, IC; An, S; Hwang, SG; Park, MJ; Suh, Y; Lee, SJ				Yoon, Chang-Hwan; Kim, Min-Jung; Lee, Hyejin; Kim, Rae-Kwon; Lim, Eun-Jung; Yoo, Ki-Chun; Lee, Ga-Haeng; Cui, Yan-Hong; Oh, Yeong Seok; Gye, Myung Chan; Lee, Young Yiul; Park, In-Chul; An, Sungkwan; Hwang, Sang-Gu; Park, Myung-Jin; Suh, Yongjoon; Lee, Su-Jae			PTTG1 Oncogene Promotes Tumor Malignancy via Epithelial to Mesenchymal Transition and Expansion of Cancer Stem Cell Population	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING GENE PTTG; TRANSCRIPTION FACTOR SNAIL; IN-VITRO PROPAGATION; EXPRESSION; IDENTIFICATION; ACTIVATION; PATHWAY; PROTEIN; KINASE; EMT	The prognosis of breast cancer patients is related to the degree of metastasis. However, the mechanisms by which epithelial tumor cells escape from the primary tumor and colonize at a distant site are not entirely understood. Here, we analyzed expression levels of pituitary tumor-transforming gene-1 (PTTG1), a relatively uncharacterized oncoprotein, in patient-derived breast cancer tissues with corresponding normal breast tissues. We found that PTTG1 is highly expressed in breast cancer patients, compared with normal tissues. Also, PTTG1 expression levels were correlated with the degree of malignancy in breast cancer cell lines; the more migratory and invasive cancer cell lines MDA-MB-231 and BT549 displayed the higher expression levels of PTTG1 than the less migratory and invasive MCP7 and SK-BR3 and normal MCF10A cell lines. By modulating PTTG1 expression levels, we found that PTTG1 enhances the migratory and invasive properties of breast cancer cells by inducing epithelial to mesenchymal transition, as evidenced by altered morphology and epithelial/mesenchymal cell marker expression patterns and up-regulation of the transcription factor Snail. Notably, down-regulation of PTTG1 also suppressed cancer stem cell population in BT549 cells by decreasing self-renewing ability and tumorigenic capacity, accompanying decreasing CD44(high) CD24(low) cells and Sox2 expression. Up-regulation of PTTG1 had the opposite effects, increasing sphere-forming ability and Sox2 expression. Importantly, PTTG1-mediated malignant tumor properties were due, at least in part, to activation of AKT, known to be a key regulator of both EMT and stemness in cancer cells. Collectively, these results suggest that PTTG1 may represent a new therapeutic target for malignant breast cancer.	[Yoon, Chang-Hwan; Kim, Min-Jung; Lee, Hyejin; Kim, Rae-Kwon; Lim, Eun-Jung; Yoo, Ki-Chun; Lee, Ga-Haeng; Cui, Yan-Hong; Suh, Yongjoon; Lee, Su-Jae] Hanyang Univ, Res Inst Nat Sci, Dept Chem, Seoul 133791, South Korea; [Oh, Yeong Seok; Gye, Myung Chan] Hanyang Univ, Dept Life Sci, Coll Nat Sci, Seoul 133791, South Korea; [Lee, Young Yiul] Hanyang Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Seoul 133791, South Korea; [Park, In-Chul; Hwang, Sang-Gu; Park, Myung-Jin] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea	Hanyang University; Hanyang University; Hanyang University; Korea Institute of Radiological & Medical Sciences; Konkuk University	Suh, Y (corresponding author), Hanyang Univ, Res Inst Nat Sci, Dept Chem, Seoul 133791, South Korea.	hiswork@hanmail.net; sj0420@hanyang.ac.kr	Cui, Yanhong/ABB-1148-2021; Yoon, Changhwan/AAK-7842-2021	Cui, Yanhong/0000-0002-4169-6521; Yoon, Changhwan/0000-0002-8420-9818; Gye, Myung Chan/0000-0001-5682-3709	National Nuclear Technology Program [2008-2003935]; Ministry of Education, Science, and Technology.; Converging Research Center Program [2011K000877]	National Nuclear Technology Program; Ministry of Education, Science, and Technology.(Ministry of Education, Science & Technology (MEST), Republic of Korea); Converging Research Center Program	This work was supported by National Nuclear Technology Program Grant 2008-2003935 and Converging Research Center Program Grant 2011K000877 funded by the Ministry of Education, Science, and Technology.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brognard J, 2001, CANCER RES, V61, P3986; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Grille SJ, 2003, CANCER RES, V63, P2172; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hamid T, 2003, HISTOL HISTOPATHOL, V18, P245, DOI 10.14670/HH-18.245; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hyun KH, 2011, TOXICOL APPL PHARM, V254, P32, DOI 10.1016/j.taap.2011.04.006; Inagaki A, 2007, BIOCHEM BIOPH RES CO, V361, P586, DOI 10.1016/j.bbrc.2007.07.037; Karreth F, 2004, CANCER BIOL THER, V3, P1058, DOI 10.4161/cbt.3.11.1302; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Liang XH, 2011, ORAL ONCOL, V47, P686, DOI 10.1016/j.oraloncology.2011.04.016; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Molina-Jimenez F, 2010, HEPATOLOGY, V51, P777, DOI 10.1002/hep.23468; Panguluri SK, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-6; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ringel MD, 2001, CANCER RES, V61, P6105; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P4222, DOI 10.1210/en.2003-1661; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	43	71	78	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19516	19527		10.1074/jbc.M111.337428	http://dx.doi.org/10.1074/jbc.M111.337428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511756	Green Published, hybrid			2022-12-28	WOS:000306411900064
J	Han, WN; Ming, M; Zhao, R; Pi, JB; Wu, CL; He, YY				Han, Weinong; Ming, Mei; Zhao, Rui; Pi, Jingbo; Wu, Chunli; He, Yu-Ying			Nrf1 CNC-bZIP Protein Promotes Cell Survival and Nucleotide Excision Repair through Maintaining Glutathione Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; LEUCINE-ZIPPER; XERODERMA-PIGMENTOSUM; ANTIOXIDANT RESPONSE; LUNG-CANCER; SKIN-CANCER; DNA-REPAIR; MOLECULAR-CLONING; ULTRAVIOLET-B; GENE	Skin cancer is the most common cancer in the United States. Its major environmental risk factor is UVB radiation in sunlight. In response to UVB damage, epidermal keratinocytes activate a specific repair pathway, i.e. nucleotide excision repair, to remove UVB-induced DNA lesions. However, the regulation of UVB response is not fully understood. Here we show that the long isoform of the nuclear factor erythroid 2-related factor 1 (Nrf1, also called NFE2L1), a cytoprotective transcription factor critical for the expression of multiple antioxidant response element-dependent genes, plays an important role in the response of keratinocytes to UVB. Nrf1 loss sensitized keratinocytes to UVB-induced apoptosis by up-regulating the expression of the proapoptotic Bcl-2 family member Bik through reducing glutathione levels. Knocking down Bik reduced UVB-induced apoptosis in Nrf1-inhibited cells. In UVB-irradiated surviving cells, however, disruption of Nrf1 impaired nucleotide excision repair through suppressing the transcription of xeroderma pigmentosum C (XPC), a factor essential for initiating the global genome nucleotide excision repair by recognizing the DNA lesion and recruiting downstream factors. Nrf1 enhanced XPC expression by increasing glutathione availability but was independent of the transcription repressor of XPC. Adding XPC or glutathione restored the DNA repair capacity in Nrf1-inhibited cells. Finally, we demonstrate that Nrf1 levels are significantly reduced by UVB radiation in mouse skin and are lower in human skin tumors than in normal skin. These results indicate a novel role of Nrf1 in UVB-induced DNA damage repair and suggest Nrf1 as a tumor suppressor in the skin.	[Han, Weinong; Ming, Mei; Wu, Chunli; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Zhao, Rui; Pi, Jingbo] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Zhao, Rui] China Med Univ, Sch Forens Med, Shenyang 110001, Peoples R China; [Wu, Chunli] China Med Univ, Affiliated Hosp 4, Dept Radiat Oncol, Shenyang 110001, Peoples R China	University of Chicago; The Hamner Institutes for Health Sciences; China Medical University; China Medical University	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Institutes of Health [ES016936, ES016005]; University of Chicago Comprehensive Cancer Center Pilot program [P30 CA014599]; Clinical and Translational Science Awards (National Institutes of Health) [UL1RR024999]; University of Chicago Friends of Dermatology Research Funds; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936, R01ES016005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center Pilot program; Clinical and Translational Science Awards (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Friends of Dermatology Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016936 (to Y. Y. H.) and ES016005 (to J. P.), the University of Chicago Comprehensive Cancer Center Pilot program (Grant P30 CA014599), and the Clinical and Translational Science Awards (National Institutes of Health Grant UL1RR024999). This work was also supported by the University of Chicago Friends of Dermatology Research Funds.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Daniel PT, 1999, BLOOD, V94, P1100, DOI 10.1182/blood.V94.3.1100.415a16_1100_1107; Dominguez-Brauer C, 2009, EMBO REP, V10, P1036, DOI 10.1038/embor.2009.139; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Hu ZB, 2005, INT J CANCER, V115, P478, DOI 10.1002/ijc.20911; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Johnson TM, 1998, J AM ACAD DERMATOL, V38, P681, DOI 10.1016/S0190-9622(98)70196-3; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Lee GY, 2005, INT J CANCER, V115, P807, DOI 10.1002/ijc.20900; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; Maeda T, 2001, J INVEST DERMATOL, V117, P1490, DOI 10.1046/j.0022-202x.2001.01562.x; Marin MS, 2004, CANCER EPIDEM BIOMAR, V13, P1788; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Murphy P, 2000, MECH DEVELOP, V97, P141, DOI 10.1016/S0925-4773(00)00413-5; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pi JB, 2010, TOXICOL APPL PHARM, V244, P1, DOI 10.1016/j.taap.2010.01.005; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Real PJ, 2006, FEBS LETT, V580, P5905, DOI 10.1016/j.febslet.2006.08.088; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304; Zhu YM, 2007, CARCINOGENESIS, V28, P698, DOI 10.1093/carcin/bgl201	46	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18788	18795		10.1074/jbc.M112.363614	http://dx.doi.org/10.1074/jbc.M112.363614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22500024	hybrid, Green Published			2022-12-28	WOS:000306411600087
J	Niimi, S; Arakawa-Takeuchi, S; Uranbileg, B; Park, J; Jinno, S; Okayama, H				Niimi, Shinichiro; Arakawa-Takeuchi, Shiho; Uranbileg, Baasanjav; Park, Jun-ha; Jinno, Shigeki; Okayama, Hiroto			Cdc6 Protein Obstructs Apoptosome Assembly and Consequent Cell Death by Forming Stable Complexes with Activated Apaf-1 Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; DEPENDENT ACTIVATION; TSC2 GENE; EKER RAT; ANCHORAGE; CASPASE-3; PATHWAY; CYCLE; REPLICATION; EXPRESSION	Cdc6 is the bifunctional AAA + ATPase that assembles prereplicative complexes on origins of replication and activates p21(CIP1)- or p27(KIP1)-bound Cdk2. During the G(1)-S transition, the Cdc6 gene essential for chromosomal replication is activated by the E2F transcriptional factor. Paradoxically, Apaf-1 encoding the central component of the apoptosome is also activated at the same time and by E2F. Consequently, genes for antipodal life and death are regulated in the same manner by the same transcriptional factor. Here we report a striking solution to this paradox. Besides performing prereplicative complex assembly and Cdk2 activation, Cdc6 obstructed apoptosome assembly by forming stable complexes very likely with a monomer of cytochrome c-activated Apaf-1 molecules. This function depended on its own ATPase domain but not on the cyclin-binding motif. In proliferating rodent fibroblasts, Cdc6 continued to block apoptosome assembly induced by a non-cytochrome c or some other mechanism, suppressing seemingly unintended apoptosis when promoting cell proliferation. Thus, Cdc6 is an AAA + ATPase with three functions, all working for life.	[Okayama, Hiroto] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130031, Japan; Univ Tokyo, Fac Med, Tokyo 1130031, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130031, Japan.	okayama-tky@umin.net			Ministry of Education, Science and Culture of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (S) and the Global Center of Excellence from the Ministry of Education, Science and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Karassek S, 2010, J BIOL CHEM, V285, P33979, DOI 10.1074/jbc.M109.095968; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Pelizon C, 2002, EMBO REP, V3, P780, DOI 10.1093/embo-reports/kvf161; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PINES J, 1994, SEMIN CANCER BIOL, V5, P305; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Yang SH, 2006, APOPTOSIS, V11, P1987, DOI 10.1007/s10495-006-0084-y; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	39	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18573	18583		10.1074/jbc.M112.347690	http://dx.doi.org/10.1074/jbc.M112.347690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493447	Green Published, hybrid			2022-12-28	WOS:000306411600063
J	Bar, Y; Russ, HA; Sintov, E; Anker-Kitai, L; Knoller, S; Efrat, S				Bar, Yael; Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Knoller, Sarah; Efrat, Shimon			Redifferentiation of Expanded Human Pancreatic beta-Cell-derived Cells by Inhibition of the NOTCH Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; MESENCHYMAL TRANSITION; ENDOCRINE-CELLS; SIGNALING PATHWAY; GENE-EXPRESSION; HUMAN ISLETS; PROLIFERATION; APOPTOSIS; DIFFERENTIATION	In vitro expansion of beta-cells from adult human pancreatic islets would overcome donor beta-cell shortage for cell replacement therapy for diabetes. Using a beta-cell-specific labeling system we have shown that beta-cell expansion is accompanied by dedifferentiation resembling epithelial-mesenchymal transition and loss of insulin expression. Epigenetic analyses indicate that key beta-cell genes maintain open chromatin structure in expanded beta-cell-derived (BCD) cells, although they are not transcribed. In the developing pancreas important cell-fate decisions are regulated by NOTCH receptors, which signal through the Hairy and Enhancer of Split 1 (HES1) transcription regulator. We have reported that BCD cell dedifferentiation and proliferation in vitro correlate with reactivation of the NOTCH pathway. Inhibition of HES1 expression using shRNA during culture initiation results in reduced beta-cell replication and dedifferentiation, suggesting that HES1 inhibition may also affect BCD cell redifferentiation following expansion. Here, we used HES1 shRNA to down-regulate HES1 expression in expanded human BCD cells, showing that HES1 inhibition is sufficient to induce BCD cell redifferentiation, as manifested by a significant increase in insulin expression. Combined treatment with HES1 shRNA, cell aggregation in serum-free medium, and a mixture of soluble factors further stimulated the redifferentiation of BCD cells. In vivo analyses demonstrated the ability of the redifferentiated cells to replace beta-cell function in hyperglycemic immunodeficient mice. These findings demonstrate the redifferentiation potential of ex vivo expanded BCD cells and the reproducible differentiating effect of HES1 inhibition in these cells.	[Bar, Yael; Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Knoller, Sarah; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X	Juvenile Diabetes Research Foundation [31-2008-413]; Israel Science Foundation; Integrated Islet Distribution Program	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Integrated Islet Distribution Program	This work was supported by grants from the Juvenile Diabetes Research Foundation and Israel Science Foundation grants (to S. E.). Human islets were provided through Award 31-2008-413 (ECIT Islets for Basic Research Program) from the Juvenile Diabetes Research Foundation and the Integrated Islet Distribution Program.	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Bocian-Sobkowska J, 1999, HISTOCHEM CELL BIOL, V112, P147, DOI 10.1007/s004180050401; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Demeterco C, 2000, J CLIN ENDOCR METAB, V85, P3892, DOI 10.1210/jc.85.10.3892; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gittes GK, 2010, STEM CELLS BIOL REG, P3, DOI 10.1007/978-1-60761-366-4_1; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jehn BM, 1999, J IMMUNOL, V162, P635; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Krestel HE, 2004, NEUROBIOL DIS, V17, P310, DOI 10.1016/j.nbd.2004.05.012; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; LUKINIUS A, 1992, DEV BIOL, V153, P376, DOI 10.1016/0012-1606(92)90122-W; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Rasul S, 2009, BRIT J CANCER, V100, P1879, DOI 10.1038/sj.bjc.6605034; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200	49	48	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17269	17280		10.1074/jbc.M111.319152	http://dx.doi.org/10.1074/jbc.M111.319152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457355	Green Published, hybrid			2022-12-28	WOS:000306373000027
J	Song, CS; Sutton, L; Johnson, ME; D'Aquila, RT; Donahue, JP				Song, Chisu; Sutton, Lorraine; Johnson, Megan E.; D'Aquila, Richard T.; Donahue, John P.			Signals in APOBEC3F N-terminal and C-terminal Deaminase Domains Each Contribute to Encapsidation in HIV-1 Virions and Are Both Required for HIV-1 Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; CYTIDINE DEAMINASES; 7SL RNA; VIRAL-RNA; ASSOCIATION; INTEGRASE; GAG; HYPERMUTATION; INHIBITION	Human cytidine deaminases APOBEC3F (A3F) and APOBEC3G (A3G) inhibit human immunodeficiency virus type-1 (HIV-1) replication. In the absence of HIV-1 Vif, A3F and/or A3G are incorporated into assembling virions and exert antiviral functions in subsequently infected target cells. Encapsidation of A3F or A3G within the protease-matured virion core following their incorporation into virions is hypothesized to be important for the antiviral function of these proteins. In this report, we demonstrated that A3F was quantitatively encapsidated in the mature virion core. In distinct contrast, A3G was distributed both within and outside of the virion core. Analysis of a series of A3F-A3G chimeras comprised of exchanged N- and C-terminal deaminase domains identified a 14 amino acid segment in the A3F C-terminal deaminase domain that contributed to preferential encapsidation and anti-HIV activity. Amino acid residue L306 in this C-terminal segment was determined to be necessary, but not sufficient, for these effects. Amino acid residue W126 in the N-terminal deaminase domain was determined also to contribute to preferential encapsidation and antiviral activity of A3F. Analysis of the A3F (W126A L306A) double mutant revealed that both residues are required for full anti-HIV function. The results reported here advance our understanding of the mechanisms of A3F virion encapsidation and antiviral function and may lead to innovative strategies to inhibit HIV-1 replication.	[Song, Chisu; Sutton, Lorraine; D'Aquila, Richard T.; Donahue, John P.] Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, Nashville, TN 37232 USA; [Johnson, Megan E.; D'Aquila, Richard T.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Div Infect Dis, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Donahue, JP (corresponding author), Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, A-2200,Med Ctr N, Nashville, TN 37232 USA.	john.donahue@vanderbilt.edu			Vanderbilt-Meharry Center for AIDS Research (CFAR); National Institutes of Health [AI 29193, P30 AI 54999]; NCRR/National Institutes of Health [UL1 RR024975-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024977, UL1RR024975, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999, R01AI029193] Funding Source: NIH RePORTER	Vanderbilt-Meharry Center for AIDS Research (CFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a Vanderbilt-Meharry Center for AIDS Research (CFAR) Developmental Core Award (to J.P.D.) and National Institutes of Health Grant AI 29193 (to R.T.D.).; We thank Chris Aiken for cells, plasmids, and the generous use of his equipment, David Hout for instruction on fractionating HIV-1 virions by sucrose density gradient centrifugation, Una O'Doherty for provirus pNL4-3 Vif<SUP>-</SUP>) and Vinay Pathak for plasmids encoding A3F-G chimeras, the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH which provided HIV-1 IN monoclonal antibody 8G4) from Dag E. Helland, APOBEC3G antibody ApoC17 from Klaus Strebel, and anti-APOBEC3F(C18) from Michael Malim. This work has been facilitated by the infrastructure and resources provided by the Vanderbilt-Meharry CFAR, a National Institutes of Health-funded program P30 AI 54999. Shared equipment was provided by Vanderbilt's CTSA award UL1 RR024975-01 from NCRR/National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Khan MA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-99; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nilsen BM, 1996, J VIROL, V70, P1580, DOI 10.1128/JVI.70.3.1580-1587.1996; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Song C, 2003, J VIROL, V77, P5192, DOI 10.1128/JVI.77.9.5192-5200.2003; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang T, 2008, VIROLOGY, V377, P71, DOI 10.1016/j.virol.2008.04.012; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang WY, 2010, J VIROL, V84, P12903, DOI 10.1128/JVI.01632-10; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	43	20	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16965	16974		10.1074/jbc.M111.310839	http://dx.doi.org/10.1074/jbc.M111.310839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451677	hybrid, Green Published			2022-12-28	WOS:000304030900081
J	Karve, TM; Rosen, EM				Karve, Tejaswita M.; Rosen, Eliot M.			B-cell Translocation Gene 2 (BTG2) Stimulates Cellular Antioxidant Defenses through the Antioxidant Transcription Factor NFE2L2 in Human Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENE; NRF2 KNOCKOUT MICE; BREAST-CANCER; OXIDATIVE STRESS; SIGNALING PATHWAY; DNA-DAMAGE; EXPRESSION; PROTEIN; INHIBITION	The B-cell translocation gene 2, BTG2, a member of the BTG/TOB (B-cell translocation gene/transducers of ErbB2) gene family, has been implicated in cell cycle regulation, normal development, and possibly tumor suppression. Previously, it was shown that BTG2 expression is lost or down-regulated in human breast cancers. We now report that BTG2 protects human mammary epithelial cells from oxidative stress due to hydrogen peroxide and other oxidants. BTG2 protection against oxidative stress is BRCA1-independent but requires the antioxidant transcription factor NFE2L2 and is associated with up-regulation of the expression of antioxidant enzymes, including catalase and superoxide dismutases 1 and 2. BTG2 stimulation of antioxidant gene expression is also NFE2L2-dependent. We further demonstrate that BTG2 is a binding partner for NFE2L2 and increases its transcriptional activity. In addition, BTG2 is detectable at the antioxidant response element (ARE) of several NFE2L2-responsive genes. Finally, we show that the ability of BTG2 to associate with NFE2L2, to protect cells against oxidative stress, and to stimulate antioxidant gene expression requires box B, a short highly conserved amino acid motif characteristic of BTG2/TOB family proteins, but does not require boxes A or C. These findings suggest a novel role for BTG2 as a co-activator for NFE2L2 in up-regulating cellular antioxidant defenses.	[Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA; [Karve, Tejaswita M.; Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20057 USA; [Karve, Tejaswita M.; Rosen, Eliot M.] Georgetown Univ, Med Ctr, Dept Cellular & Mol Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health through the USPHS [RO1-CA80000, RO1-CA104546, RO1-CA150646]; Susan G. Komen for the Cure [KG110580]; Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10069]; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA080000, R01CA150646] Funding Source: NIH RePORTER	National Institutes of Health through the USPHS; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA80000, RO1-CA104546 and RO1-CA150646 through the USPHS (to E. M. R.). This work was also supported by Susan G. Komen for the Cure (KG110580), and Living in Pink (to E. M. R.).; Supported by the World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10069). To whom correspondence should be addressed: Dept. of Oncology, Georgetown University Medical Center, 3970 Reservoir Rd., NW, Washington, D. C. 20057. Tel.: 202-687-7695; Fax: 202-687-7256; E-mail: emr36@georgetown.edu.	ARENANDER AT, 1989, J NEUROSCI RES, V23, P257, DOI 10.1002/jnr.490230303; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; Duriez Cyril, 2004, Bull Cancer, V91, pE242; Fan SJ, 2009, CANCER RES, V69, P6083, DOI 10.1158/0008-5472.CAN-08-3309; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Fiedler F, 1998, BIOCHEM BIOPH RES CO, V249, P562, DOI 10.1006/bbrc.1998.9195; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hayashida M, 2010, NEUROREPORT, V21, P90, DOI 10.1097/WNR.0b013e328332c4d7; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Karmakar S, 2009, INT J CANCER, V124, P1841, DOI 10.1002/ijc.24133; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Katiyar P, 2009, MOL ENDOCRINOL, V23, P1135, DOI 10.1210/me.2008-0347; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Mollerstrom E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-296; Mollerstrom E, 2010, CANCER GENET CYTOGEN, V198, P79, DOI 10.1016/j.cancergencyto.2009.12.012; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ryu MS, 2004, EXP CELL RES, V299, P159, DOI 10.1016/j.yexcr.2004.05.014; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Slevin M, 2009, PATHOBIOLOGY, V76, P129, DOI 10.1159/000209390; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Takahashi F, 2011, ONCOGENE, V30, P3084, DOI 10.1038/onc.2011.24; Terra R, 2008, INT IMMUNOL, V20, P317, DOI 10.1093/intimm/dxm152; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tomlinson GE, 1998, CANCER RES, V58, P3237; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; Wheaton K, 2010, AGING CELL, V9, P747, DOI 10.1111/j.1474-9726.2010.00601.x; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Yuan RQ, 2001, CANCER RES, V61, P8022; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang ZM, 2011, CELL BIOCHEM BIOPHYS, V61, P83, DOI 10.1007/s12013-011-9164-x	48	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31503	31514		10.1074/jbc.M112.367433	http://dx.doi.org/10.1074/jbc.M112.367433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22493435	Green Published, hybrid			2022-12-28	WOS:000308791300063
J	Zhang, Y; Xie, RL; Gordon, J; LeBlanc, K; Stein, JL; Lian, JB; van Wijnen, AJ; Stein, GS				Zhang, Ying; Xie, Rong-lin; Gordon, Jonathan; LeBlanc, Kimberly; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.			Control of Mesenchymal Lineage Progression by MicroRNAs Targeting Skeletal Gene Regulators Trps1 and Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; EXPRESSION; IDENTIFICATION; PROLIFERATION; MUTATIONS; NETWORK; CHONDROGENESIS; TRANSCRIPTION; CHONDROCYTES; APOPTOSIS	Multiple microRNAs (miRNAs) that target the osteogenic Runt-related transcription factor 2 (RUNX2) define an interrelated network of miRNAs that control osteoblastogenesis. We addressed whether these miRNAs have functional targets beyond RUNX2 that coregulate skeletal development. Here, we find that seven RUNX2-targeting miRNAs (miR-23a, miR-30c, miR-34c, miR-133a, miR-135a, miR-205, and miR-217) also regulate the chondrogenic GATA transcription factor tricho-rhino-phalangeal syndrome I (TRPS1). Although the efficacy of each miRNA to target RUNX2 or TRPS1 differs in osteoblasts and chondrocytes, each effectively blocks maturation of pre-committed osteoblasts and chondrocytes. Furthermore, these miRNAs can redirect mesenchymal stem cells into adipogenic cell fate with concomitant up-regulation of key lineage-specific transcription factors. Thus, a program of multiple miRNAs controls mesenchymal lineage progression by selectively blocking differentiation of osteoblasts and chondrocytes to control skeletal development.	[Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Gordon, Jonathan/B-3904-2016	van Wijnen, Andre J./0000-0002-4458-0946; Gordon, Jonathan/0000-0003-2644-696X	National Institutes of Health [R01 AR039588, R01 AR049069, R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR039588 (to G. S. S. and J. B. L.), R01 AR049069 (to A. v. W.), and R37 DE012528 (to J. B. L.).	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kanno S, 2011, EXP MOL PATHOL, V90, P143, DOI 10.1016/j.yexmp.2010.11.010; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Piccione M, 2009, AM J MED GENET A, V149A, P1837, DOI 10.1002/ajmg.a.32952; Piscopo DM, 2009, J BIOL CHEM, V284, P31690, DOI 10.1074/jbc.M109.052316; Qiao B, 2005, J BIOL CHEM, V280, P17562, DOI 10.1074/jbc.M500646200; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rozenblum E, 2002, HUM GENET, V110, P111, DOI 10.1007/s00439-001-0646-6; Shi S, 2009, J BIOL CHEM, V284, P6697, DOI 10.1074/jbc.M807859200; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Suda S, 2006, BIOCHEM BIOPH RES CO, V344, P246, DOI 10.1016/j.bbrc.2006.03.138; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Wuelling M, 2009, DEV BIOL, V328, P40, DOI 10.1016/j.ydbio.2009.01.012; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	45	90	97	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21926	21935		10.1074/jbc.M112.340398	http://dx.doi.org/10.1074/jbc.M112.340398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544738	Green Published, hybrid			2022-12-28	WOS:000306418600032
J	Bisht, S; Rajaram, V; Bharath, SR; Kalyani, JN; Khan, F; Rao, AN; Savithri, HS; Murthy, MRN				Bisht, Shveta; Rajaram, Venkatesan; Bharath, Sakshibeedu R.; Kalyani, Josyula Nitya; Khan, Farida; Rao, Appaji N.; Savithri, Handanahal S.; Murthy, Mathur R. N.			Crystal Structure of Escherichia coli Diaminopropionate Ammonia-lyase Reveals Mechanism of Enzyme Activation and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; X-RAY-DIFFRACTION; SALMONELLA-TYPHIMURIUM; L-SERINE; ACID; BIOSYNTHESIS; INTERMEDIATE; PURIFICATION; 2,3-DIAMINOPROPIONATE; DEAMINASE	Pyridoxal 5'-phosphate (PLP)-dependent enzymes utilize the unique chemistry of a pyridine ring to carry out diverse reactions involving amino acids. Diaminopropionate (DAP) ammonia-lyase (DAPAL) is a prokaryotic PLP-dependent enzyme that catalyzes the degradation of D-and L-forms of DAP to pyruvate and ammonia. Here, we report the first crystal structure of DAPAL from Escherichia coli (EcDAPAL) in tetragonal and monoclinic forms at 2.0 and 2.2 angstrom resolutions, respectively. Structures of EcDAPAL soaked with substrates were also determined. EcDAPAL has a typical fold type II PLP-dependent enzyme topology consisting of a large and a small domain with the active site at the interface of the two domains. The enzyme is a homodimer with a unique biological interface not observed earlier. Structure of the enzyme in the tetragonal form had PLP bound at the active site, whereas the monoclinic structure was in the apo-form. Analysis of the apo and holo structures revealed that the region around the active site undergoes transition from a disordered to ordered state and assumes a conformation suitable for catalysis only upon PLP binding. A novel disulfide was found to occur near a channel that is likely to regulate entry of ligands to the active site. EcDAPAL soaked with DL-DAP revealed density at the active site appropriate for the reaction intermediate aminoacrylate, which is consistent with the observation that EcDAPAL has low activity under crystallization conditions. Based on the analysis of the structure and results of site-directed mutagenesis, a two-base mechanism of catalysis involving Asp(120) and Lys(77) is suggested.	[Bisht, Shveta; Rajaram, Venkatesan; Bharath, Sakshibeedu R.; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Kalyani, Josyula Nitya; Khan, Farida; Rao, Appaji N.; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Murthy, MRN (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mrn@mbu.iisc.ernet.in		Venkatesan, Rajaram/0000-0002-7257-1211; Bisht, Shveta/0000-0002-5566-3472	Department of Biotechnology; J. C. Bose fellowship, Government of India; Department of Science and Technology	Department of Biotechnology; J. C. Bose fellowship, Government of India; Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by the Department of Biotechnology, the Department of Science and Technology, and J. C. Bose fellowship, Government of India.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharath SR, 2011, FEBS J, V278, P2879, DOI 10.1111/j.1742-4658.2011.08210.x; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; CHEEMA PS, 1969, BIOCHEM J, V112, P29, DOI 10.1042/bj1120029; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; CORRIGAN JJ, 1966, BIOCHEMISTRY-US, V5, P1185, DOI 10.1021/bi00868a010; DeLano W.L, PYMOL MOL GRAPHICS S; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DUPOURQUE D, 1966, J BIOL CHEM, V241, P1233; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; GMELIN R, 1959, H-S Z PHYSIOL CHEM, V314, P28, DOI 10.1515/bchm2.1959.314.1.28; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; HASKELL TH, 1952, J AM CHEM SOC, V74, P599, DOI 10.1021/ja01123a006; HILLEBRAND GG, 1979, BIOCHEMISTRY-US, V18, P1751, DOI 10.1021/bi00576a018; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Khan F, 2003, BIOCHEM BIOPH RES CO, V306, P1083, DOI 10.1016/S0006-291X(03)01100-8; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MALATHI K, 1970, PHYTOCHEMISTRY, V9, P1603, DOI 10.1016/S0031-9422(00)85283-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSHAHWA.IK, 1973, J BIOL CHEM, V248, P7407; NAGASAWA T, 1988, J BIOL CHEM, V263, P958; Ngo H, 2007, BIOCHEMISTRY-US, V46, P7740, DOI 10.1021/bi7003872; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajaram V, 2003, ACTA CRYSTALLOGR D, V59, P1668, DOI 10.1107/S0907444903015476; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shimon LJW, 2007, J MOL BIOL, V366, P611, DOI 10.1016/j.jmb.2006.11.041; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; Smith MA, 2010, J BIOL CHEM, V285, P12873, DOI 10.1074/jbc.M109.050062; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; Uo T, 2002, BIOSCI BIOTECH BIOCH, V66, P2639, DOI 10.1271/bbb.66.2639; VIJAYALAKSHMI KR, 1975, H-S Z PHYSIOL CHEM, V356, P193, DOI 10.1515/bchm2.1975.356.1.193; WADA S, 1965, BIOCHEM BIOPH RES CO, V19, P482, DOI 10.1016/0006-291X(65)90150-6; WANG M, 1993, J ORG CHEM, V58, P5176, DOI 10.1021/jo00071a029; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Zhao CM, 2008, FEBS LETT, V582, P3125, DOI 10.1016/j.febslet.2008.07.054	50	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20369	20381		10.1074/jbc.M112.351809	http://dx.doi.org/10.1074/jbc.M112.351809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22505717	Green Published, hybrid			2022-12-28	WOS:000306414500056
J	Deng, X; Zhang, WW; O-Sullivan, I; Williams, JB; Dong, QM; Park, EA; Raghow, R; Unterman, TG; Elam, MB				Deng, Xiong; Zhang, Wenwei; O-Sullivan, InSug; Williams, J. Bradley; Dong, Qingming; Park, Edwards A.; Raghow, Rajendra; Unterman, Terry G.; Elam, Marshall B.			FoxO1 Inhibits Sterol Regulatory Element-binding Protein-1c (SREBP-1c) Gene Expression via Transcription Factors Sp1 and SREBP-1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FKHR PHOSPHORYLATION SITES; FATTY-ACID SYNTHESIS; SIGNALING PATHWAYS; HEPATIC FOXO1; HEPG2 CELLS; X-RECEPTOR; KINASE B; INSULIN; PROMOTER; FORKHEAD	Induction of lipogenesis in response to insulin is critically dependent on the transcription factor, sterol regulatory element-binding protein-1c (SREBP-1c). FoxO1, a forkhead box class-O transcription factor, is an important mediator of insulin action, but its role in the regulation of lipid metabolism has not been clearly defined. We examined the effects of FoxO1 on srebp1 gene expression in vivo and in vitro. In vivo studies showed that constitutively active (CA) FoxO1 (CA-FoxO1) reduced basal expression of SREBP-1c mRNA in liver by similar to 60% and blunted induction of SREBP-1c in response to feeding. In liver-specific FoxO knock-out mice, SREBP-1c expression was increased similar to 2-fold. Similarly, in primary hepatocytes, CA-FoxO1 suppressed SREBP1-c expression and inhibited basal and insulin-induced SREBP-1c promoter activity. SREBP-1c gene expressionis induced by the liver X receptor (LXR), but CA-FoxO1 did not block the activation of SREBP-1c by the LXR agonist TO9. Insulin stimulates SREBP-1c transcription through Sp1 and via "feed forward" regulation by newly synthesized SREBP-1c. CA-FoxO1 inhibited SREBP-1c by reducing the transactivational capacity of both Sp1 and SREBP-1c. In addition, chromatin immunoprecipitation assays indicate that FoxO1 can associate with the proximal promoter region of the srebp1 gene and disrupt the assembly of key components of the transcriptional complex of the SREBP-1c promoter. We conclude that FoxO1 inhibits SREBP-1c transcription via combined actions on multiple transcription factors and that this effect is exerted atleast in part through reduced transcriptional activity of Sp1 and SREBP-1c and disrupted assembly of the transcriptional initiation complex on the SREBP-1c promoter.	[Unterman, Terry G.] Jesse Brown VA Med Ctr, Med Res Unit MP151, Chicago, IL 60612 USA; [Deng, Xiong; Dong, Qingming; Raghow, Rajendra; Elam, Marshall B.] Memphis Vet Affairs Med Ctr, Dept Med, Memphis, TN 38104 USA; [Deng, Xiong; Dong, Qingming; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Deng, Xiong; Dong, Qingming; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Zhang, Wenwei; O-Sullivan, InSug; Williams, J. Bradley; Unterman, Terry G.] Univ Illinois, Dept Med, Coll Med, Chicago, IL 60612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Unterman, TG (corresponding author), Jesse Brown VA Med Ctr, Med Res Unit MP151, 820 S Damen Ave, Chicago, IL 60612 USA.	unterman@uic.edu; melam@uthsc.edu		O-Sullivan, InSug/0000-0003-0161-2028	National Institutes of Health [DK075505, DK0059368, DK41430]; Department of Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041430, R01DK041430, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075505 (to M. B. E.), DK0059368 (to E. A. P.), and DK41430 (to T. G. U.) and a grant from the Department of Veterans Affairs Merit Review Program (to X. D., T. G. U., R. R., and M. B. E).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howell G, 2009, BBA-MOL CELL BIOL L, V1791, P1190, DOI 10.1016/j.bbalip.2009.08.008; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Liu XJ, 2010, FEBS LETT, V584, P4330, DOI 10.1016/j.febslet.2010.09.027; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Naimi M, 2007, ENDOCRINOLOGY, V148, P2424, DOI 10.1210/en.2006-1411; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Scheimann AO, 2001, HORM METAB RES, V33, P631, DOI 10.1055/s-2001-18687; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Thijssen-Timmer DC, 2006, J MOL ENDOCRINOL, V37, P251, DOI 10.1677/jme.1.01914; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; UNTERMAN TG, 1992, BIOCHEM BIOPH RES CO, V185, P993, DOI 10.1016/0006-291X(92)91725-6; Wasner C, 2001, BBA-GENE STRUCT EXPR, V1521, P126, DOI 10.1016/S0167-4781(01)00303-7; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	48	92	97	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20132	20143		10.1074/jbc.M112.347211	http://dx.doi.org/10.1074/jbc.M112.347211			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511764	Green Published, hybrid			2022-12-28	WOS:000306414500034
J	Rybalchenko, V; Ahuja, M; Coblentz, J; Churamani, D; Patel, S; Kiselyov, K; Muallem, S				Rybalchenko, Volodymyr; Ahuja, Malini; Coblentz, Jessica; Churamani, Dev; Patel, Sandip; Kiselyov, Krill; Muallem, Shmuel			Membrane Potential Regulates Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Dependence of the pH- and Ca2+- sensitive Organellar Two-pore Channel TPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILIZES CALCIUM; RELEASE CHANNEL; MECHANISM; STORES; ROLES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent second messenger that mobilizes Ca2+ from the acidic endolysosomes by activation of the two-pore channels TPC1 and TPC2. The channel properties of human TPC1 have not been studied before, and its cellular function is not known. In the present study, we characterized TPC1 incorporated into lipid bilayers. The native and recombinant TPC1 channels are activated by NAADP. TPC1 activity requires acidic luminal pH and high luminal Ca2+. With Ba2+ as the permeable ion, luminal Ca2+ activates TPC1 with an apparent K-m of 180 mu M. TPC1 operates in two tightly coupled conductance states of 47 +/- 8 and 200 +/- 9 picosiemens. Importantly, opening of the large conductance markedly increases the small conductance mean open time. Changes in membrane potential from 0 to -60 mV increased linearly both the small and the large conductances and NPo, indicating that TPC1 is regulated by voltage. Intriguingly, the apparent affinity for activation of TPC1 by its ligand NAADP is not constant. Rather, hyperpolarization increases the apparent affinity of TPC1 for NAADP by 10 nM/mV. The concerted regulation of TPC1 activity by luminal Ca2+ and by membrane potential thus provides a potential mechanism to explain NAADP-induced Ca2+ oscillations. These findings reveal unique properties of TPC1 to explain its role in Ca2+ oscillations and cell function.	[Rybalchenko, Volodymyr; Ahuja, Malini; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Coblentz, Jessica; Kiselyov, Krill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	; Patel, Sandip/O-9591-2015	Kiselyov, Kirill/0000-0001-6683-2895; Rybalchenko, Volodymyr/0000-0003-4092-0779; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health through the NIDCR/DIR [Z1A-DE000735, HD058577, ES01678]; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; BBSRC [BB/G013721/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by an intramural National Institutes of Health grant (to S. M.) through the NIDCR/DIR Z1A-DE000735 and extramural Grants HD058577 and ES01678 (to K. K.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G013721/1 (to S. P.).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; Koivusalo M, 2011, TRAFFIC, V12, P972, DOI 10.1111/j.1600-0854.2011.01215.x; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Patel S, 2011, CELL CALCIUM, V50, P109, DOI 10.1016/j.ceca.2011.03.009; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Petersen OH, 2004, BIOL RES, V37, P661, DOI 10.4067/s0716-97602004000400023; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pottosin I, 2004, PLANTA, V219, P1057, DOI 10.1007/s00425-004-1293-7; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; WARD JM, 1994, PLANT CELL, V6, P669; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	44	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20407	20416		10.1074/jbc.M112.359612	http://dx.doi.org/10.1074/jbc.M112.359612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500018	Green Published, hybrid			2022-12-28	WOS:000306414500059
J	Suzuki, H; Ikeda, A; Tsuchimoto, S; Adachi, K; Noguchi, A; Fukumori, Y; Kanemori, M				Suzuki, Hirotaka; Ikeda, Ayami; Tsuchimoto, Sachie; Adachi, Ko-ichi; Noguchi, Aki; Fukumori, Yoshihiro; Kanemori, Masaaki			Synergistic Binding of DnaJ and DnaK Chaperones to Heat Shock Transcription Factor sigma(32) Ensures Its Characteristic High Metabolic Instability IMPLICATIONS FOR HEAT SHOCK PROTEIN 70 (Hsp70)-Hsp40 MODE OF FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; FTSH PROTEASE; CELLULAR FUNCTIONS; HSP70 CHAPERONES; TURNOVER ELEMENT; IN-VIVO; PROTEINS; MECHANISM; DEGRADATION	Escherichia coli heat shock transcription factor sigma(32) is rapidly degraded by ATP-dependent proteases, such as FtsH and ClpYQ. Although the DnaK chaperone system (DnaK, DnaJ, and GrpE) promotes sigma(32) degradation in vivo, the precise mechanism that is involved remains unknown. Our previous results indicated that sigma(32) mutants containing amino acid substitution in the N-terminal half of Region 2.1 are markedly stabilized in vivo. Here, we report the further characterization of these mutants by examining purified sigma(32) mutants in vitro. Surprisingly, I54A sigma(32), a very stable mutant, is more susceptible to ClpYQ and FtsH proteases than wild-type sigma(32), indicating that the stability of sigma(32) does not always reflect its susceptibility to proteases. Co-precipitation and gel filtration analyses show that purified sigma(32) mutants exhibit a reduced affinity for DnaJ, leading to a marked decrease in forming a complex with DnaK in the presence of DnaJ and ATP. Other mutants with modestly increased stability (A50S sigma(32) and K51E sigma(32)) show an intermediate efficiency of complex formation with DnaK, suggesting that defects in binding to DnaK and DnaJ are well correlated with metabolic stability; effective interaction with DnaK promotes sigma(32) degradation in vivo. We argue that the stable and effective interaction of heat shock protein 70 (Hsp70) with a substrate polypeptide may generally require the simultaneous binding of heat shock protein 40 (Hsp40) to distinct sites on the substrate.	[Suzuki, Hirotaka; Ikeda, Ayami; Tsuchimoto, Sachie; Adachi, Ko-ichi; Noguchi, Aki; Fukumori, Yoshihiro; Kanemori, Masaaki] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Kanemori, M (corresponding author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	mkanemo@staff.kanazawa-u.ac.jp	Fukumori, Yoshihiro/J-2483-2014					AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Blaszczak A, 1999, MOL MICROBIOL, V31, P157, DOI 10.1046/j.1365-2958.1999.01155.x; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; ISHIAI M, 1992, J BACTERIOL, V174, P5597, DOI 10.1128/JB.174.17.5597-5603.1992; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanemori M, 1999, J BIOL CHEM, V274, P22002, DOI 10.1074/jbc.274.31.22002; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kim SY, 2002, J BIOL CHEM, V277, P44778, DOI 10.1074/jbc.M206176200; KUSUKAWA N, 1988, GENE DEV, V2, P874, DOI 10.1101/gad.2.7.874; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIBEREK K, 1993, P NATL ACAD SCI USA, V90, P11019, DOI 10.1073/pnas.90.23.11019; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; NAGAI H, 1994, P NATL ACAD SCI USA, V91, P10280, DOI 10.1073/pnas.91.22.10280; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Obrist M, 2007, MICROBIOL-SGM, V153, P2560, DOI 10.1099/mic.0.2007/007047-0; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Sambrook J, 1989, MOL CLONING LAB MANU, P2; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRAUS DB, 1989, GENE DEV, V3, P2003, DOI 10.1101/gad.3.12a.2003; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; TAURA T, 1989, BIOCHEM BIOPH RES CO, V163, P438, DOI 10.1016/0006-291X(89)92155-4; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; Yura T, 2007, P NATL ACAD SCI USA, V104, P17638, DOI 10.1073/pnas.0708819104	44	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19275	19283		10.1074/jbc.M111.331470	http://dx.doi.org/10.1074/jbc.M111.331470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496372	hybrid, Green Published			2022-12-28	WOS:000306411900037
J	Bulling, S; Schicker, K; Zhang, YW; Steinkellner, T; Stockner, T; Gruber, CW; Boehm, S; Freissmuth, M; Rudnick, G; Sitte, HH; Sandtner, W				Bulling, Simon; Schicker, Klaus; Zhang, Yuan-Wei; Steinkellner, Thomas; Stockner, Thomas; Gruber, Christian W.; Boehm, Stefan; Freissmuth, Michael; Rudnick, Gary; Sitte, Harald H.; Sandtner, Walter			The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; CONFORMATIONAL-CHANGES; BACTERIAL HOMOLOG; MEDIATED EFFLUX; LIGAND-BINDING; RAT-BRAIN; COCAINE; AMPHETAMINE	Ibogaine, a hallucinogenic alkaloid proposed as a treatment for opiate withdrawal, has been shown to inhibit serotonin transporter (SERT) noncompetitively, in contrast to all other known inhibitors, which are competitive with substrate. Ibogaine binding to SERT increases accessibility in the permeation pathway connecting the substrate-binding site with the cytoplasm. Because of the structural similarity between ibogaine and serotonin, it had been suggested that ibogaine binds to the substrate site of SERT. The results presented here show that ibogaine binds to a distinct site, accessible from the cell exterior, to inhibit both serotonin transport and serotonin-induced ionic currents. Ibogaine noncompetitively inhibited transport by both SERT and the homologous dopamine transporter (DAT). Ibogaine blocked substrate-induced currents also in DAT and increased accessibility of the DAT cytoplasmic permeation pathway. When present on the cell exterior, ibogaine inhibited SERT substrate-induced currents, but not when it was introduced into the cytoplasm through the patch electrode. Similar to noncompetitive transport inhibition, the current block was not reversed by increasing substrate concentration. The kinetics of inhibitor binding and dissociation, as determined by their effect on SERT currents, indicated that ibogaine does not inhibit by forming a long-lived complex with SERT, but rather binds directly to the transporter in an inward-open conformation. A kinetic model for transport describing the noncompetitive action of ibogaine and the competitive action of cocaine accounts well for the results of the present study.	[Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Zhang, Yuan-Wei; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Medical University of Vienna; Yale University	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at	Stockner, Thomas/A-9509-2014; Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019; Gruber, Christian/C-4406-2011	Stockner, Thomas/0000-0002-7071-8283; Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; ZHANG, YUAN-WEI/0000-0002-4276-9251; Steinkellner, Thomas/0000-0003-4591-4992; Freissmuth, Michael/0000-0001-9398-1765; Gruber, Christian/0000-0001-6060-7048; Schicker, Klaus/0000-0002-3068-7830; Boehm, Stefan/0000-0002-0205-2459	National Institutes of Health [DA007259]; Austrian Science Fund (FWF) [P18706, SFB35-06, P17611]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grant DA007259 (to G. R.) and The Austrian Science Fund (FWF) Grants P18706 and SFB35-06 (to H. H. S.) and P17611 (to S. B.).	Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Baumann M. H., 2001, JPET, V297, P2531; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Boehm S, 1999, J NEUROSCI, V19, P737; CZECH MP, 1973, J BIOL CHEM, V248, P3636; DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364; Donnelly JR, 2011, J LEGAL MED, V32, P93, DOI 10.1080/01947648.2011.550832; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; HENDERSON PJ, 1970, BIOCHEMISTRY-US, V9, P3453, DOI 10.1021/bi00819a026; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lauger P., 1991, ELECTROGENIC ION PUM; Leal MB, 2003, PROG NEURO-PSYCHOPH, V27, P781, DOI 10.1016/S0278-5846(03)00109-X; Levi MS, 2002, CURR MED CHEM, V9, P1807, DOI 10.2174/0929867023368980; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Martin RS, 2008, J PHARMACOL EXP THER, V327, P991, DOI 10.1124/jpet.108.142307; NELSON PJ, 1979, J BIOL CHEM, V254, P84; PIFL C, 1995, MOL PHARMACOL, V47, P368; Reid MS, 1996, J NEURAL TRANSM, V103, P967, DOI 10.1007/BF01291787; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Segel IH, 1975, ENZYME KINETICS BEHA; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2000, J NEUROCHEM, V74, P1317; Sonders MS, 1997, J NEUROSCI, V17, P960; Stein WD, 1967, MOVEMENT MOL CELL ME; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; WALL SC, 1993, MOL PHARMACOL, V43, P264; Wells GB, 1999, BRAIN RES BULL, V48, P641, DOI 10.1016/S0361-9230(99)00053-2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	56	77	77	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18524	18534		10.1074/jbc.M112.343681	http://dx.doi.org/10.1074/jbc.M112.343681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22451652	hybrid, Green Published			2022-12-28	WOS:000306411600058
J	Fujikawa, M; Imamura, H; Nakamura, J; Yoshida, M				Fujikawa, Makoto; Imamura, Hiromi; Nakamura, Junji; Yoshida, Masasuke			Assessing Actual Contribution of IF1, Inhibitor of Mitochondrial FoF1, to ATP Homeostasis, Cell Growth, Mitochondrial Morphology, and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISTAE MORPHOLOGY; F1F0-ATP SYNTHASE; PROTEIN IF1; COMPLEX; HEART; YEAST; OLIGOMERIZATION; ORGANIZATION; DIMERIZATION; LACKING	FoF1-ATP synthase (FoF1) synthesizes ATP in mitochondria coupled with proton flow driven by the proton motive force (pmf) across membranes. It has been known that isolated IF1, an evolutionarily well conserved mitochondrial protein, can inhibit the ATP hydrolysis activity of FoF1. Here, we generated HeLa cells with permanent IF1 knockdown (IF1-KD cells) and compared their energy metabolism with control cells. Under optimum growth conditions, IF1-KD cells have lower cellular ATP levels and generate a higher pmf and more reactive oxygen species. Nonetheless, IF1-KD cells and control cells show the same rates of cell growth, glucose consumption, and mitochondrial ATP synthesis. Furthermore, contrary to previous reports, the morphology of mitochondria in IF1-KD cells appears to be normal. When cells encounter sudden dissipation of pmf, the cytoplasmic ATP level in IF1-KD cells drops immediately (similar to 1 min), whereas it remains unchanged in the control cells, indicating occurrence of futile ATP hydrolysis by FoF1 in the absence of IF1. The lowered ATP level in IF1-KD cells then recovers gradually (similar to 10 min) to the original level by consuming more glucose than control cells. The viability of IF1-KD cells and control cells is the same in the absence of pmf. Thus, IF1 contributes to ATP homeostasis, but its deficiency does not affect the growth and survival of HeLa cells. Only when cells are exposed to chemical ischemia (no glycolysis and no respiration) or high concentrations of reactive oxygen species does IF1 exhibit its ability to alleviate cell injury.	[Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan; [Fujikawa, Makoto; Nakamura, Junji; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project ICORP, Tokyo 1350064, Japan; [Imamura, Hiromi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 2788510, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Project, Kyoto 6058501, Japan	Kyoto Sangyo University; Japan Science & Technology Agency (JST); Tokyo University of Science; Kyoto University	Yoshida, M (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Imamura, Hiromi/AAD-5109-2019; FUNG, John Julian/A-2679-2012	Imamura, Hiromi/0000-0002-1896-0443; FUNG, John Julian/0000-0002-3038-0441; Fujikawa, Makoto/0000-0002-8100-3718	ATP Synthesis Regulation Project (ICORP) by Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	ATP Synthesis Regulation Project (ICORP) by Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the ATP Synthesis Regulation Project (ICORP) by the Japan Science and Technology Agency (to M. Y.).	Aggeler R, 2002, J BIOL CHEM, V277, P33906, DOI 10.1074/jbc.M204538200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Castillo DD, 2011, J BIOL CHEM, V286, P23911, DOI 10.1074/jbc.M111.252056; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; Ichikawa N, 1999, BIOSCI BIOTECH BIOCH, V63, P2225, DOI 10.1271/bbb.63.2225; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Lu YM, 2001, J BIOCHEM-TOKYO, V130, P873, DOI 10.1093/oxfordjournals.jbchem.a003060; MANSOUR TE, 1968, J BIOL CHEM, V243, P2523; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Yamada E, 1997, IMMUNOLOGY, V92, P571, DOI 10.1046/j.1365-2567.1997.00370.x	28	48	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18781	18787		10.1074/jbc.M112.345793	http://dx.doi.org/10.1074/jbc.M112.345793			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493494	hybrid, Green Published			2022-12-28	WOS:000306411600086
J	Ho, BT; Olson, G; Figel, S; Gelman, I; Cance, WG; Golubovskaya, VM				Ho, Baotran; Olson, Gretchen; Figel, Sheila; Gelman, Irwin; Cance, William G.; Golubovskaya, Vita M.			Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; DECREASES TUMOR-GROWTH; EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; N-TERMINAL DOMAIN; GENE-EXPRESSION; HUMAN NEUROBLASTOMA; CARCINOMA-CELLS; HUMAN GLIOMAS; P53	Nanog and FAK were shown to be overexpressed in cancer cells. In this report, the Nanog overexpression increased FAK expression in 293, SW480, and SW620 cancer cells. Nanog binds the FAK promoter and up-regulates its activity, whereas Nanog siRNA decreases FAK promoter activity and FAK mRNA. The FAK promoter contains four Nanog-binding sites. The site-directed mutagenesis of these sites significantly decreased up-regulation of FAK promoter activity by Nanog. EMSA showed the specific binding of Nanog to each of the four sites, and binding was confirmed by ChIP assay. Nanog directly binds the FAK protein by pulldown and immunoprecipitation assays, and proteins co-localize by confocal microscopy. Nanog binds the N-terminal domain of FAK. In addition, FAK directly phosphorylates Nanog in a dose-dependent manner by in vitro kinase assay and in cancer cells in vivo. The site-directed mutagenesis of Nanog tyrosines, Y35F and Y174F, blocked phosphorylation and binding by FAK. Moreover, overexpression of wild type Nanog increased filopodia/lamellipodia formation, whereas mutant Y35F and Y174F Nanog did not. The wild type Nanog increased cell invasion that was inhibited by the FAK inhibitor and increased by FAK more significantly than with the mutants Y35F and Y174F Nanog. Down-regulation of Nanog with siRNA decreased cell growth reversed by FAK overexpression. Thus, these data demonstrate the regulation of the FAK promoter by Nanog, the direct binding of the proteins, the phosphorylation of Nanog by FAK, and the effect of FAK and Nanog cross-regulation on cancer cell morphology, invasion, and growth that plays a significant role in carcinogenesis.	[Ho, Baotran; Olson, Gretchen; Cance, William G.; Golubovskaya, Vita M.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Figel, Sheila; Gelman, Irwin] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Cance, WG (corresponding author), Roswell Pk Canc Inst, Dept Surg Oncol, Elm & Carlton St, Buffalo, NY 14263 USA.	William.Cance@Roswellpark.org; Vita.Golubovskaya@Roswellpark.org			National Institutes of Health [CA65910]; Susan Komen for the Cure Grant [BCTR0707148]; Roswell Park Cancer Institute; NCI [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA065910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen for the Cure Grant; Roswell Park Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA65910 (to W. G. C.) and Grant P30 CA016056 from NCI. This work was also supported by Susan Komen for the Cure Grant BCTR0707148 (to V. M. G.) and the Roswell Park Cancer Institute.	Afrikanova I, 2011, J BIOL CHEM, V286, P36042, DOI 10.1074/jbc.M111.290825; Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Beviglia L, 2003, BIOCHEM J, V373, P201, DOI 10.1042/BJ20021846; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya V, 2002, J BIOL CHEM, V277, P38978, DOI 10.1074/jbc.M205002200; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Golubovskaya VM, 2008, BIOCHEM J, V411, P151, DOI 10.1042/BJ20071657; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Golubovskaya VM, 2010, FRONT BIOSCI-LANDMRK, V15, P901, DOI 10.2741/3653; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Herberg M, 2011, CELL CYCLE, V10, P2252, DOI 10.4161/cc.10.14.16203; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kobayashi K, 2012, J CELL BIOCHEM, V113, P508, DOI 10.1002/jcb.23374; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lin T., 2011, MED ONCOL, V20, P2252; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lin YL, 2011, MOL CELL BIOCHEM, V351, P109, DOI 10.1007/s11010-011-0717-5; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Niu CS, 2011, ONCOL REP, V26, P593, DOI 10.3892/or.2011.1308; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tomuleasa C, 2010, J BUON, V15, P583; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tu LC, 2001, J BIOMED SCI, V8, P184, DOI 10.1007/BF02256411; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Yamamoto D, 2003, CELL SIGNAL, V15, P575, DOI 10.1016/S0898-6568(02)00142-0; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094; Zhou X, 2011, INT J GYNECOL PATHOL, V30, P262, DOI 10.1097/PGP.0b013e3182055a1f	62	56	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18656	18673		10.1074/jbc.M111.322883	http://dx.doi.org/10.1074/jbc.M111.322883			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493428	Green Published, hybrid			2022-12-28	WOS:000306411600075
J	Shah, CA; Bei, L; Wang, H; Platanias, LC; Eklund, EA				Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.			HoxA10 Protein Regulates Transcription of Gene Encoding Fibroblast Growth Factor 2 (FGF2) in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; TGF-BETA ISOFORMS; DNA-BINDING; IN-VITRO; ACTIVATES TRANSCRIPTION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION; LEUKEMIA	HoxA10 is a member of a highly conserved family of homeodomain transcription factors that are involved in definitive hematopoiesis and implicated in the pathogenesis of acute myeloid leukemia (AML). During normal hematopoiesis, HoxA10 facilitates myeloid progenitor expansion and impedes myeloid differentiation. To better understand the molecular mechanisms that control these events, we have been identifying and characterizing HoxA10 target genes. In this study, we identified the gene encoding fibroblast growth factor 2 (Fgf2 or basic fibroblast growth factor) as a target gene that is relevant to the biological effects of HoxA10. We identified two cis elements in the proximal FGF2 promoter that are activated by HoxA10 in myeloid progenitor cells and differentiating phagocytes. We determined that Fgf2 expression and secretion are regulated in a HoxA10-dependent manner in these cells. We found that increased Fgf2 production by HoxA10-overexpressing myeloid progenitor cells induced a phosphoinositol 3-kinase-dependent increase in beta-catenin protein. This resulted in autocrine stimulation of proliferation in HoxA10-overexpressing cells and hypersensitivity to other cytokines that share this pathway. Therefore, these studies identified expression of Fgf2 as a mechanism by which HoxA10 controls the size of the myeloid progenitor population. These studies also suggested that aberrant production of Fgf2 may contribute to leukemogenesis in the subset of AML with dysregulated Hox expression. Therapeutic targeting of Fgf2-stimulated signaling pathways might be a rational approach to this poor prognosis subset of AML.	[Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review.	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; PAREKH T, 1994, J IMMUNOL, V152, P2456; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Salzman SA, 2002, CYTOKINES CELL MOL T, V7, P31, DOI 10.1080/13684730216400; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Szymkowiak CH, 2000, CYTOKINE, V12, P397, DOI 10.1006/cyto.1999.0572; Takagi S, 2000, ACTA HAEMATOL-BASEL, V103, P78, DOI 10.1159/000041024; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; WILSON EL, 1991, BLOOD, V77, P954; Yoon SY, 2000, ACTA HAEMATOL-BASEL, V104, P151, DOI 10.1159/000046507; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	51	32	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18230	18248		10.1074/jbc.M111.328401	http://dx.doi.org/10.1074/jbc.M111.328401			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493287	Green Published, hybrid			2022-12-28	WOS:000306411600031
J	Baranovskiy, AG; Lada, AG; Siebler, HM; Zhang, YB; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Lada, Artem G.; Siebler, Hollie M.; Zhang, Yinbo; Pavlov, Youri I.; Tahirov, Tahir H.			DNA Polymerase delta and zeta Switch by Sharing Accessory Subunits of DNA Polymerase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; REV1 PROTEIN; POL-ZETA; IN-VIVO; PCNA BINDING; B-SUBUNIT; YEAST; REPAIR	Translesion DNA synthesis is an important branch of the DNA damage tolerance pathway that assures genomic integrity of living organisms. The mechanisms of DNA polymerase (Pol) switches during lesion bypass are not known. Here, we show that the C-terminal domain of the Pol zeta catalytic subunit interacts with accessory subunits of replicative DNA Pol delta. We also show that, unlike other members of the human B-family of DNA polymerases, the highly conserved and similar C-terminal domains of Pol delta and Pol zeta contain a [4Fe-4S] cluster coordinated by four cysteines. Amino acid changes in Pol zeta that prevent the assembly of the [4Fe-4S] cluster abrogate Pol zeta function in UV mutagenesis. On the basis of these data, we propose that Pol switches at replication-blocking lesions occur by the exchange of the Pol delta and Pol zeta catalytic subunits on a preassembled complex of accessory proteins retained on DNA during translesion DNA synthesis.	[Baranovskiy, Andrey G.; Lada, Artem G.; Siebler, Hollie M.; Zhang, Yinbo; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 600 S 42nd St, Omaha, NE 68198 USA.	ttahirov@unmc.edu	; Pavlov, Youri/T-7532-2017	Siebler, Hollie/0000-0002-1406-1184; Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	National Institutes of Health from NIGMS [R01 GM082923]; Eppley Cancer Center; National Institutes of Health from NCI [CA129925]; Smoking Disease Research Program Department of Health and Human Services [2011-27]; Russian Federal Program "Innovation Scientific Personnel" State [14.740.11.0916]; NATIONAL CANCER INSTITUTE [R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eppley Cancer Center; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Smoking Disease Research Program Department of Health and Human Services; Russian Federal Program "Innovation Scientific Personnel" State; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM082923 from NIGMS (to T. H. T.). This work was also supported by Eppley Cancer Center seed grants. The work related to yeast genetics experiments was supported by National Institutes of Health Grant CA129925 from NCI, Smoking Disease Research Program Department of Health and Human Services Grant 2011-27, and Russian Federal Program "Innovation Scientific Personnel" State Contract 14.740.11.0916 (to Y. I. P.).	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2008, ACTA CRYSTALLOGR F, V64, P822, DOI 10.1107/S1744309108025086; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia JS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-82; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Giot L, 1997, GENETICS, V146, P1239; Hanna M, 2007, MUTAT RES-FUND MOL M, V625, P164, DOI 10.1016/j.mrfmmm.2007.06.008; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Jain R, 2009, J MOL BIOL, V394, P377, DOI 10.1016/j.jmb.2009.09.066; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Pavlov YI, 2001, GENETICS, V159, P47; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Pursell ZF, 2008, PROG NUCLEIC ACID RE, V82, P101, DOI 10.1016/S0079-6603(08)00004-4; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Stone JE, 2011, DNA REPAIR, V10, P826, DOI 10.1016/j.dnarep.2011.04.032; SUGIMOTO K, 1995, NUCLEIC ACIDS RES, V23, P3493, DOI 10.1093/nar/23.17.3493; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200	45	128	133	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17281	17287		10.1074/jbc.M112.351122	http://dx.doi.org/10.1074/jbc.M112.351122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22465957	Green Published, hybrid			2022-12-28	WOS:000306373000028
J	Hung, CW; Aoh, QL; Joglekar, AP; Payne, GS; Duncan, MC				Hung, Chao-Wei; Aoh, Quyen L.; Joglekar, Ajit P.; Payne, Gregory S.; Duncan, Mara C.			Adaptor Autoregulation Promotes Coordinated Binding within Clathrin Coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; GAMMA-ADAPTIN; YEAST; ENTH; DOMAINS; FAMILY; AP-1; GGAS	Membrane traffic is an essential process that allows protein and lipid exchange between the endocytic, lysosomal, and secretory compartments. Clathrin-mediated traffic between the trans-Golgi network and endosomes mediates responses to the environment through the sorting of biosynthetic and endocytic protein cargo. Traffic through this pathway is initiated by the controlled assembly of a clathrin-adaptor protein coat on the cytosolic surface of the originating organelle. In this process, clathrin is recruited by different adaptor proteins that act as a bridge between clathrin and the transmembrane cargo proteins to be transported. Interactions between adaptors and clathrin and between different types of adaptors lead to the formation of a densely packed protein network within the coat. A key unresolved issue is how the highly complex adaptor-clathrin interaction and adaptor-adaptor interaction landscape lead to the correct spatiotemporal assembly of the clathrin coat. Here we report the discovery of a new autoregulatory motif within the clathrin adaptor Gga2 that drives synergistic binding of Gga2 to clathrin and the adaptor Ent5. This autoregulation influences the temporal and/or spatial location of the Gga2-Ent5 interaction. We propose that this synergistic binding provides built-in regulation to ensure the correct assembly of clathrin coats.	[Hung, Chao-Wei; Aoh, Quyen L.; Duncan, Mara C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Joglekar, Ajit P.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Payne, Gregory S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Duncan, MC (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	mduncan@bio.unc.edu	Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109; Joglekar, Ajit/0000-0002-0607-5332	National Institutes of Health [GM092741, GM39040]; state of North Carolina; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039040, R01GM092741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of North Carolina; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM092741 (to M. C. D.) and GM39040 (to G. P.). This work was also supported by funds from the state of North Carolina (to M. C. D. and Q. A.).; Recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Bai HD, 2004, J BIOL CHEM, V279, P17411, DOI 10.1074/jbc.M401158200; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Brady RJ, 2008, J CELL SCI, V121, P3433, DOI 10.1242/jcs.032573; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Costaguta G, 2006, MOL BIOL CELL, V17, P3907, DOI 10.1091/mbc.E06-05-0410; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; LEMMON SK, 1988, J CELL BIOCHEM, V36, P329, DOI 10.1002/jcb.240360403; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Morgan JR, 2000, J NEUROSCI, V20, P8667; Mullins C, 2001, MOL CELL BIOL, V21, P7981, DOI 10.1128/MCB.21.23.7981-7994.2001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; RAD MR, 1995, J CELL SCI, V108, P1605; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scheele U, 2003, J BIOL CHEM, V278, P25357, DOI 10.1074/jbc.M303738200; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; WOODWARD MP, 1978, P NATL ACAD SCI USA, V75, P4394, DOI 10.1073/pnas.75.9.4394; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643	38	8	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17398	17407		10.1074/jbc.M112.349035	http://dx.doi.org/10.1074/jbc.M112.349035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457357	hybrid, Green Published			2022-12-28	WOS:000306373000039
J	Osanai-Futahashi, M; Tatematsu, K; Yamamoto, K; Narukawa, J; Uchino, K; Kayukawa, T; Shinoda, T; Banno, Y; Tamura, T; Sezutsu, H				Osanai-Futahashi, Mizuko; Tatematsu, Ken-ichiro; Yamamoto, Kimiko; Narukawa, Junko; Uchino, Keiro; Kayukawa, Takumi; Shinoda, Tetsuro; Banno, Yutaka; Tamura, Toshiki; Sezutsu, Hideki			Identification of the Bombyx Red Egg Gene Reveals Involvement of a Novel Transporter Family Gene in Late Steps of the Insect Ommochrome Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT GRANULE BIOGENESIS; EYE-COLOR GENES; DROSOPHILA-MELANOGASTER; MOLECULAR CHARACTERIZATION; UBER OMMOCHROME; DEEP-ORANGE; LINKAGE MAP; SILKWORM; EXPRESSION; VERMILION	Ommochromes are one of the major pigments involved in coloration of eggs, eyes, and body surface of insects. However, the molecular mechanisms of the final steps of ommochrome pigment synthesis have been largely unknown. The eggs of the silkworm Bombyx mori contain a mixture of ommochrome pigments, and exhibit a brownish lilac color. The recessive homozygous of egg and eye color mutant, red egg (re), whose eggs display a pale orange color instead of normal dark coloration, has been long suggested to have a defect in the biosynthesis of the final ommochrome pigments. Here, we identify the gene responsible for the re locus by positional cloning, mutant analysis, and RNAi experiments. In the re mutants, we found that a 541-bp transposable element is inserted into the ORF of BGIBMGA003497-1 (Bm-re) encoding a novel member of a major facilitator super-family transporter, causing disruption of the splicing of exon 9, resulting in two aberrant transcripts with frameshifts yielding nonfunctional proteins lacking the C-terminal transmembrane domains. Bm-re function in pigmentation was confirmed by embryonic RNAi experiments. Homologs of the Bm-re gene were found in all insect genomes sequenced at present, except for 12 sequenced Drosophila genomes, which seemed to correlate with the previous studies that have demonstrated that eye ommochrome composition is different from other insects in several Dipterans. Knockdown of the Bm-re homolog by RNAi in the red flour beetle Tribolium castaneum caused adult compound eye coloration defects, indicating a conserved role in ommochrome pigment biosynthesis at least among holometabolous insects.	[Osanai-Futahashi, Mizuko; Tatematsu, Ken-ichiro; Uchino, Keiro; Tamura, Toshiki; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Yamamoto, Kimiko; Narukawa, Junko] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Kayukawa, Takumi; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Banno, Yutaka] Kyushu Univ, Fac Agr, Lab Insect Genet Resources, Fukuoka 8128581, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Kyushu University	Osanai-Futahashi, M (corresponding author), Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	mfutahashi@nias.affrc.go.jp		Uchino, Keiro/0000-0003-3650-7359; Sezutsu, Hideki/0000-0001-8886-1611	MAFF-NIAS (Integrated research program for plant, insect and animal using genome technology) [INSECT-1102]; National BioResource Project, Japan	MAFF-NIAS (Integrated research program for plant, insect and animal using genome technology); National BioResource Project, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the MAFF-NIAS (Integrated research program for plant, insect and animal using genome technology (INSECT-1102)) and the National BioResource Project, Japan.	Abrabam EG, 2000, MOL GEN GENET, V264, P11, DOI 10.1007/s004380000283; AJAMI AM, 1971, BIOCHEMISTRY-US, V10, P1451; Banno Y, 2010, EXP ANIM TOKYO, V59, P139, DOI 10.1538/expanim.59.139; Becker E., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P157, DOI 10.1007/BF01741981; BUTENANDT A, 1959, H-S Z PHYSIOL CHEM, V314, P15, DOI 10.1515/bchm2.1959.314.1.15; BUTENANDT A, 1958, H-S Z PHYSIOL CHEM, V312, P227, DOI 10.1515/bchm2.1958.312.1.227; Butenandt A, 1962, RECENT PROGR CHEM NA, P13; Ferguson LC, 2009, EVOL DEV, V11, P498, DOI 10.1111/j.1525-142X.2009.00358.x; FRIDELL YWC, 1991, NUCLEIC ACIDS RES, V19, P5082, DOI 10.1093/nar/19.18.5082; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Hashimoto H., 1940, J SERIC SCI JPN, V11, P29; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; KAWASE S., 1954, JAPANESE JOUR GENETICS, V29, P114, DOI 10.1266/jjg.29.114; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kikkawa H, 1941, GENETICS, V26, P587; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Kobayashi Isao, 2007, Journal of Insect Biotechnology and Sericology, V76, P145; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Krauss V, 2008, MOL BIOL EVOL, V25, P821, DOI 10.1093/molbev/msn013; Kretzschmar D, 2000, GENETICS, V155, P213; LINZEN B, 1970, H-S Z PHYSIOL CHEM, V351, P622, DOI 10.1515/bchm2.1970.351.1.622; Linzen B., 1974, P117; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Lorenzen MD, 2002, GENETICS, V160, P225; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Mullins C, 1999, MOL GEN GENET, V262, P401, DOI 10.1007/s004380051099; Nakaizawa K., 1977, J SERIC SCI JPN, V48, P147; Nijhout HF, 1997, ARCH INSECT BIOCHEM, V36, P215, DOI 10.1002/(SICI)1520-6327(1997)36:3<215::AID-ARCH5>3.0.CO;2-S; Ooi CE, 1997, EMBO J, V16, P4508; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PEPLING M, 1990, NUCLEIC ACIDS RES, V18, P1633, DOI 10.1093/nar/18.6.1633; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; Reed RD, 2005, EVOL DEV, V7, P301, DOI 10.1111/j.1525-142X.2005.05036.x; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sawada H, 2000, COMP BIOCHEM PHYS B, V125, P421, DOI 10.1016/S0305-0491(99)00179-0; SEARLES LL, 1990, MOL CELL BIOL, V10, P1423, DOI 10.1128/MCB.10.4.1423; SEARLES LL, 1986, P NATL ACAD SCI USA, V83, P404, DOI 10.1073/pnas.83.2.404; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Shestopal SA, 1997, MOL GEN GENET, V253, P642; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Syrzycka M, 2007, GENOME, V50, P548, DOI 10.1139/G07-032; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; TEARLE RG, 1989, GENETICS, V122, P595; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; TIRELLI M, 1946, J HERED, V37, P377, DOI 10.1093/oxfordjournals.jhered.a105566; Toyama K, 1913, J GENET, V2, P351, DOI 10.1007/BF02981559; Uda H., 1928, B HIGHER AGR FORESTR, V1, P1; Warner TS, 1998, GENOME, V41, P236, DOI 10.1139/gen-41-2-236; Warren WD, 1996, GENETICA, V98, P249, DOI 10.1007/BF00057589; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801	57	40	47	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17706	17714		10.1074/jbc.M111.321331	http://dx.doi.org/10.1074/jbc.M111.321331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474291	hybrid, Green Published			2022-12-28	WOS:000306373000069
J	Toro, EJ; Zuo, J; Ostrov, DA; Catalfamo, D; Bradaschia-Correa, V; Arana-Chavez, V; Caridad, AR; Neubert, JK; Wronski, TJ; Wallet, SM; Holliday, LS				Toro, Edgardo J.; Zuo, Jian; Ostrov, David A.; Catalfamo, Dana; Bradaschia-Correa, Vivian; Arana-Chavez, Victor; Caridad, Aliana R.; Neubert, John K.; Wronski, Thomas J.; Wallet, Shannon M.; Holliday, L. Shannon			Enoxacin Directly Inhibits Osteoclastogenesis without Inducing Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; ACTIN-BINDING ACTIVITY; V-ATPASE; PROTON PUMP; BONE-RESORPTION; CROSS-LINKING; SUBUNIT-C; B-SUBUNIT; DC-STAMP; F-ACTIN	Enoxacin has been identified as a small molecule inhibitor of binding between the B2-subunit of vacuolar H+-ATPase (V-ATPase) and microfilaments. It inhibits bone resorption by calcitriol-stimulated mouse marrow cultures. We hypothesized that enoxacin acts directly and specifically on osteoclasts by disrupting the interaction between plasma membrane-directed V-ATPases, which contain the osteoclast-selective a3-subunit of V-ATPase, and microfilaments. Consistent with this hypothesis, enoxacin dose-dependently reduced the number of multinuclear cells expressing tartrate-resistant acid phosphatase (TRAP) activity produced by RANK-L-stimulated osteoclast precursors. Enoxacin (50 mu M) did not induce apoptosis as measured by TUNEL and caspase-3 assays. V-ATPases containing the a3-subunit, but not the "housekeeping" a1-subunit, were isolated bound to actin. Treatment with enoxacin reduced the association of V-ATPase subunits with the detergent-insoluble cytoskeleton. Quantitative PCR revealed that enoxacin triggered significant reductions in several osteoclast-selective mRNAs, but levels of various osteoclast proteins were not reduced, as determined by quantitative immunoblots, even when their mRNA levels were reduced. Immunoblots demonstrated that proteolytic processing of TRAP5b and the cytoskeletal protein L-plastin was altered in cells treated with 50 mu M enoxacin. Flow cytometry revealed that enoxacin treatment favored the expression of high levels of DC-STAMP on the surface of osteoclasts. Our data show that enoxacin directly inhibits osteoclast formation without affecting cell viability by a novel mechanism that involves changes in post-translational processing and trafficking of several proteins with known roles in osteoclast function. We propose that these effects are downstream to blocking the binding interaction between a3-containing V-ATPases and microfilaments.	[Toro, Edgardo J.; Zuo, Jian; Caridad, Aliana R.; Neubert, John K.; Holliday, L. Shannon] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL 32610 USA; [Ostrov, David A.] Univ Florida, Coll Dent, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Catalfamo, Dana; Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Bradaschia-Correa, Vivian; Arana-Chavez, Victor] Univ Sao Paulo, Sch Dent, Dept Dent Mat, Lab Oral Biol, BR-05508900 Sao Paulo, SP, Brazil; [Wronski, Thomas J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Holliday, L. Shannon] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade de Sao Paulo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Holliday, LS (corresponding author), Univ Florida, Coll Dent, Dept Orthodont, D7-18,CB100444,1395 Ctr Dr, Gainesville, FL 32611 USA.	sholliday@dental.ufl.edu	Bradaschia-Correa, Vivian/N-7452-2013; Arana-Chavez, V/G-4948-2012; Holliday, Lexie/GYQ-4972-2022	Bradaschia-Correa, Vivian/0000-0002-4395-3106; Arana-Chavez, V/0000-0002-6767-7812; Holliday, Lexie/0000-0002-0844-1965; Villmore, Dana/0000-0001-7362-4605	National Institutes of Health from NIDCR [R21-DE19862 01A1]; University of Florida Opportunity Fund; NIDCR [T32 DE07200-15]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019862, T32DE007200] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; University of Florida Opportunity Fund; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-DE19862 01A1 from NIDCR (to L.S.H.). This work was also supported by a grant from the University of Florida Opportunity Fund (to L.S.H., D.A.O., and T.J.W.).; Supported by Grant T32 DE07200-15 from NIDCR.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Carnell M, 2011, J CELL BIOL, V193, P831, DOI 10.1083/jcb.201009119; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; CHIN NX, 1983, ANTIMICROB AGENTS CH, V24, P754, DOI 10.1128/AAC.24.5.754; Chiu YH, 2012, J BONE MINER RES, V27, P79, DOI 10.1002/jbmr.531; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Hanein D, 1998, NAT STRUCT BIOL, V5, P787, DOI 10.1038/1828; Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Niikura K, 2007, CANCER CHEMOTH PHARM, V60, P555, DOI 10.1007/s00280-006-0401-8; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Ostrov DA, 2009, J MED CHEM, V52, P5144, DOI 10.1021/jm900277z; PACAUD M, 1993, BIOCHEMISTRY-US, V32, P3448, DOI 10.1021/bi00064a031; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Rubinstein E, 2001, CHEMOTHERAPY, V47, P3, DOI 10.1159/000057838; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; SHINOMIYA H, 1994, BIOCHEM BIOPH RES CO, V202, P1631, DOI 10.1006/bbrc.1994.2120; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023; Zhang QZ, 2008, CELL RES, V18, P1077, DOI 10.1038/cr.2008.287; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	55	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17894	17904		10.1074/jbc.M111.280511	http://dx.doi.org/10.1074/jbc.M111.280511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474295	hybrid, Green Published			2022-12-28	WOS:000306373000086
J	Baresova, P; Pitha, PM; Lubyova, B				Baresova, Petra; Pitha, Paula M.; Lubyova, Barbora			Kaposi Sarcoma-associated Herpesvirus vIRF-3 Protein Binds to F-box of Skp2 Protein and Acts as a Regulator of c-Myc Protein Function and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; EPSTEIN-BARR-VIRUS; TRANSCRIPTIONAL ACTIVITY; BURKITT-LYMPHOMA; NUCLEAR ANTIGEN; DNA-SEQUENCES; PROTEOLYSIS; CELLS; ESTABLISHMENT; DEREGULATION	The Kaposi sarcoma-associated herpesvirus (KSHV) has been linked to Kaposi sarcoma, body cavity-based lymphoma, and Castleman disease. vIRF-3 is a KSHV latent gene that is critical for proliferation of KSHV-positive lymphoid cells. Furthermore, vIRF-3 contributes to KSHV-associated pathogenesis by stimulating c-Myc transcription activity. Here we show that vIRF-3 can associate with Skp2, a key component of the SCFskp2 ubiquitin ligase complex. Skp2 is a transcriptional co-factor for c-Myc that was shown to regulate the stability of c-Myc protein as well as c-Myc-dependent transcription. In this study, we show that vIRF-3 binds to the F-box of Skp2 and recruits it to c-Myc-regulated promoters to activate c-Myc-dependent transcription. Additionally, cells overexpressing vIRF-3 exhibit higher levels of c-Myc ubiquitylation, suggesting that ubiquitylation is necessary for c-Myc-mediated transcription. Moreover, vIRF-3 can stabilize the c-Myc protein by increasing its half-life. Collectively, these results indicate that vIRF-3 can effectively manipulate c-Myc stability and function and thus contribute to c-Myc-induced KSHV-associated lymphomagenesis.	[Baresova, Petra; Lubyova, Barbora] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague 12800, Czech Republic; [Pitha, Paula M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Biol, Baltimore, MD 21231 USA	Charles University Prague; Johns Hopkins University; Johns Hopkins Medicine	Lubyova, B (corresponding author), Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Studnickova 7, Prague 12800, Czech Republic.	bluby@lf1.cuni.cz	Riegerova, Petra/J-6462-2017; Lubyova, Barbora/G-5921-2014	Riegerova, Petra/0000-0002-8269-5496; Lubyova, Barbora/0000-0002-8714-0414	Grant Agency of the Czech Republic [204/09/0773]; Charles University [PRVOUK-P24/LF1/3, SVV-2012-264506]; Ministry of Education of the Czech Republic [MSM0021620806]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Charles University; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by grants from the Grant Agency of the Czech Republic (Project 204/09/0773 to B. L.), from the Charles University (Projects PRVOUK-P24/LF1/3 and SVV-2012-264506), and from the Ministry of Education of the Czech Republic (Project MSM0021620806).	Ahmad A, 2010, CANCER BIOL THER, V10, P1033, DOI 10.4161/cbt.10.10.13291; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Bajaj BG, 2008, J VIROL, V82, P4082, DOI 10.1128/JVI.02500-07; BARRIOS C, 1994, ONCOLOGY, V51, P13; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; Carbone A, 1998, BRIT J HAEMATOL, V102, P1081, DOI 10.1046/j.1365-2141.1998.00877.x; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Dupin N, 2000, BLOOD, V95, P1406, DOI 10.1182/blood.V95.4.1406.004k26_1406_1412; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gaidano G, 1996, ACTA HAEMATOL-BASEL, V95, P193; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HERMEKING H, 1995, ONCOGENE, V11, P1409; Jin JP, 2003, CANCER CELL, V3, P517, DOI 10.1016/S1535-6108(03)00145-4; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kalra N, 2006, FEBS LETT, V580, P431, DOI 10.1016/j.febslet.2005.12.034; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lee HR, 2009, J INTERF CYTOK RES, V29, P621, DOI 10.1089/jir.2009.0067; Li XD, 2010, J VIROL, V84, P8945, DOI 10.1128/JVI.00244-10; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; von der Lehr N, 2003, CELL CYCLE, V2, P403, DOI 10.4161/cc.2.5.484; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200	45	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16199	16208		10.1074/jbc.M111.335216	http://dx.doi.org/10.1074/jbc.M111.335216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22453922	Green Published, hybrid			2022-12-28	WOS:000304030900012
J	Crenshaw, CM; Nam, K; Oo, K; Kutchukian, PS; Bowman, BR; Karplus, M; Verdine, GL				Crenshaw, Charisse M.; Nam, Kwangho; Oo, Kimberly; Kutchukian, Peter S.; Bowman, Brian R.; Karplus, Martin; Verdine, Gregory L.			Enforced Presentation of an Extrahelical Guanine to the Lesion Recognition Pocket of Human 8-Oxoguanine Glycosylase, hOGG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; REPAIR; SYSTEM; 8-HYDROXYGUANINE; COMPLEX; 7,8-DIHYDRO-8-OXOGUANINE; IDENTIFICATION	A poorly understood aspect of DNA repair proteins is their ability to identify exceedingly rare sites of damage embedded in a large excess of nearly identical undamaged DNA, while catalyzing repair only at the damaged sites. Progress toward understanding this problem has been made by comparing the structures and biochemical behavior of these enzymes when they are presented with either a target lesion or a corresponding undamaged nucleobase. Trapping and analyzing such DNA-protein complexes is particularly difficult in the case of base extrusion DNA repair proteins because of the complexity of the repair reaction, which involves extrusion of the target base from DNA followed by its insertion into the active site where glycosidic bond cleavage is catalyzed. Here we report the structure of a human 8-oxoguanine (oxoG) DNA glycosylase, hOGG1, in which a normal guanine from DNA has been forcibly inserted into the enzyme active site. Although the interactions of the nucleobase with the active site are only subtly different for G versus oxoG, hOGG1 fails to catalyze excision of the normal nucleobase. This study demonstrates that even if hOGG1 mistakenly inserts a normal base into its active site, the enzyme can still reject it on the basis of catalytic incompatibility.	[Crenshaw, Charisse M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Nam, Kwangho; Oo, Kimberly; Kutchukian, Peter S.; Bowman, Brian R.; Karplus, Martin; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Crenshaw, Charisse M.; Nam, Kwangho; Kutchukian, Peter S.; Bowman, Brian R.; Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol & Chem Biol Initiat, Boston, MA 02115 USA; [Karplus, Martin] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu	Kutchukian, Peter/A-9826-2016	Kutchukian, Peter/0000-0002-5684-1971	National Institutes of Health [GM044853, CA100742, GM030804]; National Science Foundation; National Cancer Center; Harvard College Program for Research in Science and Engineering; Herchel Smith Harvard Summer Undergraduate Research Fellowship; Harvard College Research Program; Ruth Kirschstein National Research Service Award Fellowship [F32 GM077935-01]; United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853, R01GM030804, F32GM077935, R37GM030804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Cancer Center; Harvard College Program for Research in Science and Engineering; Herchel Smith Harvard Summer Undergraduate Research Fellowship; Harvard College Research Program; Ruth Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044853 and CA100742 (to G. L. V.) and GM030804 (to M. K.), pre-doctoral fellowships from the National Science Foundation (2004) (to C. M. C. and P. S. K.), a postdoctoral fellowship from the National Cancer Center (to K. N.), the Harvard College Program for Research in Science and Engineering (2007) (to K. O.), Herchel Smith Harvard Summer Undergraduate Research Fellowship (2007) (to K. O.), the Harvard College Research Program (2008) (to K. O.), and Ruth Kirschstein National Research Service Award Fellowship F32 GM077935-01 (to B. R. B.).; We thank the staff at the NE-CAT at the Advanced Photon Source, especially C. Narayanasami Sukumar, for assistance during data collection, the National Energy Research Scientific Computing Center and FAS Science Division Research Computing Group at Harvard University for providing computer resources. We also thank Drs. Lourdes Gude-Rodriguez, Seongmin Lee, Danaya Pakotiprapha, Marie Spong, and especially Gordon Louie for critical reading of the manuscript, and data analysis advice. We also thank Rachelle Gaudet and David Jeruzalmi and other laboratory members for useful discussions and guidance on data processing. Use of the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Abu-Amero KK, 2006, ONCOGENE, V25, P677, DOI 10.1038/sj.onc.1209094; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agback P, 1998, NAT STRUCT BIOL, V5, P579, DOI 10.1038/836; Albright RA, 1998, PROTEIN SCI, V7, P1485, DOI 10.1002/pro.5560070701; Allen M. P., 1989, COMPUTER SIMULATIONS; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bialkowski K, 1996, Z NATURFORSCH C, V51, P119; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; Bowman BR, 2010, J BIOL CHEM, V285, P35783, DOI 10.1074/jbc.M110.155663; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHENG KC, 1992, J BIOL CHEM, V267, P166; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Corn JE, 2007, STRUCTURE, V15, P773, DOI 10.1016/j.str.2007.05.006; Crenshaw CM, 2011, BIOCHEMISTRY-US, V50, P8463, DOI 10.1021/bi201007t; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L, PYMOL MOL GRAPHICS S; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KOIZUME S, 1994, NUCLEOS NUCLEOT, V13, P1517, DOI 10.1080/15257779408012168; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACMILLAN AM, 1991, TETRAHEDRON, V47, P2603, DOI 10.1016/S0040-4020(01)81793-2; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Qi Y, 2010, J BIOL CHEM, V285, P1468, DOI 10.1074/jbc.M109.069799; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Townson SA, 2007, STRUCTURE, V15, P449, DOI 10.1016/j.str.2007.03.002; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; WOOD ML, 1992, NUCLEIC ACIDS RES, V20, P6023, DOI 10.1093/nar/20.22.6023; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889	67	44	46	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24916	24928		10.1074/jbc.M111.316497	http://dx.doi.org/10.1074/jbc.M111.316497			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22511791	Green Published, hybrid			2022-12-28	WOS:000306651700006
J	Ma, HT; Chan, YY; Chen, X; On, KF; Poon, RYC				Ma, Hoi Tang; Chan, Yan Yan; Chen, Xiao; On, Kin Fan; Poon, Randy Y. C.			Depletion of p31(comet) Protein Promotes Sensitivity to Antimitotic Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MITOTIC CATASTROPHE; CYCLIN-A; CELLS; MAD2; MITOSIS; DETERMINANTS; MECHANISMS; BINDING; CANCER	Antimitotic spindle poisons are among the most important chemotherapeutic agents available. However, precocious mitotic exit by mitotic slippage limits the cytotoxicity of spindle poisons. The MAD2-binding protein p31(comet) is implicated in silencing the spindle assembly checkpoint after all kinetochores are attached to spindles. In this study, we report that the levels of p31(comet) and MAD2 in different cell lines are closely linked with susceptibility to mitotic slippage. Down-regulation of p31(comet) increased the sensitivity of multiple cancer cell lines to spindle poisons, including nocodazole, vincristine, and Taxol. In the absence of p31(comet), lower concentrations of spindle poisons were required to induce mitotic block. The delay in checkpoint silencing was induced by an accumulation of mitotic checkpoint complexes. The increase in the duration of mitotic block after p31(comet) depletion resulted in a dramatic increase in mitotic cell death upon challenge with spindle poisons. Significantly, cells that are normally prone to mitotic slippage and resistant to spindle disruption-mediated mitotic death were also sensitized after p31(comet) depletion. These results highlight the importance of p31(comet) in checkpoint silencing and its potential as a target for antimitotic therapies.	[Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	rycpoon@ust.hk	Chen, Xiao/R-2157-2016	Poon, Randy/0000-0001-5571-6231; MA, Hoi Tang/0000-0001-5876-0107	Research Grants Council [662208, AOE-MG/M-08/06, HKU7/CRG/09]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Research Grants Council Grants 662208, AOE-MG/M-08/06, and HKU7/CRG/09 (to R. Y. C. P.).	Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chow JPH, 2010, CONTEMP CANCER RES, P79, DOI 10.1007/978-1-4419-1770-6_5; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Ma HT, 2011, J BIOL CHEM, V286, P13052, DOI 10.1074/jbc.M110.201897; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Siu WY, 2004, MOL CANCER THER, V3, P621; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	29	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21561	21569		10.1074/jbc.M112.364356	http://dx.doi.org/10.1074/jbc.M112.364356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544748	Green Published, hybrid			2022-12-28	WOS:000306416800073
J	Platt, RJ; Han, TS; Green, BR; Smith, MD; Skalicky, J; Gruszczynski, P; White, HS; Olivera, B; Bulaj, G; Gajewiak, J				Platt, Randall J.; Han, Tiffany S.; Green, Brad R.; Smith, Misty D.; Skalicky, Jack; Gruszczynski, Pawel; White, H. Steve; Olivera, Baldomero; Bulaj, Grzegorz; Gajewiak, Joanna			Stapling Mimics Noncovalent Interactions of gamma-Carboxyglutamates in Conantokins, Peptidic Antagonists of N-Methyl-D-Aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX STABILIZATION; BH3 HELIX; IN-VIVO; 6 HZ; NMDA; RESIDUES; EPILEPSY; BINDING; ACTIVATION; METATHESIS	Conantokins are short peptides derived from the venoms of marine cone snails that act as antagonists of the N-methyl-D-aspartate (NMDA) receptor family of excitatory glutamate receptors. These peptides contain gamma-carboxyglutamic acid residues typically spaced at i,i+4 and/or i,i+7 intervals, which by chelating divalent cations induce and stabilize helical conformation of the peptide. Introduction of a dicarba bridge (or a staple) can covalently stabilize peptide helicity and improve its pharmacological properties. To test the hypothesis that stapling can effectively replace gamma-carboxyglutamic acid residues in stabilizing the helical conformation of conantokins, we designed, synthesized, and characterized several stapled analogs of conantokin G (conG), with varying connectivities in terms of staple length and location along the face of the alpha-helix. NMR studies confirmed that the ring-closing metathesis reaction yielded a single product with the Z configuration of the olefinic bond. Based on circular dichroism and molecular modeling, the stapled analogs exhibited significantly enhanced helicity compared with the native peptide in a metal-free environment. Stapling i,i+4 was benign with respect to effects on in vitro and in vivo pharmacological properties. One analog, namely conG[11-15,Si,i+4S(8)], blocked NR2B-containing NMDA receptors with IC50 = 0.7 mu M and provided significant protection in the 6-Hz psychomotor model of pharmacoresistant epilepsy in mice. Remarkably, unlike native conG, conG[11-15,Si,i+4S(8)] produced no behavioral motor toxicity. Our results extend the applications of peptide stapling to helical peptides with extracellular targets and provide a means for engineering conantokins with improved pharmacological properties.	[Platt, Randall J.; Han, Tiffany S.; Green, Brad R.; Olivera, Baldomero; Bulaj, Grzegorz; Gajewiak, Joanna] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Smith, Misty D.; White, H. Steve] Univ Utah, Dept Pharmacol Toxicol, Salt Lake City, UT 84112 USA; [Skalicky, Jack] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Green, Brad R.; Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Gruszczynski, Pawel] Univ Gdansk, Intercoll Fac Biotechnol, PL-80952 Gdansk, Poland; [Gruszczynski, Pawel] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Gruszczynski, Pawel] Biolab Innovat Res Technol, PL-80172 Gdansk, Poland; [Gruszczynski, Pawel] Med Univ Gdansk, Gdansk, Poland	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Gajewiak, J (corresponding author), Univ Utah, Dept Biol, 257 South,1400 East, Salt Lake City, UT 84112 USA.	jgajewiak@gmail.com		Platt, Randall/0000-0002-2914-7052	National Institute of General Medical Sciences from the National Institute of General Medical Sciences [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48677 from the National Institute of General Medical Sciences.	Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 1998, FEBS LETT, V435, P257, DOI 10.1016/S0014-5793(98)01077-1; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Case D. A., 2021, AMBER 2022; Cnudde SE, 2007, J AM CHEM SOC, V129, P1586, DOI 10.1021/ja065722q; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dai QY, 2004, J MOL BIOL, V336, P731, DOI 10.1016/j.jmb.2003.12.027; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Gowd KH, 2010, J PEPT SCI, V16, P375, DOI 10.1002/psc.1249; Gowd KH, 2008, TOXICON, V52, P203, DOI 10.1016/j.toxicon.2008.04.178; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; HAACK JA, 1990, J BIOL CHEM, V265, P6025; Jain A, 2011, BIOMACROMOLECULES, V12, P2729, DOI 10.1021/bm2005017; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaul R, 1999, BIOORGAN MED CHEM, V7, P105, DOI 10.1016/S0968-0896(98)00221-1; Kim YW, 2010, ORG LETT, V12, P3046, DOI 10.1021/ol1010449; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Ma MT, 2009, J AM CHEM SOC, V131, P4505, DOI 10.1021/ja900047w; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Mayne L, 1998, J AM CHEM SOC, V120, P10643, DOI 10.1021/ja981592c; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; PRASAD BVV, 1984, CRC CR REV BIOCH MOL, V16, P307; Pretsch E., 2000, TABLES SPECTRAL DATA; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Rigby AC, 1997, BIOCHEMISTRY-US, V36, P15677, DOI 10.1021/bi9718550; Rigby AC, 1997, BIOCHEMISTRY-US, V36, P12394, DOI 10.1021/bi975016p; RUAN FQ, 1990, J AM CHEM SOC, V112, P9403, DOI 10.1021/ja00181a058; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Warder SE, 1998, J BIOL CHEM, V273, P7512, DOI 10.1074/jbc.273.13.7512; Whelan J, 2004, DRUG DISCOV TODAY, V9, P907, DOI 10.1016/S1359-6446(04)03268-4; White HS, 2000, J PHARMACOL EXP THER, V292, P425; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhou LM, 1996, J NEUROCHEM, V66, P620	50	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20727	20736		10.1074/jbc.M112.350462	http://dx.doi.org/10.1074/jbc.M112.350462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518838	hybrid, Green Published			2022-12-28	WOS:000306414500091
J	Sato, M; Hutchinson, DS; Halls, ML; Furness, SGB; Bengtsson, T; Evans, BA; Summers, RJ				Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Bengtsson, Tore; Evans, Bronwyn A.; Summers, Roger J.			Interaction with Caveolin-1 Modulates G Protein Coupling of Mouse beta(3)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES GLUCOSE-TRANSPORT; BROWN ADIPOSE-TISSUE; PDZ-BINDING MOTIF; ADENYLYL-CYCLASE; NONSHIVERING THERMOGENESIS; NANOSCALE ORGANIZATION; MEMBRANE RAFT; RECEPTOR; LOCALIZATION; ACTIVATION	Caveolins act as scaffold proteins in multiprotein complexes and have been implicated in signaling by G protein-coupled receptors. Studies using knock-out mice suggest that beta(3)-adrenoceptor (beta(3)-AR) signaling is dependent on caveolin-1; however, it is not known whether caveolin-1 is associated with the beta(3)-AR or solely with downstream signaling proteins. We have addressed this question by examining the impact of membrane rafts and caveolin-1 on the differential signaling of mouse beta(3a)- and beta(3b)-AR isoforms that diverge at the distal C terminus. Only the beta(3b)-AR promotes pertussis toxin (PTX)-sensitive cAMP accumulation. When cells expressing the beta(3a)-AR were treated with filipin III to disrupt membrane rafts or transfected with caveolin-1 siRNA, the cyclic AMP response to the beta(3)-AR agonist CL316243 became PTX-sensitive, suggesting G alpha(i/o) coupling. The beta(3a)-AR C terminus, S (P-384) under bar PLNR (P-389) under bar DG (Y-392) under bar EGARP (P-398) under bar PT, resembles a caveolin interaction motif. Mutant beta(3a)-ARs (F389A/Y392A/F398A or P384S/F389A) promoted PTX-sensitive cAMP responses, and in situ proximity assays demonstrated an association between caveolin-1 and the wild type beta(3a)-AR but not the mutant receptors. In membrane preparations, the beta(3b)-AR activated G alpha(o) and mediated PTX-sensitive cAMP responses, whereas the beta(3a)-AR did not activate G alpha(i/o) proteins. The endogenous beta(3a)-AR displayed G alpha(i/o) coupling in brown adipocytes from caveolin-1 knock-out mice or in wild type adipocytes treated with filipin III. Our studies indicate that interaction of the beta(3a)-AR with caveolin inhibits coupling to G alpha(i/o) proteins and suggest that signaling is modulated by a raft-enriched complex containing the beta(3a)-AR, caveolin-1, G alpha(s), and adenylyl cyclase.	[Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Evans, Bronwyn A.; Summers, Roger J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sato, Masaaki; Hutchinson, Dana S.; Halls, Michelle L.; Furness, Sebastian G. B.; Evans, Bronwyn A.; Summers, Roger J.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Sato, Masaaki; Bengtsson, Tore] Stockholm Univ, Dept Physiol, Wenner Gren Inst, Arrhenius Labs F3, SE-10691 Stockholm, Sweden	Monash University; Monash University; Stockholm University	Evans, BA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	bronwyn.evans@monash.edu	Hutchinson, Dana/K-3795-2012; Furness, Sebastian/Q-9068-2018; Summers, Roger J/F-6351-2011	Furness, Sebastian/0000-0001-8655-8221; Summers, Roger J/0000-0002-8367-4056; Sato, Masaaki/0000-0003-0564-4318; Hutchinson, Dana/0000-0001-9947-0106; Halls, Michelle/0000-0001-8555-8959	National Health and Medical Research Council of Australia [519461, 545952, 519581]; Australian Research Council [LX0989791]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Program Grant 519461 (to P. M. Sexton, A. Christopoulos, and R. J.), National Health and Medical Research Council of Australia Career Development Award 545952 (to D. S. H.), National Health and Medical Research Council of Australia C. J. Martin Fellowship 519581 (to M. L. H.), and by Australian Research Council Linkage International Fellowship LX0989791 (to M. S.).	Abrami L, 2001, J BIOL CHEM, V276, P30729, DOI 10.1074/jbc.M102039200; Adli H, 1997, AM J PHYSIOL-ENDOC M, V273, pE247, DOI 10.1152/ajpendo.1997.273.2.E247; Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Alves ID, 2005, BIOCHEMISTRY-US, V44, P9168, DOI 10.1021/bi050207a; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bethani I, 2010, EMBO J, V29, P2677, DOI 10.1038/emboj.2010.175; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chernogubova E, 2005, ENDOCRINOLOGY, V146, P2271, DOI 10.1210/en.2004-1104; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Evans BA, 1999, BRIT J PHARMACOL, V127, P1525, DOI 10.1038/sj.bjp.0702688; Halls ML, 2009, MOL PHARMACOL, V75, P415, DOI 10.1124/mol.108.051227; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hutchinson DS, 2005, J PHARMACOL EXP THER, V312, P1064, DOI 10.1124/jpet.104.076901; Hutchinson DS, 2002, BRIT J PHARMACOL, V135, P1903, DOI 10.1038/sj.bjp.0704654; KASLOW HR, 1987, BIOCHEMISTRY-US, V26, P123, DOI 10.1021/bi00375a018; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lenard NR, 2006, AM J PHYSIOL-ENDOC M, V291, pE704, DOI 10.1152/ajpendo.00048.2006; Malo A, 2001, EUR J ENDOCRINOL, V145, P87, DOI 10.1530/eje.0.1450087; Mattsson CL, 2010, AM J PHYSIOL-ENDOC M, V299, pE374, DOI 10.1152/ajpendo.00071.2010; Mattsson CL, 2010, BBA-MOL CELL RES, V1803, P983, DOI 10.1016/j.bbamcr.2010.03.015; Mistry R, 2011, METHODS MOL BIOL, V746, P263, DOI 10.1007/978-1-61779-126-0_14; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; MOSS J, 1983, J BIOL CHEM, V258, P1879; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Nevzorova J, 2002, BRIT J PHARMACOL, V137, P9, DOI 10.1038/sj.bjp.0704845; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sato M, 2005, J PHARMACOL EXP THER, V315, P1354, DOI 10.1124/jpet.105.091736; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SILLENCE MN, 1993, BRIT J PHARMACOL, V109, P1157, DOI 10.1111/j.1476-5381.1993.tb13743.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tanishita T, 1997, J BIOCHEM, V122, P90; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; Varga EV, 1998, EUR J PHARMACOL, V348, pR1, DOI 10.1016/S0014-2999(98)00258-1; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	59	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20674	20688		10.1074/jbc.M111.280651	http://dx.doi.org/10.1074/jbc.M111.280651			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535965	hybrid, Green Published			2022-12-28	WOS:000306414500086
J	Aleshin, AE; DiScipio, RG; Stec, B; Liddington, RC				Aleshin, Alexander E.; DiScipio, Richard G.; Stec, Boguslaw; Liddington, Robert C.			Crystal Structure of C5b-6 Suggests Structural Basis for Priming Assembly of the Membrane Attack Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I MODULES; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RHEUMATOID-ARTHRITIS; ALTERNATIVE-PATHWAY; PLASMA-PROTEINS; BINDING-SITES; ACTIVATION; C5; COMPONENTS; DOMAINS	The complement membrane attack complex ( MAC) forms transmembrane pores in pathogen membranes. The first step in MAC assembly is cleavage of C5 to generate metastable C5b, which forms a stable complex with C6, termed C5b-6. C5b-6 initiates pore formation via the sequential recruitment of homologous proteins: C7, C8, and 12-18 copies of C9, each of which comprises a central MAC-perforin domain flanked by auxiliary domains. We recently proposed a model of pore assembly, in which the auxiliary domains play key roles, both in stabilizing the closed conformation of the protomers and in driving the sequential opening of the MAC-perforin beta-sheet of each new recruit to the growing pore. Here, we describe an atomic model of C5b-6 at 4.2 angstrom resolution. We show that C5b provides four interfaces for the auxiliary domains of C6. The largest interface is created by the insertion of an interdomain linker from C6 into a hydrophobic groove created by a major reorganization of the alpha-helical domain of C5b. In combination with the rigid body docking of N-terminal elements of both proteins, C5b becomes locked into a stable conformation. Both C6 auxiliary domains flanking the linker pack tightly against C5b. The net effect is to induce the clockwise rigid body rotation of four auxiliary domains, as well as the opening/twisting of the central beta-sheet of C6, in the directions predicted by our model to activate or prime C6 for the subsequent steps in MAC assembly. The complex also suggests novel small molecule strategies for modulating pathological MAC assembly.	[Aleshin, Alexander E.; Stec, Boguslaw; Liddington, Robert C.] Sanford Burnham Med Res Inst, Program Infect Dis, La Jolla, CA 92037 USA; [DiScipio, Richard G.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Program Infect Dis, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [AI055789, AI055860]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; Multiple Sclerosis National Research Institute [4061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Multiple Sclerosis National Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860 (to R. C. L.). This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038 (to R. C. L.) and Multiple Sclerosis National Research Institute Grant 4061 (to R. G. D.).	Aleshin AE, 2012, J BIOL CHEM, V287, P10210, DOI 10.1074/jbc.M111.327809; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; CAMUSSI G, 1985, J IMMUNOL, V135, P2409; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; DiScipio R. G, 1998, COMPLEMENT SYSTEM, P50; DISCIPIO RG, 1992, J BIOL CHEM, V267, P17087; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1983, J BIOL CHEM, V258, P629; DISCIPIO RG, 1981, BIOCHEM J, V199, P497, DOI 10.1042/bj1990497; DISCIPIO RG, 1994, PROTEIN EXPRES PURIF, V5, P170, DOI 10.1006/prep.1994.1027; EHRENGRUBER MU, 1994, FEBS LETT, V346, P181, DOI 10.1016/0014-5793(94)00463-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; KOLB WP, 1972, J EXP MED, V135, P549, DOI 10.1084/jem.135.3.549; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Lee M., 2012, NEUROBIOL AGING; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; McKeage K, 2011, DRUGS, V71, P2327, DOI 10.2165/11208300-000000000-00000; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Phelan MM, 2009, J BIOL CHEM, V284, P19637, DOI 10.1074/jbc.M901993200; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; PODACK ER, 1979, P NATL ACAD SCI USA, V76, P897, DOI 10.1073/pnas.76.2.897; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; ROSS GD, 1985, J IMMUNOL, V135, P2005; ROSS GD, 1983, J EXP MED, V158, P334, DOI 10.1084/jem.158.2.334; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Stahl AL, 2009, MOL IMMUNOL, V46, P2236, DOI 10.1016/j.molimm.2009.04.012; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; TSCHOPP J, 1984, J BIOL CHEM, V259, P1922; TSCHOPP J, 1982, NATURE, V298, P534, DOI 10.1038/298534a0; Turnberg D, 2004, AM J PATHOL, V165, P825, DOI 10.1016/S0002-9440(10)63345-7; Welch TR, 2001, FRONT BIOSCI, V6, pD898, DOI 10.2741/Welch; WHALEY K, 1997, COMPLEMENT PRACTICAL, P19; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Williams AS, 2004, ARTHRITIS RHEUM-US, V50, P3035, DOI 10.1002/art.20478; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	61	46	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19642	19652		10.1074/jbc.M112.361121	http://dx.doi.org/10.1074/jbc.M112.361121			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500023	Green Published, hybrid			2022-12-28	WOS:000306411900075
J	Mallipattu, SK; Liu, RJ; Zheng, F; Narla, G; Ma'ayan, A; Dikman, S; Jain, MK; Saleem, M; D'Agati, V; Klotman, P; Chuang, PY; He, JC				Mallipattu, Sandeep K.; Liu, Ruijie; Zheng, Feng; Narla, Goutham; Ma'ayan, Avi; Dikman, Steven; Jain, Mukesh K.; Saleem, Moin; D'Agati, Vivette; Klotman, Paul; Chuang, Peter Y.; He, John C.			Kruppel-like Factor 15 (KLF15) Is a Key Regulator of Podocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED NEPHROPATHY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR PODOCYTES; TRANSGENIC MICE; IN-VIVO; EXPRESSION; PROLIFERATION; RETINOIDS; KIDNEY; PATHOGENESIS	Podocyte injury resulting from a loss of differentiation is the hallmark of many glomerular diseases. We previously showed that retinoic acid (RA) induces podocyte differentiation via stimulation of the cAMP pathway. However, many podocyte maturity markers lack binding sites for RA-response element or cAMP-response element (CREB) in their promoter regions. We hypothesized that transcription factors induced by RA and downstream of CREB mediate podocyte differentiation. We performed microarray gene expression studies in human podocytes treated with and without RA to identify differentially regulated genes. In comparison with known CREB target genes, we identified Kruppel-like factor 15 (KLF15), a kidney-enriched nuclear transcription factor, that has been previously shown to mediate cell differentiation. We confirmed that RA increased KLF15 expression in both murine and human podocytes. Overexpression of KLF15 stimulated expression of differentiation markers in both wild-type and HIV-1-infected podocytes. Also, KLF15 binding to the promoter regions of nephrin and podocin was increased in RA-treated podocytes. Although KLF15(-/-) mice at base line had minimal phenotype, lipopolysaccharide or adriamycin-treated KLF15(-/-) mice had a significant increase in proteinuria and podocyte foot process effacement with a reduction in the expression of podocyte differentiation markers as compared with the wild-type treated mice. Finally, KLF15 expression was reduced in glomeruli isolated from HIV transgenic mice as well as in kidney biopsies from patients with HIV-associated nephropathy and idiopathic focal segmental glomerulosclerosis. These results indicate a critical role of KLF15 in mediating podocyte differentiation and in protecting podocytes against injury.	[Mallipattu, Sandeep K.; Chuang, Peter Y.; He, John C.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Liu, Ruijie; He, John C.] James J Peters Vet Affairs Med Ctr, Renal Sect, New York, NY 10468 USA; [Zheng, Feng] Mt Sinai Sch Med, Dept Geriatr, Div Geriatr, New York, NY 10029 USA; [Narla, Goutham] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ma'ayan, Avi; He, John C.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Dikman, Steven] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Inst, Dept Med, Res Inst, Cleveland, OH 44106 USA; [Saleem, Moin] Univ Bristol, Southmead Hosp, Childrens Renal Unit, Bristol BS10 5NB, Avon, England; [Saleem, Moin] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England; [Klotman, Paul] Baylor Coll Med, Houston, TX 77030 USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Southmead Hospital; University of Bristol; Southmead Hospital; University of Bristol; Baylor College of Medicine; Columbia University	He, JC (corresponding author), Mt Sinai Sch Med, Dept Med Nephrol, 1 Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	cijiang.he@mssm.edu	Mallipattu, Sandeep/M-7009-2014; Narla, Goutham/AAZ-5710-2020; Ma'ayan, Avi/AAG-3131-2019	Narla, Goutham/0000-0003-4098-4203; Ma'ayan, Avi/0000-0002-6904-1017; Saleem, Moin/0000-0002-9808-4518	National Institutes of Health from NIDDK [1R01DK078897-01, R01HL084154, P01DK056492, T32 DK07757-12, 5K08DK082760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094635, P01DK056492, K08DK082760, R01DK078897, T32DK007757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM098316] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK078897-01 (to J. H.), R01HL084154 (to M. K. J.), P01DK056492 (to P. K.), 5K08DK082760 (to P. Y. C.), and T32 DK07757-12 (to S. K. M.) from NIDDK.	Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Bruggeman LA, 2001, KIDNEY INT, V59, P2174, DOI 10.1046/j.1523-1755.2001.0590062174.x; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Feng XB, 2009, J AM SOC NEPHROL, V20, P2138, DOI 10.1681/ASN.2008080879; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Katsuya K, 2006, KIDNEY INT, V69, P2101, DOI 10.1038/sj.ki.5000398; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Lehrke I, 2002, AM J PHYSIOL-RENAL, V282, pF741, DOI 10.1152/ajprenal.00026.2001; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Reiser J, 2004, J AM SOC NEPHROL, V15, P2246, DOI 10.1097/01.ASN.0000136312.46464.33; Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Sun Y, 2009, AM J NEPHROL, V29, P558, DOI 10.1159/000191469; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Vaughan MR, 2005, KIDNEY INT, V68, P133, DOI 10.1111/j.1523-1755.2005.00387.x; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x	39	76	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19122	19135		10.1074/jbc.M112.345983	http://dx.doi.org/10.1074/jbc.M112.345983			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493483	Green Published, hybrid			2022-12-28	WOS:000306411900023
J	Lee, J; Kim, JCK; Lee, SE; Quinley, C; Kim, H; Herdman, S; Corr, M; Raz, E				Lee, Jongdae; Kim, Joanna C. K.; Lee, Shee-Eun; Quinley, Christine; Kim, HyeRi; Herdman, Scott; Corr, Maripat; Raz, Eyal			Signal Transducer and Activator of Transcription 3 (STAT3) Protein Suppresses Adenoma-to-carcinoma Transition in Apc(min/+) Mice via Regulation of Snail-1 (SNAI) Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HUMAN COLORECTAL ADENOCARCINOMA; INTESTINAL EPITHELIAL-CELLS; TAU PHOSPHORYLATION; TUMOR PROGRESSION; CANCER; TUMORIGENESIS; EXPRESSION; INCREASES; RECEPTOR	STAT3 was recently reported to suppress tumor invasion in Apc(min/+) mice. We investigated the mechanisms by which STAT3 inhibits intestinal epithelial tumors using Apc(min/+)/Stat3(IEC-KO) mice (intestinal epithelial cell (IEC)-specific deletion of STAT3 in the Apc(min/+) background) to determine the role of STAT3 in carcinogenesis in vivo as well as colorectal cancer cell lines in vitro. To inhibit invasion of IEC tumors, STAT3 functions as a molecular adaptor rather than a transcription factor. Accordingly, the tumors in Apc(min/+)/Stat3(IEC-KO) mice undergo adenoma-to-carcinoma transition and acquire an invasive phenotype. Similarly, STAT3 knockdown in a colorectal cell line enhances IEC invasion. We demonstrate that STAT3 down-regulates SNAI (Snail-1) expression levels and hence suppresses epithelial-mesenchymal transition of colorectal cancer cells. Mechanistically, STAT3 facilitates glycogen synthase kinase (GSK) 3 beta-mediated degradation of SNAI by regulating phosphorylation of GSK3 beta. Our data identified a new role for STAT3 in the adenoma-to-carcinoma sequence of intestinal tumors.	[Lee, Jongdae; Kim, Joanna C. K.; Lee, Shee-Eun; Quinley, Christine; Kim, HyeRi; Herdman, Scott; Corr, Maripat; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lee, J (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	j142lee@ucsd.edu; eraz@ucsd.edu		Lee, Jongdae/0000-0002-6270-4658	National Institutes of Health [A1068685, A1095623, DK35108, DK080506]; Crohns and Colitis Foundation of America; National Institutes of Health through the NINDS [P30 NS047101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068685, U01AI095623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, R24DK080506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants A1068685, A1095623, DK35108, and DK080506. This work was also supported by a grant from Crohns and Colitis Foundation of America.; We thank Jennifer Meerloo for assistance in confocal imaging at the University of California at San Diego Neuroscience Microscopy Shared Facility funded by National Institutes of Health Grant P30 NS047101 through the NINDS.	Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bilger A, 1996, SEMIN CANCER BIOL, V7, P249, DOI 10.1006/scbi.1996.0033; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Park JK, 2008, ONCOL REP, V20, P597, DOI 10.3892/or_00000047; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Rivat C, 2004, ONCOGENE, V23, P3317, DOI 10.1038/sj.onc.1207437; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	42	53	54	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18182	18189		10.1074/jbc.M111.328831	http://dx.doi.org/10.1074/jbc.M111.328831			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496368	Green Published, hybrid			2022-12-28	WOS:000306411600026
J	Marcelin, B; Lugo, JN; Brewster, AL; Liu, ZQ; Lewis, AS; McClelland, S; Chetkovich, DM; Baram, TZ; Anderson, AE; Becker, A; Esclapez, M; Bernard, C				Marcelin, Beatrice; Lugo, Joaquin N.; Brewster, Amy L.; Liu, Zhiqiang; Lewis, Alan S.; McClelland, Shawn; Chetkovich, Dane M.; Baram, Tallie Z.; Anderson, Anne E.; Becker, Albert; Esclapez, Monique; Bernard, Christophe			Differential Dorso-ventral Distributions of Kv4.2 and HCN Proteins Confer Distinct Integrative Properties to Hippocampal CA1 Pyramidal Cell Distal Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIAL ENTORHINAL CORTEX; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; FREQUENCY PREFERENCES; GENE-EXPRESSION; VENTRAL AXIS; H-CURRENT; NEURONS; CHANNEL; DORSAL	The dorsal and ventral regions of the hippocampus perform different functions. Whether the integrative properties of hippocampal cells reflect this heterogeneity is unknown. We focused on dendrites where most synaptic input integration takes place. We report enhanced backpropagation and theta resonance and decreased summation of synaptic inputs in ventral versus dorsal CA1 pyramidal cell distal dendrites. Transcriptional Kv4.2 down-regulation and post-transcriptional hyperpolarization-activated cyclic AMP-gated channel (HCN1/2) up-regulation may underlie these differences, respectively. Our results reveal differential dendritic integrative properties along the dorso-ventral axis, reflecting diverse computational needs.	[Marcelin, Beatrice; Esclapez, Monique; Bernard, Christophe] INSERM, U1106, F-13385 Marseille, France; [Marcelin, Beatrice; Esclapez, Monique; Bernard, Christophe] Aix Marseille Univ, F-13385 Marseille, France; [Lugo, Joaquin N.; Brewster, Amy L.; Anderson, Anne E.] Baylor Coll Med, Dept Pediat, Neurol Sect, Cain Fdn Labs, Houston, TX 77030 USA; [Anderson, Anne E.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Anderson, Anne E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Liu, Zhiqiang; Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [McClelland, Shawn; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat Neurobiol, Irvine, CA 92697 USA; [McClelland, Shawn; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Becker, Albert] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Bonn	Bernard, C (corresponding author), INSERM, U1106, F-13385 Marseille, France.	christophe.bernard@univmed.fr	bernard, christophe/A-4929-2012; Chetkovich, Dane/AAV-5457-2021; bernard, christophe/S-5937-2016; Baram, Tallie Z/J-6447-2014; Lewis, Alan/AAV-9582-2021; Becker, Albert J/F-6248-2012; Esclapez, Monique/O-6509-2016	bernard, christophe/0000-0003-3014-1966; bernard, christophe/0000-0003-3014-1966; Lewis, Alan/0000-0002-7165-5376; Esclapez, Monique/0000-0002-8558-1363	Agence Nationale de la Recherche ANTARES; MINOS; Deutsche Forschungsgemeinschaft-KForG "Innate Immunity" TP2; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (NGFNplus); European Union EPICURE; National Institutes of Health National Research Service Award postdoctoral fellowship [NS056664]; National Institutes of Health [T32 NS45540, T32 NS43124, NS049427, NS039943, NS35439]; Conventions Industrielles de Formation par la REcherche fellowship; Epilepsy Foundation; Institut de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045540, R01NS035439, R37NS035439, T32NS043124, R01NS039943, F32NS056664, R01NS049427] Funding Source: NIH RePORTER	Agence Nationale de la Recherche ANTARES(French National Research Agency (ANR)); MINOS; Deutsche Forschungsgemeinschaft-KForG "Innate Immunity" TP2; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (NGFNplus)(Federal Ministry of Education & Research (BMBF)); European Union EPICURE(European Commission); National Institutes of Health National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conventions Industrielles de Formation par la REcherche fellowship; Epilepsy Foundation; Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Institut de la Sante et de la Recherche Medicale, Agence Nationale de la Recherche ANTARES, and MINOS (to C. B.) Deutsche Forschungsgemeinschaft-KForG "Innate Immunity" TP2 (to A. B.), Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (NGFNplus; to A. B.), European Union EPICURE (to A. B. and C. B.), National Institutes of Health National Research Service Award postdoctoral fellowship (NS056664) (to J. N. L.), National Institutes of Health Grants T32 NS45540 (to S. M.) and T32 NS43124 (to A. L. B.), and National Institutes of Health Grants NS049427 and NS039943 (to A. E. A.) and NS35439 (to T. Z. B.).; Recipient of a Conventions Industrielles de Formation par la REcherche fellowship.; Recipient of an Epilepsy Foundation postdoctoral fellowship.	Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Boehlen A, 2010, J NEUROSCI, V30, P4585, DOI 10.1523/JNEUROSCI.4939-09.2010; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Buzsaki G., 2006, RHYTHMS BRAIN; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leonardo ED, 2006, NEUROSCIENCE, V137, P177, DOI 10.1016/j.neuroscience.2005.08.082; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Magee JC, 1998, J NEUROSCI, V18, P7613; Maggio N, 2007, HIPPOCAMPUS, V17, P10, DOI 10.1002/hipo.20237; Marcelin B, 2012, J NEUROSCI, V32, P3736, DOI 10.1523/JNEUROSCI.5870-11.2012; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	38	35	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17656	17661		10.1074/jbc.C112.367110	http://dx.doi.org/10.1074/jbc.C112.367110			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22511771	Green Published, hybrid			2022-12-28	WOS:000306373000064
J	Millerioux, Y; Morand, P; Biran, M; Mazet, M; Moreau, P; Wargnies, M; Ebikeme, C; Deramchia, K; Gales, L; Portais, JC; Boshart, M; Franconi, JM; Bringaud, F				Millerioux, Yoann; Morand, Pauline; Biran, Marc; Mazet, Muriel; Moreau, Patrick; Wargnies, Marion; Ebikeme, Charles; Deramchia, Kamel; Gales, Lara; Portais, Jean-Charles; Boshart, Michael; Franconi, Jean-Michel; Bringaud, Frederic			ATP Synthesis-coupled and -uncoupled Acetate Production from Acetyl-CoA by Mitochondrial Acetate: Succinate CoA-transferase and Acetyl-CoA Thioesterase in Trypanosoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; DEPENDENT FUMARATE REDUCTASE; PROLINE METABOLISM; MOLECULAR CHARACTERIZATION; PROCYCLIC TRYPANOSOMES; GLUCOSE-METABOLISM; HYDROLASE ACTIVITY; ENERGY-METABOLISM; BRUCEI; HYDROGENOSOMES	Insect stage trypanosomes use an "acetate shuttle" to transfer mitochondrial acetyl-CoA to the cytosol for the essential fatty acid biosynthesis. The mitochondrial acetate sources are acetate: succinate CoA-transferase (ASCT) and an unknown enzymatic activity. We have identified a gene encoding acetyl-CoA thioesterase (ACH) activity, which is shown to be the second acetate source. First, RNAi-mediated repression of ASCT in the ACH null background abolishes acetate production from glucose, as opposed to both single ASCT and ACH mutants. Second, incorporation of radiolabeled glucose into fatty acids is also abolished in this ACH/ASCT double mutant. ASCT is involved in ATP production, whereas ACH is not, because the ASCT null mutant is similar to 1000 times more sensitive to oligomycin, a specific inhibitor of the mitochondrial F-0/F-1-ATP synthase, than wild-type cells or the ACH null mutant. This was confirmed by RNAi repression of the F-0/F-1-ATP synthase F-1 beta subunit, which is lethal when performed in the ASCT null background but not in the wild-type cells or the ACH null background. We concluded that acetate is produced from both ASCT and ACH; however, only ASCT is responsible, together with the F-0/F-1-ATP synthase, for ATP production in the mitochondrion.	[Millerioux, Yoann; Morand, Pauline; Biran, Marc; Mazet, Muriel; Wargnies, Marion; Ebikeme, Charles; Deramchia, Kamel; Franconi, Jean-Michel; Bringaud, Frederic] Univ Bordeaux Segalen, CNRS, UMR 5536, Ctr Rosonance Magnet Syst Biol, F-33076 Bordeaux, France; [Moreau, Patrick] Univ Bordeaux Segalen, CNRS, UMR 5200, Lab Biogenese Membranaire, F-33076 Bordeaux, France; [Gales, Lara; Portais, Jean-Charles] Univ Toulouse, LISBP, INP, UPS,INSA, F-31077 Toulouse, France; [Gales, Lara; Portais, Jean-Charles] INRA, UMR792, F-31400 Toulouse, France; [Gales, Lara; Portais, Jean-Charles] CNRS, UMR5504, F-31400 Toulouse, France; [Boshart, Michael] Univ Munich, Biozentrum, D-82152 Martinsried, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; University of Munich	Bringaud, F (corresponding author), Univ Bordeaux Segalen, CNRS, UMR 5536, Ctr Rosonance Magnet Syst Biol, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	bringaud@rmsb.u-bordeaux2.fr	MILLERIOUX, Yoann/AAT-8857-2020; Boshart, Michael/A-2700-2011	MILLERIOUX, Yoann/0000-0003-3782-3118; Boshart, Michael/0000-0002-5070-2663; Ebikeme, Charles/0000-0002-9989-6489; Moreau, Patrick/0000-0001-9318-3464; Portais, Jean-Charles/0000-0002-3480-0933	CNRS; Universite Bordeaux Segalen; Conseil Regional d'Aquitaine; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche programs [ANR-MIME2007, ANR-BioSys2007, ANR-BLANC-2010]; Prod'Innov; Franco-Bavarian University Cooperation Center [BFHZ/CCUFB]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche programs(French National Research Agency (ANR)); Prod'Innov; Franco-Bavarian University Cooperation Center	This work was supported by CNRS, the Universite Bordeaux Segalen, the Conseil Regional d'Aquitaine, the Fondation pour la Recherche Medicale, Agence Nationale de la Recherche programs (Grants METABOTRYP of the ANR-MIME2007 call, SysTryp of the ANR-BioSys2007 call, and ACETOTRYP of the ANR-BLANC-2010 call), Prod'Innov, and Franco-Bavarian University Cooperation Center Grant BFHZ/CCUFB (to M. B. and F. B.).	Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2010, PARASITOLOGY, V137, P1315, DOI 10.1017/S0031182009991843; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BRUN R, 1979, ACTA TROP, V36, P289; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Choe J, 2003, J MOL BIOL, V329, P335, DOI 10.1016/S0022-2836(03)00421-2; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; deMata ZS, 1997, COMP BIOCHEM PHYS B, V116, P379, DOI 10.1016/S0305-0491(96)00266-0; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Harlow E., 1988, ANTIBODIES LAB MANUA; HEAPE AM, 1985, J CHROMATOGR, V322, P391, DOI 10.1016/S0021-9673(01)97702-7; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lemasters J J, 1979, Methods Enzymol, V56, P530; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; MARVINSIKKEMA FD, 1993, ARCH MICROBIOL, V160, P388; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saz HJ, 1996, J PARASITOL, V82, P694, DOI 10.2307/3283876; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Suematsu N, 2003, J CHROMATOGR B, V790, P239, DOI 10.1016/S1570-0232(03)00167-3; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P202, DOI 10.1093/oxfordjournals.molbev.a026234; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamashita H, 2006, BBA-MOL CELL BIOL L, V1761, P17, DOI 10.1016/j.bbalip.2006.01.001	43	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17186	17197		10.1074/jbc.M112.355404	http://dx.doi.org/10.1074/jbc.M112.355404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474284	Green Published, hybrid			2022-12-28	WOS:000306373000018
J	Katkere, B; Rosa, S; Drake, JR				Katkere, Bhuvana; Rosa, Sarah; Drake, James R.			The Syk-binding Ubiquitin Ligase c-Cbl Mediates Signaling-dependent B Cell Receptor Ubiquitination and B Cell Receptor-mediated Antigen Processing and Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN 2A; TYROSINE KINASE; COMPLEX; ACTIVATION; INTERNALIZATION; IMMUNOGLOBULIN; COMPARTMENTS; TRAFFICKING; LYMPHOCYTES; ENDOSOMES	B cell receptor (BCR)-mediated antigen (Ag) processing and presentation lead to B cell-T cell interactions, which support affinity maturation and immunoglobulin class switching. These interactions are supported by generation of peptide-MHC class II complexes in multivesicular body-like MIIC compartments of B cells. Previous studies have shown that trafficking of Ag.BCR complexes to MVB-like MIIC occurs via an ubiquitin-dependent pathway and that ubiquitination of Ag.BCR complexes occurs by an Src family kinase signaling-dependent mechanism that is restricted to lipid raft-resident Ag.BCR complexes. This study establishes that downstream Syk-dependent BCR signaling is also required for BCR ubiquitination and BCR-mediated antigen processing and presentation. Knockdown studies reveal that of the two known Syk-binding E3 ubiquitin ligases c-Cbl and Cbl-b, only c-Cbl appears to have a central role in BCR ubiquitination, trafficking to MIIC, and ubiquitin-dependent BCR-mediated antigen processing and presentation. These results establish the novel role for Syk signaling and the Syk-binding ubiquitin ligase c-Cbl in the BCR-mediated processing and presentation of cognate antigen and define one mechanism by which antigen-induced BCR ubiquitination is modulated to impact the initiation and maturation of the humoral immune response.	[Katkere, Bhuvana; Rosa, Sarah; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA.	drakej@mail.amc.edu			National Institutes of Health [AI-065773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-065773 (to J. R. D.).	Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Azakir BA, 2009, CELL SIGNAL, V21, P1326, DOI 10.1016/j.cellsig.2009.03.020; BARNES KA, 1995, J EXP MED, V181, P1715, DOI 10.1084/jem.181.5.1715; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; Caballero A, 2006, EUR J IMMUNOL, V36, P3131, DOI 10.1002/eji.200636447; DeFranco AL, 1995, ANN NY ACAD SCI, V766, P195, DOI 10.1111/j.1749-6632.1995.tb26662.x; Drake JR, 1997, J EXP MED, V186, P1299, DOI 10.1084/jem.186.8.1299; Drake JR, 1999, J IMMUNOL, V162, P1150; Drake L, 2006, BLOOD, V108, P4086, DOI 10.1182/blood-2006-05-025338; GEAHLEN RL, 1994, ADV EXP MED BIOL, V365, P103; Gondre-Lewis TA, 2001, J IMMUNOL, V166, P6657, DOI 10.4049/jimmunol.166.11.6657; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; Jacob M, 2008, INT IMMUNOL, V20, P485, DOI 10.1093/intimm/dxn010; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; Lankar D, 1998, J EXP MED, V188, P819, DOI 10.1084/jem.188.5.819; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Nashar TO, 2005, J IMMUNOL, V174, P1306, DOI 10.4049/jimmunol.174.3.1306; Putnam MA, 2003, J IMMUNOL, V170, P905, DOI 10.4049/jimmunol.170.2.905; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; RETH M, 1991, ADV EXP MED BIOL, V292, P207; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; SONG WX, 1995, J IMMUNOL, V155, P4255; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	40	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16636	16644		10.1074/jbc.M112.357640	http://dx.doi.org/10.1074/jbc.M112.357640			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451666	Green Published, hybrid			2022-12-28	WOS:000304030900052
J	Haque, ME; Mount, MP; Safarpour, F; Abdel-Messih, E; Callaghan, S; Mazerolle, C; Kitada, T; Slack, RS; Wallace, V; Shen, J; Anisman, H; Park, DS				Haque, M. Emdadul; Mount, Matthew P.; Safarpour, Farzaneh; Abdel-Messih, Elizabeth; Callaghan, Steve; Mazerolle, Chantal; Kitada, Tohru; Slack, Ruth S.; Wallace, Valerie; Shen, Jie; Anisman, Hymie; Park, David S.			Inactivation of Pink1 Gene in Vivo Sensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes, Parkin or DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; PINK1/PARKIN PATHWAY; PINK1-DEFICIENT MICE; SYNAPTIC PLASTICITY; NEUROTOXIN MPTP; MOUSE MODEL; PROTECTS; DROSOPHILA-PINK1; DEGENERATION	Mutations in the mitochondrial PTEN-induced kinase 1 (Pink1) gene have been linked to Parkinson disease (PD). Recent reports including our own indicated that ectopic Pink1 expression is protective against toxic insult in vitro, suggesting a potential role for endogenous Pink1 in mediating survival. However, the role of endogenous Pink1 in survival, particularly in vivo, is unclear. To address this critical question, we examined whether down-regulation of Pink1 affects dopaminergic neuron loss following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the adult mouse. Two model systems were utilized: virally delivered shRNA-mediated knockdown of Pink1 and germ line-deficient mice. In both instances, loss of Pink1 generated significant sensitivity to damage induced by systemic MPTP treatment. This sensitivity was associated with greater loss of dopaminergic neurons in the Substantia Nigra pars compacta and terminal dopamine fiber density in the striatum region. Importantly, we also show that viral mediated expression of two other recessive PD-linked familial genes, DJ-1 and Parkin, can protect dopaminergic neurons even in the absence of Pink1. This evidence not only provides strong evidence for the role of endogenous Pink1 in neuronal survival, but also supports a role of DJ-1 and Parkin acting parallel or downstream of endogenous Pink1 to mediate survival in a mammalian in vivo context.	[Haque, M. Emdadul; Mount, Matthew P.; Safarpour, Farzaneh; Abdel-Messih, Elizabeth; Callaghan, Steve; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Mazerolle, Chantal; Kitada, Tohru; Wallace, Valerie] Ottawa Hosp, Res Inst, Ottawa, ON K1Y 4E9, Canada; [Shen, Jie] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1H 6N5, Canada; [Park, David S.] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Carleton University; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	Shen, Jie/GXH-9449-2022	Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784	Neuroscience Canada; Canadian Institute of Health Research; Centre for Stroke Recovery; Parkinson's Disease Foundation; Parkinson's Society Canada; Parkinson's Research Consortium; Centres of Excellence in Neurodegeneration (COEN); National Research Foundation of Korea; Ministry of Education, Science and Technology, South Korea [R31-2008-000-20004-0]; Heart and Stroke Foundation Ontario; Heart and Stroke Foundation, Ontario	Neuroscience Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Stroke Recovery; Parkinson's Disease Foundation; Parkinson's Society Canada; Parkinson's Research Consortium; Centres of Excellence in Neurodegeneration (COEN); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Heart and Stroke Foundation Ontario(Heart & Stroke Foundation of CanadaHeart & Stroke Foundation of Ontario); Heart and Stroke Foundation, Ontario(Heart & Stroke Foundation of CanadaHeart & Stroke Foundation of Ontario)	Supported by grants from Neuroscience Canada, Canadian Institute of Health Research, Heart and Stroke Foundation, Ontario, Centre for Stroke Recovery, Parkinson's Disease Foundation, Parkinson's Society Canada, Parkinson's Research Consortium, Centres of Excellence in Neurodegeneration (COEN), and World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea, Grant R31-2008-000-20004-0. Holder of a Career Scientist award from the Heart and Stroke Foundation Ontario. To whom correspondence should be addressed: Dept. of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, ON K1H 8M5, Canada. Tel.: 613-562-5800 (ext. 8816); Fax: 613-562-5403; E-mail: dpark@uottawa.ca.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Jensen AM, 1997, DEVELOPMENT, V124, P363; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lin W, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-90; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zhou HX, 2007, INT J BIOL SCI, V3, P242; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	50	66	69	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23162	23170		10.1074/jbc.M112.346437	http://dx.doi.org/10.1074/jbc.M112.346437			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22511790	Green Published, hybrid			2022-12-28	WOS:000306495000071
J	Fried, D; Bohm, BB; Krause, K; Burkhardt, H				Fried, Dorothee; Boehm, Beate B.; Krause, Kristin; Burkhardt, Harald			ADAM15 Protein Amplifies Focal Adhesion Kinase Phosphorylation under Genotoxic Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEINASE ADAM15; OSTEOARTHRITIC CARTILAGE; MDC15 METARGIDIN; TYROSINE KINASE; CELL-SURVIVAL; UP-REGULATION; CANCER; SRC; INHIBITOR; APOPTOSIS	ADAM15, a disintegrin and metalloproteinase, is capable of counteracting genotoxic stress-induced apoptosis by the suppression of caspase-3 activation. A cell line expressing the membrane-bound ADAM15 without its cytoplasmic tail, however, lost this anti-apoptotic property, suggesting a crucial role of the intracellular domain as a scaffold for recruitment of survival signal-transducingkinases. Accordingly, an enhanced phosphorylation of FAK at Tyr-397, Tyr-576, and Tyr-861 was detected upon genotoxic stress by camptothecin in ADAM15-transfected T/C28a4 cells, but not in transfectants expressing an ADAM15 mutant without the cytoplasmic tail. Accordingly, a specific binding of the cytoplasmic ADAM15 domain to the C terminus of FAK could be shown by mammalian two-hybrid, pulldown, and far Western studies. In cells expressing full-length ADAM15, a concomitant activation of Src at Tyr-416 was detected upon camptothecin exposure. Cells transfected with a chimeric construct consisting of the extracellular IL-2 receptor alpha-chain and the cytoplasmic ADAM15 domain were IL-2-stimulated to prove that the ADAM15 tail can transduce a percepted extracellular signal to enhance FAK and Src phosphorylation. Our studies further demonstrate Src binding to FAK but not a direct Src interaction with ADAM15, suggesting FAK as a critical intracellular adaptor for ADAM15-dependent enhancement of FAK/Src activation. Moreover, the apoptosis induction elicited by specific inhibitors (PP2, FAK 14 inhibitor) of FAK/Src signaling was significantly reduced by ADAM15 expression. The newly uncovered counter-regulatory response to genotoxic stress in a chondrocytic survival pathway is potentially also relevant to apoptosis resistance in neoplastic growth.	[Fried, Dorothee; Boehm, Beate B.; Krause, Kristin; Burkhardt, Harald] Goethe Univ Hosp Frankfurt Am Main, Div Rheumatol, D-60590 Frankfurt, Germany		Fried, D (corresponding author), Goethe Univ Hosp Frankfurt Am Main, Div Rheumatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	harald.burkhardt@kgu.de			Deutsche Forschungsgemeinschaft [BU584/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant BU584/4-1.	Aigner T, 2002, ARTHRITIS RHEUM-US, V46, P1986, DOI 10.1002/art.10554; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm B, 2010, ARTHRITIS RHEUM-US, V62, P1372, DOI 10.1002/art.27387; Bohm BB, 2009, J CELL MOL MED, V13, P2634, DOI 10.1111/j.1582-4934.2008.00490.x; Bohm BB, 1999, ARTHRITIS RHEUM, V42, P1946, DOI 10.1002/1529-0131(199909)42:9<1946::AID-ANR21>3.0.CO;2-E; Bohm BB, 2005, ARTHRITIS RHEUM-US, V52, P1100, DOI 10.1002/art.20974; Bohm BB, 2001, ARTHRITIS RHEUM-US, V44, P2046, DOI 10.1002/1529-0131(200109)44:9<2046::AID-ART354>3.0.CO;2-3; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Lucas N, 2009, J CELL BIOCHEM, V106, P967, DOI 10.1002/jcb.22087; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Maretzky T, 2009, BIOCHEM J, V420, P105, DOI 10.1042/BJ20082127; Marzia M, 2011, BIOL CHEM, V392, P877, DOI 10.1515/BC.2011.080; Mechai N, 2005, J NEUROSCI RES, V82, P753, DOI 10.1002/jnr.20693; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nath D, 1999, J CELL SCI, V112, P579; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21214	21223		10.1074/jbc.M112.347120	http://dx.doi.org/10.1074/jbc.M112.347120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544741	Green Published, hybrid			2022-12-28	WOS:000306416800041
J	Sojka, D; Franta, Z; Frantova, H; Bartosova, P; Horn, M; Vachova, J; O'Donoghue, AJ; Eroy-Reveles, AA; Craik, CS; Knudsen, GM; Caffrey, CR; McKerrow, JH; Mares, M; Kopacek, P				Sojka, Daniel; Franta, Zdenek; Frantova, Helena; Bartosova, Pavla; Horn, Martin; Vachova, Jana; O'Donoghue, Anthony J.; Eroy-Reveles, Alegra A.; Craik, Charles S.; Knudsen, Giselle M.; Caffrey, Conor R.; McKerrow, James H.; Mares, Michael; Kopacek, Petr			Characterization of Gut-associated Cathepsin D Hemoglobinase from Tick Ixodes ricinus (IrCD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIPICEPHALUS BOOPHILUS MICROPLUS; HARD TICK; ORNITHODOROS-MOUBATA; ASPARTIC PROTEINASE; RECOGNITION DOMAIN; MOLECULAR-CLONING; ACTIVE-SITE; EXPRESSION; INHIBITOR; PROTEASE	To identify the gut-associated tick aspartic hemoglobinase, this work focuses on the functional diversity of multiple Ixodes ricinus cathepsin D forms (IrCDs). Out of three encoding genes representing Ixodes scapularis genome paralogs, IrCD1 is the most distinct enzyme with a shortened propeptide region and a unique pattern of predicted post-translational modifications. IrCD1 gene transcription is induced by tick feeding and is restricted to the gut tissue. The hemoglobinolytic role of IrCD1 was further supported by immunolocalization of IrCD1 in the vesicles of tick gut cells. Properties of recombinantly expressed rIrCD1 are consistent with the endo-lysosomal environment because the zymogen is autoactivated and remains optimally active in acidic conditions. Hemoglobin cleavage pattern of rIrCD1 is identical to that produced by the native enzyme. The preference for hydrophobic residues at the P1 and P1' position was confirmed by screening a novel synthetic tetradecapeptidyl substrate library. Outside the S1-S1' regions, rIrCD1 tolerates most amino acids but displays a preference for tyrosine at P3 and alanine at P2'. Further analysis of the cleavage site location within the peptide substrate indicated that IrCD1 is a true endopeptidase. The role in hemoglobinolysis was verified with RNAi knockdown of IrCD1 that decreased gut extract cathepsin D activity by >90%. IrCD1 was newly characterized as a unique hemoglobinolytic cathepsin D contributing to the complex intestinal proteolytic network of mainly cysteine peptidases in ticks.	[Sojka, Daniel; Franta, Zdenek; Frantova, Helena; Bartosova, Pavla; Kopacek, Petr] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, CZ-37005 Ceske Budejovice, Czech Republic; [Horn, Martin; Vachova, Jana; Mares, Michael] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CZ-16610 Prague, Czech Republic; [Knudsen, Giselle M.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA; [O'Donoghue, Anthony J.; Eroy-Reveles, Alegra A.; Craik, Charles S.; Knudsen, Giselle M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94720 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sojka, D (corresponding author), Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.	sojkadan@gmail.com	Mares, Michael/B-2413-2009; Sojka, Daniel/G-8354-2014; Kopacek, Petr/G-8414-2014; Horn, Martin/A-8701-2008; Sojková, Pavla/G-7314-2014	Mares, Michael/0000-0002-0847-5022; Sojka, Daniel/0000-0002-9848-9435; Kopacek, Petr/0000-0003-2412-5724; Horn, Martin/0000-0001-9110-2018; Sojková, Pavla/0000-0003-2370-6981; Frantova, Helena/0000-0002-8462-0914; Franta, Zdenek/0000-0002-7709-0097	Academy of Sciences of the Czech Republic Grant Agency [IAA 600960910]; Ministry of Education, Youth, and Sports of the Czech Republic [LC06009]; Academy of Sciences of the Czech Republic; Institute of Organic Chemistry and Biochemistry; Academy of Sciences of the Czech Republic [Z602205728, 61388963, KJB 600960911]; Sandler Foundation; Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award; Grant Agency of the Czech Republic [P502/11/P682, P20/10/2183]; Grant Agency ASCR [IAA400550705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, K12GM081266] Funding Source: NIH RePORTER	Academy of Sciences of the Czech Republic Grant Agency; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institute of Organic Chemistry and Biochemistry; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Sandler Foundation; Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency ASCR(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant IAA 600960910 (to P. K.), The Academy of Sciences of the Czech Republic Grant Agency, and by Research Center LC06009 (The Ministry of Education, Youth, and Sports of the Czech Republic). Research at the Institute of Parasitology BC, The Academy of Sciences of the Czech Republic, and the Institute of Organic Chemistry and Biochemistry, The Academy of Sciences of the Czech Republic, supported by Research Projects Z602205728 and 61388963 and research performed at the Sandler Center was supported in part by the Sandler Foundation and the Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award.; Supported by Postdoctoral Project Grants KJB 600960911 from the Grant Agency of The Academy of Sciences of the Czech Republic and P502/11/P682 from the Grant Agency of the Czech Republic. To whom correspondence should be addressed: Institute of Parasitology, Biology Centre ASCR, Branisovska 31, CZ-370 05 Ceske Budejovice, Czech Republic. Tel.: 420-38-777-5453; Fax: 420-38-5310388; E-mail: sojkadan@gmail.com.; Supported by Grant IAA400550705 from Grant Agency ASCR and Grant P20/10/2183 from Grant Agency of the Czech Republic.	Akov S., 1976, Acta Tropica, V33, P37; AOYAGI T, 1969, J ANTIBIOT, V22, P283, DOI 10.7164/antibiotics.22.283; AULD DS, 1988, METHOD ENZYMOL, V158, P110, DOI 10.1016/0076-6879(88)58051-5; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cruz CE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-63; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Franta Z, 2011, INT J PARASITOL, V41, P1253, DOI 10.1016/j.ijpara.2011.06.006; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; GABAY T, 1993, EXP PARASITOL, V77, P261, DOI 10.1006/expr.1993.1084; Grunclova L, 2006, BIOL CHEM, V387, P1635, DOI 10.1515/BC.2006.204; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Hajdusek O, 2010, VACCINE, V28, P2993, DOI 10.1016/j.vaccine.2010.02.008; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Hurst M, 2000, DRUGS, V60, P1371, DOI 10.2165/00003495-200060060-00009; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; Kopacek P, 2003, INSECT BIOCHEM MOLEC, V33, P103, DOI 10.1016/S0965-1748(02)00181-9; Kopacek P, 1995, INSECT BIOCHEM MOLEC, V25, P1081, DOI 10.1016/0965-1748(95)00040-2; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liu P, 2009, BIOCHEMISTRY-US, V48, P4086, DOI 10.1021/bi802059r; Logullo C, 1998, PARASITOLOGY, V116, P525, DOI 10.1017/S0031182098002698; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; MARES M, 1989, FEBS LETT, V251, P94, DOI 10.1016/0014-5793(89)81435-8; Mendiola J, 1996, EXP PARASITOL, V82, P27, DOI 10.1006/expr.1996.0004; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Nussbaumerova M, 2010, CHEMBIOCHEM, V11, P1538, DOI 10.1002/cbic.201000182; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimenta DC, 2001, BBA-PROTEIN STRUCT M, V1544, P113, DOI 10.1016/S0167-4838(00)00209-0; Renard G, 2002, INSECT MOL BIOL, V11, P325, DOI 10.1046/j.1365-2583.2002.00342.x; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Sorgine MHF, 2000, J BIOL CHEM, V275, P28659, DOI 10.1074/jbc.M005675200; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; TARNOWSKI BI, 1989, EXP APPL ACAROL, V6, P263, DOI 10.1007/BF01193300; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VUNDLA WRM, 1992, INSECT BIOCHEM MOLEC, V22, P405, DOI 10.1016/0965-1748(92)90079-T; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Wu DD, 2009, MOL BIOL EVOL, V26, P2333, DOI 10.1093/molbev/msp139	52	31	31	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21152	21163		10.1074/jbc.M112.347922	http://dx.doi.org/10.1074/jbc.M112.347922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539347	hybrid, Green Published			2022-12-28	WOS:000306416800036
J	Hu, P; Carlesso, N; Xu, MJ; Liu, Y; Nebreda, AR; Takemoto, C; Kapur, R				Hu, Ping; Carlesso, Nadia; Xu, Mingjiang; Liu, Yan; Nebreda, Angel R.; Takemoto, Clifford; Kapur, Reuben			Genetic Evidence for Critical Roles of P38 alpha Protein in Regulating Mast Cell Differentiation and Chemotaxis through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; TYROSINE KINASE; MAP KINASE; ACTIVATION; PROLIFERATION; MOUSE; MITF; STEM; MELANOCYTE	Mast cells mediate a range of immune responses. However, the mechanisms that contribute to their development remain poorly understood. Here, using a P38 alpha conditional knockout system, we provide evidence to suggest that P38 alpha plays critical roles in regulating mast cell differentiation and migration via distinct mechanisms. Induced deletion of P38 alpha in bone marrow cells retards the maturation of mast cells in part by inhibiting the activation of cAMP response element-binding protein and expression of microphthalmia-associated transcription factor, which encourages the generation of basophils over mast cells. In fully differentiated mast cells, absence of P38 alpha inhibits stem cell factor-induced activation of Akt and ERK, which is associated with reduced chemotaxis. In vivo, conditional deletion of P38 alpha results in reduced numbers of mast cells in certain tissues and a failure to reconstitute these cells in W-sh mice transplanted with P38 alpha(-/-) Lin(-)c-kit(+)Sca-1(+) (LKS+) cells. Our findings suggest that P38 alpha plays a dual role in mast cell development by regulating IL-3-induced differentiation of mast cell progenitor cells as well as by regulating stem cell factor-induced migration of fully differentiated mast cells.	[Hu, Ping; Carlesso, Nadia; Xu, Mingjiang; Liu, Yan; Kapur, Reuben] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nebreda, Angel R.] Inst Catalana Recerca & Estudios Avancats, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Takemoto, Clifford] Johns Hopkins Univ, Div Pediat Hematol, Baltimore, MD 21202 USA	Indiana University System; Indiana University Bloomington; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Johns Hopkins University	Kapur, R (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, 1044 W Walnut St,Room W168, Indianapolis, IN 46202 USA.	rkapur@iupui.edu	Takemoto, Clifford M/Y-7558-2018; Nebreda, Angel Rodriguez/R-9594-2019		National Institutes of Health [R01 HL077177, R01 HL08111]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077177 and R01 HL08111 (to R. K.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; DVORAK AM, 1994, AM J PATHOL, V144, P160; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Galli S J, 1994, Curr Opin Hematol, V1, P33; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ito A, 1998, BLOOD, V91, P3210, DOI 10.1182/blood.V91.9.3210.3210_3210_3221; Jippo T, 2003, J EXP MED, V197, P1417, DOI 10.1084/jem.20022157; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Morii E, 2004, J BIOL CHEM, V279, P48923, DOI 10.1074/jbc.M407026200; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Ogihara H, 2001, BLOOD, V97, P645, DOI 10.1182/blood.V97.3.645; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Zhang D, 2011, J BIOL CHEM, V286, P44913, DOI 10.1074/jbc.M111.310052; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	38	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20258	20269		10.1074/jbc.M112.358119	http://dx.doi.org/10.1074/jbc.M112.358119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518842	hybrid, Green Published			2022-12-28	WOS:000306414500046
J	Kanamarlapudi, V; Thompson, A; Kelly, E; Bernal, AL				Kanamarlapudi, Venkateswarlu; Thompson, Aiysha; Kelly, Eamonn; Bernal, Andres Lopez			ARF6 Activated by the LHCG Receptor through the Cytohesin Family of Guanine Nucleotide Exchange Factors Mediates the Receptor Internalization and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSYLATION FACTOR 6; PROTEIN-COUPLED RECEPTORS; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMA-MEMBRANE; BREFELDIN-A; PHOSPHOINOSITIDE 3-KINASE; STIMULATED TRANSLOCATION; ENDOCYTOSIS; CELLS	The luteinizing hormone chorionic gonadotropin receptor (LHCGR) is a G(s)-coupled GPCR that is essential for the maturation and function of the ovary and testis. LHCGR is internalized following its activation, which regulates the biological responsiveness of the receptor. Previous studies indicated that ADP-ribosylation factor (ARF)6 and its GTP-exchange factor (GEF) cytohesin 2 regulate LHCGR internalization in follicular membranes. However, the mechanisms by which ARF6 and cytohesin 2 regulate LHCGR internalization remain incompletely understood. Here we investigated the role of the ARF6 signaling pathway in the internalization of heterologously expressed human LHCGR (HLHCGR) in intact cells using a combination of pharmacological inhibitors, siRNA and the expression of mutant proteins. We found that human CG (HCG)-induced HLHCGR internalization, cAMP accumulation and ARF6 activation were inhibited by Gallein (beta gamma inhibitor), Wortmannin (PI 3-kinase inhibitor), SecinH3 (cytohesin ARF GEF inhibitor), QS11 (an ARF GAP inhibitor), an ARF6 inhibitory peptide and ARF6 siRNA. However, Dynasore (dynamin inhibitor), the dominant negative mutants of NM23-H1 (dynamin activator) and clathrin, and PBP10 (PtdIns 4,5-P2-binding peptide) inhibited agonist- induced HLHCGR and cAMP accumulation but not ARF6 activation. These results indicate that heterotrimeric G-protein, phosphatidylinositol (PI) 3-kinase (PI3K), cytohesin ARF GEF and ARF GAP function upstream of ARF6 whereas dynamin and clathrin act downstream of ARF6 in the regulation of HCG-induced HLHCGR internalization and signaling. In conclusion, we have identified the components and molecular details of the ARF6 signaling pathway required for agonist-induced HLHCGR internalization.	[Kanamarlapudi, Venkateswarlu; Thompson, Aiysha] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [Kelly, Eamonn] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Bernal, Andres Lopez] Univ Bristol, Div Obstet & Gynaecol, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	Swansea University; University of Bristol; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	BBSRC UK; MRC UK; Royal Society UK; Biotechnology and Biological Sciences Research Council [1095087, BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; MRC [G0401232] Funding Source: UKRI	BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society UK(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BBSRC UK, MRC UK, and the Royal Society UK.	Abel K, 2001, J CELL SCI, V114, P2207; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Benmerah A, 1999, J CELL SCI, V112, P1303; Bhaskaran RS, 2005, J MOL ENDOCRINOL, V34, P447, DOI 10.1677/jme.1.01745; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Claing A, 2004, BIOCHEM CELL BIOL, V82, P610, DOI 10.1139/O04-113; Cullen PJ, 1999, BIOCHEM SOC T, V27, P683, DOI 10.1042/bst0270683; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fu HM, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-50; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Lazari RDM, 1998, J BIOL CHEM, V273, P18316, DOI 10.1074/jbc.273.29.18316; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; OKADA T, 1994, J BIOL CHEM, V269, P3568; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 1999, BIOCHEM J, V340, P359, DOI 10.1042/0264-6021:3400359; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; WANG H, 1991, J BIOL CHEM, V266, P780; YANO H, 1993, J BIOL CHEM, V268, P25846; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	58	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20443	20455		10.1074/jbc.M112.362087	http://dx.doi.org/10.1074/jbc.M112.362087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523074	Green Published, hybrid			2022-12-28	WOS:000306414500062
J	Ming, AYK; Yoo, E; Vorontsov, EN; Altamentova, SM; Kilkenny, DM; Rocheleau, JV				Ming, Aaron Y. K.; Yoo, Eunjong; Vorontsov, Eugene N.; Altamentova, Svetlana M.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.			Dynamics and Distribution of Klotho beta (KLB) and Fibroblast Growth Factor Receptor-1 (FGFR1) in Living Cells Reveal the Fibroblast Growth Factor-21 (FGF21)-induced Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METABOLIC-ACTIVITY; STRUCTURAL BASIS; PPAR-ALPHA; NUMBER; BRIGHTNESS; FAMILY; ORGANIZATION; EXPRESSION; ECTODOMAIN	FGF21 stimulates FGFR1c activity in cells that co-express Klotho beta (KLB); however, relatively little is known about the interaction of these receptors at the plasma membrane. We measured the dynamics and distribution of fluorescent protein-tagged KLB and FGFR1c in living cells using fluorescence recovery after photobleaching and number and brightness analysis. We confirmed that fluorescent protein-tagged KLB translocates to the plasma membrane and is active when co-expressed with FGFR1c. FGF21-induced signaling was enhanced in cells treated with lactose, a competitive inhibitor of the galectin lattice, suggesting that lattice-binding modulates KLB and/or FGFR1c activity. Fluorescence recovery after photobleaching analysis consistently revealed that lactose treatment increased KLB mobility at the plasma membrane, but did not affect the mobility of FGFR1c. The association of endogenous KLB with the galectin lattice was also confirmed by co-immunoprecipitation with galectin-3. KLB mobility increased when co-expressed with FGFR1c, suggesting that the two receptors form a heterocomplex independent of the galectin lattice. Number and brightness analysis revealed that KLB and FGFR1c behave as monomers and dimers at the plasma membrane, respectively. Co-expression resulted in monomeric expression of KLB and FGFR1c consistent with formation of a 1:1 heterocomplex. Subsequent addition of FGF21 induced FGFR1 dimerization without changing KLB aggregate size, suggesting formation of a 1:2 KLB-FGFR1c signaling complex. Overall, these data suggest that KLB and FGFR1 form a 1:1 heterocomplex independent of the galectin lattice that transitions to a 1:2 complex upon the addition of FGF21.	[Ming, Aaron Y. K.; Yoo, Eunjong; Vorontsov, Eugene N.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Rocheleau, Jonathan V.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Rocheleau, Jonathan V.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Ming, Aaron Y. K.; Vorontsov, Eugene N.; Altamentova, Svetlana M.; Rocheleau, Jonathan V.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Rocheleau, JV (corresponding author), Toronto Med Discovery Tower,10th Fl,Rm 10-707,101, Toronto, ON M5G 1L7, Canada.	Jon.Rocheleau@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Foundation for Innovation Leaders Opportunity Fund [18301]; Canadian Institutes for Health Research [NMD106997]; Heart and Stroke Foundation of Ontario [NA6591]; Banting and Best Diabetes Centre, University of Toronto	Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Banting and Best Diabetes Centre, University of Toronto(University of Toronto)	The microscope used in these studies was purchased through a Canadian Foundation for Innovation Leaders Opportunity Fund (18301) to J. V. Rocheleau.; This work was supported by grants from the Canadian Institutes for Health Research (NMD106997) (to J. V. R. and D. M. K.) and the Heart and Stroke Foundation of Ontario (NA6591) (to J. V. R.).; Supported by the Banting and Best Diabetes Centre, University of Toronto.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nakamura M, 2011, J BIOL CHEM, V286, P26418, DOI 10.1074/jbc.M111.251140; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	39	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19997	20006		10.1074/jbc.M111.325670	http://dx.doi.org/10.1074/jbc.M111.325670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523080	hybrid, Green Published			2022-12-28	WOS:000306414500021
J	Sakuraba, H; Satomura, T; Kawakami, R; Kim, K; Hara, Y; Yoneda, K; Ohshima, T				Sakuraba, Haruhiko; Satomura, Takenori; Kawakami, Ryushi; Kim, Kwang; Hara, Yusuke; Yoneda, Kazunari; Ohshima, Toshihisa			Crystal Structure of Novel Dye-linked L-Proline Dehydrogenase from Hyperthermophilic Archaeon Aeropyrum pernix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMERIC SARCOSINE OXIDASE; AMINO-ACID DEHYDROGENASE; SUCCINATE-DEHYDROGENASE; GLUTAMATE-DEHYDROGENASE; THERMOCOCCUS-PROFUNDUS; PYROBACULUM-ISLANDICUM; PYROCOCCUS-HORIKOSHII; MOLECULAR-GRAPHICS; ESCHERICHIA-COLI; PURIFICATION	Two types of dye-linked L-proline dehydrogenase (PDH1, alpha 4 beta 4-type hetero-octamer, and PDH2, alpha beta gamma delta-type heterotetramer) have been identified so far in hyperthermophilic archaea. Here, we report the crystal structure of a third type of L-proline dehydrogenase, found in the aerobic hyperthermophilic archaeon Aeropyrum pernix, whose structure (homodimer) is much simpler than those of previously studied L-proline dehydrogenases. The structure was determined at a resolution of 1.92 angstrom. The asymmetric unit contained one subunit, and a crystallographic 2-fold axis generated the functional dimer. The overall fold of the subunit showed similarity to that of the PDH1 beta-subunit, which is responsible for catalyzing L-proline dehydrogenation. However, the situation at the subunit-subunit interface of the A. pernix enzyme was totally different from that in PDH1. The presence of additional surface elements in the A. pernix enzyme contributes to a unique dimer association. Moreover, the C-terminal Leu(428), which is provided by a tail extending from the FAD-binding domain, shielded the active site, and an L-proline molecule was entrapped within the active site cavity. The K-m value of a Leu(428) deletion mutant for L-proline was about 800 times larger than the K-m value of the wild-type enzyme, although the k(cat) values did not differ much between the two enzymes. This suggests the C-terminal Leu(428) is not directly involved in catalysis, but it is essential for maintaining a high affinity for the substrate. This is the first description of an LPDH structure with L-proline bound, and it provides new insight into the substrate binding of LPDH.	[Ohshima, Toshihisa] Kyushu Univ, Inst Genet Resources, Fac Agr, Fukuoka 8128581, Japan; [Sakuraba, Haruhiko; Hara, Yusuke] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan; [Satomura, Takenori] Univ Fukui, Dept Appl Chem & Biotechnol, Grad Sch Engn, Fukui 9108507, Japan; [Kawakami, Ryushi] Saga Univ, Analyt Res Ctr Expt Sci, Saga 8408502, Japan; [Kim, Kwang] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Osaka 5600043, Japan; [Yoneda, Kazunari] Tokai Univ, Dept Biosci, Sch Agr, Kumamoto 8691404, Japan	Kyushu University; Kagawa University; University of Fukui; Saga University; Osaka University; Tokai University	Ohshima, T (corresponding author), Kyushu Univ, Inst Genet Resources, Fac Agr, Fukuoka 8128581, Japan.	ohshima@agr.kyushu-u.ac.jp		Yoneda, Kazunari/0000-0001-9152-8772	Japan Society for the Promotion of Science; Novozymes Japan Research Fund; Ministry of Education, Science, Sports and Culture of Japan [22248010]; Grants-in-Aid for Scientific Research [24780105] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novozymes Japan Research Fund; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research (C) (to H. S.) from the Japan Society for the Promotion of Science, Novozymes Japan Research Fund 2010 (to H. S.), and in part by Grant-in-aid for Scientific Research 22248010 (to T. O.) from the Ministry of Education, Science, Sports and Culture of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bhuiya MW, 2005, J MOL BIOL, V345, P325, DOI 10.1016/j.jmb.2004.10.063; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DANCEY GF, 1976, J BIOL CHEM, V251, P5911; DAVIS KA, 1971, BIOCHEMISTRY-US, V10, P2509; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; FREW JE, 1987, ANAL CHEM, V59, pA933, DOI 10.1021/ac00142a001; HEDERSTEDT L, 1979, J BACTERIOL, V138, P370, DOI 10.1128/JB.138.2.370-376.1979; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; Larson ET, 2007, VIROLOGY, V368, P249, DOI 10.1016/j.virol.2007.06.040; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Menon SK, 2008, VIROLOGY, V376, P270, DOI 10.1016/j.virol.2008.03.026; Monaghan PJ, 2007, FEBS J, V274, P2070, DOI 10.1111/j.1742-4658.2007.05750.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Sakuraba H, 2001, APPL ENVIRON MICROB, V67, P1470, DOI 10.1128/AEM.67.4.1470-1475.2001; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Satomura T, 2008, J BIOSCI BIOENG, V106, P16, DOI 10.1263/jbb.106.16; Satomura T, 2012, BIOSCI BIOTECH BIOCH, V76, P589, DOI 10.1271/bbb.110775; Satomura T, 2011, APPL MICROBIOL BIOT, V89, P1075, DOI 10.1007/s00253-010-2914-7; Satomura T, 2010, ACTA CRYSTALLOGR F, V66, P1508, DOI 10.1107/S1744309110036808; Suraveratum N, 2000, MOL BIOCHEM PARASIT, V105, P215, DOI 10.1016/S0166-6851(99)00180-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Zhao GH, 2005, BIOCHEMISTRY-US, V44, P16866, DOI 10.1021/bi051898d; Zhao GH, 2002, BIOCHEMISTRY-US, V41, P9751, DOI 10.1021/bi020286f	42	4	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20070	20080		10.1074/jbc.M111.319038	http://dx.doi.org/10.1074/jbc.M111.319038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511758	Green Published, hybrid			2022-12-28	WOS:000306414500028
J	O'Brien, JE; Sharkey, LM; Vallianatos, CN; Han, CY; Blossom, JC; Yu, T; Waxman, SG; Dib-Hajj, SD; Meisler, MH				O'Brien, Janelle E.; Sharkey, Lisa M.; Vallianatos, Christina N.; Han, Chongyang; Blossom, Julie C.; Yu, Ting; Waxman, Stephen G.; Dib-Hajj, Sulayman D.; Meisler, Miriam H.			Interaction of Voltage-gated Sodium Channel Na(v)1.6 (SCN8A) with Microtubule-associated Protein Map1b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE NEURONS; LIGHT-CHAIN; MUTATIONS; CURRENTS; RANVIER; NODES; 1B; LOCALIZATION; INACTIVATION; TRAFFICKING	The mechanism by which voltage-gated sodium channels are trafficked to the surface of neurons is not well understood. Our previous work implicated the cytoplasmic N terminus of the sodium channel Na(v)1.6 in this process. We report that the N terminus plus the first transmembrane segment (residues 1-153) is sufficient to direct a reporter to the cell surface. To identify proteins that interact with the 117-residue N-terminal domain, we carried out a yeast two-hybrid screen of a mouse brain cDNA library. Three clones containing overlapping portions of the light chain of microtubule-associated protein Map1b (Mtap1b) were recovered from the screen. Interaction between endogenous Na(v)1.6 channels and Map1b in mouse brain was confirmed by co-immunoprecipitation. Map1b did not interact with the N terminus of the related channel Na(v)1.1. Alanine-scanning mutagenesis of the Na(v)1.6 N terminus demonstrated that residues 77-80 (VAVP) contribute to interaction with Map1b. Co-expression of Na(v)1.6 with Map1b in neuronal cell line ND7/23 resulted in a 50% increase in current density, demonstrating a functional role for this interaction. Mutation of the Map1b binding site of Na(v)1.6 prevented generation of sodium current in transfected cells. The data indicate that Map1b facilitates trafficking of Na(v)1.6 to the neuronal cell surface.	[O'Brien, Janelle E.; Sharkey, Lisa M.; Vallianatos, Christina N.; Blossom, Julie C.; Yu, Ting; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Han, Chongyang; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	University of Michigan System; University of Michigan; Yale University	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Waxman, Stephen/Z-2507-2019; Han, Chongyang/F-4986-2011; Yu, Ting/N-7231-2017	Waxman, Stephen/0000-0001-5718-7177; Garrison, Janelle/0000-0002-5031-9234; Vallianatos, Christina/0000-0003-3159-3200	National Institutes of Health Research through US Public Health Service [R01 NS34509]; National Institutes of Health [T32 GM007544]; Rackham School of Graduate Studies at the University of Michigan; Veterans Affairs Medical Research Service; Rehabilitation Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034509] Funding Source: NIH RePORTER	National Institutes of Health Research through US Public Health Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham School of Graduate Studies at the University of Michigan; Veterans Affairs Medical Research Service(US Department of Veterans Affairs); Rehabilitation Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01 NS34509 through the US Public Health Service (to M. H. M.).; Supported by National Institutes of Health Predoctoral Training Program in Genetics Grant T32 GM007544 and the Rackham School of Graduate Studies at the University of Michigan.; Supported by grants from the Veterans Affairs Medical Research Service and Rehabilitation Research Service.	Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cummins TR, 2005, FEBS LETT, V579, P2166, DOI 10.1016/j.febslet.2005.03.009; Dib-Hajj SD, 2010, NEUROSCI LETT, V486, P84, DOI 10.1016/j.neulet.2010.08.077; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Eriksson M, 2010, NEUROSCI LETT, V475, P33, DOI 10.1016/j.neulet.2010.03.039; Everitt AB, 2004, J BIOL CHEM, V279, P21701, DOI 10.1074/jbc.M312806200; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Kanai K, 2004, NEUROLOGY, V63, P329, DOI 10.1212/01.WNL.0000129829.31179.5B; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Leterrier C, 2011, SEMIN CELL DEV BIOL, V22, P171, DOI 10.1016/j.semcdb.2010.09.014; Levin SI, 2004, GENESIS, V39, P234, DOI 10.1002/gene.20050; Levin SI, 2006, J NEUROPHYSIOL, V96, P785, DOI 10.1152/jn.01193.2005; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; O'Brien JE, 2012, MOL CELL NEUROSCI, V49, P120, DOI 10.1016/j.mcn.2011.10.005; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Poon WYL, 2004, FEBS LETT, V558, P114, DOI 10.1016/S0014-5793(03)01512-6; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; Schaller KL, 2000, J COMP NEUROL, V420, P84; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Zhang YQ, 2012, NEURON, V73, P92, DOI 10.1016/j.neuron.2011.10.016; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	35	30	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18459	18466		10.1074/jbc.M111.336024	http://dx.doi.org/10.1074/jbc.M111.336024			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474336	hybrid, Green Published			2022-12-28	WOS:000306411600052
J	Rangarajan, ES; Izard, T				Rangarajan, Erumbi S.; Izard, Tina			The Cytoskeletal Protein alpha-Catenin Unfurls upon Binding to Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; BETA-CATENIN; CRYSTAL-STRUCTURE; ACTIVATE VINCULIN; TALIN ROD; F-ACTIN; STRUCTURAL BASIS; N-CADHERIN; COMPLEX; SITES	Adherens junctions (AJs) are essential for cell-cell contacts, morphogenesis, and the development of all higher eukaryotes. AJs are formed by calcium-dependent homotypic interactions of the ectodomains of single membrane-pass cadherin family receptors. These homotypic interactions in turn promote binding of the intracellular cytoplasmic tail domains of cadherin receptors with beta-catenin, a multifunctional protein that plays roles in both transcription and AJs. The cadherin receptor-beta-catenin complex binds to the cytoskeletal protein alpha-catenin, which is essential for both the formation and the stabilization of these junctions. Precisely how alpha-catenin contributes to the formation and stabilization of AJs is hotly debated, although the latter is thought to involve its interactions with the cytoskeletal protein vinculin. Here we report the crystal structure of the vinculin binding domain (VBD) of alpha-catenin in complex with the vinculin head domain (Vh1). This structure reveals that alpha-catenin is in a unique unfurled mode allowing dimer formation when bound to vinculin. Finally, binding studies suggest that vinculin must be in an activated state to bind to alpha-catenin and that this interaction is stabilized by the formation of a ternary alpha-catenin-vinculin-F-actin complex, which can be formed via the F-actin binding domain of either protein. We propose a feed-forward model whereby alpha-catenin-vinculin interactions promote their binding to the actin cytoskeleton to stabilize AJs.	[Rangarajan, Erumbi S.; Izard, Tina] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	Scripps Research Institute	Izard, T (corresponding author), Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA.	mkernick@scripps.edu			National Institutes of Health; State of Florida; Scripps Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida; Scripps Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health grants and by start-up funds provided to Scripps Florida from the State of Florida. To whom correspondence should be addressed.; We are indebted to our colleagues at Scripps Florida: John Cleveland for discussions and critical review of the manuscript, Zhen Wu and Philippe Bois for sequencing, and Philippe Bois for fruitful discussions. V. Nayak generated the alpha-catenin 82-906, 144-906, and 277-382 constructs, and HaJeung Park and Ewa Folta-Stogniew (Yale) provided SLS data. We are grateful to the staff at the SER-CAT (beamline BM22) for synchrotron support.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Braga VMM, 2004, SEMIN CELL DEV BIOL, V15, P631, DOI 10.1016/j.semcdb.2004.09.009; Brault V, 2001, DEVELOPMENT, V128, P1253; Bricogne G., 2011, BUSTER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lecuit T, 2010, NAT CELL BIOL, V12, P522, DOI 10.1038/ncb2066; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; Park H, 2011, J BIOL CHEM, V286, P23214, DOI 10.1074/jbc.M110.184283; Park H, 2010, ACTA CRYSTALLOGR F, V66, P595, DOI 10.1107/S1744309110011875; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Nhieu GT, 2007, EMBO J, V26, P4588; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Yogesha SD, 2012, PROTEIN SCI, V21, P583, DOI 10.1002/pro.2041; Yogesha SD, 2011, PROTEIN SCI, V20, P1471, DOI 10.1002/pro.671; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	56	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18492	18499		10.1074/jbc.M112.351023	http://dx.doi.org/10.1074/jbc.M112.351023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493458	Green Published, hybrid			2022-12-28	WOS:000306411600055
J	Sung, RJ; Zhang, M; Qi, Y; Verdine, GL				Sung, Rou-Jia; Zhang, Michael; Qi, Yan; Verdine, Gregory L.			Sequence-dependent Structural Variation in DNA Undergoing Intrahelical Inspection by the DNA glycosylase MutM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR ENZYME; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BASE-EXCISION; LESION RECOGNITION; PROTEIN-STRUCTURE; ABASIC SITE; DAMAGED DNA; RAS GENE; 8-OXOGUANINE	MutM, a bacterial DNA-glycosylase, plays a critical role in maintaining genome integrity by catalyzing glycosidic bond cleavage of 8-oxoguanine (oxoG) lesions to initiate base excision DNA repair. The task faced by MutM of locating rare oxoG residues embedded in an overwhelming excess of undamaged bases is especially challenging given the close structural similarity between oxoG and its normal progenitor, guanine (G). MutM actively interrogates the DNA to detect the presence of an intrahelical, fully base-paired oxoG, whereupon the enzyme promotes extrusion of the target nucleobase from the DNA duplex and insertion into the extrahelical active site. Recent structural studies have begun to provide the first glimpse into the protein DNA interactions that enable MutM to distinguish an intrahelical oxoG from G; however, these initial studies left open the important question of how MutM can recognize oxoG residues embedded in 16 different neighboring sequence contexts (considering only the 5'- and 3'-neighboring base pairs). In this study we set out to understand the manner and extent to which intrahelical lesion recognition varies as a function of the 5'-neighbor. Here we report a comprehensive, systematic structural analysis of the effect of the 5'-neighboring base pair on recognition of an intrahelical oxoG lesion. These structures reveal that MutM imposes the same extrusion-prone ("extrudogenic") backbone conformation on the oxoG lesion irrespective of its 5'-neighbor while leaving the rest of the DNA relatively free to adjust to the particular demands of individual sequences.	[Sung, Rou-Jia; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Zhang, Michael; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Qi, Yan] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu		Zhang, Michael/0000-0002-7067-0689	National Institutes of Health [GM044853, CA100742]; Harvard College Research Program; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard College Research Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044853 and CA100742.; Supported by a grant by the Harvard College Research Program.; Supported by a predoctoral fellowship from the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cheng XL, 2005, J AM CHEM SOC, V127, P13906, DOI 10.1021/ja052542s; Cooper VR, 2008, J AM CHEM SOC, V130, P1304, DOI 10.1021/ja0761941; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; de Jesus KP, 2005, NUCLEIC ACIDS RES, V33, P5936, DOI 10.1093/nar/gki879; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng ZH, 2002, J NATL CANCER I, V94, P1527; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hatahet Z, 1998, P NATL ACAD SCI USA, V95, P8556, DOI 10.1073/pnas.95.15.8556; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; KAMIYA H, 1995, CARCINOGENESIS, V16, P883, DOI 10.1093/carcin/16.4.883; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pastoriza-Gallego M, 2007, MUTAGENESIS, V22, P343, DOI 10.1093/mutage/gem024; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Qi Y, 2010, J BIOL CHEM, V285, P1468, DOI 10.1074/jbc.M109.069799; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Watanabe T, 2001, BIOCHEM BIOPH RES CO, V284, P179, DOI 10.1006/bbrc.2001.4946; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	50	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18044	18054		10.1074/jbc.M111.313635	http://dx.doi.org/10.1074/jbc.M111.313635			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22465958	hybrid, Green Published			2022-12-28	WOS:000306411600014
J	van Meeteren, LA; Thorikay, M; Bergqvist, S; Pardali, E; Stampino, CG; Hu-Lowe, D; Goumans, MJ; ten Dijke, P				van Meeteren, Laurens A.; Thorikay, Midory; Bergqvist, Simon; Pardali, Evangelia; Stampino, Corrado Gallo; Hu-Lowe, Dana; Goumans, Marie-Jose; ten Dijke, Peter			Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ANGIOGENESIS; EXPRESSION; ENDOGLIN; IDENTIFICATION; ACTIVATION; PATHWAYS; BINDS; BMP-9; GENE	Genetic and molecular studies suggest that activin receptor-like kinase 1 (ALK1), a transforming growth factor beta (TGF-beta) type I receptor, and endoglin, a TGF-beta co-receptor, play an essential role in vascular development and pathological angiogenesis. Several agents that interfere with ALK1 and endoglin function are currently in clinical trials for antiangiogenic activity in cancer therapy. One of these agents, PF-03446962 (anti-hALK1 antibody), shows promising results in the clinic. However, its effects on endothelial cell function and mechanism of action are unclear. Here we demonstrate that anti-hALK1 antibody selectively recognizes human ALK1. The anti-hALK1 antibody interfered with bone morphogenetic protein 9 (BMP9)-induced signaling in endothelial cells. Consistent with this notion, anti-hALK1 antibody was found to compete highly efficiently with the binding of the ALK1 ligand BMP9 and TGF-beta to ALK1. Moreover, it prevented BMP9-dependent recruitment of co-receptor endoglin into this angiogenesis-mediating signaling complex. In addition, we demonstrated that anti-hALK1 antibody inhibited endothelial cell sprouting but did not directly interfere with vascular endothelial growth factor (VEGF) signaling, VEGF-induced proliferation, and migration of endothelial cells. Finally, we demonstrated that BMP9 in serum is essential for endothelial sprouting and that anti-hALK1 antibody inhibits this potently. Our data suggest that both the VEGF/VEGF receptor and the BMP9/ALK1 pathways are essential for stimulating angiogenesis, and targeting both pathways simultaneously may be an attractive strategy to overcome resistance to antiangiogenesis therapy.	[van Meeteren, Laurens A.; Thorikay, Midory; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [van Meeteren, Laurens A.; Thorikay, Midory; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Bergqvist, Simon; Hu-Lowe, Dana] Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA; [Pardali, Evangelia] Univ Munster, Dept Cardiol & Angiol, D-48149 Munster, Germany; [Stampino, Corrado Gallo] Pfizer Italia Srl, Clin Oncol, I-20152 Milan, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pfizer; University of Munster; Pfizer	van Meeteren, LA (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Postzone S-1-P,Postbus 9600, NL-2300 RC Leiden, Netherlands.	L.A.van_Meeteren@lumc.nl; p.ten_dijke@lumc.nl	Van Meeteren, Laurens A./AGQ-6139-2022; Goumans, Marie-José/AAG-4994-2021; Dijke, Peter ten/AAG-4660-2021; van Meeteren, Laurens/A-9890-2008; Goumans, Marie Jose/U-1455-2019	Dijke, Peter ten/0000-0002-7234-342X; van Meeteren, Laurens/0000-0001-9885-0668; Goumans, Marie Jose/0000-0001-9344-6746	Dutch Cancer Society; Pfizer Inc.; Le Ducq Foundation; Centre for Biomedical Genetics	Dutch Cancer Society(KWF Kankerbestrijding); Pfizer Inc.(Pfizer); Le Ducq Foundation(Leducq Foundation); Centre for Biomedical Genetics	This work was supported by the Dutch Cancer Society (to L.A.v.M.), Pfizer Inc., the Le Ducq Foundation, and the Centre for Biomedical Genetics. D. Hu-Lowe and S. Bergqvist are full-time Pfizer Inc. employees and own Pfizer Inc. stock. P. ten Dijke has received research funding from Pfizer Inc.	Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Ebisawa T, 1999, J CELL SCI, V112, P3519; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Goff LW, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3034; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Hu-Lowe D., 2009, P 100 ANN M AM ASS C; Hughes Christopher C W, 2007, J Vis Exp, P175, DOI 10.3791/175; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kellermann SA, 2002, CURR OPIN BIOTECH, V13, P593, DOI 10.1016/S0958-1669(02)00354-3; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Mancuso P, 2009, J CLIN ONCOL, V27; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; NORTH MA, 2007, Patent No. 2007040912; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Roman BL, 2002, DEVELOPMENT, V129, P3009; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scotti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026431; SEEHRA J, 2009, Patent No. 2009139891; Seki T, 2006, LAB INVEST, V86, P116, DOI 10.1038/labinvest.3700376; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; WU XY, 1995, BIOCHEM BIOPH RES CO, V216, P78, DOI 10.1006/bbrc.1995.2594; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217	40	73	74	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18551	18561		10.1074/jbc.M111.338103	http://dx.doi.org/10.1074/jbc.M111.338103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493445	Green Published, hybrid			2022-12-28	WOS:000306411600061
J	Zhang, YM; Jiang, DS; Zhang, Y; Jiang, XH; Wang, F; Tao, J				Zhang, Yiming; Jiang, Dongsheng; Zhang, Yuan; Jiang, Xinghong; Wang, Fen; Tao, Jin			Neuromedin U Type 1 Receptor Stimulation of A-type K+ Current Requires the beta gamma Subunits of G(o) Protein, Protein Kinase A, and Extracellular Signal-regulated Kinase 1/2 (ERK1/2) in Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-ROOT GANGLION; INACTIVATING POTASSIUM CURRENT; CENTRAL-NERVOUS-SYSTEM; PYRAMIDAL NEURONS; ENHANCED EXCITABILITY; ADENYLYL-CYCLASE; CALCIUM-CHANNELS; DOWN-REGULATION; HORN NEURONS; RAT	Although neuromedin U (NMU) has been implicated in analgesia, the detailed mechanisms still remain unclear. In this study, we identify a novel functional role of NMU type 1 receptor (NMUR1) in regulating the transient outward K+ currents (I-A) in small dorsal root ganglion (DRG) neurons. We found that NMU reversibly increased I-A in a dose-dependent manner, instead the sustained delayed rectifier K+ current (I-DR) was not affected. This NMU-induced I-A increase was pertussis toxin-sensitive and was totally reversed by NMUR1 knockdown. Intracellular application of GDP beta S (guanosine 5'-O-(2-thiodiphosphate)), QEHA peptide, or a selective antibody raised against the G alpha(o) or G beta blocked the stimulatory effects of NMU. Pretreatment of the cells with the protein kinase A (PKA) inhibitor or ERK inhibitor abolished the NMU-induced I-A response, whereas inhibition of phosphatidylinositol 3-kinase or PKC had no such effects. Exposure of DRG neurons to NMU markedly induced the phosphorylation of ERK (p-ERK), whereas p-JNK or p-p38 was not affected. Moreover, the NMU-induced p-ERK increase was attenuated by PKA inhibition and activation of PKA by foskolin would mimic the NMU-induced I-A increase. Functionally, we observed a significant decrease of the firing rate of neuronal action potential induced by NMU and pretreatment of DRG neurons with 4-AP could abolish this effect. In summary, these results suggested that NMU increases I-A via activation of NMUR1 that couples sequentially to the down-stream activities of G beta gamma of the G(o) protein, PKA, and ERK, which could contribute to its physiological functions including neuronal hypoexcitability in DRG neurons.	[Zhang, Yiming; Zhang, Yuan; Jiang, Xinghong; Wang, Fen; Tao, Jin] Soochow Univ, Coll Med, Key Lab Pain Res & Therapy, Dept Neurobiol, Suzhou 215123, Peoples R China; [Jiang, Dongsheng] Univ Ulm, Dept Dermatol & Allerg Dis, D-89081 Ulm, Germany; [Zhang, Yuan] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou 215004, Peoples R China	Soochow University - China; Ulm University; Soochow University - China	Tao, J (corresponding author), 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	taoj@suda.edu.cn	Zhang, Yiming/HGB-7344-2022; Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671; Tao, Jin/0000-0002-8481-3732	National Natural Science Foundation of China [30900437, 81171056]; Natural Science Funding of Jiangsu Province [BK2009118, BK2011440]; Natural Science Funding for Colleges and Universities in Jiangsu Province [09KJB18000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; Soochow University [Q4134901]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funding of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Funding for Colleges and Universities in Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 30900437 and 81171056, Natural Science Funding of Jiangsu Province Grants BK2009118 and BK2011440, Natural Science Funding for Colleges and Universities in Jiangsu Province Grant 09KJB180008, a grant from the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to J. T.), Start-up Funding of Soochow University Grant Q4134901, and Dong-Wu Scholar Funding of Soochow University (to J. T.), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P630, DOI 10.1152/jn.2001.85.2.630; AKINS PT, 1993, NEUROSCIENCE, V56, P759, DOI 10.1016/0306-4522(93)90372-M; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bailey TW, 2002, J NEUROSCI, V22, P8230; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Budhiraja S, 2009, FUND CLIN PHARMACOL, V23, P149, DOI 10.1111/j.1472-8206.2009.00667.x; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Choi S, 2006, ARCH PHARM RES, V29, P998, DOI 10.1007/BF02969284; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Dong Y, 2003, J NEUROSCI, V23, P2686; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gold MS, 1996, NEUROSCIENCE, V71, P265, DOI 10.1016/0306-4522(95)00433-5; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Moriyama M, 2004, J PHYSIOL-LONDON, V559, P707, DOI 10.1113/jphysiol.2004.070110; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; Ocana M, 2004, EUR J PHARMACOL, V500, P203, DOI 10.1016/j.ejphar.2004.07.026; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; PETERSEN M, 1991, BRAIN RES, V561, P20, DOI 10.1016/0006-8993(91)90744-G; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Raddatz R, 2000, J BIOL CHEM, V275, P32452, DOI 10.1074/jbc.M004613200; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tao J, 2009, CELL SIGNAL, V21, P1436, DOI 10.1016/j.cellsig.2009.05.002; Tao J, 2009, CELL CALCIUM, V45, P133, DOI 10.1016/j.ceca.2008.07.004; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; Van Hoorick D, 2003, MOL CELL NEUROSCI, V24, P357, DOI 10.1016/S1044-7431(03)00174-X; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang F, 2011, CELL CALCIUM, V49, P12, DOI 10.1016/j.ceca.2010.11.002; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waxman SG, 1999, PAIN, pS133, DOI 10.1016/S0304-3959(99)00147-5; Westfall TD, 2002, J PHARMACOL EXP THER, V301, P987, DOI 10.1124/jpet.301.3.987; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Won JH, 2008, CELL SIGNAL, V20, P884, DOI 10.1016/j.cellsig.2007.12.022; Xu GY, 2006, AM J PHYSIOL-GASTR L, V291, pG424, DOI 10.1152/ajpgi.00560.2005; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Yoshimura N, 1996, J PHYSIOL-LONDON, V494, P1; Yu XH, 2003, NEUROSCIENCE, V120, P467, DOI 10.1016/S0306-4522(03)00300-2; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359; Zhang YM, 2011, CELL SIGNAL, V23, P1057, DOI 10.1016/j.cellsig.2011.02.001; Zhang YA, 2010, CELL SIGNAL, V22, P1660, DOI 10.1016/j.cellsig.2010.06.006	56	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18562	18572		10.1074/jbc.M111.322271	http://dx.doi.org/10.1074/jbc.M111.322271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493291	Green Published, hybrid			2022-12-28	WOS:000306411600062
J	Ehlen, A; Rossello, CA; von Stedingk, K; Hoog, G; Nilsson, E; Pettersson, HM; Jirstrom, K; Alvarado-Kristensson, M				Ehlen, Asa; Rossello, Catalina A.; von Stedingk, Kristoffer; Hoog, Greta; Nilsson, Elise; Pettersson, Helen M.; Jirstrom, Karin; Alvarado-Kristensson, Maria			Tumors with Nonfunctional Retinoblastoma Protein Are Killed by Reduced gamma-Tubulin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-LINES; COPY NUMBER; EXPRESSION; TRANSCRIPTION; E2F; PHOSPHORYLATION; NEUROBLASTOMA; PROGNOSIS; BINDING; ROLES	In various tumors inactivation of growth control is achieved by interfering with the RB1 signaling pathway. Here, we describe that RB1 and gamma-tubulin proteins moderate each other's expression by binding to their respective gene promoters. Simultaneous reduction of RB1 and gamma-tubulin protein levels results in an E2F1-dependent up-regulation of apoptotic genes such as caspase 3. We report that in various tumors types, there is an inverse correlation between the expression levels of gamma-tubulin and RB1 and that in tumor cell lines with a nonfunctioning RB1, reduction of gamma-tubulin protein levels leads to induction of apoptosis. Thus, the RB1/gamma- tubulin signal network can be considered as a new target for cancer treatment.	[Ehlen, Asa; Rossello, Catalina A.; von Stedingk, Kristoffer; Hoog, Greta; Nilsson, Elise; Pettersson, Helen M.; Alvarado-Kristensson, Maria] Lund Univ, Skane Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci, SE-22185 Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Alvarado-Kristensson, M (corresponding author), Lund Univ, SUS, Ctr Mol Pathol, Entrance 78,Floor 2, SE-20502 Malmo, Sweden.	maria.alvarado-kristensson@med.lu.se	Castillo, Catalina Ana Rosselló/L-6477-2014; Castillo, Catalina Ana Rosselló/R-9426-2019; Alvarado-Kristensson, Maria T./C-4543-2014	Castillo, Catalina Ana Rosselló/0000-0002-8977-607X; Castillo, Catalina Ana Rosselló/0000-0002-8977-607X; Eklund, Greta/0000-0002-2498-7765; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986	Swedish Research Council; Swedish Cancer Society; Royal Physiographic Society in Lund; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund; Per-Eric and Ulla Schyberg Foundation; Cradfoord Foundation; Gunnar Nilsson, H. Foundation; G. Jeanssons Foundation; O. and E. Ericsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Royal Physiographic Society in Lund; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund; Per-Eric and Ulla Schyberg Foundation; Cradfoord Foundation; Gunnar Nilsson, H. Foundation; G. Jeanssons Foundation; O. and E. Ericsson Foundation	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Royal Physiographic Society in Lund, Per-Eric and Ulla Schyberg, Cradfoord, Gunnar Nilsson, H. and G. Jeanssons and O. and E. Ericsson Foundations; Gyllenstiernska Krapperupsstiftelsen; and the Skane University Hospital in Malmo Cancer Research Fund.	Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; De Preter K, 2002, MODERN PATHOL, V15, P159, DOI 10.1038/modpathol.3880508; Ehlen A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-78; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Gaber A, 2009, BRIT J CANCER, V100, P1540, DOI 10.1038/sj.bjc.6605047; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hoog G, 2011, FASEB J, V25, P3815, DOI 10.1096/fj.11-187484; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; Mizuarai S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-31; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NYGREN P, 1991, BRIT J CANCER, V64, P1011, DOI 10.1038/bjc.1991.456; Persson MM, 2012, AM J PATHOL, V180, P494, DOI 10.1016/j.ajpath.2011.10.014; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Svensson KJ, 2011, INT J ONCOL, V39, P1421, DOI 10.3892/ijo.2011.1164; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	24	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17241	17247		10.1074/jbc.M112.357038	http://dx.doi.org/10.1074/jbc.M112.357038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493456	hybrid, Green Published			2022-12-28	WOS:000306373000024
J	Fonseca, BD; Diering, GH; Bidinosti, MA; Dalal, K; Alain, T; Balgi, AD; Forestieri, R; Nodwell, M; Rajadurai, CV; Gunaratnam, C; Tee, AR; Duong, F; Andersen, RJ; Orlowski, J; Numata, M; Sonenberg, N; Roberge, M				Fonseca, Bruno D.; Diering, Graham H.; Bidinosti, Michael A.; Dalal, Kush; Alain, Tommy; Balgi, Aruna D.; Forestieri, Roberto; Nodwell, Matt; Rajadurai, Charles V.; Gunaratnam, Cynthia; Tee, Andrew R.; Duong, Franck; Andersen, Raymond J.; Orlowski, John; Numata, Masayuki; Sonenberg, Nahum; Roberge, Michel			Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUBEROUS SCLEROSIS COMPLEX; INITIATION-FACTOR 4E; CAP-BINDING PROTEIN; CELL-GROWTH; MOTIF PHOSPHORYLATION; INHIBITOR; PATHWAY; RAPTOR; MNK1	Mammalian target of rapamycin complex 1 (mTORC1) signaling is frequently dysregulated in cancer. Inhibition of mTORC1 is thus regarded as a promising strategy in the treatment of tumors with elevated mTORC1 activity. We have recently identified niclosamide (a Food and Drug Administration-approved antihelminthic drug) as an inhibitor of mTORC1 signaling. In the present study, we explored possible mechanisms by which niclosamide may inhibit mTORC1 signaling. We tested whether niclosamide interferes with signaling cascades upstream of mTORC1, the catalytic activity of mTOR, or mTORC1 assembly. We found that niclosamide does not impair PI3K/Akt signaling, nor does it inhibit mTORC1 kinase activity. We also found that niclosamide does not interfere with mTORC1 assembly. Previous studies in helminths suggest that niclosamide disrupts pH homeostasis of the parasite. This prompted us to investigate whether niclosamide affects the pH balance of cancer cells. Experiments in both breast cancer cells and cell-free systems demonstrated that niclosamide possesses protonophoric activity in cells and in vitro. In cells, niclosamide dissipated protons (down their concentration gradient) from lysosomes to the cytosol, effectively lowering cytoplasmic pH. Notably, analysis of five niclosamide analogs revealed that the structural features of niclosamide required for protonophoric activity are also essential for mTORC1 inhibition. Furthermore, lowering cytoplasmic pH by means other than niclosamide treatment (e.g. incubation with propionic acid or bicarbonate withdrawal) recapitulated the inhibitory effects of niclosamide on mTORC1 signaling, lending support to a possible role for cytoplasmic pH in the control of mTORC1. Our data illustrate a potential mechanism for chemical inhibition of mTORC1 signaling involving modulation of cytoplasmic pH.	[Fonseca, Bruno D.; Bidinosti, Michael A.; Alain, Tommy; Rajadurai, Charles V.; Sonenberg, Nahum] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Forestieri, Roberto; Nodwell, Matt; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Forestieri, Roberto; Nodwell, Matt; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada; [Tee, Andrew R.] Cardiff Univ, Wales Coll Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Fonseca, Bruno D.; Diering, Graham H.; Dalal, Kush; Balgi, Aruna D.; Gunaratnam, Cynthia; Duong, Franck; Numata, Masayuki; Roberge, Michel] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	McGill University; University of British Columbia; University of British Columbia; Cardiff University; McGill University; University of British Columbia	Fonseca, BD (corresponding author), McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	bd.fonseca@mcgill.ca; michelr@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Tee, Andrew/0000-0002-5577-4631; Orlowski, John/0000-0001-7371-175X	Canadian Breast Cancer Foundation; Canadian Cancer Society; Canadian Institute of Health Research postdoctoral fellowship; Worldwide Cancer Research [06-0914] Funding Source: researchfish	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institute of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Worldwide Cancer Research	This work was supported in part by grants from the Canadian Breast Cancer Foundation (to M. R.) and from the Canadian Cancer Society (to N. S.).; Supported by a Canadian Institute of Health Research postdoctoral fellowship.	Anand N, 1997, APPROACHES DESIGN SY, P240; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barlund M, 2000, CANCER RES, V60, P5340; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Becker ML, 2004, BIOCONJUGATE CHEM, V15, P699, DOI 10.1021/bc049946e; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chang YW, 2006, J FOOD DRUG ANAL, V14, P329; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Curnock AP, 2001, BIOCHEM PHARMACOL, V61, P227, DOI 10.1016/S0006-2952(00)00552-9; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Drose S, 1997, J EXP BIOL, V200, P1; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Gingras AC, 2001, GENE DEV, V15, P2852; GRINSTEIN S, 1987, J GEN PHYSIOL, V89, P185, DOI 10.1085/jgp.89.2.185; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartford CM, 2007, CLIN PHARMACOL THER, V82, P381, DOI 10.1038/sj.clpt.6100317; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kenerson HL, 2002, CANCER RES, V62, P5645; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825, DOI 10.1152/physrev.1980.60.3.825; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rizzieri DA, 2008, CLIN CANCER RES, V14, P2756, DOI 10.1158/1078-0432.CCR-07-1372; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sandoval A, 2007, VET IMMUNOL IMMUNOP, V115, P286, DOI 10.1016/j.vetimm.2006.11.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shih TM, 1998, METHOD ENZYMOL, V293, P529; Smith MA, 1998, J PHYSIOL-LONDON, V513, P733, DOI 10.1111/j.1469-7793.1998.733ba.x; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Steinberg GR, 2009, APPL PHYSIOL NUTR ME, V34, P315, DOI 10.1139/H09-009; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; WANG GJ, 1995, NEUROSCI LETT, V186, P139, DOI 10.1016/0304-3940(95)11305-G; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wu GJ, 2000, CANCER RES, V60, P5371; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; Yatscoff RW, 1996, TRANSPLANT P, V28, P970; Yea SS, 2011, SCIENCE, V332, P1270, DOI 10.1126/science.1208071; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007; Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	101	110	116	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17530	17545		10.1074/jbc.M112.359638	http://dx.doi.org/10.1074/jbc.M112.359638			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474287	Green Published, hybrid			2022-12-28	WOS:000306373000052
J	Hojo, H; Ohba, S; Yano, F; Saito, T; Ikeda, T; Nakajima, K; Komiyama, Y; Nakagata, N; Suzuki, K; Takato, T; Kawaguchi, H; Chung, U				Hojo, Hironori; Ohba, Shinsuke; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Nakagata, Naomi; Suzuki, Kentaro; Takato, Tsuyoshi; Kawaguchi, Hiroshi; Chung, Ung-il			Gli1 Protein Participates in Hedgehog-mediated Specification of Osteoblast Lineage during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REQUIRES ADDITIONAL EFFECTORS; BONE-FORMATION; DIFFERENTIATION; IHH; EXPRESSION; GROWTH; CANCER; GENES; RUNX2	With regard to Hedgehog signaling in mammalian development, the majority of research has focused on Gli2 and Gli3 rather than Gli1. This is because Gli1(-/-) mice do not show any gross abnormalities in adulthood, and no detailed analyses of fetal Gli1(-/-) mice are available. In this study, we investigated the physiological role of Gli1 in osteogenesis. Histological analyses revealed that bone formation was impaired in Gli1(-/-) fetuses compared with WT fetuses. Gli1(-/-) perichondrial cells expressed neither runt-related transcription factor 2 (Runx2) nor osterix, master regulators of osteogenesis, in contrast to WT cells. In vitro analyses showed that overexpression of Gli1 up-regulated early osteogenesis-related genes in both WT and Runx2(-/-) perichondrial cells, and Gli1 activated transcription of those genes via its association with their 5'-regulatory regions, underlying the function of Gli1 in the perichondrium. Moreover, Gli1(-/-);Gli2(-/-) mice showed more severe phenotypes of impaired bone formation than either Gli1(-/-) or Gli2(-/-) mice, and osteoblast differentiation was impaired in Gli1(-/-);Gli3(-/-) perichondrial cells compared with Gli3(-/-) cells in vitro. These data suggest that Gli1 itself can induce early osteoblast differentiation, at least to some extent, in a Runx2-independent manner. It also plays a redundant role with Gli2 and is involved in the repressor function of Gli3 in osteogenesis. On the basis of these findings, we propose that upon Hedgehog input, Gli1 functions collectively with Gli2 and Gli3 in osteogenesis.	[Hojo, Hironori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hojo, Hironori; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Takato, Tsuyoshi; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Tokyo 1130033, Japan; [Nakagata, Naomi; Suzuki, Kentaro] Kumamoto Univ, CARD, Kumamoto 8600811, Japan	University of Tokyo; University of Tokyo; Kumamoto University	Hojo, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hojo@bmw.t.u-tokyo.ac.jp; soba@bmw.t.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022	Ohba, Shinsuke/0000-0002-6874-8539; Hojo, Hironori/0000-0003-2245-6853; Nakagata, Naomi/0000-0002-5737-9993	Japan Society for the Promotion of Science (JSPS); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) and by the Center for NanoBio Integration, the Center for Medical System Innovation, and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program).	Arai F, 2002, J EXP MED, V195, P1549, DOI 10.1084/jem.20011700; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drakopoulou E, 2010, CELL CYCLE, V9, P4144, DOI 10.4161/cc.9.20.13453; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2010, J BONE MINER METAB, V28, P627, DOI 10.1007/s00774-010-0179-y; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Mo R, 1997, DEVELOPMENT, V124, P113; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park HL, 2000, DEVELOPMENT, V127, P1593; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tu XL, 2012, DEV BIOL, V362, P76, DOI 10.1016/j.ydbio.2011.11.013; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008	33	64	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17860	17869		10.1074/jbc.M112.347716	http://dx.doi.org/10.1074/jbc.M112.347716			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493482	hybrid, Green Published			2022-12-28	WOS:000306373000083
J	Oh, Y; Chung, KC				Oh, Yohan; Chung, Kwang Chul			Small Ubiquitin-like Modifier (SUMO) Modification of Zinc Finger Protein 131 Potentiates Its Negative Effect on Estrogen Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; CONJUGATING ENZYME; CEREBRAL-ISCHEMIA; POLYCOMB PROTEIN; IN-VITRO; SUMOYLATION; RECEPTOR; PC2; E3	Like ubiquitin, small ubiquitin-like modifier (SUMO) covalently attaches to specific target proteins and modulates their functional properties, including subcellular localization, protein dimerization, DNA binding, and transactivation of transcription factors. Diverse transcriptional co-regulator complexes regulate the ability of estrogen receptors to respond to positive and negative acting hormones. Zinc finger protein 131 (ZNF131) is poorly characterized but may act as a repressor of estrogen receptor alpha (ER alpha)-mediated trans-activation. Here, we identify ZNF131 as a target for SUMO modification and as a substrate for the SUMO E3 ligase human polycomb protein 2 (hPc2). We report that the SUMO-interacting motif 1 (SIM1) and the C-box of hPc2 are critical regions required for ZNF131 SUMOylation and define the ZNF131 SUMOylation site as lysine 567. We further show that SUMO modification potentiates the negative effect of ZNF131 on estrogen signaling and consequently attenuates estrogen-induced cell growth in a breast cancer cell line. Our findings suggest that SUMOylation is a novel regulator of ZNF131 action in estrogen signaling and breast cancer cell proliferation.	[Oh, Yohan; Chung, Kwang Chul] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Ro 50, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; rchnds, rchnds/D-7595-2016	Oh, Yohan/0000-0002-9249-8664; 	Ministry of Education, Science and Technology (MEST), a Republic of Korea; National Research Foundation of Korea (NRF); Korea Healthcare Technology R D Project [A092004, A111653]; Ministry for Health, Welfare & Family Affairs, Republic of Korea; Brain Research Center of the 21st Century Frontier Research Program Technology Grant [2009K-001251]; MEST [2010-0018916]; NRF [2012-0000810]	Ministry of Education, Science and Technology (MEST), a Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Healthcare Technology R D Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program Technology Grant; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF	This work was supported by Brain Research Center of the 21st Century Frontier Research Program Technology Grant 2009K-001251 (to K. C. C.) funded by the Ministry of Education, Science and Technology (MEST), a Republic of Korea, a National Research Foundation of Korea (NRF) grant funded by MEST Grant 2010-0018916 (to K. C. C.), Basic Science Research Program through NRF Grant 2012-0000810 (to K. C. C.), Korea Healthcare Technology R&D Project Grants A092004 and A111653 (to K. C. C.), and the Ministry for Health, Welfare & Family Affairs, Republic of Korea.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Alkema MJ, 1997, J MOL BIOL, V273, P993, DOI 10.1006/jmbi.1997.1372; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Donaldson NS, 2007, BBA-MOL CELL RES, V1773, P546, DOI 10.1016/j.bbamcr.2006.12.005; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Germain D., 2011, ENDOCRIN METAB CLIN, V40, pvii; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Han X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-476; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oh Y, 2011, BRAIN RES, V1381, P78, DOI 10.1016/j.brainres.2011.01.039; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523	53	17	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17517	17529		10.1074/jbc.M111.336354	http://dx.doi.org/10.1074/jbc.M111.336354			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467880	Green Published, hybrid			2022-12-28	WOS:000306373000051
J	Sinha, PK; Nakamaru-Ogiso, E; Torres-Bacete, J; Sato, M; Castro-Guerrero, N; Ohnishi, T; Matsuno-Yagi, A; Yagi, T				Sinha, Prem Kumar; Nakamaru-Ogiso, Eiko; Torres-Bacete, Jesus; Sato, Motoaki; Castro-Guerrero, Norma; Ohnishi, Tomoko; Matsuno-Yagi, Akemi; Yagi, Takao			Electron Transfer in Subunit NuoI (TYKY) of Escherichia coli NADH:Quinone Oxidoreductase (NDH-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; IRON-SULFUR CLUSTERS; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; PARACOCCUS-DENITRIFICANS; MEMBRANE DOMAIN; THERMUS-THERMOPHILUS; OXIDATION-REDUCTION; NQO3 SUBUNIT	Bacterial proton-translocating NADH:quinone oxidoreductase (NDH-1) consists of a peripheral and a membrane domain. The peripheral domain catalyzes the electron transfer from NADH to quinone through a chain of seven iron-sulfur (Fe/S) clusters. Subunit NuoI in the peripheral domain contains two [4Fe-4S] clusters (N6a and N6b) and plays a role in bridging the electron transfer from cluster N5 to the terminal cluster N2. We constructed mutants for eight individual Cys-coordinating Fe/S clusters. With the exception of C63S, all mutants had damaged architecture of NDH-1, suggesting that Cys-coordinating Fe/S clusters help maintain the NDH-1 structure. Studies of three mutants (C63S-coordinating N6a, P110A located near N6a, and P71A in the vicinity of N6b) were carried out using EPR measurement. These three mutations did not affect the EPR signals from [2Fe-2S] clusters and retained electron transfer activities. Signals at g(z) = 2.09 disappeared in C63S and P110A but not in P71A. Considering our data together with the available information, g(z,x) = 2.09, 1.88 signals are assigned to cluster N6a. It is of interest that, in terms of g(z,x) values, cluster N6a is similar to cluster N4. In addition, we investigated the residues (Ile-94 and Ile-100) that are predicted to serve as electron wires between N6a and N6b and between N6b and N2, respectively. Replacement of Ile-100 and Ile-94 with Ala/Gly did not affect the electron transfer activity significantly. It is concluded that conserved Ile-100 and Ile-94 are not essential for the electron transfer.	[Sinha, Prem Kumar; Torres-Bacete, Jesus; Sato, Motoaki; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Nakamaru-Ogiso, Eiko; Ohnishi, Tomoko] Univ Penn, Sch Med, Johnson Res Fdn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Scripps Research Institute; University of Pennsylvania	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Castro Guerrero, Norma/0000-0002-8645-2694; Torres, Jesus/0000-0003-3410-6930	National Institutes of Health [R01GM033712, 3R01GM030736-25S1]; American Heart Association [IISDG5560001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM033712 (to T. Y. and A. M,-Y.) and 3R01GM030736-25S1 (to T. O.). This work was also supported by American Heart Association Grant IISDG5560001 (to E. N-O.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; Dupuis A, 1998, BBA-BIOENERGETICS, V1364, P147, DOI 10.1016/S0005-2728(98)00025-5; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Forzi L, 2005, FEBS J, V272, P4741, DOI 10.1111/j.1742-4658.2005.04889.x; Ghelli A, 1997, J BIOCHEM, V121, P746; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hayashi T, 2011, J PHYS CHEM B, V115, P5354, DOI 10.1021/jp109410j; Hayashi T, 2010, P NATL ACAD SCI USA, V107, P19157, DOI 10.1073/pnas.1009181107; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Nakamaru-Ogiso E, 2008, J BIOL CHEM, V283, P25979, DOI 10.1074/jbc.M804015200; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Rasmussen T, 2001, BIOCHEMISTRY-US, V40, P6124, DOI 10.1021/bi0026977; Roessler MM, 2010, P NATL ACAD SCI USA, V107, P1930, DOI 10.1073/pnas.0908050107; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Sinha P.K, 2009, CURR TOP BIOCH RES, V11, P79; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Wittekindt C, 2009, J AM CHEM SOC, V131, P8134, DOI 10.1021/ja900352t; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; YANO T, 1995, J BIOL CHEM, V270, P18264, DOI 10.1074/jbc.270.31.18264; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; YANO T, 1994, BIOCHEMISTRY-US, V33, P494, DOI 10.1021/bi00168a014	61	13	13	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17363	17373		10.1074/jbc.M111.329649	http://dx.doi.org/10.1074/jbc.M111.329649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474289	Green Published, hybrid			2022-12-28	WOS:000306373000036
J	Ye, ZY; Li, L; Li, DP; Pan, HL				Ye, Zeng-You; Li, Li; Li, De-Pei; Pan, Hui-Lin			Casein Kinase 2-mediated Synaptic GluN2A Up-regulation Increases N-Methyl-D-aspartate Receptor Activity and Excitability of Hypothalamic Neurons in Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC VASOMOTOR TONE; NMDA RECEPTORS; PARAVENTRICULAR NUCLEUS; GLUTAMATERGIC INPUTS; SUBUNIT COMPOSITION; ZINC INHIBITION; NERVE ACTIVITY; VISUAL-CORTEX; NR2B SUBUNIT; IN-VITRO	Increased glutamatergic input, particularly N-methyl-D-aspartate receptor (NMDAR) activity, in the paraventricular nucleus (PVN) of the hypothalamus is closely associated with high sympathetic outflow in essential hypertension. The molecular mechanisms underlying augmented NMDAR activity in hypertension are unclear. GluN2 subunit composition at the synaptic site critically determines NMDAR functional properties. Here, we found that evoked NMDAR-excitatory postsynaptic currents (EPSCs) of retrogradely labeled spinally projecting PVN neurons displayed a larger amplitude and shorter decay time in spontaneously hypertensive rats (SHRs) than in Wistar-Kyoto (WKY) rats. Blocking GluN2B caused a smaller decrease in NMDAR-EPSCs of PVN neurons in SHRs than in WKY rats. In contrast, GluN2A blockade resulted in a larger reduction in evoked NMDAR-EPSCs and puff NMDA-elicited currents of PVN neurons in SHRs than in WKY rats. Blocking presynaptic GluN2A, but not GluN2B, significantly reduced the frequency of miniature EPSCs and the firing activity of PVN neurons in SHRs. The mRNA and total protein levels of GluN2A and GluN2B in the PVN were greater in SHRs than in WKY rats. Furthermore, the GluN2B Ser(1480) phosphorylation level and the synaptosomal GluN2A protein level in the PVN were significantly higher in SHRs than in WKY rats. Inhibition of protein kinase CK2 normalized the GluN2B Ser(1480) phosphorylation level and the contribution of GluN2A to NMDAR-EPSCs and miniature EPSCs of PVN neurons in SHRs. Collectively, our findings suggest that CK2-mediated GluN2B phosphorylation contributes to increased synaptic GluN2A, which potentiates pre- and post-synaptic NMDAR activity and the excitability of PVN presympathetic neurons in hypertension.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Unit 110, Houston, TX 77030 USA; [Li, De-Pei] Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Grad Programs Neurosci & Expt Therapeut, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Ye, Zengyou/B-7245-2013; Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770; Ye, Zengyou/0000-0003-1106-5371	National Institutes of Health [R01 HL077400]; American Heart Association South Central Affiliate; N. G. and Helen T. Hawkins Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association South Central Affiliate(American Heart Association); N. G. and Helen T. Hawkins Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part by National Institutes of Health Grant R01 HL077400. This work was also supported by a postdoctoral fellowship from the American Heart Association South Central Affiliate (to Z.- Y. Y.) and the N. G. and Helen T. Hawkins Endowment (to H.- L. P.).	Allen AM, 2002, HYPERTENSION, V39, P275, DOI 10.1161/hy0202.104272; ANDERSON EA, 1989, HYPERTENSION, V14, P177, DOI 10.1161/01.HYP.14.2.177; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chamberlain Sophie E. L., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/872456; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; CIRIELLO J, 1984, BRAIN RES, V310, P355, DOI 10.1016/0006-8993(84)90159-8; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; EILAM R, 1991, J NEUROSCI, V11, P401; EILAM R, 1994, J NEUROSCI, V14, P4891; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Herman JP, 2000, J COMP NEUROL, V422, P352; JUDY WV, 1976, CIRC RES, V38, P21, DOI 10.1161/01.RES.38.6.21; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li DP, 2008, J PHYSIOL-LONDON, V586, P1637, DOI 10.1113/jphysiol.2007.149732; Li DP, 2007, HYPERTENSION, V49, P916, DOI 10.1161/01.HYP.0000259666.99449.74; Li DP, 2003, J NEUROSCI, V23, P5041; Li R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-55; Lieberman DN, 1999, NAT NEUROSCI, V2, P125, DOI 10.1038/5680; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Paoletti P, 1997, J NEUROSCI, V17, P5711; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Soto D, 2004, BIOCHEM BIOPH RES CO, V322, P542, DOI 10.1016/j.bbrc.2004.07.158; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Ye ZY, 2011, J NEUROSCI, V31, P8271, DOI 10.1523/JNEUROSCI.1147-11.2011; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	42	30	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17438	17446		10.1074/jbc.M111.331165	http://dx.doi.org/10.1074/jbc.M111.331165			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474321	Green Published, hybrid			2022-12-28	WOS:000306373000044
J	Sampels, V; Hartmann, A; Dietrich, I; Coppens, I; Sheiner, L; Striepen, B; Herrmann, A; Lucius, R; Gupta, N				Sampels, Vera; Hartmann, Anne; Dietrich, Isabelle; Coppens, Isabelle; Sheiner, Lilach; Striepen, Boris; Herrmann, Andreas; Lucius, Richard; Gupta, Nishith			Conditional Mutagenesis of a Novel Choline Kinase Demonstrates Plasticity of Phosphatidylcholine Biogenesis and Gene Expression in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS; PATHWAY; CELLS; TRANSFORMATION; PURIFICATION; ETHANOLAMINE; DISRUPTION; METABOLISM; MARKER	The obligate intracellular and promiscuous protozoan parasite Toxoplasma gondii needs an extensive membrane biogenesis that must be satisfied irrespective of its host-cell milieu. We show that the synthesis of the major lipid in T. gondii, phosphatidylcholine (PtdCho), is initiated by a novel choline kinase (TgCK). Full-length (similar to 70-kDa) TgCK displayed a low affinity for choline (K-m similar to 0.77 mM) and harbors a unique N-terminal hydrophobic peptide that is required for the formation of enzyme oligomers in the parasite cytosol but not for activity. Conditional mutagenesis of the TgCK gene in T. gondii attenuated the protein level by similar to 60%, which was abolished in the off state of the mutant (Delta tgck(i)). Unexpectedly, the mutant was not impaired in its growth and exhibited a normal PtdCho biogenesis. The parasite compensated for the loss of full-length TgCK by two potential 53- and 44-kDa isoforms expressed through a cryptic promoter identified within exon 1. TgCK-Exon1 alone was sufficient in driving the expression of GFP in E. coli. The presence of a cryptic promoter correlated with the persistent enzyme activity, PtdCho synthesis, and susceptibility of T. gondii to a choline analog, dimethylethanolamine. Quite notably, the mutant displayed a regular growth in the off state despite a 35% decline in PtdCho content and lipid synthesis, suggesting a compositional flexibility in the membranes of the parasite. The observed plasticity of gene expression and membrane biogenesis can ensure a faithful replication and adaptation of T. gondii in disparate host or nutrient environments.	[Sampels, Vera; Hartmann, Anne; Dietrich, Isabelle; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Inst Biol, D-10115 Berlin, Germany; [Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Sheiner, Lilach; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Herrmann, Andreas] Humboldt Univ, Dept Biophys, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Georgia; University of Georgia; Humboldt University of Berlin	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Inst Biol, Philippstr 13,House 14, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126; Striepen, Boris/0000-0002-7426-432X; Dietrich, Isabelle/0000-0002-6300-109X	German Research Foundation [GRK1121, SFB618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084415] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by German Research Foundation Grants GRK1121 (to N. G. and A. H.) and SFB618 (to N. G. and R. L.).	Alberge B, 2010, BIOCHEM J, V425, P149, DOI 10.1042/BJ20091119; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Charron AJ, 2002, J CELL SCI, V115, P3049; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gibellini F, 2008, BIOCHEM J, V415, P135, DOI 10.1042/BJ20080435; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Sinai AP, 1997, J CELL SCI, V110, P2117; UCHIDA T, 1992, METHOD ENZYMOL, V209, P147; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200	31	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16289	16299		10.1074/jbc.M112.347138	http://dx.doi.org/10.1074/jbc.M112.347138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451671	Green Published, hybrid			2022-12-28	WOS:000304030900021
J	Ma, SS; Liu, SJ; Huang, QY; Xie, B; Lai, BQ; Wang, C; Song, B; Li, MT				Ma, Shanshan; Liu, Shaojun; Huang, Qiaoying; Xie, Bo; Lai, Bingquan; Wang, Chong; Song, Bin; Li, Mingtao			Site-specific Phosphorylation Protects Glycogen Synthase Kinase-3 beta from Calpain-mediated Truncation of Its N and C Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; POTASSIUM DEPRIVATION; KINASE 3-BETA; APOPTOSIS; INHIBITION; CLEAVAGE; SURVIVAL; GSK-3; EXPRESSION; GSK3-BETA	Glycogen synthase kinase-3 beta (GSK-3 beta), a key regulator of neuronal apoptosis, is inhibited by the phosphorylation of Ser-9/Ser-389 and was recently shown to be cleaved by calpain at the N terminus, leading to its subsequent activation. In this study calpain was found to cleave GSK-3 beta not only at the N terminus but also at the C terminus, and cleavage sites were identified at residues Thr-38-Thr-39 and Ile-384-Gln-385. Furthermore, the cleavage of GSK-3 beta occurred in tandem with Ser-9 dephosphorylation during cerebellar granule neuron apoptosis. Increasing Ser-9 phosphorylation of GSK-3 beta by inhibiting phosphatase 1/2A or pretreating with purified active Akt inhibited calpain-mediated cleavage of GSK-3 beta at both N and C termini, whereas non-phosphorylatable mutant GSK-3 beta S9A facilitated its cleavage. In contrast, Ser-389 phosphorylation selectively inhibited the cleavage of GSK-3 beta at the C terminus but not the N terminus. Calpain-mediated cleavage resulted in three truncated products, all of which contained an intact kinase domain: Delta N-GSK-3 beta (amino acids 39-420), Delta C-GSK-3 beta (amino acids 1-384), and Delta N/Delta C-GSK-3 beta (amino acids 39-384). All three truncated products showed increased kinase and pro-apoptotic activity, with Delta N/Delta C-GSK-3 beta being the most active form. This observation suggests that the GSK-3 beta C terminus acts as an autoinhibitory domain similar to the N terminus. Taken together, these findings demonstrate that calpain-mediated cleavage activates GSK-3 beta by removing its N- and C-terminal autoinhibitory domains and that Ser-9 phosphorylation inhibits the cleavage of GSK-3 beta at both termini. In contrast, Ser-389 phosphorylation inhibits only C-terminal cleavage but not N-terminal cleavage. These findings also identify a mechanism by which site-specific phosphorylation and calpain-mediated cleavage operate in concert to regulate GSK-3 beta activity.	[Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, MT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	limt@mail.sysu.edu.cn		Liu, Shaojun/0000-0001-7895-5577; Ma, Shanshan/0000-0002-3004-9468; Huang, Qiaoying/0000-0001-6643-2509	National Basic Research Program of China 973 Program [2011CB504105]; National Natural Science Foundation of China [81030024]; Natural Science Foundation of Guangdong Province China [9351008901000003]; Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China [cxzd1002]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province China(National Natural Science Foundation of Guangdong Province); Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China	This work was supported by National Basic Research Program of China 973 Program Grant 2011CB504105, National Natural Science Foundation of China Grant 81030024, Natural Science Foundation of Guangdong Province China Grant 9351008901000003, and Key Program for Scientific and Technological Innovations of Higher Education Institutes in Guangdong Province China Grant cxzd1002.	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Crespo-Biel N, 2010, HIPPOCAMPUS, V20, P962, DOI 10.1002/hipo.20691; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dunker A K, 1998, Pac Symp Biocomput, P473; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Goni-Oliver P, 2011, NEUROCHEM INT, V59, P97, DOI 10.1016/j.neuint.2011.03.021; Goni-Oliver P, 2009, J ALZHEIMERS DIS, V18, P843, DOI 10.3233/JAD-2009-1190; Goni-Oliver P, 2009, J NEUROSCI RES, V87, P1156, DOI 10.1002/jnr.21932; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hetman M, 2000, J NEUROSCI, V20, P2567; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Miller TM, 1996, J NEUROSCI, V16, P7487; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; SAKAI K, 1987, J BIOCHEM-TOKYO, V101, P911, DOI 10.1093/oxfordjournals.jbchem.a121959; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200	42	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22521	22532		10.1074/jbc.M111.321349	http://dx.doi.org/10.1074/jbc.M111.321349			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22496446	hybrid, Green Published			2022-12-28	WOS:000306495000010
J	Bruder, J; Siewert, K; Obermeier, B; Malotka, J; Scheinert, P; Kellermann, J; Ueda, T; Hohlfeld, R; Dornmair, K				Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Malotka, Joachim; Scheinert, Peter; Kellermann, Josef; Ueda, Takuya; Hohlfeld, Reinhard; Dornmair, Klaus			Target Specificity of an Autoreactive Pathogenic Human gamma delta-T Cell Receptor in Myositis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; ANTIGEN RECOGNITION; POLYMYOSITIS; MHC; MUSCLE; LYMPHOCYTES; REPERTOIRE; BINDING; DERMATOMYOSITIS; AUTOANTIGENS	In polymyositis and inclusion body myositis, muscle fibers are surrounded and invaded by CD8-positive cytotoxic T cells expressing the alpha beta-T cell receptor (alpha beta-TCR) for antigen. In a rare variant of myositis, muscle fibers are similarly attacked by CD8-negative T cells expressing the gamma delta-TCR (gamma delta-T cell-mediated myositis). We investigated the antigen specificity of a human gamma delta-TCR previously identified in an autoimmune tissue lesion of gamma delta-T cell-mediated myositis. We show that this V gamma 1.3V delta 2-TCR, termed M88, recognizes various proteins from different species. Several of these proteins belong to the translational apparatus, including some bacterial and human aminoacyl-tRNA synthetases (AA-RS). Specifically, M88 recognizes histidyl-tRNA synthetase, an antigen known to be also targeted by autoantibodies called anti-Jo-1. The M88 target epitope is strictly conformational, independent of post-translational modification, and exposed on the surface of the respective antigenic protein. Extensive mutagenesis of the translation initiation factor-1 from Escherichia coli (EcIF1), which served as a paradigm antigen with known structure, showed that a short alpha-helical loop around amino acids 39 to 42 of EcIF1 is a major part of the M88 epitope. Mutagenesis of M88 showed that the complementarity determining regions 3 of both gamma delta-TCR chains contribute to antigen recognition. M88 is the only known example of a molecularly characterized gamma delta-TCR expressed by autoaggressive T cells in tissue. The observation that AA-RS are targeted by a gamma delta-T cell and by autoantibodies reveals an unexpected link between T cell and antibody responses in autoimmune myositis.	[Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Hohlfeld, Reinhard; Dornmair, Klaus] Univ Munich, Inst Clin Neuroimmunol, D-81377 Munich, Germany; [Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Malotka, Joachim; Hohlfeld, Reinhard; Dornmair, Klaus] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Scheinert, Peter] AmpTec GmbH, D-22767 Hamburg, Germany; [Kellermann, Josef] Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany; [Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	University of Munich; Max Planck Society; Max Planck Society; University of Tokyo	Dornmair, K (corresponding author), Univ Munich, Inst Clin Neuroimmunol, D-81377 Munich, Germany.	klaus.dornmair@med.uni-muenchen.de	; Ueda, Takuya/K-5217-2014	Siewert, Katherina/0000-0003-0380-1594; Ueda, Takuya/0000-0002-7760-8271	Deutsche Forschungsgemeinschaft [SFB 571-A1]; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hermann and Lilly Schilling Foundation	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 571-A1 and the Hermann and Lilly Schilling Foundation.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; AMOR S, 1994, J IMMUNOL, V153, P4349; ARAHATA K, 1988, ANN NEUROL, V23, P168, DOI 10.1002/ana.410230210; Arden Bernhard, 1995, Immunogenetics, V42, P455; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; BENDER A, 1995, J EXP MED, V181, P1863, DOI 10.1084/jem.181.5.1863; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2; Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006; Dornmair K, 2004, J NEUROIMMUNOL, V152, P168, DOI 10.1016/j.jneuroim.2004.03.016; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HOHLFELD R, 1991, NEW ENGL J MED, V324, P877, DOI 10.1056/NEJM199103283241303; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; PLUSCHKE G, 1992, J EXP MED, V176, P1785, DOI 10.1084/jem.176.6.1785; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wiendl H, 2002, J IMMUNOL, V169, P515, DOI 10.4049/jimmunol.169.1.515; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008	50	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20986	20995		10.1074/jbc.M112.356709	http://dx.doi.org/10.1074/jbc.M112.356709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549773	Green Published, hybrid			2022-12-28	WOS:000306416800020
J	Fieldhouse, RJ; Jorgensen, R; Lugo, MR; Merrill, AR				Fieldhouse, Robert J.; Jorgensen, Rene; Lugo, Miguel R.; Merrill, A. Rod			The 1.8 angstrom Cholix Toxin Crystal Structure in Complex with NAD(+) and Evidence for a New Kinetic Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; NICOTINAMIDE ADENINE-DINUCLEOTIDE; ADP-RIBOSYLATING FACTOR; CATALYTIC MECHANISM; VIBRIO-CHOLERAE; ACTIVE-SITE; DOMAIN-III; INHIBITORS; GENERATION; DISCOVERY	Certain Vibrio cholerae strains produce cholix, a potent protein toxin that has diphthamide-specific ADP-ribosyltransferase activity against eukaryotic elongation factor 2. Here we present a 1.8 angstrom crystal structure of cholix in complex with its natural substrate, nicotinamide adenine dinucleotide (NAD(+)). We also substituted hallmark catalytic residues by site-directed mutagenesis and analyzed both NAD(+) binding and ADP-ribosyltransferase activity using a fluorescence-based assay. These data are the basis for a new kinetic model of cholix toxin activity. Further, the new structural data serve as a reference for continuing inhibitor development for this toxin class.	[Fieldhouse, Robert J.; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jorgensen, Rene] Statens Serum Inst, Dept Microbiol Diagnost, DK-2300 Copenhagen S, Denmark	University of Guelph; Statens Serum Institut	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,488 Gordon St, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014; Jørgensen, René/P-5619-2014	Jørgensen, René/0000-0003-0672-466X	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Cystic Fibrosis Canada; Canadian Institutes of Health Research, Cystic Fibrosis Canada; Human Frontier Science Program; Carlsberg-fondet	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Canadian Institutes of Health Research, Cystic Fibrosis Canada(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Carlsberg-fondet(Carlsberg Foundation)	Supported by the Natural Sciences and Engineering Research Council.; Supported by the Canadian Institutes of Health Research and Carlsberg-fondet.; Supported by Cystic Fibrosis Canada.; Supported by the Canadian Institutes of Health Research, Cystic Fibrosis Canada, and the Human Frontier Science Program. To whom correspondence should be addressed: Dept. of Molecular and Cellular Biology, University of Guelph, Science Complex, 488 Gordon St., Guelph, Ontario N1G 2W1, Canada. Tel.: 519-824-4120 (Ext. 53806); Fax: 519-837-1802; E-mail: rmerrill@uoguelph.ca.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong S, 2004, BIOCHEMISTRY-US, V43, P183, DOI 10.1021/bi034772u; Armstrong S, 2002, J BIOL CHEM, V277, P46669, DOI 10.1074/jbc.M206916200; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beattie BK, 1999, J BIOL CHEM, V274, P15646, DOI 10.1074/jbc.274.22.15646; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Bell CE, 1997, ADV EXP MED BIOL, V419, P35; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Choudhary S, 2011, DRUG DISCOV TODAY, V16, P495, DOI 10.1016/j.drudis.2011.04.003; Costantino G, 2001, J MED CHEM, V44, P3786, DOI 10.1021/jm010116l; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dunn D, 2007, BIOORG MED CHEM LETT, V17, P542, DOI 10.1016/j.bmcl.2006.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Fraser CM, 2005, ANNU REV MED, V56, P459, DOI 10.1146/annurev.med.56.062904.144853; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Hattori K, 2004, J MED CHEM, V47, P4151, DOI 10.1021/jm0499256; Heifets A, 2010, J MOL GRAPH MODEL, V29, P93, DOI 10.1016/j.jmgm.2010.05.005; Ishida J, 2006, BIOORGAN MED CHEM, V14, P1378, DOI 10.1016/j.bmc.2005.09.061; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kinoshita T, 2004, FEBS LETT, V556, P43, DOI [10.1016/S0014-5793(03)01362-0, 10.5940/jcrsj.46.421]; Kirby CA, 2012, ACTA CRYSTALLOGR F, V68, P115, DOI 10.1107/S1744309111051219; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORY S, 1980, INFECT IMMUN, V28, P494; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Maurer B, 2011, MOL BIOSYST, V7, P799, DOI 10.1039/c0mb00151a; Mohammadi F, 2001, BIOCHEMISTRY-US, V40, P10273, DOI 10.1021/bi011035u; Morlon-Guyot J, 2009, INFECT IMMUN, V77, P3090, DOI 10.1128/IAI.01390-08; Novikov FN, 2009, J MOL MODEL, V15, P1337, DOI 10.1007/s00894-009-0497-y; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; OGATA M, 1990, J BIOL CHEM, V265, P20678; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Purdy AE, 2010, ENV MICROBIOL REP, V2, P198, DOI 10.1111/j.1758-2229.2010.00139.x; Ritter H, 2003, BIOCHEMISTRY-US, V42, P10155, DOI 10.1021/bi034625w; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Sarnovsky R, 2010, CANCER IMMUNOL IMMUN, V59, P737, DOI 10.1007/s00262-009-0794-4; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yates SP, 2001, J BIOL CHEM, V276, P35029, DOI 10.1074/jbc.M105002200	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21176	21188		10.1074/jbc.M111.337311	http://dx.doi.org/10.1074/jbc.M111.337311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535961	Green Published, hybrid			2022-12-28	WOS:000306416800038
J	Asuthkar, S; Gondi, CS; Nalla, AK; Velpula, KK; Gorantla, B; Rao, JS				Asuthkar, Swapna; Gondi, Christopher S.; Nalla, Arun Kumar; Velpula, Kiran Kumar; Gorantla, Bharathi; Rao, Jasti S.			Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Regulation of WNT/beta-Catenin Signaling Is Enhanced in Irradiated Medulloblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; CANCER CELLS; TUMOR-GROWTH; STEM-CELLS; GENE-EXPRESSION; ANTISENSE UPAR; INVASION; ANGIOGENESIS; WNT	Urokinase plasminogen activator receptor (uPAR) is known to promote invasion, migration, and metastasis in cancer cells. In this report, we showed that ionizing radiation (IR)-induced uPAR has a role in WNT-beta-catenin signaling and mediates induction of cancer stem cell (CSC)-like properties in medulloblastoma cell lines UW228 and D283. We observed that IR induced the expression of uPAR and CSC markers, such as Musashi-1 and CD44, and activated WNT-7a-beta-catenin signaling molecules. Overexpression of uPAR alone or with IR treatment led to increased WNT-7a-beta-catenin-TCF/LEF-mediated transactivation, thereby promoting cancer stemness. In contrast, treatment with shRNA specific for uPAR (pU) suppressed WNT-7a-beta-catenin-TCF/LEF-mediated transactivation both in vitro and in vivo. Quercetin, a potent WNT/beta-catenin inhibitor, suppressed uPAR and uPAR-mediated WNT/beta-catenin activation, and furthermore, addition of recombinant human WNT-7a protein induced uPAR, indicating the existence of a mutual regulatory relationship between uPAR and WNT/beta-catenin signaling. We showed that uPAR was physically associated with the WNT effector molecule beta-catenin on the membrane, cytoplasm, and nucleus of IR-treated cells and CSC. Most interestingly, we demonstrated for the first time that localization of uPAR in the nucleus was associated with transcription factors (TF) and their specific response elements. We observed from uPAR-ChIP, TF protein, and protein/DNA array analyses that uPAR associates with activating enhancer-binding protein 2 alpha (AP2a) and mediates beta-catenin gene transcription. Moreover, association of uPAR with the beta-catenin-TCF/LEF complex and various other TF involved during embryonic development and cancer indicates that uPAR is a potent activator of stemness, and targeting of uPAR in combination with radiation has significant therapeutic implications.	[Asuthkar, Swapna; Gondi, Christopher S.; Nalla, Arun Kumar; Velpula, Kiran Kumar; Gorantla, Bharathi; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Rao, JS (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	jsrao@uic.edu		Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA138409 (to J.S.R.).	Asuthkar S, 2011, NEURO-ONCOLOGY, V13, P1059, DOI 10.1093/neuonc/nor109; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; D'Alessio S, 2004, INT J CANCER, V110, P125, DOI 10.1002/ijc.20077; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; de Witte JH, 2001, BRIT J CANCER, V85, P85, DOI 10.1054/bjoc.2001.1867; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Del Rosso M, 2011, BLOOD, V117, P3941, DOI 10.1182/blood-2011-02-337733; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Gondi CS, 2003, ONCOGENE, V22, P5967, DOI 10.1038/sj.onc.1206535; Gorantla B, 2011, MOL CANCER RES, V9, P377, DOI 10.1158/1541-7786.MCR-10-0452; Ingraham CA, 2011, J BIOL CHEM, V286, P17649, DOI 10.1074/jbc.M111.229427; JANKUN J, 1993, J CELL BIOCHEM, V53, P135, DOI 10.1002/jcb.240530206; Jo MJ, 2010, CANCER RES, V70, P8948, DOI 10.1158/0008-5472.CAN-10-1936; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Katoh M, 2007, INT J MOL MED, V19, P699; Killeen S, 2008, DRUG NEWS PERSPECT, V21, P107, DOI 10.1358/dnp.2008.21.2.1188197; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; Kurashina R, 2009, CANCER LETT, V284, P62, DOI 10.1016/j.canlet.2009.04.012; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2002, ONCOGENE, V21, P8011, DOI 10.1038/sj.onc.1205894; Lannering B, 2009, ACTA PAEDIATR, V98, P1620, DOI 10.1111/j.1651-2227.2009.01417.x; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mekkawy AH, 2010, BIOCHEM BIOPH RES CO, V399, P738, DOI 10.1016/j.bbrc.2010.08.010; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Saldanha RG, 2008, J PROTEOME RES, V7, P4792, DOI 10.1021/pr800357h; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Thomas S, 2007, CLIN EXP METASTAS, V24, P363, DOI 10.1007/s10585-007-9073-y; Velpula KK, 2011, ONCOTARGET, V2, P1028; Wang Y, 2001, MED RES REV, V21, P146, DOI 10.1002/1098-1128(200103)21:2<146::AID-MED1004>3.0.CO;2-B; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031158	58	44	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20576	20589		10.1074/jbc.M112.348888	http://dx.doi.org/10.1074/jbc.M112.348888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511755	Green Published, hybrid			2022-12-28	WOS:000306414500078
J	Lee, PS; Zhang, HM; Marshall, AG; Yang, XL; Schimmel, P				Lee, Peter S.; Zhang, Hui-Min; Marshall, Alan G.; Yang, Xiang-Lei; Schimmel, Paul			Uncovering of a Short Internal Peptide Activates a tRNA Synthetase Procytokine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; ION-CYCLOTRON RESONANCE; AMIDE HYDROGEN-EXCHANGE; SMALL-ANGLE SCATTERING; MASS-SPECTROMETRY; CYTOKINE ACTIVITIES; CRYSTAL-STRUCTURE; INTERLEUKIN-8; ANGIOGENESIS; RESOLUTION	In higher organisms, aminoacyl-tRNA synthetases developed receptor-mediated ex-translational functions that are activated by various natural mechanisms. Hydrogen-deuterium exchange combined with mass spectrometry and small-angle x-ray scattering showed that activation of the cytokine function of the 528-amino acid human tyrosyl-tRNA synthetase was associated with pinpointed uncovering of a miniature internal ELR tripeptide that triggers receptor signaling. The results reveal the structural simplicity of how the ex-translational function is implemented.	[Lee, Peter S.; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yang, Xiang-Lei] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Zhang, Hui-Min; Marshall, Alan G.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; State University System of Florida; Florida State University	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,BCC379, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 15539, 23562, 088278]; National Institutes of Health through NCI [CA92577]; National Science Foundation [DMR-06-54118]; State of Florida; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539, R01GM088278, R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); State of Florida; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 15539, 23562, and 088278 and National Institutes of Health Grant CA92577 through the NCI). This work was also supported by the National Science Foundation Division of Materials Research through Grant DMR-06-54118, by the State of Florida, and by a fellowship from the National Foundation for Cancer Research.	BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liu JM, 2002, BIOCHEMISTRY-US, V41, P14232, DOI 10.1021/bi0205395; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vo MN, 2011, J BIOL CHEM, V286, P11563, DOI 10.1074/jbc.C110.213876; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yesylevskyy SO, 2011, BIOPHYS CHEM, V154, P90, DOI 10.1016/j.bpc.2011.01.005; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	33	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20504	20508		10.1074/jbc.C112.369439	http://dx.doi.org/10.1074/jbc.C112.369439			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22549774	hybrid, Green Published			2022-12-28	WOS:000306414500071
J	Matte, SL; Laue, TM; Cote, RH				Matte, Suzanne L.; Laue, Thomas M.; Cote, Rick H.			Characterization of Conformational Changes and Protein-Protein Interactions of Rod Photoreceptor Phosphodiesterase (PDE6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY GAMMA-SUBUNIT; CGMP-BINDING-SITES; CYCLIC-GMP PHOSPHODIESTERASE; FLUORESCENCE-DETECTED SEDIMENTATION; OUTER SEGMENTS; GAF DOMAINS; ANALYTICAL ULTRACENTRIFUGATION; NUCLEOTIDE PHOSPHODIESTERASES; RETINAL PHOSPHODIESTERASE; ALLOSTERIC REGULATION	As the central effector of visual transduction, the regulation of photoreceptor phosphodiesterase (PDE6) is controlled by both allosteric mechanisms and extrinsic binding partners. However, the conformational changes and interactions of PDE6 with known interacting proteins are poorly understood. Using a fluorescence detection system for the analytical ultracentrifuge, we examined allosteric changes in PDE6 structure and protein-protein interactions with its inhibitory gamma-subunit, the prenyl-binding protein (PrBP/delta), and activated transducin. In solution, the PDE6 catalytic dimer (P alpha beta) exhibits a more asymmetric shape (axial ratio of 6.6) than reported previously. The inhibitory P gamma subunit behaves as an intrinsically disordered protein in solution but binds with high affinity to the catalytic dimer to reconstitute the holoenzyme without a detectable change in shape. Whereas the closely related PDE5 homodimer undergoes a significant change in its sedimentation properties upon cGMP binding to its regulatory cGMP binding site, no such change was detected upon ligand binding to the PDE6 catalytic dimer. However, when P alpha beta was reconstituted with P gamma truncation mutants lacking the C-terminal inhibitory region, cGMP-dependent allosteric changes were observed. PrBP/delta bound to the PDE6 holoenzyme with high affinity (K-D = 6.2 nM) and induced elongation of the protein complex. Binding of activated transducin to PDE6 holoenzyme resulted in a concentration-dependent increase in the sedimentation coefficient, reflecting a dynamic equilibrium between transducin and PDE6. We conclude that allosteric regulation of PDE6 is more complex than for PDE5 and is dependent on interactions of regions of P gamma with the catalytic dimer.	[Matte, Suzanne L.; Laue, Thomas M.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Laue, Thomas M.] Univ New Hampshire, Ctr Adv Mol Interact Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013; Laue, Tom/AAI-5136-2020	Cote, Rick H/0000-0002-1573-6526; Laue, Tom/0000-0003-3571-9368	National Institutes of Health [EY-05798]; New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2473.	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Berger AL, 1997, J BIOL CHEM, V272, P2714, DOI 10.1074/jbc.272.5.2714; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote R. H., 2008, VISUAL TRANSDUCTION, P141; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Francis SH, 1998, METHODS, V14, P81, DOI 10.1006/meth.1997.0567; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gitschier H. J., 2011, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a001757.01, DOI 10.1038/MP.A001757.01]; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Kingsbury JS, 2011, METHOD ENZYMOL, V492, P283, DOI 10.1016/B978-0-12-381268-1.00021-5; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KOHNKEN RE, 1981, J BIOL CHEM, V256, P2502; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pentia Dana C., 2005, V307, P125; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel Theodore G., 2005, V307, P289; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; Yamazaki A, 2011, FEBS J, V278, P1854, DOI 10.1111/j.1742-4658.2011.08104.x; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	70	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20111	20121		10.1074/jbc.M112.354647	http://dx.doi.org/10.1074/jbc.M112.354647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22514270	Green Published, hybrid			2022-12-28	WOS:000306414500032
J	Nishimori, H; Ehata, S; Suzuki, HI; Katsuno, Y; Miyazono, K				Nishimori, Hikaru; Ehata, Shogo; Suzuki, Hiroshi I.; Katsuno, Yoko; Miyazono, Kohei			Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; INDIAN HEDGEHOG; I RECEPTOR; GROWTH; METASTASIS; EXPRESSION; MODEL; DIFFERENTIATION; INHIBITOR; APOPTOSIS	Functional interactions between cancer cells and the bone microenvironment contribute to the development of bone metastasis. Although the bone metastasis of prostate cancer is characterized by increased ossification, the molecular mechanisms involved in this process are not fully understood. Here, the roles of bone morphogenetic proteins (BMPs) in the interactions between prostate cancer cells and bone stromal cells were investigated. In human prostate cancer LNCaP cells, BMP-4 induced the production of Sonic hedgehog (SHH) through a Smad-dependent pathway. In mouse stromal MC3T3-E1 cells, SHH up-regulated the expression of activin receptor IIB (ActR-IIB) and Smad1, which in turn enhanced BMP-responsive reporter activities in these cells. The combined stimulation with BMP-4 and SHH of MC3T3-E1 cells cooperatively induced the expression of osteoblastic markers, including alkaline phosphatase, bone sialoprotein, collagen type II alpha 1, and osteocalcin. When MC3T3-E1 cells and LNCaP cells were co-cultured, the osteoblastic differentiation of MC3T3-E1 cells, which was induced by BMP-4, was accelerated by SHH from LNCaP cells. Furthermore, LNCaP cells and BMP-4 cooperatively induced the production of growth factors, including fibroblast growth factor (FGF)-2 and epidermal growth factor (EGF) in MC3T3-E1 cells, and these may promote the proliferation of LNCaP cells. Taken together, our findings suggest that BMPs provide favorable circumstances for the survival of prostate cancer cells and the differentiation of bone stromal cells in the bone microenvironment, possibly leading to the osteoblastic metastasis of prostate cancer.	[Nishimori, Hikaru; Ehata, Shogo; Suzuki, Hiroshi I.; Katsuno, Yoko; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ehata, S (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ehata-jun@umin.ac.jp; miyazono@m.u-tokyo.ac.jp		Ehata, Shogo/0000-0002-6740-9391; Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; KAKENHI from the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22112002] Funding Source: KAKEN	KAKENHI from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI (grant-in-aid for scientific research) on Innovative Areas (Integrative Research on Cancer Microenvironment Network) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to K. M.). This work was also supported by a KAKENHI (grant-in-aid for Young Scientists) from the Japan Society for the Promotion of Science (to S. E.).	ACHBAROU A, 1994, CANCER RES, V54, P2372; Andresen C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P148; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Cheng L, 1996, J NATL CANCER I, V88, P607, DOI 10.1093/jnci/88.9.607; Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Hamdy FC, 1997, CANCER RES, V57, P4427; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jung K, 2004, INT J CANCER, V111, P783, DOI 10.1002/ijc.20314; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kwon H, 2010, J TISSUE ENG REGEN M, V4, P590, DOI 10.1002/term.268; LANG SH, 1995, PROSTATE, V27, P287, DOI 10.1002/pros.2990270508; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nemeth JA, 1999, CANCER RES, V59, P1987; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zunich SM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-12	43	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20037	20046		10.1074/jbc.M112.353094	http://dx.doi.org/10.1074/jbc.M112.353094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532569	Green Published, hybrid			2022-12-28	WOS:000306414500025
J	Karimzadeh, F; Primeau, M; Mountassif, D; Rouiller, I; Lamarche-Vane, N				Karimzadeh, Fereshteh; Primeau, Martin; Mountassif, Driss; Rouiller, Isabelle; Lamarche-Vane, Nathalie			A Stretch of Polybasic Residues Mediates Cdc42 GTPase-activating Protein (CdGAP) Binding to Phosphatidylinositol 3,4,5-Trisphosphate and Regulates Its GAP Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RHO-FAMILY GTPASES; PHOSPHORYLATES CDGAP; CELL MOTILITY; RAC; MEMBRANE; DOMAIN; PHOSPHOLIPIDS; LOCALIZATION; TRANSPORT	The Rho family of small GTPases are membrane-associated molecular switches involved in the control of a wide range of cellular activities, including cell migration, adhesion, and proliferation. Cdc42 GTPase-activating protein (CdGAP) is a phosphoprotein showing GAP activity toward Rac1 and Cdc42. CdGAP activity is regulated in an adhesion-dependent manner and more recently, we have identified CdGAP as a novel molecular target in signaling and an essential component in the synergistic interaction between TGF beta and Neu/ErbB-2 signaling pathways in breast cancer cells. In this study, we identified a small polybasic region (PBR) preceding the RhoGAP domain that mediates specific binding to negatively charged phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). In vitro reconstitution of membrane vesicles loaded with prenylated Rac1 demonstrates that the PBR is required for full activation of CdGAP in the presence of PI(3,4,5)P3. In fibroblast cells, the expression of CdGAP protein mutants lacking an intact PBR shows a significant reduced ability of the protein mutants to induce cell rounding or to mediate negative effects on cell spreading. Furthermore, an intact PBR is required for CdGAP to inactivate Rac1 signaling into cells, whereas it is not essential in an in vitro context. Altogether, these studies reveal that specific interaction between negatively charged phospholipid PI(3,4,5)P3 and the stretch of polybasic residues preceding the RhoGAP domain regulates CdGAP activity in vivo and is required for its cellular functions.	[Karimzadeh, Fereshteh; Primeau, Martin; Mountassif, Driss; Rouiller, Isabelle; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University	Lamarche-Vane, N (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St,Rm 1-38, Montreal, PQ H3A 2B2, Canada.	nathalie.lamarche@mcgill.ca	Karimzadeh, Fathallah/ABA-6967-2021; Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	Karimzadeh, Fathallah/0000-0002-7561-5021; rouiller, isabelle/0000-0002-1288-8575	Canadian Institutes for Health Research [MOP-84449]; Canada Foundation for Innovation-Leaders Opportunity Fund	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation-Leaders Opportunity Fund	This work was supported by the Canadian Institutes for Health Research Grant MOP-84449 and the Canada Foundation for Innovation-Leaders Opportunity Fund.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Danek EI, 2007, J BIOL CHEM, V282, P3624, DOI 10.1074/jbc.M610073200; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Naji L, 2011, BIOCHEM BIOPH RES CO, V409, P96, DOI 10.1016/j.bbrc.2011.04.116; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Primeau M, 2011, FEBS LETT, V585, P847, DOI 10.1016/j.febslet.2011.02.022; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zhao CM, 2003, J BIOL CHEM, V278, P34641, DOI 10.1074/jbc.M304594200; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	41	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19610	19621		10.1074/jbc.M112.344606	http://dx.doi.org/10.1074/jbc.M112.344606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518840	Green Published, hybrid			2022-12-28	WOS:000306411900072
J	Liu, XJ; Liu, D; Qian, DM; Dai, J; An, Y; Jiang, SY; Stanley, B; Yang, JM; Wang, B; Liu, XY; Liu, DX				Liu, Xijun; Liu, Dan; Qian, Dongmeng; Dai, Jenny; An, Yi; Jiang, Shaoyan; Stanley, Bruce; Yang, Jinming; Wang, Bin; Liu, Xinyuan; Liu, David X.			Nucleophosmin (NPM1/B23) Interacts with Activating Transcription Factor 5 (ATF5) Protein and Promotes Proteasome- and Caspase-dependent ATF5 Degradation in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL PROGENITOR CELLS; C6 GLIOMA; TARGET; DIFFERENTIATION; PROLIFERATION; INTERFERENCE; INHIBITION; EXPRESSION; APOPTOSIS; FAMILY	Nucleophosmin (NPM1/B23) and the activating transcription factor 5 (ATF5) are both known to subject to cell type-dependent regulation. NPM1 is expressed weakly in hepatocytes and highly expressed in hepatocellular carcinomas (HCC) with a clear correlation between enhanced NPM1 expression and increased tumor grading and poor prognosis, whereas in contrast, ATF5 is expressed abundantly in hepatocytes and down-regulated in HCC. Re-expression of ATF5 in HCC inhibits cell proliferation. We report here that using an unbiased approach, tandem affinity purification (TAP) followed with mass spectrometry (MS), we identified NPM1 as a novel ATF5-interacting protein. Unlike many other NPM1-interacting proteins that interact with the N-terminal oligomerization domain of NPM1, ATF5 binds via its basic leucine zipper to the C-terminal region of NPM1 where its nucleolar localization signal is located. NPM1 association with ATF5, whose staining patterns partially overlap in the nucleoli, promotes ATF5 protein degradation through proteasome-dependent and caspase-dependent pathways. NPM1-c, a mutant NPM1 that is defective in nucleolar localization, failed to stimulate ATF5 polyubiquitination and was unable to down-regulate ATF5. NPM1 interaction with ATF5 displaces HSP70, a known ATF5-interacting protein, from ATF5 protein complexes and antagonizes its role in stabilization of ATF5 protein. NPM1-promoted ATF5 down-regulation diminished ATF5-mediated repression of cAMP-responsive element-dependent gene transcription and abrogates ATF5-induced G(2)/M cell cycle blockade and inhibition of cell proliferation in HCC cells. Our study establishes a mechanistic link between elevated NPM1 expression and depressed ATF5 in HCC and suggests that regulation of ATF5 by NPM1 plays an important role in the proliferation and survival of HCC.	[Liu, Xijun; Liu, Dan; Dai, Jenny; Stanley, Bruce; Yang, Jinming; Liu, David X.] Penn State Coll Med, Hershey, PA 17033 USA; [Qian, Dongmeng; Wang, Bin] Qingdao Univ, Dept Microbiol, Coll Med, Qingdao 266071, Shandong, Peoples R China; [An, Yi] Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266071, Shandong, Peoples R China; [Jiang, Shaoyan] Qingdao Univ, Affiliated Cardiovasc Hosp, Coll Med, Qingdao 266071, Shandong, Peoples R China; [Liu, Xinyuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Liu, Xinyuan; Liu, David X.] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Qingdao University; Qingdao University; Qingdao University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University	Liu, DX (corresponding author), Penn State Coll Med, Hershey, PA 17033 USA.	dliu@psu.edu	Liu, Xinyuan/HDM-5505-2022; Stanley, Bruce/R-9856-2019	Stanley, Bruce/0000-0003-1338-2928; Liu, Xijun/0000-0002-5712-9142	American Cancer Society; U.S. Army Medical Research and Material Command; NATIONAL CANCER INSTITUTE [R01CA135038] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the American Cancer Society and the U.S. Army Medical Research and Material Command (to D. X. L.).	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; den Besten W, 2005, CELL CYCLE, V4, P1593; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Liu DX, 2011, MOL CELL BIOL, V31, P3906, DOI 10.1128/MCB.05887-11; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Muratake T, 1996, GENOMICS, V36, P63, DOI 10.1006/geno.1996.0426; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pati D, 1999, MOL CELL BIOL, V19, P5001; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Prieto C, 2002, BIOCHEMISTRY-US, V41, P7802, DOI 10.1021/bi020120e; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Uekusa H, 2009, BIOCHEM BIOPH RES CO, V380, P673, DOI 10.1016/j.bbrc.2009.01.158; Verheggen C, 2000, J CELL BIOL, V149, P293, DOI 10.1083/jcb.149.2.293; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wei YY, 2008, J BIOL CHEM, V283, P18773, DOI 10.1074/jbc.M707879200; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Wei YY, 2006, BIOCHEM BIOPH RES CO, V339, P591, DOI 10.1016/j.bbrc.2005.11.054; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Xu LS, 2009, J BIOL CHEM, V284, P2706, DOI 10.1074/jbc.M808184200; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	57	35	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19599	19609		10.1074/jbc.M112.363622	http://dx.doi.org/10.1074/jbc.M112.363622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22528486	hybrid, Green Published			2022-12-28	WOS:000306411900071
J	Wratting, D; Thistlethwaite, A; Harris, M; Zeef, LAH; Millar, CB				Wratting, Daniel; Thistlethwaite, Angela; Harris, Michael; Zeef, Leo A. H.; Millar, Catherine B.			A Conserved Function for the H2A.Z C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2A.Z; SACCHAROMYCES-CEREVISIAE; DOCKING DOMAIN; VARIANT; GENOME; ACETYLATION; REGIONS; YEAST; HETEROCHROMATIN; EUCHROMATIN	Histone H2A variants generate diversity in chromatin structure and functions, as nucleosomes containing variant H2A histones have altered physical, chemical, and biological properties. H2A.Z is an evolutionarily ancient and highly conserved H2A variant that regulates processes ranging from gene expression to the DNA damage response. Here we find that the unstructured portion of the C-terminal tail of H2A.Z is required for the normal functions of this histone variant in budding yeast. We have also identified a novel splice isoform of the human H2A.Z-2 gene that encodes a C-terminally truncated H2A.Z protein that is similar to the truncation mutants we identified in yeast. The short forms of H2A.Z in both yeast and human cells are more loosely associated with chromatin than the full-length proteins, indicating a conserved function for the H2A.Z C-terminal tail in regulating the association of H2A.Z with nucleosomes.	[Wratting, Daniel; Thistlethwaite, Angela; Harris, Michael; Zeef, Leo A. H.; Millar, Catherine B.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Millar, CB (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	catherine.millar@manchester.ac.uk		Millar, Catherine/0000-0002-8649-5408	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Career Development Fellowship (to C. B. M.) and a BBSRC Doctoral Training Studentship (to D. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Ausio J, 2002, BIOCHEMISTRY-US, V41, P5945, DOI 10.1021/bi020059d; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; EICKBUSH TH, 1988, J BIOL CHEM, V263, P18972; Eirin-Lopez JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-31; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jensen K, 2011, MOL GENET GENOMICS, V285, P287, DOI 10.1007/s00438-011-0604-5; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Karaczyn AA, 2003, CHEM RES TOXICOL, V16, P1555, DOI 10.1021/tx0300277; Karaczyn AA, 2009, ANN CLIN LAB SCI, V39, P251; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shukla MS, 2011, NUCLEIC ACIDS RES, V39, P2559, DOI 10.1093/nar/gkq1174; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Van Doninck K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000401; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Vogler C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001234; Wang AY, 2011, MOL CELL BIOL, V31, P3871, DOI 10.1128/MCB.05182-11; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	49	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19148	19157		10.1074/jbc.M111.317990	http://dx.doi.org/10.1074/jbc.M111.317990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493515	Green Published, hybrid			2022-12-28	WOS:000306411900025
J	Fu, W; Ruangkittisakul, A; MacTavish, D; Shi, JY; Ballanyi, K; Jhamandas, JH				Fu, Wen; Ruangkittisakul, Araya; MacTavish, David; Shi, Jenny Y.; Ballanyi, Klaus; Jhamandas, Jack H.			Amyloid beta (A beta) Peptide Directly Activates Amylin-3 Receptor Subtype by Triggering Multiple Intracellular Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-MODIFYING PROTEINS; CALCITONIN RECEPTOR; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; COUPLED RECEPTORS; TOXICITY; NEURONS; PHARMACOLOGY; PATHOLOGY; ISOFORM	The two age-prevalent diseases Alzheimer disease and type 2 diabetes mellitus share many common features including the deposition of amyloidogenic proteins, amyloid beta protein (A beta) and amylin (islet amyloid polypeptide), respectively. Recent evidence suggests that both A beta and amylin may express their effects through the amylin receptor, although the precise mechanisms for this interaction at a cellular level are unknown. Here, we studied this by generating HEK293 cells with stable expression of an isoform of the amylin receptor family, amylin receptor-3 (AMY3). A beta 1-42 and human amylin (hAmylin) increase cytosolic cAMP and Ca2+, trigger multiple pathways involving the signal transduction mediators protein kinase A, MAPK, Akt, and cFos. A beta 1-42 and hAmylin also induce cell death during exposure for 24-48 h at low micromolar concentrations. In the presence of hAmylin, A beta 1-42 effects on HEK293-AMY3-expressing cells are occluded, suggesting a shared mechanism of action between the two peptides. Amylin receptor antagonist AC253 blocks increases in intracellular Ca2+, activation of protein kinase A, MAPK, Akt, cFos, and cell death, which occur upon AMY3 activation with hAmylin, A beta 1-42, or their co-application. Our data suggest that AMY3 plays an important role by serving as a receptor target for actions A beta and thus may represent a novel therapeutic target for development of compounds to treat neurodegenerative conditions such as Alzheimer disease.	[Fu, Wen; MacTavish, David; Shi, Jenny Y.; Jhamandas, Jack H.] Univ Alberta, Centres Neurosci & Prions & Prot Folding Dis, Dept Med, Div Neurol, Edmonton, AB T6G 2S2, Canada; [Ruangkittisakul, Araya; Ballanyi, Klaus] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Jhamandas, JH (corresponding author), Univ Alberta, Heritage Med Res Ctr 530, Dept Med Neurol, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca	Ungpakawa, Araya/J-3849-2013	Ungpakawa, Araya/0000-0002-9606-8557	Canadian Institutes of Health Research [CIHR MOP 93601]; Canada Foundation of Innovation; Alberta-Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation of Innovation(Canada Foundation for Innovation); Alberta-Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical Research)	This work was supported by Canadian Institutes of Health Research Grant CIHR MOP 93601 (to J. H. J.), the Canada Foundation of Innovation, and a scientist award from the Alberta-Heritage Foundation for Medical Research (to K. B.).	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Andreetto E, 2011, CHEMBIOCHEM, V12, P1313, DOI 10.1002/cbic.201100192; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beeley NRA, 1996, EXPERT OPIN THER PAT, V6, P555; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BHOGAL R, 1992, ENDOCRINOLOGY, V130, P906, DOI 10.1210/en.130.2.906; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Enns LC, 2010, AGEING RES REV, V9, P269, DOI 10.1016/j.arr.2010.02.004; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Huang X, 2010, NEUROSCIENCE, V165, P1429, DOI 10.1016/j.neuroscience.2009.11.063; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jhamandas JH, 2004, J NEUROSCI, V24, P5579, DOI 10.1523/JNEUROSCI.1051-04.2004; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Raggatt LJ, 2000, J ENDOCRINOL, V167, P93, DOI 10.1677/joe.0.1670093; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006	37	79	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18820	18830		10.1074/jbc.M111.331181	http://dx.doi.org/10.1074/jbc.M111.331181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22500019	Green Published, hybrid			2022-12-28	WOS:000306411600090
J	Bruser, A; Kirchberger, J; Kloos, M; Strater, N; Schoneberg, T				Brueser, Antje; Kirchberger, Juergen; Kloos, Marco; Straeter, Norbert; Schoeneberg, Torsten			Functional Linkage of Adenine Nucleotide Binding Sites in Mammalian Muscle 6-Phosphofructokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC PHOSPHOFRUCTOKINASES; ALLOSTERIC REGULATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; SKELETAL-MUSCLE; YEAST; EVOLUTION; PHOSPHOFRUCTO-1-KINASE; IDENTIFICATION; PURIFICATION	6-Phosphofructokinases (Pfk) are homo- and heterooligomeric, allosteric enzymes that catalyze one of the rate-limiting steps of the glycolysis: the phosphorylation of fructose 6-phosphate at position 1. Pfk activity is modulated by a number of regulators including adenine nucleotides. Recent crystal structures from eukaryotic Pfk revealed several adenine nucleotide binding sites. Herein, we determined the functional relevance of two adenine nucleotide binding sites through site-directed mutagenesis and enzyme kinetic studies. Subsequent characterization of Pfk mutants allowed the identification of the activating (AMP, ADP) and inhibitory (ATP, ADP) allosteric binding sites. Mutation of one binding site reciprocally influenced the allosteric regulation through nucleotides interacting with the other binding site. Such reciprocal linkage between the activating and inhibitory binding sites is in agreement with current models of allosteric enzyme regulation. Because the allosteric nucleotide binding sites in eukaryotic Pfk did not evolve from prokaryotic ancestors, reciprocal linkage of functionally opposed allosteric binding sites must have developed independently in prokaryotic and eukaryotic Pfk (convergent evolution).	[Schoeneberg, Torsten] Univ Leipzig, Fak Med, Inst Biochem, Abt Mol Biochem, D-04103 Leipzig, Germany; [Kloos, Marco; Straeter, Norbert] Univ Leipzig, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Fak Med, Inst Biochem, Abt Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Strater, Norbert/P-4856-2018	Strater, Norbert/0000-0002-2001-0500	Deutsche Forschungsgemeinschaft [Sfb610]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Sfb610.	ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; BOHME HJ, 1972, J CHROMATOGR, V69, P209, DOI 10.1016/S0021-9673(00)83103-9; Changeux J. P, 2012, ANNU REV BIOPHYS, V41, P83; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; Fenton AW, 2009, BIOCHEMISTRY-US, V48, P12323, DOI 10.1021/bi901456p; Fenton AW, 2004, BIOCHEMISTRY-US, V43, P14104, DOI 10.1021/bi048569q; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; HEINISCH J, 1989, GENE, V78, P309; HEINISCH JJ, 1993, FEBS LETT, V328, P35, DOI 10.1016/0014-5793(93)80960-3; HOFMANN E, 1982, METHOD ENZYMOL, V90, P49; HOFMANN E, 1976, REV PHYSIOL BIOCH P, V75, P1, DOI 10.1007/BFb0030484; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KEMP RG, 1967, BIOCHEMISTRY-US, V6, P423, DOI 10.1021/bi00854a009; Kirchberger J, 2002, YEAST, V19, P933, DOI 10.1002/yea.885; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Martinez-Costa OH, 2004, BIOCHEM J, V377, P77, DOI 10.1042/BJ20031032; Mediavilla D, 2008, J BIOCHEM, V144, P235, DOI 10.1093/jb/mvn066; Peracchi A, 2011, BBA-PROTEINS PROTEOM, V1814, P922, DOI 10.1016/j.bbapap.2010.10.008; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1995, AM J HUM GENET, V56, P131; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; Strater N, 2011, FASEB J, V25, P89, DOI 10.1096/fj.10-163865; Usenik A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015447; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; Zancan P, 2007, ARCH BIOCHEM BIOPHYS, V467, P275, DOI 10.1016/j.abb.2007.08.032	29	18	19	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17546	17553		10.1074/jbc.M112.347153	http://dx.doi.org/10.1074/jbc.M112.347153			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474333	Green Published, hybrid			2022-12-28	WOS:000306373000053
J	D'Agostino, J; Ding, XX; Zhang, P; Jia, KZ; Fang, C; Zhu, Y; Spink, DC; Zhang, QY				D'Agostino, Jaime; Ding, Xinxin; Zhang, Peng; Jia, Kunzhi; Fang, Cheng; Zhu, Yi; Spink, David C.; Zhang, Qing-Yu			Potential Biological Functions of Cytochrome P450 Reductase-dependent Enzymes in Small Intestine NOVEL LINK TO EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; LIVER-SPECIFIC DELETION; MICROSOMAL CYTOCHROME-P450; P450 OXIDOREDUCTASE; MICROARRAY DATA; HEME OXYGENASE; QUANTITATIVE-DETERMINATION; INTERFERON-GAMMA; P-450 REDUCTASE; NULL MICE	NADPH-cytochrome P450 reductase (POR) is essential for the functioning of microsomal cytochrome P450 (P450) monooxygenases and heme oxygenases. The biological roles of the POR-dependent enzymes in the intestine have not been defined, despite the wealth of knowledge on the biochemical properties of the various oxygenases. In this study, cDNA microarray analysis revealed significant changes in gene expression in enterocytes isolated from the small intestine of intestinal epithelium-specific Por knock-out (named IE-Cpr-null) mice compared with that observed in wild-type (WT) littermates. Gene ontology analyses revealed significant changes in terms related to P450s, transporters, cholesterol biosynthesis, and, unexpectedly, antigen presentation/processing. The genomic changes were confirmed at either mRNA or protein level for selected genes, including those of the major histocompatibility complex class II (MHC II). Cholesterol biosynthetic activity was greatly reduced in the enterocytes of the IE-Cpr-null mice, as evidenced by the accumulation of the lanosterol metabolite, 24-dihydrolanosterol. However, no differences in either circulating or enterocyte cholesterol levels were observed between IE-Cpr-null and WT mice. Interestingly, the levels of the cholesterol precursor farnesyl pyrophosphate and its derivative geranylgeranyl pyrophosphate were also increased in the enterocytes of the IE-Cpr-null mice. Furthermore, the expression of STAT1 (signal transducer and activator of transcription 1), a downstream target of geranylgeranyl pyrophosphate signaling, was enhanced. STAT1 is an activator of CIITA, the class II transactivator for MHC II expression; CIITA expression was concomitantly increased in IE-Cpr-null mice. Overall, these findings provide a novel and mechanistic link between POR-dependent enzymes and the expression of MHC II genes in the small intestine.	[Zhang, Qing-Yu] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12201 USA; SUNY Albany, Sch Publ Hlth, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Zhang, QY (corresponding author), SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Empire State Pl,Box 509, Albany, NY 12201 USA.	zhangq@wadsworth.org			National Institutes of Health [GM082978]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health were observed in the livers, which revealed the importance of Grant GM082978.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arai M, 1997, INT J CANCER, V70, P390, DOI 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BOS JL, 1989, CANCER RES, V49, P4682; Brandtzaeg P, 1997, SPRINGER SEMIN IMMUN, V18, P555, DOI 10.1007/BF00824058; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cheng C, 2010, CIRC RES, V106, P1656, DOI 10.1161/CIRCRESAHA.110.216945; D'Agostino J, 2008, DRUG METAB DISPOS, V36, P2316, DOI 10.1124/dmd.108.022822; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; DE SK, 1990, J BIOL CHEM, V265, P15267; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Fang C, 2010, J PHARMACOL EXP THER, V334, P156, DOI 10.1124/jpet.110.167742; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; GUENTHNER TM, 1980, BIOCHEM PHARMACOL, V29, P89, DOI 10.1016/0006-2952(80)90249-X; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Lee SJ, 2008, EUR J IMMUNOL, V38, P2325, DOI 10.1002/eji.200838189; Li L, 2007, ARCH BIOCHEM BIOPHYS, V461, P76, DOI 10.1016/j.abb.2007.02.010; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; MARINELLO AJ, 1981, BIOCHEM BIOPH RES CO, V99, P399, DOI 10.1016/0006-291X(81)91759-9; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; MAYRHOFER G, 1995, IMMUNOL CELL BIOL, V73, P433, DOI 10.1038/icb.1995.67; Mingone CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL337, DOI 10.1152/ajplung.00482.2005; Mutch DM, 2007, J PROTEOME RES, V6, P3976, DOI 10.1021/pr0700448; Najjar I, 2008, J LEUKOCYTE BIOL, V84, P1604, DOI 10.1189/jlb.0508287; Ohto C, 2010, APPL MICROBIOL BIOT, V87, P1327, DOI 10.1007/s00253-010-2571-x; Ohto C, 2009, APPL MICROBIOL BIOT, V82, P837, DOI 10.1007/s00253-008-1807-5; ONO T, 1975, J BIOL CHEM, V250, P1571; Potten C. S., 1983, STEM CELLS; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Sadeghi MM, 2001, TRANSPLANTATION, V71, P1262, DOI 10.1097/00007890-200105150-00014; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; STANGE EF, 1983, J BIOL CHEM, V258, P2868; TANIGUCHI H, 1984, ARCH BIOCHEM BIOPHYS, V232, P585, DOI 10.1016/0003-9861(84)90577-0; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; TRAKSHEL GM, 1986, ARCH BIOCHEM BIOPHYS, V251, P175, DOI 10.1016/0003-9861(86)90064-0; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Wang S, 2010, MOL CANCER RES, V8, P798, DOI 10.1158/1541-7786.MCR-10-0027; Wang X., 2006, CURRENT PAEDIAT, V16, P70, DOI [10.1016/j.cupe.2005.10.002, DOI 10.1016/J.CUPE.2005.10.002]; Wang XJ, 2005, BIOCHEM J, V388, P857, DOI 10.1042/BJ20042087; Ware JA, 1998, CHEM RES TOXICOL, V11, P164, DOI 10.1021/tx970182j; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wu J, 2005, BIOCHEM BIOPH RES CO, V338, P890, DOI 10.1016/j.bbrc.2005.10.021; Wu L, 2005, J PHARMACOL EXP THER, V312, P35, DOI 10.1124/jpet.104.073353; Yee CSK, 2004, J IMMUNOL, V172, P5528, DOI 10.4049/jimmunol.172.9.5528; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005; Zhang QY, 2009, DRUG METAB DISPOS, V37, P651, DOI 10.1124/dmd.108.025429; Zhang QY, 2003, DRUG METAB DISPOS, V31, P1346, DOI 10.1124/dmd.31.11.1346; Zhu Y, 2011, DRUG METAB DISPOS, V39, P939, DOI 10.1124/dmd.110.037861	70	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17777	17788		10.1074/jbc.M112.354274	http://dx.doi.org/10.1074/jbc.M112.354274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22453923	Green Published, hybrid			2022-12-28	WOS:000306373000076
J	Ripoll-Rozada, J; Pena, A; Rivas, S; Moro, F; de la Cruz, F; Cabezon, E; Arechaga, I				Ripoll-Rozada, Jorge; Pena, Alejandro; Rivas, Susana; Moro, Fernando; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio			Regulation of the Type IV Secretion ATPase TrwD by Magnesium IMPLICATIONS FOR CATALYTIC MECHANISM OF THE SECRETION ATPase SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAMERIC TRAFFIC ATPASE; ESCHERICHIA-COLI; PLASMID R388; BACTERIAL CONJUGATION; HYDROLYTIC ACTIVITY; CHLOROPLAST ATPASE; CRYSTAL-STRUCTURE; BINDING SITES; TNP-ATP; PROTEIN	TrwD, the VirB11 homologue in conjugative plasmid R388, is a member of the large secretion ATPase superfamily, which includes ATPases from bacterial type II and type IV secretion systems, type IV pilus, and archaeal flagellae assembly. Based on structural studies of the VirB11 homologues in Helicobacter pylori and Brucella suis and the archaeal type II secretion ATPase GspE, a unified mechanism for the secretion ATPase superfamily has been proposed. Here, we have found that the ATP turnover of TrwD is down-regulated by physiological concentrations of magnesium. This regulation is exerted by increasing the affinity for ADP, hence delaying product release. Circular dichroism and limited proteolysis analysis indicate that magnesium induces conformational changes in the protein that promote a more rigid, but less active, form of the enzyme. The results shown here provide new insights into the catalytic mechanism of the secretion ATPase superfamily.	[Arechaga, Ignacio] UC, Dept Mol Biol, Santander 39011, Spain; [Arechaga, Ignacio] IBBTEC CSIC UC IDICAN, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain; [Rivas, Susana; Moro, Fernando] Univ Basque Country, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; [Rivas, Susana; Moro, Fernando] Univ Basque Country, Unidad Biofis CSIC UPV EH, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Cabezon, E (corresponding author), UC, Dept Mol Biol, Santander 39011, Spain.	cabezone@unican.es; arechagai@unican.es	Arechaga, Ignacio/K-2198-2014; Rozada, Jorge Ripoll/AAA-8049-2020; Ripoll Rozada, Jorge/L-1574-2016; Moro Pérez, Fernando/P-3891-2015; de la Cruz, Fernando/L-2812-2014; Cabezon, Elena/K-5874-2014	Arechaga, Ignacio/0000-0002-1342-9370; Rozada, Jorge Ripoll/0000-0001-7235-317X; Ripoll Rozada, Jorge/0000-0001-7235-317X; Moro Pérez, Fernando/0000-0002-3568-3388; de la Cruz, Fernando/0000-0003-4758-6857; Pena, Alejandro/0000-0001-5674-7064	Ministerio de Ciencia e Innovacion (MCINN, Spain) [BFU2008-00806]; MCINN [BFU2008-00995/BMC, BFU2010-15443]; Instituto de Salud Carlos III [RD06/0008/1012]; European VI Framework Program [LSHM-CT-2005_019023]; University of Cantabria	Ministerio de Ciencia e Innovacion (MCINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MCINN(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European VI Framework Program; University of Cantabria	This work was supported by the Ministerio de Ciencia e Innovacion (MCINN, Spain) Grant BFU2008-00806 (to E. C. and I. A.), Grant BFU2008-00995/BMC from the MCINN, Grant RD06/0008/1012 from the Instituto de Salud Carlos III, and Grant LSHM-CT-2005_019023 from the European VI Framework Program (to F. d. l. C.), and Grant BFU2010-15443 (to F. M.) from the MCINN.; Supported by a predoctoral fellowship from the University of Cantabria.	Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; BERGER G, 1994, J BIOENERG BIOMEMBR, V26, P335, DOI 10.1007/BF00763105; Berger G, 2001, J BIOENERG BIOMEMBR, V33, P93, DOI 10.1023/A:1010792213254; Buy C, 1996, BIOCHEMISTRY-US, V35, P9880, DOI 10.1021/bi960532l; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Gold VAM, 2007, J BIOL CHEM, V282, P17424, DOI 10.1074/jbc.M702066200; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; HIRATSUKA T, 1973, BIOCHIM BIOPHYS ACTA, V320, P635, DOI 10.1016/0304-4165(73)90143-8; Jezewska MJ, 2005, BIOCHEMISTRY-US, V44, P3865, DOI 10.1021/bi048037+; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krause S, 2000, J BACTERIOL, V182, P2761, DOI 10.1128/JB.182.10.2761-2770.2000; Machon C, 2002, J BACTERIOL, V184, P1661, DOI 10.1128/JB.184.6.1661-1668.2002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOLNAR M, 1993, BIOCHEM J, V293, P595, DOI 10.1042/bj2930595; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Pena A, 2011, J BIOL CHEM, V286, P17376, DOI 10.1074/jbc.M110.208942; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Rangrez AY, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-10; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schobert B, 1998, EUR J BIOCHEM, V254, P363, DOI 10.1046/j.1432-1327.1998.2540363.x; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Weber J, 1996, J BIOL CHEM, V271, P3474; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	36	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17408	17414		10.1074/jbc.M112.357905	http://dx.doi.org/10.1074/jbc.M112.357905			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467878	hybrid, Green Published			2022-12-28	WOS:000306373000040
J	Lo Re, AE; Fernandez-Barrena, MG; Almada, LL; Mills, LD; Elsawa, SF; Lund, G; Ropolo, A; Molejon, MI; Vaccaro, MI; Fernandez-Zapico, ME				Lo Re, Andrea E.; Fernandez-Barrena, Maite G.; Almada, Luciana L.; Mills, Lisa D.; Elsawa, Sherine F.; Lund, George; Ropolo, Alejandro; Molejon, Maria I.; Vaccaro, Maria I.; Fernandez-Zapico, Martin E.			Novel AKT1-GLI3-VMP1 Pathway Mediates KRAS Oncogene-induced Autophagy in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCTAL PANCREATIC-CANCER; K-RAS; TRANSFORMATION; HEDGEHOG; DISEASE; INHIBITION; EXPRESSION; SURVIVAL; MOUSE; DEATH	Autophagy is an evolutionarily conserved degradation process of cytoplasmic cellular constituents. It has been suggested that autophagy plays a role in tumor promotion and progression downstream oncogenic pathways; however, the molecular mechanisms underlying this phenomenon have not been elucidated. Here, we provide both in vitro and in vivo evidence of a novel signaling pathway whereby the oncogene KRAS induces the expression of VMP1, a molecule needed for the formation of the authophagosome and capable of inducing autophagy, even under nutrient-replete conditions. RNAi experiments demonstrated that KRAS requires VMP1 to induce autophagy. Analysis of the mechanisms identified GLI3, a transcription factor regulated by the Hedgehog pathway, as an effector of KRAS signaling. GLI3 regulates autophagy as well as the expression and promoter activity of VMP1 in a Hedgehog-independent manner. Chromatin immunoprecipitation assays demonstrated that GLI3 binds to the VMP1 promoter and complexes with the histone acetyltransferase p300 to regulate promoter activity. Knockdown of p300 impaired KRAS- and GLI3-induced activation of this promoter. Finally, we identified the PI3K-AKT1 pathway as the signaling pathway mediating the expression and promoter activity of VMP1 upstream of the GLI3-p300 complex. Together, these data provide evidence of a new regulatory mechanism involved in autophagy that integrates this cellular process into the molecular network of events regulating oncogene-induced autophagy.	[Lo Re, Andrea E.; Fernandez-Barrena, Maite G.; Almada, Luciana L.; Mills, Lisa D.; Elsawa, Sherine F.; Lund, George; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Lo Re, Andrea E.; Ropolo, Alejandro; Molejon, Maria I.; Vaccaro, Maria I.] Univ Buenos Aires, Dept Pathophysiol, Sch Pharm & Biochem, Buenos Aires, DF, Argentina	Mayo Clinic; University of Buenos Aires	Vaccaro, MI (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	mvaccaro@ffyb.uba.ar; fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Vaccaro, Maria I./L-8348-2017	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Elsawa, Sherine/0000-0002-3917-3078; Vaccaro, Maria/0000-0002-2456-747X	National Institutes of Health Grant [CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology Grant [P30 DK84567]; Agencia Nacional de Promocion Cientfica y Tecnologica Grants [ANPCyT-PICT01627, ANPCyT-PICT0411]; Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant [CONICET-PIP2527]; University of Buenos Aires Grant [UBA-UBACyTM072]; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Pancreatic SPORE Grant; Mayo Clinic Center for Cell Signaling in Gastroenterology Grant; Agencia Nacional de Promocion Cientfica y Tecnologica Grants; Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant; University of Buenos Aires Grant(University of Buenos Aires); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grant CA136526, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.- Z.); Agencia Nacional de Promocion Cientfica y Tecnologica Grants ANPCyT-PICT01627 and ANPCyT-PICT0411 (to A. R.); Consejo Nacional de Investigaciones Cientficas y Tecnicas Grant CONICET-PIP2527; and University of Buenos Aires Grant UBA-UBACyTM072 (to M. I. V.).	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Grasso D., 2012, INT J CELL BIOL, V2012; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; Grasso D, 2009, PANCREATOLOGY, V9, P81, DOI 10.1159/000178878; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Lock R, 2011, CELL CYCLE, V10, P1516, DOI 10.4161/cc.10.10.15434; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Marino G, 2011, MOL CELL, V42, P1, DOI 10.1016/j.molcel.2011.03.003; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Perez-Mancera PA, 2006, METHOD ENZYMOL, V407, P676, DOI 10.1016/S0076-6879(05)07053-9; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Vaccaro MI, 2008, AUTOPHAGY, V4, P388, DOI 10.4161/auto.5656; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	33	54	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25325	25334		10.1074/jbc.M112.370809	http://dx.doi.org/10.1074/jbc.M112.370809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22535956	Green Published, hybrid			2022-12-28	WOS:000306651700040
J	Jeanes, AI; Wang, PB; Moreno-Layseca, P; Paul, N; Cheung, J; Tsang, R; Akhtar, N; Foster, FM; Brennan, K; Streuli, CH				Jeanes, Alexa I.; Wang, Pengbo; Moreno-Layseca, Paulina; Paul, Nikki; Cheung, Julia; Tsang, Ricky; Akhtar, Nasreen; Foster, Fiona M.; Brennan, Keith; Streuli, Charles H.			Specific beta-containing Integrins Exert Differential Control on Proliferation and Two-dimensional Collective Cell Migration in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK NUCLEAR TRANSLOCATION; CYCLE PROGRESSION; BREAST-CANCER; BETA-1-INTEGRIN DELETION; BASEMENT-MEMBRANE; MEDIATED ADHESION; G(1) PHASE; EXPRESSION; MOUSE; ALPHA-V-BETA-3	Understanding how cell cycle is regulated in normal mammary epithelia is essential for deciphering defects of breast cancer and therefore for developing new therapies. Signals provided by both the extracellular matrix and growth factors are essential for epithelial cell proliferation. However, the mechanisms by which adhesion controls cell cycle in normal epithelia are poorly established. In this study, we describe the consequences of removing the beta 1-integrin gene from primary cultures of mammary epithelial cells in situ, using CreER. Upon beta 1-integrin gene deletion, the cells were unable to progress efficiently through S-phase, but were still able to undergo collective two-dimensional migration. These responses are explained by the presence of beta 3-integrin in beta 1-integrin-null cells, indicating that integrins containing different beta-subunits exert differential control on mammary epithelial proliferation and migration. beta 1-Integrin deletion did not inhibit growth factor signaling to Erk or prevent the recruitment of core adhesome components to focal adhesions. Instead the S-phase arrest resulted from defective Rac activation and Erk translocation to the nucleus. Rac inhibition prevented Erk translocation and blocked proliferation. Activated Rac1 rescued the proliferation defect in beta 1-integrin-depleted cells, indicating that this GTPase is essential in propagating proliferative beta 1-integrin signals. These results show that beta 1-integrins promote cell cycle in mammary epithelial cells, whereas beta 3-integrins are involved in migration.	[Jeanes, Alexa I.; Wang, Pengbo; Moreno-Layseca, Paulina; Paul, Nikki; Cheung, Julia; Tsang, Ricky; Akhtar, Nasreen; Foster, Fiona M.; Brennan, Keith; Streuli, Charles H.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Streuli, CH (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England.	cstreuli@manchester.ac.uk		Brennan, Keith/0000-0002-9384-125X; Akhtar, Nasreen/0000-0002-5099-8767; Moreno-Layseca, Paulina/0000-0002-9456-4178	Breast Cancer Campaign [2006NovPhD12]; Wellcome Trust [081203/Z/06/Z, 088785/Z/09/Z]	Breast Cancer Campaign; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Breast Cancer Campaign (Grant 2006NovPhD12) and Wellcome Trust (Grant 081203/Z/06/Z).; We thank Cord Brakebush for providing the L61-Rac1 construct. The Wellcome Trust Centre for Cell-Matrix Research is supported by core funding from the Wellcome Trust (Grant 088785/Z/09/Z).	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; GUI GPH, 1995, SURGERY, V117, P102, DOI 10.1016/S0039-6060(05)80236-3; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Jeanes AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018144; Klinowska TCM, 1999, DEV BIOL, V215, P13, DOI 10.1006/dbio.1999.9435; Klinowska TCM, 2001, DEV BIOL, V233, P449, DOI 10.1006/dbio.2001.0204; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Miao H, 2002, J CELL SCI, V115, P2199; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Pullan S, 1996, J CELL SCI, V109, P631; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200	44	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24103	24112		10.1074/jbc.M112.360834	http://dx.doi.org/10.1074/jbc.M112.360834			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22511753	Green Published, hybrid			2022-12-28	WOS:000306651100005
J	Kammerer, R; Ruttiger, L; Riesenberg, R; Schauble, C; Krupar, R; Kamp, A; Sunami, K; Eisenried, A; Hennenberg, M; Grunert, F; Bress, A; Battaglia, S; Schrewe, H; Knipper, M; Schneider, MR; Zimmermann, W				Kammerer, Robert; Ruettiger, Lukas; Riesenberg, Rainer; Schaeuble, Constanze; Krupar, Rosemarie; Kamp, Annegret; Sunami, Kishiko; Eisenried, Andreas; Hennenberg, Martin; Grunert, Fritz; Bress, Andreas; Battaglia, Sebastiano; Schrewe, Heinrich; Knipper, Marlies; Schneider, Marlon R.; Zimmermann, Wolfgang			Loss of Mammal-specific Tectorial Membrane Component Carcinoembryonic Antigen Cell Adhesion Molecule 16 (CEACAM16) Leads to Hearing Impairment at Low and High Frequencies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; TONOTOPIC AXIS; ALPHA-TECTORIN; CEA FAMILY; INNER-EAR; RECEPTOR; MURINE; MOUSE; DOMAIN; MICE	The vertebrate-restricted carcinoembryonic antigen gene family evolves extremely rapidly. Among their widely expressed members, the mammal-specific, secreted CEACAM16 is exceptionally well conserved and specifically expressed in the inner ear. To elucidate a potential auditory function, we inactivated murine Ceacam16 by homologous recombination. In young Ceacam16(-/-) mice the hearing threshold for frequencies below 10 kHz and above 22 kHz was raised. This hearing impairment progressed with age. A similar phenotype is observed in hearing-impaired members of Family 1070 with non-syndromic autosomal dominant hearing loss (DFNA4) who carry a missense mutation in CEACAM16. CEACAM16 was found in interdental and Deiters cells and was deposited in the tectorial membrane of the cochlea between postnatal days 12 and 15, when hearing starts in mice. In cochlear sections of Ceacam16(-/-) mice tectorial membranes were significantly more often stretched out as compared with wild-type mice where they were mostly contracted and detached from the outer hair cells. Homotypic cell sorting observed after ectopic cell surface expression of the carboxyl-terminal immunoglobulin variable-like N2 domain of CEACAM16 indicated that CEACAM16 can interact in trans. Furthermore, Western blot analyses of CEACAM16 under reducing and non-reducing conditions demonstrated oligomerization via unpaired cysteines. Taken together, CEACAM16 can probably form higher order structures with other tectorial membrane proteins such as alpha-tectorin and beta-tectorin and influences the physical properties of the tectorial membrane. Evolution of CEACAM16 might have been an important step for the specialization of the mammalian cochlea, allowing hearing over an extended frequency range.	[Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, D-17493 Greifswald, Germany; [Ruettiger, Lukas; Bress, Andreas; Knipper, Marlies] Univ Tubingen, Dept Otorhinolaryngol, Hearing Res Ctr Tubingen, D-72076 Tubingen, Germany; [Riesenberg, Rainer; Schaeuble, Constanze; Krupar, Rosemarie; Kamp, Annegret; Eisenried, Andreas; Zimmermann, Wolfgang] Univ Clin Munich, Tumor Immunol Lab, LIFE Ctr, D-81377 Munich, Germany; [Sunami, Kishiko] Osaka City Univ, Dept Otolaryngol, Sch Med, Osaka 5458585, Japan; [Hennenberg, Martin] Univ Clin Munich, Dept Urol, D-81377 Munich, Germany; [Battaglia, Sebastiano; Schrewe, Heinrich] Aldevron Freiburg, D-79111 Freiburg, Germany; [Grunert, Fritz] Charite, Inst Med Genet CBF, D-12203 Berlin, Germany; [Grunert, Fritz] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Schneider, Marlon R.] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, D-81377 Munich, Germany	Friedrich Loeffler Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Osaka Metropolitan University; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Munich	Zimmermann, W (corresponding author), Univ Munich, Tumor Immunol Lab, LIFE Ctr, Univ Hosp Munich, Marchioninistr 23, D-81377 Munich, Germany.	wolfgang.zimmermann@med.uni-muenchen.de	Kammerer, Robert/AAQ-1338-2021; Zimmermann, Wolfgang/L-9277-2013; Hennenberg, Martin/M-3474-2016	Kammerer, Robert/0000-0003-3038-8205; Schneider, Marlon/0000-0002-9570-3491	Faculty of Medicine, University of Munich	Faculty of Medicine, University of Munich	This work was supported in part by the FoFoLe program of the Faculty of Medicine, University of Munich, and is part of the doctoral theses of Constanze Schauble, Rosemarie Krupar, and Annegret Kamp at the University of Munich.	Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Conrad M, 2003, BIOTECHNIQUES, V34, P1136, DOI 10.2144/03346bm03; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; LIM DJ, 1987, HEARING RES, V28, P9; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; OBRINK B, 1991, BIOESSAYS, V13, P227, DOI 10.1002/bies.950130505; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Rau A, 1999, J COMP NEUROL, V405, P271; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sarantis H, 2007, CELL MICROBIOL, V9, P2167, DOI 10.1111/j.1462-5822.2007.00947.x; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	39	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21584	21598		10.1074/jbc.M111.320481	http://dx.doi.org/10.1074/jbc.M111.320481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544735	Green Published, hybrid			2022-12-28	WOS:000306418600003
J	Callen, L; Moreno, E; Barroso-Chinea, P; Moreno-Delgado, D; Cortes, A; Mallol, J; Casado, V; Lanciego, JL; Franco, R; Lluis, C; Canela, EI; McCormick, PJ				Callen, Lucia; Moreno, Estefania; Barroso-Chinea, Pedro; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Luis Lanciego, Jose; Franco, Rafael; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.			Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PINEAL-GLAND; ARYLALKYLAMINE N-ACETYLTRANSFERASE; NEURAL PROGENITOR PROLIFERATION; PROXIMITY LIGATION ASSAY; ENDOCANNABINOID SYSTEM; ADENOSINE A(2A); RETINOIC ACID; HUMAN NEUROBLASTOMA; NUCLEUS-ACCUMBENS; MICROGLIAL CELLS	Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.	[Callen, Lucia; Moreno, Estefania; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Callen, Lucia; Moreno, Estefania; Barroso-Chinea, Pedro; Moreno-Delgado, David; Cortes, Antoni; Mallol, Josefa; Casado, Vicent; Luis Lanciego, Jose; Lluis, Carmen; Canela, Enric I.; McCormick, Peter J.] Univ Navarra, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Pamplona 31008, Spain; [Barroso-Chinea, Pedro; Luis Lanciego, Jose; Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain	University of Barcelona; CIBERNED; University of Navarra; University of Navarra	McCormick, PJ (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, 643 Ave Diagonal,Planta 2, E-08028 Barcelona, Spain.	pmccormick@ub.edu	Lanciego, Jose L./G-7759-2015; Mallol, Josefa/I-4194-2015; Franco, Rafael/C-3694-2015; Canela, Enric I./M-8726-2013; Guillén, Estefanía Moreno/ABE-4371-2020; McCormick, Peter/E-7387-2012; Casadó, Vicent/K-1660-2014	Lanciego, Jose L./0000-0003-2301-5419; Mallol, Josefa/0000-0002-2479-4162; Franco, Rafael/0000-0003-2549-4919; Canela, Enric I./0000-0003-4992-7440; McCormick, Peter/0000-0002-2225-5181; Casadó, Vicent/0000-0002-1764-3825; Moreno, Estefania/0000-0002-2491-5753	Spanish Ministerio de Economia and Competitividad [SAF2010-18472, SAF2008-03229-E, SAF2008-03118-E]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) [PI2011/02-7]; Formacion de Profesorado Univesitario [AP2007-00808]	Spanish Ministerio de Economia and Competitividad; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Formacion de Profesorado Univesitario	This work was supported by Spanish Ministerio de Economia and Competitividad Grants SAF2010-18472, SAF2008-03229-E, and SAF2008-03118-E within the framework of the Era-NET Neuron program) and a grant for collaborative projects (Grant PI2011/02-7) from the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED). A Formacion de Profesorado Univesitario Fellow (Grant AP2007-00808).	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Akirav I, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00067; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Benito C, 2003, J NEUROSCI, V23, P11136; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Brusco A, 2008, SYNAPSE, V62, P944, DOI 10.1002/syn.20569; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Carriba P, 2007, NEUROPSYCHOPHARMACOL, V32, P2249, DOI 10.1038/sj.npp.1301375; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fernandez-Ruiz J, 2004, NEUROTOX RES, V6, P389, DOI 10.1007/BF03033314; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fiorentini C, 2010, CURR OPIN PHARMACOL, V10, P87, DOI 10.1016/j.coph.2009.09.008; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Garcia-Gutierrez MS, 2011, J PSYCHOPHARMACOL, V25, P111, DOI 10.1177/0269881110379507; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gonzalez S, 2012, MOL PSYCHIATR, V17, P650, DOI 10.1038/mp.2011.93; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Hosohata Y, 1997, EUR J PHARMACOL, V321, pR1, DOI 10.1016/S0014-2999(97)00047-2; HOWLETT AC, 1990, TRENDS NEUROSCI, V13, P420, DOI 10.1016/0166-2236(90)90124-S; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Irving A, 2011, CELL RES, V21, P1391, DOI 10.1038/cr.2011.77; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kleyer J, 2012, BIOCHEM PHARMACOL, V83, P1393, DOI 10.1016/j.bcp.2012.02.014; Koch M, 2008, J PINEAL RES, V45, P351, DOI 10.1111/j.1600-079X.2008.00597.x; Koch M, 2006, J NEUROCHEM, V98, P267, DOI 10.1111/j.1471-4159.2006.03873.x; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mackie K, 2005, LIFE SCI, V77, P1667, DOI 10.1016/j.lfs.2005.05.011; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Martin AB, 2008, NEUROPSYCHOPHARMACOL, V33, P1667, DOI 10.1038/sj.npp.1301558; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Moreno E, 2011, J NEUROSCI, V31, P7412, DOI 10.1523/JNEUROSCI.0191-11.2011; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarro G, 2008, THESCIENTIFICWORLDJO, V8, P1088, DOI 10.1100/tsw.2008.136; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Pertwee RG, 2007, BRIT J PHARMACOL, V152, P984, DOI 10.1038/sj.bjp.0707464; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pickel VM, 2006, J COMP NEUROL, V495, P299, DOI 10.1002/cne.20881; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Romero J, 2002, PHARMACOL THERAPEUT, V95, P137, DOI 10.1016/S0163-7258(02)00253-X; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Schneider U, 2005, NERVENARZT, V76, P1062, DOI 10.1007/s00115-005-1888-7; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tebano MT, 2009, J NEUROCHEM, V110, P1921, DOI 10.1111/j.1471-4159.2009.06282.x; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Venance L, 2004, M S-MED SCI, V20, P45, DOI 10.1051/medsci/200420145; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057	91	152	155	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20851	20865		10.1074/jbc.M111.335273	http://dx.doi.org/10.1074/jbc.M111.335273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532560	hybrid, Green Published			2022-12-28	WOS:000306416800007
J	Khromov, AS; Momotani, K; Jin, L; Artamonov, MV; Shannon, J; Eto, M; Somlyo, AV				Khromov, Alexander S.; Momotani, Ko; Jin, Li; Artamonov, Mykhaylo V.; Shannon, John; Eto, Masumi; Somlyo, Avril V.			Molecular Mechanism of Telokin-mediated Disinhibition of Myosin Light Chain Phosphatase and cAMP/cGMP-induced Relaxation of Gastrointestinal Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOA/RHO KINASE PATHWAY; RHO-ASSOCIATED KINASE; PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION; HEAVY-MEROMYOSIN; IN-VIVO; PHOSPHORYLATION; SUBUNIT; INHIBITION	Phospho-telokin is a target of elevated cyclic nucleotide concentrations that lead to relaxation of gastrointestinal and some vascular smooth muscles (SM). Here, we demonstrate that in telokin-null SM, both Ca2+-activated contraction and Ca(2+)sensitization of force induced by a GST-MYPT1(654-880) fragment inhibiting myosin light chain phosphatase were antagonized by the addition of recombinant S13D telokin, without changing the inhibitory phosphorylation status of endogenous MYPT1 (the regulatory subunit of myosin light chain phosphatase) at Thr-696/Thr-853 or activity of Rho kinase. Cyclic nucleotide-induced relaxation of force in telokin-null ileum muscle was reduced but not correlated with a change in MYPT1 phosphorylation. The 40% inhibited activity of phosphorylated MYPT1 in telokin-null ileum homogenates was restored to nonphosphorylated MYPT1 levels by addition of S13D telokin. Using the GST-MYPT1 fragment as a ligand and SM homogenates from WT and telokin KO mice as a source of endogenous proteins, we found that only in the presence of endogenous telokin, thiophospho-GST-MYPT1 co-precipitated with phospho-20-kDa myosin regulatory light chain 20 and PP1. Surface plasmon resonance studies showed that S13D telokin bound to full-length phospho-MYPT1. Results of a protein ligation assay also supported interaction of endogenous phosphorylated MYPT1 with telokin in SM cells. We conclude that the mechanism of action of phospho-telokin is not through modulation of the MYPT1 phosphorylation status but rather it contributes to cyclic nucleotide-induced relaxation of SM by interacting with and activating the inhibited full-length phospho-MYPT1/PP1 through facilitating its binding to phosphomyosin and thus accelerating 20-kDa myosin regulatory light chain dephosphorylation.	[Khromov, Alexander S.; Momotani, Ko; Jin, Li; Artamonov, Mykhaylo V.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Shannon, John] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Virginia; University of Virginia; Jefferson University	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021; Eto, Masumi/ABE-4700-2020	Artamonov, Mykhaylo/0000-0002-0848-2054; Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [R01 DK088905]; NIGMS [R01 GM086457]; School of Medicine, University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); School of Medicine, University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK088905 (to A. V. S. and M. E.) and Grant R01 GM086457 from NIGMS (to A. V. S.).; We thank Howard Phipps for excellent help in preparation of the manuscript. SPR analysis was performed in the Biomolecular Research Facility, which is supported by the School of Medicine, University of Virginia. We are grateful to Bartosz Zieba for production of recombinant telokins.	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hilgers RHP, 2007, J HYPERTENS, V25, P1687, DOI 10.1097/HJH.0b013e32816f778d; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; IKEBE M, 1988, J BIOL CHEM, V263, P10698; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; ITO M, 1989, J BIOL CHEM, V264, P13971; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319; Karandikar M, 1999, CELL CALCIUM, V26, P219, DOI 10.1054/ceca.1999.0074; Kawano S, 1999, J BIOL CHEM, V274, P2085, DOI 10.1074/jbc.274.4.2085; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2000, FEBS LETT, V479, P83, DOI 10.1016/S0014-5793(00)01884-6; Madden JA, 2008, AM J PHYSIOL-LUNG C, V294, pL1166, DOI 10.1152/ajplung.00375.2007; Masato T, 1997, J BIOCHEM, V121, P225; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Mori D, 2011, NEUROGASTROENT MOTIL, V23, P1111, DOI 10.1111/j.1365-2982.2011.01799.x; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Puetz S., 2010, ACTA PHYSL, V198; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRINSKY VP, 1993, J BIOL CHEM, V268, P16578; Silver DL, 1997, J BIOL CHEM, V272, P25353, DOI 10.1074/jbc.272.40.25353; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	60	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20975	20985		10.1074/jbc.M112.341479	http://dx.doi.org/10.1074/jbc.M112.341479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544752	hybrid, Green Published			2022-12-28	WOS:000306416800019
J	Kim, JK; Kwon, O; Kim, J; Kim, EK; Park, HK; Lee, JE; Kim, KL; Choi, JW; Lim, S; Seok, H; Lee-Kwon, W; Choi, JH; Kang, BH; Kim, S; Ryu, SH; Suh, PG				Kim, Jung Kuk; Kwon, Ohman; Kim, Jinho; Kim, Eung-Kyun; Park, Hye Kyung; Lee, Ji Eun; Kim, Kyung Lock; Choi, Jung Woong; Lim, Seyoung; Seok, Heon; Lee-Kwon, Whaseon; Choi, Jang Hyun; Kang, Byoung Heon; Kim, Sanguk; Ryu, Sung Ho; Suh, Pann-Ghill			PDZ Domain-containing 1 (PDZK1) Protein Regulates Phospholipase C-beta 3 (PLC-beta 3)-specific Activation of Somatostatin by Forming a Ternary Complex with PLC-beta 3 and Somatostatin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-BETA; SIGNAL-TRANSDUCTION; INTRINSIC DISORDER; SCAFFOLD PROTEINS; ACID SEQUENCES; BINDING SITES; SPECIFICITY; ISOZYMES; HORMONE; INAD	Phospholipase C-beta(PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. Many studies have shown that the four PLC-beta subtypes have different physiological functions despite their similar structures. Because the PLC-beta subtypes possess different PDZ-binding motifs, they have the potential to interact with different PDZ proteins. In this study, we identified PDZ domain-containing 1 (PDZK1) as a PDZ protein that specifically interacts with PLC-beta 3. To elucidate the functional roles of PDZK1, we next screened for potential interacting proteins of PDZK1 and identified the somatostatin receptors (SSTRs) as another protein that interacts with PDZK1. Through these interactions, PDZK1 assembles as a ternary complex with PLC-beta 3 and SSTRs. Interestingly, the expression of PDZK1 and PLC-beta 3, but not PLC-beta 1, markedly potentiated SST-induced PLC activation. However, disruption of the ternary complex inhibited SST-induced PLC activation, which suggests that PDZK1-mediated complex formation is required for the specific activation of PLC-beta 3 by SST. Consistent with this observation, the knockdown of PDZK1 or PLC-beta 3, but not that of PLC-beta 1, significantly inhibited SST-induced intracellular Ca2+ mobilization, which further attenuated subsequent ERK1/2 phosphorylation. Taken together, our results strongly suggest that the formation of a complex between SSTRs, PDZK1, and PLC-beta 3 is essential for the specific activation of PLC-beta 3 and the subsequent physiologic responses by SST.	[Kim, Jung Kuk; Kim, Eung-Kyun; Park, Hye Kyung; Lee, Ji Eun; Seok, Heon; Lee-Kwon, Whaseon; Choi, Jang Hyun; Kang, Byoung Heon; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea; [Kim, Jung Kuk; Kim, Jinho; Kim, Kyung Lock; Choi, Jung Woong; Lim, Seyoung; Kim, Sanguk; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Kwon, Ohman] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	Ulsan National Institute of Science & Technology (UNIST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea.	pgsuh@unist.ac.kr	Kwon, Ohman/AAQ-6377-2021; Kang, Byoung Heon/E-6165-2010; Choi, Jang Hyun/B-3055-2012; Suh, Pann-Ghill/F-3610-2010	Kang, Byoung Heon/0000-0001-5902-0549; Kim, Kyung Lock/0000-0001-6514-4935; Ryu, Sung Ho/0000-0003-0913-3048; Kim, Sanguk/0000-0002-3449-3814	National Research Foundation of Korea [KRP-2007-341-C00027, 2011-0000878, PGB013]; Korean Government; Korea Health Technology Research and Development Project [A084022]; Ministry of Health and Welfare, Republic of Korea; UNIST (Ulsan National Institute of Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Korea Health Technology Research and Development Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); UNIST (Ulsan National Institute of Science and Technology)	This work was supported by National Research Foundation of Korea Grants KRP-2007-341-C00027 and 2011-0000878 funded by the Korean Government, Fusion Pioneer Project PGB013 from the National Research Foundation of Korea, and Korea Health Technology Research and Development Project A084022, Ministry of Health and Welfare, Republic of Korea and the year of 2010 Research Fund of the UNIST (Ulsan National Institute of Science and Technology).	AKBAR M, 1994, FEBS LETT, V348, P192, DOI 10.1016/0014-5793(94)00603-2; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BRISTOL JA, 1994, TRENDS ENDOCRIN MET, V5, P402, DOI 10.1016/1043-2760(95)92522-K; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; COSIC I, 1994, IEEE T BIO-MED ENG, V41, P1101, DOI 10.1109/10.335859; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Day P, 2006, TRENDS PHARMACOL SCI, V27, P509, DOI 10.1016/j.tips.2006.08.003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Ghosh MG, 2000, CANCER RES, V60, P6367; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Kim JK, 2011, CELL SIGNAL, V23, P1022, DOI 10.1016/j.cellsig.2011.01.017; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rosskopf D, 2003, AM J PHYSIOL-CELL PH, V284, pC179, DOI 10.1152/ajpcell.00160.2001; Rubina K, 2005, MOL CELL BIOCHEM, V273, P33, DOI 10.1007/s11010-005-0250-5; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Strassheim D, 2000, J BIOL CHEM, V275, P39767, DOI 10.1074/jbc.M007775200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vaccaro P, 2001, J BIOL CHEM, V276, P42122, DOI 10.1074/jbc.M104208200; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	65	20	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21012	21024		10.1074/jbc.M111.337865	http://dx.doi.org/10.1074/jbc.M111.337865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22528496	hybrid, Green Published			2022-12-28	WOS:000306416800023
J	Valley, CC; Lewis, AK; Mudaliar, DJ; Perlmutter, JD; Braun, AR; Karim, CB; Thomas, DD; Brody, JR; Sachs, JN				Valley, Christopher C.; Lewis, Andrew K.; Mudaliar, Deepti J.; Perlmutter, Jason D.; Braun, Anthony R.; Karim, Christine B.; Thomas, David D.; Brody, Jonathan R.; Sachs, Jonathan N.			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Death Receptor 5 Networks That Are Highly Organized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; DR5 MONOCLONAL-ANTIBODY; TUMORICIDAL ACTIVITY; CRYSTAL-STRUCTURE; CANCER-CELLS; TRANSMEMBRANE HELICES; FUNCTIONAL-ANALYSIS; REGULATORY COMPLEX; TARGETING DEATH; SOLID TUMORS	Recent evidence suggests that TNF-related apoptosis-inducing ligand (TRAIL), a death-inducing cytokine with anti-tumor potential, initiates apoptosis by re-organizing TRAIL receptors into large clusters, although the structure of these clusters and the mechanism by which they assemble are unknown. Here, we demonstrate that TRAIL receptor 2 (DR5) forms receptor dimers in a ligand-dependent manner at endogenous receptor levels, and these receptor dimers exist within high molecular weight networks. Using mutational analysis, FRET, fluorescence microscopy, synthetic biochemistry, and molecular modeling, we find that receptor dimerization relies upon covalent and noncovalent interactions between membrane-proximal residues. Additionally, by using FRET, we show that the oligomeric structure of two functional isoforms of DR5 is indistinguishable. The resulting model of DR5 activation should revise the accepted architecture of the functioning units of DR5 and the structurally homologous TNF receptor superfamily members.	[Valley, Christopher C.; Lewis, Andrew K.; Mudaliar, Deepti J.; Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Karim, Christine B.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Brody, Jonathan R.] Thomas Jefferson Univ, Jefferson Med Coll, Div Surg Res, Dept Surg, Philadelphia, PA 19107 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University	Sachs, JN (corresponding author), Univ Minnesota, Dept Biomed Engn, Rm 7-105 NHH,312 Church St SE, Minneapolis, MN 55455 USA.	jnsachs@umn.edu		Thomas, David D./0000-0002-8822-2040; Braun, Anthony/0000-0002-9942-3390; Perlmutter, Jason/0000-0003-2855-2360; Karim, Christine/0000-0002-7321-7695	NIH [R21 CA152668, GM27906]; ACS [IRG-58-001-49 IRG 49-28]; NATIONAL CANCER INSTITUTE [R21CA152668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by grants to J. N. S. (NIH R21 CA152668 and ACS IRG-58-001-49 IRG 49-28) and to D. D. T. (NIH GM27906).	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Arai T, 1998, CANCER LETT, V133, P197, DOI 10.1016/S0304-3835(98)00230-4; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Baritaki S, 2007, MOL CANCER THER, V6, P1387, DOI 10.1158/1535-7163.MCT-06-0521; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Camidge DR, 2008, EXPERT OPIN BIOL TH, V8, P1167, DOI 10.1517/14712598.8.8.1167 ; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li J, 2008, DRUG DEVELOP RES, V69, P69, DOI 10.1002/ddr.20229; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Ozsoy HZ, 2008, J BIOL CHEM, V283, P23419, DOI 10.1074/jbc.M802967200; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pavet V, 2010, CANCER RES, V70, P1101, DOI 10.1158/0008-5472.CAN-09-2889; Raghunathan A, 2001, EXP CELL RES, V268, P230, DOI 10.1006/excr.2001.5290; Ranzinger J, 2009, NANO LETT, V9, P4240, DOI 10.1021/nl902429b; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Rosevear HM, 2010, CURR OPIN INVEST DR, V11, P688; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Thomas LR, 2004, J BIOL CHEM, V279, P52479, DOI 10.1074/jbc.M409578200; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Yasuda T, 2008, MOL CANCER RES, V6, P1852, DOI 10.1158/1541-7786.MCR-08-0012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062	73	53	57	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21265	21278		10.1074/jbc.M111.306480	http://dx.doi.org/10.1074/jbc.M111.306480			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22496450	hybrid, Green Published			2022-12-28	WOS:000306416800046
J	Wang, GH; Dinkins, M; He, Q; Zhu, G; Poirier, C; Campbell, A; Mayer-Proschel, M; Bieberich, E				Wang, Guanghu; Dinkins, Michael; He, Qian; Zhu, Gu; Poirier, Christophe; Campbell, Andrew; Mayer-Proschel, Margot; Bieberich, Erhard			Astrocytes Secrete Exosomes Enriched with Proapoptotic Ceramide and Prostate Apoptosis Response 4 (PAR-4) POTENTIAL MECHANISM OF APOPTOSIS INDUCTION IN ALZHEIMER DISEASE (AD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE C-ZETA; AMYLOID-BETA; UP-REGULATION; MOUSE-BRAIN; GLIAL-CELLS; STEM-CELLS; ASTROGLIA; NEURONS; PROTEIN; DEGENERATION	Amyloid protein is well known to induce neuronal cell death, whereas only little is known about its effect on astrocytes. We found that amyloid peptides activated caspase 3 and induced apoptosis in primary cultured astrocytes, which was prevented by caspase 3 inhibition. Apoptosis was also prevented by shRNA-mediated down-regulation of PAR-4, a protein sensitizing cells to the sphingolipid ceramide. Consistent with a potentially proapoptotic effect of PAR-4 and ceramide, astrocytes surrounding amyloid plaques in brain sections of the 5xFAD mouse (and Alzheimer disease patient brain) showed caspase 3 activation and were apoptotic when co-expressing PAR-4 and ceramide. Apoptosis was not observed in astrocytes with deficient neutral sphingomyelinase 2 (nSMase2), indicating that ceramide generated by nSMase2 is critical for amyloid-induced apoptosis. Antibodies against PAR-4 and ceramide prevented amyloid-induced apoptosis in vitro and in vivo, suggesting that apoptosis was mediated by exogenous PAR-4 and ceramide, potentially associated with secreted lipid vesicles. This was confirmed by the analysis of lipid vesicles from conditioned medium showing that amyloid peptide induced the secretion of PAR-4 and C18 ceramide-enriched exosomes. Exosomes were not secreted by nSMase2-deficient astrocytes, indicating that ceramide generated by nSMase2 is critical for exosome secretion. Consistent with the ceramide composition in amyloid-induced exosomes, exogenously added C18 ceramide restored PAR-4-containing exosome secretion in nSMase2-deficient astrocytes. Moreover, isolated PAR-4/ceramide-enriched exosomes were taken up by astrocytes and induced apoptosis in the absence of amyloid peptide. Taken together, we report a novel mechanism of apoptosis induction by PAR-4/ceramide-enriched exosomes, which may critically contribute to Alzheimer disease.	[Bieberich, Erhard] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Poirier, Christophe] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA; [Campbell, Andrew; Mayer-Proschel, Margot] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Rochester	Bieberich, E (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, 1120 15th St,Rm CA4012, Augusta, GA 30912 USA.	ebieberich@georgiahealth.edu			National Institutes of Health [1R01AG034389]; Georgia Health Sciences University; American Heart Association; NATIONAL INSTITUTE ON AGING [R01AG034389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Health Sciences University; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AG034389 (to E. B.). G. W. is supported by awards from Georgia Health Sciences University and American Heart Association.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bieberich E, 2000, J BIOL CHEM, V275, P177, DOI 10.1074/jbc.275.1.177; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bieberich E, 2011, JOVE-J VIS EXP, DOI 10.3791/2657; Bieberich E, 2011, NEUROCHEM RES, V36, P1601, DOI 10.1007/s11064-010-0338-5; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Caraci F, 2005, BRAIN RES, V1047, P30, DOI 10.1016/j.brainres.2005.04.004; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fukunaga T, 2000, J CELL SCI, V113, P3299; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gamen S, 1998, J IMMUNOL, V161, P1758; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Kobayashi K, 2002, NEUROPATH APPL NEURO, V28, P238, DOI 10.1046/j.1365-2990.2002.00390.x; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lopez-Montero I, 2005, J BIOL CHEM, V280, P25811, DOI 10.1074/jbc.M412052200; Mattson MP, 1999, J MOL NEUROSCI, V13, P17, DOI 10.1385/JMN:13:1-2:17; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Wang GH, 2009, J BIOL CHEM, V284, P14469, DOI 10.1074/jbc.M808909200; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	48	246	258	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21384	21395		10.1074/jbc.M112.340513	http://dx.doi.org/10.1074/jbc.M112.340513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532571	Green Published, hybrid			2022-12-28	WOS:000306416800056
J	Winkler, E; Kamp, F; Scheuring, J; Ebke, A; Fukumori, A; Steiner, H				Winkler, Edith; Kamp, Frits; Scheuring, Johannes; Ebke, Amelie; Fukumori, Akio; Steiner, Harald			Generation of Alzheimer Disease-associated Amyloid beta(42/43) Peptide by gamma-Secretase Can Be Inhibited Directly by Modulation of Membrane Thickness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN; BILAYER THICKNESS; PRESENILIN; LIPIDS; CHOLESTEROL; COMPLEX; RECONSTITUTION; TRAFFICKING; MUTATIONS; MECHANISM	Pathogenic generation of amyloid beta-peptide (A beta) by sequential cleavage of beta-amyloid precursor protein (APP) by beta- and gamma-secretases is widely believed to causally underlie Alzheimer disease (AD). beta-Secretase initially cleaves APP thereby generating a membrane-bound APP C-terminal fragment, from which gamma-secretase subsequently liberates 37-43-amino acid long A beta species. Although the latter cleavages are intramembranous and although lipid alterations have been implicated in AD, little is known of how the gamma-secretase-mediated release of the various A beta species, in particular that of the pathogenic longer variants A beta(42) and A beta(43), is affected by the lipid environment. Using a cell-free system, we have directly and systematically investigated the activity of gamma-secretase reconstituted in defined model membranes of different thicknesses. We found that bilayer thickness is a critical parameter affecting both total activity as well as cleavage specificity of gamma-secretase. Whereas the generation of the pathogenic A beta(42/43) species was markedly attenuated in thick membranes, that of the major and rather benign A beta(40) species was enhanced. Moreover, the increased production of A beta(42/43) by familial AD mutants of presenilin 1, the catalytic subunit of gamma-secretase, could be substantially lowered in thick membranes. Our data demonstrate an effective modulation of gamma-secretase activity by membrane thickness, which may provide an approach to lower the generation of the pathogenic A beta(42/43) species.	[Winkler, Edith; Kamp, Frits; Ebke, Amelie; Fukumori, Akio; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Winkler, Edith; Kamp, Frits; Ebke, Amelie; Fukumori, Akio; Steiner, Harald] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Scheuring, Johannes] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich	Steiner, H (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen); Alzheimer Research Award of the Hans and Ilse Breuer Foundation; Center of Integrated Protein Science Munich; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen)(Federal Ministry of Education & Research (BMBF)); Alzheimer Research Award of the Hans and Ilse Breuer Foundation; Center of Integrated Protein Science Munich; Elitenetzwerk Bayern	This work was supported by the Deutsche Forschungsgemeinschaft (SFB596), the Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerative Demenzen), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and the Center of Integrated Protein Science Munich.; Supported by the Elitenetzwerk Bayern.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Small D. M., 1986, PHYS CHEM LIPIDS ALK; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200; Zhou H, 2010, BIOCHEM BIOPH RES CO, V402, P291, DOI 10.1016/j.bbrc.2010.10.017; Zinser EG, 2007, BBA-BIOMEMBRANES, V1768, P1991, DOI 10.1016/j.bbamem.2007.02.014	49	76	79	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21326	21334		10.1074/jbc.M112.356659	http://dx.doi.org/10.1074/jbc.M112.356659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532566	Green Published, hybrid			2022-12-28	WOS:000306416800051
J	Adijanto, J; Castorino, JJ; Wang, ZX; Maminishkis, A; Grunwald, GB; Philp, NJ				Adijanto, Jeffrey; Castorino, John J.; Wang, Zi-Xuan; Maminishkis, Arvydas; Grunwald, Gerald B.; Philp, Nancy J.			Microphthalmia-associated Transcription Factor (MITF) Promotes Differentiation of Human Retinal Pigment Epithelium (RPE) by Regulating microRNAs-204/211 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; GENE-THERAPY; CONGENITAL AMAUROSIS; MICRORNA EXPRESSION; MIR-200 FAMILY; CELL FATE; LET-7; GROWTH; HMGA2; IDENTIFICATION	The retinal pigment epithelium (RPE) plays a fundamental role in maintaining visual function and dedifferentiation of RPE contributes to the pathophysiology of several ocular diseases. To identify microRNAs (miRNAs) that may be involved in RPE differentiation, we compared the miRNA expression profiles of differentiated primary human fetal RPE (hfRPE) cells to dedifferentiated hfRPE cells. We found that miR-204/211, the two most highly expressed miRNAs in the RPE, were significantly down-regulated in dedifferentiated hfRPE cells. Importantly, transfection of pre-miR-204/211 into hfRPE cells promoted differentiation whereas adding miR-204/211 inhibitors led to their dedifferentiation. Microphthalmia-associated transcription factor (MITF) is a key regulator of RPE differentiation that was also down-regulated in dedifferentiated hfRPE cells. MITF knockdown decreased miR-204/211 expression and caused hfRPE dedifferentiation. Significantly, co-transfection of MITF siRNA with pre-miR-204/211 rescued RPE phenotype. Collectively, our data show that miR-204/211 promote RPE differentiation, suggesting that miR-204/211-based therapeutics may be effective treatments for diseases that involve RPE dedifferentiation such as proliferative vitreoretinopathy.	[Adijanto, Jeffrey; Castorino, John J.; Wang, Zi-Xuan; Grunwald, Gerald B.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Anat Pathol & Cell Biol, Philadelphia, PA 19107 USA; [Maminishkis, Arvydas] NEI, NIH, Bethesda, MD 20892 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Anat Pathol & Cell Biol, 1020 Locust St,Rm 534, Philadelphia, PA 19107 USA.	nancy.philp@jefferson.edu		Maminishkis, Arvydas/0000-0003-3345-3375; Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY-012042]; NATIONAL EYE INSTITUTE [ZIAEY000419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-012042 (to N. J. P.).	Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gallagher-Colombo S, 2010, INVEST OPHTH VIS SCI, V51, P5343, DOI 10.1167/iovs.09-5028; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; King IN, 2011, DEV CELL, V20, P497, DOI 10.1016/j.devcel.2011.03.010; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/bjo.2009.174912; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Sparrrow JR, 2010, CURR MOL MED, V10, P802; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tsukiji N, 2009, DEV BIOL, V326, P335, DOI 10.1016/j.ydbio.2008.11.029; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yasumoto K, 1997, J BIOL CHEM, V272, P503; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhu Y, 2011, NUCL ACIDS IN PRESS	57	78	85	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20491	20503		10.1074/jbc.M112.354761	http://dx.doi.org/10.1074/jbc.M112.354761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523078	Green Published, hybrid			2022-12-28	WOS:000306414500070
J	Cliffe, LJ; Hirsch, G; Wang, J; Ekanayake, D; Bullard, W; Hu, MH; Wang, YS; Sabatini, R				Cliffe, Laura J.; Hirsch, Gwen; Wang, Jin; Ekanayake, Dilrukshi; Bullard, Whitney; Hu, Muhan; Wang, Yinsheng; Sabatini, Robert			JBP1 and JBP2 Proteins Are Fe2+/2-Oxoglutarate-dependent Dioxygenases Regulating Hydroxylation of Thymidine Residues in Trypanosome DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED BASE J; 2-OXOGLUTARATE OXYGENASES; SWI2/SNF2-LIKE PROTEIN; BINDING PROTEIN; BRUCEI; GENE; BIOSYNTHESIS; THYMINE; KETOGLUTARATE; GLYCOSYLATION	We have recently demonstrated that O-linked glucosylation of thymine in trypanosome DNA(base J) regulates polymerase II transcription initiation. In vivo analysis has indicated that base J synthesis is initiated by the hydroxylation of thymidine by proteins (JBP1 and JBP2) homologous to the Fe2+/2-oxoglutarate (2-OG)-dependent dioxygenase superfamily where hydroxylation is driven by the oxidative decarboxylation of 2-OG, forming succinate and CO2. However, no direct evidence for hydroxylase activity has been reported for the JBP proteins. We now demonstrate recombinant JBP1 hydroxylates thymine specifically in the context of dsDNA in a Fe2+-, 2-OG-, and O-2-dependent manner. Under anaerobic conditions, the addition of Fe2+ to JBP1/2-OG results in the formation of a broad absorption spectrum centered at 530 nm attributed to metal chelation of 2-OG bound to JBP, a spectroscopic signature of Fe2+/2-OG-dependent dioxygenases. The N-terminal thymidine hydroxylase domain of JBP1 is sufficient for full activity and mutation of residues involved in coordinating Fe2+ inhibit iron binding and thymidine hydroxylation. Hydroxylation in vitro and J synthesis in vivo is inhibited by known inhibitors of Fe2+/2-OG-dependent dioxygenases. The data clearly demonstrate the JBP enzymes are dioxygenases acting directly on dsDNA, confirming the two-step J synthesis model. Growth of trypanosomes in hypoxic conditions decreases JBP1 and -2 activity, resulting in reduced levels of J and changes in parasite virulence previously characterized in the JBP KO. The influence of environment upon J biosynthesis via oxygen-sensitive regulation of JBP1/2 has exciting implications for the regulation of gene expression and parasite adaptation to different host niches.	[Cliffe, Laura J.; Hirsch, Gwen; Ekanayake, Dilrukshi; Bullard, Whitney; Hu, Muhan; Sabatini, Robert] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Wang, Jin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University System of Georgia; University of Georgia; University of California System; University of California Riverside	Sabatini, R (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Davidson Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	rsabatini@bmb.uga.edu	Wang, Jin/AAE-3809-2022	Wang, Jin/0000-0001-5511-3983	National Institutes of Health [2R56AI063523-07A1, R01 CA101864]; NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063523, R01AI063523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R56AI063523-07A1 (to R. S.) and R01 CA101864 (to Y. W.).	Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cazzulo Juan Jose, 1992, V18, P235; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; DiPaolo C, 2005, MOL CELL, V17, P441, DOI 10.1016/j.molcel.2004.12.022; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Ekanayake DK, 2011, MOL CELL BIOL, V31, P1690, DOI 10.1128/MCB.01277-10; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; FAIRLAMB AH, 1986, MOL BIOCHEM PARASIT, V21, P247, DOI 10.1016/0166-6851(86)90130-1; Frelon S, 2000, CHEM RES TOXICOL, V13, P1002, DOI 10.1021/tx000085h; Genest PA, 2005, NUCLEIC ACIDS RES, V33, P1699, DOI 10.1093/nar/gki304; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; HOLME E, 1970, BIOCHIM BIOPHYS ACTA, V212, P50, DOI 10.1016/0005-2744(70)90177-4; Hong HZ, 2006, CHEM RES TOXICOL, V19, P614, DOI 10.1021/tx060025x; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kieft R, 2007, MOL BIOCHEM PARASIT, V156, P24, DOI 10.1016/j.molbiopara.2007.06.010; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Sabatini R, 2002, J BIOL CHEM, V277, P958, DOI 10.1074/jbc.M109000200; Sabatini R. C., 2008, DNA RNA MODIFICATION, P120; SIGMAN DS, 1991, METHOD ENZYMOL, V208, P414; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vainio S, 2009, MOL BIOCHEM PARASIT, V164, P157, DOI 10.1016/j.molbiopara.2008.12.001; van Leeuwen F, 1998, MOL BIOCHEM PARASIT, V94, P127, DOI 10.1016/S0166-6851(98)00060-7; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	44	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19886	19895		10.1074/jbc.M112.341974	http://dx.doi.org/10.1074/jbc.M112.341974			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22514282	Green Published, hybrid			2022-12-28	WOS:000306414500011
J	Cuperlovic-Culf, M; Ferguson, D; Culf, A; Morin, PJ; Touaibia, M				Cuperlovic-Culf, Miroslava; Ferguson, Dean; Culf, Adrian; Morin, Pier Jr; Touaibia, Mohamed			H-1 NMR Metabolomics Analysis of Glioblastoma Subtypes CORRELATION BETWEEN METABOLOMICS AND GENE EXPRESSION CHARACTERISTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SIGNALING PATHWAY; HUMAN BRAIN; CANCER; METABOLITES; NMR; SPECTROSCOPY; SPECTRA; EGFR	Glioblastoma multiforme (GBM) is the most common form of malignant glioma, characterized by unpredictable clinical behaviors that suggest distinct molecular subtypes. With the tumor metabolic phenotype being one of the hallmarks of cancer, we have set upon to investigate whether GBMs show differences in their metabolic profiles. H-1 NMR analysis was performed on metabolite extracts from a selection of nine glioblastoma cell lines. Analysis was performed directly on spectral data and on relative concentrations of metabolites obtained from spectra using a multivariate regression method developed in this work. Both qualitative and quantitative sample clustering have shown that cell lines can be divided into four groups for which the most significantly different metabolites have been determined. Analysis shows that some of the major cancer metabolic markers (such as choline, lactate, and glutamine) have significantly dissimilar concentrations in different GBM groups. The obtained lists of metabolic markers for subgroups were correlated with gene expression data for the same cell lines. Metabolic analysis generally agrees with gene expression measurements, and in several cases, we have shown in detail how the metabolic results can be correlated with the analysis of gene expression. Combined gene expression and metabolomics analysis have shown differential expression of transporters of metabolic markers in these cells as well as some of the major metabolic pathways leading to accumulation of metabolites. Obtained lists of marker metabolites can be leveraged for subtype determination in glioblastomas.	[Cuperlovic-Culf, Miroslava] Natl Res Council Canada, Moncton, NB E1A 7R1, Canada; [Ferguson, Dean; Morin, Pier Jr; Touaibia, Mohamed] Univ Moncton, Dept Chem & Biochem, Moncton, NB E1A 3E9, Canada; [Culf, Adrian] Atlantic Canc Res Inst, Moncton, NB E1C 8X3, Canada	National Research Council Canada; University of Moncton	Cuperlovic-Culf, M (corresponding author), Natl Res Council Canada, 100 Aboiteaux St, Moncton, NB E1A 7R1, Canada.	miroslava.cuperlovic-culf@nrc-cnrc.gc.ca	Cuperlovic-Culf, Miroslava/C-7876-2016	Cuperlovic-Culf, Miroslava/0000-0002-9483-8159	CFI; NRC Cluster Initiative; Atlantic Cancer Research Institute; Beatrice Hunter Cancer Research Institute; Brain Tumor Foundation of Canada	CFI(Canada Foundation for Innovation); NRC Cluster Initiative; Atlantic Cancer Research Institute; Beatrice Hunter Cancer Research Institute; Brain Tumor Foundation of Canada	We thank M. Monette (Bruker Canada) for help in setting up NMR experiments. We acknowledge the contribution of the Canadian Foundation for Innovation (CFI), the New Brunswick Innovation Foundation (NBIF), and Universite de Moncton for the acquisition of the NMR instrument. We also acknowledge the support of the CFI for the funding of a portion of operating costs and maintenance for the NMR instrument through the Infrastructure Operating Fund (IOF).; Supported by the NRC Cluster Initiative. To whom correspondence should be addressed: National Research Council of Canada, 100 des Aboiteaux St., Moncton, New Brunswick E1A 7R1, Canada. Tel.: 506-861-0952; E-mail: miroslava.cuperlovic-culf@nrc-cnrc.gc.ca.; Supported by the Atlantic Cancer Research Institute.; Supported by the Beatrice Hunter Cancer Research Institute and the Brain Tumor Foundation of Canada.	Belacel N, 2004, BIOINFORMATICS, V20, P1690, DOI 10.1093/bioinformatics/bth142; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brandes AH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2729; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; Cuperlovic-Culf M, 2009, MAGN RESON CHEM, V47, pS96, DOI 10.1002/mrc.2502; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Florian CL, 1995, NMR BIOMED, V8, P253, DOI 10.1002/nbm.1940080605; FLORIAN CL, 1995, CANCER RES, V55, P420; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffin JL, 2007, FEBS J, V274, P1132, DOI 10.1111/j.1742-4658.2007.05676.x; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; HOWELLS SI, 1992, NMR BIOMED, V5, P59, DOI 10.1002/nbm.1940050203; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuksis A, 2003, INOSITOL PHOSPHOLIPI, P335; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tulpan D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-400; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1924, BIOCHEM Z, V152, P319; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; ZANER KS, 1977, PHYSIOL CHEM PHYS M, V9, P473	28	52	54	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20164	20175		10.1074/jbc.M111.337196	http://dx.doi.org/10.1074/jbc.M111.337196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528487	Green Published, hybrid			2022-12-28	WOS:000306414500037
J	Shao, BJ; Yago, T; Coghill, PA; Klopocki, AG; Mehta-D'souza, P; Schmidtke, DW; Rodgers, W; McEver, RP				Shao, Bojing; Yago, Tadayuki; Coghill, Phillip A.; Klopocki, Arkadiusz G.; Mehta-D'souza, Padmaja; Schmidtke, David W.; Rodgers, William; McEver, Rodger P.			Signal-dependent Slow Leukocyte Rolling Does Not Require Cytoskeletal Anchorage of P-selectin Glycoprotein Ligand-1 (PSGL-1) or Integrin alpha(L)beta(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; CONFORMATIONAL-CHANGES; ACTIN CYTOSKELETON; STRUCTURAL BASIS; PLASMA-MEMBRANE; MOESIN-BINDING; CELL-ADHESION; ERM PROTEINS; CATCH BONDS; ACTIVATION	In inflamed venules, neutrophils roll on P- or E-selectin, engage P-selectin glycoprotein ligand-1 (PSGL-1), and signal extension of integrin alpha(L)beta(2) in a low affinity state to slow rolling on intercellular adhesion molecule-1 (ICAM-1). Cytoskeleton-dependent receptor clustering often triggers signaling, and it has been hypothesized that the cytoplasmic domain links PSGL-1 to the cytoskeleton. Chemokines cause rolling neutrophils to fully activate alpha(L)beta(2), leading to arrest on ICAM-1. Cytoskeletal anchorage of alpha(L)beta(2) has been linked to chemokine-triggered extension and force-regulated conversion to the high affinity state. We asked whether PSGL-1 must interact with the cytoskeleton to initiate signaling and whether alpha(L)beta(2) must interact with the cytoskeleton to extend. Fluorescence recovery after photobleaching of transfected cells documented cytoskeletal restraint of PSGL-1. The lateral mobility of PSGL-1 similarly increased by depolymerizing actin filaments with latrunculin B or by mutating the cytoplasmic tail to impair binding to the cytoskeleton. Converting dimeric PSGL-1 to a monomer by replacing its transmembrane domain did not alter its mobility. By transducing retroviruses expressing WT or mutant PSGL-1 into bone marrow-derived macrophages from PSGL-1-deficient mice, we show that PSGL-1 required neither dimerization nor cytoskeletal anchorage to signal beta(2) integrin-dependent slow rolling on P- selectin and ICAM-1. Depolymerizing actin filaments or decreasing actomyosin tension in neutrophils did not impair PSGL-1- or chemokine-mediated integrin extension. Unlike chemokines, PSGL-1 did not signal cytoskeleton-dependent swing out of the beta(2)-hybrid domain associated with the high affinity state. The cytoskeletal independence of PSGL-1- initiated, alpha(L)beta(2)-mediated slow rolling differs markedly from the cytoskeletal dependence of chemokine-initiated, alpha(L)beta(2)-mediated arrest.	[Shao, Bojing; Yago, Tadayuki; Klopocki, Arkadiusz G.; Mehta-D'souza, Padmaja; Rodgers, William; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Coghill, Phillip A.; Schmidtke, David W.] Univ Oklahoma, Ctr Bioengn, Norman, OK 73109 USA; [Coghill, Phillip A.; Schmidtke, David W.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73109 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Schmidtke, David W/A-2162-2012	Schmidtke, David W/0000-0001-6404-318X	National Institutes of Health [HL034363, HL085607]; Oklahoma Center for the Advancement of Science and Technology [HR06-102]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607, R37HL034363, R01HL034363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL034363 and HL085607. This work was also supported by Grant HR06-102 from the Oklahoma Center for the Advancement of Science and Technology.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Gimferrer I, 2011, J IMMUNOL, V186, P3892, DOI 10.4049/jimmunol.1003505; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; LENTER M, 1994, J CELL BIOL, V125, P471, DOI 10.1083/jcb.125.2.471; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lo W, 1998, BIOTECHNIQUES, V25, P94, DOI 10.2144/98251st05; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; McEver RP, 2007, NAT IMMUNOL, V8, P1035, DOI 10.1038/ni1007-1035; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Nalayanda DD, 2007, BIOMED MICRODEVICES, V9, P207, DOI 10.1007/s10544-006-9022-6; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Rodgers W, 2002, J IMMUNOL, V168, P2348, DOI 10.4049/jimmunol.168.5.2348; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Sarvepalli DP, 2009, ANN BIOMED ENG, V37, P1331, DOI 10.1007/s10439-009-9708-z; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sigalov AB, 2008, ADV EXP MED BIOL, V640, P121, DOI 10.1007/978-0-387-09789-3_12; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Spertini C, 2012, J BIOL CHEM, V287, P10693, DOI 10.1074/jbc.M111.318022; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	64	28	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19585	19598		10.1074/jbc.M112.361519	http://dx.doi.org/10.1074/jbc.M112.361519			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511754	Green Published, hybrid			2022-12-28	WOS:000306411900070
J	Tiwari, MK; Singh, RK; Singh, R; Jeya, M; Zhao, HM; Lee, JK				Tiwari, Manish Kumar; Singh, Raushan Kumar; Singh, Ranjitha; Jeya, Marimuthu; Zhao, Huimin; Lee, Jung-Kul			Role of Conserved Glycine in Zinc-dependent Medium Chain Dehydrogenase/Reductase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINITOL 4-DEHYDROGENASE; ARCHAEON HALOFERAX-MEDITERRANEI; DENSITY-FUNCTIONAL THEORY; HUMAN SERUM TRANSFERRIN; METAL-BINDING SITES; ALCOHOL-DEHYDROGENASE; GLUCOSE-DEHYDROGENASE; TRIGONAL-PLANAR; LIGAND-BINDING; ACTIVE-SITE	The medium-chain dehydrogenase/reductase (MDR) superfamily consists of a large group of enzymes with a broad range of activities. Members of this superfamily are currently the subject of intensive investigation, but many aspects, including the zinc dependence of MDR superfamily proteins, have not yet have been adequately investigated. Using a density functional theory-based screening strategy, we have identified a strictly conserved glycine residue (Gly) in the zinc-dependent MDR superfamily. To elucidate the role of this conserved Gly in MDR, we carried out a comprehensive structural, functional, and computational analysis of four MDR enzymes through a series of studies including site-directed mutagenesis, isothermal titration calorimetry, electron paramagnetic resonance (EPR), quantum mechanics, and molecular mechanics analysis. Gly substitution by other amino acids posed a significant threat to the metal binding affinity and activity of MDR superfamily enzymes. Mutagenesis at the conserved Gly resulted in alterations in the coordination of the catalytic zinc ion, with concomitant changes in metal-ligand bond length, bond angle, and the affinity (K-d) toward the zinc ion. The Gly mutants also showed different spectroscopic properties in EPR compared with those of the wild type, indicating that the binding geometries of the zinc to the zinc binding ligands were changed by the mutation. The present results demonstrate that the conserved Gly in the GHE motif plays a role in maintaining the metal binding affinity and the electronic state of the catalytic zinc ion during catalysis of the MDR superfamily enzymes.	[Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Tiwari, Manish Kumar; Singh, Raushan Kumar; Singh, Ranjitha; Jeya, Marimuthu; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul 143701, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Konkuk University	Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; jkrhee@konkuk.ac.kr	Ramakrishnan, Ranjitha/D-9087-2011; Jeya, Marimuthu/D-9063-2011; Ramakrishnan, Ranjitha/K-7554-2019; Lee, Jungkukl/D-9104-2011; Tiwari, Manish K./D-9034-2011	Ramakrishnan, Ranjitha/0000-0001-9697-9070; Jeya, Marimuthu/0000-0001-6730-4074; Ramakrishnan, Ranjitha/0000-0001-9697-9070; Tiwari, Manish K./0000-0002-4667-1112; Singh, Raushan Kumar/0000-0001-8031-1041	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-50210]; 21C Frontier Microbial Genomics and Applications Center Program.	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Microbial Genomics and Applications Center Program.(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Converging Research Center Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (Grant 2011-50210). This study also was supported by the 21C Frontier Microbial Genomics and Applications Center Program.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; [Anonymous], 2006, ACC MAT STUD; [Anonymous], 2003, DMOL US GUID S D; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bae B, 2010, J MOL BIOL, V402, P230, DOI 10.1016/j.jmb.2010.07.033; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Anota EC, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983909; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; Darensbourg DJ, 1999, INORG CHEM, V38, P1356, DOI 10.1021/ic9805325; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1031, DOI 10.2174/138945008786949405; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; DiTusa CA, 2001, BIOCHEMISTRY-US, V40, P5338, DOI 10.1021/bi001731e; Dudev T, 2000, J AM CHEM SOC, V122, P11146, DOI 10.1021/ja0010296; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Dudev T, 1999, J AM CHEM SOC, V121, P7665, DOI 10.1021/ja984470t; EKLUND H, 1979, J BIOL CHEM, V254, P3458; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Fox S, 2011, J CHEM THEORY COMPUT, V7, P1102, DOI 10.1021/ct100706u; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; GRADY JK, 1995, BIOCHEM J, V309, P403, DOI 10.1042/bj3090403; GRUFF ES, 1989, J AM CHEM SOC, V111, P8762, DOI 10.1021/ja00205a052; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; He QY, 1998, J BIOL CHEM, V273, P17018, DOI 10.1074/jbc.273.27.17018; HOAGSTROM CW, 1969, J BIOL CHEM, V244, P5967; Hullme EC, 2007, BIOCHEM SOC T, V35, P742, DOI 10.1042/BST0350742; Idupulapati NB, 2010, J PHYS CHEM A, V114, P1887, DOI 10.1021/jp9083025; KIEFER LL, 1995, J AM CHEM SOC, V117, P6831, DOI 10.1021/ja00131a004; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Kuo JM, 1997, BIOCHEMISTRY-US, V36, P1982, DOI 10.1021/bi962099l; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; LESBURG CA, 1995, J AM CHEM SOC, V117, P6838, DOI 10.1021/ja00131a005; Li KY, 2006, J PHYS CHEM A, V110, P11332, DOI 10.1021/jp062886k; Liang JA, 2010, ANGEW CHEM INT EDIT, V49, P7710, DOI 10.1002/anie.201002853; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; MAKINEN MW, 1983, P NATL ACAD SCI-BIOL, V80, P2584, DOI 10.1073/pnas.80.9.2584; Maniccia Anna Wilkins, 2009, PMC Biophys, V2, P11, DOI 10.1186/1757-5036-2-11; MARET W, 1988, BIOCHEMISTRY-US, V27, P1622, DOI 10.1021/bi00405a035; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Marino SF, 1999, CHEM BIOL, V6, P649, DOI 10.1016/S1074-5521(99)80116-1; Matzapetakis M, 2005, J AM CHEM SOC, V127, P18229, DOI 10.1021/ja055433m; Maynard AT, 2001, J AM CHEM SOC, V123, P1047, DOI 10.1021/ja0011616; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mulliken R., 1935, J CHEM PHYS, V3; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; PEARSON RG, 1986, P NATL ACAD SCI USA, V83, P8440, DOI 10.1073/pnas.83.22.8440; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Pire C, 2001, FEMS MICROBIOL LETT, V200, P221, DOI 10.1111/j.1574-6968.2001.tb10719.x; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Ryde U, 1999, BIOPHYS J, V77, P2777, DOI 10.1016/S0006-3495(99)77110-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sullivan R, 2007, APPL MICROBIOL BIOT, V77, P845, DOI 10.1007/s00253-007-1225-0; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2010, APPL MICROBIOL BIOT, V87, P571, DOI 10.1007/s00253-010-2478-6; Vipond IB, 1996, BIOCHEMISTRY-US, V35, P1712, DOI 10.1021/bi9523926; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; White CE, 2010, J PHYS CHEM A, V114, P4988, DOI 10.1021/jp911108d; White DJ, 2001, BIOCHEMISTRY-US, V40, P8918, DOI 10.1021/bi010637a; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhan CG, 2003, J PHYS CHEM A, V107, P4184, DOI 10.1021/jp0225774	74	30	32	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19429	19439		10.1074/jbc.M111.335752	http://dx.doi.org/10.1074/jbc.M111.335752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500022	hybrid, Green Published			2022-12-28	WOS:000306411900057
J	Cawston, EE; Lam, PCH; Harikumar, KG; Dong, MQ; Ball, AM; Augustine, ML; Akgun, E; Portoghese, PS; Orry, A; Abagyan, R; Sexton, PM; Miller, LJ				Cawston, Erin E.; Lam, Polo C. H.; Harikumar, Kaleeckal G.; Dong, Maoqing; Ball, Alicja M.; Augustine, Mary Lou; Akguen, Eyup; Portoghese, Philip S.; Orry, Andrew; Abagyan, Ruben; Sexton, Patrick M.; Miller, Laurence J.			Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC MODULATION; AGONIST BINDING; PEPTIDE LIGANDS; IDENTIFICATION; TYPE-1; SITE; GPCR; DISCOVERY; INSIGHTS	Allosteric binding pockets in peptide-binding G protein-coupled receptors create opportunities for the development of small molecule drugs with substantial benefits over orthosteric ligands. To gain insights into molecular determinants for this pocket within type 1 and 2 cholecystokinin receptors (CCK1R and CCK2R), we prepared a series of receptor constructs in which six distinct residues in TM2, -3, -6, and -7 were reversed. Two novel iodinated CCK1R- and CCK2R-selective 1,4-benzodiazepine antagonists, differing only in stereochemistry at C3, were used. When all six residues within CCK1R were mutated to corresponding CCK2R residues, benzodiazepine selectivity was reversed, yet peptide binding selectivity was unaffected. Detailed analysis, including observations of gain of function, demonstrated that residues 6.51, 6.52, and 7.39 were most important for binding the CCK1R-selective ligand, whereas residues 2.61 and 7.39 were most important for binding CCK2R-selective ligand, although the effect of substitution of residue 2.61 was likely indirect. Ligand-guided homology modeling was applied to wild type receptors and those reversing benzodiazepine binding selectivity. The models had high predictive power in enriching known receptor-selective ligands from related decoys, indicating a high degree of precision in pocket definition. The benzodiazepines docked in similar poses in both receptors, with C3 urea substituents pointing upward, whereas different stereochemistry at C3 directed the C5 phenyl rings and N1 methyl groups into opposite orientations. The geometry of the binding pockets and specific interactions predicted for ligand docking in these models provide a molecular framework for understanding ligand selectivity at these receptor subtypes. Furthermore, the strong predictive power of these models suggests their usefulness in the discovery of lead compounds and in drug development programs.	[Cawston, Erin E.; Harikumar, Kaleeckal G.; Dong, Maoqing; Ball, Alicja M.; Augustine, Mary Lou; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Akguen, Eyup; Portoghese, Philip S.] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Lab, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; Monash University	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK32878, U54 GM094618, U01 GM 094612]; Mayo Clinic; Australian National Health and Medical Research Council (NHMRC) [519461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032878, R01DK032878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094612, U54GM094618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK32878 (to L. J. M.) and U54 GM094618 and U01 GM 094612 (to R. A.). This work was also supported by a grant from the Mayo Clinic (to L. J. M.) and by Grant 519461 from the Australian National Health and Medical Research Council (NHMRC) (to P. M. S.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Akgun E, 2009, J MED CHEM, V52, P2138, DOI 10.1021/jm801439x; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Anders J, 1999, BIOCHEMISTRY-US, V38, P6043, DOI 10.1021/bi990269z; Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; Archer-Lahlou E, 2005, J MED CHEM, V48, P180, DOI 10.1021/jm049886y; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Cawston EE, 2010, BRIT J PHARMACOL, V159, P1009, DOI 10.1111/j.1476-5381.2009.00489.x; CHANG RSL, 1986, MOL PHARMACOL, V30, P212; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Dong MQ, 2005, BIOCHEMISTRY-US, V44, P6693, DOI 10.1021/bi050130q; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; EYSSELEIN VE, 1990, AM J PHYSIOL, V258, pG951, DOI 10.1152/ajpgi.1990.258.6.G951; Foucaud M, 2008, J BIOL CHEM, V283, P35860, DOI 10.1074/jbc.M805513200; FREIDINGER RM, 1989, TRENDS PHARMACOL SCI, V10, P270, DOI 10.1016/0165-6147(89)90026-6; GAISANO HY, 1989, J CLIN INVEST, V83, P321, DOI 10.1172/JCI113877; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Hadac EM, 2006, J MED CHEM, V49, P850, DOI 10.1021/jm049072h; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2006, J BIOL CHEM, V281, P27072, DOI 10.1074/jbc.M605098200; Jagerschmidt A, 1996, EUR J PHARMACOL, V296, P97, DOI 10.1016/0014-2999(95)00676-1; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; KOPIN AS, 1995, J BIOL CHEM, V270, P5019, DOI 10.1074/jbc.270.10.5019; KOPIN AS, 1994, ANN NY ACAD SCI, V713, P67, DOI 10.1111/j.1749-6632.1994.tb44053.x; LOTTI VJ, 1989, EUR J PHARMACOL, V162, P273, DOI 10.1016/0014-2999(89)90290-2; MANTAMADIOTIS T, 1994, BIOCHEM BIOPH RES CO, V201, P1382, DOI 10.1006/bbrc.1994.1856; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Miller LJ, 2008, PHARMACOL THERAPEUT, V119, P83, DOI 10.1016/j.pharmthera.2008.05.001; Miller LJ, 2002, PHARMACOL TOXICOL, V91, P282, DOI 10.1034/j.1600-0773.2002.910603.x; Morton M, 2011, TRENDS PHARMACOL SCI, V32, P201, DOI 10.1016/j.tips.2011.02.003; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rehfeld JF, 2001, J CLIN ENDOCR METAB, V86, P251, DOI 10.1210/jc.86.1.251; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; ULRICH CD, 1993, BIOCHEM BIOPH RES CO, V193, P204, DOI 10.1006/bbrc.1993.1610; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	51	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18618	18635		10.1074/jbc.M111.335646	http://dx.doi.org/10.1074/jbc.M111.335646			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22467877	Green Published, hybrid			2022-12-28	WOS:000306411600072
J	Danciu, TE; Chupreta, S; Cruz, O; Fox, JE; Whitman, M; Iniguez-Lluhi, JA				Danciu, Theodora E.; Chupreta, Sergey; Cruz, Osvaldo; Fox, Jennifer E.; Whitman, Malcolm; Iniguez-Lluhi, Jorge A.			Small Ubiquitin-like Modifier (SUMO) Modification Mediates Function of the Inhibitory Domains of Developmental Regulators FOXC1 and FOXC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTORS; AXENFELD-RIEGER-SYNDROME; CARDIOVASCULAR DEVELOPMENT; MISSENSE MUTATIONS; CONJUGATING ENZYME; STRUCTURAL BASIS; BOND FORMATION; DNA-BINDING; HEAT-SHOCK; GENE	FOXC1 and FOXC2 are forkhead transcription factors that play essential roles during development and physiology. Despite their critical role, the mechanisms that regulate the function of these factors remain poorly understood. We have identified conserved motifs within a previously defined N-terminal negative regulatory region of FOXC1/C2 that conforms to the definition of synergy control or SC motifs. Because such motifs inhibit the activity of transcription factors by serving as sites of post-translational modification by small ubiquitin-like modifier (SUMO), we have examined whether FOXC1/C2 are targets of SUMOylation and probed the functional significance of this modification. We find that endogenous FOXC1 forms modified by SUMO2/3 can be detected. Moreover, in cell culture, all three SUMO isoforms are readily conjugated to FOXC1 and FOXC2. The modification can be reconstituted in vitro with purified components and can be reversed in vitro by treatment with the SUMO protease SENP2. SUMOylation of FOXC1 and FOXC2 occurs primarily on one consensus synergy control motif with minor contributions of a second, more degenerate site. Notably, although FOXC1 is also phosphorylated at multiple sites, disruption of sites immediately downstream of the SC motifs does not influence SUMOylation. Consistent with a negative functional role, SUMOylation-deficient mutants displayed higher transcriptional activity when compared with wild type forms despite comparable protein levels and subcellular localization. Thus, the findings demonstrate that SC motifs mediate the inhibitory function of this region by serving as sites for SUMOylation and reveal a novel mechanism for acute and reversible regulation of FOXC1/C2 function.	[Danciu, Theodora E.; Fox, Jennifer E.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Chupreta, Sergey; Cruz, Osvaldo; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Whitman, Malcolm] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard School of Dental Medicine	Danciu, TE (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	tdanciu@umich.edu; iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health from the USPHS [R56 DK061656]; National Institutes of Health from the NIDCR [K22DE016614]; National Institutes of Health [P60 DK20572]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE016614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R56DK061656] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; National Institutes of Health from the NIDCR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56 DK061656 from the USPHS (to J. A. I.) and National Institutes of Health Grant K22DE016614 from the NIDCR (to T. E. D.).; We thank Dr. Ormond A. MacDougald for valuable discussions and suggestions and Yana Kamberov for initial SUMOylation discussions. Core facility use was also provided through Grant P60 DK20572 from the National Institutes of Health.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Berry FB, 2006, J BIOL CHEM, V281, P10098, DOI 10.1074/jbc.M513629200; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; Danciu TE, 2010, J CELL BIOCHEM, V109, P417, DOI 10.1002/jcb.22415; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiemisch H, 1998, GENE, V220, P77, DOI 10.1016/S0378-1119(98)00409-0; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Iida K, 1997, DEVELOPMENT, V124, P4627; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kaestner KH, 2000, GENE DEV, V14, P142; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kume T, 2008, TRENDS CARDIOVAS MED, V18, P224, DOI 10.1016/j.tcm.2008.11.003; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pauws E, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P301, DOI 10.1007/978-90-481-2649-1_17; PIERROU S, 1995, ANAL BIOCHEM, V229, P99, DOI 10.1006/abio.1995.1384; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Tamimi Y, 2006, HUM MOL GENET, V15, P3229, DOI 10.1093/hmg/ddl400; Tamini Y, 2004, INVEST OPHTH VIS SCI, V45, P3904, DOI 10.1167/iovs.04-0628; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; WALSH DA, 1987, TERATOLOGY, V36, P181, DOI 10.1002/tera.1420360205; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang WH, 2009, MOL CELL BIOL, V29, P613, DOI 10.1128/MCB.00295-08; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang FP, 2008, MOL CELL BIOL, V28, P5381, DOI 10.1128/MCB.00651-08	62	21	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18318	18329		10.1074/jbc.M112.339424	http://dx.doi.org/10.1074/jbc.M112.339424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493429	Green Published, hybrid			2022-12-28	WOS:000306411600038
J	Tomomura, M; Hasegawa, H; Suda, N; Sakagami, H; Tomomura, A				Tomomura, Mineko; Hasegawa, Hiroya; Suda, Naoto; Sakagami, Hiroshi; Tomomura, Akito			Serum Calcium-decreasing Factor, Caldecrin, Inhibits Receptor Activator of NF-kappa B Ligand (RANKL)-mediated Ca2+ Signaling and Actin Ring Formation in Mature Osteoclasts via Suppression of Src Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ACTIVITY; C-SRC; BONE-RESORPTION; REGULATES OSTEOCLASTOGENESIS; TERMINAL DIFFERENTIATION; ALPHA(V)BETA(3) INTEGRIN; MOLECULAR-CLONING; GROWTH-FACTORS; EXPRESSION; RANKL	Osteoclasts are essential for bone dynamics and calcium homeostasis. Recently, we reported that serum calcium-decreasing factor, caldecrin, which is a secretory-type serine protease isolated from the pancreas, inhibits osteoclast differentiation by suppression of NFATc1 activity regardless of its own protease activity (Hasegawa, H., Kido, S., Tomomura, M., Fujimoto, K., Ohi, M., Kiyomura, M., Kanegae, H., Inaba, A., Sakagami, H., and Tomomura, A. (2010) Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity. J. Biol. Chem. 285, 25448-25457). Here, we investigated the effects of caldecrin on the function of mature osteoclasts by treatment with receptor activator of NF-kappa B ligand (RANKL). Caldecrin inhibited the RANKL-stimulated bone resorptive activity of mature osteoclasts. Furthermore, caldecrin inhibited RANKL-mediated sealing actin ring formation, which is associated with RANKL-evoked Ca2+ entry through transient receptor potential vanilloid channel 4. The inhibitors of phospholipase C gamma, Syk, and c-Src suppressed RANKL-evoked Ca2+ entry and actin ring formation of mature osteoclasts. Interestingly, caldecrin significantly inhibited RANKL-stimulated phosphorylation of c-Src, Syk, phospholipase C gamma 1 and C gamma 2, SLP-76, and Pyk2 but not that of ERK, JNK, or Akt. Caldecrin inhibited RANKL-stimulated c-Src kinase activity and c-Src.Syk association. These results suggest that caldecrin inhibits RANKL-stimulated calcium signaling activation and cytoskeletal organization by suppression of the c-Src.Syk pathway, which may in turn reduce the bone resorptive activity of mature osteoclasts. Thus, caldecrin is capable of acting as a negative regulator of osteoclastogenesis and osteoclast function of bone resorption.	[Tomomura, Mineko; Tomomura, Akito] Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, Sakado, Saitama 3500283, Japan; [Hasegawa, Hiroya; Suda, Naoto] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Orthodont, Sakado, Saitama 3500283, Japan; [Tomomura, Mineko; Sakagami, Hiroshi] Meikai Univ, Sch Dent, Meikai Pharmacomed Lab, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University; Meikai University	Tomomura, A (corresponding author), Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.	atomomu@dent.meikai.ac.jp		Sakagami, Hiroshi/0000-0001-8001-2121	Japan Society for the Promotion of Science [C16591864, B21390546]; Grants-in-Aid for Scientific Research [24592811] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research C16591864 (to A. T.) and B21390546 (to N.S.) from the Japan Society for the Promotion of Science.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chamoux E, 2010, J BIOL CHEM, V285, P25354, DOI 10.1074/jbc.M109.075234; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hasegawa H, 2010, J BIOL CHEM, V285, P25448, DOI 10.1074/jbc.M109.068742; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jimi E, 1999, J IMMUNOL, V163, P434; Kajiya H, 2010, CELL CALCIUM, V48, P260, DOI 10.1016/j.ceca.2010.09.010; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Myoui A, 2003, CANCER RES, V63, P5028; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Reeve JL, 2009, J IMMUNOL, V183, P1804, DOI 10.4049/jimmunol.0804206; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; TOMOMURA A, 1993, FEBS LETT, V335, P213, DOI 10.1016/0014-5793(93)80732-A; Tomomura A, 2001, FEBS LETT, V508, P454, DOI 10.1016/S0014-5793(01)03107-6; Tomomura A, 1996, FEBS LETT, V386, P26, DOI 10.1016/0014-5793(96)00377-8; Tomomura A, 1995, J BIOL CHEM, V270, P30315, DOI 10.1074/jbc.270.51.30315; TOMOMURA A, 1992, FEBS LETT, V301, P277, DOI 10.1016/0014-5793(92)80256-G; Tomomura M, 2011, IN VIVO, V25, P157; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	49	16	18	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17963	17974		10.1074/jbc.M112.358796	http://dx.doi.org/10.1074/jbc.M112.358796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22461633	Green Published, hybrid			2022-12-28	WOS:000306411600006
J	Chen, HY; Yuan, Y; Zhang, CP; Luo, AP; Ding, F; Ma, JL; Yang, SH; Tian, YY; Tong, T; Zhan, QM; Liu, ZH				Chen, Hongyan; Yuan, Yi; Zhang, Chunpeng; Luo, Aiping; Ding, Fang; Ma, Jianlin; Yang, Shouhui; Tian, Yanyan; Tong, Tong; Zhan, Qimin; Liu, Zhihua			Involvement of S100A14 Protein in Cell Invasion by Affecting Expression and Function of Matrix Metalloproteinase (MMP)-2 via p53-dependent Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TUMOR-SUPPRESSOR P53; WILD-TYPE; GENE-EXPRESSION; PROSTATE-CANCER; GELATINASE-A; METASTASIS; ACTIVATION; PROMOTER; GROWTH	S100 proteins have been implicated in tumorigenesis and metastasis. As a member of S100 proteins, the role of S100A14 in carcinogenesis has not been fully understood. Here, we showed that ectopic overexpression of S100A14 promotes motility and invasiveness of esophageal squamous cell carcinoma cells. We investigated the underlying mechanisms and found that the expression of matrix metalloproteinase (MMP)-2 is obviously increased after S100A14 gene overexpression. Inhibition of MMP2 by a specific MMP2 inhibitor at least partly reversed the invasive phenotype of cells overexpressing S100A14. By serendipity, we found that S100A14 could affect p53 transactivity and stability. Thus, we further investigated whether the effect of MMP2 by S100A14 is dependent on p53. A series of biochemical assays showed that S100A14 requires functional p53 to affect MMP2 transcription, and p53 potently transrepresses the expression of MMP2. Finally, RT-quantitative PCR analysis of human breast cancer specimens showed a significant correlation between S100A14 mRNA expression and MMP2 mRNA expression in cases with wild-type p53 but not in cases with mutant p53. Collectively, our data strongly suggest that S100A14 promotes cell motility and invasiveness by regulating the expression and function of MMP2 in a p53-dependent manner.	[Chen, Hongyan; Yuan, Yi; Zhang, Chunpeng; Luo, Aiping; Ding, Fang; Ma, Jianlin; Yang, Shouhui; Tian, Yanyan; Tong, Tong; Zhan, Qimin; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Chen, Hongyan; Yuan, Yi; Zhang, Chunpeng; Luo, Aiping; Ding, Fang; Ma, Jianlin; Yang, Shouhui; Tian, Yanyan; Tong, Tong; Zhan, Qimin; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn	Yang, Shouhui/M-5374-2017		National Natural Science Foundation of China [81000954, 81130043]; National Basic Research Program of China [2011CB504205]; Ministry of Education of China [20101106120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 81000954 and 81130043, National Basic Research Program of China Grant 2011CB504205, and Ministry of Education of China Grant 20101106120012.	Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Bulk E, 2009, CLIN CANCER RES, V15, P22, DOI 10.1158/1078-0432.CCR-08-0953; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Moon A, 2008, MOL CANCER RES, V6, P1544, DOI 10.1158/1541-7786.MCR-08-0189; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Sapkota D, 2012, ORAL ONCOL, V48, P219, DOI 10.1016/j.oraloncology.2011.10.001; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun YB, 2000, J BIOL CHEM, V275, P11327, DOI 10.1074/jbc.275.15.11327; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Toschi E, 2000, J INVEST DERMATOL, V114, P1188, DOI 10.1046/j.1523-1747.2000.00000.x; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Zhang CP, 2010, CARCINOGENESIS, V31, P1676, DOI 10.1093/carcin/bgq134	48	54	58	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17109	17119		10.1074/jbc.M111.326975	http://dx.doi.org/10.1074/jbc.M111.326975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451655	Green Published, hybrid			2022-12-28	WOS:000306373000011
J	Lian, FM; Yu, J; Ma, XX; Yu, XJ; Chen, YX; Zhou, CZ				Lian, Fu-Ming; Yu, Jiang; Ma, Xiao-Xiao; Yu, Xiao-Jie; Chen, Yuxing; Zhou, Cong-Zhao			Structural Snapshots of Yeast Alkyl Hydroperoxide Reductase Ahp1 Peroxiredoxin Reveal a Novel Two-cysteine Mechanism of Electron Transfer to Eliminate Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE FUNCTION; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; CYTOPLASMIC THIOREDOXIN; MAMMALIAN PEROXIREDOXIN; PEROXIDE REDUCTASE; OXIDATIVE STRESS; SULFINIC ACID; ACTIVE-SITE; CYSTEINE	Peroxiredoxins (Prxs) are thiol-specific antioxidant proteins that protect cells against reactive oxygen species and are involved in cellular signaling pathways. Alkyl hydroperoxide reductase Ahp1 belongs to the Prx5 subfamily and is a two-cysteine (2-Cys) Prx that forms an intermolecular disulfide bond. Enzymatic assays and bioinformatics enabled us to re-assign the peroxidatic cysteine (C-P) to Cys-62 and the resolving cysteine (C-R) to Cys-31 but not the previously reported Cys-120. Thus Ahp1 represents the first 2-Cys Prx with a peroxidatic cysteine after the resolving cysteine in the primary sequence. We also found the positive cooperativity of the substrate t-butyl hydroperoxide binding to Ahp1 homodimer at a Hill coefficient of similar to 2, which enabled Ahp1 to eliminate hydroperoxide at much higher efficiency. To gain the structural insights into the catalytic cycle of Ahp1, we determined the crystal structures of Ahp1 in the oxidized, reduced, and Trx2-complexed forms at 2.40, 2.91, and 2.10 angstrom resolution, respectively. Structural superposition of the oxidized to the reduced form revealed significant conformational changes at the segments containing C-P and C-R. An intermolecular C-P-C-R disulfide bond crossing the A-type dimer interface distinguishes Ahp1 from other typical 2-Cys Prxs. The structure of the Ahp1-Trx2 complex showed for the first time how the electron transfers from thioredoxin to a peroxidase with a thioredoxin-like fold. In addition, site-directed mutagenesis in combination with enzymatic assays suggested that the peroxidase activity of Ahp1 would be altered upon the urmylation (covalently conjugated to ubiquitin-related modifier Urm1) of Lys-32.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; yu, xiaojie/GSI-9676-2022; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Lian, Fu-Ming/0000-0001-7999-6565	Ministry of Science and Technology of China [2012CB911002]; Chinese National Natural Science Foundation [30870490]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 project from the Ministry of Science and Technology of China (Project 2012CB911002) and Chinese National Natural Science Foundation Grant 30870490.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L, PYMOL MOL GRAPHICS S; Echalier A, 2005, BIOCHEMISTRY-US, V44, P1755, DOI 10.1021/bi048226s; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Joensson Thomas J., 2007, V44, P115; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Karplus P. Andrew, 2007, V44, P41; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Knoops Bernard, 2007, V44, P27; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Ma XX, 2011, J BIOL CHEM, V286, P13430, DOI 10.1074/jbc.M110.205161; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Poole Leslie B., 2007, V44, P61; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Trivelli X, 2003, BIOCHEMISTRY-US, V42, P14139, DOI 10.1021/bi035551r; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang ZY, 2009, BBA-PROTEINS PROTEOM, V1794, P124, DOI 10.1016/j.bbapap.2008.09.011	53	36	37	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17077	17087		10.1074/jbc.M112.357368	http://dx.doi.org/10.1074/jbc.M112.357368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474296	Green Published, hybrid			2022-12-28	WOS:000306373000008
J	Sanchez-Hernandez, N; Ruiz, L; Sanchez-Alvarez, M; Montes, M; Macias, MJ; Hernandez-Munain, C; Sune, C				Sanchez-Hernandez, Noemi; Ruiz, Lidia; Sanchez-Alvarez, Miguel; Montes, Marta; Macias, Maria J.; Hernandez-Munain, Cristina; Sune, Carlos			The FF4 and FF5 Domains of Transcription Elongation Regulator 1 (TCERG1) Target Proteins to the Periphery of Speckles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; RICH NUCLEAR SPECKLES; SPLICING IN-VIVO; CELL-NUCLEUS; SUBNUCLEAR LOCALIZATION; BACKBONE DYNAMICS; SR PROTEINS; CA150 BIND; ORGANIZATION; IDENTIFICATION	Transcription elongation regulator 1 (TCERG1) is a human factor implicated in interactions with the spliceosome as a coupler of transcription and splicing. The protein is highly concentrated at the interface between speckles (the compartments enriched in splicing factors) and nearby transcription sites. Here, we identified the FF4 and FF5 domains of TCERG1 as the amino acid sequences required to direct this protein to the periphery of nuclear speckles, where coordinated transcription/RNA processing events occur. Consistent with our localization data, we observed that the FF4 and FF5 pair is required to fold in solution, thus suggesting that the pair forms a functional unit. When added to heterologous proteins, the FF4-FF5 pair is capable of targeting the resulting fusion protein to speckles. This represents, to our knowledge, the first description of a targeting signal for the localization of proteins to sites peripheral to speckled domains. Moreover, this "speckle periphery-targeting signal" contributes to the regulation of alternative splicing decisions of a reporter pre-mRNA in vivo.	[Sune, Carlos] IPBLN CSIC, PT Ciencias Salud, Dept Mol Biol, Armilla 18100, Spain; [Ruiz, Lidia; Macias, Maria J.] IRB, Struct & Computat Biol Programme, Barcelona 08028, Spain; [Macias, Maria J.] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); ICREA	Sune, C (corresponding author), IPBLN CSIC, PT Ciencias Salud, Dept Mol Biol, Ave Conocimiento S-N, Armilla 18100, Spain.	csune@ipb.csic.es	Macias, Maria J/K-3898-2014; Suñé, Carlos/AAA-8198-2019; Sánchez, Noemí/V-7150-2017; SÁNCHEZ-ÁLVAREZ, MIGUEL/AAA-4507-2019; Montes, Marta/ABF-8298-2020; de Munain, Cristina Hernandez Lopez/S-4389-2018; Montes, Marta/G-2751-2016	Macias, Maria J/0000-0002-6915-963X; Suñé, Carlos/0000-0002-7991-0458; Sánchez, Noemí/0000-0002-1697-2352; SÁNCHEZ-ÁLVAREZ, MIGUEL/0000-0001-5287-1420; Montes, Marta/0000-0003-1223-8385; de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458; Montes, Marta/0000-0003-1223-8385; Ruiz Sainz, Lidia/0000-0002-8918-9158	Spanish Ministry of Science and Innovation [BFU2008-01599, BFU2011-24577, BFU2009-08796, CSL2009-00080]; Foundation for Research and Prevention of AIDS in Spain [FIPSE-36768/08]; Andalusian Government [CVI-4626/2009]; Institute for Research in Biomedicine; European Region Development Fund; ERDF (FEDER); Spanish Ministry of Education (Formacion Profesorado Universitario/FPU program); Consejo Superior de Investigaciones Cientificas (Junta para la Ampliacion de Estudios, CSIC/JAE program); ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation for Research and Prevention of AIDS in Spain; Andalusian Government; Institute for Research in Biomedicine; European Region Development Fund; ERDF (FEDER)(European Commission); Spanish Ministry of Education (Formacion Profesorado Universitario/FPU program)(German Research Foundation (DFG)); Consejo Superior de Investigaciones Cientificas (Junta para la Ampliacion de Estudios, CSIC/JAE program); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Innovation Grants BFU2008-01599 and BFU2011-24577), by Foundation for Research and Prevention of AIDS in Spain Grant FIPSE-36768/08, and by Andalusian Government Excellence Project CVI-4626/2009) (to C. S.). This work was also supported by Spanish Ministry of Science and Innovation Grants BFU2009-08796 (to C. H. M.) and CSL2009-00080 (to M. J. M.), and by the Institute for Research in Biomedicine (to M. J. M.). This work was also supported by the European Region Development Fund, ERDF (FEDER), by a fellowship from the Spanish Ministry of Education (Formacion Profesorado Universitario/FPU program) (to M. M.), and by a fellowship from the Consejo Superior de Investigaciones Cientificas (Junta para la Ampliacion de Estudios, CSIC/JAE program) (to N. S. H.).	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Bonet R, 2009, PROTEINS, V77, P1000, DOI 10.1002/prot.22547; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Boucher L, 2001, RNA, V7, P1693; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eilbracht J, 2001, P NATL ACAD SCI USA, V98, P3849, DOI 10.1073/pnas.071042298; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; HUANG S, 1992, P NATL ACAD SCI USA, V89, P305, DOI 10.1073/pnas.89.1.305; Huang S, 1996, J CELL BIOCHEM, V62, P191, DOI 10.1002/(SICI)1097-4644(199608)62:2<191::AID-JCB7>3.0.CO;2-N; Ko TK, 2001, J CELL SCI, V114, P2591; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lu M, 2009, J MOL BIOL, V393, P397, DOI 10.1016/j.jmb.2009.07.086; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Misteli T, 1997, TRENDS CELL BIOL, V7, P135, DOI 10.1016/S0962-8924(96)20043-1; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Montes M, 2012, MOL CELL BIOL, V32, P751, DOI 10.1128/MCB.06255-11; Murphy JM, 2009, J MOL BIOL, V393, P409, DOI 10.1016/j.jmb.2009.08.049; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sanchez-Alvarez M, 2010, J BIOL CHEM, V285, P15220, DOI 10.1074/jbc.M109.063750; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Shimada M, 1999, J BIOCHEM-TOKYO, V126, P1033, DOI 10.1093/oxfordjournals.jbchem.a022547; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; SPECTOR DL, 1983, BIOL CELL, V49, P1; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Spector DL, 2001, J CELL SCI, V114, P2891; SPECTOR DL, 1990, P NATL ACAD SCI USA, V87, P147, DOI 10.1073/pnas.87.1.147; Sun X, 2004, CHROMOSOMA, V113, P244, DOI 10.1007/s00412-004-0314-4; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Wagner S, 2003, P NATL ACAD SCI USA, V100, P3269, DOI 10.1073/pnas.0438055100; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	55	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17789	17800		10.1074/jbc.M111.304782	http://dx.doi.org/10.1074/jbc.M111.304782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22453921	Green Published, hybrid			2022-12-28	WOS:000306373000077
J	Schroder, HC; Wang, XH; Manfrin, A; Yu, SH; Grebenjuk, VA; Korzhev, M; Wiens, M; Schlossmacher, U; Muller, WEG				Schroeder, Heinz C.; Wang, Xiaohong; Manfrin, Alberto; Yu, Shu-Hong; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Mueller, Werner E. G.			Acquisition of Structure-guiding and Structure-forming Properties during Maturation from the Pro-silicatein to the Silicatein Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEMOSPONGE SUBERITES-DOMUNCULA; SILICEOUS SPICULES; MECHANICAL-PROPERTIES; BIOLOGICAL SILICA; AXIAL FILAMENT; CATHEPSIN-L; SPONGE; PROTEIN; NANOINDENTATION; SKELETOGENESIS	Silicateins are the key enzymes involved in the enzymatic polycondensation of the inorganic scaffold of the skeletal elements of the siliceous sponges, the spicules. The gene encoding pro-silicatein is inserted into the pCold TF vector, comprising the gene for the bacterial trigger factor. This hybrid gene is expressed in Escherichia coli and the synthesized fusion protein is purified. The fusion protein is split into the single proteins with thrombin by cleavage of the linker sequence present between the two proteins. At 23 degrees C, the 87 kDa trigger factor-pro-silicatein fusion protein is cleaved to the 51 kDa trigger factor and the 35 kDa pro-silicatein. The cleavage process proceeds and results in the release of the 23 kDa mature silicatein, a process which very likely proceeds by autocatalysis. Almost in parallel with its formation, the mature enzyme precipitates as pure 23 kDa protein. When the precipitate is dissolved in an urea buffer, the solubilized protein displays its full enzymatic activity which is enhanced multi-fold in the presence of the silicatein interactor silintaphin-1 or of poly(ethylene glycol) (PEG). The biosilica product formed increases its compactness if silicatein is supplemented with silintaphin-1 or PEG. The elastic modulus of the silicatein-mediated biosilica product increases in parallel with the addition of silintaphin-1 and/or PEG from 17 MPa(silicatein) via 61 MPa (silicatein: silintaphin-1) to 101 MPa (silicatein: silintaphin-1 and PEG). These data show that the maturation process from the pro-silicatein state to the mature form is the crucial step during which silicatein acquires its structureguiding and structure-forming properties.	[Schroeder, Heinz C.; Wang, Xiaohong; Manfrin, Alberto; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Grant Res Grp, D-55128 Mainz, Germany; [Wang, Xiaohong] Chinese Acad Geol Sci, Natl Res Ctr Geoanal, Beijing 100037, Peoples R China; [Yu, Shu-Hong] Univ Sci & Technol China, Div Nanomat & Chem, Hefei 230026, Peoples R China	Johannes Gutenberg University of Mainz; Chinese Academy of Geological Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Muller, WEG (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.	wmueller@uni-mainz.de	Wang, Zhong Lin/E-2176-2011; Müller, W. E. G./AAR-8651-2020; Yu, Shu-Hong/A-1903-2010; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020	Wang, Zhong Lin/0000-0002-5530-0380; Müller, W. E. G./0000-0002-8223-3689; Yu, Shu-Hong/0000-0003-3732-1011; Wiens, Matthias/0000-0001-9219-0478; Schroder, Heinz C./0000-0003-0992-6427	Deutsche Forschungsgemeinschaft [Schr 277/10-2]; European Commission [215507]; Industry-Academia Partnerships and Pathways [286059, 266033, 268476]; International Human Frontier Science Program; Ministry of Land and Resources of the People's Republic of China [201011005-06]; International Science & Technology Cooperation Program of China [2008DFA00980]; ERC Advanced Investigator [268476 BIOSILICA]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Industry-Academia Partnerships and Pathways; International Human Frontier Science Program(Human Frontier Science Program); Ministry of Land and Resources of the People's Republic of China; International Science & Technology Cooperation Program of China; ERC Advanced Investigator	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-2), the European Commission ("BIOMINTEC": No. 215507; and Industry-Academia Partnerships and Pathways "CoreShell": No. 286059; "SPECIAL": No. 266033; and "MarBioTec*EU-CN*": No. 268476), the International Human Frontier Science Program, the Public Welfare Project of Ministry of Land and Resources of the People's Republic of China (Grant No. 201011005-06) and the International Science & Technology Cooperation Program of China (Grant No. 2008DFA00980).; Recipient of an ERC Advanced Investigator Grant (No. 268476 BIOSILICA). To whom correspondence should be addressed: Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, D-55128 Mainz, Germany. Tel.: 49-6131-39-25910; Fax: 49-6131-39-25243; E-mail: wmueller@uni-mainz.de.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Akhtar R, 2009, J MATER RES, V24, P638, DOI 10.1557/JMR.2009.0130; Askeland D.R., 2006, SCI ENG MAT, V5th, P198; Boury-Esnault N, 1997, SMITHSONIAN CONTRIBU, V596, P1, DOI DOI 10.5479/SI.00810282.596; BRINKHUIS J, 1984, BIOPHYS CHEM, V19, P75, DOI 10.1016/0301-4622(84)85008-5; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Croce G, 2004, BIOPHYS J, V86, P526, DOI 10.1016/S0006-3495(04)74131-4; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; Harper S., 2008, CURR PROTOC PROTEIN, P661; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kinrade SD, 2002, J CHEM SOC DALTON, P307, DOI 10.1039/b105379p; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; Kruger N J, 1994, Methods Mol Biol, V32, P9; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; Li XD, 2005, NANO LETT, V5, P1982, DOI 10.1021/nl0513885; Meng FG, 2001, INT J BIOCHEM CELL B, V33, P701, DOI 10.1016/S1357-2725(01)00048-6; Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8; Muller WEG, 2008, J EXP BIOL, V211, P300, DOI 10.1242/jeb.008193; Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x; Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030; Muller WEG, 2007, EUR J CELL BIOL, V86, P473, DOI 10.1016/j.ejcb.2007.06.002; Muller WEG, 2011, BBA-GEN SUBJECTS, V1810, P713, DOI 10.1016/j.bbagen.2011.04.009; Muller WEG, 2010, CHEMBIOCHEM, V11, P1077, DOI 10.1002/cbic.201000078; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Muller WEG, 2003, PROG MOLEC, V33, P195; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Nishiguchi Y., 2011, ISRN ZOOLOG IN PRESS; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Prokopowicz M, 2010, J NON-CRYST SOLIDS, V356, P1711, DOI 10.1016/j.jnoncrysol.2010.06.024; REILLY JJ, 1989, BIOCHEM J, V257, P493, DOI 10.1042/bj2570493; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; Sarikaya M., 2002, 15 ASCE ENG MECH C J; Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schroder HC, 2012, SILICON-NETH, V4, P33, DOI 10.1007/s12633-010-9057-4; Sharp KA, 2001, J CHEM PHYS, V114, P1791, DOI 10.1063/1.1334678; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; Tong X, 2002, J APPL POLYM SCI, V86, P3532, DOI 10.1002/app.11152; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Wang XH, 2012, FEBS J, V279, P1721, DOI 10.1111/j.1742-4658.2012.08533.x; Wang XH, 2011, CHEMBIOCHEM, V12, P2316, DOI 10.1002/cbic.201100345; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020523; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; Wiens Matthias, 2009, V47, P111, DOI 10.1007/978-3-540-88552-8_5; Wiens M, 2009, BIOMATERIALS, V30, P1648, DOI 10.1016/j.biomaterials.2008.12.021; Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	48	26	26	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22196	22205		10.1074/jbc.M112.351486	http://dx.doi.org/10.1074/jbc.M112.351486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544742	Green Published, hybrid			2022-12-28	WOS:000306418600058
J	Vecchi, L; Petris, G; Bestagno, M; Burrone, OR				Vecchi, Lara; Petris, Gianluca; Bestagno, Marco; Burrone, Oscar R.			Selective Targeting of Proteins within Secretory Pathway for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ER; SEL1L; TRAFFICKING; DISLOCATION; PROTEASOMES; EXPRESSION; MECHANISM; COMPLEX; STRESS	The endoplasmic reticulum-associated degradation (ERAD) is a cellular quality control mechanism to dispose of misfolded proteins of the secretory pathway via proteasomal degradation. SEL1L is an ER-resident protein that participates in identification of misfolded molecules as ERAD substrates, therefore inducing their ER-to-cytosol retrotranslocation and degradation. We have developed a novel class of fusion proteins, termed degradins, composed of a fragment of SEL1L fused to a target-specific binding moiety located on the luminal side of the ER. The target-binding moiety can be a ligand of the target or derived from specific mAbs. Here, we describe the ability of degradins with two different recognition moieties to promote degradation of a model target. Degradins recognize the target protein within the ER both in secretory and membrane-bound forms, inducing their degradation following retrotranslocation to the cytosol. Thus, degradins represent an effective technique to knock-out proteins within the secretory pathway with high specificity.	[Vecchi, Lara; Petris, Gianluca; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.	burrone@icgeb.org	Petris, Gianluca/N-9754-2018; Vecchi, Lara/AAJ-8208-2021	Petris, Gianluca/0000-0002-2420-6359; 	International Centre for Genetic Engineering and Biotechnology	International Centre for Genetic Engineering and Biotechnology	Supported by an International Centre for Genetic Engineering and Biotechnology predoctoral fellowship for the Corso di Perfezionamento of the Scuola Normale Superiore di Pisa. Present address: Universidade Federal de Uberlandia, Laboratorio de Genetica Molecular, Campus Umuarama, Uberlandia, MG, Brazil.	Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Coffield VM, 2003, NAT BIOTECHNOL, V21, P1321, DOI 10.1038/nbt889; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Filesi I, 2007, J NEUROCHEM, V101, P1516, DOI 10.1111/j.1471-4159.2006.04439.x; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; SAMBROOK J, 1989, MOL CLONING LAB MANA; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Vangelista L, 1999, J CLIN INVEST, V103, P1571, DOI 10.1172/JCI6551; Vangelista L, 2002, J MOL BIOL, V322, P815, DOI 10.1016/S0022-2836(02)00853-7; Vangelista L, 2002, PROTEIN ENG, V15, P51, DOI 10.1093/protein/15.1.51; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	36	13	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20007	20015		10.1074/jbc.M112.355107	http://dx.doi.org/10.1074/jbc.M112.355107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523070	Green Published, hybrid			2022-12-28	WOS:000306414500022
J	Troxell, B; Xu, HJ; Yang, XF				Troxell, Bryan; Xu, Haijun; Yang, X. Frank			Borrelia burgdorferi, a Pathogen That Lacks Iron, Encodes Manganese-dependent Superoxide Dismutase Essential for Resistance to Streptonigrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; HYDROGEN-PEROXIDE; FREE-RADICALS; VIRULENCE; OXYGEN; TOXICITY; PARAQUAT; LIFE	Borrelia burgdorferi, the causative agent of Lyme disease, exists in nature through a complex life cycle involving ticks of the Ixodes genus and mammalian hosts. During its life cycle, B. burgdorferi experiences fluctuations in oxygen tension and may encounter reactive oxygen species (ROS). The key metalloenzyme to degrade ROS in B. burgdorferi is SodA. Although previous work suggests that B. burgdorferi SodA is an iron-dependent superoxide dismutase (SOD), later work demonstrates that B. burgdorferi is unable to transport iron and contains an extremely low intracellular concentration of iron. Consequently, the metal cofactor for SodA has been postulated to be manganese. However, experimental evidence to support this hypothesis remains lacking. In this study, we provide biochemical and genetic data showing that SodA is a manganese-dependent enzyme. First, B. burgdorferi contained SOD activity that is resistant to H2O2 and NaCN, characteristics associated with Mn-SODs. Second, the addition of manganese to the Chelex-treated BSK-II enhanced SodA expression. Third, disruption of the manganese transporter gene bmtA, which significantly lowers the intracellular manganese, greatly reduced SOD activity and SodA expression, suggesting that manganese regulates the level of SodA. In addition, we show that B. burgdorferi is resistant to streptonigrin, a metal-dependent redox cycling compound that produces ROS, and that SodA plays a protective role against the streptonigrin. Taken together, our data demonstrate the Lyme disease spirochete encodes a manganese-dependent SOD that contributes to B. burgdorferi defense against intracellular superoxide.	[Troxell, Bryan; Yang, X. Frank] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Xu, Haijun] Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Zhejiang, Peoples R China	Indiana University System; Indiana University Bloomington; Zhejiang University	Yang, XF (corresponding author), Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA.	xfyang@iupui.edu		Xu, Hai-Jun/0000-0002-7314-377X; Troxell, Bryan/0000-0002-0533-6721	National Institutes of Health [R01 AI083640, 5T32AI060519]; Indiana University; Lilly Endowment, Inc.; National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519, R01AI083640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University; Lilly Endowment, Inc.; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI083640 (to X. F. Y.). This work was also supported by Indiana INGEN and METACyt grants from Indiana University, funded by the Lilly Endowment, Inc. (to X. F. Y.) and in part by Grant C06 RR015481-01 from National Center for Research Resources, National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant 5T32AI060519.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ASADA K, 1975, J BIOL CHEM, V250, P2801; AUSTIN FE, 1981, INFECT IMMUN, V33, P372, DOI 10.1128/IAI.33.2.372-379.1981; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barriere C, 2001, J APPL MICROBIOL, V91, P514, DOI 10.1046/j.1365-2672.2001.01411.x; Barriere C, 2001, APPL ENVIRON MICROB, V67, P4096, DOI 10.1128/AEM.67.9.4096-4104.2001; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benov L, 1999, J BIOL CHEM, V274, P4202, DOI 10.1074/jbc.274.7.4202; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chang SK, 1997, APPL ENVIRON MICROB, V63, P3732, DOI 10.1128/AEM.63.9.3732-3735.1997; COHEN MS, 1987, ANTIMICROB AGENTS CH, V31, P1507, DOI 10.1128/AAC.31.10.1507; CONE R, 1976, CAN J BIOCHEM CELL B, V54, P219, DOI 10.1139/o76-034; de Paiva SR, 2003, MEM I OSWALDO CRUZ, V98, P959, DOI 10.1590/S0074-02762003000700017; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GREGORY EM, 1973, J BACTERIOL, V115, P987, DOI 10.1128/JB.115.3.987-991.1973; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; GREGORY EM, 1978, APPL ENVIRON MICROB, V35, P988, DOI 10.1128/AEM.35.5.988-991.1978; GUTTERIDGE JMC, 1984, BIOCHEM PHARMACOL, V33, P3059, DOI 10.1016/0006-2952(84)90609-9; HASSAN HM, 1977, J BACTERIOL, V129, P1574, DOI 10.1128/JB.129.3.1574-1583.1977; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; HASSETT DJ, 1987, J BIOL CHEM, V262, P13404; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; KAO SM, 1985, J BIOL CHEM, V260, P478; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; MARTIN ME, 1986, J BIOL CHEM, V261, P9361; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Ngok-Ngam P, 2009, J BACTERIOL, V191, P2083, DOI 10.1128/JB.01380-08; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; PRIVALLE CT, 1993, J BIOL CHEM, V268, P5178; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Samuels D S, 1995, Methods Mol Biol, V47, P253; Sha SH, 1999, HEARING RES, V128, P112, DOI 10.1016/S0378-5955(98)00200-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; WHITE HL, 1968, MOL PHARMACOL, V4, P549; WHITE JR, 1982, BIOCHEM BIOPH RES CO, V106, P407, DOI 10.1016/0006-291X(82)91125-1; WHITE JR, 1977, BIOCHEM BIOPH RES CO, V77, P387, DOI 10.1016/S0006-291X(77)80209-X; Whitehouse CA, 1997, INFECT IMMUN, V65, P4865, DOI 10.1128/IAI.65.11.4865-4868.1997; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; YOST FJ, 1973, J BIOL CHEM, V248, P4905; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889	60	46	46	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19284	19293		10.1074/jbc.M112.344903	http://dx.doi.org/10.1074/jbc.M112.344903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500025	hybrid, Green Published			2022-12-28	WOS:000306411900038
J	Kligys, KR; Wu, Y; Hopkinson, SB; Kaur, S; Platanias, LC; Jones, JCR				Kligys, Kristina R.; Wu, Yvonne; Hopkinson, Susan B.; Kaur, Surinder; Platanias, Leonidas C.; Jones, Jonathan C. R.			alpha 6 beta 4 Integrin, a Master Regulator of Expression of Integrins in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; ALPHA-3-BETA-1 INTEGRIN; PEMPHIGOID ANTIGEN; MESSENGER-RNA; ALPHA(6)BETA(4) INTEGRIN; EPIDERMAL-GROWTH; PYLORIC ATRESIA; CARCINOMA CELLS; GENE ITGB4; TRANSLATION	Three major laminin and collagen-binding integrins in skin (alpha 6 beta 4, alpha 3 beta 1, and alpha 2 beta 1) are involved in keratinocyte adhesion to the dermis and dissemination of skin cells during wound healing and/or tumorigenesis. Knockdown of alpha 6 integrin in keratinocytes not only results in motility defects but also leads to decreased surface expression of the alpha 2, alpha 3, and beta 4 integrin subunits. Whereas alpha 2 integrin mRNA levels are decreased in alpha 6 integrin knockdown cells, alpha 3 and beta 4 integrin mRNAs levels are unaffected. Expression of either alpha 6 or alpha 3 integrin in alpha 6 integrin knockdown cells restores alpha 2 integrin mRNA levels. Moreover, re-expression of alpha 6 integrin increases beta 4 integrin protein at the cell surface, which results in an increase in alpha 3 integrin expression via activation of initiation factor 4E-binding protein 1. Our data indicate that the alpha 6 beta 4 integrin is a master regulator of transcription and translation of other integrin subunits and underscore its pivotal role in wound healing and cancer.	[Kligys, Kristina R.; Wu, Yvonne; Hopkinson, Susan B.; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Kaur, Surinder; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 AR054184, RO1 CA77816]; Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center [CA060553]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR054184 (to J. C. R. J.) and RO1 CA77816 (to L. P.). This work was also supported by the Northwestern University Flow Cytometry and Cell Imaging Facilities through Cancer Center Support Grant CA060553.	Allegra M, 2003, J INVEST DERMATOL, V121, P1336, DOI 10.1111/j.1523-1747.2003.12625.x; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; DiPersio CM, 2000, J CELL SCI, V113, P3051; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Gingras AC, 2001, GENE DEV, V15, P2852; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Hamill KJ, 2012, J INVEST DERMATOL, V132, P448, DOI 10.1038/jid.2011.297; Hamill KJ, 2011, J BIOL CHEM, V286, P26768, DOI 10.1074/jbc.M110.203646; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; KLATTE DH, 1994, J INVEST DERMATOL, V102, P39, DOI 10.1111/1523-1747.ep12371728; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LANGHOFER M, 1993, J CELL SCI, V105, P753; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; McKendrick L, 1999, INT J BIOCHEM CELL B, V31, P31, DOI 10.1016/S1357-2725(98)00129-0; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Pulkkinen L, 1998, AM J HUM GENET, V63, P1376, DOI 10.1086/302116; Pulkkinen L, 1998, AM J PATHOL, V152, P157; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Pulkkinen L, 1997, LAB INVEST, V76, P823; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; Pulkkinen L, 1998, AM J PATHOL, V152, P935; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Rodius S, 2007, J CELL PHYSIOL, V212, P439, DOI 10.1002/jcp.21040; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wen TT, 2010, WOUND REPAIR REGEN, V18, P325, DOI 10.1111/j.1524-475X.2010.00590.x; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	52	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17975	17984		10.1074/jbc.M111.310458	http://dx.doi.org/10.1074/jbc.M111.310458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493440	hybrid, Green Published			2022-12-28	WOS:000306411600007
J	Thapa, A; Morris, L; Xu, JH; Ma, HW; Michalakis, S; Biel, M; Ding, XQ				Thapa, Arjun; Morris, Lynsie; Xu, Jianhua; Ma, Hongwei; Michalakis, Stylianos; Biel, Martin; Ding, Xi-Qin			Endoplasmic Reticulum Stress-associated Cone Photoreceptor Degeneration in Cyclic Nucleotide-gated Channel Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; RETINAL DEGENERATION; CELL-DEATH; CROSS-TALK; SUBUNIT STOICHIOMETRY; MULTIPLE PATHWAYS; TRANSGENIC RATS; MICE LACKING; ACTIVATION; MUTATIONS	Cyclic nucleotide-gated (CNG) channels play a pivotal role in phototransduction. Mutations in the cone CNG channel subunits CNGA3 and CNGB3 account for >70% of all known cases of achromatopsia. Cones degenerate in achromatopsia patients and in CNGA3(-/-) and CNGB3(-/-) mice. This work investigates the molecular basis of cone degeneration in CNG channel deficiency. As cones comprise only 2-3% of the total photoreceptor population in the wild-type mouse retina, we generated mouse lines with CNG channel deficiency on a cone-dominant background, i.e. CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) mice. The retinal phenotype and potential cell death pathways were examined by functional, biochemical, and immunohistochemical approaches. CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) mice showed impaired cone function, opsin mislocalization, and cone degeneration similar to that in the single knock-out mice. The endoplasmic reticulum stress marker proteins, including Grp78/Bip, phospho-eIF2 alpha, phospho-IP3R, and CCAAT/enhancer-binding protein homologous protein, were elevated significantly in CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) retinas, compared with the age-matched (postnatal 30 days) Nrl(-/-) controls. Along with these, up-regulation of the cysteine protease calpains and cleavage of caspase-12 and caspase-7 were found in the channel-deficient retinas, suggesting an endoplasmic reticulum stress-associated apoptosis. In addition, we observed a nuclear translocation of apoptosis-inducing factor (AIF) and endonuclease G in CNGA3(-/-)/Nrl(-/-) and CNGB3(-/-)/Nrl(-/-) retinas, implying a mitochondrial insult in the endoplasmic reticulum stress-activated cell death process. Taken together, our findings suggest a crucial role of endoplasmic reticulum stress in cone degeneration associated with CNG channel deficiency.	[Thapa, Arjun; Morris, Lynsie; Xu, Jianhua; Ma, Hongwei; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Munich	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019	Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238	NEI, National Institutes of Health [P30EY12190, R01EY019490]; National Center for Research Resources [P20RR017703]; American Health Assistance Foundation; Oklahoma Center for the Advancement of Science Technology; Deutsche Forschungsgemeinschaft; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021725, R01EY019490, P30EY012190] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Oklahoma Center for the Advancement of Science Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health Grants P30EY12190 and R01EY019490. This work was also supported by grants from the National Center for Research Resources (P20RR017703), the American Health Assistance Foundation, the Oklahoma Center for the Advancement of Science & Technology, and the Deutsche Forschungsgemeinschaft.	Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Bode C, 2003, MOL VIS, V9, P144; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Doonan F, 2003, J NEUROSCI, V23, P5723; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Gerstner A, 2000, J NEUROSCI, V20, P1324; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Griciuc A, 2010, BBA-MOL CELL RES, V1803, P424, DOI 10.1016/j.bbamcr.2010.01.008; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu CD, 1999, J NEUROSCI, V19, P4778; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Murakami Y, 2007, J BIOCHEM, V141, P401, DOI 10.1093/jb/mvm044; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Varsanyi B, 2007, INVEST OPHTH VIS SCI, V48, P2249, DOI 10.1167/iovs.06-1173; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	63	42	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18018	18029		10.1074/jbc.M112.342220	http://dx.doi.org/10.1074/jbc.M112.342220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493484	Green Published, hybrid			2022-12-28	WOS:000306411600011
J	Tretter, EM; Berger, JM				Tretter, Elsa M.; Berger, James M.			Mechanisms for Defining Supercoiling Set Point of DNA Gyrase Orthologs I-A NONCONSERVED ACIDIC C-TERMINAL TAIL MODULATES ESCHERICHIA COLI GYRASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-IV; PREFERENTIAL RELAXATION; NUCLEOTIDE-BINDING; SINGLE-MOLECULE; STRAND PASSAGE; DOMAIN; PROTEIN; ENZYME; SUBUNIT; ENERGY	DNA topoisomerases manage chromosome supercoiling and organization in all cells. Gyrase, a prokaryotic type IIA topoisomerase, consumes ATP to introduce negative supercoils through a strand passage mechanism. All type IIA topoisomerases employ a similar set of catalytic domains for function; however, the activity and specificity of gyrase are augmented by a specialized DNA binding and wrapping element, termed the C-terminal domain (CTD), which is appended to its GyrA subunit. We have discovered that a nonconserved, acidic tail at the extreme C terminus of the Escherichia coli GyrA CTD has a dramatic and unexpected impact on gyrase function. Removal of the CTD tail enables GyrA to introduce writhe into DNA in the absence of GyrB, an activity exhibited by other GyrA orthologs, but not by wild-type E. coliGyrA. Strikingly, a "tail-less" gyrase holoenzyme is markedly impaired for DNA supercoiling capacity, but displays normal ATPase function. Our findings reveal that the E. coli GyrA tail regulates DNA wrapping by the CTD to increase the coupling efficiency between ATP turnover and supercoiling, demonstrating that CTD functions can be fine-tuned to control gyrase activity in a highly sophisticated manner.	[Tretter, Elsa M.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Div Biochem & Mol Biol, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			National Institutes of Health from NCI [RO1-CA077373]; NIAID [PO1-AI068135]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA077373 from the NCI (to J. M. B.) and PO1-AI068135 from the NIAID (to J. M. B.).	Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799; Bates AD, 1996, BIOCHEMISTRY-US, V35, P1408, DOI 10.1021/bi952433y; Blanche F, 1996, ANTIMICROB AGENTS CH, V40, P2714, DOI 10.1128/AAC.40.12.2714; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Champion K, 2007, J BACTERIOL, V189, P5839, DOI 10.1128/JB.00083-07; CHAMPOUX JJ, 1972, P NATL ACAD SCI USA, V69, P143, DOI 10.1073/pnas.69.1.143; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Clark DJ, 2009, METHODS MOL BIOL, V543, P523, DOI 10.1007/978-1-60327-015-1_30; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Costenaro L, 2005, STRUCTURE, V13, P287, DOI 10.1016/j.str.2004.12.011; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; CULLIS PM, 1992, BIOCHEMISTRY-US, V31, P9642, DOI 10.1021/bi00155a017; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; DYNAN WS, 1981, J BIOL CHEM, V256, P5860; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049; Hsieh TJ, 2004, J BIOL CHEM, V279, P55587, DOI 10.1074/jbc.M408934200; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; RAU DC, 1987, J MOL BIOL, V193, P555, DOI 10.1016/0022-2836(87)90266-X; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; SUGINO A, 1980, J BIOL CHEM, V255, P6299; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103	46	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18636	18644		10.1074/jbc.M112.345678	http://dx.doi.org/10.1074/jbc.M112.345678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22457353	hybrid, Green Published			2022-12-28	WOS:000306411600073
J	Ishida-Kitagawa, N; Tanaka, K; Bao, X; Kimura, T; Miura, T; Kitaoka, Y; Hayashi, K; Sato, M; Maruoka, M; Ogawa, T; Miyoshi, J; Takeya, T				Ishida-Kitagawa, Norihiro; Tanaka, Kunitaro; Bao, Xilinqiqige; Kimura, Takanori; Miura, Tadashi; Kitaoka, Yoshiki; Hayashi, Kouhei; Sato, Mizuho; Maruoka, Masahiro; Ogawa, Takuya; Miyoshi, Jun; Takeya, Tatsuo			Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE HOMEOSTASIS; GENE-EXPRESSION; NUCLEAR-FACTOR; IMMUNE-SYSTEM; IN-VITRO; DIFFERENTIATION; RECEPTOR; CELLS; SIGNAL; SYK	Osteoclasts are multinucleated giant cells that reside in osseous tissues and resorb bone. Signaling mediated by receptor activator of nuclear factor (NF)-kappa B (RANK) and its ligand leads to the nuclear factor of activated T cells 2/c1 (NFAT2 or NFATc1) expression, a critical step in the formation of functional osteoclasts. In addition, adaptor proteins harboring immunoreceptor tyrosine-based activation motifs, such as DNAX-activating protein of 12 kDa (DAP12), play essential roles. In this study, we identified the gene encoding the lectin Siglec-15 as NFAT2-inducible, and we found that the protein product links RANK ligand-RANK-NFAT2 and DAP12 signaling in mouse osteoclasts. Both the recognition of sialylated glycans by the Siglec-15 V-set domain and the association with DAP12 through its Lys-272 are essential for its function. When Siglec-15 expression was knocked down, fewer multinucleated cells developed, and those that did were morphologically contracted with disordered actin-ring structures. These changes were accompanied by significantly reduced bone resorption. Siglec-15 formed complexes with Syk through DAP12 in response to vitronectin. Furthermore, chimeric molecules consisting of the extracellular and transmembrane regions of Siglec-15 with a K272A mutation and the cytoplasmic region of DAP12 significantly restored bone resorption in cells with knocked down Siglec-15 expression. Together, these results suggested that the Siglec-15-DAP12-Syk-signaling cascade plays a critical role in functional osteoclast formation.	[Sato, Mizuho] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Ishida-Kitagawa, Norihiro; Tanaka, Kunitaro; Bao, Xilinqiqige; Kimura, Takanori; Miura, Tadashi; Kitaoka, Yoshiki; Hayashi, Kouhei; Sato, Mizuho; Maruoka, Masahiro; Ogawa, Takuya; Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Maruoka, Masahiro] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Higashinari Ku, Osaka 5378511, Japan	Osaka University; Nara Institute of Science & Technology; Tohoku University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Ishida-Kitagawa, N (corresponding author), 8916-5 Takayama, Nara 6300101, Japan.	n-ishida@bs.naist.jp	Ogawa, Takuya/ABC-9628-2020	Ogawa, Takuya/0000-0001-9194-3079; Maruoka, Masahiro/0000-0003-4625-8544	Japan Society for the Promotion of Science KAKENHI [17791000, 19791031, 21791394, 23592214, 22791382]; Foundation for the Nara Institute of Science and Technology; Nara Institute of Science and Technology Global-Centers of Excellence Program	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Foundation for the Nara Institute of Science and Technology; Nara Institute of Science and Technology Global-Centers of Excellence Program	This work was supported by Grants-in-aid from Japan Society for the Promotion of Science KAKENHI 17791000, 19791031, 21791394, and 23592214 (to N. I. K.) and 22791382 (to T. O.), the Foundation for the Nara Institute of Science and Technology (to N. I. K.), and the Nara Institute of Science and Technology Global-Centers of Excellence Program.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Aoki N, 2000, J IMMUNOL, V165, P3790, DOI 10.4049/jimmunol.165.7.3790; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bao XLQQG, 2011, BIOCHEM BIOPH RES CO, V405, P533, DOI 10.1016/j.bbrc.2011.01.061; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Colonna M, 2007, ADV EXP MED BIOL, V602, P97; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Hiruma Y, 2011, BIOCHEM BIOPH RES CO, V409, P424, DOI 10.1016/j.bbrc.2011.05.015; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Meiyanto E, 2001, BIOCHEM BIOPH RES CO, V282, P278, DOI 10.1006/bbrc.2001.4564; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z; Ogawa T, 2006, J BONE MINER METAB, V24, P373, DOI 10.1007/s00774-006-0705-0; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Suzuki J, 2006, J BIOTECHNOL, V126, P463, DOI 10.1016/j.jbiotec.2006.04.039; Takahata M, 2007, BONE, V41, P77, DOI 10.1016/j.bone.2007.03.016; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Yogo K, 2006, ENDOCRINOLOGY, V147, P3307, DOI 10.1210/en.2005-1309; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, J CELL SCI, V123, P2955, DOI 10.1242/jcs.069872	39	58	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17493	17502		10.1074/jbc.M111.324194	http://dx.doi.org/10.1074/jbc.M111.324194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451653	Green Published, hybrid			2022-12-28	WOS:000306373000049
J	Liu, CX; Bai, Y; Chen, YL; Wang, Y; Sottejeau, Y; Liu, LJ; Li, XM; Lingrel, JB; Malhotra, D; Cooper, CJ; Shapiro, JI; Xie, ZJ; Tian, J				Liu, Changxuan; Bai, Yan; Chen, Yiliang; Wang, Yu; Sottejeau, Yoann; Liu, Lijun; Li, Xiaomei; Lingrel, Jerry B.; Malhotra, Deepak; Cooper, Christopher J.; Shapiro, Joseph I.; Xie, Zi-jian; Tian, Jiang			Reduction of Na/K-ATPase Potentiates Marinobufagenin-induced Cardiac Dysfunction and Myocyte Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HEART-FAILURE; UREMIC CARDIOMYOPATHY; ENDOGENOUS DIGITALIS; ALZHEIMERS-DISEASE; CALCIUM-OVERLOAD; NA+/K+-ATPASE; OUABAIN; GROWTH; HYPERTENSION	Decreases in cardiac Na/K-ATPase have been documented in patients with heart failure. Reduction of Na/K-ATPase alpha 1 also contributes to the deficiency in cardiac contractility in animal models. Our previous studies demonstrate that reduction of cellular Na/K-ATPase causes cell growth inhibition and cell death in renal proximal tubule cells. To test whether reduction of Na/K-ATPase in combination with increased cardiotonic steroids causes cardiac myocyte death and cardiac dysfunction, we examined heart function in Na/K-ATPase alpha 1 heterozygote knock-out mice (alpha 1(+/-)) in comparison to wild type (WT) littermates after infusion of marinobufagenin (MBG). Adult cardiac myocytes were also isolated from both WT and alpha 1(+/-) mice for in vitro experiments. The results demonstrated that MBG infusion increased myocyte apoptosis and induced significant left ventricle dilation in alpha 1(+/-) mice but not in their WT littermates. Mechanistically, it was found that in WT myocytes MBG activated the Src/Akt/mTOR signaling pathway, which further increased phosphorylation of ribosome S6 kinase (S6K) and BAD (Bcl-2-associated death promoter) and protected cells from apoptosis. In alpha 1(+/-) myocytes, the basal level of phospho-BAD is higher compared with WT myocytes, but MBG failed to induce further activation of them TOR pathway. Reduction of Na/K-ATPase also caused the activation of caspase 9 but not caspase 8 in these cells. Using cultures of neonatal cardiac myocytes, we demonstrated that inhibition of the mTOR pathway by rapamycin also enabled MBG to activate caspase 9 and induce myocyte apoptosis.	[Liu, Changxuan; Bai, Yan; Chen, Yiliang; Wang, Yu; Sottejeau, Yoann; Liu, Lijun; Shapiro, Joseph I.; Xie, Zi-jian] Univ Toledo, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Liu, Changxuan; Wang, Yu; Li, Xiaomei] Peking Univ First Hosp, Div Renal, Beijing 100034, Peoples R China; [Liu, Changxuan; Wang, Yu; Li, Xiaomei] Peking Univ First Hosp, Inst Nephrol, Beijing 100034, Peoples R China; [Lingrel, Jerry B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Tian, Jiang] Univ Toledo, Dept Med, Div Cardiovasc, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; Peking University; Peking University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Toledo	Tian, J (corresponding author), Univ Toledo, Dept Med, Div Cardiovasc, 3000 Arlington Ave,MS 1008, Toledo, OH 43614 USA.	Jiang.tian@utoledo.edu	Bai, Yan/E-3350-2012	Chen, Yiliang/0000-0001-9786-8305	National Institutes of Health, NHLBI [HL-105649, HL-109015, HL-36573]; American Heart Association [0980027N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105649, P01HL036573, R01HL109015] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Grants HL-105649, HL-109015, and HL-36573. This work was also supported by American Heart Association Grant 0980027N.	Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Balzan S, 2001, EUR J HEART FAIL, V3, P165, DOI 10.1016/S1388-9842(00)00132-X; Basset O, 2006, BIOCHEM J, V395, P267, DOI 10.1042/BJ20051265; CHEN SW, 1993, AM J HYPERTENS, V6, P397, DOI 10.1093/ajh/6.5.397; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Cho SY, 2010, EXP MOL MED, V42, P639, DOI 10.3858/emm.2010.42.9.063; CLERICO A, 1990, CLIN PHYSIOL BIOCH, V8, P153; Elkareh J, 2007, HYPERTENSION, V49, P215, DOI 10.1161/01.HYP.0000252409.36927.05; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fraser CL, 2001, AM J PHYSIOL-RENAL, V281, pF674, DOI 10.1152/ajprenal.2001.281.4.F674; Haas M, 2000, J BIOL CHEM, V275, P27832; HAMLYN JM, 1992, J HYPERTENS, V10, pS99; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; HARIK SI, 1989, ARCH NEUROL-CHICAGO, V46, P951, DOI 10.1001/archneur.1989.00520450021013; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kashkin VA, 2002, EUR NEUROPSYCHOPHARM, V12, P217, DOI 10.1016/S0924-977X(02)00026-3; Kawamoto EM, 2008, NEUROBIOL AGING, V29, P1712, DOI 10.1016/j.neurobiolaging.2007.04.008; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Komiyama Y, 2005, CLIN BIOCHEM, V38, P36, DOI 10.1016/j.clinbiochem.2004.08.005; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LIGURI G, 1990, NEUROSCI LETT, V112, P338, DOI 10.1016/0304-3940(90)90227-Z; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Moseley AE, 2004, J MOL CELL CARDIOL, V37, P913, DOI 10.1016/j.yjmcc.2004.06.005; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; NORGAARD A, 1988, AM J CARDIOL, V61, P1312, DOI 10.1016/0002-9149(88)91175-7; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Semb SO, 1998, J MOL CELL CARDIOL, V30, P1311; Tian J, 2009, HYPERTENSION, V54, P1313, DOI 10.1161/HYPERTENSIONAHA.109.140038; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; TIRUPATTUR PR, 1993, AM J HYPERTENS, V6, P626, DOI 10.1093/ajh/6.7.626; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664	37	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16390	16398		10.1074/jbc.M111.304451	http://dx.doi.org/10.1074/jbc.M111.304451			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451662	hybrid, Green Published			2022-12-28	WOS:000304030900030
J	Chakraborty, SK; Basu, NK; Jana, S; Basu, M; Raychoudhuri, A; Owens, IS				Chakraborty, Sunit K.; Basu, Nikhil K.; Jana, Sirsendu; Basu, Mousumi; Raychoudhuri, Amit; Owens, Ida S.			Protein Kinase C alpha and Src Kinase Support Human Prostate-distributed Dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PHOSPHORYLATION; EXPRESSION; CANCER; CELLS; ANDROGEN; EPITHELIUM; ESTROGENS; ENZYMES; DELTA; 5-ALPHA-REDUCTASE	Because human prostate-distributed UDP-glucuronosyl-transferase (UGT) 2B15 metabolizes 5 alpha-dihydrotestosterone (DHT) and 3 alpha-androstane-5 alpha,17 beta-diolmetabolite, we sought to determine whether 2B15 requires regulated phosphorylation similar to UGTs already analyzed. Reversible down-regulation of 2B15-transfected COS-1 cells following curcumin treatment and irreversible inhibition by calphostin C, bisindolylmaleimide, or rottlerin treatment versus activation by phorbol 12-myristate 13-acetate indicated that 2B15 undergoes PKC phosphorylation. Mutation of three predicted PKC and two tyrosine kinase sites in 2B15 caused 70-100 and 80-90% inactivation, respectively. Anti-UGT-1168 antibody trapped 2B15-His-containing co-immunoprecipitates of PKC alpha in 130-140- and >150-kDa complexes by gradient SDS-PAGE analysis. Complexes bound to WT 2B15-His remained intact during electrophoresis, whereas 2B15-His mutants at phosphorylation sites differentially dissociated. PKC alpha siRNA treatment inactivated >50% of COS-1 cell-expressed 2B15. In contrast, treatment of 2B15-transfected COS-1 cells with the Src-specific activator 1,25-dihydroxyvitamin D-3 enhanced activity; treatment with the Src-specific PP2 inhibitor or Src siRNA inhibited >50% of the activity. Solubilized 2B15-His-transfected Src-free fibroblasts subjected to in vitro [gamma-P-33]ATP-dependent phosphorylation by PKC alpha and/or Src, affinity purification, and SDS gel analysis revealed 2-fold more radiolabeling of 55-58-kDa 2B15-His by PKC alpha than by Src; labeling was additive for combined kinases. Collectively, the evidence indicates that 2B15 requires regulated phosphorylation by both PKC alpha and Src, which is consistent with the complexity of synthesis and metabolism of its major substrate, DHT. Whether basal cells import or synthesize testosterone for transport to luminal cells for reduction to DHT by 5 alpha-steroid reductase 2, comparatively low-activity luminal cell 2B15 undergoes a complex pattern of regulated phosphorylation necessary to maintain homeostatic DHT levels to support occupation of the androgen receptor for prostate-specific functions.	[Chakraborty, Sunit K.; Basu, Nikhil K.; Jana, Sirsendu; Basu, Mousumi; Raychoudhuri, Amit; Owens, Ida S.] NICHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Basu, NK (corresponding author), NICHD, Sect Genet Disorders Drug Metab, Program Dev Endocrinol & Genet, NIH, Bldg 10,Rm 9D-42, Bethesda, MD 20892 USA.	basun@mail.nih.gov; owensi@mail.nih.gov	RAYCHOUDHURI, AMIT/J-9300-2019		NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER	NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the NICHD Intramural Research Program.	Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Arlt W, 2004, BEST PRACT RES CL EN, V18, P363, DOI 10.1016/j.beem.2004.02.006; Barbier O, 2008, BEST PRACT RES CL EN, V22, P259, DOI 10.1016/j.beem.2008.01.001; Basu NK, 2008, J BIOL CHEM, V283, P23048, DOI 10.1074/jbc.M800032200; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; BELANGER G, 1995, MOL CELL ENDOCRINOL, V113, P165, DOI 10.1016/0303-7207(95)03627-J; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; El-Alfy M, 2000, MICROSC RES TECHNIQ, V51, P436, DOI 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Labrie F., 2000, DEHYDROEPIANDROSTERO, P299; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; Levesque E, 1997, PHARMACOGENETICS, V7, P317, DOI 10.1097/00008571-199708000-00007; Luu-The Van, 2011, Horm Mol Biol Clin Investig, V5, P161, DOI 10.1515/HMBCI.2011.007; Mitra PS, 2011, J BIOL CHEM, V286, P1639, DOI 10.1074/jbc.M110.165126; Mitra PS, 2009, BIOCHEM BIOPH RES CO, V382, P651, DOI 10.1016/j.bbrc.2009.03.054; Morley M, 2010, CELL TISSUE RES, V340, P229, DOI 10.1007/s00441-010-0938-z; Mostaghel EA, 2010, CANCER RES, V70, P1286, DOI 10.1158/0008-5472.CAN-09-2509; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Parsons JK, 2010, J UROLOGY, V184, P1040, DOI 10.1016/j.juro.2010.05.033; Pelletier G, 2008, BEST PRACT RES CL EN, V22, P223, DOI 10.1016/j.beem.2008.02.004; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; RITTER JK, 1990, J BIOL CHEM, V265, P7900; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Sakamaki Y, 2010, J MED CHEM, V53, P5813, DOI 10.1021/jm100649d; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Sitrin MD, 1999, STEROIDS, V64, P137, DOI 10.1016/S0039-128X(98)00102-0; Xu SZ, 2007, BASIC CLIN PHARMACOL, V101, P459, DOI 10.1111/j.1742-7843.2007.00143.x	35	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24387	24396		10.1074/jbc.M111.335067	http://dx.doi.org/10.1074/jbc.M111.335067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22532564	hybrid, Green Published			2022-12-28	WOS:000306651100033
J	Kuramoto, K; Okamura, T; Yamaguchi, T; Nakamura, TY; Wakabayashi, S; Morinaga, H; Nomura, M; Yanase, T; Otsu, K; Usuda, N; Matsumura, S; Inoue, K; Fushiki, T; Kojima, Y; Hashimoto, T; Sakai, F; Hirose, F; Osumi, T				Kuramoto, Kenta; Okamura, Tomoo; Yamaguchi, Tomohiro; Nakamura, Tomoe Y.; Wakabayashi, Shigeo; Morinaga, Hidetaka; Nomura, Masatoshi; Yanase, Toshihiko; Otsu, Kinya; Usuda, Nobuteru; Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru; Kojima, Yumiko; Hashimoto, Takeshi; Sakai, Fumie; Hirose, Fumiko; Osumi, Takashi			Perilipin 5, a Lipid Droplet-binding Protein, Protects Heart from Oxidative Burden by Sequestering Fatty Acid from Excessive Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; PAT-FAMILY; LIPOLYSIS; MICE; METABOLISM; TISSUES; CGI-58; MOUSE; LIVER	Lipid droplets (LDs) are ubiquitous organelles storing neutral lipids, including triacylglycerol (TAG) and cholesterol ester. The properties of LDs vary greatly among tissues, and LD-binding proteins, the perilipin family in particular, play critical roles in determining such diversity. Overaccumulation of TAG in LDs of non-adipose tissues may cause lipotoxicity, leading to diseases such as diabetes and cardiomyopathy. However, the physiological significance of non-adipose LDs in a normal state is poorly understood. To address this issue, we generated and characterized mice deficient in perilipin 5 (Plin5), a member of the perilipin family particularly abundant in the heart. The mutant mice lacked detectable LDs, containing significantly less TAG in the heart. Particulate structures containing another LD-binding protein, Plin2, but negative for lipid staining, remained in mutant mice hearts. LDs were recovered by perfusing the heart with an inhibitor of lipase. Cultured cardiomyocytes from Plin5-null mice more actively oxidized fatty acid than those of wild-type mice. Production of reactive oxygen species was increased in the mutant mice hearts, leading to a greater decline in heart function with age. This was, however, reduced by the administration of N-acetylcysteine, a precursor of an antioxidant, glutathione. Thus, we conclude that Plin5 is essential for maintaining LDs at detectable sizes in the heart, by antagonizing lipase(s). LDs in turn prevent excess reactive oxygen species production by sequestering fatty acid from oxidation and hence suppress oxidative burden to the heart.	[Kuramoto, Kenta; Okamura, Tomoo; Yamaguchi, Tomohiro; Kojima, Yumiko; Hashimoto, Takeshi; Sakai, Fumie; Hirose, Fumiko; Osumi, Takashi] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Yamaguchi, Tomohiro] Showa Univ, Sch Pharmaceut Sci, Tokyo 1428555, Japan; [Nakamura, Tomoe Y.; Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Res Inst, Suita, Osaka 5658565, Japan; [Morinaga, Hidetaka; Nomura, Masatoshi; Yanase, Toshihiko] Kyushu Univ, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Usuda, Nobuteru] Fujita Hlth Univ, Dept Anat & Cell Biol 2, Sch Med, Toyoake, Aichi 4701192, Japan; [Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068502, Japan	University of Hyogo; Showa University; National Cerebral & Cardiovascular Center - Japan; Kyushu University; University of London; King's College London; Fujita Health University; Kyoto University	Osumi, T (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan.	osumi@sci.u-hyogo.ac.jp	Matsumura, Shigenobu/Z-2088-2019	Hirose, Fumiko/0000-0003-4586-4892	Japan Society for the Promotion of Science and for Young Scientists; Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23390046, 21590248] Funding Source: KAKEN	Japan Society for the Promotion of Science and for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to T.O.) and for Young Scientists (to T.Y.) and by the Global Center of Excellence Program (Picobiology, Life Science at the Atomic Level), Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartholomew SR, 2012, BBA-MOL CELL BIOL L, V1821, P268, DOI 10.1016/j.bbalip.2011.10.017; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Luiken JJFP, 1997, J LIPID RES, V38, P745; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Matsumura S, 2008, AM J PHYSIOL-REG I, V295, pR82, DOI 10.1152/ajpregu.00060.2008; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; STEIN O, 1968, J CELL BIOL, V36, P63, DOI 10.1083/jcb.36.1.63; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	45	161	167	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23852	23863		10.1074/jbc.M111.328708	http://dx.doi.org/10.1074/jbc.M111.328708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22532565	Green Published, hybrid			2022-12-28	WOS:000306511300056
J	Ahmad, R; Alam, M; Rajabi, H; Kufe, D				Ahmad, Rehan; Alam, Maroof; Rajabi, Hasan; Kufe, Donald			The MUC1-C Oncoprotein Binds to the BH3 Domain of the Pro-apoptotic BAX Protein and Blocks BAX Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; SURVIVAL RESPONSE; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; PROAPOPTOTIC BAX; C-SRC; ACTIVATION; DIMERIZATION	The pro-apoptotic BAX protein contains a BH3 domain that is necessary for its dimerization and for activation of the intrinsic apoptotic pathway. The MUC1(mucin 1) heterodimeric protein is overexpressed in diverse human carcinomas and blocks apoptosis in the response to stress. In this study, we demonstrate that the oncogenic MUC1-C subunit associates with BAX in human cancer cells. MUC1-C.BAX complexes are detectable in the cytoplasm and mitochondria and are induced by genotoxic and oxidative stress. The association between MUC1-C and BAX is supported by the demonstration that the MUC1-C cytoplasmic domain is sufficient for the interaction with BAX. The results further show that the MUC1-C cytoplasmic domain CQC motif binds directly to the BAX BH3 domain at Cys-62. Consistent with binding to the BAX BH3 domain, MUC1-C blocked BAX dimerization in response to (i) truncated BID in vitro and (ii) treatment of cancer cells with DNA-damaging agents. In concert with these results, MUC1-C attenuated localization of BAX to mitochondria and the release of cytochrome c. These findings indicate that the MUC1-C oncoprotein binds directly to the BAX BH3 domain and thereby blocks BAX function in activating the mitochondrial death pathway.	[Ahmad, Rehan; Alam, Maroof; Rajabi, Hasan; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.havard.edu	Rather, R A/J-3509-2019		National Institutes of Health from NCI [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA166480, P50CA100707, R01CA042802] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA97098, CA42802, and CA100707 from NCI. D. K. holds equity in Genus Oncology and is a consultant to the company.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Polster BM, 2001, J BIOL CHEM, V276, P37887; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	41	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20866	20875		10.1074/jbc.M112.357293	http://dx.doi.org/10.1074/jbc.M112.357293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544745	hybrid, Green Published			2022-12-28	WOS:000306416800008
J	Halpern, KB; Veprik, A; Rubins, N; Naaman, O; Walker, MD				Halpern, Keren Bahar; Veprik, Anna; Rubins, Nir; Naaman, Orly; Walker, Michael D.			GPR41 Gene Expression Is Mediated by Internal Ribosome Entry Site (IRES)-dependent Translation of Bicistronic mRNA Encoding GPR40 and GPR41 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; PANCREATIC BETA-CELLS; COUPLED RECEPTOR; INSULIN-SECRETION; ENTEROENDOCRINE CELLS; TRANSCRIPTION; STIMULATION; INITIATION; INTESTINE; REGION	GPR41 is a G protein-coupled receptor activated by short chain fatty acids. The gene encoding GPR41 is located immediately downstream of a related gene encoding GPR40, a receptor for long chain fatty acids. Expression of GPR41 has been reported in a small number of cell types, including gut enteroendocrine cells and sympathetic ganglia, where it may play a role in the maintenance of metabolic homeostasis. We now demonstrate that GPR41, like GPR40, is expressed in pancreatic beta cells. Surprisingly, we found no evidence for transcriptional control elements or transcriptional initiation in the intergenic GPR40-GPR41 region. Rather, using 5'-rapid amplification of cDNA ends analysis, we demonstrated that GPR41 is transcribed from the promoter of the GPR40 gene. We confirmed this finding by generating bicistronic luciferase reporter plasmids, and we were able to map a potential internal ribosome entry site-containing region to a 2474-nucleotide region of the intergenic sequence. Consistent with this, we observed m(7)G cap-independent reporter gene expression upon transfection of RNA containing this region. Thus, GPR41 expression is mediated via an internal ribosome entry site located in the intergenic region of a bicistronic mRNA. This novel sequence organization may be utilized to permit coordinated regulation of the fatty acid receptors GPR40 and GPR41.	[Halpern, Keren Bahar; Veprik, Anna; Rubins, Nir; Naaman, Orly; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il		Veprik, Anna/0000-0002-3904-7151	Israel Science Foundation; Benjamin and Seema Pulier Charitable Foundation; Florence Blau, Morris Blau, and Rose Patterson Fund	Israel Science Foundation(Israel Science Foundation); Benjamin and Seema Pulier Charitable Foundation; Florence Blau, Morris Blau, and Rose Patterson Fund	This work was supported in part by grants from the Israel Science Foundation, the Benjamin and Seema Pulier Charitable Foundation, and the Florence Blau, Morris Blau, and Rose Patterson Fund.	Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hui DW, 2009, J BIOL CHEM, V284, P2245, DOI 10.1074/jbc.M807063200; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kimura M, 2001, J BIOL CHEM, V276, P26453, DOI 10.1074/jbc.M101289200; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zraika S, 2002, Obes Rev, V3, P103, DOI 10.1046/j.1467-789X.2002.00062.x	40	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20154	20163		10.1074/jbc.M112.358887	http://dx.doi.org/10.1074/jbc.M112.358887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493486	hybrid, Green Published			2022-12-28	WOS:000306414500036
J	Heja, D; Harmat, V; Fodor, K; Wilmanns, M; Dobo, J; Kekesi, KA; Zavodszky, P; Gal, P; Pal, G				Heja, David; Harmat, Veronika; Fodor, Krisztian; Wilmanns, Matthias; Dobo, Jozsef; Kekesi, Katalin A.; Zavodszky, Peter; Gal, Peter; Pal, Gabor			Monospecific Inhibitors Show That Both Mannan-binding Lectin-associated Serine Protease-1 (MASP-1) and-2 Are Essential for Lectin Pathway Activation and Reveal Structural Plasticity of MASP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION MOLECULES; SHOTGUN SCANNING MUTAGENESIS; PHAGE-DISPLAY; SCHISTOCERCA-GREGARIA; COMPLEMENT PATHWAY; DESERT LOCUST; PROTEINASE-INHIBITORS; MAXIMUM-LIKELIHOOD; ACTIVE-SITE; FACTOR-B	The lectin pathway is an antibody-independent activation route of the complement system. It provides immediate defense against pathogens and altered self-cells, but it also causes severe tissue damage after stroke, heart attack, and other ischemia reperfusion injuries. The pathway is triggered by target binding of pattern recognition molecules leading to the activation of zymogen mannan-binding lectin-associated serine proteases (MASPs). MASP-2 is considered as the autonomous pathway-activator, while MASP-1 is considered as an auxiliary component. We evolved a pair of monospecific MASP inhibitors. In accordance with the key role of MASP-2, the MASP-2 inhibitor completely blocks the lectin pathway activation. Importantly, the MASP-1 inhibitor does the same, demonstrating that MASP-1 is not an auxiliary but an essential pathway component. We report the first Michaelis-like complex structures of MASP-1 and MASP-2 formed with substrate-like inhibitors. The 1.28 angstrom resolution MASP-2 structure reveals significant plasticity of the protease, suggesting that either an induced fit or a conformational selection mechanism should contribute to the extreme specificity of the enzyme.	[Dobo, Jozsef; Zavodszky, Peter; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, H-1113 Budapest, Hungary; [Heja, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, H-1117 Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Prot Modeling Res Grp, Hungarian Acad Sci, H-1117 Budapest, Hungary; [Fodor, Krisztian; Wilmanns, Matthias] DESY, European Mol Biol Lab Hamburg, D-22603 Hamburg, Germany; [Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Prote Grp, Inst Biol, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Eotvos Lorand University; Eotvos Lorand University	Gal, P (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, H-1113 Budapest, Hungary.	gal.peter@ttk.mta.hu; palgabor@elte.hu	Gal, Peter/B-5886-2011; Harmat, Veronika/B-8033-2016; Dobo, Jozsef/C-7331-2014; Kékesi, Katalin Adrienna A/H-3484-2017; Pal, Gabor/A-6244-2009	Harmat, Veronika/0000-0002-1866-9904; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Pal, Gabor/0000-0001-7868-7971; Dobo, Jozsef/0000-0001-9187-8502; Wilmanns, Matthias/0000-0002-4643-5435	Hungarian Scientific Research Fund [NK81950, K68408, NK100769, NK77978, NK100834, F67937, NK67800, K72973]; Anyos Jedlik Grant [NKFP_ 07_ 1-MASPOK07]; NDA [KMOP-1.1.2-07/1-2008-0003]; European Union; European Social Fund [4.2.1./B-09/KMR2010-0003]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Anyos Jedlik Grant; NDA; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Hungarian Scientific Research Fund (OTKA) NK81950, K68408, NK100769 (to G. P.), NK77978 and NK100834 (to P. G.), and F67937, NK67800 and K72973 (to V. H.) as well as by Anyos Jedlik Grant NKFP_ 07_ 1-MASPOK07, NDA Grant KMOP-1.1.2-07/1-2008-0003, and European Union and the European Social Fund (TAMOP) 4.2.1./B-09/KMR2010-0003. David Heja, Peter Gal, Gabor Pal, and Peter Zavodszky filed patent application for the SGMI inhibitors.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; DeLano W.L, PYMOL MOL GRAPHICS S; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gaspari Z, 2002, EUR J BIOCHEM, V269, P527, DOI 10.1046/j.0014-2956.2001.02685.x; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadam AP, 2010, J IMMUNOL, V184, P7116, DOI 10.4049/jimmunol.1000200; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leone P, 2008, ACTA CRYSTALLOGR D, V64, P1165, DOI 10.1107/S0907444908030400; Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Montalto MC, 2001, J IMMUNOL, V166, P4148, DOI 10.4049/jimmunol.166.6.4148; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pal G, 2005, PROTEIN SCI, V14, P2405, DOI 10.1110/ps.051519805; Pal G, 2005, J MOL BIOL, V347, P489, DOI 10.1016/j.jmb.2005.01.040; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roos A, 2001, J IMMUNOL, V167, P7052, DOI 10.4049/jimmunol.167.12.7052; Roussel A, 2001, J BIOL CHEM, V276, P38893, DOI 10.1074/jbc.M105707200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; STRAUB FB, 1964, ADV ENZYMOL REL S BI, V26, P89; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szenthe B, 2004, BIOCHEMISTRY-US, V43, P3376, DOI 10.1021/bi035689+; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wahlgren WY, 2011, J BIOL CHEM, V286, P3587, DOI 10.1074/jbc.M110.161604; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	64	58	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20290	20300		10.1074/jbc.M112.354332	http://dx.doi.org/10.1074/jbc.M112.354332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511776	Green Published, hybrid			2022-12-28	WOS:000306414500049
J	Hotzy, J; Machtens, JP; Fahlke, C				Hotzy, Jasmin; Machtens, Jan-Philipp; Fahlke, Christoph			Neutralizing Aspartate 83 Modifies Substrate Translocation of Excitatory Amino Acid Transporter 3 (EAAT3) Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION CHANNELS; CONFORMATIONAL-CHANGES; CHLORIDE CHANNEL; SODIUM; BINDING; EAAC1; GLT-1; MICE; NEURODEGENERATION; DETERMINES	Excitatory amino acid transporters (EAATs) terminate glutamatergic synaptic transmission by removing glutamate from the synaptic cleft into neuronal and glial cells. EAATs are not only secondary active glutamate transporters but also function as anion channels. Gating of EAAT anion channels is tightly coupled to transitions within the glutamate uptake cycle, resulting in Na+- and glutamate-dependent anion currents. A point mutation neutralizing a conserved aspartic acid within the intracellular loop close to the end of transmembrane domain 2 was recently shown to modify the substrate dependence of EAAT anion currents. To distinguish whether this mutation affects transitions within the uptake cycle or directly modifies the opening/closing of the anion channel, we used voltage clamp fluorometry. Using three different sites for fluorophore attachment, V120C, M205C, and A430C, we observed time-, voltage-, and substrate-dependent alterations of EAAT3 fluorescence intensities. The voltage and substrate dependence of fluorescence intensities can be described by a 15-state model of the transport cycle in which several states are connected to branching anion channel states. D83A-mediated changes of fluorescence intensities, anion currents, and secondary active transport can be explained by exclusive modifications of substrate translocation rates. In contrast, sole modification of anion channel opening and closing is insufficient to account for all experimental data. We conclude that D83A has direct effects on the glutamate transport cycle and that these effects result in changed anion channel function.	[Hotzy, Jasmin; Machtens, Jan-Philipp; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013; Machtens, Jan-Philipp/M-8659-2013	Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant FA301/9 (to Ch. F.).	Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Gandhi Chris S., 2008, V491, P213, DOI 10.1007/978-1-59745-526-8_17; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Leinenweber A, 2011, J BIOL CHEM, V286, P1927, DOI 10.1074/jbc.M110.153486; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	45	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20016	20026		10.1074/jbc.M112.344077	http://dx.doi.org/10.1074/jbc.M112.344077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532568	Green Published, hybrid			2022-12-28	WOS:000306414500023
J	Kashlan, OB; Blobner, BM; Zuzek, Z; Carattino, MD; Kleyman, TR				Kashlan, Ossama B.; Blobner, Brandon M.; Zuzek, Zachary; Carattino, Marcelo D.; Kleyman, Thomas R.			Inhibitory Tract Traps the Epithelial Na+ Channel in a Low Activity Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-INHIBITION; ALPHA-SUBUNIT; GAMMA-SUBUNIT; SODIUM-CHANNEL; PROTEASES; PEPTIDE; DOMAIN; ENAC; RESIDUES	Proteolysis plays an important role in the maturation and activation of epithelial Na+ channels (ENaCs). Non-cleaved channels are inactive at high extracellular Na+ concentrations and fully cleaved channels are constitutively active. Cleavage of the alpha and gamma subunits at multiple sites activates the channel through the release of imbedded inhibitory tracts. Peptides derived from these released tracts are also inhibitory, likely through binding at the inhibitory tract sites. We recently reported a model of the alpha subunit. We have now cross-linked Cys derivatives of the inhibitory peptide to the channel, using our model to predict sites at a domain interface of the alpha subunit that is in proximity to the N terminus of the peptide. Further-more, peptide inhibition was mimicked in the absence of peptide by cross-linking the channel across the domain interface. Our results suggest a dynamic domain interface that can be exploited by inhibitory peptides and provides a mechanism for peptide inhibition and proteolytic activation.	[Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Dept Med, Renal Electrolyte Div, A919 Scaife,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			National Institutes of Health [DK078734, DK065161, DK084060, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, R37DK051391, K01DK078734, R56DK065161, P30DK079307, R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078734 (to O. B. K.), DK065161 (to T. R. K.), DK084060 (to M. D. C.), and DK079307 (the Pittsburgh Center for Kidney Research).	Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	20	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20720	20726		10.1074/jbc.M112.358218	http://dx.doi.org/10.1074/jbc.M112.358218			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511777	Green Published, hybrid			2022-12-28	WOS:000306414500090
J	Komori, T; Doi, A; Nosaka, T; Furuta, H; Akamizu, T; Kitamura, T; Senba, E; Morikawa, Y				Komori, Tadasuke; Doi, Asako; Nosaka, Tetsuya; Furuta, Hiroto; Akamizu, Takashi; Kitamura, Toshio; Senba, Emiko; Morikawa, Yoshihiro			Regulation of AMP-activated Protein Kinase Signaling by AFF4 Protein, Member of AF4 (ALL1-fused Gene from Chromosome 4) Family of Transcription Factors, in Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE-SECRETION; FOOD-INTAKE; GHRELIN; EXPRESSION; LEUKEMIA; BRAIN; MOUSE; RATS; PHOSPHORYLATION; PEPTIDE	In the hypothalamus, fasting induces a member of the AF4 family of transcription factors, AFF4, which was originally identified as a fusion partner of the mixed-lineage leukemia gene in infant acute lymphoblastic leukemia. However, the roles of AFF4 in the hypothalamus remain unclear. We show herein that expression of AFF4 increased upon addition of ghrelin and fasting in the growth hormone secretagogue receptor-expressing neurons of the hypothalamus. In the growth hormone secretagogue receptor-expressing hypothalamic neuronal cell line GT1-7, ghrelin markedly induced expression of AFF4 in a time- and dose-dependent manner. Overexpression of AFF4 in GT1-7 cells specifically induced expression of the AMP-activated protein kinase (AMPK) alpha 2 subunit but failed to induce other AMPK subunits and AMPK upstream kinases. The promoter activity of the AMPK alpha 2 gene increased upon addition of AFF4, suggesting that AFF4 regulates transcription of the AMPK alpha 2 gene. Additionally, AFF4 also increased the phosphorylation of acetyl-CoA carboxylase alpha(ACC alpha), a downstream target of AMPK. In GT1-7 cells, ghrelin phosphorylated ACC alpha through AMPK alpha phosphorylation in the early phase (15 min) of the activation. However, ghrelin-induced expression of AMPK alpha 2 and phosphorylation of ACC alpha in the late phase (2 h) of the activation were independent of AMPK alpha phosphorylation. Attenuation of expression of AFF4 by its siRNA in GT1-7 cells decreased ghrelin-induced AMPK alpha 2 expression and ACC alpha phosphorylation in the late phase of the activation. AFF4 may therefore help to maintain activation of AMPK downstream signaling under conditions of prolonged stimulation with ghrelin, such as during fasting.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Doi, Asako; Furuta, Hiroto; Akamizu, Takashi] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Nosaka, Tetsuya] Mie Univ, Grad Sch Med, Dept Microbiol, Tsu, Mie 5148507, Japan; [Kitamura, Toshio] Univ Tokyo, Div Cellular Therapy, Adv Clin Res Ctr, Inst Med Sci, Tokyo 1088639, Japan	Wakayama Medical University; Wakayama Medical University; Mie University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp	Kitamura, Toshio/AAA-2071-2021	Akamizu, Takashi/0000-0003-4960-8271	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790742]; Japan Society for the Promotion of Science [23659385]; Chiyoda Mutual Life Foundation; 2007 Wakayama Medical Award for Young Researchers; Wakayama Medical University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chiyoda Mutual Life Foundation(Chiyoda Mutual Life Foundation); 2007 Wakayama Medical Award for Young Researchers; Wakayama Medical University	This work was supported by Grant-in-aid for Young Scientists (B) 20790742 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Challenging Exploratory Research 23659385 from the Japan Society for the Promotion of Science, grants from the Chiyoda Mutual Life Foundation, the 2007 Wakayama Medical Award for Young Researchers, and a research grant on priority areas from Wakayama Medical University.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bagnasco M, 2002, ENDOCRINOLOGY, V143, P726, DOI 10.1210/en.143.2.726; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bitoun E, 2009, J NEUROSCI, V29, P15366, DOI 10.1523/JNEUROSCI.5188-09.2009; Britanova O, 2002, GENOMICS, V80, P31, DOI 10.1006/geno.2002.6796; Chakrabarti L, 1998, HUM MOL GENET, V7, P441, DOI 10.1093/hmg/7.3.441; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Estable MC, 2002, J BIOMED SCI, V9, P234, DOI 10.1007/BF02256070; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Guillod-Maximin E, 2009, J ENDOCRINOL, V200, P93, DOI 10.1677/JOE-08-0348; Hirsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030956; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Levin BE, 2003, AM J PHYSIOL-ENDOC M, V285, pE949, DOI 10.1152/ajpendo.00186.2003; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Niedzielski MF, 2007, INT J BIOL SCI, V3, P225; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Skinner J. A., 1998, ANAL TRIPLET REPEAT; Taki T, 1999, P NATL ACAD SCI USA, V96, P14535, DOI 10.1073/pnas.96.25.14535; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	36	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19985	19996		10.1074/jbc.M112.367854	http://dx.doi.org/10.1074/jbc.M112.367854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528490	Green Published, hybrid			2022-12-28	WOS:000306414500020
J	Liu, B; Lee, RS; Biesiadecki, BJ; Tikunova, SB; Davis, JP				Liu, Bin; Lee, Ryan S.; Biesiadecki, Brandon J.; Tikunova, Svetlana B.; Davis, Jonathan P.			Engineered Troponin C Constructs Correct Disease-related Cardiac Myofilament Calcium Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; RESTRICTIVE CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CA2+ AFFINITY; EF-HAND; SENSITIZING MUTATIONS; ALPHA-TROPOMYOSIN; BINDING SITES; GENE-TRANSFER; THIN	Aberrant myofilament Ca2+ sensitivity is commonly observed with multiple cardiac diseases, especially familial cardiomyopathies. Although the etiology of the cardiomyopathies remains unclear, improving cardiac muscle Ca2+ sensitivity through either pharmacological or genetic approaches shows promise of alleviating the disease-related symptoms. Due to its central role as the Ca2+ sensor for cardiac muscle contraction, troponin C (TnC) stands out as an obvious and versatile target to reset disease-associated myofilament Ca2+ sensitivity back to normal. To test the hypothesis that aberrant myofilament Ca2+ sensitivity and its related function can be corrected through rationally engineered TnC constructs, three thin filament protein modifications representing different proteins (troponin I or troponin T), modifications (missense mutation, deletion, or truncation), and disease subtypes (familial or acquired) were studied. A fluorescent TnC was utilized to measure Ca2+ binding to TnC in the physiologically relevant biochemical model system of reconstituted thin filaments. Consistent with the pathophysiology, the restrictive cardiomyopathy mutation, troponin I R192H, and ischemia-induced truncation of troponin I (residues 1-192) increased the Ca2+ sensitivity of TnC on the thin filament, whereas the dilated cardiomyopathy mutation, troponin T Delta K210, decreased the Ca2+ sensitivity of TnC on the thin filament. Rationally engineered TnC constructs corrected the abnormal Ca2+ sensitivities of the thin filament, reconstituted actomyosin ATPase activity, and force generation in skinned trabeculae. Thus, the present study provides a novel and versatile therapeutic strategy to restore diseased cardiac muscle Ca2+ sensitivity.	[Liu, Bin; Lee, Ryan S.; Biesiadecki, Brandon J.; Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Tikunova, Svetlana B.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	University System of Ohio; Ohio State University; University of Houston System; University of Houston	Davis, JP (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 209 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	davis.812@osu.edu	Lee, Ryan/HCI-5836-2022		National Institutes of Health [HL091986, AR020792, HL091056, HL087462]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091056, K99HL087462, R01HL091986, R56HL091986, R00HL087462, K99HL091056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR020792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091986 (to J. P. D.), AR020792 (to J. A. Rall), HL091056 (to B. J. B.), and HL087462 (to S. B. T.). This work was also supported by the American Heart Association (to B. L. and J. P. D.).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Black DJ, 2000, BIOCHEMISTRY-US, V39, P13831, DOI 10.1021/bi001106+; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 2004, J BIOL CHEM, V279, P17348, DOI 10.1074/jbc.M314095200; Davis JP, 2002, J BIOL CHEM, V277, P49716, DOI 10.1074/jbc.M208488200; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Foster DB, 2003, CIRC RES, V93, P917, DOI 10.1161/01.RES.0000099889.35340.6F; GEORGE SE, 1993, J BIOL CHEM, V268, P25213; Gillis TE, 2003, AM J PHYSIOL-CELL PH, V284, pC1176, DOI 10.1152/ajpcell.00339.2002; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Haiech J, 2011, BIOCHIMIE, V93, P2029, DOI 10.1016/j.biochi.2011.05.003; Iorga B, 2008, CARDIOVASC RES, V77, P676, DOI 10.1093/cvr/cvm113; Jagatheesan G, 2007, AM J PHYSIOL-HEART C, V293, pH949, DOI 10.1152/ajpheart.01341.2006; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; NEGELE JC, 1992, J BIOL CHEM, V267, P825; Norman C, 2007, AM J PHYSIOL-HEART C, V293, pH2580, DOI 10.1152/ajpheart.00039.2007; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2011, J BIOL CHEM, V286, P20901, DOI 10.1074/jbc.M111.234336; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SCHIAFFINO S, 1993, TRENDS CARDIOVAS MED, V3, P12, DOI 10.1016/1050-1738(93)90022-X; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; TOBACMAN LS, 1984, J BIOL CHEM, V259, P1226; Wei B, 2011, ARCH BIOCHEM BIOPHYS, V505, P144, DOI 10.1016/j.abb.2010.10.013; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yang KQ, 2001, J MOL MICROB BIOTECH, V3, P457; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zhang JC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00077; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	56	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20027	20036		10.1074/jbc.M111.334953	http://dx.doi.org/10.1074/jbc.M111.334953			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511780	hybrid, Green Published			2022-12-28	WOS:000306414500024
J	Poras, H; Duquesnoy, S; Dange, E; Pinon, A; Vialette, M; Fournie-Zaluski, MC; Ouimet, T				Poras, Herve; Duquesnoy, Sophie; Dange, Emilie; Pinon, Anthony; Vialette, Michele; Fournie-Zaluski, Marie-Claude; Ouimet, Tanja			Highly Sensitive Quenched Fluorescent Substrate of Legionella Major Secretory Protein (Msp) Based on Its Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOPHILA ZINC METALLOPROTEASE; EXTRACELLULAR PROTEASE; PSEUDOMONAS-AERUGINOSA; SEQUENCE; ELASTASE	Legionella pneumophila has been shown to secrete a protease termed major secretory protein (Msp). This protease belongs to the M4 family of metalloproteases and shares 62.9% sequence similarity with pseudolysin (EC 3.4.24.26). With the aim of developing a specific enzymatic assay for the detection and quantification of Msp, the Fluofast substrate library was screened using both enzymes in parallel. Moreover, based on the crystal structure of pseudolysin, a model of the Msp structure was built. Screening of the peptide library identified a lead substrate specifically cleaved by Msp that was subsequently optimized by rational design. The proposed model for Msp is consistent with the enzymatic characteristics of the studied peptide substrates and provides new structural information useful for the characterization of the protease. This study leads to the identification of the first selective and high affinity substrate for Msp that is able to detect picomolar concentrations of the purified enzyme. The identified substrate could be useful for the development of a novel method for the rapid detection of Legionella.	[Poras, Herve; Duquesnoy, Sophie; Dange, Emilie; Fournie-Zaluski, Marie-Claude; Ouimet, Tanja] Pharmaleads, F-75013 Paris, France; [Pinon, Anthony; Vialette, Michele] Inst Pasteur, F-59019 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Poras, H (corresponding author), Pharmaleads, Paris BioPk,11 Rue Watt, F-75013 Paris, France.	herve.poras@pharmaleads.com	PORAS, Hervé/ABE-1773-2020	Pinon, Anthony/0000-0001-7048-3085; PORAS, Herve/0000-0002-3329-7432	Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project)	Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project)(French National Research Agency (ANR))	This work was supported by a grant from Agence Nationale pour la Recherche (Programme de Recherche sur les ECOtechnologies et le Developpement Durable, Ralf project).	BAINE WB, 1979, J CLIN MICROBIOL, V9, P453; BERDAL BP, 1982, J CLIN MICROBIOL, V16, P452, DOI 10.1128/JCM.16.3.452-457.1982; BERDAL BP, 1982, ACTA PATH MICRO IM B, V90, P119; BLACK WJ, 1990, J BACTERIOL, V172, P2608, DOI 10.1128/jb.172.5.2608-2613.1990; DOWLING JN, 1992, MICROBIOL REV, V56, P32, DOI 10.1128/MMBR.56.1.32-60.1992; DREYFUS LA, 1986, INFECT IMMUN, V51, P736, DOI 10.1128/IAI.51.3.736-743.1986; GHOSE AK, 2001, COMBINATORIAL LIB DE; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KEEN MG, 1989, INFECT IMMUN, V57, P732, DOI 10.1128/IAI.57.3.732-738.1989; Lutfullah G, 2008, PROTEIN J, V27, P105, DOI 10.1007/s10930-007-9113-0; MCINTYRE M, 1991, APMIS, V99, P316, DOI 10.1111/j.1699-0463.1991.tb05155.x; MELDAL M, 1994, P NATL ACAD SCI USA, V91, P3314, DOI 10.1073/pnas.91.8.3314; MOFFAT JF, 1994, INFECT IMMUN, V62, P751, DOI 10.1128/IAI.62.2.751-753.1994; MULLER HE, 1980, INFECT IMMUN, V27, P51; Poras H, 2011, ANAL BIOCHEM, V419, P95, DOI 10.1016/j.ab.2011.08.016; QUINN FD, 1989, MOL MICROBIOL, V3, P797, DOI 10.1111/j.1365-2958.1989.tb00228.x; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Roques B. P., 2007, U. S. Patent, Patent No. [7,169,574, 7169574]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Soleilhac JM, 1996, ANAL BIOCHEM, V241, P120, DOI 10.1006/abio.1996.0385; THAYER MM, 1991, J BIOL CHEM, V266, P2864; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON MR, 1981, INFECT IMMUN, V34, P299, DOI 10.1128/IAI.34.1.299-302.1981	24	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20221	20230		10.1074/jbc.M111.334334	http://dx.doi.org/10.1074/jbc.M111.334334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528499	Green Published, hybrid			2022-12-28	WOS:000306414500042
J	Yao, Y; Bellon, M; Shelton, SN; Nicot, C				Yao, Yuan; Bellon, Marcia; Shelton, Shary N.; Nicot, Christophe			Tumor Suppressors p53, p63TA alpha, p63TAy, p73 alpha, and p73 beta Use Distinct Pathways to Repress Telomerase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE GENE; CATALYTIC SUBUNIT HTERT; CELL-CYCLE ARREST; C-MYC; DOWN-REGULATION; CANCER-CELLS; P73 GENE; NF-Y; PROMOTER; ACTIVATION	The promoter of the telomerase catalytic subunit (TERT) is subject to tight regulation and remains repressed in somatic cells to ensure their limited life span and to prevent tumor initiation. Here we report that the hTERT promoter is strongly repressed by p53 and the related family members p63 and p73. We found that p53-mediated repression was different in human and mouse cells and occurred through p53-dependent transcription inhibition of c-Myc or through E-box/E2F pathways, respectively. Although p63TA alpha-mediated repression occurred through SP1, p63TAy-mediated repression occurred through E2F signaling. Finally, p73 alpha- and p73 beta-mediated repression occurred through NF-YB2. Our results show a complex multifactorial mechanism used by p53 and its family members to keep hTERT expression under tight control. .	[Nicot, Christophe] Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Nicot, C (corresponding author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66160 USA.	cnicot@kumc.edu			National Institutes of Health [CA106258, CA115398]; NATIONAL CANCER INSTITUTE [R01CA115398, R01CA106258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106258 and CA115398.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Beitzinger M, 2006, ONCOGENE, V25, P813, DOI 10.1038/sj.onc.1209125; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chebel A, 2009, J BIOL CHEM, V284, P35725, DOI 10.1074/jbc.M109.009183; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Corn PG, 1999, CANCER RES, V59, P3352; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Datta A, 2006, BLOOD, V108, P1021, DOI 10.1182/blood-2006-01-0067; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Glasspool RM, 2005, NEOPLASIA, V7, P614, DOI 10.1593/neo.04766; Gollahon LS, 1996, ONCOGENE, V12, P715; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gunes C, 2000, CANCER RES, V60, P2116; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Hashimoto M, 2008, INT J ONCOL, V33, P333, DOI 10.3892/ijo_00000013; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Horikawa I, 2004, CYTOTECHNOLOGY, V45, P23, DOI 10.1007/s10616-004-5122-4; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Horikawa I, 1999, CANCER RES, V59, P826; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kirschner RD, 2008, NUCLEIC ACIDS RES, V36, P2969, DOI 10.1093/nar/gkn132; Kusumoto M, 1999, CLIN CANCER RES, V5, P2140; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Li H, 2007, ANN NY ACAD SCI, V1114, P56, DOI 10.1196/annals.1396.016; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; MOBERG KH, 1992, J CELL BIOCHEM, V49, P208, DOI 10.1002/jcb.240490213; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakatake M, 2007, CELL CYCLE, V6, P1496; Oh S, 2000, ONCOGENE, V19, P1485, DOI 10.1038/sj.onc.1203439; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Pei JH, 2011, TUMOR BIOL, V32, P1133, DOI 10.1007/s13277-011-0215-0; Racek T, 2005, J BIOL CHEM, V280, P40402, DOI 10.1074/jbc.C500193200; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Sitaram RT, 2010, BRIT J CANCER, V103, P1255, DOI 10.1038/sj.bjc.6605878; Takakura M, 1999, CANCER RES, V59, P551; Watanabe T, 2002, ACTA NEUROPATHOL, V104, P357, DOI 10.1007/s00401-002-0549-1; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890	54	12	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20737	20747		10.1074/jbc.M111.319236	http://dx.doi.org/10.1074/jbc.M111.319236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496369	Green Published, hybrid			2022-12-28	WOS:000306414500092
J	Zheng, J; Watanabe, H; Wines-Samuelson, M; Zhao, HL; Gridley, T; Kopan, R; Shen, J				Zheng, Jin; Watanabe, Hirotaka; Wines-Samuelson, Mary; Zhao, Huailong; Gridley, Thomas; Kopan, Raphael; Shen, Jie			Conditional Deletion of Notch1 and Notch2 Genes in Excitatory Neurons of Postnatal Forebrain Does Not Cause Neurodegeneration or Reduction of Notch mRNAs and Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; CAENORHABDITIS-ELEGANS; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; GAMMA-SECRETASE; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; MEMORY FORMATION; TRANSGENIC MICE; RADIAL GLIA	Activation of Notch signaling requires intramembranous cleavage by gamma-secretase to release the intracellular domain. We previously demonstrated that presenilin and nicastrin, components of the gamma-secretase complex, are required for neuronal survival in the adult cerebral cortex. Here we investigate whether Notch1 and/or Notch2 are functional targets of presenilin/gamma-secretase in promoting survival of excitatory neurons in the adult cerebral cortex by generating Notch1, Notch2, and Notch1/Notch2 conditional knock-out (cKO) mice. Unexpectedly, we did not detect any neuronal degeneration in the adult cerebral cortex of these Notch cKO mice up to similar to 2 years of age, whereas conditional inactivation of presenilin or nicastrin using the same alpha CaMKII-Cre transgenic mouse caused progressive, striking neuronal loss beginning at 4 months of age. More surprisingly, we failed to detect any reduction of Notch1 and Notch2 mRNAs and proteins in the cerebral cortex of Notch1 and Notch2 cKO mice, respectively, even though Cre-mediated genomic deletion of the floxed Notch1 and Notch2 exons clearly took place in the cerebral cortex of these cKO mice. Furthermore, introduction of Cre recombinase into primary cortical cultures prepared from postnatal floxed Notch1/Notch2 pups, where Notch1 and Notch2 are highly expressed, completely eliminated their expression, indicating that the floxed Notch1 and Notch2 alleles can be efficiently inactivated in the presence of Cre. Together, these results demonstrate that Notch1 and Notch2 are not involved in the age-related neurodegeneration caused by loss of presenilin or gamma-secretase and suggest that there is no detectable expression of Notch1 and Notch2 in pyramidal neurons of the adult cerebral cortex.	[Zheng, Jin; Watanabe, Hirotaka; Wines-Samuelson, Mary; Zhao, Huailong; Shen, Jie] Harvard Univ, Sch Med, Ctr Neurol Dis, Dept Neurol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Zheng, Jin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430022, Peoples R China; [Gridley, Thomas] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Kopan, Raphael] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63110 USA; [Kopan, Raphael] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Huazhong University of Science & Technology; Maine Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Shen, J (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Dept Neurol,Brigham & Womens Hosp, NRB 636E,77 Ave Louis Pasteur, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Watanabe, Hirotaka/GZA-8002-2022; Kopan, Raphael/AFG-3275-2022; Shen, Jie/GXH-9449-2022; Kopan, Raphael/AAF-1357-2022	Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health [R01 NS042818, RC2 AG036614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS042818 (to J. S.) and RC2 AG036614.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Boyles RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014332; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Chen GQ, 2010, J NEUROSCI, V30, P13066, DOI 10.1523/JNEUROSCI.2378-10.2010; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cornell M, 1999, GENETICS, V152, P567; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; Fujimoto M, 2009, DEV BIOL, V332, P339, DOI 10.1016/j.ydbio.2009.06.001; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gonsalves FC, 2007, P NATL ACAD SCI USA, V104, P531, DOI 10.1073/pnas.0609851104; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Handler M, 2000, DEVELOPMENT, V127, P2593; HIGUCHI M, 1995, MOL BRAIN RES, V29, P263, DOI 10.1016/0169-328X(94)00257-F; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Ho A, 2011, TRENDS MOL MED, V17, P617, DOI 10.1016/j.molmed.2011.06.002; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Levitan D, 1998, DEVELOPMENT, V125, P3599; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Prakash N, 2002, EXP CELL RES, V278, P31, DOI 10.1006/excr.2002.5544; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Wines-Samuelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010195; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	75	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20356	20368		10.1074/jbc.M112.349738	http://dx.doi.org/10.1074/jbc.M112.349738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22505716	Green Published, hybrid			2022-12-28	WOS:000306414500055
J	Das, A; Li, QX; Laws, MJ; Kaya, H; Bagchi, MK; Bagchi, IC				Das, Amrita; Li, Quanxi; Laws, Mary J.; Kaya, Hatice; Bagchi, Milan K.; Bagchi, Indrani C.			Estrogen-induced Expression of Fos-related Antigen 1 (FRA-1) Regulates Uterine Stromal Differentiation and Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYO IMPLANTATION; MATRIX METALLOPROTEINASES; PROGESTERONE-RECEPTOR; TRANSCRIPTION FACTORS; CELL-MIGRATION; MOUSE; MICE; DECIDUALIZATION; PREGNANCY; GENE	Concerted actions of estrogen and progesterone via their cognate receptors orchestrate changes in the uterine tissue, regulating implantation during early pregnancy. The uterine stromal cells undergo steroid-dependent differentiation into morphologically and functionally distinct decidual cells, which support embryonic growth and survival. The hormone-regulated pathways underlying this unique cellular transformation are not fully understood. Previous studies in the mouse revealed that, following embryo attachment, de novo synthesis of estrogen by the decidual cells is critical for stromal differentiation. In this study we report that Fos-related antigen 1 (FRA-1), a member of the Fos family of transcription factors, is a downstream target of regulation by intrauterine estrogen. FRA-1 expression was localized in the differentiating uterine stromal cells surrounding the implanted embryo. Attenuation of estrogen receptor alpha (Esr1) expression by siRNA mediated silencing in primary uterine stromal cells suppressed FRA-1 expression. Furthermore, chromatin immunoprecipitation demonstrated direct recruitment of ESR1 to an estrogen response element in the Fra-1 promoter. Down-regulation of Fra-1 expression during in vitro decidualization blocked stromal differentiation and resulted in a marked decrease in stromal cell migration. Interestingly, FRA-1 controls the expression of matrix metalloproteinases MMP9 and MMP13, which are critical modulators of stromal extracellular matrix remodeling. Collectively, these results suggest that FRA-1, induced in response to estrogen signaling via ESR1, is a key regulator of stromal differentiation and remodeling during early pregnancy.	[Das, Amrita; Li, Quanxi; Laws, Mary J.; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61802 USA; [Kaya, Hatice; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61802 USA; [Das, Amrita; Li, Quanxi; Laws, Mary J.; Kaya, Hatice; Bagchi, Milan K.; Bagchi, Indrani C.] Univ Illinois, Ctr Res Reprod & Infertil, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, IC (corresponding author), Univ Illinois, Dept Comparat Biosci, Urbana, IL 61802 USA.	ibagchi@illinois.edu	Laws, Mary/ABE-2782-2020; Laws, Mary/E-4394-2014	Laws, Mary/0000-0001-5140-488X; 	Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD055787]; Specialized Cooperative Centers Program in Reproduction and Infertility Research; National Center for Research Resources, National Institutes of Health [C06 RR16515-01];  [R01 HD 43381]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Specialized Cooperative Centers Program in Reproduction and Infertility Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by the Eunice Kennedy Shriver NICHD/National Institutes of Health through Grant U54 HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and also by Grant R01 HD 43381. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR16515-01 from the National Center for Research Resources, National Institutes of Health (to I. C. B.).	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Alexander CM, 1996, DEVELOPMENT, V122, P1723; BAKER DJ, 1992, BIOL REPROD, V47, P492, DOI 10.1095/biolreprod47.3.492; Ben-Zimra M, 2002, MOL CELL ENDOCRINOL, V187, P223, DOI 10.1016/S0303-7207(01)00713-4; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Cheon YP, 2004, J BIOL CHEM, V279, P10357, DOI 10.1074/jbc.M309434200; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hyder SM, 1999, MOL ENDOCRINOL, V13, P806, DOI 10.1210/me.13.6.806; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mitchell JA, 2002, BIOL REPROD, V67, P240, DOI 10.1095/biolreprod67.1.240; Peng LH, 2002, MOL CELL ENDOCRINOL, V187, P213, DOI 10.1016/S0303-7207(01)00689-X; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Ramos-Nino ME, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-81; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; YOSHINAG.K, 1966, J REPROD FERTIL, V12, P593, DOI 10.1530/jrf.0.0120593; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001	32	21	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19622	19630		10.1074/jbc.M111.297663	http://dx.doi.org/10.1074/jbc.M111.297663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22514284	hybrid, Green Published			2022-12-28	WOS:000306411900073
J	Racine, A; Page, V; Nagy, S; Grabowski, D; Tanny, JC				Racine, Ariane; Page, Viviane; Nagy, Stephen; Grabowski, David; Tanny, Jason C.			Histone H2B Ubiquitylation Promotes Activity of the Intact Set1 Histone Methyltransferase Complex in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 METHYLATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; COMPASS FAMILY; UBIQUITINATION; CHROMATIN; COMPONENT; CROSSTALK; MONOUBIQUITINATION	The methylation of histone H3 at lysine 4 (H3K4me) is critical for the formation of transcriptionally active chromatin in eukaryotes. In yeast, Drosophila, and some human cell lines, H3K4me is globally stimulated by the monoubiquitylation of histone H2B (H2Bub1), another histone modification associated with transcription. The mechanism of this "trans-histone" modification pathway remains uncertain, and studies carried out in different experimental systems have suggested that H2Bub1 could either influence the subunit composition of methyltransferase complexes or directly stimulate methyltransferase activity. We have reconstituted this pathway in vitro using the native H3K4-specific methyltransferase complex Set1C purified from the fission yeast Schizosaccharomyces pombe and chromatin substrates that contain semisynthetic H2Bub1. We found that the activity of S. pombe Set1C toward nucleosomal histone H3 is directly enhanced by H2Bub1 in vitro. Importantly, Set1C purified from cells lacking H2Bub1 retained activity on free histone substrates, suggesting that Set1C remains intact in the absence of H2Bub1. Chromatin immunoprecipitation assays revealed a defect in recruitment of intact Set1C to transcribed chromatin in H2Bub1-deficient mutants. Our data argue that trans-histone crosstalk in S. pombe involves direct enhancement of Set1C methyltransferase activity by H2Bub1 and suggest that this represents a conserved aspect of H2Bub1-H3K4me crosstalk in eukaryotes.	[Racine, Ariane; Page, Viviane; Nagy, Stephen; Grabowski, David; Tanny, Jason C.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University	Tanny, JC (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Prom Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	jason.tanny@mcgill.ca	Tanny, Jason/AAD-3624-2022		Canadian Institutes of Health Research [MOP-97890]; Sackler Program in Epigenetics; Fonds de Recherche en Sante du Quebec [20274]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Sackler Program in Epigenetics; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP-97890 (to J. C. T.) and startup funds from the Sackler Program in Epigenetics (to J. C. T.).; Supported by Fellowship 20274 from the Fonds de Recherche en Sante du Quebec. To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, McGill University, 3655 Prom. Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Tel.: 514-398-3608; E-mail: jason.tanny@mcgill.ca.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao Y, 2011, P NATL ACAD SCI USA, V108, P8305, DOI 10.1073/pnas.1019290108; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	47	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19040	19047		10.1074/jbc.M112.356253	http://dx.doi.org/10.1074/jbc.M112.356253			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505722	Green Published, hybrid			2022-12-28	WOS:000306411900015
J	Ai, LB; Skehan, RR; Saydi, J; Lin, T; Brown, KD				Ai, Lingbao; Skehan, Ryan R.; Saydi, John; Lin, Tong; Brown, Kevin D.			Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor kappa Light Chain Enhancer of Activated B Cells (NF kappa B) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT BREAST-CANCER; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; CONSTITUTIVE ACTIVATION; DRUG-SENSITIVITY; OXIDATIVE STRESS; GENOTOXIC STRESS; IKK ACTIVATION; TUMOR-CELLS; KINASE ATM	Transglutaminase 2 (TG2) is a ubiquitously expressed enzyme that cross-links proteins and its overexpression, linked to a drug resistant phenotype, is commonly observed in cancer cells. Further, up-regulation of TG2 expression occurs during response to various forms of cell stress; however, the molecular mechanisms that drive inducible expression of the TG2 gene (TGM2) require elucidation. Here we show that genotoxic stress induces TG2 expression through the Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor kappa light chain enhancer of activated B cells (NF kappa B) signaling pathway. We further document that NF kappa B is both necessary and sufficient to drive constitutive TG2 expression in cultured cell lines. Additionally, shRNA-mediated knockdown or pharmacological inhibition of the ATM kinase results in reduced constitutive TG2 expression and NF kappa B transcriptional activity. We document that the NF kappa B subunit p65 (RelA) interacts with two independent consensus NF kappa B binding sites within the TGM2 promoter, that mutation of either site or pharmacological inhibition of NF kappa B reduces TGM2 promoter activity, and genotoxic stress drives heightened association of p65 with the TGM2 promoter. Finally, we observed that knockdown of either p65 or ATM in MDA-MB-468 breast cancer cells expressing recombinant TG2 partially reduces resistance to doxorubicin, indicating that the drug resistance linked to overexpression of TG2 functions, in part, through p65 and ATM. This work establishes a novel ATM-dependent signaling loop where TG2 and NF kappa B activate each other resulting in sustained activation of NF kappa B and acquisition of a drug-resistant phenotype.	[Brown, Kevin D.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, UF Shands Canc Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu	Lin, Tong/G-4105-2012		National Institutes of Health [R01-CA102289]; Ocala Royal Dames for Cancer Research; Florida Department of Health; NATIONAL CANCER INSTITUTE [R01CA102289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocala Royal Dames for Cancer Research; Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01-CA102289), the Ocala Royal Dames for Cancer Research, and the Florida Department of Health (to K. D. B.).	Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Bensimon A., FEBS LETT, V585, P1625; Budillon A., 2011, AMINO ACIDS IN PRESS; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caccamo D, 2005, J NEUROSCI RES, V82, P858, DOI 10.1002/jnr.20683; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Dyer LM, 2011, J NEURO-ONCOL, V101, P429, DOI 10.1007/s11060-010-0277-7; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Han JA, 1999, J CANCER RES CLIN, V125, P89, DOI 10.1007/s004320050247; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Hettasch JM, 1996, LAB INVEST, V75, P637; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Kang SK, 2004, FEBS LETT, V577, P361, DOI 10.1016/j.febslet.2004.10.031; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tanaka T, 2006, CELL CYCLE, V5, P878, DOI 10.4161/cc.5.8.2681; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Veuger SJ, 2011, DNA REPAIR, V10, P235, DOI 10.1016/j.dnarep.2010.11.005; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	60	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18330	18341		10.1074/jbc.M112.339317	http://dx.doi.org/10.1074/jbc.M112.339317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493284	Green Published, hybrid			2022-12-28	WOS:000306411600039
J	Ochs, SM; Thumann, S; Richau, R; Weirauch, MT; Lowe, TM; Thomm, M; Hausner, W				Ochs, Simon M.; Thumann, Sybille; Richau, Renate; Weirauch, Matt T.; Lowe, Todd M.; Thomm, Michael; Hausner, Winfried			Activation of Archaeal Transcription Mediated by Recruitment of Transcription Factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; RNA-POLYMERASE; PYROCOCCUS-FURIOSUS; SULFOLOBUS-SOLFATARICUS; PREINITIATION COMPLEX; INITIATION COMPLEX; STRUCTURAL BASIS; TFIIE-ALPHA; DNA-BINDING	Archaeal promoters consist of a TATA box and a purine-rich adjacent upstream sequence (transcription factor B (TFB)-responsive element (BRE)), which are bound by the transcription factors TATA box-binding protein (TBP) and TFB. Currently, only a few activators of archaeal transcription have been experimentally characterized. The best studied activator, Ptr2, mediates activation by recruitment of TBP. Here, we present a detailed biochemical analysis of an archaeal transcriptional activator, PF1088, which was identified in Pyrococcus furiosus by a bioinformatic approach. Operon predictions suggested that an upstream gene, pf1089, is polycistronically transcribed with pf1088. We demonstrate that PF1088 stimulates in vitro transcription by up to 7-fold when the pf1089 promoter is used as a template. By DNase I and hydroxyl radical footprinting experiments, we show that the binding site of PF1088 is located directly upstream of the BRE of pf1089. Mutational analysis indicated that activation requires the presence of the binding site for PF1088. Furthermore, we show that activation of transcription by PF1088 is dependent upon the presence of an imperfect BRE and is abolished when the pf1089 BRE is replaced with a BRE from a strong archaeal promoter. Gel shift experiments showed that TFB recruitment to the pf1089 operon is stimulated by PF1088, and TFB seems to stabilize PF1088 operator binding even in the absence of TBP. Taken together, these results represent the first biochemical evidence for a transcriptional activator working as a TFB recruitment factor in Archaea, for which the designation TFB-RF1 is suggested.	[Ochs, Simon M.; Thumann, Sybille; Richau, Renate; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; [Weirauch, Matt T.; Lowe, Todd M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of Regensburg; University of California System; University of California Santa Cruz	Hausner, W (corresponding author), Univ Regensburg, Lehrstuhl Mikrobiol, Univ Str 31, D-93053 Regensburg, Germany.	winfried.hausner@biologie.uni-regensburg.de	Lowe, Todd Michael/ABJ-5261-2022		Deutsche Forschungsgemeinschaft [TH 422/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant TH 422/13-1.	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Bell SD, 1999, P NATL ACAD SCI USA, V96, P13662, DOI 10.1073/pnas.96.24.13662; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Grohmann D, 2009, BIOCHEM SOC T, V37, P12, DOI 10.1042/BST0370012; Grunberg S, 2007, J BIOL CHEM, V282, P35482, DOI 10.1074/jbc.M707371200; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; Hausner W, 1996, J BIOL CHEM, V271, P30144, DOI 10.1074/jbc.271.47.30144; Hethke C, 1999, GENETICS, V152, P1325; Kanai T, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703424200; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lee SJ, 2008, ARCH MICROBIOL, V190, P247, DOI 10.1007/s00203-008-0378-2; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Liu W, 2007, J MOL BIOL, V369, P474, DOI 10.1016/j.jmb.2007.03.044; Okada U, 2006, PROTEINS, V63, P1084, DOI 10.1002/prot.20913; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Ouhammouch M, 2005, MOL MICROBIOL, V56, P625, DOI 10.1111/j.1365-2958.2005.04563.x; Ouhammouch M, 2003, P NATL ACAD SCI USA, V100, P5097, DOI 10.1073/pnas.0837150100; Peeters E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/750457; Peeters E, 2009, MOL MICROBIOL, V71, P972, DOI 10.1111/j.1365-2958.2008.06578.x; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Qureshi SA, 1998, MOL CELL, V1, P389, DOI 10.1016/S1097-2765(00)80039-8; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Teufel K, 2010, ARCH MICROBIOL, V192, P143, DOI 10.1007/s00203-009-0537-0; Thomm M., 2007, ARCHAEA EVOLUTION PH, P185; Thomm M, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P139; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; van de Werken HJG, 2006, FEMS MICROBIOL LETT, V260, P69, DOI 10.1111/j.1574-6968.2006.00292.x; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Weidenbach K, 2010, FEBS J, V277, P4398, DOI 10.1111/j.1742-4658.2010.07821.x	41	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18863	18871		10.1074/jbc.M112.365742	http://dx.doi.org/10.1074/jbc.M112.365742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496454	hybrid, Green Published			2022-12-28	WOS:000306411600094
J	Panina, S; Stephan, A; la Cour, JM; Jacobsen, K; Kallerup, LK; Bumbuleviciute, R; Knudsen, KVK; Sanchez-Gonzalez, P; Villalobo, A; Olesen, UH; Berchtold, MW				Panina, Svetlana; Stephan, Alexander; la Cour, Jonas M.; Jacobsen, Kivin; Kallerup, Line K.; Bumbuleviciute, Rasita; Knudsen, Kristoffer V. K.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio; Olesen, Uffe H.; Berchtold, Martin W.			Significance of Calcium Binding, Tyrosine Phosphorylation, and Lysine Trimethylation for the Essential Function of Calmodulin in Vertebrate Cells Analyzed in a Novel Gene Replacement System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TARGET RECOGNITION; CYCLE PROGRESSION; ACTIVATION; KINASE; PROTEIN; STIMULATION; MECHANISMS; 3-KINASE; TISSUE	Calmodulin (CaM) was shown to be essential for survival of lower eukaryotes by gene deletion experiments. So far, no CaM gene deletion was reported in higher eukaryotes. In vertebrates, CaM is expressed from several genes, which encode an identical protein, making it difficult to generate a model system to study the effect of CaM gene deletion. Here, we present a novel genetic system based on the chicken DT40 cell line, in which the two functional CaM genes were deleted and one allele replaced with a CaM transgene that can be artificially regulated. We show that CaM is essential for survival of vertebrate cells as they die in the absence of CaM expression. Reversal of CaM repression or ectopic expression of HA-tagged CaM rescued the cells. Cells exclusively expressing HA-CaM with impaired individual calcium binding domains as well as HA-CaM lacking the ability to be phosphorylated at residues Tyr(99)/Tyr(138) or trimethylated at Lys(115) survived and grew well. CaM mutated at both Ca2+ binding sites 3 and 4 as well as at both sites 1 and 2, but to a lesser degree, showed decreased ability to support cell growth. Cells expressing CaM with all calcium binding sites impaired died with kinetics similar to that of cells expressing no CaM. This system offers a unique opportunity to analyze CaM structure-function relationships in vivo without the use of pharmacological inhibitors and to analyze the function of wild type and mutated CaM in modulating the activity of different target systems without interference of endogenous CaM.	[Berchtold, Martin W.] Univ Copenhagen, Dept Biol, Bioctr, DK-2200 Copenhagen, Denmark; [Sanchez-Gonzalez, Pablo; Villalobo, Antonio] CSIC, Inst Invest Biomed, Dept Canc Biol, E-28029 Madrid, Spain	University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Berchtold, MW (corresponding author), Univ Copenhagen, Dept Biol, Bioctr, DK-2200 Copenhagen, Denmark.	mabe@bio.ku.dk	Vitting-Seerup, Kristoffer/AAE-4069-2021; Villalobo, Antonio/O-9621-2019; Vitting-Seerup, Kristoffer/C-9008-2015; Berchtold, Martin/L-1695-2014; Villalobo, Antonio/K-2902-2017; la Cour, Jonas/M-5088-2016	Villalobo, Antonio/0000-0002-4200-374X; Vitting-Seerup, Kristoffer/0000-0002-6450-0608; Berchtold, Martin/0000-0001-8995-9047; Sanhez, Pablo/0000-0002-2844-6843; la Cour, Jonas/0000-0002-1588-0608; Olesen, Uffe Hogh/0000-0002-4578-684X	Danish Research Council; Lundbeeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Fraenkels Mindefond; Hansen Fonden; Danish Cancer Society [R2-A183]; Junta de Ampliacion de Estudios; Consejo Superior de Investigaciones Cientificas; Ministerio de Ciencia e Innovacion [SAF2008-00986, SAF2011-23494]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; European Commission [ITN 289033]	Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Fraenkels Mindefond; Hansen Fonden; Danish Cancer Society(Danish Cancer Society); Junta de Ampliacion de Estudios; Consejo Superior de Investigaciones Cientificas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion de la Comunidad de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Danish Research Council, the Lundbeeck Foundation, AP Moller Fonden, Dagmar Marshall Fonden, Willumsen Fonden, Danielsen Fonden, and Wedell Wedellsborg Fonden, Fraenkels Mindefond, Hansen Fonden (to M. W. B.).; Supported by the Danish Cancer Society (R2-A183).; Supported by a predoctoral fellowship from the Junta de Ampliacion de Estudios, Consejo Superior de Investigaciones Cientificas.; Supported by the Ministerio de Ciencia e Innovacion (SAF2008-00986 and SAF2011-23494), the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), and the European Commission (Contract ITN 289033).	Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Dagher R, 2011, BBA-MOL CELL RES, V1813, P1059, DOI 10.1016/j.bbamcr.2010.11.004; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fischer R, 1998, FEBS LETT, V425, P175, DOI 10.1016/S0014-5793(98)00225-7; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GREGORI L, 1985, J BIOL CHEM, V260, P5232; Harding SA, 1997, EMBO J, V16, P1137, DOI 10.1093/emboj/16.6.1137; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Joseph JD, 2002, EUKARYOT CELL, V1, P119, DOI 10.1128/EC.01.1.119-125.2002; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; Li HB, 2012, J BIOL CHEM, V287, P3273, DOI 10.1074/jbc.M111.317529; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; Machaca K, 2010, CELL CALCIUM, V48, P243, DOI 10.1016/j.ceca.2010.10.003; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MEYERS MB, 1995, FEBS LETT, V357, P230, DOI 10.1016/0014-5793(94)01338-2; MOSER MJ, 1995, J BIOL CHEM, V270, P20643, DOI 10.1074/jbc.270.35.20643; O'Day DH, 2003, CELL SIGNAL, V15, P347, DOI 10.1016/S0898-6568(02)00116-X; Roberts DM, 1996, MED VET ENTOMOL, V10, P137, DOI 10.1111/j.1365-2915.1996.tb00719.x; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; SANJOSE E, 1992, J BIOL CHEM, V267, P15237; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; TAKUWA N, 1995, CELL SIGNAL, V7, P93, DOI 10.1016/0898-6568(94)00074-L; TAKUWA N, 1993, J BIOL CHEM, V268, P138; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	43	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18173	18181		10.1074/jbc.M112.339382	http://dx.doi.org/10.1074/jbc.M112.339382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493455	Green Published, hybrid			2022-12-28	WOS:000306411600025
J	Pertusa, M; Madrid, R; Morenilla-Palao, C; Belmonte, C; Viana, F				Pertusa, Maria; Madrid, Rodolfo; Morenilla-Palao, Cruz; Belmonte, Carlos; Viana, Felix			N-Glycosylation of TRPM8 Ion Channels Modulates Temperature Sensitivity of Cold Thermoreceptor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTHOL RECEPTOR TRPM8; SODIUM-CHANNELS; VANILLOID RECEPTOR-1; POTASSIUM CHANNELS; SURFACE-CHARGE; SENSATION; RESIDUES; REVEALS; ACID; SITE	TRPM8 is a member of the transient receptor potential ion channel superfamily, which is expressed in sensory neurons and is activated by cold and cooling compounds, such as menthol. Activation of TRPM8 by agonists takes place through shifts in its voltage activation curve, allowing channel opening at physiological membrane potentials. Here, we studied the role of the N-glycosylation occurring at the pore loop of TRPM8 on the function of the channel. Using heterologous expression of recombinant channels in HEK293 cells we found that the unglycosylated TRPM8 mutant (N934Q) displays marked functional differences compared with the wild type channel. These differences include a shift in the threshold of temperature activation and a reduced response to menthol and cold stimuli. Biophysical analysis indicated that these modifications are due to a shift in the voltage dependence of TRPM8 activation toward more positive potentials. By using tunicamycin, a drug that prevents N-glycosylation of proteins, we also evaluated the effect of the N-glycosylation on the responses of trigeminal sensory neurons expressing TRPM8. These experiments showed that the lack of N-glycosylation affects the function of native TRPM8 ion channels in a similar way to heterologously expressed ones, causing an important shift of the temperature threshold of cold-sensitive thermoreceptor neurons. Altogether, these results indicate that post-translational modification of TRPM8 is an important mechanism modulating cold thermoreceptor function, explaining the marked differences in temperature sensitivity observed between recombinant and native TRPM8 ion channels.	[Pertusa, Maria; Madrid, Rodolfo; Morenilla-Palao, Cruz; Belmonte, Carlos; Viana, Felix] Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alicante 03550, Spain; [Pertusa, Maria; Madrid, Rodolfo] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Santiago de Chile	Viana, F (corresponding author), Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alicante 03550, Spain.	felix.viana@umh.es	Viana, Felix/U-8533-2017	Viana, Felix/0000-0003-1439-949X; Morenilla-Palao, Cruz/0000-0002-8159-1206; Pertusa, Maria/0000-0003-3856-9019; Madrid, Rodolfo/0000-0002-8623-5761	Spanish MICIIN [SAF2010-14990]; CONSOLIDER-INGENIO [CSD2007-00023]; Spanish Ministry of Education and Science; FONDECYT [3110128, 1100983]; Spanish Fundacion Marcelino Botin	Spanish MICIIN(Spanish Government); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Fundacion Marcelino Botin	This work was supported in part by Spanish MICIIN Projects SAF2010-14990 (to F.V.) and CONSOLIDER-INGENIO CSD2007-00023 (to C.B.).; Supported by a predoctoral fellowship from the Spanish Ministry of Education and Science and FONDECYT Grant 3110128.; Supported by a postdoctoral fellowship of the Spanish Fundacion Marcelino Botin and FONDECYT Grant 1100983.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; de la Pena E., 2005, J PHYSL, V567, P415; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HSIEH P, 1983, J BIOL CHEM, V258, P2548; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Varki A., 1999, ESSENTIALS GLYCOBIOL; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005; Zhang Y, 1999, J MEMBRANE BIOL, V171, P195, DOI 10.1007/s002329900571	56	51	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18218	18229		10.1074/jbc.M111.312645	http://dx.doi.org/10.1074/jbc.M111.312645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493431	Green Published, hybrid			2022-12-28	WOS:000306411600030
J	Yoshizawa, T; Shimizu, T; Hirano, H; Sato, M; Hashimoto, H				Yoshizawa, Takuya; Shimizu, Toshiyuki; Hirano, Hisashi; Sato, Mamoru; Hashimoto, Hiroshi			Structural Basis for Inhibition of Xyloglucan-specific Endo-beta-1,4-glucanase (XEG) by XEG-Protein Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-BETA-GLUCANASE; X-RAY-DIFFRACTION; ASPERGILLUS-ACULEATUS; CELL-WALL; GLYCOPROTEIN; CARROT; ENDOGLUCANASE; PURIFICATION; COMPLEXES; XYLANASE	Microorganisms such as plant pathogens secrete glycoside hydrolases (GHs) to digest the polysaccharide chains of plant cell walls. The degradation of cell walls by these enzymes is a crucial step for nutrition and invasion. To protect the cell wall from these enzymes, plants secrete glycoside hydrolase inhibitor proteins (GHIPs). Xyloglucan-specific endo-beta-1,4-glucanase (XEG), a member of GH family 12 (GH12), could be a great threat to many plants because xyloglucan is a major component of the cell wall in most plants. Understanding the inhibition mechanism of XEG by GHIP is therefore of great importance in the field of plant defense, but to date the mechanism and specificity of GHIPs remain unclear. We have determined the crystal structure of XEG in complex with extracellular dermal glycoprotein (EDGP), a carrot GHIP that inhibits XEG. The structure reveals that the conserved arginines of EDGP intrude into the active site of XEG and interact with the catalytic glutamates of the enzyme. We have also determined the crystal structure of the XEG-xyloglucan complex. These structures show that EDGP closely mimics the XEG-xyloglucan interaction. Although EDGP shares structural similarity to a wheat GHIP (Triticum aestivum xylanase inhibitor-IA (TAXI-IA)) that inhibits GH11 family xylanases, the arrangement of GH and GHIP in the XEG-EDGP complex is distinct from that in the xylanase-TAXI-IA complex. Our findings imply that plants have evolved structures of GHIPs to inhibit different GH family members that attack their cell walls.	[Yoshizawa, Takuya; Hirano, Hisashi; Sato, Mamoru; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yokohama City University; University of Tokyo	Hashimoto, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789	National Project on Protein Structural and Functional Analyses Protein 3000 Project; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	National Project on Protein Structural and Functional Analyses Protein 3000 Project; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI), the National Project on Protein Structural and Functional Analyses Protein 3000 Project, and the Targeted Proteins Research Program from Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) (to T. S., M. S., and H. H.).	BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fierens K, 2005, FEBS J, V272, P5872, DOI 10.1111/j.1742-4658.2005.04987.x; Gebruers K, 2004, BBA-PROTEINS PROTEOM, V1696, P213, DOI 10.1016/j.bbapap.2003.08.013; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; KANDA T, 1976, J BIOCHEM, V79, P997, DOI 10.1093/oxfordjournals.jbchem.a131167; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naqvi SMS, 2005, PLANT PHYSIOL, V139, P1389, DOI 10.1104/pp.105.065227; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauly M, 1999, GLYCOBIOLOGY, V9, P93, DOI 10.1093/glycob/9.1.93; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Qin Q, 2003, PLANT J, V34, P327, DOI 10.1046/j.1365-313X.2003.01726.x; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sansen S, 2004, J BIOL CHEM, V279, P36022, DOI 10.1074/jbc.M404212200; Shang CW, 2005, BIOCHEM BIOPH RES CO, V328, P144, DOI 10.1016/j.bbrc.2004.12.166; Shang CW, 2004, BIOCHEMISTRY-US, V43, P6281, DOI 10.1021/bi036160f; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshizawa T, 2011, ACTA CRYSTALLOGR F, V67, P830, DOI 10.1107/S1744309111020045; Yoshizawa T, 2011, FEBS J, V278, P1944, DOI 10.1111/j.1742-4658.2011.08111.x	31	43	44	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18710	18716		10.1074/jbc.M112.350520	http://dx.doi.org/10.1074/jbc.M112.350520			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496365	Green Published, hybrid			2022-12-28	WOS:000306411600079
J	Chen, ZQ; Zhang, DH; Yue, F; Zheng, MH; Kovacevic, Z; Richardson, DR				Chen, Zhiqiang; Zhang, Daohai; Yue, Fei; Zheng, Minhua; Kovacevic, Zaklina; Richardson, Des R.			The Iron Chelators Dp44mT and DFO Inhibit TGF-beta-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS SUPPRESSOR GENE; SELECTIVE ANTITUMOR-ACTIVITY; BREAST-CANCER CELLS; PANCREATIC-CANCER; E-CADHERIN; TUMOR-METASTASIS; GROWTH SUPPRESSION; EXPRESSION; DRG-1; MECHANISMS	The epithelial-mesenchymal transition (EMT) is a key step for cancer cell migration, invasion, and metastasis. Transforming growth factor-beta (TGF-beta) regulates the EMT and the metastasis suppressor gene, N-myc downstream-regulated gene-1 (NDRG1), could play a role in regulating the TGF-beta pathway. NDRG1 expression is markedly increased after chelator-mediated iron depletion via hypoxia-inducible factor 1 alpha-dependent and independent pathways (Le, N. T. and Richardson, D. R. (2004) Blood 104, 2967-2975). Moreover, novel iron chelators show marked and selective anti-tumor activity and are a potential new class of anti-metabolites. Considering this, the current study investigated the relationship between NDRG1 and the EMT to examine if iron chelators can inhibit the EMT via NDRG1 up-regulation. We demonstrated that TGF-beta induces the EMT in HT29 and DU145 cells. Further, the chelators, desferrioxamine (DFO) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), inhibited the TGF-beta-induced EMT by maintaining E-cadherin and beta-catenin, at the cell membrane. We then established stable clones with NDRG1 overexpression and knock-down in HT29 and DU145 cells. These data showed that NDRG1 overexpression maintained membrane E-cadherin and beta-catenin and inhibited TGF-beta-stimulated cell migration and invasion. Conversely, NDRG1 knock-down caused morphological changes from an epithelial- to fibroblastic-like phenotype and also increased migration and invasion, demonstrating NDRG1 knockdown induced the EMT and enhanced TGF-beta effects. We also investigated the mechanisms involved and showed the TGF-beta/SMAD and Wnt pathways were implicated in NDRG1 regulation of E-cadherin and beta-catenin expression and translocation. This study demonstrates that chelators inhibit the TGF-beta-induced EMT via a process consistent with NDRG1 up-regulation and elucidates the mechanism of their activity.	[Chen, Zhiqiang; Yue, Fei; Zheng, Minhua; Richardson, Des R.] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai 200025, Peoples R China; [Chen, Zhiqiang; Zhang, Daohai; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Dept Pathol, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia	Shanghai Jiao Tong University; University of Sydney	Zheng, MH (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai 200025, Peoples R China.	zmhtiger@yeah.net; d.richardson@med.usyd.edu.au	Kovacevic, Zaklina/ABD-9581-2021	Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274				Bambang IF, 2009, EXP CELL RES, V315, P1964, DOI 10.1016/j.yexcr.2009.02.017; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Ellenrieder V, 2001, CANCER RES, V61, P4222; Elston MS, 2009, J CLIN ENDOCR METAB, V94, P1436, DOI 10.1210/jc.2008-2075; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Guang RJ, 2000, CANCER RES, V60, P749; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Liang SX, 2003, CARCINOGENESIS, V24, P1601, DOI 10.1093/carcin/bgg116; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miller L. D., CANC RES, V71, P6728; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Salnikow K, 2003, CANCER RES, V63, P3524; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sugiki T, 2004, BIOL PHARM BULL, V27, P624, DOI 10.1248/bpb.27.624; Suzuki H, 2008, ANTICANCER RES, V28, P1821; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; vanBelzen N, 1997, LAB INVEST, V77, P85; Cespedes MV, 2010, AM J PATHOL, V177, P2067, DOI 10.2353/ajpath.2010.100079; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yu Y, 2011, MOL PHARMACOL, V79, P921, DOI 10.1124/mol.111.071324; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	51	186	188	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17016	17028		10.1074/jbc.M112.350470	http://dx.doi.org/10.1074/jbc.M112.350470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22453918	Green Published, hybrid			2022-12-28	WOS:000306373000003
J	Song, Y; Lu, BW				Song, Yan; Lu, Bingwei			Interaction of Notch Signaling Modulator Numb with alpha-Adaptin Regulates Endocytosis of Notch Pathway Components and Cell Fate Determination of Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLAST SELF-RENEWAL; LETHAL-GIANT-LARVAE; TUMOR-SUPPRESSOR; ASYMMETRIC DIVISION; MEMBRANE LOCALIZATION; DROSOPHILA; ACTIVATION; PROTEIN; SANPODO; DELTA	The ability to balance self-renewal and differentiation is a hallmark of stem cells. In Drosophila neural stem cells (NSCs), Numb/Notch (N) signaling plays a key role in this process. However, the molecular and cellular mechanisms underlying Numb function in a stem cell setting remain poorly defined. Here we show that alpha-Adaptin (alpha-Ada), a subunit of the endocytic AP-2 complex, interacts with Numb through a new mode of interaction to regulate NSC homeostasis. In alpha-ada mutants, N pathway component Sanpodo and the N receptor itself exhibited altered trafficking, and N signaling was up-regulated in the intermediate progenitors of type II NSC lineages, leading to their transformation into ectopic NSCs. Surprisingly, although the Ear domain of alpha-Ada interacts with the C terminus of Numb and is important for alpha-Ada function in the sensory organ precursor lineage, it was dispensable in the NSCs. Instead, alpha-Ada could regulate Sanpodo, N trafficking, and NSC homeostasis by inter-acting with Numb through new domains in both proteins previously not known to mediate their interaction. This interaction could be bypassed when alpha-Ada was directly fused to the phospho-tyrosine binding domain of Numb. Our results identify a critical role for the AP-2-mediated endocytosis in regulating NSC behavior and reveal a new mechanism by which Numb regulates NSC behavior through N. These findings are likely to have important implications for cancer biology.	[Song, Yan; Lu, Bingwei] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Lu, BW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	bingwei@stanford.edu		Lu, Bingwei/0000-0002-5807-7014	National Institutes of Health; Stanford University School of Medicine Dean's postdoctoral fellowship;  [R01 NS043167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine Dean's postdoctoral fellowship; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health however, remains enigmatic (17). Various studies indicate that Grant R01 NS043167 (to B. L.). This work was also supported by a Stanford University School of Medicine Dean's postdoctoral fellowship (to Y. S.).	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Benhra N, 2011, CURR BIOL, V21, P87, DOI 10.1016/j.cub.2010.12.010; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Couturier L, 2012, NAT CELL BIOL, V14, P131, DOI 10.1038/ncb2419; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Eun SH, 2008, DEVELOPMENT, V135, P1089, DOI 10.1242/dev.009530; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Klein T, 2003, DEV BIOL, V255, P313, DOI 10.1016/s0012-1606(02)00052-0; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ouyang YS, 2011, DEVELOPMENT, V138, P2185, DOI 10.1242/dev.058347; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roegiers F, 2005, MOL BIOL CELL, V16, P3480, DOI 10.1091/mbc.E05-03-0177; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Schluter T, 2009, BIOCHEM BIOPH RES CO, V379, P909, DOI 10.1016/j.bbrc.2008.12.166; Song Y, 2011, GENE DEV, V25, P2644, DOI 10.1101/gad.171959.111; Tang HY, 2005, MOL CELL BIOL, V25, P2899, DOI 10.1128/MCB.25.8.2899-2909.2005; Tong X, 2010, MOL BIOL CELL, V21, P802, DOI 10.1091/mbc.E09-09-0831; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001	71	29	34	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17716	17728		10.1074/jbc.M112.360719	http://dx.doi.org/10.1074/jbc.M112.360719			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474327	Green Published, hybrid			2022-12-28	WOS:000306373000070
J	Sommer, J; Effenberger, T; Volpi, E; Waetzig, GH; Bernhardt, M; Suthaus, J; Garbers, C; Rose-John, S; Floss, DM; Scheller, J				Sommer, Jan; Effenberger, Timo; Volpi, Elena; Waetzig, Georg H.; Bernhardt, Marten; Suthaus, Jan; Garbers, Christoph; Rose-John, Stefan; Floss, Doreen M.; Scheller, Juergen			Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma Is Inhibited by an Anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; PROXIMAL EXTRACELLULAR DOMAINS; CYTOKINE-INDEPENDENT GROWTH; EMBRYONIC STEM-CELLS; TRANSDUCER GP130; MONOCLONAL-ANTIBODIES; ONCOSTATIN-M; STAT3; ACTIVATION; MEMBRANE	Ligand-independent constitutively active gp130 mutants were described to be responsible for the development of inflammatory hepatocellular adenomas (IHCAs). These variants had gain-of-function somatic mutations within the extracellular domain 2 (D2) of the gp130 receptor chain. Cytokine-dependent Ba/F3 cells were transduced with the constitutively active variant of gp130 featuring a deletion in the domain 2 from Tyr-186 to Tyr-190 (gp130 Delta YY). These cells showed constitutive phosphorylation of signal transducer and activator of transcription-3 (STAT3) and cytokine-independent proliferation. Deletion of the Ig-like domain 1 (D1) of gp130, but not anti-gp130 mAbs directed against D1, abolished constitutive activation of gp130 Delta YY, highlighting that this domain is involved in ligand-independent activation of gp130 Delta YY. Moreover, soluble variants of gp130 were not able to inhibit the constitutive activation of gp130 Delta YY. However, the inhibition of constitutive activation of gp130 Delta YY was achieved by the anti-gp130 mAb B-P4, which specifically inhibits gp130 signaling by IL-11 but not by other IL-6 type cytokines. IL-11 but not IL-6 levels were found previously to be up-regulated in IHCAs, suggesting that mutations in gp130 are leading to IL-11-like signaling. The mAb B-P4 might be a valuable tool to inhibit the constitutive activation of naturally occurring gp130 mutants in IHCAs and rare cases of gp130-associated hepatocellular carcinoma.	[Sommer, Jan; Volpi, Elena; Garbers, Christoph; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Effenberger, Timo; Bernhardt, Marten; Suthaus, Jan; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-2300 Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Volpi, Elena/0000-0001-8776-0384	Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) [SCHE 907/2-1, SFB877 A2, SFB841 C1]	Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) SCHE 907/2-1, SFB877 A2, SFB841 C1.	Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Longerich Thomas, 2009, J Hepatol, V51, P230, DOI 10.1016/j.jhep.2009.03.004; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Pflanz S, 2001, BIOCHEM J, V356, P605, DOI 10.1042/0264-6021:3560605; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Rawat R, 2000, BLOOD, V96, P3514; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sambrook J., 2002, MOL CLONING LAB MANU; Scheller J, 2006, SIGNAL TRANSDUCTION, V6, P240, DOI [DOI 10.1002/SITA.200600086, 10.1002/sita.200600086]; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240	30	28	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13743	13751		10.1074/jbc.M111.349167	http://dx.doi.org/10.1074/jbc.M111.349167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22523320	Green Published, Bronze			2022-12-28	WOS:000303996300030
J	Bandyopadhyay, GK; Vu, CU; Gentile, S; Lee, H; Biswas, N; Chi, NW; O'Connor, DT; Mahata, SK				Bandyopadhyay, Gautam K.; Vu, Christine U.; Gentile, Stefano; Lee, Howon; Biswas, Nilima; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.			Catestatin (Chromogranin A(352-372)) and Novel Effects on Mobilization of Fat from Adipose Tissue through Regulation of Adrenergic and Leptin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE-INHIBITORY PEPTIDE; DIET-INDUCED OBESITY; A-DERIVED PEPTIDE; CATECHOLAMINE RELEASE; IN-VIVO; OB/OB MICE; ALPHA(2)-ADRENERGIC RECEPTORS; EPINEPHRINE INFUSION; INDUCED LIPOLYSIS; ACID OXIDATION	Chromogranin A knock-out (Chga-KO) mice display increased adiposity despite high levels of circulating catecholamines and leptin. Consistent with diet-induced obese mice, desensitization of leptin receptors caused by hyperleptinemia is believed to contribute to the obese phenotype of these KO mice. In contrast, obesity in ob/ob mice is caused by leptin deficiency. To characterize the metabolic phenotype, Chga-KO mice were treated with the CHGA-derived peptide catestatin (CST) that is deficient in these mice. CST treatment reduced fat depot size and increased lipolysis and fatty acid oxidation. In liver, CST enhanced oxidation of fatty acids as well as their assimilation into lipids, effects that are attributable to the up-regulation of genes promoting fatty acid oxidation (Cpt1 alpha, Ppar alpha, Acox, and Ucp2) and incorporation into lipids (Gpat and CD36). CST did not affect basal or isoproterenol-stimulated cAMP production in adipocytes but inhibited phospholipase C activation by the alpha-adrenergic receptor (AR) agonist phenylephrine, suggesting inhibition of alpha-AR signaling by CST. Indeed, CST mimicked the lipolytic effect of the alpha-AR blocker phentolamine on adipocytes. Moreover, CST reversed the hyperleptinemia of Chga-KO mice and improved leptin signaling as determined by phosphorylation of AMPK and Stat3. CST also improved peripheral leptin sensitivity in diet-induced obese mice. In ob/ob mice, CST enhanced leptin-induced signaling in adipose tissue. In conclusion, our results implicate CST in a novel pathway that promotes lipolysis and fatty acid oxidation by blocking alpha-AR signaling as well as by enhancing leptin receptor signaling.	[Bandyopadhyay, Gautam K.; Vu, Christine U.; Gentile, Stefano; Lee, Howon; Biswas, Nilima; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bandyopadhyay, Gautam K.; Chi, Nai-Wen; O'Connor, Daniel T.; Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bandyopadhyay, GK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gbandyopadhyay@ucsd.edu; smahata@ucsd.edu	Mahata, Sushil/AAF-8781-2021		National Institutes of Health [R01 DA011311]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA011311 (to S. K. M.). This work was also supported by grants from the Department of Veterans Affairs (to S. K. M., D. T. O., and N.-W. C.).	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Aung G, 2011, IMMUNOLOGY, V132, P527, DOI 10.1111/j.1365-2567.2010.03395.x; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Couillard C, 2002, OBES RES, V10, P6, DOI 10.1038/oby.2002.2; Dev NB, 2010, ENDOCRINOLOGY, V151, P2760, DOI 10.1210/en.2009-1110; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fritsche A, 1998, EXP CLIN ENDOCR DIAB, V106, P415, DOI 10.1055/s-0029-1212008; Fruhbeck G, 1998, BIOCHEM BIOPH RES CO, V250, P99, DOI 10.1006/bbrc.1998.9277; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Gaede AH, 2012, AM J PHYSIOL-REG I, V302, pR365, DOI 10.1152/ajpregu.00409.2011; Gaede AH, 2010, AM J PHYSIOL-REG I, V299, pR1538, DOI 10.1152/ajpregu.00335.2010; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; Gomez-Ambrosi J, 2001, INT J MOL MED, V8, P103; Guo XX, 2011, BIOCHEM BIOPH RES CO, V407, P807, DOI 10.1016/j.bbrc.2011.03.104; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Imbrogno S, 2010, J EXP BIOL, V213, P3636, DOI 10.1242/jeb.045567; Jensen MD, 1997, ANNU REV NUTR, V17, P127, DOI 10.1146/annurev.nutr.17.1.127; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; LAFONTAN M, 1993, J LIPID RES, V34, P1057; Lafontan M., 1997, Human Reproduction (Oxford), V12, P6; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 2004, MOL PHARMACOL, V66, P1180, DOI 10.1124/mol.104.002139; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V162, P33, DOI 10.1016/j.regpep.2010.01.006; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mazza R, 2008, AM J PHYSIOL-HEART C, V295, pH113, DOI 10.1152/ajpheart.00172.2008; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Mori S, 2007, LIPIDS, V42, P307, DOI 10.1007/S11745-007-3034-8; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Polak J, 2007, J LIPID RES, V48, P2236, DOI 10.1194/jlr.M700253-JLR200; Radek KA, 2008, J INVEST DERMATOL, V128, P1525, DOI 10.1038/sj.jid.5701225; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V161, P8, DOI 10.1016/j.regpep.2010.02.005; Scriba D, 2000, EUR J ENDOCRINOL, V143, P439, DOI 10.1530/eje.0.1430439; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Stallknecht B, 1997, J PHYSIOL-LONDON, V500, P271, DOI 10.1113/jphysiol.1997.sp022017; Stich V, 2003, AM J PHYSIOL-ENDOC M, V285, pE599, DOI 10.1152/ajpendo.00502.2002; Stich V, 1999, AM J PHYSIOL-REG I, V277, pR1076, DOI 10.1152/ajpregu.1999.277.4.R1076; Sugawara M, 2010, FASEB J, V24, P1737, DOI 10.1096/fj.09-142554; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Thalmann Sebastien, 2008, V456, P195, DOI 10.1007/978-1-59745-245-8_14; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; TOWNSEND RR, 1994, AM J PHYSIOL, V266, pE155, DOI 10.1152/ajpendo.1994.266.2.E155; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	64	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23141	23151		10.1074/jbc.M111.335877	http://dx.doi.org/10.1074/jbc.M111.335877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22535963	hybrid, Green Published			2022-12-28	WOS:000306495000069
J	Jepson, S; Vought, B; Gross, CH; Gan, L; Austen, D; Frantz, JD; Zwahlen, J; Lowe, D; Markland, W; Krauss, R				Jepson, Scott; Vought, Bryan; Gross, Christian H.; Gan, Lu; Austen, Douglas; Frantz, J. Daniel; Zwahlen, Jacque; Lowe, Derek; Markland, William; Krauss, Raul			LINGO-1, a Transmembrane Signaling Protein, Inhibits Oligodendrocyte Differentiation and Myelination through Intercellular Self-interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR FAMILY-MEMBER; PRECURSOR CELLS; NOGO RECEPTOR; REMYELINATION; ASTROCYTES; EXPRESSION; BDNF	Overcoming remyelination failure is a major goal of new therapies for demyelinating diseases like multiple sclerosis. LINGO-1, a key negative regulator of myelination, is a transmembrane signaling protein expressed in both neurons and oligodendrocytes. In neurons, LINGO-1 is an integral component of the Nogo receptor complex, which inhibits axonal growth via RhoA. Because the only ligand-binding subunit of this complex, the Nogo receptor, is absent in oligodendrocytes, the extracellular signals that inhibit myelination through a LINGO-1-mediated mechanism are unknown. Here we show that LINGO-1 inhibits oligodendrocyte terminal differentiation through intercellular interactions and is capable of a self-association in trans. Consistent with previous reports, overexpression of full-length LINGO-1 inhibited differentiation of oligodendrocyte precursor cells (OPCs). Unexpectedly, treatment with a soluble recombinant LINGO-1 ectodomain also had an inhibitory effect on OPCs and decreased myelinated axonal segments in cocultures with neurons from dorsal root ganglia. We demonstrated LINGO-1-mediated inhibition of OPCs through intercellular signaling by using a surface-bound LINGO-1 construct expressed ectopically in astrocytes. Further investigation showed that the soluble LINGO-1 ectodomain can interact with itself in trans by binding to CHO cells expressing full-length LINGO-1. Finally, we observed that soluble LINGO-1 could activate RhoA in OPCs. We propose that LINGO-1 acts as both a ligand and a receptor and that the mechanism by which it negatively regulates OPC differentiation and myelination is mediated by a homophilic intercellular interaction. Disruption of this protein-protein interaction could lead to a decrease of LINGO-1 inhibition and an increase in myelination.	[Jepson, Scott; Frantz, J. Daniel; Markland, William; Krauss, Raul] Vertex Pharmaceut Inc, Dept Cell & Mol Biol, Cambridge, MA 02139 USA; [Vought, Bryan; Gan, Lu; Austen, Douglas; Zwahlen, Jacque] Vertex Pharmaceut Inc, Dept Prot Sci, Cambridge, MA 02139 USA; [Gross, Christian H.] Vertex Pharmaceut Inc, Dept Enzymol, Cambridge, MA 02139 USA; [Lowe, Derek] Vertex Pharmaceut Inc, Dept Chem Res, Cambridge, MA 02139 USA	Vertex Pharmaceuticals; Vertex Pharmaceuticals; Vertex Pharmaceuticals; Vertex Pharmaceuticals	Krauss, R (corresponding author), Vertex Pharmaceut Inc, Dept Cell & Mol Biol, 130 Waverly St, Cambridge, MA 02139 USA.	raul_krauss@vrtx.com						Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Colognato H, 2007, DEVELOPMENT, V134, P1723, DOI 10.1242/dev.02819; Dawson J, 2003, J NEUROCHEM, V87, P947, DOI 10.1046/j.1471-4159.2003.02056.x; Du YZ, 2003, DEV NEUROSCI-BASEL, V25, P116, DOI 10.1159/000072261; Du YZ, 2006, MOL CELL NEUROSCI, V31, P366, DOI 10.1016/j.mcn.2005.11.001; Fu QL, 2010, EUR J NEUROSCI, V31, P1091, DOI 10.1111/j.1460-9568.2010.07127.x; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Li JR, 2003, J NEUROSCI, V23, P5816; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Saha N, 2011, BIOCHEM BIOPH RES CO, V413, P92, DOI 10.1016/j.bbrc.2011.08.060; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; VonDran MW, 2011, J NEUROSCI, V31, P14182, DOI 10.1523/JNEUROSCI.6595-10.2011; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Zhong XT, 2009, FEBS LETT, V583, P1034, DOI 10.1016/j.febslet.2009.02.034; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	31	77	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22184	22195		10.1074/jbc.M112.366179	http://dx.doi.org/10.1074/jbc.M112.366179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22514275	hybrid, Green Published			2022-12-28	WOS:000306418600057
J	Gao, YW; Cimica, V; Reich, NC				Gao, Yiwei; Cimica, Velasco; Reich, Nancy C.			Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRECEPTOR TYROSINE KINASE; CANCER CELLS; SH2 DOMAIN; SOCS BOX; IN-VIVO; BRK; PROTEIN; DEGRADATION; GROWTH; PHOSPHORYLATION	Breast tumor kinase (Brk) was originally isolated from a human metastatic breast tumor, but also is found expressed in other epithelial tumors and in a subset of normal epithelia. Brk is a tyrosine kinase and its expression in breast carcinoma has been linked to tumor progression. The signal transducer and activator of transcription 3 (STAT3) is one of the substrate targets of Brk, and elevated tyrosine phosphorylation of STAT3 is known to contribute to oncogenesis. Conventional activation of STAT3 occurs in response to cytokine stimulation of Janus tyrosine kinases (JAK). One of the negative regulators discovered in cytokine signaling of the JAK-STAT pathway is the suppressor of cytokine signaling 3 (SOCS3). In this report we describe the finding that SOCS3 can also inhibit the unconventional target, Brk. Investigation of the mechanism by which SOCS3 inhibits Brk reveals the SOCS3 protein binds to Brk primarily via its SH2 domain, and its main inhibitory effect is mediated by the SOCS3 kinase inhibitory region (KIR). SOCS3 has only a modest effect on promoting Brk degradation, and this requires the C-terminal SOCS box domain. SOCS3 is the only known inhibitor of Brk, and knowledge of the mechanisms by which SOCS3 inhibits Brk may lead to methods that block Brk in cancer progression.	[Gao, Yiwei; Cimica, Velasco; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu	Cimica, Velasco/H-2656-2014	Cimica, Velasco/0000-0001-7489-3145	National Institutes of Health [R01CA122910]; Carol Baldwin Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA122910 and the Carol Baldwin Foundation for Breast Cancer Research (to N. C. R.).	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Ying MZ, 2010, J CANCER RES CLIN, V136, P1617, DOI 10.1007/s00432-010-0819-6; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	53	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20904	20912		10.1074/jbc.M111.334144	http://dx.doi.org/10.1074/jbc.M111.334144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547065	hybrid, Green Published			2022-12-28	WOS:000306416800012
J	Zhang, NZ; Li, BS; Al-Ramahi, I; Cong, X; Held, JM; Kim, E; Botas, J; Gibson, BW; Ellerby, LM				Zhang, Ningzhe; Li, Bensheng; Al-Ramahi, Ismael; Cong, Xin; Held, Jason M.; Kim, Eugene; Botas, Juan; Gibson, Bradford W.; Ellerby, Lisa M.			Inhibition of Lipid Signaling Enzyme Diacylglycerol Kinase epsilon Attenuates Mutant Huntingtin Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; DISEASE; METABOLISM; MODELS; ROLES; GENE; GM1	Huntington disease (HD) is a dominantly inherited neurodegenerative disease caused by a polyglutamine expansion in the protein huntingtin (Htt). Striatal and cortical neuronal loss are prominent features of this disease. No disease-modifying treatments have been discovered for HD. To identify new therapeutic targets in HD, we screened a kinase inhibitor library for molecules that block mutant Htt cellular toxicity in a mouse HD striatal cell model, Hdh(111Q/111Q) cells. We found that diacylglycerol kinase (DGK) inhibitor II (R59949) decreased caspase-3/7 activity after serum withdrawal in striatal Hdh(111Q/111Q) cells. In addition, R59949 decreased the accumulation of a 513-amino acid N-terminal Htt fragment processed by caspase-3 and blocked alterations in lipid metabolism during serum withdrawal. To identify the diacylglycerol kinase mediating this effect, we knocked down all four DGK isoforms expressed in the brain (beta, gamma, epsilon, and zeta) using siRNA. Only the knockdown of the family member, DGK epsilon, blocked striatal Hdh(111Q/111Q)-mediated toxicity. We also investigated the significance of these findings in vivo. First, we found that reduced function of the Drosophila DGK epsilon homolog significantly improves Htt-induced motor dysfunction in a fly model of HD. In addition, we find that the levels of DGK epsilon are increased in the striatum of R6/2 HD transgenic mice when compared with littermate controls. Together, these findings indicate that increased levels of kinase DGK epsilon contribute to HD pathogenesis and suggest that reducing its levels or activity is a potential therapy for HD.	[Zhang, Ningzhe; Li, Bensheng; Cong, Xin; Held, Jason M.; Gibson, Bradford W.; Ellerby, Lisa M.] Buck Inst Res Aging, Novato, CA 94945 USA; [Al-Ramahi, Ismael; Kim, Eugene; Botas, Juan] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA	Buck Institute for Research on Aging; Baylor College of Medicine	Ellerby, LM (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	lellerby@buckinstitute.org	Al-Ramahi, Ismael/B-4000-2017	Al-Ramahi, Ismael/0000-0002-1275-1114; Held, Jason/0000-0001-8024-2736	National Institutes of Health [NS40251, NS42179]; CHDI; National Center for Research Resources shared instrumentation Program [S10RR027953]; Mass Spectrometry and Imaging Core [PL1 AG032118]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS042179, R56NS042179, R01NS040251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI; National Center for Research Resources shared instrumentation Program; Mass Spectrometry and Imaging Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40251 (to L. M. E.), NS42179 (to J. B.), and CHDI (to L. M. E. and J. B.). Mass spectrometry instrumentation was supported by National Center for Research Resources shared instrumentation Program Grant S10RR027953 (to B. G.) and the Mass Spectrometry and Imaging Core funded through PL1 AG032118 (to B. G.).	Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; Dicu AO, 2007, BIOCHEMISTRY-US, V46, P6109, DOI 10.1021/bi6024726; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim Y, 2010, EXP MOL MED, V42, P1, DOI 10.3858/emm.2010.42.1.001; Leyva MJ, 2010, CHEM BIOL, V17, P1189, DOI 10.1016/j.chembiol.2010.08.014; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maglione V, 2010, J NEUROSCI, V30, P4072, DOI 10.1523/JNEUROSCI.6348-09.2010; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Tang TS, 2009, J NEUROSCI, V29, P1257, DOI 10.1523/JNEUROSCI.4411-08.2009; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Valenza M, 2011, TRENDS NEUROSCI, V34, P474, DOI 10.1016/j.tins.2011.06.005; WALSH JP, 1994, J BIOL CHEM, V269, P21155; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wu J, 2011, CHEM BIOL, V18, P777, DOI 10.1016/j.chembiol.2011.04.012; Zhao Q, 2007, CHANNELS, V1, P46	26	21	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21204	21213		10.1074/jbc.M111.321661	http://dx.doi.org/10.1074/jbc.M111.321661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22511757	Green Published, hybrid			2022-12-28	WOS:000306416800040
J	Lin, HC; Lai, PY; Lin, YP; Huang, JY; Yang, BC				Lin, Huan-Ching; Lai, Po-Yin; Lin, Yu-ping; Huang, Jyun-Yuan; Yang, Bei-Chang			Fas Ligand Enhances Malignant Behavior of Tumor Cells through Interaction with Met, Hepatocyte Growth Factor Receptor, in Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD178 CYTOPLASMIC TAIL; T-LYMPHOCYTES; C-MET; DOMAIN; ACTIVATION; DEATH; MICE; INVASIVENESS; INHIBITION; REGULATOR	Many late-stage cancer cells express Fas ligand (FasL) and show high malignancy with metastatic potential. We report here a novel signaling mechanism for FasL that hijacks the Met signal pathway to promote tumor metastasis. FasL-expressing human tumor cells express a significant amount of phosphorylated Met. The down-regulation of FasL in these cells led to decreased Met activity and reduced cell motility. Ectopic expression of human FasL in NIH3T3 cells significantly stimulated their migration and invasion. The inhibition of Met and Stat3 activities reverted the FasL-associated phenotype. Notably, FasL variants activated the Met pathway, even though most of their intracellular domain or Fas binding sites were deleted. FasL interacted with Met through the FasL(105-130) extracellular region in lipid rafts, which consequently led to Met activation. Knocking down Met gene expression by RNAi technology reverted the FasL-associated motility to basal levels. Furthermore, treatment with synthetic peptides corresponding to FasL(117-126) significantly reduced the FasL/Met interaction, Met phosphorylation, and cell motility of FasL(+) transfectants and tumor cells. Finally, the transfectants of truncated FasL showed strong anchorage-independent growth and lung metastasis potential in null mice. Collectively, our results establish the FasL-Met-Stat3 signaling pathway and explains the metastatic phenotype of FasL-expressing tumors.	[Lai, Po-Yin; Yang, Bei-Chang] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Yang, Bei-Chang] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Lin, Huan-Ching; Lin, Yu-ping; Huang, Jyun-Yuan; Yang, Bei-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Yang, BC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan.	y1357@mail.ncku.edu.tw			National Science Council of Taiwan [NSC 96-2320-B-006-021-MY3]; Infectious Disease and Signaling Research Center of National Cheng Kung University; Aim for the Top University Project	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Infectious Disease and Signaling Research Center of National Cheng Kung University; Aim for the Top University Project	This work was supported in part by grants (to B.C.Y) from the National Science Council of Taiwan (NSC 96-2320-B-006-021-MY3) and the Infectious Disease and Signaling Research Center of National Cheng Kung University and Aim for the Top University Project.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Chen YL, 2003, J IMMUNOL, V171, P1183, DOI 10.4049/jimmunol.171.3.1183; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Cramer A, 2005, J CELL BIOCHEM, V95, P805, DOI 10.1002/jcb.20459; Cui HL, 1996, CELL IMMUNOL, V167, P276, DOI 10.1006/cimm.1996.0036; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HANE M, 1995, FEBS LETT, V373, P265, DOI 10.1016/0014-5793(95)01051-F; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; Jodo S, 2005, J IMMUNOL, V174, P4470, DOI 10.4049/jimmunol.174.8.4470; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Knox PG, 2003, J IMMUNOL, V170, P677, DOI 10.4049/jimmunol.170.2.677; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Orlinick JR, 1997, J BIOL CHEM, V272, P32221, DOI 10.1074/jbc.272.51.32221; P'Reilly L. A., 2009, NATURE, V461, P659; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Seino K, 1997, TRANSPLANTATION, V64, P1050, DOI 10.1097/00007890-199710150-00018; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Suzuki I, 2000, P NATL ACAD SCI USA, V97, P1707, DOI 10.1073/pnas.97.4.1707; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Ueoka Y, 2000, BRIT J CANCER, V82, P891, DOI 10.1054/bjoc.1999.1016; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Xiao S, 2004, J IMMUNOL, V173, P5095, DOI 10.4049/jimmunol.173.8.5095	30	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20664	20673		10.1074/jbc.M111.326058	http://dx.doi.org/10.1074/jbc.M111.326058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535954	Green Published, hybrid			2022-12-28	WOS:000306414500085
J	Fournier, B; Andargachew, R; Robin, AZ; Laur, O; Voelker, DR; Lee, WY; Weber, D; Parkos, CA				Fournier, Benedicte; Andargachew, Rakieb; Robin, Alexander Z.; Laur, Oskar; Voelker, Dennis R.; Lee, Winston Y.; Weber, Dominique; Parkos, Charles A.			Surfactant Protein D (Sp-D) Binds to Membrane-proximal Domain (D3) of Signal Regulatory Protein alpha (SIRP alpha), a Site Distant from Binding Domain of CD47, while Also Binding to Analogous Region on Signal Regulatory Protein beta (SIRP beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; PROMYELOCYTIC LEUKEMIA; NEGATIVE REGULATION; TYROSINE KINASE; CELLS; PHAGOCYTOSIS; MACROPHAGES; SHPS-1; INFLAMMATION; EXPRESSION	Signal regulatory protein alpha (SIRP alpha), a highly glycosylated type-1 transmembrane protein, is composed of three immunoglobulin-like extracellular loops as well as a cytoplasmic tail containing three classical tyrosine-based inhibitory motifs. Previous reports indicate that SIRP alpha binds to humoral pattern recognition molecules in the collectin family, namely surfactant proteins D and A (Sp-D and Sp-A, respectively), which are heavily expressed in the lung and constitute one of the first lines of innate immune defense against pathogens. However, little is known about molecular details of the structural interaction of Sp-D with SIRPs. In the present work, we examined the molecular basis of Sp-D binding to SIRP alpha using domain-deleted mutant proteins. We report that Sp-D binds to the membrane-proximal Ig domain (D3) of SIRP alpha in a calcium- and carbohydrate-dependent manner. Mutation of predicted N-glycosylation sites on SIRP alpha indicates that Sp-D binding is dependent on interactions with specific N-glycosylated residues on the membrane-proximal D3 domain of SIRP alpha. Given the remarkable sequence similarity of SIRP alpha to SIRP beta and the lack of known ligands for the latter, we examined Sp-D binding to SIRP beta. Here, we report specific binding of Sp-D to the membrane-proximal D3 domain of SIRP beta. Further studies confirmed that Sp-D binds to SIRP alpha expressed on human neutrophils and differentiated neutrophil-like cells. Because the other known ligand of SIRP alpha, CD47, binds to the membrane-distal domain D1, these findings indicate that multiple, distinct, functional ligand binding sites are present on SIRP alpha that may afford differential regulation of receptor function.	[Fournier, Benedicte; Andargachew, Rakieb; Robin, Alexander Z.; Lee, Winston Y.; Weber, Dominique; Parkos, Charles A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Res Unit, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	Emory University; Emory University; National Jewish Health	Fournier, B (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Res Unit, 105-B Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	bfourni@emory.edu			National Institutes of Health [DK079392, DK072564]; Crohn's and Colitis Foundation of America; Rodenberry Foundation; Digestive Diseases Research Development Center [R24 DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072564, R24DK064399, R01DK079392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Rodenberry Foundation; Digestive Diseases Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079392 and DK072564 (to C. A. P.). This work was also supported by a Senior Research Award from the Crohn's and Colitis Foundation of America sponsored by the Rodenberry Foundation (to B. F.) and by core facilities (confocal microscopy, molecular cloning, and cell culture) funded by a National Institutes of Health sponsored Digestive Diseases Research Development Center Grant R24 DK064399.	Adams S, 1998, J IMMUNOL, V161, P1853; Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E C, 2000, Respir Res, V1, P93; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; DREXLER HG, 1995, LEUKEMIA RES, V19, P681, DOI 10.1016/0145-2126(95)00036-N; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lee WY, 2007, J IMMUNOL, V179, P7741, DOI 10.4049/jimmunol.179.11.7741; Lee WY, 2010, J BIOL CHEM, V285, P37953, DOI 10.1074/jbc.M110.180018; LIM BL, 1994, BIOCHEM BIOPH RES CO, V202, P1674, DOI 10.1006/bbrc.1994.2127; Lin ZW, 2002, PHYSIOL GENOMICS, V11, P235, DOI 10.1152/physiolgenomics.00061.2002; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Mackarel AJ, 2001, J IMMUNOL, V167, P2839, DOI 10.4049/jimmunol.167.5.2839; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; PERSSON A, 1990, J BIOL CHEM, V265, P5755; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Soerensen CM, 2005, IMMUNOLOGY, V114, P72, DOI 10.1111/j.1365-2567.2004.01999.x; TUCKER KA, 1987, BLOOD, V70, P372; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200	48	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19386	19398		10.1074/jbc.M111.324533	http://dx.doi.org/10.1074/jbc.M111.324533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511785	Green Published, hybrid			2022-12-28	WOS:000306411900053
J	Koike, A; Kato, T; Sugiura, R; Ma, Y; Tabata, Y; Ohmoto, K; Sio, SO; Kuno, T				Koike, Atsushi; Kato, Toshiaki; Sugiura, Reiko; Ma, Yan; Tabata, Yuki; Ohmoto, Koji; Sio, Susie O.; Kuno, Takayoshi			Genetic Screening for Regulators of Prz1, a Transcriptional Factor Acting Downstream of Calcineurin in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; NUCLEAR EXPORT; PHOSPHORYLATION; PATHWAY; BINDING; SIGNAL; IDENTIFICATION; ACTIVATION; HOMOLOG; ENCODES	Calcineurin phosphatase plays crucial roles in a wide variety of cell types and organisms. Dephosphorylation of the nuclear factor of activated T-cell (NFAT) family of transcriptional factors by calcineurin is essential for activating immune-responsive genes in mammals. NFAT activity is also regulated by diverse signaling pathways, which affect NFAT kinases and nuclear partner proteins. In fission yeast, calcineurin dephosphorylates and activates Prz1, a C2H2-type zinc finger transcriptional factor. Calcineurin-Prz1 signaling regulates the expression of the Pmc1 Ca2+ pump. Prz1-overexpressing cells showed extremely slow growth and high transcriptional activity of Prz1 in the absence of stimulation. Here, we isolated seven genes as dosage-dependent suppressors of this slow growth phenotype. These seven genes encode Rad24, Rad25, Pka1, Msn5 (SPAC328.01c), Pac1, Ape2, and Tfs1. All of them decreased the high transcriptional activity caused by Prz1 overexpression. Overexpression of Pka1, Rad24, and Rad25 also repressed the Ca2+-induced transcriptional activity in cells with Prz1 expressed at wild-type levels. Knock-out of rad24 or rad25 significantly enhanced the transcriptional activity of Prz1, whereas knock-out or mutation of other genes did not enhance the activity. The 14-3-3 proteins, Rad24 and Rad25, bound Prz1 and the Rad24-binding site located at residues 421-426 of Prz1. In msn5 deletion mutants, GFP-Prz1 localized at nucleus in the absence of Ca2+ stimulation, suggesting that Msn5 functions as an exportin for Prz1. In summary, our data suggest that Rad24 and Rad25 negatively regulate Prz1 and that Pka1, Msn5, Pac1, Tfs1, and Ape2 also regulate Prz1.	[Koike, Atsushi; Kato, Toshiaki; Ma, Yan; Tabata, Yuki; Ohmoto, Koji; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Koike, Atsushi] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka 5691094, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan; [Sio, Susie O.] Univ Philippines, Coll Med, Dept Pharmacol & Toxicol, Manila 1000, Philippines	Kobe University; Osaka University of Pharmaceutical Sciences; Kindai University (Kinki University); University of the Philippines System; University of the Philippines Manila	Koike, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	koike@gly.oups.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	[Anonymous], 1992, NATURE, V357, P2; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rotondo G, 1997, RNA, V3, P1182; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Williams LA, 1996, YEAST, V12, P227, DOI 10.1002/(SICI)1097-0061(19960315)12:3<227::AID-YEA905>3.3.CO;2-0; Xiao Z, 2003, J BIOL CHEM, V278, P34245, DOI 10.1074/jbc.M301596200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	38	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19294	19303		10.1074/jbc.M111.310615	http://dx.doi.org/10.1074/jbc.M111.310615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496451	Green Published, hybrid			2022-12-28	WOS:000306411900039
J	Mo, C; Dai, YM; Kang, N; Cui, LX; He, W				Mo, Chen; Dai, Yumei; Kang, Ning; Cui, Lianxian; He, Wei			Ectopic Expression of Human MutS Homologue 2 on Renal Carcinoma Cells Is Induced by Oxidative Stress with Interleukin-18 Promotion via p38 Mitogen-activated Protein Kinase (MAPK) and c-Jun N-terminal Kinase (JNK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-T-CELLS; DNA MISMATCH REPAIR; 1-METHYLPROPYL 2-IMIDAZOLYL DISULFIDE; PRO-INFLAMMATORY CYTOKINES; PEROXIDE-INDUCED APOPTOSIS; MICROSATELLITE INSTABILITY; TRANSCRIPTION FACTOR-3; ADOPTIVE IMMUNOTHERAPY; PERIPHERAL-BLOOD; EPITHELIAL-CELLS	Human MutS homologue 2 (hMSH2), a crucial element of the highly conserved DNA mismatch repair system, maintains genetic stability in the nucleus of normal cells. Our previous studies indicate that hMSH2 is ectopically expressed on the surface of epithelial tumor cells and recognized by both T cell receptor gamma delta (TCR gamma delta) and natural killer group 2 member D (NKG2D) on V delta 2 T cells. Ectopically expressed hMSH2 could trigger a gamma delta T cell-mediated cytolysis. In this study, we showed that oxidative stress induced ectopic expression of hMSH2 on human renal carcinoma cells. Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways. Moreover, renal carcinoma cell-derived interleukin (IL)-18 in oxidative stress was a prominent stimulator for ectopically induced expression of hMSH2, which was promoted by interferon (IFN)-gamma as well. Finally, oxidative stress or pretreatment with IL-18 and IFN-gamma enhanced gamma delta T cell-mediated cytolysis of renal carcinoma cells. Our results not only establish a mechanism of ectopic hMSH2 expression in tumor cells but also find a biological linkage between ectopic expression of hMSH2 and activation of gamma delta T cells in stressful conditions. Because gamma delta T cells play an important role in the early stage of innate anti-tumor response, gamma delta T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.	[Mo, Chen; Dai, Yumei; Kang, Ning; Cui, Lianxian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [He, Wei] Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			National Natural Science Foundation of China [30930083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30930083.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; AHN YS, 1994, TOXICOL PATHOL, V22, P415, DOI 10.1177/019262339402200407; Altavilla G, 2010, ONCOL REP, V24, P927, DOI 10.3892/or_00000938; Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chaum E, 2009, J CELL BIOCHEM, V108, P1280, DOI 10.1002/jcb.22358; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Cho ES, 2008, MUTAT RES-FUND MOL M, V640, P123, DOI 10.1016/j.mrfmmm.2007.12.012; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Ciucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023766; Dai YM, 2012, J BIOL CHEM, V287, P16812, DOI 10.1074/jbc.M111.327650; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Frederiks WM, 2010, ACTA HISTOCHEM, V112, P364, DOI 10.1016/j.acthis.2009.03.003; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Geller SF, 2003, ADV EXP MED BIOL, V533, P249; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Hamid AA, 2002, CANCER, V94, P997, DOI 10.1002/cncr.10341.abs; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; Hussein MR, 2006, INT J EXP PATHOL, V87, P297, DOI 10.1111/j.1365-2613.2006.00482.x; Hussein MR, 2002, MOL CARCINOGEN, V34, P35, DOI 10.1002/mc.10047; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kang N, 2009, CANCER BIOL THER, V8, P1540, DOI 10.4161/cbt.8.16.8950; Kastrinos F, 2008, CANCER EPIDEM BIOMAR, V17, P2044, DOI 10.1158/1055-9965.EPI-08-0301; Khanna A, 2011, TRANSPLANTATION, V91, P590, DOI 10.1097/TP.0b013e31820d3b82; Kiersnowska-Rogowska Beata, 2005, Przegl Lek, V62, P772; Kondo M, 2008, CYTOTHERAPY, V10, P842, DOI 10.1080/14653240802419328; Kunzmann V, 2005, LEUKEMIA LYMPHOMA, V46, P671, DOI 10.1080/10428190500051893; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee SF, 2011, METHOD CELL BIOL, V103, P99, DOI 10.1016/B978-0-12-385493-3.00005-X; Lee YJ, 2002, MOL PHARMACOL, V62, P1409, DOI 10.1124/mol.62.6.1409; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li W, 2010, J IMMUNOTHER, V33, P287, DOI 10.1097/CJI.0b013e3181c80ffa; Liu T, 2010, METHODS MOL BIOL, V653, P193, DOI 10.1007/978-1-60761-759-4_11; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maheshwari A, 2009, FEBS J, V276, P870, DOI 10.1111/j.1742-4658.2008.06831.x; Maroney AC, 1998, J NEUROSCI, V18, P104; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Ogata Atsushi, 2004, Mod Rheumatol, V14, P267, DOI 10.1007/s10165-004-0306-5; Park S, 2009, LEUKEMIA RES, V33, P315, DOI 10.1016/j.leukres.2008.08.001; Pljesa-Ercegovac M, 2008, UROL ONCOL-SEMIN ORI, V26, P175, DOI 10.1016/j.urolonc.2007.02.007; Qi XF, 2011, J CELL PHYSIOL, V226, P58, DOI 10.1002/jcp.22303; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Saitoh A, 2008, MED ONCOL, V25, P137, DOI 10.1007/s12032-007-9004-4; Scherer SJ, 2000, J BIOL CHEM, V275, P37469, DOI 10.1074/jbc.M006990200; Son YO, 2009, MOL CELLS, V28, P545, DOI 10.1007/s10059-009-0149-1; Son YO, 2009, APOPTOSIS, V14, P796, DOI 10.1007/s10495-009-0353-7; Song H, 2008, IMMUNOL LETT, V120, P103, DOI 10.1016/j.imlet.2008.07.007; Srivastava T, 2004, J NEURO-ONCOL, V66, P51, DOI 10.1023/B:NEON.0000013482.99032.b0; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Wyman TH, 2002, J LEUKOCYTE BIOL, V72, P401; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023	77	26	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19242	19254		10.1074/jbc.M112.349936	http://dx.doi.org/10.1074/jbc.M112.349936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493490	Green Published, hybrid			2022-12-28	WOS:000306411900034
J	Nunes-Tavares, N; Santos, LE; Stutz, B; Brito-Moreira, J; Klein, WL; Ferreira, ST; de Mello, FG				Nunes-Tavares, Nilson; Santos, Luis Eduardo; Stutz, Bernardo; Brito-Moreira, Jordano; Klein, William L.; Ferreira, Sergio T.; de Mello, Fernando G.			Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid-beta Peptide Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEPENDENT MECHANISM; EMBRYONIC AVIAN RETINA; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTOR; A-BETA; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; CHICKEN RETINA; ACTIVATION	Dysregulated cholinergic signaling is an early hallmark of Alzheimer disease (AD), usually ascribed to degeneration of cholinergic neurons induced by the amyloid-beta peptide (A beta). It is now generally accepted that neuronal dysfunction and memory deficits in the early stages of AD are caused by the neuronal impact of soluble A beta oligomers (A beta Os). A beta Os build up in AD brain and specifically attach to excitatory synapses, leading to synapse dysfunction. Here, we have investigated the possibility that A beta Os could impact cholinergic signaling. The activity of choline acetyltransferase (ChAT, the enzyme that carries out ACh production) was inhibited by similar to 50% in cultured cholinergic neurons exposed to low nanomolar concentrations of A beta Os. 3-(4,5-Dimethylthiazol-2-yl)-2,5-di-phenyltetrazoliumbromide (MTT) reduction, lactatedehydrogenase release, and [H-3] choline uptake assays showed no evidence of neuronal damage or loss of viability that could account for reduced ChAT activity under these conditions. Glutamate receptor antagonists fully blocked ChAT inhibition and oxidative stress induced by A beta Os. Antioxidant polyunsaturated fatty acids had similar effects, indicating that oxidative damage may be involved in ChAT inhibition. Treatment with insulin, previously shown to down-regulate neuronal A beta O binding sites, fully prevented A beta O-induced inhibition of ChAT. Interestingly, we found that A beta Os selectively bind to similar to 50% of cultured cholinergic neurons, suggesting that ChAT is fully inhibited in A beta O-targeted neurons. Reduction in ChAT activity instigated by A beta Os may thus be a relevant event in early stage AD pathology, preceding the loss of cholinergic neurons commonly observed in AD brains.	[Nunes-Tavares, Nilson; Santos, Luis Eduardo; Stutz, Bernardo; de Mello, Fernando G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil; [Brito-Moreira, Jordano; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21944590 Rio De Janeiro, RJ, Brazil; [Klein, William L.] Northwestern Univ, Evanston, IL 60208 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Northwestern University	de Mello, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.	fgmello@biof.ufrj.br	Ferreira, Sergio/AAZ-1576-2020; Santos, Luís/B-4961-2015; Neurociencia, Inct/I-1011-2013	Ferreira, Sergio/0000-0001-7160-9866; Santos, Luís/0000-0002-0694-733X; 	Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Translational Neuroscience	Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Translational Neuroscience	This work was supported by grants from Conselho Nacional de Desenvolvi-mento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and National Institute of Translational Neuroscience (to F.G.d.M. and S.T.F.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bate C, 2010, NEUROTOX RES, V17, P203, DOI 10.1007/s12640-009-9093-2; BAUGHMAN RW, 1977, BRAIN RES, V138, P469, DOI 10.1016/0006-8993(77)90684-9; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Blasina MF, 2000, CELL TISSUE RES, V299, P173, DOI 10.1007/s004419900117; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917; Contestabile A, 2011, BEHAV BRAIN RES, V221, P334, DOI 10.1016/j.bbr.2009.12.044; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DEMELLO FG, 1991, CELL MOL NEUROBIOL, V11, P485, DOI 10.1007/BF00734811; DEMELLO FG, 1990, J NEUROCHEM, V54, P886, DOI 10.1111/j.1471-4159.1990.tb02334.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Loureiro-dos-Santos NE, 2002, CELL MOL NEUROBIOL, V22, P727, DOI 10.1023/A:1021809124814; Loureiro-dos-Santos NE, 2001, J NEUROCHEM, V77, P1136, DOI 10.1046/j.1471-4159.2001.00330.x; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASLAND R H, 1980, Neurochemistry International, V1, P501, DOI 10.1016/0197-0186(80)90083-2; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; SPIRA AW, 1987, J COMP NEUROL, V260, P526, DOI 10.1002/cne.902600406; STRADA O, 1992, P NATL ACAD SCI USA, V89, P9549, DOI 10.1073/pnas.89.20.9549; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	47	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19377	19385		10.1074/jbc.M111.321448	http://dx.doi.org/10.1074/jbc.M111.321448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505713	Green Published, hybrid			2022-12-28	WOS:000306411900052
J	Zhao, J; Wei, JX; Mialki, R; Zou, CB; Mallampalli, RK; Zhao, YT				Zhao, Jing; Wei, Jianxin; Mialki, Rachel; Zou, Chunbin; Mallampalli, Rama K.; Zhao, Yutong			Extracellular Signal-regulated Kinase (ERK) Regulates Cortactin Ubiquitination and Degradation in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; F-BOX PROTEINS; KAPPA-B-ALPHA; ARP2/3 COMPLEX; TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; BETA-TRCP; BARRIER ENHANCEMENT; PROTEASOME PATHWAY; MIGRATION	Cortactin, an actin-binding protein, is essential for cell growth and motility. We have shown that cortactin is regulated by reversible phosphorylation, but little is known regarding cortactin protein stability. Here, we show that lipopolysaccharide (LPS)-induced cortactin degradation is mediated by extracellular regulated signal kinase (ERK). LPS induces cortactin serine phosphorylation, ubiquitination, and degradation in mouse lung epithelia, an effect abrogated by ERK inhibition. Serine phosphorylation sites mutant, cortactin(S405A/S418A), enhances its protein stability. Cortactin is polyubiquitinated and degraded within the proteasome, whereas a cortactin(K79R) mutant exhibited proteolytic stability during cyclohexamide (CHX) or LPS treatment. The E3 ligase subunit beta-Trcp interacts with cortactin, and its overexpression reduced cortactin protein levels, an effect attenuated by ERK inhibition. Overexpression of beta-Trcp was sufficient to reduce the protective effects of exogenous cortactin on epithelial cell barrier integrity, an effect not observed after expression of a cortactin(K79R) mutant. These results provide evidence that LPS modulation of cortactin stability is coordinately regulated by stress kinases and the ubiquitin-proteasomal network.	[Zhao, Jing; Wei, Jianxin; Mialki, Rachel; Zou, Chunbin; Mallampalli, Rama K.; Zhao, Yutong] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zhao, J (corresponding author), Univ Pittsburgh, Dept Med, 3459 5th Ave,MUH NW628, Pittsburgh, PA 15213 USA.	zhaoj@upmc.edu	Wei, Jianxin/P-5431-2016; Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [R01 HL091916, R01 HL096376, R01 HL097376, R01 HL098174]; United States Department of Veterans Affairs; American Heart Association Scientist Development [12SDG9050005]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097376, R01HL091916, R01HL098174, R01HL096376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association Scientist Development(American Heart Association); United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL091916 (to Y. Z.), and R01 HL096376, R01 HL097376, and R01 HL098174 (to R. K. M.). This work was also supported by a Merit Review Award from the United States Department of Veterans Affairs and American Heart Association Scientist Development Grant 12SDG9050005 (to J. Z.). This material is based upon work supported, in part, by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development.	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Arce FT, 2008, BIOPHYS J, V95, P886, DOI 10.1529/biophysj.107.127167; Banerjee S, 2010, J BIOL CHEM, V285, P2665, DOI 10.1074/jbc.M109.060822; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; Chen JX, 2003, J CELL PHYSIOL, V197, P86, DOI 10.1002/jcp.10353; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He DH, 2009, J BIOL CHEM, V284, P24123, DOI 10.1074/jbc.M109.007393; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hideshima T, 2005, CLIN CANCER RES, V11, P8530, DOI 10.1158/1078-0432.CCR-05-2305; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Huang C, 1997, J BIOL CHEM, V272, P19248, DOI 10.1074/jbc.272.31.19248; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Kaksonen M, 2000, J CELL SCI, V113, P4421; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kelley Laura C, 2011, Commun Integr Biol, V4, P205, DOI 10.4161/cib.4.2.14420; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li YS, 2004, EXP CELL RES, V298, P107, DOI 10.1016/j.yexcr.2004.03.023; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yamada S, 2010, PATHOL ONCOL RES, V16, P523, DOI 10.1007/s12253-009-9245-y; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhao J, 2012, CELL SIGNAL, V24, P77, DOI 10.1016/j.cellsig.2011.08.004; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhao J, 2011, BIOCHEM J, V439, P45, DOI 10.1042/BJ20110274; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	52	26	26	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19105	19114		10.1074/jbc.M112.339507	http://dx.doi.org/10.1074/jbc.M112.339507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22514278	hybrid, Green Published			2022-12-28	WOS:000306411900021
J	Pino, E; Wang, H; McDonald, ME; Qiang, L; Farmer, SR				Pino, Elizabeth; Wang, Hong; McDonald, Meghan E.; Qiang, Li; Farmer, Stephen R.			Roles for Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) and PPAR gamma Coactivators 1 alpha and 1 beta in Regulating Response of White and Brown Adipocytes to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; ADIPOSE-TISSUE; CELL-METABOLISM; OBESITY; INFLAMMATION; DYSFUNCTION; ANGIOGENESIS; PGC-1-ALPHA; OXYGENATION; EXPRESSION	Obese white adipose tissue is hypoxic but is incapable of inducing compensatory angiogenesis. Brown adipose tissue is highly vascularized, facilitating delivery of nutrients to brown adipocytes for heat production. In this study, we investigated the mechanisms by which white and brown adipocytes respond to hypoxia. Brown adipocytes produced lower amounts of hypoxia-inducible factor 1 alpha (HIF-1 alpha) than white adipocytes in response to low O-2 but induced higher levels of hypoxia-associated genes. The response of white adipocytes to hypoxia required HIF-1 alpha, but its presence alone was incapable of inducing target gene expression under normoxic conditions. In addition to the HIF-1 alpha targets, hypoxia also induced many inflammatory genes. Exposure of white adipocytes to a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand (troglitazone) attenuated induction of these genes but enhanced expression of the HIF-1 alpha targets. Knockdown of PPAR gamma in mature white adipocytes prevented the usual robust induction of HIF-1 alpha targets in response to hypoxia. Similarly, knockdown of PPAR gamma coactivator (PGC) 1 beta in PGC-1 alpha-deficient brown adipocytes eliminated their response to hypoxia. These data demonstrate that the response of white adipocytes requires HIF-1 alpha but also depends on PPAR gamma in white cells and the PPAR gamma cofactors PGC-1 alpha and PGC-1 beta in brown cells.	[Pino, Elizabeth; Wang, Hong; McDonald, Meghan E.; Qiang, Li; Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	sfarmer@bu.edu	Qiang, Li/C-9560-2012	Pino, Elizabeth/0000-0003-0626-5221; Farmer, Stephen/0000-0003-2483-2795; Qiang, Li/0000-0001-8322-1797	United States Public Health Service [DK51586, DK58825, DK086629]; National Institutes of Health [5T32AG000115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086629, R56DK058825, R56DK051586, R01DK058825, R01DK051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000115] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by United States Public Health Service Grants DK51586, DK58825, and DK086629 (to S. R. F.) and National Institutes of Health Training Grant 5T32AG000115-24 (to E. P.).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	30	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18351	18358		10.1074/jbc.M112.350918	http://dx.doi.org/10.1074/jbc.M112.350918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493496	Green Published, hybrid			2022-12-28	WOS:000306411600041
J	Takeda, T; Fujii, M; Taura, J; Ishii, Y; Yamada, H				Takeda, Tomoki; Fujii, Misaki; Taura, Junki; Ishii, Yuji; Yamada, Hideyuki			Dioxin Silences Gonadotropin Expression in Perinatal Pups by Inducing Histone Deacetylases A NEW INSIGHT INTO THE MECHANISM FOR THE IMPRINTING OF SEXUAL IMMATURITY BY DIOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT GENES; MATERNAL EXPOSURE; ARYL-HYDROCARBON; CROSS-TALK; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PITUITARY GONADOTROPIN; FETAL RATS; RECEPTOR; RESPONSIVENESS; HORMONE	Maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes the impairment of reproduction and development in the pups. Our previous studies have revealed that maternal treatment with TCDD attenuates the fetal production of pituitary gonadotropins (luteinizing hormone (LH) and follicle-stimulating hormone) at gestational day (GD) 20, leading to the impairment of sexual behavior in adulthood. However, the mechanism underlying such a reduction has remained unknown until now. When pregnant rats at GD15 were given an oral dose of TCDD (1 mu g/kg), the testicular expression of steroidogenic proteins was reduced between GD20 and postnatal days (PND) 2. In accordance with this, the pituitary expression of gonadotropin beta-subunit and serum gonadotropin were also attenuated from GD20 to PND0 in a pup-specific fashion. To identify the target genes linked to a fetal reduction in gonadotropin beta-subunit, we performed a DNA microarray analysis using the fetal pituitary and its regulatory organ, the hypothalamus. The results obtained showed that TCDD induced histone deacetylases (HDACs) in the fetal pituitary. In support with this, TCDD markedly deacetylated histones H3 and H4 twined around the promoter of the fetal LH beta gene. This effect was fetus- and LH beta-specific, and this was not observed in the maternal pituitary or for other pituitary hormone genes. Finally, an LH beta reduction caused by TCDD was completely restored by maternal co-treatment with valproic acid, an HDAC inhibitor. These results strongly suggest that the increased deacetylation of histone owing to HDAC induction plays a critical role in the TCDD-induced reduction in LH beta in the fetal pituitary.	[Takeda, Tomoki; Fujii, Misaki; Taura, Junki; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Yamada, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyamada@phar.kyushu-u.ac.jp	Ishii, Yuji/AAU-3300-2021		Ministry of Health, Labor, and Welfare, Japan [H21-Kagaku-Ippan-005, H21-Shokuhin-Ippan-014]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor, and Welfare, Japan: Research on Risk of Chemical Substances (Project No: H21-Kagaku-Ippan-005), and Research on Food Safety (Project No: H21-Shokuhin-Ippan-014).	Abe T, 2004, INT J DEV BIOL, V48, P327, DOI 10.1387/ijdb.041838ta; Badawi AF, 2000, CARCINOGENESIS, V21, P1593, DOI 10.1093/carcin/21.8.1593; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Khan S, 2006, MOL ENDOCRINOL, V20, P2199, DOI 10.1210/me.2006-0100; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; KIM DS, 1994, MOL ENDOCRINOL, V8, P528, DOI 10.1210/me.8.4.528; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Matsumoto Y, 2010, J TOXICOL SCI, V35, P365, DOI 10.2131/jts.35.365; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moran FM, 2000, BIOL REPROD, V62, P1102, DOI 10.1095/biolreprod62.4.1102; Mutoh J, 2006, ENDOCRINOLOGY, V147, P927, DOI 10.1210/en.2005-1125; Ohsako S, 2001, TOXICOL SCI, V60, P132, DOI 10.1093/toxsci/60.1.132; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; PENNATHUR S, 1993, MOL ENDOCRINOL, V7, P797, DOI 10.1210/me.7.6.797; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; Schecter A, 2006, ENVIRON RES, V101, P419, DOI 10.1016/j.envres.2005.12.003; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takeda T, 2011, J TOXICOL SCI, V36, P221, DOI 10.2131/jts.36.221; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Taketoh J, 2007, LIFE SCI, V80, P1259, DOI 10.1016/j.lfs.2006.12.029; Wang Y, 2010, J MOL ENDOCRINOL, V44, P349, DOI 10.1677/JME-09-0142; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107	42	26	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18440	18450		10.1074/jbc.M111.335158	http://dx.doi.org/10.1074/jbc.M111.335158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493514	Green Published, hybrid			2022-12-28	WOS:000306411600050
J	Li, ZD; Zhang, HS; Chen, Y; Fan, L; Fang, J				Li, Zhaodong; Zhang, Haisheng; Chen, Ying; Fan, Li; Fang, Jing			Forkhead Transcription Factor FOXO3a Protein Activates Nuclear Factor kappa B through B-cell lymphoma/leukemia 10 (BCL10) Protein and Promotes Tumor Cell Survival in Serum Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; SIGNALING PATHWAYS; CANCER CELLS; KINASE; INDUCTION; APOPTOSIS; TUMORIGENESIS; METABOLISM; INHIBITION; EXPRESSION	FOXO3a, a member of the Forkhead box O (FoxO) transcription factor family, is believed to be a tumor suppressor because it was found that FOXO3a inactivation promoted cell transformation and tumor progression. There are also a few studies showing that FOXO3a protected cells under stress conditions, including oxidative stress, serum deprivation, and hypoxia. It was reported that FOXO3a promoted invasion of cancer cells. Thus, the role of FOXO3a in cancer is complicated. Here, we report that FOXO3a is a positive regulator of nuclear factor kappa B (NF-kappa B) signaling. We found that overexpression of FOXO3a increased and knockdown of FOXO3a repressed NF-kappa B activities. Mechanistic studies indicate that FOXO3a activated NF-kappa B via inducing expression of B-cell lymphoma/leukemia 10 (BCL10), an upstream regulator of I kappa B kinase (IKK)/NF-kappa B signaling. We found that the serum deprivation activated NF-kappa B, which was blocked by inhibition of FOXO3a. Knockdown of FOXO3a enhanced cell apoptosis under serum-free conditions, which was inhibited by overexpression of BCL10. These results suggest that FOXO3a promotes cell survival via BCL10/NF-kappa B in serum starvation. Our findings may add another layer to the complexity of the role of FOXO3a in cancer. Therefore, caution should be taken when FOXO3a is employed as a target for cancer therapy.	[Li, Zhaodong; Zhang, Haisheng; Chen, Ying; Fan, Li; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn			Natural Science Foundation of China [30970586]; Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-08]; Chinese Ministry of Science and Technology [2007BAC27B02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Natural Science Foundation of China Grant 30970586, by Innovation Program of the Chinese Academy of Sciences Grant KSCX2-EW-R-08, and by Chinese Ministry of Science and Technology Grant 2007BAC27B02.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Fang J, 2005, FASEB J, V19, P342, DOI 10.1096/fj.04-2175com; Gomez-Gutierrez JG, 2006, CANCER BIOL THER, V5, P875, DOI 10.4161/cbt.5.7.2911; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zeng ZH, 2006, CANCER RES, V66, P3737, DOI 10.1158/0008-5472.CAN-05-1278; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	41	51	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17737	17745		10.1074/jbc.M111.291708	http://dx.doi.org/10.1074/jbc.M111.291708			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474286	Green Published, hybrid			2022-12-28	WOS:000306373000072
J	Chakravarti, R; Stuehr, DJ				Chakravarti, Ritu; Stuehr, Dennis J.			Thioredoxin-1 Regulates Cellular Heme Insertion by Controlling S-Nitrosation of Glyceraldehyde-3-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN DENITROSYLATION; GAPDH; NITROSYLATION; NITROSOTHIOLS; CATALYZES; BINDING; ASTHMA; DEATH; GSNOR	NO generated by inducible NOS (iNOS) causes buildup of S-nitrosated GAPDH (SNO-GAPDH) in cells, which then inhibits further iNOS maturation by limiting the heme insertion step (Chakravarti, R., Aulak, K. S., Fox, P. L., and Stuehr, D. J. (2010) Proc. Natl. Acad. Sci. U. S. A. 107, 18004-18009). We investigated what regulates this process utilizing a slow-release NO donor (NOC-18) and studying changes in cellular SNO-GAPDH levels during and after NO exposure. Culturing macrophage-like cells with NOC-18 during cytokine activation caused buildup of heme-free (apo) iNOS and SNO-GAPDH. Upon NOC-18 removal, the cells quickly recovered their heme insertion capacity in association with rapid SNO-GAPDH denitrosation, implying that these processes are linked. We then altered cell expression of thioredoxin-1 (Trx1) or S-nitrosoglutathione reductase, both of which can function as a protein denitrosylase. Trx1 knockdown increased SNO-GAPDH levels in cells, made heme insertion hypersensitive to NO, and increased the recovery time, whereas Trx1 overexpression greatly diminished SNO-GAPDH buildup and protected heme insertion from NO inhibition. In contrast, knockdown of S-nitrosoglutathione reductase expression had little effect on these parameters. Experiments utilizing C152S GAPDH confirmed that the NO effects are all linked to S-nitrosation of GAPDH at Cys-152. We conclude (i) that NO inhibition of heme insertion and its recovery can be rapid and dynamic processes and are inversely linked to the S-nitrosation of GAPDH and (ii) that the NO sensitivity of heme insertion can vary depending on the Trx1 expression level due to Trx1 acting as an SNO-GAPDH denitrosylase. Together, our results identify a new way that cells regulate heme protein maturation during inflammation.	[Chakravarti, Ritu; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Chakravarti, Ritu/K-8928-2019	Chakravarti, Ritu/0000-0003-4680-8374	National Institutes of Health [GM097041, HL076491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097041 and HL076491.	Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Ecco G, 2010, CHEM COMMUN, V46, P7501, DOI 10.1039/c0cc01704c; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Guikema B, 2005, ANTIOXID REDOX SIGN, V7, P593, DOI 10.1089/ars.2005.7.593; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Ito T, 2011, J BIOL CHEM, V286, P11179, DOI 10.1074/jbc.M110.201780; JAFFREY SR, 2001, SCI STKE; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Koenitzer JR, 2010, ANN NY ACAD SCI, V1203, P45, DOI 10.1111/j.1749-6632.2010.05559.x; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; MOORADIAN DL, 1995, J CARDIOVASC PHARM, V25, P674, DOI 10.1097/00005344-199504000-00023; Moore PE, 2009, PEDIATR PULM, V44, P649, DOI 10.1002/ppul.21033; PADGETT CM, 1995, AM J PHYSIOL-CELL PH, V269, pC739, DOI 10.1152/ajpcell.1995.269.3.C739; Padgett CM, 1997, AM J PHYSIOL-CELL PH, V272, pC99, DOI 10.1152/ajpcell.1997.272.1.C99; Panda K, 2005, P NATL ACAD SCI USA, V102, P10117, DOI 10.1073/pnas.0408972102; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Sengupta R., 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbagen.2011.08/012, DOI 10.1016/J.BBAGEN.2011.08/012]; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Sengupta R, 2010, BIOCHEM BIOPH RES CO, V391, P1127, DOI 10.1016/j.bbrc.2009.12.036; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Tang CH, 2012, BBA-GEN SUBJECTS, V1820, P730, DOI 10.1016/j.bbagen.2011.04.014; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Wei W, 2011, CARCINOGENESIS, V32, P973, DOI 10.1093/carcin/bgr041; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu WL, 2006, FREE RADICAL BIO MED, V41, P19, DOI 10.1016/j.freeradbiomed.2006.01.037; Yang ZY, 2010, J IMMUNOL, V185, P6664, DOI 10.4049/jimmunol.1000080	38	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16179	16186		10.1074/jbc.M112.342758	http://dx.doi.org/10.1074/jbc.M112.342758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22457359	Green Published, hybrid			2022-12-28	WOS:000304030900010
J	Fennewald, SM; Kantara, C; Sastry, SK; Resto, VA				Fennewald, Susan M.; Kantara, Carla; Sastry, Sarita K.; Resto, Vicente A.			Laminin Interactions with Head and Neck Cancer Cells under Low Fluid Shear Conditions Lead to Integrin Activation and Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATCH BONDS; EXTRACELLULAR-MATRIX; ADHESION MOLECULES; LYMPH-NODES; FLOW; CA2+; CARCINOMA; BETA-1-INTEGRIN; RECEPTORS; CALCIUM	Lymphatic metastasis of cancer cells involves movement from the primary tumor site to the lymph node, where the cells must be able to productively lodge and grow. It is there that tumor cells encounter cellular and non-cellular constituent elements that make up the lymph node parenchyma. Our work shows that head and neck squamous cell carcinoma (HNSCC) cell lines are able to bind to laminin, fibronectin, vitronectin, and hyaluronic acid, which are extracellular matrix elements within the lymph node parenchyma. HNSCC cell lines bound to laminin under lymphodynamic low shear stress (0.07 dynes/cm(2)), consistent with lymph flow via beta 1 integrins, including alpha 2 beta 1, alpha 3 beta 1, and alpha 6 beta 1. Binding occurred in the presence of shear stress and not in the absence of flow. Additionally, tumor cell binding to laminin under flow did result in calcium signaling. Our data indicate a novel role for beta 1 integrin-mediated binding of HNSCC cells to laminin under conditions of lymphodynamic flow that results in intracellular calcium signaling within the cancer cell.	[Sastry, Sarita K.; Resto, Vicente A.] Univ Texas Med Branch, UTMB Hlth, UTMB Canc Ctr, Galveston, TX 77555 USA; [Fennewald, Susan M.; Resto, Vicente A.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Kantara, Carla; Sastry, Sarita K.; Resto, Vicente A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Resto, VA (corresponding author), Univ Texas Med Branch, UTMB Hlth, UTMB Canc Ctr, 301 Univ Blvd, Galveston, TX 77555 USA.	varesto@utmb.edu	Sastry, Sarita/A-1291-2013; Resto, Vicente/D-9891-2014		National Institutes of Heath from NCI [K08 CA132988]; Howard Hughes Medical Institute career physician scientist award; NATIONAL CANCER INSTITUTE [K08CA132988] Funding Source: NIH RePORTER	National Institutes of Heath from NCI; Howard Hughes Medical Institute career physician scientist award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Heath Grant K08 CA132988 from NCI (to V. A. R.). This work was also supported by a Howard Hughes Medical Institute career physician scientist award (to V. A. R.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; CYBULSKY AV, 1993, AM J PHYSIOL, V264, pC323, DOI 10.1152/ajpcell.1993.264.2.C323; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Haier J, 2001, APMIS, V109, P241, DOI 10.1034/j.1600-0463.2001.d01-118.x; Kitayama J, 1999, BRIT J CANCER, V80, P1927, DOI 10.1038/sj.bjc.6690622; Kitayama J, 2000, CELL IMMUNOL, V199, P97, DOI 10.1006/cimm.1999.1596; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Ricard I, 1997, EUR J IMMUNOL, V27, P1530, DOI 10.1002/eji.1830270632; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; SCHER RL, 1993, ARCH OTOLARYNGOL, V119, P432; Schottelndreier H, 2001, CELL SIGNAL, V13, P895, DOI 10.1016/S0898-6568(01)00225-X; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; TOZEREN A, 1994, J CELL SCI, V107, P3153; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wrenn RW, 1996, BIOCHEM BIOPH RES CO, V226, P876, DOI 10.1006/bbrc.1996.1443	33	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21058	21066		10.1074/jbc.M112.360313	http://dx.doi.org/10.1074/jbc.M112.360313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547070	Green Published, hybrid			2022-12-28	WOS:000306416800027
J	Li, W; Liu, H; Zhou, JS; Cao, JF; Zhou, XB; Choi, AMK; Chen, ZH; Shen, HH				Li, Wen; Liu, Hui; Zhou, Jie-Sen; Cao, Jiao-Fei; Zhou, Xiao-Bo; Choi, Augustine M. K.; Chen, Zhi-Hua; Shen, Hua-Hao			Caveolin-1 Inhibits Expression of Antioxidant Enzymes through Direct Interaction with Nuclear Erythroid 2 p45-related Factor-2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1/CARBON MONOXIDE; NITRIC-OXIDE SYNTHASE; PC12 CELL TOLERANCE; ADAPTIVE RESPONSE; PREMATURE SENESCENCE; TRANSCRIPTION FACTOR; UP-REGULATION; INDUCTION; LUNG; GLUTATHIONE	The Nrf2 (nuclear erythroid 2 p45-related factor-2) signaling pathway is known to play a pivotal role in a variety of oxidative stress-related human disorders. It has been reported recently that the plasma membrane resident protein caveolin-1 (Cav-1) can regulate expression of certain antioxidant enzymes and involves in the pathogenesis of oxidative lung injury, but the detailed molecular mechanisms remain incompletely understood. Here, we demonstrated that Cav-1 inhibited the expression of antioxidant enzymes through direct interaction with Nrf2 and subsequent suppression of its transcriptional activity in lung epithelial Beas-2B cells. Cav-1 deficiency cells exhibited higher levels of antioxidant enzymes and were more resistant to oxidative stress induced cytotoxicity, whereas overexpression of Cav-1 suppressed the induction of these enzymes and further augmented the oxidative cell death. Cav-1 constitutively interacted with Nrf2 in both cytosol and nucleus. Stimulation of 4-hydroxynonenol increased the Cav-1-Nrf2 interaction in cytosol but disrupted their association in the nucleus. Knock-down of Cav-1 also disassociated the interaction between Nrf2 and its cytoplasmic inhibitor Keap1 (Kelch-like ECH-associated protein 1) and increased the Nrf2 transcription activity. Mutation of the resembling Cav-1 binding motif on Nrf2 effectively attenuated their interaction, which exhibited higher transcription activity and induced higher levels of antioxidant enzymes relative to the wild-type control. Altogether, these studies clearly demonstrate that Cav-1 inhibits cellular antioxidant capacity through direct interaction with Nrf2 and subsequent suppression of its activity, thereby implicating in certain oxidative stress-related human pathologies.	[Li, Wen; Liu, Hui; Zhou, Jie-Sen; Chen, Zhi-Hua; Shen, Hua-Hao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Xiao-Bo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Cao, Jiao-Fei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Xiao-Bo; Choi, Augustine M. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Shen, Hua-Hao] State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China	Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State Key Laboratory of Respiratory Disease	Chen, ZH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zhihuachen2010@yahoo.com.cn; hh_shen@yahoo.com.cn			National Natural Science Foundation of China [31170859, 81170037, 30825019]; Natural Science Foundation of Zhejiang Province [R2110323]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported in part by Young Investigator Award 30825019 by the National Natural Science Foundation of China (to H. H. S.), Distinguished Young Investigator Award R2110323 by the Natural Science Foundation of Zhejiang Province (to Z. H. C.), and General Projects of the National Natural Science Foundation of China Grants 31170859 (to Z. H. C.) and 81170037 (to W. L.).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chen ZH, 2006, IUBMB LIFE, V58, P372, DOI 10.1080/15216540600686896; Chen ZH, 2006, FEBS LETT, V580, P479, DOI 10.1016/j.febslet.2005.12.045; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chretien A, 2008, FEBS LETT, V582, P1685, DOI 10.1016/j.febslet.2008.04.026; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Ghosh S, 1998, J BIOL CHEM, V273, P22267, DOI 10.1074/jbc.273.35.22267; Gobeil F, 2003, J BIOL CHEM, V278, P38875, DOI 10.1074/jbc.M212481200; Halliwell B., 2007, FREE RADICALS BIOL M; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Kim HP, 2009, METHOD ENZYMOL, V453, P197, DOI 10.1016/S0076-6879(08)04010-X; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Niki E, 2004, BIOCHEM SOC T, V32, P156, DOI 10.1042/BST0320156; Papas, 1999, ANTIOXIDANT STATUS D; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ryter SW, 2011, AUTOPHAGY, V7, P436, DOI 10.4161/auto.7.4.14501; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	38	62	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20922	20930		10.1074/jbc.M112.352336	http://dx.doi.org/10.1074/jbc.M112.352336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547061	Green Published, hybrid			2022-12-28	WOS:000306416800014
J	Seong, HA; Jung, H; Manoharan, R; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung			PDK1 Protein Phosphorylation at Thr(354) by Murine Protein Serine-Threonine Kinase 38 Contributes to Negative Regulation of PDK1 Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSICAL INTERACTION; DEPENDENT MANNER; SMAD PROTEINS; MELK; ACTIVATION; IDENTIFICATION; SPECIFICITY; INVOLVEMENT; AKT/PKB; INSULIN	Murine protein serine-threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family, which acts as cellular energy sensors. In this study, MPK38-induced PDK1 phosphorylation was examined to elucidate the biochemical mechanisms underlying phosphorylation-dependent regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) activity. The results showed that MPK38 interacted with and inhibited PDK1 activity via Thr(354) phosphorylation. MPK38-PDK1 complex formation was mediated by the amino-terminal catalytic kinase domain of MPK38 and the pleckstrin homology domain of PDK1. This activity was dependent on insulin, a PI3K/PDK1 stimulator, as well as various apoptotic stimuli, including TNF-alpha, H2O2, thapsigargin, and ionomycin. MPK38 inhibited PDK1 activity in a kinase-dependent manner and alleviated PDK1-mediated suppression of TGF-beta (or ASK1) signaling, probably via the phosphorylation of PDK1 at Thr(354). In addition, MPK38-mediated inhibition of PDK1 activity was accompanied by the modulation of PDK1 binding to its positive and negative regulators, serine/threonine kinase receptor-associated protein and 14-3-3, respectively. Together, these findings suggest an important role for MPK38-mediated phosphorylation of PDK1 in the negative regulation of PDK1 activity.	[Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation of Korea [R0A-2007-000-20006-0]; Korean Government	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0 funded by the Korean Government.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; ITO T, 1993, CANCER RES, V53, P2940; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Saito R, 2005, MOL CELL BIOL, V25, P6682, DOI 10.1128/MCB.25.15.6682-6693.2005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2011, J BIOL CHEM, V286, P31123, DOI 10.1074/jbc.M111.248674; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200	36	16	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20811	20822		10.1074/jbc.M111.331827	http://dx.doi.org/10.1074/jbc.M111.331827			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544756	hybrid, Green Published			2022-12-28	WOS:000306416800003
J	Abe, H; Tominaga, T; Matsubara, T; Abe, N; Kishi, S; Nagai, K; Murakami, T; Araoka, T; Doi, T				Abe, Hideharu; Tominaga, Tatsuya; Matsubara, Takeshi; Abe, Naoko; Kishi, Seiji; Nagai, Kojiro; Murakami, Taichi; Araoka, Toshikazu; Doi, Toshio			Scleraxis Modulates Bone Morphogenetic Protein 4 (BMP4)-Smad1 Protein-Smooth Muscle alpha-Actin (SMA) Signal Transduction in Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; MESANGIAL MATRIX EXPANSION; LOOP-HELIX PROTEINS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTION FACTORS; PULMONARY-FIBROSIS; TENDON PROGENITORS; ENDOTHELIAL-CELLS	Activation of mesangial cells (MCs), which is characterized by induction of smooth muscle alpha-actin (SMA) expression, contributes to a key event in various renal diseases; however, the mechanisms controlling MC differentiation are still largely undefined. Activated Smad1 induced SMA in a dose-dependent manner in MCs. As a direct regulating molecule for SMA, we identified and characterized scleraxis (Scx) as a new phenotype modulator in advanced glycation end product (AGE)-exposed MCs. Scx physically associated with E12 and bound the E-box in the promoter of SMA and negatively regulated the AGE-induced SMA expression. Scx induced expression and secretion of bone morphogenetic protein 4 (BMP4), thereby controlling the Smad1 activation in AGE-treated MCs. In diabetic mice, Scx was concomitantly expressed with SMA in the glomeruli. Inhibitor of differentiation 1 (Id1) was further induced by extended treatment with AGE, thereby dislodging Scx from the SMA promoter. These data suggest that Scx and Id1 are involved in the BMP4-Smad1-SMA signal transduction pathway besides the TGF beta 1-Smad1-SMA signaling pathway and modulate phenotypic changes in MCs in diabetic nephropathy.	[Abe, Hideharu; Tominaga, Tatsuya; Abe, Naoko; Kishi, Seiji; Nagai, Kojiro; Murakami, Taichi; Araoka, Toshikazu; Doi, Toshio] Univ Tokushima, Grad Sch Med, Dept Nephrol, Inst Hlth Biosci, Tokushima 7708503, Japan; [Matsubara, Takeshi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068303, Japan	Tokushima University; Kyoto University	Abe, H (corresponding author), Univ Tokushima, Grad Sch, Dept Nephrol, Inst Hlth Biosci, Tokushima 7708503, Japan.	abeabe@clin.med.tokushima-u.ac.jp			Kidney Foundation of Japan [JKFB09-41]; Mitsui Sumitomo Welfare Foundation; Japan Science and Technology Agency;  [19590973];  [21591033]; Grants-in-Aid for Scientific Research [22390169] Funding Source: KAKEN	Kidney Foundation of Japan; Mitsui Sumitomo Welfare Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Kidney Foundation of Japan Grant JKFB09-41, funds from The Mitsui Sumitomo Welfare Foundation, Grants-in-aid for Scientific Research 19590973 and 21591033, and Japan Science and Technology Agency.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abe H, 1999, J BIOL CHEM, V274, P20874, DOI 10.1074/jbc.274.30.20874; ADLER S, 1986, AM J PATHOL, V123, P553; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; KUHN C, 1991, AM J PATHOL, V138, P1257; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Moustakas A, 2001, J CELL SCI, V114, P4359; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nagasaki T, 1997, BIOCHEM BIOPH RES CO, V233, P81, DOI 10.1006/bbrc.1997.6399; Narumi O, 2000, J BIOL CHEM, V275, P3510, DOI 10.1074/jbc.275.5.3510; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; ORLANDI A, 1994, EXP CELL RES, V214, P528, DOI 10.1006/excr.1994.1290; Petersen W, 2002, J BONE JOINT SURG BR, V84B, P141, DOI 10.1302/0301-620X.84B1.11592; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; SAPPINO AP, 1990, LAB INVEST, V63, P144; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; SIMONSON MS, 1993, NUCLEIC ACIDS RES, V21, P5767, DOI 10.1093/nar/21.24.5767; Strutz F, 1996, EXP NEPHROL, V4, P267; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Sundberg C, 1996, LAB INVEST, V74, P452; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Takeoka H, 1998, BIOCHEM BIOPH RES CO, V252, P290, DOI 10.1006/bbrc.1998.9530; Tang MK, 2000, DEV BIOL, V218, P89, DOI 10.1006/dbio.1999.9578; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; ZHANG K, 1994, AM J PATHOL, V145, P114	65	23	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20430	20442		10.1074/jbc.M111.275610	http://dx.doi.org/10.1074/jbc.M111.275610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22474292	hybrid, Green Published			2022-12-28	WOS:000306414500061
J	Alvaro-Benito, M; Sainz-Polo, MA; Gonzalez-Perez, D; Gonzalez, B; Plou, FJ; Fernandez-Lobato, M; Sanz-Aparicio, J				Alvaro-Benito, Miguel; Angela Sainz-Polo, M.; Gonzalez-Perez, David; Gonzalez, Beatriz; Plou, Francisco J.; Fernandez-Lobato, Maria; Sanz-Aparicio, Julia			Structural and Kinetic Insights Reveal That the Amino Acid Pair Gln-228/Asn-254 Modulates the Transfructosylating Specificity of Schwanniomyces occidentalis beta-Fructofuranosidase, an Enzyme That Produces Prebiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICORY FRUCTAN 1-EXOHYDROLASE; CARBOHYDRATE-BINDING MODULES; CRYSTAL-STRUCTURE; ACTIVE-SITE; MICROBIAL INULINASES; SUBSTRATE; INVERTASE; SUCROSE; COMPLEX; TRISACCHARIDE	Schwanniomyces occidentalis beta-fructofuranosidase (Ffase) is a GH32 dimeric enzyme that releases fructose from the nonreducing end of various oligosaccharides and essential storage fructans such as inulin. It also catalyzes the transfer of a fructosyl unit to an acceptor producing 6-kestose and 1-kestose, prebiotics that stimulate the growth of bacteria beneficial for human health. We report here the crystal structure of inactivated Ffase complexed with fructosylnystose and inulin, which shows the intricate net of interactions keeping the substrate tightly bound at the active site. Up to five subsites were observed, the sugar unit located at subsite +3 being recognized by interaction with the beta-sandwich domain of the adjacent subunit within the dimer. This explains the high activity observed against long substrates, giving the first experimental evidence of the direct role of a GH32 beta-sandwich domain in substrate binding. Crucial residues were mutated and their hydrolase/transferase (H/T) activities were fully characterized, showing the involvement of the Gln-228/Asn-254 pair in modulating the H/T ratio and the type beta(2-1)/beta(2-6) linkage formation. We generated Ffase mutants with new transferase activity; among them, Q228V gives almost specifically 6-kestose, whereas N254T produces a broader spectrum product including also neokestose. A model for the mechanism of the Ffase transfructosylation reaction is proposed. The results contribute to an understanding of the molecular basis regulating specificity among GH-J clan members, which represent an interesting target for rational design of enzymes, showing redesigned activities to produce tailor-made fructooligosaccharides.	[Alvaro-Benito, Miguel; Gonzalez-Perez, David; Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Angela Sainz-Polo, M.; Gonzalez, Beatriz; Sanz-Aparicio, Julia] Inst Quim Fis Rocasolano CSIC, Dept Cristalog & Biol Estruct, Madrid 28006, Spain; [Plou, Francisco J.] Inst Catalisis & Petroleoquim CSIC, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Fernandez-Lobato, M (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	mfernandez@cbm.uam.es; xjulia@iqfr.csic.es	Alvaro-Benito, Miguel/AAC-9704-2022; González Pérez, David/M-2210-2016; Sanz-Aparicio, Julia/F-6201-2013; Sainz-Polo, Maria-Angela/F-3947-2016; Lobato, Maria Fernandez/F-1338-2016; Gonzalez-Perez, David/ABI-6737-2020; Gonzalez, Beatriz/M-1219-2014	Alvaro-Benito, Miguel/0000-0002-6019-3567; Sanz-Aparicio, Julia/0000-0002-6849-8621; Sainz-Polo, Maria-Angela/0000-0002-6269-4330; Lobato, Maria Fernandez/0000-0003-0778-7443; Gonzalez, Beatriz/0000-0002-0710-0202; Gonzalez-Perez, David/0000-0001-9613-4705; Plou, Francisco J./0000-0003-0831-893X	Ministry of Education and Science, Spain [BIO2010-20508-C04-01, BIO2010-20508-C04-03, BIO2010-20508-C04-04, BIO2007-67708-C04-01, BIO2007-67708-C04-03, BIO2007-67708-C04-04]; Spanish Comunidad de Madrid program	Ministry of Education and Science, Spain(Spanish Government); Spanish Comunidad de Madrid program	This work was supported by Grants BIO2010-20508-C04-01, -03, and -04, as well as BIO2007-67708-C04-01, -03, and -04, from the Ministry of Education and Science, Spain.; Supported by the Spanish Comunidad de Madrid program.	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Altenbach D, 2009, PLANT MOL BIOL, V69, P47, DOI 10.1007/s11103-008-9404-7; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Alvaro-Benito M, 2010, APPL ENVIRON MICROB, V76, P7491, DOI 10.1128/AEM.01614-10; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Andre I, 1996, MACROMOLECULES, V29, P4626, DOI 10.1021/ma951799f; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P211, DOI 10.1007/s00253-008-1827-1; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farine S, 2001, APPL MICROBIOL BIOT, V55, P55, DOI 10.1007/s002530000493; Franck A., 2005, BIOPOLYMERS ONLINE, DOI [10.1002/3527600035.bpol6014, DOI 10.1002/3527600035.BP0L6014]; Gill PK, 2004, APPL BIOCHEM BIOTECH, V117, P19, DOI 10.1385/ABAB:117:1:19; Gutierrez-Alonso P, 2009, FEMS YEAST RES, V9, P768, DOI 10.1111/j.1567-1364.2009.00526.x; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaur N, 2002, J BIOSCIENCES, V27, P703, DOI 10.1007/BF02708379; Kilian S, 2002, WORLD J MICROB BIOT, V18, P637, DOI 10.1023/A:1016808015630; Lammens W., 2011, PLANT J IN PRESS; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Le Roy K, 2008, NEW PHYTOL, V178, P572, DOI 10.1111/j.1469-8137.2008.02386.x; Lee JH, 2004, FEMS MICROBIOL LETT, V234, P105, DOI 10.1016/j.femsle.2004.03.013; LESLIE AGW, 1992, CRYSTALLOGRAPHIC COM, V5, P39; Linde D, 2012, BIORESOURCE TECHNOL, V109, P123, DOI 10.1016/j.biortech.2012.01.023; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; OKUYAMA K, 1993, B CHEM SOC JPN, V66, P374, DOI 10.1246/bcsj.66.374; Pandey A, 1999, APPL BIOCHEM BIOTECH, V81, P35, DOI 10.1385/ABAB:81:1:35; Pijning T, 2011, J MOL BIOL, V412, P80, DOI 10.1016/j.jmb.2011.07.031; Polo A, 2009, ACTA CRYSTALLOGR F, V65, P1162, DOI 10.1107/S1744309109039384; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Sabater-Molina M, 2009, J PHYSIOL BIOCHEM, V65, P315, DOI 10.1007/BF03180584; Schroeven L, 2008, NEW PHYTOL, V180, P822, DOI 10.1111/j.1469-8137.2008.02603.x; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Swennen K, 2006, CRIT REV FOOD SCI, V46, P459, DOI 10.1080/10408390500215746; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDAMME EJ, 1983, ADV APPL MICROBIOL, V29, P139, DOI 10.1016/S0065-2164(08)70356-3; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x	48	33	36	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19674	19686		10.1074/jbc.M112.355503	http://dx.doi.org/10.1074/jbc.M112.355503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511773	Green Published, hybrid			2022-12-28	WOS:000306411900078
J	Bailey, CK; Mittal, MK; Misra, S; Chaudhuri, G				Bailey, Charvann K.; Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam			High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; DECOY OLIGONUCLEOTIDES; TRANSCRIPTION FACTORS; AFRICAN-AMERICAN; CARCINOMA CELLS; IN-VIVO; EXPRESSION; ACTIVATION; ADHESION	One of highly pathogenic breast cancer cell types are the triple negative (negative in the expression of estrogen, progesterone, and ERBB2 receptors) breast cancer cells. These cells are highly motile and metastatic and are characterized by high levels of the metastasis regulator protein SLUG. Using isogenic breast cancer cell systems we have shown here that high motility of these cells is directly correlated with the levels of the SLUG in these cells. Because epithelial/mesenchymal cell motility is known to be negatively regulated by the catenin protein plakoglobin, we postulated that the transcriptional repressor protein SLUG increases the motility of the aggressive breast cancer cells through the knockdown of the transcription of the plakoglobin gene. We found that SLUG inhibits the expression of plakoglobin gene directly in these cells. Overexpression of SLUG in the SLUG-deficient cancer cells significantly decreased the levels of mRNA and protein of plakoglobin. On the contrary, knockdown of SLUG in SLUG-high cancer cells elevated the levels of plakoglobin. Blocking of SLUG function with a double-stranded DNA decoy that competes with the E2-box binding of SLUG also increased the levels of plakoglobin mRNA, protein, and promoter activity in the SLUG-high triple negative breast cancer cells. Overexpression of SLUG in the SLUG-deficient cells elevated the motility of these cells. Knockdown of plakoglobin in these low motility non-invasive breast cancer cells rearranged the actin filaments and increased the motility of these cells. Forced expression of plakoglobin in SLUG-high cells had the reverse effects on cellular motility. This study thus implicates SLUG-induced repression of plakoglobin as a motility determinant in highly disseminating breast cancer.	[Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Bailey, Charvann K.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd,Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Mittal, Mukul/0000-0002-9795-7372	National Institutes of Health [1U54RR026140-01, R25GM059993, T32HL007737, T32HL007735, U01NS041071, U54RR026140, U54CA091408, S10RR0254970]; Department of Defense Congressionally Directed Medical Research Program [W81XWH-06-1-0466, BC103645, W81XWH-09-1-0676]; Center for Research Resources, National Institutes of Health [UL1 RR024975]; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737, T32HL007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1U54RR026140-01 (to S. M.) and R25GM059993, T32HL007737, and T32HL007735 (graduate student fellowships to C. K. B.). This work was also supported in part by Department of Defense Congressionally Directed Medical Research Program Grants W81XWH-06-1-0466, BC103645, and W81XWH-09-1-0676 (to G. C.); Confocal microscopy was performed through the use of the Meharry Medical College Morphology Core, which was supported in part by National Institutes of Health grants U01NS041071, U54RR026140, U54CA091408, and S10RR0254970. Other Core facility research was supported in part by Vanderbilt Clinical and Translational Science Awards Grant UL1 RR024975 from the Center for Research Resources, National Institutes of Health.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bailey CK, 2007, BIOCHEM BIOPH RES CO, V353, P661, DOI 10.1016/j.bbrc.2006.12.097; Cabrini G, 2010, CURR MED CHEM, V17, P4392, DOI 10.2174/092986710793361243; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; De Stefano D, 2010, CURR OPIN MOL THER, V12, P203; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Gambari R, 2010, BIOCHEM PHARMACOL, V80, P1887, DOI 10.1016/j.bcp.2010.06.047; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hajra KM, 2002, CANCER RES, V62, P1613; Huang H, 2008, CELL MOTIL CYTOSKEL, V65, P964, DOI 10.1002/cm.20319; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Katafiasz D, 2011, CELL ADHES MIGR, V5, P315, DOI 10.4161/cam.5.4.17040; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li YF, 2010, MOL CANCER RES, V8, P1579, DOI 10.1158/1541-7786.MCR-10-0081; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Pan HJ, 2007, CANCER BIOL THER, V6, P1638, DOI 10.4161/cbt.6.10.4904; Penolazzi L, 2007, MOL PHARMACOL, V71, P1457, DOI 10.1124/mol.107.034561; Piva R, 2006, ANN NY ACAD SCI, V1091, P509, DOI 10.1196/annals.1378.092; Piva R, 2002, TECHNOL CANCER RES T, V1, P405, DOI 10.1177/153303460200100512; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Shirley SH, 2010, MOL CARCINOGEN, V49, P851, DOI 10.1002/mc.20674; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tawfik O, 2010, ANN CLIN LAB SCI, V40, P315; Todorovic V, 2010, J CELL SCI, V123, P3576, DOI 10.1242/jcs.070391; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tripathi MK, 2005, BIOCHEM BIOPH RES CO, V329, P508, DOI 10.1016/j.bbrc.2005.02.006; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Zilfou JT, 2005, CELL, V123, P545, DOI 10.1016/j.cell.2005.11.003	49	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19472	19486		10.1074/jbc.M112.345728	http://dx.doi.org/10.1074/jbc.M112.345728			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496452	hybrid, Green Published			2022-12-28	WOS:000306411900061
J	Chanoux, RA; Robay, A; Shubin, CB; Kebler, C; Suaud, L; Rubenstein, RC				Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.			Hsp70 Promotes Epithelial Sodium Channel Functional Expression by Increasing Its Association with Coat Complex II and Its Exit from Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BIP ATPASE MUTANTS; NA+ CHANNEL; CYSTIC-FIBROSIS; LIDDLES-SYNDROME; MOLECULAR CHAPERONES; PROTEASE ACTIVATION; SURFACE EXPRESSION; GAMMA-SUBUNIT; BETA-SUBUNIT	The epithelial sodium channel(ENaC) plays an important role in the homeostasis of blood pressure and of the airway surface liquid, and inappropriate regulation of ENaC results in refractory hypertension (in Liddle syndrome) and impaired mucociliary clearance (in cystic fibrosis). The regulation of ENaC by molecular chaperones, such as the 70-kDa heat shock protein Hsp70, is not completely understood. Building on the previous suggestion by our group that Hsp70 promotes ENaC functional and surface expression in Xenopus oocytes, we investigated the mechanism by which Hsp70 acts upon ENaC in epithelial cells. In Madin-Darby canine kidney cells stably expressing epitope-tagged alpha beta gamma-ENaC and with tetracycline-inducible overexpression of Hsp70, treatment with 1 or 2 mu g/ml doxycycline increased total Hsp70 expression similar to 2-fold and ENaC functional expression similar to 1.4-fold. This increase in ENaC functional expression corresponded to an increase in ENaC expression at the apical surface of the cells and was not present when an ATPase-deficient Hsp70 was similarly over expressed. The increase in functional expression was not due to a change in the rate at which ENaC was retrieved from the apical membrane. Instead, Hsp70 overexpression increased the association of ENaC with the Sec24D cargo recognition component of coat complex II, which carries protein cargo from the endoplasmic reticulum to the Golgi. These data support the hypothesis that Hsp70 promotes ENaC biogenesis and trafficking to the apical surface of epithelial cells.	[Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Chanoux, Rebecca A.; Robay, Amal; Shubin, Calla B.; Kebler, Catherine; Suaud, Laurence; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Rubenstein, Ronald C.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Rubenstein, RC (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Abramson 410C,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rrubenst@mail.med.upenn.edu		Shubin, Calla/0000-0002-4618-2722; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health [T32 DK07748, R01 DK58046, R01 DK73185]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058046, T32DK007748, R01DK073185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK07748 (to R. A. C.), R01 DK58046, (to R. C. R.), and R01 DK73185 (to R. C. R.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jovov B, 2002, J BIOL CHEM, V277, P4134, DOI 10.1074/jbc.M108354200; Kamynina E, 2001, KIDNEY INT, V60, P466, DOI 10.1046/j.1523-1755.2001.060002466.x; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Pradervand S, 2003, J AM SOC NEPHROL, V14, P2219, DOI 10.1097/01.ASN.0000080204.65527.E6; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Rossi E, 2008, J HYPERTENS, V26, P921, DOI 10.1097/HJH.0b013e3282f85dfe; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Suaud L, 2011, J BIOL CHEM, V286, P45083, DOI 10.1074/jbc.M111.293282; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200	50	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19255	19265		10.1074/jbc.M112.357756	http://dx.doi.org/10.1074/jbc.M112.357756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496374	Green Published, hybrid			2022-12-28	WOS:000306411900035
J	Mase, Y; Yokogawa, M; Osawa, M; Shimada, I				Mase, Yoko; Yokogawa, Mariko; Osawa, Masanori; Shimada, Ichio			Structural Basis for Modulation of Gating Property of G Protein-gated Inwardly Rectifying Potassium Ion Channel (GIRK) by i/o-family G Protein alpha Subunit (G alpha(i/o))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; ACTIVATED K+ CHANNEL; TRIPLE-RESONANCE EXPERIMENTS; CRYSTAL-STRUCTURE; CROSS-SATURATION; IDENTIFICATION; COMPLEX; TERMINATION; MEMBRANE; SURFACES	G protein-gated inwardly rectifying potassium channel (GIRK) plays a crucial role in regulating heart rate and neuronal excitability. The gating of GIRK is regulated by the association and dissociation of G protein beta gamma subunits (G beta gamma), which are released from pertussis toxin-sensitive G protein alpha subunit (G alpha(i/o)) upon GPCR activation in vivo. Several lines of evidence indicate that G alpha(i/o) also interacts directly with GIRK, playing functional roles in the signaling efficiency and the modulation of the channel activity. However, the underlying mechanism for GIRK regulation by G alpha(i/o) remains to be elucidated. Here, we performed NMR analyses of the interaction between the cytoplasmic region of GIRK1 and G alpha(i3) in the GTP-bound state. The NMR spectral changes of G alpha upon the addition of GIRK as well as the transferred cross-saturation (TCS) results indicated their direct binding mode, where the K-d value was estimated as similar to 1 mM. The TCS experiments identified the direct binding sites on G alpha and GIRK as the alpha 2/alpha 3 helices on the GTPase domain of G alpha and the alpha A helix of GIRK. In addition, the TCS and paramagnetic relaxation enhancement results suggested that the helical domain of G alpha transiently interacts with the alpha A helix of GIRK. Based on these results, we built a docking model of G alpha and GIRK, suggesting the molecular basis for efficient GIRK deactivation by G alpha(i/o).	[Mase, Yoko; Yokogawa, Mariko; Osawa, Masanori; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Aomi, Tokyo 1350064, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Osawa, Masanori/GRS-5726-2022	Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Global COE Program "Medical System Innovation on Multidisciplinary Integration" from MEXT; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program "Medical System Innovation on Multidisciplinary Integration" from MEXT; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) ( to I. S.), a grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to M. O. and I. S.), Global COE Program "Medical System Innovation on Multidisciplinary Integration" from MEXT (to Y. M.), and a grant from Takeda Science Foundation (to M. O.)	Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Berlin S, 2011, J BIOL CHEM, V286, P33223, DOI 10.1074/jbc.M111.271056; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Clore GM, 2011, PROTEIN SCI, V20, P229, DOI 10.1002/pro.576; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kovoor A, 2002, NEURON, V33, P6, DOI 10.1016/S0896-6273(01)00572-4; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; KURACHI Y, 1995, AM J PHYSIOL-CELL PH, V269, pC821, DOI 10.1152/ajpcell.1995.269.4.C821; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mal TK, 2004, J MOL BIOL, V339, P681, DOI 10.1016/j.jmb.2004.04.020; Mase Y., BIOMOL NMR IN PRESS; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Scholich K, 1999, SCIENCE, V283, P1328, DOI 10.1126/science.283.5406.1328; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f	55	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19537	19549		10.1074/jbc.M112.353888	http://dx.doi.org/10.1074/jbc.M112.353888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511772	Green Published, hybrid			2022-12-28	WOS:000306411900066
J	Turczynska, KM; Sadegh, MK; Hellstrand, P; Sward, K; Albinsson, S				Turczynska, Karolina M.; Sadegh, Mardjaneh Karbalaei; Hellstrand, Per; Sward, Karl; Albinsson, Sebastian			MicroRNAs Are Essential for Stretch-induced Vascular Smooth Muscle Contractile Differentiation via MicroRNA (miR)-145-dependent Expression of L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA ISOFORM REGULATION; CELL-DIFFERENTIATION; ACTIN POLYMERIZATION; DEPENDENT GROWTH; KINASE; MODULATION; MYOCARDIN; RHOA; TRANSCRIPTION; ACTIVATION	Stretch of the vascular wall is an important stimulus to maintain smooth muscle contractile differentiation that is known to depend on L-type calcium influx, Rho-activation, and actin polymerization. The role of microRNAs in this response was investigated using tamoxifen-inducible and smooth muscle-specific Dicer KO mice. In the absence of Dicer, which is required for microRNA maturation, smooth muscle microRNAs were completely ablated. Stretch-induced contractile differentiation and Rho-dependent cofilin-2 phosphorylation were dramatically reduced in Dicer KO vessels. On the other hand, acute stretch-sensitive growth signaling, which is independent of influx through L-type calcium channels, was not affected by Dicer KO. Contractile differentiation induced by the actin polymerizing agent jasplakinolide was not altered by deletion of Dicer, suggesting an effect upstream of actin polymerization. Basal and stretch-induced L-type calcium channel expressions were both decreased in Dicer KO portal veins, and inhibition of L-type channels in control vessels mimicked the effects of Dicer deletion. Furthermore, inhibition of miR-145, a highly expressed microRNA in smooth muscle, resulted in a similar reduction of L-type calcium channel expression. This was abolished by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN93, suggesting that Ca2+/calmodulin-dependent protein kinase II delta, a target of miR-145 and up-regulated in Dicer KO, plays a role in the regulation of L-type channel expression. These results show that microRNAs play a crucial role in stretch-induced contractile differentiation in the vascular wall in part via miR-145-dependent regulation of L-type calcium channels.	[Turczynska, Karolina M.; Sadegh, Mardjaneh Karbalaei; Hellstrand, Per; Sward, Karl; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden	Lund University	Albinsson, S (corresponding author), Lund Univ, Dept Expt Med Sci, BMC D12, S-22184 Lund, Sweden.	sebastian.albinsson@med.lu.se	Albinsson, Sebastian/B-4105-2010; sward, karl/J-5798-2012	Albinsson, Sebastian/0000-0001-6936-3967; Sward, Karl/0000-0002-7255-5510	Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4, 524-2009-7774, 64X-28]; Swedish Heart and Lung Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Faculty of Medicine at Lund University; European Union FP7 Marie Curie Initial Training Network Small Artery Remodeling	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Faculty of Medicine at Lund University; European Union FP7 Marie Curie Initial Training Network Small Artery Remodeling	This work was supported in part by Swedish Research Council Grants K2009-65X-4955-01-3 and K2011-67P-20608-02-4 (to K. S.); 524-2009-7774 (to S. A.), and 64X-28 (to P. H.); the Swedish Heart and Lung Foundation (to K. S. and S. A.); The Crafoord Foundation; The Royal Physiographic Society; The Ake Wiberg Foundation; The Tore Nilson Foundation; The Greta and Johan Kock Foundation; The Magnus Bergvall Foundation; The Lars Hierta Memorial Foundation; and the Faculty of Medicine at Lund University (to S. A.).; Supported by the European Union FP7 Marie Curie Initial Training Network Small Artery Remodeling.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2008, AM J PHYSIOL-CELL PH, V294, pC271, DOI 10.1152/ajpcell.00297.2007; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birukov KG, 1998, ARTERIOSCL THROM VAS, V18, P922, DOI 10.1161/01.ATV.18.6.922; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Dubroca C, 2007, CARDIOVASC RES, V73, P190, DOI 10.1016/j.cardiores.2006.10.020; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; Gomez M, 1997, AM J PHYSIOL-CELL PH, V273, pC1714, DOI 10.1152/ajpcell.1997.273.5.C1714; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Lehoux S, 2005, CIRCULATION, V111, P643, DOI 10.1161/01.CIR.0000154548.16191.2F; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; McCarron JG, 1997, J PHYSIOL-LONDON, V498, P371, DOI 10.1113/jphysiol.1997.sp021864; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Numaguchi K, 1999, CIRC RES, V85, P5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046; Riha GM, 2005, ANN BIOMED ENG, V33, P772, DOI 10.1007/s10439-005-3310-9; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Zeidan A, 2000, CIRC RES, V87, P228, DOI 10.1161/01.RES.87.3.228; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002	45	55	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19199	19206		10.1074/jbc.M112.341073	http://dx.doi.org/10.1074/jbc.M112.341073			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22474293	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000306411900030
J	Acsadi, G; Moore, SA; Cheron, A; Delalande, O; Bennett, L; Kupsky, W; El-Baba, M; Le Rumeur, E; Hubert, JF				Acsadi, Gyula; Moore, Steven A.; Cheron, Angelique; Delalande, Olivier; Bennett, Lindsey; Kupsky, William; El-Baba, Mohammad; Le Rumeur, Elisabeth; Hubert, Jean-Francois			Novel Mutation in Spectrin-like Repeat 1 of Dystrophin Central Domain Causes Protein Misfolding and Mild Becker Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISSENSE MUTATIONS; MOLECULAR-BASIS; GENE-THERAPY; ROD DOMAIN; DUCHENNE; DELETION; STABILITY; PHENOTYPE; EXPRESSION; MEMBRANE	Mutations in the dystrophin gene without disruption of the reading frame often lead to Becker muscular dystrophy, but a genotype/phenotype correlation is difficult to establish. Amino acid substitutions may disrupt binding capacities of dystrophin and have a major impact on the functionality of this protein. We have identified two brothers (ages 8 and 10 years) with very mild proximal weakness, recurrent abdominal pain, and moderately elevated serum creatine kinase levels. Gene sequencing revealed a novel mutation in exon 11 of the dystrophin gene (c.1280T>C) leading to a L427P amino acid substitution in repeat 1 of the central rod domain. Immunostaining of skeletal muscle showed weak staining of the dystrophin region encoded by exons 7 and 8 corresponding to the end of the actin-binding domain 1 and the N-terminal part of hinge 1. Spectrofluorescence and circular dichroism analysis of the domain repeat 1-2 (R1-2) revealed partial misfolding of the L427P mutated protein as well as a reduced refolding rate after denaturation. Based on computational homology models of the wild-type and mutated R1-2, a molecular dynamics study showed an alteration in the flexibility of the structure, which also strongly affects the conformational space available in the N-terminal region of the fragment. Our results suggest that this missense mutation hinders the dynamic properties of the entire N-terminal region of dystrophin.	[Cheron, Angelique; Delalande, Olivier; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Rennes 1, CNRS 6026, Fac Med, CS 34317, F-35043 Rennes, France; [Acsadi, Gyula] Connecticut Childrens Med Ctr, Hartford, CT 06106 USA; [Acsadi, Gyula] Univ Connecticut, Sch Med, Farmington, CT 06030 USA; [Moore, Steven A.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Cheron, Angelique; Delalande, Olivier; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Europeenne Bretagne, F-35000 Rennes, France; [Bennett, Lindsey; Kupsky, William; El-Baba, Mohammad] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Bennett, Lindsey; Kupsky, William; El-Baba, Mohammad] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	Universite de Rennes; Connecticut Children's Medical Center; University of Connecticut; University of Iowa; Universite de Bretagne Occidentale; Wayne State University; Wayne State University	Hubert, JF (corresponding author), Univ Rennes 1, CNRS, UMR 6026, Bat 5,Campus Villejean, F-35043 Rennes, France.	jfhubert@univ-rennes1.fr		Moore, Steven/0000-0002-6353-7900	Association Francaise contre les Myopathies and Iowa Wellstone Muscular Dystrophy Cooperative Research Center [NS053672]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Association Francaise contre les Myopathies and Iowa Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Association Francaise contre les Myopathies and Iowa Wellstone Muscular Dystrophy Cooperative Research Center Grant NS053672.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; BUSHBY KMD, 1993, J NEUROL, V240, P105, DOI 10.1007/BF00858726; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chamberlain JS, 1997, SOC GEN PHY, V52, P19; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Hanft LM, 2007, NEUROMUSCULAR DISORD, V17, P569, DOI 10.1016/j.nmd.2007.03.004; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HART KA, 1987, HUM GENET, V75, P281, DOI 10.1007/BF00281075; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; JAFFE KM, 1990, ARCH PHYS MED REHAB, V71, P742; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; KOENIG M, 1989, AM J HUM GENET, V45, P498; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Legrand B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023819; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Moore SA, 2006, J NEUROPATH EXP NEUR, V65, P995, DOI 10.1097/01.jnen.0000235854.77716.6c; NORMAN AM, 1990, J MED GENET, V27, P236, DOI 10.1136/jmg.27.4.236; Odom GL, 2010, J CHILD NEUROL, V25, P1149, DOI 10.1177/0883073810371006; PALMUCCI L, 1994, NEUROLOGY, V44, P541, DOI 10.1212/WNL.44.3_Part_1.541; Rey J, 2010, J STRUCT BIOL, V171, P266, DOI 10.1016/j.jsb.2010.05.002; SANKARARAMAKRISHNAN R, 1993, PROTEINS, V15, P26, DOI 10.1002/prot.340150105; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; STAIANO A, 1992, J PEDIATR-US, V121, P720, DOI 10.1016/S0022-3476(05)81899-2; Taylor PJ, 2007, J MED GENET, V44, P368, DOI 10.1136/jmg.2006.047464; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; Yokota R, 2004, INTERNAL MED, V43, P204, DOI 10.2169/internalmedicine.43.204	42	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18153	18162		10.1074/jbc.M111.284521	http://dx.doi.org/10.1074/jbc.M111.284521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22453924	hybrid, Green Published			2022-12-28	WOS:000306411600023
J	Campbell, ZT; Menichelli, E; Friend, K; Wu, J; Kimble, J; Williamson, JR; Wickens, M				Campbell, Zachary T.; Menichelli, Elena; Friend, Kyle; Wu, Joann; Kimble, Judith; Williamson, James R.; Wickens, Marvin			Identification of a Conserved Interface between PUF and CPEB Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B1 MESSENGER-RNA; PUMILIO-HOMOLOGY DOMAIN; TRANSLATIONAL CONTROL; C-ELEGANS; CYTOPLASMIC POLYADENYLATION; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; OOCYTE MATURATION; XENOPUS PUMILIO; BRAIN-TUMOR	Members of the PUF ((Pu) under bar milio and (F) under bar BF) and CPEB ((c) under bar ytoplasmic (p) under bar olyadenylation (e) under bar lement-(b) under bar inding) protein families collaborate to regulate mRNA expression throughout eukaryotes. Here, we focus on the physical interactions between members of these two families, concentrating on Caenorhabditis elegans FBF-2 and CPB-1. To localize the site of interaction on FBF-2, we identified conserved amino acids within C. elegans PUF proteins. Deletion of an extended loop containing several conserved residues abolished binding to CPB-1. We analyzed alanine substitutions at 13 individual amino acids in FBF-2, each identified via its conservation. Multiple single point mutations disrupted binding to CPB-1 but not to RNA. Position Tyr-479 was particularly critical as multiple substitutions to other amino acids at this position did not restore binding. The complex of FBF-2 and CPB-1 repressed translation of an mRNA containing an FBF binding element. Repression required both proteins and was disrupted by FBF-2 alleles that failed to bind CPB-1 or RNA. The equivalent loop in human PUM2 is required for binding to human CPEB3 in vitro, although the primary sequences of the human and C. elegans PUF proteins have diverged in that region. Our findings define a key region in PUF/CPEB interactions and imply a conserved platform through which PUF proteins interact with their protein partners.	[Campbell, Zachary T.; Friend, Kyle; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Menichelli, Elena; Wu, Joann; Williamson, James R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Menichelli, Elena; Wu, Joann; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Scripps Research Institute	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Campbell, Zachary/0000-0002-3768-6996	National Institutes of Health [F32 GM095169, GM069454, GM53320, GM031892, GM050942]; American Cancer Society [PF-10-127-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454, F32GM095169, R37GM031892, R01GM031892, R01GM050942, R01GM053320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant F32 GM095169.; Supported by Grant PF-10-127-01-DDC from the American Cancer Society.; An Investigator of the Howard Hughes Medical Institute. Supported by National Institutes of Health Grant GM069454.; Supported by National Institutes of Health Grant GM53320.; Supported by National Institutes of Health Grants GM031892 and GM050942. To whom correspondence should be addressed: Dept. of Biochemistry, University of Wisconsin-Madison, 433 Babcock Dr., Madison, WI 53706. Tel.: 608-263-0858; Fax 608-262-9108; E-mail: wickens@biochem. wisc.edu.	Ariz M, 2009, DEV BIOL, V326, P295, DOI 10.1016/j.ydbio.2008.11.024; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cho S, 2007, CURR BIOL, V17, P203, DOI 10.1016/j.cub.2006.12.027; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Haag ES, 2007, GENETICA, V129, P45, DOI 10.1007/s10709-006-0032-3; Haag ES, 2005, EVOLUTION, V59, P1620, DOI 10.1111/j.0014-3820.2005.tb01813.x; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Houshmandi SS, 2005, RNA, V11, P1655, DOI 10.1261/rna.2168505; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Luitjens C, 2000, GENE DEV, V14, P2596, DOI 10.1101/gad.831700; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Osborne H B, 1997, Prog Mol Subcell Biol, V18, P173; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rajagopalan Lavanya, 2009, V493, P287, DOI 10.1007/978-1-59745-523-7_17; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M., 1996, TRANSLATIONAL CONTRO, P411; Wreden C, 1997, DEVELOPMENT, V124, P3015; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	58	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18854	18862		10.1074/jbc.M112.352815	http://dx.doi.org/10.1074/jbc.M112.352815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496444	hybrid, Green Published			2022-12-28	WOS:000306411600093
J	Tretter, EM; Berger, JM				Tretter, Elsa M.; Berger, James M.			Mechanisms for Defining Supercoiling Set Point of DNA Gyrase Orthologs II-THE SHAPE OF THE GyrA SUBUNIT C-TERMINAL DOMAIN (CTD) IS NOT A SOLE DETERMINANT FOR CONTROLLING SUPERCOILING EFFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; TOPOISOMERASE-IV; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN; ENZYME; MODEL; TOPOLOGY; BINDING; REPLICATION	DNA topoisomerases are essential enzymes that can over-wind, underwind, and disentangle double-helical DNA segments to maintain the topological state of chromosomes. Nearly all bacteria utilize a unique type II topoisomerase, gyrase, which actively adds negative supercoils to chromosomes using an ATP-dependent DNA strand passage mechanism; however, the specific activities of these enzymes can vary markedly from species to species. Escherichia coli gyrase is known to favor supercoiling over decatenation (Zechiedrich, E. L., Khodursky, A. B., and Cozzarelli, N. R. (1997) Genes Dev. 11, 2580-2592), whereas the opposite has been reported for Mycobacterium tuberculosis gyrase (Aubry, A., Fisher, L. M., Jarlier, V., and Cambau, E. (2006) Biochem. Biophys. Res. Commun. 348, 158-165). Here, we set out to understand the molecular basis for these differences using structural and biochemical approaches. Contrary to expectations based on phylogenetic inferences, we find that the dedicated DNA wrapping domains (the C-terminal domains) of both gyrases are highly similar, both architecturally and in their ability to introduce writhe into DNA. However, the M. tuberculosis enzyme lacks a C-terminal control element recently uncovered in E. coli gyrase (see accompanying article (Tretter, E. M., and Berger, J. M. (2012) J. Biol. Chem. 287, 18636-18644)) and turns over ATP at a much slower rate. Together, these findings demonstrate that C-terminal domain shape is not the sole regulatory determinant of gyrase activity and instead indicate that an inability to tightly couple DNA wrapping to ATP turnover is why M. tuberculosis gyrase cannot supercoil DNA to the same extent as its gamma-proteobacterial counterpart. Our observations demonstrate that gyrase has been modified in multiple ways throughout evolution to fine-tune its specific catalytic properties.	[Tretter, Elsa M.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Div Biochem & Mol Biol, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			National Institutes of Health from NCI [RO1-CA077373]; NIAID [PO1-AI068135]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA077373 from the NCI (to J. M. B.) and PO1-AI068135 from the NIAID (to J. M. B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Booker BM, 2010, MOL MICROBIOL, V78, P1348, DOI 10.1111/j.1365-2958.2010.07394.x; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Champion K, 2007, J BACTERIOL, V189, P5839, DOI 10.1128/JB.00083-07; CHAMPOUX JJ, 1972, P NATL ACAD SCI USA, V69, P143, DOI 10.1073/pnas.69.1.143; Clark DJ, 2009, METHODS MOL BIOL, V543, P523, DOI 10.1007/978-1-60327-015-1_30; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DRLICA K, 1990, TRENDS GENET, V6, P433, DOI 10.1016/0168-9525(90)90306-Q; DYNAN WS, 1981, J BIOL CHEM, V256, P5860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forterre P, 1996, FEMS MICROBIOL REV, V18, P237; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049; Hsieh TJ, 2004, J BIOL CHEM, V279, P55587, DOI 10.1074/jbc.M408934200; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LIU LF, 1979, J BIOL CHEM, V254, P1082; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; RAU DC, 1987, J MOL BIOL, V193, P555, DOI 10.1016/0022-2836(87)90266-X; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Shapiro TA, 1999, METH MOL B, V94, P61; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103	51	40	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18645	18654		10.1074/jbc.M112.345736	http://dx.doi.org/10.1074/jbc.M112.345736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22457352	hybrid, Green Published			2022-12-28	WOS:000306411600074
J	Bhutani, N; Piccirillo, R; Hourez, R; Venkatraman, P; Goldberg, AL				Bhutani, Nidhi; Piccirillo, Rosanna; Hourez, Raphael; Venkatraman, Prasanna; Goldberg, Alfred L.			Cathepsins L and Z Are Critical in Degrading Polyglutamine-containing Proteins within Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; AGGREGATE-PRONE PROTEINS; REDUCES TOXICITY; DEGRADATION; AUTOPHAGY; INHIBITION; PROTEASOME; DISEASE; AGGRESOMES; PEPTIDES	In neurodegenerative diseases caused by extended polyglutamine (polyQ) sequences in proteins, aggregation-prone polyQ proteins accumulate in intraneuronal inclusions. PolyQ proteins can be degraded by lysosomes or proteasomes. Proteasomes are unable to hydrolyze polyQ repeat sequences, and during breakdown of polyQ proteins, they release polyQ repeat fragments for degradation by other cellular enzymes. This study was undertaken to identify the responsible proteases. Lysosomal extracts (unlike cytosolic enzymes) were found to rapidly hydrolyze polyQ sequences in peptides, proteins, or insoluble aggregates. Using specific inhibitors against lysosomal proteases, enzyme-deficient extracts, and pure cathepsins, we identified cathepsins L and Z as the lysosomal cysteine proteases that digest polyQ proteins and peptides. RNAi for cathepsins L and Z in different cell lines and adult mouse muscles confirmed that they are critical in degrading polyQ proteins (expanded huntingtin exon 1) but not other types of aggregation-prone proteins (e.g. mutant SOD1). Therefore, the activities of these two lysosomal cysteine proteases are important in host defense against toxic accumulation of polyQ proteins.	[Bhutani, Nidhi; Piccirillo, Rosanna; Hourez, Raphael; Venkatraman, Prasanna; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu	Piccirillo, Rosanna/K-6619-2016; Piccirillo, Rosanna/AAQ-3653-2020	Piccirillo, Rosanna/0000-0002-1613-9352; Piccirillo, Rosanna/0000-0002-1613-9352	National Institutes of Health [R01 AR055255]; High Q Foundation; Amyotrophic Lateral Sclerosis Association; Packard Center for Amyotrophic Lateral Sclerosis Research at Johns Hopkins; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); High Q Foundation; Amyotrophic Lateral Sclerosis Association; Packard Center for Amyotrophic Lateral Sclerosis Research at Johns Hopkins; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR055255 (to A. L. G.). This work was also supported by grants from the High Q Foundation, the Amyotrophic Lateral Sclerosis Association, and the Packard Center for Amyotrophic Lateral Sclerosis Research at Johns Hopkins.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhutani N, 2007, EMBO J, V26, P1385, DOI 10.1038/sj.emboj.7601592; Brix Klaudia, 2005, P50; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Edinger AL, 2003, CANCER RES, V63, P8451; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONAS AJ, 1986, BIOCHEM J, V236, P671, DOI 10.1042/bj2360671; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kitamura A, 2010, FEBS J, V277, P1369, DOI 10.1111/j.1742-4658.2010.07570.x; Menzies FM, 2010, HUM MOL GENET, V19, P4573, DOI 10.1093/hmg/ddq385; Nishimura F, 2002, AM J PATHOL, V161, P2047, DOI 10.1016/S0002-9440(10)64483-5; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; UMEZAWA H, 1982, ANNU REV MICROBIOL, V36, P75, DOI 10.1146/annurev.mi.36.100182.000451; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	41	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17471	17482		10.1074/jbc.M112.352781	http://dx.doi.org/10.1074/jbc.M112.352781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451661	Green Published, hybrid			2022-12-28	WOS:000306373000047
J	Joetham, A; Ohnishi, H; Okamoto, M; Takeda, K; Schedel, M; Domenico, J; Dakhama, A; Gelfand, EW				Joetham, Anthony; Ohnishi, Hiroshi; Okamoto, Masakazu; Takeda, Katsuyuki; Schedel, Michaela; Domenico, Joanne; Dakhama, Azzeddine; Gelfand, Erwin W.			Loss of T Regulatory Cell Suppression following Signaling through Glucocorticoid-induced Tumor Necrosis Receptor (GITR) Is Dependent on c-Jun N-terminal Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TNF RECEPTOR; TRANSCRIPTION FACTOR FOXP3; LUNG ALLERGIC RESPONSES; KAPPA-B ACTIVATION; AIRWAY HYPERREACTIVITY; CUTTING EDGE; TGF-BETA; PROTEIN; LIGAND; COSTIMULATION	Naturally occurring Foxp3(+)CD4(+)CD25(+) T regulatory cell (nTreg)-mediated suppression of lung allergic responses is abrogated following ligation of glucocorticoid-induced tumor necrosis receptor (GITR) family-related protein. In vitro stimulation of nTregs with GITR ligand increased phosphorylation of c-Jun N-terminal kinase (JNK) but not extracellular signal-regulated protein kinase (ERK) or p38 MAPK. SP600125, a known JNK inhibitor, prevented GITR-mediated phosphorylation of JNK. Activation of JNK was associated with increases in the upstream mitogen-activated protein kinase kinase 7 (MKK7) and the downstream transcription factor NF-kappa beta. Phosphorylated c-Jun (p-c-Jun), indicative of the activation of JNK, was detected in the immunoprecipitates of nTregs from wild-type but not JNK- or GITR-deficient mice. Treatment with an inhibitor of JNK phosphorylation resulted in complete reversal of all GITR-induced changes in nTreg phenotype and function, with full restoration of suppression of in vivo lung allergic responses and in vitro proliferation of activated CD4(+)CD25(-) T cells. Thus, regulation of JNK phosphorylation plays a central role in T regulatory cell function with therapeutic implications for the treatment of asthma and autoimmune diseases.	[Joetham, Anthony; Ohnishi, Hiroshi; Okamoto, Masakazu; Takeda, Katsuyuki; Schedel, Michaela; Domenico, Joanne; Dakhama, Azzeddine; Gelfand, Erwin W.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Cell Biol, 1400 Jackson St, Denver, CO 80206 USA.	gelfande@njhealth.org	Schedel, Michaela/B-3065-2019	Schedel, Michaela/0000-0001-8465-2986; Ohnishi, Hiroshi/0000-0002-7863-4519	National Institutes of Health [AI-77609, HL-36577, HL-61005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061005, P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077609, R56AI077609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-77609, HL-36577, and HL-61005.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Bae EM, 2008, MOL IMMUNOL, V45, P523, DOI 10.1016/j.molimm.2007.05.013; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Cardona ID, 2006, J ALLERGY CLIN IMMUN, V117, P688, DOI 10.1016/j.jaci.2005.11.037; Chialda L, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-36; Clark LB, 1999, J IMMUNOL, V162, P2546; Cuzzocrea S, 2006, J IMMUNOL, V177, P631, DOI 10.4049/jimmunol.177.1.631; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Esparza EM, 2005, J IMMUNOL, V174, P7875, DOI 10.4049/jimmunol.174.12.7875; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Joetham A, 2008, J IMMUNOL, V180, P7117, DOI 10.4049/jimmunol.180.11.7117; Joetham A, 2007, P NATL ACAD SCI USA, V104, P15057, DOI 10.1073/pnas.0706765104; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; Joetham A, 2011, J IMMUNOL, V186, P113, DOI 10.4049/jimmunol.1001663; Joetham A, 2009, J IMMUNOL, V183, P1821, DOI 10.4049/jimmunol.0900303; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Liao GX, 2010, INT IMMUNOL, V22, P259, DOI 10.1093/intimm/dxq001; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Whitmarsh A. J., 1996, J MOL MED, V17, P2360; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	40	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17100	17108		10.1074/jbc.M111.316943	http://dx.doi.org/10.1074/jbc.M111.316943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461627	Green Published, hybrid			2022-12-28	WOS:000306373000010
J	Yuan, C; Qi, JN; Zhao, XY; Gao, CJ				Yuan, Chao; Qi, Jianni; Zhao, Xueying; Gao, Chengjiang			Smurf1 Protein Negatively Regulates Interferon-gamma Signaling through Promoting STAT1 Protein Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PHOSPHORYLATION; MURINE MACROPHAGES; CELL POLARITY; V-PROTEIN; PATHWAY; LIGASE; IFN; DIFFERENTIATION; SPECIFICITY; ACTIVATION	Interferons are important cytokines that mediate antiviral, antiproliferative, antitumor, and immunoregulatory activities. However, uncontrolled IFN signaling may lead to autoimmune diseases. Here we identified Smurf1 as a negative regulator for IFN-gamma signaling by targeting STAT1 for ubiquitination and proteasomal degradation. Smurf1 interacted with STAT1 through the WW domains of Smurf1 and the PY motif in STAT1 and catalyzed K48-linked polyubiquitination of STAT1. Interestingly, the Smurf1-mediated ubiquitination and degradation did not require STAT1 tyrosine and serine phosphorylation. Subsequently, overexpression of Smurf1 attenuated IFN-gamma-mediated STAT1 activation and antiviral immune responses, whereas knockdown of Smurf1 enhanced IFN-gamma-mediated STAT1 activation, expression of STAT1 target genes, and antiviral immune responses. Furthermore, IFN-gamma stimulation led to enhanced expression of Smurf1. Therefore, our results demonstrate that Smurf1 is a negative feedback regulator for IFN-gamma signaling by targeting STAT1 for ubiquitination and proteasomal degradation.	[Gao, Chengjiang] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China; Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University	Gao, CJ (corresponding author), Shandong Univ, Sch Med, Dept Immunol, 44 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	cgao@sdu.edu.cn		Gao, Chengjiang/0000-0002-9365-4497	National Natural Science Foundation of China; Taishan Scholar Program of Shandong Province; Shandong Provincial Nature Science Foundation for Distinguished Young Scholars [JQ201120]; Independent Innovation Foundation of Shandong University [2009JQ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong Province; Shandong Provincial Nature Science Foundation for Distinguished Young Scholars; Independent Innovation Foundation of Shandong University	This work was supported in part by grants from the National Natural Science Foundation of China, the Taishan Scholar Program of Shandong Province, the Shandong Provincial Nature Science Foundation for Distinguished Young Scholars (Grant JQ201120), and the Independent Innovation Foundation of Shandong University (Grant 2009JQ001).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; EILERS A, 1995, MOL CELL BIOL, V15, P3579; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kubota T, 2005, J VIROL, V79, P4451, DOI 10.1128/JVI.79.7.4451-4459.2005; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zheng YJ, 2010, J IMMUNOL, V184, P6447, DOI 10.4049/jimmunol.0901750; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	32	54	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17006	17015		10.1074/jbc.M112.341198	http://dx.doi.org/10.1074/jbc.M112.341198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474288	Green Published, hybrid			2022-12-28	WOS:000306373000002
J	Ladiwala, ARA; Litt, J; Kane, RS; Aucoin, DS; Smith, SO; Ranjan, S; Davis, J; Van Nostrand, WE; Tessier, PM				Ladiwala, Ali Reza A.; Litt, Jeffrey; Kane, Ravi S.; Aucoin, Darryl S.; Smith, Steven O.; Ranjan, Swarnim; Davis, Judianne; Van Nostrand, William E.; Tessier, Peter M.			Conformational Differences between Two Amyloid beta Oligomers of Similar Size and Dissimilar Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; FIBRIL FORMATION; MONOCLONAL-ANTIBODIES; ALZHEIMERS-DISEASE; PROTEIN OLIGOMERS; AGGREGATION; COMMON; NEUROTOXICITY; ASSEMBLIES; CONFORMERS	Several protein conformational disorders (Parkinson and prion diseases) are linked to aberrant folding of proteins into prefibrillar oligomers and amyloid fibrils. Although prefibrillar oligomers are more toxic than their fibrillar counterparts, it is difficult to decouple the origin of their dissimilar toxicity because oligomers and fibrils differ both in terms of structure and size. Here we report the characterization of two oligomers of the 42-residue amyloid beta (A beta 42) peptide associated with Alzheimer disease that possess similar size and dissimilar toxicity. We find that A beta 42 spontaneously forms prefibrillar oligomers at A beta concentrations below 30 mu M in the absence of agitation, whereas higher A beta concentrations lead to rapid formation of fibrils. Interestingly, A beta prefibrillar oligomers do not convert into fibrils under quiescent assembly conditions but instead convert into a second type of oligomer with size and morphology similar to those of A beta prefibrillar oligomers. Strikingly, this alternative A beta oligomer is non-toxic to mammalian cells relative to A beta monomer. We find that two hydrophobic peptide segments within A beta (residues 16-22 and 30-42) are more solvent-exposed in the more toxic A beta oligomer. The less toxic oligomer is devoid of beta-sheet structure, insoluble, and non-immunoreactive with oligomer-and fibril-specific antibodies. Moreover, the less toxic oligomer is incapable of disrupting lipid bilayers, in contrast to its more toxic oligomeric counterpart. Our results suggest that the ability of non-fibrillar A beta oligomers to interact with and disrupt cellular membranes is linked to the degree of solvent exposure of their central and C-terminal hydrophobic peptide segments.	[Ladiwala, Ali Reza A.; Litt, Jeffrey; Kane, Ravi S.; Ranjan, Swarnim; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Aucoin, Darryl S.; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Davis, Judianne; Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Smith, Steven/HDM-9496-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X; Aucoin, Darryl/0000-0002-0595-8045; /0000-0001-9135-2607	National Institutes of Health [AG-27317]; Alzheimer's Association [NIRG-08-90967]; American Health Assistance Foundation [ADR-A2011355]; National Science Foundation [CBET NIRT 0608978]; P. K. Lashmet Chair; NATIONAL INSTITUTE ON AGING [RF1AG027317, R01AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Science Foundation(National Science Foundation (NSF)); P. K. Lashmet Chair; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-27317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant NIRG-08-90967 (to P. M. T.), American Health Assistance Foundation Grant ADR-A2011355 (to P. M. T.), National Science Foundation Grant CBET NIRT 0608978 (to R. S. K.), and the P. K. Lashmet Chair (to R. S. K.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Keshet B, 2010, BIOTECHNOL BIOENG, V106, P333, DOI 10.1002/bit.22691; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Ladiwala ARA, 2011, CHEMBIOCHEM, V12, P1749, DOI 10.1002/cbic.201100123; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068	37	163	165	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24765	24773		10.1074/jbc.M111.329763	http://dx.doi.org/10.1074/jbc.M111.329763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22547072	Green Published, hybrid			2022-12-28	WOS:000306651100069
J	Visser, WF; Verhoeven-Duif, NM; de Koning, TJ				Visser, Wouter F.; Verhoeven-Duif, Nanda M.; de Koning, Tom J.			Identification of a Human trans-3-Hydroxy-L-proline Dehydratase, the First Characterized Member of a Novel Family of Proline Racemase-like Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO ACIDS; BASEMENT-MEMBRANE COLLAGEN; TRYPANOSOMA-CRUZI; D-SERINE; QUANTIFICATION; SUSCEPTIBILITY; MECHANISM	A family of eukaryotic proline racemase-like genes has recently been identified. Several members of this family have been well characterized and are known to catalyze the racemization of free proline or trans-4-hydroxyproline. However, the majority of eukaryotic proline racemase-like proteins, including a human protein called C14orf149, lack a specific cysteine residue that is known to be critical for racemase activity. Instead, these proteins invariably contain a threonine residue at this position. The function of these enzymes has remained unresolved until now. In this study, we demonstrate that three enzymes of this type, including human C14orf149, catalyze the dehydration of trans-3-hydroxy-L-proline to Delta(1)-pyrroline-2-carboxylate (Pyr2C). These are the first enzymes of this subclass of proline racemase-like genes for which the enzymatic activity has been resolved. C14orf149 is also the first human enzyme that acts on trans-3-hydroxy-L-proline. Interestingly, a mutant enzyme in which the threonine in the active site is mutated back into cysteine regained 3-hydroxyproline epimerase activity. This result suggests that the enzymatic activity of these enzymes is dictated by a single residue. Presumably, human C14orf149 serves to degrade trans-3-hydroxy-L-proline from the diet and originating from the degradation of proteins that contain this amino acid, such as collagen IV, which is an important structural component of basement membrane.	[Visser, Wouter F.; Verhoeven-Duif, Nanda M.; de Koning, Tom J.] UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp Utrecht, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Visser, WF (corresponding author), UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp Utrecht, Huispost KC 02-069-1,Postbus 85090, NL-3508 AB Utrecht, Netherlands.	w.visser-2@umcutrecht.nl	Pinheiro, Maísa/E-7424-2012; De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309				ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuchs SA, 2005, MOL GENET METAB, V85, P168, DOI 10.1016/j.ymgme.2005.03.003; GARWEG G, 1980, J NEUROCHEM, V35, P616, DOI 10.1111/j.1471-4159.1980.tb03700.x; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; MEISTER A, 1957, J BIOL CHEM, V229, P789; MEISTER A, 1954, J BIOL CHEM, V206, P577; MESTICHELLI LJJ, 1979, J BIOL CHEM, V254, P640; Mineharu Y, 2008, J HUM GENET, V53, P325, DOI 10.1007/s10038-008-0255-5; NAGATA Y, 1992, EXPERIENTIA, V48, P986, DOI 10.1007/BF01919147; Ozturk AK, 2006, STROKE, V37, P1021, DOI 10.1161/01.STR.0000206153.92675.b9; Patzold R, 2005, BIOMED CHROMATOGR, V19, P466, DOI 10.1002/bmc.515; RADHAKRISHNAN AN, 1957, J BIOL CHEM, V226, P559; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; RUDNICK G, 1975, BIOCHEMISTRY-US, V14, P4515, DOI 10.1021/bi00691a028; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Visser WF, 2011, J CHROMATOGR A, V1218, P7130, DOI 10.1016/j.chroma.2011.07.087; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WELLNER D, 1964, BIOCHEMISTRY-US, V3, P1746, DOI 10.1021/bi00899a028; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721	29	28	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21654	21662		10.1074/jbc.M112.363218	http://dx.doi.org/10.1074/jbc.M112.363218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22528483	Green Published, hybrid			2022-12-28	WOS:000306418600008
J	Bridges, D; Fisher, K; Zolov, SN; Xiong, TT; Inoki, K; Weisman, LS; Saltiel, AR				Bridges, Dave; Fisher, Kaleigh; Zolov, Sergey N.; Xiong, Tingting; Inoki, Ken; Weisman, Lois S.; Saltiel, Alan R.			Rab5 Proteins Regulate Activation and Localization of Target of Rapamycin Complex 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SACCHAROMYCES-CEREVISIAE; AMINO-ACIDS; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; ACTIN CYTOSKELETON; PHOSPHOLIPASE-D; GENE-PRODUCTS; LIPID KINASE; CELL-GROWTH; RAG GTPASES	The mechanistic target of rapamycin (mTOR) complex 1 is regulated by small GTPase activators and localization signals. We examine here the role of the small GTPase Rab5 in the localization and activation of TORC1 in yeast and mammalian cells. Rab5 mutants disrupt mTORC1 activation and localization in mammalian cells, whereas disruption of the Rab5 homolog in yeast, Vps21, leads to decreased TORC1 function. Additionally, regulation of PI(3)P synthesis by Rab5 and Vps21 is essential for TORC1 function in both contexts.	[Bridges, Dave; Fisher, Kaleigh; Zolov, Sergey N.; Xiong, Tingting; Inoki, Ken; Weisman, Lois S.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Xiong, Tingting; Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Weisman, Lois S.; Saltiel, Alan R.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019; Bridges, Dave/A-8825-2010	Bridges, Dave/0000-0002-5334-972X; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health [DK-061618, GM-050403, DK-083491]; American Diabetes Association fellowship; Rackham graduate studies grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491, P30DK020572, R01DK061618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association fellowship(American Diabetes Association); Rackham graduate studies grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-061618 (to A. R. S.), GM-050403 (to L. S. W.), and DK-083491 (to K. I.). This work was also supported an American Diabetes Association fellowship (to D. B.) and a Rackham graduate studies grant (to T. X.).	Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	48	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20913	20921		10.1074/jbc.M111.334060	http://dx.doi.org/10.1074/jbc.M111.334060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547071	Green Published, hybrid			2022-12-28	WOS:000306416800013
J	Roston, RL; Gao, JP; Murcha, MW; Whelan, J; Benning, C				Roston, Rebecca L.; Gao, Jinpeng; Murcha, Monika W.; Whelan, James; Benning, Christoph			TGD1,-2, and-3 Proteins Involved in Lipid Trafficking Form ATP-binding Cassette (ABC) Transporter with Multiple Substrate-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; BLUE-NATIVE PAGE; ARABIDOPSIS-THALIANA; INSERTIONAL MUTAGENESIS; CHLOROPLAST ENVELOPES; PHOSPHATIDIC-ACID; PEA-CHLOROPLASTS; OUTER-MEMBRANE; COMPLEX; SYSTEM	Members of the ATP-binding cassette (ABC) transporter family are essential proteins in species as diverse as archaea and humans. Their domain architecture has remained relatively fixed across these species, with rare exceptions. Here, we show one exception to be the TRIGALACTOSYLDIACYLGLYCEROL 1, 2, and 3 (TGD1, -2, and -3) putative lipid transporter located at the chloroplast inner envelope membrane. TGD2 was previously shown to be in a complex of >500 kDa. We demonstrate that this complex also contains TGD1 and -3 and is very stable because it cannot be broken down by gentle denaturants to form a "core" complex similar in size to standard ABC transporters. The complex was purified from Pisum sativum (pea) chloroplast envelopes by native gel electrophoresis and examined by mass spectrometry. Identified proteins besides TGD1, -2, or -3 included a potassium efflux antiporter and a TIM17/ 22/23 family protein, but these were shown to be in separate high molecular mass complexes. Quantification of the complex components explained the size of the complex because 8-12 copies of the substrate-binding protein (TGD2) were found per functional transporter.	[Roston, Rebecca L.; Gao, Jinpeng; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Murcha, Monika W.; Whelan, James] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	Michigan State University; University of Western Australia	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@cns.msu.edu	Benning, Christoph/Y-2528-2019; Murcha, Monika W/H-5495-2014; Roston, Rebecca/AAQ-5309-2020; Murcha, Monika W/C-3834-2011; Whelan, James/F-6402-2011; Gao, Jinpeng/F-8460-2012	Benning, Christoph/0000-0001-8585-3667; Murcha, Monika W/0000-0002-3689-6158; Whelan, James/0000-0001-5754-025X; Roston, Rebecca/0000-0002-3063-5002	National Science Foundation [MCB0741395]; US Department of Energy, Basic Energy Sciences [DE-FG02-98ER20305]; Div Of Molecular and Cellular Bioscience [1157231] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0741395 and the US Department of Energy, Basic Energy Sciences, DE-FG02-98ER20305 (to C. B.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Albers SV, 2004, J BIOENERG BIOMEMBR, V36, P5, DOI 10.1023/B:JOBB.0000019593.84933.e6; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Brautigam A, 2008, J BIOTECHNOL, V136, P44, DOI 10.1016/j.jbiotec.2008.02.007; Bruce B.D., 1994, PLANT MOL BIOL MANUA, VJ1, P1; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; CLINE K, 1981, P NATL ACAD SCI-BIOL, V78, P3595, DOI 10.1073/pnas.78.6.3595; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Krimm I, 1999, J BIOL CHEM, V274, P34539, DOI 10.1074/jbc.274.49.34539; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; Ladig R, 2011, PLANT J, V67, P181, DOI 10.1111/j.1365-313X.2011.04577.x; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; McElver J, 2001, GENETICS, V159, P1751; Murcha MW, 2007, PLANT PHYSIOL, V143, P199, DOI 10.1104/pp.106.090688; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Roston R, 2011, PLANT J, V66, P759, DOI 10.1111/j.1365-313X.2011.04536.x; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schuurman-Wolters GK, 2005, J BIOL CHEM, V280, P23785, DOI 10.1074/jbc.M500522200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEBERTZ HP, 1979, EUR J BIOCHEM, V101, P429, DOI 10.1111/j.1432-1033.1979.tb19736.x; Uteng M, 2003, BIOCHEMISTRY-US, V42, P11417, DOI 10.1021/bi034572i; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wang Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2518; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	51	65	84	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21406	21415		10.1074/jbc.M112.370213	http://dx.doi.org/10.1074/jbc.M112.370213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544736	hybrid, Green Published			2022-12-28	WOS:000306416800058
J	Good, DW; George, T; Watts, BA				Good, David W.; George, Thampi; Watts, Bruns A., III			Toll-like Receptor 2 Is Required for LPS-induced Toll-like Receptor 4 Signaling and Inhibition of Ion Transport in Renal Thick Ascending Limb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSEPITHELIAL HCO3-ABSORPTION; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE-SYSTEM; NERVE GROWTH-FACTOR; CUTTING EDGE; LIPOTEICHOIC ACID; NA+/H+-EXCHANGE; LIPOPOLYSACCHARIDE-BINDING; MEDIATES INHIBITION; SEPTIC SHOCK	Previously we demonstrated that basolateral LPS inhibits HCO3- absorption in the renal medullary thick ascending limb (MTAL) through TLR4-dependent ERK activation. Here we report that the response of the MTAL to basolateral LPS requires TLR2 in addition to TLR4. The basolateral addition of LPS (ultrapure Escherichia coli K12) decreased HCO3- absorption in isolated, perfused MTALs from wild-type mice but had no effect in MTALs from TLR2(-/-) mice. In contrast, inhibition of HCO3- absorption by lumen LPS was preserved in TLR2(-/-) MTALs, indicating that TLR2 is involved specifically in mediating the basolateral LPS response. LPS also did not increase ERK phosphorylation in MTALs from TLR2(-/-) mice. TLR2 deficiency had no effect on expression of TLR4, MD-2, or MyD88. However, LPS-induced recruitment of MyD88 to the basolateral membrane was impaired in TLR2(-/-) MTALs. Inhibition of HCO3- absorption by LPS did not require CD14. Co-immuno-precipitation studies demonstrated an association between TLR4 and TLR2. Inhibition of HCO3- absorption by TLR2-specific ligands was preserved in MTALs from TLR4(-/-) mice. These results indicate that the effect of basolateral LPS to inhibit HCO3- absorption in the MTAL through MyD88-dependent ERK activation depends on a novel interaction between TLR4 and TLR2. TLR2 plays a dual role in the induction of intracellular signals that impair MTAL function, both through cooperation with TLR4 to mediate ERK signaling by LPS and through a TLR4-independent signaling pathway activated by Gram-positive bacterial ligands. Regulation of TLR2 expression and its interaction with TLR4 may provide new mechanisms for controlling and therapeutic targeting of TLR4-mediated LPS responses.	[Good, David W.] Univ Texas Med Branch, Div Nephrol, Dept Internal Med, Galveston, TX 77555 USA; [Good, David W.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Good, DW (corresponding author), Univ Texas Med Branch, Div Nephrol, Dept Internal Med, 4-200 John Sealy Annex,301 Univ Blvd, Galveston, TX 77555 USA.	dgood@utmb.edu			National Institutes of Health, NIDDK [DK-038217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038217] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-038217.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; AUSTGEN TR, 1991, ARCH SURG-CHICAGO, V126, P23; Baumgart K, 2008, CRIT CARE MED, V36, P640, DOI 10.1097/CCM.0B013E318162ED7B; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown HJ, 2006, J IMMUNOL, V177, P1925, DOI 10.4049/jimmunol.177.3.1925; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; El-Achkar TM, 2008, EUR J CLIN INVEST, V38, P39, DOI 10.1111/j.1365-2362.2008.02007.x; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Good DW, 2008, J BIOL CHEM, V283, P26602, DOI 10.1074/jbc.M803019200; Good DW, 2011, AM J PHYSIOL-RENAL, V301, pF334, DOI 10.1152/ajprenal.00106.2011; Good DW, 2010, AM J PHYSIOL-RENAL, V299, pF536, DOI 10.1152/ajprenal.00108.2010; Good DW, 2009, AM J PHYSIOL-RENAL, V297, pF866, DOI 10.1152/ajprenal.00335.2009; Good DW, 2004, AM J PHYSIOL-RENAL, V287, pF1244, DOI 10.1152/ajprenal.00176.2004; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; Good DW, 2000, AM J PHYSIOL-CELL PH, V279, pC1443, DOI 10.1152/ajpcell.2000.279.5.C1443; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heine H, 1999, J IMMUNOL, V162, P6971; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kim GH, 1999, J AM SOC NEPHROL, V10, P935; Klenzak J, 2005, CRIT CARE CLIN, V21, P211, DOI 10.1016/j.ccc.2005.01.002; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Laghmani K, 1997, J CLIN INVEST, V99, P24, DOI 10.1172/JCI119128; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SW, 2008, EMERG MED J, V25, P659, DOI 10.1136/emj.2007.055558; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Lim SW, 2005, TRANSPLANTATION, V80, P691, DOI 10.1097/01.tp.0000173594.69089.a0; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011; Oppert M, 2008, NEPHROL DIAL TRANSPL, V23, P904, DOI 10.1093/ndt/gfm610; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schmidt C, 2007, AM J PHYSIOL-RENAL, V292, pF804, DOI 10.1152/ajprenal.00258.2006; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2002, J CELL SCI, V115, P2603; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Wang WD, 2008, AM J PHYSIOL-RENAL, V294, pF1473, DOI 10.1152/ajprenal.00036.2008; Watts B. A., 2011, J AM SOC NEPHROL, V22, p80A; Watts BA, 2005, J BIOL CHEM, V280, P11439, DOI 10.1074/jbc.M410719200; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 2006, AM J PHYSIOL-RENAL, V291, pF1005, DOI 10.1152/ajprenal.00507.2005; Watts BA, 2011, AM J PHYSIOL-CELL PH, V301, pC1296, DOI 10.1152/ajpcell.00237.2011; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WRIGHT SD, 1995, J IMMUNOL, V155, P6; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	87	52	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20208	20220		10.1074/jbc.M111.336255	http://dx.doi.org/10.1074/jbc.M111.336255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523073	Green Published, hybrid			2022-12-28	WOS:000306414500041
J	Ngoh, GA; Papanicolaou, KN; Walsh, K				Ngoh, Gladys A.; Papanicolaou, Kyriakos N.; Walsh, Kenneth			Loss of Mitofusin 2 Promotes Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; (ROS)-INDUCED ROS RELEASE; MITOCHONDRIAL FUSION; ER STRESS; CARDIAC MYOCYTES; CELL-DEATH; OXIDATIVE STRESS; SKELETAL-MUSCLE; TRANSLATION	The outer mitochondrial membrane GTPase mitofusin 2 (Mfn2) is known to regulate endoplasmic reticulum (ER) shape in addition to its mitochondrial fusion effects. However, its role in ER stress is unknown. We report here that induction of ER stress with either thapsigargin or tunicamycin in mouse embryonic fibroblasts leads to up-regulation of Mfn2 mRNA and protein levels with no change in the expression of the mitochondrial shaping factors Mfn1, Opa1, Drp1, and Fis1. Genetic deletion of Mfn2 but not Mfn1 in mouse embryonic fibroblasts or cardiac myocytes in mice led to an increase in the expression of the ER chaperone proteins. Genetic ablation of Mfn2 in mouse embryonic fibroblasts amplified ER stress and exacerbated ER stress-induced apoptosis. Deletion of Mfn2 delayed translational recovery through prolonged eIF2 alpha phosphorylation associated with decreased GADD34 and p58(IPK) expression and elevated C/EBP homologous protein induction at late time points. These changes in the unfolded protein response were coupled to increased cell death reflected by augmented caspase 3/7 activity, lactate dehydrogenase release from cells, and an increase in propidium iodide-positive nuclei in response to thapsigargin or tunicamycin treatment. In contrast, genetic deletion of Mfn1 did not affect ER stress-mediated increase in ER chaperone synthesis or eIF2 alpha phosphorylation. Additionally, ER stress-induced C/EBP homologous protein, GADD34, and p58(IPK) induction and cell death were not affected by loss of Mfn1. We conclude that Mfn2 but not Mfn1 is an ER stress-inducible protein that is required for the proper temporal sequence of the ER stress response.	[Ngoh, Gladys A.; Papanicolaou, Kyriakos N.; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu		Ngoh, Gladys/0000-0002-6907-5700	National Institutes of Health [HL102874, AG34972, AG15052, HL68758];  [HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, P01HL068758, R21HL102874, R01HL120160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG015052, R01AG015052, R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL102874, AG34972, AG15052, and HL68758 (to K. W.) This work was also supported by a postdoctoral fellowship on T32 Training Grant HL007224 to the Whitaker Cardiovascular Institute (to G. N.).	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Brady NR, 2006, ANTIOXID REDOX SIGN, V8, P1651, DOI 10.1089/ars.2006.8.1651; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cybulsky AV, 2011, AM J PHYSIOL-RENAL, V301, pF496, DOI 10.1152/ajprenal.00728.2010; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Brito OM, 2008, ANTIOXID REDOX SIGN, V10, P621, DOI 10.1089/ars.2007.1934; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Li YQ, 2009, J MOL CELL CARDIOL, V46, P876, DOI 10.1016/j.yjmcc.2009.02.020; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Lugus JJ, 2011, J MOL CELL CARDIOL, V51, P885, DOI 10.1016/j.yjmcc.2011.07.023; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; PRICE BD, 1992, J CELL PHYSIOL, V152, P545, DOI 10.1002/jcp.1041520314; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sack MN, 2011, J MOL CELL CARDIOL, V51, P881, DOI 10.1016/j.yjmcc.2011.09.004; Santel A, 2001, J CELL SCI, V114, P867; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PL, 2004, ANN CLIN LAB SCI, V34, P449; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	60	121	132	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20321	20332		10.1074/jbc.M112.359174	http://dx.doi.org/10.1074/jbc.M112.359174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511781	hybrid, Green Published			2022-12-28	WOS:000306414500052
J	Chen, ZX; Wu, JM; Yang, CH; Fan, P; Balazs, L; Jiao, Y; Lu, MF; Gu, WK; Li, CY; Pfeffer, LM; Tigyi, G; Yue, JM				Chen, Zixuan; Wu, Jianmin; Yang, Chuanhe; Fan, Pei; Balazs, Louisa; Jiao, Yan; Lu, Meifeng; Gu, Weikuan; Li, Chengyao; Pfeffer, Lawrence M.; Tigyi, Gabor; Yue, Junming			DiGeorge Syndrome Critical Region 8 (DGCR8) Protein-mediated microRNA Biogenesis Is Essential for Vascular Smooth Muscle Cell Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-17-92 CLUSTER; MIRNA BIOGENESIS; EXPRESSION; RECEPTOR; COMPLEX; GENE; CONTRACTILITY; INACTIVATION; DEFECTS; PATHWAY	DiGeorge Critical Region 8 (DGCR8) is a double-stranded RNA-binding protein that interacts with Drosha and facilitates microRNA (miRNA) maturation. However, the role of DGCR8 in vascular smooth muscle cells (VSMCs) is not well understood. To investigate whether DGCR8 contributes to miRNA maturation in VSMCs, we generated DGCR8 conditional knockout (cKO) mice by crossing VSMC-specific Cre mice (SM22-Cre) with DGCR8(loxp/loxp) mice. We found that loss of DGCR8 in VSMCs resulted in extensive liver hemorrhage and embryonic mortality between embryonic days (E) 12.5 and E13.5. DGCR8 cKO embryos displayed dilated blood vessels and disarrayed vascular architecture. Blood vessels were absent in the yolk sac of DGCR8 KOs after E12.5. Disruption of DGCR8 in VSMCs reduced VSMC proliferation and promoted apoptosis in vitro and in vivo. In DGCR8 cKO embryos and knockout VSMCs, differentiation marker genes, including alpha SMA, SM22, and CNN1, were significantly down-regulated, and the survival pathways of ERK1/2 mitogen-activated protein kinase and the phosphatidylinositol 3-kinase/AKT were attenuated. Knock-out of DGCR8 in VSMCs has led to down-regulation of the miR-17/92 and miR-143/145 clusters. We further demonstrated that the miR-17/92 cluster promotes VSMC proliferation and enhances VSMC marker gene expression, which may contribute to the defects of DGCR8 cKO mutants. Our results indicate that the DGCR8 gene is required for vascular development through the regulation of VSMC proliferation, apoptosis, and differentiation.	[Chen, Zixuan; Wu, Jianmin; Fan, Pei; Tigyi, Gabor; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Yang, Chuanhe; Balazs, Louisa; Lu, Meifeng; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; [Chen, Zixuan; Wu, Jianmin; Yang, Chuanhe; Fan, Pei; Pfeffer, Lawrence M.; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Campbell Clin, Memphis, TN 38163 USA; [Chen, Zixuan; Li, Chengyao] So Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Fan, Pei] So Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China; [Wu, Jianmin] Vet Res Inst, Guangxi, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China; Southern Medical University - China	Yue, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 19 S Manassas St,Rm 266, Memphis, TN 38163 USA.	jyue@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Heart, Lung, and Blood Institute, National Institutes of Health [HL095957]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD061420]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061420] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Heart, Lung, and Blood Institute, National Institutes of Health Award HL095957 and by Eunice Kennedy Shriver National Institute of Child Health and Human Development Award HD061420 (to J. Y.).	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Benoit C, 2008, PLACENTA, V29, P503, DOI 10.1016/j.placenta.2008.03.002; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kotlo KU, 2011, AM J PHYSIOL-CELL PH, V301, pC929, DOI 10.1152/ajpcell.00088.2011; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Skryabin BV, 2004, GENESIS, V39, P288, DOI 10.1002/gene.20056; Thieszen SL, 1996, EXP CELL RES, V227, P135, DOI 10.1006/excr.1996.0258; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yue JM, 2011, ADV DRUG DELIVER REV, V63, P616, DOI 10.1016/j.addr.2011.01.001; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047	37	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19018	19028		10.1074/jbc.M112.351791	http://dx.doi.org/10.1074/jbc.M112.351791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511778	Green Published, hybrid			2022-12-28	WOS:000306411900013
J	Liu, XD; Ko, S; Xu, Y; Fattah, EA; Xiang, Q; Jagannath, C; Ishii, T; Komatsu, M; Eissa, NT				Liu, Xian-De; Ko, Soyoung; Xu, Yi; Fattah, Elmoataz Abdel; Xiang, Qian; Jagannath, Chinnaswamy; Ishii, Tetsuro; Komatsu, Masaaki; Eissa, N. Tony			Transient Aggregation of Ubiquitinated Proteins Is a Cytosolic Unfolded Protein Response to Inflammation and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; AUTOPHAGY-DEFICIENT MICE; QUALITY-CONTROL; P62; DEGRADATION; MACROPHAGES; P62/SQSTM1; ACTIVATION; CELLS; COMPARTMENTS	Failure to maintain protein homeostasis (proteostasis) leads to accumulation of unfolded proteins and contributes to the pathogenesis of many human diseases. Accumulation of unfolded proteins in the endoplasmic reticulum (ER) elicits unfolded protein response (UPR) that serves to attenuate protein translation, and increase protein refolding or degradation. In contrast to UPR in the ER, the regulatory molecules operative in cytosolic responses and their potential relation to ER stress are not well elucidated. Aggresome-like induced structures (ALIS) have been described as transient aggregation of ubiquitinated proteins in the cytosol. In this study, we show that cells respond to inflammation, infection or ER stress by cytosolic formation of ALIS, indicating that ALIS formation represents an early event in cellular adjustment to altered proteostasis that occurs under these conditions. This response was aided by rapid transcriptional up-regulation of polyubiqutin-binding protein p62. NF-kappa B and mTOR activation were also required for ALIS formation. Importantly, we show a cross talk between UPR in the ER and cytosolic ALIS. Down-regulation of ER UPR in XBP1 deficient cells increases cyotosolic ALIS formation. Furthermore, lysosomal activity but not macroautophagy is responsible for ALIS clearance. This study reveals the underlying regulatory mechanisms of ALIS formation and clearance, and provides a previously unrecognized common adaptive mechanism for cellular responses against inflammation and ER stress.	[Liu, Xian-De; Ko, Soyoung; Xu, Yi; Fattah, Elmoataz Abdel; Xiang, Qian; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Jagannath, Chinnaswamy] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Ishii, Tetsuro] Univ Tsukuba, Tsukuba, Ibaraki 3058575, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Tokyo 156850, Japan	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Eissa, NT (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM 285 Suite 535E, Houston, TX 77030 USA.	teissa@bcm.edu	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Liu, xiande/0000-0002-9639-0458	NHLBI; NIAID; National Institutes of Health; American Heart Association	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by NHLBI and NIAID, National Institutes of Health and the American Heart Association.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Conn CS, 2011, CELL CYCLE, V10, P1940, DOI 10.4161/cc.10.12.15858; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okazaki M, 1999, GENOMICS, V60, P87, DOI 10.1006/geno.1999.5902; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	48	70	72	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19687	19698		10.1074/jbc.M112.350934	http://dx.doi.org/10.1074/jbc.M112.350934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518844	Green Published, hybrid			2022-12-28	WOS:000306411900079
J	Mizumoto, S; Takahashi, J; Sugahara, K				Mizumoto, Shuji; Takahashi, Jun; Sugahara, Kazuyuki			Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; GROWTH-FACTOR BINDING; EMBRYONIC PIG BRAIN; CHONDROITIN-SULFATE; HEPARAN-SULFATE; CARCINOMA-CELLS; GEL DIGESTION; HYBRID CHAINS; P-SELECTIN; CANCER	Altered expression of chondroitin sulfate (CS) and heparan sulfate (HS) at the surfaces of tumor cells plays a key role in malignant transformation and tumor metastasis. Previously we demonstrated that a Lewis lung carcinoma (LLC)-derived tumor cell line with high metastatic potential had a higher proportion of E-disaccharide units, GlcUA-GalNAc(4,6-O-disulfate), in CS chains than low metastatic LLC cells and that such CS chains are involved in the metastatic process. The metastasis was markedly inhibited by the pre-administration of CS-E from squid cartilage rich in E units or by preincubation with a phage display antibody specific for CS-E. However, the molecular mechanism of the inhibition remains to be investigated. In this study the receptor molecule for CS chains containing E-disaccharides expressed on LLC cells was revealed to be receptor for advanced glycation end products (RAGE), which is a member of the immunoglobulin superfamily predominantly expressed in the lung. Interestingly, RAGE bound strongly to not only E-disaccharide, but also HS-expressing LLC cells. Furthermore, the colonization of the lungs by LLC cells was effectively inhibited by the blocking of CS or HS chains at the tumor cell surface with an anti-RAGE antibody through intravenous injections in a dose-dependent manner. These results provide the clear evidence that RAGE is at least one of the critical receptors for CS and HS chains expressed at the tumor cell surface and involved in experimental lung metastasis and that CS/HS and RAGE are potential molecular targets in the treatment of pulmonary metastasis.	[Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan	Hokkaido University	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, West 11,North 21, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [23390016, 23790066]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (B) 23390016 (to K. S.), Future Drug Discovery and Medical Care Innovation Program (to K. S.) and Young Scientists (B) 23790066 (to S. M.) from The Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT).	BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; FUNAHASHI M, 1982, ANAL BIOCHEM, V126, P414, DOI 10.1016/0003-2697(82)90537-1; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KLOMPMAKERS AA, 1986, ANAL BIOCHEM, V153, P80, DOI 10.1016/0003-2697(86)90064-3; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Xu D, 2011, J BIOL CHEM, V286, P41736, DOI 10.1074/jbc.M111.299685; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	49	73	76	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18985	18994		10.1074/jbc.M111.313437	http://dx.doi.org/10.1074/jbc.M111.313437			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493510	Green Published, hybrid			2022-12-28	WOS:000306411900010
J	Qu, XP; Zhuang, GL; Yu, LL; Meng, G; Ferrara, N				Qu, Xueping; Zhuang, Guanglei; Yu, Lanlan; Meng, Gloria; Ferrara, Napoleone			Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b(+)Gr1(+) Cells KEY ROLE OF Stat3 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; DEPENDENT TUMOR ANGIOGENESIS; PROTEIN-COUPLED RECEPTORS; PROGENITOR CELLS; MYELOID CELLS; CANCER; IDENTIFICATION; INFLAMMATION; MOBILIZATION; ACTIVATION	Bv8, also known as prokineticin 2, has been characterized as an important mediator of myeloid cell mobilization and myeloid cell-dependent tumor angiogenesis. Bv8 expression is dramatically enhanced by G-CSF, both in vitro and in vivo. The mechanisms involved in such up-regulation remain unknown. Using pharmacological inhibitors that interfere with multiple signaling pathways known to be activated by G-CSF, we show that signal transducer and activator of transcription 3 (Stat3) activation is required for Bv8 up-regulation in mouse bone marrow cells, whereas other Stat family members and extracellular signal-regulated kinase (ERK) activation are not involved. We further identified CD11b(+) Gr1(+) myeloid cells as the primary cell population in which Stat3 signaling is activated by G-CSF. Bv8 expression induced by G-CSF was also significantly reduced by siRNA-mediated Stat3 knockdown. Moreover, chromatin immunoprecipitation studies indicate that G-CSF significantly induces binding of phospho-Stat3 to the Bv8 promoter, which was abolished by pretreatment with the Stat3 inhibitor WP1066. Luciferase assay confirmed that the phospho-Stat3 binding site is a functional enhancer of the Bv8 promoter. The key role of Stat3 signaling in regulating G-CSF-induced Bv8 expression was further confirmed by in vivo studies. We show that the regulation of Bv8 expression in human bone marrow cells is also Stat3 signaling-dependent. Stat3 is recognized as a key regulator of inflammation-dependent tumorigenesis. We propose that such a role of Stat3 reflects at least in part its ability to regulate Bv8 expression.	[Qu, Xueping; Zhuang, Guanglei; Yu, Lanlan; Meng, Gloria; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	nf@gene.com	Zhuang, Guanglei/K-6097-2013	Zhuang, Guanglei/0000-0001-8141-5096				Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Belvin M., 2011, U. S. Patent, Patent No. [20,110,086,837, 20110086837]; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Johnston S., 2007, AACR NCI EORTC S MOL; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TIAN SS, 1994, BLOOD, V84, P1760; Voloshin T, 2011, BLOOD, V118, P3426, DOI 10.1182/blood-2010-11-320812; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong CL, 2009, CLIN CANCER RES, V15, P2675, DOI 10.1158/1078-0432.CCR-08-1954	50	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19574	19584		10.1074/jbc.M111.326801	http://dx.doi.org/10.1074/jbc.M111.326801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22528488	hybrid, Green Published			2022-12-28	WOS:000306411900069
J	Saxena, A; Banasavadi-Siddegowda, YK; Fan, YF; Bhattacharya, S; Roy, G; Giovannucci, DR; Frizzell, RA; Wang, XD				Saxena, Anita; Banasavadi-Siddegowda, Yeshavanth K.; Fan, Yifei; Bhattacharya, Sumit; Roy, Gargi; Giovannucci, David R.; Frizzell, Raymond A.; Wang, Xiaodong			Human Heat Shock Protein 105/110 kDa (Hsp105/110) Regulates Biogenesis and Quality Control of Misfolded Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; DELTA-F508 CFTR TRAFFICKING; CHLORIDE CHANNEL ACTIVITY; ENDOPLASMIC-RETICULUM; EPITHELIAL-CELLS; INTRACELLULAR-TRANSPORT; CO-CHAPERONE; CONFORMATIONAL MATURATION; PROTEASOMAL DEGRADATION; HSP90 COCHAPERONE	Heat shock protein 105/110-kDa (Hsp105/110), a member of the Hsp70 super family of molecular chaperones, serves as a nucleotide exchange factor for Hsc70, independently prevents the aggregation of misfolded proteins, and functionally relates to Hsp90. We investigated the roles of human Hsp105 alpha, the constitutively expressed isoform, in the biogenesis and quality control of the cystic fibrosis transmembrane conductance regulator (CFTR). In the endoplasmic reticulum (ER), Hsp105 facilitates CFTR quality control at an early stage in its biosynthesis but promotes CFTR post-translational folding. Deletion of Phe-508 (Delta F508), the most prevalent mutation causing cystic fibrosis, interferes with de novo folding of CFTR, impairing its export from the ER and accelerating its clearance in the ER and post-Golgi compartments. We show that Hsp105 preferentially associates with and stabilizes Delta F508 CFTR at both levels. Introduction of the Hsp105 substrate binding domain potently increases the steady state level of Delta F508 CFTR by reducing its early-stage degradation. This in turn dramatically enhances Delta F508 CFTR cell surface functional expression in cystic fibrosis airway epithelial cells. Although other Hsc70 nucleotide exchange factors such as HspBP1 and BAG-2 inhibit CFTR post-translational degradation in the ER through cochaperone CHIP, Hsp105 has a primary role promoting CFTR quality control at an earlier stage. The Hsp105-mediated multilevel regulation of Delta F508 CFTR folding and quality control provides new opportunities to understand how chaperone machinery regulates the homeostasis and functional expression of misfolded proteins in the cell. Future studies in this direction will inform therapeutics development for cystic fibrosis and other protein misfolding diseases.	[Saxena, Anita; Banasavadi-Siddegowda, Yeshavanth K.; Fan, Yifei; Roy, Gargi; Wang, Xiaodong] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, XD (corresponding author), 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	xiaodong.wang@utoledo.edu	Giovannucci, David R/A-5657-2018	/0000-0002-4730-6918	Cystic Fibrosis Foundation; University of Toledo Health Science Campus; National Institutes of Health [DE14756, DK68196]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Toledo Health Science Campus; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was primarily supported by the Cystic Fibrosis Foundation and the University of Toledo Health Science Campus (both to X. W.). This work was also supported in part by National Institutes of Health Grants DE14756 (to D. R. G.) and DK68196 (to R. A. F.).	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Clain J, 2005, HUM MUTAT, V25, P360, DOI 10.1002/humu.20156; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Henderson MJ, 2010, J BIOL CHEM, V285, P11314, DOI 10.1074/jbc.M109.044057; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 1999, J CELL SCI, V112, P2091; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; SCHMID SL, 1985, J BIOL CHEM, V260, P10050; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Yamagishi N, 2010, EXP CELL RES, V316, P2424, DOI 10.1016/j.yexcr.2010.06.003; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	80	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19158	19170		10.1074/jbc.M111.297580	http://dx.doi.org/10.1074/jbc.M111.297580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505710	hybrid, Green Published			2022-12-28	WOS:000306411900026
J	Chen, YJ; Hsieh, MY; Chang, MY; Chen, HC; Jan, MS; Maa, MC; Leu, TH				Chen, Yen-Jen; Hsieh, Ming-Yu; Chang, Miao Ying; Chen, Hui-Chen; Jan, Ming-Shiou; Maa, Ming-Chei; Leu, Tzeng-Horng			Eps8 Protein Facilitates Phagocytosis by Increasing TLR4-MyD88 Protein Interaction in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SRC-MEDIATED TRANSFORMATION; FOCAL ADHESION KINASE; NITRIC-OXIDE; C-SRC; ACTIVATION; EXPRESSION; RAC; INVOLVEMENT; IMMUNITY	Toll-like receptors (TLRs) are crucial in macrophage phagocytosis, which is pivotal in host innate immune response. However, the detailed mechanism is not fully defined. Here, we demonstrated that the induction of Src and Eps8 in LPS-treated macrophages was TLR4- and MyD88-dependent, and their attenuation reduced LPS-promoted phagocytosis. Confocal microscopy indicated the colocalization of Eps8 and TLR4 in the cytosol and at the phagosome. Consistently, both Eps8 and TLR4 were present in the same immunocomplex regard-less of LPS stimulation. Inhibition of this complex formation by eps8 siRNA or overexpression of pleckstrin homology domain-truncated Eps8 (i.e. 261-p97(Eps8)) decreased LPS-induced TLR4-MyD88 interaction and the following activation of Src, focal adhesion kinase, and p38 MAPK. Importantly, attenuation of Eps8 impaired the bacterium-killing ability of macrophages. Thus, Eps8 is a key regulator of the LPS-stimulated TLR4-MyD88 interaction and contributes to macrophage phagocytosis.	[Chen, Hui-Chen; Maa, Ming-Chei] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan; [Chen, Yen-Jen; Hsieh, Ming-Yu; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chen, Yen-Jen; Hsieh, Ming-Yu; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Leu, Tzeng-Horng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Miao Ying] China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan; [Maa, Ming-Chei] China Med Univ, Inst Mol Syst Biomed, Taichung 40402, Taiwan; [Jan, Ming-Shiou] Chung Shan Med Univ, Coll Med, Inst Microbiol & Immunol, Taichung 40201, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University	Maa, MC (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw	Chen, Hui-Chen/L-8149-2013	Chen, Hui-Chen/0000-0001-9751-5729	National Health Research Institute [NHRI-EX101-10131BI]; National Science Council [NSC100-2325-B-006-011, NSC98-2311-B-039-002-MY3]; Comprehensive Cancer Center in Southern Taiwan [DOH100-TD-C-111-003]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; China Medical University [CMU97-193]; National Research Program for Genomic Medicine, National Science Council [NSC94-3112-B-001-003, NSC94-3112-B-001-018-Y]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Comprehensive Cancer Center in Southern Taiwan; Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University(China Medical University); National Research Program for Genomic Medicine, National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by National Health Research Institute Grant NHRI-EX101-10131BI (to T.-H. L.); National Science Council Grants NSC100-2325-B-006-011 (to T.-H. L.) and NSC98-2311-B-039-002-MY3 (to M.-C. M.); Comprehensive Cancer Center in Southern Taiwan Grant DOH100-TD-C-111-003 (to T.-H. L.), Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH101-TD-B-111-004 (to M.-C. M.), and China Medical University Grant CMU97-193 (to M.-C. M.).; We thank Dr. C. H. A. Cheung for critical comments on the manuscript. The lentivirus encoding luciferase siRNA or eps8 siRNA-503 and the DNA constructs of pLKO.1-shLuc, pLKO.1-meps8-503, pLKO.1-meps8-1847, pLKO.1-mfak-1, pLKO.1-mfak-2, pLKO.1-mmyd88-1, and pLKO.1-mmyd88-2 were provided by the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by National Research Program for Genomic Medicine, National Science Council Grants NSC94-3112-B-001-003 and NSC94-3112-B-001-018-Y.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Cote-Velez MJA, 2001, IMMUNOL LETT, V78, P189, DOI 10.1016/S0165-2478(01)00251-6; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2001, ONCOGENE, V20, P106, DOI 10.1038/sj.onc.1204069; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Metheniti A, 2001, FEBS LETT, V496, P55, DOI 10.1016/S0014-5793(01)02405-X; Owen KA, 2007, CELL MICROBIOL, V9, P596, DOI 10.1111/j.1462-5822.2006.00811.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125	49	35	36	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18806	18819		10.1074/jbc.M112.340935	http://dx.doi.org/10.1074/jbc.M112.340935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493489	hybrid, Green Published			2022-12-28	WOS:000306411600089
J	El Fakhry, Y; Alturaihi, H; Yacoub, D; Liu, LH; Guo, WY; Leveille, C; Jung, D; Khzam, LB; Merhi, Y; Wilkins, JA; Li, HM; Mourad, W				El Fakhry, Youssef; Alturaihi, Haydar; Yacoub, Daniel; Liu, Lihui; Guo, Wenyan; Leveille, Claire; Jung, Daniel; Khzam, Lara Bou; Merhi, Yahye; Wilkins, John A.; Li, Hongmin; Mourad, Walid			Functional Interaction of CD154 Protein with alpha 5 beta 1 Integrin Is Totally Independent from Its Binding to alpha IIb beta 3 Integrin and CD40 Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET P-SELECTIN; CLASS-II; COSTIMULATORY MOLECULES; CELL-SURFACE; T-CELLS; LIGAND; INDUCTION; PATHWAY; DISEASE; ACTIVATION	In addition to its classical CD40 receptor, CD154 also binds to alpha IIb beta 3, alpha 5 beta 1, and alpha M beta 2 integrins. Binding of CD154 to these receptors seems to play a key role in the pathogenic processes of chronic inflammation. This investigation was aimed at analyzing the functional interaction of CD154 with CD40, alpha IIb beta 3, and alpha 5 beta 1 receptors. We found that the binding affinity of CD154 for alpha IIb beta 3 is similar to 4-fold higher than for alpha 5 beta 1. We also describe the generation of sCD154 mutants that lost their ability to bind CD40 or alpha IIb beta 3 and show that CD154 residues involved in its binding to CD40 or alpha IIb beta 3 are distinct from those implicated in its interaction to alpha 5 beta 1, suggesting that sCD154 may bind simultaneously to different receptors. Indeed, sCD154 can bind simultaneously to CD40 and alpha 5 beta 1 and biologically activate human monocytic U937 cells expressing both receptors. The simultaneous engagement of CD40 and alpha 5 beta 1 activates the mitogen-activated protein kinases, p38, and extracellular signal-related kinases 1/2 and synergizes in the release of inflammatory mediators MMP-2 and -9, suggesting a cross-talk between these receptors.	[El Fakhry, Youssef; Alturaihi, Haydar; Yacoub, Daniel; Guo, Wenyan; Leveille, Claire; Mourad, Walid] Ctr Hosp Univ Montreal, Hop St Luc, Ctr Rech, Montreal, PQ H2X 1P1, Canada; [Liu, Lihui; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Jung, Daniel] Hema Quebec, Ste Foy, PQ G1V 4M3, Canada; [Khzam, Lara Bou; Merhi, Yahye] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wilkins, John A.] Univ Manitoba, Winnipeg, MB R3E 3P4, Canada; [Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	Universite de Montreal; State University of New York (SUNY) System; Wadsworth Center; Hema-Quebec; Universite de Montreal; University of Manitoba; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mourad, W (corresponding author), Ctr Hosp Univ Montreal, Hop St Luc, Ctr Rech, Pavillon Edward Asselin,264 Rene Levesque Est,Rm, Montreal, PQ H2X 1P1, Canada.	mw.mourad@umontreal.ca	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Mourad, Walid/0000-0002-1859-9387	Canadian Institutes of Health Research; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported by the Canadian Institutes of Health Research and the Canadian Arthritis Network.	Abou-Saleh H, 2005, THROMB HAEMOSTASIS, V94, P1230, DOI 10.1160/TH05-05-0344; Alegre ML, 2006, CURR PHARM DESIGN, V12, P149, DOI 10.2174/138161206775193046; An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Bajorath J, 1998, J BIOL CHEM, V273, P24603, DOI 10.1074/jbc.273.38.24603; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P9884, DOI 10.1021/bi00031a009; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Danese S, 2005, CRIT REV IMMUNOL, V25, P103; Grabellus F, 2007, PATHOL RES PRACT, V203, P135, DOI 10.1016/j.prp.2007.01.001; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Hou X, 2009, GRAEF ARCH CLIN EXP, V247, P1477, DOI 10.1007/s00417-009-1135-1; Howard LM, 2004, AUTOIMMUNITY, V37, P411, DOI 10.1080/08916930410001716095; Hsu YM, 1997, J BIOL CHEM, V272, P911, DOI 10.1074/jbc.272.2.911; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khandekar SS, 2001, PROTEIN EXPRES PURIF, V23, P301, DOI 10.1006/prep.2001.1501; Krokhin OV, 2003, BIOCHEMISTRY-US, V42, P12950, DOI 10.1021/bi034726u; Lazetic S, 2002, J BIOL CHEM, V277, P38660, DOI 10.1074/jbc.M205808200; Leveille C, 1999, EUR J IMMUNOL, V29, P3516, DOI 10.1002/(SICI)1521-4141(199911)29:11<3516::AID-IMMU3516>3.3.CO;2-4; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Li HM, 2007, J BIOL CHEM, V282, P5991, DOI 10.1074/jbc.M608482200; Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322; Masuta Y, 2007, J IMMUNOTHER, V30, P694, DOI 10.1097/CJI.0b013e31811a5c51; Matthies KMG, 2006, CELL IMMUNOL, V241, P47, DOI 10.1016/j.cellimm.2006.08.001; Mehlhop PD, 2000, AM J RESP CELL MOL, V23, P646, DOI 10.1165/ajrcmb.23.5.3954; Menchen L, 2009, GUT, V58, P920, DOI 10.1136/gut.2008.150318; Moreaux J, 2009, EUR J HAEMATOL, V83, P119, DOI 10.1111/j.1600-0609.2009.01262.x; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; Noelle RJ, 1997, ANN NY ACAD SCI, V815, P384, DOI 10.1111/j.1749-6632.1997.tb52089.x; Park JE, 2009, ONCOL REP, V22, P1373, DOI 10.3892/or_00000577; Ribbens C, 2000, IMMUNOLOGY, V99, P279, DOI 10.1046/j.1365-2567.2000.00948.x; Robert P, 2009, BIOPHYS J, V96, P4642, DOI 10.1016/j.bpj.2009.03.020; Sandilands GP, 2006, IMMUNOLOGY, V119, P562, DOI 10.1111/j.1365-2567.2006.02471.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Sotiriou SN, 2006, FASEB J, V20, P559, DOI 10.1096/fj.05-4857fje; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; vanKooten C, 1997, INT ARCH ALLERGY IMM, V113, P393, DOI 10.1159/000237614; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	45	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18055	18066		10.1074/jbc.M111.333989	http://dx.doi.org/10.1074/jbc.M111.333989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22461623	Green Published, hybrid			2022-12-28	WOS:000306411600015
J	Lauffer, S; Mabert, K; Czupalla, C; Pursche, T; Hoflack, B; Rodel, G; Krause-Buchholz, U				Lauffer, Susann; Maebert, Katrin; Czupalla, Cornelia; Pursche, Theresia; Hoflack, Bernard; Roedel, Gerhard; Krause-Buchholz, Udo			Saccharomyces cerevisiae Porin Pore Forms Complexes with Mitochondrial Outer Membrane Proteins Om14p and Om45p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; BLUE NATIVE ELECTROPHORESIS; CYTOCHROME-C PEROXIDASE; BENZODIAZEPINE-RECEPTOR; YEAST MITOCHONDRIA; PROTEOMIC ANALYSIS; OLIGOMERIC STATES; CARRIER PROTEIN; INNER MEMBRANE; IN-VITRO	Numerous transport processes occur between the two mitochondrial (mt) membranes due to the diverse functions and metabolic processes of the mt organelle. The metabolite and ion transport through the mt outer membrane (OM) is widely assumed to be mediated by the porin pore, whereas in the mt inner membrane (IM) specific carriers are responsible for transport processes. Here, we provide evidence by means of Blue Native (BN)-PAGE analysis, co-immunoprecipitation, and tandem affinity purification that the two mt OM proteins Om14p and Om45p associate with the porin pore. Porin molecules seem to assemble independently to build the core unit. A subpopulation of these core units interacts with Om14p and Om45p. With preparative tandem affinity purification followed by MS analysis, we could identify interaction partners of this OM complex, which are mainly localized within the mt IM and function as carriers for diverse molecules. We propose a model for the role of the two OM proteins in addressing the porin pore to bind to specific channels in the mt IM to facilitate transport of metabolites.	[Lauffer, Susann; Maebert, Katrin; Roedel, Gerhard; Krause-Buchholz, Udo] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Czupalla, Cornelia; Pursche, Theresia; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Lauffer, S (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	Susann.Lauffer@tu-dresden.de	Krause, Udo/N-8167-2014; Roedel, Gerhard/AAH-3762-2022; Roedel, Gerhard/AFQ-8997-2022; HOFLACK, Bernard/AAZ-6668-2020	Krause, Udo/0000-0001-9493-4522; 				Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; BRAUN HP, 1995, TRENDS BIOCHEM SCI, V20, P171, DOI 10.1016/S0968-0004(00)88999-9; Burri L, 2006, FEBS J, V273, P1507, DOI 10.1111/j.1742-4658.2006.05171.x; Cardona F, 2011, ARCH MICROBIOL, V193, P515, DOI 10.1007/s00203-011-0696-7; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; COOPER CE, 1991, BIOCHEM CELL BIOL, V69, P586, DOI 10.1139/o91-089; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Czupalla C, 2003, RAPID COMMUN MASS SP, V17, P690, DOI 10.1002/rcm.967; DAUM G, 1982, J BIOL CHEM, V257, P3028; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Gavish M, 1999, PHARMACOL REV, V51, P629; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krause-Buchholz U, 2005, BIOL CHEM, V386, P407, DOI 10.1515/BC.2005.049; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; OHBA M, 1987, EMBO J, V6, P2109, DOI 10.1002/j.1460-2075.1987.tb02477.x; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Ostuni MA, 2009, BIOL CELL, V101, P573, DOI 10.1042/BC20080231; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PENG SZ, 1992, J BIOENERG BIOMEMBR, V24, P27, DOI 10.1007/BF00769527; Przybyla-Zawislak B, 1998, EUR J BIOCHEM, V258, P736, DOI 10.1046/j.1432-1327.1998.2580736.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2000, P NATL ACAD SCI USA, V97, P7819, DOI 10.1073/pnas.140115397; Ryan MT, 2000, INT J BIOCHEM CELL B, V32, P13, DOI 10.1016/S1357-2725(99)00114-4; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Vanhee C, 2011, J EXP BOT, V62, P497, DOI 10.1093/jxb/erq283; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YAFFE MP, 1989, J BIOL CHEM, V264, P21091; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zara V, 1996, MOL CELL BIOL, V16, P6524; Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200	83	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17447	17458		10.1074/jbc.M111.328328	http://dx.doi.org/10.1074/jbc.M111.328328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461620	Green Published, hybrid			2022-12-28	WOS:000306373000045
J	Monet, M; Francoeur, N; Boulay, G				Monet, Michael; Francoeur, Nancy; Boulay, Guylain			Involvement of Phosphoinositide 3-Kinase and PTEN Protein in Mechanism of Activation of TRPC6 Protein in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PLASMA-MEMBRANE; CALCIUM-ENTRY; INTRACELLULAR TRAFFICKING; CHANNEL ACTIVATION; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CA2+ ENTRY; RECEPTOR; PATHWAY	TRPC6 is a cation channel in the plasma membrane that plays a role in Ca2+ entry after the stimulation of a G(q)-protein-coupled or tyrosine-kinase receptor. TRPC6 translocates to the plasma membrane upon stimulation and remains there as long as the stimulus is present. However, the mechanism that regulates the trafficking and activation of TRPC6 are unclear. In this study we showed phosphoinositide 3-kinase and its antagonistic phosphatase, PTEN, are involved in the activation of TRPC6. The inhibition of PI3K by PIK-93, LY294002, or wortmannin decreased carbachol-induced translocation of TRPC6 to the plasma membrane and carbachol-induced net Ca2+ entry into T6.11 cells. Conversely, a reduction of PTEN expression did not affect carbachol-induced externalization of TRPC6 but increased Ca2+ entry through TRPC6 in T6.11 cells. We also showed that the PI3K/PTEN pathway regulates vasopressin-induced translocation of TRPC6 to the plasma membrane and vasopressin-induced Ca2+ entry into A7r5 cells, which endogenously express TRPC6. In summary, we provided evidence that the PI3K/PTEN pathway plays an important role in the translocation of TRPC6 to the plasma membrane and may thus have a significant impact on Ca2+ signaling in cells that endogenously express TRPC6.	[Monet, Michael; Francoeur, Nancy; Boulay, Guylain] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boulay, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001-12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart and Stroke Foundation; Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke; Institut de Pharmacologie de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart and Stroke Foundation; Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke; Institut de Pharmacologie de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart and Stroke Foundation.; Recipient of a fellowship from the Centre de Recherche en Pharmacologie Structurale de l'Universite de Sherbrooke and the Institut de Pharmacologie de Sherbrooke.; Recipient of a scholarship from the Fonds de Recherche en Sante du Quebec.	Albert AP, 2008, J PHYSIOL-LONDON, V586, P3087, DOI 10.1113/jphysiol.2008.153676; Andrews S., 2007, SCI STKE 2007; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1986, J EXP BIOL, V124, P323; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cayouette S, 2010, BBA-MOL CELL RES, V1803, P805, DOI 10.1016/j.bbamcr.2010.03.010; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gradilone SA, 2005, BIOL CELL, V97, P831, DOI 10.1042/BC20040115; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kawanabe Y, 2003, AM J PHYSIOL-CELL PH, V284, pC506, DOI 10.1152/ajpcell.00384.2002; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu DY, 2008, ARTERIOSCL THROM VAS, V28, P746, DOI 10.1161/ATVBAHA.108.162222; MacDonald PE, 2009, ISLETS, V1, P266, DOI 10.4161/isl.1.3.9678; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	66	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17672	17681		10.1074/jbc.M112.341354	http://dx.doi.org/10.1074/jbc.M112.341354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493444	Green Published, hybrid			2022-12-28	WOS:000306373000066
J	Yamashita, S; Miyaki, S; Kato, Y; Yokoyama, S; Sato, T; Barrionuevo, F; Akiyama, H; Scherer, G; Takada, S; Asahara, H				Yamashita, Satoshi; Miyaki, Shigeru; Kato, Yoshio; Yokoyama, Shigetoshi; Sato, Tempei; Barrionuevo, Francisco; Akiyama, Haruhiko; Scherer, Gerd; Takada, Shuji; Asahara, Hiroshi			L-Sox5 and Sox6 Proteins Enhance Chondrogenic miR-140 MicroRNA Expression by Strengthening Dimeric Sox9 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; GENE-EXPRESSION; CARTILAGE FORMATION; RETINOIC ACID; COLLAGEN GENE; AGGRECAN GENE; IN-VIVO; TRANSCRIPTION; DIFFERENTIATION; MOUSE	Sox9 plays a critical role in early chondrocyte initiation and promotion as well as repression of later maturation. Fellow Sox family members L-Sox5 and Sox6 also function as regulators of cartilage development by boosting Sox9 activation of chondrocyte-specific genes such as Col2a1 and Agc1; however, the regulatory mechanism and other target genes are largely unknown. MicroRNAs are a class of short, non-coding RNAs that act as negative regulators of gene expression by promoting target mRNA degradation and/or repressing translation. Analysis of genetically modified mice identified miR-140 as a cartilage-specific microRNA that could be a critical regulator of cartilage development and homeostasis. Recent findings suggest Sox9 promotes miR-140 expression, although the detailed mechanisms are not fully understood. In this study we demonstrate that the proximal upstream region of pri-miR-140 has chondrogenic promoter activity in vivo. We found an L-Sox5/Sox6/Sox9 (Sox trio) response element and detailed binding site in the promoter region. Furthermore, detailed analysis suggests the DNA binding and/or transactivation ability of Sox9 as a homodimer is boosted by L-Sox5 and Sox6. These findings provide new insight into cartilage-specific gene regulation by the Sox trio.	[Yamashita, Satoshi; Yokoyama, Shigetoshi; Sato, Tempei; Takada, Shuji; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Setagaya Ku, Tokyo 1578535, Japan; [Miyaki, Shigeru; Asahara, Hiroshi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Sato, Tempei; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst Biomed, Bunkyo Ku, Tokyo 1138510, Japan; [Barrionuevo, Francisco] Univ Granada, Dept Genet, Ctr Biomed Res, Lab 127, ES-18100 Granada, Spain; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthoped, Kyoto 6068507, Japan; [Scherer, Gerd] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Asahara, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	National Center for Child Health & Development - Japan; Scripps Research Institute; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Medical & Dental University (TMDU); University of Granada; Kyoto University; University of Freiburg; Japan Science & Technology Agency (JST)	Asahara, H (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	asahara@scripps.edu	Kato, Yoshio/M-1093-2018; yokoyama, shigetoshi/S-5912-2016; Miyaki, Shigeru/E-4293-2013; Barrionuevo, Francisco/AAA-7639-2019	Kato, Yoshio/0000-0001-8584-367X; yokoyama, shigetoshi/0000-0003-4175-0548; Miyaki, Shigeru/0000-0002-1602-5777; Barrionuevo, Francisco/0000-0003-2651-1530; Takada, Shuji/0000-0002-9406-4683; Sato, Tempei/0000-0002-8966-3374	National Institutes of Health [AR050631, AR056120]; Health and Labor Sciences research grants; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR050631, R21AR056120, R01AR050631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labor Sciences research grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050631 and AR056120. This work was also supported by Health and Labor Sciences research grants, grants-in-aid for Scientific Research (Ministry of Education, Culture, Sports, Science, and Technology of Japan), and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (to G. S.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 2003, NUCLEIC ACIDS RES, V31, P1541, DOI 10.1093/nar/gkg230; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Coustry F, 2010, NUCLEIC ACIDS RES, V38, P6018, DOI 10.1093/nar/gkq417; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Haag J, 2008, PATHOBIOLOGY, V75, P195, DOI 10.1159/000124980; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nakamura Y., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P321; Nakamura Y, 2012, APPL BIOCHEM BIOTECH, V166, P64, DOI 10.1007/s12010-011-9404-y; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	41	59	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22206	22215		10.1074/jbc.M112.343194	http://dx.doi.org/10.1074/jbc.M112.343194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547066	hybrid, Green Published			2022-12-28	WOS:000306418600059
J	Christian, WV; Li, N; Hinkle, PM; Ballatori, N				Christian, Whitney V.; Li, Na; Hinkle, Patricia M.; Ballatori, Nazzareno			beta-Subunit of the Ost alpha-Ost beta Organic Solute Transporter Is Required Not Only for Heterodimerization and Trafficking but Also for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; BASOLATERAL BILE-ACID; MEMBRANE-PROTEINS; LIVING CELLS; TRANSMEMBRANE HELICES; ENDOPLASMIC-RETICULUM; STEROID TRANSPORTER; MAMMALIAN-CELLS; POLAR RESIDUES; CHO-CELLS	The organic solute transporter, Ost/Slc51, is composed of two distinct proteins that must heterodimerize to generate transport activity, but the role of the individual subunits in mediating transport activity is unknown. The present study identified regions in Ost beta required for heterodimerization with Ost alpha, trafficking of the Ost alpha-Ost beta complex to the plasma membrane, and bile acid transport activity in HEK293 cells. Bimolecular fluorescence complementation analysis revealed that a 25-amino acid peptide containing the Ost beta transmembrane (TM) domain heterodimerized with Ost alpha, although the resulting complex failed to reach the plasma membrane and generate cellular [H-3]taurocholate transport activity. Deletion of the single TM domain of Ost beta abolished interaction with Ost alpha, demonstrating that the TM segment is necessary and sufficient for formation of a heteromeric complex with Ost alpha. Mutation of the highly conserved tryptophan-asparagine sequence within the TM domain of Ost beta to alanines did not prevent cell surface trafficking, but abolished transport activity. Removal of the N-terminal 27 amino acids of Ost beta resulted in a transporter complex that reached the plasma membrane and exhibited transport activity at 30 degrees C. Complete deletion of the C terminus of Ost beta abolished [H-3]taurocholate transport activity, but reinsertion of two native arginines immediately C-terminal to the TM domain rescued this defect. These positively charged residues establish the correct N-exo/C-cyt topology of the peptide, in accordance with the positive inside rule. Together, the results demonstrate that Ost beta is required for both proper trafficking of Ost alpha and formation of the functional transport unit, and identify specific residues of Ost beta critical for these processes.	[Hinkle, Patricia M.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Christian, Whitney V.; Li, Na; Ballatori, Nazzareno] Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Box 711, Rochester, NY 14642 USA.	patricia_hinkle@urmc.rochester.edu			National Institute of Health [DK067214, DK48823, DK19974]; NIEHS/National Institutes of Health [ES07026, ES03828, ES01247]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048823, R01DK067214, R01DK019974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003828, P50ES003828, R01ES007026, T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institute of Health Grants DK067214, DK48823, and DK19974 and NIEHS/National Institutes of Health Training Grant ES07026 and Center Grants ES03828 and ES01247. This work has been partially published in abstract form (Christian, W. V., Li, N., and Ballatori, N. (2011) FASEB J. 25, 554.1).	Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; Ballatori N, 2011, DIGEST DIS, V29, P13, DOI 10.1159/000324123; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; CASTELLINO RC, 1995, AM J PHYSIOL-HEART C, V269, pH385, DOI 10.1152/ajpheart.1995.269.1.H385; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cooray SN, 2009, MOL CELL ENDOCRINOL, V300, P17, DOI 10.1016/j.mce.2008.10.004; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dawson JP, 2003, J MOL BIOL, V331, P255, DOI 10.1016/S0022-2836(03)00714-9; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dolly JO, 1996, J BIOENERG BIOMEMBR, V28, P231, DOI 10.1007/BF02110698; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Galbraith DJ, 2006, BIOTECHNOL PROGR, V22, P753, DOI 10.1021/bp050339v; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Geisse S, 2009, METHOD ENZYMOL, V463, P223, DOI 10.1016/S0076-6879(09)63015-9; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Gorokhova S, 2007, HUM MOL GENET, V16, P2394, DOI 10.1093/hmg/ddm167; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MacKinnon R, 2005, SCIENCE, V307, P1425, DOI 10.1126/science.1110525; March JC, 2003, APPL MICROBIOL BIOT, V62, P303, DOI 10.1007/s00253-003-1339-y; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Powell K, 2002, ADV DRUG DELIVER REV, V54, P1395, DOI 10.1016/S0169-409X(02)00148-5; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Sun AQ, 2007, AM J PHYSIOL-GASTR L, V292, pG1586, DOI 10.1152/ajpgi.00457.2006; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang W, 2001, P NATL ACAD SCI USA, V98, P9431, DOI 10.1073/pnas.161099898; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	52	21	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21233	21243		10.1074/jbc.M112.352245	http://dx.doi.org/10.1074/jbc.M112.352245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535958	Green Published, hybrid			2022-12-28	WOS:000306416800043
J	Pompeo, F; Freton, C; Wicker-Planquart, C; Grangeasse, C; Jault, JM; Galinier, A				Pompeo, Frederique; Freton, Celine; Wicker-Planquart, Catherine; Grangeasse, Christophe; Jault, Jean-Michel; Galinier, Anne			Phosphorylation of CpgA Protein Enhances Both Its GTPase Activity and Its Affinity for Ribosome and Is Crucial for Bacillus subtilis Growth and Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; SER/THR KINASE; IN-VITRO; SUBUNIT; PRKC; DORMANCY; BINDING; YJEQ	In Bacillus subtilis, the ribosome-associated GTPase CpgA is crucial for growth and proper morphology and was shown to be phosphorylated in vitro by the Ser/Thr protein kinase PrkC. To further understand the function of the Escherichia coli RsgA ortholog, CpgA, we first demonstrated that its GTPase activity is stimulated by its association with the 30 S ribosomal subunit. Then the role of CpgA phosphorylation was analyzed. A single phosphorylated residue, threonine 166, was identified by mass spectrometry. Phosphoablative replacement of this residue in CpgA induces a decrease of both its affinity for the 30 S ribosomal subunit and its GTPase activity, whereas a phosphomimetic replacement has opposite effects. Furthermore, cells expressing a nonphosphorylatable CpgA protein present the morphological and growth defects similar to those of a cpgA-deleted strain. Altogether, our results suggest that CpgA phosphorylation on Thr-166 could modulate its ribosome-induced GTPase activity. Given the role of PrkC in B. subtilis spore germination, we propose that CpgA phosphorylation is a key regulatory process that is essential for B. subtilis development.	[Pompeo, Frederique] Aix Marseille Univ, CNRS, IMM, Lab Chim Bacterienne,UMR7283,FR 3479, F-13402 Marseille 20, France; [Wicker-Planquart, Catherine; Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct JP Ebel, Commissariat Energie Atom, UMR 5075,CNRS, F-38027 Grenoble 1, France; [Grangeasse, Christophe] Univ Lyon 1, CNRS, Inst Biol & Chem Prot, Bases Mol & Struct Syst Infect,UMR 5086, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pompeo, F (corresponding author), Aix Marseille Univ, CNRS, IMM, Lab Chim Bacterienne,UMR7283,FR 3479, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	fpompeo@ifr88.cnrs-mrs.fr	Pompeo, Frederique/Q-5772-2017; jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; Agence Nationale de la Recherche [ANR-08-BLAN-0143]; Universities of Aix-Marseille; Grenoble; Lyon	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universities of Aix-Marseille; Grenoble(Region Auvergne-Rhone-Alpes); Lyon(Region Auvergne-Rhone-Alpes)	This work was supported by the CNRS, Agence Nationale de la Recherche "P-loop proteins" Grant ANR-08-BLAN-0143, and the Universities of Aix-Marseille, Grenoble and Lyon.	Absalon C, 2008, J BACTERIOL, V190, P3786, DOI 10.1128/JB.01994-07; Absalon C, 2009, MICROBIOL-SGM, V155, P932, DOI 10.1099/mic.0.022475-0; Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Cladiere L, 2006, MOL GENET GENOMICS, V275, P409, DOI 10.1007/s00438-006-0097-9; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Goto S, 2011, EMBO J, V30, P104, DOI 10.1038/emboj.2010.291; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; Inoue K, 2003, MOL MICROBIOL, V48, P1005, DOI 10.1046/j.1365-2958.2003.03475.x; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Levdikov VM, 2004, J MOL BIOL, V340, P767, DOI 10.1016/j.jmb.2004.05.029; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pompeo F, 2011, J MOL MICROB BIOTECH, V20, P156, DOI 10.1159/000329298; Sambrook J., 2002, MOL CLONING LAB MANU; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shin DH, 2004, P NATL ACAD SCI USA, V101, P13198, DOI 10.1073/pnas.0405202101; Squeglia F, 2011, J AM CHEM SOC, V133, P20676, DOI 10.1021/ja208080r; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	38	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20830	20838		10.1074/jbc.M112.340331	http://dx.doi.org/10.1074/jbc.M112.340331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544754	hybrid, Green Published			2022-12-28	WOS:000306416800005
J	Shan, Q; Han, L; Lynch, JW				Shan, Qiang; Han, Lu; Lynch, Joseph W.			Distinct Properties of Glycine Receptor beta+/alpha- Interface UNAMBIGUOUSLY CHARACTERIZING HETEROMERIC INTERFACE RECONSTITUTED IN HOMOMERIC PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACID(A) RECEPTOR; BENZODIAZEPINE BINDING-SITE; X-RAY-STRUCTURE; LIGAND-BINDING; CHLORIDE CHANNEL; OPEN STATE; M2 DOMAIN; SUBUNIT	The glycine receptor (GlyR) exists either in homomeric alpha or heteromeric alpha beta forms. Its agonists bind at extracellular subunit interfaces. Unlike subunit interfaces from the homomeric alpha GlyR, subunit interfaces from the heteromeric alpha beta GlyR have not been characterized unambiguously because of the existence of multiple types of interface within single receptors. Here, we report that, by reconstituting beta+/alpha- interfaces in a homomeric GlyR (alpha Chb+a- GlyR), we were able to functionally characterize the alpha beta GlyR beta+/alpha- interfaces. We found that the beta+/alpha- interface had a higher agonist sensitivity than that of the beta+/alpha- interface. This high sensitivity was contributed primarily by loop A. We also found that the beta+/alpha- interface differentially modulates the agonist properties of glycine and taurine. Using voltage clamp fluorometry, we found that the conformational changes induced by glycine binding to the beta+/alpha- interface were different from those induced by glycine binding to the beta+/alpha- interface in the alpha GlyR. Moreover, the distinct conformational changes found at the beta+/alpha- interface in the alpha Chb+a- GlyR were also found in the heteromeric alpha beta GlyR, which suggests that the alpha Chb+a- GlyR reconstitutes structural components and recapitulates functional properties, of the beta+/alpha- interface in the heteromeric alpha beta GlyR. Our investigation not only provides structural and functional information about the GlyR beta+/alpha- interface, which could direct GlyR beta+/alpha- interface-specific drug design, but also provides a general methodology for unambiguously characterizing properties of specific protein interfaces from heteromeric proteins.	[Shan, Qiang] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; [Shan, Qiang; Han, Lu; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Sydney; University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia.	qshan@yahoo.com			Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.	Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kucken AM, 2000, MOL PHARMACOL, V57, P932; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynagh T, 2011, J BIOL CHEM, V286, P43913, DOI 10.1074/jbc.M111.262634; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan Q, 2012, BRIT J PHARMACOL, V165, P2113, DOI 10.1111/j.1476-5381.2011.01701.x; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; SINE SM, 1991, J BIOL CHEM, V266, P19369; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448	41	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21244	21252		10.1074/jbc.M111.337741	http://dx.doi.org/10.1074/jbc.M111.337741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535951	Green Published, hybrid			2022-12-28	WOS:000306416800044
J	Sheng, JZ; Xu, YM; Dulaney, SB; Huang, XF; Liu, J				Sheng, Juzheng; Xu, Yongmei; Dulaney, Steven B.; Huang, Xuefei; Liu, Jian			Uncovering Biphasic Catalytic Mode of C-5-epimerase in Heparan Sulfate Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN/HEPARAN SULFATE; GLUCURONYL C5-EPIMERASE; SPECIFICITY; 2-O-SULFOTRANSFERASE; SULFOTRANSFERASES; OLIGOSACCHARIDES; ANTITHROMBIN; DERIVATIVES; EXPRESSION; CLONING	Heparan sulfate (HS), a highly sulfated polysaccharide, is biosynthesized through a pathway involving several enzymes. C-5-epimerase (C-5-epi) is a key enzyme in this pathway. C-5-epi is known for being a two-way catalytic enzyme, displaying a "reversible" catalytic mode by converting a glucuronic acid to an iduronic acid residue, and vice versa. Here, we discovered that C-5-epi can also serve as a one-way catalyst to convert a glucuronic acid to an iduronic acid residue, displaying an "irreversible" catalytic mode. Our data indicated that the reversible or irreversible catalytic mode strictly depends on the saccharide substrate structures. The biphasic mode of C-5-epi offers a novel mechanism to regulate the biosynthesis of HS with the desired biological functions.	[Dulaney, Steven B.; Huang, Xuefei] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Sheng, Juzheng; Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Michigan State University; University of North Carolina; University of North Carolina Chapel Hill	Huang, XF (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	xuefei@chemistry.msu.edu; jian_liu@unc.edu	Huang, Xuefei/G-3371-2014; Sheng, Juzheng/G-2693-2013	Huang, Xuefei/0000-0002-6468-5526; Sheng, Juzheng/0000-0003-2856-9162	National Institutes of Health [AI50050, HL094463, GM072667]; National Science Foundation [CHE-1111550]; Direct For Mathematical & Physical Scien [1111550] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI50050, HL094463, and GM072667 and National Science Foundation Grant CHE-1111550.	Babu P, 2011, ANAL BIOANAL CHEM, V401, P237, DOI 10.1007/s00216-011-5087-z; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Das SK, 2001, CHEM-EUR J, V7, P4821; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Wang Z, 2010, CHEM-EUR J, V16, P8365, DOI 10.1002/chem.201000987; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Xu YM, 2012, GLYCOBIOLOGY, V22, P96, DOI 10.1093/glycob/cwr109; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	25	48	52	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20996	21002		10.1074/jbc.M112.359885	http://dx.doi.org/10.1074/jbc.M112.359885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22528493	hybrid, Green Published			2022-12-28	WOS:000306416800021
J	Ramos, C; Chardonnet, S; Marchand, CH; Decottignies, P; Ango, F; Daniel, H; Le Marechal, P				Ramos, Cathy; Chardonnet, Solenne; Marchand, Christophe H.; Decottignies, Paulette; Ango, Fabrice; Daniel, Herve; Le Marechal, Pierre			Native Presynaptic Metabotropic Glutamate Receptor 4 (mGluR4) Interacts with Exocytosis Proteins in Rat Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC TRANSMISSION; PROTEOMIC ANALYSIS; BINDING; PHOSPHORYLATION; SYNAPTOTAGMIN; LOCALIZATION; EXPRESSION; COMPLEXES; MEMBRANE; MUNC18-1	The eight pre- or/and post-synaptic metabotropic glutamatergic receptors (mGluRs) modulate rapid excitatory transmission sustained by ionotropic receptors. They are classified in three families according to their percentage of sequence identity and their pharmacological properties. mGluR4 belongs to group III and is mainly localized presynaptically. Activation of group III mGluRs leads to depression of excitatory transmission, a process that is exclusively provided by mGluR4 at parallel fiber-Purkinje cell synapse in rodent cerebellum. This function relies at least partly on an inhibition of presynaptic calcium influx, which controls glutamate release. To improve the understanding of molecular mechanisms of the mGluR4 depressant effect, we decided to identify the proteins interacting with this receptor. Immunoprecipitations using anti-mGluR4 antibodies were performed with cerebellar extracts. 183 putative partners that co-immunoprecipitated with anti-mGluR4 antibodies were identified and classified according to their cellular functions. It appears that native mGluR4 interacts with several exocytosis proteins such as Munc18-1, synapsins, and syntaxin. In addition, native mGluR4 was retained on a Sepharose column covalently grafted with recombinant Munc18-1, and immunohistochemistry experiments showed that Munc18-1 and mGluR4 colocalized at plasma membrane in HEK293 cells, observations in favor of an interaction between the two proteins. Finally, affinity chromatography experiments using peptides corresponding to the cytoplasmic domains of mGluR4 confirmed the interaction observed between mGluR4 and a selection of exocytosis proteins, including Munc18-1. These results could give indications to explain how mGluR4 can modulate glutamate release at parallel fiber-Purkinje cell synapses in the cerebellum in addition to the inhibition of presynaptic calcium influx.	[Ramos, Cathy; Chardonnet, Solenne; Marchand, Christophe H.; Decottignies, Paulette; Daniel, Herve; Le Marechal, Pierre] Univ Paris Sud, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Ango, Fabrice] CNRS, Inst Genom Fonct, Mise Pl Circuits GABAerg, UMR5203, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Le Marechal, P (corresponding author), Univ Paris Sud, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France.	pierre.le-marechal@u-psud.fr	MARCHAND, Christophe H/B-5854-2008	MARCHAND, Christophe H/0000-0002-0729-3841; Ango, Fabrice/0000-0002-5548-209X	Agence Nationale pour la Recherche [ANR-07-NEURO-047-01]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported in part by Agence Nationale pour la Recherche Grant ANR-07-NEURO-047-01).	Abitbol K, 2008, J NEUROCHEM, V105, P2069, DOI 10.1111/j.1471-4159.2008.05290.x; Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Farr CD, 2004, J NEUROCHEM, V91, P438, DOI 10.1111/j.1471-4159.2004.02735.x; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Khanna R, 2007, J BIOCHEM MOL BIOL, V40, P302; LARSONPRIOR LJ, 1990, J NEUROPHYSIOL, V63, P637, DOI 10.1152/jn.1990.63.3.637; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lorez M, 2003, BRIT J PHARMACOL, V138, P614, DOI 10.1038/sj.bjp.0705099; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; Mateos JM, 1998, HISTOCHEM CELL BIOL, V109, P135, DOI 10.1007/s004180050211; Moritz A, 2009, BIOCHEM BIOPH RES CO, V390, P82, DOI 10.1016/j.bbrc.2009.09.070; Nakajima Y, 2011, BIOCHEM BIOPH RES CO, V412, P602, DOI 10.1016/j.bbrc.2011.08.006; Nakajima Y, 2009, P NATL ACAD SCI USA, V106, P18385, DOI 10.1073/pnas.0910088106; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TANABE Y, 1993, J NEUROSCI, V13, P1372; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	42	10	11	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20176	20186		10.1074/jbc.M112.347468	http://dx.doi.org/10.1074/jbc.M112.347468			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528491	Green Published, hybrid			2022-12-28	WOS:000306414500038
J	Lach, A; Grzybek, M; Heger, E; Korycka, J; Wolny, M; Kubiak, J; Kolondra, A; Boguslawska, DM; Augoff, K; Majkowski, M; Podkalicka, J; Kaczor, J; Stefanko, A; Kuliczkowski, K; Sikorski, AF				Lach, Agnieszka; Grzybek, Michal; Heger, Elzbieta; Korycka, Justyna; Wolny, Marcin; Kubiak, Jakub; Kolondra, Adam; Boguslawska, Dzamila M.; Augoff, Katarzyna; Majkowski, Michal; Podkalicka, Joanna; Kaczor, Jakub; Stefanko, Adam; Kuliczkowski, Kazimierz; Sikorski, Aleksander F.			RETRACTED: Palmitoylation of MPP1 (Membrane-palmitoylated Protein 1)/p55 Is Crucial for Lateral Membrane Organization in Erythroid Cells (Retracted article. See vol. 293, pg. 2786, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							DETERGENT-RESISTANT MEMBRANES; GPI-ANCHORED PROTEINS; LIPID RAFTS; GLYCOPHORIN C; CHOLESTEROL; ASSOCIATION; IDENTIFICATION; BINDING; DOMAIN; LOCALIZATION	S-Acylation of proteins is a ubiquitous post-translational modification and a common signal for membrane association. The major palmitoylated protein in erythrocytes is MPP1, a member of the MAGUK family and an important component of the ternary complex that attaches the spectrin-based skeleton to the plasma membrane. Here we show that DHHC17 is the only acyltransferase present in red blood cells (RBC). Moreover, we give evidence that protein palmitoylation is essential for membrane organization and is crucial for proper RBC morphology, and that the effect is specific for MPP1. Our observations are based on the clinical cases of two related patients whose RBC had no palmitoylation activity, caused by a lack of DHHC17 in the membrane, which resulted in a strong decrease of the amount of detergent-resistant membrane (DRM) material. We confirmed that this loss of detergent-resistant membrane was due to the lack of palmitoylation by treatment of healthy RBC with 2-bromopalmitic acid (2-BrP, common palmitoylation inhibitor). Concomitantly, fluorescence lifetime imaging microscopy (FLIM) analyses of an order-sensing dye revealed a reduction of membrane order after chemical inhibition of palmitoylation in erythrocytes. These data point to a pathophysiological relationship between the loss of MPP1-directed palmitoylation activity and perturbed lateral membrane organization.	[Lach, Agnieszka; Korycka, Justyna; Wolny, Marcin; Kubiak, Jakub; Kolondra, Adam; Majkowski, Michal; Podkalicka, Joanna; Kaczor, Jakub; Stefanko, Adam; Sikorski, Aleksander F.] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-51148 Wroclaw, Poland; [Grzybek, Michal] Max Planck Inst Mol Biol & Genet, D-01307 Dresden, Germany; [Heger, Elzbieta; Boguslawska, Dzamila M.] Univ Zielona Gora, Dept Mol Biol, PL-65565 Zielona Gora, Poland; [Augoff, Katarzyna] Med Univ Wroclaw, Dept Gastrointestinal & Gen Surg, PL-50417 Wroclaw, Poland; [Kuliczkowski, Kazimierz] Med Univ Wroclaw, Dept Hematol, PL-50367 Wroclaw, Poland	University of Wroclaw; Max Planck Society; University of Zielona Gora; Wroclaw Medical University; Wroclaw Medical University	Sikorski, AF (corresponding author), Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, Przybyszewskiego 63-77, PL-51148 Wroclaw, Poland.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander/HGD-5159-2022; Grzybek, Michal/D-3802-2017	Wolny, Marcin/0000-0003-1030-7607; Augoff, Katarzyna/0000-0002-6133-3621; Sikorski, Aleksander F./0000-0003-3779-8266; Kolondra, Adam/0000-0001-5849-7185; Grzybek, Michal/0000-0003-2083-0506; Kubiak, Jakub/0000-0002-6734-9763; Kuliczkowski, Kazimierz/0000-0001-6812-1421	DNA Sequencing and Oligonucleotide Synthesis Service of the Institute of Biochemistry and Biophysics, Warsaw, Poland; European Union Social Fund [POKL.04.01.01-00-054/10-00]; European Social Fund; Ethics Committee of the Medical University of Wroclaw [494/2007]; Polish Ministry of Science and Higher Education [NN3011611435]	DNA Sequencing and Oligonucleotide Synthesis Service of the Institute of Biochemistry and Biophysics, Warsaw, Poland; European Union Social Fund(European Commission); European Social Fund(European Social Fund (ESF)); Ethics Committee of the Medical University of Wroclaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported in part by Grant NN3011611435 from the Polish Ministry of Science and Higher Education and a sequencing grant from the DNA Sequencing and Oligonucleotide Synthesis Service of the Institute of Biochemistry and Biophysics, Warsaw, Poland.; Recipient of Grant POKL.04.01.01-00-054/10-00 from the European Union Social Fund.; Scholar within Sub-measure 8.2.2 Regional Innovation Strategies, Measure 8.2, Priority VIII: Regional human resources for the economy Human Capital Operational Programme co-financed by the European Social Fund and state budget.; We thank Unal Coskun and Ilya Levental (both Max Planck Institute, Dresden) and Daniel Lingwood (NIH, Vaccine Research Centre, Washington) for discussions and help; the HA patients and their sister for voluntary participation in this study are particularly acknowledged. The patient study was performed according to permission from the Ethics Committee of the Medical University of Wroclaw: project No. 494/2007. The help of Dr. Jan Korzeniewski from the Medical University of Wroclaw on the work with umbilical cord blood is greatly appreciated.	Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Balamuth F, 2004, J IMMUNOL, V172, P5887, DOI 10.4049/jimmunol.172.10.5887; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chishti AH, 1996, BLOOD, V87, P3462, DOI 10.1182/blood.V87.8.3462.bloodjournal8783462; Chorzalska A, 2010, CELL MOL BIOL LETT, V15, P406, DOI 10.2478/s11658-010-0012-6; Ciana A, 2005, J BIOSCIENCES, V30, P317, DOI 10.1007/BF02703669; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grzybek M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005053; Guzzi F, 2001, BIOCHEM J, V355, P323, DOI 10.1042/0264-6021:3550323; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; HEMMING NJ, 1995, J BIOL CHEM, V270, P5360, DOI 10.1074/jbc.270.10.5360; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Hummel I, 2011, MOL PHARMACOL, V79, P229, DOI 10.1124/mol.110.069013; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kamata K, 2008, AM J HEMATOL, V83, P371, DOI 10.1002/ajh.21126; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Koshino I, 2009, EXP PARASITOL, V123, P381, DOI 10.1016/j.exppara.2009.08.019; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Levitan I, 2011, J LIPIDS, V2011, DOI 10.1155/2011/730209; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; MARETZKI D, 1990, FEBS LETT, V259, P305, DOI 10.1016/0014-5793(90)80033-F; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; Masuda M, 2011, J ONCOL, V2011, DOI 10.1155/2011/540148; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Nada S, 2003, J BIOL CHEM, V278, P47610, DOI 10.1074/jbc.M303873200; Niemela PS, 2009, BBA-BIOMEMBRANES, V1788, P122, DOI 10.1016/j.bbamem.2008.08.018; NOBLE NA, 1989, BLOOD, V74, P475; Owen DM, 2007, SEMIN CELL DEV BIOL, V18, P591, DOI 10.1016/j.semcdb.2007.07.011; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Pasini EM, 2010, J PROTEOMICS, V73, P421, DOI 10.1016/j.jprot.2009.07.004; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Robinson P, 2010, CELL CALCIUM, V48, P183, DOI 10.1016/j.ceca.2010.08.006; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schengrund CL, 2010, BRAIN RES BULL, V82, P7, DOI 10.1016/j.brainresbull.2010.02.013; Seo PS, 2009, EXP BIOL MED, V234, P255, DOI 10.3181/0809-RM-275; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Sim DS, 2007, ARTERIOSCL THROM VAS, V27, P1478, DOI 10.1161/ATVBAHA.106.139287; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yanagisawa K, 2011, J NEUROCHEM, V116, P806, DOI 10.1111/j.1471-4159.2010.07006.x; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	61	27	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18974	18984		10.1074/jbc.M111.332981	http://dx.doi.org/10.1074/jbc.M111.332981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496366	Green Published, hybrid			2022-12-28	WOS:000306411900009
J	Kwak, D; Choi, S; Jeong, H; Jang, JH; Lee, Y; Jeon, H; Lee, MN; Noh, J; Cho, K; Yoo, JS; Hwang, D; Suh, PG; Ryu, SH				Kwak, Dongoh; Choi, Sunkyu; Jeong, Heeyoon; Jang, Jin-Hyeok; Lee, Youngmi; Jeon, Hyeona; Lee, Mi Nam; Noh, Jungeun; Cho, Kun; Yoo, Jong Shin; Hwang, Daehee; Suh, Pann-Ghill; Ryu, Sung Ho			Osmotic Stress Regulates Mammalian Target of Rapamycin (mTOR) Complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CELL-GROWTH; S6 KINASE; ACTIVATION; PATHWAY; TOR; PHOSPHATASE; MECHANISMS; INTERACTS; P70(S6K)	mTOR complex 1 (mTORC1) is a multiprotein complex that integrates diverse signals including growth factors, nutrients, and stress to control cell growth. Raptor is an essential component of mTORC1 that functions to recruit specific substrates. Recently, Raptor was suggested to be a key target of regulation of mTORC1. Here, we show that Raptor is phosphorylated by JNK upon osmotic stress. We identified that osmotic stress induces the phosphorylation of Raptor at Ser-696, Thr-706, and Ser-863 using liquid chromatography-tandem mass spectrometry. We found that JNK is responsible for the phosphorylation. The inhibition of JNK abolishes the phosphorylation of Raptor induced by osmotic stress in cells. Furthermore, JNK physically associates with Raptor and phosphorylates Raptor in vitro, implying that JNK is responsible for the phosphorylation of Raptor. Finally, we found that osmotic stress activates mTORC1 kinase activity in a JNK-dependent manner. Our findings suggest that the molecular link between JNK and Raptor is a potential mechanism by which stress regulates the mTORC1 signaling pathway.	[Kwak, Dongoh; Choi, Sunkyu; Jeong, Heeyoon; Jeon, Hyeona; Lee, Mi Nam; Noh, Jungeun; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Jang, Jin-Hyeok; Lee, Youngmi; Hwang, Daehee; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyungbuk, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, Kyungbuk, South Korea; [Cho, Kun; Yoo, Jong Shin] Korea Basic Sci Inst, Mass Spectrometry Res Ctr, Cheong Won 363883, Chungbuk, South Korea; [Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Basic Science Institute (KBSI); Ulsan National Institute of Science & Technology (UNIST)	Ryu, SH (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	sungho@postech.ac.kr	Cho, Kun/B-9319-2012; Suh, Pann-Ghill/F-3610-2010	Cho, Kun/0000-0003-1154-4065; Ryu, Sung Ho/0000-0003-0913-3048	Global Frontier Project [NRF-MI-AXA002-2010-0029764]; Global Research Network [KRF-2008-220-C00036]	Global Frontier Project; Global Research Network	This work was supported by the Global Frontier Project (Grant NRF-MI-AXA002-2010-0029764) and Global Research Network Program (Grant KRF-2008-220-C00036).	Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Ho SN, 2006, J CELL PHYSIOL, V206, P9, DOI 10.1002/jcp.20445; Huang CS, 2002, CANCER RES, V62, P5689; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	35	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18398	18407		10.1074/jbc.M111.326538	http://dx.doi.org/10.1074/jbc.M111.326538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493283	hybrid, Green Published			2022-12-28	WOS:000306411600046
J	Lee, SY; Kim, JR; Hu, YY; Khan, R; Kim, SJ; Bharadwaj, KG; Davidson, MM; Choi, CS; Shin, KO; Lee, YM; Park, WJ; Park, IS; Jiang, XC; Goldberg, IJ; Park, TS				Lee, Su-Yeon; Kim, Jung Ran; Hu, Yunying; Khan, Raffay; Kim, Su-Jung; Bharadwaj, Kalyani G.; Davidson, Mercy M.; Choi, Cheol-Soo; Shin, Kyong-Oh; Lee, Yong-Moon; Park, Woo-Jin; Park, In-Sun; Jiang, Xian-Cheng; Goldberg, Ira J.; Park, Tae-Sik			Cardiomyocyte Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Reduces Ceramide but Leads to Cardiac Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITOYL-COA TRANSFERASE; SPHINGOLIPID METABOLISM; HEART-FAILURE; FATTY-ACIDS; INSULIN-RESISTANCE; KEY ENZYME; SYNTHASE 2; IN-VIVO; SPHINGOMYELIN; ACTIVATION	The role of serine palmitoyltransferase (SPT) and de novo ceramide biosynthesis in cardiac ceramide and sphingomyelin metabolism is unclear. To determine whether the de novo synthetic pathways, rather than ceramide uptake from circulating lipoproteins, is important for heart ceramide levels, we created cardiomyocyte-specific deficiency of Sptlc2, a subunit of SPT. Heart-specific Sptlc2-deficient (hSptlc2 KO) mice had a >35% reduction in ceramide, which was limited to C18:0 and very long chain ceramides. Sphingomyelinase expression, and levels of sphingomyelin and diacylglycerol were unchanged. But surprisingly phospholipids and acyl CoAs contained increased saturated long chain fatty acids. hSptlc2 KO mice had decreased fractional shortening and thinning of the cardiac wall. While the genes regulating glucose and fatty acid metabolism were not changed, expression of cardiac failure markers and the genes involved in the formation of extracellular matrices were up-regulated in hSptlc2 KO hearts. In addition, ER-stress markers were up-regulated leading to increased apoptosis. These results suggest that Sptlc2-mediated de novo ceramide synthesis is an essential source of C18:0 and very long chain, but not of shorter chain, ceramides in the heart. Changes in heart lipids other than ceramide levels lead to cardiac toxicity.	[Lee, Su-Yeon; Kim, Jung Ran; Kim, Su-Jung; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea; [Hu, Yunying; Khan, Raffay; Bharadwaj, Kalyani G.; Goldberg, Ira J.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Davidson, Mercy M.] Columbia Univ, Dept Radiat Oncol, New York, NY 10032 USA; [Choi, Cheol-Soo] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, Coll Pharm, Chonju 361763, South Korea; [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, MRC, Chonju 361763, South Korea; [Park, Woo-Jin] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Park, In-Sun] Inha Univ, Coll Med, Dept Anat, Inchon 402751, South Korea; [Jiang, Xian-Cheng] State Univ New York Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Gachon University; Columbia University; Columbia University; Gachon University; Chungbuk National University; Chungbuk National University; Gwangju Institute of Science & Technology (GIST); Inha University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Park, TS (corresponding author), Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea.	tspark@gachon.ac.kr	Lorkiewicz, Pawel/A-2126-2011	Lorkiewicz, Pawel/0000-0002-1755-9826	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2010-0000590, NRF2011-0025903, HL73029, HL45095]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073029, R37HL045095, R01HL045095] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology NRF-2010-0000590, NRF2011-0025903)(to T.S.P.) and HL73029 and HL45095 (to I.J.G.).	Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Cole LK, 2011, CIRC RES, V108, P686, DOI 10.1161/CIRCRESAHA.110.238691; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Haq S, 2001, CIRCULATION, V103, P670; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; Linn SC, 2006, FEBS LETT, V580, P6217, DOI 10.1016/j.febslet.2006.10.025; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Matsui T, 2006, AM J PHYSIOL-ENDOC M, V290, pE789, DOI 10.1152/ajpendo.00564.2004; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Saito H, 2000, BBA-MOL CELL BIOL L, V1486, P312, DOI 10.1016/S1388-1981(00)00071-8; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Wang CY, 2002, CIRCULATION, V105, P1609, DOI 10.1161/01.CIR.0000013022.11250.30; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Wolfe RR, 1992, RADIOACTIVE STABLE I; Yoo HH, 2006, J CHROMATOGR B, V843, P327, DOI 10.1016/j.jchromb.2006.06.025; Yoshimura A, 2005, ACTA PHYSIOL SCAND, V185, P41, DOI 10.1111/j.1365-201X.2005.01455.x; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	48	50	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18429	18439		10.1074/jbc.M111.296947	http://dx.doi.org/10.1074/jbc.M111.296947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493506	Green Published, hybrid			2022-12-28	WOS:000306411600049
J	Nishiwaki, T; Kondo, T				Nishiwaki, Taeko; Kondo, Takao			Circadian Autodephosphorylation of Cyanobacterial Clock Protein KaiC Occurs via Formation of ATP as Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC-DATA; PHOSPHORYLATION; PHOSPHATASES; OSCILLATION; EXPLORER; PROGRAM; SYSTEM; RHYTHM	The cyanobacterial circadian oscillator can be reconstituted in vitro; mixing three clock proteins (KaiA, KaiB, and KaiC) with ATP results in an oscillation of KaiC phosphorylation with a periodicity of similar to 24 h. The hexameric ATPase KaiC hydrolyzes ATP bound at subunit interfaces. KaiC also exhibits autokinase and autophosphatase activities, the latter of which is particularly noteworthy because KaiC is phylogenetically distinct from typical protein phosphatases. To examine this activity, we performed autodephosphorylation assays using P-32-labeled KaiC. The residual radioactive ATP bound to subunit interfaces was removed using a newly established method, which included the dissociation of KaiC hexamers into monomers and the reconstitution of KaiC hexamers with nonradioactive ATP. This approach ensured that only the signals derived from P-32-labeled KaiC were examined. We detected the transient formation of [P-32] ATP preceding the accumulation of P-32(i). Together with kinetic analyses, our data demonstrate that KaiC undergoes dephosphorylation via a mechanism that differs from those of conventional protein phosphatases. A phosphate group at a phosphorylation site is first transferred to KaiC-bound ADP to form ATP as an intermediate, which can be regarded as a reversal of the autophosphorylation reaction. Subsequently, the ATP molecule is hydrolyzed to form P-i. We propose that the ATPase active site mediates not only ATP hydrolysis but also the bidirectional transfer of the phosphate between phosphorylation sites and the KaiC-bound nucleotide. On the basis of these findings, we can now dissect the dynamics of the KaiC phosphorylation cycle relative to ATPase activity.	[Kondo, Takao] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Agcy JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Furo Cho, Nagoya, Aichi 4648602, Japan.	kondo@bio.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21570037, 23118708]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid 21570037 and 23118708 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. N.).	Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yegutkin GG, 2006, J BIOL CHEM, V281, P29441, DOI 10.1074/jbc.M602480200	27	57	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18030	18035		10.1074/jbc.M112.350660	http://dx.doi.org/10.1074/jbc.M112.350660			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493509	Green Published, hybrid			2022-12-28	WOS:000306411600012
J	Ortiz, D; Voyvodic, P; Gossack, L; Quast, U; Bryan, J				Ortiz, David; Voyvodic, Peter; Gossack, Lindsay; Quast, Ulrich; Bryan, Joseph			Two Neonatal Diabetes Mutations on Transmembrane Helix 15 of SUR1 Increase Affinity for ATP and ADP at Nucleotide Binding Domain 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR SUBTYPES; MULTIDRUG ABC TRANSPORTER; SENSITIVE K+ CHANNELS; PANCREATIC-B-CELLS; P-GLYCOPROTEIN; CONFORMATIONAL-CHANGES; GLIBENCLAMIDE BINDING; POTASSIUM CHANNEL; TOLBUTAMIDE SITE; PICHIA-PASTORIS	K-ATP channels, (SUR1/Kir6.2)(4) (sulfonylurea receptor type 1/potassium inward rectifier type 6.2) respond to the metabolic state of pancreatic beta-cells, modulating membrane potential and insulin exocytosis. Mutations in both subunits cause neonatal diabetes by overactivating the pore. Hyperactive channels fail to close appropriately with increased glucose metabolism; thus, beta-cell hyperpolarization limits insulin release. K-ATP channels are inhibited by ATP binding to the Kir6.2 pore and stimulated, via an uncertain mechanism, by magnesium nucleotides at SUR1. Glibenclamide (GBC), a sulfonylurea, was used as a conformational probe to compare nucleotide action on wild type versus Q1178R and R1182Q SUR1 mutants. GBC binds with high affinity to aporeceptors, presumably in the inward facing ATP-binding cassette configuration; MgATP reduces binding affinity via a shift to the outward facing conformation. To determine nucleotide affinities under equilibrium, non-hydrolytic conditions, Mg2+ was eliminated. A four-state equilibrium model describes the allosteric linkage. The K-D for ATP(4-) is similar to 1 versus 12 mM, Q1178R versus wild type, respectively. The linkage constant is similar to 10, implying that outward facing conformations bind GBC with a lower affinity, 9-10 nM for Q1178R. Thus, nucleotides cannot completely inhibit GBC binding. Binding of channel openers is reported to require ATP hydrolysis, but diazoxide, a SUR1-selective agonist, concentration-dependently augments ATP(4-) action. An eight-state model describes linkage between diazoxide and ATP(4-) binding; diazoxide markedly increases the affinity of Q1178R for ATP(4-) and ATP(4-) augments diazoxide binding. NBD2, but not NBD1, has a higher affinity for ATP (and ADP) in mutant versus wild type (with or without Mg2+). Thus, the mutants spend more time in nucleotide-bound conformations, with reduced affinity for GBC, that activate the pore.	[Ortiz, David; Voyvodic, Peter; Gossack, Lindsay; Bryan, Joseph] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA; [Ortiz, David] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Quast, Ulrich] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany	Pacific Northwest Diabetes Research Institute (PNDRI); Baylor College of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bryan, J (corresponding author), Pacific NW Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan@pnri.org		Voyvodic, Peter/0000-0001-6578-8837	American Diabetes Association [ADA 1-10-BS21]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Grant ADA 1-10-BS21 (to J. B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Alberty R. A., 2003, THERMODYNAMICS BIOCH, P5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Doyle SA, 2005, METH MOL B, V310, P107; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; Hambrock A, 2004, DIABETES, V53, pS128, DOI 10.2337/diabetes.53.suppl_3.S128; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kreimer DI, 2000, BIOCHEMISTRY-US, V39, P14183, DOI 10.1021/bi001066+; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Loffler-Walz C, 1998, BRIT J PHARMACOL, V123, P1395, DOI 10.1038/sj.bjp.0701756; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Manciu L, 2003, J BIOL CHEM, V278, P3347, DOI 10.1074/jbc.M207963200; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; ROSANO TG, 1976, CLIN CHEM, V22, P1078; SCHWANSTECHER M, 1994, J NEUROCHEM, V63, P698; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V106, P295, DOI 10.1111/j.1476-5381.1992.tb14331.x; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V105, P531, DOI 10.1111/j.1476-5381.1992.tb09014.x; SCHWANSTECHER M, 1991, N-S ARCH PHARMACOL, V343, P83; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	54	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17985	17995		10.1074/jbc.M112.349019	http://dx.doi.org/10.1074/jbc.M112.349019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22451668	hybrid, Green Published			2022-12-28	WOS:000306411600008
J	Wang, XD; Deng, XF; Yan, WJ; Zhu, ZX; Shen, Y; Qiu, YF; Shi, ZX; Shao, DH; Wei, JC; Xia, XZ; Ma, ZY				Wang, Xiaodu; Deng, Xufang; Yan, Wenjun; Zhu, Zixiang; Shen, Yang; Qiu, Yafeng; Shi, Zixue; Shao, Donghua; Wei, Jianchao; Xia, Xianzhu; Ma, Zhiyong			Stabilization of p53 in Influenza A Virus-infected Cells Is Associated with Compromised MDM2-mediated Ubiquitination of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; TUMOR-SUPPRESSOR P53; VIRAL REPLICATION; APOPTOSIS; PROTEIN; MDM2; SEQUESTRATION; ACCUMULATION; DERIVATIVES; DEFENSE	Influenza A virus (IAV) induces apoptosis of infected cells. In response to IAV infection, p53, a tumor suppressor involved in regulating apoptosis and host antiviral defense, accumulates and becomes activated. This study was undertaken to examine the mechanism of p53 accumulation in IAV-infected cells. Here we show that p53 accumulation in IAV-infected cells results from protein stabilization, which was associated with compromised Mdm2-mediated ubiquitination of p53. In IAV-infected cells, p53 was stabilized and its half-life was remarkably extended. The ladders of polyubiquitinated p53 were not detectable in the presence of the proteasome inhibitor MG132 and were less sensitive to proteasome-mediated degradation. IAV infection did not affect the abundance of Mdm2, a major ubiquitin E3 ligase responsible for regulating p53 ubiquitination and degradation, but weakened the interaction between p53 and Mdm2. Viral nucleoprotein (NP) was able to increase the transcriptional activity and stability of p53. Furthermore, NP was found to associate with p53 and to impair the p53-Mdm2 interaction and Mdm2-mediated p53 ubiquitination, demonstrating its role in inhibiting Mdm2-mediated p53 ubiquitination and degradation.	[Wang, Xiaodu; Deng, Xufang; Yan, Wenjun; Zhu, Zixiang; Shen, Yang; Qiu, Yafeng; Shi, Zixue; Shao, Donghua; Wei, Jianchao; Ma, Zhiyong] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Wang, Xiaodu] Zhejiang Agr & Forestry Univ, Forestry & Biotechnol Sch, Hangzhou 311300, Peoples R China; [Xia, Xianzhu] Acad Mil Med Sci, Inst Vet Sci, Changchun 130062, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Zhejiang A&F University; Academy of Military Medical Sciences - China	Ma, ZY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai 200241, Peoples R China.	zhiyongma@shvri.ac.cn	Deng, Xufang/I-3001-2013	Shi, Zixue/0000-0001-5357-1171; Deng, Xufang/0000-0002-7604-3627	National Natural Science Foundation of China [30970141, 81171547]; Natural Science Foundation of Shanghai [10JC1417300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was sponsored by the National Natural Science Foundation of China (No. 30970141 and No. 81171547) and the Natural Science Foundation of Shanghai (No. 10JC1417300).	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; *CDCP, 1998, MMWR-MORBID MORTAL W, V46, P1245; Chen ZP, 2007, J BIOL CHEM, V282, P29284, DOI 10.1074/jbc.M705349200; Collot-Teixeira S, 2004, REV MED VIROL, V14, P301, DOI 10.1002/rmv.431; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Koyama AH, 2003, INT REV IMMUNOL, V22, P341, DOI 10.1080/08830180305210; Kumar SK, 2003, J MED CHEM, V46, P2813, DOI 10.1021/jm030213+; Kurokawa M, 1999, INT J MOL MED, V3, P527; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Li WZ, 2010, CELL MOL IMMUNOL, V7, P235, DOI 10.1038/cmi.2010.6; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Moll UM, 2003, MOL CANCER RES, V1, P1001; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Qiu YF, 2008, DEV COMP IMMUNOL, V32, P1522, DOI 10.1016/j.dci.2008.05.016; RAMPHAL R, 1980, INFECT IMMUN, V27, P614, DOI 10.1128/IAI.27.2.614-619.1980; SAITO Y, 1990, NEUROSCI LETT, V120, P1, DOI 10.1016/0304-3940(90)90153-Z; Shen Y, 2009, BIOCHEM BIOPH RES CO, V382, P331, DOI 10.1016/j.bbrc.2009.03.018; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y	38	38	38	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18366	18375		10.1074/jbc.M111.335422	http://dx.doi.org/10.1074/jbc.M111.335422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474335	hybrid, Green Published			2022-12-28	WOS:000306411600043
J	Choudhury, SR; Westfall, CS; Laborde, JP; Bisht, NC; Jez, JM; Pandey, S				Choudhury, Swarup Roy; Westfall, Corey S.; Laborde, John P.; Bisht, Naveen C.; Jez, Joseph M.; Pandey, Sona			Two Chimeric Regulators of G-protein Signaling (RGS) Proteins Differentially Modulate Soybean Heterotrimeric G-protein Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; BETA-SUBUNIT; ARABIDOPSIS-THALIANA; CELL-PROLIFERATION; GTP HYDROLYSIS; RICE; INSIGHTS; SPECIFICITY; ACTIVATION; RECEPTORS	Heterotrimeric G-proteins and the regulator of G-protein signaling (RGS) proteins, which accelerate the inherent GTPase activity of G alpha proteins, are common in animals and encoded by large gene families; however, in plants G-protein signaling is thought to be more limited in scope. For example, Arabidopsis thaliana contains one G alpha, one G beta, three G gamma, and one RGS protein. Recent examination of the Glycine max (soybean) genome reveals a larger set of G-protein-related genes and raises the possibility of more intricate G-protein networks than previously observed in plants. Stopped-flow analysis of GTP-binding and GDP/GTP exchange for the four soybean G alpha proteins (GmG alpha 1-4) reveals differences in their kinetic properties. The soybean genome encodes two chimeric RGS proteins with an N-terminal seven transmembrane domain and a C-terminal RGS box. Both GmRGS interact with each of the four GmG alpha and regulate their GTPase activity. The GTPase-accelerating activities of GmRGS1 and -2 differ for each GmG alpha, suggesting more than one possible rate of the G-protein cycle initiated by each of the G alpha proteins. The differential effects of GmRGS1 and GmRGS2 on GmG alpha 1-4 result from a single valine versus alanine difference. The emerging picture suggests complex regulation of the G-protein cycle in soybean and in other plants with expanded G-protein networks.	[Choudhury, Swarup Roy; Laborde, John P.; Bisht, Naveen C.; Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Donald Danforth Plant Science Center; Washington University (WUSTL)	Pandey, S (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	spandey@danforthcenter.org	Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120	United States Department of Agriculture/Agriculture and Food Research Initiative [2010-65116-20454, MOW-2010-05240]; National Science Foundation [NSF-MCB-0851838]; National Institute of Plant Genome Research, New Delhi, India	United States Department of Agriculture/Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); National Institute of Plant Genome Research, New Delhi, India	This work was supported in part by United States Department of Agriculture/Agriculture and Food Research Initiative Grant 2010-65116-20454 (to S. P.).; Supported by United States Department of Agriculture/Agriculture and Food Research Initiative Pre-doctoral Research Fellowship MOW-2010-05240.; Supported by National Science Foundation Research Experiences for Undergraduates Grant NSF-MCB-0851838. Present address: Liberty University, Lynchburg, VA 24502.; Supported by a visiting scholar fellowship from the National Institute of Plant Genome Research, New Delhi, India. Present address: National Institute of Plant Genome Research, New Delhi, India 110067.	Anantharaman V, 2011, GENE, V475, P63, DOI 10.1016/j.gene.2010.12.001; Assmann Sarah M, 2004, Sci STKE, V2004, pre20; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bisht NC, 2011, NEW PHYTOL, V190, P35, DOI 10.1111/j.1469-8137.2010.03581.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Choudhury SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023361; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Hajduch M, 2010, PLANT PHYSIOL, V152, P2078, DOI 10.1104/pp.109.152413; Iwasaki Y, 1997, PLANT MOL BIOL, V34, P563, DOI 10.1023/A:1005807010811; Jez JM, 2004, J BIOL CHEM, V279, P42726, DOI 10.1074/jbc.M407961200; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kosloff M, 2011, NAT STRUCT MOL BIOL, V18, P846, DOI 10.1038/nsmb.2068; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Nilson SE, 2010, NEW PHYTOL, V185, P734, DOI 10.1111/j.1469-8137.2009.03120.x; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pandey S, 2008, PLANT J, V55, P311, DOI 10.1111/j.1365-313X.2008.03506.x; Pandey S, 2011, PLANT SIGNAL BEHAV, V6, P780, DOI 10.4161/psb.6.6.15145; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seo HS, 2003, J BIOCHEM MOL BIOL, V36, P196; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Sun J, 2007, PLANT PHYSIOL, V144, P695, DOI 10.1104/pp.106.093294; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005	49	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17870	17881		10.1074/jbc.M112.353219	http://dx.doi.org/10.1074/jbc.M112.353219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474294	Green Published, hybrid			2022-12-28	WOS:000306373000084
J	Nguyen, GKT; Lim, WH; Nguyen, PQT; Tam, JP				Nguyen, Giang Kien Truc; Lim, Wei Han; Nguyen, Phuong Quoc Thuc; Tam, James P.			Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; CIRCULAR PROTEINS; KALATA B1; MACROCYCLIC POLYPEPTIDES; MEMBRANE INTERACTIONS; OLDENLANDIA-AFFINIS; STRUCTURAL MOTIF; PLANT CYCLOTIDES; VIOLA-ODORATA; DISCOVERY	Cyclotides are a new class of plant biologics that display a diverse range of bioactivities with therapeutic potentials. They possess an unusual end-to-end cyclic backbone combined with a cystine knot arrangement, making them exceptionally stable to heat, chemical and enzymatic degradation. Currently, >200 cyclotides have been discovered but only three naturally occurring linear variants (also known as uncyclotides) have been isolated. In this study, we report the discovery of 18 novel peptides, chassatides C1 to C18, composed of 14 new cyclotides and four uncyclotides from Chassalia chartacea (Rubiaceae family). Thus far, this is the largest number of uncyclotides being reported in a single species. Activity testing showed that the uncyclotides not only retain the effectiveness but also are the most potent chassatides in the assays for antimicrobial, cytotoxic, and hemolytic activities. Genetic characterization of novel chassatides revealed that they have the shortest precursors of all known cyclotides hitherto isolated, which represents a new class of cyclotide precursors. This is the first report of cyclotide genes in a second genus, the Chassalia, other than the Hedyotis (Old-enlandia) of the Rubiaceae family. In addition, we also report the characterization of two Met-oxidized derivatives of chassatides C2 and C11. The oxidation of Met residue causes loss of bioactivities, strengthening the importance of the hydrophobic patch for membrane interaction.	[Nguyen, Giang Kien Truc; Lim, Wei Han; Nguyen, Phuong Quoc Thuc; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X	A*STAR Biomedical Research Council [09/1/22/19/612]; Ministry of Education in Singapore [ARC21/08]	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education in Singapore(Ministry of Education, Singapore)	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/612 and Academic Research Fund Grant ARC21/08 from the Ministry of Education in Singapore.	ANDRES DA, 1991, J BIOL CHEM, V266, P14277; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; Gracy J, 2005, NUCLEIC ACIDS RES, V33, pW65, DOI 10.1093/nar/gki455; Gracy J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-535; GRAN L, 1973, LLOYDIA, V36, P207; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Gustafson KR, 2000, J NAT PROD, V63, P176, DOI 10.1021/np990432r; Henriques S. T., 2012, ACS CHEM BIOL; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jiang XY, 1996, J MASS SPECTROM, V31, P1309, DOI 10.1002/(SICI)1096-9888(199611)31:11<1309::AID-JMS423>3.0.CO;2-R; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Lindholm P, 2002, MOL CANCER THER, V1, P365; Norhajar Eswani, 2010, Journal of Agricultural Science (Toronto), V2, P189; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Skillman JB, 1997, PLANT PHYSIOL, V113, P441, DOI 10.1104/pp.113.2.441; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953	45	61	78	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17598	17607		10.1074/jbc.M111.338970	http://dx.doi.org/10.1074/jbc.M111.338970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467870	hybrid, Green Published			2022-12-28	WOS:000306373000058
J	Liu, Y; El-Achkar, TM; Wu, XR				Liu, Yan; El-Achkar, Tarek M.; Wu, Xue-Ru			Tamm-Horsfall Protein Regulates Circulating and Renal Cytokines by Affecting Glomerular Filtration Rate and Acting as a Urinary Cytokine Trap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; 1-FIMBRIATED ESCHERICHIA-COLI; TUMOR-NECROSIS-FACTOR; HUMAN-PREGNANCY URINE; HUMAN INTERLEUKIN-1-BETA; DIABETIC-PATIENTS; INTERFERON-ALPHA; COMPLEMENT 1Q; GLYCOPROTEIN; UROMODULIN	Although few organ systems play a more important role than the kidneys in cytokine catabolism, the mechanism(s) regulating this pivotal physiological function and how its deficiency affects systemic cytokine homeostasis remain unclear. Here we show that elimination of Tamm-Horsfall protein (THP) expression from mouse kidneys caused a marked elevation of circulating IFN-gamma IL1 alpha, TNF-alpha, IL6, CXCL1, and IL13. Accompanying this were enlarged spleens with prominent white-pulp macrophage infiltration. Lipopolysaccharide (LPS) exacerbated the increase of serum cytokines without a corresponding increase in their urinary excretion in THP knock-out (KO) mice. This, along with the rise of serum cystatin C and the reduced inulin and creatinine clearance from the circulation, suggested that diminished glomerular filtration may contribute to reduced cytokine clearance in THP KO mice both at the baseline and under stress. Unlike wild-type mice where renal and urinary cytokines formed specific in vivo complexes with THP, this "trapping" effect was absent in THP KO mice, thus explaining why cytokine signaling pathways were activated in renal epithelial cells in such mice. Our study provides new evidence implicating an important role of THP in influencing cytokine clearance and acting as a decoy receptor for urinary cytokines. Based on these and other data, we present a unifying model that underscores the role of THP as a major regulator of renal and systemic immunity.	[Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA; [El-Achkar, Tarek M.] St Louis Univ, Div Nephrol, St Louis, MO 63108 USA; [El-Achkar, Tarek M.] St Louis Vet Affairs Med Ctr, St Louis, MO 63108 USA	New York University; New York University; Saint Louis University	Wu, XR (corresponding author), 423 E23 St,Rm 18064 S, New York, NY 10010 USA.	xue-ru.wu@med.nyu.edu		Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health [R01DK56903]; Veterans Administration's Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration's Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK56903 and Merit Review Awards from the Veterans Administration's Research Program (to T.E.-A. and X.-R.W.).	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bemelmans MHA, 1996, CRIT REV IMMUNOL, V16, P1; BENIGNI A, 1995, LAB INVEST, V73, P461; Benigni A, 2001, AM J KIDNEY DIS, V37, pS21, DOI 10.1053/ajkd.2001.20734; BERNARD AM, 1987, CLIN CHEM, V33, P1264; Bleyer AJ, 2003, AM J KIDNEY DIS, V42, DOI 10.1016/S0272-6386(03)00670-X; BOCCI V, 1983, J LAB CLIN MED, V101, P857; BOCCI V, 1982, J INTERFERON RES, V2, P309, DOI 10.1089/jir.1982.2.309; Carrero JJ, 2008, BLOOD PURIFICAT, V26, P291, DOI 10.1159/000126926; Cavallone D, 2004, J BIOL CHEM, V279, P216, DOI 10.1074/jbc.M308821200; DALLOLIO F, 1991, CELL IMMUNOL, V137, P303, DOI 10.1016/0008-8749(91)90081-L; DAWNAY ABS, 1981, CLIN NEPHROL, V15, P5; Devuyst O, 2005, NEPHROL DIAL TRANSPL, V20, P1290, DOI 10.1093/ndt/gfh851; Dong XY, 2005, KIDNEY INT, V68, P1096, DOI 10.1111/j.1523-1755.2005.00502.x; Dworkin L. D., 1992, KIDNEY PHYSL PATHOPH, P979; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; El-Achkar TM, 2011, AM J PHYSIOL-RENAL, V300, pF999, DOI 10.1152/ajprenal.00621.2010; Fukuoka SI, 2001, BIOCHEM BIOPH RES CO, V289, P1044, DOI 10.1006/bbrc.2001.6112; Gilbert R. E., 2011, BRENNER RECTORS KIDN, P384; GREIG NH, 1988, J PHARMACOL EXP THER, V245, P574; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; ICHIKAWA I, 1984, AM J MED, V76, P43, DOI 10.1016/0002-9343(84)90882-9; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; KATZ AI, 1978, NEPHRON, V22, P69, DOI 10.1159/000181425; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; Kreft B, 2002, INFECT IMMUN, V70, P2650, DOI 10.1128/IAI.70.5.2650-2656.2002; Kudo S, 1999, J INTERF CYTOK RES, V19, P1161, DOI 10.1089/107999099313109; KUDO S, 1990, CANCER RES, V50, P5751; Kumar S, 1998, EUR J CLIN INVEST, V28, P483; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Langelueddecke C, 2012, J BIOL CHEM, V287, P159, DOI 10.1074/jbc.M111.308296; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; MOONEN P, 1988, FEBS LETT, V226, P314, DOI 10.1016/0014-5793(88)81446-7; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUCHMORE AV, 1987, J IMMUNOL, V138, P2547; MUCHMORE AV, 1990, J LEUKOCYTE BIOL, V48, P457, DOI 10.1002/jlb.48.5.457; MUCHMORE AV, 1986, AM J REPROD IMMUNOL, V11, P89; MUCHMORE AV, 1986, J BIOL CHEM, V261, P3404; NAKAMURA A, 1995, NEPHRON, V70, P416, DOI 10.1159/000188638; NESSELHUT T, 1989, ARCH GYNECOL OBSTET, V246, P97, DOI 10.1007/BF00934126; NESSELHUT T, 1993, EUR J OBSTET GYN R B, V48, P23, DOI 10.1016/0028-2243(93)90049-I; NEWTON RC, 1988, LYMPHOKINE RES, V7, P207; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Olczak T, 1998, EUR J CLIN INVEST, V28, P475; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; PHIMISTER GM, 1983, CLIN CHIM ACTA, V128, P261; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Ratsimandresy RA, 2009, CURR PHARM DESIGN, V15, P1998, DOI 10.2174/138161209788453130; Rhodes DCJ, 2000, IMMUNOL CELL BIOL, V78, P474, DOI 10.1111/j.1440-1711.2000.t01-3-.x; Rhodes DCJ, 2006, IMMUNOL CELL BIOL, V84, P357, DOI 10.1111/j.1440-1711.2006.01434.x; Rhodes DCJ, 1999, KIDNEY INT, V56, P759, DOI 10.1016/S0085-2538(15)46353-7; Rhodes DCJ, 2002, IMMUNOL CELL BIOL, V80, P558, DOI 10.1046/j.1440-1711.2002.01125.x; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; ROSENSTREICH DL, 1987, REV INFECT DIS, V9, pS594; Saemann MD, 2005, EUR J CLIN INVEST, V35, P227, DOI 10.1111/j.1365-2362.2005.01483.x; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; SCHROTER J, 1993, KIDNEY INT, V44, P401, DOI 10.1038/ki.1993.258; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Sejdiu I, 2008, SCAND J UROL NEPHROL, V42, P168, DOI 10.1080/00365590701644691; Serafini-Cessi F, 2005, GLYCOCONJUGATE J, V22, P383, DOI 10.1007/s10719-005-2142-z; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; SHERBLOM AP, 1988, J BIOL CHEM, V263, P5418; SMAGULA RM, 1990, GLYCOCONJUGATE J, V7, P609, DOI 10.1007/BF01189081; Sturgeon C, 1998, J APPL PHYSIOL, V84, P2154, DOI 10.1152/jappl.1998.84.6.2154; Su SJ, 1997, J IMMUNOL, V158, P3449; Su SJ, 1999, LIFE SCI, V65, P2581, DOI 10.1016/S0024-3205(99)00527-5; Thomson AW, 2003, CYTOKINE HDB; TORFFVIT O, 1994, J DIABETES COMPLICAT, V8, P77, DOI 10.1016/1056-8727(94)90055-8; Torffvit O, 1999, SCAND J UROL NEPHROL, V33, P187, DOI 10.1080/003655999750015970; Tsai CY, 2000, NEPHRON, V85, P207, DOI 10.1159/000045663; Wang SN, 1999, KIDNEY INT, V56, P1247, DOI 10.1046/j.1523-1755.1999.00698.x; Zhu XH, 2003, TRANSGENIC RES, V12, P155, DOI 10.1023/A:1022967505222; Zhu XH, 2002, AM J PHYSIOL-RENAL, V282, pF608, DOI 10.1152/ajprenal.00297.2001	80	31	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16365	16378		10.1074/jbc.M112.348243	http://dx.doi.org/10.1074/jbc.M112.348243			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451664	Green Published, hybrid			2022-12-28	WOS:000304030900028
J	Tajeddine, N; Gailly, P				Tajeddine, Nicolas; Gailly, Philippe			TRPC1 Protein Channel Is Major Regulator of Epidermal Growth Factor Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; TYROSINE PHOSPHORYLATION; A431 CELLS; CA2+ ENTRY; CALCIUM; PROLIFERATION; ACTIVATION; MIGRATION; LOCALIZATION; RESISTANCE	TRP channels have been associated with cell proliferation and aggressiveness in several cancers. In particular, TRPC1 regulates cell proliferation and motility, two processes underlying cancer progression. We and others have described the mechanisms of TRPC1-dependent cell migration. However, the involvement of TRPC1 in cell proliferation remains unexplained. In this study, we show that siRNA-mediated TRPC1 depletion in non small cell lung carcinoma cell lines induced G(0)/G(1) cell cycle arrest resulting in dramatic decrease in cell growth. The expression of cyclins D1 and D3 was reduced after TRPC1 knockdown, pointing out the role of TRPC1 in G(1)/S transition. This was associated with a decreased phosphorylation and activation of EGFR and with a subsequent disruption of PI3K/Akt and MAPK downstream pathways. Stimulation of EGFR by its natural ligand, EGF, induced Ca2+ release from the endoplasmic reticulum and Ca2+ entry through TRPC1. Ca2+ entry through TRPC1 conversely activated EGFR, suggesting that TRPC1 is a component of a Ca(2+)dependent amplification of EGF-dependent cell proliferation.	[Tajeddine, Nicolas; Gailly, Philippe] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium	Universite Catholique Louvain	Gailly, P (corresponding author), Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, Ave Hippocrate,B1-55-12, B-1200 Brussels, Belgium.	philippe.gailly@uclouvain.be			General Direction of Scientific Research of the French Community of Belgium [FNRS-FRSM 3.4.515.09.F, ARC 10-15/029]	General Direction of Scientific Research of the French Community of Belgium	This work was supported by Grants FNRS-FRSM 3.4.515.09.F and ARC 10-15/029 from the General Direction of Scientific Research of the French Community of Belgium.	Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; Bomben VC, 2010, GLIA, V58, P1145, DOI 10.1002/glia.20994; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; CHEYETTE TE, 1991, CELL REGUL, V2, P827, DOI 10.1091/mbc.2.10.827; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; El Hiani Y, 2009, ARCH BIOCHEM BIOPHYS, V486, P58, DOI 10.1016/j.abb.2009.03.010; Fabian A, 2008, PFLUG ARCH EUR J PHY, V457, P475, DOI 10.1007/s00424-008-0515-4; Fabian A, 2011, PFLUG ARCH EUR J PHY, V461, P295, DOI 10.1007/s00424-010-0901-6; Flockerzi V, 2005, PFLUG ARCH EUR J PHY, V451, P81, DOI 10.1007/s00424-005-1443-1; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; MOOLENAAR WH, 1986, J BIOL CHEM, V261, P279; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Rychkov G., 2007, V179, P23; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Tajeddine N, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.L109.073221; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97	44	74	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16146	16157		10.1074/jbc.M112.340034	http://dx.doi.org/10.1074/jbc.M112.340034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451676	Green Published, hybrid			2022-12-28	WOS:000304030900007
J	Kikutani, S; Tanaka, R; Yamazaki, Y; Hara, S; Hisabori, T; Kroth, PG; Matsuda, Y				Kikutani, Sae; Tanaka, Rie; Yamazaki, Yukiko; Hara, Satoshi; Hisabori, Toru; Kroth, Peter G.; Matsuda, Yusuke			Redox Regulation of Carbonic Anhydrases via Thioredoxin in Chloroplast of the Marine Diatom Phaeodactylum tricornutum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO2; PROTEINS; ACCUMULATION; ARABIDOPSIS; GENOME; IDENTIFICATION; LOCALIZATION; EXPRESSION; PROTEOMICS; EVOLUTION	Thioredoxins (Trxs) are important regulators of photosynthetic fixation of CO2 and nitrogen in plant chloroplasts. To date, they have been considered to play a minor role in controlling the Calvin cycle in marine diatoms, aquatic primary producers, although diatoms possess a set of plastidic Trxs. In this study we examined the influences of the redox state and the involvement of Trxs in the enzymatic activities of pyrenoidal carbonic anhydrases, PtCA1 and PtCA2, in the marine diatom Phaeodactylum tricornutum. The recombinant mature PtCA1 and -2 (mPtCA1 and -2) were completely inactivated following oxidation by 50 mu M CuCl2, whereas DTT activated CAs in a concentration-dependent manner. The maximum activity of mPtCAs in the presence of 6 mM reduced DTT increased significantly by addition of 10 mu M Trxs from Arabidopsis thaliana (AtTrx-f2 and -m2) and 5 mu M Trxs from P. tricornutum (PtTrxF and -M). Analyses of mPtCA activation by Trxs in the presence of DTT revealed that the maximum mPtCA1 activity was enhanced similar to 3-fold in the presence of Trx, whereas mPtCA2 was only weakly activated by Trxs, and that PtTrxs activate PtCAs more efficiently compared with AtTrxs. Site-directed mutagenesis of potential disulfide-forming cysteines in mPtCA1 and mPtCA2 resulted in a lack of oxidative inactivation of both mPtCAs. These results reveal the first direct evidence of a target of plastidic Trxs in diatoms, indicating that Trxs may participate in the redox control of inorganic carbon flow in the pyrenoid, a focal point of the CO2-concentrating mechanism.	[Kikutani, Sae; Tanaka, Rie; Yamazaki, Yukiko; Matsuda, Yusuke] Kwansei Gakuin Univ, Res Ctr Environm Biosci, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Hara, Satoshi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Tokyo, Kanagawa 2268503, Japan; [Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany	Kwansei Gakuin University; Tokyo Institute of Technology; University of Konstanz	Matsuda, Y (corresponding author), Kwansei Gakuin Univ, Res Ctr Environm Biosci, Dept Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	yusuke@kwansei.ac.jp	Kroth, Peter G/A-9728-2008; Hara, Satoshi/C-1341-2015; Hisabori, Toru/E-5205-2014	Kroth, Peter G/0000-0003-4734-8955; Hara, Satoshi/0000-0001-6275-6469; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Steel Industry Foundation for the Advancement of Environmental Protection Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Steel Industry Foundation for the Advancement of Environmental Protection Technology(Steel Industry Foundation for the Advancement of Environmental Protection Technology)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Kwansei Gakuin University, Research Center for Environmental Bioscience, and by the Steel Industry Foundation for the Advancement of Environmental Protection Technology (to Y. M.).	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Bosco MB, 2012, PROTIST, V163, P188, DOI 10.1016/j.protis.2011.07.001; Bjorkbacka H, 1997, BIOCHEMISTRY-US, V36, P4287, DOI 10.1021/bi962825k; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; COLMAN B, 1995, PLANT CELL ENVIRON, V18, P919, DOI 10.1111/j.1365-3040.1995.tb00601.x; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FUKUZAWA H, 1992, P NATL ACAD SCI USA, V89, P4437, DOI 10.1073/pnas.89.10.4437; Funke RP, 1997, PLANT PHYSIOL, V114, P237, DOI 10.1104/pp.114.1.237; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harada H, 2005, CAN J BOT, V83, P909, DOI 10.1139/B05-078; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Harada H, 2006, PLANT PHYSIOL, V142, P1318, DOI 10.1104/pp.106.086561; Hiltonen T, 1998, PLANT PHYSIOL, V117, P1341, DOI 10.1104/pp.117.4.1341; JOHANSSON IM, 1993, EUR J BIOCHEM, V218, P439, DOI 10.1111/j.1432-1033.1993.tb18394.x; Johnston AM, 1996, EUR J PHYCOL, V31, P285, DOI 10.1080/09670269600651491; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaire SD, 2004, PHOTOSYNTH RES, V82, P203, DOI 10.1007/s11120-004-1091-x; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Matsuda Y, 2001, PLANT CELL ENVIRON, V24, P611, DOI 10.1046/j.1365-3040.2001.00702.x; Meyer Y, 2002, METHOD ENZYMOL, V347, P394; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michels AK, 2005, PLANT PHYSIOL, V137, P911, DOI 10.1104/pp.104.055285; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; Raven JA, 1997, PLANT CELL ENVIRON, V20, P147, DOI 10.1046/j.1365-3040.1997.d01-67.x; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Stumpp MT, 1999, BIOCHEM J, V341, P157, DOI 10.1042/0264-6021:3410157; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tanaka Y, 2005, PLANT PHYSIOL, V138, P207, DOI 10.1104/pp.104.058982; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Vallat BK, 2008, PROTEINS, V72, P910, DOI 10.1002/prot.21976; Van K, 1999, PLANT PHYSIOL, V120, P757, DOI 10.1104/pp.120.3.757; Weber T, 2009, MOL PLANT, V2, P468, DOI 10.1093/mp/ssp010; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636	50	33	34	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20689	20700		10.1074/jbc.M111.322743	http://dx.doi.org/10.1074/jbc.M111.322743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535967	Green Published, hybrid			2022-12-28	WOS:000306414500087
J	Li, ZQ; Ding, TB; Pan, XY; Li, Y; Li, RH; Sanders, PE; Kuo, MS; Hussain, MM; Cao, GQ; Jiang, XC				Li, Zhiqiang; Ding, Tingbo; Pan, Xiaoyue; Li, Yan; Li, Ruohan; Sanders, Philip E.; Kuo, Ming-Shang; Hussain, M. Mahmood; Cao, Guoqing; Jiang, Xian-Cheng			Lysophosphatidylcholine Acyltransferase 3 Knockdown-mediated Liver Lysophosphatidylcholine Accumulation Promotes Very Low Density Lipoprotein Production by Enhancing Microsomal Triglyceride Transfer Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B SECRETION; RAT HEPATOCYTES; MCA-RH7777 CELLS; INTRACELLULAR DEGRADATION; LIPID-SYNTHESIS; MESSENGER-RNA; APOPROTEIN-B; II CELLS; METABOLISM; GENE	After de novo biosynthesis phospholipids undergo extensive remodeling by the Lands' cycle. Enzymes involved in phospholipid biosynthesis have been studied extensively but not those involved in reacylation of lysophosphopholipids. One key enzyme in the Lands' cycle is fatty acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT), which utilizes lysophosphatidylcholine (LysoPC) and fatty acyl-CoA to produce various phosphatidylcholine (PC) species. Four isoforms of LPCAT have been identified. In this study we found that LPCAT3 is the major hepatic isoform, and its knockdown significantly reduces hepatic LPCAT activity. Moreover, we report that hepatic LPCAT3 knockdown increases certain species of LysoPCs and decreases certain species of PC. A surprising observation was that LPCAT3 knockdown significantly reduces hepatic triglycerides. Despite this, these mice had higher plasma triglyceride and apoB levels. Lipoprotein production studies indicated that reductions in LPCAT3 enhanced assembly and secretion of triglyceride-rich apoB-containing lipoproteins. Furthermore, these mice had higher microsomal triglyceride transfer protein (MTP) mRNA and protein levels. Mechanistic studies in hepatoma cells revealed that LysoPC enhances secretion of apoB but not apoA-I in a concentration-dependent manner. Moreover, LysoPC increased MTP mRNA, protein, and activity. In short, these results indicate that hepatic LPCAT3 modulates VLDL production by regulating LysoPC levels and MTP expression.	[Li, Zhiqiang; Ding, Tingbo; Pan, Xiaoyue; Li, Yan; Li, Ruohan; Hussain, M. Mahmood; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Li, Zhiqiang; Jiang, Xian-Cheng] Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA; [Sanders, Philip E.; Kuo, Ming-Shang; Cao, Guoqing] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Ding, Tingbo] Fudan Univ, Dept Biochem, Sch Pharm, Shanghai 201203, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Eli Lilly; Fudan University	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	mhussain@downstate.edu; guoqing_cao@lilly.com; xjiang@downstate.edu			National Institutes of Health [HL093419]; American Heart Association [10SDG4040054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL093419 (to X.-C. J.). This study was also supported by American Heart Association Grant 10SDG4040054 (to Z. L.).	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; BARON H, 1971, BIOCHIM BIOPHYS ACTA, V248, P1, DOI 10.1016/0005-2760(71)90068-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOREN J, 1994, J BIOL CHEM, V269, P25879; BRUNZELL JD, 1983, J LIPID RES, V24, P147; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Choy PC, 1997, BBA-LIPID LIPID MET, V1348, P124, DOI 10.1016/S0005-2760(97)00114-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginsberg HN, 1997, CLIN EXP PHARMACOL P, V24, pA29, DOI 10.1111/j.1440-1681.1997.tb03051.x; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; Hamilton RL, 1998, J LIPID RES, V39, P1543; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANG CA, 1990, J LIPID RES, V31, P2079; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P9741, DOI 10.1073/pnas.87.24.9741; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; PORTMAN OW, 1969, J LIPID RES, V10, P158; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Shi AH, 1999, HORM METAB RES, V31, P283, DOI 10.1055/s-2007-978734; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; SWIFT LL, 1995, J LIPID RES, V36, P395; Tew DG, 1996, ARTERIOSCL THROM VAS, V16, P591, DOI 10.1161/01.ATV.16.4.591; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Tran K, 2006, BBA-MOL CELL BIOL L, V1761, P463, DOI 10.1016/j.bbalip.2006.03.018; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; WANG HX, 1993, J CLIN INVEST, V91, P1380, DOI 10.1172/JCI116340; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WETTERAU JR, 1992, SCIENCE, V258, P999; Wiggins D, 1996, BIOCHEM J, V320, P673, DOI 10.1042/bj3200673; Xian-Cheng J, 2005, J BIOL CHEM, V280, P18336, DOI 10.1074/jbc.M500007200; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; Zhang B, 2006, ATHEROSCLEROSIS, V186, P291, DOI 10.1016/j.atherosclerosis.2005.07.029; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zhou ZY, 1998, BBA-LIPID LIPID MET, V1391, P13, DOI 10.1016/S0005-2760(97)00200-2	52	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20122	20131		10.1074/jbc.M111.334664	http://dx.doi.org/10.1074/jbc.M111.334664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511767	Green Published, hybrid			2022-12-28	WOS:000306414500033
J	Mittal, A; Bohm, S; Grutter, MG; Bordignon, E; Seeger, MA				Mittal, Anshumali; Boehm, Simon; Gruetter, Markus G.; Bordignon, Enrica; Seeger, Markus A.			Asymmetry in the Homodimeric ABC Transporter MsbA Recognized by a DARPin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MSBA; P-GLYCOPROTEIN; CONFORMATIONAL CYCLE; ALTERNATING ACCESS; ATP HYDROLYSIS; IN-VITRO; BINDING; MEMBRANE; PROTEINS; DEPENDENCE	ABC transporters harness the energy from ATP binding and hydrolysis to translocate substrates across the membrane. Binding of two ATP molecules at the nucleotide binding domains (NBDs) leads to the formation of an outward-facing state. The conformational changes required to reset the transporter to the inward-facing state are initiated by sequential hydrolysis of the bound nucleotides. In a homodimeric ABC exporter such as MsbA responsible for lipid A transport in Escherichia coli, sequential ATP hydrolysis implies the existence of an asymmetric conformation. Here we report the in vitro selection of a designed ankyrin repeat protein (DARPin) specifically binding to detergent-solubilized MsbA. Only one DARPin binds to the homodimeric transporter in the absence as well as in the presence of nucleotides, suggesting that it recognizes asymmetries in MsbA. DARPin binding increases the rate of ATP hydrolysis by a factor of two independent of the substrate-induced ATPase stimulation. Electron paramagnetic resonance (EPR) measurements are found to be in good agreement with the available crystal structures and reveal that DARPin binding does not affect the large nucleotide-driven conformational changes of MsbA. The binding epitope was mapped by cross-linking and EPR to the membrane-spanning part of the transmembrane domain (TMD). Using cross-linked DARPin-MsbA complexes, 8-azido-ATP was found to preferentially photolabel one chain of the homodimer, suggesting that the asymmetries captured by DARPin binding at the TMDs are propagated to the NBDs. This work demonstrates that in vitro selected binders are useful tools to study the mechanism of membrane proteins.	[Boehm, Simon; Bordignon, Enrica] Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Mittal, Anshumali; Gruetter, Markus G.; Seeger, Markus A.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bordignon, E (corresponding author), Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch; m.seeger@bioc.uzh.ch	Mittal, Anshumali/G-9685-2012	Mittal, Anshumali/0000-0002-0478-2682; Seeger, Markus/0000-0003-1761-8571; Bordignon, Enrica/0000-0003-2450-5161	Swiss National Science Foundation; Forschungskredit of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of the University of Zurich	This work was funded by the Swiss NCCR Structural Biology program, an Ambizione Grant from the Swiss National Science Foundation (to M. A. S.) and a Forschungskredit of the University of Zurich (to M. A. S.).	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Booth PJ, 2005, CURR OPIN STRUC BIOL, V15, P435, DOI 10.1016/j.sbi.2005.06.002; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Forrer J, 2008, J MAGN RESON, V190, P280, DOI 10.1016/j.jmr.2007.11.009; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Koide S, 2009, CURR OPIN STRUC BIOL, V19, P449, DOI 10.1016/j.sbi.2009.04.008; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	49	40	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20395	20406		10.1074/jbc.M112.359794	http://dx.doi.org/10.1074/jbc.M112.359794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523072	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000306414500058
J	Santa-Maria, I; Varghese, M; Ksiezak-Reding, H; Dzhun, A; Wang, J; Pasinetti, GM				Santa-Maria, Ismael; Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Wang, Jun; Pasinetti, Giulio M.			Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; SEED POLYPHENOLIC EXTRACT; NEURONAL CELLS; NEUROFIBRILLARY DEGENERATION; NEURODEGENERATIVE DISEASES; EXTRACELLULAR TAU; ALPHA-SYNUCLEIN; EXOSOMES; TAUOPATHY; MODEL	Abnormal folding of tau protein leads to the generation of paired helical filaments (PHFs) and neurofibrillary tangles, a key neuropathological feature in Alzheimer disease and tauopathies. A specific anatomical pattern of pathological changes developing in the brain suggests that once tau pathology is initiated it propagates between neighboring neuronal cells, possibly spreading along the axonal network. We studied whether PHFs released from degenerating neurons could be taken up by surrounding cells and promote spreading of tau pathology. Neuronal and non-neuronal cells overexpressing green fluorescent protein-tagged tau (GFP-Tau) were treated with isolated fractions of human Alzheimer disease-derived PHFs for 24 h. We found that cells internalized PHFs through an endocytic mechanism and developed intracellular GFP-Tau aggregates with attributes of aggresomes. This was particularly evident by the perinuclear localization of aggregates and redistribution of the vimentin intermediate filament network and retrograde motor protein dynein. Furthermore, the content of Sarkosyl-insoluble tau, a measure of abnormal tau aggregation, increased 3-fold in PHF-treated cells. An exosome-related mechanism did not appear to be involved in the release of GFP-Tau from untreated cells. The evidence that cells can internalize PHFs, leading to formation of aggresome-like bodies, opens new therapeutic avenues to prevent propagation and spreading of tau pathology.	[Santa-Maria, Ismael; Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Wang, Jun; Pasinetti, Giulio M.] Mt Sinai Sch Med, Ctr Excellence Res Complementary & Alternat Med A, Ctr Excellence Novel Approaches Neurodiagnost & N, Brain Inst,Dept Neurol, New York, NY 10029 USA; [Varghese, Merina; Ksiezak-Reding, Hanna; Dzhun, Anastasiya; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY 10468 USA; [Santa-Maria, Ismael] Queen Sofia Fdn, Ctr Invest Enfermedades Neurol Fdn, Alzheimer Dis Res Unit, Madrid 28031, Spain	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Ctr Excellence Res Complementary & Alternat Med A, Ctr Excellence Novel Approaches Neurodiagnost & N, Brain Inst,Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu	Santa-Maria, Ismael/AAI-7630-2020; Varghese, Merina/H-5472-2019	Varghese, Merina/0000-0002-1517-3903; Pasinetti, Giulio/0000-0002-1524-5196; Santa-Maria Perez, Ismael/0000-0003-2801-5020	NCI, National Institutes of Health [5R24 CA095823-04, PO1 AT004511]; National Institutes of Health Shared Instrumentation [1 S10 RR0 9145-01]; Society for Progressive Supranuclear Palsy; Veterans Affairs merit review grant; National Science Foundation Major Research Instrumentation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Progressive Supranuclear Palsy; Veterans Affairs merit review grant(US Department of Veterans Affairs); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Confocal laser scanning microscopy was performed at the James J. Peters Veteran Affairs Medical Center and conventional fluorescence microscopy was performed at the Mount Sinai School of Medicine Microscopy Shared Resource Facility supported with funding from NCI, National Institutes of Health Shared Resource Grant 5R24 CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health Shared Instrumentation Grant 1 S10 RR0 9145-01. We thank Jesus Avila (Universidad Auto noma de Madrid, Madrid, Spain) for help with preparing GFP and GFP-Tau plasmids. We also thank Miguel Gama-Sosa (Mount Sinai School of Medicine, New York, NY) for lending his expertise in confocal microscopy.; This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 (to G. M. P.). This work was also supported by the Society for Progressive Supranuclear Palsy and in part by Veterans Affairs merit review grant (to G. M. P.). Dr. Pasinetti has filed a patent application (pending) through Mount Sinai School of Medicine related to grape seed polyphenolic extract. In the event that the pending patent is licensed, Dr. Pasinetti would be entitled to a share of any proceeds Mount Sinai School of Medicine receives from the license.	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; BIEDLER JL, 1978, CANCER RES, V38, P3751; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guthrie CR, 2011, J MOL NEUROSCI, V45, P32, DOI 10.1007/s12031-011-9502-x; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Ho L, 2009, J ALZHEIMERS DIS, V16, P433, DOI 10.3233/JAD-2009-0969; Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Ksiezak-Reding H, 2012, NEUROBIOL AGING, V33, P1427, DOI 10.1016/j.neurobiolaging.2010.11.006; KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li Z., 2012, INT J ALZHEIMERS DIS; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pasinetti GM, 2010, J NEUROCHEM, V114, P1557, DOI 10.1111/j.1471-4159.2010.06875.x; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2008, J ALZHEIMERS DIS, V13, P177; Santa-Maria I, 2012, NEUROBIOL AGING, V33, P2072, DOI 10.1016/j.neurobiolaging.2011.09.027; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Takahashi M, 2002, J NEUROPATH EXP NEUR, V61, P33, DOI 10.1093/jnen/61.1.33; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Zhao Z, 2003, MOL CELL NEUROSCI, V24, P367, DOI 10.1016/S1044-7431(03)00175-1	67	91	95	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20522	20533		10.1074/jbc.M111.323279	http://dx.doi.org/10.1074/jbc.M111.323279			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496370	hybrid, Green Published			2022-12-28	WOS:000306414500073
J	Szabo, A; Sahin-Toth, M				Szabo, Andras; Sahin-Toth, Miklos			Increased Activation of Hereditary Pancreatitis-associated Human Cationic Trypsinogen Mutants in Presence of Chymotrypsin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZYMOGEN ACTIVATION; MUTATION; PRSS1; GENE; AUTOACTIVATION; SECRETION; EXPRESSION; MECHANISM; VARIANTS; JUICE	Mutations in human cationic trypsinogen (PRSS1) cause autosomal dominant hereditary pancreatitis. Increased intra-pancreatic autoactivation of trypsinogen mutants has been hypothesized to initiate the disease. Autoactivation of cationic trypsinogen is proteolytically regulated by chymotrypsin C (CTRC), which mitigates the development of trypsin activity by promoting degradation of both trypsinogen and trypsin. Paradoxically, CTRC also increases the rate of autoactivation by processing the trypsinogen activation peptide to a shorter form. The aim of this study was to investigate the effect of CTRC on the autoactivation of clinically relevant trypsinogen mutants. We found that in the presence of CTRC, trypsinogen mutants associated with classic hereditary pancreatitis (N29I, N29T, V39A, R122C, and R122H) autoactivated at increased rates and reached markedly higher active trypsin levels compared with wild-type cationic trypsinogen. The A16V mutant, known for its variable disease penetrance, exhibited a smaller increase in autoactivation. The mechanistic basis of increased activation was mutation-specific and involved resistance to degradation (N29I, N29T, V39A, R122C, and R122H) and/or increased N-terminal processing by CTRC (A16V and N29I). These observations indicate that hereditary pancreatitis is caused by CTRC-dependent dysregulation of cationic trypsinogen autoactivation, which results in elevated trypsin levels in the pancreas.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01 DK058088, R01 DK082412, R01 DK082412-S2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK058088, R01 DK082412, and R01 DK082412-S2 (to M.S.-T.).	Arduino C, 2005, GUT, V54, P1663, DOI 10.1136/gut.2004.062992; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Furui T, 2000, PANCREAS, V21, P257, DOI 10.1097/00006676-200010000-00006; GEROLAMI A, 1989, GASTROENTEROLOGY, V96, P881; Grocock CJ, 2010, GUT, V59, P357, DOI 10.1136/gut.2009.186817; HARADA H, 1980, Gastroenterologia Japonica, V15, P355; Howes N, 2004, CLIN GASTROENTEROL H, V2, P252, DOI 10.1016/S1542-3565(04)00013-8; Joergensen MT, 2011, PANCREAS, V40, P540, DOI 10.1097/MPA.0b013e3182152fdf; Joergensen MT, 2010, AM J GASTROENTEROL, V105, P1876, DOI 10.1038/ajg.2010.193; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Ozsvari B, 2008, PANCREAS, V37, P182, DOI 10.1097/MPA.0b013e3181663066; Rebours V, 2009, GUT, V58, P97, DOI 10.1136/gut.2008.149179; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2010, J MED GENET, V47, P348, DOI 10.1136/jmg.2009.072751; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 2005, HUM MUTAT, V25, P343, DOI 10.1002/humu.20148; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zhou JY, 2011, J GASTROEN HEPATOL, V26, P1238, DOI 10.1111/j.1440-1746.2011.06791.x	33	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20701	20710		10.1074/jbc.M112.360065	http://dx.doi.org/10.1074/jbc.M112.360065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22539344	Green Published, hybrid			2022-12-28	WOS:000306414500088
J	Bui, SH; McLean, KJ; Cheesman, MR; Bradley, JM; Rigby, SEJ; Levy, CW; Leys, D; Munro, AW				Bui, Soi H.; McLean, Kirsty J.; Cheesman, Myles R.; Bradley, Justin M.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.			Unusual Spectroscopic and Ligand Binding Properties of the Cytochrome P450-Flavodoxin Fusion Enzyme XplA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; MYCOBACTERIUM-TUBERCULOSIS; FLAVOCYTOCHROME P450BM3; HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; BIOPHYSICAL CHARACTERIZATION; REDUCTIVE DECHLORINATION; CRYSTAL-STRUCTURE; SELF-SUFFICIENT; HEME; DEGRADATION	The Rhodococcus rhodochrous strain 11Y XplA enzyme is an unusual cytochrome P450-flavodoxin fusion enzyme that catalyzes reductive denitration of the explosive hexahydro-1,3,5-trinitro-1,3,5-triazene (RDX). We show by light scattering that XplA is a monomeric enzyme. XplA has high affinity for imidazole (K-d = 1.6 mu M), explaining previous reports of a red-shifted XplA Soret band in pure enzyme. The true Soret maximum of XplA is at 417 nm. Similarly, unusually weak XplA flavodoxin FMN binding (K-d = 1.09 mu M) necessitates its purification in the presence of the cofactor to produce hallmark flavin contributions absent in previously reported spectra. Structural and ligand-binding data reveal a constricted active site able to accommodate RDX and small inhibitory ligands (e.g. 4-phenylimidazole and morpholine) while discriminating against larger azole drugs. The crystal structure also identifies a high affinity imidazole binding site, consistent with its low K-d, and shows active site penetration by PEG, perhaps indicative of an evolutionary lipid-metabolizing function for XplA. EPR studies indicate heterogeneity in binding mode for RDX and other ligands. The substrate analog trinitrobenzene does not induce a substrate-like type I optical shift but creates a unique low spin EPR spectrum due to influence on structure around the distal water heme ligand. The substrate-free heme iron potential (-268mV versus NHE) is positive for a low spin P450, and the elevated potential of the FMN semiquinone/hydroquinone couple (-172 mV) is also an adaptation that may reflect (along with the absence of a key Thr/Ser residue conserved in oxygen-activating P450s) the evolution of XplA as a specialized RDX reductase catalyst.	[Bui, Soi H.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Cheesman, Myles R.; Bradley, Justin M.] Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England	University of Manchester; University of East Anglia	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044	United Kingdom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E013252/1, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013252/1, BB/E013007/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council.; Supported by a Biotechnology and Biological Sciences Research Council Ph.D. studentship.	Aliverti A, 1999, METH MOL B, V131, P9; Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Ayoub K, 2010, J HAZARD MATER, V178, P10, DOI 10.1016/j.jhazmat.2010.02.042; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; BOHAN TL, 1977, J MAGN RESON, V26, P109, DOI 10.1016/0022-2364(77)90240-2; Cargill R., 1990, CARBON MONOXIDE, V43, P5; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dutton P L, 1978, Methods Enzymol, V54, P411; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; French CE, 1999, NAT BIOTECHNOL, V17, P491, DOI 10.1038/8673; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Girvan HM, 2010, BIOCHEM J, V427, P455, DOI 10.1042/BJ20091603; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; HARTLINE RA, 1971, J BACTERIOL, V106, P468, DOI 10.1128/JB.106.2.468-478.1971; Hawkes DB, 2010, CHEMBIOCHEM, V11, P1107, DOI 10.1002/cbic.201000119; Jackson CJ, 2002, J BIOL CHEM, V277, P46959, DOI 10.1074/jbc.M203523200; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kammer FVD, 2005, ANAL CHIM ACTA, V552, P166, DOI 10.1016/j.aca.2005.07.049; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kurumata M, 2005, Z NATURFORSCH C, V60, P272; Lachance B, 1999, MUTAT RES-GEN TOX EN, V444, P25, DOI 10.1016/S1383-5718(99)00073-X; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Lederer F, 1999, METH MOL B, V131, P149; Martinis SA, 1996, BIOCHEMISTRY-US, V35, P14530, DOI 10.1021/bi961511u; McCarthy AA, 2002, BIOCHEMISTRY-US, V41, P10950, DOI 10.1021/bi020225h; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Munro AW, 1996, BBA-PROTEIN STRUCT M, V1296, P127, DOI 10.1016/0167-4838(96)00061-1; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1998, BIOCHEMISTRY-US, V37, P15799, DOI 10.1021/bi980462d; Okeke BC, 2001, CAN J MICROBIOL, V47, P448; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RUX JJ, 1991, FEBS LETT, V290, P49, DOI 10.1016/0014-5793(91)81222-T; Rylott EL, 2006, NAT BIOTECHNOL, V24, P216, DOI 10.1038/nbt1184; Rylott EL, 2011, BBA-PROTEINS PROTEOM, V1814, P230, DOI 10.1016/j.bbapap.2010.07.004; Sabbadin F, 2009, J BIOL CHEM, V284, P28467, DOI 10.1074/jbc.M109.031559; Seth-Smith HMB, 2008, APPL ENVIRON MICROB, V74, P4550, DOI 10.1128/AEM.00391-08; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shao ZQ, 1996, APPL ENVIRON MICROB, V62, P403, DOI 10.1128/AEM.62.2.403-407.1996; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; SONO M, 1982, J BIOL CHEM, V257, P8308; SONO M, 1982, J BIOL CHEM, V257, P5496; Thompson KT, 2005, APPL ENVIRON MICROB, V71, P8265, DOI 10.1128/AEM.71.12.8265-8272.2005; ULLRICH V, 1975, BIOCHEM SOC T, V3, P803, DOI 10.1042/bst0030803; Van Aken B, 2009, CURR OPIN BIOTECH, V20, P231, DOI 10.1016/j.copbio.2009.01.011; Warman AJ, 2005, BIOCHEM SOC T, V33, P747, DOI 10.1042/BST0330747; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x	71	23	23	2	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19699	19714		10.1074/jbc.M111.319202	http://dx.doi.org/10.1074/jbc.M111.319202			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500029	Green Published, hybrid			2022-12-28	WOS:000306411900080
J	Garcia-Ruiz, I; Solis-Munoz, P; Gomez-Izquierdo, E; Munoz-Yague, MT; Valverde, AM; Solis-Herruzo, JA				Garcia-Ruiz, Inmaculada; Solis-Munoz, Pablo; Gomez-Izquierdo, Erica; Teresa Munoz-Yaguee, Maria; Valverde, Angela M.; Solis-Herruzo, Jose A.			Protein-tyrosine Phosphatases Are Involved in Interferon Resistance Associated with Insulin Resistance in HepG2 Cells and Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEPATITIS-C; NECROSIS-FACTOR-ALPHA; METALLOPROTEINASE-13 GENE-EXPRESSION; STIMULATED JAK/STAT PATHWAY; NEGATIVE REGULATOR; PLUS RIBAVIRIN; OB/OB MICE; METFORMIN; RECEPTOR; PTP1B	Insulin resistance is a risk factor for non-response to interferon/ribavirin therapy in patients with chronic hepatitis C. The aim of this study was to determine the role played by protein-tyrosine phosphatases (PTPs) in the absence of interferon-alpha (IFN alpha) response associated with insulin resistance. We induced insulin resistance by silencing IRS-2 or by treating HepG2 cells with tumor necrosis factor-alpha (TNF alpha) and analyzed insulin response by evaluating Akt phosphorylation and IFN alpha response by measuring Stat-1 tyrosine phosphorylation and 2',5'-oligoadenylate synthase and myxovirus resistance gene expression. The response to IFN alpha was also measured in insulin-resistant obese mice (high fat diet and ob/ob mice) untreated and treated with metformin. Silencing IRS-2 mRNA induces insulin resistance and inhibits IFN alpha response. Likewise, TNF alpha suppresses insulin and IFN alpha response. Treatment of cells with pervanadate and knocking down PTP-1B restores insulin and IFN alpha response. Both silencing IRS-2 and TNF alpha treatment increase PTP and PTP-1B activity. Metformin inhibits PTP and improves IFN alpha response in insulin-resistant cells. Insulin-resistant ob/ob mice have increased PTP-1B gene expression and activity in the liver and do not respond to IFN alpha administration. Treatment with metformin improves this response. In HepG2 cells, insulin resistance provokes IFN alpha resistance, which is associated with an increased PTP-1B activity in the liver. Inhibition of PTP-1B activity with pervanadate and metformin or knocking down PTP-1B reestablishes IFN alpha response. Likewise, metformin decreases PTP-1B activity and improves response to IFN alpha in insulin-resistant obese mice. The use of PTP-1B inhibitors may improve the response to IFN alpha/ribavirin therapy.	[Garcia-Ruiz, Inmaculada; Gomez-Izquierdo, Erica; Teresa Munoz-Yaguee, Maria; Solis-Herruzo, Jose A.] Univ Complutense, Res Inst, Univ Hosp 12 Octubre, Sch Med, Madrid 28041, Spain; [Solis-Munoz, Pablo] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; [Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedad Metab A, Madrid 28029, Spain; [Valverde, Angela M.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid 28029, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Solis-Herruzo, JA (corresponding author), Hosp 12 Octubre, Ctr Invest, Ave Cordoba S-N, E-28041 Madrid, Spain.	jsolis.hdoc@salud.madrid.org	Solis-Muñoz, Pablo/N-5955-2017; García-Ruiz, Inmaculada/G-8204-2015	Solis-Muñoz, Pablo/0000-0002-5550-1350; García-Ruiz, Inmaculada/0000-0003-4185-8524; Martinez Valverde, Angela/0000-0003-1192-9045	Fundacion Mutua Madrilena; "Fondo de Investigacion Sanitaria", Spain [PI07/0052;PI10/0312]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); "Fondo de Investigacion Sanitaria", Spain(Instituto de Salud Carlos III)	This study was supported in part by Grants from the "Fundacion Mutua Madrilena" and from the "Fondo de Investigacion Sanitaria" (PI07/0052; PI10/0312), Spain.	AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; Andujar-Plata P, 2012, DIABETES RES CLIN PR, V95, P1, DOI 10.1016/j.diabres.2011.09.022; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Brackett CC, 2010, J AM PHARM ASSOC, V50, P407, DOI 10.1331/JAPhA.2010.08090; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; CHEN J, 1994, J BIOL CHEM, V269, P7957; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Diaz-Sanjuan T, 2009, J HEPATOL, V50, P128, DOI 10.1016/j.jhep.2008.07.034; Duong FHT, 2006, HEPATOLOGY, V43, P796, DOI 10.1002/hep.21116; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Emslie-Smith AM, 2001, DIABETIC MED, V18, P483, DOI 10.1046/j.1464-5491.2001.00509.x; Franceschini L, 2011, HEPATOLOGY, V54, P484, DOI 10.1002/hep.24394; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; GIN H, 1985, METABOLISM, V34, P923, DOI 10.1016/0026-0495(85)90139-8; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Holland W, 2004, BIOCHEM PHARMACOL, V67, P2081, DOI 10.1016/j.bcp.2004.02.016; Hong F, 2001, FASEB J, V15, P1595, DOI 10.1096/fj.00-0908fje; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Lang A, 2000, AM J PHYSIOL-GASTR L, V279, pG1333, DOI 10.1152/ajpgi.2000.279.6.G1333; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Mashimo T, 2003, GENOMICS, V82, P537, DOI 10.1016/S0888-7543(03)00176-9; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2009, HEPATOLOGY, V50, P1702, DOI 10.1002/hep.23206; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Solis-Herruzo JA, 1999, J BIOL CHEM, V274, P30919, DOI 10.1074/jbc.274.43.30919; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stith BJ, 1996, ENDOCRINOLOGY, V137, P2990, DOI 10.1210/en.137.7.2990; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224	49	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19564	19573		10.1074/jbc.M112.342709	http://dx.doi.org/10.1074/jbc.M112.342709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493491	Green Published, hybrid			2022-12-28	WOS:000306411900068
J	Jang, SY; Kang, HT; Hwang, ES				Jang, So-young; Kang, Hyun Tae; Hwang, Eun Seong			Nicotinamide-induced Mitophagy EVENT MEDIATED BY HIGH NAD(+)/NADH RATIO AND SIRT1 PROTEIN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; LIFE-SPAN; CALORIE RESTRICTION; MITOCHONDRIAL BIOGENESIS; CELLULAR SENESCENCE; AMPK ACTIVATION; HUMAN-CELLS; AUTOPHAGY; FUSION; METABOLISM	Active autophagy coupled with rapid mitochondrial fusion and fission constitutes an important mitochondrial quality control mechanism and is critical to cellular health. In our previous studies, we found that exposure of cells to nicotinamide causes a decrease in mitochondrial content and an increase in mitochondrial membrane potential (MMP) by activating autophagy and inducing mitochondrial fragmentation. Here, we present evidence to show that the effect of nicotinamide is mediated through an increase of the [NAD(+)]/[NADH] ratio and the activation of SIRT1, an NAD(+)-dependent deacetylase that plays a role in autophagy flux. The [NAD(+)]/[NADH] ratio was inversely correlated with the mitochondrial content, and an increase in the ratio by the mobilization of the malate-aspartate shuttle resulted in autophagy activation and mitochondrial transformation from lengthy filaments to short dots. Furthermore, treatment of cells with SIRT1 activators, fisetin or SRT1720, induced similar changes in the mitochondrial content. Importantly, the activators induced mitochondrial fragmentation only when SIRT1 expression was intact. Meanwhile, MMP did not increase when the cells were treated with the activators, suggesting that the change in MMP is not induced by the mitochondrial turnover per se and that elevation of the [NAD(+)]/[NADH] ratio may activate additional mechanisms that cause MMP augmentation. Together, our results indicate that a metabolic state resulting in an elevated [NAD(+)]/[NADH] ratio can modulate mitochondrial quantity and quality via pathways that may include SIRT1-mediated mitochondrial autophagy.	[Jang, So-young; Kang, Hyun Tae; Hwang, Eun Seong] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Hwang, ES (corresponding author), Univ Seoul, Dept Life Sci, Seoul 130743, South Korea.	eshwang@uos.ac.kr		Hwang, Eun Seong/0000-0001-8580-8444	Mid-career Researcher Program NRF [2009-0086432]; MEST	Mid-career Researcher Program NRF(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Mid-career Researcher Program NRF Grant 2009-0086432 funded by the MEST.	Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chen CJ, 2009, BIOCHEM BIOPH RES CO, V378, P389, DOI 10.1016/j.bbrc.2008.11.110; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasmann M, 2003, CANCER RES, V63, P7436; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; JACKSON TM, 1995, J NUTR, V125, P1455; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kloting N, 2005, EXP GERONTOL, V40, P878, DOI 10.1016/j.exger.2005.07.004; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Milner J, 2009, CURR PHARM DESIGN, V15, P39, DOI 10.2174/138161209787185841; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Nelson D. L., 2000, LEHNINGER PRINCIPLES, P685; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Park JW, 1998, INT J CARDIOL, V65, P139, DOI 10.1016/S0167-5273(98)00117-X; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	56	163	169	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19304	19314		10.1074/jbc.M112.363747	http://dx.doi.org/10.1074/jbc.M112.363747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493485	Green Published, hybrid			2022-12-28	WOS:000306411900040
J	Kfoury, N; Holmes, BB; Jiang, H; Holtzman, DM; Diamond, MI				Kfoury, Najla; Holmes, Brandon B.; Jiang, Hong; Holtzman, David M.; Diamond, Marc I.			Trans-cellular Propagation of Tau Aggregation by Fibrillar Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGLE MOUSE MODEL; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; POLYGLUTAMINE AGGREGATION; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; PATHOLOGY; CELLS	Aggregation of the microtubule associated protein Tau is associated with several neurodegenerative disorders, including Alzheimer disease and frontotemporal dementia. In Alzheimer disease, Tau pathology spreads progressively throughout the brain, possibly along existing neural networks. However, it is still unclear how the propagation of Tau misfolding occurs. Intriguingly, in animal models, vaccine-based therapies have reduced Tau and synuclein pathology by uncertain mechanisms, given that these proteins are intracellular. We have previously speculated that trans-cellular propagation of misfolding could be mediated by a process similar to prion pathogenesis, in which fibrillar Tau aggregates spread pathology from cell to cell. However, there has been little evidence to demonstrate true trans-cellular propagation of Tau misfolding, in which Tau aggregates from one cell directly contact Tau protein in the recipient cell to trigger further aggregation. Here we have observed that intracellular Tau fibrils are directly released into the medium and then taken up by co-cultured cells. Internalized Tau aggregates induce fibrillization of intracellular Tau in these naive recipient cells via direct protein-protein contact that we demonstrate using FRET. Tau aggregation can be amplified across several generations of cells. An anti-Tau monoclonal antibody blocks Tau aggregate propagation by trapping fibrils in the extracellular space and preventing their uptake. Thus, propagation of Tau protein misfolding among cells can be mediated by release and subsequent uptake of fibrils that directly contact native protein in recipient cells. These results support the model of aggregate propagation by templated conformational change and suggest a mechanism for vaccine-based therapies in neurodegenerative diseases.	[Kfoury, Najla; Holmes, Brandon B.; Jiang, Hong; Holtzman, David M.; Diamond, Marc I.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu		Holmes, Brandon/0000-0002-1153-840X	National Institutes of Health (NIH), NINDS [P50AG005681, 1R01NS071835-01]; NIH Neuroscience Blueprint Interdisciplinary Center [P30 (NS057105)]; Muscular Dystrophy Association; American Health Assistance Foundation; Ruth K. Broad Foundation; Tau Consortium; Hope Center for Neurological Disorders at Washington University in St. Louis; Donald H. and Mary Jane Buchanan Foundation; Barnes-Jewish Hospital Foundation; Siteman Cancer Center of Washington University in St. Louis; Bakewell Neuroimaging Core; Alafi Neuroimaging Laboratory; Bakewell Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, F31NS079039, R01NS071835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Neuroscience Blueprint Interdisciplinary Center; Muscular Dystrophy Association(Muscular Dystrophy Association); American Health Assistance Foundation(BrightFocus Foundation); Ruth K. Broad Foundation; Tau Consortium; Hope Center for Neurological Disorders at Washington University in St. Louis; Donald H. and Mary Jane Buchanan Foundation; Barnes-Jewish Hospital Foundation; Siteman Cancer Center of Washington University in St. Louis; Bakewell Neuroimaging Core; Alafi Neuroimaging Laboratory; Bakewell Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant 1R01NS071835-01; NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 (NS057105) (to Washington University); and NIH Grant P50AG005681 (to the Knight Alzheimer's Disease Research Center at Washington University). This work was also supported by grants from the Muscular Dystrophy Association, the American Health Assistance Foundation, the Ruth K. Broad Foundation, the Tau Consortium, the Hope Center for Neurological Disorders at Washington University in St. Louis, the Donald H. and Mary Jane Buchanan Foundation Alzheimer's Disease Research Fund, the Barnes-Jewish Hospital Foundation, the Siteman Cancer Center of Washington University in St. Louis, the Bakewell Neuroimaging Core (supported in part by the Bakewell Family Foundation), and the Alafi Neuroimaging Laboratory.	Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gousset K, 2009, PRION, V3, P94, DOI 10.4161/pri.3.2.8917; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Kondo K, 2011, BIOL PHARM BULL, V34, P1078, DOI 10.1248/bpb.34.1078; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	43	402	426	1	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19440	19451		10.1074/jbc.M112.346072	http://dx.doi.org/10.1074/jbc.M112.346072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22461630	Green Published, hybrid			2022-12-28	WOS:000306411900058
J	Matsushima, T; Saito, Y; Elliott, JI; Iijima-Ando, K; Nishimura, M; Kimura, N; Hata, S; Yamamoto, T; Nakaya, T; Suzuki, T				Matsushima, Takahide; Saito, Yuhki; Elliott, James I.; Iijima-Ando, Kanae; Nishimura, Masaki; Kimura, Nobuyuki; Hata, Saori; Yamamoto, Tohru; Nakaya, Tadashi; Suzuki, Toshiharu			Membrane-Microdomain Localization of Amyloid beta-Precursor Protein (APP) C-terminal Fragments Is Regulated by Phosphorylation of the Cytoplasmic Thr(668) Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; A-BETA; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; DEPENDENT REGULATION; MOUSE-BRAIN; DOMAIN; METABOLISM; BINDING; SITE	Amyloid beta-precursor protein (APP) is primarily cleaved by alpha-or beta-secretase to generate membrane-bound, C-terminal fragments (CTFs). In turn, CTFs are potentially subject to a second, intramembrane cleavage by gamma-secretase, which is active in a lipid raft-like membrane microdomain. Mature APP (N-and O-glycosylated APP), the actual substrate of these secretases, is phosphorylated at the cytoplasmic residue Thr(668) and this phosphorylation changes the overall conformation of the cytoplasmic domain of APP. We found that phosphorylated and nonphosphorylated CTFs exist equally in mouse brain and are kinetically equivalent as substrates for gamma-secretase, in vitro. However, in vivo, the level of the phosphorylated APP intracellular domain peptide (pAICD) generated by gamma-cleavage of CTFs was very low when compared with the level of nonphosphorylated AICD (nAICD). Phosphorylated CTFs (pCTFs), rather than nonphosphorylated CTFs (nCTFs), were preferentially located outside of detergent-resistant, lipid raft-like membrane microdomains. The APP cytoplasmic domain peptide (APP(648-695)) with Thr(P)(668) did not associate with liposomes composed of membrane lipids from mouse brain to which the nonphosphorylated peptide preferentially bound. In addition, APP lacking the C-terminal 8 amino acids (APP-Delta C8), which are essential for membrane association, decreased A beta generation in N2a cells. These observations suggest that the pCTFs and CTF Delta C8 are relatively movable within the membrane, whereas the nCTFs are susceptible to being anchored into the membrane, an interaction made available as a consequence of not being phosphorylated. By this mechanism, nCTFs can be preferentially captured and cleaved by gamma-secretase. Preservation of the phosphorylated state of APP-CTFs may be a potential treatment to lower the generation of A beta in Alzheimer disease.	[Matsushima, Takahide; Saito, Yuhki; Hata, Saori; Yamamoto, Tohru; Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido 0600812, Japan; [Elliott, James I.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Iijima-Ando, Kanae] Thomas Jefferson Univ, Dept Neurosci, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA; [Iijima-Ando, Kanae] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan; [Kimura, Nobuyuki] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Dis Control, Tsukuba, Ibaraki 3050843, Japan	Hokkaido University; Yale University; Jefferson University; Jefferson University; Shiga University of Medical Science; National Institute of Health Sciences - Japan	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Hata, Saori/AAP-9634-2020; Suzuki, Toshiharu/B-5342-2013; Hata, Saori/A-3829-2012; Yamamoto, Tohru/A-3801-2012	Yamamoto, Tohru/0000-0002-1652-0233; Hata, Saori/0000-0003-4723-5993	MEXT Japan [2339001, 23790069]; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [22590055, 23390017] Funding Source: KAKEN	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 2339001 (to T. S.) and 23790069 (to Y. S.) from MEXT Japan.; Recipient of a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Feyt C, 2007, BIOCHEM BIOPH RES CO, V357, P1004, DOI 10.1016/j.bbrc.2007.04.036; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Kondo M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-35; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liu F, 2003, FEBS LETT, V547, P193, DOI 10.1016/S0014-5793(03)00714-2; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Oikawa N, 2010, BRAIN RES, V1315, P137, DOI 10.1016/j.brainres.2009.12.005; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858	48	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19715	19724		10.1074/jbc.M111.334847	http://dx.doi.org/10.1074/jbc.M111.334847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511769	Green Published, hybrid			2022-12-28	WOS:000306411900081
J	Sharotri, V; Collier, DM; Olson, DR; Zhou, RF; Snyder, PM				Sharotri, Vikas; Collier, Daniel M.; Olson, Diane R.; Zhou, Ruifeng; Snyder, Peter M.			Regulation of Epithelial Sodium Channel Trafficking by Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; NA+ CHANNEL; GAMMA-SUBUNIT; CYSTIC-FIBROSIS; CELL-SURFACE; SELF-INHIBITION; SECRETED PCSK9; LDL RECEPTOR; ENAC; DEGRADATION	The epithelial Na+ channel (ENaC) is critical for Na+ homeostasis and blood pressure control. Defects in its regulation cause inherited forms of hypertension and hypotension. Previous work found that ENaC gating is regulated by proteases through cleavage of the extracellular domains of the alpha and gamma subunits. Here we tested the hypothesis that ENaC is regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9), a protease that modulates the risk of cardiovascular disease. PCSK9 reduced ENaC current in Xenopus oocytes and in epithelia. This occurred through a decrease in ENaC protein at the cell surface and in the total cellular pool, an effect that did not require the catalytic activity of PCSK9. PCSK9 interacted with all three ENaC subunits and decreased their trafficking to the cell surface by increasing proteasomal degradation. In contrast to its previously reported effects on the LDL receptor, PCSK9 did not alter ENaC endocytosis or degradation of the pool of ENaC at the cell surface. These results support a role for PCSK9 in the regulation of ENaC trafficking in the biosynthetic pathway, likely by increasing endoplasmic reticulum-associated degradation. By reducing ENaC channel number, PCSK9 could modulate epithelial Na+ absorption, a major contributor to blood pressure control.	[Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health [HL058812]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R29HL058812, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL058812 (to P. M. S.). This work was also supported by fellowship grants from the American Heart Association (to V. S. and D. M. C.).	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Frindt G, 2001, AM J PHYSIOL-RENAL, V280, pF112, DOI 10.1152/ajprenal.2001.280.1.F112; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	53	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19266	19274		10.1074/jbc.M112.363382	http://dx.doi.org/10.1074/jbc.M112.363382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493497	Green Published, hybrid			2022-12-28	WOS:000306411900036
J	Wang, XH; Pineau, C; Gu, S; Guschinskaya, N; Pickersgill, RW; Shevchik, VE				Wang, Xiaohui; Pineau, Camille; Gu, Shuang; Guschinskaya, Natalia; Pickersgill, Richard W.; Shevchik, Vladimir E.			Cysteine Scanning Mutagenesis and Disulfide Mapping Analysis of Arrangement of GspC and GspD Protomers within the Type 2 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; II SECRETION; ERWINIA-CHRYSANTHEMI; MULTIPLE INTERACTIONS; CRYSTAL-STRUCTURE; CHOLERA-TOXIN; DOMAIN; MACHINERY; PATHWAY; SPECIFICITY	The type II secretion system (T2SS) secretes enzymes and toxins across the outer membrane of Gram-negative bacteria. The precise assembly of T2SS, which consists of at least 12 core-components called Gsp, remains unclear. The outer membrane secretin, GspD, forms the channels, through which folded proteins are secreted, and interacts with the inner membrane component, GspC. The periplasmic regions of GspC and GspD consist of several structural domains, HRGspC and PDZ(GspC), and N0(GspD) to N3(GspD), respectively, and recent structural and functional studies have proposed several interaction sites between these domains. We used cysteine mutagenesis and disulfide bonding analysis to investigate the organization of GspC and GspD protomers and to map their interaction sites within the secretion machinery of the plant pathogen Dickeya dadantii. At least three distinct GspC-GspD interactions were detected, and they involve two sites in HRGspC, two in N0(GspD), and one in N2(GspD). None of these interactions occurs through static interfaces because the same sites are also involved in self-interactions with equivalent neighboring domains. Disulfide self-bonding of critical interaction sites halts secretion, indicating the transient nature of these interactions. The secretion substrate diminishes certain interactions and provokes an important rearrangement of the HRGspC structure. The T2SS components OutE/L/M affect various interaction sites differently, reinforcing some but diminishing the others, suggesting a possible switching mechanism of these interactions during secretion. Disulfide mapping shows that the organization of GspD and GspC subunits within the T2SS could be compatible with a hexamer of dimers arrangement rather than an organization with 12-fold rotational symmetry.	[Gu, Shuang; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Univ Lyon, F-69003 Lyon, France; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Univ Lyon 1, INSA Lyon, F-69621 Villeurbanne, France; [Wang, Xiaohui; Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] CNRS, UMR5240, F-69622 Lyon, France	University of London; Queen Mary University London; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Pickersgill, RW (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	r.w.pickersgill@qmul.ac.uk; vladimir.shevchik@insa-lyon.fr		Shevchik, Vladimir/0000-0002-8031-8638	French ANR-2010-BLANC-1531 SecPath program [ANR-2010-BLANC-1531]; LyonBioPole; Biotechnology and Biological Sciences Research Council; Higher Education Funding Council for England; Queen Mary University of London; CNRS; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish	French ANR-2010-BLANC-1531 SecPath program(French National Research Agency (ANR)); LyonBioPole; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Queen Mary University of London; CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the CNRS, a grant from French ANR-2010-BLANC-1531 SecPath program and LyonBioPole, the Biotechnology and Biological Sciences Research Council, Higher Education Funding Council for England, and Queen Mary University of London.	Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hugouvieux-Cotte-Pattat N, 2009, J BACTERIOL, V191, P6960, DOI 10.1128/JB.00594-09; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016624; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HM, 2004, J BACTERIOL, V186, P2946, DOI 10.1128/JB.186.10.2946-2955.2004; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Patrick M, 2011, J BIOL CHEM, V286, P10378, DOI 10.1074/jbc.M110.167031; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Thomas JD, 1997, MICROBIOL-UK, V143, P713, DOI 10.1099/00221287-143-3-713; Tsai RT, 2002, BIOCHEM J, V367, P865, DOI 10.1042/BJ20020909; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	45	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19082	19093		10.1074/jbc.M112.346338	http://dx.doi.org/10.1074/jbc.M112.346338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523076	Green Published, hybrid			2022-12-28	WOS:000306411900019
J	Bornhorst, J; Wehe, CA; Huwel, S; Karst, U; Galla, HJ; Schwerdtle, T				Bornhorst, Julia; Wehe, Christoph A.; Huewel, Sabine; Karst, Uwe; Galla, Hans-Joachim; Schwerdtle, Tanja			Impact of Manganese on and Transfer across Blood-Brain and Blood-Cerebrospinal Fluid Barrier in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLEXUS EPITHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; CHOROID-PLEXUS; OXIDATIVE DAMAGE; DRUG TRANSPORT; PERMEABILITY; EXPOSURE; MODEL; OCCLUDIN; CALCIUM	Manganese occupational and dietary overexposure has been shown to result in specific clinical central nervous system syndromes, which are similar to those observed in Parkinson disease. To date, modes of neurotoxic action of Mn are still to be elucidated but are thought to be strongly related to Mn accumulation in brain and oxidative stress. However, the pathway and the exact process of Mn uptake in the brain are yet not fully understood. Here, two well characterized primary porcine in vitro models of the blood-brain and the blood-cerebrospinal fluid (CSF) barrier were applied to assess the transfer of Mn in the brain while monitoring its effect on the barrier properties. Thus, for the first time effects of MnCl2 on the integrity of these two barriers as well as Mn transfer across the respective barriers are compared in one study. The data reveal a stronger Mn sensitivity of the in vitro blood-CSF barrier compared with the blood-brain barrier. Very interestingly, the negative effects of Mn on the structural and functional properties of the highly Mn-sensitive blood-CSF barrier were partly reversible after incubation with calcium. In summary, both the observed stronger Mn sensitivity of the in vitro blood-CSF barrier and the observed site-directed, most probably active, Mn transport toward the brain facing compartment, reveal that, in contrast to the general assumption in literature, after oral Mn intake the blood-CSF barrier might be the major route for Mn into the brain.	[Bornhorst, Julia; Schwerdtle, Tanja] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Bornhorst, Julia] Univ Munster, Grad Sch Chem, D-48149 Munster, Germany; [Wehe, Christoph A.; Karst, Uwe] Univ Munster, Inst Inorgan & Analyt Chem, D-48149 Munster, Germany; [Huewel, Sabine; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Schwerdtle, T (corresponding author), Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany.	tanja.schwerdtle@uni-muenster.de	Wehe, Christoph/C-2212-2012	Wehe, Christoph/0000-0001-8985-1167	Graduate School of Chemistry (Westfa-lische Wilhelms-Universitat Munster, Germany)	Graduate School of Chemistry (Westfa-lische Wilhelms-Universitat Munster, Germany)	This work was supported by the Graduate School of Chemistry (Westfa-lische Wilhelms-Universitat Munster, Germany).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; AMBUDKAR IS, 1992, MOL CELL BIOCHEM, V114, P73; Angelow S, 2004, ADV DRUG DELIVER REV, V56, P1859, DOI 10.1016/j.addr.2004.07.012; ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, pG798, DOI 10.1152/ajpgi.90342.2008; Chtourou Y, 2011, NEUROCHEM RES, V36, P1546, DOI 10.1007/s11064-011-0483-5; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; DASTUR DK, 1971, J CLIN INVEST, V50, P9, DOI 10.1172/JCI106487; Fitsanakis VA, 2007, HUM EXP TOXICOL, V26, P295, DOI 10.1177/0960327107070496; Flynn MR, 2009, INT J HYG ENVIR HEAL, V212, P459, DOI 10.1016/j.ijheh.2008.12.003; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gath U, 1997, EUR J CELL BIOL, V74, P68; Gerber GB, 2002, CRIT REV ONCOL HEMAT, V42, P25, DOI 10.1016/S1040-8428(01)00178-0; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hakvoort A, 1998, J NEUROCHEM, V71, P1141; Haselbach M, 2001, MICROSC RES TECHNIQ, V52, P137, DOI 10.1002/1097-0029(20010101)52:1<137::AID-JEMT15>3.3.CO;2-A; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Huang PL, 2012, EXP TOXICOL PATHOL, V64, P197, DOI 10.1016/j.etp.2010.08.006; Kroll S, 2009, ANN NY ACAD SCI, V1165, P228, DOI 10.1111/j.1749-6632.2009.04040.x; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Liu XH, 2006, TOXICOL SCI, V91, P521, DOI 10.1093/toxsci/kfj150; Lohmann C, 2002, J DRUG TARGET, V10, P263, DOI 10.1080/10611860290031903; dos Santos APM, 2011, BRAIN RES, V1382, P282, DOI 10.1016/j.brainres.2011.01.047; McCarthy KM, 1996, J CELL SCI, V109, P2287; Michalke B, 2007, J ENVIRON MONITOR, V9, P650, DOI 10.1039/b704173j; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; MURPHY VA, 1991, J NEUROCHEM, V57, P948, DOI 10.1111/j.1471-4159.1991.tb08242.x; Nagasawa K, 2009, GLIA, V57, P622, DOI 10.1002/glia.20791; Nagatomo S, 1999, J NEUROL SCI, V162, P102, DOI 10.1016/S0022-510X(98)00289-5; Nischwitz V, 2008, ANAL CHIM ACTA, V627, P258, DOI 10.1016/j.aca.2008.08.018; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Pan DPJ, 2011, WIRES NANOMED NANOBI, V3, P162, DOI 10.1002/wnan.116; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; RABIN O, 1993, J NEUROCHEM, V61, P509; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; Santamaria AB, 2008, INDIAN J MED RES, V128, P484; Santamaria AB, 2010, J TOXICOL ENV HEAL A, V73, P128, DOI 10.1080/15287390903337118; Schmitt C, 2011, J NEUROCHEM, V117, P747, DOI 10.1111/j.1471-4159.2011.07246.x; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; Wang XQ, 2008, TOXICOL APPL PHARM, V230, P167, DOI 10.1016/j.taap.2008.02.024; Wang XQ, 2006, BRAIN RES, V1097, P1, DOI 10.1016/j.brainres.2006.04.046; Wehe CA, 2011, METALLOMICS, V3, P1291, DOI 10.1039/c1mt00170a; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524; Yokel RA, 2003, NEUROTOXICOLOGY, V24, P15, DOI 10.1016/S0161-813X(02)00090-6; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223; Yokel RA, 2009, NEUROMOL MED, V11, P297, DOI 10.1007/s12017-009-8101-2	61	56	57	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17140	17151		10.1074/jbc.M112.344093	http://dx.doi.org/10.1074/jbc.M112.344093			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457347	Green Published, hybrid			2022-12-28	WOS:000306373000014
J	Luo, RB; Akpan, IO; Hayashi, R; Sramko, M; Barr, V; Shiba, Y; Randazzo, PA				Luo, Ruibai; Akpan, Itoro O.; Hayashi, Ryo; Sramko, Marek; Barr, Valarie; Shiba, Yoko; Randazzo, Paul A.			GTP-binding Protein-like Domain of AGAP1 Is Protein Binding Site That Allosterically Regulates ArfGAP Protein Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CANINE KIDNEY-CELLS; RHO-GTPASES; ACTIVATING-PROTEIN; KINASE-ACTIVITY; PARKINSONS-DISEASE; ACTIN CYTOSKELETON; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; LYSOSOME TRAFFICKING; MYRISTOYLATED ARF1	AGAPs are a subtype of Arf GTPase-activating proteins (GAPs) with 11 members in humans. In addition to the Arf GAP domain, the proteins contain a G-protein-like domain (GLD) with homology to Ras superfamily proteins and a PH domain. AGAPs bind to clathrin adaptors, function in post Golgi membrane traffic, and have been implicated in glioblastoma. The regulation of AGAPs is largely unexplored. Other enzymes containing GTP binding domains are regulated by nucleotide binding. However, nucleotide binding to AGAPs has not been detected. Here, we found that neither nucleotides nor deleting the GLD of AGAP1 affected catalysis, which led us to hypothesize that the GLD is a protein binding site that regulates GAP activity. Two-hybrid screens identified RhoA, Rac1, and Cdc42 as potential binding partners. Coimmunoprecipitation confirmed that AGAP1 and AGAP2 can bind to RhoA. Binding was mediated by the C terminus of RhoA and was independent of nucleotide. RhoA and the C-terminal peptide from RhoA increased GAP activity specifically for the substrate Arf1. In contrast, a C-terminal peptide from Cdc42 neither bound nor activated AGAP1. Based on these results, we propose that AGAPs are allosterically regulated through protein binding to the GLD domain.	[Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Natl Inst Hlth, Ctr Canc Res, Bethesda, MD 20892 USA; [Hayashi, Ryo] Saga Univ, Fac Sci & Engn, Dept Chem, Honjo, Saga 8408502, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saga University	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Natl Inst Hlth, Ctr Canc Res, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Shiba, Yoko/AAX-3885-2020	Shiba, Yoko/0000-0001-8229-541X	National Institutes of Health (Intramural Program of the NCI) [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365, ZICBC010978] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Program of the NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant BC 007365 (Intramural Program of the NCI).	Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Koshiba T, 2011, J BIOL CHEM, V286, P354, DOI 10.1074/jbc.M110.180034; Leung SM, 1999, MOL BIOL CELL, V10, P4369, DOI 10.1091/mbc.10.12.4369; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2008, J BIOL CHEM, V283, P21965, DOI 10.1074/jbc.M802268200; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo R, 2009, CELL SIGNAL, V21, P1169, DOI 10.1016/j.cellsig.2009.03.006; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Nishimura Y, 2003, PATHOL ONCOL RES, V9, P83, DOI 10.1007/BF03033750; Nishimura Y, 2002, HISTOCHEM J, V34, P189, DOI 10.1023/A:1021702812146; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Randazzo Paul A, 2002, Methods Mol Biol, V189, P169; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Ridley AJ, 2001, J CELL SCI, V114, P2713; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Shiba Y, 2010, J CELL SCI, V123, P2381, DOI 10.1242/jcs.057778; Soundararajan M, 2007, BIOCHEM J, V401, P679, DOI 10.1042/BJ20060555; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200	69	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17176	17185		10.1074/jbc.M111.334458	http://dx.doi.org/10.1074/jbc.M111.334458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22453919	hybrid, Green Published			2022-12-28	WOS:000306373000017
J	Imamura, S; Yabu, T; Yamashita, M				Imamura, Shintaro; Yabu, Takeshi; Yamashita, Michiaki			Protective Role of Cell Division Cycle 48 (CDC48) Protein against Neurodegeneration via Ubiquitin-Proteasome System Dysfunction during Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; ENDOPLASMIC-RETICULUM; COLD-ACCLIMATION; MYOPATHY; VCP; P97; VCP/P97; DISEASE	Cell division cycle 48 (CDC48), a ubiquitin-dependent molecular chaperone, is thought to mediate a variety of degradative and regulatory processes and maintain cellular homoeostasis. To investigate the protective function of CDC48 against accumulated ubiquitinated proteins during neurodevelopment, we developed an in vivo bioassay technique that detects expression and accumulation of fluorescent proteins with a polyubiquitination signal at the N terminus. When we introduced CDC48 antisense morpholino oligonucleotides into zebrafish embryos, the morphant embryos were lethal and showed defects in neuronal outgrowth and neurodegeneration, and polyubiquitinated fluorescent proteins accumulated in the inner plexiform and ganglion cell layers, as well as the diencephalon and mesencephalon, indicating that the degradation of polyubiquitinated proteins by the ubiquitin-proteasome system was blocked. These abnormal phenotypes in the morphant were rescued by CDC48 or human valosin-containing protein overexpression. Therefore, the protective function of CDC48 is essential for neurodevelopment.	[Imamura, Shintaro; Yabu, Takeshi; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Yabu, Takeshi] Nihon Univ, Fujisawa, Kanagawa 2520880, Japan	Japan Fisheries Research & Education Agency (FRA); Nihon University	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	mic@affrc.go.jp			 [22780195];  [20880045]	; 	This work was supported by Grants-in-aid for Scientific Research 22780195 and 20880045 (to S. I.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Imamura S., 2004, MAR BIOTECHNOL, V6, pS1; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; MOIR D, 1982, GENETICS, V100, P547; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Sasagawa Y, 2009, J CELL SCI, V122, P3663, DOI 10.1242/jcs.052415; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yamashita M, 1996, FEBS LETT, V382, P261, DOI 10.1016/0014-5793(96)00172-X; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	55	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23047	23056		10.1074/jbc.M111.332882	http://dx.doi.org/10.1074/jbc.M111.332882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549779	Green Published, hybrid			2022-12-28	WOS:000306495000061
J	Su, Y; Orelli, B; Madireddy, A; Niedernhofer, LJ; Scharer, OD				Su, Yan; Orelli, Barbara; Madireddy, Advaitha; Niedernhofer, Laura J.; Schaerer, Orlando D.			Multiple DNA Binding Domains Mediate the Function of the ERCC1-XPF Protein in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASES; STRUCTURE-SPECIFIC NUCLEASES; HOLLIDAY JUNCTION RESOLVASE; XERODERMA-PIGMENTOSUM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DUAL-INCISION; SLX4; MECHANISMS; ERCC1/XPF	ERCC1-XPF is a heterodimeric, structure-specific endonuclease that cleaves single-stranded/double-stranded DNA junctions and has roles in nucleotide excision repair (NER), interstrand crosslink (ICL) repair, homologous recombination, and possibly other pathways. In NER, ERCC1-XPF is recruited to DNA lesions by interaction with XPA and incises the DNA 5' to the lesion. We studied the role of the four C-terminal DNA binding domains in mediating NER activity and cleavage of model substrates. We found that mutations in the helix-hairpin-helix domain of ERCC1 and the nuclease domain of XPF abolished cleavage activity on model substrates. Interestingly, mutations in multiple DNA binding domains were needed to significantly diminish NER activity in vitro and in vivo, suggesting that interactions with proteins in the NER incision complex can compensate for some defects in DNA binding. Mutations in DNA binding domains of ERCC1-XPF render cells more sensitive to the crosslinking agent mitomycin C than to ultraviolet radiation, suggesting that the ICL repair function of ERCC1-XPF requires tighter substrate binding than NER. Our studies show that multiple domains of ERCC1-XPF contribute to substrate binding, and are consistent with models of NER suggesting that multiple weak protein-DNA and protein-protein interactions drive progression through the pathway. Our findings are discussed in the context of structural studies of individual domains of ERCC1-XPF and of its role in multiple DNA repair pathways.	[Su, Yan; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Orelli, Barbara; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Madireddy, Advaitha] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr 2 6, Dept Microbiol, Pittsburgh, PA 15213 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr 2 6, Mol Genet & Canc Inst, Pittsburgh, PA 15213 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Scharer, OD (corresponding author), SUNY Stony Brook, Dept Chem, Chem 619, Stony Brook, NY 11794 USA.	orlando@pharm.stonybrook.edu	Schärer, Orlando D./AAF-8613-2021; Classen, Scott/AAY-8176-2020; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715; Madireddy, Advaitha/0000-0002-4730-5325	National Institute of Health [GM080454, CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080454] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grants GM080454 and CA092584.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Biggerstaff M, 1999, METH MOL B, V113, P357; Coin F, 2004, EMBO J, V23, P4835, DOI 10.1038/sj.emboj.7600480; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gillet LCJ, 2005, NUCLEIC ACIDS RES, V33, P1961, DOI 10.1093/nar/gki335; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; HOY CA, 1985, CANCER RES, V45, P1737; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LI L, 1995, MOL CELL BIOL, V15, P1993; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Orelli B, 2010, J BIOL CHEM, V285, P3705, DOI 10.1074/jbc.M109.067538; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Salmon P, 2000, BLOOD, V96, P3392; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Scharer OD, 2008, ADV EXP MED BIOL, V637, P83; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Shivji MKK, 1999, METH MOL B, V113, P373; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	64	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21846	21855		10.1074/jbc.M111.337899	http://dx.doi.org/10.1074/jbc.M111.337899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547097	hybrid, Green Published			2022-12-28	WOS:000306418600026
J	Carrasco, P; Sahun, I; McDonald, J; Ramirez, S; Jacas, J; Gratacos, E; Sierra, AY; Serra, D; Herrero, L; Acker-Palmer, A; Hegardt, FG; Dierssen, M; Casals, N				Carrasco, Patricia; Sahun, Ignasi; McDonald, Jerome; Ramirez, Sara; Jacas, Jordi; Gratacos, Esther; Sierra, Adriana Y.; Serra, Dolors; Herrero, Laura; Acker-Palmer, Amparo; Hegardt, Fausto G.; Dierssen, Mara; Casals, Nuria			Ceramide Levels Regulated by Carnitine Palmitoyltransferase 1C Control Dendritic Spine Maturation and Cognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; EXPRESSION; PROTEIN; CPT1C; MICE; PHOSPHATASE-1; MORPHOGENESIS; HOMEOSTASIS; NEURONS; GROWTH	The brain-specific isoform carnitine palmitoyltransferase 1C (CPT1C) has been implicated in the hypothalamic regulation of food intake and energy homeostasis. Nevertheless, its molecular function is not completely understood, and its role in other brain areas is unknown. We demonstrate that CPT1C is expressed in pyramidal neurons of the hippocampus and is located in the endoplasmic reticulum throughout the neuron, even inside dendritic spines. We used molecular, cellular, and behavioral approaches to determine CPT1C function. First, we analyzed the implication of CPT1C in ceramide metabolism. CPT1C overexpression in primary hippocampal cultured neurons increased ceramide levels, whereas in CPT1C-deficient neurons, ceramide levels were diminished. Correspondingly, CPT1C knock-out (KO) mice showed reduced ceramide levels in the hippocampus. At the cellular level, CPT1C deficiency altered dendritic spine morphology by increasing immature filopodia and reducing mature mushroom and stubby spines. Total protrusion density and spine head area in mature spines were unaffected. Treatment of cultured neurons with exogenous ceramide reverted the KO phenotype, as did ectopic overexpression of CPT1C, indicating that CPT1C regulation of spine maturation is mediated by ceramide. To study the repercussions of the KO phenotype on cognition, we performed the hippocampus-dependent Morris water maze test on mice. Results show that CPT1C deficiency strongly impairs spatial learning. All of these results demonstrate that CPT1C regulates the levels of ceramide in the endoplasmic reticulum of hippocampal neurons, and this is a relevant mechanism for the correct maturation of dendritic spines and for proper spatial learning.	[Carrasco, Patricia; Ramirez, Sara; Jacas, Jordi; Gratacos, Esther; Sierra, Adriana Y.; Casals, Nuria] Univ Int Catalunya, Dept Basic Sci, Fac Med & Ciencies Salut, E-08195 Sant Cugat Del Valles, Spain; [Carrasco, Patricia; Ramirez, Sara; Jacas, Jordi; Serra, Dolors; Herrero, Laura; Hegardt, Fausto G.; Casals, Nuria] Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Inst Salud Carlos III, E-28029 Madrid, Spain; [Sahun, Ignasi; McDonald, Jerome; Dierssen, Mara] CRG, Genes & Dis Program, E-08003 Barcelona, Spain; [Serra, Dolors; Herrero, Laura; Hegardt, Fausto G.] Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Acker-Palmer, Amparo] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Dierssen, Mara] CIBER Enfermedades RARAS CIBERER, Inst Salud Carlos III, E-28029 Madrid, Spain	Universitat Internacional de Catalunya (UIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Goethe University Frankfurt; Goethe University Frankfurt; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Casals, N (corresponding author), Univ Int Catalunya, Dept Basic Sci, Fac Med & Ciencies Salut, Josep Trueta S-N, E-08195 Sant Cugat Del Valles, Spain.	ncasals@csc.uic.es	Ramírez, Sara/AAE-4400-2022; Gratacòs-Batlle, Esther/L-8740-2014; Dierssen, Mara/G-3552-2015; Casals, Nuria/L-3378-2014; Herrero, Laura/D-4011-2014; Serra, Dolors/L-3657-2014; Sahun, Ignasi/H-6892-2015	Gratacòs-Batlle, Esther/0000-0001-8093-3713; Dierssen, Mara/0000-0003-0853-6865; Casals, Nuria/0000-0002-6719-4300; Herrero, Laura/0000-0003-4244-4673; Serra, Dolors/0000-0002-4936-4206; Ramirez Flores, Sara/0000-0002-2072-2495; Sahun, Ignasi/0000-0002-4257-9255	Ministerio de Educacion y Ciencia, Spain [SAF2007-61926, 2009SGR131, SAF2010-16427, CureFXSEU/FISPS09102673, SAF2011-30520-C02-02]; Fundacio La Marato de TV3, Catalunya	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacio La Marato de TV3, Catalunya	This work was supported by Ministerio de Educacion y Ciencia, Spain, Grants SAF2007-61926, 2009SGR131, SAF2010-16427, CureFXSEU/FISPS09102673, and SAF2011-30520-C02-02 and by a grant from Fundacio La Marato de TV3 (2007), Catalunya.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; ESSER V, 1993, J BIOL CHEM, V268, P5817; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gao XF, 2009, DIABETOLOGIA, V52, P912, DOI 10.1007/s00125-009-1284-0; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Hering H, 2003, J NEUROSCI, V23, P3262; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Melon I, 2009, NEUROSCIENCE, V159, P657, DOI 10.1016/j.neuroscience.2008.11.056; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mitoma J, 1998, J NEUROSCI RES, V51, P712, DOI 10.1002/(SICI)1097-4547(19980315)51:6<712::AID-JNR5>3.3.CO;2-Q; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Tokutake Y, 2010, BIOCHEM BIOPH RES CO, V402, P158, DOI 10.1016/j.bbrc.2010.10.009; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	26	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21224	21232		10.1074/jbc.M111.337493	http://dx.doi.org/10.1074/jbc.M111.337493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539351	Green Published, hybrid			2022-12-28	WOS:000306416800042
J	Graybill, C; Wee, B; Atwood, SX; Prehoda, KE				Graybill, Chiharu; Wee, Brett; Atwood, Scott X.; Prehoda, Kenneth E.			Partitioning-defective Protein 6 (Par-6) Activates Atypical Protein Kinase C (aPKC) by Pseudosubstrate Displacement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; POLARITY; COMPLEX; DOMAIN; PKC; PHOSPHORYLATION; BINDING; SIGNAL; LGL; DIACYLGLYCEROL	Atypical protein kinase C (aPKC) controls cell polarity by modulating substrate cortical localization. Aberrant aPKC activity disrupts polarity, yet the mechanisms that control aPKC remain poorly understood. We used a reconstituted system with purified components and a cultured cell cortical displacement assay to investigate aPKC regulation. We find that aPKC is autoinhibited by two domains within its NH2-terminal regulatory half, a pseudosubstrate motif that occupies the kinase active site, and a C1 domain that assists in this process. The Par complex member Par-6, previously thought to inhibit aPKC, is a potent activator of aPKC in our assays. Par-6 and aPKC interact via PB1 domain heterodimerization, and this interaction activates aPKC by displacing the pseudosubstrate, although full activity requires the Par-6 CRIB-PDZ domains. We propose that, along with its previously described roles in controlling aPKC localization, Par-6 allosterically activates aPKC to allow for high spatial and temporal control of substrate phosphorylation and polarization.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Prehoda, KE (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu		Atwood, Scott/0000-0001-7407-9792	National Institutes of Health [GM068032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068032 (to K. E. P.).	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; HOUSE C, 1987, J BIOL CHEM, V262, P772; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Wee B, 2011, J CELL BIOL, V195, P369, DOI 10.1083/jcb.201102130; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	36	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21003	21011		10.1074/jbc.M112.360495	http://dx.doi.org/10.1074/jbc.M112.360495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544755	Green Published, hybrid			2022-12-28	WOS:000306416800022
J	Inoue, K; Furukawa, T; Kumada, T; Yamada, J; Wang, TY; Inoue, R; Fukuda, A				Inoue, Koichi; Furukawa, Tomonori; Kumada, Tatsuro; Yamada, Junko; Wang, Tianying; Inoue, Rieko; Fukuda, Atsuo			Taurine Inhibits K+-Cl- Cotransporter KCC2 to Regulate Embryonic Cl- Homeostasis via With-no-lysine (WNK) Protein Kinase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; GABA; EXPRESSION; BRAIN; NEURONS; PHOSPHORYLATION; TRANSPORTER; CELLS; MOUSE	GABA inhibits mature neurons and conversely excites immature neurons due to lower K+-Cl- cotransporter 2 (KCC2) expression. We observed that ectopically expressed KCC2 in embryonic cerebral cortices was not active; however, KCC2 functioned in newborns. In vitro studies revealed that taurine increased KCC2 inactivation in a phosphorylation-dependent manner. When Thr-906 and Thr-1007 residues in KCC2 were substituted with Ala (KCC2T906A/T1007A), KCC2 activity was facilitated, and the inhibitory effect of taurine was not observed. Exogenous taurine activated the with-no-lysine protein kinase 1 (WNK1) and downstream STE20/SPS1-related proline/alanine-rich kinase (SPAK)/oxidative stress response 1 (OSR1), and overexpression of active WNK1 resulted in KCC2 inhibition in the absence of taurine. Phosphorylation of SPAK was consistently higher in embryonic brains compared with that of neonatal brains and down-regulated by a taurine transporter inhibitor in vivo. Furthermore, cerebral radial migration was perturbed by a taurine-insensitive form of KCC2, KCC2T906A/T1007A, which may be regulated by WNK-SPAK/OSR1 signaling. Thus, taurine and WNK-SPAK/OSR1 signaling may contribute to embryonic neuronal Cl- homeostasis, which is required for normal brain development.	[Inoue, Koichi; Furukawa, Tomonori; Kumada, Tatsuro; Wang, Tianying; Inoue, Rieko; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamada, Junko] Hirosaki Univ, Grad Sch Med, Dept Neurophysiol, Hirosaki, Aomori 0368562, Japan	Hamamatsu University School of Medicine; Hirosaki University	Inoue, K (corresponding author), Hamamatsu Univ Sch Med, Dept Physiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ino-k@umin.ac.jp; axfukuda@hama-med.ac.jp	Fukuda, Atsuo/ABA-6843-2020; Kumada, Tatsuro/AAY-9117-2020; Furukawa, Tomonori/G-7014-2014	Fukuda, Atsuo/0000-0001-7112-4834; 	Ministry of Education, Culture, Sports, Science, and Technology, Japan [2002195, 21026013, 23123505]; Japan Society for the Promotion of Science [19390058, 23500387]; Kanzawa Medical Research Foundation; Salt Science Research Foundation [1125]; Grants-in-Aid for Scientific Research [23123505] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas Elucidation of Neural Network Function in the Brain 2002195 (to A. F.) and Molecular Interaction and Modal Shift of Cellular Sensor 21026013 (to A. F.) and Grant-in-Aid for Scientific Research on Innovative Area Neural Diversity and Neocortical Organization 23123505 (to K. I.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Grants-in-Aid from the Japan Society for the Promotion of Science 19390058 (to A. F.) and 23500387 (to K. I.), Salt Science Research Foundation Grant 1125 (to K. I.), and a grant from the Kanzawa Medical Research Foundation (to K. I.).	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; AKAHORI S, 1986, ACTA MED OKAYAMA, V40, P93; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Barakat L, 2002, J PHYSIOL-LONDON, V541, P753, DOI 10.1113/jphysiol.2001.015834; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Behar TN, 1998, J NEUROSCI, V18, P6378; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benitez-Diaz P, 2003, DEV NEUROSCI-BASEL, V25, P366, DOI 10.1159/000073514; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Caric D, 1997, DEVELOPMENT, V124, P5087; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; DeFazio RA, 2000, J NEUROSCI, V20, P8069; del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3; Dominy J, 2004, J NEUROCHEM, V89, P1195, DOI 10.1111/j.1471-4159.2004.02410.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fukuda A, 2005, NAT MED, V11, P1153, DOI 10.1038/nm1105-1153; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Garzon-Muvdi T, 2007, AM J PHYSIOL-RENAL, V292, pF1197, DOI 10.1152/ajprenal.00335.2006; GAULL GE, 1989, PEDIATRICS, V83, P433; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; Hanganu IL, 2009, CEREB CORTEX, V19, P89, DOI 10.1093/cercor/bhn061; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2005, BIOCHEM BIOPH RES CO, V327, P300, DOI 10.1016/j.bbrc.2004.12.010; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Janeke G, 2003, J INVEST DERMATOL, V121, P354, DOI 10.1046/j.1523-1747.2003.12366.x; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kilb W, 2008, J NEUROPHYSIOL, V100, P698, DOI 10.1152/jn.00657.2007; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mienville JM, 1998, J PHYSIOL-LONDON, V512, P809, DOI 10.1111/j.1469-7793.1998.809bd.x; MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; RAMAMOORTHY S, 1994, BIOCHEM J, V300, P893, DOI 10.1042/bj3000893; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2011, J BIOL CHEM, V286, P30171, DOI 10.1074/jbc.M111.222893; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SHIMADA M, 1984, HISTOCHEMISTRY, V80, P225, DOI 10.1007/BF00495770; Shimizu-Okabe C, 2002, NEUROREPORT, V13, P2433, DOI 10.1097/00001756-200212200-00012; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	86	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20839	20850		10.1074/jbc.M111.319418	http://dx.doi.org/10.1074/jbc.M111.319418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544747	Green Published, hybrid			2022-12-28	WOS:000306416800006
J	Campellone, KG; Siripala, AD; Leong, JM; Welch, MD				Campellone, Kenneth G.; Siripala, Anosha D.; Leong, John M.; Welch, Matthew D.			Membrane-deforming Proteins Play Distinct Roles in Actin Pedestal Biogenesis by Enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP-WIP COMPLEX; N-WASP; ARP2/3 COMPLEX; EFFECTORS TIR; BAR PROTEINS; ESPF(U); CYTOSKELETON; NCK; POLYMERIZATION; MOTILITY	Many bacterial pathogens reorganize the host actin cytoskeleton during the course of infection, including enterohemorrhagic Escherichia coli (EHEC), which utilizes the effector protein EspF(U) to assemble actin filaments within plasma membrane protrusions called pedestals. EspF(U) activates N-WASP, a host actin nucleation-promoting factor that is normally auto-inhibited and found in a complex with the actin-binding protein WIP. Under native conditions, this N-WASP/WIP complex is activated by the small GTPase Cdc42 in concert with several different SH3 (Src-homology-3) domain-containing proteins. In the current study, we tested whether SH3 domains from the F-BAR (FCH-Bin-Amphiphysin-Rvs) subfamily of membrane-deforming proteins are involved in actin pedestal formation. We found that three F-BAR proteins: CIP4, FBP17, and TOCA1 (transducer of Cdc42-dependent actin assembly), play different roles during actin pedestal biogenesis. Whereas CIP4 and FBP17 inhibited actin pedestal assembly, TOCA1 stimulated this process. TOCA1 was recruited to pedestals by its SH3 domain, which bound directly to proline-rich sequences within EspF(U). Moreover, EspF(U) and TOCA1 activated the N-WASP/WIP complex in an additive fashion in vitro, suggesting that TOCA1 can augment actin assembly within pedestals. These results reveal that EspF(U) acts as a scaffold to recruit multiple actin assembly factors whose functions are normally regulated by Cdc42.	[Campellone, Kenneth G.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Siripala, Anosha D.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Leong, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	University of Connecticut; University of California System; University of California Berkeley; Tufts University	Campellone, KG (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	kenneth.campellone@uconn.edu		Siripala, Anosha/0000-0003-4073-9195	National Institutes of Health (NIH) [R01-AI46454, R01-GM59609]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-AI46454 (to J.M.L.) and R01-GM59609 (to M.D.W.).	Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Allen-Vercoe E, 2006, INFECT IMMUN, V74, P6196, DOI 10.1128/IAI.00753-06; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Brady MJ, 2007, CELL MICROBIOL, V9, P2242, DOI 10.1111/j.1462-5822.2007.00954.x; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2006, CELL MICROBIOL, V8, P1488, DOI 10.1111/j.1462-5822.2006.00728.x; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Campellone KG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000191; Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Cantarelli VV, 2007, CELL MICROBIOL, V9, P1782, DOI 10.1111/j.1462-5822.2007.00913.x; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vingadassalom D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001056; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003	47	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20613	20624		10.1074/jbc.M112.363473	http://dx.doi.org/10.1074/jbc.M112.363473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22544751	Green Published, hybrid			2022-12-28	WOS:000306414500081
J	Tao, YY; Li, X; Liu, YW; Ruan, JB; Qi, SL; Niu, LW; Teng, MK				Tao, Yuyong; Li, Xu; Liu, Yiwei; Ruan, Jianbin; Qi, Shali; Niu, Liwen; Teng, Maikun			Structural Analysis of Shu Proteins Reveals a DNA Binding Role Essential for Resisting Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE POSTREPLICATION REPAIR; HOMOLOGOUS RECOMBINATION; RAD51 PARALOGUES; SRS2; UBIQUITIN; COMPLEX	The yeast Shu complex, consisting of the proteins Shu1, Shu2, Psy3, and Csm2, maintains genomic stability by coupling post-replication repair to homologous recombination. However, a lack of biochemical and structural information on the Shu proteins precludes revealing their precise roles within the pathway. Here, we report on the 1.9-angstrom crystal structure of the Psy3-Csm2 complex. The crystal structure shows that Psy3 forms a heterodimer with Csm2 mainly through a hydrophobic core. Unexpectedly, Psy3 and Csm2 share a similar architecture that closely resembles the ATPase core domain of Rad51. The L2 loop present in Psy3 and Csm2 is similar to that of Rad51 and confers the DNA binding activity of the Shu complex. As with Rad51, the Shu complex appears to form a nucleoprotein filament by binding nonspecifically to DNA. Structure-based mutagenesis studies have demonstrated that the DNA binding activity of the Shu complex is essential for repair of the methyl methanesulfonate-induced DNA damage. Our findings provide good foundations for the understanding of the Srs2 regulation by the Shu complex.	[Niu, Liwen] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China; [Tao, Yuyong; Li, Xu; Liu, Yiwei; Ruan, Jianbin; Qi, Shali; Niu, Liwen; Teng, Maikun] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Niu, LW (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China.	lwniu@ustc.edu.cn; mkteng@ustc.edu.cn		Li, Xu/0000-0001-5221-0817; Ruan, Jianbin/0000-0001-5843-8273	Fundamental Research Funds for the Central Universities; Chinese National Natural Science Foundation [31130018, 30900224, 10979039]; Chinese Ministry of Science and Technology [2009CB825500, 2012CB917200]; Science and Technological Fund of Anhui Province for Outstanding Youth [10040606Y11]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Science and Technological Fund of Anhui Province for Outstanding Youth	This work was supported by Fundamental Research Funds for the Central Universities, Chinese National Natural Science Foundation Grants 31130018, 30900224, and 10979039, Chinese Ministry of Science and Technology Grants 2009CB825500 and 2012CB917200, Science and Technological Fund of Anhui Province for Outstanding Youth Grant 10040606Y11.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liu J, 2011, NATURE, V479, P245, DOI 10.1038/nature10522; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Martin V, 2006, EMBO J, V25, P2564, DOI 10.1038/sj.emboj.7601141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	32	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20231	20239		10.1074/jbc.M111.334698	http://dx.doi.org/10.1074/jbc.M111.334698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22465956	Green Published, hybrid			2022-12-28	WOS:000306414500043
J	Wu, S; Dole, K; Hong, F; Noman, AM; Issacs, J; Liu, B; Li, ZH				Wu, Shuang; Dole, Krystal; Hong, Feng; Noman, Abu Shadat M.; Issacs, Jennifer; Liu, Bei; Li, Zihai			Chaperone gp96-independent Inhibition of Endotoxin Response by Chaperone-based Peptide Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SHOCK-PROTEIN GP96; CELL-SURFACE; BACTERIAL LIPOPOLYSACCHARIDE; CRYSTAL-STRUCTURE; HSP90; CANCER; IMMUNITY; COMPLEX; TOLL-LIKE-RECEPTOR-4	HSP90 chaperones a large number of proteins, and it plays essential roles in multiple signaling pathways to maintain protein homeostasis in the cytosol. In addition, HSP90 has been implicated in mediating recognition of lipopolysaccharide (LPS). However, no pharmacologic agents have been developed to interrogate this pathway. Herein we demonstrate that a peptide-based inhibitor that was previously reported to inhibit the master Toll-like receptor-chaperone gp96, an endoplasmic reticulum paralog of HSP90, in fact blocks HSP90-LPS interaction. It inhibited the binding of LPS to the cell surface of both wild type and gp96-null cells and thereby abrogated the cellular response to LPS but not to other Toll-like receptor ligands. We also generated a series of peptide derivatives (named peptide inhibitors of endotoxin responsiveness (PIERs)) from the N-terminal helix structure of HSP90 and demonstrated their effectiveness in blocking LPS activity. PIER inhibition of LPS signaling was partially reversed by CD14 expression. Moreover, we found that a cell-permeable PIER abrogated HSP90 function and caused degradation of multiple known HSP90 client proteins in cancer cells. Thus, targeting HSP90 is a promising modality for treatment of both LPS-mediated pathology and cancer.	[Li, Zihai] Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Dole, Krystal; Issacs, Jennifer] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Li, ZH (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283]; Hollings Cancer Center at the Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center at the Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070603 and AI077283 (to Z. L.) and P30 CA138313 (a pilot research grant from the Hollings Cancer Center at the Medical University of South Carolina).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; ERKELLERYUKSEL FM, 1992, J AUTOIMMUN, V5, P803, DOI 10.1016/0896-8411(92)90194-U; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Montanari P, 2012, CELL MICROBIOL, V14, P368, DOI 10.1111/j.1462-5822.2011.01722.x; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Triantafilou K, 2001, J CELL SCI, V114, P2535; Triantafilou K, 2001, HUM IMMUNOL, V62, P50, DOI 10.1016/S0198-8859(00)00222-6; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Triantafilou M, 2008, NOVART FDN SYMP, V291, P79; Triantafilou M, 2008, NOVART FDN SYMP, V291, P137; Triantafilou Martha, 2008, Novartis Found Symp, V291, P74; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	45	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19896	19903		10.1074/jbc.M112.343848	http://dx.doi.org/10.1074/jbc.M112.343848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22532561	hybrid, Green Published			2022-12-28	WOS:000306414500012
J	Branagan, AM; Maher, RL; Morrical, SW				Branagan, Amy M.; Maher, Robyn L.; Morrical, Scott W.			Assembly and Dynamics of Gp59-Gp32-Single-stranded DNA (ssDNA), a DNA Helicase Loading Complex Required for Recombination-dependent Replication in Bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 59 PROTEIN; LEADING-STRAND SYNTHESIS; VIROLOGY JOURNAL SERIES; BINDING-PROTEIN; T4 HELICASE; UVSX RECOMBINASE; SINGLE-MOLECULE; POLYMERASE GP43; NUCLEIC-ACIDS; GP59	The Gp59 protein of bacteriophage T4 plays critical roles in recombination-dependent DNA replication and repair by correctly loading the replicative helicase, Gp41, onto recombination intermediates. Previous work demonstrated that Gp59 is required to load helicase onto single-stranded DNA that is saturated with Gp32, the T4 single-stranded DNA (ssDNA)-binding protein. Gp59 and Gp32 bind simultaneously to ssDNA, forming a Gp59-Gp32-ssDNA complex that is a key intermediate in helicase loading. Here we characterize the assembly and dynamics of this helicase loading complex (HLC) through changes in the fluorescent states of Gp32F, a fluorescein-Gp32 conjugate. Results show that HLC formation requires a minimum Gp32-ssDNA cluster size and that Gp59 co-localizes with Gp32-ssDNA clusters in the presence of excess free ssDNA. These and other results indicate that Gp59 targets helicase assembly onto Gp32-ssDNA clusters that form on the displaced strand of D-loops, which suggests a mechanism for the rapid initiation of recombination-dependent DNA replication. Helicase loading at the HLC requires ATP binding (not hydrolysis) by Gp41 and results in local remodeling of Gp32 within the HLC. Subsequent ATPase-driven translocation of Gp41 progressively disrupts Gp32-ssDNA interactions. Evidence suggests that Gp59 from the HLC is recycled to promote multiple rounds of helicase assembly on Gp32-ssDNA, a capability that could be important for the restart of stalled replication forks.	[Branagan, Amy M.; Maher, Robyn L.; Morrical, Scott W.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Morrical, SW (corresponding author), Univ Vermont, Coll Med, Dept Biochem, B407 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	smorrica@uvm.edu			National Institutes of Health [R01GM48847, T32ES07122]; American Cancer Society [PF-09-254-01-DMC]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM48847 (to S. W. M.) and Training Grant T32ES07122 (to A. M. B.).; Supported by Postdoctoral Fellowship PF-09-254-01-DMC from the American Cancer Society.	Alberts B.M., 1971, METHODS ENZYMOL, V21, P198; ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; BARRY J, 1994, J BIOL CHEM, V269, P33049; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Delagoutte E, 2005, J MOL BIOL, V347, P257, DOI 10.1016/j.jmb.2005.01.036; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GIEDROC DP, 1990, J BIOL CHEM, V265, P11444; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Jones JM, 2000, MOL MICROBIOL, V36, P519, DOI 10.1046/j.1365-2958.2000.01888.x; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; Kadyrov FA, 2003, J BIOL CHEM, V278, P25247, DOI 10.1074/jbc.M302564200; KODADEK T, 1990, J BIOL CHEM, V265, P20966; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KOWALCZYKOWSKI SC, 1990, LANDOLTBORNSTEIN NUM, P244; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Morrical S., 2009, U. S. Patent, Patent No. [7,544,469 B2, 7544469]; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; MORRICAL SW, 1991, J BIOL CHEM, V266, P14031; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Pant K, 2005, J MOL BIOL, V349, P317, DOI 10.1016/j.jmb.2005.03.065; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; VILLEMAIN JL, 1993, BIOCHEMISTRY-US, V32, P11235, DOI 10.1021/bi00092a038; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu H, 2001, BIOCHEMISTRY-US, V40, P7651, DOI 10.1021/bi010116n; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102	46	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19070	19081		10.1074/jbc.M112.343830	http://dx.doi.org/10.1074/jbc.M112.343830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500043	Green Published, hybrid			2022-12-28	WOS:000306411900018
J	Gagnon, KT; Biswas, S; Zhang, XX; Brown, BA; Wollenzien, P; Mattos, C; Maxwell, ES				Gagnon, Keith T.; Biswas, Shyamasri; Zhang, Xinxin; Brown, Bernard A., II; Wollenzien, Paul; Mattos, Carla; Maxwell, E. Stuart			Structurally Conserved Nop56/58 N-terminal Domain Facilitates Archaeal Box C/D Ribonucleoprotein-guided Methyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSE METHYLATION; RNA; PROTEIN; SRNP; 2'-O-METHYLATION; COMPLEXES	Box C/D RNA-protein complexes (RNPs) guide the 2'-O-methylation of nucleotides in both archaeal and eukaryotic ribosomal RNAs. The archaeal box C/D and C'/D' RNP subcomplexes are each assembled with three sRNP core proteins. The archaeal Nop56/58 core protein mediates crucial protein-protein interactions required for both sRNP assembly and the methyltransferase reaction by bridging the L7Ae and fibrillarin core proteins. The interaction of Methanocaldococcus jannaschii (Mj) Nop56/58 with the methyltransferase fibrillarin has been investigated using site-directed mutagenesis of specific amino acids in the N-terminal domain of Nop56/58 that interacts with fibrillarin. Extensive mutagenesis revealed an unusually strong Nop56/58-fibrillarin interaction. Only deletion of the NTD itself prevented dimerization with fibrillarin. The extreme stability of the Nop56/58-fibrillarin heterodimer was confirmed in both chemical and thermal denaturation analyses. However, mutations that did not affect Nop56/58 binding to fibrillarin or sRNP assembly nevertheless disrupted sRNP-guided nucleotide modification, revealing a role for Nop56/58 in methyltransferase activity. This conclusion was supported with the cross-linking of Nop56/58 to the target RNA substrate. The Mj Nop56/58 NTD was further characterized by solving its three-dimensional crystal structure to a resolution of 1.7 angstrom. Despite low primary sequence conservation among the archaeal Nop56/58 homologs, the overall structure of the archaeal NTD domain is very well conserved. In conclusion, the archaeal Nop56/58 NTD exhibits a conserved domain structure whose exceptionally stable interaction with fibrillarin plays a role in both RNP assembly and methyltransferase activity.	[Gagnon, Keith T.; Biswas, Shyamasri; Zhang, Xinxin; Brown, Bernard A., II; Wollenzien, Paul; Mattos, Carla; Maxwell, E. Stuart] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Maxwell, ES (corresponding author), 128 Polk Hall, Raleigh, NC 27695 USA.	stu_maxwell@ncsu.edu			National Institutes of Health [GM069699, 1F32HD060377-01A1]; National Science Foundation [MCB 0543741]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD060377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069699 (to B. A. B.) and 1F32HD060377-01A1 (to K. T. G.) and National Science Foundation Grant MCB 0543741 (to E. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Appel CD, 2007, RNA, V13, P899, DOI 10.1261/rna.517307; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagnon K, 2008, RNA DNA EDITING MOL, P313; Gagnon KT, 2006, J MOL BIOL, V362, P1025, DOI 10.1016/j.jmb.2006.07.091; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nanda K, 2004, BIOCHEMISTRY-US, V43, P8923, DOI 10.1021/bi049702h; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanjay KS, 2004, J BIOL CHEM, V279, P47661, DOI 10.1074/jbc.M408868200; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran E, 2004, TRENDS BIOCHEM SCI, V29, P343, DOI 10.1016/j.tibs.2004.05.001; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	38	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19418	19428		10.1074/jbc.M111.323253	http://dx.doi.org/10.1074/jbc.M111.323253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496443	Green Published, hybrid			2022-12-28	WOS:000306411900056
J	Kaul, R; Saha, P; Saradhi, M; Prasad, RLA; Chatterjee, S; Ghosh, I; Tyagi, RK; Datta, K				Kaul, Rachna; Saha, Paramita; Saradhi, Mallampati; Prasad, Ramachandra L. A.; Chatterjee, Soumya; Ghosh, Ilora; Tyagi, Rakesh K.; Datta, Kasturi			Overexpression of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) in HepG2 Cells Leads to Increased Hyaluronan Synthesis and Cell Proliferation by Up-regulation of Cyclin D1 in AKT-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING FACTOR SF2; GLOBULAR HEADS; EXPRESSION; ACID; CD44; CLONING; KINASE; GROWTH; P-32; BIOSYNTHESIS	Overexpression of the mature form of hyaluronan-binding protein 1 (HABP1/gC1qR/p32), a ubiquitous multifunctional protein involved in cellular signaling, in normal murine fibroblast cells leads to enhanced generation of reactive oxygen species (ROS), mitochondrial dysfunction, and ultimately apoptosis with the release of cytochrome c. In the present study, human liver cancer cell line HepG2, having high intracellular antioxidant levels was chosen for stable overexpression of HABP1. The stable transformant of HepG2, overexpressing HABP1 does not lead to ROS generation, cellular stress, and apoptosis, rather it induced enhanced cell growth and proliferation over longer periods. Phenotypic changes in the stable transformant were associated with the increased "HA pool," formation of the "HA cable" structure, up-regulation of HA synthase-2, and CD44, a receptor for HA. Enhanced cell survival was further supported by activation of MAP kinase and AKT-mediated cell survival pathways, which leads to an increase in CYCLIN D1 promoter activity. Compared with its parent counterpart HepG2, the stable transformant showed enhanced tumorigenicity as evident by its sustained growth in low serum conditions, formation of the HA cable structure, increased anchorage-independent growth, and cell-cell adhesion. This study suggests that overexpression of HABP1 in HepG2 cells leads to enhanced cell survival and tumorigenicity by activating HA-mediated cell survival pathways.	[Kaul, Rachna; Saradhi, Mallampati; Tyagi, Rakesh K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India; [Kaul, Rachna; Saha, Paramita; Prasad, Ramachandra L. A.; Chatterjee, Soumya; Ghosh, Ilora; Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, Biochem Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Tyagi, RK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	rktyagi@yahoo.com; kdatta@mail.jnu.ac.in		Chatterjee, Soumya/0000-0002-7889-8389; Ghosh, Ilora/0000-0003-3957-8152	Department of Biotechnology, Ministry of Science and Technology, India; Indian Council of Medical Research; Council for Scientific and Industrial Research	Department of Biotechnology, Ministry of Science and Technology, India; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from Department of Biotechnology, Ministry of Science and Technology, India.; Supported by research fellowships from the Indian Council of Medical Research and Council for Scientific and Industrial Research in support of doctoral studies.	Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Chowdhury AR, 2008, EXP CELL RES, V314, P651, DOI 10.1016/j.yexcr.2007.10.033; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DSOUZA M, 1985, BIOCHEM INT, V10, P43; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Ghosh I, 2004, MOL CELL BIOCHEM, V267, P133, DOI 10.1023/B:MCBI.0000049362.04033.ea; GUPTA S, 1991, EXP CELL RES, V195, P386, DOI 10.1016/0014-4827(91)90388-B; HAMILOS DL, 1989, IMMUNOPHARMACOLOGY, V18, P223, DOI 10.1016/0162-3109(89)90020-9; HONORE B, 1993, GENE, V134, P283, DOI 10.1016/0378-1119(93)90108-F; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jha BK, 2003, J BIOL CHEM, V278, P27464, DOI 10.1074/jbc.M206696200; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; KONGTAWELERT P, 1990, ANAL BIOCHEM, V185, P313, DOI 10.1016/0003-2697(90)90300-X; Kosaki R, 1999, CANCER RES, V59, P1141; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Krasinski R, 2009, POSTEP HIG MED DOSW, V63, P205; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Majumdar M, 1998, GENOMICS, V51, P476, DOI 10.1006/geno.1998.5364; Meenakshi J, 2003, BIOCHEM BIOPH RES CO, V300, P686, DOI 10.1016/S0006-291X(02)02788-2; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Murakami C, 2002, J NUTR SCI VITAMINOL, V48, P89, DOI 10.3177/jnsv.48.89; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prehm P, 2006, BIOCHEM J, V398, P469, DOI 10.1042/BJ20060431; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Rubinstein DB, 2004, INT J CANCER, V110, P741, DOI 10.1002/ijc.20105; Sengupta A, 2004, BIOCHEM J, V380, P837, DOI 10.1042/BJ20040264; Serbulea M, 1999, INT J ONCOL, V14, P733; SHAW JP, 1986, J CELL PHYSIOL, V129, P193, DOI 10.1002/jcp.1041290210; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; van Leeuwen HC, 2001, J CELL SCI, V114, P2115	49	31	32	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19750	19764		10.1074/jbc.M111.266270	http://dx.doi.org/10.1074/jbc.M111.266270			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22451658	hybrid, Green Published			2022-12-28	WOS:000306411900084
J	Bomberger, JM; Coutermarsh, BA; Barnaby, RL; Stanton, BA				Bomberger, Jennifer M.; Coutermarsh, Bonita A.; Barnaby, Roxanna L.; Stanton, Bruce A.			Arsenic Promotes Ubiquitinylation and Lysosomal Degradation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channels in Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRINKING-WATER; DEUBIQUITINATING ENZYME; CANCER-MORTALITY; LUNG-CANCER; C-CBL; UBIQUITINATED PROTEINS; ENDOCYTIC TRAFFICKING; FUNDULUS-HETEROCLITUS; CAUSES ACCUMULATION; SURFACE EXPRESSION	Arsenic exposure significantly increases respiratory bacterial infections and reduces the ability of the innate immune system to eliminate bacterial infections. Recently, we observed in the gill of killifish, an environmental model organism, that arsenic exposure induced the ubiquitinylation and degradation of cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that is essential for the mucociliary clearance of respiratory pathogens in humans. Accordingly, in this study, we tested the hypothesis that low dose arsenic exposure reduces the abundance and function of CFTR in human airway epithelial cells. Arsenic induced a time- and dose-dependent increase in multiubiquitinylated CFTR, which led to its lysosomal degradation, and a decrease in CFTR-mediated chloride secretion. Although arsenic had no effect on the abundance or activity of USP10, a deubiquitinylating enzyme, siRNA-mediated knock-down of c-Cbl, an E3 ubiquitin ligase, abolished the arsenic-stimulated degradation of CFTR. Arsenic enhanced the degradation of CFTR by increasing phosphorylated c-Cbl, which increased its interaction with CFTR, and subsequent ubiquitinylation of CFTR. Because epidemiological studies have shown that arsenic increases the incidence of respiratory infections, this study suggests that one potential mechanism of this effect involves arsenic-induced ubiquitinylation and degradation of CFTR, which decreases chloride secretion and airway surface liquid volume, effects that would be proposed to reduce mucociliary clearance of respiratory pathogens.	[Coutermarsh, Bonita A.; Barnaby, Roxanna L.; Stanton, Bruce A.] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stanton, BA (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, 604 Remsen Bldg, Hanover, NH 03755 USA.	BAS@dartmouth.edu			National Institutes of Health [5T32DK007301, 5P42ES007373, 4K99HL098342]; Cystic Fibrosis Foundation [BOMBER08F0, STANTO07R0, STANTO11R0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098342, R01HL074175, K99HL098342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32DK007301 and 5P42ES007373 (to B. A. S.) and 4K99HL098342 (to J. M. B.). This work was also supported by Cystic Fibrosis Foundation Grants BOMBER08F0 (to J. M. B.) and STANTO07R0 and STANTO11R0 (to B. A. S.).	Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bates MN, 2004, AM J EPIDEMIOL, V159, P381, DOI 10.1093/aje/kwh054; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2011, METHODS MOL BIOL, V741, P271, DOI 10.1007/978-1-61779-117-8_18; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bredfeldt TG, 2004, TOXICOL APPL PHARM, V198, P412, DOI 10.1016/j.taap.2003.10.013; Buitrago L, 2011, BLOOD, V118, P5631, DOI 10.1182/blood-2011-01-328807; Carapito C, 2006, BIOCHIMIE, V88, P595, DOI 10.1016/j.biochi.2005.11.004; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Gaworecki KM, 2012, TOXICOL SCI, V125, P522, DOI 10.1093/toxsci/kfr302; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; HopenhaynRich C, 1996, EPIDEMIOLOGY, V7, P117, DOI 10.1097/00001648-199603000-00003; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li YC, 2011, BRAZ J MED BIOL RES, V44, P105, DOI 10.1590/S0100-879X2011000200004; Li YC, 2009, CANCER LETT, V284, P208, DOI 10.1016/j.canlet.2009.04.035; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Mao JH, 2010, P NATL ACAD SCI USA, V107, P21683, DOI 10.1073/pnas.1016311108; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Martin-Chouly C, 2011, MOL IMMUNOL, V48, P956, DOI 10.1016/j.molimm.2011.01.005; Mazumder DNG, 2000, INT J EPIDEMIOL, V29, P1047, DOI 10.1093/ije/29.6.1047; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nayak AS, 2007, TOXICOL SCI, V98, P118, DOI 10.1093/toxsci/kfm072; Parvez F, 2010, THORAX, V65, P528, DOI 10.1136/thx.2009.119347; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Shaw JR, 2007, AM J PHYSIOL-REG I, V292, pR1052, DOI 10.1152/ajpregu.00328.2006; Shaw JR, 2010, AQUAT TOXICOL, V98, P157, DOI 10.1016/j.aquatox.2010.02.001; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Smith AH, 2011, AM J EPIDEMIOL, V173, P414, DOI 10.1093/aje/kwq383; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, 2011, ATSDR 2011 PRIOR LIS; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155; Zhang WQ, 2011, BIOCHEM J, V435, P451, DOI 10.1042/BJ20101725	74	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17130	17139		10.1074/jbc.M111.338855	http://dx.doi.org/10.1074/jbc.M111.338855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467879	Green Published, hybrid			2022-12-28	WOS:000306373000013
J	Bauer, AF; Sonzogni, S; Meyer, L; Zeuzem, S; Piiper, A; Biondi, RM; Neimanis, S				Bauer, Angelika F.; Sonzogni, Silvina; Meyer, Lucas; Zeuzem, Stefan; Piiper, Albrecht; Biondi, Ricardo M.; Neimanis, Sonja			Regulation of Protein Kinase C-related Protein Kinase 2 (PRK2) by an Intermolecular PRK2-PRK2 Interaction Mediated by Its N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIF-BINDING POCKET; CATALYTIC DOMAIN; POTENTIAL EFFECTOR; CRYSTAL-STRUCTURE; DOCKING SITE; AGC KINASES; PKC-ZETA; ACTIVATION; PDK1; RHO	Protein kinase C-related protein kinases (PRKs) are effectors of the Rho family of small GTPases and play a role in the development of diseases such as prostate cancer and hepatitis C. Here we examined the mechanism underlying the regulation of PRK2 by its N-terminal region. We show that the N-terminal region of PRK2 prevents the interaction with its upstream kinase, the 3-phosphoinositide-dependent kinase 1 (PDK1), which phos-porylates the activation loop of PRK2. We confirm that the N-terminal region directly inhibits the kinase activity of PRK2. However, in contrast to previous models, our data indicate that this inhibition is mediated in trans through an intermolecular PRK2-PRK2 interaction. Our results also suggest that amino acids 487-501, located in the linker region between the N-terminal domains and the catalytic domain, contribute to the PRK2-PRK2 dimer formation. This dimerization is further supported by other N-terminal domains. Additionally, we provide evidence that the region C-terminal to the catalytic domain intramolecularly activates PRK2. Finally, we discovered that the catalytic domain mediates a cross-talk between the inhibitory N-terminal region and the activating C-terminal region. The results presented here describe a novel mechanism of regulation among AGC kinases and offer new insights into potential approaches to pharmacologically regulate PRK2.	[Bauer, Angelika F.; Sonzogni, Silvina; Meyer, Lucas; Zeuzem, Stefan; Piiper, Albrecht; Biondi, Ricardo M.; Neimanis, Sonja] Goethe Univ Hosp Frankfurt, Res Grp PhosphoSites, Dept Internal Med 1, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Biondi, RM (corresponding author), Goethe Univ Hosp Frankfurt, Res Grp PhosphoSites, Dept Internal Med 1, D-60590 Frankfurt, Germany.	biondi@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	Sonzogni, Silvina/0000-0002-6237-6594; Biondi, Ricardo/0000-0002-8873-7167	Bundesministerium fur Bildung und Forschung GO-Bio; Deutsche Forschungsgemeinschaft [BI 1044/5-1]	Bundesministerium fur Bildung und Forschung GO-Bio(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Bundesministerium fur Bildung und Forschung GO-Bio and Deutsche Forschungsgemeinschaft Grant BI 1044/5-1.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CATO ACB, 1987, EMBO J, V6, P363, DOI 10.1002/j.1460-2075.1987.tb04763.x; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Dettori R, 2009, J BIOL CHEM, V284, P30318, DOI 10.1074/jbc.M109.051151; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frohner W, 2011, J MED CHEM, V54, P6714, DOI 10.1021/jm2005892; GABRIELLI B, 1984, FEBS LETT, V175, P219, DOI 10.1016/0014-5793(84)80740-1; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Keshwani MM, 2011, J BIOL CHEM, V286, P23552, DOI 10.1074/jbc.M111.258004; Kim SJ, 2009, J VIRAL HEPATITIS, V16, P697, DOI 10.1111/j.1365-2893.2009.01108.x; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; Lachmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021732; Leslie NR, 2001, CHEM REV, V101, P2365, DOI 10.1021/cr000091i; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Masters TA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000738; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; PALMER RH, 1995, BIOCHEM J, V309, P315, DOI 10.1042/bj3090315; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Shiga K, 2010, BIOCHEM J, V425, P445, DOI 10.1042/BJ20090380; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Stroba A, 2009, J MED CHEM, V52, P4683, DOI 10.1021/jm9001499; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476; Yu WP, 1997, J BIOL CHEM, V272, P10030; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	55	20	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20590	20602		10.1074/jbc.M111.327437	http://dx.doi.org/10.1074/jbc.M111.327437			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511787	hybrid, Green Published			2022-12-28	WOS:000306414500079
J	Miller, JP; Yeh, N; Hofstetter, CP; Keskin, D; Goldstein, AS; Koff, A				Miller, Jeffrey P.; Yeh, Nancy; Hofstetter, Christoph P.; Keskin, Doruk; Goldstein, Andrew S.; Koff, Andrew			p27(kip1) Protein Levels Reflect a Nexus of Oncogenic Signaling during Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-T ANTIGEN; SMALL TUMOR-ANTIGEN; HUMAN-DIPLOID FIBROBLASTS; CYCLE PROGRESSION; PHOSPHATASE 2A; MEDIATED TRANSFORMATION; VIRAL TRANSFORMATION; PROSTATE-CANCER; SUPPRESSOR PP2A; P27	SV40 small t-antigen (ST) collaborates with SV40 large T-antigen (LT) and activated rasv12 to promote transformation in a variety of immortalized human cells. A number of oncogenes or the disruption of the general serine-threonine phosphatase protein phosphatase 2A (PP2A) can replace ST in this paradigm. However, the relationship between these oncogenes and PP2A activity is not clear. To address this, we queried the connectivity of these molecules in silico. We found that p27 was connected to each of those oncogenes that could substitute for ST. We further determined that p27 loss can substitute for the expression of ST during transformation of both rodent and human cells. Conversely, knock-in cells expressing the degradation-resistant S10A and T187A mutants of p27 were resistant to the transforming activities of ST. This suggests that p27 is an important target of the tumor-suppressive effects of PP2A and likely an important target of the multitude of cellular oncoproteins that emulate the transforming function of ST.	[Miller, Jeffrey P.; Yeh, Nancy; Keskin, Doruk; Goldstein, Andrew S.; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10021 USA; [Miller, Jeffrey P.; Koff, Andrew] Cornell Univ, Weill Coll Med, Grad Program Biochem Cell & Dev Biol, New York, NY 10021 USA; [Hofstetter, Christoph P.] Cornell Univ, Weill Coll Med, Dept Neurol Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Mol Biol, 1275 York Ave,RRL917C,Box 207, New York, NY 10021 USA.	a-koff@ski.mskcc.org		Koff, Andrew/0000-0003-3271-3067; Goldstein, Andrew/0000-0003-0434-9149	National Institutes of Health; National Institutes of Health from the NCI [CA89563]; Golfers Against Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA089563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Golfers Against Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prasad Jallepalli, David Cobrinik, Mary Alpaugh, John Petrini, Travis Stracker, Neal Rosen, David Solit, David Shaffer, Robert Bowman, and David Liu (Memorial Sloan-Kettering Cancer Center) and Rebecca Katzman and Kathleen Rundell (Northwestern University) for help with experiments and discussions throughout the course of these studies. We also thank James Roberts (Fred Hutchinson Cancer Research Center) for generous gift of S10A and T187A cells for these studies. The Memorial Sloan-Kettering Cancer Center was supported by a core grant from the National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grant CA89563 from the NCI (to A. K.). This work was also supported by funding from The Golfers Against Cancer Foundation (to A. K.).	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Akagi T, 2004, TRENDS MOL MED, V10, P542, DOI 10.1016/j.molmed.2004.09.001; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Akagi T, 2004, CELL CYCLE, V3, P257; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; BOUCK N, 1978, P NATL ACAD SCI USA, V75, P2473, DOI 10.1073/pnas.75.5.2473; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Fink LS, 2011, AGING-US, V3, P836, DOI 10.18632/aging.100381; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Haller K, 2006, ONCOGENE, V25, P2137, DOI 10.1038/sj.onc.1209259; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kasper S, 1998, LAB INVEST, V78, P319; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mateer SC, 1998, J BIOL CHEM, V273, P35339, DOI 10.1074/jbc.273.52.35339; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Porras A, 1996, J VIROL, V70, P6902; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Shaffer DR, 2005, P NATL ACAD SCI USA, V102, P210, DOI 10.1073/pnas.0407362102; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Skoczylas C, 2004, CELL CYCLE, V3, P606; SLEIGH MJ, 1978, CELL, V14, P79, DOI 10.1016/0092-8674(78)90303-3; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Soucek T, 2001, ONCOGENE, V20, P4904, DOI 10.1038/sj.onc.1204627; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vidal A, 2005, P NATL ACAD SCI USA, V102, P6890, DOI 10.1073/pnas.0405823102; Vidal A, 2002, J BIOL CHEM, V277, P16433, DOI 10.1074/jbc.M112090200; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh N, 2007, MOL CELL BIOL, V27, P5161, DOI 10.1128/MCB.02431-06; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhu XH, 2004, MOL CELL BIOL, V24, P6058, DOI 10.1128/MCB.24.13.6058-6066.2004	54	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19775	19785		10.1074/jbc.M112.361972	http://dx.doi.org/10.1074/jbc.M112.361972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511779	Green Published, hybrid			2022-12-28	WOS:000306414500001
J	Pandey, V; Kumar, V				Pandey, Vijaya; Kumar, Vijay			HBx Protein of Hepatitis B Virus Promotes Reinitiation of DNA Replication by Regulating Expression and Intracellular Stability of Replication Licensing Factor CDC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; X-PROTEIN; MAMMALIAN CDC6; CHROMOSOMAL INSTABILITY; HEPATOCELLULAR-CARCINOMA; RETINOBLASTOMA PROTEIN; TUMOR-GROWTH; GENE; E2F; PHOSPHORYLATION	Prevention of re-replication via negative regulation of replication initiator proteins, such as CDC6, is key to maintenance of genomic integrity, whereas their up-regulation is generally associated with perturbation in cell cycle, genomic instability, and potentially, tumorigenesis. The HBx oncoprotein of hepatitis B virus is well known to deregulate cell cycle and has been intricately linked to development of hepatocellular carcinoma. Despite a clear understanding of the proliferative effects of HBx on cell cycle, a mechanistic link between HBx-mediated hepato-carcinogenesis and host cell DNA replication remains poorly perused. Here we show that HBx overexpression in both the cellular as well as the transgenic environment resulted in the accumulation of CDC6 through transcriptional and post-translational up-regulation. The HBx-mediated increase in CDK2 activity altered the E2F1-Rb (retinoblastoma) balance, which favored CDC6 gene expression by E2F1. Besides, HBx impaired the APC(Cdh1)-dependent protein degradation pathway and conferred intracellular stability to CDC6 protein. Increase in CDC6 levels correlated with increase in CDC6 occupancy on the beta-globin origin of replication, suggesting increment in origin licensing and re-replication. In conclusion, our findings strongly suggest a novel role for CDC6 in abetting the oncogenic sabotage carried out by HBx and support the paradigm that pre-replicative complex proteins have a role in oncogenic transformation.	[Pandey, Vijaya; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in		Pandey, Vijaya/0000-0002-5675-5504	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi [BT/PR13228/Med/29/157/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by Grant BT/PR13228/Med/29/157/2009 of the Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi.	Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Di Paola D, 2010, NUCLEIC ACIDS RES, V38, P2314, DOI 10.1093/nar/gkp1192; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Enjuanes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019736; Francis D, 2007, NEW PHYTOL, V174, P261, DOI 10.1111/j.1469-8137.2007.02038.x; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Herbig U, 2000, MOL BIOL CELL, V11, P4117, DOI 10.1091/mbc.11.12.4117; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Janbandhu VC, 2010, J BIOL CHEM, V285, P17453, DOI 10.1074/jbc.M109.058974; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Kumar V, 1998, HYBRIDOMA, V17, P157, DOI 10.1089/hyb.1998.17.157; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Lau E, 2006, CELL CYCLE, V5, P1602, DOI 10.4161/cc.5.15.3124; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mukherji A., 2008, PLEIOTROPIC FUNCTION, P165; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Ohta S, 2001, ONCOL REP, V8, P1063; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; VOUSDEN KH, 1995, SEMIN CANCER BIOL, V6, P109, DOI 10.1006/scbi.1995.0014; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603	47	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20545	20554		10.1074/jbc.M112.359760	http://dx.doi.org/10.1074/jbc.M112.359760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523071	Green Published, hybrid			2022-12-28	WOS:000306414500075
J	Turban, S; Stretton, C; Drouin, O; Green, CJ; Watson, ML; Gray, A; Ross, F; Lantier, L; Viollet, B; Hardie, DG; Marette, A; Hundal, HS				Turban, Sophie; Stretton, Clare; Drouin, Olivier; Green, Charlotte J.; Watson, Maria L.; Gray, Alexander; Ross, Fiona; Lantier, Louise; Viollet, Benoit; Hardie, D. Grahame; Marette, Andre; Hundal, Harinder S.			Defining the Contribution of AMP-activated Protein Kinase (AMPK) and Protein Kinase C (PKC) in Regulation of Glucose Uptake by Metformin in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; INSULIN-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; GLUT4 TRANSLOCATION; MECHANISM; STIMULATION; INHIBITION; MEMBRANE; ALPHA; LIVER	The importance of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) as effectors of metformin (Met) action on glucose uptake (GU) in skeletal muscle cells was investigated. GU in L6 myotubes was stimulated 2-fold following 16 h of Met treatment and acutely enhanced by insulin in an additive fashion. Insulin-stimulated GU was sensitive to PI3K inhibition, whereas that induced by Met was not. Met and its related biguanide, phenformin, stimulated AMPK activation/phosphorylation to a level comparable with that induced by the AMPK activator, 5-amino-1-beta-D-ribofuranosyl-imidazole-4-carboxamide (AICAR). However, the increase in GU elicited by AICAR was significantly lower than that induced by either biguanide. Expression of a constitutively active AMPK mimicked the effects of AICAR on GU, whereas a dominant interfering AMPK or shRNA silencing of AMPK prevented AICAR-stimulated GU and Met-induced AMPK signaling but only repressed biguanide-stimulated GU by similar to 20%. Consistent with this, analysis of GU in muscle cells from alpha 1(-/-)/alpha 2(-/-) AMPK-deficient mice revealed a significant retention of Met-stimulated GU, being reduced by similar to 35% compared with that of wild type cells. Atypical PKCs (aPKCs) have been implicated in Met-stimulated GU, and in line with this, Met and phenformin induced activation/phosphorylation of aPKC in L6 myotubes. However, although cellular depletion of aPKC (>90%) led to loss in biguanide-induced aPKC phosphorylation, it had no effect on Met-stimulated GU, whereas inhibitors targeting novel/conventional PKCs caused a significant reduction in biguanide-induced GU. Our findings indicate that although Met activates AMPK, a significant component of Met-stimulated GU in muscle cells is mediated via an AMPK-independent mechanism that involves novel/conventional PKCs.	[Turban, Sophie; Stretton, Clare; Green, Charlotte J.; Watson, Maria L.; Gray, Alexander; Ross, Fiona; Hardie, D. Grahame; Hundal, Harinder S.] Univ Dundee, Div Cell Signaling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Drouin, Olivier; Marette, Andre] Univ Laval, Dept Med, Quebec Heart & Lung Inst, Ste Foy, PQ G1V 4G2, Canada; [Drouin, Olivier; Marette, Andre] Laval Univ Hosp, Res Ctr, Renal Hlth Axis, Ste Foy, PQ G1V 4G2, Canada; [Lantier, Louise; Viollet, Benoit] INSERM, Inst Cochin, U1016, Paris, France; [Lantier, Louise; Viollet, Benoit] CNRS, UMR8104, Paris, France; [Lantier, Louise; Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	University of Dundee; Laval University; Quebec Heart & Lung Institute; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hundal, HS (corresponding author), Univ Dundee, Div Cell Signaling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Marette, Andre/E-9342-2013; GREEN, Charlotte/B-9742-2014; Viollet, Benoit/N-2397-2019; Hardie, David/Z-1979-2019; Viollet, Benoit/O-6927-2017; Hundal, Hari/A-8990-2008; Drouin, Olivier/AAJ-1988-2020	GREEN, Charlotte/0000-0003-1631-3186; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Hundal, Hari/0000-0002-7621-4932; Hardie, Grahame/0000-0002-8373-7379; Gray, Alexander/0000-0001-9227-0363; Marette, Andre/0000-0003-3950-5973	Canadian Diabetes Association; Canadian Institutes for Health Research; European Commission [LSHM-CT-20004-005272]; Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust [081195]; Diabetes Research and Wellness Foundation; Diabetes UK; MRC [G0801865] Funding Source: UKRI; Medical Research Council [G0801865] Funding Source: researchfish	Canadian Diabetes Association; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Diabetes Research and Wellness Foundation; Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Canadian Diabetes Association, Canadian Institutes for Health Research, Integrated Project Contract LSHM-CT-20004-005272 from the European Commission, Medical Research Council, Biotechnology and Biological Sciences Research Council, Wellcome Trust Programme Grant 081195, Diabetes Research and Wellness Foundation, and Diabetes UK.	Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Bogachus LD, 2010, AM J PHYSIOL-CELL PH, V299, pC1549, DOI 10.1152/ajpcell.00279.2010; Borst SE, 2000, LIFE SCI, V67, P165, DOI 10.1016/S0024-3205(00)00612-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Diamanti-Kandarakis E, 2010, EUR J ENDOCRINOL, V162, P193, DOI 10.1530/EJE-09-0733; Dominguez LJ, 1996, ENDOCRINOLOGY, V137, P113, DOI 10.1210/en.137.1.113; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FANTUS IG, 1986, J CLIN ENDOCR METAB, V63, P898, DOI 10.1210/jcem-63-4-898; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holland W, 2004, BIOCHEM PHARMACOL, V67, P2081, DOI 10.1016/j.bcp.2004.02.016; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535; Kumar N, 2002, BRIT J PHARMACOL, V137, P329, DOI 10.1038/sj.bjp.0704878; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Longnus SL, 2005, DIABETOLOGIA, V48, P2591, DOI 10.1007/s00125-005-0016-3; Luna V, 2006, DIABETOLOGIA, V49, P375, DOI 10.1007/s00125-005-0112-4; Lutz TA, 2001, BBA-BIOMEMBRANES, V1513, P176, DOI 10.1016/S0005-2736(01)00352-2; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Patel N, 2001, BIOCHEM BIOPH RES CO, V285, P1066, DOI 10.1006/bbrc.2001.5275; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stretton C, 2010, AM J PHYSIOL-ENDOC M, V299, pE402, DOI 10.1152/ajpendo.00171.2010; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Thomas CR, 1998, BIOCHEM PHARMACOL, V56, P1145, DOI 10.1016/S0006-2952(98)00151-8; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	60	73	74	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20088	20099		10.1074/jbc.M111.330746	http://dx.doi.org/10.1074/jbc.M111.330746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511782	Green Published, hybrid			2022-12-28	WOS:000306414500030
J	Hebecker, M; Jozsi, M				Hebecker, Mario; Jozsi, Mihaly			Factor H-related Protein 4 Activates Complement by Serving as a Platform for the Assembly of Alternative Pathway C3 Convertase via Its Interaction with C3b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; REACTIVE-PROTEIN; MOLECULAR-BASIS; NECROTIC CELLS; BINDING; FHR-4; POLYANIONS; PROPERDIN; DISEASE; HEPARIN	Human complement factor H-related protein (CFHR) 4 belongs to the factor H family of plasma glycoproteins that are composed of short consensus repeat (SCR) domains. Although factor H is a well known inhibitor of the alternative complement pathway, the functions of the CFHR proteins are poorly understood. CFHR4 lacks SCRs homologous to the complement inhibitory domains of factor H and, accordingly, has no significant complement regulatory activities. We have previously shown that CFHR4 binds C-reactive protein via its most N-terminal SCR, which leads to classical complement pathway activation. CFHR4 binds C3b via its C terminus, but the significance of this interaction is unclear. Therefore, we set out to clarify the functional relevance of C3b binding by CFHR4. Here, we report a novel role for CFHR4 in the complement system. CFHR4 serves as a platform for the assembly of an alternative pathway C3 convertase by binding C3b. This is based on the sustained ability of CFHR4-bound C3b to bind factor B and properdin, leading to an active convertase that generates C3a and C3b from C3. The CFHR4-C3bBb convertase is less sensitive to the factor H-mediated decay compared with the C3bBb convertase. CFHR4 mutants containing exchanges of conserved residues within the C-terminal C3b-binding site showed significantly reduced C3b binding and alternative pathway complement activation. In conclusion, our results suggest that, in contrast to the complement inhibitor factor H, CFHR4 acts as an enhancer of opsonization by promoting complement activation.	[Hebecker, Mario; Jozsi, Mihaly] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, D-07745 Jena, Germany	Hans Knoll Institute (HKI)	Jozsi, M (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, Beutenbergstr 11A, D-07745 Jena, Germany.	mihaly.jozsi@gmx.net	Jozsi, Mihaly/I-7872-2018	Jozsi, Mihaly/0000-0002-5520-5535				de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Friberg N, 2008, J IMMUNOL, V181, P8624, DOI 10.4049/jimmunol.181.12.8624; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hellwage J, 1997, IMMUNOPHARMACOLOGY, V38, P149, DOI 10.1016/S0162-3109(97)00075-1; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2005, EUR J HUM GENET, V13, P321, DOI 10.1038/sj.ejhg.5201324; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Losse J, 2010, J IMMUNOL, V184, P912, DOI 10.4049/jimmunol.0901702; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; NEWMAN SL, 1985, J EXP MED, V161, P1414, DOI 10.1084/jem.161.6.1414; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	30	60	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19528	19536		10.1074/jbc.M112.364471	http://dx.doi.org/10.1074/jbc.M112.364471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518841	hybrid, Green Published			2022-12-28	WOS:000306411900065
J	Hu, C; Zhang, SP; Gao, X; Gao, XJ; Xu, XH; Lv, Y; Zhang, Y; Zhu, ZH; Zhang, CQ; Li, Q; Wong, JM; Cui, YP; Zhang, W; Ma, L; Wang, CG				Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Zhang, Yan; Zhu, Zhenhong; Zhang, Changqing; Li, Qiao; Wong, Jiemin; Cui, Yongping; Zhang, Wen; Ma, Lin; Wang, Chuangui			Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC FINGER PROTEINS; DOUBLE-STRAND BREAKS; CHECKPOINT KINASE; CHK2 KINASE; CELL-CYCLE; COREPRESSOR; ATM; E2F1; P53; TARGET	The Kruppel-associated box (KRAB)-associated co-repressor KAP1 is an essential nuclear co-repressor for the KRAB zinc finger protein superfamily of transcriptional factors. Ataxia telangiectasia mutated (ATM)-Chk2 and ATM- and Rad3-related (ATR)-Chk1 are two primary kinase signaling cascades activated in response to DNA damage. A growing body of evidence suggests that ATM and ATR phosphorylate KAP1 at Ser-824 in response to DNA damage and regulate KAP1-dependent chromatin condensation, DNA repair, and gene expression. Here, we show that, depending on the type of DNA damage that occurs, KAP1 Ser-473 can be phosphorylated by ATM-Chk2 or ATR-Chk1 kinases. Phosphorylation of KAP1 at Ser-473 attenuated its binding to the heterochromatin protein 1 family proteins and inhibited its transcriptional repression of KRAB-zinc finger protein (KRAB-ZFP) target genes. Moreover, KAP1 Ser-473 phosphorylation induced by DNA damage stimulated KAP1-E2F1 binding. Overexpression of heterochromatin protein 1 significantly inhibited E2F1-KAP1 binding. Elimination of KAP1 Ser-473 phosphorylation increased E2F1-targeted proapoptotic gene expression and E2F1-induced apoptosis in response to DNA damage. Furthermore, loss of phosphorylation of KAP1 Ser-473 led to less BRCA1 focus formation and slower kinetics of loss of gamma H2AX foci after DNA damage. KAP1 Ser-473 phosphorylation was required for efficient DNA repair and cell survival in response to DNA damage. Our studies reveal novel functions of KAP1 Ser-473 phosphorylation under stress.	[Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Wong, Jiemin; Ma, Lin; Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Hu, Chen; Zhang, Shengping; Gao, Xuan; Gao, Xiaojing; Xu, Xiaohong; Lv, Ya; Wong, Jiemin; Ma, Lin; Wang, Chuangui] E China Normal Univ, Coll Life Sci, Shanghai 200241, Peoples R China; [Zhang, Wen] E China Normal Univ, Dept Chem, Shanghai 200241, Peoples R China; [Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200025, Peoples R China; [Zhu, Zhenhong; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China; [Li, Qiao] Univ Ottawa, Fac Med, Dept Pathol & Lab Med, Ottawa, ON K1H 8M5, Canada; [Cui, Yongping] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China	East China Normal University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; University of Ottawa; Shanxi Medical University	Wang, CG (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	cgwang@bio.ecnu.edu.cn		Li, Qiao/0000-0002-5941-1985; Zhu, Zhen-Hong/0000-0002-2292-949X; Wong, Jiemin/0000-0002-5311-842X; zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [31071248, 31171361]; National Basic Research Program of China [2009CB918401]; program for New Century Excellent Talents in University [NCET-08-0194]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grants 31071248 and 31171361), the National Basic Research Program of China (Grant 2009CB918401), the program for New Century Excellent Talents in University (Grant NCET-08-0194), and the Science and Technology Commission of Shanghai Municipality (Grant 11DZ2260300) (to C. W.).	Adams CJ, 2008, EMBO REP, V9, P1222, DOI 10.1038/embor.2008.186; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; HALL TJ, 1995, CALCIFIED TISSUE INT, V56, P336, DOI 10.1007/BF00318056; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kherrouche Z, 2006, BIOCHEM J, V396, P547, DOI 10.1042/BJ20051981; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Krum SA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/801594; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin WC, 2001, GENE DEV, V15, P1833; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shieh SY, 2000, GENE DEV, V14, P289; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weber P, 2002, DEVELOPMENT, V129, P2329; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	56	54	57	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18937	18952		10.1074/jbc.M111.313262	http://dx.doi.org/10.1074/jbc.M111.313262			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496453	hybrid, Green Published			2022-12-28	WOS:000306411900006
J	Ying, TL; Chen, WZ; Gong, R; Feng, Y; Dimitrov, DS				Ying, Tianlei; Chen, Weizao; Gong, Rui; Feng, Yang; Dimitrov, Dimiter S.			Soluble Monomeric IgG1 Fc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOMAIN ANTIBODIES; THERAPEUTIC ANTIBODIES; PROTEIN THERAPEUTICS; CRYSTAL-STRUCTURE; CONSTANT DOMAINS; FUSION PROTEIN; RECEPTOR; COMPLEX; STOICHIOMETRY	Antibody fragments are emerging as promising biopharma-ceuticals because of their relatively small size and other unique properties. However, compared with full-size antibodies, these antibody fragments lack the ability to bind the neonatal Fc receptor (FcRn) and have reduced half-lives. Fc engineered to bind antigens but preserve interactions with FcRn and Fc fused with monomeric proteins currently are being developed as candidate therapeutics with prolonged half-lives; in these and other cases, Fc is a dimer of two CH2-CH3 chains. To further reduce the size of Fc but preserve FcRn binding, we generated three human soluble monomeric IgG1 Fcs (mFcs) by using a combination of structure-based rational protein design combined with multiple screening strategies. These mFcs were highly soluble and retained binding to human FcRn comparable with that of Fc. These results provide direct experimental evidence that efficient binding to human FcRn does not require human Fc dimerization. The newly identified mFcs are promising for the development of mFc fusion proteins and for novel types of mFc-based therapeutic antibodies of small size and long half-lives.	[Ying, Tianlei; Chen, Weizao; Gong, Rui; Feng, Yang; Dimitrov, Dimiter S.] NIH, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ying, TL (corresponding author), NIH, Prot Interact Grp, Ctr Canc Res, Nanobiol Program,Frederick Natl Lab Canc Res, Bldg 469,Rm 140, Frederick, MD 21702 USA.	yingt@mail.nih.gov	应, 天雷/P-5396-2019	应, 天雷/0000-0002-9597-2843	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010701, ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research, under Contract No. N01-CO-12400.	Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Flanagan Meg L, 2007, Methods Mol Biol, V378, P33, DOI 10.1007/978-1-59745-323-3_3; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; JAIN RK, 1990, CANCER RES, V50, pS814; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269	38	51	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19399	19408		10.1074/jbc.M112.368647	http://dx.doi.org/10.1074/jbc.M112.368647			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518843	Green Published, hybrid			2022-12-28	WOS:000306411900054
J	Eggers, CM; Kline, ER; Zhong, DS; Zhou, W; Marcus, AI				Eggers, Carrie M.; Kline, Erik R.; Zhong, Diansheng; Zhou, Wei; Marcus, Adam I.			STE20-related Kinase Adaptor Protein alpha (STRAD alpha) Regulates Cell Polarity and Invasion through PAK1 Signaling in LKB1-null Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEUTZ-JEGHERS-SYNDROME; LUNG-CANCER; LKB1-STRAD-MO25 COMPLEX; C. ELEGANS; LKB1; ACTIVATION; MUTATIONS; PATHWAYS; CDC42; ADENOCARCINOMAS	LKB1 is a Ser/Thr kinase, and its activity is regulated by the pseudokinase, STE20-related adaptor alpha (STRAD alpha). The STRAD alpha-LKB1 pathway plays critical roles in epithelial cell polarity, neuronal polarity, and cancer metastasis. Though much attention is given to the STRAD alpha-LKB1 pathway, the function of STRAD alpha itself, including a role outside of the LKB1 pathway, has not been well-studied. Data in Caenorhabditis elegans suggest that STRAD alpha has an LKB1-independent role in regulating cell polarity, and therefore we tested the hypothesis that STRAD alpha regulates cancer cell polarity and motility when wild-type LKB1 is absent. These results show that STRAD alpha protein is reduced in LKB1-null cell lines (mutation or homozygous deletion) and this partial degradation occurs through the Hsp90-dependent proteasome pathway. The remaining STRAD alpha participates in cell polarity and invasion, such that STRAD alpha depletion results in misaligned lamellipodia, improper Golgi positioning, and reduced invasion. To probe the molecular basis of this defect, we show that STRAD alpha associates in a complex with PAK1, and STRAD alpha loss disrupts PAK1 activity via Thr(423) PAK1 phosphorylation. When STRAD alpha is depleted, PAK1-induced invasion could not occur, suggesting that STRAD alpha is necessary for PAK1 to drive motility. Furthermore, STRAD alpha overexpression caused increased activity of the PAK1-activating protein, rac1, and a constitutively active rac1 mutant (Q61L) rescued pPAK(Thr423) and STRAD alpha invasion defects. Taken together, these results show that a STRAD alpha-rac1-PAK1 pathway regulates cell polarity and invasion in LKB1-null cells. It also suggests that while the function of LKB1 and STRAD alpha undoubtedly overlap, they may also have mutually exclusive roles.	[Eggers, Carrie M.; Kline, Erik R.; Zhong, Diansheng; Zhou, Wei; Marcus, Adam I.] Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA	Emory University	Marcus, AI (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, 1365C Clifton Rd, Atlanta, GA 30322 USA.	aimarcu@emory.edu			American Cancer Society [RSG-08-035-01-CSM]; National Lung Cancer Partnership; Lung Cancer Program Project [5P01 CA116676];  [R01 (1R01CA142858)]; NATIONAL CANCER INSTITUTE [P01CA116676, R01CA142858] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Lung Cancer Partnership; Lung Cancer Program Project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Research Scholar Award (RSG-08-035-01-CSM), the National Lung Cancer Partnership, and an R01 (1R01CA142858) (to A. I. M.). This work was also supported by a Lung Cancer Program Project Grant (5P01 CA116676) (to A. I. M. and W. Z.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Boudeau J, 2003, BIOCHEM J, V370, P849, DOI 10.1042/BJ20021813; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Deguchi A, 2010, J BIOL CHEM, V285, P18283, DOI 10.1074/jbc.M109.079137; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim JSM, 2010, DEVELOPMENT, V137, P93, DOI 10.1242/dev.041459; Kline ER, 2011, HEAD NECK-J SCI SPEC, V33, P1501, DOI 10.1002/hed.21638; Kumar A, 2009, J CELL BIOCHEM, V107, P579, DOI 10.1002/jcb.22159; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; McCabe MT, 2010, CANCER GENET CYTOGEN, V197, P130, DOI 10.1016/j.cancergencyto.2009.11.017; Narbonne P, 2010, DEVELOPMENT, V137, P661, DOI 10.1242/dev.042044; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2006, LUNG CANCER, V53, P285, DOI 10.1016/j.lungcan.2006.05.018	42	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18758	18768		10.1074/jbc.M111.316422	http://dx.doi.org/10.1074/jbc.M111.316422			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493453	hybrid, Green Published			2022-12-28	WOS:000306411600084
J	Sura, L; Zima, V; Marsakova, L; Hynkova, A; Barvik, I; Vlachova, V				Sura, Lucie; Zima, Vlastimil; Marsakova, Lenka; Hynkova, Anna; Barvik, Ivan; Vlachova, Viktorie			C-terminal Acidic Cluster Is Involved in Ca2+-induced Regulation of Human Transient Receptor Potential Ankyrin 1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; CHEMICAL STIMULI; CALCIUM-IONS; TIME-SCALE; BK CHANNEL; TRPA1; ACTIVATION; VOLTAGE; A1; SENSITIVITY	The transient receptor potential ankyrin 1 (TRPA1) channel is a Ca2+-permeable cation channel whose activation results from a complex synergy between distinct activation sites, one of which is especially important for determining its sensitivity to chemical, voltage and cold stimuli. From the cytoplasmic side, TRPA1 is critically regulated by Ca2+ ions, and this mechanism represents a self-modulating feedback loop that first augments and then inhibits the initial activation. We investigated the contribution of the cluster of acidic residues in the distal C terminus of TRPA1 in these processes using mutagenesis, whole cell electrophysiology, and molecular dynamics simulations and found that the neutralization of four conserved residues, namely Glu(1077) and Asp(1080)-Asp(1082) in human TRPA1, had strong effects on the Ca2+-and voltage-dependent potentiation and/or inactivation of agonist-induced responses. The surprising finding was that truncation of the C terminus by only 20 residues selectively slowed down the Ca2+-dependent inactivation 2.9-fold without affecting other functional parameters. Our findings identify the conserved acidic motif in the C terminus that is actively involved in TRPA1 regulation by Ca2+.	[Sura, Lucie; Marsakova, Lenka; Hynkova, Anna; Vlachova, Viktorie] Acad Sci Czech Republ, Inst Physiol, Dept Cellular Neurophysiol, CR-14220 Prague 4, Czech Republic; [Zima, Vlastimil; Barvik, Ivan] Charles Univ Prague, Inst Phys, Fac Math & Phys, Div Biomol Phys, CR-12116 Prague 2, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Vlachova, V (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Cellular Neurophysiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	vlachova@biomed.cas.cz	Marsakova, Lenka/F-8637-2014; Vlachova, Viktorie/A-4380-2012; Barvik, Ivan/G-8906-2014; Kádková, Anna/M-9391-2017; Vlachova, Viktorie/Q-2040-2019; Zimova, Lucie/C-4018-2019	Vlachova, Viktorie/0000-0002-8621-0935; Kádková, Anna/0000-0001-6648-9679; Vlachova, Viktorie/0000-0002-8621-0935; Zimova, Lucie/0000-0002-4116-3565; Vyklicka, Lenka/0000-0003-4108-5701	Czech Science Foundation [305/09/0081]; Academy of Sciences of the Czech Republic [AV0Z50110509]; Ministry of Education, Youth and Sports of the Czech Republic [1M0517, MSM0021620835, SVV-2010-261 304, GAUK 426311]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech Science Foundation Grant 305/09/0081, Research Project Fund of the Academy of Sciences of the Czech Republic Grant AV0Z50110509, and Ministry of Education, Youth and Sports of the Czech Republic Grants 1M0517, MSM0021620835, SVV-2010-261 304, and GAUK 426311.	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Case D. A., 2021, AMBER 2022; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javaherian AD, 2011, J BIOL CHEM, V286, P20701, DOI 10.1074/jbc.M111.235234; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lightstone FC, 2005, CHEMPHYSCHEM, V6, P1745, DOI 10.1002/cphc.200500053; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Salazar M, 2011, J NEUROSCI, V31, P5554, DOI 10.1523/JNEUROSCI.6775-10.2011; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	43	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18067	18077		10.1074/jbc.M112.341859	http://dx.doi.org/10.1074/jbc.M112.341859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22461626	Green Published, hybrid			2022-12-28	WOS:000306411600016
J	Chowdhury, MM; Dosche, C; Lohmannsroben, HG; Leimkuhler, S				Chowdhury, Mita Mullick; Dosche, Carsten; Loehmannsroeben, Hans-Gerd; Leimkuehler, Silke			Dual Role of the Molybdenum Cofactor Biosynthesis Protein MOCS3 in tRNA Thiolation and Molybdenum Cofactor Biosynthesis in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDOPTERIN SYNTHASE; ESCHERICHIA-COLI; SULFUR TRANSFER; FLUORESCENT PROTEIN; MODIFIER URM1; UBIQUITIN; YEAST; CONJUGATION; ACTIVATION; SYSTEM	We studied two pathways that involve the transfer of persulfide sulfur in humans, molybdenum cofactor biosynthesis and tRNA thiolation. Investigations using human cells showed that the two-domain protein MOCS3 is shared between both pathways. MOCS3 has an N-terminal adenylation domain and a C-terminal rhodanese-like domain. We showed that MOCS3 activates both MOCS2A and URM1 by adenylation and a subsequent sulfur transfer step for the formation of the thiocarboxylate group at the C terminus of each protein. MOCS2A and URM1 are beta-grasp fold proteins that contain a highly conserved C-terminal double glycine motif. The role of the terminal glycine of MOCS2A and URM1 was examined for the interaction and the cellular localization with MOCS3. Deletion of the C-terminal glycine of either MOCS2A or URM1 resulted in a loss of interaction with MOCS3. Enhanced cyan fluorescent protein and enhanced yellow fluorescent protein fusions of the proteins were constructed, and the fluorescence resonance energy transfer efficiency was determined by the decrease in the donor lifetime. The cellular localization results showed that extension of the C terminus with an additional glycine of MOCS2A and URM1 altered the localization of MOCS3 from the cytosol to the nucleus.	[Chowdhury, Mita Mullick; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany; [Dosche, Carsten; Loehmannsroeben, Hans-Gerd] Univ Potsdam, Inst Chem, Dept Phys Chem, D-14476 Potsdam, Germany	University of Potsdam; University of Potsdam	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Löhmannsröben, Hans-Gerd/U-5884-2019	Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 (to S. L.).	CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Cohnen A, 2010, CYTOSKELETON, V67, P635, DOI 10.1002/cm.20477; Dardalhon V, 1999, HUM GENE THER, V10, P5, DOI 10.1089/10430349950019147; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kim S, 2010, GENETICS, V185, P1235, DOI 10.1534/genetics.110.118406; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A., 2009, DNA RNA MODIFICATION, P392; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Petroski MD, 2011, P NATL ACAD SCI USA, V108, P1749, DOI 10.1073/pnas.1019043108; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schindelin H, 2005, PROTEIN DEGRADATION: UBIQUITIN AND THE CHEMISTRY OF LIFE, VOL 1, P21; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	43	34	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17297	17307		10.1074/jbc.M112.351429	http://dx.doi.org/10.1074/jbc.M112.351429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22453920	Green Published, hybrid			2022-12-28	WOS:000306373000030
J	Staudt, H; Oesterhelt, D; Grininger, M; Wachtveitl, J				Staudt, Heike; Oesterhelt, Dieter; Grininger, Martin; Wachtveitl, Josef			Ultrafast Excited-state Deactivation of Flavins Bound to Dodecin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ADENINE-DINUCLEOTIDE; ABSORPTION-SPECTRA; PROTEIN NANOSPACE; AQUEOUS-SOLUTIONS; BINDING-PROTEIN; DNA PHOTOLYASE; DIMER REPAIR; FLUORESCENCE; DYNAMICS	Dodecins, a group of flavin-binding proteins with a dodecameric quaternary structure, are able to incorporate two flavins within each of their six identical binding pockets building an aromatic tetrade with two tryptophan residues. Dodecin from the archaeal Halobacterium salinarum is a riboflavin storage device. We demonstrate that unwanted side reactions induced by reactive riboflavin species and degradation of riboflavin are avoided by ultrafast depopulation of the reactive excited state of riboflavin. Intriguingly, in this process, the staggered riboflavin dimers do not interact in ground and photoexcited states. Rather, within the tetrade assembly, each riboflavin is kept under the control of the respective adjacent tryptophan, which suggests that the stacked arrangement is a matter of optimizing the flavin load. We further identify an electron transfer in combination with a proton transfer as a central element of the effective excited state depopulation mechanism. Structural and functional comparisons of the archaeal dodecin with bacterial homologs reveal diverging evolution. Bacterial dodecins bind the flavin FMN instead of riboflavin and exhibit a clearly different binding pocket design with inverse incorporations of flavin dimers. The different adoption of flavin changes photochemical properties, making bacterial dodecin a comparably less efficient quencher of flavins. This supports a functional role different for bacterial and archaeal dodecins.	[Staudt, Heike; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Oesterhelt, Dieter; Grininger, Martin] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany	Goethe University Frankfurt; Max Planck Society	Grininger, M (corresponding author), Goethe Univ Frankfurt, Ctr Excellence Macromol Complexes, Buchmann Inst Mol Life Sci, Inst Organ Chem & Chem Biol, Max von Laue Str 15, D-60438 Frankfurt, Germany.	grininger@chemie.uni-frankfurt.de; wveitl@theochem.uni-frankfurt.de	Wachtveitl, Josef/A-7590-2017	Wachtveitl, Josef/0000-0002-8496-8240; Grininger, Martin/0000-0002-7269-0667	Collaborative Research Center [807]; Cluster of Excellence Frankfurt "Macromolecular Complexes"	Collaborative Research Center; Cluster of Excellence Frankfurt "Macromolecular Complexes"	This work was supported by Collaborative Research Center 807 and Cluster of Excellence Frankfurt "Macromolecular Complexes".	Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Chosrowjan H, 2003, CHEM PHYS LETT, V378, P354, DOI 10.1016/S0009-2614(03)01339-3; Ernsting NP, 2001, J PHYS CHEM A, V105, P3443, DOI 10.1021/jp003298o; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Grajek H, 2005, J PHOTOCH PHOTOBIO B, V80, P145, DOI 10.1016/j.jphotobiol.2005.04.002; Grajek H, 2007, CHEM PHYS LETT, V439, P151, DOI 10.1016/j.cplett.2007.03.042; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; HARBURY HA, 1958, P NATL ACAD SCI USA, V44, P662, DOI 10.1073/pnas.44.7.662; HEELIS PF, 1982, CHEM SOC REV, V11, P15, DOI 10.1039/cs9821100015; Huber R, 2005, BIOCHEMISTRY-US, V44, P1800, DOI 10.1021/bi048318h; Islam SDM, 2003, CHEM PHYS, V295, P137, DOI 10.1016/j.chemphys.2003.08.013; Katz AK, 1998, J PHYS CHEM B, V102, P6342, DOI 10.1021/jp9815412; Kovalenko SA, 1999, PHYS REV A, V59, P2369, DOI 10.1103/PhysRevA.59.2369; KOZIOL J, 1965, BIOCHIM BIOPHYS ACTA, V102, P289, DOI 10.1016/0926-6585(65)90221-9; Liu FX, 2011, J STRUCT BIOL, V175, P31, DOI 10.1016/j.jsb.2011.04.013; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Lorenc M, 2002, APPL PHYS B-LASERS O, V74, P19, DOI 10.1007/s003400100750; MacFarlane AW, 2001, BIOCHEMISTRY-US, V40, P15203, DOI 10.1021/bi0114224; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MASSEY V, 1965, BIOCHEMISTRY-US, V4, P1161, DOI 10.1021/bi00882a027; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mataga N, 2000, J PHYS CHEM B, V104, P10667, DOI 10.1021/jp002145y; Mataga N, 1998, J PHYS CHEM B, V102, P7081, DOI 10.1021/jp982583t; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Meissner B, 2007, J BIOL CHEM, V282, P33142, DOI 10.1074/jbc.M704951200; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; Nakabayashi T, 2010, J PHYS CHEM B, V114, P15254, DOI 10.1021/jp1063066; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Riedle E, 2000, APPL PHYS B-LASERS O, V71, P457, DOI 10.1007/s003400000351; Shirdel J, 2007, CHEM PHYS, V331, P427, DOI 10.1016/j.chemphys.2006.11.014; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; SONG PS, 1968, PHOTOCHEM PHOTOBIOL, V7, P311, DOI 10.1111/j.1751-1097.1968.tb08018.x; Stanley RJ, 2000, J PHYS CHEM A, V104, P6899, DOI 10.1021/jp000003y; SUN M, 1972, J AM CHEM SOC, V94, P1730, DOI 10.1021/ja00760a052; Tanaka F, 2007, J PHYS CHEM B, V111, P5694, DOI 10.1021/jp066450g; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Vinzenz X, 2011, CHEM COMMUN, V47, P11071, DOI 10.1039/c1cc12929e; WEBER G, 1950, BIOCHEM J, V47, P114, DOI 10.1042/bj0470114; Weigel A, 2008, J PHYS CHEM A, V112, P12054, DOI 10.1021/jp805962u; Wilhelm T, 1997, OPT LETT, V22, P1494, DOI 10.1364/OL.22.001494; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	49	23	23	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17637	17644		10.1074/jbc.M111.331652	http://dx.doi.org/10.1074/jbc.M111.331652			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451648	Green Published, hybrid			2022-12-28	WOS:000306373000062
J	Fujita, N; Markova, D; Anderson, DG; Chiba, K; Toyama, Y; Shapiro, IM; Risbud, MV				Fujita, Nobuyuki; Markova, Dessislava; Anderson, D. Greg; Chiba, Kazuhiro; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			Expression of Prolyl Hydroxylases (PHDs) Is Selectively Controlled by HIF-1 and HIF-2 Proteins in Nucleus Pulposus Cells of the Intervertebral Disc DISTINCT ROLES OF PHD2 AND PHD3 PROTEINS IN CONTROLLING HIF-1 alpha ACTIVITY IN HYPOXIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; RESPONSIVE ELEMENT; GENE-EXPRESSION; BACK-PAIN; OXYGEN; DEGENERATION; DOMAIN; DEGRADATION; RAT; IDENTIFICATION	Adaptive response to hypoxia in nucleus pulposus cells of the intervertebral disc is regulated by the hypoxia-inducible factors, HIF-1 alpha and HIF-2 alpha. Moreover, oxygen-dependent turnover of HIF-1 alpha in these cells is controlled by the prolyl-4-hydroxylase domain (PHD) family of proteins. Whether HIF homologues control expression of PHDs and whether PHDs control hypoxia-inducible factor (HIF) turnover and/or activity under hypoxia is not known. Here, we show that in nucleus pulposus cells, hypoxia robustly induces PHD3 expression and, to a lesser extent, of PHD2 and PHD1. Reporter analysis shows that the hypoxic induction of the PHD2 promoter is HIF-1 alpha dependent, whereas PHD3 promoter/enhancer activity is dependent on both HIF-1 alpha and HIF-2 alpha. Lentiviral delivery of HIF-1 alpha, ShHIF-1 alpha, and ShHIF-1 alpha confirmed these observations. Noteworthy, HIF-1 alpha maintains basal expression of PHD1 in hypoxia at the posttranscriptional level. Finally, loss of function studies using lentiviral transduction of ShPHDs clearly shows that even at 1% O-2, PHD2 selectively degrades HIF-1 alpha. In contrast, in hypoxia, PHD3 enhances HIF-1 alpha transcriptional activity without affecting protein levels. To correlate these observations with disc disease, a condition characterized by tissue vascularization, we analyzed human tissues. Increased PHD1 mRNA expression but decreased PHD2 and PHD3 expression is observed in degenerate tissues. Interestingly, the hypoxic responsiveness of all the PHDs is maintained in isolated nucleus pulposus cells regardless of the disease state. We propose that PHD2 and PHD3 can be used as a biomarker of tissue oxygenation in the disc and that, as such, it may have important clinical implications.	[Fujita, Nobuyuki; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Chiba, Kazuhiro; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Fujita, Nobuyuki] Int Univ Hlth & Welf, Spine & Spinal Cord Ctr, Mita Hosp, Tokyo 1088329, Japan	Jefferson University; Jefferson University; Keio University; International University of Health & Welfare	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthoped Surg, 1015 Walnut St,Suite 501,Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Fujita, Nobuyuki/L-4800-2013; Toyama, Yoshiaki/K-5743-2013		National Institutes of Health [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR050087 and R01-AR055655.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Arana E, 2004, SKELETAL RADIOL, V33, P29, DOI 10.1007/s00256-003-0699-9; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hiwatashi Y, 2011, EXP CELL RES, V317, P2789, DOI 10.1016/j.yexcr.2011.09.005; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; KAUPPILA LI, 1995, J BONE JOINT SURG AM, V77A, P26, DOI 10.2106/00004623-199501000-00004; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Seth P, 2002, ONCOGENE, V21, P836, DOI 10.1038/sj.onc.1205113; Sowter HM, 2003, CANCER RES, V63, P6130; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Tian YM, 2006, BIOCHEM J, V397, P179, DOI 10.1042/BJ20051996; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Yan B, 2011, BIOCHEM BIOPH RES CO, V409, P315, DOI 10.1016/j.bbrc.2011.05.012; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	41	61	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16975	16986		10.1074/jbc.M111.334466	http://dx.doi.org/10.1074/jbc.M111.334466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451659	Green Published, hybrid			2022-12-28	WOS:000304030900082
J	Umekawa, M; Klionsky, DJ				Umekawa, Midori; Klionsky, Daniel J.			Ksp1 Kinase Regulates Autophagy via the Target of Rapamycin Complex 1 (TORC1) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; SIGNALING PATHWAYS; YEAST; INDUCTION; CYTOPLASM; TRANSPORT; ATG9	Macroautophagy (hereafter autophagy) is a bulk degradation system conserved in all eukaryotes, which engulfs cytoplasmic components within double-membrane vesicles to allow their delivery to, and subsequent degradation within, the vacuole/lysosome. Autophagy activity is tightly regulated in response to the nutritional state of the cell and also to maintain organelle homeostasis. In nutrient-rich conditions, Tor kinase complex 1 (TORC1) is activated to inhibit autophagy, whereas inactivation of this complex in response to stress leads to autophagy induction; however, it is unclear how the activity of TORC1 is controlled to allow precise adjustments in autophagy activity. In this study, we performed genetic analyses in Saccharomyces cerevisiae to identify factors that regulate TORC1 activity. We determined that the Ksp1 kinase functions in part as a negative regulator of autophagy; deletion of KSP1 facilitated dephosphorylation of Atg13, a TORC1 substrate, which correlates with enhanced autophagy. These results suggest that Ksp1 down-regulates autophagy activity via the TORC1 pathway. The suppressive function of Ksp1 is partially activated by the Ras/cAMP-dependent protein kinase A (PKA), which is another negative regulator of autophagy. Our study therefore identifies Ksp1 as a new component that functions as part of the PKA and TORC1 signaling network to control the magnitude of autophagy.	[Umekawa, Midori; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu		Umekawa, Midori/0000-0002-8071-3902	National Institutes of Health [GM53396]; Japan Society for the Promotion of Science [214774]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53396 (to D. J. K.). This work was also supported in part by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 214774 (to M. U.).	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; Dunn WA, 2005, AUTOPHAGY, V1, P75; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Ma J, 2007, GENETICS, V177, P205, DOI 10.1534/genetics.107.076596; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Vinod PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001663; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091	41	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16300	16310		10.1074/jbc.M112.344952	http://dx.doi.org/10.1074/jbc.M112.344952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447937	Green Published, hybrid			2022-12-28	WOS:000304030900022
J	van Hooren, KWEM; van Agtmaal, EL; Fernandez-Borja, M; van Mourik, JA; Voorberg, J; Bierings, R				van Hooren, Kathinka W. E. M.; van Agtmaal, Ellen L.; Fernandez-Borja, Mar; van Mourik, Jan A.; Voorberg, Jan; Bierings, Ruben			The Epac-Rap1 Signaling Pathway Controls cAMP-mediated Exocytosis of Weibel-Palade Bodies in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-KINASE-A; EXCHANGE FACTOR; BARRIER FUNCTION; 1-DEAMINO-8-D-ARGININE VASOPRESSIN; MICROTUBULE DYNAMICS; PLATELET-AGGREGATION; EXOCYST COMPLEX; FACTOR RELEASE; RAP1	Endothelial cells contain specialized storage organelles called Weibel-Palade bodies (WPBs) that release their content into the vascular lumen in response to specific agonists that raise intracellular Ca2+ or cAMP. We have previously shown that cAMP-mediated WPB release is dependent on protein kinase A (PKA) and involves activation of the small GTPase RalA. Here, we have investigated a possible role for another PKA-independent cAMP-mediated signaling pathway in the regulation of WPB exocytosis, namely the guanine nucleotide exchange factor Epac1 and its substrate, the small GTPase Rap1. Epinephrine stimulation of endothelial cells leads to Rap1 activation in a PKA-independent fashion. siRNA-mediated knockdown of Epac1 abolished epinephrine-induced activation of Rap1 and resulted in decreased epinephrine-induced WPB exocytosis. Down-regulation of Rap1 expression and prevention of Rap1 activation through overexpression of Rap1GAP effectively reduced epinephrine-but not thrombin-induced WPB exocytosis. Taken together, these data uncover a new Epac-Rap1-dependent pathway by which endothelial cells can regulate WPB exocytosis in response to agonists that signal through cAMP.	[van Hooren, Kathinka W. E. M.; van Agtmaal, Ellen L.; van Mourik, Jan A.; Voorberg, Jan; Bierings, Ruben] Amsterdam Med Ctr, Dept Plasma Prot, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Fernandez-Borja, Mar] Amsterdam Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bierings, R (corresponding author), Amsterdam Med Ctr, Dept Plasma Prot, Sanquin Res & Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	r.bierings@sanquin.nl	van Agtmaal, Ellen/G-4489-2016; Bierings, Ruben/AAQ-8854-2020	Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621	Netherlands Heart Foundation [2002.B187]; Landsteiner Foundation for Blood Transfusion Research Grant [LSBR 08.19]; Dutch Organization for Scientific Research NWO TOP-Grant [91209006]	Netherlands Heart Foundation(Netherlands Heart Foundation); Landsteiner Foundation for Blood Transfusion Research Grant; Dutch Organization for Scientific Research NWO TOP-Grant	This work was supported by the Netherlands Heart Foundation Grant 2002.B187, Landsteiner Foundation for Blood Transfusion Research Grant LSBR 08.19, and Dutch Organization for Scientific Research NWO TOP-Grant 91209006.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; de Bruyn KMT, 2003, J BIOL CHEM, V278, P22412, DOI 10.1074/jbc.M212036200; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; de Leeuw HPJC, 2001, ARTERIOSCL THROM VAS, V21, P899, DOI 10.1161/01.ATV.21.6.899; de Leeuw HPJC, 1999, THROMB HAEMOSTASIS, V82, P1177, DOI 10.1055/s-0037-1614349; de Wit TR, 2003, ARTERIOSCL THROM VAS, V23, P755, DOI 10.1161/01.ATV.0000069847.72001.E8; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Goehring AS, 2007, J BIOL CHEM, V282, P33155, DOI 10.1074/jbc.M705167200; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; MANNUCCI PM, 1977, LANCET, V1, P869; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Nightingale TD, 2009, BLOOD, V113, P5010, DOI 10.1182/blood-2008-09-181206; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; RICKLES FR, 1976, J CLIN INVEST, V57, P1618, DOI 10.1172/JCI108432; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P49, DOI 10.1161/01.ATV.0000191639.08082.04; Rondaij MG, 2004, ARTERIOSCL THROM VAS, V24, P1315, DOI 10.1161/01.ATV.0000131267.13425.45; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Sehrawat S, 2011, BLOOD, V117, P708, DOI 10.1182/blood-2010-02-268870; STEL HV, 1984, BLOOD, V63, P1408; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Yang SX, 2004, CHINESE MED J-PEKING, V117, P1143; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053	51	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24713	24720		10.1074/jbc.M111.321976	http://dx.doi.org/10.1074/jbc.M111.321976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22511766	Green Published, hybrid			2022-12-28	WOS:000306651100064
J	Calandria, JM; Mukherjee, PK; Vaccari, JCD; Zhu, M; Petasis, NA; Bazan, NG				Calandria, Jorgelina M.; Mukherjee, Pranab K.; Vaccari, Juan Carlos de Rivero; Zhu, Min; Petasis, Nicos A.; Bazan, Nicolas G.			Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis Are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT EPITHELIAL-CELLS; UP-REGULATING BAX; OXIDATIVE STRESS; MEDIATES NEURODEGENERATION; AXH DOMAIN; PROTEIN; RHODOPSIN; DISEASE; DEGENERATION; MECHANISMS	Neurodegenerative diseases share two common features: enhanced oxidative stress and cellular inability to scavenge structurally damaged abnormal proteins. Pathogenesis of polyglutamine (poly(Q)) diseases involves increased protein misfolding, along with ubiquitin and chaperon protein-containing nuclear aggregates. In spinocerebellar ataxia, the brain and retina undergo degeneration. Neuroprotectin D1 (NPD1) is made on-demand in the nervous system and retinal pigment epithelial (RPE) cells in response to oxidative stress, which activates pro-survival signaling via regulation of gene expression and other processes. We hypothesized that protein misfolding-induced proteotoxic stress triggers NPD1 synthesis. We used ARPE-19 cells as a cellular model to assess stress due to ataxin-1 82Q protein expression and determine whether NPD1 prevents apoptosis. Ectopic ataxin-1 expression induced RPE cell apoptosis, which was abrogated by 100 nM docosahexaenoic acid, 10 ng/ml pigment epithelium-derived factor, or NPD1. Similarly, NPD1 was protective in neurons and primary human RPE cells. Furthermore, when ataxin-1 82Q was expressed in 15-lipoxygenase-1-deficient cells, apoptosis was greatly enhanced, and only NPD1 (50 nM) rescued cells from death. NPD1 reduced misfolded ataxin-1-induced accumulation of proapoptotic Bax in the cytoplasm, suggesting that NPD1 acts by preventing proapoptotic signaling pathways from occurring. Finally, NPD1 signaling interfered with ataxin-1/capicua repression of gene expression and decreased phosphorylated ataxin-1 in an Akt-independent manner, suggesting that NPD1 signaling modulates formation or stabilization of ataxin-1 complexes. These data suggest that 1) NPD1 synthesis is an early response induced by proteotoxic stress due to abnormally folded ataxin-1, and 2) NPD1 promotes cell survival through modulating stabilization of ataxin-1 functional complexes and pro-/antiapoptotic and inflammatory pathways.	[Calandria, Jorgelina M.; Mukherjee, Pranab K.; Vaccari, Juan Carlos de Rivero; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Zhu, Min; Petasis, Nicos A.] Univ So Calif, Loker Hydrocarbon Res Inst, Dept Chem, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009	Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446	National Institutes of Health (NIH), NEI [EY005121]; NIH, NCRR [RR016816]; Research to Prevent Blindness, Inc., New York; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research to Prevent Blindness, Inc., New York(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant EY005121 and NIH, NCRR, Grant RR016816. This work was also supported in part by an unrestricted departmental grant from Research to Prevent Blindness, Inc., New York.	Abe T, 1997, ARCH OPHTHALMOL-CHIC, V115, P231, DOI 10.1001/archopht.1997.01100150233013; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Azadi S, 2007, BRAIN RES, V1129, P116, DOI 10.1016/j.brainres.2006.10.031; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chou AH, 2006, NEUROBIOL DIS, V21, P333, DOI 10.1016/j.nbd.2005.07.011; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2008, FEBS J, V275, P2548, DOI 10.1111/j.1742-4658.2008.06403.x; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Dikshit P, 2008, NEUROCHEM RES, V33, P945, DOI 10.1007/s11064-007-9459-x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Isashiki Y, 2001, AM J OPHTHALMOL, V131, P808, DOI 10.1016/S0002-9394(00)00891-6; Ishida M, 1998, CURR EYE RES, V17, P392, DOI 10.1080/02713689808951220; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kaytor MD, 2005, HUM MOL GENET, V14, P1095, DOI 10.1093/hmg/ddi122; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Koshy B, 1996, HUM MOL GENET, V5, P1311, DOI 10.1093/hmg/5.9.1311; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito Y, 2006, J NEUROL NEUROSUR PS, V77, P1293, DOI 10.1136/jnnp.2006.092676; Saliba RS, 2002, J CELL SCI, V115, P2907; Shaw CA, 2008, NEUROMOL MED, V10, P1, DOI 10.1007/s12017-007-8016-8; Stark DT, 2011, J NEUROSCI, V31, P13710, DOI 10.1523/JNEUROSCI.3544-11.2011; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang HL, 2006, CELL SIGNAL, V18, P541, DOI 10.1016/j.cellsig.2005.05.024; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wu CL, 2010, ANN NY ACAD SCI, V1201, P8, DOI 10.1111/j.1749-6632.2010.05628.x; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	49	27	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23726	23739		10.1074/jbc.M111.287078	http://dx.doi.org/10.1074/jbc.M111.287078			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22511762	Green Published, hybrid			2022-12-28	WOS:000306511300043
J	Mo, JY; Boyle, JP; Howard, CB; Monie, TP; Davis, BK; Duncan, JA				Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.			Pathogen Sensing by Nucleotide-binding Oligomerization Domain-containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; CRITICAL RESIDUES; HOST RECOGNITION; CARD15 MUTATIONS; FAMILY; PEPTIDOGLYCAN; INNATE; GENE; RECRUITMENT; ACTIVATION	Nucleotide binding and oligomerization domain-containing protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide. Mutations in the gene encoding NOD2 are associated with inherited inflammatory disorders, including Crohn disease and Blau syndrome. NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-containing protein gene (NLR) family. Nucleotide binding is thought to play a critical role in signaling by NLR family members. However, the molecular mechanisms underlying signal transduction by these proteins remain largely unknown. Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays. Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP. Additionally, we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can associate with known NOD2-interacting proteins in vitro. Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the molecular mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex. These findings set the stage for further studies into the molecular mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-containing signaling complexes.	[Davis, Beckley K.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mo, Jinyao; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill	Davis, BK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Beckley.davis@fandm.edu; jaduncan@med.unc.edu	Howard, Christopher/D-3859-2017	Howard, Christopher/0000-0001-9797-8686; Monie, Tom/0000-0003-4097-1680	National Institutes of Health [CA131645, AI088255]; Burroughs Wellcome Fund Career Award for Medical Scientists; Crohn's and Colitis Foundation Career Development Award; Franklin and Marshall College; Wellcome Trust [WT0805090MA]; Biotechnology and Biological Sciences Research Council [RG52820]; NATIONAL CANCER INSTITUTE [R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Crohn's and Colitis Foundation Career Development Award; Franklin and Marshall College; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131645 (to B. K. D. and J. A. D.) and AI088255 (to J. A. D.). This work was supported by the Burroughs Wellcome Fund Career Award for Medical Scientists (to J. A. D.), the Crohn's and Colitis Foundation Career Development Award and Franklin and Marshall College (to B. K. D.), Wellcome Trust Grant WT0805090MA (to T. P. M.), and Biotechnology and Biological Sciences Research Council Grant RG52820 (to T. P. M.).	Albrecht M, 2003, BIOINFORMATICS, V19, P2171, DOI 10.1093/bioinformatics/btg370; Albrecht M, 2003, FEBS LETT, V554, P520, DOI 10.1016/S0014-5793(03)01222-5; Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Chen DQ, 2004, BIOCHEMISTRY-US, V43, P11796, DOI 10.1021/bi0490789; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marinis JM, 2011, J BIOL CHEM, V286, P1938, DOI 10.1074/jbc.M110.189308; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; von Kampen O, 2010, J BIOL CHEM, V285, P19921, DOI 10.1074/jbc.M110.127480; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wang XJ, 2002, ARTHRITIS RHEUM, V46, P3041, DOI 10.1002/art.10618; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Zhao Y, 2012, INFLAMM BOWEL DIS, V18, P603, DOI 10.1002/ibd.21851; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	54	123	126	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23057	23067		10.1074/jbc.M112.344283	http://dx.doi.org/10.1074/jbc.M112.344283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549783	Green Published, hybrid			2022-12-28	WOS:000306495000062
J	Becker, GL; Lu, YH; Hardes, K; Strehlow, B; Levesque, C; Lindberg, I; Sandvig, K; Bakowsky, U; Day, R; Garten, W; Steinmetzer, T				Becker, Gero L.; Lu, Yinghui; Hardes, Kornelia; Strehlow, Boris; Levesque, Christine; Lindberg, Iris; Sandvig, Kirsten; Bakowsky, Udo; Day, Robert; Garten, Wolfgang; Steinmetzer, Torsten			Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; SUBTILISIN-LIKE ENDOPROTEASE; SHIGA TOXIN; D-ARGININE; ALPHA-CHYMOTRYPSIN; PROCESSING ENZYME; CRYSTAL-STRUCTURE; INDUCED CLEAVAGE; IN-VIVO; ACTIVATION	Optimization of our previously described peptidomimetic furin inhibitors was performed and yielded several analogs with a significantly improved activity. The most potent compounds containing an N-terminal 4- or 3-(guanidinomethyl) phenylacetyl residue inhibit furin with K-i values of 16 and 8 pM, respectively. These analogs inhibit other proprotein convertases, such as PC1/3, PC4, PACE4, and PC5/6, with similar potency, whereas PC2, PC7, and trypsin-like serine proteases are poorly affected. Incubation of selected compounds with Madin-Darby canine kidney cells over a period of 96 h revealed that they exhibit great stability, making them suitable candidates for further studies in cell culture. Two of the most potent derivatives were used to inhibit the hemagglutinin cleavage and viral propagation of a highly pathogenic avian H7N1 influenza virus strain. The treatment with inhibitor 24 (4-(guanidinomethyl)phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide) resulted in significantly delayed virus propagation compared with an inhibitor-free control. The same analog was also effective in inhibiting Shiga toxin activation in HEp-2 cells. This antiviral effect, as well as the protective effect against a bacterial toxin, suggests that inhibitors of furin or furin-like proprotein convertases could represent promising lead structures for future drug development, in particular for the treatment of infectious diseases.	[Becker, Gero L.; Hardes, Kornelia; Steinmetzer, Torsten] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany; [Lu, Yinghui; Garten, Wolfgang] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Strehlow, Boris; Bakowsky, Udo] Univ Marburg, Inst Pharmaceut Technol & Biopharm, D-35032 Marburg, Germany; [Levesque, Christine; Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H SN4, Canada; [Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Sandvig, Kirsten] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; [Sandvig, Kirsten] Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed, N-0310 Oslo, Norway	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; University of Sherbrooke; University System of Maryland; University of Maryland Baltimore; University of Oslo; University of Oslo	Steinmetzer, T (corresponding author), Univ Marburg, Inst Pharmaceut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	steinmetzer@staff.uni-marburg.de	Lindberg, Iris/Q-3825-2019	Bakowsky, Udo/0000-0002-3895-0453	National Institutes of Health Grant [DA05084]; Ministere du Developpement Economique, Innovation et Exportation; Canadian Institutes of Health Research; Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen; Roland and Elfriede Schauer-Stiftung; FAZIT-Stiftung; Fonds de Recherche du Quebec-Sante studentship; Deutsche Forschungsgemeinschaft [SFB 593]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministere du Developpement Economique, Innovation et Exportation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen; Roland and Elfriede Schauer-Stiftung; FAZIT-Stiftung; Fonds de Recherche du Quebec-Sante studentship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant DA05084 (to I. L.). This work was supported in part by the Ministere du Developpement Economique, Innovation et Exportation, and Canadian Institutes of Health Research (to R. D.).; Supported by the Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen, the Roland and Elfriede Schauer-Stiftung, and the FAZIT-Stiftung.; Supported by Fonds de Recherche du Quebec-Sante studentship.; Supported by Deutsche Forschungsgemeinschaft SFB 593.	ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016; Bakowsky H, 2008, BBA-BIOMEMBRANES, V1778, P242, DOI 10.1016/j.bbamem.2007.09.033; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; Basak A, 2010, CURR MED CHEM, V17, P2214, DOI 10.2174/092986710791331040; Becker GL, 2011, BIOORG MED CHEM LETT, V21, P4695, DOI 10.1016/j.bmcl.2011.06.091; Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455; BENDER ML, 1966, J AM CHEM SOC, V88, P5890, DOI 10.1021/ja00976a034; BERNATOWICZ MS, 1992, J ORG CHEM, V57, P2497, DOI 10.1021/jo00034a059; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; BRAUN PJ, 1988, BIOCHEMISTRY-US, V27, P6517, DOI 10.1021/bi00417a048; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; DANG QD, 1994, J PROTEIN CHEM, V13, P367, DOI 10.1007/BF01901692; De Vos L, 2008, INT J ONCOL, V32, P1073; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; GARRED O, 1995, J BIOL CHEM, V270, P10817; GARRED O, 1995, EXP CELL RES, V218, P39, DOI 10.1006/excr.1995.1128; GARTEN W, 1989, VIROLOGY, V172, P25, DOI 10.1016/0042-6822(89)90103-7; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Garten Wolfgang, 2008, V27, P156; GU ML, 1995, FEBS LETT, V365, P95, DOI 10.1016/0014-5793(95)00447-H; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Katayama S, 2011, J CONTROL RELEASE, V149, P29, DOI 10.1016/j.jconrel.2010.02.004; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; Kuester M, 2011, BIOL CHEM, V392, P973, DOI 10.1515/BC.2011.100; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; Lahlil R, 2009, RECENT PAT ANTI-CANC, V4, P83, DOI 10.2174/157489209787002470; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsubara T, 2009, J MED CHEM, V52, P4247, DOI 10.1021/jm801570y; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Schweinitz A, 2004, J BIOL CHEM, V279, P33613, DOI 10.1074/jbc.M314151200; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sielaff F, 2011, BIOORG MED CHEM LETT, V21, P836, DOI 10.1016/j.bmcl.2010.11.092; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Wheatley JL, 2007, P NATL ACAD SCI USA, V104, P6626, DOI 10.1073/pnas.0701983104; Williams J W, 1979, Methods Enzymol, V63, P437	68	78	84	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21992	22003		10.1074/jbc.M111.332643	http://dx.doi.org/10.1074/jbc.M111.332643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22539349	hybrid, Green Published			2022-12-28	WOS:000306418600038
J	McDaniel, FK; Molden, BM; Mohammad, S; Baldini, G; McPike, L; Narducci, P; Granell, S; Baldini, G				McDaniel, Faith K.; Molden, Brent M.; Mohammad, Sameer; Baldini, Giovanna; McPike, Lakisha; Narducci, Paola; Granell, Susana; Baldini, Giulia			Constitutive Cholesterol-dependent Endocytosis of Melanocortin-4 Receptor (MC4R) Is Essential to Maintain Receptor Responsiveness to alpha-Melanocyte-stimulating Hormone (alpha-MSH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INVERSE AGONIST; BETA-ARRESTIN; THROMBIN RECEPTORS; CELL-SURFACE; FOOD-INTAKE; INTERNALIZATION; TRAFFICKING; ADAPTER; OBESITY	Melanocortin-4 receptor (MC4R) is a G-protein-coupled receptor expressed in the hypothalamus where it controls feeding behavior. MC4R cycles constitutively and is internalized at the same rate in the presence or absence of stimulation by the agonist, melanocyte-stimulating hormone (alpha-MSH). This is different from other G-protein-coupled receptors, such as beta(2)-adrenergic receptor (beta(2)AR), which internalizes more rapidly in response to agonist stimulation. Here, it is found that in immortalized neuronal Neuro2A cells expressing exogenous receptors, constitutive endocytosis of MC4R and agonist-dependent internalization of beta(2)AR were equally sensitive to clathrin depletion. Inhibition of MC4R endocytosis by clathrin depletion decreased the number of receptors at the cell surface that were responsive to the agonist, alpha-MSH, by 75%. Mild membrane cholesterol depletion also inhibited constitutive endocytosis of MC4R by similar to 5-fold, while not affecting recycling of MC4R or agonist-dependent internalization of beta(2)AR. Reduced cholesterol did not change the MC4R dose-response curve to alpha-MSH, but it decreased the amount of cAMP generated per receptor number indicating that a population of MC4R at the cell surface becomes nonfunctional. The loss of MC4R function increased over time (25-50%) and was partially reversed by mutations at putative phosphorylation sites (T312A and S329A). This was reproduced in hypothalamic GT1-7 cells expressing endogenous MC4R. The data indicate that constitutive endocytosis of MC4R is clathrin- and cholesterol-dependent. MC4R endocytosis is required to maintain MC4R responsiveness to alpha-MSH by constantly eliminating from the plasma membrane a pool of receptors modified at Thr-312 and Ser-329 that have to be cycled to the endosomal compartment to regain function.	[McDaniel, Faith K.; Molden, Brent M.; Mohammad, Sameer; McPike, Lakisha; Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Baldini, Giovanna; Narducci, Paola] Univ Trieste, Dipartimento Univ Clin Biomed, I-34100 Trieste, Italy	University of Arkansas System; University of Arkansas Medical Sciences; University of Trieste	Granell, S (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	SGranell@uams.edu; gbaldini@uams.edu	Mohammad, Sameer/GWV-2875-2022; granell, susana/H-2734-2012		National Institutes of Health [R01-DK080424]; National Center for Research Resources [UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK080424 (to G. B.) and by Grant UL1RR029884 from the National Center for Research Resources (to the University of Arkansas for Medical Sciences Translational Research Institute).	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baratti-Elbaz C, 1999, MOL ENDOCRINOL, V13, P1751, DOI 10.1210/me.13.10.1751; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Breit A, 2006, J BIOL CHEM, V281, P37447, DOI 10.1074/jbc.M605982200; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; Dalvi PS, 2011, AM J PHYSIOL-REG I, V300, pR1030, DOI 10.1152/ajpregu.00649.2010; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Dumont LM, 2001, MOL CELL ENDOCRINOL, V184, P173, DOI 10.1016/S0303-7207(01)00558-5; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson Stephen S. G., 2003, V237, P121; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Granell S, 2010, MOL ENDOCRINOL, V24, P1805, DOI 10.1210/me.2010-0071; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; HEIN L, 1994, J BIOL CHEM, V269, P27719; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Murphy B, 2000, J APPL PHYSIOL, V89, P273, DOI 10.1152/jappl.2000.89.1.273; Nickolls SA, 2005, J PHARMACOL EXP THER, V313, P1281, DOI 10.1124/jpet.105.083337; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Overton JD, 2011, J BIOL CHEM, V286, P18914, DOI 10.1074/jbc.M111.224592; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Rossi M, 1999, BRAIN RES, V846, P164, DOI 10.1016/S0006-8993(99)02005-3; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; TeclemariamMesbah R, 1997, J HISTOCHEM CYTOCHEM, V45, P619, DOI 10.1177/002215549704500414; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Wang GY, 1997, J CELL SCI, V110, P505; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	62	20	20	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21873	21890		10.1074/jbc.M112.346890	http://dx.doi.org/10.1074/jbc.M112.346890			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544740	Green Published, hybrid			2022-12-28	WOS:000306418600029
J	Wang, HL; Shao, ZP; Shi, LZ; Hwang, PYH; Truong, LN; Berns, MW; Chen, DJ; Wu, XH				Wang, Hailong; Shao, Zhengping; Shi, Linda Z.; Hwang, Patty Yi-Hwa; Truong, Lan N.; Berns, Michael W.; Chen, David J.; Wu, Xiaohua			CtIP Protein Dimerization Is Critical for Its Recruitment to Chromosomal DNA Double-stranded Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MRE11 COMPLEX; HOMOLOGOUS RECOMBINATION; END RESECTION; DAMAGE RESPONSE; COILED-COIL; REPAIR; TRANSLATION; SAE2; RNA	CtIP (CtBP-interacting protein) associates with BRCA1 and the Mre11-Rad50-Nbs1 (MRN) complex and plays an essential role in homologous recombination (HR)-mediated DNA double-stranded break (DSB) repair. It has been described that CtIP forms dimers in mammalian cells, but the biological significance is not clear. In this study, we identified a conserved motif in the the N terminus of CtIP, which is required for dimer formation. We further showed that CtIP mutants impaired in forming dimers are strongly defective in HR, end resection, and activation of the ataxia telangiectasia and Rad3-related pathway, without notable change of CtIP interactions with BRCA1 or Nbs1. In addition to HR, CtIP dimerization is also required for microhomology-mediated end joining. Live cell imaging of enhanced GFP-tagged CtIP demonstrates that the CtIP dimerization mutant fails to be localized to DSBs, whereas placing a heterologous dimerization motif to the dimerization mutant restores CtIP recruitment to DSBs. These studies suggest that CtIP dimer formation is essential for its recruitment to DSBs on chromatin upon DNA damage. Furthermore, DNA damage-induced phosphorylation of CtIP is significantly reduced in the CtIP dimerization mutants. Therefore, in addition to the C-terminal conserved domains critical for CtIP function, the dimerization motif on the N terminus of CtIP is also conserved and essential for its function in DNA damage responses. The severe repair defects of CtIP dimerization mutants are likely due to the failure in localization to chromosomal DSBs upon DNA damage.	[Wang, Hailong; Hwang, Patty Yi-Hwa; Truong, Lan N.; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Shao, Zhengping; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA162804]; Beckman Laser Institute; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute; Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.) and CA162804 (to D. J. C.). This work was also supported by funds from the Beckman Laser Institute (to M. W. B.) and Cancer Prevention Research Institute of Texas Grant RP110465 (to D. J. C.).	Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dubin MJ, 2004, J BIOL CHEM, V279, P26932, DOI 10.1074/jbc.M313974200; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	33	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21471	21480		10.1074/jbc.M112.355354	http://dx.doi.org/10.1074/jbc.M112.355354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544744	Green Published, hybrid			2022-12-28	WOS:000306416800064
J	Kimple, ME; Moss, JB; Brar, HK; Rosa, TC; Truchan, NA; Pasker, RL; Newgard, CB; Casey, PJ				Kimple, Michelle E.; Moss, Jennifer B.; Brar, Harpreet K.; Rosa, Taylor C.; Truchan, Nathan A.; Pasker, Renee L.; Newgard, Christopher B.; Casey, Patrick J.			Deletion of G alpha(Z) Protein Protects against Diet-induced Glucose Intolerance via Expansion of beta-Cell Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; NUCLEOTIDE-BINDING PROTEIN; INSULIN-RESISTANCE; DIABETIC-RATS; PERTUSSIS TOXIN; ALPHA-SUBUNIT; CA2+ CHANNELS; MICE; G(Z); DYSFUNCTION	Insufficient plasma insulin levels caused by deficits in both pancreatic beta-cell function and mass contribute to the pathogenesis of type 2 diabetes. This loss of insulin-producing capacity is termed beta-cell decompensation. Our work is focused on defining the role(s) of guanine nucleotide-binding protein (G protein) signaling pathways in regulating beta-cell decompensation. We have previously demonstrated that the alpha-subunit of the hetero-trimeric G(z) protein, G alpha(z), impairs insulin secretion by suppressing production of cAMP. Pancreatic islets from G alpha(z)-null mice also exhibit constitutively increased cAMP production and augmented glucose-stimulated insulin secretion, suggesting that G alpha(z) is a tonic inhibitor of adenylate cyclase, the enzyme responsible for the conversion of ATP to cAMP. In the present study, we show that mice genetically deficient for G alpha(z) are protected from developing glucose intolerance when fed a high fat (45 kcal%) diet. In these mice, a robust increase in beta-cell proliferation is correlated with significantly increased beta-cell mass. Further, an endogenous G alpha(z) signaling pathway, through circulating prostaglandin E activating the EP3 isoform of the E prostanoid receptor, appears to be up-regulated in insulin-resistant, glucose-intolerant mice. These results, along with those of our previous work, link signaling through G alpha(z) to both major aspects of beta-cell decompensation: insufficient beta-cell function and mass.	[Kimple, Michelle E.; Brar, Harpreet K.; Truchan, Nathan A.; Pasker, Renee L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Moss, Jennifer B.; Rosa, Taylor C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Med, Durham, NC 27704 USA; [Rosa, Taylor C.; Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; [Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27704 USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University; Duke University	Kimple, ME (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Endocrinol Diabet & Metab, 4th Floor,Med Fdn Centennial Bldg, Madison, WI 53705 USA.	mkimple@medicine.wisc.edu		Casey, Patrick/0000-0002-7366-9309	National Institutes of Health [DK080845, DK042583, DK076488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076488, K01DK080845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080845 (to M. E. K.), DK042583 (to C. B. N.), and DK076488 (to P. J. C.).	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; AXELROD L, 1986, DIABETES, V35, P1004, DOI 10.2337/diabetes.35.9.1004; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Furman B, 2006, CURR OPIN INVEST DR, V7, P898; Garzon J, 1997, EUR J NEUROSCI, V9, P1194, DOI 10.1111/j.1460-9568.1997.tb01474.x; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; Gerich JE, 2002, EUR J CLIN INVEST, V32, P46, DOI 10.1046/j.1365-2362.32.s3.6.x; Greenberg AS, 2002, EUR J CLIN INVEST, V32, P24, DOI 10.1046/j.1365-2362.32.s3.4.x; Hendry IA, 2000, BRAIN RES, V870, P10, DOI 10.1016/S0006-8993(00)02387-8; HINTON DR, 1990, J NEUROSCI, V10, P2763; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hsu CC, 2004, J NUTR, V134, P3245, DOI 10.1093/jn/134.12.3245; Jellinger PS, 2011, POSTGRAD MED, V123, P53, DOI 10.3810/pgm.2011.01.2245; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kelleher KL, 2001, THROMB HAEMOSTASIS, V85, P529; Keren P, 2000, DIABETES, V49, P1064, DOI 10.2337/diabetes.49.6.1064; Kielgast U, 2009, CURR DIABETES REV, V5, P266, DOI 10.2174/157339909789804413; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kimple ME, 2008, J BIOL CHEM, V283, P4560, DOI 10.1074/jbc.M706481200; Leck KJ, 2004, NEUROPHARMACOLOGY, V46, P836, DOI 10.1016/j.neuropharm.2003.11.024; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; MADSBAD S, 1980, ACTA ENDOCRINOL-COP, V95, P359, DOI 10.1530/acta.0.0950359; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; Meng JW, 2002, J BIOL CHEM, V277, P43417, DOI 10.1074/jbc.M204074200; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nonogaki K, 1997, TRENDS ENDOCRIN MET, V8, P192, DOI 10.1016/S1043-2760(97)00038-6; Oleskevich S, 2005, NEUROREPORT, V16, P921, DOI 10.1097/00001756-200506210-00009; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; Triplitt CL, 2007, AM J MANAG CARE, V13, pS47; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yanay O, 2010, J GENE MED, V12, P538, DOI 10.1002/jgm.1466; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yang J, 2002, J BIOL CHEM, V277, P46035, DOI 10.1074/jbc.M208519200	53	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20344	20355		10.1074/jbc.M112.359745	http://dx.doi.org/10.1074/jbc.M112.359745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22457354	Green Published, hybrid			2022-12-28	WOS:000306414500054
J	Tsai, YCC; Mueller-Cajar, O; Saschenbrecker, S; Hartl, FU; Hayer-Hartl, M				Tsai, Yi-Chin C.; Mueller-Cajar, Oliver; Saschenbrecker, Sandra; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Chaperonin Cofactors, Cpn10 and Cpn20, of Green Algae and Plants Function as Hetero-oligomeric Ring Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CO-CHAPERONIN; ARABIDOPSIS-THALIANA; MOLECULAR CHAPERONES; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; CHLOROPLAST CHAPERONINS; ESCHERICHIA-COLI; CENTRAL CAVITY; MOBILE LOOP	The chloroplast chaperonin system of plants and green algae is a curiosity as both the chaperonin cage and its lid are encoded by multiple genes, in contrast to the single genes encoding the two components of the bacterial and mitochondrial systems. In the green alga Chlamydomonas reinhardtii (Cr), three genes encode chaperonin cofactors, with cpn10 encoding a single similar to 10-kDa domain and cpn20 and cpn23 encoding tandem cpn10 domains. Here, we characterized the functional interaction of these proteins with the Escherichia coli chaperonin, GroEL, which normally cooperates with GroES, a heptamer of similar to 10-kDa subunits. The C. reinhardtii cofactor proteins alone were all unable to assist GroEL-mediated refolding of bacterial ribulosebisphosphate carboxylase/oxygenase but gained this ability when CrCpn20 and/or CrCpn23 was combined with CrCpn10. Native mass spectrometry indicated the formation of hetero-oligomeric species, consisting of seven similar to 10-kDa domains. The cofactor "heptamers" interacted with GroEL and encapsulated substrate protein in a nucleotide-dependent manner. Different hetero-oligomer arrangements, generated by constructing cofactor concatamers, indicated a preferential heptamer configuration for the functional CrCpn10-CrCpn23 complex. Formation of heptamer Cpn10/Cpn20 hetero-oligomers was also observed with the Arabidopsis thaliana (At) cofactors, which functioned with the chloroplast chaperonin, AtCpn60 alpha(7)beta(7). It appears that hetero-oligomer formation occurs more generally for chloroplast chaperonin cofactors, perhaps adapting the chaperonin system for the folding of specific client proteins.	[Tsai, Yi-Chin C.; Mueller-Cajar, Oliver; Saschenbrecker, Sandra; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Saschenbrecker, Sandra] EUROIMMUN AG, D-23560 Lubeck, Germany	Max Planck Society; EUROIMMUN	Hayer-Hartl, M (corresponding author), Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Mueller-Cajar, Oliver/A-7237-2018; Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Mueller-Cajar, Oliver/0000-0003-2866-5963; Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X	Deutsche Forschungsgemeinschaft [SFB 594]; Munich Center for Integrated Protein Science	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Munich Center for Integrated Protein Science	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 594 and Munich Center for Integrated Protein Science.	Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; Bonshtien AL, 2009, CELL STRESS CHAPERON, V14, P509, DOI 10.1007/s12192-009-0104-2; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Clare DK, 2006, J MOL BIOL, V358, P905, DOI 10.1016/j.jmb.2006.02.033; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Geels RBJ, 2008, RAPID COMMUN MASS SP, V22, P3633, DOI 10.1002/rcm.3782; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Krutchinsky AN, 2000, METH MOL B, V146, P239, DOI 10.1385/1-59259-045-4:239; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Nishio K, 1999, BIOCHEM BIOPH RES CO, V266, P584, DOI 10.1006/bbrc.1999.1868; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Richardson A, 1999, J BIOL CHEM, V274, P52, DOI 10.1074/jbc.274.1.52; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Rostom Adam A., 1999, Current Opinion in Structural Biology, V9, P135, DOI 10.1016/S0959-440X(99)80018-9; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Shewmaker F, 2004, PROTEIN SCI, V13, P2139, DOI 10.1110/ps.04773204; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Uetrecht C, 2011, ANGEW CHEM INT EDIT, V50, P8248, DOI 10.1002/anie.201008120; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Wysocki VH, 2008, J AM SOC MASS SPECTR, V19, P903, DOI 10.1016/j.jasms.2008.04.026; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	39	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20471	20481		10.1074/jbc.M112.365411	http://dx.doi.org/10.1074/jbc.M112.365411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518837	Green Published, hybrid			2022-12-28	WOS:000306414500068
J	Berger, M; Hsieh, CY; Bakele, M; Marcos, V; Rieber, N; Kormann, M; Mays, L; Hofer, L; Neth, O; Vitkov, L; Krautgartner, WD; von Schweinitz, D; Kappler, R; Hector, A; Weber, A; Hartl, D				Berger, Michael; Hsieh, Chin-Yuan; Bakele, Martina; Marcos, Veronica; Rieber, Nikolaus; Kormann, Michael; Mays, Lauren; Hofer, Laura; Neth, Olaf; Vitkov, Ljubomir; Krautgartner, Wolf Dietrich; von Schweinitz, Dietrich; Kappler, Roland; Hector, Andreas; Weber, Alexander; Hartl, Dominik			Neutrophils Express Distinct RNA Receptors in a Non-canonical Way	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; RIG-I; CELLS; RECOGNITION; ACTIVATION; DIFFERENTIATION; TLR7; MDA5	RNAs are capable of modulating immune responses by binding to specific receptors. Neutrophils represent the major fraction of circulating immune cells, but receptors and mechanisms by which neutrophils sense RNA are poorly defined. Here, we analyzed the mRNA and protein expression patterns and the subcellular localization of the RNA receptors RIG-I, MDA-5, TLR3, TLR7, and TLR8 in primary neutrophils and immortalized neutrophil-like differentiated HL-60 cells. Our results demonstrate that both neutrophils and differentiated HL-60 cells express RIG-I, MDA-5, and TLR8 at the mRNA and protein levels, whereas TLR3 and TLR7 are not expressed at the protein level. Subcellular fractionation, flow cytometry, confocal laser scanning microscopy, and immuno-transmission electron microscopy provided evidence that, besides the cytoplasm, RIG-I and MDA-5 are stored in secretory vesicles of neutrophils and showed that RIG-I and its ligand, 3p-RNA, co-localize at the cell surface without triggering neutrophil activation. In summary, this study demonstrates that neutrophils express a distinct pattern of RNA recognition receptors in a non-canonical way, which could have essential implications for future RNA-based therapeutics.	[Bakele, Martina; Rieber, Nikolaus; Kormann, Michael; Mays, Lauren; Hofer, Laura; Hector, Andreas; Hartl, Dominik] Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany; [Berger, Michael; von Schweinitz, Dietrich; Kappler, Roland] Univ Munich, Dept Pediat Surg, Res Ctr, Dr von Hauner Childrens Hosp, D-80539 Munich, Germany; [Hsieh, Chin-Yuan; Marcos, Veronica] Univ Munich, Dept Pediat, Res Ctr, Dr von Hauner Childrens Hosp, D-80539 Munich, Germany; [Bakele, Martina; Rieber, Nikolaus; Kormann, Michael; Mays, Lauren; Hofer, Laura; Hector, Andreas; Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, D-72076 Tubingen, Germany; [Weber, Alexander] Univ Tubingen, Inst Cell Biol, D-72076 Tubingen, Germany; [Berger, Michael; Neth, Olaf] Virgen del Rocio Childrens Hosp, Seville 41013, Spain; [Vitkov, Ljubomir] Univ Saarland, Dept Operat Dent & Periodontol, D-66421 Homburg, Germany; [Vitkov, Ljubomir; Krautgartner, Wolf Dietrich] Salzburg Univ, Div Light & Electron Microscopy, Dept Organism Biol, A-5020 Salzburg, Austria	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Virgen del Rocio University Hospital; Saarland University; Salzburg University	Hartl, D (corresponding author), Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany.	dominik.hartl@med.uni-tuebingen.de	Vitkov, Ljubomir/H-5873-2019; Neth, Olaf/F-1167-2015; Kormann, Michael SD/C-7723-2014; IBIS, INMUNODEFICIEN/C-1245-2016	Vitkov, Ljubomir/0000-0002-1249-0161; Neth, Olaf/0000-0001-5018-0466; Weber, Alexander/0000-0002-8627-7056; Hector, Andreas/0000-0002-5745-4746; Kappler, Roland/0000-0002-8581-2803	Deutsche Forschungsgemeinschaft (DFG) [HA 5274/3-1]; PINA e.V.; Novartis Foundation; German Academic Exchange Service (DAAD); Friedrich-Baur-Institut; German Society of Pediatric Pneumology; Department of Clinical Pharmacology, Ludwig Maximilians University of Munich	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); PINA e.V.; Novartis Foundation(Novartis); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Friedrich-Baur-Institut; German Society of Pediatric Pneumology; Department of Clinical Pharmacology, Ludwig Maximilians University of Munich	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Emmy Noether Programme Grant HA 5274/3-1, PINA e.V., and the Novartis Foundation (to D. H.); the German Academic Exchange Service (DAAD) and the Friedrich-Baur-Institut (to M. B.); and the German Society of Pediatric Pneumology (to D. H. and V. M.).; We thank Stefan Endres (Department of Clinical Pharmacology, Ludwig Maximilians University of Munich) for support with RNA synthesis and Dr. Samuel Wagner for proofreading the manuscript.	Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Berger M, 2009, J IMMUNOTHER, V32, P262, DOI 10.1097/CJI.0b013e318198bd2a; BLAIR OC, 1986, CYTOMETRY, V7, P171, DOI 10.1002/cyto.990070208; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung Veit, 2008, V183, P71; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Janke M, 2009, J ALLERGY CLIN IMMUN, V123, P1026, DOI 10.1016/j.jaci.2009.02.015; Jeong E, 2011, YONSEI MED J, V52, P379, DOI [10.3349/ymj.2011.52.3.379, 10.3349/ymj.2011.52.3.429]; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; NOVAKHOFER I, 1990, CANCER RES, V50, P7437; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Udby Lene, 2007, V412, P35, DOI 10.1007/978-1-59745-467-4_4; Wornle M, 2009, MOL CELL BIOCHEM, V322, P193, DOI 10.1007/s11010-008-9957-4	23	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19409	19417		10.1074/jbc.M112.353557	http://dx.doi.org/10.1074/jbc.M112.353557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22532562	Green Published, hybrid			2022-12-28	WOS:000306411900055
J	Kambara, T; Ohashi, K; Shibata, R; Ogura, Y; Maruyama, S; Enomoto, T; Uemura, Y; Shimizu, Y; Yuasa, D; Matsuo, K; Miyabe, M; Kataoka, Y; Murohara, T; Ouchi, N				Kambara, Takahiro; Ohashi, Koji; Shibata, Rei; Ogura, Yasuhiro; Maruyama, Sonomi; Enomoto, Takashi; Uemura, Yusuke; Shimizu, Yuuki; Yuasa, Daisuke; Matsuo, Kazuhiro; Miyabe, Megumi; Kataoka, Yoshiyuki; Murohara, Toyoaki; Ouchi, Noriyuki			CTRP9 Protein Protects against Myocardial Injury following Ischemia-Reperfusion through AMP-activated Protein Kinase (AMPK)-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; ADIPOSE-TISSUE; HEART-FAILURE; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLUCOSE; INFLAMMATION; INFARCTION; DISEASE; OBESITY	Ischemic heart disease is the major cause of death in Western countries. CTRP9 (C1q/TNF-related protein 9) is a fat-derived plasma protein that has salutary effects on glucose metabolism and vascular function. However, the functional role of CTRP9 in ischemic heart disease has not been clarified. Here, we examined the regulation of CTRP9 in response to acute cardiac injury and investigated whether CTRP9 modulates cardiac damage after ischemia and reperfusion. Myocardial ischemia-reperfusion injury resulted in reduced plasma CTRP9 levels and increased plasma free fatty acid levels, which were accompanied by a decrease in CTRP9 expression and an increase in NADPH oxidase component expression in fat tissue. Treatment of cultured adipocytes with palmitic acid or hydrogen peroxide reduced CTRP9 expression. Systemic administration of CTRP9 to wild-type mice, before the induction of ischemia or at the time of reperfusion, led to a reduction in myocardial infarct size following ischemia-reperfusion. Administration of CTRP9 also attenuated myocyte apoptosis in ischemic heart, which was accompanied by increased phosphorylation of AMP-activated protein kinase (AMPK). Treatment of cardiac myocytes with CTRP9 protein reduced apoptosis in response to hypoxia/reoxygenation and stimulated AMPK phosphorylation. Blockade of AMPK activity reversed the suppressive actions of CTRP9 on cardiomyocyte apoptosis. Knockdown of adiponectin receptor 1 diminished CTRP9-induced increases in AMPK phosphorylation and survival of cardiac myocytes. Our data suggest that CTRP9 protects against acute cardiac injury following ischemia-reperfusion via an AMPK-dependent mechanism.	[Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Kambara, Takahiro; Shibata, Rei; Ogura, Yasuhiro; Maruyama, Sonomi; Enomoto, Takashi; Uemura, Yusuke; Shimizu, Yuuki; Yuasa, Daisuke; Matsuo, Kazuhiro; Miyabe, Megumi; Kataoka, Yoshiyuki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Showa Ku, Dept Mol Cardiol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Takeda Science Foundation (to N. O.), by grants from the Uehara Memorial Foundation (to N. O. and R. S.), and by Grant-in-aids for Young Scientists B from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. S. and K. O.).	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Carrabba N, 2004, CIRCULATION, V110, P1974, DOI 10.1161/01.CIR.0000143376.64970.4A; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; ORLANDER PR, 1994, DIABETES, V43, P897, DOI 10.2337/diabetes.43.7.897; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Woodfield SL, 1996, J AM COLL CARDIOL, V28, P1661, DOI 10.1016/S0735-1097(96)00397-X; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	30	129	140	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18965	18973		10.1074/jbc.M112.357939	http://dx.doi.org/10.1074/jbc.M112.357939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22514273	hybrid, Green Published			2022-12-28	WOS:000306411900008
J	Zhang, Y; Gladysheva, IP; Houng, AK; Reed, GL				Zhang, Yi; Gladysheva, Inna P.; Houng, Aiilyan K.; Reed, Guy L.			Streptococcus uberis Plasminogen Activator (SUPA) Activates Human Plasminogen through Novel Species-specific and Fibrin-targeted Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; STREPTOKINASE; BINDING; COMPLEX; SITE; STAPHYLOKINASE; ANTIPLASMIN; INHIBITORS; INFECTION; TITRATION	Bacterial plasminogen (Pg) activators generate plasmin to degrade fibrin blood clots and other proteins that modulate the pathogenesis of infection, yet despite strong homology between mammalian Pgs, the activity of bacterial Pg activators is thought to be restricted to the Pg of their host mammalian species. Thus, we found that Streptococcus uberis Pg activator (SUPA), isolated from a Streptococcus species that infects cows but not humans, robustly activated bovine but not human Pg in purified systems and in plasma. Consistent with this, SUPA formed a higher avidity complex (118-fold) with bovine Pg than with human Pg and non-proteolytically activated bovine but not human Pg. Surprisingly, however, the presence of human fibrin overrides the species-restricted action of SUPA. First, human fibrin enhanced the binding avidity of SUPA for human Pg by 4-8-fold in the presence and absence of chloride ion (a negative regulator). Second, although SUPA did not protect plasmin from inactivation by alpha(2)-antiplasmin, fibrin did protect human plasmin, which formed a 31-fold higher avidity complex with SUPA than Pg. Third, fibrin significantly enhanced Pg activation by reducing the K-m (4-fold) and improving the catalytic efficiency of the SUPA complex (6-fold). Taken together, these data suggest that indirect molecular interactions may override the species-restricted activity of bacterial Pg activators; this may affect the pathogenesis of infections or may be exploited to facilitate the design of new blood clot-dissolving drugs.	[Zhang, Yi; Gladysheva, Inna P.; Houng, Aiilyan K.; Reed, Guy L.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Reed, GL (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Suite D334,956 Court Ave, Memphis, TN 38163 USA.	glreed@uthsc.edu	Gladysheva, Inna/AAU-9465-2020	Gladysheva, Inna/0000-0002-2501-9029	National Institutes of Health [HL58496, HL78562]; American Heart Association [SDG 0835376N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058496, R01HL078562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported, in whole or in part, by National Institutes of Health Grants HL58496 and HL78562 (to G. L. R.). This work was also supported by American Heart Association Grant SDG 0835376N (to I. P. G.).	BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bode W, 1997, CURR OPIN STRUC BIOL, V7, P865, DOI 10.1016/S0959-440X(97)80159-5; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CLIFFTON EE, 1953, BLOOD, V8, P554, DOI 10.1182/blood.V8.6.554.554; Collen D, 2004, J THROMB HAEMOST, V2, P541, DOI 10.1111/j.1538-7933.2004.00645.x; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Gladysheva IP, 2002, J BIOL CHEM, V277, P26846, DOI 10.1074/jbc.M202999200; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Johnsen LB, 2000, BIOCHEMISTRY-US, V39, P6440, DOI 10.1021/bi9922502; KOLEV K, 1994, J BIOL CHEM, V269, P17030; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LEE PP, 1988, BIOCHEMISTRY-US, V27, P7506, DOI 10.1021/bi00419a049; Leigh JA, 1999, VACCINE, V17, P851, DOI 10.1016/S0264-410X(98)00270-9; LEIGH JA, 1994, FEMS MICROBIOL LETT, V118, P153, DOI 10.1016/0378-1097(94)90611-4; LIJNEN HR, 1986, J BIOL CHEM, V261, P1253; RAMPLING MW, 1976, CLIN CHIM ACTA, V67, P43, DOI 10.1016/0009-8981(76)90215-1; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; REED GL, 1990, P NATL ACAD SCI USA, V87, P1114, DOI 10.1073/pnas.87.3.1114; Sazonova IY, 2004, J BIOL CHEM, V279, P24994, DOI 10.1074/jbc.M400253200; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Ward PN, 2004, J MOL BIOL, V342, P1101, DOI 10.1016/j.jmb.2004.07.079; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730; WOHL RC, 1980, J BIOL CHEM, V255, P2005	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19171	19176		10.1074/jbc.M112.359315	http://dx.doi.org/10.1074/jbc.M112.359315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22518846	Green Published, hybrid			2022-12-28	WOS:000306411900027
J	Barker, KD; Barkovits, K; Wilks, A				Barker, Kylie D.; Barkovits, Katalin; Wilks, Angela			Metabolic Flux of Extracellular Heme Uptake in Pseudomonas aeruginosa Is Driven by the Iron-regulated Heme Oxygenase (HemO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; BINDING PROTEIN PHUS; TRAFFICKING PROTEIN; OUTER-MEMBRANE; SYSTEM; TRANSPORT; IDENTIFICATION; RECOMBINATION; ACQUISITION; VIRULENCE	Heme utilization by Pseudomonas aeruginosa involves several proteins required for internalization and degradation of heme. In the following report we provide the first direct in vivo evidence for the specific degradation of extracellular heme to biliverdin (BV) by the iron-regulated HemO. Moreover, through isotopic labeling (C-13-heme) and electrospray ionization-MS analysis we have confirmed the regioselectivity and ratio of C-13-delta and beta-BV IX (70:30) is identical in vivo to that previously observed for the purified protein. Furthermore, the C-13-BV IX delta and BV IX beta products are effluxed from the cell by an as yet unidentified transporter. Conversion of extracellular heme to BV is dependent solely on the iron-regulated HemO as evidenced by the lack of BV production in the P. aeruginosa hemO deletion strain. Complementation of P. aeruginosa Delta hemO with a plasmid expressing either the wild type HemO or alpha-regioselective HemO mutant restored extracellular heme uptake and degradation. In contrast deletion of the gene encoding the cytoplasmic heme-binding protein, PhuS, homologs of which have been proposed to be heme oxygenases, did not eliminate C-13-BV IX delta and IX beta production. In conclusion the metabolic flux of extracellular heme as a source of iron is driven by the catalytic action of HemO.	[Barker, Kylie D.; Barkovits, Katalin; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		Barkovits, Katalin/0000-0003-2554-8796	National Institutes of Health [AI-55912, AI-85535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055912, R01AI055912, R01AI085535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55912 and AI-85535 (to A. W.).	Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bonnett R, 1973, J Chem Soc Perkin 1, V9, P881; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fuhrop J. H., 1975, PORPHYRINS METALLOPO; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wilks A, 2011, HANDB PORPHYR SCI, V15, P357; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005	27	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18342	18350		10.1074/jbc.M112.359265	http://dx.doi.org/10.1074/jbc.M112.359265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493498	Green Published, hybrid			2022-12-28	WOS:000306411600040
J	Behrens, DT; Villone, D; Koch, M; Brunner, G; Sorokin, L; Robenek, H; Bruckner-Tuderman, L; Bruckner, P; Hansen, U				Behrens, Daniel Timo; Villone, Daniela; Koch, Manuel; Brunner, Georg; Sorokin, Lydia; Robenek, Horst; Bruckner-Tuderman, Leena; Bruckner, Peter; Hansen, Uwe			The Epidermal Basement Membrane Is a Composite of Separate Laminin- or Collagen IV-containing Networks Connected by Aggregated Perlecan, but Not by Nidogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; VII COLLAGEN; BINDING; PROTEIN; SKIN; CHAINS	The basement membrane between the epidermis and the dermis is indispensable for normal skin functions. It connects, and functionally separates, the epidermis and the dermis. To understand the suprastructural and functional basis of these connections, heterotypic supramolecular aggregates were isolated from the dermal-epidermal junction zone of human skin. Individual suprastructures were separated and purified by immunomagnetic beads, each recognizing a specific, molecular component of the aggregates. The molecular compositions of the suprastructures were determined by immunogold electron microscopy and immunoblotting. A composite of two networks was obtained from fibril-free suspensions by immunobeads recognizing either laminin 332 or collagen IV. After removal of perlecan-containing suprastructures or after enzyme digestion of heparan sulfate chains, a distinct network with a diffuse electron-optical appearance was isolated with magnetic beads coated with antibodies to collagen IV. The second network was more finely grained and comprised laminin 332 and laminins with alpha 5-chains. The core protein of perlecan was an exclusive component of this network whereas its heparan sulfate chains were integrated into the collagen IV-containing network. Nidogens 1 and 2 occurred in both networks but did not form strong molecular cross-bridges. Their incorporation into one network appeared to be masked after their incorporation into the other one. We conclude that the epidermal basement membrane is a composite of two structurally independent networks that are tightly connected in a spot-welding-like manner by perlecan-containing aggregates.	[Behrens, Daniel Timo; Villone, Daniela; Sorokin, Lydia; Bruckner, Peter; Hansen, Uwe] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Koch, Manuel] Univ Cologne, Ctr Biochem, Inst Dent Res & Musculoskeletal Biol, D-50931 Cologne, Germany; [Brunner, Georg] Fachklin Hornheide, Dept Tumor Res, D-48157 Munster, Germany; [Robenek, Horst] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Bruckner-Tuderman, Leena] Univ Med Ctr, Dept Dermatol, D-79104 Freiburg, Germany	University of Munster; University of Cologne; University of Freiburg	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Koch, Manuel/AAG-9914-2021; Bruckner, Peter/F-4817-2019	Koch, Manuel/0000-0002-2962-7814; Bruckner, Peter/0000-0002-5566-5611; Sorokin, Lydia/0000-0001-7704-7921	Deutsche Forschungsgemeinschaft Collaborative Research Centre [A2]; Collaborative Research Centre [A2]; German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa	Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG)); Collaborative Research Centre; German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa	This work was supported by the Deutsche Forschungsgemeinschaft Collaborative Research Centre 492 Project A2 (to P. B.), Collaborative Research Centre 829 Project A2 (to M. K.), and the German Federal Ministry of Science and Technology, Network on rare diseases: Epidermolysis Bullosa.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GAMMON WR, 1984, J AM ACAD DERMATOL, V11, P820, DOI 10.1016/S0190-9622(84)80459-4; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hasegawa H, 2007, ARCH HISTOL CYTOL, V70, P255, DOI 10.1679/aohc.70.255; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MAYER U, 1995, EUR J BIOCHEM, V227, P681, DOI 10.1111/j.1432-1033.1995.tb20188.x; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	28	104	105	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18700	18709		10.1074/jbc.M111.336073	http://dx.doi.org/10.1074/jbc.M111.336073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493504	Green Published, hybrid			2022-12-28	WOS:000306411600078
J	He, P; Ng, BG; Losfeld, ME; Zhu, WH; Freeze, HH				He, Ping; Ng, Bobby G.; Losfeld, Marie-Estelle; Zhu, Wenhong; Freeze, Hudson H.			Identification of Intercellular Cell Adhesion Molecule 1 (ICAM-1) as a Hypoglycosylation Marker in Congenital Disorders of Glycosylation Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MASS-SPECTROMETRY; QUALITY-CONTROL; AMINO-ACIDS; EXPRESSION; PROTEINS; DOLICHOL; CULTURE; SURFACE; GOLGI	Many human inherited disorders cause protein N-glycosylation defects, but there are few cellular markers to test gene complementation for such defects. Plasma membrane glycoproteins are potential biomarkers because they may be reduced or even absent in plasma membranes of glycosylation-deficient cells. We combined stable isotope labeling by amino acids in cell culture (SILAC) with linear ion trap mass spectrometry (LTQ Orbitrap (TM)) to identify and quantify membrane proteins from wild-type CHO and glycosylation-deficient CHO (Lec9) cells. We identified 165 underrepresented proteins from 1447 unique quantified proteins, including 18 N-glycosylated plasma membrane proteins. Using various methods, we found that intercellular cell adhesion molecule 1 (ICAM-1) was reduced in Lec9 cells and in fibroblasts from 31 congenital disorder of glycosylation (CDG) patients compared with normal controls. Mannose supplementation of phosphomannose isomerase-deficient CDG-Ib (MPI-CDG) cells and complementation with PMM2 in PMM2-deficient CDG-Ia (PMM2-CDG) cells partially corrected hypoglycosylation based on increased ICAM-1 presence on the plasma membrane. These data indicate that ICAM-1 could be a useful hypoglycosylation biomarker to assess gene complementation of CDG-I patient cells and to monitor improved glycosylation in response to therapeutic drugs.	[Zhu, Wenhong; Freeze, Hudson H.] NCI, Ctr Prote Facil, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [He, Ping; Ng, Bobby G.; Losfeld, Marie-Estelle; Freeze, Hudson H.] Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), NCI, Ctr Prote Facil, Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Freeze, Hudson/0000-0001-6316-0501	National Institutes of Health [R01 DK55615]; Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK55615. This work was also supported by the Rocket Fund.	Blonder J, 2002, J PROTEOME RES, V1, P351, DOI 10.1021/pr0255248; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Dhawan S, 1997, BLOOD, V90, P1535; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; Fujita N, 2008, FEBS J, V275, P788, DOI 10.1111/j.1742-4658.2008.06246.x; HORIKOSHI T, 1995, FEBS LETT, V363, P141, DOI 10.1016/0014-5793(95)00299-O; Jones MA, 2012, AM J HUM GENET, V90, P363, DOI 10.1016/j.ajhg.2011.12.024; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; Pino M, 2009, REPRODUCTION, V138, P837, DOI 10.1530/REP-09-0196; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; ROSENWALD AG, 1990, J LIPID RES, V31, P523; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Van Geet C, 2001, J INHERIT METAB DIS, V24, P477, DOI 10.1023/A:1010581613821; Westphal V, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.9195; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zdebska E, 2003, PEDIATR RES, V54, P224, DOI 10.1203/01.PDR.0000072327.55955.F7; Zhang GA, 2011, J PROTEOME RES, V10, P2546, DOI 10.1021/pr200016n	28	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18210	18217		10.1074/jbc.M112.355677	http://dx.doi.org/10.1074/jbc.M112.355677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496445	Green Published, hybrid			2022-12-28	WOS:000306411600029
J	Poon, GMK				Poon, Gregory M. K.			Sequence Discrimination by DNA-binding Domain of ETS Family Transcription Factor PU.1 Is Linked to Specific Hydration of Protein-DNA Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAPOR-PRESSURE OSMOMETRY; MURINE PU.1; PREFERENTIAL INTERACTIONS; SOLVENT COMPONENTS; CRYSTAL-STRUCTURE; IN-VITRO; RECOGNITION; COMPLEX; WATER; ASSOCIATION	PU.1 is an essential transcription factor in normal hematopoietic lineage development. It recognizes a large number of promoter sites differing only in bases flanking a core consensus of 5'-GGAA-3'. DNA binding is mediated by its ETS domain, whose sequence selectivity directly corresponds to the transactivational activity and frequency of binding sites for full-length PU.1 in vivo. To better understand the basis of sequence discrimination, we characterized its binding properties to a high affinity and low affinity site. Despite sharing a homologous structural framework as confirmed by DNase I and hydroxyl radical footprinting, the two complexes exhibit striking hetero-geneity in terms of hydration properties. High affinity binding is destabilized by osmotic stress, whereas low affinity binding is insensitive. Dimethyl sulfate footprinting showed that the major groove at the core consensus is protected in the high affinity complex but accessible in the low affinity one. Finally, destabilization of low affinity binding by salt is in quantitative agreement with the number of phosphate contacts but is substantially attenuated in high affinity binding. These observations support a mechanism of sequence discrimination wherein specifically bound water molecules couple flanking backbone contacts with base-specific interactions in a sequestered cavity at the core consensus. The implications of this model with respect to other ETS paralogs are discussed.	[Poon, Gregory M. K.] Washington State Univ, Dept Pharmaceut Sci, Pullman, WA 99164 USA	Washington State University	Poon, GMK (corresponding author), POB 646534, Pullman, WA 99164 USA.	gpoon@wsu.edu			College of Pharmacy, Washington State University	College of Pharmacy, Washington State University	This investigation was supported by the College of Pharmacy, Washington State University.	ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; Coffman RE, 1996, J PHARM SCI, V85, P848, DOI 10.1021/js9505197; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Graves BJ, 1996, NATURE, V384, P322, DOI 10.1038/384322a0; Gross P, 1998, BIOCHEMISTRY-US, V37, P9802, DOI 10.1021/bi9731448; Gross P, 1998, BIOCHEMISTRY-US, V37, P5129, DOI 10.1021/bi972591k; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; Harries D, 2008, METHOD CELL BIOL, V84, P679, DOI 10.1016/S0091-679X(07)84022-2; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Li SL, 1999, J BIOL CHEM, V274, P32453, DOI 10.1074/jbc.274.45.32453; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Obika S, 2003, J MOL BIOL, V331, P345, DOI 10.1016/S0022-2836(03)00726-5; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Pio F, 1999, PROTEIN SCI, V8, P2098, DOI 10.1110/ps.8.10.2098; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; Poon GMK, 2004, J MOL BIOL, V335, P113, DOI 10.1016/j.jmb.2003.09.046; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2002, BIOCHEMISTRY-US, V41, P2361, DOI 10.1021/bi015572q; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1977, BIOCHEMISTRY-US, V16, P4791, DOI 10.1021/bi00641a005; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Scatchard G, 1938, J AM CHEM SOC, V60, P3061, DOI 10.1021/ja01279a066; Shadle SE, 1997, NUCLEIC ACIDS RES, V25, P850, DOI 10.1093/nar/25.4.850; Sidorova NY, 2010, ELECTROPHORESIS, V31, P648, DOI 10.1002/elps.200900573; Sidorova NY, 1996, P NATL ACAD SCI USA, V93, P12272, DOI 10.1073/pnas.93.22.12272; StraussSoukup JK, 1997, J BIOL CHEM, V272, P31570, DOI 10.1074/jbc.272.50.31570; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	43	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18297	18307		10.1074/jbc.M112.342345	http://dx.doi.org/10.1074/jbc.M112.342345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474303	Green Published, hybrid			2022-12-28	WOS:000306411600036
J	Sir, D; Kuo, CF; Tian, YJ; Liu, HM; Huang, EJ; Jung, JU; Machida, K; Ou, JHJ				Sir, Donna; Kuo, Cheng-fu; Tian, Yongjun; Liu, Helene Minyi; Huang, Eric J.; Jung, Jae U.; Machida, Keigo; Ou, Jing-hsiung James			Replication of Hepatitis C Virus RNA on Autophagosomal Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL REPLICATION; PROTEIN; COMPLEX; INDUCTION; PATHWAY	Previous studies indicated that hepatitis C virus (HCV) perturbs the autophagic pathway to induce the accumulation of autophagosomes in cells. To understand the role of autophagosomes in the HCV life cycle, we established a stable Huh7 hepatoma cell line that contained an HCV subgenomic RNA replicon and also expressed a GFP-LC3 fusion protein. The GFP-LC3 protein is localized to autophagosomes during autophagy and served as a convenient marker for autophagosomes. Our results indicate that the silencing of the expression of LC3 or Atg7, two protein factors critical for the formation of autophagosomes, suppresses the replication of HCV RNA. Confocal microscopy studies revealed the localization of HCV NS5A and NS5B proteins, which are two important components of the HCV RNA replication complex, and nascent HCV RNA to autophagosomes. The association of the HCV RNA replication complex with the autophagosomal membranes was further confirmed by co-immunoprecipitation and immunoelectron microscopy studies. Interestingly, inhibition of Class III PI3K activity had no effect on the autophagosomes induced by HCV. These results indicate that HCV induces autophagosomes via a Class III PI3K-independent pathway and uses autophagosomal membranes as sites for its RNA replication.	[Sir, Donna; Kuo, Cheng-fu; Tian, Yongjun; Liu, Helene Minyi; Jung, Jae U.; Machida, Keigo; Ou, Jing-hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Huang, Eric J.] Vet Affairs Med Ctr, Pathol Serv, San Francisco, CA 94121 USA	University of Southern California; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ou, JHJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR 401, Los Angeles, CA 90033 USA.	jamesou@hsc.usc.edu	Liu, Helene Minyi/Y-1834-2019; Huang, Eric J./AAH-7997-2019; Tian, Yongjun/F-8007-2011	Liu, Helene Minyi/0000-0003-4837-5373; Huang, Eric J./0000-0002-5381-3801; Kuo, Cheng-Fu/0000-0002-8933-0799	National Institutes of Health [AI083025, DK094652, CA123328]; NATIONAL CANCER INSTITUTE [R01CA031363, P01CA123328] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083025, DK094652, and CA123328.	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2008, AUTOPHAGY, V4, P830, DOI 10.4161/auto.6566; Sir D, 2010, MOL CELLS, V29, P1, DOI 10.1007/s10059-010-0014-2; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	27	127	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18036	18043		10.1074/jbc.M111.320085	http://dx.doi.org/10.1074/jbc.M111.320085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22496373	hybrid, Green Published			2022-12-28	WOS:000306411600013
J	Kumar, P; Chimenti, MS; Pemble, H; Schonichen, A; Thompson, O; Jacobson, MP; Wittmann, T				Kumar, Praveen; Chimenti, Michael S.; Pemble, Hayley; Schoenichen, Andre; Thompson, Oliver; Jacobson, Matthew P.; Wittmann, Torsten			Multisite Phosphorylation Disrupts Arginine-Glutamate Salt Bridge Networks Required for Binding of Cytoplasmic Linker-associated Protein 2 (CLASP2) to End-binding Protein 1 (EB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWING MICROTUBULE ENDS; TRACKING PROTEINS; HYDROGEN-BONDS; DYNAMICS; SPINDLE; INHIBITOR; GSK3-BETA; ALGORITHM; P-31; SIMULATIONS	A group of diverse proteins reversibly binds to growing microtubule plus ends through interactions with end-binding proteins (EBs). These +TIPs control microtubule dynamics and microtubule interactions with other intracellular structures. Here, we use cytoplasmic linker-associated protein 2 (CLASP2) binding to EB1 to determine how multisite phosphorylation regulates interactions with EB1. The central, intrinsically disordered region of vertebrate CLASP proteins contains two SXIP EB1 binding motifs that are required for EB1-mediated plus-end-tracking in vitro. In cells, both EB1 binding motifs can be functional, but most of the binding free energy results from nearby electrostatic interactions. By employing molecular dynamics simulations of the EB1 interaction with a minimal CLASP2 plus-end-tracking module, we find that conserved arginine residues in CLASP2 form extensive hydrogen-bond networks with glutamate residues predominantly in the unstructured, acidic C-terminal tail of EB1. Multisite phosphorylation of glycogen synthase kinase 3 (GSK3) sites near the EB1 binding motifs disrupts this electrostatic "molecular Velcro." Molecular dynamics simulations and P-31 NMR spectroscopy indicate that phosphorylated serines participate in intramolecular interactions with and sequester arginine residues required for EB1 binding. Multisite phosphorylation of these GSK3 motifs requires priming phosphorylation by interphase or mitotic cyclin-dependent kinases (CDKs), and we find that CDK- and and GSK3-dependent phosphorylation completely disrupts CLASP2 microtubule plus-end-tracking in mitosis.	[Kumar, Praveen; Pemble, Hayley; Schoenichen, Andre; Thompson, Oliver; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Chimenti, Michael S.; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wittmann, T (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	torsten.wittmann@ucsf.edu	Wittmann, Torsten/F-9833-2013; Jacobson, Matthew/Y-5161-2018	Wittmann, Torsten/0000-0001-9134-691X; Jacobson, Matthew/0000-0001-6262-655X; Thompson, Oliver/0000-0002-4134-8674	National Institutes of Health [R01 GM079139]; American Heart Association [11PRE7590115]; National Center for Research Resources of the National Institutes of Health [C06 RR16490]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM079139 (to T. W.). This work was also supported by American Heart Association Predoctoral Fellowship 11PRE7590115 (to H. P.).; We thank Peter Bieling for advice on the plus-end- tracking assay, Colin Smith and Cristina Melero for helpful discussions and assistance with fluorescence polarization assays, and Mark Kelly for assistance with NMR spectroscopy. This research was conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR16490 from the National Center for Research Resources of the National Institutes of Health.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Marco VB, 2001, J CHROMATOGR A, V931, P1, DOI 10.1016/S0021-9673(01)01136-0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Genschik P, 1998, PLANT CELL, V10, P2063; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HOFFMANN R, 1994, INT J PEPT PROT RES, V44, P193; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; JAMESON DM, 1995, METHOD ENZYMOL, V246, P283; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Li H, 2004, PROTEINS, V55, P689, DOI 10.1002/prot.20032; Maffini S, 2009, CURR BIOL, V19, P1566, DOI 10.1016/j.cub.2009.07.059; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; Meireles AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024174; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2006, GENES CELLS, V11, P845, DOI 10.1111/j.1365-2443.2006.00990.x; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Telley IA, 2011, METHODS MOL BIOL, V777, P127, DOI 10.1007/978-1-61779-252-6_10; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; VOGEL HJ, 1982, BIOCHEMISTRY-US, V21, P5825, DOI 10.1021/bi00266a016; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2008, J CELL BIOL, V183, P1183, DOI 10.1083/jcb.200811136; Wong SE, 2005, J PHYS CHEM B, V109, P5249, DOI 10.1021/jp046333q; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P640, DOI 10.1021/ct600129f	64	62	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17050	17064		10.1074/jbc.M111.316661	http://dx.doi.org/10.1074/jbc.M111.316661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467876	Green Published, hybrid			2022-12-28	WOS:000306373000006
J	Palavicini, JP; Correa-Rojas, RA; Rosenthal, JJC				Palavicini, Juan Pablo; Correa-Rojas, Rodrigo A.; Rosenthal, Joshua J. C.			Extra Double-stranded RNA Binding Domain (dsRBD) in a Squid RNA Editing Enzyme Confers Resistance to High Salt Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ADENOSINE DEAMINASES; SELECTIVE ADENOSINE; UNWINDING ACTIVITY; CANDIDATE ENZYME; NUCLEIC-ACIDS; INOSINE; PROTEIN; DIMERIZATION; TARGETS	A-to-I RNA editing is particularly common in coding regions of squid mRNAs. Previously, we isolated a squid editing enzyme (sqADAR2) that shows a unique structural feature when compared with other ADAR2 family members: an additional double-stranded RNA (dsRNA) binding domain (dsRBD). Alternative splicing includes or excludes this motif, generating a novel or a conventional variant termed sqADAR2a and sqADAR2b, respectively. The extra dsRBD of sqADAR2a increases its editing activity in vitro. We hypothesized that the high activity is due to an increase in the affinity of the enzyme for dsRNA. This may be important because protein-RNA interactions can be influenced by physical factors. We became particularly interested in analyzing the effects of salt on interactions between sqADAR2 and RNA because squid cells have a similar to 3- fold higher ionic strength and proportionally more Cl- than vertebrate cells. To date, in vitro biochemical analyses of adenosine deamination have been conducted using vertebrate-like ionic strength buffers containing chloride as the major anion, although the vast majority of cellular anions are known to be organic. We found that squid-like salt conditions severely impair the binding affinity of conventional ADAR2s for dsRNA, leading to a decrease in nonspecific and site-specific editing activity. Inhibition of editing was mostly due to high Cl- levels and not to the high concentrations of K+, Na+, and organic anions like glutamate. Interestingly, the extra dsRBD in sqADAR2a conferred resistance to the high Cl- levels found in squid neurons. It does so by increasing the affinity of sqADAR2 for dsRNA by 30- or 100-fold in vertebrate-like or squid-like conditions, respectively. Site-directed mutagenesis of squid ADAR2a showed that its increased affinity and editing activity are directly attributable to the RNA binding activity of the extra dsRBD.	[Palavicini, Juan Pablo; Correa-Rojas, Rodrigo A.; Rosenthal, Joshua J. C.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Rosenthal, Joshua J. C.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico	Rosenthal, JJC (corresponding author), Univ Puerto Rico, Inst Neurobiol, 201 Blvd Valle, San Juan, PR 00901 USA.	rosenthal.joshua@gmail.com			Research Centers in Minority Institutions [G12 RR 03051]; National Institutes of Health [2 U54 NS039405-06, R01 NS064259]; National Science Foundation [IBN-0344070]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039405, R01NS064259] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Dr. Record for useful discussions about the interactions between ions and protein-nucleic acid macromolecules. We also thank Sonia Soto for technical support. Part of this work was conducted in the Molecular Biology Core Facility at the Institute of Neurobiology, which is supported by Research Centers in Minority Institutions Grant G12 RR 03051.; This work was supported, in whole or in part, by National Institutes of Health Grants 2 U54 NS039405-06 and R01 NS064259. This work was also supported by National Science Foundation Grant IBN-0344070.	Alberts B., 2002, MOL BIOL CELL, P651; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; Bass BL, 1997, RNA, V3, P947; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Colina C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000540; Doyle M, 2002, J STRUCT BIOL, V140, P147, DOI 10.1016/S1047-8477(02)00544-0; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gommans WM, 2008, RNA, V14, P2074, DOI 10.1261/rna.816908; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D; Hofmeister F, 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI [10.1007/BF01918191, DOI 10.1007/BF01918191]; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Jaikaran DCJ, 2002, J BIOL CHEM, V277, P37624, DOI 10.1074/jbc.M204126200; Keegan LP, 2011, NUCLEIC ACIDS RES, V39, P7249, DOI 10.1093/nar/gkr423; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; KEYNES RD, 1963, J PHYSIOL-LONDON, V169, P690, DOI 10.1113/jphysiol.1963.sp007289; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; KOECHLIN BA, 1955, J BIOPHYS BIOCHEM CY, V1, P511, DOI 10.1083/jcb.1.6.511; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kontur WS, 2010, BIOCHEMISTRY-US, V49, P4361, DOI 10.1021/bi100092a; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Meulen KAV, 2008, J MOL BIOL, V377, P9, DOI 10.1016/j.jmb.2007.11.104; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; OCONNELL MA, 1994, P NATL ACAD SCI USA, V91, P10596, DOI 10.1073/pnas.91.22.10596; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni169; Ohman M, 2000, RNA, V6, P687, DOI 10.1017/S1355838200000200; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Palavicini JP, 2009, RNA, V15, P1208, DOI 10.1261/rna.1471209; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Pegram LM, 2008, J PHYS CHEM B, V112, P9428, DOI 10.1021/jp800816a; Poulsen H, 2006, RNA, V12, P1350, DOI 10.1261/rna.2314406; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Saum Stephan H, 2008, Saline Syst, V4, P4, DOI 10.1186/1746-1448-4-4; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; VILLEGAS J, 1965, J GEN PHYSIOL, V49, P1, DOI 10.1085/jgp.49.1.1; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Xia SL, 2005, PHYSIOL GENOMICS, V20, P195, DOI 10.1152/physiolgenomics.00093.2003; Yang Y, 2008, RNA, V14, P1516, DOI 10.1261/rna.1063708; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	56	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17754	17764		10.1074/jbc.M112.366005	http://dx.doi.org/10.1074/jbc.M112.366005			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457361	hybrid, Green Published			2022-12-28	WOS:000306373000074
J	Padler-Karavani, V; Song, XZ; Yu, H; Hurtado-Ziola, N; Huang, SS; Muthana, S; Chokhawala, HA; Cheng, JS; Verhagen, A; Langereis, MA; Kleene, R; Schachner, M; de Groot, RJ; Lasanajak, Y; Matsuda, H; Schwab, R; Chen, X; Smith, DF; Cummings, RD; Varki, A				Padler-Karavani, Vered; Song, Xuezheng; Yu, Hai; Hurtado-Ziola, Nancy; Huang, Shengshu; Muthana, Saddam; Chokhawala, Harshal A.; Cheng, Jiansong; Verhagen, Andrea; Langereis, Martijn A.; Kleene, Ralf; Schachner, Melitta; de Groot, Raoul J.; Lasanajak, Yi; Matsuda, Haruo; Schwab, Richard; Chen, Xi; Smith, David F.; Cummings, Richard D.; Varki, Ajit			Cross-comparison of Protein Recognition of Sialic Acid Diversity on Two Novel Sialoglycan Microarrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFICIENT CHEMOENZYMATIC SYNTHESIS; NEURITE OUTGROWTH; GENE-EXPRESSION; CARBOHYDRATE MICROARRAYS; GLYCAN MICROARRAYS; SIALOSIDES; BINDING; SPECIFICITY; ANTIGENS; REVEALS	DNA and protein arrays are commonly accepted as powerful exploratory tools in research. This has mainly been achieved by the establishment of proper guidelines for quality control, allowing cross-comparison between different array platforms. As a natural extension, glycan microarrays were subsequently developed, and recent advances using such arrays have greatly enhanced our understanding of protein-glycan recognition in nature. However, although it is assumed that biologically significant protein-glycan binding is robustly detected by glycan microarrays, there are wide variations in the methods used to produce, present, couple, and detect glycans, and systematic cross-comparisons are lacking. We address these issues by comparing two arrays that together represent the marked diversity of sialic acid modifications, linkages, and underlying glycans in nature, including some identical motifs. We compare and contrast binding interactions with various known and novel plant, vertebrate, and viral sialic acid-recognizing proteins and present a technical advance for assessing specificity using mild periodate oxidation of the sialic acid chain. These data demonstrate both the diversity of sialic acids and the analytical power of glycan arrays, showing that different presentations in different formats provide useful and complementary interpretations of glycan-binding protein specificity. They also highlight important challenges and questions for the future of glycan array technology and suggest that glycan arrays with similar glycan structures cannot be simply assumed to give similar results.	[Padler-Karavani, Vered; Lasanajak, Yi; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Glyc Ctr, Atlanta, GA 30322 USA; [Padler-Karavani, Vered; Verhagen, Andrea; Schwab, Richard; Varki, Ajit] Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; [Yu, Hai; Huang, Shengshu; Muthana, Saddam; Chokhawala, Harshal A.; Cheng, Jiansong; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Hurtado-Ziola, Nancy] Sialix Inc, Vista, CA 92081 USA; [Langereis, Martijn A.; de Groot, Raoul J.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Virol, Utrecht, Netherlands; [Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; [Matsuda, Haruo] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Hiroshima 7398528, Japan	Emory University; University of California System; University of California San Diego; University of California System; University of California Davis; Utrecht University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Hiroshima University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Glyc Ctr, Atlanta, GA 30322 USA.	rdcummi@emory.edu; a1varki@ucsd.edu	Langereis, Martijn/D-3532-2013; Schwab, Richard/AAX-9262-2020; PADLER-KARAVANI, VERED/AAC-6055-2022; Chen, Xi/H-1811-2018; Langereis, martijn/K-2965-2012	Langereis, Martijn/0000-0003-4950-961X; PADLER-KARAVANI, VERED/0000-0002-4761-3571; Chen, Xi/0000-0002-3160-614X; 	National Institutes of Health [R01GM32373, U01 CA128442, RO1GM085448, R01GM076360]; Consortium for Functional Glycomics under National Institutes of Health, NIGMS [GM62116]; International Sepharadic Education Foundation postdoctoral fellowship; Defense Advanced Research Projects Agency [HR0011-10-00]; NATIONAL CANCER INSTITUTE [U01CA128442, R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076360, R01GM085448, R01GM032373, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics under National Institutes of Health, NIGMS; International Sepharadic Education Foundation postdoctoral fellowship; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and U01 CA128442 (to A. V.), RO1GM085448 (to D. F. S.), and R01GM076360 (to X. C.) and a bridging grant from the Consortium for Functional Glycomics under National Institutes of Health, NIGMS, Grant GM62116 (to R. D. C.). This work was also supported by an International Sepharadic Education Foundation postdoctoral fellowship (to V. P.K.) and Defense Advanced Research Projects Agency Grant HR0011-10-00 (to R. D. C.). A. Varki is a cofounder of Sialix, Inc. (formerly Gc-Free, Inc.). N. Hurtado-Ziola is currently an employee of Sialix, Inc.	Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; [Anonymous], 2011, MOL IMMUNOLOGY COMPL, DOI 10.1007/978-1-4419-7877-6_28; ASAOKA H, 1992, IMMUNOL LETT, V32, P91; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Cao HZ, 2009, BIOORG MED CHEM LETT, V19, P5869, DOI 10.1016/j.bmcl.2009.08.078; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHERESH DA, 1984, SCIENCE, V225, P844, DOI 10.1126/science.6206564; Chokhawala HA, 2008, ACS CHEM BIOL, V3, P567, DOI 10.1021/cb800127n; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; de Groot RJ, 2006, GLYCOCONJUGATE J, V23, P59, DOI 10.1007/s10719-006-5438-8; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Ding L, 2011, CHEM COMMUN, V47, P8691, DOI 10.1039/c1cc12732b; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kricka LJ, 2006, ANN CLIN BIOCHEM, V43, P457, DOI 10.1258/000456306778904731; Lau K, 2011, ORG BIOMOL CHEM, V9, P2784, DOI 10.1039/c0ob01269f; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Liang CH, 2011, ANGEW CHEM INT EDIT, V50, P1608, DOI 10.1002/anie.201003482; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ogawa G, 2009, J NEUROIMMUNOL, V214, P125, DOI 10.1016/j.jneuroim.2009.06.017; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Reis CA, 2011, EXPERT REV PROTEOMIC, V8, P435, DOI 10.1586/EPR.11.30; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shengshu H., 2011, SCI CHINA CHEM, V54, P117; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Damme EJM, 2011, ADV EXP MED BIOL, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A., 2009, ESSENTIALS GLYCOBIOL; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2006, NAT PROTOC, V1, P2485, DOI 10.1038/nprot.2006.401; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Yu H, 2011, BIOORG MED CHEM LETT, V21, P5037, DOI 10.1016/j.bmcl.2011.04.083; Yu H, 2009, J AM CHEM SOC, V131, P18467, DOI 10.1021/ja907750r; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105	52	99	103	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22593	22608		10.1074/jbc.M112.359323	http://dx.doi.org/10.1074/jbc.M112.359323			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549775	Green Published, hybrid			2022-12-28	WOS:000306495000016
J	Gu, SJ; Boyer, TG; Naski, MC				Gu, Shoujun; Boyer, Thomas G.; Naski, Michael C.			Basic Helix-Loop-Helix Transcription Factor Twist1 Inhibits Transactivator Function of Master Chondrogenic Regulator Sox9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAETHRE-CHOTZEN-SYNDROME; II COLLAGEN GENE; CHONDROCYTE DIFFERENTIATION; DORSOVENTRAL PATTERN; DROSOPHILA EMBRYOS; AGGRECAN GENE; ZYGOTIC GENE; BETA-CATENIN; EXPRESSION; CARTILAGE	Canonical Wnt signaling strongly inhibits chondrogenesis. Previously, we identified Twist1 as a critical downstream mediator of Wnt in repression of chondrocyte differentiation. However, the mechanistic basis for the antichondrogenic activity of Twist1 has not heretofore been established. Here, we show that Twist1 suppresses cartilage development by directly inhibiting the transcriptional activity of Sox9, the master regulator of chondrogenesis. Twist1, through its carboxyl-terminal Twist-box, binds to the Sox9 high mobility group DNA-binding domain, inhibiting Sox9 transactivation potential. In chondrocyte precursor cells, Twist1, in a Twist-box-dependent manner, inhibits Sox9-dependent activation of chondrocyte marker gene expression by blocking Sox9-enhancer DNA association. These findings identify Twist1 as an inhibitor of Sox9 and further suggest that the balance between Twist1 and Sox9 may determine the earliest steps of chondrogenesis.	[Gu, Shoujun; Naski, Michael C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78245 USA; [Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Boyer, TG (corresponding author), 19715 Lambda Dr, San Antonio, TX 78245 USA.	boyer@uthscsa.edu; mikenaski@yahoo.com			NIAMS, National Institutes of Health [AR053100]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053100] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS, National Institutes of Health Public Health Grant AR053100.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; ElGhouzzi V, 1997, NAT GENET, V15, P42; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; REARDON W, 1994, J MED GENET, V31, P393, DOI 10.1136/jmg.31.5.393; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; SIMPSON P, 1983, GENETICS, V105, P615; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	42	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21082	21092		10.1074/jbc.M111.328567	http://dx.doi.org/10.1074/jbc.M111.328567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22532563	hybrid, Green Published			2022-12-28	WOS:000306416800029
J	Hu, D; Tateno, H; Kuno, A; Yabe, R; Hirabayashi, J				Hu, Dan; Tateno, Hiroaki; Kuno, Atsushi; Yabe, Rikio; Hirabayashi, Jun			Directed Evolution of Lectins with Sugar-binding Specificity for 6-Sulfo-galactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARTHWORM LUMBRICUS-TERRESTRIS; KERATAN SULFATE GAL-6-SULFOTRANSFERASE; L-SELECTIN; LEWIS-X; GALACTOSE; LIGAND; DOMAIN; MICROARRAY; PROTEINS; OLIGOSACCHARIDES	6-sulfo-galactose (6S-Gal) is a prevalent motif observed in highly sulfated keratan sulfate, which is closely associated with the glioblastoma malignancy while acting as a critical determinant for endogenous lectins. However, facile detection of this unique glycoepitope is greatly hampered because of a lack of appropriate probes. We have previously reported tailoring an alpha 2-6-linked sialic acid-binding lectin from a ricin-B chain-like galactose-binding protein, EW29Ch, by a reinforced ribosome display system following an error-prone PCR. In this study, we challenged the creation of novel lectins to recognize 6S-Gal-terminated glycans by incorporating a high-throughput screening system with a glycoconjugate microarray. After two rounds of selection procedures, 20 mutants were obtained and 12 were then successfully expressed in Escherichia coli, 8 of which showed a significant affinity for 6'-Sulfo-LN (6-O-sulfo-Gal beta 1-4GlcNAc), which the parental EW29Ch lacked. Analysis of two representative mutants by frontal affinity chromatography revealed a substantial affinity (K-d similar to 3 mu M) for a 6S-Gal-terminated glycan. On the basis of the observation that all eight mutants have a common mutation at Glu-20 to Lys, site-directed mutagenesis experiments were performed focusing on this aspect. The results clearly indicated that the E20K mutation is necessary and sufficient to acquire the specificity for 6S-Gal. We also confirmed a difference in binding between E20K and EW29Ch to CHO cells, in which enzymes to catalyze the synthesis of 6S-Gal were overexpressed. The results clearly demonstrate that these mutants have potential to distinguish between cells containing different amounts of 6S-Gal-terminated glycans. This new technology will be used to provide novel tools essential for sulfoglycomics.	[Hu, Dan; Tateno, Hiroaki; Kuno, Atsushi; Yabe, Rikio; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hirabayashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Kuno, Atsushi/M-2151-2018; Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018	Kuno, Atsushi/0000-0002-6147-6171; Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659	Japan Society for the Promotion of Science Scholarship; Grants-in-Aid for Scientific Research [10F00218] Funding Source: KAKEN	Japan Society for the Promotion of Science Scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Japan Society for the Promotion of Science Scholarship.	Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Fukushima K, 2010, GLYCOBIOLOGY, V20, P452, DOI 10.1093/glycob/cwp197; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V368, P217, DOI 10.1016/j.bbrc.2008.01.058; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hemmi H, 2009, FEBS J, V276, P2095, DOI 10.1111/j.1742-4658.2009.06944.x; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaku H, 1996, J BIOL CHEM, V271, P1480, DOI 10.1074/jbc.271.3.1480; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Nakamura S, 2005, FEBS J, V272, P2784, DOI 10.1111/j.1742-4658.2005.04698.x; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Seko A, 2012, GLYCOBIOLOGY, V22, P181, DOI 10.1093/glycob/cwr118; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Suzuki R, 2009, ACTA CRYSTALLOGR D, V65, P49, DOI 10.1107/S0907444908037451; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Wang YF, 2011, FEBS LETT, V585, P3927, DOI 10.1016/j.febslet.2011.10.035; Yabe R, 2007, J BIOCHEM, V141, P389, DOI 10.1093/jb/mvm043; YAMASHITA K, 1992, BIOCHEMISTRY-US, V31, P11647, DOI 10.1021/bi00161a052	31	36	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20313	20320		10.1074/jbc.M112.351965	http://dx.doi.org/10.1074/jbc.M112.351965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22493425	hybrid, Green Published			2022-12-28	WOS:000306414500051
J	Lusher, SJ; Raaijmakers, HCA; Vu-Pham, D; Kazemier, B; Bosch, R; McGuire, R; Azevedo, R; Hamersma, H; Dechering, K; Oubrie, A; van Duin, M; de Vlieg, J				Lusher, Scott J.; Raaijmakers, Hans C. A.; Vu-Pham, Diep; Kazemier, Bert; Bosch, Rolien; McGuire, Ross; Azevedo, Rita; Hamersma, Hans; Dechering, Koen; Oubrie, Arthur; van Duin, Marcel; de Vlieg, Jacob			X-ray Structures of Progesterone Receptor Ligand Binding Domain in Its Agonist State Reveal Differing Mechanisms for Mixed Profiles of 11 beta-Substituted Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; UTERINE LEIOMYOMA CELLS; ESTROGEN-RECEPTOR; MODULATOR ASOPRISNIL; MINERALOCORTICOID RECEPTOR; CRYSTAL-STRUCTURES; AMINO-ACID; ANTAGONISM; CONFORMATION; ACTIVATION	We present here the x-ray structures of the progesterone receptor (PR) in complex with two mixed profile PR modulators whose functional activity results from two differing molecular mechanisms. The structure of Asoprisnil bound to the agonist state of PR demonstrates the contribution of the ligand to increasing stability of the agonist conformation of helix-12 via a specific hydrogen-bond network including Glu(723). This interaction is absent when the full antagonist, RU486, binds to PR. Combined with a previously reported structure of Asoprisnil bound to the antagonist state of the receptor, this structure extends our understanding of the complex molecular interactions underlying the mixed agonist/antagonist profile of the compound. In addition, we present the structure of PR in its agonist conformation bound to the mixed profile compound Org3H whose reduced antagonistic activity and increased agonistic activity compared with reference antagonists is due to an induced fit around Trp(755), resulting in a decreased steric clash with Met(909) but inducing a new internal clash with Val(912) in helix-12. This structure also explains the previously published observation that 16 alpha attachments to RU486 analogs induce mixed profiles by altering the binding of 11 beta substituents. Together these structures further our understanding of the steric and electrostatic factors that contribute to the function of steroid receptor modulators, providing valuable insight for future compound design.	[Lusher, Scott J.; Raaijmakers, Hans C. A.; Bosch, Rolien; McGuire, Ross; Azevedo, Rita; Hamersma, Hans; Oubrie, Arthur; de Vlieg, Jacob] MSD, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands; [Vu-Pham, Diep; Kazemier, Bert; Dechering, Koen] MSD, Dept Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [van Duin, Marcel] MSD, Dept Womens Hlth, NL-5340 BH Oss, Netherlands; [de Vlieg, Jacob] Radboud Univ Nijmegen, Computat Drug Discovery Grp, NL-6526 HP Nijmegen, Netherlands	Merck & Company; Merck & Company; Merck & Company; Radboud University Nijmegen	Lusher, SJ (corresponding author), MSD, Dept Mol Design & Informat, POB 20, NL-5340 BH Oss, Netherlands.	s.lusher@esciencecenter.nl	McGuire, Ross/P-8855-2015	McGuire, Ross/0000-0003-3404-6456; Azevedo, Rita/0000-0002-0180-3636; raaijmakers, hans/0000-0002-2567-7363; Oubrie, Arthur/0000-0001-6765-9246				Afhuppe W, 2009, J STEROID BIOCHEM, V113, P105, DOI 10.1016/j.jsbmb.2008.11.015; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2473, DOI [10.1517/14656566.9.14.2473, 10.1517/14656566.9.14.2473 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2459, DOI [10.1517/14656566.9.14.2459, 10.1517/14656566.9.14.2459 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2487, DOI [10.1517/14656566.9.14.2487, 10.1517/14656566.9.14.2487 ]; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bohl CE, 2008, BIOORG MED CHEM LETT, V18, P5567, DOI 10.1016/j.bmcl.2008.09.002; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Brown AR, 2011, BIOORG MED CHEM LETT, V21, P137, DOI 10.1016/j.bmcl.2010.11.054; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Cantin L, 2007, J BIOL CHEM, V282, P30910, DOI 10.1074/jbc.M705524200; Chen W, 2006, J CLIN ENDOCR METAB, V91, P1296, DOI 10.1210/jc.2005-2379; Chwalisz K, 2005, ENDOCR REV, V26, P423, DOI 10.1210/er.2005-0001; Chwalisz K, 2007, FERTIL STERIL, V87, P1399, DOI 10.1016/j.fertnstert.2006.11.094; Dayan G, 2006, MOL PHARMACOL, V70, P579, DOI 10.1124/mol.105.021931; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; DeManno D, 2003, STEROIDS, V68, P1019, DOI 10.1016/j.steroids.2003.09.008; Duke CB, 2011, J MED CHEM, V54, P3973, DOI 10.1021/jm2000097; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Hubbard RE, 2000, EUR J CANCER, V36, pS17; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Kallander LS, 2010, BIOORG MED CHEM LETT, V20, P371, DOI 10.1016/j.bmcl.2009.10.092; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Kong EH, 2003, BIOCHEM SOC T, V31, P56, DOI 10.1042/BST0310056; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Levenson AS, 1998, CANCER RES, V58, P1872; Levenson AS, 2001, J STEROID BIOCHEM, V76, P61, DOI 10.1016/S0960-0760(00)00143-6; Lusher SJ, 2011, J BIOL CHEM, V286, P35079, DOI 10.1074/jbc.M111.273029; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Ohara Noriyuki, 2007, Reprod Sci, V14, P20, DOI 10.1177/1933719107311464; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pike ACW, 2000, BIOCHEM SOC T, V28, P396, DOI 10.1042/0300-5127:0280396; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Spitz IM, 2003, STEROIDS, V68, P981, DOI 10.1016/j.steroids.2003.08.007; Spitz IM, 2000, STEROIDS, V65, P807, DOI 10.1016/S0039-128X(00)00194-X; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Thompson SK, 2009, BIOORG MED CHEM LETT, V19, P4777, DOI 10.1016/j.bmcl.2009.06.055; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wagner BL, 1996, P NATL ACAD SCI USA, V93, P8739, DOI 10.1073/pnas.93.16.8739; Wang JY, 2006, HUM REPROD, V21, P1869, DOI 10.1093/humrep/del035; Williams ARW, 2007, HUM REPROD, V22, P1696, DOI 10.1093/humrep/dem026; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Zhang ZM, 2005, J BIOL CHEM, V280, P28468, DOI 10.1074/jbc.M504144200	60	24	26	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20333	20343		10.1074/jbc.M111.308403	http://dx.doi.org/10.1074/jbc.M111.308403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535964	hybrid, Green Published			2022-12-28	WOS:000306414500053
J	Chen, SH; Wu, CH; Plank, JL; Hsieh, TS				Chen, Stefanie Hartman; Wu, Chung-Hsuan; Plank, Jody L.; Hsieh, Tao-shih			Essential Functions of C Terminus of Drosophila Topoisomerase III alpha in Double Holliday Junction Dissolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; SYNDROME PROTEIN; HOMOLOGOUS RECOMBINATION; ESSENTIAL COMPONENT; SUPERCOILED DNA; GENOME; BETA; BLM; DISSOLVASOME; STABILITY	Topoisomerase III alpha (Top3 alpha) is an essential component of the double Holliday junction (dHJ) dissolvasome complex in metazoans, along with Blm and Rmi1/2. This important anti-recombinogenic function cannot be performed by Top3 beta, the other type IA topoisomerase present in metazoans. The two share a catalytic core but diverge in their tail regions. To understand this difference in function, we investigated the role of the unique C terminus of Top3 alpha. The Drosophila C terminus contains an insert region not conserved among metazoans. This insert contributes an independent interaction with Blm, which may account for the absence of Rmi1 in Drosophila. Mutant Top3 alpha lacking this insert maintains the ability to perform dHJ dissolution but only partially rescues a top3 alpha null fly line, indicating an in vivo role for the insert. Truncation of the C terminus has a minimal effect on the type IA relaxation activity of Top3 alpha; however, dHJ dissolution is greatly reduced. The Top3 alpha C terminus was found to strongly interact with both Blm and DNA, which are critical to the dissolution reaction; these interactions are greatly reduced in the truncated enzyme. The truncation mutant also cannot rescue the viability of top3 alpha null flies, indicating an essential in vivo role. Our data therefore suggest that the Top3 alpha C terminus has an important role in dHJ dissolution (by providing an interaction interface for Blm and DNA) and an essential function in vivo.	[Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Wu, Chung-Hsuan; Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Plank, Jody L.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	Duke University; Academia Sinica - Taiwan; University of California System; University of California Davis	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	thsieh@duke.edu	Hsieh, Tao-shih/G-9305-2012; Wu, Wan-lin/G-8937-2012	Chen, Stefanie/0000-0002-9550-971X				Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Seki T, 1998, J BIOL CHEM, V273, P28553, DOI 10.1074/jbc.273.44.28553; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wu JH, 2010, P NATL ACAD SCI USA, V107, P6228, DOI 10.1073/pnas.1001855107; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	30	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19346	19353		10.1074/jbc.M112.363044	http://dx.doi.org/10.1074/jbc.M112.363044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511792	Green Published, hybrid			2022-12-28	WOS:000306411900049
J	Garcia-Tardon, N; Gonzalez-Gonzalez, IM; Martinez-Villarreal, J; Fernandez-Sanchez, E; Gimenez, C; Zafra, F				Garcia-Tardon, Noemi; Gonzalez-Gonzalez, Inmaculada M.; Martinez-Villarreal, Jaime; Fernandez-Sanchez, Enrique; Gimenez, Cecilio; Zafra, Francisco			Protein Kinase C (PKC)-promoted Endocytosis of Glutamate Transporter GLT-1 Requires Ubiquitin Ligase Nedd4-2-dependent Ubiquitination but Not Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CELL-SURFACE EXPRESSION; DOPAMINE TRANSPORTER; DEPENDENT ENDOCYTOSIS; DIFFERENTIAL REGULATION; WW DOMAINS; NEDD4-2; DEGRADATION; SERUM; INTERNALIZATION	Glutamate transporter-1 (GLT-1) is the main glutamate transporter in the central nervous system, and its concentration severely decreases in neurodegenerative diseases. The number of transporters in the plasma membrane reflects the balance between their insertion and removal, and it has been reported that the regulated endocytosis of GLT-1 depends on its ubiquitination triggered by protein kinase C (PKC) activation. Here, we identified serine 520 of GLT-1 as the primary target for PKC-dependent phosphorylation, although elimination of this serine did not impair either GLT-1 ubiquitination or endocytosis in response to phorbol esters. In fact, we present evidence indicating that the ubiquitin ligase Nedd4-2 mediates the PKC-dependent ubiquitination and down-regulation of GLT-1. Overexpression of Nedd4-2 increased the ubiquitination of the transporter and promoted its degradation. Moreover, phorbol myristate acetate enhanced Nedd4-2 phosphorylation and the formation of GLT-1.Nedd4-2 complexes, whereas siRNA knockdown of Nedd4-2 prevented ubiquitination, endocytosis, and the concomitant decrease in GLT-1 activity triggered by PKC activation. These results indicate that GLT-1 endocytosis is independent of its phosphorylation and that Nedd4-2 mediates PKC-dependent down-regulation of the transporter.	[Zafra, Francisco] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, E-28049 Madrid, Spain; Univ Autonoma Madrid, Dept Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain; CIBERER, Madrid 28049, Spain; Inst Salud Carlos III, Inst Invest Hosp Univ La Paz, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Instituto de Salud Carlos III	Zafra, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fzafra@cbm.uam.es	Zafra, Francisco/A-6121-2008; Gimenez, Cecilio/K-8027-2014	Zafra, Francisco/0000-0003-3801-3109; Gimenez, Cecilio/0000-0001-6726-8405; Martinez Villarreal, Jaime/0000-0002-3003-7766; Gonzalez-Gonzalez, Maria Inmaculada/0000-0001-9888-0760	Spanish Direccion General de Investigacion Cientifica y Tecnica [SAF2011-29961]; Fondo de Investigaciones Sanitarias (CIBERER); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); Fondo de Investigaciones Sanitarias (CIBERER)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Grant SAF2011-29961, grants from Fondo de Investigaciones Sanitarias (CIBERER) and Comunidad Autonoma de Madrid, and an institutional grant from the Fundacion Ramon Areces.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; CASADO M, 1993, J BIOL CHEM, V268, P27313; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Robinson MB, 2006, HANDB EXP PHARM, V175, P251; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Sheldon AL, 2008, NEUROCHEM INT, V53, P296, DOI 10.1016/j.neuint.2008.07.010; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; TROTTI D, 1995, J BIOL CHEM, V270, P9890, DOI 10.1074/jbc.270.17.9890; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	47	73	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19177	19187		10.1074/jbc.M112.355909	http://dx.doi.org/10.1074/jbc.M112.355909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505712	Green Published, hybrid			2022-12-28	WOS:000306411900028
J	Lee, KN; Jang, WG; Kim, EJ; Oh, SH; Son, HJ; Kim, SH; Franceschi, R; Zhang, XK; Lee, SE; Koh, JT				Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Franceschi, Renny; Zhang, Xiao-Kun; Lee, Shee-Eun; Koh, Jeong-Tae			Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) Protein Negatively Regulates Bone Morphogenetic Protein 2-induced Osteoblast Differentiation through Suppressing Runt-related Gene 2 (Runx2) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; OSTEOCALCIN GENE; THYROID-HORMONE; EXPRESSION; CELLS; TRANSACTIVATION; ADIPOGENESIS; INHIBITION; ACTIVATION; INDUCTION	Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) is an orphan nuclear receptor of the steroid-thyroid hormone receptor superfamily. COUP-TFII is widely expressed in multiple tissues and organs throughout embryonic development and has been shown to regulate cellular growth, differentiation, and organ development. However, the role of COUP-TFII in osteoblast differentiation has not been systematically evaluated. In the present study, COUP-TFII was strongly expressed in multipotential mesenchymal cells, and the endogenous expression level decreased during osteoblast differentiation. Overexpression of COUP-TFII inhibited bone morphogenetic protein 2 (BMP2)-induced osteoblastic gene expression. The results of alkaline phosphatase, Alizarin Red staining, and osteocalcin production assay showed that COUP-TFII overexpression blocks BMP2-induced osteoblast differentiation. In contrast, the down-regulation of COUP-TFII synergistically induced the expression of BMP2-induced osteoblastic genes and osteoblast differentiation. Furthermore, the immunoprecipitation assay showed that COUP-TFII and Runx2 physically interacted and COUP-TFII significantly impaired the Runx2-dependent activation of the osteocalcin promoter. From the ChIP assay, we found that COUP-TFII repressed DNA binding of Runx2 to the osteocalcin gene, whereas Runx2 inhibited COUP-TFII expression via direct binding to the COUP-TFII promoter. Taken together, these findings demonstrate that COUP-TFII negatively regulates osteoblast differentiation via interaction with Runx2, and during the differentiation state, BMP2-induced Runx2 represses COUP-TFII expression and promotes osteoblast differentiation.	[Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Lee, Shee-Eun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Med Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea; [Lee, Kkot-Nim; Jang, Won-Gu; Kim, Eun-Jung; Oh, Sin-Hye; Son, Hye-Ju; Kim, Sun-Hun; Lee, Shee-Eun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Project BK21, Kwangju 500757, South Korea; [Franceschi, Renny] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Zhang, Xiao-Kun] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA	Chonnam National University; Chonnam National University; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Med Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea [2011-0010666, 2011-0030759]; Korea government (Ministry of Education, Science and Technology, MEST)	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Education, Science and Technology, MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea Grants 2011-0010666 and 2011-0030759 funded by the Korea government (Ministry of Education, Science and Technology, MEST).	Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Bailey P, 1998, NUCLEIC ACIDS RES, V26, P5501, DOI 10.1093/nar/26.23.5501; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Javed A, 2000, J CELL SCI, V113, P2221; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lian JB, 1999, VITAM HORM, V55, P443; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANOLAGAS SC, 1981, J BIOL CHEM, V256, P7115; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; QIU YH, 1994, TRENDS ENDOCRIN MET, V5, P234, DOI 10.1016/1043-2760(94)P3081-H; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; Zhang R, 1997, J BIOL CHEM, V272, P110, DOI 10.1074/jbc.272.1.110	35	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18888	18899		10.1074/jbc.M111.311878	http://dx.doi.org/10.1074/jbc.M111.311878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493443	hybrid, Green Published			2022-12-28	WOS:000306411900002
J	Nixon, BR; Thawornkaiwong, A; Jin, J; Brundage, EA; Little, SC; Davis, JP; Solaro, RJ; Biesiadecki, BJ				Nixon, Benjamin R.; Thawornkaiwong, Ariyoporn; Jin, Janel; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Solaro, R. John; Biesiadecki, Brandon J.			AMP-activated Protein Kinase Phosphorylates Cardiac Troponin I at Ser-150 to Increase Myofilament Calcium Sensitivity and Blunt PKA-dependent Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTENSION; THIN-FILAMENTS; HEART; RABBIT; MUSCLE; MICE; CARDIOMYOPATHY; MYOCARDIUM; DYNAMICS; SUBUNITS	AMP-activated protein kinase (AMPK) is an energy-sensing enzyme central to the regulation of metabolic homeostasis. In the heart AMPK is activated during cardiac stress-induced ATP depletion and functions to stimulate metabolic pathways that restore the AMP/ATP balance. Recently it was demonstrated that AMPK phosphorylates cardiac troponin I (cTnI) at Ser-150 in vitro. We sought to determine if the metabolic regulatory kinase AMPK phosphorylates cTnI at Ser-150 in vivo to alter cardiac contractile function directly at the level of the myofilament. Rabbit cardiac myofibrils separated by two-dimensional isoelectric focusing subjected to a Western blot with a cTnI phosphorylation-specific antibody demonstrates that cTnI is endogenously phosphorylated at Ser-150 in the heart. Treatment of myofibrils with the AMPK holoenzyme increased cTnI Ser-150 phosphorylation within the constraints of the muscle lattice. Compared with controls, cardiac fiber bundles exchanged with troponin containing cTnI pseudo-phosphorylated at Ser-150 demonstrate increased sensitivity of calcium-dependent force development, blunting of both PKA-dependent calcium desensitization, and PKA-dependent increases in length dependent activation. Thus, in addition to the defined role of AMPK as a cardiac metabolic energy gauge, these data demonstrate AMPK Ser-150 phosphorylation of cTnI directly links the regulation of cardiac metabolic demand to myofilament contractile energetics. Furthermore, the blunting effect of cTnI Ser-150 phosphorylation cross-talk can uncouple the effects of myofilament PKA-dependent phosphorylation from beta-adrenergic signaling as a novel thin filament contractile regulatory signaling mechanism.	[Nixon, Benjamin R.; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Biesiadecki, Brandon J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Nixon, Benjamin R.; Brundage, Elizabeth A.; Little, Sean C.; Davis, Jonathan P.; Biesiadecki, Brandon J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Thawornkaiwong, Ariyoporn; Jin, Janel; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60614 USA; [Thawornkaiwong, Ariyoporn; Jin, Janel; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60614 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Biesiadecki, BJ (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 1645 Neil Ave,304 Hamilton Hall, Columbus, OH 43210 USA.	biesiadecki.1@osu.edu	Brundage, Elizabeth/AAY-9819-2020	Nixon, Benjamin/0000-0003-1840-0179	NICHD, National Institutes of Health; National Institutes of Health [T32 007692, HL 091986, HL 062426, HL 091056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL091986, R01HL091986, R01HL022231, P01HL062426, K99HL091056, R00HL091056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The CT3 monoclonal antibody developed by J. J.-C. Lin was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD, National Institutes of Health, and maintained by the University of Iowa Dept. of Biology, IA City, IA 52242.; This work was supported, in whole or in part, by National Institutes of Health Grant T32 007692.; Supported by National Institutes of Health Grant HL 091986.; Supported by National Institutes of Health Grant HL 062426.; Supported by National Institutes of Health Grant HL 091056. To whom correspondence should be addressed: Dept. of Physiology and Cell Biology, The Ohio State University, 1645 Neil Ave., 304 Hamilton Hall, Columbus, OH. Tel.: 614-247-4091; Fax: 614-292-4888; E-mail: biesiadecki.1@osu.edu.	Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Arteaga GM, 2000, J PHYSIOL-LONDON, V526, P541, DOI 10.1111/j.1469-7793.2000.t01-1-00541.x; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Behunin S. M., 2012, BIOPHYS J; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Buscemi N, 2002, CIRC RES, V91, P509, DOI 10.1161/01.RES.0000035246.27856.53; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Li MX, 2003, BIOCHEMISTRY-US, V42, P14460, DOI 10.1021/bi035408y; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MOIR AJG, 1977, BIOCHEM J, V167, P333, DOI 10.1042/bj1670333; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Oliveira S. M., 2007, J MUSCLE RES CELL M, V28, P445; Ouyang YX, 2010, J MOL BIOL, V400, P1036, DOI 10.1016/j.jmb.2010.06.007; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Solis RS, 2011, PROTEIN SCI, V20, P894, DOI 10.1002/pro.623; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Wolska BM, 1999, CIRC RES, V84, P745; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005	42	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19136	19147		10.1074/jbc.M111.323048	http://dx.doi.org/10.1074/jbc.M111.323048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493448	hybrid, Green Published			2022-12-28	WOS:000306411900024
J	Chau, DM; Crump, CJ; Villa, JC; Scheinberg, DA; Li, YM				Chau, De-Ming; Crump, Christina J.; Villa, Jennifer C.; Scheinberg, David A.; Li, Yue-Ming			Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TERMINAL FRAGMENT; TRANSGENIC MICE; INHIBITORS; ACTIVATION; DOMAIN; NOTCH; TRAFFICKING; DEFICIENCY; MEMBRANE	Presenilin-1 (PS1) is the catalytic subunit of gamma-secretase, and mutations in this protein cause familial Alzheimer Disease (FAD). However, little is known about how these mutations affect the active site of gamma-secretase. Here, we show that PS1 mutations alter the S2 subsite within the active site of gamma-secretase using a multiple photoaffinity probe approach called "photophore walking." Moreover, we developed a unique in vitro assay with a biotinylated recombinant Notch1 substrate and demonstrated that PS1 FAD mutations directly and significantly reduced gamma-secretase activity for Notch1 cleavage. Substitution of the Notch Cys-1752 residue, which interacts with the S2 subsite, with Val, Met, or Ile has little effect on wild-type PS1 but leads to more efficient substrates for mutant PS1s. This study indicates that alteration of this S2 subsite plays an important role in determining the activity and specificity of gamma-secretase for APP and Notch1 processing, which provides structural basis and insights on how certain PS1 FAD mutations lead to AD pathogenesis.	[Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; Cornell Univ, Weill Cornell Grad Sch Med Sci, Dept Pharmacol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Li, YM (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10065 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022		National Institutes of Health [R01-AG026660]; American Health Assistance Foundation; Alzheimer Association; Institutional Training Grant [T32 GM073546-01A19, T32 GM073546-04]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; NATIONAL CANCER INSTITUTE [P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Institutional Training Grant; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AG026660 (to Y. M. L.). This work was also supported by the American Health Assistance Foundation (to Y. M. L.), by the Alzheimer Association (Y. M. L.), by Institutional Training Grants T32 GM073546-01A19 (to C. J. C.) and T32 GM073546-04 (to J. C. V.), by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, by the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center, and by the William Randolph Hearst Fund in Experimental Therapeutics.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Chun J, 2004, J ORG CHEM, V69, P7344, DOI 10.1021/jo0486948; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lessard CB, 2010, P NATL ACAD SCI USA, V107, P21236, DOI 10.1073/pnas.1016284108; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Nakajima M, 2000, J NEUROSCI RES, V62, P311, DOI 10.1002/1097-4547(20001015)62:2<311::AID-JNR16>3.0.CO;2-G; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yang GL, 2009, BIOORG MED CHEM LETT, V19, P922, DOI 10.1016/j.bmcl.2008.11.117	39	51	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17288	17296		10.1074/jbc.M111.300483	http://dx.doi.org/10.1074/jbc.M111.300483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461631	Green Published, hybrid			2022-12-28	WOS:000306373000029
J	Dai, MS; Challagundla, KB; Sun, XX; Palam, LR; Zeng, SX; Wek, RC; Lu, H				Dai, Mu-Shui; Challagundla, Kishore B.; Sun, Xiao-Xin; Palam, Lakshmi Reddy; Zeng, Shelya X.; Wek, Ronald C.; Lu, Hua			Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; ZINC-FINGER DOMAIN; CELL-CYCLE ARREST; P53 ACTIVATION; DNA-DAMAGE; NUCLEOLAR LOCALIZATION; NUCLEAR EXPORT; STABILIZES P53; MDM2; INHIBITION	The ARF tumor suppressor protein activates p53 in response to oncogenic stress, whereas ribosomal protein L11 induces p53 following ribosomal stress. Both proteins bind to central, albeit non-overlapping, regions of MDM2 and suppress MDM2 activity toward p53. However, it is not known whether the two pathways are functionally connected. Here we show that ARF directly binds to L11 in vitro and in cells, which then forms a complex with MDM2 and p53. L11 collaboratively enhances ARF-induced p53 transcriptional activity and cell cycle arrest. Supporting these results, knocking down L11 reduces ARF-mediated p53 accumulation and alleviates ARF-induced cell cycle arrest. Interestingly, overexpression of ARF increases the levels of ribosome-free L11 and enhances the interaction of L11 with MDM2 and p53. These results demonstrate that ARF activates p53, at least partly by induction of ribosomal stress, which results in L11 suppression of MDM2, and suggest that the ARF-MDM2-p53 and the L11-MDM2-p53 pathways are functionally connected.	[Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Dai, Mu-Shui; Sun, Xiao-Xin; Palam, Lakshmi Reddy; Zeng, Shelya X.; Wek, Ronald C.; Lu, Hua] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Dai, Mu-Shui; Sun, Xiao-Xin; Palam, Lakshmi Reddy; Zeng, Shelya X.; Wek, Ronald C.; Lu, Hua] Indiana Univ, Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Dai, Mu-Shui; Challagundla, Kishore B.; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97239 USA; [Dai, Mu-Shui; Challagundla, Kishore B.; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Sch Med, Dept Mol, Portland, OR 97239 USA; [Dai, Mu-Shui; Challagundla, Kishore B.; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Sch Med, Dept Med Genet, Portland, OR 97239 USA	Tulane University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Challagundla, Kishore B./H-8189-2019; palam, lakshmi reddy/H-4902-2015	Challagundla, Kishore B./0000-0001-8654-7717; 	NCI, National Institutes of Health [CA93614, CA095441, CA079721, CA127134, GM049164]; NATIONAL CANCER INSTITUTE [R01CA093614, R00CA127134, R01CA079721, K99CA127134, R01CA095441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA93614, CA095441, and CA079721 (to H. L.), CA127134 (to M.-S. D.), and GM049164 (to R. C. W.).	Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Morton JP, 2007, NUCLEIC ACIDS RES, V35, P3046, DOI 10.1093/nar/gkm208; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Olson MOJ, 2002, INT REV CYTOL, V219, P199; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang Q, 2011, J BIOL CHEM, V286, P38264, DOI 10.1074/jbc.M111.277012; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	65	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17120	17129		10.1074/jbc.M111.311902	http://dx.doi.org/10.1074/jbc.M111.311902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467867	Green Published, hybrid			2022-12-28	WOS:000306373000012
J	Kinney, JN; Salmeen, A; Cai, F; Kerfeld, CA				Kinney, James N.; Salmeen, Annette; Cai, Fei; Kerfeld, Cheryl A.			Elucidating Essential Role of Conserved Carboxysomal Protein CcmN Reveals Common Feature of Bacterial Microcompartment Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ORGANELLES; SHELL; PROKARYOTES; LEVEL; CO2	Bacterial microcompartments are organelles composed of a protein shell that surrounds functionally related proteins. Bioinformatic analysis of sequenced genomes indicates that homologs to shell protein genes are widespread among bacteria and suggests that the shell proteins are capable of encapsulating diverse enzymes. The carboxysome is a bacterial microcompartment that enhances CO2 fixation in cyanobacteria and some chemoautotrophs by sequestering ribulose-1,5-bisphosphate carboxylase/oxygenase and carbonic anhydrase in the microcompartment shell. Here, we report the in vitro and in vivo characterization of CcmN, a protein of previously unknown function that is absolutely conserved in beta-carboxysomal gene clusters. We show that CcmN localizes to the carboxysome and is essential for carboxysome biogenesis. CcmN has two functionally distinct regions separated by a poorly conserved linker. The N-terminal portion of the protein is important for interaction with CcmM and, by extension, ribulose-1,5-bisphosphate carboxylase/oxygenase and the carbonic anhydrase CcaA, whereas the C-terminal peptide is essential for interaction with the carboxysome shell. Deletion of the peptide abolishes carboxysome formation, indicating that its interaction with the shell is an essential step in microcompartment formation. Peptides with similar length and sequence properties to those in CcmN can be bioinformatically detected in a large number of diverse proteins proposed to be encapsulated in functionally distinct microcompartments, suggesting that this peptide and its interaction with its cognate shell proteins are common features of microcompartment assembly.	[Kinney, James N.; Salmeen, Annette; Cai, Fei; Kerfeld, Cheryl A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Kinney, James N.; Salmeen, Annette; Cai, Fei; Kerfeld, Cheryl A.] Univ Calif Berkeley, Phys Biosci Div, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), Joint Genome Inst, Dept Energy, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	ckerfeld@lbl.gov			Director, Office of Science, of the United States Department of Energy [DE-AC02-05CH11231]; National Science Foundation [MCB-0851070]	Director, Office of Science, of the United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Director, Office of Science, of the United States Department of Energy under Contract DE-AC02-05CH11231 and by National Science Foundation Grant MCB-0851070 (to C. A. K. and F. C.)	Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BYERS B, 1991, METHOD ENZYMOL, V194, P602; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; DREWS G, 1956, ARCH MIKROBIOL, V24, P147, DOI 10.1007/BF00408629; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; FRIEDBERG D, 1989, J BACTERIOL, V171, P6069, DOI 10.1128/jb.171.11.6069-6076.1989; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schulz EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017403; Schuster-Bockler B, 2005, BIOINFORMATICS, V21, P2912, DOI 10.1093/bioinformatics/bti434; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	33	108	111	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17729	17736		10.1074/jbc.M112.355305	http://dx.doi.org/10.1074/jbc.M112.355305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461622	hybrid, Green Published			2022-12-28	WOS:000306373000071
J	Lin, ME; Rivera, RR; Chun, J				Lin, Mu-En; Rivera, Richard R.; Chun, Jerold			Targeted Deletion of LPA(5) Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE ELEMENT-BINDING; DORSAL-HORN NEURONS; NERVE INJURY; SPINAL-CORD; UP-REGULATION; PROTEIN CREB; RECEPTOR; PHOSPHORYLATION; HYPERALGESIA; ACTIVATION	Lysophosphatidic acid (LPA) is a bioactive lipid that serves as an extracellular signaling molecule acting through cognate G protein-coupled receptors designated LPA(1-6) that mediate a wide range of both normal and pathological effects. Previously, LPA(1), a G(alpha i)-coupled receptor (which also couples to other G(alpha) proteins) to reduce cAMP, was shown to be essential for the initiation of neuropathic pain in the partial sciatic nerve ligation (PSNL) mouse model. Subsequent gene expression studies identified LPA(5), a G(alpha 12/13)- and G(q)-coupled receptor that increases cAMP, in a subset of dorsal root ganglion neurons and also within neurons of the spinal cord dorsal horn in a pattern complementing, yet distinct from LPA(1), suggesting its possible involvement in neuropathic pain. We therefore generated an Lpar5 null mutant by targeted deletion followed by PSNL challenge. Homozygous null mutants did not show obvious base-line phenotypic defects. However, following PSNL, LPA(5)-deficient mice were protected from developing neuropathic pain. They also showed reduced phosphorylated cAMP response element-binding protein expression within neurons of the dorsal horn despite continued up-regulation of the characteristic pain-related markers Ca alpha(2)delta(1) and glial fibrillary acidic protein, results that were distinct from those previously observed for LPA(1) deletion. These data expand the influences of LPA signaling in neuropathic pain through a second LPA receptor subtype, LPA(5), involving a mechanistically distinct downstream signaling pathway compared with LPA(1).	[Lin, Mu-En; Rivera, Richard R.; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol Biol, La Jolla, CA 92037 USA; [Lin, Mu-En] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Chun, J (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol Biol, 10550 N Torrey Pines Rd,DNC 118, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019		National Institutes of Health [MH051699, NS048478]; Amira predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051699, R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amira predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH051699 and NS048478 (to J. C.). This work was also supported by an Amira predoctoral fellowship (to M. L.).	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Bezzi P, 2001, Prog Brain Res, V132, P255; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Braissant O, 1998, BIOCHEMICA, V1, P10; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Coyle DE, 1998, GLIA, V23, P75; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Gao X, 2005, PAIN, V116, P62, DOI 10.1016/j.pain.2005.03.045; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Hoeger-Bement MK, 2003, J NEUROSCI, V23, P5437; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ji RR, 1997, J NEUROSCI, V17, P1776; Karliner JS, 2004, J CELL BIOCHEM, V92, P1095, DOI 10.1002/jcb.20129; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liou JT, 2007, ANESTH ANALG, V105, P1830, DOI 10.1213/01.ane.0000287652.42309.5c; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Miletic G, 2002, PAIN, V99, P493, DOI 10.1016/S0304-3959(02)00242-7; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Plenz G., 2003, BIOCHEMICA, V1, P19; RASMINSKY M, 1978, ANN NEUROL, V3, P351, DOI 10.1002/ana.410030413; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SMITH KJ, 1982, J NEUROL SCI, V55, P39, DOI 10.1016/0022-510X(82)90168-X; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Sorkin LS, 2009, NEUROTHERAPEUTICS, V6, P609, DOI 10.1016/j.nurt.2009.07.007; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Wang YX, 2011, J ANESTH, V25, P87, DOI 10.1007/s00540-010-1068-1; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Xie WJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-46; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095	47	86	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17608	17617		10.1074/jbc.M111.330183	http://dx.doi.org/10.1074/jbc.M111.330183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461625	Green Published, hybrid			2022-12-28	WOS:000306373000059
J	Gushulak, L; Hemming, R; Martin, D; Seyrantepe, V; Pshezhetsky, A; Triggs-Raine, B				Gushulak, Lara; Hemming, Richard; Martin, Dianna; Seyrantepe, Volkan; Pshezhetsky, Alexey; Triggs-Raine, Barbara			Hyaluronidase 1 and beta-Hexosaminidase Have Redundant Functions in Hyaluronan and Chondroitin Sulfate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; MUCOPOLYSACCHARIDOSIS-IX; MICE; CATABOLISM; MOUSE; ACID; RECEPTOR; BINDING; MODEL; CD44	Hyaluronan (HA), a member of the glycosaminoglycan (GAG) family, is a critical component of the extracellular matrix. A model for HA degradation that invokes the activity of both hyaluronidases and exoglycosidases has been advanced. However, no in vivo studies have been done to determine the extent to which these enzymes contribute to HA breakdown. Herein, we used mouse models to investigate the contributions of the endoglycosidase HYAL1 and the exoglycosidase beta-hexosaminidase to the lysosomal degradation of HA. We employed histochemistry and fluorophore-assisted carbohydrate electrophoresis to determine the degree of HA accumulation in mice deficient in one or both enzyme activities. Global HA accumulation was present in mice deficient in both enzymes, with the highest levels found in the lymph node and liver. Chondroitin, a GAG similar in structure to HA, also broadly accumulated in mice deficient in both enzymes. Accumulation of chondroitin sulfate derivatives was detected in mice deficient in both enzymes, as well as in beta-hexosaminidase-deficient mice, indicating that both enzymes play a significant role in chondroitin sulfate breakdown. Extensive accumulation of HA and chondroitin when both enzymes are lacking was not observed in mice deficient in only one of these enzymes, suggesting that HYAL1 and beta-hexosaminidase are functionally redundant in HA and chondroitin breakdown. Furthermore, accumulation of sulfated chondroitin in tissues provides in vivo evidence that both HYAL1 and beta-hexosaminidase cleave chondroitin sulfate, but it is a preferred substrate for beta-hexosaminidase. These studies provide in vivo evidence to support and extend existing knowledge of GAG breakdown.	[Gushulak, Lara; Hemming, Richard; Triggs-Raine, Barbara] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada; [Martin, Dianna] Hosp Sick Children, Toronto, ON M5S 2Y9, Canada; [Seyrantepe, Volkan] Izmir Inst Technol, Fac Sci, Dept Mol Biol & Genet, TR-35430 Izmir, Turkey; [Pshezhetsky, Alexey] Univ Montreal, CHU St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada; [Pshezhetsky, Alexey] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada	University of Manitoba; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Izmir Institute of Technology; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Triggs-Raine, B (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	traine@cc.umanitoba.ca	Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779; A, Pshezhetsky/0000-0002-6612-1062	Canadian Institutes of Health Research [MOP-89873]; Manitoba Health Research Council; Manitoba Institute of Child Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Manitoba Institute of Child Health	This work was supported in part by Canadian Institutes of Health Research Grant MOP-89873.; Supported by a Canadian Institutes of Health Research studentship and a joint studentship from the Manitoba Health Research Council and the Manitoba Institute of Child Health.	Allen T. C., 1994, HEMATOXYLIN EOSIN LA; ARONSON NN, 1967, J BIOL CHEM, V242, P441; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Evers M, 1996, P NATL ACAD SCI USA, V93, P8214, DOI 10.1073/pnas.93.16.8214; FISCHER J, 1995, BIOCHEM J, V312, P215, DOI 10.1042/bj3120215; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Gaffney E., 1994, CARBOHYDRATES LAB ME; Gao NG, 2003, GLYCOBIOLOGY, V13, p1G, DOI 10.1093/glycob/cwg009; GLASER JH, 1979, J BIOL CHEM, V254, P2316; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARDINGHAM TE, 1973, BIOCHEM J, V135, P905, DOI 10.1042/bj1350905; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Hascall V. C., 1999, REGULATION PROTEOGLY; HASCALL VC, 1974, J BIOL CHEM, V249, P4242; Imundo L, 2011, J INHERIT METAB DIS, V34, P1013, DOI 10.1007/s10545-011-9343-3; Jadin L, 2012, MATRIX BIOL, V31, P81, DOI 10.1016/j.matbio.2011.11.002; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; LAURENT UBG, 1981, BIOCHEM INT, V2, P195; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; MEYER K, 1969, AM J MED, V47, P664, DOI 10.1016/0002-9343(69)90162-4; Natowicz MR, 1996, NEW ENGL J MED, V335, P1029, DOI 10.1056/NEJM199610033351405; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Plaas A H, 2001, Methods Mol Biol, V171, P117; PROIA RL, 1984, J BIOL CHEM, V259, P3350; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; ROME LH, 1986, BIOCHEM J, V235, P707, DOI 10.1042/bj2350707; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; SANDHOFF K, 1984, NEUROPEDIATRICS, V15, P85, DOI 10.1055/s-2008-1052387; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Suzuki K, 1997, J NEUROPATH EXP NEUR, V56, P693; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; VOGLER C, 1990, AM J PATHOL, V136, P207; Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138; Wegrzyn G, 2010, MED HYPOTHESES, V75, P605, DOI 10.1016/j.mehy.2010.07.044; WOOD KM, 1973, BIOCHEM J, V134, P1009, DOI 10.1042/bj1341009; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	48	33	36	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16689	16697		10.1074/jbc.M112.350447	http://dx.doi.org/10.1074/jbc.M112.350447			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451654	Green Published, hybrid			2022-12-28	WOS:000304030900057
J	Sakurama, H; Fushinobu, S; Hidaka, M; Yoshida, E; Honda, Y; Ashida, H; Kitaoka, M; Kumagai, H; Yamamoto, K; Katayama, T				Sakurama, Haruko; Fushinobu, Shinya; Hidaka, Masafumi; Yoshida, Erina; Honda, Yuji; Ashida, Hisashi; Kitaoka, Motomitsu; Kumagai, Hidehiko; Yamamoto, Kenji; Katayama, Takane			1,3-1,4-alpha-L-Fucosynthase That Specifically Introduces Lewis a/x Antigens into Type-1/2 Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-FUCOSIDASE; HUMAN-MILK OLIGOSACCHARIDES; ENGINEERED ESCHERICHIA-COLI; BIFIDOBACTERIUM-LONGUM; THERMOTOGA-MARITIMA; REACTION-MECHANISM; PENICILLIUM-MULTICOLOR; CATALYTIC NUCLEOPHILE; GLYCOSIDE HYDROLASE; ENZYMATIC-SYNTHESIS	alpha-L-Fucosyl residues attached at the non-reducing ends of glycoconjugates constitute histo-blood group antigens Lewis (Le) and ABO and play fundamental roles in various biological processes. Therefore, establishing a method for synthesizing the antigens is important for functional glycomics studies. However, regiospecific synthesis of glycosyl linkages, especially alpha-L-fucosyl linkages, is quite difficult to control both by chemists and enzymologists. Here, we generated an alpha-L-fucosynthase that specifically introduces Le(a) and Le(x) antigens into the type-1 and type-2 chains, respectively; i.e. the enzyme specifically accepts the disaccharide structures (Gal beta 1-3/4GlcNAc) at the non-reducing ends and attaches a Fuc residue via an alpha-(1,4/3)-linkage to the GlcNAc. X-ray crystallographic studies revealed the structural basis of this strict regio- and acceptor specificity, which includes the induced fit movement of the catalytically important residues, and the difference between the active site structures of 1,3-1,4-alpha-L-fucosidase (EC 3.2.1.111) and alpha-L-fucosidase (EC 3.2.1.51) in glycoside hydrolase family 29. The glycosynthase developed in this study should serve as a potentially powerful tool to specifically introduce the Le(a/x) epitopes onto labile glycoconjugates including glycoproteins. Mining glycosidases with strict specificity may represent the most efficient route to the specific synthesis of glycosidic bonds.	[Sakurama, Haruko; Yoshida, Erina; Honda, Yuji; Kumagai, Hidehiko; Yamamoto, Kenji; Katayama, Takane] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Fushinobu, Shinya; Hidaka, Masafumi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Ishikawa Prefecture University; University of Tokyo; Kyoto University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Katayama, T (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan.	takane@ishikawa-pu.ac.jp	Ashida, Hisashi/HCI-0293-2022; Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019	Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874	Ministry of Education, Culture, Sports, Science and Technology, Japan [24580119]; Urakami Foundation; Grants-in-Aid for Scientific Research [24580119] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (C) 24580119 from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant-in-aid from the Urakami Foundation.	Ajisaka K, 1998, CARBOHYD RES, V309, P125, DOI 10.1016/S0008-6215(98)00112-8; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cobucci-Ponzano B, 2011, ADV SYNTH CATAL, V353, P2284, DOI 10.1002/adsc.201100461; Cobucci-Ponzano B, 2011, GLYCOBIOLOGY, V21, P448, DOI 10.1093/glycob/cwq177; Cobucci-Ponzano B, 2009, CHEM BIOL, V16, P1097, DOI 10.1016/j.chembiol.2009.09.013; COHENFORD MA, 1989, ANAL BIOCHEM, V177, P172, DOI 10.1016/0003-2697(89)90035-3; Drouillard S, 2006, ANGEW CHEM INT EDIT, V45, P1778, DOI 10.1002/anie.200503427; Dumon C, 2006, CHEMBIOCHEM, V7, P359, DOI 10.1002/cbic.200500293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farkas E, 2000, CARBOHYD RES, V328, P293, DOI 10.1016/S0008-6215(00)00113-0; FISHER KJ, 1989, BIOCHEM J, V264, P695, DOI 10.1042/bj2640695; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Honda Y, 2006, J BIOL CHEM, V281, P1426, DOI 10.1074/jbc.M511202200; Honda Y, 2004, BIOCHEM J, V377, P225, DOI 10.1042/BJ20031171; INOUE M, 1987, CANCER, V60, P2985, DOI 10.1002/1097-0142(19871215)60:12<2985::AID-CNCR2820601222>3.0.CO;2-5; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Liu SW, 2009, BIOCHEMISTRY-US, V48, P110, DOI 10.1021/bi801529t; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murata T, 1999, CARBOHYD RES, V320, P192, DOI 10.1016/S0008-6215(99)00156-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Osanjo G, 2007, BIOCHEMISTRY-US, V46, P1022, DOI 10.1021/bi061444w; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANO M, 1992, J BIOL CHEM, V267, P1522; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Shaikh FA, 2008, BIOCHEM CELL BIOL, V86, P169, DOI 10.1139/O07-149; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wada J, 2008, FEBS LETT, V582, P3739, DOI 10.1016/j.febslet.2008.09.054; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Wang LX, 2009, CURR OPIN CHEM BIOL, V13, P592, DOI 10.1016/j.cbpa.2009.08.014; Wang W, 2009, P NATL ACAD SCI USA, V106, P16096, DOI 10.1073/pnas.0908248106; Wu HJ, 2010, ANGEW CHEM INT EDIT, V49, P337, DOI 10.1002/anie.200905597; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zeleny R, 2006, PHYTOCHEMISTRY, V67, P641, DOI 10.1016/j.phytochem.2006.01.021	55	64	70	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16709	16719		10.1074/jbc.M111.333781	http://dx.doi.org/10.1074/jbc.M111.333781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451675	hybrid, Green Published			2022-12-28	WOS:000304030900059
J	Dai, Q; Lei, TJ; Zhao, CH; Zhong, JQ; Tang, YZ; Chen, B; Yang, J; Li, CH; Wang, SY; Song, X; Li, L; Li, QT				Dai, Qian; Lei, Tingjun; Zhao, Changhong; Zhong, Jianqiao; Tang, Yi-zhi; Chen, Bin; Yang, Jie; Li, Chenghua; Wang, Siyu; Song, Xu; Li, Li; Li, Qintong			Cyclin K-containing Kinase Complexes Maintain Self-renewal in Murine Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; TRANSCRIPTIONAL ACTIVITY; TERMINAL DOMAIN; IN-VIVO; PHOSPHORYLATION; DIFFERENTIATION; CDK9; PLURIPOTENCY; PRECURSORS	Protein phosphorylation plays an important role in the regulation of self-renewal and differentiation of embryonic stem cells. However, the responsible intracellular kinases are not well characterized. Here, we discovered that cyclin K protein was highly expressed in pluripotent embryonic stem cells but low in their differentiated derivatives or tissue-specific stem cells. Upon cell differentiation, the level of cyclin K protein was decreased. Furthermore, knockdown of cyclin K led to cell differentiation, which could be rescued by an expression construct resistant to RNA interference. Surprisingly, cyclin K did not interact with CDK9 protein in cells as thought previously. Instead, it associated with CrkRS (also known as CDK12) and CDC2L5 (also known as CDK13). Similar to cyclin K, both CDK12 and CDK13 proteins were highly expressed in murine embryonic stem cells and were decreased upon cell differentiation. Importantly, knockdown of either kinase resulted in differentiation. Thus, our studies have uncovered two novel protein kinase complexes that maintain self-renewal in embryonic stem cells.	[Dai, Qian; Lei, Tingjun; Zhao, Changhong; Chen, Bin; Yang, Jie; Li, Chenghua; Li, Qintong] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China; [Zhong, Jianqiao; Wang, Siyu; Li, Li] Sichuan Univ, Dept Dermatol, W China Ctr Med Sci, Chengdu 610064, Sichuan, Peoples R China; [Tang, Yi-zhi] Aviat Ind Corp China, Hosp 363, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; Aviation Industry Corporation of China (AVIC)	Li, QT (corresponding author), Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China.	liqintong@scu.edu.cn	LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; Li, Chenghua/L-9825-2019; li, li/HII-4157-2022	Li, Chenghua/0000-0003-2978-8762; Dai, Qian/0000-0002-9887-0156; Li, Qintong/0000-0002-8447-9770	National Basic Research Program of China/973 Program [2011CB504200, 2012CB910700]; National Natural Science Foundation of China [30970625, 31171260]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0565]	National Basic Research Program of China/973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from National Basic Research Program of China/973 Program (2011CB504200 and 2012CB910700), National Natural Science Foundation of China (30970625 and 31171260), and Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0565 to Q. L.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Ko TK, 2001, J CELL SCI, V114, P2591; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Marques F, 2000, BIOCHEM BIOPH RES CO, V279, P832, DOI 10.1006/bbrc.2000.4042; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Napolitano G, 2000, GENE, V254, P139, DOI 10.1016/S0378-1119(00)00278-X; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Shore SM, 2005, GENE, V350, P51, DOI 10.1016/j.gene.2005.01.015; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	29	39	40	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25344	25352		10.1074/jbc.M111.321760	http://dx.doi.org/10.1074/jbc.M111.321760			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22547058	hybrid, Green Published			2022-12-28	WOS:000306651700042
J	Wu, JX; Liu, C; Chen, JJ; Yu, XC				Wu, Jiaxue; Liu, Chao; Chen, Junjie; Yu, Xiaochun			RAP80 Protein Is Important for Genomic Stability and Is Required for Stabilizing BRCA1-A Complex at DNA Damage Sites in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; CANCER SUSCEPTIBILITY; POLYUBIQUITIN CHAINS; UBIQUITIN STRUCTURES; TARGETS BRCA1; ACTIVATION; DOMAIN; MUTATIONS; INTERACTS; BRCC36	RAP80 (receptor-associated protein 80) is a ubiquitin-binding protein that can specifically recognize and bind to Lys-63-linked polyubiquitin chains, thus targeting the BRCA1-A complex to DNA damage sites. To study the role of RAP80 in vivo, we generated RAP80-deficient mice. The deficient mice are prone to B-cell lymphomagenesis. B-cell lymphomas in RAP80-deficient mice are nearly diploid but harbor clonal chromosome translocations. Moreover, the deficient mice are hypersensitive to ionizing radiation. Repair of ionizing radiation-induced DNA double-strand breaks is impaired in RAP80-deficient mouse embryonic fibroblasts. Mechanistically, loss of RAP80 suppresses recruitment of the BRCA1-A complex to DNA damage sites and abrogates the DNA damage repair process at DNA damage sites. Taken together, these results reveal that RAP80 plays a crucial role in the DNA damage response and in maintaining genomic integrity.	[Wu, Jiaxue; Liu, Chao; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; American Cancer Society [RSG-08-125-01-CCG]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.). This work was also supported by American Cancer Society Grant RSG-08-125-01-CCG (to X. Y.).; Recipient of the Era of Hope Scholar Award from the United States Department of Defense. To whom correspondence should be addressed. Tel.: 734-615-4945; Fax: 734-647-7950; E-mail: xiayu@umich.edu.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	53	30	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22919	22926		10.1074/jbc.M112.351007	http://dx.doi.org/10.1074/jbc.M112.351007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22539352	Green Published, hybrid			2022-12-28	WOS:000306495000049
J	Mininno, M; Brugiere, S; Pautre, V; Gilgen, A; Ma, S; Ferro, M; Tardif, M; Alban, C; Ravanel, S				Mininno, Morgane; Brugiere, Sabine; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Ferro, Myriam; Tardif, Marianne; Alban, Claude; Ravanel, Stephane			Characterization of Chloroplastic Fructose 1,6-Bisphosphate Aldolases as Lysine-methylated Proteins in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SUBUNIT; POSTTRANSLATIONAL MODIFICATIONS; TERMINAL REGION; ARABIDOPSIS; PURIFICATION; RUBISCO; PHOTOSYNTHESIS; BIOSYNTHESIS; MECHANISM; PROTEOME	In pea (Pisum sativum), the protein-lysine methyltransferase (PsLSMT) catalyzes the trimethylation of Lys-14 in the large subunit (LS) of ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme catalyzing the CO2 fixation step during photosynthesis. Homologs of PsLSMT, herein referred to as LSMT-like enzymes, are found in all plant genomes, but methylation of LS Rubisco is not universal in the plant kingdom, suggesting a species-specific protein substrate specificity of the methyltransferase. In this study, we report the biochemical characterization of the LSMT-like enzyme from Arabidopsis thaliana (AtLSMT-L), with a focus on its substrate specificity. We show that, in Arabidopsis, LS Rubisco is not naturally methylated and that the physiological substrates of AtLSMT-L are chloroplastic fructose 1,6-bisphosphate aldolase isoforms. These enzymes, which are involved in the assimilation of CO2 through the Calvin cycle and in chloroplastic glycolysis, are trimethylated at a conserved lysyl residue located close to the C terminus. Both AtLSMT-L and PsLSMT are able to methylate aldolases with similar kinetic parameters and product specificity. Thus, the divergent substrate specificity of LSMT-like enzymes from pea and Arabidopsis concerns only Rubisco. AtLSMT-L is able to interact with unmethylated Rubisco, but the complex is catalytically unproductive. Trimethylation does not modify the kinetic properties and tetrameric organization of aldolases in vitro. The identification of aldolases as methyl proteins in Arabidopsis and other species like pea suggests a role of protein lysine methylation in carbon metabolism in chloroplasts.	[Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] INRA, USC1359, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] CNRS, UMR5168, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] Commissariat Energie Atom, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] Univ Grenoble 1, UMR5168, F-38041 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] Commissariat Energie Atom, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] INSERM, U1038, F-38054 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] Univ Grenoble 1, U1038, F-38041 Grenoble, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ravanel, S (corresponding author), INRA, USC1359, F-38054 Grenoble, France.	stephane.ravanel@cea.fr	Tardif, Marianne/AAA-5357-2019; FERRO, Myriam/O-6588-2014; Alban, Claude/ABG-2296-2021	Tardif, Marianne/0000-0003-4438-8281; FERRO, Myriam/0000-0002-4222-6847; Alban, Claude/0000-0003-3587-6339; Sabine, BRUGIERE/0000-0002-0757-0968; Ravanel, Stephane/0000-0001-9475-4222	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes; French National Research Agency [SVSE6]	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); French National Research Agency(French National Research Agency (ANR))	This work was supported by the Department of Plant Biology INRA, the Cluster 9 of the Region Rhone-Alpes, and the French National Research Agency Chloro-Pro Project Blanc SVSE6, 2010.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aquea F, 2011, PLANT CELL REP, V30, P1087, DOI 10.1007/s00299-011-1015-0; Baginsky S, 2009, MOL PLANT, V2, P1141, DOI 10.1093/mp/ssp058; BERTHIAUME L, 1991, J BIOL CHEM, V266, P17099; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Curien G, 2003, EUR J BIOCHEM, V270, P4615, DOI 10.1046/j.1432-1033.2003.03851.x; Dirk LMA, 2006, ENZYMES, V24, P179, DOI 10.1016/S1874-6047(06)80009-0; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Erales J, 2008, FEBS J, V275, P1248, DOI 10.1111/j.1742-4658.2008.06284.x; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Haake V, 1999, PLANT J, V17, P479, DOI 10.1046/j.1365-313X.1999.00391.x; Haake V, 1998, PLANT J, V14, P147, DOI 10.1046/j.1365-313X.1998.00089.x; Horecker B. L., 1975, METHOD ENZYMOL, V42, P234; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-175; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Magnani R, 2007, J BIOL CHEM, V282, P27857, DOI 10.1074/jbc.M702069200; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Raines CA, 2011, PLANT PHYSIOL, V155, P36, DOI 10.1104/pp.110.168559; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Salvi Daniel, 2008, V432, P19, DOI 10.1007/978-1-59745-028-7_2; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Uematsu K., 2012, J EXP BOT IN PRESS; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	36	42	50	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21034	21044		10.1074/jbc.M112.359976	http://dx.doi.org/10.1074/jbc.M112.359976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547063	Green Published, hybrid			2022-12-28	WOS:000306416800025
J	Popp, D; Narita, A; Lee, LJ; Ghoshdastider, U; Xue, B; Srinivasan, R; Balasubramanian, MK; Tanaka, T; Robinson, RC				Popp, David; Narita, Akihiro; Lee, Lin Jie; Ghoshdastider, Umesh; Xue, Bo; Srinivasan, Ramanujam; Balasubramanian, Mohan K.; Tanaka, Toshitsugu; Robinson, Robert C.			Novel Actin-like Filament Structure from Clostridium tetani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID-DNA-SEGREGATION; DYNAMIC INSTABILITY; ELECTRON-MICROGRAPHS; MOLECULAR-STRUCTURE; PARM; POLYMERIZATION; PROTEIN; MECHANISM; OSCILLATIONS; CYTOSKELETON	Eukaryotic F-actin is constructed from two protofilaments that gently wind around each other to form a helical polymer. Several bacterial actin-like proteins (Alps) are also known to form F-actin-like helical arrangements from two protofilaments, yet with varied helical geometries. Here, we report a unique filament architecture of Alp12 from Clostridium tetani that is constructed from four protofilaments. Through fitting of an Alp12 monomer homology model into the electron microscopy data, the filament was determined to be constructed from two antiparallel strands, each composed of two parallel protofilaments. These four protofilaments form an open helical cylinder separated by a wide cleft. The molecular interactions within single protofilaments are similar to F-actin, yet interactions between protofilaments differ from those in F-actin. The filament structure and assembly and disassembly kinetics suggest Alp12 to be a dynamically unstable force-generating motor involved in segregating the pE88 plasmid, which encodes the lethal tetanus toxin, and thus a potential target for drug design. Alp12 can be repeatedly cycled between states of polymerization and dissociation, making it a novel candidate for incorporation into fuel-propelled nanobiopolymer machines.	[Robinson, Robert C.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Narita, Akihiro; Tanaka, Toshitsugu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Tanaka, Toshitsugu] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ghoshdastider, Umesh] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Srinivasan, Ramanujam; Balasubramanian, Mohan K.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Balasubramanian, Mohan K.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Balasubramanian, Mohan K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Robinson, Robert C.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Robinson, Robert C.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nagoya University; Nagoya University; Goethe University Frankfurt; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University		dpopp@imcb.a-star.edu.sg	Srinivasan, Ramanujam/AAY-7779-2021; Ghoshdastider, Umesh/O-5327-2015; Robinson, Robert/G-9702-2011	Srinivasan, Ramanujam/0000-0001-8071-6110; Robinson, Robert/0000-0001-6367-6903; Ghoshdastider, Umesh/0000-0003-4471-9394; Xue, Bo/0000-0002-5172-2519; Balasubramanian, Mohan/0000-0002-1292-8602	Agency for Science, Technology, and Research (A*STAR) of Singapore; Joint Council Office [10/03/FG/06/04]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiko Research Foundation; Grants-in-Aid for Scientific Research [20227008] Funding Source: KAKEN	Agency for Science, Technology, and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Joint Council Office; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiko Research Foundation(Daiko Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Agency for Science, Technology, and Research (A*STAR) of Singapore (to D. P., L. J. L., B. X., and R. C. R.); Joint Council Office Grant Project 10/03/FG/06/04 (to D. P. and R. C. R.); and a grant-in-aid for scientific research and a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Daiko Research Foundation (to A. N.).	Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; MANDELKOW EM, 1992, CELL MOTIL CYTOSKEL, V22, P235, DOI 10.1002/cm.970220403; MELKI R, 1988, EMBO J, V7, P2653, DOI 10.1002/j.1460-2075.1988.tb03118.x; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Oosawa F., 1975, THERMODYNAMICS POLYM; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Popp D, 2011, MOL MICROBIOL, V80, P300, DOI 10.1111/j.1365-2958.2011.07599.x; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Popp D, 2010, J MOL BIOL, V397, P1031, DOI 10.1016/j.jmb.2010.02.010; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Popp D, 2010, BIOCHEM BIOPH RES CO, V391, P1598, DOI 10.1016/j.bbrc.2009.12.078; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; STEWART M, 1988, J ELECTRON MICR TECH, V9, P325, DOI 10.1002/jemt.1060090404; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Zhao FQ, 2003, J STRUCT BIOL, V141, P43, DOI 10.1016/S1047-8477(02)00546-4	37	23	23	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21121	21129		10.1074/jbc.M112.341016	http://dx.doi.org/10.1074/jbc.M112.341016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22514279	hybrid, Green Published			2022-12-28	WOS:000306416800033
J	Ashpole, NM; Herren, AW; Ginsburg, KS; Brogan, JD; Johnson, DE; Cummins, TR; Bers, DM; Hudmon, A				Ashpole, Nicole M.; Herren, Anthony W.; Ginsburg, Kenneth S.; Brogan, Joseph D.; Johnson, Derrick E.; Cummins, Theodore R.; Bers, Donald M.; Hudmon, Andy			Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Regulates Cardiac Sodium Channel Na(V)1.5 Gating by Multiple Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; SPOT SYNTHESIS; EF-HAND; MODULATION; CALCIUM; CALMODULIN; CA2+; ISOFORM; BETA-1-SUBUNIT; HYPERTROPHY	The cardiac Na+ channel Na(V)1.5 current (I-Na) is critical to cardiac excitability, and altered I-Na gating has been implicated in genetic and acquired arrhythmias. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is up-regulated in heart failure and has been shown to cause I-Na gating changes that mimic those induced by a point mutation in humans that is associated with combined long QT and Brugada syndromes. We sought to identify the site(s) on Na(V)1.5 that mediate(s) the CaMKII-induced alterations in I-Na gating. We analyzed both CaMKII binding and CaMKII-dependent phosphorylation of the intracellularly accessible regions of Na(V)1.5 using a series of GST fusion constructs, immobilized peptide arrays, and soluble peptides. A stable interaction between delta(C)-CaMKII and the intracellular loop between domains 1 and 2 of Na(V)1.5 was observed. This region was also phosphorylated by delta(C)-CaMKII, specifically at the Ser-516 and Thr-594 sites. Wild-type (WT) and phospho-mutant hNa(V)1.5 were co-expressed with GFP-delta(C)-CaMKII in HEK293 cells, and I-Na was recorded. As observed in myocytes, CaMKII shifted WT I-Na availability to a more negative membrane potential and enhanced accumulation of I-Na into an intermediate inactivated state, but these effects were abolished by mutating either of these sites to non-phosphorylatable Ala residues. Mutation of these sites to phosphomimetic Glu residues negatively shifted I-Na availability without the need for CaMKII. CaMKII-dependent phosphorylation of Na(V)1.5 at multiple sites (including Thr-594 and Ser-516) appears to be required to evoke loss-of-function changes in gating that could contribute to acquired Brugada syndrome-like effects in heart failure.	[Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Sch Med, Davis, CA 95616 USA; [Hudmon, Andy] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	University of California System; University of California Davis; Indiana University System; Indiana University Bloomington	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Sch Med, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu; ahudmon@iupui.edu		Bers, Donald/0000-0002-2237-9483	National Institutes of Health [NS053422, P01-HL080101, R37HL30077]; American Heart Association [0930064N]; Ralph W. and Grace M. Showalter foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105242, R37HL030077, P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ralph W. and Grace M. Showalter foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS053422 (to T. R. C.), P01-HL080101 (to D. M. B.), and R37HL30077 (to D. M. B.). This work was also supported by American Heart Association National Scientist Development Grant 0930064N (to A. H.) and a grant from the Ralph W. and Grace M. Showalter foundation (to A. H.).	Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Aiba T, 2010, CARDIOVASC RES, V85, P454, DOI 10.1093/cvr/cvp324; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2007, J MOL MED-JMM, V85, P5, DOI 10.1007/s00109-006-0125-6; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Ko SH, 2005, PFLUG ARCH EUR J PHY, V449, P403, DOI 10.1007/s00424-004-1348-4; Maier LS, 2011, HEART RHYTHM, V8, P474, DOI 10.1016/j.hrthm.2010.09.080; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; Maltsev VA, 2009, J PHYSIOL SCI, V59, P217, DOI 10.1007/s12576-009-0029-7; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Mishra S, 2011, AM J PHYSIOL-HEART C, V301, pH1596, DOI 10.1152/ajpheart.00948.2009; Mori M, 2003, BIOCHEM BIOPH RES CO, V307, P290, DOI 10.1016/S0006-291X(03)01183-5; Naffin JL, 2003, CHEM BIOL, V10, P251, DOI 10.1016/S1074-5521(03)00049-8; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Yoon JY, 2009, J MOL CELL CARDIOL, V47, P475, DOI 10.1016/j.yjmcc.2009.06.020; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	50	117	121	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19856	19869		10.1074/jbc.M111.322537	http://dx.doi.org/10.1074/jbc.M111.322537			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22514276	hybrid, Green Published			2022-12-28	WOS:000306414500008
J	Boncompagni, S; Moussa, CEH; Levy, E; Pezone, MJ; Lopez, JR; Protasi, F; Shtifman, A				Boncompagni, Simona; Moussa, Charbel E. -H.; Levy, Ezra; Pezone, Matthew J.; Lopez, Jose R.; Protasi, Feliciano; Shtifman, Alexander			Mitochondrial Dysfunction in Skeletal Muscle of Amyloid Precursor Protein-overexpressing Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM STRESS; BETA-PEPTIDE; CA2+; ABNORMALITIES; APP; ACCUMULATION; BIOPSIES; INCREASE; CALCIUM	Inclusion body myositis, the most common muscle disorder in the elderly, is partly characterized by abnormal expression of amyloid precursor protein (APP) and intracellular accumulation of its proteolytic fragments collectively known as beta-amyloid. The present study examined the effects of beta-amyloid accumulation on mitochondrial structure and function of skeletal muscle from transgenic mice (MCK-beta APP) engineered to accumulate intramyofiber beta-amyloid. Electron microscopic analysis revealed that a large fraction of myofibers from 2-3-month-old MCK-beta APP mice contained numerous, heterogeneous alterations in mitochondria, and other cellular organelles. [H-1-decoupled] C-13 NMR spectroscopy showed a substantial reduction in TCA cycle activity and indicated a switch from aerobic to anaerobic glucose metabolism in the MCK-beta APP muscle. Isolated muscle fibers from the MCK-beta APP mice also exhibited a reduction in cytoplasmic pH, an increased rate of ROS production, and a partially depolarized plasmalemma. Treatment of MCK-beta APP muscle cells with Ru360, a mitochondrial Ca2+ uniporter antagonist, reversed alterations in the plasmalemmal membrane potential (V-m) and pH. Consistent with altered redox state of the cells, treatment of MCK-beta APP muscle cells with glutathione reversed the effects of beta-amyloid accumulation on Ca2+ transient amplitudes. We conclude that structural and functional alterations in mitochondria precede the reported appearance of histopathological and clinical features in the MCK-beta APP mice and may represent key early events in the pathogenesis of inclusion body myositis.	[Levy, Ezra; Pezone, Matthew J.; Shtifman, Alexander] Tufts Univ, Dept Neurol, Steward St Elizabeths Med Ctr, Sch Med, Boston, MA 02135 USA; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, CeSI Ctr Sci Invecchiamento, I-66100 Chieti, Italy; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, DNI Dept Neurosci & Imaging, I-66100 Chieti, Italy; [Moussa, Charbel E. -H.] Georgetown Univ, Sch Med, Dept Neurosci, Dept Biochem & Mol & Cell Biol, Washington, DC 20057 USA; [Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA	St. Elizabeth's Medical Center; Tufts University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Georgetown University; Harvard University; Brigham & Women's Hospital	Shtifman, A (corresponding author), Tufts Univ, Dept Neurol, Steward St Elizabeths Med Ctr, Sch Med, 736 Cambridge St,CBR-406, Boston, MA 02135 USA.	alex.shtifman@steward.org			National Institutes of Health [K01-AR053114, R03-AR054519, AG30378]; Italian Telethon ONLUS Foundation [GGP08153]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054519, K01AR053114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon ONLUS Foundation(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K01-AR053114 and R03-AR054519 (to A. S.) and AG30378 (to C. M.). This work was also supported by Research Grant GGP08153 from the Italian Telethon ONLUS Foundation (to F. P.).	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; ASKANAS V, 1991, NEUROSCI LETT, V130, P73, DOI 10.1016/0304-3940(91)90230-Q; ASKANAS V, 1992, AM J PATHOL, V141, P31; Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314; ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408; Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012; ASKANAS V, 1994, AM J PATHOL, V144, P177; Askanas V., 1998, INCLUSION BODY MYOSI; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Casley CS, 2002, NEUROBIOL DIS, V10, P258, DOI 10.1006/nbdi.2002.0516; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chung MJ, 2002, ULTRASTRUCT PATHOL, V26, P3, DOI 10.1080/01913120252934260; DENTON RM, 1986, CELL CALCIUM, V7, P377, DOI 10.1016/0143-4160(86)90040-0; DENTON RM, 1985, NATURE, V315, P635, DOI 10.1038/315635a0; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Fidzianska A, 2006, ACTA NEUROPATHOL, V112, P185, DOI 10.1007/s00401-006-0079-3; Grant SM, 1999, NEUROREPORT, V10, P41, DOI 10.1097/00001756-199901180-00008; Hong WK, 2007, NEUROCHEM RES, V32, P1483, DOI 10.1007/s11064-007-9336-7; Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Khalifat N, 2012, J ALZHEIMERS DIS, V28, P33, DOI 10.3233/JAD-2011-110389; Kim S, 2011, MOL CELLS, V32, P289, DOI 10.1007/s10059-011-0075-x; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Lopez JR, 2010, MUSCLE NERVE, V42, P731, DOI 10.1002/mus.21745; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Nogalska A, 2010, ACTA NEUROPATHOL, V120, P661, DOI 10.1007/s00401-010-0737-3; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d; Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Scragg JL, 2004, FASEB J, V18, P150, DOI 10.1096/fj.04-2659fje; Shtifman A, 2010, NEUROBIOL AGING, V31, P2080, DOI 10.1016/j.neurobiolaging.2008.11.003; Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011; Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599; Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Wolosker H, 1997, BIOCHEM J, V321, P545, DOI 10.1042/bj3210545; YUNIS EJ, 1971, LAB INVEST, V25, P240; Zissimopoulos S, 2006, BIOCHEM SOC T, V34, P919, DOI 10.1042/BST0340919; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	48	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20534	20544		10.1074/jbc.M112.359588	http://dx.doi.org/10.1074/jbc.M112.359588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518836	Green Published, hybrid			2022-12-28	WOS:000306414500074
J	Garcia-Manyes, S; Badilla, CL; Alegre-Cebollada, J; Javadi, Y; Fernandez, JM				Garcia-Manyes, Sergi; Badilla, Carmen L.; Alegre-Cebollada, Jorge; Javadi, Yalda; Fernandez, Julio M.			Spontaneous Dimerization of Titin Protein Z1Z2 Domains Induces Strong Nanomechanical Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASSICAL CADHERINS; ADHESIVE BINDING; SINGLE-PROTEIN; CELL-ADHESION; Z-DISK; MUSCLE; ELASTICITY; SARCOMERE; COMPLEX; TELETHONIN	Muscle elasticity strongly relies on the mechanical anchoring of the giant protein titin to both the sarcomere M-band and the Z-disk. Such strong attachment ensures the reversible dynamics of the stretching-relaxing cycles determining the muscle passive elasticity. Similarly, the design of biomaterials with enhanced elastic function requires experimental strategies able to secure the constituent molecules to avoid mechanical failure. Here we show that an engineered titin-mimicking protein is able to spontaneously dimerize in solution. Our observations reveal that the titin Z1Z2 domains are key to induce dimerization over a long-range distance in proteins that would otherwise remain in their monomeric form. Using single molecule force spectroscopy, we measure the threshold force that triggers the noncovalent transition from protein dimer to monomer, occurring at similar to 700 piconewtons. Such extremely high mechanical stability is likely to be a natural protective mechanism that guarantees muscle integrity. We propose a simple molecular model to understand the force-induced dimer-to-monomer transition based on the geometric distribution of forces occurring within a dimeric protein under mechanical tension.	[Garcia-Manyes, Sergi] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Garcia-Manyes, Sergi] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Garcia-Manyes, Sergi; Badilla, Carmen L.; Alegre-Cebollada, Jorge; Javadi, Yalda; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of London; King's College London; University of London; King's College London; Columbia University	Garcia-Manyes, S (corresponding author), Kings Coll London, Dept Phys, London WC2R 2LS, England.	sergi.garcia-manyes@kcl.ac.uk; jfernandez@columbia.edu	Alegre-Cebollada, Jorge/I-4301-2014	Alegre-Cebollada, Jorge/0000-0003-0542-0170; Garcia-Manyes, Sergi/0000-0001-5140-2606	Fundacion IberCaja; Fundacion Mart Martin Escudero; National Institute of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	Fundacion IberCaja; Fundacion Mart Martin Escudero; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fundacion IberCaja (to S. G. M. and J. A. C.), by the Fundacion Mart Martin Escudero (J. A. C.), and by National Institute of Health Grants HL66030 and HL61228 (to J. M. F.).	Bertz M, 2009, P NATL ACAD SCI USA, V106, P13307, DOI 10.1073/pnas.0902312106; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, NAT NANOTECHNOL, V3, P512, DOI 10.1038/nnano.2008.168; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Hagel L., 2001, CURR PROTOC PROTEIN; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kellermayer MSZ, 2003, BBA-BIOENERGETICS, V1604, P105, DOI 10.1016/S0005-2728(03)00029-X; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009; Markert CD, 2010, HUM MOL GENET, V19, P2268, DOI 10.1093/hmg/ddq105; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sarkar A, 2007, BIOPHYS J, V92, pL36, DOI 10.1529/biophysj.106.097741; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Voelkel T, 2011, PFLUG ARCH EUR J PHY, V462, P143, DOI 10.1007/s00424-011-0938-1; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	42	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20240	20247		10.1074/jbc.M112.355883	http://dx.doi.org/10.1074/jbc.M112.355883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523089	hybrid, Green Published			2022-12-28	WOS:000306414500044
J	Schmid, M; Lehmann, MJ; Lucius, R; Gupta, N				Schmid, Manuela; Lehmann, Maik J.; Lucius, Richard; Gupta, Nishith			Apicomplexan Parasite, Eimeria falciformis, Co-opts Host Tryptophan Catabolism for Life Cycle Progression in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL PROLIFERATION; NITRIC-OXIDE SYNTHASE; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; INTERFERON-GAMMA; IFN-GAMMA; KYNURENINE PATHWAY; TOXOPLASMA-GONDII; INTRACELLULAR CHLAMYDIA; EPITHELIAL-CELLS	The obligate intracellular apicomplexan parasites, e.g. Toxoplasma gondii and Plasmodium species, induce an IFN gamma-driven induction of host indoleamine 2,3-dioxygenase (IDO), the first and rate-limiting enzyme of tryptophan catabolism in the kynurenine pathway. Induction of IDO1 supposedly depletes cellular levels of tryptophan in host cells, which is proposed to inhibit the in vitro growth of auxotrophic pathogens. In vivo function of IDO during infections, however, is not clear, let alone controversial. We show that Eimeria falciformis, an apicomplexan parasite infecting the mouse caecum, induces IDO1 in the epithelial cells of the organ, and the enzyme expression coincides with the parasite development. The absence or inhibition of IDO1/2 and of two downstream enzymes in infected animals is detrimental to the Eimeria growth. The reduced parasite yield is not due to a lack of an immunosuppressive effect of IDO1 in the parasitized IDO1(-/-) or inhibitor-treated mice because they did not show an accentuated Th1 and IFN gamma response. Noticeably, the parasite development is entirely rescued by xanthurenic acid, a by-product of tryptophan catabolism inducing exflagellation in male gametes of Plasmodium in the mosquito mid-gut. Our data demonstrate a conceptual subversion of the host defense (IFN gamma, IDO) by an intracellular pathogen for progression of its natural life cycle. Besides, we show utility of E. falciformis, a monoxenous parasite of a well appreciated host, i.e. mouse, to identify in vivo factors underlying the parasite-host interactions.	[Schmid, Manuela; Lehmann, Maik J.; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany	Humboldt University of Berlin	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	Helmholtz Foundation; German Research Foundation	Helmholtz Foundation(Helmholtz Association); German Research Foundation(German Research Foundation (DFG))	This work was supported by fellowship and research grants from the Helmholtz Foundation to MS and from German Research Foundation (to N. G. and R. L.).	Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; Adams O, 2004, MICROBES INFECT, V6, P806, DOI 10.1016/j.micinf.2004.04.007; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Bell LV, 2011, PARASITE IMMUNOL, V33, P244, DOI 10.1111/j.1365-3024.2010.01272.x; Belli SI, 2009, INT J PARASITOL, V39, P1063, DOI 10.1016/j.ijpara.2009.05.004; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bodaghi B, 1999, J IMMUNOL, V162, P957; Bozza S, 2005, J IMMUNOL, V174, P2910, DOI 10.4049/jimmunol.174.5.2910; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CARLIN JM, 1989, EXPERIENTIA, V45, P535, DOI 10.1007/BF01990503; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujigaki S, 2002, INFECT IMMUN, V70, P779, DOI 10.1128/IAI.70.2.779-786.2002; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; MacKenzie CR, 1999, J MED MICROBIOL, V48, P935, DOI 10.1099/00222615-48-10-935; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Miu J, 2009, INT J PARASITOL, V39, P363, DOI 10.1016/j.ijpara.2008.10.005; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Knubel CP, 2010, FASEB J, V24, P2689, DOI 10.1096/fj.09-150920; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; ROSE ME, 1992, PARASITOLOGY, V105, P349, DOI 10.1017/S0031182000074515; ROSE ME, 1991, PARASITE IMMUNOL, V13, P63, DOI 10.1111/j.1365-3024.1991.tb00263.x; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; SCHMATZ DM, 1984, J PROTOZOOL, V31, P181, DOI 10.1111/j.1550-7408.1984.tb04314.x; SHI YF, 1989, INFECT IMMUN, V57, P146, DOI 10.1128/IAI.57.1.146-151.1989; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Silva NM, 2002, INFECT IMMUN, V70, P859, DOI 10.1128/IAI.70.2.859-868.2002; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; STOCKDALE PGH, 1985, INT J PARASITOL, V15, P447, DOI 10.1016/0020-7519(85)90032-3; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; THOMAS SM, 1993, J IMMUNOL, V150, P5529; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; YOSHIDA R, 1980, ARCH BIOCHEM BIOPHYS, V203, P343, DOI 10.1016/0003-9861(80)90185-X; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x	50	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20197	20207		10.1074/jbc.M112.351999	http://dx.doi.org/10.1074/jbc.M112.351999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535959	hybrid, Green Published			2022-12-28	WOS:000306414500040
J	Speretta, E; Jahn, TR; Tartaglia, GG; Favrin, G; Barros, TP; Imarisio, S; Lomas, DA; Luheshi, LM; Crowther, DC; Dobson, CM				Speretta, Elena; Jahn, Thomas R.; Tartaglia, Gian Gaetano; Favrin, Giorgio; Barros, Teresa P.; Imarisio, Sara; Lomas, David A.; Luheshi, Leila M.; Crowther, Damian C.; Dobson, Christopher M.			Expression in Drosophila of Tandem Amyloid beta Peptides Provides Insights into Links between Aggregation and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; PROTEIN A-BETA; FIBRIL FORMATION; A-BETA-40; EVOLUTION; OLIGOMERS; PATHWAYS; MEMORY; FORMS; MODEL	The generation and subsequent aggregation of amyloid beta (A beta) peptides play a crucial initiating role in the pathogenesis of Alzheimer disease (AD). The two main isoforms of these peptides have 40 (A beta(40)) or 42 residues (A beta(42)), the latter having a higher propensity to aggregate in vitro and being the main component of the plaques observed in vivo in AD patients. We have designed a series of tandem dimeric constructs of these A beta peptides to probe the manner in which changes in the aggregation kinetics of A beta affect its deposition and toxicity in a Drosophila melanogaster model system. The levels of insoluble aggregates were found to be substantially elevated in flies expressing the tandem constructs of both A beta(40) and A beta(42) compared with the equivalent monomeric peptides, consistent with the higher effective concentration, and hence increased aggregation rate, of the peptides in the tandem repeat. A unique feature of the A beta(42) constructs, however, is the appearance of highlevels of soluble oligomeric aggregates and a corresponding dramatic increase in their in vivo toxicity. The toxic nature of the A beta(42) peptide in vivo can therefore be attributed to the higher kinetic stability of the oligomeric intermediate states that it populates relative to those of A beta(40) rather than simply to its higher rate of aggregation.	[Speretta, Elena; Jahn, Thomas R.; Tartaglia, Gian Gaetano; Barros, Teresa P.; Luheshi, Leila M.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Speretta, Elena; Jahn, Thomas R.; Barros, Teresa P.; Imarisio, Sara; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Favrin, Giorgio] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Lomas, David A.; Crowther, Damian C.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Luheshi, LM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	lml25@cam.ac.uk; dcc26@cam.ac.uk; cmd44@cam.ac.uk	Barros, Teresa/F-7706-2013; Jahn, Thomas/F-8134-2013; Tartaglia, Gian Gaetano/K-1229-2014	Barros, Teresa/0000-0003-4889-1597; Favrin, Giorgio/0000-0002-1884-7352; Jahn, Thomas/0000-0002-9266-6736; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Speretta, Elena/0000-0003-1506-7438	Medical Research Council; Engineering and Physical Sciences Research Council [G0700990]; Wellcome Trust; MRC [G0901786, MC_G1000734, G0700990] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2] Funding Source: researchfish; Medical Research Council [G0901786, MC_G1000734, G0700990] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a combined grant from the Medical Research Council and Engineering and Physical Sciences Research Council G0700990.; Supported by the Wellcome Trust.	Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Green C, 2000, GENETICS, V156, P1117; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jahn TR, 2011, J NEUROSCI METH, V197, P186, DOI 10.1016/j.jneumeth.2011.01.026; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x	29	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20748	20754		10.1074/jbc.M112.350124	http://dx.doi.org/10.1074/jbc.M112.350124			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22461632	Green Published, hybrid			2022-12-28	WOS:000306414500093
J	Zhang, QH; Yu, DH; Seo, SJ; Stone, EM; Sheffield, VC				Zhang, Qihong; Yu, Dahai; Seo, Seongjin; Stone, Edwin M.; Sheffield, Val C.			Intrinsic Protein-Protein Interaction-mediated and Chaperonin-assisted Sequential Assembly of Stable Bardet-Biedl Syndrome Protein Complex, the BBSome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; COUPLED-RECEPTORS; 20S PROTEASOME; MOUSE MODEL; GENE; OBESITY; CILIA; TRANSPORT; TRIM32; IDENTIFICATION	The pleiotropic features of obesity, retinal degeneration, polydactyly, kidney abnormalities, cognitive impairment, hypertension, and diabetes found in Bardet-Biedl syndrome (BBS) make this disorder an important model disorder for identifying molecular mechanisms involved in common human diseases. To date, 16 BBS genes have been reported, seven of which (BBS1, 2, 4, 5, 7, 8, and 9) code for proteins that form a complex known as the BBSome. The function of the BBSome involves ciliary membrane biogenesis. Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a complex termed the BBS-chaperonin complex. This complex is required for BBSome assembly. Little is known about the process and the regulation of BBSome formation. We utilized point mutations and null alleles of BBS proteins to disrupt assembly of the BBSome leading to the accumulation of BBSome assembly intermediates. By characterizing BBSome assembly intermediates, we show that the BBS-chaperonin complex plays a role in BBS7 stability. BBS7 interacts with BBS2 and becomes part of a BBS7-BBS2-BBS9 assembly intermediate referred to as the BBSome core complex because it forms the core of the BBSome. BBS1, BBS5, BBS8, and finally BBS4 are added to the BBSome core to form the complete BBSome.	[Zhang, Qihong; Yu, Dahai; Seo, Seongjin; Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; [Stone, Edwin M.] Univ Iowa, Howard Hughes Med Inst, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Yu, Dahai] China Med Univ, Key Lab Med Cell Biol, Res Ctr Med Genom, Shenyang 110001, Peoples R China	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; China Medical University	Sheffield, VC (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, 4181 MERF, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Seo, Seongjin/0000-0002-7908-3210	National Institutes of Health [R01EY110298, R01EY017168]; NATIONAL EYE INSTITUTE [R01EY017168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY110298 and R01EY017168 (to V.C.S).	Benzinou M, 2006, DIABETES, V55, P2876, DOI 10.2337/db06-0337; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Beyer AM, 2010, AM J PHYSIOL-HEART C, V299, pH1902, DOI 10.1152/ajpheart.00336.2010; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deveault C, 2011, HUM MUTAT, V32, P610, DOI 10.1002/humu.21480; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Feuillan PP, 2011, J CLIN ENDOCR METAB, V96, pE528, DOI 10.1210/jc.2010-2290; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Putoux A, 2012, PEDIATR NEPHROL, V27, P7, DOI 10.1007/s00467-010-1751-3; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Slavotinek AM, 2002, HUM GENET, V110, P561, DOI 10.1007/s00439-002-0733-3; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	39	116	118	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20625	20635		10.1074/jbc.M112.341487	http://dx.doi.org/10.1074/jbc.M112.341487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500027	hybrid, Green Published			2022-12-28	WOS:000306414500082
J	Knyazhitsky, M; Moas, E; Shaginov, E; Luria, A; Braiman, A				Knyazhitsky, Mira; Moas, Etay; Shaginov, Ekaterina; Luria, Anna; Braiman, Alex			Vav1 Oncogenic Mutation Inhibits T Cell Receptor-induced Calcium Mobilization through Inhibition of Phospholipase C gamma 1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ANTIGEN RECEPTOR; INOSITOL 1,4,5-TRISPHOSPHATE; ACTIN CYTOSKELETON; IMMUNOLOGICAL SYNAPSE; FAMILY PROTEINS; HOMOLOGY DOMAIN; LIVING CELLS; MICROCLUSTERS; SIGNALS	Robust elevation of the cytosolic calcium concentration is a crucial early step for T cell activation triggered by the T cell antigen receptor. Vav1 is a proto-oncogene expressed in hematopoietic cells that is indispensable for transducing the calcium-mobilizing signal. Following T cell receptor stimulation, Vav1 facilitates formation of signaling microclusters through multiple interactions with other proteins participating in the signaling cascade. Truncation of the N terminus of Vav1 produces its oncogenic version, which is unable to support normal calcium flux following T cell activation. We show here that truncation of the N-terminal region of Vav1 alters the fine structure of protein complexes in the signaling clusters, affecting the interaction of Vav1 with phospholipase C gamma 1 (PLC gamma 1). This alteration is accompanied by a decrease in PLC gamma 1 phosphorylation and inhibition of inositol 1,4,5-trisphosphate production. We suggest that the structural integrity of the N-terminal region of Vav1 is important for the proper formation of the Vav1-associated signaling complexes. The oncogenic truncation of this region elicits conformational changes that interfere with the Vav1-mediated activation of PLC gamma 1 and that inhibit calcium mobilization.	[Knyazhitsky, Mira; Moas, Etay; Shaginov, Ekaterina; Luria, Anna; Braiman, Alex] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Braiman, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	braiman@bgu.ac.il	Braiman, Alex/F-2179-2012; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Braiman, Alex/0000-0003-2802-1148	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israeli Science Foundation.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3121pe16; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Groysman M, 2000, FEBS LETT, V467, P75, DOI 10.1016/S0014-5793(00)01121-2; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hobert O, 1996, MOL CELL BIOL, V16, P3066; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Miletic AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006599; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Perez-Villar JJ, 2002, BIOCHEMISTRY-US, V41, P10732, DOI 10.1021/bi025554o; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Randriamampita C, 2004, BIOL CELL, V96, P69, DOI 10.1016/j.biolcel.2003.10.008; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Simeoni L, 2005, SEMIN IMMUNOL, V17, P35, DOI 10.1016/j.smim.2004.09.002; Sylvain NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001178; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WU J, 1995, MOL CELL BIOL, V15, P4337; Yabana N, 2002, ONCOGENE, V21, P7720, DOI 10.1038/sj.onc.1205927; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zacharias D. A., 2002, SCI STKE, V2002, ppe23; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	54	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19725	19735		10.1074/jbc.M111.309799	http://dx.doi.org/10.1074/jbc.M111.309799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22474331	Green Published, hybrid			2022-12-28	WOS:000306411900082
J	Sanz-Salvador, L; Andres-Borderia, A; Ferrer-Montiel, A; Planells-Cases, R				Sanz-Salvador, Lucia; Andres-Borderia, Amparo; Ferrer-Montiel, Antonio; Planells-Cases, Rosa			Agonist- and Ca2+-dependent Desensitization of TRPV1 Channel Targets the Receptor to Lysosomes for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CLATHRIN-INDEPENDENT ENDOCYTOSIS; VANILLOID RECEPTOR; PLASMA-MEMBRANE; CAPSAICIN; PATHWAY; PHOSPHORYLATION; TRAFFICKING; NEURONS; CELLS	TRPV1 receptor agonists such as the vanilloid capsaicin and the potent analog resiniferatoxin are well known potent analgesics. Depending on the vanilloid, dose, and administration site, nociceptor refractoriness may last from minutes up to months, suggesting the contribution of different cellular mechanisms ranging from channel receptor desensitization to Ca2+ cytotoxicity of TRPV1-expressing neurons. The molecular mechanisms underlying agonist-induced TRPV1 desensitization and/or tachyphylaxis are still incompletely understood. Here, we report that prolonged exposure of TRPV1 to agonists induces rapid receptor endocytosis and lysosomal degradation in both sensory neurons and recombinant systems. Agonist-induced receptor internalization followed a clathrin- and dynamin-independent endocytic route, triggered by TRPV1 channel activation and Ca2+ influx through the receptor. This process appears strongly modulated by PKA-dependent phosphorylation. Taken together, these findings indicate that TRPV1 agonists induce long-term receptor down-regulation by modulating the expression level of the channel through a mechanism that promotes receptor endocytosis and degradation and lend support to the notion that cAMP signaling sensitizes nociceptors through several mechanisms.	[Sanz-Salvador, Lucia; Andres-Borderia, Amparo; Planells-Cases, Rosa] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Ferrer-Montiel, Antonio] Univ Miguel Hernandez Elche, Inst Biol Mol & Celular, Elche 03202, Spain	Prince Felipe Research Center; Universidad Miguel Hernandez de Elche	Planells-Cases, R (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Alicante 03202, Spain.	rosamplanells@gmail.com	Ferrer-Montiel, Antonio/C-3072-2015; Borderia, Amparo Andres/AAH-6525-2021	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Borderia, Amparo Andres/0000-0003-2864-5444	Spanish Ministry of Science and Innovation [SAF2007-63193, SAF2010-17045, BFU2009-08346, PROMETEO/2010/046]; Consolider-Ingenio [CSD2008-00005]; Formacion del Profesorado Universitario (FPU) (Spanish Education Ministry)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Formacion del Profesorado Universitario (FPU) (Spanish Education Ministry)(German Research Foundation (DFG))	This work was supported by Spanish Ministry of Science and Innovation Grants SAF2007-63193 and SAF2010-17045 (to R. P. C.), BFU2009-08346 and PROMETEO/2010/046 (to A. F. M.), and Consolider-Ingenio 2010 CSD2008-00005 (to R. P. C. and A. F. M.).; Supported by an Formacion del Profesorado Universitario (FPU) Fellowship (Spanish Education Ministry).	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Chaudhury S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-34; Cinar H, 2001, BIOCHEMISTRY-US, V40, P14030, DOI 10.1021/bi011025t; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Planells-Cases R, 2011, ADV EXP MED BIOL, V704, P491, DOI 10.1007/978-94-007-0265-3_27; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roseberry AG, 2001, J CELL SCI, V114, P739; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	44	91	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19462	19471		10.1074/jbc.M111.289751	http://dx.doi.org/10.1074/jbc.M111.289751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493457	Green Published, hybrid			2022-12-28	WOS:000306411900060
J	Guturi, KKN; Mandal, T; Chatterjee, A; Sarkar, M; Bhattacharya, S; Chatterjee, U; Ghosh, MK				Guturi, Kiran Kumar Naidu; Mandal, Tapashi; Chatterjee, Anirban; Sarkar, Moumita; Bhattacharya, Seemana; Chatterjee, Uttara; Ghosh, Mrinal K.			Mechanism of beta-Catenin-mediated Transcriptional Regulation of Epidermal Growth Factor Receptor Expression in Glycogen Synthase Kinase 3 beta-inactivated Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDEPENDENCE; ABERRANT EXPRESSION; PROTEIN-KINASE; COLON-CANCER; PATHWAY; PHOSPHORYLATION; ACTIVATION; MUTATIONS; TARGET; GENE	Wnt/beta-catenin and EGFR pathways are important in cancer development and often aberrantly activated in human cancer. However, it is very important to understand the mechanism responsible for this activation and the relation between them. Here, we report the mechanism of EGFR expression by transcriptionally active beta-catenin in GSK3 beta-inactivated prostate cancer cells that eventually leads to its enhanced proliferation and survival. Expressions of beta-catenin and EGFR are elevated in various cancers specifically in prostate cancer cells, DU145. When GSK3 beta is inactivated in these cells, beta-catenin gets stabilized, phosphorylated at Ser-552 by protein kinase A, accumulates in the nucleus, and regulates the expression of its target genes that include EGFR. Chromatin immunoprecipitation (ChIP) and promoter analysis revealed that the EGFR promoter gets occupied by transcriptionally active beta-catenin when elevated in GSK3 beta-inactivated cells. This phenomenon not only leads to increased expression of EGFR but also initiates the activation of its downstream molecules such as ERK1/2 and Stat3, ultimately resulting in up-regulation of multiple genes involved in cell proliferation and survival.	[Guturi, Kiran Kumar Naidu; Mandal, Tapashi; Chatterjee, Anirban; Sarkar, Moumita; Bhattacharya, Seemana; Ghosh, Mrinal K.] Indian Inst Chem Biol, Council Sci & Ind Res, Signal Transduct Canc & Stem Cells Lab, Kolkata 700032, W Bengal, India; [Chatterjee, Uttara] Inst Postgrad Med Educ & Res Hosp, Kolkata, India; [Chatterjee, Uttara] Inst Postgrad Med Educ & Res, Dept Pathol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ghosh, MK (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Signal Transduct Canc & Stem Cells Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com		Chatterjee, Anirban/0000-0002-9082-2221	Department of Science Technology [SR/SO/HS-0126/2007]; Council of Scientific and Industrial Research (EMPOWER) [OLP-2]	Department of Science Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (EMPOWER)	This work was supported by grants provided by Department of Science & Technology (SR/SO/HS-0126/2007) and Council of Scientific and Industrial Research (EMPOWER: OLP-2) (to M. K. G.).	Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; CONNOLLY JM, 1991, PROSTATE, V19, P173, DOI 10.1002/pros.2990190210; Das T, 2010, MOL CELL BIOCHEM, V336, P85, DOI 10.1007/s11010-009-0269-0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Djakiew D, 2000, PROSTATE, V42, P150, DOI 10.1002/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Lorenzo Giuseppe Di, 2003, Clin Prostate Cancer, V2, P50; Lu ZM, 2004, CELL CYCLE, V3, P571; Luwor R., 2008, NATURE PRECEDIN 0123; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Musgrove EA, 2004, BREAST CANCER RES, V6, P65, DOI 10.1186/bcr737; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Saia G, 2007, CURR CANCER THER REV, V3, P25, DOI 10.2174/157339407780126647; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161	52	48	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18287	18296		10.1074/jbc.M111.324798	http://dx.doi.org/10.1074/jbc.M111.324798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493441	Green Published, hybrid			2022-12-28	WOS:000306411600035
J	Dwarakanath, S; Chaplin, AK; Hough, MA; Rigali, S; Vijgenboom, E; Worrall, JAR				Dwarakanath, Srivatsa; Chaplin, Amanda K.; Hough, Michael A.; Rigali, Sebastien; Vijgenboom, Erik; Worrall, Jonathan A. R.			Response to Copper Stress in Streptomyces lividans Extends beyond Genes under Direct Control of a Copper-sensitive Operon Repressor Protein (CsoR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; COELICOLOR A3(2); ANTIBIOTIC PRODUCTION; MOLECULAR-GRAPHICS; RNA-SEQ; METAL; SELECTIVITY; INSIGHTS	A copper-sensitive operon repressor protein (CsoR) has been identified in Streptomyces lividans (CsoR(Sl)) and found to regulate copper homeostasis with attomolar affinity for Cu(I). Solution studies reveal apo-and Cu-I-CsoR(sl) to be a tetramer assembly, and a 1.7-angstrom resolution crystal structure of apo-CsoR(Sl) reveals that a significant conformational change is necessary to enable Cu(I) binding. In silico prediction of the CsoR regulon was confirmed in vitro (EMSA) and in vivo (RNA-seq), which highlighted that next to the csoR gene itself, the regulon consists of two Cu(I) efflux systems involving a CopZ-like copper metallochaperone protein and a CopA P-1-type ATPase. Although deletion of csoR has only minor effects on S. lividans development when grown under high copper concentrations, mutations of the Cu(I) ligands decrease tolerance to copper as a result of the Cu(I)-CsoR mutants failing to disengage from the DNA targets, thus inhibiting the derepression of the regulon. RNA-seq experiments carried out on samples incubated with exogenous copper and a Delta csoR strain showed that the set of genes responding to copper stress is much wider than anticipated and largely extends beyond genes targeted by CsoR. This suggests more control levels are operating and directing other regulons in copper homeostasis beside the CsoR regulon.	[Dwarakanath, Srivatsa; Chaplin, Amanda K.; Hough, Michael A.; Worrall, Jonathan A. R.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Rigali, Sebastien] Univ Liege, Ctr Prot Engn, Inst Chim B6A, B-4000 Liege, Belgium; [Vijgenboom, Erik] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands	University of Essex; University of Liege; Leiden University; Leiden University - Excl LUMC	Worrall, JAR (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jworrall@essex.ac.uk	Hough, Michael/H-4409-2013; Johnson, Michael D. L./B-4352-2012	Vijgenboom, Erik/0000-0002-5059-069X; Hough, Michael/0000-0001-7377-6713; Rigali, Sebastien/0000-0003-4022-7325; Chaplin, Amanda/0000-0002-9606-8346	University of Essex; Biochemical Society; Leiden University; NWO	University of Essex; Biochemical Society; Leiden University; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the University of Essex (to S. D., A. K. C., M. A. H., and J. A. R. W.), The Biochemical Society (to A. K. C.), and Leiden University and NWO (to E. V.).	Andreini C, 2008, J PROTEOME RES, V7, P209, DOI 10.1021/pr070480u; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertram R, 2011, J BACTERIOL, V193, P3525, DOI 10.1128/JB.00264-11; Buttner M. J., 2000, PRACTICAL STREPTOMYC, P1; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fedoryshyn M, 2008, APPL MICROBIOL BIOT, V78, P1065, DOI 10.1007/s00253-008-1382-9; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Fujimoto M., 2011, BIOTECHNOL IN PRESS; GREEN GN, 1983, J BACTERIOL, V154, P1269, DOI 10.1128/JB.154.3.1269-1275.1983; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Hiard S, 2007, BIOCHEM BIOPH RES CO, V357, P861, DOI 10.1016/j.bbrc.2007.03.180; Jayapal KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-229; Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; Lerch K, 1972, Pathol Microbiol (Basel), V38, P23; Lewis RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-682; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOTAMEDI H, 1995, GENE, V160, P25, DOI 10.1016/0378-1119(95)00191-8; MUELLER JP, 1989, J BACTERIOL, V171, P4967, DOI 10.1128/jb.171.9.4967-4978.1989; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; Ueda K, 1997, J ANTIBIOT, V50, P693, DOI 10.7164/antibiotics.50.693; van Wezel GP, 2000, J MOL MICROB BIOTECH, V2, P551; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Vijgenboom Erik, 2002, P503; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Worrall JAR, 2010, NAT PROD REP, V27, P742, DOI 10.1039/b804465c; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2008, INORG CHEM, V47, P4338, DOI 10.1021/ic702440e; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007462	56	41	41	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17833	17847		10.1074/jbc.M112.352740	http://dx.doi.org/10.1074/jbc.M112.352740			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451651	Green Published, hybrid			2022-12-28	WOS:000306373000081
J	Lepur, A; Salomonsson, E; Nilsson, UJ; Leffler, H				Lepur, Adriana; Salomonsson, Emma; Nilsson, Ulf J.; Leffler, Hakon			Ligand Induced Galectin-3 Protein Self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; BINDING; LECTIN; VISUALIZATION; COMPLEXES; SURFACE	Many functions of galectin-3 entail binding of its carbohydrate recognition site to glycans of a glycoprotein, resulting in cross-linking thought to be mediated by its N-terminal noncarbohydrate-binding domain. Here we studied interaction of galectin-3 with the model glycoprotein asialofetuin (ASF), using a fluorescence anisotropy assay to measure the concentration of free galectin carbohydrate recognition sites in solution. Surprisingly, in the presence of ASF, this remained low even at high galectin-3 concentrations, showing that many more galectin-3 molecules were engaged than expected due to the about nine known glycan-based binding sites per ASF molecule. This suggests that after ASF-induced nucleation, galectin-3 associates with itself by the carbohydrate recognition site binding to another galectin-3 molecule, possibly forming oligomers. We named this type-C self-association to distinguish it from the previously proposed models (type-N) where galectin-3 molecules bind to each other through the N-terminal domain, and all carbohydrate recognition sites are available for binding glycans. Both types of self-association can result in precipitates, as measured here by turbidimetry and dynamic light scattering. Type-C self-association and precipitation occurred even with a galectin-3 mutant (R186S) that bound poorly to ASF but required much higher concentration (similar to 50 mu M) as compared with wild type (similar to 1 mu M). ASF also induced weaker type-C self-association of galectin-3 lacking its N-terminal domains, but as expected, no precipitation. Neither a monovalent nor a divalent N-acetyl-D-lactosamine-containing glycan induced type-C self-association, even if the latter gave precipitates with high concentrations of galectin-3 (>similar to 50 mu M) in agreement with published results and perhaps due to type-N self-association.	[Lepur, Adriana] Lund Univ, Dept Lab Med, Microbiol Immunol Glycobiol MIG Sect, S-22362 Lund, Sweden; [Nilsson, Ulf J.] Lund Univ, Ctr Anal & Synth, SE-22100 Lund, Sweden	Lund University; Lund University	Lepur, A (corresponding author), Lund Univ, Dept Lab Med, Microbiol Immunol Glycobiol MIG Sect, Solvegatan 23, S-22362 Lund, Sweden.	adrianalepur@gmail.com; hakon.leffler@med.lu.se	Nilsson, Ulf J./L-3219-2014; Leffler, Hakon/A-2416-2019	Nilsson, Ulf J./0000-0001-5815-9522; Leffler, Hakon/0000-0003-4482-8945	FP6 project "EuroPharm" [043682]; Swedish Research Council [621-2009-5656, 621-2003-4265]; Swedish Strategic Research Foundation; European Community Seventh Framework Programme [HEALTH-F2-2011-256986 (PANACREAS)]	FP6 project "EuroPharm"; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); European Community Seventh Framework Programme(European Commission)	This work was funded by the FP6 project "EuroPharm" Grant 043682 (to A. L.), the Swedish Research Council Grants 621-2009-5656 (to H. L.) and 621-2003-4265 (to U. N.), the program "Chemistry for Life Sciences" sponsored by the Swedish Strategic Research Foundation, and European Community Seventh Framework Programme (FP7-2007-2013) under Grant HEALTH-F2-2011-256986 (PANACREAS).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Barboni EAM, 1999, GLYCOCONJUGATE J, V16, P365, DOI 10.1023/A:1007004330048; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; HSU DK, 1992, J BIOL CHEM, V267, P14167; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; OOSAWA F, 1970, J THEOR BIOL, V27, P69, DOI 10.1016/0022-5193(70)90129-3; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c	25	99	107	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21751	21756		10.1074/jbc.C112.358002	http://dx.doi.org/10.1074/jbc.C112.358002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549776	hybrid, Green Published			2022-12-28	WOS:000306418600016
J	Mangeat, B; Cavagliotti, L; Lehmann, M; Gers-Huber, G; Kaur, I; Thomas, Y; Kaiser, L; Piguet, V				Mangeat, Bastien; Cavagliotti, Lorris; Lehmann, Martin; Gers-Huber, Gustavo; Kaur, Inderdeep; Thomas, Yves; Kaiser, Laurent; Piguet, Vincent			Influenza Virus Partially Counteracts Restriction Imposed by Tetherin/BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-VIRUS; NS1 PROTEIN; GENE-EXPRESSION; CELL-SURFACE; HIV-1 VPU; CYTOKINE RESPONSES; PARTICLE RELEASE; EPITHELIAL-CELLS; APICAL MEMBRANE; INHIBITS HIV-1	Influenza virus infections lead to a burst of type I interferon (IFN) in the human respiratory tract, which most probably accounts for a rapid control of the virus. Although in mice, IFN-induced Mx1 factor mediates a major part of this response, the situation is less clear in humans. Interestingly, a recently identified IFN-induced cellular protein, tetherin (also known as CD317, BST-2, or HM1.24), exerts potent antiviral activity against a broad range of retroviruses, as well as several other enveloped viruses, by impeding the release of newly generated viral particles from the cell surface. Here we show that influenza virus belongs to the targets of this potent antiviral factor. Ectopic expression of tetherin strongly inhibited fully replicative influenza virus. In addition, depleting endogenous tetherin increased viral production of influenza virions, both in cells constitutively expressing tetherin and upon its induction by IFN. We further demonstrate, by biochemical and morphological means, that tetherin exerts its antiviral action by tethering newly budded viral particles, a mechanism similar to the one that operates against HIV-1. In addition, we determined that the magnitude of tetherin antiviral activity is comparable with or higher than the one of several previously identified anti-influenza cellular factors, such as MxA, ADAR1, ISG15, and viperin. Finally, we demonstrate that influenza virus reduces the impact of tetherin-mediated restriction on its replication by several mechanisms. First, the influenza virus NS1 protein impedes IFN-mediated tetherin induction. Second, influenza infection leads to a decrease of tetherin steady state levels, and the neuraminidase surface protein partly counteracts its activity. Overall, our study helps to delineate the intricate molecular battle taking place between influenza virus and its host cells.	[Mangeat, Bastien; Piguet, Vincent] Cardiff Univ, Inst Infect & Immun, Dept Dermatol & Wound Healing, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Mangeat, Bastien; Cavagliotti, Lorris; Lehmann, Martin; Gers-Huber, Gustavo; Kaur, Inderdeep; Piguet, Vincent] Univ Geneva, Univ Hosp & Med Sch Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Thomas, Yves] Univ Geneva, Univ Hosp & Med Sch Geneva, Virol Lab, CH-1211 Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp & Med Sch Geneva, Swiss Natl Reference Ctr Influenza, CH-1211 Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp & Med Sch Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland	Cardiff University; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Piguet, V (corresponding author), Cardiff Univ, Inst Infect & Immun, Dept Dermatol & Wound Healing, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	piguetv@cardiff.ac.uk		Mangeat, Bastien/0000-0003-2592-0236; Kaiser, Laurent/0000-0002-0857-2252; Piguet, Vincent/0000-0001-6079-4517	Swiss National Science Foundation grant; Cardiff University School of Medicine	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Cardiff University School of Medicine	This work was supported by a Swiss National Science Foundation grant (to V. P.). This work was also supported by Cardiff University School of Medicine (to V. P. and B. M.).	ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CALIGUIRI LA, 1979, VIROLOGY, V92, P15, DOI 10.1016/0042-6822(79)90211-3; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Ferko B, 2004, J VIROL, V78, P13037, DOI 10.1128/JVI.78.23.13037-13045.2004; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Henkel JR, 2000, J CELL BIOL, V148, P495, DOI 10.1083/jcb.148.3.495; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; RICHMAN DD, 1976, J CLIN MICROBIOL, V3, P223; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tong HH, 2004, MICROB PATHOGENESIS, V37, P193, DOI 10.1016/j.micpath.2004.06.012; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Xu WL, 2006, J INTERF CYTOK RES, V26, P609, DOI 10.1089/jir.2006.26.609; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10	68	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22015	22029		10.1074/jbc.M111.319996	http://dx.doi.org/10.1074/jbc.M111.319996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22493439	Green Published, hybrid			2022-12-28	WOS:000306418600040
J	Shiratsuchi, A; Mori, T; Sakurai, K; Nagaosa, K; Sekimizu, K; Lee, BL; Nakanishi, Y				Shiratsuchi, Akiko; Mori, Toshinobu; Sakurai, Kenji; Nagaosa, Kaz; Sekimizu, Kazuhisa; Lee, Bok Luel; Nakanishi, Yoshinobu			Independent Recognition of Staphylococcus aureus by Two Receptors for Phagocytosis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR IMMUNE-RESPONSE; GRAM-NEGATIVE BACTERIA; APOPTOTIC CELLS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; INTEGRINS; INFECTION; IDENTIFICATION; ENGULFMENT	Integrin beta v, one of two beta subunits of Drosophila integrin, acts as a receptor in the phagocytosis of apoptotic cells. We here examined the involvement of this receptor in defense against infection by Staphylococcus aureus. Flies lacking integrin beta v died earlier than control flies upon a septic but not oral infection with this bacterium. A loss of integrin beta v reduced the phagocytosis of S. aureus and increased bacterial growth in flies. In contrast, the level of mRNA of an antimicrobial peptide produced upon infection was unchanged in integrin beta v-lacking flies. The simultaneous loss of integrin beta v and Draper, another receptor involved in the phagocytosis of S. aureus, brought about a further decrease in the level of phagocytosis and accelerated death of flies compared with the loss of either receptor alone. A strain of S. aureus lacking lipoteichoic acid, a cell wall component serving as a ligand for Draper, was susceptible to integrin beta v-mediated phagocytosis. In contrast, a S. aureus mutant strain that produces small amounts of peptidoglycan was less efficiently phagocytosed by larval hemocytes, and a loss of integrin beta v in hemocytes reduced a difference in the susceptibility to phagocytosis between parental and mutant strains. Furthermore, a series of experiments revealed the binding of integrin beta v to peptidoglycan of S. aureus. Taken together, these results suggested that Draper and integrin beta v cooperate in the phagocytic elimination of S. aureus by recognizing distinct cell wall components, and that this dual recognition system is necessary for the host organism to survive infection.	[Shiratsuchi, Akiko; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Shiratsuchi, Akiko; Mori, Toshinobu; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan; [Shiratsuchi, Akiko; Sakurai, Kenji; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Kanazawa University; Kanazawa University; Kanazawa University; University of Tokyo; Pusan National University	Shiratsuchi, A (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ashira@staff.kanazawa-u.ac.jp; nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Shiratsuchi, Akiko/D-8391-2015; Nakanishi, Yoshinobu/D-4602-2014	Nagaosa, Kaz/0000-0002-1695-2562; Shiratsuchi, Akiko/0000-0002-7811-4409; Nakanishi, Yoshinobu/0000-0002-8767-3587	Japan Society for the Promotion of Science [20570127, 23570160, 22370049]; Astellas Foundation for Research on Metabolic Disorders; Danone Foundation; Hayashi Memorial Grant for Female Scientists; Kanazawa University; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Danone Foundation(Danone Nutricia); Hayashi Memorial Grant for Female Scientists; Kanazawa University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Grant Numbers 20570127 and 23570160, to A. S.; 22370049, to Y. N.), Hayashi Memorial Grant for Female Scientists (to A. S.), a grant from Astellas Foundation for Research on Metabolic Disorders (to A. S.), a grant from Danone Foundation (to A. S.), and an institutional research grant from Kanazawa University (to A. S.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Ha H. M., 2005, SCIENCE         0609, V310, P847; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Mamali I, 2009, DEV COMP IMMUNOL, V33, P858, DOI 10.1016/j.dci.2009.02.004; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Moita LF, 2006, INSECT BIOCHEM MOLEC, V36, P282, DOI 10.1016/j.ibmb.2006.01.004; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nehme NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014743; Nishida S, 2006, J BIOL CHEM, V281, P1714, DOI 10.1074/jbc.M509277200; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xavier MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019504; Yu Y, 2010, J BIOL CHEM, V285, P32937, DOI 10.1074/jbc.M110.144014	60	48	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21663	21672		10.1074/jbc.M111.333807	http://dx.doi.org/10.1074/jbc.M111.333807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547074	hybrid, Green Published			2022-12-28	WOS:000306418600009
J	Icenogle, LM; Hengel, SM; Coye, LH; Streifel, A; Collins, CM; Goodlett, DR; Moseley, SL				Icenogle, Laura M.; Hengel, Shawna M.; Coye, Lisette H.; Streifel, Amber; Collins, Carleen M.; Goodlett, David R.; Moseley, Steve L.			Molecular and Biological Characterization of Streptococcal SpyA-mediated ADP-ribosylation of Intermediate Filament Protein Vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STRUCTURE; HUMAN NEUTROPHIL PEPTIDE-1; BOTULINUM C3 EXOENZYME; CLOSTRIDIUM-BOTULINUM; PERTUSSIS TOXIN; RIBOSYLTRANSFERASE ACTIVITY; STAPHYLOCOCCUS-AUREUS; PHOSPHORYLATION SITES; FLUOROMETRIC ASSAY; MASS-SPECTROMETRY	The Gram-positive bacterial pathogen Streptococcus pyogenes produces a C3 family ADP-ribosyltransferase designated SpyA (S. pyogenes ADP-ribosyltransferase). Our laboratory has identified a number of eukaryotic protein targets for SpyA, prominent among which are the cytoskeletal proteins actin and vimentin. Because vimentin is an unusual target for modification by bacterial ADP-ribosyltransferases, we quantitatively compared the activity of SpyA on vimentin and actin. Vimentin was the preferred substrate for SpyA (k(cat), 58.5 +/- 3.4 min(-1)) relative to actin (kcat, 10.1 +/- 0.6 min(-1)), and vimentin was modified at a rate 9.48 +/- 1.95-fold greater than actin. We employed tandem mass spectrometry analysis to identify sites of ADP-ribosylation on vimentin. The primary sites of modification were Arg-44 and -49 in the head domain, with several additional secondary sites identified. Because the primary sites are located in a domain of vimentin known to be important for the regulation of polymerization by phosphorylation, we investigated the effects of SpyA activity on vimentin polymerization, utilizing an in vitro NaCl-induced filamentation assay. SpyA inhibited vimentin filamentation, whereas a catalytic site mutant of SpyA had no effect. Additionally, we demonstrated that expression of SpyA in HeLa cells resulted in collapse of the vimentin cytoskeleton, whereas expression in RAW 264.7 cells impeded vimentin reorganization upon stimulation of this macrophage-like cell line with LPS. We conclude that SpyA modification of vimentin occurs in an important regulatory region of the head domain and has significant functional effects on vimentin assembly.	[Icenogle, Laura M.; Coye, Lisette H.; Streifel, Amber; Collins, Carleen M.; Moseley, Steve L.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hengel, Shawna M.; Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moseley, SL (corresponding author), 1705 NW Pacific St,J257, Seattle, WA 98195 USA.	Moseley@u.washington.edu			National Institutes of Health (NIH) [A1064515, 1U54 AI57141-02]; NIH Pharmacological Sciences Training [T32 GM07750]; NIGMS; National Research Service [GM07270]; University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacological Sciences Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Service; University of Washington(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants A1064515 and 1U54 AI57141-02, NIH Pharmacological Sciences Training Grant T32 GM07750, and NIH, NIGMS, National Research Service Award T32 GM07270. This work was also supported by the University of Washington Proteomics Resource.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKTORIES K, 1988, BIOCHEM BIOPH RES CO, V156, P361, DOI 10.1016/S0006-291X(88)80849-0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Benes P, 2006, DIFFERENTIATION, V74, P265, DOI 10.1111/j.1432-0436.2006.00077.x; Bohmer J, 1996, BIOCHEMISTRY-US, V35, P282, DOI 10.1021/bi951784+; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Chou YH, 1996, J CELL SCI, V109, P817; COBURN J, 1989, INFECT IMMUN, V57, P996, DOI 10.1128/IAI.57.3.996-998.1989; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Dolan KM, 2000, BIOCHEMISTRY-US, V39, P8266, DOI 10.1021/bi992856q; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; FENDRICK JL, 1989, P NATL ACAD SCI USA, V86, P554, DOI 10.1073/pnas.86.2.554; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; GEISLER N, 1989, EUR J BIOCHEM, V183, P441, DOI 10.1111/j.1432-1033.1989.tb14947.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Hengel SM, 2010, RAPID COMMUN MASS SP, V24, P2312, DOI 10.1002/rcm.4600; Hengel SM, 2009, J AM SOC MASS SPECTR, V20, P477, DOI 10.1016/j.jasms.2008.10.025; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Hoff JS, 2011, INFECT IMMUN, V79, P2404, DOI 10.1128/IAI.01191-10; Huang HY, 1996, EXP CELL RES, V226, P147, DOI 10.1006/excr.1996.0213; HUANG HY, 1993, BIOCHEM BIOPH RES CO, V197, P570, DOI 10.1006/bbrc.1993.2517; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jager D, 2011, MOL CELL BIOCHEM, V348, P125, DOI 10.1007/s11010-010-0646-8; Klebl BM, 1996, ANAL BIOCHEM, V239, P145, DOI 10.1006/abio.1996.0309; Knight DA, 1999, BIOCHEMISTRY-US, V38, P5858, DOI 10.1021/bi982133r; Lee KY, 2012, J CELL PHYSIOL, V227, P739, DOI 10.1002/jcp.22782; Liu XY, 2005, MOL VIS, V11, P1112; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Lupi R, 2002, BIOCHEM J, V367, P825, DOI 10.1042/BJ20020660; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Martin Judith M, 2006, Semin Pediatr Infect Dis, V17, P140, DOI 10.1053/j.spid.2006.07.001; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Miyaoka T, 1996, J BIOCHEM-TOKYO, V119, P200; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Perieteanu AA, 2010, BIOCHEMISTRY-US, V49, P8944, DOI 10.1021/bi1008062; Pryzwansky KB, 1998, MOL BIOL CELL, V9, P2933, DOI 10.1091/mbc.9.10.2933; Scheuring J, 1997, BIOCHEMISTRY-US, V36, P8215, DOI 10.1021/bi970379a; Scheuring J, 1998, BIOCHEMISTRY-US, V37, P2748, DOI 10.1021/bi972594x; Schietke R, 2006, EUR J CELL BIOL, V85, P1, DOI 10.1016/j.ejcb.2005.09.019; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; TSURU A, 1990, J CELL BIOL, V110, P1655, DOI 10.1083/jcb.110.5.1655; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Wilde C, 2002, TRENDS MICROBIOL, V10, P5, DOI 10.1016/S0966-842X(01)02281-8; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; WILSON BA, 1990, BIOCHEMISTRY-US, V29, P8643, DOI 10.1021/bi00489a021; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yuan J, 1999, ARCH BIOCHEM BIOPHYS, V363, P314, DOI 10.1006/abbi.1998.1096; Zhou H, 1996, ARCH BIOCHEM BIOPHYS, V334, P214, DOI 10.1006/abbi.1996.0449	83	21	22	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21481	21491		10.1074/jbc.M112.370791	http://dx.doi.org/10.1074/jbc.M112.370791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549780	Green Published, hybrid			2022-12-28	WOS:000306416800065
J	Kumar, A; Paslay, LC; Lyons, D; Morgan, SE; Correia, JJ; Rangachari, V				Kumar, Amit; Paslay, Lea C.; Lyons, Daniel; Morgan, Sarah E.; Correia, John J.; Rangachari, Vijayaraghavan			Specific Soluble Oligomers of Amyloid-beta Peptide Undergo Replication and Form Non-fibrillar Aggregates in Interfacial Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRION PROTEIN; CYCLIC AMPLIFICATION; PATHWAYS; PROTOFIBRILS; CONFORMATION; MEMORY; TRANSMISSION; ASSOCIATION; STRAINS	Aggregates of amyloid-beta (A beta) peptides have been implicated in the etiology of Alzheimer disease. Among the different forms of A beta aggregates, low molecular weight species ranging between similar to 2- and 50-mers, also called "soluble oligomers," have emerged as the species responsible for early synaptic dysfunction and neuronal loss. Emerging evidence suggests that the neurotoxic oligomers need not be formed along the obligatory nucleation-dependant fibril formation pathway. In our earlier work, we reported the isolation of one such " off-pathway" 12-18-mer species of A beta 42 generated from fatty acids called large fatty acid-derived oligomers (LFAOs) (Kumar, A., Bullard, R. L., Patel, P., Paslay, L. C., Singh, D., Bienkiewicz, E. A., Morgan, S. E., and Rangachari, V. (2011) PLoS One 6, e18759). Here, we report the physiochemical aspects of LFAO-monomer interactions as well as LFAO-LFAO associations in the presence of interfaces. We discovered that LFAOs are a replicating strain of oligomers that recruit A beta 42 monomers and quantitatively convert them into LFAO assemblies at the expense of fibrils, a mechanism similar to prion propagation. We also found that in the presence of hexane-buffer or chloroform-buffer interfaces LFAOs are able to associate with themselves to form larger but non-fibrillar aggregates. These results further support the hypothesis that low molecular weight oligomers can be generated via non-fibril formation pathways. Furthermore, the unique replicating property of off-pathway oligomers may hold profound significance for Alzheimer disease pathology.	[Kumar, Amit; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Lyons, Daniel; Correia, John J.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Southern Mississippi; University of Southern Mississippi; University of Mississippi; University of Mississippi Medical Center	Rangachari, V (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; 	National Institutes of Health; National Center for Research Resources [5P20RR016476-11]; NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence [8 P20 GM103476-11]; American Heart Association [10GRNT4190124]; National Science Foundation [1040372]; United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award [P200A090066]; Direct For Biological Sciences [0959211] Funding Source: National Science Foundation; Direct For Computer & Info Scie & Enginr [1158608] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health evident from many recent reports that there are alternative Grants 5P20RR016476-11 from the National Center for Research Resources and 8 P20 GM103476-11 from the NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence. This work was also supported by American Heart Association Grant 10GRNT4190124 (to V. R.), National Science Foundation Major Research Instrumentation Grant 1040372 (to J. C. and V. R.), and United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award P200A090066.	Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Ghosh P., 2010, P 1 ACM INT C BIOINF, P451; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020701, 10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520]; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Nichols MR, 2005, MICROSC RES TECHNIQ, V67, P164, DOI 10.1002/jemt.20189; Nichols MR, 2005, BIOCHEMISTRY-US, V44, P165, DOI 10.1021/bi048846t; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008	39	35	35	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21253	21264		10.1074/jbc.M112.355156	http://dx.doi.org/10.1074/jbc.M112.355156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544746	Green Published, hybrid			2022-12-28	WOS:000306416800045
J	McClure, JM; Wierman, MB; Maqani, N; Smith, JS				McClure, Julie M.; Wierman, Margaret B.; Maqani, Nazif; Smith, Jeffrey S.			Isonicotinamide Enhances Sir2 Protein-mediated Silencing and Longevity in Yeast by Raising Intracellular NAD(+) Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; SALVAGE PATHWAY; INSULIN-SECRETION; GENE DISRUPTION; CELL-SURVIVAL; RDNA	Sirtuins are an evolutionarily conserved family of NAD(+)-dependent protein deacetylases that function in the regulation of gene transcription, cellular metabolism, and aging. Their activity requires the maintenance of an adequate intracellular NAD(+) concentration through the combined action of NAD(+) biosynthesis and salvage pathways. Nicotinamide (NAM) is a key NAD(+) precursor that is also a byproduct and feedback inhibitor of the deacetylation reaction. In Saccharomyces cerevisiae, the nicotinamidase Pnc1 converts NAM to nicotinic acid (NA), which is then used as a substrate by the NAD(+) salvage pathway enzyme NA phosphoribosyltransferase (Npt1). Isonicotinamide (INAM) is an isostere of NAM that stimulates yeast Sir2 deacetylase activity in vitro by alleviating the NAM inhibition. In this study, we determined that INAM stimulates Sir2 through an additional mechanism in vivo, which involves elevation of the intracellular NAD(+) concentration. INAM enhanced normal silencing at the rDNA locus but only partially suppressed the silencing defects of an npt1 Delta mutant. Yeast cells grown in media lacking NA had a short replicative life span, which was extended by INAM in a SIR2-dependent manner and correlated with increased NAD(+). The INAM-induced increase in NAD(+) was strongly dependent on Pnc1 and Npt1, suggesting that INAM increases flux through the NAD(+) salvage pathway. Part of this effect was mediated by the NR salvage pathways, which generate NAM as a product and require Pnc1 to produce NAD(+). We also provide evidence suggesting that INAM influences the expression of multiple NAD(+) biosynthesis and salvage pathways to promote homeostasis during stationary phase.	[McClure, Julie M.; Wierman, Margaret B.; Maqani, Nazif; Smith, Jeffrey S.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Sch Med, Charlottesville, VA 22908 USA	University of Virginia	Smith, JS (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Sch Med, Jordan Hall,Box 800733, Charlottesville, VA 22908 USA.	jss5y@virginia.edu			National Institutes of Health [GM075240, AG022685, GM008136]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants GM075240 and AG022685 (to J. S. S.) and Training Grant GM008136 (to J. M. M.).	Sorolla MA, 2011, ARCH BIOCHEM BIOPHYS, V510, P27, DOI 10.1016/j.abb.2011.04.002; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Ausubel F. M., 2000, CURR PROTOC MOL BIOL, V2; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brachmann CB, 1998, YEAST, V14, P115; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Hickman MA, 2007, PLOS GENET, V3, P1325, DOI 10.1371/journal.pgen.0030126; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kucharczyk R, 1998, FEBS LETT, V424, P127, DOI 10.1016/S0014-5793(98)00153-7; Li Y, 2009, EUR J PHARMACOL, V609, P13, DOI 10.1016/j.ejphar.2009.03.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043; Ogata S, 2000, BIOSCI BIOTECH BIOCH, V64, P327, DOI 10.1271/bbb.64.327; PREISS J, 1958, J BIOL CHEM, V233, P488; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RINE J, 1987, GENETICS, V116, P9; Sandmeier JJ, 2002, GENETICS, V160, P877; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith DL, 2009, AGING CELL, V8, P633, DOI 10.1111/j.1474-9726.2009.00516.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; SU S, 1969, J BIOL CHEM, V244, P2956; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang HY, 2007, AGING CELL, V6, P35, DOI 10.1111/j.1474-9726.2006.00259.x; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	64	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20957	20966		10.1074/jbc.M112.367524	http://dx.doi.org/10.1074/jbc.M112.367524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539348	hybrid, Green Published			2022-12-28	WOS:000306416800017
J	Petkau, G; Wingen, C; Jussen, LCA; Radtke, T; Behr, M				Petkau, Georg; Wingen, Christian; Jussen, Laura C. A.; Radtke, Tina; Behr, Matthias			Obstructor-A Is Required for Epithelial Extracellular Matrix Dynamics, Exoskeleton Function, and Tubulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTIONS; AIRWAY CLEARANCE; DROSOPHILA; CHITIN; FAMILY; GENE; KNICKKOPF; PROTEINS; INSECTS; MEMBER	The epidermis and internal tubular organs, such as gut and lungs, are exposed to a hostile environment. They form an extracellular matrix to provide epithelial integrity and to prevent contact with pathogens and toxins. In arthropods, the cuticle protects, shapes, and enables the functioning of organs. During development, cuticle matrix is shielded from premature degradation; however, underlying molecular mechanisms are poorly understood. Previously, we identified the conserved obstructor multigene-family, which encodes chitin-binding proteins. Here we show that Obstructor-A is required for extracellular matrix dynamics in cuticle forming organs. Loss of obstructor-A causes severe defects during cuticle molting, wound protection, tube expansion and larval growth control. We found that Obstructor-A interacts and forms a core complex with the polysaccharide chitin, the cuticle modifier Knickkopf and the chitin deacetylase Serpentine. Knickkopf protects chitin from chitinase-dependent degradation and deacetylase enzymes ensure extracellular matrix maturation. We provide evidence that Obstructor-A is required to control the presence of Knickkopf and Serpentine in the extracellular matrix. We propose a model suggesting that Obstructor-A coordinates the core complex for extracellular matrix protection from premature degradation. This mechanism enables exoskeletal molting, tube expansion, and epithelial integrity. The evolutionary conservation suggests a common role of Obstructor-A and homologs in coordinating extracellular matrix protection in epithelial tissues of chitinous invertebrates.	[Petkau, Georg; Wingen, Christian; Jussen, Laura C. A.; Radtke, Tina; Behr, Matthias] Univ Bonn, Lab Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany	University of Bonn	Behr, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, Life & Med Sci Inst LIMES, Carl Troll Str 31, D-53115 Bonn, Germany.	mbehr@uni-bonn.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257; Petkau, Georg/0000-0002-6687-2667	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB645]; Boehringer Ingelheim Fonds	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, SFB645) (to M. B.) and by the Boehringer Ingelheim Fonds (to C. W.).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Bauer R, 2002, J CELL SCI, V115, P1859; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Behr M, 2010, RESP PHYSIOL NEUROBI, V173, pS33, DOI 10.1016/j.resp.2010.04.011; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Chavoshi TM, 2010, MECH DEVELOP, V127, P308, DOI 10.1016/j.mod.2010.01.003; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Li TR, 2000, DEVELOPMENT, V127, P2897; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Nisole A, 2010, J INSECT PHYSIOL, V56, P1427, DOI 10.1016/j.jinsphys.2009.12.006; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Stumpges B, 2011, FEBS LETT, V585, P3316, DOI 10.1016/j.febslet.2011.09.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wingen C, 2009, GENE EXPR PATTERNS, V9, P549, DOI 10.1016/j.gep.2009.06.007; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	30	68	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21396	21405		10.1074/jbc.M112.359984	http://dx.doi.org/10.1074/jbc.M112.359984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544743	hybrid, Green Published			2022-12-28	WOS:000306416800057
J	Wu, CC; Naveen, V; Chien, CH; Chang, YW; Hsiao, CD				Wu, Ching-Chung; Naveen, Vankadari; Chien, Chin-Hsiang; Chang, Yi-Wei; Hsiao, Chwan-Deng			Crystal Structure of DnaK Protein Complexed with Nucleotide Exchange Factor GrpE in DnaK Chaperone System INSIGHT INTO INTERMOLECULAR COMMUNICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR CHAPERONES; SUBSTRATE-BINDING; HSP70 CHAPERONES; DOMAIN; GENE; GROWTH; CONFORMATION; TEMPERATURES; AGGREGATION	The conserved, ATP-dependent bacterial DnaK chaperones process client substrates with the aid of the co-chaperones DnaJ and GrpE. However, in the absence of structural information, how these proteins communicate with each other cannot be fully delineated. For the study reported here, we solved the crystal structure of a full-length Geobacillus kaustophilus HTA426 GrpE homodimer in complex with a nearly full-length G. kaustophilus HTA426 DnaK that contains the interdomain linker (acting as a pseudo-substrate), and the N-terminal nucleotide-binding and C-terminal substrate-binding domains at 4.1-angstrom resolution. Each complex contains two DnaKs and two GrpEs, which is a stoichiometry that has not been found before. The long N-terminal GrpE alpha-helices stabilize the linker of DnaK in the complex. Furthermore, interactions between the DnaK substrate-binding domain and the N-terminal disordered region of GrpE may accelerate substrate release from DnaK. These findings provide molecular mechanisms for substrate binding, processing, and release during the Hsp70 chaperone cycle.	Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wu, Ching-Chung; Naveen, Vankadari; Chang, Yi-Wei; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Naveen, Vankadari] Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Defense Medical Center		chiench@ym.edu.tw; hsiao@gate.sinica.edu.tw	Hsiao, Chwan-Deng/D-7327-2013; Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/AAZ-8869-2021; Vankadari, Naveen/AAE-7381-2020	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532; Vankadari, Naveen/0000-0001-9363-080X	Academia Sinica [NSC98-2311-B-001-010-MY3]; National Science Council Taiwan, Republic of China	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Research Grant NSC98-2311-B-001-010-MY3 from Academia Sinica and the National Science Council Taiwan, Republic of China (to C.-D. H.).	ANG D, 1986, J BACTERIOL, V167, P25, DOI 10.1128/jb.167.1.25-29.1986; ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Arnau J, 1996, MICROBIOL-UK, V142, P1685, DOI 10.1099/13500872-142-7-1685; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEMACARIO EC, 1995, J BACTERIOL, V177, P544; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Grimshaw JPA, 2005, J MOL BIOL, V353, P888, DOI 10.1016/j.jmb.2005.08.069; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000931; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moro F, 2007, J MOL BIOL, V374, P1054, DOI 10.1016/j.jmb.2007.10.002; Nakamura A, 2010, J MOL BIOL, V396, P1000, DOI 10.1016/j.jmb.2009.12.028; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21461	21470		10.1074/jbc.M112.344358	http://dx.doi.org/10.1074/jbc.M112.344358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544739	hybrid, Green Published			2022-12-28	WOS:000306416800063
J	Adachi, R; Krilis, SA; Nigrovic, PA; Hamilton, MJ; Chung, K; Thakurdas, SM; Boyce, JA; Anderson, P; Stevens, RL				Adachi, Roberto; Krilis, Steven A.; Nigrovic, Peter A.; Hamilton, Matthew J.; Chung, Kyungemee; Thakurdas, Shakeel M.; Boyce, Joshua A.; Anderson, Paul; Stevens, Richard L.			Ras Guanine Nucleotide-releasing Protein-4 (RasGRP4) Involvement in Experimental Arthritis and Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; INFLAMMATORY ARTHRITIS; BONE-MARROW; ULCERATIVE-COLITIS; SIGNALING PROTEIN; MOUSE; MICE; DIACYLGLYCEROL; ACTIVATION; EXPRESSION	RasGRP4 ((Ras) under bar guanine nucleotide-(r) under bar eleasing (p) under bar rotein-(4) under bar) is an intracellular, calcium-regulated guanine nucleotide exchange factor and diacylglycerol/phorbol ester receptor expressed in mast cells (MCs) and their progenitors. To study the function of this signaling protein in inflammatory disorders, a homologous recombination approach was used to create a RasGRP4-null C57BL/6 mouse line. The resulting transgenic animals had normal numbers of MCs in their tissues that histochemically and morphologically resembled those in WT C57BL/6 mice. MCs could also be generated from RasGRP4-null mice by culturing their bone marrow cells in IL-3-enriched conditioned medium. Despite these data, the levels of the transcripts that encode the proinflammatory cytokines IL-1 beta and TNF-alpha were reduced in phorbol 12-myristate 13-acetate-treated MCs developed from RasGRP4-null mice. Although inflammation was not diminished in a Dermatophagoides farinae-dependent model of allergic airway disease, dextran sodium sulfate-induced colitis was significantly reduced in RasGRP4-null mice relative to similarly treated WT mice. Furthermore, experimental arthritis could not be induced in RasGRP4-null mice that had received K/BxN mouse serum. The latter findings raise the possibility that the pharmacologic inactivation of this intracellular signaling protein might be an effective treatment for arthritis or inflammatory bowel disease.	[Nigrovic, Peter A.; Hamilton, Matthew J.; Chung, Kyungemee; Boyce, Joshua A.; Anderson, Paul; Stevens, Richard L.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; [Nigrovic, Peter A.; Hamilton, Matthew J.; Chung, Kyungemee; Boyce, Joshua A.; Anderson, Paul; Stevens, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Adachi, Roberto; Thakurdas, Shakeel M.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Krilis, Steven A.] St George Hosp, Sydney, NSW 2217, Australia; [Krilis, Steven A.] Univ New S Wales, Sydney, NSW 2217, Australia; [Nigrovic, Peter A.] Childrens Hosp Boston, Div Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; St George Hospital; University of New South Wales Sydney; Harvard University; Boston Children's Hospital	Stevens, RL (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu		Adachi, Roberto/0000-0002-0146-0768	National Institutes of Health [AI052353, AI078908, AI059746, AI065858, AI093533]; Cancer Prevention and Research Institute of Texas [RP110166]; Harvard Club of Australia Foundation; Crohn's and Colitis Foundation of America; National Health and Medical Research Council of Australia; Cogan Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R37AI052353, R01AI093533, R01AI078908, R56AI052353, R01AI052353, R01AI059746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Harvard Club of Australia Foundation; Crohn's and Colitis Foundation of America; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cogan Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052353 and AI078908 (to J. A. B.), AI059746 and AI065858 (to R. L. S.), and AI093533 (to R. A.). This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP110166 (to R. A.), a research fellowship from the Harvard Club of Australia Foundation (to R. L. S. and S. A. K.), a research fellowship from the Crohn's and Colitis Foundation of America (to M. J. H.), a project grant from the National Health and Medical Research Council of Australia (to S. A. K.), and a grant from the Cogan Family Foundation (to P. A. N.).	Bischoff SC, 1996, HISTOPATHOLOGY, V28, P1, DOI 10.1046/j.1365-2559.1996.262309.x; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gelbmann CM, 1999, GUT, V45, P210, DOI 10.1136/gut.45.2.210; Giannattasio G, 2011, J IMMUNOL, V187, P1486, DOI 10.4049/jimmunol.1003669; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; GRUBER BL, 1988, J IMMUNOL, V140, P3936; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hashimoto T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3470; He SH, 1997, J IMMUNOL, V159, P6216; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Isozaki Y, 2006, SCAND J GASTROENTERO, V41, P944, DOI 10.1080/00365520500529470; Katsoulotos GP, 2008, J BIOL CHEM, V283, P1610, DOI 10.1074/jbc.M707042200; Kett WC, 2003, BBA-GEN SUBJECTS, V1620, P225, DOI 10.1016/S0304-4165(02)00539-1; KITAMURA Y, 1978, BLOOD, V52, P447; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Nishida M, 1999, APMIS, V107, P929, DOI 10.1111/j.1699-0463.1999.tb01493.x; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Raithel H, 2001, SCAND J GASTROENTERO, V36, P174, DOI 10.1080/003655201750065933; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Stevens R. L., 2011, ARTHRITIS RHEUM S10, V63, P1777; STEVENS RL, 1992, ARTHRITIS RHEUM, V35, P325, DOI 10.1002/art.1780350312; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; VALENT P, 1989, BLOOD, V73, P1778; VANDENBROEK MF, 1988, J RHEUMATOL, V15, P544; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zhou JS, 2005, EUR J IMMUNOL, V35, P1530, DOI 10.1002/eji.200425895; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	46	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20047	20055		10.1074/jbc.M112.360388	http://dx.doi.org/10.1074/jbc.M112.360388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511759	Green Published, hybrid			2022-12-28	WOS:000306414500026
J	Cheung, A; Newland, PL; Zaben, M; Attard, GS; Gray, WP				Cheung, Angela; Newland, Philip L.; Zaben, Malik; Attard, George S.; Gray, William P.			Intracellular Nitric Oxide Mediates Neuroproliferative Effect of Neuropeptide Y on Postnatal Hippocampal Precursor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; PANCREATIC-POLYPEPTIDE; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; PROTEIN-KINASE; SELECTIVE-INHIBITION; SIGNALING PATHWAY; RAT HIPPOCAMPUS	Neuropeptide Y (NPY) is widely expressed in the central and peripheral nervous systems and is proliferative for a range of cells types in vitro. NPY plays a key role in regulating adult hippocampal neurogenesis in vivo under both basal and pathological conditions, although the underlying mechanisms are largely unknown. We have investigated the role of nitric oxide (NO) on the neurogenic effects of NPY. Using postnatal rat hippocampal cultures, we show that the proliferative effect of NPY on nestin(+) precursor cells is NO-dependent. As well as the involvement of neuronal nitric-oxide synthase, the proliferative effect is mediated via an NO/cyclic guanosine monophosphate (cGMP)/cGMP-dependent protein kinase (PKG) and extracellular signal-regulated kinase (ERK) 1/2 signaling pathway. We show that NPY-mediated intracellular NO signaling results in an increase in neuroproliferation. By contrast, extracellular NO had an opposite, inhibitory effect on proliferation. The importance of the NO-cGMP-PKG signaling pathway in ERK1/2 activation was confirmed using Western blotting. This work unites two significant modulators of hippocampal neurogenesis within a common signaling framework and provides a mechanism for the independent extra-and intracellular regulation of postnatal neural precursors by NO.	[Cheung, Angela; Zaben, Malik; Gray, William P.] Univ Southampton, Div Clin Neurosci, Southampton SO17 1BJ, Hants, England; [Cheung, Angela; Newland, Philip L.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Attard, George S.] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Gray, William P.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF14 4XN, S Glam, Wales	University of Southampton; University of Southampton; University of Southampton; Cardiff University	Gray, WP (corresponding author), Univ Southampton, Div Clin Neurosci, Southampton SO17 1BJ, Hants, England.	graywp@cardiff.ac.uk	Attard, George S/C-3087-2009	Attard, George S/0000-0001-8304-0742; Gray, William/0000-0001-7595-8887; Zaben, Malik/0000-0002-7446-4532; Newland, Philip/0000-0003-4124-8507; Cheung, Angela M./0000-0001-8332-0744	Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council; MRC [G0300356] Funding Source: UKRI; Medical Research Council [G0801418B, G0300356] Funding Source: researchfish	Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Gerald Kerkut Charitable Trust.; We are grateful to Dr. Hansjurgen Schuppe and Dr. Andreas Wyttenbach for assistance and advice on diaminofluorescein diacetate imaging. The Nikon C1 confocal microscope system was purchased with funds from the Biotechnology and Biological Sciences Research Council (to P. L. Newland).	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; ALBERS HE, 1984, NEUROSCI LETT, V50, P163, DOI 10.1016/0304-3940(84)90480-4; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Alvaro AR, 2008, J NEUROCHEM, V105, P2501, DOI 10.1111/j.1471-4159.2008.05334.x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Cardenas A, 2005, BRAIN RES REV, V50, P1, DOI 10.1016/j.brainresrev.2005.03.006; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Cordelier P, 1999, FASEB J, V13, P2037, DOI 10.1096/fasebj.13.14.2037; Corso-Diaz X, 2010, J NEUROCHEM, V114, P864, DOI 10.1111/j.1471-4159.2010.06813.x; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Du M, 1997, BIOCHEM MOL BIOL INT, V41, P625; El Mabrouk M, 2000, LIFE SCI, V67, P1613, DOI 10.1016/S0024-3205(00)00744-X; Endo S, 2003, NEUROSCI LETT, V350, P122, DOI 10.1016/S0304-3940(03)00856-5; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FLOOD JF, 1989, PEPTIDES, V10, P963, DOI 10.1016/0196-9781(89)90176-9; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; Gray WP, 2008, MOL CELL ENDOCRINOL, V288, P52, DOI 10.1016/j.mce.2008.02.021; Hah JM, 2001, J MED CHEM, V44, P2667, DOI 10.1021/jm0101491; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Hua Y, 2008, PSYCHOPHARMACOLOGY, V200, P231, DOI 10.1007/s00213-008-1200-1; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Islam A. T. M. Shariful, 2003, Anatomical Science International, V78, P98, DOI 10.1046/j.0022-7722.2003.00045.x; Jiang W, 2004, NEUROSCI LETT, V367, P344, DOI 10.1016/j.neulet.2004.06.031; KOHLER C, 1986, J COMP NEUROL, V244, P384, DOI 10.1002/cne.902440310; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; LUNDBERG JM, 1984, J NEUROSCI, V4, P2376; Luo CX, 2010, STEM CELLS, V28, P2041, DOI 10.1002/stem.522; Matarredona ER, 2005, BRAIN RES REV, V49, P355, DOI 10.1016/j.brainresrev.2005.01.001; Michel MC, 1998, PHARMACOL REV, V50, P143; Milenkovic I, 2004, GRAEF ARCH CLIN EXP, V242, P944, DOI 10.1007/s00417-004-0954-3; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moreno-Lopez B, 2000, BRAIN RES, V869, P244, DOI 10.1016/S0006-8993(00)02474-4; Morley JE, 1999, PEPTIDES, V20, P595, DOI 10.1016/S0196-9781(99)00012-1; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Mullins DE, 2002, REGUL PEPTIDES, V105, P65, DOI 10.1016/S0167-0115(01)00388-3; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Park C, 2003, NEUROSCI LETT, V339, P9, DOI 10.1016/S0304-3940(02)01422-2; RayChaudhury A, 1996, J CELL BIOCHEM, V63, P125, DOI 10.1002/(SICI)1097-4644(19961101)63:2<125::AID-JCB1>3.0.CO;2-#; Redrobe JP, 1999, BRAIN RES, V848, P153, DOI 10.1016/S0006-8993(99)02119-8; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Sun YJ, 2005, J CEREBR BLOOD F MET, V25, P485, DOI 10.1038/sj.jcbfm.9600049; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Tolias CM, 1999, FREE RADICAL BIO MED, V26, P99, DOI 10.1016/S0891-5849(98)00146-4; Ulibarri JA, 1999, IN VITRO CELL DEV-AN, V35, P215; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhou QG, 2007, J NEUROCHEM, V103, P1843, DOI 10.1111/j.1471-4159.2007.04914.x	70	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20187	20196		10.1074/jbc.M112.346783	http://dx.doi.org/10.1074/jbc.M112.346783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22474320	hybrid, Green Published			2022-12-28	WOS:000306414500039
J	Kim, YM; Kiso, Y; Muraki, T; Kang, MS; Nakai, H; Saburi, W; Lang, W; Kang, HK; Okuyama, M; Mori, H; Suzuki, R; Funane, K; Suzuki, N; Momma, M; Fujimoto, Z; Oguma, T; Kobayashi, M; Kim, D; Kimura, A				Kim, Young-Min; Kiso, Yoshiaki; Muraki, Tomoe; Kang, Min-Sun; Nakai, Hiroyuki; Saburi, Wataru; Lang, Weeranuch; Kang, Hee-Kwon; Okuyama, Masayuki; Mori, Haruhide; Suzuki, Ryuichiro; Funane, Kazumi; Suzuki, Nobuhiro; Momma, Mitsuru; Fujimoto, Zui; Oguma, Tetsuya; Kobayashi, Mikihiko; Kim, Doman; Kimura, Atsuo			Novel Dextranase Catalyzing Cycloisomaltooligosaccharide Formation and Identification of Catalytic Amino Acids and Their Functions Using Chemical Rescue Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CIRCULANS T-3040; STREPTOCOCCUS-MUTANS; SEQUENCE-ANALYSIS; GENE; PROTEIN; CLONING; EXPRESSION; GLYCOSYLATION; HYDROLASES; CLEAVAGE	A novel endodextranase from Paenibacillus sp. (Paenibacillus sp. dextranase; PsDex) was found to mainly produce isomaltotetraose and small amounts of cycloisomaltooligosaccharides (CIs) with a degree of polymerization of 7-14 from dextran. The 1,696-amino acid sequence belonging to the glycosyl hydrolase family 66 (GH-66) has a long insertion (632 residues; Thr(451)-Val(1082)), a portion of which shares identity (35% at Ala(39)-Ser(1304) of PsDex) with Pro(32)-Ala(755) of CI glucanotransferase (CITase), a GH-66 enzyme that catalyzes the formation of CIs from dextran. This homologous sequence (Val(837)-Met(932) for PsDex and Tyr(404)-Tyr(492) for CITase), similar to carbohydrate-binding module 35, was not found in other endodextranases (Dexs) devoid of CITase activity. These results support the classification of GH-66 enzymes into three types: (i) Dex showing only dextranolytic activity, (ii) Dex catalyzing hydrolysis with low cyclization activity, and (iii) CITase showing CI-forming activity with low dextranolytic activity. The fact that a C-terminal truncated enzyme (having Ala(39)-Ser(1304)) has 50% wild-type PsDex activity indicates that the C-terminal 392 residues are not involved in hydrolysis. GH-66 enzymes possess four conserved acidic residues (Asp(189), Asp(340), Glu(412), and Asp(1254) of PsDex) of catalytic candidates. Their amide mutants decreased activity (1/1,500 to 1/40,000 times), and D1254N had 36% activity. A chemical rescue approach was applied to D189A, D340G, and E412Q using alpha-isomaltotetraosyl fluoride with NaN3. D340G or E412Q formed a beta- or alpha-isomaltotetraosyl azide, respectively, strongly indicating Asp(340) and Glu(412) as a nucleophile and acid/base catalyst, respectively. Interestingly, D189A synthesized small sized dextran from alpha-isomaltotetraosyl fluoride in the presence of NaN3.	[Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Suzuki, Ryuichiro; Funane, Kazumi] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Suzuki, Nobuhiro; Momma, Mitsuru; Fujimoto, Zui] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Oguma, Tetsuya] Noda Inst Sci Res, Noda, Chiba 2780037, Japan; [Kobayashi, Mikihiko] Jissenn Womens Univ, Dept Food & Hlth Sci, Hino, Tokyo 1918510, Japan; [Kim, Doman] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Hokkaido University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan; Chonnam National University	Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/B-7777-2012; Okuyama, Masayuki/D-8739-2012; Suzuki, Nobuhiro/M-7238-2015; Saburi, Wataru/A-4271-2012; Mori, Haruhide/AAV-6374-2021	Okuyama, Masayuki/0000-0001-7013-6032; Suzuki, Nobuhiro/0000-0001-8420-5852; Saburi, Wataru/0000-0002-2015-7086; Mori, Haruhide/0000-0001-7346-9131; Fujimoto, Zui/0000-0002-3551-6854	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research [22780082] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN).	Aga H, 2002, BIOSCI BIOTECH BIOCH, V66, P1057, DOI 10.1271/bbb.66.1057; Albert M, 2000, CARBOHYD RES, V327, P395, DOI 10.1016/S0008-6215(00)00060-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; CHIBA S, 1984, AGR BIOL CHEM TOKYO, V48, P1173, DOI 10.1080/00021369.1984.10866291; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fierobe HP, 1998, BIOCHEMISTRY-US, V37, P3743, DOI 10.1021/bi972231x; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Funane K, 2007, J BIOTECHNOL, V130, P188, DOI 10.1016/j.jbiotec.2007.03.009; Funane K, 2011, BBA-PROTEINS PROTEOM, V1814, P428, DOI 10.1016/j.bbapap.2010.12.009; Hanocq M., 1968, ANAL CHIM ACTA, V40, P15; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; IGARASHI T, 1995, MICROBIOL IMMUNOL, V39, P387, DOI 10.1111/j.1348-0421.1995.tb02217.x; IGARASHI T, 1995, MICROBIOL IMMUNOL, V39, P853, DOI 10.1111/j.1348-0421.1995.tb03282.x; Igarashi T, 2001, MICROBIOL IMMUNOL, V45, P341, DOI 10.1111/j.1348-0421.2001.tb02629.x; IWAI A, 1994, J BACTERIOL, V176, P7730, DOI 10.1128/JB.176.24.7730-7734.1994; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Khalikova E, 2005, MICROBIOL MOL BIOL R, V69, P306, DOI 10.1128/MMBR.69.2.306-325.2005; Kim YM, 2011, APPL MICROBIOL BIOT, V91, P329, DOI 10.1007/s00253-011-3201-y; KOBAYASHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P1861, DOI 10.1271/bbb.59.1861; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; MILLER AW, 1986, ANAL BIOCHEM, V156, P357, DOI 10.1016/0003-2697(86)90266-6; Monegal A, 2006, J AM CHEM SOC, V128, P16030, DOI 10.1021/ja0659931; NANJO F, 1990, J BIOL CHEM, V265, P10088; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oguma T., 1997, Journal of Applied Glycoscience, V44, P61; OGUMA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1225, DOI 10.1271/bbb.57.1225; Oguma T, 1999, BIOSCI BIOTECH BIOCH, V63, P2174, DOI 10.1271/bbb.63.2174; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; Roca H, 1996, YEAST, V12, P1187, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1187::AID-YEA986>3.0.CO;2-U; Suzuki N, 2012, J BIOL CHEM, V287, P19916, DOI 10.1074/jbc.M112.342444; Suzuki N, 2011, ACTA CRYSTALLOGR F, V67, P1542, DOI 10.1107/S1744309111038425; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Yamamoto T, 2006, BIOSCI BIOTECH BIOCH, V70, P1947, DOI 10.1271/bbb.60105; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	40	14	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19927	19935		10.1074/jbc.M111.339036	http://dx.doi.org/10.1074/jbc.M111.339036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22461618	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000306414500015
J	Leong, DW; Komen, JC; Hewitt, CA; Arnaud, E; McKenzie, M; Phipson, B; Bahlo, M; Laskowski, A; Kinkel, SA; Davey, GM; Heath, WR; Voss, AK; Zahedi, RP; Pitt, JJ; Chrast, R; Sickmann, A; Ryan, MT; Smyth, GK; Thorburn, DR; Scott, HS				Leong, Dillon W.; Komen, Jasper C.; Hewitt, Chelsee A.; Arnaud, Estelle; McKenzie, Matthew; Phipson, Belinda; Bahlo, Melanie; Laskowski, Adrienne; Kinkel, Sarah A.; Davey, Gayle M.; Heath, William R.; Voss, Anne K.; Zahedi, Rene P.; Pitt, James J.; Chrast, Roman; Sickmann, Albert; Ryan, Michael T.; Smyth, Gordon K.; Thorburn, David R.; Scott, Hamish S.			Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; AQDQ SUBUNIT; MUTATIONS; DISORDERS; APOPTOSIS; RETROTRANSPOSITION; HETEROGENEITY; INVOLVEMENT; INTEGRATION; EXPRESSION	Eukaryotic cells generate energy in the form of ATP, through a network of mitochondrial complexes and electron carriers known as the oxidative phosphorylation system. In mammals, mitochondrial complex I (CI) is the largest component of this system, comprising 45 different subunits encoded by mitochondrial and nuclear DNA. Humans diagnosed with mutations in the gene NDUFS4, encoding a nuclear DNA-encoded subunit of CI (NADH dehydrogenase ubiquinone Fe-S protein 4), typically suffer from Leigh syndrome, a neurodegenerative disease with onset in infancy or early childhood. Mitochondria from NDUFS4 patients usually lack detectable NDUFS4 protein and show a CI stability/assembly defect. Here, we describe a recessive mouse phenotype caused by the insertion of a transposable element into Ndufs4, identified by a novel combined linkage and expression analysis. Designated Ndufs4(fky), the mutation leads to aberrant transcript splicing and absence of NDUFS4 protein in all tissues tested of homozygous mice. Physical and behavioral symptoms displayed by Ndufs4(fky/fky) mice include temporary fur loss, growth retardation, unsteady gait, and abnormal body posture when suspended by the tail. Analysis of CI in Ndufs4(fky/fky) mice using blue native PAGE revealed the presence of a faster migrating crippled complex. This crippled CI was shown to lack subunits of the "Nassembly module", which contains the NADH binding site, but contained two assembly factors not present in intact CI. Metabolomic analysis of the blood by tandem mass spectrometry showed increased hydroxyacylcarnitine species, implying that the CI defect leads to an imbalanced NADH/NAD(+) ratio that inhibits mitochondrial fatty acid beta-oxidation.	[Leong, Dillon W.; Hewitt, Chelsee A.; Kinkel, Sarah A.; Voss, Anne K.; Scott, Hamish S.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Kinkel, Sarah A.; Davey, Gayle M.; Heath, William R.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; [Phipson, Belinda; Bahlo, Melanie; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Komen, Jasper C.; Laskowski, Adrienne; Thorburn, David R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Komen, Jasper C.; Laskowski, Adrienne; Thorburn, David R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Arnaud, Estelle; Chrast, Roman] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [McKenzie, Matthew] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3168, Australia; [Kinkel, Sarah A.; Voss, Anne K.; Smyth, Gordon K.; Scott, Hamish S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Bahlo, Melanie; Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Zahedi, Rene P.] Leibniz Inst Analyt Wissensch eV, D-44227 Dortmund, Germany; [Pitt, James J.; Sickmann, Albert] Royal Childrens Hosp, Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic 3052, Australia; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Ryan, Michael T.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Scott, Hamish S.] SA Pathol, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA 5000, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Lausanne; Monash University; University of Melbourne; University of Melbourne; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Ruhr University Bochum; La Trobe University; Centre for Cancer Biology; SA Pathology; University of Adelaide; University of Adelaide	Thorburn, DR (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	david.thorburn@mcri.edu.au; hamish.scott@health.sa.gov.au	Thorburn, David R/G-6266-2013; McKenzie, Matthew/H-4926-2019; Phipson, Belinda/AAP-2213-2020; Ryan, Michael T/C-6673-2011; Ryan, Michael/X-2152-2019; Sickmann, Albert/A-1010-2011; Smyth, Gordon/B-5276-2008; Zahedi, Rene/HGU-5710-2022; Zahedi, René/A-9148-2012; Scott, Hamish/B-2122-2009; Voss, Anne K/F-5110-2013	McKenzie, Matthew/0000-0001-7508-1800; Phipson, Belinda/0000-0002-1711-7454; Ryan, Michael T/0000-0003-2586-8829; Ryan, Michael/0000-0003-2586-8829; Sickmann, Albert/0000-0002-2388-5265; Smyth, Gordon/0000-0001-9221-2892; Zahedi, René/0000-0002-4960-5460; Scott, Hamish/0000-0002-5813-631X; Voss, Anne K/0000-0002-3853-9381; Hewitt, Chelsee/0000-0001-7472-6128; thorburn, david/0000-0002-7725-9470; Bahlo, Melanie/0000-0001-5132-0774; Davey, Gayle/0000-0002-9514-6023; Chrast, Roman/0000-0003-4189-3514; Heath, William/0000-0001-9670-259X	Australian Postgraduate Award; National Health and Medical Research Council(NHMRC) [257501, 607403, 602530]; Australian Research Council; Victorian Government; Walter and Eliza Hall Institute of Medical Research; Commonwealth	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; Walter and Eliza Hall Institute of Medical Research; Commonwealth	This work was supported by an Australian Postgraduate Award (to S.A.K.), National Health and Medical Research Council(NHMRC) fellowships (to H.H.S, D.R.T., G.K.S., and A.K.V.), NHMRC career development awards (to M.M. and M.B.), NHMRC Program Grant 257501, and NHMRC Project Grants 607403 and 602530, the Australian Research Council (to M.T.R.), the Victorian Government's Operational Infrastructure Support Program, and the Nossal Leadership Award from the Walter and Eliza Hall Institute of Medical Research (to H.S.S.).; Efficient animal management and data collection were facilitated by the Walter and Eliza Hall Institute of Medical Research (WEHI) and Murdoch Childrens Research Institute animal technicians. Processing of histological samples was aided by WEHI Histology and the Integrative Neuroscience Facility. Affymetrix exon arrays and linkage genotyping were performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities Program.	Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; Budde SMS, 2003, J INHERIT METAB DIS, V26, P813, DOI 10.1023/B:BOLI.0000010003.14113.af; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Dewannieux M, 2005, J MOL BIOL, V349, P241, DOI 10.1016/j.jmb.2005.03.068; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Dubinsky JM, 2009, EXP NEUROL, V218, P293, DOI 10.1016/j.expneurol.2009.05.020; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Gilbert N, 2004, HUM MUTAT, V24, P9, DOI 10.1002/humu.20060; Gu YH, 2007, BRAIN DEV-JPN, V29, P105, DOI 10.1016/j.braindev.2006.05.012; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kubota Y, 1999, J AM ACAD DERMATOL, V41, P469, DOI 10.1016/S0190-9622(99)70123-4; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Morava E, 2006, BIOL NEONATE, V90, P207, DOI 10.1159/000093590; Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Rashed MS, 1997, CLIN CHEM, V43, P1129; Rubio-Gozalbo ME, 2000, NEUROPEDIATRICS, V31, P114, DOI 10.1055/s-2000-7491; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Silengo M, 2003, EUR J PEDIATR, V162, P459, DOI 10.1007/s00431-003-1228-5; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	68	42	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20652	20663		10.1074/jbc.M111.327601	http://dx.doi.org/10.1074/jbc.M111.327601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535952	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000306414500084
J	Suzuki, H; Ito, R; Ikeda, K; Tamura, T				Suzuki, Hidefumi; Ito, Ryo; Ikeda, Kaori; Tamura, Taka-aki			TATA-binding Protein (TBP)-like Protein Is Required for p53-dependent Transcriptional Activation of Upstream Promoter of p21Waf1/Cip1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53; TBP; P21; MYOGENIN; P63; P73; DEGRADATION; EXPRESSION; INHIBITOR; PATHWAYS	TATA-binding protein-like protein (TLP) is involved in development, checkpoint, and apoptosis through potentiation of gene expression. TLP-overexpressing human cells, especially p53-containing cells, exhibited a decreased growth rate and increased proportion of of G(1) phase cells. TLP stimulated expression of several growth-related genes including p21 (p21(Waf1/Cip1)). TLP-mediated activation of the p21 upstream promoter in cells was shown by a promoter-luciferase reporter assay. The p53-binding sequence located in the p21 upstream promoter and p53 itself are required for TLP-mediated transcriptional activation. TLP and p53 bound to each other and synergistically enhanced activity of the upstream promoter. TLP specifically activated transcription from the endogenous upstream promoter, and p53 was required for this activation. Etoposide treatment also resulted in activation of the upstream promoter as well as nuclear accumulation of TLP and p53. Moreover, the upstream promoter was associated with endogenous p53 and TLP, and the p53 recruitment was enhanced by TLP. The results of the present study suggest that TLP mediates p53-governed transcriptional activation of the p21 upstream promoter.	[Suzuki, Hidefumi; Ito, Ryo; Ikeda, Kaori; Tamura, Taka-aki] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Chiba University	Tamura, T (corresponding author), Chiba Univ, Grad Sch Sci, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	ttamura@faculty.chiba-u.jp	Suzuki, Hidefumi/GRR-9474-2022; Ito, Ryo/F-8571-2016		Grants-in-Aid for Scientific Research [24570193, 20570123] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; Chan TA, 2000, GENE DEV, V14, P1584; Chong JA, 2005, MOL CELL BIOL, V25, P2632, DOI 10.1128/MCB.25.7.2632-2643.2005; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakadai T, 2004, J BIOL CHEM, V279, P7447, DOI 10.1074/jbc.M305412200; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Ohbayashi T, 2001, BIOCHEM BIOPH RES CO, V285, P616, DOI 10.1006/bbrc.2001.5217; Ohbayashi T, 2003, NUCLEIC ACIDS RES, V31, P2127, DOI 10.1093/nar/gkg315; Ozaki T, 2009, BIOCHEM BIOPH RES CO, V386, P207, DOI 10.1016/j.bbrc.2009.06.035; Park KA, 2006, MOL CELLS, V22, P203; Persengiev SP, 2003, P NATL ACAD SCI USA, V100, P14887, DOI 10.1073/pnas.2036440100; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Shiraishi S, 2009, GENE, V436, P115, DOI 10.1016/j.gene.2009.01.016; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Tanaka Y, 2007, BIOCHEM BIOPH RES CO, V352, P21, DOI 10.1016/j.bbrc.2006.10.175; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; TRUANT R, 1993, J BIOL CHEM, V268, P2284; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	49	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19792	19803		10.1074/jbc.M112.369629	http://dx.doi.org/10.1074/jbc.M112.369629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511763	Green Published, hybrid			2022-12-28	WOS:000306414500003
J	Haupt, K; Jahreis, G; Linnert, M; Maestre-Martinez, M; Malesevic, M; Pechstein, A; Edlich, F; Lucke, C				Haupt, Katja; Jahreis, Guenther; Linnert, Miriam; Maestre-Martinez, Mitcheell; Malesevic, Miroslav; Pechstein, Arndt; Edlich, Frank; Luecke, Christian			The FKBP38 Catalytic Domain Binds to Bcl-2 via a Charge-sensitive Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIAPOPTOTIC PROTEIN BCL-2; REGULATOR FKBP38; CELL-DEATH; REPLICATION; INHIBITOR; APOPTOSIS; DEPENDS; FAMILY; SITE; RHEB	FKBP38 is a regulator of the prosurvival protein Bcl-2, but in the absence of detailed structural insights, the molecular mechanism of the underlying interaction has remained unknown. Here, we report the contact regions between Bcl-2 and the catalytic domain of FKBP38 derived by heteronuclear NMR spectroscopy. The data reveal that a previously identified charge-sensitive loop near the putative active site of FKBP38 is mainly responsible for Bcl-2 binding. The corresponding binding epitope of Bcl-2 could be identified via a peptide library-based membrane assay. Site-directed mutagenesis of the key residues verified the contact sites of this electrostatic protein/protein interaction. The derived structure model of the complex between Bcl-2 and the FKBP38 catalytic domain features both electrostatic and hydrophobic intermolecular contacts and provides a rationale for the regulation of the FKBP38/Bcl-2 interaction by Ca2+.	[Edlich, Frank] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Edlich, Frank] Univ Freiburg, Ctr Biochem & Mol Cell Res ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Haupt, Katja; Jahreis, Guenther; Linnert, Miriam; Maestre-Martinez, Mitcheell; Malesevic, Miroslav; Pechstein, Arndt; Edlich, Frank; Luecke, Christian] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Saale, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Edlich, F (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Ctr Biol Signaling Studies BIOSS, Stefan Meier Str 17, D-79104 Freiburg, Germany.	frank.edlich@biochemie.uni-freiburg.de; luecke@enzyme-halle.mpg.de	Malesevic, Miroslav/D-8128-2012	Malesevic, Miroslav/0000-0002-1484-3709				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; Maestre-Martinez M, 2011, J MOL RECOGNIT, V24, P23, DOI 10.1002/jmr.1020; Malesevic M, 2010, BIOCHEMISTRY-US, V49, P8626, DOI 10.1021/bi101015p; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171	34	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19665	19673		10.1074/jbc.M111.317214	http://dx.doi.org/10.1074/jbc.M111.317214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22523079	hybrid, Green Published			2022-12-28	WOS:000306411900077
J	Lang, CM; Fellerer, K; Schwenk, BM; Kuhn, PH; Kremmer, E; Edbauer, D; Capell, A; Haass, C				Lang, Christina M.; Fellerer, Katrin; Schwenk, Benjamin M.; Kuhn, Peer-Hendrik; Kremmer, Elisabeth; Edbauer, Dieter; Capell, Anja; Haass, Christian			Membrane Orientation and Subcellular Localization of Transmembrane Protein 106B (TMEM106B), a Major Risk Factor for Frontotemporal Lobar Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRANULIN MUTATIONS; PAGET-DISEASE; DEMENTIA; CHMP2B; TRAFFICKING; INHIBITION; AUTOPHAGY; CONSENSUS; ROLES; ONSET	TMEM106B was identified as a major risk factor in a genome-wide association study for frontotemporal lobar degeneration (FTLD) with TAR DNA-binding protein (TDP)-43 pathology. The most significant association of TMEM106B single nucleotide polymorphisms with risk of FTLD-TDP was observed in patients with progranulin (GRN) mutations. Subsequent studies suggested an inverse correlation between TMEM106B expression and GRN levels in patient serum. However, in this study, this was not confirmed as we failed to detect a significant alteration of GRN levels upon knockdown or exogenous expression of TMEM106B in heterologous cells. To provide a basis for understanding TMEM106B function in health and disease, we investigated the membrane orientation and subcellular localization of this completely uncharacterized protein. By differential membrane extraction and sequential mutagenesis of potential N-glycosylation sites, we identified TMEM106B as a type 2 integral membrane protein with a highly glycosylated luminal domain. Glycosylation is partially required for the transport of TMEM106B beyond the endoplasmic reticulum to late cellular compartments. Endogenous as well as overexpressed TMEM106B localizes to late endosomes and lysosomes. Interestingly, the inhibition of vacuolar H+-ATPases significantly increased the levels of TMEM106B, a finding that may provide an unexpected biochemical link to GRN, because this protein is also strongly increased under the same conditions. Our findings provide a biochemical and cell biological basis for the understanding of the pathological role of TMEM106B in FTLD, an incurable neurodegenerative disorder.	[Lang, Christina M.; Fellerer, Katrin; Capell, Anja; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Schwenk, Benjamin M.; Kuhn, Peer-Hendrik; Edbauer, Dieter; Haass, Christian] German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Capell, A (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	anja.capell@dzne.lmu.de; christian.haass@dzne.lmu.de	Edbauer, Dieter/M-9906-2019	Edbauer, Dieter/0000-0002-7186-4653; Kuhn, Peer-Hendrik/0000-0001-7891-5102	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration [SFB 596]; Competence Network for Neurodegenerative Diseases of the Bundesministerium fur Bil-dung und Forschung; Hans and Ilse Breuer Foundation; Helmholtz Young Investigator Program [HZ-NG-607]	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration(German Research Foundation (DFG)); Competence Network for Neurodegenerative Diseases of the Bundesministerium fur Bil-dung und Forschung; Hans and Ilse Breuer Foundation; Helmholtz Young Investigator Program	This work was supported in part by Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration Grant SFB 596, the Competence Network for Neurodegenerative Diseases of the Bundesministerium fur Bil-dung und Forschung, and a fellowship from the Hans and Ilse Breuer Foundation (to C. M. L.).; Supported by the Helmholtz Young Investigator Program Grant HZ-NG-607.	Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bird TD, 2009, BRAIN, V132, P568, DOI 10.1093/brain/awp009; Bonifacino J. S., 2001, CURR PROTOC PROTEIN; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Mackenzie IRA, 2007, NEUROGENETICS, V8, P237, DOI 10.1007/s10048-007-0102-4; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rollinson S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.005; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; Van Deerlin VM, 2007, ARCH NEUROL-CHICAGO, V64, P1148, DOI 10.1001/archneur.64.8.1148; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J., 2011, J MOL NEUROSCI; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332	52	85	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19355	19365		10.1074/jbc.M112.365098	http://dx.doi.org/10.1074/jbc.M112.365098			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511793	hybrid, Green Published			2022-12-28	WOS:000306411900050
J	Li, C; Zhang, Y; Vankemmelbeke, M; Hecht, O; Aleanizy, FS; Macdonald, C; Moore, GR; James, R; Penfold, CN				Li, Chan; Zhang, Ying; Vankemmelbeke, Mireille; Hecht, Oliver; Aleanizy, Fadilah Sfouq; Macdonald, Colin; Moore, Geoffrey R.; James, Richard; Penfold, Christopher N.			Structural Evidence That Colicin A Protein Binds to a Novel Binding Site of TolA Protein in Escherichia coli Periplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FILAMENTOUS PHAGE INFECTION; OUTER-MEMBRANE; TRANSLOCATION DOMAIN; COMPETITIVE RECRUITMENT; CRYSTAL-STRUCTURE; CELL-ENVELOPE; PAL PROTEINS; IMPORT; RECOGNITION	The Tol assembly of proteins is an interacting network of proteins located in the Escherichia coli cell envelope that transduces energy and contributes to cell integrity. TolA is central to this network linking the inner and outer membranes by interactions with TolQ, TolR, TolB, and Pal. Group A colicins, such as ColA, parasitize the Tol network through interactions with TolA and/or TolB to facilitate translocation through the cell envelope to reach their cytotoxic site of action. We have determined the first structure of the C-terminal domain of TolA (TolAIII) bound to an N-terminal ColA polypeptide (TA(53-107)). The interface region of the TA(53-107)-TolAIII complex consists of polar contacts linking residues Arg-92 to Arg-96 of ColA with residues Leu-375-Pro-380 of TolA, which constitutes a beta-strand addition commonly seen in more promiscuous protein-protein contacts. The interface region also includes three cation-pi interactions (Tyr-58-Lys-368, Tyr-90-Lys-379, Phe-94-Lys-396), which have not been observed in any other colicin-Tol protein complex. Mutagenesis of the interface residues of ColA or TolA revealed that the effect on the interaction was cumulative; single mutations of either partner had no effect on ColA activity, whereas mutations of three or more residues significantly reduced ColA activity. Mutagenesis of the aromatic ring component of the cation-pi interacting residues showed Tyr-58 of ColA to be essential for the stability of complex formation. TA(53-107) binds on the opposite side of TolAIII to that used by g3p, ColN, or TolB, illustrating the flexible nature of TolA as a periplasmic hub protein.	[Li, Chan; Zhang, Ying; Vankemmelbeke, Mireille; Aleanizy, Fadilah Sfouq; James, Richard; Penfold, Christopher N.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Hecht, Oliver; Macdonald, Colin; Moore, Geoffrey R.] Univ E Anglia, Sch Chem Sci, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of East Anglia	Penfold, CN (corresponding author), Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	chris.penfold@nottingham.ac.uk	Aleanizy, Fadilah Sfouq/AAL-6436-2020; James, Richard/B-2252-2009; zhang, ying/E-2718-2017	Aleanizy, Fadilah Sfouq/0000-0002-6161-3121; Zhang, Ying/0000-0003-3074-9998; Vankemmelbeke, Mireille/0000-0002-8100-813X; James, Richard/0000-0002-5086-788X; Penfold, Christopher/0000-0003-3251-5650	Biotechnology and Biological Sciences Research Council; Wolfson Foundation; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfson Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council, the Wolfson Foundation, and The Wellcome Trust.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATY D, 1990, EUR J BIOCHEM, V189, P409, DOI 10.1111/j.1432-1033.1990.tb15503.x; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Bonsor DA, 2008, BIOCHEM SOC T, V36, P1409, DOI 10.1042/BST0361409; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Deprez C, 2002, BIOCHEMISTRY-US, V41, P2589, DOI 10.1021/bi0157262; Dubuisson JF, 2002, J BACTERIOL, V184, P4620, DOI 10.1128/JB.184.16.4620-4625.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; Gokce I, 2000, J MOL BIOL, V304, P621, DOI 10.1006/jmbi.2000.4232; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hands SL, 2005, J BACTERIOL, V187, P6733, DOI 10.1128/JB.187.19.6733-6741.2005; Hecht O, 2008, FEBS LETT, V582, P2673, DOI 10.1016/j.febslet.2008.06.022; Hecht O, 2010, FEBS LETT, V584, P2249, DOI 10.1016/j.febslet.2010.04.061; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hubbard S.J.a.J.T., 1996, NACCESS; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Macdonald CJ, 2004, J BIOMOL NMR, V30, P81, DOI 10.1023/B:JNMR.0000042963.71790.19; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pommier S, 2005, J BACTERIOL, V187, P7526, DOI 10.1128/JB.187.21.7526-7534.2005; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Schendel SL, 1997, J BACTERIOL, V179, P3683, DOI 10.1128/jb.179.11.3683-3690.1997; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tozawa K, 2005, BIOCHEMISTRY-US, V44, P11496, DOI 10.1021/bi0503596; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang Y, 2010, MOL MICROBIOL, V75, P623, DOI 10.1111/j.1365-2958.2009.06808.x	68	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19048	19057		10.1074/jbc.M112.342246	http://dx.doi.org/10.1074/jbc.M112.342246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493500	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000306411900016
J	Margalith, I; Suter, C; Ballmer, B; Schwarz, P; Tiberi, C; Sonati, T; Falsig, J; Nystrom, S; Hammarstrom, P; Aslund, A; Nilsson, KPR; Yam, A; Whitters, E; Hornemann, S; Aguzzi, A				Margalith, Ilan; Suter, Carlo; Ballmer, Boris; Schwarz, Petra; Tiberi, Cinzia; Sonati, Tiziana; Falsig, Jeppe; Nystrom, Sofie; Hammarstrom, Per; Aslund, Andreas; Nilsson, K. Peter R.; Yam, Alice; Whitters, Eric; Hornemann, Simone; Aguzzi, Adriano			Polythiophenes Inhibit Prion Propagation by Stabilizing Prion Protein (PrP) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE OPTICAL PROBES; AMYLOID-BETA PEPTIDE; CONGO RED; PENTOSAN POLYSULFATE; CONJUGATED POLYELECTROLYTES; CONFORMATIONAL STATES; SECONDARY STRUCTURE; INCUBATION PERIOD; FIBRIL FORMATION; CULTURED-CELLS	Luminescent conjugated polymers (LCPs) interact with ordered protein aggregates and sensitively detect amyloids of many different proteins, suggesting that they may possess antiprion properties. Here, we show that a variety of anionic, cationic, and zwitterionic LCPs reduced the infectivity of prion-containing brain homogenates and of prion-infected cerebellar organotypic cultured slices and decreased the amount of scrapie isoform of PrPC (PrPSc) oligomers that could be captured in an avidity assay. Paradoxically, treatment enhanced the resistance of PrPSc to proteolysis, triggered the compaction, and enhanced the resistance to proteolysis of recombinant mouse PrP(23-231) fibers. These results suggest that LCPs act as antiprion agents by transitioning PrP aggregates into structures with reduced frangibility. Moreover, ELISA on cerebellar organotypic cultured slices and in vitro conversion assays with mouse PrP(23-231) indicated that poly(thiophene-3-acetic acid) may additionally interfere with the generation of PrPSc by stabilizing the conformation of PrPC or of a transition intermediate. Therefore, LCPs represent a novel class of antiprion agents whose mode of action appears to rely on hyperstabilization, rather than destabilization, of PrPSc deposits.	[Margalith, Ilan; Suter, Carlo; Ballmer, Boris; Schwarz, Petra; Tiberi, Cinzia; Sonati, Tiziana; Falsig, Jeppe; Hornemann, Simone; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Nystrom, Sofie; Hammarstrom, Per; Aslund, Andreas; Nilsson, K. Peter R.] Linkoping Univ, IFM Dept Chem, SE-58183 Linkoping, Sweden; [Yam, Alice; Whitters, Eric] Novartis Diagnost, Emeryville, CA 94608 USA	University of Zurich; University Zurich Hospital; Linkoping University; Novartis	Hornemann, S (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	Simone.Hornemann@usz.ch; Adriano.Aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Aslund, Andreas/H-4721-2013; Åslund, Andreas/M-4483-2019	Aslund, Andreas/0000-0001-5222-9307; Åslund, Andreas/0000-0001-5222-9307; Aguzzi, Adriano/0000-0002-0344-6708; Nystrom, Sofie/0000-0002-4303-4783	European Union P-7 Health; Swiss National Foundation; Novartis Research Foundation; European Research Council; Swedish Foundation for Strategic Research [FFL-4]	European Union P-7 Health; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported in part by grants from the European Union P-7 Health (project acronym LUPAS), the Swiss National Foundation, and the Novartis Research Foundation.; Supported by European Research Council Starting Independent Researcher Grant (Project MUMID) from the European Research Council and Grant FFL-4 from the Swedish Foundation for Strategic Research.	Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Appleby BS, 2011, EXPERT OPIN PHARMACO, V12, P1, DOI 10.1517/14656566.2010.514903; Aslund A, 2007, BIOCONJUGATE CHEM, V18, P1860, DOI 10.1021/bc700180g; Aslund Andreas, 2009, J Chem Biol, V2, P161, DOI 10.1007/s12154-009-0024-8; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caspi S, 1998, J BIOL CHEM, V273, P3484, DOI 10.1074/jbc.273.6.3484; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Ding L, 2000, SYNTHETIC MET, V110, P133, DOI 10.1016/S0379-6779(99)00284-2; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Herland A, 2005, J AM CHEM SOC, V127, P2317, DOI 10.1021/ja045835e; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Ho HA, 2002, ANGEW CHEM INT EDIT, V41, P1548, DOI 10.1002/1521-3773(20020503)41:9<1548::AID-ANIE1548>3.0.CO;2-I; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; MACGREGOR IR, 1985, THROMB HAEMOSTASIS, V53, P411; Martinez-Lage JF, 2005, SURG NEUROL, V64, P542, DOI 10.1016/j.surneu.2005.03.035; Mastrianni JA, 2010, GENET MED, V12, P187, DOI 10.1097/GIM.0b013e3181cd7374; Milhavet O, 2000, J NEUROCHEM, V74, P222, DOI 10.1046/j.1471-4159.2000.0740222.x; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nilsson KPR, 2006, CHEMBIOCHEM, V7, P1096, DOI 10.1002/cbic.200500550; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Nilsson KPR, 2005, BIOCHEMISTRY-US, V44, P3718, DOI 10.1021/bi047402u; Nilsson KPR, 2003, P NATL ACAD SCI USA, V100, P10170, DOI 10.1073/pnas.1834422100; Nilsson KPR, 2003, NAT MATER, V2, P419, DOI 10.1038/nmat899; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Ouidja MO, 2007, BIOCHEM BIOPH RES CO, V363, P95, DOI 10.1016/j.bbrc.2007.08.113; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Shaked GM, 1999, J BIOL CHEM, V274, P17981, DOI 10.1074/jbc.274.25.17981; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; Supattapone S, 2009, CNS NEUROL DISORD-DR, V8, P323, DOI 10.2174/187152709789541952; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Terada T, 2010, ACTA NEUROL SCAND, V121, P127, DOI 10.1111/j.1600-0404.2009.01272.x; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; Wang YQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208934; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2002, J INFECT DIS, V186, pS157, DOI 10.1086/344575; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	81	52	52	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18872	18887		10.1074/jbc.M112.355958	http://dx.doi.org/10.1074/jbc.M112.355958			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493452	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000306411900001
J	Osipiuk, J; Mulligan, R; Bargassa, M; Hamilton, JE; Cunningham, MA; Joachimiak, A				Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Hamilton, John E.; Cunningham, Mark A.; Joachimiak, Andrzej			Characterization of Member of DUF1888 Protein Family, Self-cleaving and Self-assembling Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; AUTOCATALYTIC CLEAVAGE; ASPARTIC PROTEINASES; MATURATION CLEAVAGE; HIGH-THROUGHPUT; LOW PH; SIMULATIONS; SEQUENCE; DATABASE; CLONING	The crystal structure of SO1698 protein from Shewanella oneidensis was determined by a SAD method and refined to 1.57 angstrom. The structure is a beta sandwich that unexpectedly consists of two polypeptides; the N-terminal fragment includes residues 1-116, and the C-terminal one includes residues 117-125. Electron density also displayed the Lys-98 side chain covalently linked to Asp-116. The putative active site residues involved in self-cleavage were identified; point mutants were produced and characterized structurally and in a biochemical assay. Numerical simulations utilizing molecular dynamics and hybrid quantum/classical calculations suggest a mechanism involving activation of a water molecule coordinated by a catalytic aspartic acid.	[Hamilton, John E.; Cunningham, Mark A.] Univ Texas Pan Amer, Dept Phys & Geol, Edinburg, TX 78539 USA; [Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Osipiuk, Jerzy; Mulligan, Rory; Bargassa, Monireh; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Texas System; University of Texas Rio Grande Valley; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Cunningham, MA (corresponding author), Univ Texas Pan Amer, Dept Phys & Geol, 1201 W Univ Dr, Edinburg, TX 78539 USA.	cunningham@utpa.edu; andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; United States Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; National Science Foundation [HRD-0703584]; Midwest Center for Structural Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1040430] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Midwest Center for Structural Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. This work has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a United States Department of Energy Office of Science laboratory, is operated under Contract DE-AC02-06CH11357.; Supported by National Science Foundation FaST program Grant HRD-0703584, administered by the Department of Educational Programs at Argonne National Laboratory.; We thank the members of the Midwest Center for Structural Biology for support, in particular Frank Collart, James Adbullah, and Garrett Cobb for efforts in cloning proteins, and Marat Valiev at Pacific Northwest National Laboratory for help with NWChem. We acknowledge the Texas Advanced Computing Center at the University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOOVER WG, 1986, PHYS REV A, V34, P2499, DOI 10.1103/PhysRevA.34.2499; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lesnyak DV, 2007, J BIOL CHEM, V282, P5880, DOI 10.1074/jbc.M608214200; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osicka R, 2004, J BIOL CHEM, V279, P24944, DOI 10.1074/jbc.M314013200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014	40	4	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19452	19461		10.1074/jbc.M112.358069	http://dx.doi.org/10.1074/jbc.M112.358069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493430	Green Published, hybrid			2022-12-28	WOS:000306411900059
J	Velisetty, P; Chakrapani, S				Velisetty, Phanindra; Chakrapani, Sudha			Desensitization Mechanism in Prokaryotic Ligand-gated Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTOR; BINDING-PROTEIN REVEALS; X-RAY-STRUCTURE; CONFORMATIONAL-CHANGES; SIDE-CHAINS; THERAPEUTIC TARGETS; CRYSTAL-STRUCTURE; QUANTITATIVE DESCRIPTION; MOLECULAR ARCHITECTURE	Crystal structures of Gloeobacter violaceus ligand-gated ion channel (GLIC), a proton-gated prokaryotic homologue of pentameric ligand-gated ion channel (LGIC) from G. violaceus, have provided high-resolution models of the channel architecture and its role in selective ion conduction and drug binding. However, it is still unclear which functional states of the LGIC gating scheme these crystal structures represent. Much of this uncertainty arises from a lack of thorough understanding of the functional properties of these prokaryotic channels. To elucidate the molecular events that constitute gating, we have carried out an extensive characterization of GLIC function and dynamics in reconstituted proteoliposomes by patch clamp measurements and EPR spectroscopy. We find that GLIC channels show rapid activation upon jumps to acidic pH followed by a time-dependent loss of conductance because of desensitization. GLIC desensitization is strongly coupled to activation and is modulated by voltage, permeant ions, pore-blocking drugs, and membrane cholesterol. Many of these properties are parallel to functions observed in members of eukaryotic LGIC. Conformational changes in loop C, measured by site-directed spin labeling and EPR spectroscopy, reveal immobilization during desensitization analogous to changes in LGIC and acetylcholine binding protein. Together, our studies suggest conservation of mechanistic aspects of desensitization among LGICs of prokaryotic and eukaryotic origin.	[Velisetty, Phanindra; Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Chakrapani, S (corresponding author), 10900 Euclid Ave,Robbins Bldg E620, Cleveland, OH 44106 USA.	sudha.chakrapani@case.edu		chakrapani, sudha/0000-0003-0722-2338				Alqazzaz M, 2011, BIOPHYS J, V101, P2912, DOI 10.1016/j.bpj.2011.10.055; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; Arias HR, 1998, BBA-REV BIOMEMBRANES, V1376, P173, DOI 10.1016/S0304-4157(98)00004-5; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Colon-Saez JO, 2011, J PHYSIOL-LONDON, V589, P3163, DOI 10.1113/jphysiol.2011.209494; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; DALZIEL AW, 1980, FEBS LETT, V122, P193, DOI 10.1016/0014-5793(80)80435-2; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Donnelly-Roberts D, 2011, BIOCHEM PHARMACOL, V82, P797, DOI 10.1016/j.bcp.2011.05.002; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Gopalakrishnan M, 2007, BIOCHEM PHARMACOL, V74, P1091, DOI 10.1016/j.bcp.2007.09.007; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Gross A, 2002, BIOCHEMISTRY-US, V41, P1123, DOI 10.1021/bi015828s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hibbs RE, 2004, J BIOL CHEM, V279, P28483, DOI 10.1074/jbc.M403713200; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; JURGENS UJ, 1985, ANN INST PASTEUR MIC, V136A, P41, DOI 10.1016/S0769-2609(85)80019-3; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MAGLEBY KL, 1981, J PHYSIOL-LONDON, V316, P225, DOI 10.1113/jphysiol.1981.sp013784; MANTHEY AA, 1966, J GEN PHYSIOL, V49, P963, DOI 10.1085/jgp.49.5.963; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Milone M, 1997, J NEUROSCI, V17, P5651; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; PALLOTTA BS, 1980, J GEN PHYSIOL, V75, P693, DOI 10.1085/jgp.75.6.693; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SCUKA M, 1992, PROG NEUROBIOL, V38, P19, DOI 10.1016/0301-0082(92)90033-B; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Yakel J, 2010, J PHYSIOL-LONDON, V588, P555, DOI 10.1113/jphysiol.2009.185488; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	89	46	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18467	18477		10.1074/jbc.M112.348045	http://dx.doi.org/10.1074/jbc.M112.348045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474322	Green Published, hybrid			2022-12-28	WOS:000306411600053
J	Jeon, JP; Hong, C; Park, EJ; Jeon, JH; Cho, NH; Kim, IG; Choe, H; Muallem, S; Kim, HJ; So, I				Jeon, Jae-Pyo; Hong, Chansik; Park, Eun Jung; Jeon, Ju-Hong; Cho, Nam-Hyuk; Kim, In-Gyu; Choe, Han; Muallem, Shmuel; Kim, Hyun Jin; So, Insuk			Selective G alpha(i) Subunits as Novel Direct Activators of Transient Receptor Potential Canonical (TRPC) 4 and TRPC5 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LIGHT-CHAIN KINASE; C-TERMINAL DOMAIN; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CATIONIC CURRENT; CALCIUM-CHANNEL; HEK293 CELLS; I-TASSER; PROTEIN	The ubiquitous transient receptor potential canonical (TRPC) channels function as non-selective, Ca2+-permeable channels and mediate numerous cellular functions. It is commonly assumed that TRPC channels are activated by stimulation of G alpha(q)-PLC-coupled receptors. However, whether the G alpha(q)-PLC pathway is the main regulator of TRPC4/5 channels and how other G alpha proteins may regulate these channels are poorly understood. We previously reported that TRPC4/TRPC5 can be activated by G alpha(i). In the current work, we found that G alpha(i) subunits, rather than G alpha(q), are the primary and direct activators of TRPC4 and TRPC5. We report a novel molecular mechanism in which TRPC4 is activated by several G alpha(i) subunits, most prominently by G alpha(i2), and TRPC5 is activated primarily by G alpha(i3). Activation of G alpha(i) by the muscarinic M2 receptors or expression of the constitutively active G alpha(i) mutants equally and fully activates the channels. Moreover, both TRPC4 and TRPC5 are activated by direct interaction of their conserved C-terminal SESTD (SEC14-like and spectrin-type domains) with the G alpha(i) subunits. Two amino acids (lysine 715 and arginine 716) of the TRPC4 C terminus were identified by structural modeling as mediating the interaction with G alpha(i2). These findings indicate an essential role of G alpha(i) proteins as novel activators for TRPC4/5 and reveal the molecular mechanism by which G-proteins activate the channels.	[Kim, Hyun Jin] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; [Jeon, Jae-Pyo; Hong, Chansik; Park, Eun Jung; Jeon, Ju-Hong; So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul 110799, South Korea; [Kim, In-Gyu] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110799, South Korea; [Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul 136748, South Korea; [Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kim, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea.	kimhyunjin@skku.edu; insuk@snu.ac.kr	Cho, Nam-Hyuk/D-6032-2012; Kim, In-Gyu/J-2747-2012; Park, Eun-Jung/GVT-6113-2022; So, Insuk/J-2762-2012; Jeon, Ju-Hong/D-5740-2012	choe, han/0000-0003-4604-647X; Jeon, Ju-Hong/0000-0002-5603-2955; Hong, Chansik/0000-0001-9684-4651	National Research Foundation of Korea; Ministry of Education, Science and Technology (MEST) [2008-2005948, 2010-0019472]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST) (2008-2005948 and 2010-0019472).	Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Jikim M, 2008, BIOCHEM BIOPH RES CO, V365, P239, DOI 10.1016/j.bbrc.2007.10.154; Kim BJ, 2008, BIOL PHARM BULL, V31, P1733, DOI 10.1248/bpb.31.1733; Kim BJ, 2007, CAN J PHYSIOL PHARM, V85, P1254, DOI 10.1139/Y07-118; Kim MT, 2006, AM J PHYSIOL-CELL PH, V290, pC1031, DOI 10.1152/ajpcell.00602.2004; Kim YC, 1998, PFLUG ARCH EUR J PHY, V436, P494, DOI 10.1007/s004240050663; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Lee KP, 2005, MOL CELLS, V20, P435; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakamoto T, 2007, J PHYSIOL-LONDON, V582, P41, DOI 10.1113/jphysiol.2007.133165; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; So Insuk, 2003, Journal of Smooth Muscle Research, V39, P231, DOI 10.1540/jsmr.39.231; Sung TS, 2011, AM J PHYSIOL-CELL PH, V301, pC823, DOI 10.1152/ajpcell.00351.2010; Sung TS, 2009, MOL CELLS, V27, P167, DOI 10.1007/s10059-009-0021-3; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Yan HD, 2003, BRIT J PHARMACOL, V139, P605, DOI 10.1038/sj.bjp.0705289; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1253, DOI 10.1152/ajpcell.00271.2009; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zholos AV, 1997, BRIT J PHARMACOL, V122, P885, DOI 10.1038/sj.bjp.0701438; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004	43	68	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17029	17039		10.1074/jbc.M111.326553	http://dx.doi.org/10.1074/jbc.M111.326553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457348	Green Published, hybrid			2022-12-28	WOS:000306373000004
J	Wang, YF; Rahman, D; Lehner, T				Wang, Yufei; Rahman, Durdana; Lehner, Thomas			A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; NF-KAPPA-B; DENDRITIC CELLS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IL-1-BETA SECRETION; CARRIER MOLECULES	The efficacy of a vaccine is generally dependent on an adjuvant, which enhances the immune functions and alum has been widely used in human immunization. Alum activates the intracellular stress sensors inflammasomes, but whether these are responsible for the adjuvanticity is controversial. The objectives of this investigation were to examine the hypothesis that alum-mediated adjuvanticity is a function of stress and conversely that stress agents will elicit adjuvanticity. The investigation was carried out in BALB/c mice by SC immunization with ovalbumin (OVA) mixed with alum. This elicited inflammasomes, with significant activation of caspase 1, production of IL-1 beta, and adjuvanticity, demonstrated by enhancing OVA-specific serum IgG antibodies, CD4(+) T cells, and proliferation. The novel finding that alum induced HSP70 suggests that stress is involved in the mechanism of adjuvanticity. This was confirmed by inhibition studies with PES (phenylethynesulfonamide), which disrupts inducible HSP70 function, and inhibited both inflammasomes and the adjuvant function. Parallel studies were pursued with an oxidative agent (sodium arsenite), K-releasing agent (Gramicidin) and a metal ionophore (dithiocarbamate). All 3 stress agents induced HSP70, inflammasomes, and the adjuvant functions. Furthermore, up-regulation of membrane associated IL-15 on DC and CD40L on T cells in the animals treated with alum or the stress agents mediate the interactions between splenic CD11c DC and CD4(+) or CD8(+) T cells. The results suggest that the three stress agents elicit HSP70, a hallmark of stress, as well as inflammasomes and adjuvanticity, commensurate with those of alum, which may provide an alternative strategy in developing novel adjuvants.	[Wang, Yufei; Rahman, Durdana; Lehner, Thomas] Kings Coll London, Guys Hosp, Mucosal Immunol Unit, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lehner, T (corresponding author), Kings Coll London, Guys Hosp, Mucosal Immunol Unit, Tower Wing Floor 28, London SE1 9RT, England.	thomas.lehner@kcl.ac.uk			European Union Network of Excellence, Europrise [LSHP-CT-2006-037611C]; ADITEC [280873]	European Union Network of Excellence, Europrise; ADITEC	This work was supported by the European Union Network of Excellence, Europrise (LSHP-CT-2006-037611C) and ADITEC (280873).	Andris F, 2011, J IMMUNOL, V186, P2245, DOI 10.4049/jimmunol.1002333; BARRIOS C, 1992, EUR J IMMUNOL, V22, P1365, DOI 10.1002/eji.1830220606; Bourinbaiar AS, 1997, ARCH VIROL, V142, P2225, DOI 10.1007/s007050050237; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dubos RJ, 1941, J EXP MED, V73, P629, DOI 10.1084/jem.73.5.629; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fang HL, 2011, J BIOL CHEM, V286, P30393, DOI 10.1074/jbc.M111.266528; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilbert P, 2010, J INFECT DIS, V202, P595, DOI 10.1086/654816; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; Lemarie A, 2008, J IMMUNOL, V180, P6010, DOI 10.4049/jimmunol.180.9.6010; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUSSOW AR, 1991, EUR J IMMUNOL, V21, P2297, DOI 10.1002/eji.1830211002; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Manlapat AK, 2007, EUR J IMMUNOL, V37, P1064, DOI 10.1002/eji.200636690; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Preston CM, 2008, J VIROL, V82, P11775, DOI 10.1128/JVI.01273-08; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Seubert A, 2011, P NATL ACAD SCI USA, V108, P11169, DOI 10.1073/pnas.1107941108; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tomlin C.D.S., 1994, PESTICIDE MANUAL; Vaccari A., 1997, J PHARMACOL EXP THER, V288, P1; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628	47	33	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17152	17160		10.1074/jbc.M112.347179	http://dx.doi.org/10.1074/jbc.M112.347179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474329	Green Published, hybrid			2022-12-28	WOS:000306373000015
J	Yamaguchi, Y; Hayashi, A; Campagnoni, CW; Kimura, A; Inuzuka, T; Baba, H				Yamaguchi, Yoshihide; Hayashi, Akiko; Campagnoni, Celia W.; Kimura, Akio; Inuzuka, Takashi; Baba, Hiroko			L-MPZ, a Novel Isoform of Myelin P0, Is Produced by Stop Codon Readthrough	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM IGG ANTIBODIES; RABBIT BETA-GLOBIN; PROTEIN ZERO; PERIPHERAL MYELIN; PO PROTEIN; 2-DIMENSIONAL ELECTROPHORESIS; TRANSLATIONAL READTHROUGH; CATIONIC DETERGENTS; DROSOPHILA TRACHEA; TERMINATION CODONS	Myelin protein zero (P0 or MPZ) is a major myelin protein (similar to 30 kDa) expressed in the peripheral nervous system (PNS) in terrestrial vertebrates. Several groups have detected a P0-related 36-kDa (or 35-kDa) protein that is expressed in the PNS as an antigen for the serum IgG of patients with neuropathy. The molecular structure and function of this 36-kDa protein are, however, still unknown. We hypothesized that the 36-kDa protein may be derived from P0 mRNA by stop codon readthrough. We found a highly conserved region after the regular stop codon in predicted sequences from the 3'-UTR of P0 in higher animals. MS of the 36-kDa protein revealed that both P0 peptides and peptides deduced from the P0 3'-UTR sequence were found among the tryptic fragments. In transfected cells and in an in vitro transcription/translation system, the 36-kDa molecule was also produced from the identical mRNA that produced P0. We designated this 36-kDa molecule as large myelin protein zero (L-MPZ), a novel isoform of P0 that contains an additional domain at the C terminus. In the PNS, L-MPZ was localized in compact myelin. In transfected cells, just like P0, L-MPZ was localized at cell-cell adhesion sites in the plasma membrane. These results suggest that L-MPZ produced by the stop codon readthrough mechanism is potentially involved in myelination. Since this is the first finding of stop codon readthrough in a common mammalian protein, detailed analysis of L-MPZ expression will help to understand the mechanism of stop codon readthrough in mammals.	[Yamaguchi, Yoshihide; Hayashi, Akiko; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, Hachioji, Tokyo 1920392, Japan; [Campagnoni, Celia W.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Kimura, Akio; Inuzuka, Takashi] Gifu Univ, Grad Sch Med, Dept Neurol & Geriatr, Gifu 5011194, Japan	Tokyo University of Pharmacy & Life Sciences; University of California System; University of California Los Angeles; Gifu University	Yamaguchi, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yoshiy@toyaku.ac.jp		Yamaguchi, Yoshihide/0000-0002-5686-9325	Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health [H20-015]; Promotion and Mutual Aid Corporation for Private Schools of Japan	Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This research was supported by a Japanese Health and Labor Sciences Research Grant for Research on Psychiatry and Neurological Diseases and Mental Health (H20-015), and the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Besancon R, 1999, FEBS LETT, V457, P339, DOI 10.1016/S0014-5793(99)01069-8; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; DOYLE JP, 1995, J CELL BIOL, V131, P465, DOI 10.1083/jcb.131.2.465; Favereaux A, 2003, J NEUROL NEUROSUR PS, V74, P1262, DOI 10.1136/jnnp.74.9.1262; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; Freeze H. H., 2010, CURR PROTOC PROTEIN; HATFIELD D, 1988, BIOCHEMISTRY-US, V27, P1179, DOI 10.1021/bi00404a017; HAYASAKA K, 1991, BIOCHEM BIOPH RES CO, V180, P515, DOI 10.1016/S0006-291X(05)81094-0; Ishida K, 2001, J NEUROL SCI, V188, P43, DOI 10.1016/S0022-510X(01)00547-0; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; MARTIN R, 1989, MOL GEN GENET, V217, P411, DOI 10.1007/BF02464911; Melendez-Vasquez CV, 1998, J NEUROIMMUNOL, V91, P10, DOI 10.1016/S0165-5728(98)00102-7; NOBILEORAZIO E, 1994, J NEUROIMMUNOL, V53, P143, DOI 10.1016/0165-5728(94)90024-8; PHILLIPSJONES MK, 1995, MOL CELL BIOL, V15, P6593; Rotenstein L, 2008, BRAIN BEHAV EVOLUT, V72, P48, DOI 10.1159/000145717; Shy ME, 2006, J NEUROL SCI, V242, P55, DOI 10.1016/j.jns.2005.11.015; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; VALLE RPC, 1992, FEBS LETT, V306, P133, DOI 10.1016/0014-5793(92)80984-O; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; WONG MH, 1994, J CELL BIOL, V126, P1089, DOI 10.1083/jcb.126.4.1089; Xu WB, 2001, J CELL BIOL, V155, P439, DOI 10.1083/jcb.200107114; Yamaguchi Y, 2008, J NEUROSCI RES, V86, P766, DOI 10.1002/jnr.21549; Yamaguchi Y, 2008, J NEUROSCI RES, V86, P755, DOI 10.1002/jnr.21547; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5	31	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17765	17776		10.1074/jbc.M111.314468	http://dx.doi.org/10.1074/jbc.M111.314468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457349	Green Published, hybrid			2022-12-28	WOS:000306373000075
J	Zhou, J; Qin, L; Tien, JCY; Gao, L; Chen, X; Wang, F; Hsieh, JT; Xu, JM				Zhou, Jian; Qin, Li; Tien, Jean Ching-Yi; Gao, Li; Chen, Xian; Wang, Fen; Hsieh, Jer-Tsong; Xu, Jianming			Nkx3.1 Functions as Para-transcription Factor to Regulate Gene Expression and Cell Proliferation in Non-cell Autonomous Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC INTRAEPITHELIAL NEOPLASIA; HOMEOBOX GENE; ALLELIC LOSS; CHROMOSOME 8P12-21; CANCER; CARCINOGENESIS; MICE; IDENTIFICATION; ASSOCIATION; PROGRESSION	Nkx3.1 is a homeoprotein transcription factor (TF) that inhibits proliferation of prostate epithelial cells (PECs) and acts as a tumor suppressor for prostate cancer (PCa). Because TFs classically function within the cells that produce them, Nkx3.1-induced growth inhibition was considered to occur in a cell-autonomous manner. We, however, found that Nkx3.1 protein can be secreted from cultured PECs and is detectable in the prostatic fluid and urine. A PCa-related point mutation (T164A) abolished Nkx3.1 secretion. Amazingly, secreted Nkx3.1 protein can translocate into adjacent cells, bind to the regulatory sequence of Nkx3.1 target genes and impact the expression of these genes in these adjacent cells. Expression of Nkx3.1 in PECs can also affect gene expression in adjacent cells, and this effect is abolished by the T164A mutation. Nkx3.1 protein inhibits cell proliferation when added to the culture. Expression of Nkx3.1, not the T164A mutant, also inhibits the proliferation of co-cultured cells. These results indicate that Nkx3.1 functions as a "para-transcription factor (PTF)," with the ability to regulate genes and inhibit cell proliferation in a non-cell autonomous manner. We also demonstrate that Nkx3.1 contains an evolutionarily conserved protein transduction domain essential for its PTF function, implicating potentially common PTF function among homeoproteins. In addition to the PCa-related T164A mutant, the secreted Nkx3.1 is reduced drastically in the prostatic fluid and urine of mice with PCa. These results indicate that Nkx3.1 can function as a PTF to suppress PCa and the urinary Nkx3.1 may be a potential biomarker for PCa diagnosis.	[Zhou, Jian; Qin, Li; Tien, Jean Ching-Yi; Gao, Li; Chen, Xian; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tien, Jean Ching-Yi; Chen, Xian; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Hsieh, Jer-Tsong] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Hsieh, Jer-Tsong] China Med Univ Hosp, Grad Inst Canc Biol, Taichung 40447, Taiwan; [Xu, Jianming] Luzhou Med Coll, Luzhou 646000, Sichuan, Peoples R China	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Hospital - Taiwan; Southwest Medical University	Zhou, J (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	jian.zhou@bcm.edu; jxu@bcm.edu		Qin, Li/0000-0003-0099-4992	National Institutes of Health [R01 DK058242, R01 CA112403, 3R01CA112403-04S1]; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA112403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 DK058242, R01 CA112403, and 3R01CA112403-04S1 (to J. X.).	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Akamatsu S, 2010, HUM MOL GENET, V19, P4265, DOI 10.1093/hmg/ddq350; Aslan G, 2006, PATHOL RES PRACT, V202, P93, DOI 10.1016/j.prp.2005.11.007; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bowen C, 2000, CANCER RES, V60, P6111; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; EMMERTBUCK MR, 1995, CANCER RES, V55, P2959; Gelmann EP, 2003, PROSTATE, V55, P111, DOI 10.1002/pros.10210; Haggman MJ, 1997, UROLOGY, V50, P643, DOI 10.1016/S0090-4295(97)00304-X; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Kim MJ, 2002, CANCER RES, V62, P2999; Korkmaz CG, 2004, J UROLOGY, V172, P1134, DOI 10.1097/01.ju.0000136526.78535.b8; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Ornstein DK, 2001, J UROLOGY, V165, P1329, DOI 10.1016/S0022-5347(01)69894-X; Qin L, 2011, CANCER RES, V71, P1742, DOI 10.1158/0008-5472.CAN-10-3453; SAKR WA, 1994, CANCER RES, V54, P3273; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Swalwell JI, 2002, GENE CHROMOSOME CANC, V33, P201, DOI 10.1002/gcc.10015; Tanaka M, 1999, MECH DEVELOP, V85, P179, DOI 10.1016/S0925-4773(99)00084-2; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Vocke CD, 1996, CANCER RES, V56, P2411; Voeller HJ, 1997, CANCER RES, V57, P4455; Xu LL, 2000, J UROLOGY, V163, P972, DOI 10.1016/S0022-5347(05)67867-6; Zheng SL, 2006, CANCER RES, V66, P69, DOI 10.1158/0008-5472.CAN-05-1550; Zhou J, 2005, CANCER RES, V65, P9906, DOI 10.1158/0008-5472.CAN-05-1481; Zhou J, 2012, AMINO ACIDS, V42, P1253, DOI 10.1007/s00726-010-0817-7	32	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17248	17256		10.1074/jbc.M111.336909	http://dx.doi.org/10.1074/jbc.M111.336909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22465996	Green Published, hybrid			2022-12-28	WOS:000306373000025
J	Holakovska, B; Grycova, L; Jirku, M; Sulc, M; Bumba, L; Teisinger, J				Holakovska, Blanka; Grycova, Lenka; Jirku, Michaela; Sulc, Miroslav; Bumba, Ladislav; Teisinger, Jan			Calmodulin and S100A1 Protein Interact with N Terminus of TRPM3 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; BINDING DOMAIN; RECOGNITION; RECEPTOR; INSIGHTS; COMPLEX; ERRORS	Transient receptor potential melastatin 3 ion channel (TRPM3) belongs to the TRP family of cation-permeable ion channels involved in many important biological functions such as pain transduction, thermosensation, and mechanoregulation. The channel was reported to play an important role in Ca2+ homeostasis, but its gating mechanisms, functions, and regulation are still under research. Utilizing biophysical and biochemical methods, we characterized two independent domains, Ala-35-Lys-124 and His-291-Gly-382, on the TRPM3 N terminus, responsible for interactions with the Ca2+-binding proteins calmodulin (CaM) and S100A1. We identified several positively charged residues within these domains as having a crucial impact on CaM/S100A1 binding. The data also suggest that the interaction is calcium-dependent. We also performed competition assays, which suggested that CaM and S100A1 are able to compete for the same binding sites within the TRPM3 N terminus. This is the first time that such an interaction has been shown for TRP family members.	[Teisinger, Jan] Acad Sci Czech Republ, Inst Physiol, Dept Prot Struct, CR-14220 Prague, Czech Republic; [Sulc, Miroslav; Bumba, Ladislav] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Teisinger, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Prot Struct, Videnska 1083, CR-14220 Prague, Czech Republic.	teisingr@biomed.cas.cz	Holendova, Blanka/A-7170-2016; Bumba, Ladislav/ABC-9943-2020; Vodičková, Michaela/O-8121-2017; Bumba, Ladislav/H-2494-2014; Teisinger, Jan/B-7122-2012; Grycova, Lenka/B-7118-2012; Sulc, Miroslav/K-1029-2014	Holendova, Blanka/0000-0002-3904-8189; Bumba, Ladislav/0000-0001-6659-5447; Vodičková, Michaela/0000-0002-0163-1432; Grycova, Lenka/0000-0002-6476-3627; Sulc, Miroslav/0000-0002-2659-0489	Grant Agency of the Czech Republic [GACR 301/10/1159, GACR P205/10/P308, GACR 207/11/0717]; Academy of Sciences of the Czech Republic [AV0Z50110509]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This study was supported by the Grant Agency of the Czech Republic (Grants GACR 301/10/1159, GACR P205/10/P308, and GACR 207/11/0717) and the Academy of Sciences of the Czech Republic (Research Project AV0Z50110509).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Friedlova E, 2010, NEUROCHEM INT, V56, P363, DOI 10.1016/j.neuint.2009.11.009; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P291; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Minke B, 2006, ANNU REV PHYSIOL, V68, P649, DOI 10.1146/annurev.physiol.68.040204.100939; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Prochazkova K, 2005, J BIOL CHEM, V280, P3251, DOI 10.1074/jbc.M411232200; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	37	36	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16645	16655		10.1074/jbc.M112.350686	http://dx.doi.org/10.1074/jbc.M112.350686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451665	Green Published, hybrid			2022-12-28	WOS:000304030900053
J	Rawat, R; Yu, XH; Sweet, M; Shanklin, J				Rawat, Richa; Yu, Xiao-Hong; Sweet, Marie; Shanklin, John			Conjugated Fatty Acid Synthesis RESIDUES 111 AND 115 INFLUENCE PRODUCT PARTITIONING OF MOMORDICA CHARANTIA CONJUGASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESATURASE-RELATED ENZYMES; BIOSYNTHETIC ORIGIN; ALKANE HYDROXYLASE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SEED OIL; TOPOLOGY; BONDS; GENE; EVOLUTION	Conjugated linolenic acids (CLNs), 18: 3 Delta(9,11,13), lack the methylene groups found between the double bonds of linolenic acid (18: 3 Delta(9,12,15)). CLNs are produced by conjugase enzymes that are homologs of the oleate desaturases FAD2. The goal of this study was to map the domain(s) within the Momordica charantia conjugase (FADX) responsible for CLN formation. To achieve this, a series of Momordica FADX-Arabidopsis FAD2 chimeras were expressed in the Arabidopsis fad3fae1 mutant, and the transformed seeds were analyzed for the accumulation of CLN. These experiments identified helix 2 and the first histidine box as a determinant of conjugase product partitioning into punicic acid (18: 3 Delta(9cis,11trans,13cis)) or alpha-eleostearic acid (18:3 Delta(9cis,11trans,13trans)). This was confirmed by analysis of a FADX mutant containing six substitutions in which the sequence of helix 2 and first histidine box was converted to that of FAD2. Each of the six FAD2 substitutions was individually converted back to the FADX equivalent identifying residues 111 and 115, adjacent to the first histidine box, as key determinants of conjugase product partitioning. Additionally, expression of FADX G111V and FADX G111V/D115E resulted in an approximate doubling of eleostearic acid accumulation to 20.4% and 21.2%, respectively, compared with 9.9% upon expression of the native Momordica FADX. Like the Momordica conjugase, FADX G111V and FADX D115E produced predominantly alpha-eleostearic acid and little punicic acid, but the FADX G111V/D115E double mutant produced approximately equal amounts of alpha-eleostearic acid and its isomer, punicicacid, implicating an interactive effect of residues 111 and 115 in punicic acid formation.	[Sweet, Marie; Shanklin, John] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Rawat, Richa; Yu, Xiao-Hong; Shanklin, John] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463,50 Bell Ave, Upton, NY 11973 USA.	shanklin@bnl.gov		Shanklin, John/0000-0002-6774-8043; Yu, Xiao-Hong/0000-0003-2352-2023	Office of Basic Energy Sciences of the United States Department of Energy; National Science Foundation [DBI 0701919]; DOE Science Undergraduate Laboratory Internship	Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); DOE Science Undergraduate Laboratory Internship(United States Department of Energy (DOE))	This work was supported by the Office of Basic Energy Sciences of the United States Department of Energy (to J. S.) and by National Science Foundation Grant DBI 0701919 (to R. R. and X.-H. Y.). M. S. was supported by the 2010 and 2011 DOE Science Undergraduate Laboratory Internship program.	Badami R C, 1980, Prog Lipid Res, V19, P119; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; BUTTE W, 1982, ANAL LETT PT A, V15, P841, DOI 10.1080/00032718208069519; Cahoon EB, 1999, P NATL ACAD SCI USA, V96, P12935, DOI 10.1073/pnas.96.22.12935; Cahoon EB, 2001, J BIOL CHEM, V276, P2637, DOI 10.1074/jbc.M009188200; CAHOON EB, 2007, Patent No. 7244563; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Carlsson AS, 2004, EUR J BIOCHEM, V271, P2991, DOI 10.1111/j.1432-1033.2004.04231.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CROMBIE L, 1985, J CHEM SOC PERK T 1, P2425, DOI 10.1039/p19850002425; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Gagne SJ, 2009, BIOCHEMISTRY-US, V48, P12298, DOI 10.1021/bi901605d; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; HOPKINS CY, 1968, J AM OIL CHEM SOC, V45, P176, DOI 10.1007/BF02915346; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Iwabuchi M, 2003, J BIOL CHEM, V278, P4603, DOI 10.1074/jbc.M210748200; JOH YG, 1995, J AM OIL CHEM SOC, V72, P1037, DOI 10.1007/BF02660718; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Libisch B, 2000, BIOCHEM BIOPH RES CO, V279, P779, DOI 10.1006/bbrc.2000.4023; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; MCLEAN J, 1956, J CHEM SOC, P777; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Mitaku S, 1999, BIOPHYS CHEM, V82, P165, DOI 10.1016/S0301-4622(99)00116-7; Ozgul-Yucel S, 2005, J AM OIL CHEM SOC, V82, P893, DOI 10.1007/s11746-005-1161-7; Pidkowich MS, 2007, P NATL ACAD SCI USA, V104, P4742, DOI 10.1073/pnas.0611141104; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Qiu X, 2001, PLANT PHYSIOL, V125, P847, DOI 10.1104/pp.125.2.847; Reed DW, 2002, EUR J BIOCHEM, V269, P5024, DOI 10.1046/j.1432-1033.2002.03209.x; Sayanova O, 2000, BIOCHEM SOC T, V28, P636, DOI 10.1042/BST0280636; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Smith Jr C. R., 1971, PROGR CHEM FATS OTHE, V11, P137, DOI 10.1016/0079-6832(71)90005-X; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Stuitje AR, 2003, PLANT BIOTECHNOL J, V1, P301, DOI 10.1046/j.1467-7652.2003.00028.x; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VANBEILEN JB, 1992, J BIOL CHEM, V267, P9194; Vanhercke T, 2011, J BIOL CHEM, V286, P12860, DOI 10.1074/jbc.M110.191098; Whittle EJ, 2008, P NATL ACAD SCI USA, V105, P14738, DOI 10.1073/pnas.0805645105	41	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16230	16237		10.1074/jbc.M111.325316	http://dx.doi.org/10.1074/jbc.M111.325316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451660	hybrid, Green Published			2022-12-28	WOS:000304030900015
J	Xu, QS; Isaji, T; Lu, YY; Gu, W; Kondo, M; Fukuda, T; Du, YG; Gu, JG				Xu, Qingsong; Isaji, Tomoya; Lu, Yingying; Gu, Wei; Kondo, Madoka; Fukuda, Tomohiko; Du, Yuguang; Gu, Jianguo			Roles of N-Acetylglucosaminyltransferase III in Epithelial-to-Mesenchymal Transition Induced by Transforming Growth Factor beta 1 (TGF-beta 1) in Epithelial Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; GLYCOSYLATION AFFECTS; TUMOR PROGRESSION; BREAST-CARCINOMA; PROPELLER DOMAIN; BISECTING GLCNAC; MOUSE MELANOMA; EXPRESSION; ADHESION; CATENIN	The epithelial-to-mesenchymal transition (EMT) plays crucial roles in embryonic development, wound healing, tissue repair, and cancer progression. Results of this study show how transforming growth factor beta 1 (TGF-beta 1) down-regulates expression of N-acetylglucosaminyltransferase III (GnT-III) during EMT-like changes. Treatment with TGF-beta 1 resulted in a decrease in E-cadherin expression and GnT-III expression, as well as its product, the bisected N-glycans, which was confirmed by erythro-agglutinating phytohemagglutinin lectin blot and HPLC analysis in human MCF-10A and mouse GE11 cells. In contrast with GnT-III, the expression of N-acetylglucosaminyltransferase V was slightly enhanced by TGF-beta 1 treatment. Changes in the N-glycan patterns on alpha 3 beta 1 integrin, one of the target proteins for GnT-III, were also confirmed by lectin blot analysis. To understand the roles of GnT-III expression in EMT-like changes, the MCF-10A cell was stably transfected with GnT-III. It is of particular interest that overexpression of GnT-III influenced EMT-like changes induced by TGF-beta 1, which was confirmed by cell morphological changes of phase contrast, immunochemical staining patterns of E-cadherin, and actin. In addition, GnT-III modified E-cadherin, which served to prolong E-cadherin turnover on the cell surface examined by biotinylation and pulse-chase experiments. GnT-III expression consistently inhibited beta-catenin translocation from cell-cell contact into the cytoplasm and nucleus. Furthermore, the transwell assay showed that GnT-III expression suppressed TGF-beta 1-induced cell motility. Taken together, these observations are the first to clearly demonstrate that GnT-III affects cell properties, which in turn influence EMT-like changes, and to explain a molecular mechanism for the inhibitory effects of GnT-III on cancer metastasis.	[Xu, Qingsong; Isaji, Tomoya; Lu, Yingying; Gu, Wei; Kondo, Madoka; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Xu, Qingsong; Du, Yuguang] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China	Tohoku Medical & Pharmaceutical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Japan Society for the Promotion of Science [21370059, 22770130, 23651196]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Mizutani Foundation for Glycoscience; National Natural Science Foundation of China [NSFC 31100589]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grants-in-aid for Scientific Research 21370059 (to J. G.) and 22770130 (to T. I.), Challenging Exploratory Research Grant 23651196 (to J. G.) from the Japan Society for the Promotion of Science, the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Mizutani Foundation for Glycoscience, and in part by National Natural Science Foundation of China Grant NSFC 31100589 (to Q. S.).	Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; Asada M, 1997, CANCER RES, V57, P1073; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Granovsky M, 2000, NAT MED, V6, P306; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; MIYOSHI E, 1995, J BIOL CHEM, V270, P6216, DOI 10.1074/jbc.270.11.6216; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Schachter H, 1986, Adv Exp Med Biol, V205, P53; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Uozumi N, 1996, J BIOCHEM, V120, P385; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Xu QS, 2011, J BIOL CHEM, V286, P4310, DOI 10.1074/jbc.M110.182576; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	75	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16563	16574		10.1074/jbc.M111.262154	http://dx.doi.org/10.1074/jbc.M111.262154			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451656	Green Published, hybrid			2022-12-28	WOS:000304030900046
J	Sun, L; Lv, FX; Guo, XM; Gao, GX				Sun, Lin; Lv, Fengxiang; Guo, Xuemin; Gao, Guangxia			Glycogen Synthase Kinase 3 beta (GSK3 beta) Modulates Antiviral Activity of Zinc-finger Antiviral Protein (ZAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MESSENGER-RNAS; GSK3 INHIBITORS; EXPRESSION; MECHANISM; SUBSTRATE; SITES; TAU	Zinc-finger antiviral protein (ZAP) is a host factor that specifically inhibits the replication of certain viruses, including HIV-1, Ebola virus, and Sindbis virus. ZAP binds directly to specific viral mRNAs and recruits cellular mRNA degradation machinery to degrade the target RNA. ZAP has also been suggested to repress translation of the target mRNA. In this study, we report that ZAP is phosphorylated by glycogen synthase kinase 3 beta (GSK3 beta). GSK3 beta sequentially phosphorylated Ser-270, Ser-266, Ser-262, and Ser-257 of rat ZAP. Inhibition of GSK3 beta by inhibitor SB216763 or down-regulation of GSK3 beta by RNAi reduced the antiviral activity of ZAP. These results indicate that phosphorylation of ZAP by GSK3 beta modulates ZAP activity.	[Sun, Lin; Lv, Fengxiang; Guo, Xuemin; Gao, Guangxia] Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Gao, GX (corresponding author), Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	gaogx@moon.ibp.ac.cn	Sun, Lin/I-3146-2016		Ministry of Science and Technology [2012CB910203]; National Science Foundation [30530020, 81028011]; Ministry of Health of China [2012ZX10001-006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation(National Science Foundation (NSF)); Ministry of Health of China	This work was supported by Ministry of Science and Technology 973 Program Grant 2012CB910203, National Science Foundation Grants 30530020 and 81028011, and Ministry of Health of China Grant 2012ZX10001-006 (to G. G.).	Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hernandez F, 2009, MINI-REV MED CHEM, V9, P1024, DOI 10.2174/138955709788922647; Hernandez F, 2008, FEBS LETT, V582, P3848, DOI 10.1016/j.febslet.2008.10.026; Imahori K, 1997, J BIOCHEM, V121, P179; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang XL, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-19; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	34	11	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22882	22888		10.1074/jbc.M111.306373	http://dx.doi.org/10.1074/jbc.M111.306373			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22514281	Green Published, hybrid			2022-12-28	WOS:000306495000045
J	Benabbas, A; Karunakaran, V; Youn, H; Poulos, TL; Champion, PM				Benabbas, Abdelkrim; Karunakaran, Venugopal; Youn, Hwan; Poulos, Thomas L.; Champion, Paul M.			Effect of DNA Binding on Geminate CO Recombination Kinetics in CO-sensing Transcription Factor CooA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOMIC LIGAND-BINDING; CARBON-MONOXIDE; HEME DOMAIN; ULTRAFAST DYNAMICS; FERROUS-HEME; PROTEIN; ACTIVATOR; MECHANISM; SPECTROSCOPY; RELAXATION	Carbon monoxide oxidation activator (CooA) proteins are heme-based CO-sensing transcription factors. Here we study the ultrafast dynamics of geminate CO rebinding in two CooA homologues, Rhodospirillum rubrum (RrCooA) and Carboxydothermus hydrogenoformans (ChCooA). The effects of DNA binding and the truncation of the DNA-binding domain on the CO geminate recombination kinetics were specifically investigated. The CO rebinding kinetics in these CooA complexes take place on ultrafast time scales but remain non-exponential over many decades in time. We show that this non-exponential kinetic response is due to a quenched enthalpic barrier distribution resulting from a distribution of heme geometries that is frozen or slowly evolving on the time scale of CO rebinding. We also show that, upon CO binding, the distal pocket of the heme in the CooA proteins relaxes to form a very efficient hydrophobic trap for CO. DNA binding further tightens the narrow distal pocket and slightly weakens the iron-proximal histidine bond. Comparison of the CO rebinding kinetics of RrCooA, truncated RrCooA, and DNA-bound RrCooA proteins reveals that the uncomplexed and inherently flexible DNA-binding domain adds additional structural heterogeneity to the heme doming coordinate. When CooA forms a complex with DNA, the flexibility of the DNA-binding domain decreases, and the distribution of the conformations available in the heme domain becomes restricted. The kinetic studies also offer insights into how the architecture of the heme environment can tune entropic barriers in order to control the geminate recombination of CO in heme proteins, whereas spin selection rules play a minor or non-existent role.	[Champion, Paul M.] Northeastern Univ, Dept Phys, Dana Res Ctr 111, Boston, MA 02115 USA; [Benabbas, Abdelkrim; Karunakaran, Venugopal; Champion, Paul M.] Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; [Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Northeastern University; Northeastern University; California State University System; California State University Fresno; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Champion, PM (corresponding author), Northeastern Univ, Dept Phys, Dana Res Ctr 111, Boston, MA 02115 USA.	champ@neu.edu			National Institutes of Health [DK35090, GM42614]; National Science Foundation [MCB-0744738]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK35090 (to P. M. C.) and GM42614 (to T. L. P.). This work was also supported by National Science Foundation Grant MCB-0744738 (to P. M. C.).	Akiyama S, 2004, J MOL BIOL, V341, P651, DOI 10.1016/j.jmb.2004.06.040; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aono S, 2008, DALTON T, P3137, DOI 10.1039/b802070c; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Benabbas A, 2010, J AM CHEM SOC, V132, P2811, DOI 10.1021/ja910005b; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Coyle CM, 2003, J BIOL CHEM, V278, P35384, DOI 10.1074/jbc.M301000200; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Franzen S, 2002, P NATL ACAD SCI USA, V99, P16754, DOI 10.1073/pnas.252590999; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; Gruia F, 2007, BIOPHYS J, V93, P4404, DOI 10.1529/biophysj.107.114736; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Ibrahim M, 2007, J INORG BIOCHEM, V101, P1776, DOI 10.1016/j.jinorgbio.2007.07.010; Ibrahim M, 2006, J BIOL CHEM, V281, P29165, DOI 10.1074/jbc.M605568200; Inagaki S, 2005, J BIOL CHEM, V280, P3269, DOI 10.1074/jbc.M409884200; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; Karunakaran V, 2011, J AM CHEM SOC, V133, P18816, DOI 10.1021/ja206152m; Kruglik SG, 2007, P NATL ACAD SCI USA, V104, P7408, DOI 10.1073/pnas.0700445104; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Kuchinskas M, 2006, BIOCHEMISTRY-US, V45, P7148, DOI 10.1021/bi052609o; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; LIM M, 1995, SCIENCE, V269, P962, DOI 10.1126/science.7638619; Park J, 2010, J PHYS CHEM B, V114, P10897, DOI 10.1021/jp1050436; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Rubtsov IV, 2001, J AM CHEM SOC, V123, P10056, DOI 10.1021/ja011023w; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SRAJER V, 1988, J AM CHEM SOC, V110, P6656, DOI 10.1021/ja00228a009; Strickland N, 2007, J PHYS CHEM B, V111, P841, DOI 10.1021/jp064091j; TIAN WD, 1992, PHYS REV LETT, V68, P408, DOI 10.1103/PhysRevLett.68.408; Uchida T, 1998, J BIOL CHEM, V273, P19988, DOI 10.1074/jbc.273.32.19988; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Ye X, 2007, P NATL ACAD SCI USA, V104, P14682, DOI 10.1073/pnas.0702622104; Youn H, 2004, J BIOL CHEM, V279, P45744, DOI 10.1074/jbc.M404336200; Youn H, 2004, J BACTERIOL, V186, P1320, DOI 10.1128/JB.186.5.1320-1329.2004; Yu AC, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2126808; Zhang ZY, 2009, J PHYS CHEM B, V113, P10923, DOI 10.1021/jp9031805	54	16	16	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21729	21740		10.1074/jbc.M112.345090	http://dx.doi.org/10.1074/jbc.M112.345090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544803	Green Published, hybrid			2022-12-28	WOS:000306418600014
J	Hager, L; Li, LX; Pun, H; Liu, L; Hossain, MA; Maguire, GF; Naples, M; Baker, C; Magomedova, L; Tam, J; Adeli, K; Cummins, CL; Connelly, PW; Ng, DS				Hager, Lauren; Li, Lixin; Pun, Henry; Liu, Lu; Hossain, Mohammad A.; Maguire, Graham F.; Naples, Mark; Baker, Chris; Magomedova, Lilia; Tam, Jonathan; Adeli, Khosrow; Cummins, Carolyn L.; Connelly, Philip W.; Ng, Dominic S.			Lecithin:Cholesterol Acyltransferase Deficiency Protects against Cholesterol-induced Hepatic Endoplasmic Reticulum Stress in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK C1-LIKE 1; DIET-INDUCED OBESITY; LCAT-NULL MICE; GLUCOSE-HOMEOSTASIS; GENE-EXPRESSION; LDL RECEPTOR; LECITHIN; ATHEROSCLEROSIS; IDENTIFICATION; ACCUMULATION	We recently reported that lecithin:cholesterol acyltransferase (LCAT) knock-out mice, particularly in the LDL receptor knock-out background, are hypersensitive to insulin and resistant to high fat diet-induced insulin resistance (IR) and obesity. We demonstrated that chow-fed Ldlr-/-xLcat+/+ mice have elevated hepatic endoplasmic reticulum (ER) stress, which promotes IR, compared with wild-type controls, and this effect is normalized in Ldlr-/-xLcat-/- mice. In the present study, we tested the hypothesis that hepatic ER cholesterol metabolism differentially regulates ER stress using these models. We observed that the Ldlr-/-xLcat+/+ mice accumulate excess hepatic total and ER cholesterol primarily attributed to increased reuptake of biliary cholesterol as we observed reduced biliary cholesterol in conjunction with decreased hepatic Abcg5/g8 mRNA, increased Npc1l1 mRNA, and decreased Hmgr mRNA and nuclear SREBP2 protein. Intestinal NPC1L1 protein was induced. Expression of these genes was reversed in the Ldlr-/-xLcat-/- mice, accounting for the normalization of total and ER cholesterol and ER stress. Upon feeding a 2% high cholesterol diet (HCD), Ldlr-/-xLcat-/- mice accumulated a similar amount of total hepatic cholesterol compared with the Ldlr-/-xLcat+/+ mice, but the hepatic ER cholesterol levels remained low in conjunction with being protected from HCD-induced ER stress and IR. Hepatic ER stress correlates strongly with hepatic ER free cholesterol but poorly with hepatic tissue free cholesterol. The unexpectedly low ER cholesterol seen in HCD-fed Ldlr-/-xLcat-/- mice was attributable to a coordinated marked up-regulation of ACAT2 and suppressed SREBP2 processing. Thus, factors influencing the accumulation of ER cholesterol may be important for the development of hepatic insulin resistance.	[Hager, Lauren; Li, Lixin; Pun, Henry; Liu, Lu; Hossain, Mohammad A.; Maguire, Graham F.; Tam, Jonathan; Connelly, Philip W.; Ng, Dominic S.] St Michaels Hosp, Keenan Res Ctr, Dept Med, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Hager, Lauren; Ng, Dominic S.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON M5S 1A8, Canada; [Adeli, Khosrow; Connelly, Philip W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Naples, Mark; Baker, Chris; Adeli, Khosrow] Hosp Sick Children, Div Biochem, Toronto, ON M5G 1X8, Canada; [Magomedova, Lilia; Cummins, Carolyn L.] Univ Toronto, Fac Pharm, Toronto, ON M5S 3M2, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ng, DS (corresponding author), St Michaels Hosp, Keenan Res Ctr, Dept Med, Li Ka Shing Knowledge Inst, 30 Bond St,Shuter 3-041, Toronto, ON M5B 1W8, Canada.	ngd@smh.toronto.on.ca	Connelly, Philip W/B-7583-2012; Li, Lixin/F-3034-2014	Connelly, Philip W/0000-0001-7244-6843; Li, Lixin/0000-0003-3016-4228; Cummins, Carolyn/0000-0001-7603-6577; Adeli, Khosrow/0000-0002-5839-5709	Heart and Stroke Foundation of Ontario [NA6331]; Canadian Institutes of Health Research [MOP-97904]; Natural Science and Engineering Research Council [RGPIN 356873-08]; Canada Foundation for Innovation	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported in part by a Grant-in-aid from the Heart and Stroke Foundation of Ontario to D. S. N. (NA6331), K. A., and P. W. C., Canadian Institutes of Health Research Operating Grant MOP-97904, Natural Science and Engineering Research Council Grant RGPIN 356873-08, and a Canada Foundation for Innovation infrastructure grant (to C. L. C.).	Brown J. Mark, 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P18; Calpe-Berdiel L, 2005, ATHEROSCLEROSIS, V181, P75, DOI 10.1016/j.atherosclerosis.2004.11.025; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Das A, 2008, J BIOL CHEM, V283, P10453, DOI 10.1074/jbc.M709460200; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Elferink RPJO, 2011, EXPERT OPIN THER TAR, V15, P1173, DOI 10.1517/14728222.2011.607163; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROHLICH J, 1988, METABOLISM, V37, P3, DOI 10.1016/0026-0495(88)90021-2; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Klett EL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-21; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lambert G, 2001, J BIOL CHEM, V276, P15090, DOI 10.1074/jbc.M008466200; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Li LX, 2007, AM J PHYSIOL-ENDOC M, V293, pE587, DOI 10.1152/ajpendo.00278.2007; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Ng DS, 2004, J BIOL CHEM, V279, P7636, DOI 10.1074/jbc.M309439200; Ng DS, 2002, J BIOL CHEM, V277, P11715, DOI 10.1074/jbc.M112320200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Pramfalk C, 2011, CURR OPIN LIPIDOL, V22, P225, DOI 10.1097/MOL.0b013e3283468c28; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Song H, 2006, AM J PHYSIOL-ENDOC M, V290, pE17, DOI 10.1152/ajpendo.00597.2004; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Taghibiglou C, 2000, J LIPID RES, V41, P499; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Yamanashi Y, 2012, HEPATOLOGY, V55, P953, DOI 10.1002/hep.24772; Yamanashi Y, 2011, GASTROENTEROLOGY, V140, P1664, DOI 10.1053/j.gastro.2011.01.050; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X	39	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20755	20768		10.1074/jbc.M112.340919	http://dx.doi.org/10.1074/jbc.M112.340919			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22500017	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306414500094
J	Han, LZ; Pan, Y; Wang, BL				Han, Lizhang; Pan, Yong; Wang, Baolin			Small Ubiquitin-like Modifier (SUMO) Modification Inhibits GLI2 Protein Transcriptional Activity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; VERTEBRATE LIMB; NEURAL-TUBE; KINASE-A; DEGRADATION; REPRESSION; SIGNALS; GENE	The Gli transcription factors are key downstream mediators of the Hedgehog (Hh) signaling pathway. How the activities of Gli transcription factors are regulated by upstream Hh signaling events and protein modifications are not fully understood. Here we show that GLI2 is conjugated by small ubiquitin-like modifier (SUMO) at lysine residues 630 and 716 in the cell. The level of GLI2 sumoylation is reduced by either mutations in six serine residues that are normally phosphorylated by protein kinase A (PKA) or stimulation by HH. This suggests that PKA phosphorylation enhances GLI2 sumoylation, whereas HH signaling inhibits it. In addition, mutation of these two lysines into arginine residues significantly increases GLI2 transcriptional activity in a cell-based reporter assay. The same mutations in the GLI2 locus also result in an increase in GLI2 activity in the mouse. Interestingly, GLI2 can interact with HDAC5 (histone deacetylase 5), but the GLI2 mutant cannot. Taken together, our results suggest that SUMO modification inhibits GLI2 transcriptional activity by recruiting HDAC5.	[Han, Lizhang; Pan, Yong; Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA; [Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Han, Lizhang] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China	Cornell University; Cornell University; Shandong University	Wang, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med Genet, 1300 York Ave,W404, New York, NY 10065 USA.	baw2001@med.cornell.edu			NICHD, National Institutes of Health [NO1-HD-7-3263]; National Institutes of Health [R01GM070820, R01CA111673]; NATIONAL CANCER INSTITUTE [R01CA111673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070820] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Tso-Pang Yao for pcDNA-FLAG-HDAC4 and pcDNA-FLAG-HDAC5. Monoclonal antibodies against ISL1, HB9, PAX6, PAX7, NKX2.2, NKX6.1, and FOXA2 were obtained from the Developmental Studies Hybridoma Bank maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA, under Contract NO1-HD-7-3263 from the NICHD, National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM070820 and R01CA111673 (to B. W.).	Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HOGAN B, 1994, MANIPULATING MOUSE E, P373; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lee J, 1997, DEVELOPMENT, V124, P2537; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	23	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20483	20489		10.1074/jbc.M112.359299	http://dx.doi.org/10.1074/jbc.M112.359299			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22549777	hybrid, Green Published			2022-12-28	WOS:000306414500069
J	Lundin, D; Poole, AM; Sjoberg, BM; Hogbom, M				Lundin, Daniel; Poole, Anthony M.; Sjoberg, Britt-Marie; Hogbom, Martin			Use of Structural Phylogenetic Networks for Classification of the Ferritin-like Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE DETOXIFICATION; IB RIBONUCLEOTIDE REDUCTASE; IRON-CARBOXYLATE PROTEINS; DPS-LIKE PROTEIN; ESCHERICHIA-COLI; DNA-BINDING; LISTERIA-INNOCUA; EVOLUTION; DATABASE; BACTERIOFERRITIN	In the postgenomic era, bioinformatic analysis of sequence similarity is an immensely powerful tool to gain insight into evolution and protein function. Over long evolutionary distances, however, sequence-based methods fail as the similarities become too low for phylogenetic analysis. Macromolecular structure generally appears better conserved than sequence, but clear models for how structure evolves over time are lacking. The exponential growth of three-dimensional structural information may allow novel structure-based methods to drastically extend the evolutionary time scales amenable to phylogenetics and functional classification of proteins. To this end, we analyzed 80 structures from the functionally diverse ferritin-like superfamily. Using evolutionary networks, we demonstrate that structural comparisons can delineate and discover groups of proteins beyond the "twilight zone" where sequence similarity does not allow evolutionary analysis, suggesting that considerable and useful evolutionary signal is preserved in three-dimensional structures.	[Lundin, Daniel; Sjoberg, Britt-Marie; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lundin, Daniel] Royal Inst Technol, Sci Life Lab, S-17121 Solna, Sweden; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand	Stockholm University; Royal Institute of Technology; University of Canterbury; University of Canterbury	Lundin, D (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	daniel.lundin@scilifelab.se		Sjoberg, Britt-Marie/0000-0001-5953-3360; Hogbom, Martin/0000-0001-5574-9383; Lundin, Daniel/0000-0002-8779-6464; Poole, Anthony/0000-0001-9940-2824	Swedish Research Council; Swedish Foundation for Strategic Research; Royal Swedish Academy of Sciences Research Fellowship; Knut and Alice Wallenberg Foundation; Royal Society of New Zealand	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Royal Swedish Academy of Sciences Research Fellowship; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by grants from the Swedish Research Council (to A.M.P. and B.M.S.), and grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (to M.H.).; Recipient of a Royal Swedish Academy of Sciences Research Fellowship supported by a grant from the Knut and Alice Wallenberg Foundation. Also supported by a Rutherford Discovery Fellowship from the Royal Society of New Zealand.	Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Breitling R, 2001, MOL BIOL EVOL, V18, P2154, DOI 10.1093/oxfordjournals.molbev.a003761; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bujnicki JM, 2000, J MOL EVOL, V50, P39, DOI 10.1007/s002399910005; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Dyer DH, 2005, PROTEIN SCI, V14, P1508, DOI 10.1110/ps.041288005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FROLOW F, 1993, ACTA CRYSTALLOGR D, V49, P597, DOI 10.1107/S0907444993007073; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gauss GH, 2006, BIOCHEMISTRY-US, V45, P10815, DOI 10.1021/bi060782u; Gauss GH, 2012, J BACTERIOL, V194, P15, DOI 10.1128/JB.05260-11; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hillis DM, 2007, MOL PHYLOGENET EVOL, V42, P331, DOI 10.1016/j.ympev.2006.08.001; Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; RIDLEY M, 1986, EVOLUTION CLASSIFICA; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sjoberg BM, 2010, SCIENCE, V329, P1475, DOI 10.1126/science.1196347; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	50	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20565	20575		10.1074/jbc.M112.367458	http://dx.doi.org/10.1074/jbc.M112.367458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22535960	Green Published, hybrid			2022-12-28	WOS:000306414500077
J	Suckow, AT; Zhang, C; Egodage, S; Comoletti, D; Taylor, P; Miller, MT; Sweet, IR; Chessler, SD				Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Comoletti, Davide; Taylor, Palmer; Miller, Meghan T.; Sweet, Ian R.; Chessler, Steven D.			Transcellular Neuroligin-2 Interactions Enhance Insulin Secretion and Are Integral to Pancreatic beta Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC ADHESION; CA2+ CHANNELS; ISLET CELLS; NEUREXIN; EXOCYTOSIS; PROTEIN; REVEALS; GRANULES; DOCKING; COMPLEX	Normal glucose-stimulated insulin secretion is dependent on interactions between neighboring beta cells. Elucidation of the reasons why this cell-to-cell contact is essential will probably yield critical insights into beta cell maturation and function. In the central nervous system, transcellular protein interactions (i.e. interactions between proteins on the surfaces of different cells) involving neuroligins are key mediators of synaptic functional development. We previously demonstrated that beta cells express neuroligin-2 and that insulin secretion is affected by changes in neuroligin-2 expression. Here we show that the effect of neuroligin-2 on insulin secretion is mediated by transcellular interactions. Neuroligin-2 binds with nanomolar affinity to a partner on the beta cell surface and contributes to the increased insulin secretion brought about by beta cell-to-beta cell contact. It does so in a manner seemingly independent of interactions with neurexin, a known binding partner. As in the synapse, transcellular neuroligin-2 interactions enhance the functioning of the submembrane exocytic machinery. Also, as in the synapse, neuroligin-2 clustering is important. Neuroligin-2 in soluble form, rather than presented on a cell surface, decreases insulin secretion by rat islets and MIN-6 cells, most likely by interfering with endogenous neuroligin interactions. Prolonged contact with neuroligin-2-expressing cells increases INS-1 beta cell proliferation and insulin content. These results extend the known parallels between the synaptic and beta cell secretory machineries to extracellular interactions. Neuroligin-2 interactions are one of the few transcellular protein interactions thus far identified that directly enhance insulin secretion. Together, these results indicate a significant role for transcellular neuroligin-2 interactions in the establishment of beta cell function.	[Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Chessler, Steven D.] Univ Calif San Diego, Dept Med, UCSD Sch Med, La Jolla, CA 92093 USA; [Suckow, Arthur T.; Zhang, Charles; Egodage, Sonya; Chessler, Steven D.] Univ Calif San Diego, Pediat Diabet Res Ctr, UCSD Sch Med, La Jolla, CA 92093 USA; [Suckow, Arthur T.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Comoletti, Davide; Taylor, Palmer; Miller, Meghan T.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Chessler, SD (corresponding author), Univ Calif San Diego, Dept Med, UCSD Sch Med, 9500 Gilman Dr,MC 0983, La Jolla, CA 92093 USA.	schessler@ucsd.edu			National Institutes of Health [R01DK080971, DK17047]; Juvenile Diabetes Research Foundation [37-2009-44]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, R01DK080971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080971 and Grant DK17047 (for the University of Washington Diabetes Endocrine Research Center Islet Core). This work was also supported by Juvenile Diabetes Research Foundation Grant 37-2009-44.	Aoyagi K, 2011, FRONT BIOSCI-LANDMRK, V16, P1197, DOI 10.2741/3784; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Chen W, 2009, ENDOCRINOLOGY, V150, P570, DOI 10.1210/en.2008-1009; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2007, FEBS LETT, V581, P4080, DOI 10.1016/j.febslet.2007.07.052; Easom RA, 2000, SEMIN CELL DEV BIOL, V11, P253, DOI 10.1006/scdb.2000.0174; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; GERDES J, 1984, J IMMUNOL, V133, P1710; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; JUNGERS J, 1981, J LAB CLIN MED, V98, P30; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kenakin T. P., 2006, PHARM PRIMER THEORY, P59; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Leone P, 2010, EMBO J, V29, P2461, DOI 10.1038/emboj.2010.123; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Mosedale M, 2012, J BIOL CHEM, V287, P6350, DOI 10.1074/jbc.M111.299081; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; PAPADIMITRIOU JM, 1970, J CELL BIOL, V47, P71, DOI 10.1083/jcb.47.1.71; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; SPIESS Y, 1982, DIABETES, V31, P189, DOI 10.2337/diabetes.31.3.189; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; ZUCKER RM, 1988, CYTOMETRY, V9, P226, DOI 10.1002/cyto.990090307	59	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19816	19826		10.1074/jbc.M111.280537	http://dx.doi.org/10.1074/jbc.M111.280537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528485	hybrid, Green Published			2022-12-28	WOS:000306414500005
J	Finnigan, GC; Cronan, GE; Park, HJ; Srinivasan, S; Quiocho, FA; Stevens, TH				Finnigan, Gregory C.; Cronan, Glen E.; Park, Hae J.; Srinivasan, Sankaranarayanan; Quiocho, Florante A.; Stevens, Tom H.			Sorting of the Yeast Vacuolar-type, Proton-translocating ATPase Enzyme Complex (V-ATPase) IDENTIFICATION OF A NECESSARY AND SUFFICIENT GOLGI/ENDOSOMAL RETENTION SIGNAL IN Stv1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; H+-ATPASE; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; ALKALINE-PHOSPHATASE; GOLGI-APPARATUS; GENE ENCODES; CLUSTAL-W; SUBUNIT; VPH1P	Subunit a of the yeast vacuolar-type, proton-translocating ATPase enzyme complex (V-ATPase) is responsible for both proton translocation and subcellular localization of this highly conserved molecular machine. Inclusion of the Vph1p isoform causes the V-ATPase complex to traffic to the vacuolar membrane, whereas incorporation of Stv1p causes continued cycling between the trans-Golgi and endosome. We previously demonstrated that this targeting information is contained within the cytosolic, N-terminal portion of V-ATPase subunit a (Stv1p). To identify residues responsible for sorting of the Golgi isoform of the V-ATPase, a random mutagenesis was performed on the N terminus of Stv1p. Subsequent characterization of mutant alleles led to the identification of a short peptide sequence, (WKY)-K-83, that is necessary for proper Stv1p localization. Based on three-dimensional homology modeling to the Meiothermus ruber subunit I, we propose a structural model of the intact Stv1p-containing V-ATPase demonstrating the accessibility of the (WKY)-K-83 sequence to retrograde sorting machinery. Finally, we characterized the sorting signal within the context of a reconstructed Stv1p ancestor (Anc.Stv1). This evolutionary intermediate includes an endogenous (WKY)-K-83 sorting motif and is sufficient to compete with sorting of the native yeast Stv1p V-ATPase isoform. These data define a novel sorting signal that is both necessary and sufficient for trafficking of the V-ATPase within the Golgi/endosomal network.	[Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Srinivasan, Sankaranarayanan; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Oregon; Baylor College of Medicine	Stevens, TH (corresponding author), Univ Oregon, Inst Mol Biol, 297 Klamath Hall,1229 Univ Oregon, Eugene, OR 97403 USA.	stevens@molbio.uoregon.edu		Cronan, Glen/0000-0001-7092-6595; Stevens, Tom/0000-0001-6427-6848; Finnigan, Gregory/0000-0002-5710-173X	National Institutes of Health [GM38006, GM088803]; American Heart Association Predoctoral Fellowship [0715808Z]; Welch Foundation [Q-581]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006, T32GM007413, R01GM088803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38006 (to T. H. S.) and GM088803 (to F. A. Q.). This work was also supported by American Heart Association Predoctoral Fellowship 0715808Z (to G. E. C.) and Welch Foundation Grant Q-581 (to F. A. Q.).	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Finnigan GC, 2011, MOL BIOL CELL, V22, P3176, DOI 10.1091/mbc.E11-03-0244; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; HIRATA R, 1993, J BIOL CHEM, V268, P961; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Jo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-130; Johnston HD, 2005, MOL BIOL CELL, V16, P1456, DOI 10.1091/mbc.E04-07-0642; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishiguchi M, 2003, NEUROCHEM INT, V42, P493, DOI 10.1016/S0197-0186(02)00139-0; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Perez-Sayans M, 2010, CANCER LETT, V295, P135, DOI 10.1016/j.canlet.2010.03.019; Perzov N, 2002, J EXP BIOL, V205, P1209; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rojas JD, 2004, J CELL PHYSIOL, V201, P190, DOI 10.1002/jcp.20059; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sambrook J., 2001, MOL CLONING LAB MANU; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wassmer T, 2006, MOL BIOL CELL, V17, P917, DOI 10.1091/mbc.E05-06-0511; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	89	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19487	19500		10.1074/jbc.M112.343814	http://dx.doi.org/10.1074/jbc.M112.343814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22496448	hybrid, Green Published			2022-12-28	WOS:000306411900062
J	Cruys-Bagger, N; Elmerdahl, J; Praestgaard, E; Tatsumi, H; Spodsberg, N; Borch, K; Westh, P				Cruys-Bagger, Nicolaj; Elmerdahl, Jens; Praestgaard, Eigil; Tatsumi, Hirosuke; Spodsberg, Nikolaj; Borch, Kim; Westh, Peter			Pre-steady-state Kinetics for Hydrolysis of Insoluble Cellulose by Cellobiohydrolase Cel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; PHANEROCHAETE-CHRYSOSPORIUM; MICROCRYSTALLINE CELLULOSE; CRYSTALLINE CELLULOSE; CELLULASES; SUBSTRATE; ADSORPTION; SYNERGISM	The transient kinetic behavior of enzyme reactions prior to the establishment of steady state is a major source of mechanistic information, yet this approach has not been utilized for cellulases acting on their natural substrate, insoluble cellulose. Here, we elucidate the pre-steady-state regime for the exo-acting cellulase Cel7A using amperometric biosensors and an explicit model for processive hydrolysis of cellulose. This analysis allows the identification of a pseudo-steady-state period and quantification of a processivity number as well as rate constants for the formation of a threaded enzyme complex, processive hydrolysis, and dissociation, respectively. These kinetic parameters elucidate limiting factors in the cellulolytic process. We concluded, for example, that Cel7A cleaves about four glycosidic bonds/s during processive hydrolysis. However, the results suggest that stalling the processive movement and low off-rates result in a specific activity at pseudo-steady state that is 10-25-fold lower. It follows that the dissociation of the enzyme-substrate complex (half-time of similar to 30 s) is rate-limiting for the investigated system. We suggest that this approach can be useful in attempts to unveil fundamental reasons for the distinctive variability in hydrolytic activity found in different cellulase-substrate systems.	[Cruys-Bagger, Nicolaj; Elmerdahl, Jens; Praestgaard, Eigil; Westh, Peter] Roskilde Univ, Dept Sci Syst & Models, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Tatsumi, Hirosuke] Shinshu Univ, Int Young Researchers Empowerment Ctr, Matsumoto, Nagano 3908621, Japan; [Spodsberg, Nikolaj; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Shinshu University; Novozymes	Westh, P (corresponding author), Roskilde Univ, Dept Sci Syst & Models, Res Unit Funct Biomat, Univ Vej 1, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23760746]; Programme Commission on Sustainable Energy and Environment [2104-07-0028]	Danish Agency for Science, Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Programme Commission on Sustainable Energy and Environment	This work was supported by the Danish Agency for Science, Technology and Innovation; Grant 2104-07-0028 from the Programme Commission on Sustainable Energy and Environment (to P. W.); and Grant-in-aid for Young Scientists 23760746 and special coordination funds for promoting science and technology from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. T.).	Abel M, 2001, BIOCHEM J, V357, P195, DOI 10.1042/0264-6021:3570195; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Barr BK, 2002, BIOCHEMISTRY-US, V41, P4447, DOI 10.1021/bi015854q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Henriksson G, 1998, BBA-PROTEIN STRUCT M, V1383, P48, DOI 10.1016/S0167-4838(97)00180-5; HIGHAM CW, 1994, FEBS LETT, V351, P128, DOI 10.1016/0014-5793(94)00847-7; Hilden L, 2001, ANAL BIOCHEM, V290, P245, DOI 10.1006/abio.2000.4959; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Johnson K. A., 1992, ENZYMES, P1; KABAYAMA MA, 1958, CAN J CHEM, V36, P557, DOI 10.1139/v58-078; Karim N, 2005, THERMOCHIM ACTA, V431, P9, DOI 10.1016/j.tca.2005.01.025; Kim Y. S., 1983, WASEDA DAIGAKU RIKOG, V104, P29; Kostylev M, 2012, BIOTECHNOL BIOENG, V109, P295, DOI 10.1002/bit.23299; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Ma AZ, 2008, ENZYME MICROB TECH, V42, P543, DOI 10.1016/j.enzmictec.2008.02.009; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; MEDVE J, 1994, BIOTECHNOL BIOENG, V44, P1064, DOI 10.1002/bit.260440907; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Tatsumi H, 2006, ANAL BIOCHEM, V357, P257, DOI 10.1016/j.ab.2006.07.019; TOMME P, 1990, BIOTECHNOL LETT, V12, P525, DOI 10.1007/BF01086347; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	40	89	89	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18451	18458		10.1074/jbc.M111.334946	http://dx.doi.org/10.1074/jbc.M111.334946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493488	Green Published, hybrid			2022-12-28	WOS:000306411600051
J	Lessner, FH; Jennings, ME; Hirata, A; Duin, EC; Lessner, DJ				Lessner, Faith H.; Jennings, Matthew E.; Hirata, Akira; Duin, Eduardus C.; Lessner, Daniel J.			Subunit D of RNA Polymerase from Methanosarcina acetivorans Contains Two Oxygen-labile [4Fe-4S] Clusters IMPLICATIONS FOR OXIDANT-DEPENDENT REGULATION OF TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; GENE-CLUSTER; II RPB3; IN-VIVO; FERREDOXIN; BINDING; THERMOPHILA; COMPLEX; RESOLUTION	Subunit D of multisubunit RNA polymerase from many species of archaea is predicted to bind one to two iron-sulfur (Fe-S) clusters, the function of which is unknown. A survey of encoded subunit D in the genomes of sequenced archaea revealed six distinct groups based on the number of complete or partial [4Fe-4S] cluster motifs within domain 3. Only subunit D from strictly anaerobic archaea, including all members of the Methanosarcinales, are predicted to bind two [4Fe-4S] clusters. We report herein the purification and characterization of Methanosarcina acetivorans subunit D in complex with subunit L. Expression of subunit D and subunit L in Escherichia coli resulted in the purification of a D-L heterodimer with only partial [4Fe-4S] cluster content. Reconstitution in vitro with iron and sulfide revealed that the M. acetivorans D-L heterodimer is capable of binding two redox-active [4Fe-4S] clusters. M. acetivorans subunit D deleted of domain 3 (D Delta D3) was still capable of co-purifying with subunit L but was devoid of [4Fe-4S] clusters. Affinity purification of subunit D or subunit D Delta D3 from M. acetivorans resulted in the co-purification of endogenous subunit L with each tagged subunit D. Overall, these results suggest that domain 3 of subunit D is required for [4Fe-4S] cluster binding, but the [4Fe-4S] clusters and domain 3 are not required for the formation of the D-L heterodimer. However, exposure of two [4Fe-4S] cluster-containing D-L heterodimer to oxygen resulted in loss of the [4Fe-4S] clusters and subsequent protein aggregation, indicating that the [4Fe-4S] clusters influence the stability of the D-L heterodimer and therefore have the potential to regulate the assembly and/or activity of RNA polymerase in an oxidant-dependent manner.	[Lessner, Faith H.; Jennings, Matthew E.; Lessner, Daniel J.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Hirata, Akira] Ehime Univ, Dept Mat Sci & Biotechnol, Matsuyama 7908577, Japan; [Duin, Eduardus C.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	University of Arkansas System; University of Arkansas Fayetteville; Ehime University; Auburn University System; Auburn University	Lessner, DJ (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	dlessner@uark.edu			National Institutes of Health from Center of Biomedical Research Excellence, National Center for Research Resources [1P30RR031154-02]; National Science Foundation [MCB1121292]; Arkansas Biosciences Institute; Institute for Fermentation, Osaka; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1121292] Funding Source: National Science Foundation	National Institutes of Health from Center of Biomedical Research Excellence, National Center for Research Resources; National Science Foundation(National Science Foundation (NSF)); Arkansas Biosciences Institute; Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P30RR031154-02 from the Centers of Biomedical Research Excellence, National Center for Research Resources (to D. J. L.). This work was also supported by National Science Foundation Grant MCB1121292 (to D. J. L.), the Arkansas Biosciences Institute (to D. J. L.), and the Institute for Fermentation, Osaka (to A. H.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; CLEMENTS AP, 1994, J BACTERIOL, V176, P2689, DOI 10.1128/JB.176.9.2689-2693.1994; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cruz F, 2006, BBA-GEN SUBJECTS, V1760, P858, DOI 10.1016/j.bbagen.2006.02.016; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eloranta JJ, 1998, NUCLEIC ACIDS RES, V26, P5562, DOI 10.1093/nar/26.24.5562; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferry JG, 2003, BIOCHEMISTRY AND PHYSIOLOGY OF ANAEROBIC BACTERIA, P143, DOI 10.1007/0-387-22731-8_11; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Genereux JC, 2010, J AM CHEM SOC, V132, P891, DOI 10.1021/ja907669c; Goede B, 2006, J BIOL CHEM, V281, P30581, DOI 10.1074/jbc.M605209200; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hirata A, 2009, CURR OPIN STRUC BIOL, V19, P724, DOI 10.1016/j.sbi.2009.10.006; Ishihama A, 1981, Adv Biophys, V14, P1; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Kimura M, 2000, NUCLEIC ACIDS RES, V28, P952, DOI 10.1093/nar/28.4.952; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Lessner D.J., 2009, ELS; Lessner DJ, 2007, J BACTERIOL, V189, P7475, DOI 10.1128/JB.00891-07; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; Metcalf WW, 1997, P NATL ACAD SCI USA, V94, P2626, DOI 10.1073/pnas.94.6.2626; Mitobe J, 2001, CURR GENET, V39, P210; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Oufattole M, 2006, ENDOCRINOLOGY, V147, P2138, DOI 10.1210/en.2005-1269; PRINCE RC, 1987, J BIOL CHEM, V262, P5125; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; SOWERS KR, 1993, APPL ENVIRON MICROB, V59, P3832, DOI 10.1128/AEM.59.11.3832-3839.1993; Spahr H, 2009, P NATL ACAD SCI USA, V106, P9185, DOI 10.1073/pnas.0903361106; Svetlov V, 1998, J BIOL CHEM, V273, P10827, DOI 10.1074/jbc.273.18.10827; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tan Q, 2000, GENE DEV, V14, P339; TERLESKY KC, 1988, J BIOL CHEM, V263, P4080; TERLESKY KC, 1988, J BIOL CHEM, V263, P4075; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; Zinder Stephen H., 1993, P128	48	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18510	18523		10.1074/jbc.M111.331199	http://dx.doi.org/10.1074/jbc.M111.331199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22457356	hybrid, Green Published			2022-12-28	WOS:000306411600057
J	Li, RL; Sherbet, DP; Elsbernd, BL; Goldstein, JL; Brown, MS; Zhao, TJ				Li, Robert Lin; Sherbet, Daniel P.; Elsbernd, Benjamin L.; Goldstein, Joseph L.; Brown, Michael S.; Zhao, Tong-Jin			Profound Hypoglycemia in Starved, Ghrelin-deficient Mice Is Caused by Decreased Gluconeogenesis and Reversed by Lactate or Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-ENERGY MALNUTRITION; GROWTH-HORMONE; ANOREXIA-NERVOSA; NUTRITIONAL REHABILITATION; GLUCOSE-TURNOVER; FOOD-INTAKE; METABOLISM; CHILDREN; HUMANS; STARVATION	When mice are subjected to 7-day calorie restriction (40% of normal food intake), body fat disappears, but blood glucose is maintained as long as the animals produce ghrelin, an octanoylated peptide that stimulates growth hormone secretion. Mice can be rendered ghrelin-deficient by knock-out of the gene encoding either ghrelin O-acyltransferase, which attaches the required octanoate, or ghrelin itself. Calorie-restricted, fat-depleted ghrelin O-acyltransferase or ghrelin knock-out mice fail to show the normal increase in growth hormone and become profoundly hypoglycemic when fasted for 18-23 h. Glucose production in Goat(-/-) mice was reduced by 60% when compared with similarly treated WT mice. Plasma lactate and pyruvate were also low. Injection of lactate, pyruvate, alanine, or a fatty acid restored blood glucose in Goat(-/-) mice. Thus, when body fat is reduced by calorie restriction, ghrelin stimulates growth hormone secretion, which allows maintenance of glucose production, even when food intake is eliminated. In humans with anorexia nervosa or kwashiorkor, ghrelin and growth hormone are known to be elevated, just as they are in fat-depleted mice. We suggest that these two hormones prolong survival in starved humans as they do in mice.	[Li, Robert Lin; Sherbet, Daniel P.; Elsbernd, Benjamin L.; Goldstein, Joseph L.; Brown, Michael S.; Zhao, Tong-Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Zhao, Tong-Jin/AFH-2915-2022; Elsbernd, Benjamin/ABF-9987-2021		National Institutes of Health [HL20948-35]; Moss Heart Foundation; Medical Scientist Training Program [ST32 GM08014-30]; Physician Scientist Training Program at University of Texas Southwestern; NIDDK Research Training Grant for Medical Students [ST35DK066141-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physician Scientist Training Program at University of Texas Southwestern; NIDDK Research Training Grant for Medical Students; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL20948-35. This work was also supported by the Moss Heart Foundation.; Supported by Medical Scientist Training Program Grant ST32 GM08014-30.; Supported by the Physician Scientist Training Program at University of Texas Southwestern.; Recipient of a NIDDK Research Training Grant for Medical Students ST35DK066141-08.	Altinkaynak S, 2008, PEDIATR INT, V50, P429, DOI 10.1111/j.1442-200X.2008.02606.x; ALTSZULER N, 1975, AM J PHYSIOL, V229, P1662, DOI 10.1152/ajplegacy.1975.229.6.1662; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; El-Hodhod MA, 2009, CLIN NUTR, V28, P173, DOI 10.1016/j.clnu.2009.02.003; EXTON JH, 1972, METABOLISM, V21, P945, DOI 10.1016/0026-0495(72)90028-5; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; KATZ H, 1992, AM J PHYSIOL, V263, pE17, DOI 10.1152/ajpendo.1992.263.1.E17; Kilic M, 2004, CLIN BIOCHEM, V37, P382, DOI 10.1016/j.clinbiochem.2003.12.010; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE347, DOI 10.1152/ajpendo.00615.2004; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Nass R, 2008, J CLIN ENDOCR METAB, V93, P1988, DOI 10.1210/jc.2007-2234; Nass R, 2011, MOL CELL ENDOCRINOL, V340, P10, DOI 10.1016/j.mce.2011.03.021; Nass RM, 2010, P NATL ACAD SCI USA, V107, P8501, DOI 10.1073/pnas.1002941107; Norrelund H, 2005, GROWTH HORM IGF RES, V15, P95, DOI 10.1016/j.ghir.2005.02.005; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SOLIMAN AT, 1986, PEDIATR RES, V20, P1122, DOI 10.1203/00006450-198611000-00012; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Svedberg P, 2011, ANNU REV NUTR, V31, P263, DOI 10.1146/annurev-nutr-081810-160805; Tanaka M, 2004, REGUL PEPTIDES, V122, P163, DOI 10.1016/j.regpep.2004.06.015; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; Wolfe R. R., 2005, ISOTOPE TRACERS META, P215; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	35	81	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17942	17950		10.1074/jbc.M112.358051	http://dx.doi.org/10.1074/jbc.M112.358051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474325	Green Published, hybrid			2022-12-28	WOS:000306411600004
J	Pero, R; Palmieri, D; Angrisano, T; Valentino, T; Federico, A; Franco, R; Lembo, F; Klein-Szanto, AJ; Del Vecchio, L; Montanaro, D; Keller, S; Arra, C; Papadopoulou, V; Wagner, SD; Croce, CM; Fusco, A; Chiariotti, L; Fedele, M				Pero, Raffaela; Palmieri, Dario; Angrisano, Tiziana; Valentino, Teresa; Federico, Antonella; Franco, Renato; Lembo, Francesca; Klein-Szanto, Andres J.; Del Vecchio, Luigi; Montanaro, Donatella; Keller, Simona; Arra, Claudio; Papadopoulou, Vasiliki; Wagner, Simon D.; Croce, Carlo M.; Fusco, Alfredo; Chiariotti, Lorenzo; Fedele, Monica			POZ-, AT-hook-, and Zinc Finger-containing Protein (PATZ) Interacts with Human Oncogene B Cell Lymphoma 6 (BCL6) and Is Required for Its Negative Autoregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL-CENTER FORMATION; NON-HODGKINS-LYMPHOMA; BTB/POZ DOMAIN; GENE; EXPRESSION; TRANSCRIPTION; MAZR; MICE; DIFFERENTIATION; TRANSLOCATIONS	The PATZ1 gene encoding a POZ/AT-hook/Kruppel zinc finger (PATZ) transcription factor, is considered a cancer-related gene because of its loss or misexpression in human neoplasias. As for other POZ/domain and Kruppel zinc finger (POK) family members, the transcriptional activity of PATZ is due to the POZ-mediated oligomer formation, suggesting that it might be not a typical transactivator but an architectural transcription factor, thus functioning either as activator or as repressor depending on the presence of proteins able to interact with it. Therefore, to better elucidate PATZ function, we searched for its molecular partners. By yeast two-hybrid screenings, we found a specific interaction between PATZ and BCL6, a human oncogene that plays a key role in germinal center (GC) derived neoplasias. We demonstrate that PATZ and BCL6 interact in germinal center-derived B lymphoma cells, through the POZ domain of PATZ. Moreover, we show that PATZ is able to bind the BCL6 regulatory region, where BCL6 itself acts as a negative regulator, and to contribute to negatively modulate its activity. Consistently, disruption of one or both Patz1 alleles in mice causes focal expansion of thymus B cells, in which BCL6 is up-regulated. This phenotype was almost completely rescued by crossing Patz1(+/-) with Bcl6(+/-) mice, indicating a key role for Bcl6 expression in its development. Finally, a significant number of Patz1 knock-out mice (both heterozygous and homozygous) also develop BCL6-expressing lymphomas. Therefore, the disruption of one or both Patz1 alleles may favor lymphomagenesis by activating the BCL6 pathway.	[Pero, Raffaela; Palmieri, Dario; Angrisano, Tiziana; Valentino, Teresa; Federico, Antonella; Keller, Simona; Fusco, Alfredo; Chiariotti, Lorenzo; Fedele, Monica] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Pero, Raffaela; Palmieri, Dario; Angrisano, Tiziana; Valentino, Teresa; Federico, Antonella; Keller, Simona; Fusco, Alfredo; Chiariotti, Lorenzo; Fedele, Monica] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Pero, Raffaela; Palmieri, Dario; Angrisano, Tiziana; Valentino, Teresa; Federico, Antonella; Keller, Simona; Fusco, Alfredo; Chiariotti, Lorenzo; Fedele, Monica] CNR, I-80131 Naples, Italy; [Palmieri, Dario; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Franco, Renato; Arra, Claudio] Fdn Pascale, Ist Nazl Tumori, I-80131 Naples, Italy; [Lembo, Francesca; Chiariotti, Lorenzo] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Del Vecchio, Luigi] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Del Vecchio, Luigi; Montanaro, Donatella; Keller, Simona] CEINGE, Biotecnol Avanzate, I-80145 Naples, Italy; [Papadopoulou, Vasiliki; Wagner, Simon D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 7RH, Leics, England	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; IRCCS Fondazione Pascale; University of Naples Federico II; Fox Chase Cancer Center; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Leicester	Chiariotti, L (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.	chiariot@unina.it; mfedele@unina.it	Young, Richard A/F-6495-2012; Pero, Raffaela/L-1461-2015; Angrisano, Tiziana/AAC-5353-2022; Fedele, Monica/C-1417-2015; Chiariotti, Lorenzo/AAC-5262-2022	Young, Richard A/0000-0001-8855-8647; Pero, Raffaela/0000-0003-2182-5530; Fedele, Monica/0000-0002-9171-1312; Franco, Renato/0000-0002-8340-3184; Palmieri, Dario/0000-0002-0797-4268; Fusco, Alfredo/0000-0003-3332-5197; Arra, Claudio/0000-0003-3162-2091; Angrisano, Tiziana/0000-0002-5940-5278; Wagner, Simon/0000-0002-8914-0370; CHIARIOTTI, Lorenzo/0000-0001-6097-4171	Associazione Italiana per la Ricerca sul Cancro [IG 5728]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG 5728 (to M. F.).	Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Csernus B, 2004, LEUKEMIA LYMPHOMA, V45, P2105, DOI 10.1080/1042819042000219467; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Esposito F, 2011, J PATHOL, V224, P110, DOI 10.1002/path.2846; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2000, J BIOL CHEM, V275, P7894, DOI 10.1074/jbc.275.11.7894; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Kobayashi A, 2000, MOL CELL BIOL, V20, P1733, DOI 10.1128/MCB.20.5.1733-1746.2000; Lembo F, 2003, MOL CELL BIOL, V23, P1656, DOI 10.1128/MCB.23.5.1656-1665.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; Mastrangelo T, 2000, ONCOGENE, V19, P3799, DOI 10.1038/sj.onc.1203762; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Morii E, 2002, J BIOL CHEM, V277, P8566, DOI 10.1074/jbc.M110392200; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Muramatsu Mikiko, 1997, Leukemia (Basingstoke), V11, P318; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pero R, 2002, J BIOL CHEM, V277, P3280, DOI 10.1074/jbc.M109491200; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Skinnider BF, 1999, HUM PATHOL, V30, P803, DOI 10.1016/S0046-8177(99)90141-7; Tian XQ, 2008, ACTA BIOCH BIOPH SIN, V40, P289, DOI 10.1111/j.1745-7270.2008.00405.x; Tritz Richard, 2008, Cancer Ther, V6, P865; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Yang WL, 2010, BIOCHEM BIOPH RES CO, V391, P1318, DOI 10.1016/j.bbrc.2009.12.026; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x	38	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18308	18317		10.1074/jbc.M112.346270	http://dx.doi.org/10.1074/jbc.M112.346270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493480	Green Published, hybrid			2022-12-28	WOS:000306411600037
J	Wang, XH; Lin, WJ; Izumi, KJ; Jiang, Q; Lai, KP; Xu, DF; Fang, LY; Lu, TJ; Li, L; Xia, SJ; Chang, CS				Wang, Xiaohai; Lin, Wen-Jye; Izumi, Kouji; Jiang, Qi; Lai, Kuo-Pao; Xu, Defeng; Fang, Lei-Ya; Lu, Tianjing; Li, Lei; Xia, Shujie; Chang, Chawnshang			Increased Infiltrated Macrophages in Benign Prostatic Hyperplasia (BPH) ROLE OF STROMAL ANDROGEN RECEPTOR IN MACROPHAGE-INDUCED PROSTATE STROMAL CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INFLAMMATION; PROLIFERATION; INTERLEUKIN-8; CHEMOKINES; DISEASE; GROWTH; TISSUE; PROLACTIN; ESTROGENS	Infiltrated macrophages may play important roles in the development and progression of benign prostatic hyperplasia (BPH), but the underlying mechanisms remain largely unknown. We found increased macrophages infiltration in human and mouse BPH tissues. By establishing a co-culture transwell system, we found increased migration of macrophages and proliferation of prostate stromal cells during co-culture. Importantly, stromal androgen receptor (AR) could enhance the migration of macrophages and macrophage-mediated stromal cell proliferation. We identified CCL3 as an AR downstream player, and found CCL3 levels were notably increased in human and mouse BPH prostates. Ablation of prostate stromal AR in a mouse BPH model significantly reduced CCL3 expression levels in prostates. Consistently, targeting AR via an AR degradation enhancer, ASC-J9 (R), or neutralization of CCL3 with an antibody, resulted in suppression of macrophage migration and prostate stromal cell growth. Our study provides mechanistic insights on the regulation of prostate stromal cells by macrophages via stromal AR/CCL3 signaling pathways, which could potentially allow the development of therapeutic approaches for battling BPH with persistent inflammation.	[Wang, Xiaohai; Xia, Shujie] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200080, Peoples R China; [Wang, Xiaohai; Lin, Wen-Jye; Izumi, Kouji; Jiang, Qi; Lai, Kuo-Pao; Xu, Defeng; Fang, Lei-Ya; Lu, Tianjing; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Wang, Xiaohai; Lin, Wen-Jye; Izumi, Kouji; Jiang, Qi; Lai, Kuo-Pao; Xu, Defeng; Fang, Lei-Ya; Lu, Tianjing; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Wang, Xiaohai; Lin, Wen-Jye; Izumi, Kouji; Jiang, Qi; Lai, Kuo-Pao; Xu, Defeng; Fang, Lei-Ya; Lu, Tianjing; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Wang, Xiaohai; Lin, Wen-Jye; Izumi, Kouji; Jiang, Qi; Lai, Kuo-Pao; Xu, Defeng; Fang, Lei-Ya; Lu, Tianjing; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	Shanghai Jiao Tong University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Xia, SJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200080, Peoples R China.	xsjurologist@163.com; chang@urmc.rochester.edu	Lin, Wen-Jye/D-1028-2016	Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [CA127300, CA156700]; Department of Defense [W81XWH-10-1-0300]; Taiwan Department of Health Clinical Trial; Research Center of Excellence from China Medical University, Taichung, Taiwan [DOH99-TD-B-111-004]; National Basic Research Program of China [2012CB518305]; NATIONAL CANCER INSTITUTE [R01CA127300, R01CA156700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Taiwan Department of Health Clinical Trial; Research Center of Excellence from China Medical University, Taichung, Taiwan; National Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127300 and CA156700, Department of Defense Grant W81XWH-10-1-0300, Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 from the China Medical University, Taichung, Taiwan, and National Basic Research Program of China Grant 2012CB518305. ASC-J9 (R) was patented by the University of Rochester, the University of North Carolina, and AndroScience, and then licensed to AndroScience. Both the University of Rochester and C.C. own royalties and equity in AndroScience.	Aydin A, 2006, CLIN BIOCHEM, V39, P176, DOI 10.1016/j.clinbiochem.2005.11.018; BARTSCH G, 1979, J UROLOGY, V122, P487, DOI 10.1016/S0022-5347(17)56476-9; Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012; Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Chen SU, 2010, HUM REPROD, V25, P757, DOI 10.1093/humrep/dep432; CLAUS S, 1993, UROL RES, V21, P305, DOI 10.1007/BF00296825; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davies John Q, 2005, Methods Mol Biol, V290, P91; Dillner K, 2003, ENDOCRINOLOGY, V144, P4955, DOI 10.1210/en.2003-0415; Gu Heng, 2006, Zhonghua Nan Ke Xue, V12, P917; Kasturi Sanjay, 2006, Curr Urol Rep, V7, P288, DOI 10.1007/s11934-996-0008-y; Kindblom J, 2003, ENDOCRINOLOGY, V144, P2269, DOI 10.1210/en.2002-0187; Kramer G, 2006, CURR OPIN UROL, V16, P25; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Lai KP, 2012, MOL ENDOCRINOL, V26, P52, DOI 10.1210/me.2011-1189; Lee KL, 2004, J UROLOGY, V172, P1784, DOI 10.1097/01.ju.0000133655.71782.14; Lin VK, 2001, UROLOGY, V57, P170, DOI 10.1016/S0090-4295(00)00842-6; Macoska JA, 2008, PROSTATE, V68, P442, DOI 10.1002/pros.20717; Macoska JA, 2011, DIFFERENTIATION, V82, P253, DOI 10.1016/j.diff.2011.04.003; McVary KT, 2005, J UROLOGY, V174, P1327, DOI 10.1097/01.ju.0000173072.73702.64; NAKHLA AM, 1994, P NATL ACAD SCI USA, V91, P5402, DOI 10.1073/pnas.91.12.5402; Nicholson TM, 2011, DIFFERENTIATION, V82, P184, DOI 10.1016/j.diff.2011.04.006; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Nickel JC, 2007, J UROLOGY, V178, P896, DOI 10.1016/j.juro.2007.05.041; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Penna G, 2007, EUR UROL, V51, P524, DOI 10.1016/j.eururo.2006.07.016; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Roberts RO, 2006, PROSTATE, V66, P392, DOI 10.1002/pros.20362; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013; Sciarra A, 2007, EUR UROL, V52, P964, DOI 10.1016/j.eururo.2007.06.038; Sciarra F, 2000, ARCH ANDROLOGY, V44, P213; SHAPIRO E, 1992, J UROLOGY, V147, P1167, DOI 10.1016/S0022-5347(17)37508-0; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exger.2004.12.008; Wang L, 2008, MED HYPOTHESES, V70, P1021, DOI 10.1016/j.mehy.2007.08.022; Wang XH, 2011, CHINESE MED J-PEKING, V124, P1700, DOI 10.3760/cma.j.issn.0366-6999.2011.11.018; WILSON JD, 1980, METABOLISM, V29, P1278, DOI 10.1016/0026-0495(80)90159-6; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Yi FX, 2006, ASIAN J ANDROL, V8, P621, DOI 10.1111/j.1745-7262.2006.00188.x; Yun AJ, 2006, MED HYPOTHESES, V67, P392, DOI 10.1016/j.mehy.2005.12.008	48	57	59	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18376	18385		10.1074/jbc.M112.355164	http://dx.doi.org/10.1074/jbc.M112.355164			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474290	Green Published, hybrid			2022-12-28	WOS:000306411600044
J	Hata, S; Hirayama, J; Kajiho, H; Nakagawa, K; Hata, Y; Katada, T; Furutani-Seiki, M; Nishina, H				Hata, Shoji; Hirayama, Jun; Kajiho, Hiroaki; Nakagawa, Kentaro; Hata, Yutaka; Katada, Toshiaki; Furutani-Seiki, Makoto; Nishina, Hiroshi			A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to S(N)2 Alkylating Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; GROWTH-CONTROL; CONTACT INHIBITION; SIZE-CONTROL; DNA-DAMAGE; YAP; REPAIR; ACTIVATION; P300; PHOSPHORYLATION	Yes-associated protein (YAP) is a transcriptional co-activator that acts downstream of the Hippo signaling pathway and regulates multiple cellular processes. Although cytoplasmic retention of YAP is known to be mediated by Hippo pathway-dependent phosphorylation, post-translational modifications that regulate YAP in the nucleus remain unclear. Here we report the discovery of a novel cycle of acetylation/deacetylation of nuclear YAP induced in response to S(N)2 alkylating agents. We show that after treatment of cells with the S(N)2 alkylating agent methyl methanesulfonate, YAP phosphorylation mediated by the Hippo pathway is markedly reduced, leading to nuclear translocation of YAP and its acetylation. This YAP acetylation occurs on specific and highly conserved C-terminal lysine residues and is mediated by the nuclear acetyltransferases CBP (CREB binding protein) and p300. Conversely, the nuclear deacetylase SIRT1 is responsible for YAP deacetylation. Intriguingly, we found that YAP acetylation is induced specifically by S(N)2 alkylating agents and not by other DNA-damaging stimuli. These results identify a novel YAP acetylation cycle that occurs in the nucleus downstream of the Hippo pathway. Intriguingly, our findings also indicate that YAP acetylation is involved in responses to a specific type of DNA damage.	[Hata, Shoji; Hirayama, Jun; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Kajiho, Hiroaki; Katada, Toshiaki] Univ Tokyo, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakagawa, Kentaro; Hata, Yutaka] Tokyo Med & Dent Univ, Dept Med Biochem, Grad Sch Med, Bunkyo Ku, Tokyo 1138510, Japan; [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Bath	Nishina, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nishina.dbio@mri.tmd.ac.jp		Hirayama, Jun/0000-0002-8485-3320; Kajiho, Hiroaki/0000-0001-6376-7629	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Medical Research Council [G117/563] Funding Source: researchfish; MRC [G117/563] Funding Source: UKRI	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan.	Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jang ER, 2011, FEBS LETT, V585, P47, DOI 10.1016/j.febslet.2010.11.034; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vassilopoulos A, 2010, INT J BIOCHEM CELL B, V42, P193, DOI 10.1016/j.biocel.2009.11.020; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	38	61	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22089	22098		10.1074/jbc.M111.334714	http://dx.doi.org/10.1074/jbc.M111.334714			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544757	hybrid, Green Published			2022-12-28	WOS:000306418600046
J	Mayi, TH; Daoudi, M; Derudas, B; Gross, B; Bories, G; Wouters, K; Brozek, J; Caiazzo, R; Raverdi, V; Pigeyre, M; Allavena, P; Mantovani, A; Pattou, F; Staels, B; Chinetti-Gbaguidi, G				Mayi, Therese Hervee; Daoudi, Mehdi; Derudas, Bruno; Gross, Barbara; Bories, Gael; Wouters, Kristiaan; Brozek, John; Caiazzo, Robert; Raverdi, Violeta; Pigeyre, Marie; Allavena, Paola; Mantovani, Alberto; Pattou, Francois; Staels, Bart; Chinetti-Gbaguidi, Giulia			Human Adipose Tissue Macrophages Display Activation of Cancer-related Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; TUMOR-ASSOCIATED MACROPHAGES; OBESITY; DIFFERENTIATION; INFLAMMATION; EXPRESSION; PHENOTYPE; RECEPTOR; ALPHA; ANGIOGENESIS	Obesity is associated with a significantly increased risk for cancer suggesting that adipose tissue dysfunctions might play a crucial role therein. Macrophages play important roles in adipose tissue as well as in cancers. Here, we studied whether human adipose tissue macrophages (ATM) modulate cancer cell function. Therefore, ATM were isolated and compared with monocyte-derived macrophages (MDM) from the same obese patients. ATM, but not MDM, were found to secrete factors inducing inflammation and lipid accumulation in human T47D and HT-29 cancer cells. Gene expression profile comparison of ATM and MDM revealed overexpression of functional clusters, such as cytokine-cytokine receptor interaction (especially CXC-chemokine) signaling as well as cancer-related pathways, in ATM. Comparison with gene expression profiles of human tumor-associated macrophages showed that ATM, but not MDM resemble tumor-associated macrophages. Indirect co-culture experiments demonstrated that factors secreted by preadipocytes, but not mature adipocytes, confer an ATM-like phenotype to MDM. Finally, the concentrations of ATM-secreted factors related to cancer are elevated in serum of obese subjects. In conclusion, ATM may thus modulate the cancer cell phenotype.	[Staels, Bart] Inst Pasteur, Inserm UR 1011, F-59019 Lille, France; [Mayi, Therese Hervee; Daoudi, Mehdi; Derudas, Bruno; Gross, Barbara; Bories, Gael; Wouters, Kristiaan; Caiazzo, Robert; Pigeyre, Marie; Pattou, Francois; Staels, Bart; Chinetti-Gbaguidi, Giulia] Univ Lille Nord France, F-59000 Lille, France; [Mayi, Therese Hervee; Daoudi, Mehdi; Derudas, Bruno; Gross, Barbara; Bories, Gael; Wouters, Kristiaan; Staels, Bart; Chinetti-Gbaguidi, Giulia] INSERM, U1011, F-59000 Lille, France; [Mayi, Therese Hervee; Daoudi, Mehdi; Derudas, Bruno; Gross, Barbara; Bories, Gael; Wouters, Kristiaan; Staels, Bart; Chinetti-Gbaguidi, Giulia] Univ Lille 2, F-59000 Lille, France; [Brozek, John] Genfit, F-59120 Loos, France; [Caiazzo, Robert; Raverdi, Violeta; Pattou, Francois] Univ Hosp, Dept Endocrine Surg, Lille, France; [Caiazzo, Robert; Raverdi, Violeta; Pattou, Francois] INSERM, Biotherapies Diabet U859, Lille, France; [Pigeyre, Marie] Univ Hosp, Dept Nutr, Lille, France; [Allavena, Paola; Mantovani, Alberto] IRCCS, Humanitas Clin Inst, Dept Immunol & Inflammat, I-20089 Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, I-20133 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; IRCCS Humanitas Research Hospital; University of Milan	Staels, B (corresponding author), Inst Pasteur, Inserm UR 1011, 1 Rue Prof Calmette,BP 245, F-59019 Lille, France.	bart.staels@pasteur-lille.fr	Staels, Bart/N-9497-2016; Wouters, Kristiaan/A-8536-2013; chinetti, giulia/Q-6901-2016; Pattou, Francois/O-6151-2017; Allavena, Paola/HHM-5218-2022; Caiazzo, Robert/D-1958-2013; caiazzo, robert/Y-9692-2019; Mantovani, Alberto/HCI-7449-2022	Staels, Bart/0000-0002-3784-1503; Wouters, Kristiaan/0000-0001-7127-6950; chinetti, giulia/0000-0001-8048-8138; Pattou, Francois/0000-0001-8388-3766; Allavena, Paola/0000-0002-6697-6028; caiazzo, robert/0000-0001-5383-0540; Mantovani, Alberto/0000-0001-5578-236X; GROSS, BARBARA/0000-0001-5566-0004; Pigeyre, Marie/0000-0003-2984-8366	Nouvelle Societe Francaise d'Atherosclerose/Sanofi-Aventis; Societe Francaise de Cardiologie/Sanofi-Aventis; European Concerted Research Action [BM0602]; European Community's 7th Framework Programme (FP7) [201608]	Nouvelle Societe Francaise d'Atherosclerose/Sanofi-Aventis; Societe Francaise de Cardiologie/Sanofi-Aventis; European Concerted Research Action; European Community's 7th Framework Programme (FP7)	This work was supported by the "Nouvelle Societe Francaise d'Atherosclerose/Sanofi-Aventis" (to T. H. M.), the "Societe Francaise de Cardiologie/Sanofi-Aventis," the European Concerted Research Action BM0602, and the European Community's 7th Framework Programme (FP7/2007-2013) under Grant 201608.	Adams TD, 2009, WORLD J SURG, V33, P2028, DOI 10.1007/s00268-009-0169-1; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Antonov AV, 2008, NUCLEIC ACIDS RES, V36, pW347, DOI 10.1093/nar/gkn239; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DILORENZO D, 1993, BIOCHEM BIOPH RES CO, V192, P1066, DOI 10.1006/bbrc.1993.1525; Esslimani-Sahla M, 2007, INT J CANCER, V120, P224, DOI 10.1002/ijc.22202; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gutwein P, 2009, EUR J CANCER, V45, P478, DOI 10.1016/j.ejca.2008.10.023; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2004, BIOINFORMATICS, V20, P1651, DOI 10.1093/bioinformatics/bth133; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Mack I, 2009, AM J PHYSIOL-ENDOC M, V297, pE735, DOI 10.1152/ajpendo.90851.2008; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Ogink J, 2011, CANCER RES, V71, P1196, DOI 10.1158/0008-5472.CAN-10-4378; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Poulain-Godefroy O, 2007, BIOCHEM BIOPH RES CO, V356, P662, DOI 10.1016/j.bbrc.2007.03.053; Prieto-Hontoria PL, 2011, BBA-BIOENERGETICS, V1807, P664, DOI 10.1016/j.bbabio.2010.11.004; Ronen D, 1999, CELL GROWTH DIFFER, V10, P131; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Shah R, 2009, DIABETES, V58, P2211, DOI 10.2337/db09-0256; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	43	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21904	21913		10.1074/jbc.M111.315200	http://dx.doi.org/10.1074/jbc.M111.315200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22511784	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000306418600030
J	Agrawal, P; Chen, YT; Schilling, B; Gibson, BW; Hughes, RE				Agrawal, Pooja; Chen, Yu-Ting; Schilling, Birgit; Gibson, Bradford W.; Hughes, Robert E.			Ubiquitin-specific Peptidase 9, X-linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAM DEUBIQUITYLATING ENZYME; DEUBIQUITINATING ENZYME; EMBRYO DEVELOPMENT; BINDING PARTNER; CELL-SURVIVAL; BETA-CATENIN; FACETS GENE; IN-VIVO; PROTEIN; COMPLEX	The mammalian target of rapamycin (mTOR) is an atypical serine/threonine kinase that responds to extracellular environment to regulate a number of cellular processes. These include cell growth, proliferation, and differentiation. Although both kinase-dependent and -independent functions of mTOR are known to be critical modulators of muscle cell differentiation and regeneration, the signaling mechanisms regulating mTOR activity during differentiation are still unclear. In this study we identify a novel mTOR interacting protein, the ubiquitin-specific protease USP9X, which acts as a negative regulator of mTOR activity and muscle differentiation. USP9X can co-immunoprecipitate mTOR with both Raptor and Rictor, components of mTOR complexes 1 and 2 (mTORC1 and -2), respectively, suggesting that it is present in both mTOR complexes. Knockdown of USP9X leads to increased mTORC1 activity in response to growth factor stimulation. Interestingly, upon initiation of differentiation of C2C12 mouse skeletal myoblasts, knockdown of USP9X increases mTORC2 activity. This increase in mTORC2 activity is accompanied by accelerated differentiation of myoblasts into myotubes. Taken together, our data describe the identification of the deubiquitinase USP9X as a novel mTORC1 and -2 binding partner that negatively regulates mTOR activity and skeletal muscle differentiation.	[Agrawal, Pooja; Chen, Yu-Ting; Schilling, Birgit; Gibson, Bradford W.; Hughes, Robert E.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Gibson, BW (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	bgibson@buckinstitute.org; rhughes@buckinstitute.org			National Institutes of Health [RL1 GM084432, TL1 AG032116]; Center for Research Resources, National Institutes of Health [S10 RR024615]; Geroscience Mass Spectrometry and Imaging Core Grant [PL1 AG032118]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [TL1AG032116, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geroscience Mass Spectrometry and Imaging Core Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RL1 GM084432 (to R. H.). Mass spectrometry was supported by Center for Research Resources, National Institutes of Health shared instrumentation Grant S10 RR024615 (to B. W. G.) and Geroscience Mass Spectrometry and Imaging Core Grant PL1 AG032118; to B. W. G.).; Supported by National Institutes of Health Training Grant TL1 AG032116.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nguyen PH, 2010, BIOORG MED CHEM LETT, V20, P4128, DOI 10.1016/j.bmcl.2010.05.067; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Reddy EM, 2010, EXP CELL RES, V316, P2220, DOI 10.1016/j.yexcr.2010.05.030; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki A, 2005, J RECEPT SIG TRANSD, V25, P181, DOI 10.1080/10799890500210511; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Wang XH, 2011, ANN MED, V43, P347, DOI 10.3109/07853890.2011.573806; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Zhang J, 2010, ASIAN J ANDROL, V12, P744, DOI 10.1038/aja.2010.44; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21164	21175		10.1074/jbc.M111.328021	http://dx.doi.org/10.1074/jbc.M111.328021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544753	hybrid, Green Published			2022-12-28	WOS:000306416800037
J	Conus, S; Pop, C; Snipas, SJ; Salvesen, GS; Simon, HU				Conus, Sebastien; Pop, Cristina; Snipas, Scott J.; Salvesen, Guy S.; Simon, Hans-Uwe			Cathepsin D Primes Caspase-8 Activation by Multiple Intra-chain Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; NEUTROPHIL APOPTOSIS; INTERCHAIN PROTEOLYSIS; CLEAVAGE; DIMERIZATION; PATHWAYS; MECHANISMS; LYSOSOMES; PROTEASE; PLATFORM	During the resolution of inflammatory responses, neutrophils rapidly undergo apoptosis. A direct and fast activation of caspase-8 by cathepsin D was shown to be crucial in the initial steps of neutrophil apoptosis. Nevertheless, the activation mechanism of caspase-8 remains unclear. Here, by using site-specific mutants of caspase-8, we show that both cathepsin D-mediated proteolysis and homodimerization of caspase-8 are necessary to generate an active caspase-8. At acidic pH, cathepsin D specifically cleaved caspase-8 but not the initiator caspase-9 or -10 and significantly increased caspase-8 activity in dimerizing conditions. These events were completely abolished by pepstatin A, a pharmacological inhibitor of cathepsin D. The cathepsin D intra-chain proteolysis greatly stabilized the active site of caspase-8. Moreover, the main caspase-8 fragment generated by cathepsin D cleavage could be affinity-labeled with the active site probe biotin-VAD-fluoromethyl ketone, suggesting that this fragment is enzymatically active. Importantly, in an in vitro cell-free assay, the addition of recombinant human caspase-8 protein, pre-cleaved by cathepsin D, was followed by caspase-3 activation. Our data therefore indicate that cathepsin D is able to initiate the caspase cascade by direct activation of caspase-8. As cathepsin D is ubiquitously expressed, this may represent a general mechanism to induce apoptosis in a variety of immune and nonimmune cells.	[Conus, Sebastien; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland; [Pop, Cristina; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	University of Bern; Sanford Burnham Prebys Medical Discovery Institute	Conus, S (corresponding author), Univ Bern, Inst Pharmacol, Friedbuhlstr 49, CH-3010 Bern, Switzerland.	sebastien.conus@pki.unibe.ch	Simon, Hans-Uwe/AAU-7410-2020	Simon, Hans-Uwe/0000-0002-9404-7736	Swiss National Science Foundation [310030-129640]; Novartis Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis)	This work was supported by Swiss National Science Foundation Grant 310030-129640 and the Novartis Foundation (formerly the Ciba-Geigy Jubilee Foundation).	Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Beaujouin M, 2006, ONCOGENE, V25, P1967, DOI 10.1038/sj.onc.1209221; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; Lee AY, 1998, NAT STRUCT BIOL, V5, P866, DOI 10.1038/2306; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Simon HU, 2001, IMMUNOL REV, V179, P156, DOI 10.1034/j.1600-065X.2001.790115.x; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3	46	42	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21142	21151		10.1074/jbc.M111.306399	http://dx.doi.org/10.1074/jbc.M111.306399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22528489	Green Published, hybrid			2022-12-28	WOS:000306416800035
J	Sexton, TJ; Golczak, M; Palczewski, K; Van Gelder, RN				Sexton, Timothy J.; Golczak, Marcin; Palczewski, Krzysztof; Van Gelder, Russell N.			Melanopsin Is Highly Resistant to Light and Chemical Bleaching in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL PIGMENTS; VERTEBRATE RETINA; RHODOPSIN; CYCLE; HYDROXYLAMINE; CELLS; PHOTORECEPTION; PHOTOPIGMENT; ADAPTATION; EXPRESSION	Melanopsin is the photopigment of mammalian intrinsically photosensitive retinal ganglion cells, where it contributes to light entrainment of circadian rhythms, and to the pupillary light response. Previous work has shown that the melanopsin photocycle is independent of that used by rhodopsin (Tu, D. C., Owens, L. A., Anderson, L., Golczak, M., Doyle, S. E., McCall, M., Menaker, M., Palczewski, K., and Van Gelder, R. N. (2006) Inner retinal photoreception independent of the visual retinoid cycle. Proc. Natl. Acad. Sci. U.S.A. 103, 10426-10431). Here we determined the ability of apo-melanopsin, formed by ex vivo UV light bleaching, to use selected chromophores. We found that 9-cis-retinal, but not all-trans-retinal or 9-cis-retinol, is able to restore light-dependent ipRGC activity after bleaching. Melanopsin was highly resistant to both visible-spectrum photic bleaching and chemical bleaching with hydroxylamine under conditions that fully bleach rod and cone photoreceptor cells. These results suggest that the melanopsin photocycle can function independently of both rod and cone photocycles, and that apo-melanopsin has a strong preference for binding cis-retinal to generate functional pigment. The data support a model in which retinal is continuously covalently bound to melanopsin and may function through a reversible, bistable mechanism.	[Sexton, Timothy J.; Van Gelder, Russell N.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Case Western Reserve University	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Campus Box 359608,325 9th Ave, Seattle, WA 98104 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Sexton, Timothy/0000-0002-8821-880X	National Institutes of Health [EY009339, P30EY001730, P30EY07031, T32EY007031]; Research to Prevent Blindness; Burroughs-Wellcome Clinical Scientist Award in Translational Research; NATIONAL EYE INSTITUTE [F32EY007031, P30EY001730, R01EY009339, T32EY007031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Burroughs-Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported, in whole or in part, by National Institutes of Health Grants EY009339, P30EY001730, P30EY07031, and T32EY007031. This work was also supported by unrestricted support from Research to Prevent Blindness and the Burroughs-Wellcome Clinical Scientist Award in Translational Research (to R. N. V. G.).	ABRAHAMSON EW, 1974, EXP EYE RES, V18, P51, DOI 10.1016/0014-4835(74)90043-8; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; BOWMAKER JK, 1976, VISION RES, V16, P811, DOI 10.1016/0042-6989(76)90140-1; BRIN KP, 1977, J GEN PHYSIOL, V69, P97, DOI 10.1085/jgp.69.1.97; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chow BY, 2011, NEUROMETHODS, V55, P99, DOI 10.1007/978-1-61779-031-7_6; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Hardie R. C., 2007, SENSES COMPREHENSIVE, V1, P77; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Holy T. E., 2000, SCIENCE         0609, V289, P569; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA, V1821, P137; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Leibrock CS, 1997, J PHYSIOL-LONDON, V501, P97, DOI 10.1111/j.1469-7793.1997.00097.x; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nemargut JP, 2009, VISION RES, V49, P2936, DOI 10.1016/j.visres.2009.09.011; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; PEPPERBERG DR, 1992, EXP EYE RES, V54, P369, DOI 10.1016/0014-4835(92)90049-X; PEPPERBERG DR, 1995, METHOD ENZYMOL, V250, P348; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thompson CL, 2004, J BIOL RHYTHM, V19, P504, DOI 10.1177/0748730404270519; Tu DC, 2006, P NATL ACAD SCI USA, V103, P10426, DOI 10.1073/pnas.0600917103; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Vought BW, 2000, BIOCHEMISTRY-US, V39, P14128, DOI 10.1021/bi001135k; WALD G, 1950, P NATL ACAD SCI USA, V36, P84, DOI 10.1073/pnas.36.2.84; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	54	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20888	20897		10.1074/jbc.M111.325969	http://dx.doi.org/10.1074/jbc.M111.325969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547062	Green Published, hybrid			2022-12-28	WOS:000306416800010
J	Tarragona, M; Pavlovic, M; Arnal-Estape, A; Urosevic, J; Morales, M; Guiu, M; Planet, E; Gonzalez-Suarez, E; Gomis, RR				Tarragona, Maria; Pavlovic, Milica; Arnal-Estape, Anna; Urosevic, Jelena; Morales, Monica; Guiu, Marc; Planet, Evarist; Gonzalez-Suarez, Eva; Gomis, Roger R.			Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEINS; EPITHELIAL-CELLS; STEM-CELLS; EXPRESSION; BETA; PROLIFERATION; DIFFERENTIATION; OSTEOBLASTS; MECHANISMS; SKELETON	Metastasis requires numerous biological functions that jointly provide tumor cells from a primary site to seed and colonize a distant organ. Some of these activities are selected for in the primary site, whereas others are acquired at the metastatic niche. We provide molecular evidence showing that the BMP inhibitor, NOG, provides metastatic breast cancer cells with the ability to colonize the bone. NOG expression is acquired during the late events of metastasis, once cells have departed from the primary site, because it is not enriched in primary tumors with high risk of bone relapse. On the contrary, breast cancer bone metastatic lesions do select for high levels of NOG expression when compared with metastasis to the lung, liver, and brain. Pivotal to the bone colonization functions is the contribution of NOG to metastatic autonomous and nonautonomous cell functions. Using genetic approaches, we show that when NOG is expressed in human breast cancer cells, it facilitates bone colonization by fostering osteoclast differentiation and bone degradation and also contributes to metastatic lesions reinitiation. These findings reveal how aggressive cancer cell autonomous and nonautonomous functions can be mechanistically coupled to greater bone metastatic potential.	[Tarragona, Maria; Pavlovic, Milica; Arnal-Estape, Anna; Urosevic, Jelena; Morales, Monica; Guiu, Marc; Gomis, Roger R.] Inst Res Biomed IRB Barcelona, Oncol Programme, Barcelona 08028, Spain; [Planet, Evarist; Gomis, Roger R.] Inst Res Biomed IRB Barcelona, Biostat & Bioinformat Unit, Barcelona 08028, Spain; [Gonzalez-Suarez, Eva] Bellvitge Inst Biomed Res IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Spain; [Gomis, Roger R.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Gomis, RR (corresponding author), Inst Res Biomed IRB Barcelona, Oncol Programme, PBB52 Parc Cient Barcelona,C Baldiri i Reixac 10-, Barcelona 08028, Spain.	roger.gomis@irbbarcelona.org	Arnal-Estapé, Anna/A-4091-2011; Morales-Ballús, Mònica/AAE-3086-2021; Gonzalez-Suarez, Eva/L-6298-2014; Gomis, Roger R/E-9788-2016	Arnal-Estapé, Anna/0000-0003-0490-7040; Morales-Ballús, Mònica/0000-0002-9478-6280; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Gomis, Roger R/0000-0001-6473-2858	BBVA Foundation; Asociacion Espa ola Contra el Cancer (AECC) Foundation; Generalitat de Catalunya [2009 SGR 1429]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-21171]; IRB-Barcelona Ph.D. program; "la Caixa" Ph.D. fellowship; MICINN; Institucio Catalana de Recerca i Estudis Avancats (ICREA); ICREA Funding Source: Custom	BBVA Foundation(BBVA Foundation); Asociacion Espa ola Contra el Cancer (AECC) Foundation; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IRB-Barcelona Ph.D. program; "la Caixa" Ph.D. fellowship(La Caixa Foundation); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA); ICREA(ICREA)	This work was supported by the BBVA Foundation, Asociacion Espa ola Contra el Cancer (AECC) Foundation, the Generalitat de Catalunya (Grant 2009 SGR 1429), and the Spanish Ministerio de Ciencia e Innovacion (MICINN) (Grant SAF2010-21171) (to R. R. G.).; Supported by an IRB-Barcelona Ph.D. program.; Supported by a "la Caixa" Ph.D. fellowship.; Supported by a Ph.D. fellowship by the MICINN.; Supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA).	Arnal-Estape A, 2010, CANCER RES, V70, P9927, DOI 10.1158/0008-5472.CAN-10-0869; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mastro AM, 2004, J CELL BIOCHEM, V91, P265, DOI 10.1002/jcb.10746; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morales M, 2011, BREAST, V20, pS50, DOI 10.1016/S0960-9776(11)70294-6; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shaw A, 2010, DIFFERENTIATION, V79, P41, DOI 10.1016/j.diff.2009.08.009; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Virk MS, 2011, BONE, V48, P578, DOI 10.1016/j.bone.2010.11.003; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Vukmirovic-Popovic S, 2002, BONE, V31, P529, DOI 10.1016/S8756-3282(02)00847-5; Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	42	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21346	21355		10.1074/jbc.M112.355834	http://dx.doi.org/10.1074/jbc.M112.355834			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547073	Green Published, hybrid			2022-12-28	WOS:000306416800053
J	Cauvi, DM; Song, DH; Vazquez, DE; Hawisher, D; Bermudez, JA; Williams, MR; Bickler, S; Coimbra, R; De Maio, A				Cauvi, David M.; Song, Donghuan; Vazquez, Daniel E.; Hawisher, Dennis; Bermudez, Jose A.; Williams, Michael R.; Bickler, Stephen; Coimbra, Raul; De Maio, Antonio			Period of Irreversible Therapeutic Intervention during Sepsis Correlates with Phase of Innate Immune Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY RESPONSE; HYPERTONIC SALINE; NEUTROPHIL ACTIVATION; HEMORRHAGIC-SHOCK; ABDOMINAL SEPSIS; UNITED-STATES; SEPTIC SHOCK; GOLDEN HOUR; INJURY	Sepsis is a major health problem in the United States with high incidence and elevated patient care cost. Using an animal model of sepsis, cecum ligation, and puncture, we observed that mice became rapidly hypothermic reaching a threshold temperature of 28 degrees C within 5-10 h after initiation of the insult, resulting in a reliable predictor of mortality, which occurred within 30-72 h of the initial procedure. We also observed that the inflammatory gene expression in lung and liver developed early within 1-2 h of the insult, reaching maximum levels at 6 h, followed by a decline, approaching basal conditions within 20 h. This decrease in inflammatory gene expression at 20 h after cecal ligation and puncture was not due to resolution of the insult but rather was an immune dysfunction stage that was demonstrated by the inability of the animal to respond to a secondary external inflammatory stimulus. Removal of the injury source, ligated cecum, within 6 h of the initial insult resulted in increased survival, but not after 20 h of cecal ligation and puncture. We concluded that the therapeutic window for resolving sepsis is early after the initial insult and coincides with a stage of hyperinflammation that is followed by a condition of innate immune dysfunction in which reversion of the outcome is no longer possible.	[De Maio, Antonio] Univ Calif San Diego, Dept Surg, Sch Med, La Jolla, CA 92093 USA; [Bermudez, Jose A.; Williams, Michael R.] Univ Calif San Diego, Initiat Maximizing Student Dev Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	De Maio, A (corresponding author), Univ Calif San Diego, Dept Surg, Sch Med, 9500 Gilman Dr,0739, La Jolla, CA 92093 USA.	ademaio@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	National Institutes of Health [GM073825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073825, R25GM083275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073825.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BAKER CC, 1983, SURGERY, V94, P331; BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bone RC, 1996, CLIN CHEST MED, V17, P175, DOI 10.1016/S0272-5231(05)70307-5; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; CHAUDRY IH, 1980, J TRAUMA, V20, P649, DOI 10.1097/00005373-198008000-00003; Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577; De Maio A, 1998, SHOCK, V10, P319; De Maio A, 2005, SHOCK, V23, P11, DOI 10.1097/01.shk.0000144134.03598.c5; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; DERIJK RH, 1994, AM J PHYSIOL, V266, pR1, DOI 10.1152/ajpregu.1994.266.1.R1; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Fulton WB, 2006, J IMMUNOL, V176, P3767, DOI 10.4049/jimmunol.176.6.3767; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Merlino James I, 2004, Surg Infect (Larchmt), V5, P21, DOI 10.1089/sur.2004.5.21; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphey ED, 2006, SHOCK, V26, P417, DOI 10.1097/01.shk.0000226343.70904.4f; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; MUSTARD RA, 1991, ARCH SURG-CHICAGO, V126, P170; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Reddy RC, 2001, INFECT IMMUN, V69, P1394, DOI 10.1128/IAI.69.3.1394-1401.2001; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Remick DG, 2006, FRONT BIOSCI-LANDMRK, V11, P1006, DOI 10.2741/1858; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; RICHARDSON JD, 1982, ANN SURG, V195, P732, DOI 10.1097/00000658-198206000-00009; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sewnath ME, 2001, J IMMUNOL, V166, P6323, DOI 10.4049/jimmunol.166.10.6323; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Stewart D, 2002, SHOCK, V18, P342, DOI 10.1097/00024382-200210000-00009; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Torres MB, 2005, J SURG RES, V125, P88, DOI 10.1016/j.jss.2004.11.025; Varma TK, 2005, INFECT IMMUN, V73, P7340, DOI 10.1128/IAI.73.11.7340-7347.2005; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Ward PA, 2008, BIOCHEM PHARMACOL, V76, P1383, DOI 10.1016/j.bcp.2008.09.017; Williams MA, 1998, J INFECT DIS, V178, P1421, DOI 10.1086/314447; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05	71	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19804	19815		10.1074/jbc.M112.359562	http://dx.doi.org/10.1074/jbc.M112.359562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22518839	Green Published, hybrid			2022-12-28	WOS:000306414500004
J	Chiodelli, P; Urbinati, C; Mitola, S; Tanghetti, E; Rusnati, M				Chiodelli, Paola; Urbinati, Chiara; Mitola, Stefania; Tanghetti, Elena; Rusnati, Marco			Sialic Acid Associated with alpha(v)beta(3) Integrin Mediates HIV-1 Tat Protein Interaction and Endothelial Cell Proangiogenic Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; ALPHA-V-BETA-3 INTEGRIN; ANIONIC SITES; CANCER CELLS; GROWTH; ADHESION; ANGIOGENESIS; GLYCOSYLATION; GANGLIOSIDE; BINDING	Sialic acid (NeuAc) is a major anion on endothelial cells (ECs) that regulates different biological processes including angiogenesis. NeuAc is present in the oligosaccharidic portion of integrins, receptors that interact with extracellular matrix components and growth factors regulating cell adhesion, migration, and proliferation. Tat is a cationic polypeptide that, once released by HIV-1(+) cells, accumulates in the extracellular matrix, promoting EC adhesion and proangiogenic activation by engaging alpha(v)beta(3). By using two complementary approaches (NeuAc removal by neuraminidase or its masking by NeuAc-binding lectin from Maackia amurensis, MAA), we investigated the presence of NeuAc on endothelial alpha(v)beta(3) and its role in Tat interaction, EC adhesion, and proangiogenic activation. alpha(v)beta(3) immunoprecipitation with biotinylated MAA or Western blot analysis of neuraminidase-treated ECs demonstrated that NeuAc is associated with both the alpha(v) and the beta(3) subunits. Surface plasmon resonance analysis demonstrated that the masking of alpha(v)beta(3)-associated NeuAc by MAA prevents Tat/alpha(v)beta(3) interaction. MAA and neuraminidase prevent alpha(v)beta(3)-dependent EC adhesion to Tat, the consequent FAK and ERK1/2 phosphorylation, and EC proliferation, migration, and regeneration in a wound-healing assay. Finally, MAA inhibits Tat-induced neo-vascularization in the ex vivo human artery ring sprouting assay. The inhibitions are specific because the NeuAc-unrelated lectin from Ulex europaeus is ineffective on Tat. Also, MAA and neuraminidase affect only weakly integrin-dependent EC adhesion and proangiogenic activation by fibronectin. In conclusion, NeuAc is associated with endothelial alpha(v)beta(3) and mediates Tat-dependent EC adhesion and proangiogenic activation. These data point to the possibility to target integrin glycosylation for the treatment of angiogenesis/AIDS-associated pathologies.	[Chiodelli, Paola; Urbinati, Chiara; Mitola, Stefania; Rusnati, Marco] Univ Brescia, Unit Gen Pathol & Immunol, Dept Biomed Sci & Biotechnol, Sch Med, I-25123 Brescia, Italy; [Tanghetti, Elena] Univ Brescia, Unit Histol, Dept Biomed Sci & Biotechnol, Sch Med, I-25123 Brescia, Italy	University of Brescia; University of Brescia	Rusnati, M (corresponding author), Univ Brescia, Unit Gen Pathol & Immunol, Dept Biomed Sci & Biotechnol, Sch Med, Viale Europa 11, I-25123 Brescia, Italy.	rusnati@med.unibs.it	Rusnati, Marco/F-1168-2010; Chiodelli, Paola/K-1418-2016	Rusnati, Marco/0000-0001-9968-5908; Urbinati, Chiara Eva/0000-0002-0138-7871; MITOLA, Stefania/0000-0002-5557-738X; Chiodelli, Paola/0000-0002-8702-0623	Ministero dell'Istruzione, dell'Universita e della Ricerca; Istituto Superiore di Sanita (AIDS Project); Cassa di Risparmio delle Provincie Lombarde	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita (AIDS Project); Cassa di Risparmio delle Provincie Lombarde(Fondazione Cariplo)	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore di Sanita (AIDS Project), and Cassa di Risparmio delle Provincie Lombarde (to M. R.).	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Angelucci A, 2007, CURR PHARM DESIGN, V13, P2129; Auzzas L, 2010, CURR MED CHEM, V17, P1255, DOI 10.2174/092986710790936301; Banks WA, 2004, NEUROSCIENCE, V128, P143, DOI 10.1016/j.neuroscience.2004.06.021; Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O; Barillari G, 1999, BLOOD, V94, P663; BOUWSTRA JB, 1987, BIOL CHEM H-S, V368, P269, DOI 10.1515/bchm3.1987.368.1.269; Brockhausen I, 2002, GLYCOBIOLOGY, V12, P33, DOI 10.1093/glycob/12.1.33; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; Doiron AL, 2004, TECH PAPERS ISA, V449, P331; DOSSANTOS WLC, 1995, ACTA NEUROPATHOL, V90, P305; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eliceiri BP, 1998, MOL MED, V4, P741, DOI 10.1007/BF03401768; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; GRINSPAN JB, 1983, J CELL PHYSIOL, V114, P328, DOI 10.1002/jcp.1041140312; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Henry CBS, 1996, TISSUE CELL, V28, P449, DOI 10.1016/S0040-8166(96)80030-9; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KARLSSON KA, 1991, TRENDS PHARMACOL SCI, V12, P265, DOI 10.1016/0165-6147(91)90568-D; Kopitz J, 2010, IUBMB LIFE, V62, P624, DOI 10.1002/iub.358; Kremser ME, 2008, BBA-GEN SUBJECTS, V1780, P1421, DOI 10.1016/j.bbagen.2008.07.011; Lang ZH, 2001, BIOCHEM BIOPH RES CO, V282, P1031, DOI 10.1006/bbrc.2001.4630; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Mitola S, 2008, BLOOD, V112, P1154, DOI 10.1182/blood-2007-09-111450; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Mousa SA, 2008, MOL BIOTECHNOL, V38, P33, DOI 10.1007/s12033-007-0072-7; MURESAN V, 1987, HISTOCHEM J, V19, P170, DOI 10.1007/BF01695141; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Noonan D, 2000, Adv Pharmacol, V48, P229; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Rusnati M, 1999, MOL BIOL CELL, V10, P313, DOI 10.1091/mbc.10.2.313; Rusnati M, 2002, P NATL ACAD SCI USA, V99, P4367, DOI 10.1073/pnas.072651899; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Rusnati M, 2001, ENDOTHELIUM-J ENDOTH, V8, P65, DOI 10.3109/10623320109063158; Rusnati M, 2006, ENDOTHELIUM-J ENDOTH, V13, P93, DOI 10.1080/10623320600698011; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Terada M, 2005, BIOMED PHARMACOTHER, V59, P423, DOI 10.1016/j.biopha.2005.07.005; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Urbinati C, 2005, ARTERIOSCL THROM VAS, V25, P2315, DOI 10.1161/01.ATV.0000186182.14908.7b; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Urbinati C, 2004, FEBS LETT, V568, P171, DOI 10.1016/j.febslet.2004.05.033; Urbinati C, 2012, ARTERIOSCL THROM VAS, V32, pE25, DOI 10.1161/ATVBAHA.111.242396; Urbinati C, 2008, MOLECULES, V13, P2758, DOI 10.3390/molecules13112758; VORBRODT AW, 1989, J NEUROCYTOL, V18, P359, DOI 10.1007/BF01190839; WELIM HB, 1989, CELL TISSUE RES, V255, P627; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200	59	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20456	20466		10.1074/jbc.M111.337139	http://dx.doi.org/10.1074/jbc.M111.337139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528484	hybrid, Green Published			2022-12-28	WOS:000306414500063
J	Solomonov, I; Korkotian, E; Born, B; Feldman, Y; Bitler, A; Rahimi, F; Li, HY; Bitan, G; Sagi, I				Solomonov, Inna; Korkotian, Eduard; Born, Benjamin; Feldman, Yishay; Bitler, Arkady; Rahimi, Farid; Li, Huiyuan; Bitan, Gal; Sagi, Irit			Zn2+-A beta 40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; SYNAPTIC ZINC; AGGREGATION; FIBRILS; NEUROTOXICITY; ACCUMULATION; HYPOTHESIS	The roles of metal ions in promoting amyloid beta-protein (A beta) oligomerization associated with Alzheimer disease are increasingly recognized. However, the detailed structures dictating toxicity remain elusive for A beta oligomers stabilized by metal ions. Here, we show that small Zn2+-bound A beta 1-40 (Zn2+-A beta 40) oligomers formed in cell culture medium exhibit quasispherical structures similar to native amylospheroids isolated recently from Alzheimer disease patients. These quasi-spherical Zn2+-A beta 40 oligomers irreversibly inhibit spontaneous neuronal activity and cause massive cell death in primary hippocampal neurons. Spectroscopic and x-ray diffraction structural analyses indicate that despite their non-fibrillar morphology, the metastable Zn2+-A beta 40 oligomers are rich in beta-sheet and cross-beta structures. Thus, Zn2+ promotes A beta 40 neurotoxicity by structural organization mechanisms mediated by coordination chemistry.	[Solomonov, Inna; Born, Benjamin; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Solomonov, Inna; Born, Benjamin; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Feldman, Yishay; Bitler, Arkady] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Rahimi, Farid; Li, Huiyuan; Bitan, Gal] Univ Calif Los Angeles, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il	Bitan, Gal/U-2204-2019; Rahimi, Farid/E-6522-2018; Korkotian, Eduard/P-4559-2019; Korkotian, Eduard/K-1744-2012	Bitan, Gal/0000-0001-7046-3754; Rahimi, Farid/0000-0002-0920-8188; Korkotian, Eduard/0000-0001-5515-3387	National Institutes of Health [AG027818, CA098799]; United States-Israel Binational Science Foundation [2007187]; Weizmann Institute; Israel Science Foundation; Kimmelman Center at the Weizmann Institute; Ambach family fund; Human Frontier Science Program cross-disciplinary fellowship; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Weizmann Institute; Israel Science Foundation(Israel Science Foundation); Kimmelman Center at the Weizmann Institute; Ambach family fund; Human Frontier Science Program cross-disciplinary fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG027818 (to G.B.) and CA098799 (to I. Sagi). This work was also supported by United States-Israel Binational Science Foundation Grant 2007187 (to G.B. and I. Sagi), by a Human Frontier Science Program cross-disciplinary fellowship and a Dean of Faculty fellowship of the Weizmann Institute (to B.B.), and by the Israel Science Foundation, the Kimmelman Center at the Weizmann Institute, and the Ambach family fund (to I. Sagi).	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eilers Jens, 1995, P213; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heininger K, 2000, REV NEUROSCIENCE, V11, P213; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Neher E, 2011, IMAGING LAB MANUAL, P417; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; PAPA M, 1995, J NEUROSCI, V15, P1; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Rezaei-Ghaleh N, 2011, BIOPHYS J, V101, P1202, DOI 10.1016/j.bpj.2011.06.062; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Wolfe MS, 2003, CURR TOP DEV BIOL, V54, P233, DOI 10.1016/S0070-2153(03)54011-X	52	35	36	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20555	20564		10.1074/jbc.M112.344036	http://dx.doi.org/10.1074/jbc.M112.344036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528492	Green Published, hybrid			2022-12-28	WOS:000306414500076
J	Didangelos, A; Mayr, U; Monaco, C; Mayr, M				Didangelos, Athanasios; Mayr, Ursula; Monaco, Claudia; Mayr, Manuel			Novel Role of ADAMTS-5 Protein in Proteoglycan Turnover and Lipoprotein Retention in Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; HUMAN ARTICULAR-CARTILAGE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR 2; HUMAN AORTA; IN-VIVO; VERSICAN; ACCUMULATION; AGGRECANASE-2; ATHEROGENESIS	Atherosclerosis is initiated by the retention of lipoproteins on proteoglycans in the arterial intima. However, the mechanisms leading to proteoglycan accumulation and lipoprotein retention are poorly understood. In this study, we set out to investigate the role of ADAMTS-5(a disintegrin and metalloprotease with thrombospondin motifs-5) in the vasculature. ADAMTS-5 was markedly reduced in atherosclerotic aortas of apolipoprotein E-null (apoE(-/-)) mice. The reduction of ADAMTS-5 was accompanied by accumulation of biglycan and versican, the major lipoprotein-binding proteoglycans, in atherosclerosis. ADAMTS-5 activity induced the release of ADAMTS-specific versican (DPEAAE(441)) and aggrecan ((374)ALGS) fragments as well as biglycan and link protein from the aortic wall. Fibroblast growth factor 2 (FGF-2) inhibited ADAMTS-5 expression in isolated aortic smooth muscle cells and blocked the spontaneous release of ADAMTS-generated versican and aggrecan fragments from aortic explants. In aortas of ADAMTS-5-deficient mice, DPEAAE(441) versican neoepitopes were not detectable. Instead, biglycan levels were increased, highlighting the role of ADAMTS-5 in the catabolism of vascular proteoglycans. Importantly, ADAMTS-5 proteolytic activity reduced the LDL binding ability of biglycan and released LDL from human aortic lesions. This study provides the first evidence implicating ADAMTS-5 in the regulation of proteoglycan turnover and lipoprotein retention in atherosclerosis.	[Didangelos, Athanasios; Mayr, Ursula; Mayr, Manuel] Kings Coll London, Kings British Heart Fdn Ctr, London SE5 9NU, England; [Monaco, Claudia] Univ Oxford, Kennedy Inst Rheumatol, Oxford W6 8LH, England	University of London; King's College London; University of Oxford	Mayr, M (corresponding author), Kings Coll London, Kings British Heart Fdn Ctr, 125 Coldharbour La, London SE5 9NU, England.	manuel.mayr@kcl.ac.uk	DIDANGELOS, ATHANASIOS/Q-5763-2017	DIDANGELOS, ATHANASIOS/0000-0002-8835-0974; Mayr, Manuel/0000-0002-0597-829X; Monaco, Claudia/0000-0003-1985-4914	British Heart Foundation; British Heart Foundation [FS/08/002/24537] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation.	Agrotis A, 2004, J BIOL CHEM, V279, P42221, DOI 10.1074/jbc.M408121200; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Chia SL, 2009, ARTHRITIS RHEUM-US, V60, P2019, DOI 10.1002/art.24654; Chockalingam PS, 2004, ARTHRITIS RHEUM-US, V50, P2839, DOI 10.1002/art.20496; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Didangelos A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008128; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gilbert AM, 2008, BIOORG MED CHEM LETT, V18, P6454, DOI 10.1016/j.bmcl.2008.10.065; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; HUGHES SE, 1993, CARDIOVASC RES, V27, P1214, DOI 10.1093/cvr/27.7.1214; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kunjathoor VV, 2002, ARTERIOSCL THROM VAS, V22, P462, DOI 10.1161/hq0302.105378; Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6; Mayr M, 2008, CIRC RES, V102, P1046, DOI 10.1161/CIRCRESAHA.108.174623; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Olin KL, 2001, ARTERIOSCL THROM VAS, V21, P129, DOI 10.1161/01.ATV.21.1.129; Raj T, 2006, ARTERIOSCL THROM VAS, V26, P1845, DOI 10.1161/01.ATV.0000227689.41288.5e; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Sawaji Y, 2008, ARTHRITIS RHEUM, V58, P3498, DOI 10.1002/art.24025; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Theocharis AD, 1999, ATHEROSCLEROSIS, V145, P359, DOI 10.1016/S0021-9150(99)00117-3; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	30	69	74	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19341	19345		10.1074/jbc.C112.350785	http://dx.doi.org/10.1074/jbc.C112.350785			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493487	Green Published, hybrid			2022-12-28	WOS:000306411900048
J	Lee, W; Strumpfer, J; Bennett, V; Schulten, K; Marszalek, PE				Lee, Whasil; Struempfer, Johan; Bennett, Vann; Schulten, Klaus; Marszalek, Piotr E.			Mutation of Conserved Histidines Alters Tertiary Structure and Nanomechanics of Consensus Ankyrin Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ATOMIC-FORCE MICROSCOPY; TITIN IMMUNOGLOBULIN DOMAINS; HEREDITARY SPHEROCYTOSIS; MECHANICAL-PROPERTIES; UNFOLDING PATHWAYS; ENERGY LANDSCAPE; PROTEINS; SPECTRIN; ELASTICITY	The conserved TPLH tetrapeptide motif of ankyrin repeats (ARs) plays an important role in stabilizing AR proteins, and histidine (TPL (H) under bar)-to-arginine (TPL (R) under bar) mutations in this motif have been associated with a hereditary human anemia, spherocytosis. Here, we used a combination of atomic force microscopy-based single-molecule force spectroscopy and molecular dynamics simulations to examine the mechanical effects of His -> Arg substitutions in TPLH motifs in a model AR protein, NI6C. Our molecular dynamics results show that the mutant protein is less mechanically stable than the WT protein. Our atomic force microscopy results indicate that the mechanical energy input necessary to fully unfold the mutant protein is only half of that necessary to unfold the WT protein (53 versus 106 kcal/mol). In addition, the ability of the mutant to generate refolding forces is also reduced. Moreover, the mutant protein subjected to cyclic stretch-relax measurements displays mechanical fatigue, which is absent in the WT protein. Taken together, these results indicate that the His -> Arg substitutions in TPLH motifs compromise mechanical properties of ARs and suggest that the origin of hereditary spherocytosis may be related to mechanical failure of ARs.	[Bennett, Vann] Duke Univ, Dept Cell Biol, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Struempfer, Johan; Schulten, Klaus] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Struempfer, Johan; Schulten, Klaus] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Bennett, Vann] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA	Duke University; Duke University; Duke University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Duke University; Howard Hughes Medical Institute	Bennett, V (corresponding author), Duke Univ, 361 CARL Bldg, Durham, NC 27710 USA.	benne012@mc.duke.edu; kschulte@ks.uiuc.edu; piotr.marszalek@duke.edu		Lee, Whasil/0000-0002-3035-6687	National Institutes of Health [GM079663, P41-RR005969, R01-GM073655]; National Science Foundation [OCI-1053575]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663, R01GM073655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079663 (to P. E. M. and V. B.) and P41-RR005969 and R01-GM073655 (to J. S. and K. S.).; We thank Jane Clarke for providing the plasmids with poly-I27 domains. Supercomputer time was provided by the Texas Advance Computing Center at The University of Texas at Austin as part of XSEDE (National Science Foundation Grant OCI-1053575), and the parallel computing resource was provided by the Computational Science and Engineering Program at the University of Illinois as part of the Taub cluster.	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2; Guo Y, 2010, J MOL BIOL, V399, P168, DOI 10.1016/j.jmb.2010.04.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interlandi G, 2008, J MOL BIOL, V375, P837, DOI 10.1016/j.jmb.2007.09.042; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li LW, 2006, BIOPHYS J, V90, pL30, DOI 10.1529/biophysj.105.078436; Li MS, 2006, P NATL ACAD SCI USA, V103, P93, DOI 10.1073/pnas.0503758103; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makarov DE, 2009, BIOPHYS J, V96, P2160, DOI [10.1016/j.bpj.2008.12.3899, 10.1016/j.bpj.200X.12.3899]; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Merz T, 2008, J MOL BIOL, V376, P232, DOI 10.1016/j.jmb.2007.11.047; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Rabbi Mahir, 2007, CSH Protoc, V2007, DOI [10.1101/pdb.prot4900, 10.1101/pdb.prot4901]; Randles LG, 2007, BIOPHYS J, V92, P571, DOI 10.1529/biophysj.106.093690; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; SCHRIER SL, 1989, BLOOD, V74, P2194; Serquera D, 2010, BIOPHYS J, V98, P1294, DOI 10.1016/j.bpj.2009.12.4287; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	49	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19115	19121		10.1074/jbc.M112.365569	http://dx.doi.org/10.1074/jbc.M112.365569			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22514283	Green Published, hybrid			2022-12-28	WOS:000306411900022
J	Garcia-Rodriguez, N; de la Loza, MDD; Andreson, B; Monje-Casas, F; Rothstein, R; Wellinger, RE				Garcia-Rodriguez, Nestor; Diaz de la Loza, Maria del Carmen; Andreson, Bethany; Monje-Casas, Fernando; Rothstein, Rodney; Erik Wellinger, Ralf			Impaired Manganese Metabolism Causes Mitotic Misregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HAILEY-HAILEY-DISEASE; CELL-CYCLE CONTROL; BUDDING YEAST; SECRETORY PATHWAY; DNA-REPLICATION; S-PHASE; PROTEIN-KINASE; ION-PUMP; GOLGI CA2+/MN2+-ATPASE	Manganese is an essential trace element, whose intracellular levels need to be carefully regulated. Mn2+ acts as a cofactor for many enzymes and excess of Mn2+ is toxic. Alterations in Mn2+ homeostasis affect metabolic functions and mutations in the human Mn2+/Ca2+ transporter ATP2C1 have been linked to Hailey-Hailey disease. By deletion of the yeast orthologue PMR1 we have studied the impact of Mn2+ on cell cycle progression and show that an excess of cytosolic Mn2+ alters S-phase transit, induces transcriptional up-regulation of cell cycle regulators, bypasses the need for S-phase cell cycle checkpoints and predisposes to genomic instability. On the other hand, we find that depletion of the Golgi Mn2+ pool requires a functional morphology checkpoint to avoid the formation of polyploid cells.	[Erik Wellinger, Ralf] Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Seville 41092, Spain; [Andreson, Bethany] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Columbia University; Columbia University	Wellinger, RE (corresponding author), Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Av Amer Vespucio S-N, Seville 41092, Spain.	ralf.wellinger@cabimer.es	Díaz de la Loza, María del Carmen/C-6229-2015; Monje-Casas, Fernando/M-3062-2014; García-Rodríguez, Néstor/AAH-1450-2019; Wellinger, Ralf Erik/L-8463-2014	Díaz de la Loza, María del Carmen/0000-0002-9212-6190; Monje-Casas, Fernando/0000-0002-3587-2373; Garcia Rodriguez, Nestor/0000-0002-4049-1604; Wellinger, Ralf Erik/0000-0002-4421-6618; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [GM50237]; Spanish Ministry of Science and Innovation [BIO2006-08051, BFU2010-21339]; Junta de Andalucia [P08-CTS-04297]; University of Seville/El Monte Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); University of Seville/El Monte Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM50237) (to R. R.), the Spanish Ministry of Science and Innovation (BIO2006-08051 and BFU2010-21339), and the Junta de Andalucia (P08-CTS-04297) (to R. E. W.).; Recipient of a pre-doctoral training grant from the University of Seville/El Monte Foundation.	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bartholomew CR, 2001, MOL CELL BIOL, V21, P4949, DOI 10.1128/MCB.21.15.4949-4959.2001; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Crowley JD, 2000, MET IONS BIOL SYST, V37, P209; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Devasahayam G, 2006, P NATL ACAD SCI USA, V103, P17840, DOI 10.1073/pnas.0604303103; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hu FF, 2005, P NATL ACAD SCI USA, V102, P8910, DOI 10.1073/pnas.0406987102; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jaag HM, 2010, CELL HOST MICROBE, V7, P74, DOI 10.1016/j.chom.2009.12.009; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Keen CL, 2000, MET IONS BIOL SYST, V37, P89; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mohr MR, 2011, ARCH DERMATOL, V147, P211, DOI 10.1001/archdermatol.2010.445; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; Mondesert G, 1997, GENETICS, V147, P421; Monje-Casas F, 2009, DEV CELL, V16, P132, DOI 10.1016/j.devcel.2008.11.002; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Paidhungat M, 1998, GENETICS, V148, P1777; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Poletto NP, 2010, ARCH MICROBIOL, V192, P247, DOI 10.1007/s00203-010-0553-0; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Rice LM, 2005, EUKARYOT CELL, V4, P55, DOI 10.1128/EC.4.1.55-62.2005; Ringvoll J, 2007, FEMS YEAST RES, V7, P848, DOI 10.1111/j.1567-1364.2007.00248.x; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wellinger RE, 2003, MOL CELL BIOL, V23, P6363, DOI 10.1128/MCB.23.18.6363-6372.2003; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	71	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18717	18729		10.1074/jbc.M112.358309	http://dx.doi.org/10.1074/jbc.M112.358309			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493290	hybrid, Green Published			2022-12-28	WOS:000306411600080
J	Kita, K; Suzuki, T; Ochi, T				Kita, Kayoko; Suzuki, Toshihide; Ochi, Takafumi			Diphenylarsinic Acid Promotes Degradation of Glutaminase C by Mitochondrial Lon Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; PHOSPHATE-ACTIVATED GLUTAMINASE; PARAPLEGIN-RELATED GENE; MISFOLDED PROTEINS; SUBSTRATE PROTEINS; ESCHERICHIA-COLI; PIM1 PROTEASE; IDENTIFICATION; PROTEOLYSIS; EXPRESSION	Glutaminase C (GAC), a splicing variant of the kidney-type glutaminase (KGA) gene, is a vital mitochondrial enzyme protein that catalyzes glutamine to glutamate. Earlier studies have shown that GAC proteins in the human hepatocarcinoma cell line, HepG2, were down-regulated by diphenylarsinic acid (DPAA), but the mechanism by which DPAA induced GAC protein down-regulation remained poorly understood. Here, we showed that DPAA promoted GAC protein degradation without affecting GAC transcription and translation. Moreover, DPAA-induced GAC proteolysis was mediated by mitochondrial Lon protease. DPAA insolubilized 0.5% Triton X-100-soluble GAC protein and promoted the accumulation of insoluble GAC in Lon protease knockdown cells. DPAA destroyed the native tetrameric GAC conformation and promoted an increase in the unassembled form of GAC when DPAA was incubated with cell extracts. Decreases in the tetrameric form of GAC were observed in cells exposed to DPAA, and decreases occurred prior to a decrease in total GAC protein levels. In addition, decreases in the tetrameric form of GAC were observed independently with Lon protease. Mitochondrial heat shock protein 70 is known to be an indispensable protein that can bind to misfolded proteins, thereby supporting degradation of proteins sensitive to Lon protease. When cells were incubated with DPAA, GAC proteins that can bind with mtHsp70 increased. Interestingly, the association of mtHsp70 with GAC protein increased when the tetrameric form of GAC was reduced. These results suggest that degradation of native tetrameric GAC by DPAA may be a trigger in GAC protein degradation by Lon protease.	[Kita, Kayoko; Suzuki, Toshihide; Ochi, Takafumi] Teikyo Univ, Fac Pharmasci, Toxicol Lab, Itabashi Ku, Tokyo 1738605, Japan	Teikyo University	Kita, K (corresponding author), Teikyo Univ, Fac Pharmasci, Toxicol Lab, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	kkayoko@pharm.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20790113]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Young Scientists (B) 20790113 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; Banfi S, 1999, GENOMICS, V59, P51, DOI 10.1006/geno.1999.5818; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bayot A, 2010, J BIOL CHEM, V285, P11445, DOI 10.1074/jbc.M109.065425; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; Coppola M, 2000, GENOMICS, V66, P48, DOI 10.1006/geno.2000.6136; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Frase H, 2006, BIOCHEMISTRY-US, V45, P8264, DOI 10.1021/bi060542e; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; HASER WG, 1985, BIOCHEM J, V229, P399, DOI 10.1042/bj2290399; Holcomb T, 2000, MOL BRAIN RES, V76, P56, DOI 10.1016/S0169-328X(99)00331-9; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Ishii K, 2004, ANN NEUROL, V56, P741, DOI 10.1002/ana.20290; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009; KUZELA S, 1994, METHOD ENZYMOL, V244, P376; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Roberg B, 2000, AM J PHYSIOL-CELL PH, V279, pC648, DOI 10.1152/ajpcell.2000.279.3.C648; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SHINEBERG B, 1973, J BACTERIOL, V116, P1469, DOI 10.1128/JB.116.3.1469-1471.1973; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1185, DOI 10.1074/jbc.270.3.1185; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1191, DOI 10.1074/jbc.270.3.1191; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	44	32	34	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18163	18172		10.1074/jbc.M112.362699	http://dx.doi.org/10.1074/jbc.M112.362699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493432	hybrid, Green Published			2022-12-28	WOS:000306411600024
J	Qi, XJ; Sandmeyer, S				Qi, Xiaojie; Sandmeyer, Suzanne			In Vitro Targeting of Strand Transfer by the Ty3 Retroelement Integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; TRANSCRIPTION FACTOR IIIB; TATA-BINDING PROTEIN; POSITION-SPECIFIC INTEGRATION; HIV-1 INTEGRASE; YEAST RETROTRANSPOSON; DNA; INITIATION; ELEMENT; GENES	The Saccharomyces cerevisiae long terminal repeat retrotransposon Ty3 integrates within one or two nucleotides of the transcription initiation sites of genes transcribed by RNA polymerase III. In this study the minimal components required to re-constitute position-specific strand transfer by Ty3 integrase are defined. Ty3 integrase targeted by a synthetic fusion of RNA polymerase III transcription factor IIIB subunits, Brf1 and TBP, mediated position-specific strand transfer of duplex oligonucleotides representing the ends of the Ty3 cDNA. These results further delimit the TFIIIB domains targeted by the Ty3 element and show that IN is the Ty3 component sufficient in vitro to target integration. These results underscore the com-monality of protein interactions that mediate transcription and retrotransposon targeting. Surprisingly, in the presence of MnCl2, strand transfer was TFIIIB-independent and targeted sequences resembling the Ty3 terminal inverted repeat.	[Qi, Xiaojie; Sandmeyer, Suzanne] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Sandmeyer, Suzanne] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Sandmeyer, S (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	sbsandme@uci.edu			National Institutes of Health Public Service [GM33281]; NSF [0450159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033281] Funding Source: NIH RePORTER	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by funds from the National Institutes of Health Public Service Grant GM33281 and NSF Grant ID 0450159 (to S. S.).	AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; Clemens K, 2011, J VIROL, V85, P3055, DOI 10.1128/JVI.01055-10; Delelis O, 2010, BBA-GENE REGUL MECH, V1799, P207, DOI 10.1016/j.bbagrm.2009.08.005; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Hizi A, 2005, J BIOL CHEM, V280, P39086, DOI 10.1074/jbc.M506363200; Kassavetis GA, 2006, BIOCHEM SOC T, V34, P1082, DOI 10.1042/BST0341082; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; Kassavetis GA, 1999, EMBO J, V18, P5042, DOI 10.1093/emboj/18.18.5042; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kirchner J, 1996, J VIROL, V70, P4737, DOI 10.1128/JVI.70.7.4737-4747.1996; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Larsen Liza S Z, 2008, Int J Bioinform Res Appl, V4, P324, DOI 10.1504/IJBRA.2008.019578; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; Peterson-Burch BD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r78; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Sandmeyer S.B., 2002, MOBILE DNA-UK, P663; SHARON G, 1994, MOL CELL BIOL, V14, P6540, DOI 10.1128/MCB.14.10.6540; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; WHITEHALL SK, 1995, GENE DEV, V9, P2974, DOI 10.1101/gad.9.23.2974; Winckler T, 2005, CYTOGENET GENOME RES, V110, P288, DOI 10.1159/000084961; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Yieh L, 2002, J BIOL CHEM, V277, P25920, DOI 10.1074/jbc.M202729200; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100; ZOU S, 1995, P NATL ACAD SCI USA, V92, P920, DOI 10.1073/pnas.92.3.920	41	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18589	18595		10.1074/jbc.M111.326025	http://dx.doi.org/10.1074/jbc.M111.326025			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493285	Green Published, hybrid			2022-12-28	WOS:000306411600069
J	Tapken, W; Ravet, K; Pilon, M				Tapken, Wiebke; Ravet, Karl; Pilon, Marinus			Plastocyanin Controls the Stabilization of the Thylakoid Cu-transporting P-type ATPase PAA2/HMA8 in Response to Low Copper in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; HOMEOSTASIS; CHLOROPLASTS; THALIANA; DEGRADATION; PHOTOSYNTHESIS; CHLOROPHYLL; TOLERANCE	PAA2/HMA8 (P-type ATPase of Arabidopsis/Heavy-metal-associated 8) is a thylakoid located copper (Cu)-transporter in Arabidopsis thaliana. In tandem with PAA1/HMA6, which is located in the inner chloroplast envelope, it supplies Cu to plastocyanin (PC), an essential cuproenzyme of the photosynthetic machinery. We investigated whether the chloroplast Cu transporters are affected by Cu addition to the growth media. Immu-noblots showed that PAA2 protein abundance decreased significantly and specifically when Cu in the media was increased, while PAA1 remained unaffected. The function of SPL7, the transcriptional regulator of Cu homeostasis, was not required for this regulation of PAA2 protein abundance and Cu addition did not affect PAA2 transcript levels, as determined by qRT-PCR. We used the translational inhibitor cycloheximide to analyze turnover and observed that the stability of the PAA2 protein was decreased in plants grown with elevated Cu. Interestingly, PAA2 protein abundance was significantly increased in paa1 mutants, in which the Cu content in the chloroplast is half of that of the wild-type, due to impaired Cu import into the organ-elle. In contrast in a pc2 insertion mutant, which has strongly reduced plastocyanin expression, the PAA2 protein levels were low regardless of Cu addition to the growth media. Together, these data indicate that plastid Cu levels control PAA2 stability and that plastocyanin, which is the target of PAA2 mediated Cu delivery in thylakoids, is a major determinant of this regulatory mechanism.	[Pilon, Marinus] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Pilon, M (corresponding author), Colorado State Univ, Dept Biol, 200 W Lake St,1878 Campus Delivery, Ft Collins, CO 80523 USA.	pilon@lamar.colostate.edu	Ravet, Karl/AHD-6431-2022		United States National Science Foundation [IOS-0847442, MCB 0950726]; European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast) [PIOF-GA-2010-273586]; Div Of Molecular and Cellular Bioscience [0950726] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States National Science Foundation (Grant Numbers IOS-0847442 and MCB 0950726).; Supported by a European-FP7-International Outgoing Fellowship (Marie Curie, IntegrRegulFeSPlast; PIOF-GA-2010-273586).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abdel-Ghany SE, 2009, PLANTA, V229, P767, DOI 10.1007/s00425-008-0869-z; Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; BRUINSMA J, 1961, BIOCHIM BIOPHYS ACTA, V52, P576, DOI 10.1016/0006-3002(61)90418-8; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Kupper H, 2003, FUNCT PLANT BIOL, V30, P1187, DOI 10.1071/FP03129; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pesaresi P, 2009, MOL PLANT, V2, P236, DOI 10.1093/mp/ssn041; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wangeline AL, 2004, J ENVIRON QUAL, V33, P54, DOI 10.2134/jeq2004.0054; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2009, CHEM REV, V109, P4828, DOI 10.1021/cr800557s	36	33	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18544	18550		10.1074/jbc.M111.318204	http://dx.doi.org/10.1074/jbc.M111.318204			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493454	Green Published, hybrid			2022-12-28	WOS:000306411600060
J	Andberg, M; Maaheimo, H; Boer, H; Penttila, M; Koivula, A; Richard, P				Andberg, Martina; Maaheimo, Hannu; Boer, Harry; Penttila, Merja; Koivula, Anu; Richard, Peter			Characterization of a novel Agrobacterium tumefaciens Galactarolactone Cycloisomerase Enzyme for Direct Conversion of D-Galactarolactone to 3-Deoxy-2-keto-L-threo-hexarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCARIC ACID; ENOLASE SUPERFAMILY; MANDELATE RACEMASE; ESCHERICHIA-COLI; EVOLUTION; MECHANISM; DEHYDROGENASE; SPECIFICITY; DEHYDRATASE; ALDOLASE	Microorganisms use different pathways for D-galacturonate catabolism. In the known microbial oxidative pathway, D-galacturonate is oxidized to D-galactarolactone, the lactone hydrolyzed to galactarate, which is further converted to 3-deoxy-2-keto-hexarate and alpha-ketoglutarate. We have shown recently that Agrobacterium tumefaciens strain C58 contains an uronate dehydrogenase (At Udh) that oxidizes D-galacturonic acid to D-galactarolactone. Here we report identification of a novel enzyme from the same A. tumefaciens strain, which we named Galactarolactone cycloisomerase (At Gci) (E.C. 5.5.1.-), for the direct conversion of the D-galactarolactone to 3-deoxy-2-keto-hexarate. The At Gci enzyme is 378 amino acids long and belongs to the mandelate racemase subgroup in the enolase superfamily. At Gci was heterologously expressed in Escherichia coli, and the purified enzyme was found to exist as an octameric form. It is active both on D-galactarolactone and D-glucarolactone, but does not work on the corresponding linear hexaric acid forms. The details of the reaction mechanism were further studied by NMR and optical rotation demonstrating that the reaction product of At Gci from D-galactaro-1,4-lactone and D-glucaro-1,4-lactone conversion is in both cases the L-threo form of 3-deoxy-2-keto-hexarate.	[Andberg, Martina; Maaheimo, Hannu; Boer, Harry; Penttila, Merja; Koivula, Anu; Richard, Peter] VTT Tech Res Ctr Finland, FIN-02044 Espoo, Finland	VTT Technical Research Center Finland	Andberg, M (corresponding author), VTT Tech Res Ctr Finland, POB 1000, FIN-02044 Espoo, Finland.	martina.andberg@vtt.fi	Richard, Peter/A-4229-2009; Penttilä, Merja E/A-4710-2013	Richard, Peter/0000-0003-0922-6092; Blomster Andberg, Martina/0000-0002-8021-9947; Penttila, Merja/0000-0002-6929-1032; Boer, Harry/0000-0002-1685-2270; Koivula, Anu/0000-0002-7600-5700	Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry [118573]	Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry(Academy of Finland)	This study was supported by the Academy of Finland through the Centre of Excellence in White Biotechnology-Green Chemistry (decision number 118573).	BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; Brown JM, 2007, J CARBOHYD CHEM, V26, P455, DOI 10.1080/07328300701787172; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; CHANG YF, 1970, J BACTERIOL, V102, P85, DOI 10.1128/JB.102.1.85-96.1970; CHANG YF, 1969, J BACTERIOL, V99, P667, DOI 10.1128/JB.99.3.667-673.1969; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; JEFFCOAT R, 1969, BIOCHEM J, V115, P977, DOI 10.1042/bj1150977; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KILGORE WW, 1959, NATURE, V183, P1412, DOI 10.1038/1831412a0; MACGEE J, 1954, J BIOL CHEM, V210, P617; MITRA B, 1995, BIOCHEMISTRY-US, V34, P2777, DOI 10.1021/bi00009a006; Parkkinen T, 2011, J BIOL CHEM, V286, P27294, DOI 10.1074/jbc.M111.254854; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Rakus JF, 2009, BIOCHEMISTRY-US, V48, P11546, DOI 10.1021/bi901731c; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Schafer SL, 1996, BIOCHEMISTRY-US, V35, P5662, DOI 10.1021/bi960174m; Yew WS, 2007, BIOCHEMISTRY-US, V46, P9564, DOI 10.1021/bi7008882; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o; ZAJIC JE, 1959, J BACTERIOL, V78, P734, DOI 10.1128/JB.78.5.734-735.1959	23	28	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17662	17671		10.1074/jbc.M111.335240	http://dx.doi.org/10.1074/jbc.M111.335240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493433	hybrid, Green Published			2022-12-28	WOS:000306373000065
J	DiFranco, KM; Gupta, A; Galusha, LE; Perez, J; Nguyen, TVK; Fineza, CD; Kachlany, SC				DiFranco, Kristina M.; Gupta, Anukriti; Galusha, Lindsey E.; Perez, Jarelys; Nguyen, To-Vy K.; Fineza, Camille D.; Kachlany, Scott C.			Leukotoxin (Leukotherar (R)) Targets Active Leukocyte Function Antigen-1 (LFA-1) Protein and Triggers a Lysosomal Mediated Cell Death Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS LEUKOTOXIN; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; INTEGRIN ACTIVATION; IN-VITRO; T-CELLS; APOPTOSIS; LYMPHOCYTES; MECHANISMS; PSORIASIS; STORY	Leukotoxin (LtxA) is a protein toxin that is secreted from the oral bacterium, Aggregatibacter actinomycetemcomitans. LtxA targets specifically the beta(2) integrin, leukocyte function antigen-1 (LFA-1) on white blood cells (WBCs) and causes cell death. LtxA preferentially targets activated WBCs and is being developed as a therapeutic agent for the treatment of WBC diseases such as hematologic malignancies and autoimmune/inflammatory diseases. However, the mechanism by which interaction between LtxA and LFA-1 results in cell death is not well understood. Furthermore, how LtxA preferentially recognizes activated WBCs is not known. We show here that LtxA interacts specifically with LFA-1 in the active (exposed) conformation. In THP-1 monocytes, LtxA caused rapid activation of caspases, but LtxA could overcome the inhibition of caspases and still intoxicate. In contrast, inhibiting the vesicular trafficking pathway or cathepsin D release from the lysosome resulted in significant inhibition of LtxA-mediated cytotoxicity, indicating a more potent, lysosomal mediated cell death pathway. LtxA caused rapid disruption of the lysosomal membrane and release of lysosomal contents into the cytosol. Binding of LtxA to LFA-1 resulted in the internalization of both LtxA and LFA-1, with LtxA localizing specifically to the lysosomal compartment. To our knowledge, LtxA represents the first bacterial toxin shown to localize to the lysosome where it induces rapid cell death.	[DiFranco, Kristina M.; Gupta, Anukriti; Galusha, Lindsey E.; Perez, Jarelys; Nguyen, To-Vy K.; Fineza, Camille D.; Kachlany, Scott C.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; [Kachlany, Scott C.] Actinobac Biomed Inc, N Brunswick, NJ 08902 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kachlany, SC (corresponding author), Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, 185 S Orange Ave,Med Sci Bldg C 636, Newark, NJ 07103 USA.	kachlasc@umdnj.edu	Lauschner, Flavia H/P-2457-2018		New Jersey Commission on Cancer Research	New Jersey Commission on Cancer Research	This work was supported by a grant from the New Jersey Commission on Cancer Research (to S.C.K.).	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; Averette KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007913; Balashova NV, 2007, INFECT IMMUN, V75, P4490, DOI 10.1128/IAI.00288-07; Bartt RE, 2006, CURR OPIN NEUROL, V19, P341, DOI 10.1097/01.wco.0000236612.66839.a2; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Diaz R, 2006, MICROB PATHOGENESIS, V40, P48, DOI 10.1016/j.micpath.2005.10.005; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gupta A, 2011, LEUKEMIA RES, V35, P1498, DOI 10.1016/j.leukres.2011.05.017; Hioe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023202; HOGG N, 1993, AM REV RESPIR DIS, V148, pS55, DOI 10.1164/ajrccm/148.6_Pt_2.S55; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Johansson A, 2000, J PERIODONTAL RES, V35, P85, DOI 10.1034/j.1600-0765.2000.035002085.x; Jullien D, 2004, DERMATOLOGY, V208, P297, DOI 10.1159/000077660; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kachlany SC, 2010, LEUKEMIA RES, V34, P777, DOI 10.1016/j.leukres.2009.08.022; Kelk P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.6; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Korostoff J, 1998, INFECT IMMUN, V66, P4474; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; McGrath KE, 2008, J IMMUNOL METHODS, V336, P91, DOI 10.1016/j.jim.2008.04.012; Neeson PJ, 2000, J LEUKOCYTE BIOL, V67, P847, DOI 10.1002/jlb.67.6.847; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Stenderup K, 2011, J INVEST DERMATOL, V131, P2033, DOI 10.1038/jid.2011.161; Stevens PK, 1996, INFECT IMMUN, V64, P2687, DOI 10.1128/IAI.64.7.2687-2694.1996; Tangemann K, 1998, J IMMUNOL, V161, P6330; Wang JF, 1998, MICROB PATHOGENESIS, V25, P317, DOI 10.1006/mpat.1998.0236; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Yamaguchi N, 2001, CELL MICROBIOL, V3, P811, DOI 10.1046/j.1462-5822.2001.00161.x	36	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17618	17627		10.1074/jbc.M111.314674	http://dx.doi.org/10.1074/jbc.M111.314674			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467872	Green Published, hybrid			2022-12-28	WOS:000306373000060
J	Gu, BJ; Duce, JA; Valova, VA; Wong, B; Bush, AI; Petrou, S; Wiley, JS				Gu, Ben J.; Duce, James A.; Valova, Valentina A.; Wong, Bruce; Bush, Ashley I.; Petrou, Steven; Wiley, James S.			P2X7 Receptor-mediated Scavenger Activity of Mononuclear Phagocytes toward Non-opsonized Particles and Apoptotic Cells Is Inhibited by Serum Glycoproteins but Remains Active in Cerebrospinal Fluid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; EXTRACELLULAR ATP; P-COMPONENT; PHOSPHATIDYLSERINE RECEPTOR; INNATE IMMUNITY; CERULOPLASMIN; EXPRESSION; P2X(7); MACROPHAGES	Rapid phagocytosis of non-opsonized particles including apoptotic cells is an important process that involves direct recognition of the target by multiple scavenger receptors including P2X7 on the phagocyte surface. Using a real-time phagocytosis assay, we studied the effect of serum proteins on this phagocytic process. Inclusion of 1-5% serum completely abolished phagocytosis of non-opsonized YG beads by human monocytes. Inhibition was reversed by pretreatment of serum with 1-10 mM tetraethylenepentamine, a copper/zinc chelator. Inhibitory proteins from the serum were determined as negatively charged glycoproteins (pI < 6) with molecular masses between 100 and 300 kDa. A glycoprotein-rich inhibitory fraction of serum not only abolished YG bead uptake but also inhibited phagocytosis of apoptotic lymphocytes or neuronal cells by human monocyte-derived macrophages. Three copper-and/or zinc-containing serum glycoproteins, ceruloplasmin, serum amyloid P-component, and amyloid precursor protein, were identified, and the purified proteins were shown to inhibit the phagocytosis of beads by monocytes as well as phagocytosis of apoptotic neuronal cells by macrophages. Human adult cerebrospinal fluid, which contains very little glycoprotein, had no inhibitory effect on phagocytosis of either beads or apoptotic cells. These data suggest for the first time that metal-interacting glycoproteins present within serum are able to inhibit the scavenger activity of mononuclear the scavenger activity of mononuclear phagocytes toward insoluble toward insoluble debris and apoptotic cells.	[Gu, Ben J.; Petrou, Steven; Wiley, James S.] Univ Melbourne, Melbourne Brain Ctr, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Petrou, Steven] Univ Melbourne, Melbourne Brain Ctr, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Duce, James A.; Wong, Bruce; Bush, Ashley I.] Univ Melbourne, Melbourne Brain Ctr, Mental Hlth Res Inst, Parkville, Vic 3010, Australia; [Valova, Valentina A.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Children's Medical Research Institute - Australia; University of Sydney	Wiley, JS (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Florey Neurosci Inst, Parkville, Vic 3010, Australia.	james.wiley@florey.edu.au	Bush, Ashley/Y-2457-2019; Wong, Bruce/AAY-5884-2020; Bush, Ashley I/A-1186-2007; Petrou, Steven/M-8332-2013	Bush, Ashley/0000-0001-8259-9069; Wong, Bruce/0000-0002-1687-4138; Bush, Ashley I/0000-0001-8259-9069; Gu, Ben/0000-0001-5500-4453; Duce, James/0000-0002-8762-2245; Petrou, Steven/0000-0002-4960-6375; Wiley, James/0000-0001-9421-4154	Cure Cancer Australia Foundation; Leukemia Foundation of Australia; National Health and Medical Research Council, Australia	Cure Cancer Australia Foundation; Leukemia Foundation of Australia; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Cure Cancer Australia Foundation, the Leukemia Foundation of Australia, and the National Health and Medical Research Council, Australia.	Bowen S, 2007, EUR J NEUROSCI, V25, P2947, DOI 10.1111/j.1460-9568.2007.05554.x; Brymora A., 2004, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB1705S22; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; CALABRESE L, 1988, J BIOL CHEM, V263, P6480; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; CLINE MJ, 1968, BLOOD, V32, P423, DOI 10.1182/blood.V32.3.423.423; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Duce JA, 2013, MOL PSYCHIATR, V18, P245, DOI 10.1038/mp.2011.168; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gu BJ, 2011, J IMMUNOL, V187, P2365, DOI 10.4049/jimmunol.1101178; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Kimura M, 1999, NEUROSCI LETT, V273, P137, DOI 10.1016/S0304-3940(99)00631-X; Komohara Y, 2005, DEV DYNAM, V232, P67, DOI 10.1002/dvdy.20206; LOEFFLER DA, 1994, ALZ DIS ASSOC DIS, V8, P190, DOI 10.1097/00002093-199408030-00005; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Maurer MH, 2010, MASS SPECTROM REV, V29, P17, DOI 10.1002/mas.20213; OLDS JW, 1974, INFECT IMMUN, V9, P524, DOI 10.1128/IAI.9.3.524-529.1974; OSAKI S, 1966, J BIOL CHEM, V241, P5053; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Perneczky R, 2011, NEUROLOGY, V77, P35, DOI 10.1212/WNL.0b013e318221ad47; POTEMPA LA, 1985, J BIOL CHEM, V260, P2142; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; REISINGER P, 1985, BIOL CHEM H-S, V366, P479, DOI 10.1515/bchm3.1985.366.1.479; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; SCHROEDER F, 1983, J BIOCHEM BIOPH METH, V8, P15, DOI 10.1016/0165-022X(83)90017-9; Sexton DW, 2004, CLIN EXP ALLERGY, V34, P1514, DOI 10.1111/j.1365-2222.2004.02054.x; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Squitti Rosanna, 2009, Recent Pat CNS Drug Discov, V4, P209; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; URBANYI Z, 1992, J CHROMATOGR-BIOMED, V578, P130, DOI 10.1016/0378-4347(92)80235-I; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107	42	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17318	17330		10.1074/jbc.M112.340885	http://dx.doi.org/10.1074/jbc.M112.340885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22461619	Green Published, hybrid			2022-12-28	WOS:000306373000032
J	Jacso, T; Schneider, E; Rupp, B; Reif, B				Jacso, Tomas; Schneider, Erwin; Rupp, Bernd; Reif, Bernd			Substrate Transport Activation Is Mediated through Second Periplasmic Loop of Transmembrane Protein MalF in Maltose Transport Complex of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; RESIDUAL DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; CRYSTAL-STRUCTURE; ABC-TRANSPORTERS; ATP HYDROLYSIS; MACROMOLECULES; INTERMEDIATE; BIOMOLECULES; ASSIGNMENTS	In a recent study we described the second periplasmic loop P2 of the transmembrane protein MalF (MalF-P2) of the maltose ATP-binding cassette transporter (MalFGK(2)-E) as an important element in the recognition of substrate by the maltose-binding protein MalE. In this study, we focus on MalE and find that MalE undergoes a structural rearrangement after addition of MalF-P2. Analysis of residual dipolar couplings (RDCs) shows that binding of MalF-P2 induces a semiopen state of MalE in the presence and absence of maltose, whereas maltose is retained in the binding pocket. These data are in agreement with paramagnetic relaxation enhancement experiments. After addition of MalF-P2, an increased solvent accessibility for residues in the vicinity of the maltose-binding site of MalE is observed. MalF-P2 is thus not only responsible for substrate recognition, but also directly involved in activation of substrate transport. The observation that substrate-bound and substrate-free MalE in the presence of MalF-P2 adopts a similar semiopen state hints at the origin of the futile ATP hydrolysis of MalFGK(2)-E.	[Reif, Bernd] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany; [Jacso, Tomas; Rupp, Bernd; Reif, Bernd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Jacso, Tomas; Reif, Bernd] Deutsch Forsch Zentrum Gesundheit & Umwelt, D-85764 Neuherberg, Germany; [Schneider, Erwin] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Technical University of Munich; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin	Reif, B (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	reif@tum.de		Rupp, Bernd/0000-0001-9447-9638; Reif, Bernd/0000-0001-7368-7198	Center for Integrated Protein Science Munich; Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft; Deutsche Forschungsgemeinschaft [Re1435, SFB449, SFB740, SFB610, SFB 449, TP B14, SCHN 274/9-3]; EC [261863]	Center for Integrated Protein Science Munich; Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Center for Integrated Protein Science Munich.; Supported by the Leibniz-Gemeinschaft, the Helmholtz-Gemeinschaft, Deutsche Forschungsgemeinschaft Grants Re1435, SFB449, SFB740, SFB610, and by access to research infrastructures activity in the 7th Framework Programme of the EC Project 261863, Bio-NMR.; Supported by Deutsche Forschungsgemeinschaft Grants SFB 449, TP B14, and SCHN 274/9-3.	Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Cui JM, 2010, J BIOL CHEM, V285, P39986, DOI 10.1074/jbc.M110.147819; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Gardner KH, 1998, J AM CHEM SOC, V120, P11738, DOI 10.1021/ja982019w; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacso T, 2009, BIOMOL NMR ASSIGN, V3, P21, DOI 10.1007/s12104-008-9131-7; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	29	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17040	17049		10.1074/jbc.M112.340679	http://dx.doi.org/10.1074/jbc.M112.340679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451670	Green Published, hybrid			2022-12-28	WOS:000306373000005
J	Sanchez-Ferras, O; Coutaud, B; Samani, TD; Tremblay, I; Souchkova, O; Pilon, N				Sanchez-Ferras, Oraly; Coutaud, Baptiste; Samani, Taraneh Djavanbakht; Tremblay, Isabelle; Souchkova, Ouliana; Pilon, Nicolas			Caudal-related Homeobox (Cdx) Protein-dependent Integration of Canonical Wnt Signaling on Paired-box 3 (Pax3) Neural Crest Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR NONAXIAL MESODERM; GENE REGULATORY NETWORK; RETINOIC ACID; WAARDENBURG SYNDROME; WNT/BETA-CATENIN; BETA-CATENIN; IN-VITRO; OVERLAPPING FUNCTIONS; CELL-DIFFERENTIATION; HOMEODOMAIN PROTEIN	One of the earliest events in neural crest development takes place at the neural plate border and consists in the induction of Pax3 expression by posteriorizing Wnt.beta-catenin signaling. The molecular mechanism of this regulation is not well understood, but several observations suggest a role for posteriorizing Cdx transcription factors (Cdx1/2/4) in this process. Cdx genes are known as integrators of posteriorizing signals from Wnt, retinoic acid, and FGF pathways. In this work, we report that Wnt-mediated regulation of murine Pax3 expression is indirect and involves Cdx proteins as intermediates. We show that Pax3 transcripts co-localize with Cdx proteins in the posterior neurectoderm and that neural Pax3 expression is reduced in Cdx1-null embryos. Using Wnt3a-treated P19 cells and neural crest-derived Neuro2a cells, we demonstrate that Pax3 expression is induced by the Wnt-Cdx pathway. Co-transfection analyses, electrophoretic mobility shift assays, chromatin immuno-precipitation, and transgenic studies further indicate that Cdx proteins operate via direct binding to an evolutionarily conserved neural crest enhancer of the Pax3 proximal promoter. Taken together, these results suggest a novel neural function for Cdx proteins within the gene regulatory network controlling neural crest development.	[Pilon, Nicolas] Univ Quebec, Fac Sci, Dept Biol Sci, Montreal, PQ H2X 3Y7, Canada; Univ Quebec, Fac Sci, Biomed Res Ctr, Montreal, PQ H2X 3Y7, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Pilon, N (corresponding author), Univ Quebec, Fac Sci, Dept Biol Sci, 141 President Kennedy Ave, Montreal, PQ H2X 3Y7, Canada.	pilon.nicolas@uqam.ca	Javanbakht, Taraneh/B-7775-2015	Javanbakht, Taraneh/0000-0002-2658-330X	Canadian Institutes of Health Research [DCO190GP, IHD-94366]; Banting Research Foundation; Natural Science and Engineering Research Council (NSERC) of Canada; University of Quebec at Montreal; NSERC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting Research Foundation; Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Quebec at Montreal; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grants DCO190GP and IHD-94366 as well as a new investigator grant from the Banting Research Foundation.; Recipient of an Alexander-Graham-Bell scholarship from the Natural Science and Engineering Research Council (NSERC) of Canada.; Supported by University of Quebec at Montreal scholarships.; Supported by an NSERC undergraduate research award.	Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALDWIN CT, 1995, AM J MED GENET, V58, P115, DOI 10.1002/ajmg.1320580205; Bang AG, 1997, DEVELOPMENT, V124, P2075; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Beck F, 2002, GUT, V51, P450, DOI 10.1136/gut.51.3.450; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bouchard M, 2005, DEVELOPMENT, V132, P2633, DOI 10.1242/dev.01833; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Chang CP, 2008, DEVELOPMENT, V135, P3577, DOI 10.1242/dev.022350; Charite J, 1998, DEVELOPMENT, V125, P4349; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Conway SJ, 2000, CARDIOVASC RES, V47, P314, DOI 10.1016/S0008-6363(00)00098-5; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Degenhardt KR, 2010, DEV BIOL, V339, P519, DOI 10.1016/j.ydbio.2009.12.030; Epperlein HH, 2007, DEV DYNAM, V236, P389, DOI 10.1002/dvdy.21039; Epstein JA, 2000, DEVELOPMENT, V127, P1869; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; GAMER LW, 1993, MECH DEVELOP, V43, P71, DOI 10.1016/0925-4773(93)90024-R; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gaunt SJ, 2005, INT J DEV BIOL, V49, P901, DOI 10.1387/ijdb.052021sg; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Heydemann A, 2001, DEV BRAIN RES, V128, P83, DOI 10.1016/S0165-3806(01)00137-7; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Joo JH, 2010, DEV BIOL, V345, P191, DOI 10.1016/j.ydbio.2010.07.009; Kaufman M. H., 1992, ATLAS MOUSE DEV, P38; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li J, 1999, DEVELOPMENT, V126, P2495; Lickert H, 2000, DEVELOPMENT, V127, P3805; Liu XM, 2010, AM J PHYSIOL-LUNG C, V299, pL694, DOI 10.1152/ajplung.00140.2010; Lwigale PY, 2004, DEVELOPMENT, V131, P1979, DOI 10.1242/dev.01106; Mansouri A, 1996, DEVELOPMENT, V122, P831; Marikawa Y, 2009, GENESIS, V47, P93, DOI 10.1002/dvg.20473; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; MEYER BI, 1993, DEVELOPMENT, V117, P191; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Mita K, 2007, DEV GENES EVOL, V217, P593, DOI 10.1007/s00427-007-0168-x; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; Nagy A., 2003, MANIPULATING MOUSE E, P341; Natoli TA, 1997, DEVELOPMENT, V124, P617; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; Pilon N, 2008, DEV DYNAM, V237, P1133, DOI 10.1002/dvdy.21496; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Prinos P, 2001, DEV BIOL, V239, P257, DOI 10.1006/dbio.2001.0446; Pruitt SC, 2004, GENE EXPR PATTERNS, V4, P671, DOI 10.1016/j.modgep.2004.04.006; Saegusa M, 2007, CARCINOGENESIS, V28, P1885, DOI 10.1093/carcin/bgm105; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2011, MECH DEVELOP, V128, P41, DOI 10.1016/j.mod.2010.09.004; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Sawada A, 2005, DEVELOPMENT, V132, P4719, DOI 10.1242/dev.02059; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shi FX, 2010, J BIOL CHEM, V285, P392, DOI 10.1074/jbc.M109.059055; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shimizu T, 2006, DEVELOPMENT, V133, P4709, DOI 10.1242/dev.02660; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sturgeon K, 2011, DEVELOPMENT, V138, P65, DOI 10.1242/dev.058727; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Taneyhill LA, 2005, MOL BIOL CELL, V16, P5283, DOI 10.1091/mbc.e05-03-0210; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Thibaudeau G, 1998, PIGM CELL RES, V11, P189, DOI 10.1111/j.1600-0749.1998.tb00729.x; van de Ven C, 2011, DEVELOPMENT, V138, P3451, DOI 10.1242/dev.066118; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Wang XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029379; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YASUNAMI M, 1995, J BIOL CHEM, V270, P18649, DOI 10.1074/jbc.270.31.18649; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zhao XL, 2009, GENE EXPR PATTERNS, V9, P430, DOI 10.1016/j.gep.2009.06.003	108	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16623	16635		10.1074/jbc.M112.356394	http://dx.doi.org/10.1074/jbc.M112.356394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22457346	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000304030900051
J	van den Bogaart, G; Meyenberg, K; Diederichsen, U; Jahn, R				van den Bogaart, Geert; Meyenberg, Karsten; Diederichsen, Ulf; Jahn, Reinhard			Phosphatidylinositol 4,5-Bisphosphate Increases Ca2+ Affinity of Synaptotagmin-1 by 40-fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAINS; PHOSPHOLIPID-BINDING; MEMBRANE; CALCIUM; RELEASE; REGULATOR	Synaptotagmin-1 is the main Ca2+ sensor of neuronal exocytosis. It binds to both Ca2+ and the anionic phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2), but the precise cooperativity of this binding is still poorly understood. Here, we used microscale thermophoresis to quantify the cooperative binding of PIP2 and Ca2+ to synaptotagmin-1. We found that PIP2 bound to the well conserved polybasic patch of the C2B domain with an apparent dissociation constant of similar to 20 mu M. PIP2 binding reduced the apparent dissociation constant for Ca2+ from similar to 250 to <5 mu M. Thus, our data show that PIP2 makes synaptotagmin-1 >40-fold more sensitive to Ca2+. This interplay between Ca2+, synaptotagmin-1, and PIP2 is crucial for neurotransmitter release.	[van den Bogaart, Geert; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Meyenberg, Karsten; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	r.jahn@gwdg.de	van den Bogaart, Geert/A-1089-2014; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Jahn, Reinhard/0000-0003-1542-3498; Diederichsen, Ulf/0000-0002-2654-9160	National Institutes of Health [P01 GM072694]; Deutsche Forschungsgemeinschaft [SFB803]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM072694 (to R. J.) This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB803.; Supported by the Human Frontier Science Program.	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; CHU A, 1991, J BIOL CHEM, V266, P7699; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Kuo WW, 2011, BIOCHEMISTRY-US, V50, P2633, DOI 10.1021/bi200049c; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	30	81	81	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16447	16453		10.1074/jbc.M112.343418	http://dx.doi.org/10.1074/jbc.M112.343418			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447935	Green Published, hybrid			2022-12-28	WOS:000304030900035
J	Dixon, MJ; Gray, A; Schenning, M; Agacan, M; Tempel, W; Tong, YF; Nedyalkova, L; Park, HW; Leslie, NR; van Aalten, DMF; Downes, CP; Batty, IH				Dixon, Miles J.; Gray, Alexander; Schenning, Martijn; Agacan, Mark; Tempel, Wolfram; Tong, Yufeng; Nedyalkova, Lyudmila; Park, Hee-Won; Leslie, Nicholas R.; van Aalten, Daan M. F.; Downes, C. Peter; Batty, Ian H.			IQGAP Proteins Reveal an Atypical Phosphoinositide (aPI) Binding Domain with a Pseudo C2 Domain Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN; CELL; RECEPTOR; 3-KINASE; PHOSPHATASES; RECOGNITION; SECONDARY; ACTIN; TOOL	Class I phosphoinositide (PI) 3-kinases act through effector proteins whose 3-PI selectivity is mediated by a limited repertoire of structurally defined, lipid recognition domains. We describe here the lipid preferences and crystal structure of a new class of PI binding modules exemplified by select IQGAPs (IQ motif containing GTPase-activating proteins) known to coordinate cellular signaling events and cytoskeletal dynamics. This module is defined by a C-terminal 105-107 amino acid region of which IQGAP1 and -2, but not IQGAP3, binds preferentially to phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3). The binding affinity for PtdInsP3, together with other, secondary target-recognition characteristics, are comparable with those of the pleckstrin homology domain of cytohesin-3 (general receptor for phosphoinositides 1), an established PtdInsP3 effector protein. Importantly, the IQGAP1 C-terminal domain and the cytohesin- 3 pleckstrin homology domain, each tagged with enhanced green fluorescent protein, were both re-localized from the cytosol to the cell periphery following the activation of PI 3-kinase in Swiss 3T3 fibroblasts, consistent with their common, selective recognition of endogenous 3-PI(s). The crystal structure of the C-terminal IQGAP2 PI binding module reveals unexpected topological similarity to an integral fold of C2 domains, including a putative basic binding pocket. We propose that this module integrates select IQGAP proteins with PI 3-kinase signaling and constitutes a novel, atypical phosphoinositide binding domain that may represent the first of a larger group, each perhaps structurally unique but collectively dissimilar from the known PI recognition modules.	[Dixon, Miles J.; Gray, Alexander; Schenning, Martijn; Leslie, Nicholas R.; van Aalten, Daan M. F.; Downes, C. Peter; Batty, Ian H.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Agacan, Mark] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Tempel, Wolfram; Tong, Yufeng; Nedyalkova, Lyudmila; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada	University of Dundee; University of Dundee; University of Toronto; Structural Genomics Consortium; University of Toronto	Batty, IH (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dow St, Dundee DD1 5EH, Scotland.	i.h.batty@dundee.ac.uk	Leslie, Nicholas/D-2699-2009; Tong, Yufeng/D-2785-2011	Tong, Yufeng/0000-0001-7740-1812; van Aalten, Daan/0000-0002-1499-6908; Gray, Alexander/0000-0001-9227-0363; LESLIE, Nicholas/0000-0001-5131-0541	Medical Research Council, United Kingdom Programme [G0801865]; Wellcome Trust [083481, WT087590MA]; MRC [G0900138, G9403619, G0801865] Funding Source: UKRI; Medical Research Council [G9403619, G0900138, G0801865] Funding Source: researchfish	Medical Research Council, United Kingdom Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council, United Kingdom Programme Grant G0801865 (to M. J. D., A. G., M. S., N. R. L., C. P. D., and I. H. B.).; Supported by Wellcome Trust Grant 083481.; Supported by Wellcome Trust Senior Research Fellowship WT087590MA.	Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; BATTY IH, 1994, BIOCHEM J, V297, P529, DOI 10.1042/bj2970529; BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Dixon MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003178; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Downes CP, 2007, BIOCHEM SOC T, V35, P188, DOI 10.1042/BST0350188; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Stenmark H, 1999, J CELL SCI, V112, P4175; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tirnauer JS, 2004, DEV CELL, V7, P778, DOI 10.1016/j.devcel.2004.11.012; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007	51	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22483	22496		10.1074/jbc.M112.352773	http://dx.doi.org/10.1074/jbc.M112.352773			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22493426	hybrid, Green Published			2022-12-28	WOS:000306495000007
J	Hwang, S; Zimmerman, NP; Agle, KA; Turner, JR; Kumar, SN; Dwinell, MB				Hwang, Soonyean; Zimmerman, Noah P.; Agle, Kimberle A.; Turner, Jerrold R.; Kumar, Suresh N.; Dwinell, Michael B.			E-cadherin Is Critical for Collective Sheet Migration and Is Regulated by the Chemokine CXCL12 Protein During Restitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; ACTIN CYTOSKELETON; BARRIER FUNCTION; TIGHT JUNCTIONS; CROHNS-DISEASE; IN-VITRO; CATENIN	Chemokines and other immune mediators enhance epithelial barrier repair. The intestinal barrier is established by highly regulated cell-cell contacts between epithelial cells. The goal of these studies was to define the role for the chemokine CXCL12 in regulating E-cadherin during collective sheet migration during epithelial restitution. Mechanisms regulating E-cadherin were investigated using Caco2(BBE) and IEC-6 model epithelia. Genetic knockdown confirmed a critical role for E-cadherin in in vitro restitution and in vivo wound repair. During restitution, both CXCL12 and TGF-beta 1 tightened the monolayer by decreasing the paracellular space between migrating epithelial cells. However, CXCL12 differed from TGF-beta 1 by stimulating the significant increase in E-cadherin membrane localization during restitution. Chemokine-stimulated relocalization of E-cadherin was paralleled by an increase in barrier integrity of polarized epithelium during restitution. CXCL12 activation of its cognate receptor CXCR4 stimulated E-cadherin localization and monolayer tightening through Rho-associated protein kinase activation and F-actin reorganization. These data demonstrate a key role for E-cadherin in intestinal epithelial restitution.	[Hwang, Soonyean; Zimmerman, Noah P.; Agle, Kimberle A.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Kumar, Suresh N.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Chicago	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu	Turner, Jerrold/H-1502-2019		National Institutes of Health [R01 DK062066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062066, R01DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK062066 (to M. B. D.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Agle KA, 2010, J BIOL CHEM, V285, P16066, DOI 10.1074/jbc.M109.061416; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Azarschab P, 2002, GENE CHROMOSOME CANC, V35, P121, DOI 10.1002/gcc.10101; Barshack I, 2001, J CLIN PATHOL, V54, P684, DOI 10.1136/jcp.54.9.684; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bjerknes M, 1999, AM J PATHOL, V154, P1831, DOI 10.1016/S0002-9440(10)65439-9; BLAY J, 1985, J CELL PHYSIOL, V124, P107, DOI 10.1002/jcp.1041240117; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; LACY ER, 1984, LAB INVEST, V51, P573; Lin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015331; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Moriyama N, 2001, J LAB CLIN MED, V138, P236, DOI 10.1067/mlc.2001.118177; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Nguyen TN, 2010, J BIOL CHEM, V285, P35439, DOI 10.1074/jbc.M110.119487; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Okabe S, 2002, J HEMATOTH STEM CELL, V11, P923, DOI 10.1089/152581602321080583; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada A, 2004, GENES CELLS, V9, P843, DOI 10.1111/j.1365-2443.2004.00768.x; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77	68	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22227	22240		10.1074/jbc.M112.367979	http://dx.doi.org/10.1074/jbc.M112.367979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549778	hybrid, Green Published			2022-12-28	WOS:000306418600061
J	Niu, JX; Shi, YL; Tan, GY; Yang, CH; Fan, MY; Pfeffer, LM; Wu, ZH				Niu, Jixiao; Shi, Yuling; Tan, Guangyun; Yang, Chuan He; Fan, Meiyun; Pfeffer, Lawrence M.; Wu, Zhao-Hui			RETRACTED: DNA Damage Induces NF-kappa B-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion (Retracted article. See vol. 294, pg. 18015, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NEGATIVE FEEDBACK; HISTONE H3; MIR-21; METASTASIS; INDUCTION; ACTIVATION; RESISTANCE; ALPHA; ATM; PHOSPHORYLATION	NF-kappa B activation induced by genotoxic treatment in cancer cells has been associated with therapeutic resistance in multiple human malignancies. Therapeutic resistance also correlates with high metastatic potential in human cancers, including breast cancer. Whether genotoxic treatment-activated NF-kappa B also contributes to cancer metastasis following radiation and chemotherapy is unclear. Here, we show that chemotherapeutic drug-induced NF-kappa B activation promotes breast cancer cell migration and invasion. The increased metastatic potential is dependent on IL-6 induction mediated by genotoxic NF-kappa B activation. Moreover, genotoxic treatment also up-regulates oncogenic microRNA-21 (miR-21) expression through eliciting NF-kappa B recruitment to the miR-21 promoter region, where it cooperates with signal transducer and activator of transcription 3 (STAT3) to activate miR-21 transcription. DNA damage-induced histone H3 phosphorylation via activated MSK1 creates an open chromatin structure for NF-kappa B/STAT3-driven transactivation of miR-21. NF-kappa B-dependent IL-6 up-regulation is responsible for STAT3 activation and recruitment to the miR-21 promoter upon genotoxic stress. Induction of miR-21 may enable cancer cells to elude DNA damage-induced apoptosis and enhance the metastatic potential of breast cancer cells through repressing expression of PTEN and PDCD4. Our data support a critical role of DNA damage-induced NF-kappa B activation in promoting cancer metastasis following genotoxic treatment, and NF-kappa B-dependent miR-21 induction may contribute to both therapeutic resistance and metastasis in breast cancer.	[Niu, Jixiao; Shi, Yuling; Tan, Guangyun; Yang, Chuan He; Fan, Meiyun; Pfeffer, Lawrence M.; Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Niu, Jixiao; Shi, Yuling; Tan, Guangyun; Yang, Chuan He; Fan, Meiyun; Pfeffer, Lawrence M.; Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Ctr Adult Canc Res, Memphis, TN 38163 USA; [Tan, Guangyun] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Jilin, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Jilin University	Wu, ZH (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, 19 S Manassas St, Memphis, TN 38163 USA.	zwu6@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA149251, CA133322]; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA140346, R01CA149251, R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA149251 (to Z. W.) and CA133322 (to L. M. P.).; Supported by a scholarship from the Chinese Scholarship Council.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-334; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Ohno M, 2009, MOL CANCER RES, V7, P2022, DOI 10.1158/1541-7786.MCR-09-0319; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	59	128	131	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21783	21795		10.1074/jbc.M112.355495	http://dx.doi.org/10.1074/jbc.M112.355495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547075	Green Published, hybrid			2022-12-28	WOS:000306418600020
J	Sethumadhavan, S; Vasquez-Vivar, J; Migrino, RQ; Harmann, L; Jacob, HJ; Lazar, J				Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette; Migrino, Raymond Q.; Harmann, Leanne; Jacob, Howard J.; Lazar, Jozef			Mitochondrial DNA Variant for Complex I Reveals a Role in Diabetic Cardiac Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; STRAIN ECHOCARDIOGRAPHY; CARDIOMYOPATHY; DYSFUNCTION; HEART; RAT; OBESITY; NUCLEOTIDES; METABOLISM; ACTIVATION	Myocardial remodeling and dysfunction are serious complications of type 2 diabetes mellitus (T2DM). Factors controlling their development are not well established. To specifically address the role of the mitochondrial genome, we developed novel conplastic rat strains, i.e. strains with the same nuclear genome but a different mitochondrial genome. The new animals were named T2DN(mtFHH) and T2DN(mtWistar), where the acronym T2DN denotes their common nuclear genome (type 2 diabetic nephropathy (T2DN) rats) and mtFHH or mtWistar the origin of their mitochondria, Fawn Hooded Hypertensive (FHH) or Wistar rats, respectively. The T2DN(mtFHH) and T2DN(mtWistar) showed a similar progression of diabetes as determined by HbA1c, cholesterol, and triglycerides with normal blood pressure, thus enabling investigation of the specific role of the mitochondrial genome in cardiac function without the confounding effects of obesity or hypertension found in other models of diabetes. Echocardiographic analysis of 12-week-old animals showed no abnormalities, but at 12 months of age the T2DN(mtFHH) showed left ventricular remodeling that was verified by histology. Decreased complex I and complex IV but not complex II activity within the electron transport chain was found only in T2DN(mtFHH), which was not explained by differences in protein content. Decreased cardiac ATP levels in T2DN(mtFHH) were in agreement with a lower ATP synthetic capacity by isolated mitochondria. Together, our data provide experimental evidence that mtDNA sequence variations have an additional role in energetic heart deficiency. The mitochondrial DNA background may explain the increased susceptibility of certain T2DM patients to develop myocardial dysfunction.	[Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette] Med Coll Wisconsin, Redox Biol Program, Milwaukee, WI 53226 USA; [Migrino, Raymond Q.; Harmann, Leanne] Med Coll Wisconsin, Cardiovasc Med Sect, Milwaukee, WI 53226 USA; [Jacob, Howard J.; Lazar, Jozef] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Jacob, Howard J.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Jacob, Howard J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lazar, Jozef] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Migrino, Raymond Q.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Vasquez-Vivar, J (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jvvivar@mcw.edu			National Institutes of Health [HL-67244]; American Heart Association [11POST5480016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-67244 (to J. V. V.). This work was also supported by Postdoctoral Fellow Grant 11POST5480016 (to S. S.) from the American Heart Association.	Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bell DSH, 2003, DIABETES CARE, V26, P2949, DOI 10.2337/diacare.26.10.2949; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diamant M, 2003, J AM COLL CARDIOL, V42, P328, DOI 10.1016/S0735-1097(03)00625-9; El-Omar MM, 2004, BASIC RES CARDIOL, V99, P133, DOI 10.1007/s00395-004-0440-4; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ganzera M, 2006, ANAL BIOCHEM, V359, P132, DOI 10.1016/j.ab.2006.09.012; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kosmala W, 2004, DIABETES CARE, V27, P2736, DOI 10.2337/diacare.27.11.2736; Kwitek AE, 2006, PHYSIOL GENOMICS, V25, P303, DOI 10.1152/physiolgenomics.00288.2005; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Migrino RQ, 2007, J AM SOC ECHOCARDIOG, V20, P342, DOI 10.1016/j.echo.2006.09.011; Migrino RQ, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-17; Nobrega MA, 2004, DIABETES, V53, P735, DOI 10.2337/diabetes.53.3.735; Pieper GM, 2010, J HEART LUNG TRANSPL, V29, P1039, DOI 10.1016/j.healun.2010.04.009; Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2001, J BIOL CHEM, V276, P37861; Schlick NE, 2006, AM J PHYSIOL-CELL PH, V291, pC1183, DOI 10.1152/ajpcell.00234.2006; Shoghi KI, 2009, CIRC-CARDIOVASC IMAG, V2, P373, DOI 10.1161/CIRCIMAGING.108.843227; SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	36	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22174	22182		10.1074/jbc.M111.327866	http://dx.doi.org/10.1074/jbc.M111.327866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544750	Green Published, hybrid			2022-12-28	WOS:000306418600056
J	David, M; Macias, A; Moreno, C; Prieto, A; Martinez-Marmol, R; Vicente, R; Gonzalez, T; Felipe, A; Tamkun, MM; Valenzuela, C				David, Miren; Macias, Alvaro; Moreno, Cristina; Prieto, Angela; Martinez-Marmol, Ramon; Vicente, Ruben; Gonzalez, Teresa; Felipe, Antonio; Tamkun, Michael M.; Valenzuela, Carmen			Protein Kinase C (PKC) Activity Regulates Functional Effects of K-v beta 1.3 Subunit on K(V)1.5 Channels IDENTIFICATION OF A CARDIAC K(v)1.5 CHANNELOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; BETA-SUBUNIT; HUMAN HEART; BINDING; ALPHA; RACK1; RECEPTOR; INACTIVATION; MODULATION; INHIBITOR	K(v)1.5 channels are the primary channels contributing to the ultrarapid outward potassium current (I-Kur). The regulatory K-v beta 1.3 subunit converts K(v)1.5 channels from delayed rectifiers with a modest degree of slow inactivation to channels with both fast and slow inactivation components. Previous studies have shown that inhibition of PKC with calphostin C abolishes the fast inactivation induced by K-v beta 1.3. In this study, we investigated the mechanisms underlying this phenomenon using electrophysiological, biochemical, and confocal microscopy approaches. To achieve this, we used HEK293 cells (which lack K-v beta subunits) transiently cotransfected with with K(v)1.5+K-v beta 1.3 and also rat ventricular and atrial tissue to study native alpha-beta subunit interactions. Immunocytochemistry assays demonstrated that these channel subunits colocalize in control conditions and after calphostin C treatment. Moreover, coimmunoprecipitation studies showed that Kv1.5 and K-v beta 1.3 remain associated after PKC inhibition. After knocking down all PKC isoforms by siRNA or inhibiting PKC with calphostin C, K-v beta 1.3-induced fast inactivation at +60mV was abolished. However, depolarization to +100 mV revealed K-v beta 1.3-induced inactivation, indicating that PKC inhibition causes a dramatic positive shift of the inactivation curve. Our results demonstrate that calphostin C-mediated abolishment of fast inactivation is not due to the dissociation of Kv1.5 and K-v beta 1.3. Finally, immunoprecipitation and immunocytochemistry experiments revealed an association between K(v)1.5, K-v beta 1.3, the receptor for activated C kinase (RACK1), PKC beta I, PKC beta II, and PKC theta in HEK293 cells. A very similar K(v)1.5 channelosome was found in rat ventricular tissue but not in atrial tissue.	[Gonzalez, Teresa; Valenzuela, Carmen] Univ Autonoma Madrid, Madrid Consejo Super Invest Cient, Inst Invest Biomed, Madrid 28029, Spain; [Martinez-Marmol, Ramon; Felipe, Antonio] Univ Barcelona, Mol Physiol Lab, Dept Bioquim & Biol Mol, Inst Biomed IBUB, E-08028 Barcelona, Spain; [Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Program Mol Cellular & Dev Neurosci, Ft Collins, CO 80523 USA; [Tamkun, Michael M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Autonomous University of Madrid; University of Barcelona; Pompeu Fabra University; Colorado State University; Colorado State University	Valenzuela, C (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Lab 1 13, C Arturo Duperier 4, Madrid 28029, Spain.	cvalenzuela@iib.uam.es	Gonzalez, Teresa/K-9305-2015; García, Rubén Vicente/L-1097-2014; Felipe, Antonio/M-8297-2015; Macias, Alvaro/N-7267-2015; Valenzuela, Carmen/L-3219-2015; Martínez-Mármol, Ramón/D-2821-2018	Gonzalez, Teresa/0000-0002-0930-0021; García, Rubén Vicente/0000-0003-0401-4808; Felipe, Antonio/0000-0002-7294-6431; Macias, Alvaro/0000-0002-9952-6947; Valenzuela, Carmen/0000-0003-3929-1960; Martínez-Mármol, Ramón/0000-0003-0929-8627	Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-14916]; Ministerio de Educacion y Ciencia [PR2003-0056]; Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS [RD06/0014/0006, BFU2011-23268, CSD2008-00005]; RECAVA; JAE;  [MEC-PR2003-0056]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS; RECAVA; JAE; 	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2010-14916, Ministerio de Educacion y Ciencia-PR2003-0056, and Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS RD06/0014/0006 (to C. V.) and BFU2011-23268 and CSD2008-00005 (to A. F.).; Recipient of an RECAVA grant.; Recipient of a JAE predoctoral grant.; Recipient of Grant MEC-PR2003-0056. addressed: Instituto de Investigaciones Biomedicas 'Alberto Sols' (CSICUAM), Laboratory 1.13, C/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-91-585-4493; Fax.: 34-91-585-4401; E-mail: cvalenzuela@iib.uam.es.	Arias C, 2007, ANESTHESIOLOGY, V107, P641, DOI 10.1097/01.anes.0000282100.32923.5c; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CARPENTER D, 1987, NATURE, V325, P107, DOI 10.1038/325107a0; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Decher N, 2005, MOL PHARMACOL, V68, P995, DOI 10.1124/mol.105.011668; Decher N, 2008, EMBO J, V27, P3164, DOI 10.1038/emboj.2008.231; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DISATNIK MH, 1994, P NATL ACAD SCI USA, V91, P559, DOI 10.1073/pnas.91.2.559; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Gonzalez T, 2002, MOL PHARMACOL, V62, P1456, DOI 10.1124/mol.62.6.1456; Gonzalez T, 2001, J PHARMACOL EXP THER, V296, P573; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Isacson CK, 2007, AM J PHYSIOL-CELL PH, V292, pC1459, DOI 10.1152/ajpcell.00322.2006; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kerkela R, 2002, MOL PHARMACOL, V62, P1482, DOI 10.1124/mol.62.6.1482; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kuhlkamp V, 2000, J AM COLL CARDIOL, V36, P139, DOI 10.1016/S0735-1097(00)00693-8; Kwak YG, 1999, J BIOL CHEM, V274, P13928, DOI 10.1074/jbc.274.20.13928; Kwak YG, 1999, J BIOL CHEM, V274, P25355, DOI 10.1074/jbc.274.36.25355; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MURRAY KT, 1994, CIRC RES, V75, P999, DOI 10.1161/01.RES.75.6.999; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schlaich MP, 2005, J HYPERTENS, V23, P1077, DOI 10.1097/01.hjh.0000166850.80344.cf; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Sossin WS, 1997, LEARN MEMORY, V3, P389, DOI 10.1101/lm.3.5.389; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; Valenzuela C, 2003, CARDIOVASC RES, V58, P498, DOI 10.1016/S0008-6363(03)00370-5; Wadsworth SJ, 2002, INFECT IMMUN, V70, P4650, DOI 10.1128/IAI.70.8.4650-4660.2002; Wang HZ, 2002, CANCER RES, V62, P4843; Williams CP, 2002, J PHARMACOL EXP THER, V302, P545, DOI 10.1124/jpet.102.033357; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Workman AJ, 2003, CARDIOVASC RES, V58, P518, DOI 10.1016/S0008-6363(03)00263-3; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255	63	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21416	21428		10.1074/jbc.M111.328278	http://dx.doi.org/10.1074/jbc.M111.328278			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547057	Green Published, hybrid			2022-12-28	WOS:000306416800059
J	Tanimoto, Y; Veistinen, L; Alakurtti, K; Takatalo, M; Rice, DPC				Tanimoto, Yukiho; Veistinen, Lotta; Alakurtti, Kirsi; Takatalo, Maarit; Rice, David P. C.			Prevention of Premature Fusion of Calvarial Suture in GLI-Kruppel Family Member 3 (Gli3)-deficient Mice by Removing One Allele of Runt-related Transcription Factor 2 (Runx2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; BONE-DEVELOPMENT; EXPRESSION PATTERNS; DLX5; CRANIOSYNOSTOSIS; MORPHOGENESIS; MUTATIONS; BMP; FGF; CBFA1	Mutations in the gene encoding the zinc finger transcription factor GLI3 (GLI-Kruppel family member 3) have been identified in patients with Grieg cephalopolysyndactyly syndrome in which premature fusion of calvarial suture (craniosynostosis) is an infrequent but important feature. Here, we show that Gli3 acts as a repressor in the developing murine calvaria and that Dlx5, Runx2 type II isoform (Runx2-II), and Bmp2 are expressed ectopically in the calvarial mesenchyme, which results in aberrant osteoblastic differentiation in Gli3-deficient mouse (Gli3(Xt-J/Xt-J)) and resulted in craniosynostosis. At the same time, enhanced activation of phospho-Smad1/5/8 (pSmad1/5/8), which is a downstream mediator of canonical Bmp signaling, was observed in Gli3(Xt-J/Xt-J) embryonic calvaria. Therefore, we generated Gli3; Runx2 compound mutant mice to study the effects of decreasing Runx2 dosage in a Gli3(Xt-J/Xt-J) background. Gli3(Xt-J/Xt-J) Runx2(+/-) mice have neither craniosynostosis nor additional ossification centers in interfrontal suture and displayed a normalization of Dlx5, Runx2-II, and pSmad1/5/8 expression as well as sutural mesenchymal cell proliferation. These findings suggest a novel role for Gli3 in regulating calvarial suture development by controlling canonical Bmp-Smad signaling, which integrates a Dlx5/Runx2-II cascade. We propose that targeting Runx2 might provide an attractive way of preventing craniosynostosis in patients.	[Tanimoto, Yukiho; Veistinen, Lotta; Alakurtti, Kirsi; Takatalo, Maarit; Rice, David P. C.] Univ Helsinki, Dept Orthodont, Inst Dent, FIN-00014 Helsinki, Finland; [Rice, David P. C.] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki 00029, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Rice, DPC (corresponding author), Univ Helsinki, Dept Orthodont, Inst Dent, POB 63,Haart Maninkatu 8, Helsinki 00014, Finland.	david.rice@helsinki.fi		Rice, David/0000-0001-9301-3078; Takatalo, Maarit/0000-0003-4825-6358	Academy of Finland; Biocentrum Helsinki; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland, Biocentrum Helsinki, The University of Helsinki, and the Sigrid Juselius Foundation.	Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Bastida MF, 2004, DEV DYNAM, V231, P148, DOI 10.1002/dvdy.20121; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hartmann C, 2009, CURR OPIN GENET DEV, V19, P437, DOI 10.1016/j.gde.2009.09.001; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Holleville N, 2003, DEV BIOL, V257, P177, DOI 10.1016/S0012-1606(03)00059-9; Hurst JA, 2011, EUR J HUM GENET, V19, P757, DOI 10.1038/ejhg.2011.13; Iseki S, 1999, DEVELOPMENT, V126, P5611; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; McDonald-McGinn DM, 2010, AM J MED GENET A, V152A, P1654, DOI 10.1002/ajmg.a.33495; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473	36	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21429	21438		10.1074/jbc.M112.362145	http://dx.doi.org/10.1074/jbc.M112.362145			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547067	Green Published, hybrid			2022-12-28	WOS:000306416800060
J	Xiao, QL; Gil, SC; Yan, P; Wang, Y; Han, SR; Gonzales, E; Perez, R; Cirrito, JR; Lee, JM				Xiao, Qingli; Gil, So-Chon; Yan, Ping; Wang, Yan; Han, Sharon; Gonzales, Ernie; Perez, Ronaldo; Cirrito, John R.; Lee, Jin-Moo			Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION; A-BETA-PP; DEPENDENT ENDOCYTOSIS; IDENTIFIES VARIANTS; COMMON VARIANTS; COATED VESICLES; IN-VIVO; CALM; CLU	One of the pathological hallmarks of Alzheimer disease is the accumulation of amyloid plaques in the extracellular space in the brain. Amyloid plaques are primarily composed of aggregated amyloid beta peptide (A beta), a proteolytic fragment of the transmembrane amyloid precursor protein (APP). For APP to be proteolytically cleaved into A beta, it must be internalized into the cell and trafficked to endosomes where specific protease complexes can cleave APP. Several recent genome-wide association studies have reported that several single nucleotide polymorphisms (SNPs) in the phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) gene were significantly associated with Alzheimer disease, suggesting a role in APP endocytosis and A beta generation. Here, we show that PICALM co-localizes with APP in intracellular vesicles of N2a-APP cells after endocytosis is initiated. PICALM knockdown resulted in reduced APP internalization and A beta generation. Conversely, PICALM overexpression increased APP internalization and A beta production. In vivo, PICALM was found to be expressed in neurons and co-localized with APP throughout the cortex and hippocampus in APP/PS1 mice. PICALM expression was altered using AAV8 gene transfer of PICALM shRNA or PICALM cDNA into the hippocampus of 6-month-old APP/PS1 mice. PICALM knockdown decreased soluble and insoluble A beta levels and amyloid plaque load in the hippocampus. Conversely, PICALM overexpression increased A beta levels and amyloid plaque load. These data indicate that PICALM, an adaptor protein involved in clathrin-mediated endocytosis, regulates APP internalization and subsequent A beta generation. PICALM con-tributes to amyloid plaque load in brain likely via its effect on A beta metabolism.	[Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lee, JM (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	leejm@neuro.wustl.edu	Lee, Jin-Moo/K-2024-2015	Lee, Jin-Moo/0000-0002-3979-0906	National Institutes of Health [R01 NS67905, P01 NS32636, K01 AG029524]; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067905, P01NS032636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS67905, P01 NS32636 (to J. M. L.), and K01 AG029524 (to J. R. C). This work was also supported by a grant from the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University (to J. R. C).	Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rudinskiy N, 2009, J BIOL CHEM, V284, P12447, DOI 10.1074/jbc.M804740200; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Sorkina T, 1999, J CELL SCI, V112, P317; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wu FB, 2009, BIOCHEM BIOPH RES CO, V385, P247, DOI 10.1016/j.bbrc.2009.05.050; Yan P, 1999, J NEUROSCI, V19, P9355; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	48	122	127	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21279	21289		10.1074/jbc.M111.338376	http://dx.doi.org/10.1074/jbc.M111.338376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539346	Green Published, hybrid			2022-12-28	WOS:000306416800047
J	Yi, X; Hong, M; Gui, B; Chen, Z; Li, L; Xie, GJ; Liang, J; Wang, XC; Shang, YF				Yi, Xia; Hong, Mei; Gui, Bin; Chen, Zhe; Li, Lei; Xie, Guojia; Liang, Jing; Wang, Xiaocheng; Shang, Yongfeng			RNA Processing and Modification Protein, Carbon Catabolite Repression 4 (Ccr4), Arrests the Cell Cycle through p21-dependent and p53-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21 MESSENGER-RNA; GENE-EXPRESSION; BINDING PROTEIN; 3'-UNTRANSLATED REGION; DEADENYLASE SUBUNITS; HUR; COMPLEX; STABILITY; TARGET; IDENTIFICATION	Ccr4d is a new member of the Ccr4 (carbon catabolite repression 4) family of proteins that are implicated in the regulation of mRNA stability and translation through mRNA deadenylation. However, Ccr4d is not believed to be involved in mRNA deadenylation. Thus, its biological function and mechanistic activity remain to be determined. Here, we report that Ccr4d is broadly expressed in various normal tissues, and the expression of Ccr4d is markedly down-regulated during cell cycle progression. We showed that Ccr4d inhibits cell proliferation and induces cell cycle arrest at G(1) phase. Our experiments further revealed that Ccr4d regulates the expression of p21 in a p53-independent manner. Mechanistic studies indicated that Ccr4d strongly bound to the 3'-UTR of p21 mRNA, leading to the stabilization of p21 mRNA. Interestingly, we found that the expression of Ccr4d is down-regulated in various tumor tissues. Collectively, our data indicate that Ccr4d functions as an anti-proliferating protein through the induction of cell cycle arrest via a p21-dependent and p53-independent pathway and suggest that Ccr4d might have an important role in carcinogenesis.	[Yi, Xia; Hong, Mei; Gui, Bin; Chen, Zhe; Li, Lei; Xie, Guojia; Liang, Jing; Wang, Xiaocheng; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157	Natural Science Foundation of China [81130048, 30921062, 30871252]; Ministry of Science and Technology of China 973 Program [2011CB504204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China)	This work was supported by Natural Science Foundation of China Grants 81130048 and 30921062 (to Y. S.) and 30871252 (to X. Y.) and Ministry of Science and Technology of China 973 Program Grant 2011CB504204 (to Y. S.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HEIN J, 1990, METHOD ENZYMOL, V183, P626; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; KAO PN, 1994, J BIOL CHEM, V269, P20691; KING PH, 1994, J NEUROSCI, V14, P1943; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Su AI, 2001, CANCER RES, V61, P7388; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yi X, 2008, CYTOM PART A, V73A, P637, DOI 10.1002/cyto.a.20579; Yi X, 2009, MOL BIOL CELL, V20, P983, DOI 10.1091/mbc.E08-06-0639; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	50	9	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21045	21057		10.1074/jbc.M112.355321	http://dx.doi.org/10.1074/jbc.M112.355321			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547059	Green Published, hybrid			2022-12-28	WOS:000306416800026
J	Ma, CIJ; Martin, C; Ma, Z; Hafiane, A; Dai, MO; Lebrun, JJ; Kiss, RS				Ma, Cheng-I J.; Martin, Cyril; Ma, Zhong; Hafiane, Anouar; Dai, Meiou; Lebrun, Jean-Jacques; Kiss, Robert S.			Engulfment Protein GULP Is Regulator of Transforming Growth Factor-beta Response in Ovarian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; MESENCHYMAL TRANSITION EMT; E3 UBIQUITIN LIGASE; TGF-BETA; SIGNAL-TRANSDUCTION; HUMAN-DISEASE; ENDOMETRIOID-ADENOCARCINOMAS; PSEUDOMONAS EXOTOXIN; DISABLED-2 DAB2; EARLY ENDOSOMES	Transforming growth factor beta (TGF-beta) is a key regulatory molecule with pleiotropic effects on cell growth, migration, and invasion. As a result, impairment of proper TGF-beta signaling is central to tumorigenesis and metastasis. The TGF-beta receptor V (TGFBRV or LRP1) has been shown to be responsible for TGF-beta-mediated cell growth inhibition in Chinese hamster ovary (CHO) cells. The LRP1 adapter protein GULP mediates internalization of the various LRP1-specific ligands, and we hypothesize that GULP acts as a novel regulator of TGF-beta signaling in ovarian cells. CHO cells that overexpress exogenous GULP (FL) demonstrate enhancement in growth inhibition, migration, and invasion from TGF-beta treatment, whereas cells that lack GULP (AS) show impairment of growth inhibition and decreased migration and invasion. The enhanced TGF-beta response in FL cells was confirmed by a prolonged TGF-beta-induced SMAD3 phosphorylation, whereas a shortening of the phosphorylation event is observed in AS cells. Mechanistically, the presence of GULP retains the TGF-beta in a signaling-competent early endosome for enhanced signaling. To address this mechanism in a physiological setting, TGF-beta insensitive ovarian adenocarcinoma cells (HEY) have a very low GULP expression level, similar to the observation made in a wide selection of human ovarian adenocarcinomas. Transfection of GULP into the HEY cells restored the TGF-beta responsiveness, as measured by SMAD3 phosphorylation and impairment of cell growth. Because GULP expression positively regulates TGF-beta signaling leading to growth inhibition, this may represent an attractive target to achieve TGF-beta responsiveness in ovarian cells.	[Ma, Cheng-I J.; Martin, Cyril; Hafiane, Anouar; Dai, Meiou; Lebrun, Jean-Jacques; Kiss, Robert S.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Ma, Zhong] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA	McGill University; University of Virginia	Kiss, RS (corresponding author), Royal Victoria Hosp, 687 Pine Ave W,Rm H7-02, Montreal, PQ H3A 1A1, Canada.	robert.kiss@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022; Hafiane, Anouar/AAE-3481-2020	Hafiane, Anouar/0000-0001-7494-722X; Ma, Cheng-I Jonathan/0000-0003-4345-3926	Canadian Institutes of Health [230670, MOP-89972]; Heart and Stroke Foundation of Quebec	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec	Supported by Canadian Institutes of Health Research Grant 230670. Recipient of the Sir William Dawson Research Chair.; Supported by funding from the Canadian Institutes of Health Research (Grant MOP-89972) and a grant-in-aid from the Heart and Stroke Foundation of Quebec.	Avramoglu RK, 1998, J BIOL CHEM, V273, P6057, DOI 10.1074/jbc.273.11.6057; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Chatterjee S, 2005, MED SCI MONITOR, V11, pLE10; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dawson C W, 2001, Methods Mol Biol, V174, P165; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Eslami P, 2008, BRAIN RES, V1241, P176, DOI 10.1016/j.brainres.2008.08.086; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hernandez-Deviez D, 2007, TRAFFIC, V8, P1750, DOI 10.1111/j.1600-0854.2007.00649.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McLean S, 2010, BIOCHEM J, V429, P137, DOI 10.1042/BJ20091598; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Penheiter SG, 2010, MOL BIOL CELL, V21, P4009, DOI 10.1091/mbc.E09-12-1019; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; ROBERTS AB, 1985, CANCER SURV, V4, P683; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Schwartz DR, 2003, CANCER RES, V63, P2913; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shultz T, 2006, BIOCHEM BIOPH RES CO, V351, P106, DOI 10.1016/j.bbrc.2006.10.024; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; UEKI N, 1993, JPN J CANCER RES, V84, P589, DOI 10.1111/j.1349-7006.1993.tb02017.x; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zhang H, 2008, BIOCHEM J, V409, P53, DOI 10.1042/BJ20071127; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; ZHOU L, 1992, BIOCHIM BIOPHYS ACTA, V1180, P130, DOI 10.1016/0925-4439(92)90061-Q; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	73	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20636	20651		10.1074/jbc.M111.314997	http://dx.doi.org/10.1074/jbc.M111.314997			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22451657	Green Published, hybrid			2022-12-28	WOS:000306414500083
J	Park, SH; Choi, HJ; Yang, H; Do, KH; Kim, J; Kim, HH; Lee, H; Oh, CG; Lee, DW; Moon, Y				Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Kim, Hyun-Hong; Lee, Heejeong; Oh, Chang Gyu; Lee, Dong Won; Moon, Yuseok			Two In-and-out Modulation Strategies for Endoplasmic Reticulum Stress-linked Gene Expression of Pro-apoptotic Macrophage-inhibitory Cytokine 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; CCAAT/ENHANCER-BINDING-PROTEIN; NF-KAPPA-B; HOMOLOGOUS PROTEIN; C/EBP-BETA; HUR; REPRESSION; INDUCTION; PROSTATE; NAG-1	Excessive and persistent insults during endoplasmic reticulum (ER) stress lead to apoptotic cell death that is implicated in a range of chronic inflammatory diseases and cancers. Macrophage inhibitory cytokine 1 (MIC-1), a member of the transforming growth factor-beta superfamily, is diversely linked to the pathogenesis of cancer. To investigate the precise molecular mechanisms of MIC-1 gene regulation, ER stress and its related signals were studied in human colon cancer cells. Functionally, MIC-1 played pivotal roles in ER stress-linked apoptotic death, which was also influenced by C/EBP homologous protein, a well known apoptotic mediator of ER stress. ER stress enhanced MIC-1 mRNA stability instead of transcriptional activation, and there were two mechanistic translocations critical for mRNA stabilization. First, C/EBP homologous protein triggered protein kinase C-linked cytosolic translocation of the HuR/ELAVL1 (Elav-like RNA-binding protein 1) RNA-binding protein, which bound to and stabilized MIC-1 transcript. As the second critical in-and-out regulation, ER stress-activated ERK1/2 signals contributed to enhanced stabilization of MIC-1 transcript by controlling the extended holding of the nucleated mRNA in the stress granules fusing with the mRNA-decaying processing body. We propose that these two sequential in-and-out modulations can account for stabilized transcription and subsequent translation of pro-apoptotic MIC-1 gene in human cancer cells under ER stress.	[Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Kim, Hyun-Hong; Lee, Heejeong; Oh, Chang Gyu; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Syst Mucosal Biomodulat, Yangsan 626870, South Korea; [Lee, Dong Won] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan 626870, South Korea; [Moon, Yuseok] Pusan Natl Univ, Res Inst Basic Sci, Pusan 609735, South Korea; [Moon, Yuseok] Pusan Natl Univ, Med Res Inst, Pusan 609735, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan 626813, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012R1A1A2005837]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science, and Technology Grant 2012R1A1A2005837.	Anderson P, 2002, J CELL SCI, V115, P3227; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Choi HJ, 2009, TOXICOL APPL PHARM, V240, P46, DOI 10.1016/j.taap.2009.06.023; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jang TJ, 2004, CARCINOGENESIS, V25, P1853, DOI 10.1093/carcin/bgh199; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Lee DH, 2003, CANCER RES, V63, P4648; Lee E, 2006, EXP MOL MED, V38, P325, DOI 10.1038/emm.2006.39; Liu T, 2003, CANCER RES, V63, P5034; Martinez JM, 2006, J PHARMACOL EXP THER, V318, P899, DOI 10.1124/jpet.105.100081; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mohr B, 2005, CYTOGENET GENOME RES, V108, P359, DOI 10.1159/000081532; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Okazaki R, 2006, RADIAT RES, V165, P125, DOI 10.1667/RR3492.1; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park SH, 2010, J IMMUNOL, V185, P5522, DOI 10.4049/jimmunol.1001315; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Russo P, 1999, ANN NY ACAD SCI, V886, P252, DOI 10.1111/j.1749-6632.1999.tb09429.x; Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200; Sok J, 1999, MOL CELL BIOL, V19, P495; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Thomas R, 2001, INT J CANCER, V93, P47, DOI 10.1002/ijc.1291; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamaguchi K, 2006, CANCER RES, V66, P2376, DOI 10.1158/0008-5472.CAN-05-1987; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200	50	24	26	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19841	19855		10.1074/jbc.M111.330639	http://dx.doi.org/10.1074/jbc.M111.330639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511768	Green Published, hybrid			2022-12-28	WOS:000306414500007
J	Singh, AK; McMillan, J; Bukiya, AN; Burton, B; Parrill, AL; Dopico, AM				Singh, Aditya K.; McMillan, Jacob; Bukiya, Anna N.; Burton, Brittany; Parrill, Abby L.; Dopico, Alex M.			Multiple Cholesterol Recognition/Interaction Amino Acid Consensus (CRAC) Motifs in Cytosolic C Tail of Slo1 Subunit Determine Cholesterol Sensitivity of Ca2+- and Voltage-gated K+ (BK) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CONDUCTANCE; MEMBRANE CHOLESTEROL; SMOOTH-MUSCLE; BENZODIAZEPINE-RECEPTOR; POTASSIUM CHANNELS; ION CHANNELS; DOMAIN; BINDING; IDENTIFICATION; ACTIVATION	Large conductance, Ca2+-and voltage-gatedK(+) (BK) channel proteins are ubiquitously expressed in cell membranes and control a wide variety of biological processes. Membrane cholesterol regulates the activity of membrane-associated proteins, including BK channels. Cholesterol modulation of BK channels alters action potential firing, colonic ion transport, smooth muscle contractility, endothelial function, and the channel alcohol response. The structural bases underlying cholesterol-BK channel interaction are unknown. Such interaction is determined by strict chemical requirements for the sterol molecule, suggesting cholesterol recognition by a protein surface. Here, we demonstrate that cholesterol action on BK channel-forming Cbv1 proteins is mediated by their cytosolic C tail domain, where we identified seven cholesterol recognition/interaction amino acid consensus motifs (CRAC4 to 10), a distinct feature of BK proteins. Cholesterol sensitivity is provided by the membrane-adjacent CRAC4, where Val-444, Tyr-450, and Lys-453 are required for cholesterol sensing, with hydrogen bonding and hydrophobic interactions participating in cholesterol location and recognition. However, cumulative truncations or Tyr-to-Phe substitutions in CRAC5 to 10 progressively blunt cholesterol sensitivity, documenting involvement of multiple CRACs in cholesterol-BK channel interaction. In conclusion, our study provides for the first time the structural bases of BK channel cholesterol sensitivity; the presence of membrane-adjacent CRAC4 and the long cytosolic C tail domain with several other CRAC motifs, which are not found in other members of the TM6 superfamily of ion channels, very likely explains the unique cholesterol sensitivity of BK channels.	[Singh, Aditya K.; Bukiya, Anna N.; Dopico, Alex M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Coll Med, Memphis, TN 38163 USA; [McMillan, Jacob; Burton, Brittany; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis	Dopico, AM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	adopico@uthsc.edu	Bukiya, Anna/N-5361-2019	Parrill, Abby/0000-0003-1658-8497; Singh, Aditya/0000-0001-7549-8163	National Institutes of Health [2R37 AA011560, R01 HL104632]; University of Tennessee Health Science Center Neuroscience Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Health Science Center Neuroscience Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R37 AA011560 and R01 HL104632 (to A. M. D.). This work was also supported by a University of Tennessee Health Science Center Neuroscience Institute postdoctoral fellowship (to A. K. S.).	Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes FJ, 2010, SUBCELL BIOCHEM, V51, P467, DOI 10.1007/978-90-481-8622-8_17; Bittman R, 1997, Subcell Biochem, V28, P145; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2011, ARTERIOSCL THROM VAS, V31, P2410, DOI 10.1161/ATVBAHA.111.233965; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Cox DH, 2005, J GEN PHYSIOL, V125, P253, DOI 10.1085/jgp.200509270; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Dopico A. M., 2012, CHOLESTEROL IN PRESS; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Epand RM, 2010, SUBCELL BIOCHEM, V51, P253, DOI 10.1007/978-90-481-8622-8_9; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jeremy RW, 2000, AM J PHYSIOL-HEART C, V279, pH1600, DOI 10.1152/ajpheart.2000.279.4.H1600; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Liang F, 2005, NEUROSCIENCE, V135, P263, DOI 10.1016/j.neuroscience.2005.05.055; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; Loura LMS, 1997, BIOPHYS J, V72, P2226, DOI 10.1016/S0006-3495(97)78866-0; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Luo XY, 2007, BIOPHYS J, V92, P1585, DOI 10.1529/biophysj.106.094722; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Morris CE, 2007, CURR TOP MEMBR, V59, P297, DOI 10.1016/S1063-5823(06)59011-8; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Piskorowski R, 2002, NATURE, V420, P499, DOI 10.1038/nature01199; Prendergast C, 2010, CELL CALCIUM, V47, P84, DOI 10.1016/j.ceca.2009.11.009; Saher G, 2010, SUBCELL BIOCHEM, V51, P489, DOI 10.1007/978-90-481-8622-8_18; Saher G, 2009, J NEUROSCI, V29, P6094, DOI 10.1523/JNEUROSCI.0686-09.2009; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	55	63	63	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20509	20521		10.1074/jbc.M112.356261	http://dx.doi.org/10.1074/jbc.M112.356261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22474334	Green Published, hybrid			2022-12-28	WOS:000306414500072
J	Chung, H; Lee, JH; Jeong, D; Han, IO; Oh, ES				Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Han, Inn-Oc; Oh, Eok-Soo			Melanocortin 1 Receptor Regulates Melanoma Cell Migration by Controlling Syndecan-2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGOUTI SIGNAL PROTEIN; FOCAL ADHESION KINASE; NECROSIS-FACTOR-ALPHA; STIMULATING HORMONE; SKIN PIGMENTATION; HEPARAN-SULFATE; RED HAIR; MELANOCYTES; MC1R; KERATINOCYTES	The melanocortin 1 receptor (MC1R), a key regulator of melanogenesis, is known to control inflammation, acting in concert with the MC1R ligand alpha-melanocyte-stimulating hormone. Although cell migration is a key event in inflammation, few studies have addressed the function of MC1R in this context. Using highly motile melanoma cells, we found that the expression level of MC1R was associated with the extent of migration of mouse melanoma cells, suggesting that MC1R plays a functional role in controlling this migration. Overexpression of MC1R enhanced melanoma cell migration, whereas the opposite was true when MC1R levels were knocked down using small inhibitory RNAs. Interestingly, MC1R expression enhanced the synthesis of syndecan-2, a cell surface heparan sulfate proteoglycan known to be involved in melanoma cell migration. Knockdown of syndecan-2 expression decreased MC1R-mediated cell migration. Further, MC1R inhibited the activation of p38 MAPK, subsequently enhancing expression of sydnecan-2, in parallel with an increase in the extent of cell migration. Consistently, activation of p38 by H2O2 inhibited syndecan-2 expression and cell migration, whereas inhibition of p38 activation enhanced syndecan-2 expression and cell migration. Finally, we found that alpha-melanocyte-stimulating hormone inhibited MC1R-mediated cell migration via activation of p38 and inhibition of syndecan-2 expression. Together, the data strongly suggest that MC1R regulates melanoma cell migration via inhibition of syndecan-2 expression.	[Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chung, Heesung; Lee, Jung-hyun; Jeong, Dayun; Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Lee, Jung-Hyun/AAL-2954-2021	Lee, Jung-Hyun/0000-0003-1913-0027	National Research Foundation of Korea; Ministry of Education, Science and Technology [2009-0071381, 2010-0028042]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grants 2009-0071381 and 2010-0028042 (to E.-S. O.).	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chluba-de Tapia J, 1996, J CELL SCI, V109, P2023; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; DELUCA M, 1993, J CELL SCI, V105, P1079; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Haycock JW, 2000, J BIOL CHEM, V275, P15629, DOI 10.1074/jbc.275.21.15629; Kauser S, 2005, ENDOCRINOLOGY, V146, P532, DOI 10.1210/en.2004-1145; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Newton RA, 2007, PEPTIDES, V28, P2387, DOI 10.1016/j.peptides.2007.10.003; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; POSTE G, 1982, CANCER RES, V42, P2770; Redondo P, 1998, ARCH DERMATOL RES, V290, P425, DOI 10.1007/s004030050330; Roberts DW, 2008, J CELL PHYSIOL, V215, P344, DOI 10.1002/jcp.21318; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Salazar-Onfray F, 2002, BRIT J CANCER, V87, P414, DOI 10.1038/sj.bjc.6600441; Scott GA, 1998, J INVEST DERMATOL, V111, P243, DOI 10.1046/j.1523-1747.1998.00276.x; SOLCA FF, 1993, FEBS LETT, V322, P177, DOI 10.1016/0014-5793(93)81563-F; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	33	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19326	19335		10.1074/jbc.M111.334730	http://dx.doi.org/10.1074/jbc.M111.334730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493442	hybrid, Green Published			2022-12-28	WOS:000306411900042
J	Park, JE; Cullins, D; Zalduondo, L; Barnett, SL; Yi, AK; Kleinau, S; Stuart, JM; Kang, AH; Myers, LK				Park, Jeoung-Eun; Cullins, David; Zalduondo, Lillian; Barnett, Stacey L.; Yi, Ae-Kyung; Kleinau, Sandra; Stuart, John M.; Kang, Andrew H.; Myers, Linda K.			Molecular Basis for T Cell Response Induced by Altered Peptide Ligand of Type II Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE ARTHRITIS; TYROSINE KINASE; FCR-GAMMA; SYK; EXPRESSION; ZAP-70; INDUCTION; ANALOG; DETERMINANT; ACTIVATION	Mounting evidence from animal models has demonstrated that alterations in peptide-MHC interactions with the T cell receptor (TCR) can lead to dramatically different T cell outcomes. We have developed an altered peptide ligand of type II collagen, referred to as A9, which differentially regulates TCR signaling in murine T cells leading to suppression of arthritis in the experimental model of collagen-induced arthritis. This study delineates the T cell signaling pathway used by T cells stimulated by the A9.I-A(q) complex. We have found that T cells activated by A9 bypass the requirement for Zap-70 and CD3-zeta and signal via FcR gamma and Syk. Using collagen-specific T cell hybridomas engineered to overexpress either Syk, Zap-70, TCR-FcR gamma, or CD3-zeta, we demonstrate that A9.I-A(q) preferentially activates FcR gamma/Syk but not CD3-zeta/Zap-70. Moreover, a genetic absence of Syk or FcR gamma significantly reduces the altered peptide ligand induction of the nuclear factor GATA3. By dissecting the molecular mechanism of A9-induced T cell signaling we have defined a new alternate pathway that is dependent upon FcR gamma and Syk to secrete immunoregulatory cytokines. Given the interest in using Syk inhibitors to treat patients with rheumatoid arthritis, understanding this pathway may be critical for the proper application of this therapy.	[Park, Jeoung-Eun; Cullins, David; Stuart, John M.; Kang, Andrew H.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Yi, Ae-Kyung; Myers, Linda K.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Zalduondo, Lillian; Barnett, Stacey L.] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN 38163 USA; [Stuart, John M.; Kang, Andrew H.] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; [Kleinau, Sandra] Uppsala Univ, Dept Cell & Mol Biol, S-75105 Uppsala, Sweden	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Uppsala University	Myers, LK (corresponding author), Div Rheumatol, 956 Court Ave,Rm G326, Memphis, TN 38163 USA.	lmyers@uthsc.edu	Kleinau, Sandra/C-9545-2013	Kleinau, Sandra/0000-0002-9729-2286	National Institutes of Health; United States Public Health Service [AR-55661, AR-55266]; Department of Veterans Affairs; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055266, R01AR055661, R01AR043589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Veterans Affairs(US Department of Veterans Affairs); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, United States Public Health Service Grants AR-55661 and AR-55266 and program-directed funds from the Department of Veterans Affairs. This work was also supported by and the Arthritis Foundation.	BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; Brand DD, 2002, J IMMUNOL, V168, P490, DOI 10.4049/jimmunol.168.1.490; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Chauhan AK, 2012, CLIN EXP IMMUNOL, V167, P235, DOI 10.1111/j.1365-2249.2011.04505.x; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Datta S, 2011, J ALLERGY CLIN IMMUN, V127, P351, DOI 10.1016/j.jaci.2010.11.033; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P337, DOI 10.1002/art.30114; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Jakob T, 2008, J ALLERGY CLIN IMMUN, V121, P179, DOI 10.1016/j.jaci.2007.07.018; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kleinau S, 2003, CURR PHARM DESIGN, V9, P1861, DOI 10.2174/1381612033454414; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Myers LK, 2007, CRIT REV IMMUNOL, V27, P345, DOI 10.1615/CritRevImmunol.v27.i4.40; MYERS LK, 1993, J IMMUNOL, V150, P4652; Myers LK, 2004, AM J MED SCI, V327, P212, DOI 10.1097/00000441-200404000-00007; Myers LK, 1998, J IMMUNOL, V161, P3589; Myers LK, 1997, LIFE SCI, V61, P1861, DOI 10.1016/S0024-3205(97)00480-3; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Nepom GT, 2005, ADV IMMUNOL, V88, P51, DOI 10.1016/S0065-2776(05)88002-2; Rosloniec E. F., 1997, CURRENT PROTOCOLS IM, P11; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Simon DI, 2011, CIRC RES, V109, P1199, DOI 10.1161/CIRCRESAHA.111.257980; Tang B, 2009, CLIN IMMUNOL, V133, P145, DOI 10.1016/j.clim.2009.06.006; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zoller KE, 1997, J IMMUNOL, V158, P1650	39	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19765	19774		10.1074/jbc.M112.349688	http://dx.doi.org/10.1074/jbc.M112.349688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511761	hybrid, Green Published			2022-12-28	WOS:000306411900085
J	Meir, A; Bayer, EA; Livnah, O				Meir, Amit; Bayer, Edward A.; Livnah, Oded			Structural Adaptation of a Thermostable Biotin-binding Protein in a Psychrophilic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIDIN; STREPTAVIDIN; TRYPTOPHAN; SINGLE; DIMER; PURIFICATION; TECHNOLOGY; EXPRESSION; STABILITY; BACTERIUM	Shwanavidin is an avidin-like protein from the marine proteo-bactrium Shewanella denitrificans, which exhibits an innate dimeric structure while maintaining high affinity toward biotin. A unique residue (Phe-43) from the L3,4 loop and a distinctive disulfide bridge were shown to account for the high affinity toward biotin. Phe-43 emulates the function and position of the critical intermonomeric Trp that characterizes the tetrameric avidins but is lacking in shwanavidin. The 18 copies of the apo-monomer revealed distinctive snapshots of L3,4 and Phe-43, providing rare insight into loop flexibility, binding site accessibility, and psychrophilic adaptation. Nevertheless, as in all avidins, shwanavidin also displays high thermostability properties. The unique features of shwanavidin may provide a platform for the design of a long sought after monovalent form of avidin, which would be ideal for novel types of biotechnological application.	[Meir, Amit; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Livnah, O (corresponding author), Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	oded.livnah@huji.ac.il		Meir, Amit/0000-0001-9635-1021				Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER EA, 1995, BBA-GENE STRUCT EXPR, V1263, P60, DOI 10.1016/0167-4781(95)00077-T; BAYER EA, 1990, J CHROMATOGR, V510, P3, DOI 10.1016/S0021-9673(01)93733-1; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brettar I, 2012, ISME J, V6, P195, DOI 10.1038/ismej.2011.80; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; Chivers CE, 2011, BIOCHEM J, V435, P55, DOI 10.1042/BJ20101593; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Freitag S, 1998, J MOL BIOL, V279, P211, DOI 10.1006/jmbi.1998.1735; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KURZBAN GP, 1991, J BIOL CHEM, V266, P14470; Laitinen OH, 1999, FEBS LETT, V461, P52, DOI 10.1016/S0014-5793(99)01423-4; Lim KH, 2011, BIOCHEMISTRY-US, V50, P8682, DOI 10.1021/bi2010366; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; LIVNAH O, 1993, FEBS LETT, V328, P165, DOI 10.1016/0014-5793(93)80986-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Pazy Y, 2003, J BACTERIOL, V185, P4050, DOI 10.1128/JB.185.14.4050-4056.2003; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sano T, 1997, Methods Mol Biol, V63, P119; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Teulon JM, 2011, J MOL RECOGNIT, V24, P490, DOI 10.1002/jmr.1109; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WILCHEK M, 1989, TRENDS BIOCHEM SCI, V14, P408, DOI 10.1016/0968-0004(89)90289-2; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17951	17962		10.1074/jbc.M112.357186	http://dx.doi.org/10.1074/jbc.M112.357186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493427	hybrid, Green Published			2022-12-28	WOS:000306411600005
J	Freyaldenhoven, S; Li, YC; Kocabas, AM; Ziu, E; Ucer, S; Ramanagoudr-Bhojappa, R; Miller, GP; Kilic, F				Freyaldenhoven, Samuel; Li, Yicong; Kocabas, Arif M.; Ziu, Enrit; Ucer, Serra; Ramanagoudr-Bhojappa, Raman; Miller, Grover P.; Kilic, Fusun			RETRACTED: The Role of ERp44 in Maturation of Serotonin Transporter Protein (Retracted article. See vol. 294, pg. 70, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							N-LINKED OLIGOSACCHARIDES; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; HETERO-OLIGOMERIZATION; DOPAMINE TRANSPORTER; HOMO-OLIGOMERIZATION; SURFACE EXPRESSION; RETENTION; GLYCOSYLATION	In heterologous and endogenous expression systems, we studied the role of ERp44 and its complex partner endoplasmic reticulum (ER) oxidase 1-alpha (Ero1-L alpha) in mechanisms regulating disulfide bond formation for serotonin transporter (SERT), an oligomeric glycoprotein. ERp44 is an ER lumenal chaperone protein that favors the maturation of disulfide-linked oligomeric proteins. ERp44 plays a critical role in the release of proteins from the ER via binding to Ero1-L alpha. Mutation in the thioredoxin- like domain hampers the association of ERp44C29S with SERT, which has three Cys residues (Cys-200, Cys-209, and Cys-109) on the second external loop. We further explored the role of the protein chaperones through shRNA knockdown experiments for ERp44 and Ero1-L alpha. Those efforts resulted in increased SERT localization to the plasma membrane but decreased serotonin (5-HT) uptake rates, indicating the importance of the ERp44 retention mechanism in the proper maturation of SERT proteins. These data were strongly supported with the data received from the N-biotinylaminoethyl methanethiosulfonate (MTSEA-biotin) labeling of SERT on ERp44 shRNA cells. MTSEA-biotin only interacts with the free Cys residues from the external phase of the plasma membrane. Interestingly, it appears that Cys200 and Cys-209 of SERT in ERp44-silenced cells are accessible to labeling by MTSEA-biotin. However, in the control cells, these Cys residues are occupied and produced less labeling with MTSEA-biotin. Furthermore, ERp44 preferentially associated with SERT mutants (C200S, C209S, and C109A) when compared with wild type. These interactions with the chaperone may reflect the inability of Cys-200 and Cys-209 SERT mutants to form a disulfide bond and self-association as evidenced by immunoprecipitation assays. Based on these collective findings, we hypothesize that ERp44 together with Ero1-L alpha plays an important role in disulfide formation of SERT, which may be a prerequisite step for the assembly of SERT molecules in oligomeric form.	[Freyaldenhoven, Samuel; Li, Yicong; Kocabas, Arif M.; Ziu, Enrit; Ucer, Serra; Ramanagoudr-Bhojappa, Raman; Miller, Grover P.; Kilic, Fusun] Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Kilic, F (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, 4301W MarkhamSt 516, Little Rock, AR 72205 USA.	kilicfusun@uams.edu	Miller, Grover P/AAY-7582-2020	Miller, Grover P/0000-0002-4743-8187	National Institutes of Health [HD058697, HD053477, HL091196, HL091196-01A2W1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053477, R03HD058697] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD058697, HD053477, HL091196, and HL091196-01A2W1 (to F. K.).	Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; Ahmed BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004730; Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Aridor M, 1996, NATURE, V383, P220, DOI 10.1038/383220a0; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Chamba A, 2008, J NEUROIMMUNOL, V204, P75, DOI 10.1016/j.jneuroim.2008.07.014; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; LODISH HF, 1988, HARVEY LECT, V82, P19; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; Nguyen TT, 1996, J NEUROCHEM, V67, P645; Otsu M, 2007, CURR MED CHEM, V14, P1639, DOI 10.2174/092986707780830952; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; QIAN Y, 1995, J NEUROSCI, V15, P1261; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; Reith MEA., 1997, NEUROTRANSMITTER TRA, P29, DOI 10.1007/978-1-59259-470-2_2; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; TATE CG, 1994, J BIOL CHEM, V269, P26303; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wood MJ, 1999, J BIOMOL NMR, V13, P149, DOI 10.1023/A:1008398313350; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p	37	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17801	17811		10.1074/jbc.M112.345058	http://dx.doi.org/10.1074/jbc.M112.345058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451649	Green Published, hybrid			2022-12-28	WOS:000306373000078
J	Naci, D; El Azreq, MA; Chetoui, N; Lauden, L; Sigaux, F; Charron, D; Al-Daccak, R; Aoudjit, F				Naci, Dalila; El Azreq, Mohammed-Amine; Chetoui, Nizar; Lauden, Laura; Sigaux, Francois; Charron, Dominique; Al-Daccak, Reem; Aoudjit, Fawzi			alpha 2 beta 1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ADHESION-MEDIATED DRUG; T-LYMPHOCYTES; INDUCED APOPTOSIS; DOWN-REGULATION; STROMAL CELLS; ACTIVATION; SURVIVAL; PROTEIN; MCL-1	The role and the mechanisms by which beta 1 integrins regulate the survival and chemoresistance of T cell acute lymphoblastic leukemia (T-ALL) still are poorly addressed. In this study, we demonstrate in T-ALL cell lines and primary blasts, that engagement of alpha 2 beta 1 integrin with its ligand collagen I (ColI), reduces doxorubicin-induced apoptosis, whereas fibronectin (Fn) had no effect. ColI but not Fn inhibited doxorubicin-induced mitochondrial depolarization, cytochrome c release, and activation of caspase-9 and -3. ColI but not Fn also prevented doxorubicin from down-regulating the levels of the prosurvival Bcl-2 protein family member Mcl-1. The effect of ColI on Mcl-1 occurred through the inhibition of doxorubicin-induced activation of c-Jun N-terminal kinase (JNK). Mcl-1 knockdown experiments showed that the maintenance of Mcl-1 levels is essential for ColI-mediated T-ALL cell survival. Furthermore, activation of MAPK/ERK, but not PI3K/AKT, is required for ColI-mediated inhibition of doxorubicin-induced JNK activation and apoptosis and for ColI-mediated maintenance of Mcl-1 levels. Thus, our study identifies alpha 2 beta 1 integrin as an important survival pathway in drug-induced apoptosis of T-ALL cells and suggests that its activation can contribute to the generation of drug resistance.	[Naci, Dalila; El Azreq, Mohammed-Amine; Chetoui, Nizar; Aoudjit, Fawzi] Ctr Hosp Univ Quebec, Ctr Rech Rhumatol Immunol, Quebec City, PQ G1V 4G2, Canada; [Naci, Dalila; El Azreq, Mohammed-Amine; Chetoui, Nizar; Aoudjit, Fawzi] Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada; [Lauden, Laura; Charron, Dominique; Al-Daccak, Reem] Univ Paris Denis Diderot, Hop St Louis, Inst Univ Hematol, INSERM,UMRS 940, F-75010 Paris, France; [Sigaux, Francois] Univ Paris Denis Diderot, Hop St Louis, Inst Univ Hematol, INSERM,U944, F-75010 Paris, France	Laval University; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Aoudjit, F (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Rhumatol Immunol, Pavillon CHUL, Quebec City, PQ G1V 4G2, Canada.	fawzi.aoudjit@crchul.ulaval.ca	Al-Daccak, Reem/L-8804-2018	Al-Daccak, Reem/0000-0002-6146-2845	Canadian Institutes of Health Research [MOP-98005]; Faculte de Medecine, Universite Laval; French Ministry of Education	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculte de Medecine, Universite Laval; French Ministry of Education	This work was supported by Canadian Institutes of Health Research Grant MOP-98005 (to F. A.).; Recipient of a doctoral fellowship from Faculte de Medecine, Universite Laval.; Recipient of a doctoral fellowship from the French Ministry of Education.	Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; Aoudjit F, 2004, EXP CELL RES, V299, P79, DOI 10.1016/j.yexcr.2004.05.011; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; Aoudjit F, 1999, INT J CANCER, V82, P743, DOI 10.1002/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6; Bijian K, 2007, MOL IMMUNOL, V44, P3682, DOI 10.1016/j.molimm.2007.04.005; Bouchard F, 2010, BLOOD, V116, P759, DOI 10.1182/blood-2009-12-257030; Bozzo C, 1997, EXP CELL RES, V237, P326, DOI 10.1006/excr.1997.3777; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Celebi B, 2011, J IMMUNOL METHODS, V370, P93, DOI 10.1016/j.jim.2011.06.006; CHAN BMC, 1991, J IMMUNOL, V147, P398; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Cleaver AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-105; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; DAMLE NK, 1993, J IMMUNOL, V151, P2368; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Estrugo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000269; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Garamszegi N, 2009, MOL CANCER RES, V7, P319, DOI 10.1158/1541-7786.MCR-08-0227; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Guo DM, 2009, LEUKEMIA LYMPHOMA, V50, P270, DOI 10.1080/10428190802553257; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; Holleran BJ, 2003, J LEUKOCYTE BIOL, V73, P243, DOI 10.1189/jlb.0902439; Ishihara M, 2012, LEUKEMIA, V26, P332, DOI 10.1038/leu.2011.203; Ivanoff J, 2005, IMMUNOLOGY, V114, P53, DOI 10.1111/j.1365-2567.2004.02005.x; JUNEJA HS, 1992, EXP HEMATOL, V20, P1263; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Krilleke D, 2003, INT J CANCER, V107, P520, DOI 10.1002/ijc.11331; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Lopez-Royuela N, 2010, BIOCHEM PHARMACOL, V79, P1746, DOI 10.1016/j.bcp.2010.02.010; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Ozgen U, 2000, CYTOMETRY, V42, P74, DOI 10.1002/(SICI)1097-0320(20000215)42:1<74::AID-CYTO11>3.0.CO;2-6; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Pillozzi S, 2011, BLOOD, V117, P902, DOI 10.1182/blood-2010-01-262691; Saldanha-Gama RF, 2010, BBA-MOL CELL RES, V1803, P848, DOI 10.1016/j.bbamcr.2010.03.012; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; SUGAHARA H, 1994, J EXP MED, V179, P1757, DOI 10.1084/jem.179.6.1757; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Vacca A, 2000, Dev Immunol, V7, P77, DOI 10.1155/2000/74372; Van de Walle GR, 2005, J BIOL CHEM, V280, P36873, DOI 10.1074/jbc.M508148200; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Yu CR, 2004, EXP CELL RES, V295, P555, DOI 10.1016/j.yexcr.2004.02.001	50	71	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17065	17076		10.1074/jbc.M112.349365	http://dx.doi.org/10.1074/jbc.M112.349365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457358	Green Published, hybrid			2022-12-28	WOS:000306373000007
J	Shigi, N				Shigi, Naoki			Posttranslational Modification of Cellular Proteins by a Ubiquitin-like Protein in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; ESCHERICHIA-COLI; EXTREME THERMOPHILE; THERMUS-THERMOPHILUS; SULFUR TRANSFER; MODIFIER URM1; BIOSYNTHESIS; PUP; CONJUGATION; THIOLATION	Posttranslational modification of proteins with ubiquitin and ubiquitin-like proteins plays important regulatory roles in eukaryotes. Although a homologous conjugation system has recently been reported in Archaea, there is no similar report in Bacteria. This report describes the identification of a ubiquitin-like conjugation system in the bacterium Thermus thermophilus. A series of in vivo analyses revealed that TtuB, a bacterial ubiquitin-like protein that functions as a sulfur carrier in tRNA thiouridine synthesis, was covalently attached to target proteins, most likely via its C-terminal glycine. The involvement of the ubiquitin-activating enzyme-like protein TtuC in conjugate formation and the attachments of TtuB to TtuC and TtuA, which are proteins required for tRNA thiouridine synthesis, were demonstrated. Mass spectrometry analysis revealed that lysine residues (Lys-137/Lys-226/Lys-229) of TtuA were covalently modified by the C-terminal carboxylate of TtuB. Intriguingly, a deletion mutant of a JAMM (JAB1/MPN/Mov34 metalloenzyme) ubiquitin isopeptidase homolog showed aberrant TtuB conjugates of TtuC and TtuA and an similar to 50% decrease in thiouridine amounts in tRNA. These results would support the hypothesis that thiouridine synthesis is regulated by TtuB-conjugation.	Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Shigi, N (corresponding author), Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	naoki-shigi@aist.go.jp	Shigi, Naoki/L-7135-2018	Shigi, Naoki/0000-0003-4452-8264	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22770140]; Kurata memorial Hitachi Science and Technology Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [22770140] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata memorial Hitachi Science and Technology Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by KAKENHI Grant 22770140 of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Naito Foundation, and the Kurata memorial Hitachi Science and Technology Foundation.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Brouns SJJ, 2005, J BIOL CHEM, V280, P11422, DOI 10.1074/jbc.M413623200; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Godert AM, 2007, J BACTERIOL, V189, P2941, DOI 10.1128/JB.01200-06; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Noma A., 2009, DNA RNA MODIFICATION, P395; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; PITTERLE DM, 1993, J BIOL CHEM, V268, P13499; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; TAKADA T, 1993, APPL ENVIRON MICROB, V59, P2737, DOI 10.1128/AEM.59.8.2737-2739.1993; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; WATANABE K, 1974, FEBS LETT, V43, P59, DOI 10.1016/0014-5793(74)81105-1; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103; Yokoyama S, 1987, Adv Biophys, V23, P115, DOI 10.1016/0065-227X(87)90006-2; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172	50	41	45	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17568	17577		10.1074/jbc.M112.359844	http://dx.doi.org/10.1074/jbc.M112.359844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22467871	hybrid, Green Published			2022-12-28	WOS:000306373000055
J	Teichman, S; Qu, SG; Kanner, BI				Teichman, Shlomit; Qu, Shaogang; Kanner, Baruch I.			Conserved Asparagine Residue Located in Binding Pocket Controls Cation Selectivity and Substrate Interactions in Neuronal Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; CHLORIDE CHANNEL; REENTRANT LOOP; GLT-1; ION; HOMOLOG; SODIUM	Transporters of the major excitatory neurotransmitter glutamate play a crucial role in glutamatergic neurotransmission by removing their substrate from the synaptic cleft. The transport mechanism involves co-transport of glutamic acid with three Na+ ions followed by countertransport of one K+ ion. Structural work on the archeal homologue Glt(Ph) indicates a role of a conserved asparagine in substrate binding. According to a recent proposal, this residue may also participate in a novel Na+ binding site. In this study, we characterize mutants of this residue from the neuronal transporter EAAC1, Asn-451. None of the mutants, except for N451S, were able to exhibit transport. However, the K-m of this mutant for L-aspartate was increased similar to 30-fold. Remarkably, the increase for D-aspartate and L-glutamate was 250- and 400-fold, respectively. Moreover, the cation specificity of N451S was altered because sodium but not lithium could support transport. A similar change in cation specificity was observed with a mutant of a conserved threonine residue, T370S, also implicated to participate in the novel Na+ site together with the bound substrate. In further contrast to the wild type transporter, only L-aspartate was able to activate the uncoupled anion conductance by N451S, but with an almost 1000-fold reduction in apparent affinity. Our results not only provide experimental support for the Na+ site but also suggest a distinct orientation of the substrate in the binding pocket during the activation of the anion conductance.	[Teichman, Shlomit; Qu, Shaogang; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			National Institutes of Neurological Disorders and Stroke through National Institutes of Health [NS 16708]; United States-Israel Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke through National Institutes of Health; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Neurological Disorders and Stroke through National Institutes of Health Grant NS 16708 and United States-Israel Binational Science Foundation Grant 2007051.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17198	17205		10.1074/jbc.M112.355040	http://dx.doi.org/10.1074/jbc.M112.355040			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493292	Green Published, hybrid			2022-12-28	WOS:000306373000019
J	Zhang, YH; Yan, WS; Jung, YS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Jung, Yong Sam; Chen, Xinbin			Mammary Epithelial Cell Polarity Is Regulated Differentially by p73 Isoforms via Epithelial-to-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE CULTURES; P53 FAMILY; TUMOR PROGRESSION; DNA-DAMAGE; APOPTOSIS; EXPRESSION; ACINI; P63; MORPHOGENESIS; ONCOGENE	p73 is expressed as TA and Delta N isoforms, both of which are implicated in tumor suppression and/or promotion. To address how p73 possesses these opposing functions, we developed three-dimensional culture of MCF10A cells, which undergo cell morphogenesis to form polarized spheroids with hollow lumen similar to normal mammary acini in vivo. Here, we showed that upon knockdown of p73, particularly TAp73 but not Delta Np73, MCF10A cells formed irregular and near-normal acini without hollow lumen in three-dimensional culture. We also found that upon knockdown of p73 or TAp73, but not Delta Np73, MCF10A cells underwent epithelial-to-mesenchymal transition (EMT) via down-regulation of E-cadherin coupled with up-regulation of beta-catenin and laminin V. In addition, we found that Snail-1, Slug, and Twist, all of which are known to act as EMT inducers by repressing E-cadherin expression, were increased markedly upon knockdown of p73 and TAp73 but little if any by Delta Np73. Furthermore, we showed that knockdown of p73 or TAp73 in MCF10A cells led to a marked increase in cell proliferation and migration. Together, our data suggest that TAp73 is necessary for maintaining normal cell polarity by suppressing EMT.	[Chen, Xinbin] Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA; Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Sch Med, Comparat Oncol Lab, 2128A Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health; NCI [CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, NCI Grant CA081237.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004373; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; MIYASHITA T, 1995, CELL, V80, P293; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Puig P, 2003, CLIN CANCER RES, V9, P5642; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Weber A, 2002, VIRCHOWS ARCH, V441, P428, DOI 10.1007/s00428-002-0705-y; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wilson C, 2004, NEUROPATH APPL NEURO, V30, P19, DOI 10.1046/j.0305-1846.2003.00496.x; Yamamoto T, 2001, INT J ONCOL, V19, P271; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	45	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17746	17753		10.1074/jbc.M112.358143	http://dx.doi.org/10.1074/jbc.M112.358143			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22457351	hybrid, Green Published			2022-12-28	WOS:000306373000073
J	Liu, ZP; Zaki, MH; Vogel, P; Gurung, P; Finlay, BB; Deng, WY; Lamkanfi, M; Kanneganti, TD				Liu, Zhiping; Zaki, Md Hasan; Vogel, Peter; Gurung, Prajwal; Finlay, B. Brett; Deng, Wanyin; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Role of Inflammasomes in Host Defense against Citrobacter rodentium Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFACING PATHOGEN; INDUCED COLITIS; MICE DEFICIENT; DISEASE; INTERLEUKIN-1-BETA; ACTIVATION; CASPASE-1; SECRETION; VIRULENCE; MYD88	Citrobacter rodentium is an enteric bacterial pathogen of the mouse intestinal tract that triggers inflammatory responses resembling those of humans infected with enteropathogenic and enterohemorrhagic Escherichia coli. Inflammasome signaling is emerging as a central regulator of inflammatory and host responses to several pathogens, but the in vivo role of inflammasome signaling in host defense against C. rodentium has not been characterized. Here, we show that mice lacking the inflammasome components Nlrp3, Nlrc4, and caspase-1 were hypersusceptible to C. rodentium-induced gastrointestinal inflammation. This was due to defective interleukin (IL)-1 beta and IL-18 production given that il-1 beta(-/-) and il-18(-/-) mice also suffered from increased bacterial burdens and exacerbated histopathology. C. rodentium specifically activated the Nlrp3 inflammasome in in vitro-infected macrophages independently of a functional bacterial type III secretion system. Thus, production of IL-1 beta and IL-18 downstream of the Nlrp3 and Nlrc4 inflammasomes plays a critical role in host defense against enteric infections caused by C. rodentium.	[Liu, Zhiping; Zaki, Md Hasan; Gurung, Prajwal; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Finlay, B. Brett; Deng, Wanyin] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Finlay, B. Brett; Deng, Wanyin] Ghent Univ VIB, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Ghent Univ VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of British Columbia; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Suite E7004, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Vogel, Peter/N-2490-2018; Liu, Zhiping/O-3510-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019	Vogel, Peter/0000-0002-7535-0545; Liu, Zhiping/0000-0002-5109-4153; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Gurung, Prajwal/0000-0002-7451-9433; Zaki, Hasan/0000-0001-9002-5399	National Institutes of Health [R01AR056296]; American Lebanese Syrian Associated Charities (ALSAC); Gephardt fellowship; Fund for Scientific Research-Flanders [1.5.122.11N, 1.2.201.10N]; European Union [256432]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Gephardt fellowship; Fund for Scientific Research-Flanders(FWO); European Union(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR056296. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) (to T.-D.K.).; Supported by a Gephardt fellowship.; Supported by Fund for Scientific Research-Flanders Grants 1.5.122.11N and 1.2.201.10N and European Union Marie-Curie Grant 256432.	Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Wickham ME, 2007, MICROBES INFECT, V9, P400, DOI 10.1016/j.micinf.2006.12.016	22	110	111	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16955	16964		10.1074/jbc.M112.358705	http://dx.doi.org/10.1074/jbc.M112.358705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22461621	Green Published, hybrid			2022-12-28	WOS:000304030900080
J	Ryan, TM; Friedhuber, A; Lind, M; Howlett, GJ; Masters, C; Roberts, BR				Ryan, Timothy M.; Friedhuber, Anna; Lind, Monica; Howlett, Geoffrey J.; Masters, Colin; Roberts, Blaine R.			Small Amphipathic Molecules Modulate Secondary Structure and Amyloid Fibril-forming Kinetics of Alzheimer Disease Peptide A beta(1-42)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; A-BETA; FATTY-ACIDS; MASS-SPECTROMETRY; SELF-ASSOCIATION; IN-VITRO; CHOLESTEROL; BINDING; PROTEIN; PHOSPHATIDYLCHOLINE	Amyloid fibril formation is associated with a number of debilitating systemic and neurodegenerative diseases. One of the most prominent is Alzheimer disease in which aggregation and deposition of the A beta peptide occur. A beta is widely considered to mediate the extensive neuronal loss observed in this disease through the formation of soluble oligomeric species, with the final fibrillar end product of the aggregation process being relatively inert. Factors that influence the aggregation of these amyloid-forming proteins are therefore very important. We have screened a library of 96 amphipathic molecules for effects on A beta(1-42) aggregation and self-association. We find, using thioflavin T fluorescence and electron microscopy assays, that 30 of the molecules inhibit the aggregation process, whereas 36 activate fibril formation. Several activators and inhibitors were subjected to further analysis using analytical ultracentrifugation and circular dichroism. Activators typically display a 1: 10 peptide: detergent stoichiometry for maximal activation, whereas the inhibitors are effective at a 1: 1 stoichiometry. Analytical ultracentrifugation and circular dichroism experiments show that activators promote a mixture of unfolded and beta-sheet structures and rapidly form large aggregates, whereas inhibitors induce beta-helical structures that form stable dimeric/trimeric oligomers. The results suggest that A beta(1-42) contains at least one small molecule binding site, which modulates the secondary structure and aggregation processes. Further studies of the binding of these compounds to A beta may provide insight for developing therapeutic strategies aimed at stabilizing A beta in a favorable conformation.	[Ryan, Timothy M.; Lind, Monica; Masters, Colin; Roberts, Blaine R.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia; [Friedhuber, Anna] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Howlett, Geoffrey J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Roberts, BR (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia.	b.roberts@mhri.edu.au		Roberts, Blaine/0000-0001-5466-0053				Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; Bazoti FN, 2008, J AM SOC MASS SPECTR, V19, P1078, DOI 10.1016/j.jasms.2008.03.011; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Chai Chen K, 2007, Am J Alzheimers Dis Other Demen, V22, P37, DOI 10.1177/1533317506295655; Chi EY, 2007, BIOCHEMISTRY-US, V46, P1913, DOI 10.1021/bi062177x; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21990, DOI 10.1073/pnas.1006091107; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Galanakis PA, 2011, BIOPOLYMERS, V96, P316, DOI 10.1002/bip.21558; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hane F, 2010, NANOMED-NANOTECHNOL, V6, P808, DOI 10.1016/j.nano.2010.05.001; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V370, P525, DOI 10.1016/j.bbrc.2008.03.130; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kokubo H, 2005, NEUROBIOL AGING, V26, P409, DOI 10.1016/j.neurobiolaging.2004.04.008; Liu YZ, 2004, J LIPID RES, V45, P2368, DOI 10.1194/jlr.M400317-JLR200; Lorenzo A, 1996, ANN NY ACAD SCI, V777, P89, DOI 10.1111/j.1749-6632.1996.tb34406.x; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mandal PK, 2004, NEUROCHEM RES, V29, P447, DOI 10.1023/B:NERE.0000013750.80925.25; Mandal PK, 2007, BIOCHEMISTRY-US, V46, P762, DOI 10.1021/bi062184l; Mandal PK, 2006, NEUROCHEM RES, V31, P883, DOI 10.1007/s11064-006-9092-0; Marchesi VT, 2005, P NATL ACAD SCI USA, V102, P9093, DOI 10.1073/pnas.0503181102; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Narayanan S, 2006, FEBS LETT, V580, P5941, DOI 10.1016/j.febslet.2006.09.063; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Olofsson A, 2007, J MOL BIOL, V374, P186, DOI 10.1016/j.jmb.2007.08.064; Pal-Gabor H, 2009, BIOCHEMISTRY-US, V48, P5689, DOI 10.1021/bi900356r; Panchal M, 2010, J LIPID RES, V51, P598, DOI 10.1194/jlr.M001859; Rojo L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73976; Ryan TM, 2011, J MOL BIOL, V406, P416, DOI 10.1016/j.jmb.2010.12.023; Ryan TM, 2010, J MOL BIOL, V399, P731, DOI 10.1016/j.jmb.2010.04.042; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Wood WG, 2003, BBA-BIOMEMBRANES, V1610, P281, DOI 10.1016/S0005-2736(03)00025-7; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yoda M, 2008, BIOCHEM BIOPH RES CO, V376, P56, DOI 10.1016/j.bbrc.2008.08.093	51	37	37	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16947	16954		10.1074/jbc.M111.321778	http://dx.doi.org/10.1074/jbc.M111.321778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22461629	Green Published, hybrid			2022-12-28	WOS:000304030900079
J	Wang, H; Luo, K; Tan, LZ; Ren, BG; Gu, LQ; Michalopoulos, G; Luo, JH; Yu, YP				Wang, Hui; Luo, Katherine; Tan, Lang-Zhu; Ren, Bao-Guo; Gu, Li-Qun; Michalopoulos, George; Luo, Jian-Hua; Yu, Yan P.			p53-induced Gene 3 Mediates Cell Death Induced by Glutathione Peroxidase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ENDOMETRIAL ADENOCARCINOMA; EXPRESSION; PIG3; GROWTH; GLUTATHIONE-PEROXIDASE-3; IDENTIFICATION; SELENOCYSTEINE; METASTASIS; SIGNATURE	Expression of glutathione peroxidase 3 (GPx3) is down-regulated in a variety of human malignancies. Both methylation and deletion of GPx3 gene underlie the alterations of GPx3 expression in prostate cancer. A strong correlation between the down-regulation of GPx3 expression and progression of prostate cancer and the suppression of prostate cancer xenografts in SCID mice by forced expression of GPx3 suggests a tumor suppression role of GPx3 in prostate cancer. However, the mechanism of GPx3-mediated tumor suppression remains unclear. In this report, GPx3 was found to interact directly with p53-induced gene 3 (PIG3). Forced overexpression of GPx3 in prostate cancer cell lines DU145 and PC3 as well as immortalized prostate epithelial cells RWPE-1 increased apoptotic cell death. Expression of GPx3(x73c), a peroxidase-negative OPAL codon mutant, in DU145 and PC3 cells also increased cell death. The induced expression of GPx3 in DU145 and PC3 cells resulted in an increase in reactive oxygen species and caspase-3 activity. These activities were abrogated by either knocking down PIG3 or mutating the PIG3 binding motif in GPx3 or binding interference from a peptide corresponding to PIG3 binding motif in GPx3. In addition, UV-treated RWPE-1 cells underwent apoptotic death, which was partially prevented by knocking down GPx3 or PIG3, suggesting that GPx3-PIG3 signaling is critical for UV-induced apoptosis. Taken together, these results reveal a novel signaling pathway of GPx3-PIG3 in the regulation of cell death in prostate cancer.	[Wang, Hui; Luo, Katherine; Tan, Lang-Zhu; Ren, Bao-Guo; Gu, Li-Qun; Michalopoulos, George; Luo, Jian-Hua; Yu, Yan P.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, YP (corresponding author), 3550 Terrace St,BST S423, Pittsburgh, PA 15261 USA.	ypyu@pitt.edu	Luo, jian/HGE-7331-2022; Yu, Yan/GYV-4514-2022		National Institutes of Health through NCI [R01 CA098249]; American Cancer Society [RSG-08-137-01-CNE]; NATIONAL CANCER INSTITUTE [R56CA098249, R01CA098249] Funding Source: NIH RePORTER	National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA098249 through the NCI (to J.-H. L.). This work was also supported by American Cancer Society Grant RSG-08-137-01-CNE (to Y. P. Y.).	Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Blomquist T, 2009, CANCER RES, V69, P8629, DOI 10.1158/0008-5472.CAN-09-1568; Brigelius-Flohe R, 2003, BIOFACTORS, V17, P93, DOI 10.1002/biof.5520170110; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brigelius-Flohe R, 2002, METHOD ENZYMOL, V347, P101; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Brown K M, 2001, Public Health Nutr, V4, P593; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Falck E, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-46; Flatt PM, 2000, CANCER LETT, V156, P63, DOI 10.1016/S0304-3835(00)00441-9; Giannattasio A, 2002, J ENDOCRINOL INVEST, V25, P983, DOI 10.1007/BF03344072; He YL, 2011, DIGEST DIS SCI, V56, P681, DOI 10.1007/s10620-010-1369-0; Karlsson S, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-12; Kho CW, 2006, BIOCHEM BIOPH RES CO, V348, P25, DOI 10.1016/j.bbrc.2006.06.067; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Lin JC, 2009, SURGERY, V145, P508, DOI 10.1016/j.surg.2008.12.008; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Muller C, 2003, BIOL CHEM, V384, P11, DOI 10.1515/BC.2003.002; Nomdedeu JF, 2008, LEUKEMIA RES, V32, P186, DOI 10.1016/j.leukres.2007.01.023; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Saga Y, 2008, ONCOL REP, V20, P1299, DOI 10.3892/or_00000144; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zhang X, 2010, INT J ONCOL, V36, P405, DOI 10.3892/ijo_00000513	33	46	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16890	16902		10.1074/jbc.M111.322636	http://dx.doi.org/10.1074/jbc.M111.322636			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22461624	hybrid, Green Published			2022-12-28	WOS:000304030900075
J	Hamard, PJ; Lukin, DJ; Manfredi, JJ				Hamard, Pierre-Jacques; Lukin, Dana J.; Manfredi, James J.			p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; TRANSCRIPTIONAL ACTIVITY; POSTTRANSLATIONAL MODIFICATIONS; APOPTOSIS; ISOFORMS; DAMAGE; PHOSPHORYLATION; ACETYLATION; ACTIVATION; DOMAIN	The p53 gene encodes a transcription factor that is composed of several functional domains: the N-terminal transactivation domain, the central sequence-specific DNA binding domain, the tetramerization domain, and the highly basic C-terminal regulatory domain (CTD). The p53 CTD is a nonspecific DNA binding domain that is subject to extensive post-translational modifications. However, the functional significance of the p53 CTD remains unclear. The role of this domain in the regulation of p53 functions is explored by comparing the activity of ectopically expressed wild-type (WT) p53 protein to that of a truncated mutant lacking the 24 terminal amino acids (Delta 24). Using quantitative real time PCR and chromatin Immuno-Precipitation experiments, a p53 CTD deletion is shown to alter the p53-dependent induction of a subset of its target genes due to impaired specific DNA binding. Moreover, p53-induced growth arrest and apoptosis both require an intact p53 CTD. These data indicate that the p53 CTD is a positive regulator of p53 tumor suppressor functions.	[Hamard, Pierre-Jacques; Lukin, Dana J.; Manfredi, James J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Manfredi, JJ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, Box 1130, New York, NY 10029 USA.	james.manfredi@mssm.edu	Hamard, Pierre-Jacques/B-7740-2015; Lukin, Dana/K-4820-2019	Hamard, Pierre-Jacques/0000-0002-2484-6161; Lukin, Dana/0000-0003-4581-2267	National Institutes of Health, NCI Grant [PO1 CA080058]; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health, NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI Grant PO1 CA080058 (to J.J.M.).	Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Appella E, 2000, PATHOL BIOL, V48, P227; ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Belyi VA, 2009, P NATL ACAD SCI USA, V106, P17609, DOI 10.1073/pnas.0910634106; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CHOW VTK, 1993, CANCER LETT, V73, P141, DOI 10.1016/0304-3835(93)90256-9; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Flaman JM, 1996, ONCOGENE, V12, P813; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kim H, 2012, J MOL BIOL, V415, P843, DOI 10.1016/j.jmb.2011.12.001; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu YG, 2004, CANCER BIOL THER, V3, P1102, DOI 10.4161/cbt.3.11.1189; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; PELLEGATA NS, 1995, ONCOGENE, V11, P337; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Wang YYV, 2011, GENE DEV, V25, P1426, DOI 10.1101/gad.2024411; WOLF D, 1984, MOL CELL BIOL, V4, P552, DOI 10.1128/MCB.4.3.552; Xiao G, 1998, ONCOGENE, V16, P1171, DOI 10.1038/sj.onc.1201631; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	60	28	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22397	22407		10.1074/jbc.M111.331298	http://dx.doi.org/10.1074/jbc.M111.331298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22514277	hybrid, Green Published			2022-12-28	WOS:000306418600076
J	Pempe, EH; Xu, YM; Gopalakrishnan, S; Liu, J; Harris, EN				Pempe, Elizabeth H.; Xu, Yongmei; Gopalakrishnan, Sandhya; Liu, Jian; Harris, Edward N.			Probing Structural Selectivity of Synthetic Heparin Binding to Stabilin Protein Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; MOLECULAR-WEIGHT HEPARINS; HYALURONAN RECEPTOR; DERMATAN SULFATE; EXPRESSION; CLEARANCE; 3-O-SULFOTRANSFERASE; SPECIFICITY; SITES	As one of the most widely used drugs worldwide, heparin is an essential anticoagulant required for surgery, dialysis, treatment of thrombosis, cancer, and general circulatory management. Stabilin-2 is a scavenger clearance receptor with high expression in the sinusoidal endothelium of liver. It is believed that Stabilin-2 is the primary receptor for the clearance of unfractionated and low molecular weight heparins in the liver. Here, we identify the modifications and length of the heparin polymer that are required for binding and endocytosis by both human Stabilin receptors: Stabilin-2 and its homolog Stabilin-1 (also found in liver endothelium). Using enzymatically synthesized S-35-labeled heparan sulfate oligomers, we identified that sulfation of the 3-OH position of N-sulfated glucosamine (GlcNS) is the most beneficial modification for binding and endocytosis via both Stabilin receptors. In addition, our data suggest that a decasaccharide is the minimal size for binding to the Stabilin receptors. These findings define the physical parameters of the heparin structure required for efficient clearance from blood circulation. These results will also aid in the design of synthetic heparins with desired clearance rates.	[Gopalakrishnan, Sandhya; Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Pempe, Elizabeth H.; Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill	Harris, EN (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	eharris5@unl.edu		Chappell, Elizabeth/0000-0003-4491-0631	National Institutes of Health [1R01HL094463, F31AG040927-01]; University of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HL094463 (to J. L.). This work was also supported by funds from the University of Nebraska (to E. N. H.).; A recipient of the Ruth L. Kirschstein National Research Service Award for Individuals Predoctoral Fellowships from the National Institutes of Health (F31AG040927-01).	ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Dinwoodey DL, 2006, CLIN GERIATR MED, V22, P1, DOI 10.1016/j.cger.2005.09.007; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; GOERDT S, 1993, AM J PATHOL, V142, P1409; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Jacobs LG, 2003, J AM GERIATR SOC, V51, P1472, DOI 10.1046/j.1532-5415.2003.51469.x; Kzhyshkowska J, 2005, IMMUNOBIOLOGY, V210, P161, DOI 10.1016/j.imbio.2005.05.022; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Oie CI, 2008, AM J PHYSIOL-GASTR L, V294, pG520, DOI 10.1152/ajpgi.00489.2007; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Richard B, 2009, J BIOL CHEM, V284, P27054, DOI 10.1074/jbc.M109.029892; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Tobu M, 2004, CLIN APPL THROMB-HEM, V10, P301, DOI 10.1177/107602960401000402; Verhaeghe R, 1998, ACTA CARDIOL, V53, P15; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Weitz JI, 2010, THROMB RES, V125, pS30, DOI 10.1016/S0049-3848(10)70009-8; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	42	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20774	20783		10.1074/jbc.M111.320069	http://dx.doi.org/10.1074/jbc.M111.320069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547069	Green Published, hybrid			2022-12-28	WOS:000306416800002
J	Seong, HA; Ha, H				Seong, Hyun-A; Ha, Hyunjung			Murine Protein Serine-threonine Kinase 38 Activates p53 Function through Ser(15) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Murine protein serine-threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family. In this study, we show that MPK38 physically associates with p53 via the carboxyl-terminal domain of MPK38 and the central DNA-binding domain of p53. This interaction is increased by 5-fluorouracil or doxorubicin treatment and is responsible for Ser(15) phosphorylation of p53. Ectopic expression of wild-type Mpk38, but not kinase-dead Mpk38, stimulates p53-mediated transcription in a dose-dependent manner and up-regulates p53 targets, including p53, p21, MDM2, and BAX. Consistently, knockdown of MPK38 shows an opposite trend, inhibiting p53-mediated transcription. MPK38 functionally enhances p53-mediated apoptosis and cell cycle arrest in a kinase-dependent manner by stimulating p53 nuclear translocation. We also demonstrate that MPK38-mediated p53 activation is induced by removing MDM2, a negative regulator of p53, from the p53-MDM2 complex as well as by stabilization of interaction between p53 and its positive regulators, including NM23-H1, serine/threonine kinase receptor-associated protein, and 14-3-3. This leads to the enhancement of p53 stability. Together, these results suggest that MPK38 may act as a novel regulator for promoting p53 activity through direct phosphorylation of p53 at Ser(15).	[Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			National Research Foundation of Korea [R0A-2007-000-20006-0]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chartrain I, 2006, BIOL CELL, V98, P253, DOI 10.1042/BC20050041; Chehab NH, 2000, GENE DEV, V14, P278; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Prives C, 1999, J PATHOL, V187, P112; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Stavridi ES, 2001, CANCER RES, V61, P7030; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200	42	35	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20797	20810		10.1074/jbc.M112.347757	http://dx.doi.org/10.1074/jbc.M112.347757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V32MR	22532570	hybrid, Green Published			2022-12-28	WOS:000208955800002
J	Nimlos, MR; Beckham, GT; Matthews, JF; Bu, LT; Himmel, ME; Crowley, MF				Nimlos, Mark R.; Beckham, Gregg T.; Matthews, James F.; Bu, Lintao; Himmel, Michael E.; Crowley, Michael F.			Binding Preferences, Surface Attachment, Diffusivity, and Orientation of a Family 1 Carbohydrate-binding Module on Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTORS INFLUENCING GLYCOSYLATION; TRICHODERMA-REESEI CELLULASES; GLYCOSIDE HYDROLASE FAMILY; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE-I; MOLECULAR-DYNAMICS; HYPOCREA-JECORINA; LIGNOCELLULOSIC BIOMASS; N-GLYCOSYLATION; CATALYTIC CORE	Cellulase enzymes often contain carbohydrate-binding modules (CBMs) for binding to cellulose. The mechanisms by which CBMs recognize specific surfaces of cellulose and aid in deconstruction are essential to understand cellulase action. The Family 1 CBM from the Trichoderma reesei Family 7 cellobiohydrolase, Cel7A, is known to selectively bind to hydrophobic surfaces of native cellulose. It is most commonly suggested that three aromatic residues identify the planar binding face of this CBM, but several recent studies have challenged this hypothesis. Here, we use molecular simulation to study the CBM binding orientation and affinity on hydrophilic and hydrophobic cellulose surfaces. Roughly 43 mu s of molecular dynamics simulations were conducted, which enables statistically significant observations. We quantify the fractions of the CBMs that detach from crystal surfaces or diffuse to other surfaces, the diffusivity along the hydrophobic surface, and the overall orientation of the CBM on both hydrophobic and hydrophilic faces. The simulations demonstrate that there is a thermodynamic driving force for the Cel7A CBM to bind preferentially to the hydrophobic surface of cellulose relative to hydrophilic surfaces. In addition, the simulations demonstrate that the CBM can diffuse from hydrophilic surfaces to the hydrophobic surface, whereas the reverse transition is not observed. Lastly, our simulations suggest that the flat faces of Family 1 CBMs are the preferred binding surfaces. These results enhance our understanding of how Family 1 CBMs interact with and recognize specific cellulose surfaces and provide insights into the initial events of cellulase adsorption and diffusion on cellulose.	[Nimlos, Mark R.; Beckham, Gregg T.; Bu, Lintao] Natl Renewable Energy Ctr, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Matthews, James F.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Ctr, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	Nimlos, MR (corresponding author), Natl Renewable Energy Ctr, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	mark.nimlos@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	Department of Energy Office of the Biomass; NSF Teragrid [MCB090159]	Department of Energy Office of the Biomass(United States Department of Energy (DOE)); NSF Teragrid(National Science Foundation (NSF))	This work was supported in part by the Department of Energy Office of the Biomass Program. Computer time was provided by the TACC Ranger cluster and the NICS Athena and Kraken clusters under NSF Teragrid Grant MCB090159.	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hall M, 2011, BIORESOURCE TECHNOL, V102, P2910, DOI 10.1016/j.biortech.2010.11.010; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Helbert W, 1998, J STRUCT BIOL, V124, P42, DOI 10.1006/jsbi.1998.4045; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horikawa Y, 2006, CELLULOSE, V13, P309, DOI 10.1007/s10570-005-9037-9; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KOTTALAM J, 1988, J AM CHEM SOC, V110, P7690, DOI 10.1021/ja00231a018; Koyama M, 1997, CELLULOSE, V4, P147, DOI 10.1023/A:1018427604670; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lantz SE, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-20; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Matthews JF, 2012, J CHEM THEORY COMPUT, V8, P735, DOI 10.1021/ct2007692; Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Newman RH, 1998, HOLZFORSCHUNG, V52, P157, DOI 10.1515/hfsg.1998.52.2.157; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2009, J WOOD SCI, V55, P241, DOI 10.1007/s10086-009-1029-1; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; REESE ET, 1976, BIOTECHNOL BIOENG, P9; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Tavagnacco L, 2011, CARBOHYD RES, V346, P839, DOI 10.1016/j.carres.2011.01.019; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007	67	67	67	0	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20603	20612		10.1074/jbc.M112.358184	http://dx.doi.org/10.1074/jbc.M112.358184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496371	Green Published, hybrid			2022-12-28	WOS:000306414500080
J	Zheng, Z; Jia, JL; Bou, G; Hu, LL; Wang, ZD; Shen, XH; Shan, ZY; Shen, JL; Liu, ZH; Lei, L				Zheng, Zhong; Jia, Jia-Lin; Bou, Gerelchimeg; Hu, Li-Li; Wang, Zhen-Dong; Shen, Xing-Hui; Shan, Zhi-Yan; Shen, Jing-Ling; Liu, Zhong-Hua; Lei, Lei			rRNA Genes Are Not Fully Activated in Mouse Somatic Cell Nuclear Transfer Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACYTOPLASMIC SPERM INJECTION; BOVINE OOCYTE GROWTH; CLONING EFFICIENCY; POLYMERASE-I; STEM-CELLS; RDNA TRANSCRIPTION; NUCLEOLAR PROTEINS; MEIOTIC MATURATION; MICE; INHIBITION	The well known and most important function of nucleoli is ribosome biogenesis. However, the nucleolus showed delayed development and malfunction in somatic cell nuclear transfer (NT) embryos. Previous studies indicated that nearly half rRNA genes (rDNA) in somatic cells were inactive and not transcribed. We compared the rDNA methylation level, active nucleolar organizer region (NORs) numbers, nucleolar proteins (upstream binding factor (UBF), nucleophosmin (B23)) distribution, and nucleolar-related gene expression in three different donor cells and NT embryos. The results showed embryonic stem cells (ESCs) had the most active NORs and lowest rDNA methylation level (7.66 and 6.76%), whereas mouse embryonic fibroblasts (MEFs) were the opposite (4.70 and 22.57%). After the donor cells were injected into enucleated MII oocytes, cumulus cells and MEFs nuclei lost B23 and UBF signals in 20 min, whereas in ESC-NT embryos, B23 and UBF signals could still be detected at 60 min post-NT. The embryos derived from ESCs, cumulus cells, and MEFs showed the same trend in active NORs numbers (7.19 versus 6.68 versus 5.77, p < 0.05) and rDNA methylation levels (6.36 versus 9.67% versus 15.52%) at the 4-cell stage as that in donor cells. However, the MEF-NT embryos displayed low rRNA synthesis/processing potential at morula stage and had an obvious decrease in blastocyst developmental rate. The results presented clear evidences that the rDNA reprogramming efficiency in NT embryos was determined by the rDNA activity in donor cells from which they derived.	[Zheng, Zhong; Jia, Jia-Lin; Hu, Li-Li; Wang, Zhen-Dong; Shen, Xing-Hui; Shan, Zhi-Yan; Shen, Jing-Ling; Lei, Lei] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China; [Bou, Gerelchimeg; Liu, Zhong-Hua] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China	Harbin Medical University; Northeast Agricultural University - China	Lei, L (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China.	leil086@yahoo.com.cn	Liu, Zhunghua/F-2485-2010; Shen, Xinghui/ABF-9560-2021	Liu, Zhunghua/0000-0002-9199-6493; Zheng, Zhong/0000-0001-5961-2122; Lei, Lei/0000-0001-5372-8749	State Key Development Program of Basic Research of China [2012CBA01303]; Harbin Medical University Graduate Student [HCXB2010005]	State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); Harbin Medical University Graduate Student	This work was supported by grants from the State Key Development Program of Basic Research of China (2012CBA01303) and the Innovative Fund of Harbin Medical University Graduate Student (HCXB2010005).	Araki Y, 2004, ZYGOTE, V12, P111, DOI 10.1017/S0967199404002606; Baran V, 2004, BIOL REPROD, V70, P877, DOI 10.1095/biolreprod.103.018408; Baran V, 2003, ZYGOTE, V11, P271, DOI 10.1017/S0967199403002326; Baran V, 2002, BIOL REPROD, V66, P534, DOI 10.1095/biolreprod66.2.534; Bjerregaard B, 2004, BIOL REPROD, V70, P925, DOI 10.1095/biolreprod.103.020941; Bjerregaard B, 2007, MOL REPROD DEV, V74, P35, DOI 10.1002/mrd.20594; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; DEV VG, 1977, GENETICS, V86, P389; DYBAN AP, 1990, CELL DIFFER DEV, V29, P165, DOI 10.1016/0922-3371(90)90119-H; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fair T, 2001, BIOL REPROD, V64, P1516, DOI 10.1095/biolreprod64.5.1516; Gao SR, 2003, CLONING STEM CELLS, V5, P287, DOI 10.1089/153623003772032790; GEUSKENS M, 1984, CELL DIFFER DEV, V14, P125, DOI 10.1016/0045-6039(84)90037-X; Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Bui HT, 2011, BIOL REPROD, V85, P1048, DOI 10.1095/biolreprod.110.089474; Hu LL, 2012, ZYGOTE, V20, P361, DOI 10.1017/S0967199411000438; JEAN P, 1983, ANAT REC, V205, P375, DOI 10.1002/ar.1092050402; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; Kato Y, 2010, INT J DEV BIOL, V54, P1623, DOI 10.1387/ijdb.103203yk; KING WA, 1988, J REPROD FERTIL, V82, P87, DOI 10.1530/jrf.0.0820087; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; KOPECNY V, 1989, Molecular Reproduction and Development, V1, P79; Korobova F. V., 2004, Ontogenez, V35, P336; KURIHARA Y, 1994, MAMM GENOME, V5, P225, DOI 10.1007/BF00360550; Laurincik J, 2002, MOL REPROD DEV, V61, P477, DOI 10.1002/mrd.10109; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Maddox-Hyttel P, 2007, THERIOGENOLOGY, V68, pS63, DOI 10.1016/j.theriogenology.2007.03.015; Maddox-Hyttel P, 2005, REPROD FERT DEVELOP, V17, P3, DOI 10.1071/RD04108; MAMAEVA SE, 1985, CANCER GENET CYTOGEN, V16, P199, DOI 10.1016/0165-4608(85)90046-9; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; ROUSSEL P, 1993, J CELL SCI, V104, P327; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; SCHULTZ RM, 1977, J CELL SCI, V24, P167; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Su GH, 2000, CANCER RES, V60, P3137; Suzuki T, 2007, J REPROD DEVELOP, V53, P663, DOI 10.1262/jrd.19014; Svarcova O, 2009, MOL REPROD DEV, V76, P132, DOI 10.1002/mrd.20936; Tesarik J, 2002, FERTIL STERIL, V78, P619, DOI 10.1016/S0015-0282(02)03291-0; Tsunoda Yukio, 2003, Nihon Rinsho, V61, P406; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; WEISENBERGER D, 1995, J CELL BIOL, V129, P561, DOI 10.1083/jcb.129.3.561; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	56	18	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19949	19960		10.1074/jbc.M112.355099	http://dx.doi.org/10.1074/jbc.M112.355099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22467869	Green Published, hybrid			2022-12-28	WOS:000306414500017
J	Li, ZH; De Gaudenzi, JG; Alvarez, VE; Mendiondo, N; Wang, HM; Kissinger, JC; Frasch, AC; Docampo, R				Li, Zhu-Hong; De Gaudenzi, Javier G.; Alvarez, Vanina E.; Mendiondo, Nicolas; Wang, Haiming; Kissinger, Jessica C.; Frasch, Alberto C.; Docampo, Roberto			A 43-Nucleotide U-rich Element in 3 '-Untranslated Region of Large Number of Trypanosoma cruzi Transcripts Is Important for mRNA Abundance in Intracellular Amastigotess	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; AU-RICH; BINDING PROTEINS; TRANS-SIALIDASE; GENOME; FAMILY; SEQUENCE; LIFE; TRYPOMASTIGOTE; IDENTIFICATION	Trypanosoma cruzi, the agent of Chagas disease, does not seem to control gene expression through regulation of transcription initiation and makes use of post-transcriptional mechanisms. We report here a 43-nt U-rich RNA element located in the 3'-untranslated region (3'-UTR) of a large number of T. cruzi mRNAs that is important for mRNA abundance in the intracellular amastigote stage of the parasite. Whole genome scan analysis, differential display RT-PCR, Northern blot, and RT-PCR analyses were used to determine the transcript levels of more than 900 U-rich-containing mRNAs of large gene families as well as single and low copy number genes. Our results indicate that the 43-nt U-rich mRNA element is preferentially present in amastigotes. The cis-element of a protein kinase 3'-UTR but not its mutated version promoted the expression of the green fluorescent protein reporter gene in amastigotes. The regulatory cis-element, but not its mutated version, was also shown to interact with the trypanosome-specific RNA-binding protein (RBP) TcUBP1 but not with other related RBPs. Co-immunoprecipitation experiments of TcUBP1-containing ribonucleoprotein complexes formed in vivo validated the interaction with representative endogenous RNAs having the element. These results suggest that this 43-nt U-rich element together with other yet unidentified sequences might be involved in the modulation of abundance and/or translation of subsets of transcripts in the amastigote stage.	[Li, Zhu-Hong; Wang, Haiming; Kissinger, Jessica C.; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [De Gaudenzi, Javier G.; Alvarez, Vanina E.; Mendiondo, Nicolas; Frasch, Alberto C.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 350B Paul D Coverdell Ctr,500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu	Kissinger, Jessica/M-9920-2019; Kissinger, Jessica C/E-9610-2010	Kissinger, Jessica/0000-0002-6413-1101; Kissinger, Jessica C/0000-0002-6413-1101; Alvarez, Vanina/0000-0002-9890-6980; Frasch, Alberto Carlos/0000-0001-7532-653X	National Institutes of Health [R01AI-068647, D43TW-07888, D43TW-07820]; Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Consejo Nacional de Investigaciones Clentificas y Tecnicas; FOGARTY INTERNATIONAL CENTER [D43TW007888, R03TW007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Clentificas y Tecnicas; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI-068647, D43TW-07888, and D43TW-07820 (to R. D.). Work at the Frasch laboratory was supported in part by an international scholarship from the Howard Hughes Medical Institute, Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to A. C. F. and J. G. D. G.) and Consejo Nacional de Investigaciones Clentificas y Tecnicas (to J. G. D. G.).	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartholomeu DC, 2009, NUCLEIC ACIDS RES, V37, P3407, DOI 10.1093/nar/gkp172; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hendriks E, 2007, TRYPANOSOMES GENOME, P209; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jager AV, 2008, FEMS MICROBIOL LETT, V283, P182, DOI 10.1111/j.1574-6968.2008.01170.x; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Mao Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-355; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Nardelli SC, 2007, EUKARYOT CELL, V6, P337, DOI 10.1128/EC.00279-06; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264	52	17	17	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19058	19069		10.1074/jbc.M111.338699	http://dx.doi.org/10.1074/jbc.M111.338699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500021	Green Published, hybrid			2022-12-28	WOS:000306411900017
J	Shimizu, T; Lin, FQ; Hasegawa, M; Okada, K; Nojiri, H; Yamane, H				Shimizu, Takafumi; Lin, Fengqiu; Hasegawa, Morifumi; Okada, Kazunori; Nojiri, Hideaki; Yamane, Hisakazu			Purification and Identification of Naringenin 7-O-Methyltransferase, a Key Enzyme in Biosynthesis of Flavonoid Phytoalexin Sakuranetin in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DITERPENE PHYTOALEXIN; FLAVANONE PHYTOALEXIN; METHYLTRANSFERASE; PROTEINS; LEAVES; CELLS; ACID	Sakuranetin, the major flavonoid phytoalexin in rice, is induced by ultraviolet (UV) irradiation, CuCl2 treatment, jasmonic acid treatment, and infection by phytopathogens. It was recently demonstrated that sakuranetin has anti-inflammatory activity, anti-mutagenic activity, anti-pathogenic activities against Helicobacter pylori, Leishmania, and Trypanosoma and contributes to the maintenance of glucose homeostasis in animals. Thus, sakuranetin is a useful compound as a plant antibiotic and a potential pharmaceutical agent. Sakuranetin is biosynthesized from naringenin by naringenin 7-O-methyltransferase (NOMT). In previous research, rice NOMT (OsNOMT) was purified to apparent homogeneity from UV-treated wild-type rice leaves, but the purified protein, named OsCOMT1, exhibited caffeic acid O-methyltransferase (COMT) activity and not NOMT activity. In this study, we found that OsCOMT1 does not contribute to sakuranetin production in rice in vivo, and we purified OsNOMT using the oscomt1 mutant. A crude protein preparation from UV-treated oscomt1 leaves was subjected to three sequential purification steps, resulting in a 400-fold purification from the crude enzyme preparation. Using SDS-PAGE, the purest enzyme preparation showed a minor band at an apparent molecular mass of 40 kDa. Two O-methyltransferase-like proteins, encoded by Os04g0175900 and Os12g0240900, were identified from the 40-kDa band by MALDI-TOF/TOF analysis. Recombinant Os12g0240900 protein showed NOMT activity, but the recombinant Os04g0175900 protein did not. Os12g0240900 expression was induced by jasmonic acid treatment in rice leaves prior to sakuranetin accumulation, and the Os12g0240900 protein showed reasonable kinetic properties to OsNOMT. On the basis of these results, we conclude that Os12g0240900 encodes an OsNOMT.	[Shimizu, Takafumi; Lin, Fengqiu; Okada, Kazunori; Nojiri, Hideaki; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Morifumi] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	University of Tokyo; Ibaraki University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Hasegawa, Morifumi/G-6053-2011; Shimizu, Takafumi/C-4123-2017	Hasegawa, Morifumi/0000-0001-9829-2811; Shimizu, Takafumi/0000-0003-4372-1337; Nojiri, Hideaki/0000-0003-3091-8691	Program for Promotion of Basic Research Activities for Innovative Biosciences	Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; Asahina Y., 1908, ARCH PHARM, V246, P259, DOI 10.1002/ardp.19082460404.; ATTIEH JM, 1995, J BIOL CHEM, V270, P9250, DOI 10.1074/jbc.270.16.9250; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Christensen AB, 1998, PLANT MOL BIOL, V36, P219, DOI 10.1023/A:1005985609313; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Grecco SD, 2012, EXP PARASITOL, V130, P141, DOI 10.1016/j.exppara.2011.11.002; HARBORNE JB, 1999, PHYTOCHEMICAL DICT H, P976; Horinouchi S, 2009, CURR OPIN CHEM BIOL, V13, P197, DOI 10.1016/j.cbpa.2009.02.004; Kanno H, 2012, APPL ENTOMOL ZOOL, V47, P27, DOI 10.1007/s13355-011-0085-3; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1973, TETRAHEDRON LETT, P3861; Kim BG, 2006, J AGR FOOD CHEM, V54, P823, DOI 10.1021/jf0522715; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; KOGA H, 1994, CAN J BOT, V72, P1463, DOI 10.1139/b94-180; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; Lin FQ, 2006, J PESTIC SCI, V31, P47, DOI 10.1584/jpestics.31.47; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Miyazawa M, 2003, J FOOD SCI, V68, P52, DOI 10.1111/j.1365-2621.2003.tb14113.x; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Plowright RA, 1996, NEMATOLOGICA, V42, P564, DOI 10.1163/004625996X00063; Rakwal R, 2000, PLANT SCI, V155, P213, DOI 10.1016/S0168-9452(00)00223-5; Rakwal R, 1996, BIOCHEM BIOPH RES CO, V222, P732, DOI 10.1006/bbrc.1996.0812; Saito T, 2008, BIOCHEM BIOPH RES CO, V372, P835, DOI 10.1016/j.bbrc.2008.05.146; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yajima A, 2000, EUR J ORG CHEM, V2000, P4079; Zhang L, 2008, PROTEIN SCI, V17, P1971, DOI 10.1110/ps.036186.108; Zhang XF, 2006, ARCH PHARM RES, V29, P1102, DOI 10.1007/BF02969299	33	70	76	11	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19315	19325		10.1074/jbc.M112.351270	http://dx.doi.org/10.1074/jbc.M112.351270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22493492	Green Published, hybrid			2022-12-28	WOS:000306411900041
J	Suhasini, AN; Sommers, JA; Yu, S; Wu, YL; Xu, T; Kelman, Z; Kaplan, DL; Brosh, RM				Suhasini, Avvaru N.; Sommers, Joshua A.; Yu, Stephen; Wu, Yuliang; Xu, Ting; Kelman, Zvi; Kaplan, Daniel L.; Brosh, Robert M., Jr.			DNA Repair and Replication Fork Helicases Are Differentially Affected by Alkyl Phosphotriester Lesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINYLPHOSPHONATE INTERNUCLEOTIDE LINKAGES; WERNER-SYNDROME PROTEIN; ESCHERICHIA-COLI RECQ; MCM HELICASE; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; BLOOMS-SYNDROME; FANCJ HELICASE; DAMAGED DNA; UVRD	DNA helicases are directly responsible for catalytically unwinding duplex DNA in an ATP-dependent and directionally specific manner and play essential roles in cellular nucleic acid metabolism. It has been conventionally thought that DNA helicases are inhibited by bulky covalent DNA adducts in a strand-specific manner. However, the effects of highly stable alkyl phosphotriester (PTE) lesions that are induced by chemical mutagens and refractory to DNA repair have not been previously studied for their effects on helicases. In this study, DNA repair and replication helicases were examined for unwinding a forked duplex DNA substrate harboring a single isopropyl PTE specifically positioned in the helicase-translocating or -nontranslocating strand within the double-stranded region. A comparison of SF2 helicases (RecQ, RECQ1, WRN, BLM, FANCJ, and ChlR1) with a SF1 DNA repair helicase (UvrD) and two replicative helicases(MCM and DnaB) demonstrates unique differences in the effect of the PTE on the DNA unwinding reactions catalyzed by these enzymes. All of the SF2 helicases tested were inhibited by the PTE lesion, whereas UvrD and the replication fork helicases were fully tolerant of the isopropyl backbone modification, irrespective of strand. Sequestration studies demonstrated that RECQ1 helicase was trapped by the PTE lesion only when it resided in the helicase-translocating strand. Our results are discussed in light of the current models for DNA unwinding by helicases that are likely to encounter sugar phosphate backbone damage during biological DNA transactions.	[Suhasini, Avvaru N.; Sommers, Joshua A.; Yu, Stephen; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Xu, Ting] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Kelman, Zvi] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Xu, Ting/A-3296-2012	Kaplan, Daniel/0000-0003-2760-7745	National Institutes of Health Intramural Research Program of NIA; NIDDK; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [ZIAAG000752, ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NIA; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health Intramural Research Program of NIA and NIDDK. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Aygun O, 2010, DNA REPAIR, V9, P345, DOI 10.1016/j.dnarep.2009.12.008; Bertram RD, 2002, BIOCHEMISTRY-US, V41, P7725, DOI 10.1021/bi025755s; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Forsburg SL, 2008, BIOCHEM SOC T, V36, P114, DOI 10.1042/BST0360114; Garcia PL, 2004, NUCLEIC ACIDS RES, V32, P3771, DOI 10.1093/nar/gkh709; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jones GDD, 2010, MUTAGENESIS, V25, P3, DOI 10.1093/mutage/gep038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lu XC, 2011, J MOL CELL BIOL, V3, P31, DOI 10.1093/jmcb/mjq056; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shin JH, 2009, J BIOL CHEM, V284, P540, DOI 10.1074/jbc.M806803200; Sontz PA, 2012, P NATL ACAD SCI USA, V109, P1856, DOI 10.1073/pnas.1120063109; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yashiki T, 1992, Nucleic Acids Symp Ser, P197; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	52	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19188	19198		10.1074/jbc.M112.352757	http://dx.doi.org/10.1074/jbc.M112.352757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500020	Green Published, hybrid			2022-12-28	WOS:000306411900029
J	Barthel, D; Schindler, S; Zipfel, PF				Barthel, Diana; Schindler, Susann; Zipfel, Peter F.			Plasminogen Is a Complement Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H FAMILY PROTEINS; BORRELIA-BURGDORFERI; BINDING-PROTEIN; HUMAN-DISEASES; STREPTOCOCCUS-PNEUMONIAE; THROMBIN GENERATION; CANDIDA-ALBICANS; SURFACE PROTEIN; IMMUNE EVASION; 2 PARTS	Plasminogen is a 92-kDa single chain glycoprotein that circulates in plasma as a zymogen and when converted to proteolytically active plasmin dissolves preformed fibrin clots and extracellular matrix components. Here, we characterize the role of plasmin(ogen) in the complement cascade. Plasminogen binds the central complement protein C3, the C3 cleavage products C3b and C3d, and C5. Plasminogen binds to C3, C3b, C3d, and C5 via lysine residues, and the interaction is ionic strength-dependent. Plasminogen and Factor Factor H bind C3b; however, the two proteins bind to different sites and do not compete for binding. Plasminogen affects complement action in multiple ways. Plasminogen enhanced Factor I-mediated C3b degradation in the presence of the cofactor Factor H. Plasminogen when activated to plasmin inhibited complement as demonstrated by hemolytic assays using either rabbit or sheep erythrocytes. Similarly, plasmin either in the fluid phase or attached to surfaces inhibited complement that was activated via the alternative and classical pathways and cleaved C3b to fragments of 68, 40, 30, and 17 kDa. The C3b fragments generated by plasmin differ in size from those generated by the complement protease Factor I, suggesting that plasmin-mediated C3b cleavage fragments lack effector function. Plasmin also cleaved C5 to products of 65, 50, 30, and 25 kDa. Thus, plasmin(ogen) regulates both complement and coagulation, the two central cascade systems of a vertebrate organism. This complement-inhibitory activity of plasmin provides a new explanation why pathogenic microbes utilize plasmin(ogen) for immune evasion and tissue penetration.	[Barthel, Diana; Schindler, Susann; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Friedrich Schiller Univ, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenbergstr 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann SN, 2004, INDIAN J MED RES, V119, P29; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2006, WIEN KLIN WOCHENSCHR, V118, P669, DOI 10.1007/s00508-006-0691-1; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2000, METHODS, V21, P125, DOI 10.1006/meth.2000.0983; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; LASSER EC, 1979, AM J ROENTGENOL, V132, P171, DOI 10.2214/ajr.132.2.171; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; MIYASHITA C, 1988, Haemostasis, V18, P7; MOROZ LA, 1976, BLOOD, V48, P531; Myohanen H, 2004, CELL MOL LIFE SCI, V61, P2840, DOI 10.1007/s00018-004-4230-9; Peerschke EIB, 2008, ADV EXP MED BIOL, V632, P81, DOI 10.1007/978-0-387-78952-1_7; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; PILLEMER L, 1953, J EXP MED, V97, P573, DOI 10.1084/jem.97.4.573; POLLEY MJ, 1978, J EXP MED, V147, P1713, DOI 10.1084/jem.147.6.1713; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Seling A, 2010, INFECT IMMUN, V78, P39, DOI 10.1128/IAI.00691-09; SEYA T, 1985, Complement, V2, P165; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; SOTTRUPJENSEN L, 1975, P NATL ACAD SCI USA, V72, P2577, DOI 10.1073/pnas.72.7.2577; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TAYLOR FB, 1967, J EXP MED, V126, P149, DOI 10.1084/jem.126.1.149; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189; WEBER S, 1995, J BACTERIOL, V177, P11, DOI 10.1128/jb.177.1.11-19.1995; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2007, ADV EXP MED BIOL, V598, P80; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	54	120	120	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18831	18842		10.1074/jbc.M111.323287	http://dx.doi.org/10.1074/jbc.M111.323287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22451663	Green Published, hybrid			2022-12-28	WOS:000306411600091
J	Huang, ZP; Wang, YL; Nayak, PS; Dammann, CE; Sanchez-Esteban, J				Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Dammann, Christiane E.; Sanchez-Esteban, Juan			Stretch-induced Fetal Type II Cell Differentiation Is Mediated via ErbB1-ErbB4 Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ERBB SIGNALING NETWORK; RAT LUNG FIBROBLASTS; EGF-RECEPTOR; MICE LACKING; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; MECHANICAL FORCES; EPITHELIAL-CELLS; TGF-ALPHA	Stretch-induced differentiation of lung fetal type II epithelial cells is mediated through EGFR (ErbB1) via release of HB-EGF and TGF-alpha ligands. Employing an EGFR knock-out mice model, we further investigated the role of the ErbB family of receptors in mechanotranduction during lung development. Deletion of EGFR prevented endogenous and mechanical stretch-induced type II cell differentiation via the ERK pathway, which was rescued by overexpression of a constitutively active MEK. Interestingly, the expression of ErbB4, the only ErbB receptor that EGFR co-precipitates in wild-type cells, was decreased in EGFR-deficient type II cells. Similar to EGFR, ErbB4 was activated by stretch and participated in ERK phosphorylation and type II cell differentiation. However, neuregulin (NRG) or stretch-induced ErbB4 activation were blunted in EGFR-deficient cells and not rescued after ErbB4 overexpression, suggesting that induction of ErbB4 phosphorylation is EGFR-dependent. Finally, we addressed how shedding of ligands is regulated by EGFR. In knock-out cells, TGF-alpha, a ligand for EGFR, was not released by stretch, while HB-EGF, a ligand for EGFR and ErbB4, was shed by stretch although to a lower magnitude than in normal cells. Release of these ligands was inhibited by blocking EGFR and ERK pathway. In conclusion, our studies show that EGFR and ErbB4 regulate stretch-induced type II cell differentiation via ERK pathway. Interactions between these two receptors are important for mechanical signals in lung fetal type II cells. These studies provide novel insights into the cell signaling mechanisms regulating ErbB family receptors in lung cell differentiation.	[Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Sanchez-Esteban, Juan] Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02905 USA; [Huang, Zheping; Wang, Yulian; Nayak, Pritha S.; Sanchez-Esteban, Juan] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Dammann, Christiane E.] Floating Hosp Children, Tufts Med Ctr, Div Newborn Med, Boston, MA 02111 USA	Women & Infants Hospital Rhode Island; Brown University; Floating Hospital For Children; Tufts Medical Center	Sanchez-Esteban, J (corresponding author), Women & Infants Hosp Rhode Isl, Dept Pediat, 101 Dudley Str, Providence, RI 02905 USA.	jsanchezesteban@wihri.org			National Institutes of Health [R01 HD052670, P20 RR018728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052670] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD052670 (to J. S.-E.) and P20 RR018728.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; GOLDSTEIN JD, 1980, J PEDIATR-US, V97, P282, DOI 10.1016/S0022-3476(80)80496-3; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Harding R., 1997, LUNG SCI FDN, P2093; Joe P, 1997, AM J PHYSIOL-LUNG C, V272, pL95, DOI 10.1152/ajplung.1997.272.1.L95; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu MY, 2000, J APPL PHYSIOL, V89, P2078, DOI 10.1152/jappl.2000.89.5.2078; Liu W, 2007, BBA-MOL BASIS DIS, V1772, P737, DOI 10.1016/j.bbadis.2007.04.008; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; MOESSINGER AC, 1990, J CLIN INVEST, V86, P1270, DOI 10.1172/JCI114834; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Purevdorj E, 2008, AM J PHYSIOL-LUNG C, V294, pL516, DOI 10.1152/ajplung.00423.2007; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Esteban J, 2006, AM J PHYSIOL-LUNG C, V290, pL343, DOI 10.1152/ajplung.00189.2005; Sanchez-Esteban J, 1998, AM J MED SCI, V316, P200, DOI 10.1097/00000441-199809000-00009; Sanchez-Esteban J, 2004, AM J RESP CELL MOL, V30, P76, DOI 10.1165/rcmb.2003-0121OC; Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; SCARPELLI EM, 1975, PEDIATR RES, V9, P190, DOI 10.1203/00006450-197504000-00010; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Torday JS, 1998, AM J MED SCI, V316, P205, DOI 10.1097/00000441-199809000-00010; Wang YL, 2006, AM J PHYSIOL-LUNG C, V291, pL820, DOI 10.1152/ajplung.00068.2006; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899; WIGGLESWORTH JS, 1979, EARLY HUM DEV, V3, P51, DOI 10.1016/0378-3782(79)90020-3; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zscheppang K, 2007, AM J PHYSIOL-LUNG C, V293, pL429, DOI 10.1152/ajplung.00451.2006; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	44	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18091	18102		10.1074/jbc.M111.313163	http://dx.doi.org/10.1074/jbc.M111.313163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493501	hybrid, Green Published			2022-12-28	WOS:000306411600018
J	Shin, I; Percudani, R; Rhee, S				Shin, Inchul; Percudani, Riccardo; Rhee, Sangkee			Structural and Functional Insights into (S)-Ureidoglycine Aminohydrolase, Key Enzyme of Purine Catabolism in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY; ALLANTOINASE; DEGRADATION; BIOSYNTHESIS; MECHANISM; REVEALS; SYSTEM; SUITE	The ureide pathway has recently been identified as the metabolic route of purine catabolism in plants and some bacteria. In this pathway, uric acid, which is a major product of the early stage of purine catabolism, is degraded into glyoxylate and ammonia via stepwise reactions of seven different enzymes. Therefore, the pathway has a possible physiological role in mobilization of purine ring nitrogen for further assimilation. (S)-Ureidoglycine aminohydrolase enzyme converts (S)-ureidoglycine into (S)-ureidoglycolate and ammonia, providing the final substrate to the pathway. Here, we report a structural and functional analysis of this enzyme from Arabidopsis thaliana (AtUGlyAH). The crystal structure of AtUGlyAH in the ligand-free form shows a monomer structure in the bicupin fold of the beta-barrel and an octameric functional unit as well as a Mn2+ ion binding site. The structure of AtUGlyAH in complex with (S)-ureidoglycine revealed that the Mn2+ ion acts as a molecular anchor to bind (S)-ureidoglycine, and its binding mode dictates the enantioselectivity of the reaction. Further kinetic analysis characterized the functional roles of the active site residues, including the Mn2+ ion binding site and residues in the vicinity of (S)-ureidoglycine. These analyses provide molecular insights into the structure of the enzyme and its possible catalytic mechanism.	[Shin, Inchul; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy	Seoul National University (SNU); Seoul National University (SNU); University of Parma	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008059]; Rural Development Administration; National Research Foundation [R11-2008-062-01002-0, 2010-0025883]; Ministry of Education, Science, and Technology, Republic of Korea	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008059), Rural Development Administration, and from National Research Foundation (R11-2008-062-01002-0 and 2010-0025883) funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Atkins C, 2000, PROKARYOTIC NITROGEN FIXATION, P559; Boldt R, 2003, PHYSIOL PLANTARUM, V117, P297, DOI 10.1034/j.1399-3054.2003.00030.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; French JB, 2010, J BIOL CHEM, V285, P35446, DOI 10.1074/jbc.M110.156034; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kamat SS, 2011, BIOCHEMISTRY-US, V50, P1917, DOI 10.1021/bi101788n; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Lamberto I, 2010, PLANT CELL, V22, P1564, DOI 10.1105/tpc.109.070102; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Muratsubaki H, 2006, ANAL BIOCHEM, V359, P161, DOI 10.1016/j.ab.2006.09.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; SGRAVENMADE EJ, 1970, BIOCHIM BIOPHYS ACTA, V198, P569, DOI 10.1016/0005-2744(70)90134-8; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Werner AK, 2011, TRENDS PLANT SCI, V16, P381, DOI 10.1016/j.tplants.2011.03.012; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18796	18805		10.1074/jbc.M111.331819	http://dx.doi.org/10.1074/jbc.M111.331819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493446	Green Published, hybrid			2022-12-28	WOS:000306411600088
J	Lu, DM; Sun, HQ; Wang, HZ; Barylko, B; Fukata, Y; Fukata, M; Albanesi, JP; Yin, HL				Lu, Dongmei; Sun, Hui-qiao; Wang, Hanzhi; Barylko, Barbara; Fukata, Yuko; Fukata, Masaki; Albanesi, Joseph P.; Yin, Helen L.			Phosphatidylinositol 4-Kinase II alpha Is Palmitoylated by Golgi-localized Palmitoyltransferases in Cholesterol-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; FAMILY; MEMBRANE; TRANSFERASES; ENZYMES; PSD-95; CELLS; YEAST; IDENTIFICATION; COMPARTMENTS	Phosphatidylinositol 4-kinase II alpha (PI4KII alpha) is predominantly Golgi-localized, and it generates >50% of the phosphatidylinositol 4-phosphate in the Golgi. The lipid kinase activity, Golgi localization, and "integral" membrane binding of PI4KII alpha and its association with low buoyant density "raft" domains are critically dependent on palmitoylation of its cysteine-rich (CCPCC177)-C-173 motif and are also highly cholesterol-dependent. Here, we identified the palmitoyl acyltransferases (Asp-His-His-Cys (DHHC) PATs) that palmitoylate PI4KII alpha and show for the first time that palmitoylation is cholesterol-dependent. DHHC3 and DHHC7 PATs, which robustly palmitoylated PI4KII alpha and were colocalized with PI4KII alpha in the trans-Golgi network (TGN), were characterized in detail. Overexpression of DHHC3 or DHHC7 increased PI4KII alpha palmitoylation by >3-fold, whereas overexpression of the dominant-negative PATs or PAT silencing by RNA interference decreased PI4KII alpha palmitoylation, "integral" membrane association, and Golgi localization. Wild-type and dominant-negative DHHC3 and DHHC7 co-immunoprecipitated with PI4KII alpha, whereas non-candidate DHHC18 and DHHC23 did not. The PI4KII alpha (CCPCC177)-C-173 palmitoylation motif is required for interaction because the palmitoylation-defective SSPSS mutant did not co-immunoprecipitate with DHHC3. Cholesterol depletion and repletion with methyl-beta-cyclodextrin reversibly altered PI4KII alpha association with these DHHCs as well as PI4KII alpha localization at the TGN and "integral" membrane association. Significantly, the Golgi phosphatidylinositol 4-phosphate level was altered in parallel with changes in PI4KII alpha behavior. Our study uncovered a novel mechanism for the preferential recruitment and activation of PI4KII alpha to the TGN by interaction with Golgi- and raft-localized DHHCs in a cholesterol-dependent manner.	[Lu, Dongmei; Sun, Hui-qiao; Wang, Hanzhi; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Barylko, Barbara; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fukata, Yuko; Fukata, Masaki] Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yin, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643	National Institutes of Health [R01 GM66110, P50 GM21681, GM75401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066110, R01GM075401, P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM66110 and P50 GM21681 (to H. L. Y.) and GM75401 (to J. P. A.).	Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Santiago-Tirado FH, 2011, DEV CELL, V20, P47, DOI 10.1016/j.devcel.2010.11.006; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waugh MG, 2011, J LIPID RES, V52, P582, DOI 10.1194/jlr.D012807; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	42	60	63	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21856	21865		10.1074/jbc.M112.348094	http://dx.doi.org/10.1074/jbc.M112.348094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22535966	Green Published, hybrid			2022-12-28	WOS:000306418600027
J	Altamirano, F; Lopez, JR; Henriquez, C; Molinski, T; Allen, PD; Jaimovich, E				Altamirano, Francisco; Lopez, Jose R.; Henriquez, Carlos; Molinski, Tadeusz; Allen, Paul D.; Jaimovich, Enrique			Increased Resting Intracellular Calcium Modulates NF-kappa B-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DUCHENNE MUSCULAR-DYSTROPHY; OPERATED CA2+ ENTRY; MOUSE MUSCLE-FIBERS; KNOCKOUT MICE; CELLS; CONTRACTION; PATHWAY; DAMAGE; INVOLVEMENT	Duchenne muscular dystrophy (DMD) is a genetic disorder caused by dystrophin mutations, characterized by chronic inflammation and severe muscle wasting. Dystrophic muscles exhibit activated immune cell infiltrates, up-regulated inflammatory gene expression, and increased NF-kappa B activity, but the contribution of the skeletal muscle cell to this process has been unclear. The aim of this work was to study the pathways that contribute to the increased resting calcium ([Ca2+](rest)) observed in mdx myotubes and its possible link with up-regulation of NF-kappa B and pro-inflammatory gene expression in dystrophic muscle cells. [Ca2+](rest) was higher in mdx than in WT myotubes (308 +/- 6 versus 113 +/- 2 nM, p < 0.001). In mdx myotubes, both the inhibition of Ca2+ entry (low Ca2+ solution, Ca2+-free solution, and Gd3+) and blockade of either ryanodine receptors or inositol 1,4,5-trisphosphate receptors reduced [Ca2+](rest). Basal activity of NF-kappa B was significantly up-regulated in mdx versus WT myotubes. There was an increased transcriptional activity and p65 nuclear localization, which could be reversed when [Ca2+](rest) was reduced. Levels of mRNA for TNF alpha, IL-1 beta, and IL-6 were similar in WT and mdx myotubes, whereas inducible nitric-oxide synthase (iNOS) expression was increased 5-fold. Reducing [Ca2+](rest) using different strategies reduced iNOS gene expression presumably as a result of decreased activation of NF-kappa B. We propose that NF-kappa B, modulated by increased [Ca2+](rest), is constitutively active in mdx myotubes, and this mechanism can account for iNOS overexpression and the increase in reactive nitrogen species that promote damage in dystrophic skeletal muscle cells.	[Altamirano, Francisco; Henriquez, Carlos; Jaimovich, Enrique] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 8389100, Chile; [Lopez, Jose R.; Allen, Paul D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Molinski, Tadeusz] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Universidad de Chile; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego	Jaimovich, E (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Henríquez-Olguín, Carlos/K-7671-2012; Altamirano, Francisco/I-1928-2013; Jaimovich, Enrique/AAY-7632-2020; Molinski, Tadeusz F/P-2125-2018; Henríquez-Olguín, Carlos/ABB-6846-2021	Henríquez-Olguín, Carlos/0000-0002-9315-9365; Altamirano, Francisco/0000-0002-1612-2729; Henríquez-Olguín, Carlos/0000-0002-9315-9365	National Institutes of Health [AR43140, AR052354]; Fondo Nacional de Investigacion Cientifica y Tecnologica [1110467]; Fondo de Financiamiento de Centros de Excelencia en Investigacion [15010006]; Asotiation Francaise Contre les Myopathies [14562]; Comision Nacional de Investigacion Cientifica y Tecnologica [AT-24100066]; Vicerrectoria de Asuntos Academicos; Universidad de Chile; Programa de Mejoramiento de lo Calidad y Equidad de la Educacion [UCH 0714]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Investigacion Cientifica y Tecnologica(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Financiamiento de Centros de Excelencia en Investigacion; Asotiation Francaise Contre les Myopathies; Comision Nacional de Investigacion Cientifica y Tecnologica; Vicerrectoria de Asuntos Academicos; Universidad de Chile; Programa de Mejoramiento de lo Calidad y Equidad de la Educacion; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR43140 and AR052354 (to P. D. A. and J. R. L.). This work was also supported by Grants Fondo Nacional de Investigacion Cientifica y Tecnologica 1110467, Fondo de Financiamiento de Centros de Excelencia en Investigacion 15010006, and Asotiation Francaise Contre les Myopathies 14562 (to E. J.), Grant AT-24100066 from Comision Nacional de Investigacion Cientifica y Tecnologica, Vicerrectoria de Asuntos Academicos, Universidad de Chile, and Programa de Mejoramiento de lo Calidad y Equidad de la Educacion travel support UCH 0714, Universidad de Chile (to F. A.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Badger AM, 1998, J IMMUNOL, V161, P467; BAKKER AJ, 1993, J PHYSIOL-LONDON, V460, P1; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Carlson CG, 2005, NEUROBIOL DIS, V20, P719, DOI 10.1016/j.nbd.2005.05.003; Casas M, 2010, J GEN PHYSIOL, V136, P455, DOI 10.1085/jgp.200910397; Cases M, 2012, METHODS MOL BIOL, V798, P383, DOI 10.1007/978-1-61779-343-1_22; Culligan K, 2002, J APPL PHYSIOL, V92, P435, DOI 10.1152/japplphysiol.00903.2001; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Durham WJ, 2006, MUSCLE NERVE, V34, P298, DOI 10.1002/mus.20579; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Hollingworth S, 2008, J PHYSIOL-LONDON, V586, P5063, DOI 10.1113/jphysiol.2008.160507; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kargacin ME, 1996, BBA-GEN SUBJECTS, V1290, P4, DOI 10.1016/0304-4165(95)00180-8; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; LOPEZ JR, 1987, ACTA CIENT VENEZ, V38, P503; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACK MM, 1994, J BIOL CHEM, V269, P23236; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Miles MT, 2011, J NEUROL SCI, V303, P53, DOI 10.1016/j.jns.2011.01.015; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Mokri B, 1998, NEUROLOGY, V51, pA1; Morine KJ, 2010, HUM GENE THER, V21, P1735, DOI 10.1089/hum.2010.077; Nakamura A, 2001, NEUROMUSCULAR DISORD, V11, P251, DOI 10.1016/S0960-8966(00)00201-7; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan Y, 2008, MOL CELLS, V25, P531; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Porreca E, 1999, THROMB HAEMOSTASIS, V81, P543; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; PRESSMAR J, 1994, PFLUG ARCH EUR J PHY, V426, P499, DOI 10.1007/BF00378527; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Robin G, 2012, J GEN PHYSIOL, V139, P209, DOI 10.1085/jgp.201110738; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Siegel AL, 2009, NEUROMUSCULAR DISORD, V19, P131, DOI 10.1016/j.nmd.2008.10.006; Singh R, 2009, J NEUROL SCI, V285, P159, DOI 10.1016/j.jns.2009.06.030; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Won JS, 2001, MOL BRAIN RES, V89, P1, DOI 10.1016/S0169-328X(01)00047-X; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	82	67	67	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20876	20887		10.1074/jbc.M112.344929	http://dx.doi.org/10.1074/jbc.M112.344929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549782	hybrid, Green Published			2022-12-28	WOS:000306416800009
J	Gorski, PA; Trieber, CA; Lariviere, E; Schuermans, M; Wuytack, F; Young, HS; Vangheluwe, P				Gorski, Przemek A.; Trieber, Catharine A.; Lariviere, Els; Schuermans, Marleen; Wuytack, Frank; Young, Howard S.; Vangheluwe, Peter			Transmembrane Helix 11 Is a Genuine Regulator of the Endoplasmic Reticulum Ca2+ Pump and Acts as a Functional Parallel of beta-Subunit on alpha-Na+, K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PHOSPHOLAMBAN; ISOFORMS; SERCA2A	The housekeeping sarco(endo) plasmic reticulum Ca2+ ATPase SERCA2b transports Ca2+ across the endoplasmic reticulum membrane maintaining a vital Ca2+ gradient. Compared with the muscle-specific isoforms SERCA2a and SERCA1a, SERCA2b houses an 11th transmembrane segment (TM11) and a short luminal extension (LE) at its C terminus (2b-tail). The 2b-tail imposes a 2-fold higher apparent Ca2+ affinity and lower V-max. Previously, we assumed that LE is the sole functional region of the 2b-tail and that TM11 is a passive element providing an additional membrane passage. However, here we show that peptides corresponding to the TM11 region specifically modulate the activity of the homologous SERCA1a in co-reconstituted proteoliposomes and mimic the 2b-tail effect (i.e. lower V-max and higher Ca2+ affinity). Using truncated 2b-tail variants we document that TM11 regulates SERCA1a independently from LE, confirming that TM11 is a second, previously unrecognized functional region of the 2b-tail. A phylogenetic analysis further indicates that TM11 is the oldest and most conserved feature of the 2b-tail, found in the SERCA pump of all Bilateria, whereas LE is only present in Nematoda and vertebrates. Considering remarkable similarities with the Na+, K+-ATPase alpha-beta interaction, we now propose a model for interaction of TM11 with TM7 and TM10 in the anchoring sub-domain of the Ca2+ pump. This model involves a TM11-induced helix bending of TM7. In conclusion, more than just a passive structural feature, TM11 acts as a genuine regulator of Ca2+ transport through interaction with the pump.	[Gorski, Przemek A.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada; [Lariviere, Els; Schuermans, Marleen; Wuytack, Frank; Vangheluwe, Peter] Katholieke Univ KU Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium	University of Alberta; National Research Council Canada; University of Alberta; KU Leuven	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca; peter.vangheluwe@med.kuleuven.be	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Flanders Research Foundation (FWO-Vlaanderen) [G.0646.08]; Interuniversity Attraction Poles Program P6/28 of the Belgian State; Federal Office for Scientific Technical and Cultural Affairs; Canadian Institutes of Health Research [MOP53306]; Alberta Innovates-Technology Futures	Flanders Research Foundation (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Program P6/28 of the Belgian State; Federal Office for Scientific Technical and Cultural Affairs; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures	This work was supported by the Research Program of the Flanders Research Foundation (FWO-Vlaanderen) G.0646.08 and by the Interuniversity Attraction Poles Program P6/28 of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs. This work was also supported by Grant MOP53306 from the Canadian Institutes of Health Research (to H. S. Y.).; Recipient of a Canada graduate scholarship doctoral award from the Canadian Institutes of Health Research and the Alberta Innovates-Technology Futures.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Dally S, 2010, J MOL CELL CARDIOL, V48, P633, DOI 10.1016/j.yjmcc.2009.11.012; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; ESCALANTE R, 1993, J BIOL CHEM, V268, P14090; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Menguy T, 1998, J BIOL CHEM, V273, P20134, DOI 10.1074/jbc.273.32.20134; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Vandecaetsbeek I, 2011, BBA-MOL CELL RES, V1813, P1118, DOI 10.1016/j.bbamcr.2010.12.020; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	27	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19876	19885		10.1074/jbc.M111.335620	http://dx.doi.org/10.1074/jbc.M111.335620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528494	Green Published, hybrid			2022-12-28	WOS:000306414500010
J	Saad, NY; Schiel, B; Braye, M; Heap, JT; Minton, NP; Durre, P; Becker, HD				Saad, Nizar Y.; Schiel, Bettina; Braye, Melanie; Heap, John T.; Minton, Nigel P.; Duerre, Peter; Becker, Hubert Dominique			Riboswitch (T-box)-mediated Control of tRNA-dependent Amidation in Clostridium acetobutylicum Rationalizes Gene and Pathway Redundancy for Asparagine and Asparaginyl-tRNA(Asn) Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; IN-VITRO; TRANSCRIPTION ANTITERMINATION; MISSING LINK; AMINO-ACID; SYNTHETASE; EVOLUTION; POLYMERASE; AMIDOTRANSFERASE	Analysis of the Gram-positive Clostridium acetobutylicum genome reveals an inexplicable level of redundancy for the genes putatively involved in asparagine (Asn) and Asn-tRNA(Asn) synthesis. Besides a duplicated set of gatCAB tRNA-dependent amidotransferase genes, there is a triplication of aspartyl-tRNA synthetase genes and a duplication of asparagine synthetase B genes. This genomic landscape leads to the suspicion of the incoherent simultaneous use of the direct and indirect pathways of Asn and Asn-tRNA(Asn) formation. Through a combination of biochemical and genetic approaches, we show that C. acetobutylicum forms Asn and Asn-tRNA(Asn) by tRNA-dependent amidation. We demonstrate that an entire transamidation pathway composed of aspartyl-tRNA synthetase and one set of GatCAB genes is organized as an operon under the control of a tRNA(Asn)-dependent T-box riboswitch. Finally, our results suggest that this exceptional gene redundancy might be interconnected to control tRNA-dependent Asn synthesis, which in turn might be involved in controlling the metabolic switch from acidogenesis to solventogenesis in C. acetobutylicum.	[Schiel, Bettina; Duerre, Peter] Univ Ulm, Inst Mikrobiol & Biotechnol, D-89069 Ulm, Germany; [Becker, Hubert Dominique] Univ Strasbourg, CNRS, Unite Mixte Rech Genet Mol Genom Microbiol, F-67084 Strasbourg, France; [Saad, Nizar Y.; Braye, Melanie; Becker, Hubert Dominique] Univ Strasbourg, Unite Propre Rech Architecture & Reactivite Acide, Inst Biol Mol & Cellulaire, CNRS, F-67084 Strasbourg, France; [Heap, John T.; Minton, Nigel P.] Univ Nottingham, Natl Inst Hlth Res Biomed Res Unit, Sch Mol Med Sci, Clostridia Res Grp,Ctr Biomol Sci,Nottingham Dige, Nottingham NG7 2RD, England	Ulm University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Nottingham	Schiel, B (corresponding author), Univ Ulm, Inst Mikrobiol & Biotechnol, D-89069 Ulm, Germany.	bettina.schiel@uni-ulm.de; h.becker@unistra.fr		Becker, Hubert/0000-0002-4102-7520; Saad, Nizar/0000-0002-5453-1152; Minton, Nigel/0000-0002-9277-1261	Association pour la Recherche sur le Cancer; University of Strasbourg; CNRS; Agence Nationale de la Recherche [ANR-09-BLAN-0091-02]; Ministere de l'Education Nationale, de la Recherche et de la Technology-bourse de la Presidence de l'Universite de Strasbourg; Federation of European Biochemical Societies summer scholarship; BBSRC [BB/F003390/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003390/1] Funding Source: researchfish	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Education Nationale, de la Recherche et de la Technology-bourse de la Presidence de l'Universite de Strasbourg; Federation of European Biochemical Societies summer scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Association pour la Recherche sur le Cancer, the University of Strasbourg, the CNRS, and Agence Nationale de la Recherche Grant ANR-09-BLAN-0091-02.; Recipient of a fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technology-bourse de la Presidence de l'Universite de Strasbourg and a Federation of European Biochemical Societies summer scholarship fellow.	Bailly M, 2008, METHODS, V44, P146, DOI 10.1016/j.ymeth.2007.11.012; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Becker HD, 1997, BIOCHEMISTRY-US, V36, P8785, DOI 10.1021/bi970392v; Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Becker HD, 1996, BIOCHEMISTRY-US, V35, P7447, DOI 10.1021/bi9601058; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Chang KM, 2009, NUCLEIC ACIDS RES, V37, P6942, DOI 10.1093/nar/gkp754; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Durre P, 2008, ANN NY ACAD SCI, V1125, P353, DOI 10.1196/annals.1419.009; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; FELTON J, 1980, J BACTERIOL, V142, P221, DOI 10.1128/JB.142.1.221-228.1980; Feustel L, 2004, APPL ENVIRON MICROB, V70, P798, DOI 10.1128/AEM.70.2.798-803.2004; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; Gerdeman MS, 2002, NUCLEIC ACIDS RES, V30, P1065, DOI 10.1093/nar/30.4.1065; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grundy FJ, 1997, J BACTERIOL, V179, P2587, DOI 10.1128/jb.179.8.2587-2594.1997; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; GRUPE H, 1992, APPL ENVIRON MICROB, V58, P3896, DOI 10.1128/AEM.58.12.3896-3902.1992; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Henkin T. M., 2008, U.S. Patent, Patent No. [7,413,856, 7413856]; Henkin Tina M., 2009, V540, P281, DOI 10.1007/978-1-59745-558-9_20; HENKIN TM, 1992, J BACTERIOL, V174, P1299, DOI 10.1128/jb.174.4.1299-1306.1992; Janssen H, 2010, APPL MICROBIOL BIOT, V87, P2209, DOI 10.1007/s00253-010-2741-x; Johnson John L., 1994, P655; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; LEVEQUE F, 1990, NUCLEIC ACIDS RES, V18, P305, DOI 10.1093/nar/18.2.305; Luo D, 1998, NUCLEIC ACIDS RES, V26, P5379, DOI 10.1093/nar/26.23.5379; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Nelson AR, 2006, RNA, V12, P1254, DOI 10.1261/rna.29906; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Nureki O, 2010, NUCLEIC ACIDS RES, V38, P7286, DOI 10.1093/nar/gkq605; Poggio S, 2002, FEMS MICROBIOL LETT, V206, P151, DOI 10.1016/S0378-1097(01)00537-7; Putzer H, 2002, NUCLEIC ACIDS RES, V30, P3026, DOI 10.1093/nar/gkf415; ROOS JW, 1985, BIOTECHNOL BIOENG, V27, P681, DOI 10.1002/bit.260270518; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; SALUTA MV, 1995, J BACTERIOL, V177, P1872, DOI 10.1128/jb.177.7.1872-1878.1995; Sambrook J, 1989, MOL CLONING; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; ten Broeke-Smits NJP, 2010, NUCLEIC ACIDS RES, V38, P3263, DOI 10.1093/nar/gkq058; Thormann K, 2002, J BACTERIOL, V184, P1966, DOI 10.1128/JB.184.7.1966-1973.2002; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Wels M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-330; Yousef MR, 2005, J MOL BIOL, V349, P273, DOI 10.1016/j.jmb.2005.03.061; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20382	20394		10.1074/jbc.M111.332304	http://dx.doi.org/10.1074/jbc.M111.332304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22505715	Green Published, hybrid			2022-12-28	WOS:000306414500057
J	Truschel, ST; Zhang, M; Bachert, C; Macbeth, MR; Linstedt, AD				Truschel, Steven T.; Zhang, Ming; Bachert, Collin; Macbeth, Mark R.; Linstedt, Adam D.			Allosteric Regulation of GRASP Protein-dependent Golgi Membrane Tethering by Mitotic Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; BINDING; COMPLEX	Mitotic phosphorylation of the conserved GRASP domain of GRASP65 disrupts its self-association, leading to a loss of Golgi membrane tethering, cisternal unlinking, and Golgi breakdown. Recently, the structural basis of the GRASP self-interaction was determined, yet the mechanism by which phosphorylation disrupts this activity is unknown. Here, we present the crystal structure of a GRASP phosphomimic containing an aspartic acid substitution for a serine residue (Ser-189) that in GRASP65 is phosphorylated by PLK1, causing a block in membrane tethering and Golgi ribbon formation. The structure revealed a conformational change in the GRASP internal ligand that prevented its insertion into the PDZ binding pocket, and gel filtration assays showed that this phosphomimic mutant exhibited a significant reduction in dimer formation. Interestingly, the structure also revealed an apparent propagation of conformational change from the site of phosphorylation to the shifted ligand, and alanine substitution of two residues (Glu-145 and Ser-146) at penultimate positions in this chain rescued dimer formation by the phosphomimic. These data reveal the structural basis of the phosphoinhibition of GRASP-mediated membrane tethering and provide a mechanism for its allosteric regulation.	[Truschel, Steven T.; Zhang, Ming; Bachert, Collin; Macbeth, Mark R.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@andrew.cmu.edu		Truschel, Steven/0000-0003-3394-6006	National Institutes of Health [GM095549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grant GM095549 (to A. D. L. and M. R. M.).	Adey NB, 2000, CANCER RES, V60, P35; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317	20	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19870	19875		10.1074/jbc.M111.326256	http://dx.doi.org/10.1074/jbc.M111.326256			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22523075	hybrid, Green Published			2022-12-28	WOS:000306414500009
J	Gude, L; Berkovitch, SS; Santos, WL; Kutchukian, PS; Pawloski, AR; Kuimelis, R; McGall, G; Verdine, GL				Gude, Lourdes; Berkovitch, Shaunna S.; Santos, Webster L.; Kutchukian, Peter S.; Pawloski, Adam R.; Kuimelis, Robert; McGall, Glenn; Verdine, Gregory L.			Mapping Targetable Sites on Human Telomerase RNA Pseudoknot/Template Domain Using 2 '-OMe RNA-interacting Polynucleotide (RIPtide) Microarrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; COMPLEMENTARY OLIGONUCLEOTIDES; REVERSE-TRANSCRIPTASE; NUCLEIC-ACIDS; HUMAN-CELLS; IN-VIVO; INHIBITION; ARRAYS; PROTEIN; CANCER	Most cellular RNAs engage in intrastrand base-pairing that gives rise to complex three-dimensional folds. This self-pairing presents an impediment toward binding of the RNA by nucleic acid-based ligands. An important step in the discovery of RNA-targeting ligands is therefore to identify those regions in a folded RNA that are accessible toward the nucleic acid-based ligand. Because the folding of RNA targets can involve interactions between nonadjacent regions and employ both Watson-Crick and non-Watson-Crick base-pairing, screening of candidate binder ensembles is typically necessary. Microarray-based screening approaches have shown great promise in this regard and have suggested that achieving complete sequence coverage would be a valuable attribute of a next generation system. Here, we report a custom microarray displaying a library of RNA-interacting polynucleotides comprising all possible 2'-OMe RNA sequences from 4- to 8-nucleotides in length. We demonstrate the utility of this array in identifying RNA-interacting polynucleotides that bind tightly and specifically to the highly conserved, functionally essential template/pseudoknot domain of human telomerase RNA and that inhibit telomerase function in vitro.	[Gude, Lourdes; Kutchukian, Peter S.; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Berkovitch, Shaunna S.; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Pawloski, Adam R.; Kuimelis, Robert; McGall, Glenn] Affymetrix Inc, Santa Clara, CA 95051 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Affymetrix; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	Gregory_verdine@harvard.edu	Kutchukian, Peter/A-9826-2016; Gude, Lourdes/E-5860-2012	Kutchukian, Peter/0000-0002-5684-1971; Gude, Lourdes/0000-0002-0220-3755; Santos, Webster/0000-0002-4731-8548	National Institutes of Health [R01 GM044853]; NRSA [F32 GM067380]; High-Tech Fund of the Dana-Farber Cancer Institute; Spanish Ministerio de Educacion y Ciencia; National Science Foundation;  [T32 GM007598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM044853, F32GM067380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); High-Tech Fund of the Dana-Farber Cancer Institute; Spanish Ministerio de Educacion y Ciencia(Spanish Government); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM044853 (to G. L. V.), Grant F32 GM067380 from NRSA (to W. L. S.), and Training Grant T32 GM007598 (to S. S. B.). This work was also supported by the High-Tech Fund of the Dana-Farber Cancer Institute, postdoctoral fellowships from the Spanish Ministerio de Educacion y Ciencia (to L. G.), and a National Science Foundation predoctoral fellowship (to P. S. K.). Affymetrix Inc. is a for-profit entity. G. L. V. is a shareholder, consultant to, and corporate officer of Ontorii, Inc., which has secured an option from Harvard University to commercialize the RIPtide technology.	Antal M, 2002, NUCLEIC ACIDS RES, V30, P912, DOI 10.1093/nar/30.4.912; Bennett C.F., 2008, ANTISENSE DRUG TECHN, P273; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen Z, 2002, J MED CHEM, V45, P5423, DOI 10.1021/jm025563v; Childs JL, 2002, P NATL ACAD SCI USA, V99, P11091, DOI 10.1073/pnas.172391199; Childs JL, 2003, RNA, V9, P1437, DOI 10.1261/rna.5780503; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Duan SH, 2006, BIOCHEMISTRY-US, V45, P9819, DOI 10.1021/bi052618x; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Gavory G, 2006, BIOCHEMISTRY-US, V45, P13304, DOI 10.1021/bi061150a; Hamilton SE, 1999, CHEM BIOL, V6, P343, DOI 10.1016/S1074-5521(99)80046-5; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kaur H, 2007, CHEM REV, V107, P4672, DOI 10.1021/cr050266u; Keppler BR, 2004, BIOCHEMISTRY-US, V43, P334, DOI 10.1021/bi035583e; Kierzek E, 2006, BIOCHEMISTRY-US, V45, P581, DOI 10.1021/bi051409+; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lagoja IM, 2007, EXPERT OPIN DRUG DIS, V2, P889, DOI 10.1517/17460441.2.6.889; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Liang RT, 2010, BIOCHEMISTRY-US, V49, P8155, DOI 10.1021/bi100286n; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Matthes E, 1999, NUCLEIC ACIDS RES, V27, P1152, DOI 10.1093/nar/27.4.1152; Milner N, 1997, NAT BIOTECHNOL, V15, P537, DOI 10.1038/nbt0697-537; Mir KU, 1999, NAT BIOTECHNOL, V17, P788, DOI 10.1038/11732; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Ooms M, 2004, NUCLEIC ACIDS RES, V32, P819, DOI 10.1093/nar/gkh206; Pawloski AR, 2007, J VAC SCI TECHNOL B, V25, P2537, DOI 10.1116/1.2794325; Pitts AE, 1998, P NATL ACAD SCI USA, V95, P11549, DOI 10.1073/pnas.95.20.11549; Pruzan R, 2002, NUCLEIC ACIDS RES, V30, P559, DOI 10.1093/nar/30.2.559; Schlegel MK, 2007, CHEMBIOCHEM, V8, P927, DOI 10.1002/cbic.200600435; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sohail M, 1999, RNA, V5, P646, DOI 10.1017/S1355838299982195; SOUTHERN EM, 1994, NUCLEIC ACIDS RES, V22, P1368, DOI 10.1093/nar/22.8.1368; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Zhang Q, 2010, P NATL ACAD SCI USA, V107, P18761, DOI 10.1073/pnas.1013269107	55	12	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18843	18853		10.1074/jbc.M111.316596	http://dx.doi.org/10.1074/jbc.M111.316596			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22451672	Green Published, hybrid			2022-12-28	WOS:000306411600092
J	Hinerman, JM; Dignam, JD; Mueser, TC				Hinerman, Jennifer M.; Dignam, J. David; Mueser, Timothy C.			Models for the Binary Complex of Bacteriophage T4 Gp59 Helicase Loading Protein GP32 SINGLE-STRANDED DNA-BINDING PROTEIN AND TERNARY COMPLEX WITH PSEUDO-Y JUNCTION DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; ISOTHERMAL TITRATION CALORIMETRY; REPLICATION FORK; SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; POLYMERASE GP43; GENE-59 PROTEIN; GP32; RECOMBINATION; ARCHITECTURE	Bacteriophage T4 gp59 helicase assembly protein (gp59) is required for loading of gp41 replicative helicase onto DNA protected by gp32 single-stranded DNA-binding protein. The gp59 protein recognizes branched DNA structures found at replication and recombination sites. Binding of gp32 protein (full-length and deletion constructs) to gp59 protein measured by isothermal titration calorimetry demonstrates that the gp32 protein C-terminal A-domain is essential for protein-protein interaction in the absence of DNA. Sedimentation velocity experiments with gp59 protein and gp32 Delta B protein (an N-terminal B-domain deletion) show that these proteins are monomers but form a 1:1 complex with a dissociation constant comparable with that determined by isothermal titration calorimetry. Small angle x-ray scattering (SAXS) studies indicate that the gp59 protein is a prolate monomer, consistent with the crystal structure and hydrodynamic properties determined from sedimentation velocity experiments. SAXS experiments also demonstrate that gp32 Delta B protein is a prolate monomer with an elongated A-domain protruding from the core. Fitting structures of gp59 protein and the gp32 core into the SAXS-derived molecular envelope supports a model for the gp59 protein-gp32 Delta B protein complex. Our earlier work demonstrated that gp59 protein attracts full-length gp32 protein to pseudo-Y junctions. A model of the gp59 protein-DNA complex, modified to accommodate new SAXS data for the binary complex together with mutational analysis of gp59 protein, is presented in the accompanying article (Dolezal, D., Jones, C. E., Lai, X., Brister, J. R., Mueser, T. C., Nossal, N. G., and Hinton, D. M. (2012) J. Biol. Chem. 287, 18596-18607).	[Hinerman, Jennifer M.; Mueser, Timothy C.] Univ Toledo, Coll Nat Sci & Math, Dept Chem, Toledo, OH 43606 USA; [Dignam, J. David] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA	University of Toledo; University of Toledo	Mueser, TC (corresponding author), Univ Toledo, Coll Nat Sci & Math, Dept Chem, Toledo, OH 43606 USA.	Timothy.Mueser@utoledo.edu			National Science Foundation [0346960]; Division Of Chemistry [0822838] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by a grant from the National Science Foundation CAREER Award 0346960 (to T. C. M.).	ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; Aves Stephen J., 2009, V521, P3, DOI 10.1007/978-1-60327-817-5_1; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; BARRY J, 1994, J BIOL CHEM, V269, P33049; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Dolezal D, 2012, J BIOL CHEM, V287, P18596, DOI 10.1074/jbc.M111.332080; Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-817-5_2, 10.1007/978-1-60327-815-7_2]; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Izaac A, 2006, ACTA CRYSTALLOGR D, V62, P833, DOI 10.1107/S0907444906018385; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kong DC, 1997, J BIOL CHEM, V272, P8380; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; PRIGODICH RV, 1986, BIOCHEMISTRY-US, V25, P3666, DOI 10.1021/bi00360a029; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah D. B, 1975, J VIROL, V17, P175; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SPICER EK, 1979, J BIOL CHEM, V254, P6433; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu H, 2001, BIOCHEMISTRY-US, V40, P7651, DOI 10.1021/bi010116n; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	38	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18608	18617		10.1074/jbc.M111.333476	http://dx.doi.org/10.1074/jbc.M111.333476			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493434	Green Published, hybrid			2022-12-28	WOS:000306411600071
J	Rius, M; Chillaron, J				Rius, Monica; Chillaron, Josep			Carrier Subunit of Plasma Membrane Transporter Is Required for Oxidative Folding of Its Helper Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; GENOTYPE-PHENOTYPE CORRELATION; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; I CYSTINURIA; PROTEIN; MUTATIONS; MECHANISM; SYSTEM; ALPHA	We study the amino acid transport system b(0,+) as a model for folding, assembly, and early traffic of membrane protein complexes. System b(0,+) is made of two disulfide-linked membrane subunits: the carrier, b(0,+) amino acid transporter (b(0,+) AT), a polytopic protein, and the helper, related to b(0,+) amino acid transporter (rBAT), a type II glycoprotein. rBAT ectodomain mutants display folding/trafficking defects that lead to type I cystinuria. Here we show that, in the presence of b(0,+) AT, three disulfides were formed in the rBAT ectodomain. Disulfides Cys-242-Cys-273 and Cys-571-Cys-666 were essential for biogenesis. Cys-673-Cys-685 was dispensable, but the single mutants C673S, and C685S showed compromised stability and trafficking. Cys-242-Cys-273 likely was the first disulfide to form, and unpaired Cys-242 or Cys-273 disrupted oxidative folding. Strikingly, unassembled rBAT was found as an ensemble of different redox species, mainly monomeric. The ensemble did not change upon inhibition of rBAT degradation. Overall, these results indicated a b(0,+) AT-dependent oxidative folding of the rBAT ectodomain, with the initial and probably cotranslational formation of Cys-242-Cys-273, followed by the oxidation of Cys-571-Cys-666 and Cys-673-Cys-685,that was completed posttranslationally.	[Rius, Monica; Chillaron, Josep] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, E-08028 Barcelona, Spain	University of Barcelona	Chillaron, J (corresponding author), Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Av Diagonal 643, E-08028 Barcelona, Spain.	jchillaron@ub.edu	Chillaron, Josep/ABF-7663-2021	Chillaron, Josep/0000-0003-3068-7598	Spanish Ministerio de Ciencia e Innovacion [BFU2006-06788/BMC, BFU2009-07215/BMC]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2006-06788/BMC and BFU2009-07215/BMC (to J.C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Bartoccioni P, 2008, HUM MOL GENET, V17, P1845, DOI 10.1093/hmg/ddn080; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Bisceglia L, 2001, KIDNEY INT, V59, P1250, DOI 10.1046/j.1523-1755.2001.0590041250.x; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Chang JY, 2011, BIOCHEMISTRY-US, V50, P3414, DOI 10.1021/bi200131j; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Deora AB, 1998, J BIOL CHEM, V273, P32980, DOI 10.1074/jbc.273.49.32980; Egoshi K, 2000, KIDNEY INT, V57, P25, DOI 10.1046/j.1523-1755.2000.00821.x; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Fitter J, 2005, CELL MOL LIFE SCI, V62, P1925, DOI 10.1007/s00018-005-5079-2; Font M, 2001, HUM MOL GENET, V10, P305, DOI 10.1093/hmg/10.4.305; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Pineda M, 2004, BIOCHEM J, V377, P665, DOI 10.1042/BJ20030956; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Sakamoto S, 2009, BIOCHEM J, V417, P441, DOI 10.1042/BJ20081798; Shao SC, 2011, CELL, V146, P13, DOI 10.1016/j.cell.2011.06.028; Tansey William P, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4619; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; van Lith M, 2006, J IMMUNOL, V177, P5430, DOI 10.4049/jimmunol.177.8.5430; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; von Heijne G, 2011, ANNU REV BIOCHEM, V80, P157, DOI 10.1146/annurev-biochem-111910-091345; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18190	18200		10.1074/jbc.M111.321943	http://dx.doi.org/10.1074/jbc.M111.321943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493502	hybrid, Green Published			2022-12-28	WOS:000306411600027
J	Stampoulis, P; Ueda, T; Matsumoto, M; Terasawa, H; Miyano, K; Sumimoto, H; Shimada, I				Stampoulis, Pavlos; Ueda, Takumi; Matsumoto, Masahiko; Terasawa, Hiroaki; Miyano, Kei; Sumimoto, Hideki; Shimada, Ichio			Atypical Membrane-embedded Phosphatidylinositol 3,4-Bisphosphate (PI(3,4)P-2)-binding Site on p47(phox) Phox Homology (PX) Domain Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOCYTE NADPH OXIDASE; CROSS-SATURATION EXPERIMENTS; CHRONIC GRANULOMATOUS-DISEASE; COLLAGEN-BINDING MODE; SH3 DOMAIN; STRUCTURAL BASIS; INTRAMOLECULAR INTERACTION; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; ACTIVATION	The Phox homology (PX) domain is a functional module that targets membranes through specific interactions with phosphoinositides. The p47(phox) PX domain preferably binds phosphatidylinositol 3,4-bisphosphate (PI(3,4)P-2) and plays a pivotal role in the assembly of phagocyte NADPH oxidase. We describe the PI(3,4)P-2 binding mode of the p47(phox) PX domain as identified by a transferred cross-saturation experiment. The identified PI(3,4)P-2-binding site, which includes the residues of helices alpha 1 and alpha 1' and the following loop up to the distorted left-handed PPII helix, is located at a unique position, as compared with the phosphoinositide-binding sites of all other PX domains characterized thus far. Mutational analyses corroborated the results of the transferred cross-saturation experiments. Moreover, experiments with intact cells demonstrated the importance of this unique binding site for the function of the NADPH oxidase. The low affinity and selectivity of the atypical phosphoinositide-binding site on the p47(phox) PX domain suggest that different types of phosphoinositides sequentially bind to the p47(phox) PX domain, allowing the regulation of the multiple events that characterize the assembly and activation of phagocyte NADPH oxidase.	[Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Stampoulis, Pavlos] Japan Biol Informat Consortium, Tokyo 1040032, Japan; [Miyano, Kei; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Japan New Energy and Industrial Development Organization; Ministry of Economy, Trade, and Industry; Grants-in-Aid for Scientific Research [23790338] Funding Source: KAKEN	Japan New Energy and Industrial Development Organization; Ministry of Economy, Trade, and Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan New Energy and Industrial Development Organization and the Ministry of Economy, Trade, and Industry.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Duzgunes N, 2003, METHOD ENZYMOL, V367, P23; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Frohlich M, 2001, CHEM PHYS LIPIDS, V109, P103, DOI 10.1016/S0009-3084(00)00220-6; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Koharudin LMI, 2009, J BIOL CHEM, V284, P23697, DOI 10.1074/jbc.M109.008995; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lu J, 2002, BIOCHEMISTRY-US, V41, P5956, DOI 10.1021/bi020050b; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Miyano K, 2012, METHODS MOL BIOL, V827, P195, DOI 10.1007/978-1-61779-442-1_14; Nagasawa T, 2003, ARCH BIOCHEM BIOPHYS, V416, P92, DOI 10.1016/S0003-9861(03)00296-0; Nakamura T, 2010, J MED CHEM, V53, P1917, DOI 10.1021/jm901099v; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Riek R, 2002, J AM CHEM SOC, V124, P12144, DOI 10.1021/ja026763z; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200; Takeuchi K, 2003, STRUCTURE, V11, P1381, DOI 10.1016/j.str.2003.10.003; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	53	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17848	17859		10.1074/jbc.M111.332874	http://dx.doi.org/10.1074/jbc.M111.332874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22493288	Green Published, hybrid			2022-12-28	WOS:000306373000082
J	Li, XM; McClellan, ME; Tanito, M; Garteiser, P; Towner, R; Bissig, D; Berkowitz, BA; Fliesler, SJ; Woodruff, ML; Fain, GL; Birch, DG; Khan, MS; Ash, JD; Elliott, MH				Li, Xiaoman; McClellan, Mark E.; Tanito, Masaki; Garteiser, Philippe; Towner, Rheal; Bissig, David; Berkowitz, Bruce A.; Fliesler, Steven J.; Woodruff, Michael L.; Fain, Gordon L.; Birch, David G.; Khan, M. Suhaib; Ash, John D.; Elliott, Michael H.			Loss of Caveolin-1 Impairs Retinal Function Due to Disturbance of Subretinal Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RESISTANT MEMBRANE RAFTS; MANGANESE-ENHANCED MRI; DETERGENT-RESISTANT; SIGNAL-TRANSDUCTION; COMMON VARIANTS; MOUSE MODEL; PROTEIN; CHOLESTEROL; MODULATION	Caveolin-1 (Cav-1), an integral component of caveolar membrane domains, is expressed in several retinal cell types, including photoreceptors, retinal vascular endothelial cells, Muller glia, and retinal pigment epithelium (RPE) cells. Recent evidence links Cav-1 to ocular diseases, including autoimmune uveitis, diabetic retinopathy, and primary open angle glaucoma, but its role in normal vision is largely undetermined. In this report, we show that ablation of Cav-1 results in reduced inner and outer retinal function as measured, in vivo, by electroretinography and manganese-enhanced MRI. Somewhat surprisingly, dark current and light sensitivity were normal in individual rods (recorded with suction electrode methods) from Cav-1 knock-out (KO) mice. Although photoreceptor function was largely normal, in vitro, the apparent K+ affinity of the RPE-expressed alpha 1-Na+/K+-ATPase was decreased in Cav-1 KO mice. Cav-1 KO retinas also displayed unusually tight adhesion with the RPE, which could be resolved by brief treatment with hyperosmotic medium, suggesting alterations in outer retinal fluid homeostasis. Collectively, these findings demonstrate that reduced retinal function resulting from Cav-1 ablation is not photoreceptor-intrinsic but rather involves impaired subretinal and/or RPE ion/fluid homeostasis.	[Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Li, Xiaoman; McClellan, Mark E.; Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane 6938501, Japan; [Garteiser, Philippe; Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Oklahoma City, OK 73104 USA; [Bissig, David; Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Fliesler, Steven J.] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY 14215 USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Ophthalmol, Buffalo, NY 14215 USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14215 USA; [Woodruff, Michael L.; Fain, Gordon L.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Birch, David G.] Retina Fdn SW, Dallas, TX 75231 USA; [Khan, M. Suhaib; Ash, John D.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Shimane University; Oklahoma Medical Research Foundation; Wayne State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Los Angeles; Retina Foundation of the Southwest; State University System of Florida; University of Florida	Elliott, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA.	michael-elliott@ouhsc.edu	Fliesler, Steven J./AAE-9243-2020; Garteiser, Philippe/P-5719-2017	Garteiser, Philippe/0000-0003-0157-8851; Towner, Rheal/0000-0001-7368-8983; Ash, John/0000-0002-8330-7301; Bissig, David/0000-0001-9664-5433; Fliesler, Steven/0000-0002-2557-142X; Fain, Gordon/0000-0002-9813-0342; Birch, David/0000-0002-6594-2897	National Institutes of Health (NIH), NEI [EY019494, EY007361, AG034752]; NIH, NCRR [RR017703]; NIH, NEI [EY012190]; Oklahoma Center for the Advancement of Science and Technology [HR09-028]; Juvenile Diabetes Research Foundation; Wayne State University School of Medicine; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007361, P30EY012190, R01EY019494, R01EY016459, P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wayne State University School of Medicine; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grants EY019494 (to M. H. E.), EY007361 (S. J. F.), and AG034752 (D. B.); NIH, NCRR, Centers of Biomedical Research Excellence Grant RR017703; and NIH, NEI, Core Grant EY012190. This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR09-028, grants from the Juvenile Diabetes Research Foundation (to B. A. B.), Wayne State University School of Medicine M.D./Ph.D. program (to D. B.), and an unrestricted grant (to M. H. E. and S. J. F.) and a Sybil B. Harrington Special Scholar Award for Macular Degeneration (to M. H. E.) from Research to Prevent Blindness, Inc.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Berkowitz BA, 1996, INVEST OPHTH VIS SCI, V37, P2089; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P3796, DOI 10.1167/iovs.06-1278; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P1880, DOI 10.1167/iovs.08-2958; Berta AI, 2011, J MOL HISTOL, V42, P523, DOI 10.1007/s10735-011-9360-4; Boesze-Battaglia K, 2002, J BIOL CHEM, V277, P41843, DOI 10.1074/jbc.M207111200; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Bridges CC, 2001, HISTOCHEM J, V33, P149, DOI 10.1023/A:1017991925821; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bui BV, 2004, INVEST OPHTH VIS SCI, V45, P584, DOI 10.1167/iovs.03-0695; Calkins DJ, 2008, INVEST OPHTH VIS SCI, V49, P5083, DOI 10.1167/iovs.08-2205; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen WQ, 2007, INVEST OPHTH VIS SCI, V48, P18, DOI 10.1167/iovs.06-0619; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Corley SC, 2011, EXP EYE RES, V92, P20, DOI 10.1016/j.exer.2010.10.008; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Ding XQ, 2008, BIOCHEMISTRY-US, V47, P3677, DOI 10.1021/bi7019645; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Elliott MH, 2003, BIOCHEMISTRY-US, V42, P7892, DOI 10.1021/bi027162n; Elliott MH, 2008, J NEUROCHEM, V104, P336, DOI 10.1111/j.1471-4159.2007.04971.x; Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; FINDL O, 1995, INVEST OPHTH VIS SCI, V36, P1019; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GARDINER TA, 1986, BRIT J OPHTHALMOL, V70, P249, DOI 10.1136/bjo.70.4.249; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Isshiki M, 2002, J BIOL CHEM, V277, P43389, DOI 10.1074/jbc.M205411200; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Kachi S, 2001, INVEST OPHTH VIS SCI, V42, P850; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; LIEBMAN PA, 1984, J PHYSIOL-LONDON, V347, P85, DOI 10.1113/jphysiol.1984.sp015055; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; MARMOR MF, 1989, INVEST OPHTH VIS SCI, V30, P1511; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mora RC, 2006, AM J PHYSIOL-CELL PH, V290, pC832, DOI 10.1152/ajpcell.00405.2005; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; NIEMEYER G, 1984, VISION RES, V24, P275, DOI 10.1016/0042-6989(84)90131-7; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; RAVIOLA G, 1983, INVEST OPHTH VIS SCI, V24, P1465; Razani B, 2001, J BIOL CHEM, V276, P38121; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Senin II, 2004, J BIOL CHEM, V279, P48647, DOI 10.1074/jbc.M402516200; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stitt AW, 2000, FASEB J, V14, P2390; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Way M, 1996, FEBS LETT, V378, P101, DOI 10.1016/0014-5793(96)82884-5; Wetzel RK, 1999, J NEUROSCI, V19, P9878; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V727, P39, DOI 10.1016/0005-2736(83)90366-8; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	91	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16424	16434		10.1074/jbc.M112.353763	http://dx.doi.org/10.1074/jbc.M112.353763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451674	Green Published, hybrid			2022-12-28	WOS:000304030900033
J	Sarkar, DK; Sengupta, A; Zhang, CQ; Boyadjieva, N; Murugan, S				Sarkar, Dipak K.; Sengupta, Amitabha; Zhang, Changqing; Boyadjieva, Nadka; Murugan, Sengottuvelan			Opiate Antagonist Prevents mu- and delta-Opiate Receptor Dimerization to Facilitate Ability of Agonist to Control Ethanol-altered Natural Killer Cell Functions and Mammary Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPIOID-RECEPTORS; BETA-ENDORPHIN; CYTOLYTIC ACTIVITY; NERVOUS-SYSTEM; RAT-BRAIN; TOLERANCE; EXPRESSION; WITHDRAWAL; DEPENDENCE; EXPOSURE	In the natural killer (NK) cells, delta-opiate receptor (DOR) and mu-opioid receptor (MOR) interact in a feedback manner to regulate cytolytic function with an unknown mechanism. Using RNK16 cells, a rat NK cell line, we show that MOR and DOR monomer and dimer proteins existed in these cells and that chronic treatment with a receptor antagonist reduced protein levels of the targeted receptor but increased levels of opposing receptor monomer and homodimer. The opposing receptor-enhancing effects of MOR and DOR antagonists were abolished following receptor gene knockdown by siRNA. Ethanol treatment increased MOR and DOR heterodimers while it decreased the cellular levels of MOR and DOR monomers and homodimers. The opioid receptor homodimerization was associated with an increased receptor binding, and heterodimerization was associated with a decreased receptor binding and the production of cytotoxic factors. Similarly, in vivo, opioid receptor dimerization, ligand binding of receptors, and cell function in immune cells were promoted by chronic treatment with an opiate antagonist but suppressed by chronic ethanol feeding. Additionally, a combined treatment of an MOR antagonist and a DOR agonist was able to reverse the immune suppressive effect of ethanol and reduce the growth and progression of mammary tumors in rats. These data identify a role of receptor dimerization in the mechanism of DOR and MOR feedback interaction in NK cells, and they further elucidate the potential for the use of a combined opioid antagonist and agonist therapy for the treatment of immune incompetence and cancer and alcohol-related diseases.	[Sarkar, Dipak K.; Sengupta, Amitabha; Zhang, Changqing; Boyadjieva, Nadka; Murugan, Sengottuvelan] Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Endocrine Program, 67 Poultry Farm Lane, New Brunswick, NJ 08901 USA.	sarkar@aesop.rutgers.edu	Sarkar, Dipak K/O-7942-2017; Murugan, Sengottuvelan/G-9153-2012	Sarkar, Dipak K/0000-0003-3237-9871; /0000-0002-9823-351X	National Institutes of Health [1R21AA016296, R37AA08757]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA008757, R21AA016296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R21AA016296 and R37AA08757 (to D. K. S.).	Balenga NAB, 2011, ADV PHARMACOL, V62, P251, DOI 10.1016/B978-0-12-385952-5.00004-X; Bidlack JM, 2006, J NEUROIMMUNE PHARM, V1, P260, DOI 10.1007/s11481-006-9026-2; Boyadjieva N, 2001, J IMMUNOL, V167, P5645, DOI 10.4049/jimmunol.167.10.5645; Boyadjieva N, 2006, ALCOHOL CLIN EXP RES, V30, P1761, DOI 10.1111/j.1530-0277.2006.00209.x; Boyadjieva NI, 2004, J IMMUNOL, V173, P42, DOI 10.4049/jimmunol.173.1.42; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; Burford NT, 2000, BIOCHEM J, V348, P531, DOI 10.1042/0264-6021:3480531; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Chen F, 2000, J PHARMACOL EXP THER, V293, P159; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; De A, 2002, ALCOHOL CLIN EXP RES, V26, P1420, DOI 10.1097/01.ALC.0000030621.35354.E0; Dokur M, 2005, J NEUROIMMUNOL, V166, P29, DOI 10.1016/j.jneuroim.2005.03.015; Dokur M, 2004, ALCOHOL CLIN EXP RES, V28, P1180, DOI 10.1097/01.ALC.0000134222.20309.71; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Leriche M, 2010, NEUROPEPTIDES, V44, P9, DOI 10.1016/j.npep.2009.11.009; Liu JG, 2002, J PHARMACOL EXP THER, V302, P1070, DOI 10.1124/jpet.102.035964; MANDLER RN, 1986, J IMMUNOL, V136, P934; Merkouris M, 1997, J NEUROCHEM, V69, P2115; PRATHER PL, 1994, J PHARMACOL EXP THER, V270, P177; Pruett S B, 1994, Alcohol Alcohol Suppl, V2, P431; Rasmussen DD, 2002, ALCOHOL CLIN EXP RES, V26, P535, DOI 10.1097/00000374-200204000-00015; Rozenfeld Raphael, 2007, ScientificWorldJournal, V7, P64; Saland LC, 2008, ALCOHOL, V42, P493, DOI 10.1016/j.alcohol.2008.06.002; Sarkar DK, 2007, ENDOCRINOLOGY, V148, P2828, DOI 10.1210/en.2006-1606; Shahabi NA, 2000, CELL IMMUNOL, V205, P84, DOI 10.1006/cimm.2000.1717; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sharp BM, 2006, BRAIN BEHAV IMMUN, V20, P9, DOI 10.1016/j.bbi.2005.02.002; Sharp BM, 2003, ADV EXP MED BIOL, V521, P98; Stefano GB, 2009, MED SCI MONITOR, V15, pRA189; Ueda H, 2009, FRONT BIOSCI, V14, P5260, DOI 10.2741/3596; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Wang ZJJ, 2006, LIFE SCI, V79, P1681, DOI 10.1016/j.lfs.2006.05.023	39	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16734	16747		10.1074/jbc.M112.347583	http://dx.doi.org/10.1074/jbc.M112.347583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451667	Green Published, hybrid			2022-12-28	WOS:000304030900061
J	Smollett, KL; Smith, KM; Kahramanoglou, C; Arnvig, KB; Buxton, RS; Davis, EO				Smollett, Katherine L.; Smith, Kimberley M.; Kahramanoglou, Christina; Arnvig, Kristine B.; Buxton, Roger S.; Davis, Elaine O.			Global Analysis of the Regulon of the Transcriptional Repressor LexA, a Key Component of SOS Response in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCIBLE GENES; CHIP-SEQ DATA; DNA-DAMAGE; ESCHERICHIA-COLI; CELL-DIVISION; GENOME SEQUENCE; PROMOTER MOTIF; BETA-PROPELLER; RECA; IDENTIFICATION	The DNA damage response is crucial for bacterial survival. The transcriptional repressor LexA is a key component of the SOS response, the main mechanism for the regulation of DNA repair genes in many bacteria. In contrast, in mycobacteria gene induction by DNA damage is carried out by two mechanisms; a relatively small number of genes are thought to be regulated by LexA, and a larger number by an alternate, independent mechanism. In this study we have used ChIP-seq analysis to identify 25 in vivo LexA-binding sites, including nine regulating genes not previously known to be part of this regulon. Some of these binding sites were found to be internal to the predicted open reading frame of the gene they are thought to regulate; experimental analysis has confirmed that these LexA-binding sites regulate the expression of the expected genes, and transcriptional start site analysis has found that their apparent relative location is due to misannotation of these genes. We have also identified novel binding sites for LexA in the promoters of genes that show no apparent DNA damage induction, show positive regulation by LexA, and those encoding small RNAs.	[Smollett, Katherine L.; Smith, Kimberley M.; Kahramanoglou, Christina; Arnvig, Kristine B.; Buxton, Roger S.; Davis, Elaine O.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	MRC National Institute for Medical Research	Smollett, KL (corresponding author), UCL, RNAP Lab, Darwin Bldg,Gower St, London WC1E 6BT, England.	k.smollett@ucl.ac.uk	Smollett, Katherine/AAC-2362-2020; Smollett, Katherine L/E-3650-2012	Smollett, Katherine/0000-0001-7961-7377; Smollett, Katherine L/0000-0001-7961-7377; Arnvig, Kristine/0000-0002-6850-2547	United Kingdom Medical Research Council Program [U1175 32056]; European Union FP7 Program SysteMtb [HEALTH-241587]; United Kingdom Medical Research Council Programs [U117585867, U117581288]; MRC [MC_U117585867] Funding Source: UKRI; Medical Research Council [MC_U117585867] Funding Source: researchfish	United Kingdom Medical Research Council Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union FP7 Program SysteMtb; United Kingdom Medical Research Council Programs(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council Program U1175 32056 and in part by European Union FP7 Program SysteMtb HEALTH-241587 and United Kingdom Medical Research Council Programs U117585867 and U117581288.	[Anonymous], 2011, GLOB TUB CONTR; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Brooks PC, 2006, J BACTERIOL, V188, P6034, DOI 10.1128/JB.00340-06; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis Elaine O., 2009, P79; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dawson LF, 2010, J BACTERIOL, V192, P599, DOI 10.1128/JB.01066-09; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3609, DOI 10.1099/00221287-148-11-3609; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Jochmann N, 2009, MICROBIOL-SGM, V155, P1459, DOI 10.1099/mic.0.025841-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller J. H, 1972, EXPT MOL GENETICS; Movahedzadeh F, 1997, MICROBIOL-UK, V143, P929, DOI 10.1099/00221287-143-3-929; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Oatway WH, 1936, J INFECT DIS, V59, P306, DOI 10.1093/infdis/59.3.306; Pang XH, 2011, TUBERCULOSIS, V91, pS142, DOI 10.1016/j.tube.2011.10.024; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Smollett KL, 2009, MICROBIOL-SGM, V155, P186, DOI 10.1099/mic.0.022889-0; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Tapias A, 2002, NUCLEIC ACIDS RES, V30, P1539, DOI 10.1093/nar/30.7.1539; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Warner DF, 2010, P NATL ACAD SCI USA, V107, P13093, DOI 10.1073/pnas.1002614107	53	56	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22004	22014		10.1074/jbc.M112.357715	http://dx.doi.org/10.1074/jbc.M112.357715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22528497	Green Published, hybrid			2022-12-28	WOS:000306418600039
J	Tennstaedt, A; Popsel, S; Truebestein, L; Hauske, P; Brockmann, A; Schmidt, N; Irle, I; Sacca, B; Niemeyer, CM; Brandt, R; Ksiezak-Reding, H; Tirniceriu, AL; Egensperger, R; Baldi, A; Dehmelt, L; Kaiser, M; Huber, R; Clausen, T; Ehrmann, M				Tennstaedt, Annette; Poepsel, Simon; Truebestein, Linda; Hauske, Patrick; Brockmann, Anke; Schmidt, Nina; Irle, Inga; Sacca, Barbara; Niemeyer, Christof M.; Brandt, Roland; Ksiezak-Reding, Hanna; Tirniceriu, Anca Laura; Egensperger, Rupert; Baldi, Alfonso; Dehmelt, Leif; Kaiser, Markus; Huber, Robert; Clausen, Tim; Ehrmann, Michael			Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-DISEASE; QUALITY CONTROL; IN-VITRO; INDUCED CYTOTOXICITY; BETA-STRUCTURE; PROTEOLYSIS; DEGP; DOMAIN; GENE	Protective proteases are key elements of protein quality control pathways that are up-regulated, for example, under various protein folding stresses. These proteases are employed to prevent the accumulation and aggregation of misfolded proteins that can impose severe damage to cells. The high temperature requirement A (HtrA) family of serine proteases has evolved to perform important aspects of ATP-independent protein quality control. So far, however, no HtrA protease is known that degrades protein aggregates. We show here that human HTRA1 degrades aggregated and fibrillar tau, a protein that is critically involved in various neurological disorders. Neuronal cells and patient brains accumulate less tau, neurofibrillary tangles, and neuritic plaques, respectively, when HTRA1 is expressed at elevated levels. Furthermore, HTRA1 mRNA and HTRA1 activity are up-regulated in response to elevated tau concentrations. These data suggest that HTRA1 is performing regulated proteolysis during protein quality control, the implications of which are discussed.	[Tennstaedt, Annette; Poepsel, Simon; Truebestein, Linda; Hauske, Patrick; Brockmann, Anke; Schmidt, Nina; Irle, Inga; Kaiser, Markus; Huber, Robert; Ehrmann, Michael] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45141 Essen, Germany; [Sacca, Barbara; Niemeyer, Christof M.] Tech Univ Dortmund, Fak Chem, D-44227 Dortmund, Germany; [Brandt, Roland] Univ Osnabruck, Fachbereich Biol Chem, D-49076 Osnabruck, Germany; [Ksiezak-Reding, Hanna] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Tirniceriu, Anca Laura; Egensperger, Rupert] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Baldi, Alfonso] Univ Naples 2, Sect Pathol, Dept Biochem & Biophys, I-80100 Naples, Italy; [Dehmelt, Leif] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Huber, Robert] Tech Univ Dortmund Univ, Dept Chem Biol, D-44227 Dortmund, Germany; [Huber, Robert] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Huber, Robert; Ehrmann, Michael] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Duisburg Essen; Dortmund University of Technology; University Osnabruck; Icahn School of Medicine at Mount Sinai; University of Munich; Universita della Campania Vanvitelli; Max Planck Society; Dortmund University of Technology; Max Planck Society; Cardiff University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Ehrmann, M (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany.	michael.ehrmann@uni-due.de	Baldi, Alfonso/ABG-2397-2021; Sacca, Barbara/B-9554-2015; Poepsel, Simon/AAG-2009-2019; Ehrmann, Michael/A-7307-2012; Dehmelt, Leif/AAF-9616-2020; Niemeyer, Christof M/L-3568-2013	Sacca, Barbara/0000-0003-2708-2272; Ehrmann, Michael/0000-0002-1927-260X; Dehmelt, Leif/0000-0002-6559-6496; Niemeyer, Christof M/0000-0002-8837-081X; Poepsel, Simon/0000-0002-8304-4062; Brandt, Roland/0000-0003-0101-1257; Baldi, Alfonso/0000-0002-8693-3842; Clausen, Tim/0000-0003-1582-6924	Federal Ministry of Education and Research; Second University of Naples; Futura-onlus; Deutsche Forschungsgemeinschaft; Alzheimer's Research Trust; Fonds der Chemischen Industrie; Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany; Alzheimers Research UK [ART-PPG2005A-4] Funding Source: researchfish	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Second University of Naples; Futura-onlus; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alzheimer's Research Trust; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	Brain tissue was obtained from the German Brain Bank "Brain-Net," which is supported by the Federal Ministry of Education and Research.; Supported by grants from Second University of Naples and Futura-onlus.; Supported by Deutsche Forschungsgemeinschaft, Alzheimer's Research Trust, the Fonds der Chemischen Industrie, and a grant from the Innovation, Science, Research, and Technology Ministry of Nordrhein-West-falen, Germany.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2009, J CELL BIOCHEM, V107, P253, DOI 10.1002/jcb.22121; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Clawson GA, 2008, J CELL BIOCHEM, V105, P81, DOI 10.1002/jcb.21804; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Dentillo DB, 2010, REPROD SCI, V17, P1016, DOI 10.1177/1933719110377662; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Fath T, 2002, J NEUROSCI, V22, P9733; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasenbein S, 2010, J MOL BIOL, V397, P957, DOI 10.1016/j.jmb.2010.02.027; Hauske P, 2009, BIOORGAN MED CHEM, V17, P2920, DOI 10.1016/j.bmc.2009.01.073; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Severino A, 2007, J AM COLL CARDIOL, V50, P1029, DOI 10.1016/j.jacc.2007.06.006; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Xia SJ, 2007, LAB INVEST, V87, P318, DOI 10.1038/labinvest.3700521; Yang LS, 1997, J NEUROCHEM, V69, P1548; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836	62	57	58	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20931	20941		10.1074/jbc.M111.316232	http://dx.doi.org/10.1074/jbc.M111.316232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22535953	hybrid, Green Published			2022-12-28	WOS:000306416800015
J	Park, JN; Lee, DJ; Kwon, O; Oh, DB; Bahn, YS; Kang, HA				Park, Jeong-Nam; Lee, Dong-Jik; Kwon, Ohsuk; Oh, Doo-Byoung; Bahn, Yong-Sun; Kang, Hyun Ah			Unraveling Unique Structure and Biosynthesis Pathway of N-Linked Glycans in Human Fungal Pathogen Cryptococcus neoformans by Glycomics Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER CHAIN ELONGATION; CELL-WALL; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYLTRANSFERASE FAMILY; POLYSACCHARIDE CAPSULE; PROTEIN GLYCOSYLATION; PICHIA-PASTORIS; MATING TYPES; IDENTIFICATION	The encapsulated fungal pathogen Cryptococcus neoformans causes cryptococcosis in immunocompromised individuals. Although cell surface mannoproteins have been implicated in C. neoformans pathogenicity, the structure of N-linked glycans assembled on mannoproteins has not yet been elucidated. By analyzing oligosaccharide profiles combined with exoglycosi-dase treatment, we report here that C. neoformans has serotype-specific high mannose-type N-glycans with or without a beta 1,2-xylose residue, which is attached to the trimannosyl core of N-glycans. Interestingly, the neutral N-glycans of serotypes A and D were shown to contain a xylose residue, whereas those of serotype B appeared to be much shorter and devoid of a xylose residue. Moreover, analysis of the C. neoformans uxs1 Delta mutant demonstrated that UDP-xylose is utilized as a donor sugar in N-glycan biosynthesis. We also constructed and analyzed a set of C. neoformans mutant strains lacking genes putatively assigned to the reconstructed N-glycan biosynthesis pathway. It was shown that the outer chain of N-glycan is initiated by CnOch1p with addition of an alpha 1,6-mannose residue and then subsequently extended by CnMnn2p with multiple additions of alpha 1,2-mannose residues. Finally, comparative analysis of acidic N-glycans from wild-type, Cnoch1 Delta, Cnmnn2 Delta, and Cnuxs1 Delta strains strongly indicated the presence of xylose phosphate attached to mannose residues in the core and outer region of N-glycans. Our data present the first report on the unique structure and biosynthesis pathway of N-glycans in C. neoformans.	[Park, Jeong-Nam; Lee, Dong-Jik; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea; [Kwon, Ohsuk; Oh, Doo-Byoung] Korea Res Inst Biosci & Biotechnol, Syst & Synthet Biol Res Ctr, Taejon 305806, South Korea; [Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea	Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752; Oh, Doo-Byoung/0000-0002-4432-0941	Korean Ministry of Education, Science, and Technology [2010-0029117, 2012-0001150]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the National Research Foundation of cerevisiae are modified by the addition of phosphomannan by Korea Grants 2010-0029117 and 2012-0001150 from the Korean Ministry of Education, Science, and Technology.	Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Biondo C, 2005, INFECT IMMUN, V73, P7348, DOI 10.1128/IAI.73.11.7348-7355.2005; Biondo C, 2006, FEMS YEAST RES, V6, P645, DOI 10.1111/j.1567-1364.2006.00043.x; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Leach MD, 2012, EUKARYOT CELL, V11, P98, DOI 10.1128/EC.05238-11; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nakayama K, 1997, FEBS LETT, V412, P547, DOI 10.1016/S0014-5793(97)00634-0; Park JN, 2011, APPL ENVIRON MICROB, V77, P1187, DOI 10.1128/AEM.02323-10; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reilly MC, 2011, J BIOL CHEM, V286, P26888, DOI 10.1074/jbc.M111.262162; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Song Y, 2007, APPL ENVIRON MICROB, V73, P4446, DOI 10.1128/AEM.02058-06; Turner KM, 2006, BBA-GEN SUBJECTS, V1760, P1569, DOI 10.1016/j.bbagen.2006.07.002; Uccelletti D, 2006, FEMS YEAST RES, V6, P449, DOI 10.1111/j.1567-1364.2006.00027.x; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wozniak Karen L., 2009, V470, P71, DOI 10.1007/978-1-59745-204-5_7; Yoko-o T, 2001, FEBS LETT, V489, P75, DOI 10.1016/S0014-5793(01)02082-8	50	31	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19501	19515		10.1074/jbc.M112.354209	http://dx.doi.org/10.1074/jbc.M112.354209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22500028	hybrid, Green Published			2022-12-28	WOS:000306411900063
J	Yount, JS; Karssemeijer, RA; Hang, HC				Yount, Jacob S.; Karssemeijer, Roos A.; Hang, Howard C.			S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCTS; IFITM3; CAVEOLIN; FAMILY; IDENTIFICATION; LOCALIZATION; CHOLESTEROL; CYTOTOXIN; AUTOPHAGY; EFFECTORS	The interferon (IFN)-induced transmembrane protein 3 (IFITM3) is a cellular restriction factor that inhibits infection by influenza virus and many other pathogenic viruses. IFITM3 prevents endocytosed virus particles from accessing the host cytoplasm although little is known regarding its regulatory mechanisms. Here we demonstrate that IFITM3 localization to and antiviral remodeling of endolysosomes is differentially regulated by S-palmitoylation and lysine ubiquitination. Although S-palmitoylation enhances IFITM3 membrane affinity and antiviral activity, ubiquitination decreases localization with endolysosomes and decreases antiviral activity. Interestingly, autophagy reportedly induced by IFITM3 expression is also negatively regulated by ubiquitination. However, the canonical ATG5-dependent autophagy pathway is not required for IFITM3 activity, indicating that virus trafficking from endolysosomes to autophagosomes is not a pre-requisite for influenza virus restriction. Our characterization of IFITM3 ubiquitination sites also challenges the dual-pass membrane topology predicted for this protein family. We thus evaluated topology by N-linked glycosylation site insertion and protein lipidation mapping in conjunction with cellular fractionation and fluorescence imaging. Based on these studies, we propose that IFITM3 is predominantly an intramembrane protein where both the N and C termini face the cytoplasm. In sum, by characterizing S-palmitoylation and ubiquitination of IFITM3, we have gained a better understanding of the trafficking, activity, and intramembrane topology of this important IFN-induced effector protein.	[Yount, Jacob S.; Karssemeijer, Roos A.; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	Rockefeller University	Hang, HC (corresponding author), Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA.	hhang@rockefeller.edu	Yount, Jacob/F-9905-2014	Yount, Jacob/0000-0002-6128-4575	National Institutes of Health (NIAID) [1K99AI095348, 1R01GM087544]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI095348, R00AI095348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1K99AI095348 (NIAID; to J. S. Y) and 1R01GM087544 (NIGMS'; to H. C. H.). This work was also supported by the Ellison Medical Foundation (to H. C. H.).	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Charron G, 2011, MOL BIOSYST, V7, P67, DOI 10.1039/c0mb00183j; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Gauthier NC, 2004, J BIOL CHEM, V279, P9481, DOI 10.1074/jbc.M312040200; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seyfried NT, 2008, CANCER LETT, V263, P243, DOI 10.1016/j.canlet.2008.01.007; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yount JS, 2010, J AM CHEM SOC, V132, P8244, DOI 10.1021/ja102257v; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Zou K, 2011, STEM CELLS DEV, V20, P2197, DOI 10.1089/scd.2011.0091	41	137	146	5	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19631	19641		10.1074/jbc.M112.362095	http://dx.doi.org/10.1074/jbc.M112.362095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22511783	Green Published, hybrid			2022-12-28	WOS:000306411900074
J	Richart, AN; Brunner, CIW; Stott, K; Murzina, NV; Thomas, JO				Richart, Alexandria N.; Brunner, Clair I. W.; Stott, Katherine; Murzina, Natalia V.; Thomas, Jean O.			Characterization of Chromoshadow Domain-mediated Binding of Heterochromatin Protein 1 alpha (HP1 alpha) to Histone H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HP1 BINDING; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; MAMMALIAN-CELLS; NUCLEOSOMAL DNA; LYSINE 9; CHROMATIN; DYNAMICS; CHROMODOMAIN; RECOGNITION	The chromoshadow domain (CSD) of heterochromatin protein 1 (HP1) was recently shown to contribute to chromatin binding and transcriptional regulation through interaction with histone H3. Here, we demonstrate the structural basis of this interaction for the CSD of HP1 alpha. This mode of H3 binding is dependent on dimerization of the CSD and recognition of a PxVxL-like motif, as for other CSD partners. NMR chemical shift mapping showed that the H3 residues that mediate the CSD interaction occur in and adjacent to the alpha N helix just within the nucleosome core. Access to the binding region would require some degree of unwrapping of the DNA near the nucleosomal DNA entry/exit site.	[Richart, Alexandria N.; Brunner, Clair I. W.; Stott, Katherine; Murzina, Natalia V.; Thomas, Jean O.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Murzina, NV (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	nm@mole.bio.cam.ac.uk; jot1@cam.ac.uk		Stott, Katherine/0000-0002-4014-1188	Wellcome Trust [094519/Z/10/Z]; Gates Cambridge Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Gates Cambridge Trust	This work was supported by Project Grant 094519/Z/10/Z from the Wellcome Trust (to J. O. T. and N. V. M.) and by a scholarship from the Gates Cambridge Trust (to A. N. R.).	Ayoub N, 2009, CELL CYCLE, V8, P2945; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Kato H, 2009, J AM CHEM SOC, V131, P15104, DOI 10.1021/ja9070078; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Muller KP, 2009, BIOPHYS J, V97, P2876, DOI 10.1016/j.bpj.2009.08.057; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Somers J, 2009, NUCLEIC ACIDS RES, V37, P2504, DOI 10.1093/nar/gkp114; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18730	18737		10.1074/jbc.M111.337204	http://dx.doi.org/10.1074/jbc.M111.337204			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493481	Green Published, hybrid			2022-12-28	WOS:000306411600081
J	Scranton, MA; Yee, A; Park, SY; Walling, LL				Scranton, Melissa A.; Yee, Ashley; Park, Sang-Youl; Walling, Linda L.			Plant Leucine Aminopeptidases Moonlight as Molecular Chaperones to Alleviate Stress-induced Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; END RULE PATHWAY; ARABIDOPSIS-THALIANA; MANDUCA-SEXTA; LAP-A; NICOTIANA-ATTENUATA; GENE-EXPRESSION; JASMONIC ACID; AMINO-ACID; IN-VITRO	Leucine aminopeptidases (LAPs) are present in animals, plants, and microbes. In plants, there are two classes of LAPs. The neutral LAPs (LAP-N and its orthologs) are constitutively expressed and detected in all plants, whereas the stress-induced acidic LAPs (LAP-A) are expressed only in a subset of the Solanaceae. LAPs have a role in insect defense and act as a regulator of the late branch of wound signaling in Solanum lycopersicum (tomato). Although the mechanism of LAP-A action is unknown, it has been presumed that LAP peptidase activity is essential for regulating wound signaling. Here we show that plant LAPs are bifunctional. Using three assays to monitor protein protection from heat-induced damage, it was shown that the tomato LAP-A and LAP-N and the Arabidopsis thaliana LAP1 and LAP2 are molecular chaperones. Assays using LAP-A catalytic site mutants demonstrated that LAP-A chaperone activity was independent of its peptidase activity. Furthermore, disruption of the LAP-A hexameric structure increased chaperone activity. Together, these data identify a new class of molecular chaperones and a new function for the plant LAPs as well as suggesting new mechanisms for LAP action in the defense of solanaceous plants against stress.	[Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	Linda.walling@ucr.edu		Scranton, Melissa/0000-0003-1910-3117	National Science Foundation [IOB 0645230, MCB 0313579, DGE 0504249, IOB 064523]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants IOB 0645230 and MCB 0313579 (to L. L. W.).; Supported in part by the National Science Foundation-funded ChemlGERT program (Grant DGE 0504249) and Grant IOB 064523.	[Anonymous], 2004, HDB PROTEOLYTIC ENZY; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; BARTLING D, 1992, EUR J BIOCHEM, V205, P425, DOI 10.1111/j.1432-1033.1992.tb16796.x; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chen H, 2007, PLANT PHYSIOL, V143, P1954, DOI 10.1104/pp.106.095588; DOW JAT, 1992, J EXP BIOL, V172, P355; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Gu YQ, 2000, EUR J BIOCHEM, V267, P1178, DOI 10.1046/j.1432-1327.2000.01116.x; Gu YQ, 1996, PLANT PHYSIOL, V110, P1257, DOI 10.1104/pp.110.4.1257; Gu YQ, 1996, J BIOL CHEM, V271, P25880, DOI 10.1074/jbc.271.42.25880; Gu YQ, 2002, EUR J BIOCHEM, V269, P1630, DOI 10.1046/j.1432-1327.2002.02795.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Huynh KH, 2009, ACTA CRYSTALLOGR F, V65, P952, DOI 10.1107/S1744309109031467; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; Kale A, 2010, J MOL BIOL, V398, P703, DOI 10.1016/j.jmb.2010.03.042; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Lawrence SD, 2008, J CHEM ECOL, V34, P1013, DOI 10.1007/s10886-008-9507-2; Lee GJ, 1998, METHOD ENZYMOL, V290, P350, DOI 10.1016/S0076-6879(98)90031-3; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Lee S, 2009, BMB REP, V42, P812, DOI 10.5483/BMBRep.2009.42.12.812; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Narvaez-Vasquez J, 2008, PLANTA, V227, P341, DOI 10.1007/s00425-007-0621-0; Neuwald AF, 1999, GENOME RES, V9, P27; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pautot V, 2001, MOL PLANT MICROBE IN, V14, P214, DOI 10.1094/MPMI.2001.14.2.214; Peer WA, 2011, ANN BOT-LONDON, V107, P1171, DOI 10.1093/aob/mcq265; Peer WA, 2009, PLANT CELL, V21, P1693, DOI 10.1105/tpc.108.059634; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ross S, 2005, PLANT PHYSIOL, V137, P623, DOI 10.1104/pp.104.056861; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Santhoshkumar P, 2001, MOL VIS, V7, P172; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Taylor A, 1985, Prog Clin Biol Res, V180, P299; Tu CJ, 2003, PLANT PHYSIOL, V132, P243, DOI 10.1104/pp.102.013854; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 2004, HDB PROTEOLYTIC ENZY, P901; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006	66	41	43	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18408	18417		10.1074/jbc.M111.309500	http://dx.doi.org/10.1074/jbc.M111.309500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493451	Green Published, hybrid			2022-12-28	WOS:000306411600047
J	Rogers, MA; Liu, J; Kushnir, MM; Bryleva, E; Rockwood, AL; Meikle, AW; Shapiro, D; Vaisman, BL; Remaley, AT; Chang, CCY; Chang, TY				Rogers, Maximillian A.; Liu, Jay; Kushnir, Mark M.; Bryleva, Elena; Rockwood, Alan L.; Meikle, A. Wayne; Shapiro, David; Vaisman, Boris L.; Remaley, Alan T.; Chang, Catherine C. Y.; Chang, Ta-Yuan			Cellular Pregnenolone Esterification by Acyl-CoA:Cholesterol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; FATTY-ACID-ESTERS; LIPOIDAL DERIVATIVES; COENZYME; DEHYDROEPIANDROSTERONE; NEUROSTEROIDS; ENZYMES; PLASMA; BRAIN; CELLS	Pregnenolone (PREG) can be converted to PREG esters (PE) by the plasma enzyme lecithin: cholesterol acyltransferase (LCAT), and by other enzyme(s) with unknown identity. Acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2) convert various sterols to steryl esters; their activities are activated by cholesterol. PREG is a sterol-like molecule, with 3-beta-hydroxy moiety at steroid ring A, but with much shorter side chain at steroid ring D. Here we show that without cholesterol, PREG is a poor ACAT substrate; with cholesterol, the V-max for PREG esterification increases by 100-fold. The binding affinity of ACAT1 for PREG is 30-50-fold stronger than that for cholesterol; however, PREG is only a substrate but not an activator, while cholesterol is both a substrate and an activator. These results indicate that the sterol substrate site in ACAT1 does not involve significant sterol-phospholipid interaction, while the sterol activator site does. Studies utilizing small molecule ACAT inhibitors show that ACAT plays a key role in PREG esterification in various cell types examined. Mice lacking ACAT1 or ACAT2 do not have decreased PREG ester contents in adrenals, nor do they have altered levels of the three major secreted adrenal steroids in serum. Mice lacking LCAT have decreased levels of PREG esters in the adrenals. These results suggest LCAT along with ACAT1/ACAT2 contribute to control pregnenolone ester content in different cell types and tissues.	[Rogers, Maximillian A.; Liu, Jay; Bryleva, Elena; Shapiro, David; Chang, Catherine C. Y.; Chang, Ta-Yuan] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Kushnir, Mark M.; Rockwood, Alan L.; Meikle, A. Wayne] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA; [Kushnir, Mark M.; Rockwood, Alan L.; Meikle, A. Wayne] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Vaisman, Boris L.; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA	Dartmouth College; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chang, CCY (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	Catherine.Chang@Dartmouth.Edu; Ta.Yuan.Chang@Dartmouth.Edu	Vaisman, Boris L/B-3453-2008	Kushnir, Mark/0000-0003-4480-0854; Chang, Ta-Yuan/0000-0002-3249-0468; Rogers, Maximillian/0000-0001-9277-3200	National Institutes of Health (NIH) NRSA; ARUP Institute for Clinical and Experimental Pathology; NIH [R01AG37609, HL60306]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058, R01HL060306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037609] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARUP Institute for Clinical and Experimental Pathology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health (NIH) NRSA T32 Postdoctoral Fellowship (to M. A. R.), an NIH Institutional Predoctoral Training Grant Fellowship (to J. L.), and NIH Grants R01AG37609 (to T. Y. C.), and HL60306 (to T. Y. C. and C. C. Y. C.). This work was also supported in part by the ARUP Institute for Clinical and Experimental Pathology.	BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BELANGER B, 1990, J ENDOCRINOL, V127, P505, DOI 10.1677/joe.0.1270505; BISHOP JE, 1980, ANAL BIOCHEM, V106, P344, DOI 10.1016/0003-2697(80)90531-X; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chang C.C.Y., 2011, FRONT BIOL, V6, P177, DOI DOI 10.1007/S11515-011-1149-Z; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; DAMON M, 1982, J STEROID BIOCHEM, V16, P771, DOI 10.1016/0022-4731(82)90034-6; Fersht A., 1985, ENZYME STRUCTURE MEC; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Kushnir MM, 2006, CLIN CHEM, V52, P1559, DOI 10.1373/clinchem.2006.068445; Lavallee B, 1996, BBA-LIPID LIPID MET, V1299, P306, DOI 10.1016/0005-2760(95)00222-7; Liere P, 2004, J LIPID RES, V45, P2287, DOI 10.1194/jlr.M400244-JLR200; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; MELLONNUSSBAUM S, 1979, J BIOL CHEM, V254, P2500; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; ROBERTS E, 1995, BIOCHEM PHARMACOL, V49, P1, DOI 10.1016/0006-2952(94)00258-N; Rousset X, 2010, J PHARMACOL EXP THER, V335, P140, DOI 10.1124/jpet.110.169540; VOURCH C, 1992, STEROIDS, V57, P210, DOI 10.1016/0039-128X(92)90104-H; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yu CJ, 2002, BIOCHEMISTRY-US, V41, P3762, DOI 10.1021/bi0120188; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139; Zhang Y, 2003, J BIOL CHEM, V278, P11642, DOI 10.1074/jbc.M211559200	27	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17483	17492		10.1074/jbc.M111.331306	http://dx.doi.org/10.1074/jbc.M111.331306			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22474282	Green Published, hybrid			2022-12-28	WOS:000306373000048
J	van den Boom, J; Heider, D; Martin, SR; Pastore, A; Mueller, JW				van den Boom, Johannes; Heider, Dominik; Martin, Stephen R.; Pastore, Annalisa; Mueller, Jonathan W.			3 '-Phosphoadenosine 5 '-Phosphosulfate (PAPS) Synthases, Naturally Fragile Enzymes Specifically Stabilized by Nucleotide Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL DEVELOPMENT; KINETIC-PROPERTIES; KINASE DOMAIN; LOCALIZATION; EXPRESSION; FAMILY; ACCUMULATION; SYNTHETASE-1; MUTATIONS; PROTEINS	Activated sulfate in the form of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) is needed for all sulfation reactions in eukaryotes with implications for the build-up of extracellular matrices, retroviral infection, protein modification, and steroid metabolism. In metazoans, PAPS is produced by bifunctional PAPS synthases (PAPSS). A major question in the field is why two human protein isoforms, PAPSS1 and -S2, are required that cannot complement for each other. We provide evidence that these two proteins differ markedly in their stability as observed by unfolding monitored by intrinsic tryptophan fluorescence as well as circular dichroism spectroscopy. At 37 degrees C, the half-life for unfolding of PAPSS2 is in the range of minutes, whereas PAPSS1 remains structurally intact. In the presence of their natural ligand, the nucleotide adenosine 5'-phosphosulfate (APS), PAPS synthase proteins are stabilized. Invertebrates only possess one PAPS synthase enzyme that we classified as PAPSS2-type by sequence-based machine learning techniques. To test this prediction, we cloned and expressed the PPS-1 protein from the roundworm Caenorhabditis elegans and also subjected this protein to thermal unfolding. With respect to thermal unfolding and the stabilization by APS, PPS-1 behaved like the unstable human PAPSS2 protein suggesting that the less stable protein is evolutionarily older. Finally, APS binding more than doubled the half-life for unfolding of PAPSS2 at physiological temperatures and effectively prevented its aggregation on a time scale of days. We propose that protein stability is a major contributing factor for PAPS availability that has not as yet been considered. Moreover, naturally occurring changes in APS concentrations may be sensed by changes in the conformation of PAPSS2.	[van den Boom, Johannes; Mueller, Jonathan W.] Univ Duisburg Essen, ZMB, Dept Struct & Med Biochem, D-45117 Essen, Germany; [Heider, Dominik] Univ Duisburg Essen, ZMB, Dept Bioinformat, D-45117 Essen, Germany; [van den Boom, Johannes; Martin, Stephen R.; Pastore, Annalisa; Mueller, Jonathan W.] MRC Natl Inst Med Res, London NW7 1AA, England	University of Duisburg Essen; University of Duisburg Essen; MRC National Institute for Medical Research	Mueller, JW (corresponding author), Univ Duisburg Essen, ZMB, Dept Struct & Med Biochem, D-45117 Essen, Germany.	jonathan.mueller@uni-due.de	Heider, Dominik/F-8545-2010; Mueller, Jonathan Wolf/D-1632-2010	Heider, Dominik/0000-0002-3108-8311; Mueller, Jonathan Wolf/0000-0003-1212-189X	EMBO Fellowship [ASTF 151/2011]; Fonds der Chemischen Industrie	EMBO Fellowship(European Molecular Biology Organization (EMBO)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by EMBO Fellowship ASTF 151/2011 (to J.W.M.).; Supported by a scholarship from the Fonds der Chemischen Industrie.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Ford-Hutchinson AF, 2005, OSTEOARTHR CARTILAGE, V13, P418, DOI 10.1016/j.joca.2004.12.011; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; He DN, 2006, DRUG METAB DISPOS, V34, P1749, DOI 10.1124/dmd.106.011114; Heider D, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-16; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Lansdon EB, 2004, BIOCHEMISTRY-US, V43, P4356, DOI 10.1021/bi049827m; Lederer C, 2011, EVOL BIOINFORM, V7, P135, DOI 10.4137/EBO.S7683; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; R Development Core Team, 2009, R LANG ENV STAT COMP; Schroder E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029559; Sekulic N, 2007, J BIOL CHEM, V282, P22112, DOI 10.1074/jbc.M701713200; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Shih WL, 2009, EUR J HUM GENET, V17, P1250, DOI 10.1038/ejhg.2009.48; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Todeschini AL, 2006, J BIOL CHEM, V281, P3276, DOI 10.1074/jbc.M511688200; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	39	28	30	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17645	17655		10.1074/jbc.M111.325498	http://dx.doi.org/10.1074/jbc.M111.325498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22451673	Green Published, hybrid			2022-12-28	WOS:000306373000063
J	Guo, A; Cala, SE; Song, LS				Guo, Ang; Cala, Steven E.; Song, Long-Sheng			Calsequestrin Accumulation in Rough Endoplasmic Reticulum Promotes Perinuclear Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CARDIAC MYOCYTES; JUNCTIONAL SARCOPLASMIC-RETICULUM; SCANNING CONFOCAL MICROSCOPY; RYANODINE-RECEPTORS; NUCLEAR-ENVELOPE; ATRIAL MYOCYTES; HEART-FAILURE; LUMINAL CA2+; CALCIUM; TRIADIN	Molecular mechanisms underlying Ca2+ regulation by perinuclear endoplasmic/sarcoplasmic reticulum (ER/SR) cisternae in cardiomyocytes remain obscure. To investigate the mechanisms of changes in cardiac calsequestrin ( CSQ2) trafficking on perinuclear Ca2+ signaling, we manipulated the subcellular distribution of CSQ2 by overexpression of CSQ2-DsRed, which specifically accumulates in the perinuclear rough ER. Adult ventricular myocytes were infected with adenoviruses expressing CSQ2-DsRed, CSQ2-WT, or empty vector. We found that perinuclear enriched CSQ2-DsRed, but not normally distributed CSQ2-WT, enhanced nuclear Ca2+ transients more potently than cytosolic Ca2+ transients. Overexpression of CSQ2-DsRed produced more actively propagating Ca2+ waves from perinuclear regions than did CSQ2-WT. Activities of the SR/ER Ca2+-ATPase and ryanodine receptor type 2, but not inositol 1,4,5-trisphosphate receptor type 2, were required for the generation of these perinuclear initiated Ca2+ waves. In addition, CSQ2-DsRed was more potent than CSQ2-WT in inducing cellular hypertrophy in cultured neonatal cardiomyocytes. Our data demonstrate for the first time that CSQ2 retention in the rough ER/perinuclear region promotes perinuclear Ca2+ signaling and predisposes to ryanodine receptor type 2-mediated Ca2+ waves from CSQ2-enriched perinuclear compartments and myocyte hypotrophy. These findings provide new insights into the mechanism of CSQ2 in Ca2+ homeostasis, suggesting that rough ER-localized Ca2+ stores can operate independently in raising levels of cytosolic/nucleoplasmic Ca2+ as a source of Ca2+ for Ca2+-dependent signaling in health and disease.	[Cala, Steven E.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Guo, Ang; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA	Wayne State University; University of Iowa	Cala, SE (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	s.cala@wayne.edu; long-sheng-song@uiowa.edu	Guo, Ang/M-3549-2013	Guo, Ang/0000-0002-5551-2279; Song, Long-Sheng/0000-0002-6035-8106	National Institutes of Health [R01 HL090905, R01 HL062586]; American Heart Association [0635056N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062586, R01HL090905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL090905 (to L.-S. S.) and R01 HL062586 (to S. E. C.). This work was also supported by American Heart Association Scientific Development Grant 0635056N (to L.-S. S.). The work performed in the University of Iowa Gene Transfer Vector Core was supported by the National Institutes of Health.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Escobar M, 2011, J MOL CELL CARDIOL, V50, P451, DOI 10.1016/j.yjmcc.2010.11.021; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Genka C, 1999, CELL CALCIUM, V25, P199, DOI 10.1054/ceca.1999.0026; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Ibarra C, 2004, J BIOL CHEM, V279, P7554, DOI 10.1074/jbc.M311604200; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Kockskamper J, 2008, J CELL SCI, V121, P186, DOI 10.1242/jcs.021386; Kubalova Z, 2004, J PHYSIOL-LONDON, V561, P515, DOI 10.1113/jphysiol.2004.073940; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; McFarland TP, 2011, MOL CELL BIOCHEM, V353, P81, DOI 10.1007/s11010-011-0777-6; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Qin J, 2008, J GEN PHYSIOL, V131, P325, DOI 10.1085/jgp.200709907; Ram ML, 2004, MOL CELL BIOCHEM, V266, P209, DOI 10.1023/B:MCBI.0000049164.28580.56; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Tanaka H, 1996, JPN J PHARMACOL, V70, P235, DOI 10.1254/jjp.70.235; Tanaka H, 1996, J CARDIOVASC PHARM, V27, P761, DOI 10.1097/00005344-199606000-00001; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	39	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16670	16680		10.1074/jbc.M112.340927	http://dx.doi.org/10.1074/jbc.M112.340927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22457350	Green Published, hybrid			2022-12-28	WOS:000304030900055
J	Lim, J; Lee, Y; Kim, HW; Rhyu, IJ; Oh, MS; Youdim, MBH; Yue, ZY; Oh, YJ				Lim, Junghyun; Lee, Yunsu; Kim, Hyun-Wook; Rhyu, Im Joo; Oh, Myung Sook; Youdim, Moussa B. H.; Yue, Zhenyu; Oh, Young J.			Nigericin-induced Impairment of Autophagic Flux in Neuronal Cells Is Inhibited by Overexpression of Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; MULTIVESICULAR BODIES; CATION COMPLEXES; MAMMALIAN-CELLS; X-L; APOPTOSIS; PROTEIN; DEATH; BECLIN-1; MACROAUTOPHAGY	Bak is a prototypic pro-apoptotic Bcl-2 family protein expressed in a wide variety of tissues and cells. Recent studies have revealed that Bcl-2 family proteins regulate apoptosis as well as autophagy. To investigate whether and how Bak exerts a regulatory role on autophagy-related events, we treated independent cell lines, including MN9D neuronal cells, with nigericin, a K+/H+ ionophore. Treatment of MN9D cells with nigericin led to an increase of LC3-II and p62 levels with concomitant activation of caspase. Ultrastructural examination revealed accumulation of autophagic vacuoles and swollen vacuoles in nigericin-treated cells. We further found that the LC3-II accumulated as a consequence of impaired autophagic flux and the disrupted degradation of LC3-II in nigericin-treated cells. In this cell death paradigm, both transient and stable overexpression of various forms of Bak exerted a protective role, whereas it did not inhibit the extent of nigericin-mediated activation of caspase-3. Subsequent biochemical and electron microscopic studies revealed that overexpressed Bak maintained autophagic flux and reduced the area occupied by swollen vacuoles in nigericin-treated cells. Similar results were obtained in nigericin-treated non-neuronal cells and another proton ionophore-induced cell death paradigm. Taken together, our study indicates that a protective role for Bak during ionophore-induced cell death may be closely associated with its regulatory effect on maintenance of autophagic flux and vacuole homeostasis.	[Lim, Junghyun; Lee, Yunsu; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biol, Seoul 120749, South Korea; [Kim, Hyun-Wook; Rhyu, Im Joo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Oh, Myung Sook] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Youdim, Moussa B. H.] Technion Israel Inst Technol, IL-31096 Haifa, Israel; [Yue, Zhenyu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA	Yonsei University; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Technion Israel Institute of Technology; Icahn School of Medicine at Mount Sinai	Oh, YJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	yjoh@yonsei.ac.kr	Oh, Myung Sook/AAH-9948-2020	Rhyu, Im Joo/0000-0002-5558-6278	Ministry of Science and Technology through BRC; Korea Science and Engineering Foundation (SRC) [2012-0000496]; Mid-Career Research Program through NRF; Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060123] Funding Source: NIH RePORTER	Ministry of Science and Technology through BRC; Korea Science and Engineering Foundation (SRC)(Korea Science and Engineering Foundation); Mid-Career Research Program through NRF; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Ministry of Science and Technology through BRC, and in part by the Korea Science and Engineering Foundation (SRC, 2012-0000496) and the Mid-Career Research Program through NRF funded by the Ministry of Education, Science, and Technology (to Y. J. O.).	Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim JE, 1999, J NEUROCHEM, V72, P2456, DOI 10.1046/j.1471-4159.1999.0722456.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Oh JH, 1997, NEUROREPORT, V8, P1851, DOI 10.1097/00001756-199705260-00012; PINKERTO.M, 1970, J MOL BIOL, V49, P533, DOI 10.1016/0022-2836(70)90279-2; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; STEINRAUF LK, 1971, BIOCHEM BIOPH RES CO, V45, P1279, DOI 10.1016/0006-291X(71)90156-2; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thorens B, 1996, J CELL SCI, V109, P1311; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	47	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23271	23282		10.1074/jbc.M112.364281	http://dx.doi.org/10.1074/jbc.M112.364281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22493436	Green Published, hybrid			2022-12-28	WOS:000306511300002
J	Nakamura, A; Fujihashi, M; Aono, R; Sato, T; Nishiba, Y; Yoshida, S; Yano, A; Atomi, H; Imanaka, T; Miki, K				Nakamura, Akira; Fujihashi, Masahiro; Aono, Riku; Sato, Takaaki; Nishiba, Yosuke; Yoshida, Shosuke; Yano, Ayumu; Atomi, Haruyuki; Imanaka, Tadayuki; Miki, Kunio			Dynamic, Ligand-dependent Conformational Change Triggers Reaction of Ribose-1,5-bisphosphate Isomerase from Thermococcus kodakarensis KOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Ribose-1,5-bisphosphate isomerase (R15Pi) is a novel enzyme recently identified as a member of an AMP metabolic pathway in archaea. The enzyme converts D-ribose 1,5-bisphosphate into ribulose 1,5-bisphosphate, providing the substrate for archaeal ribulose-1,5-bisphosphate carboxylase/oxygenases. We here report the crystal structures of R15Pi from Thermococcus kodakarensis KOD1 (Tk-R15Pi) with and without its substrate or product. Tk-R15Pi is a hexameric enzyme formed by the trimerization of dimer units. Biochemical analyses show that Tk-R15Pi only accepts the alpha-anomer of D-ribose 1,5-bisphosphate and that Cys(133) and Asp(202) residues are essential for ribulose 1,5-bisphosphate production. Comparison of the determined structures reveals that the unliganded and product-binding structures are in an open form, whereas the substrate-binding structure adopts a closed form, indicating domain movement upon substrate binding. The conformational change to the closed form optimizes active site configuration and also isolates the active site from the solvent, which may allow deprotonation of Cys(133) and protonation of Asp(202) to occur. The structural features of the substrate-binding form and biochemical evidence lead us to propose that the isomerase reaction proceeds via a cis-phosphoenolate intermediate.	[Nakamura, Akira; Fujihashi, Masahiro; Nishiba, Yosuke; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Aono, Riku; Sato, Takaaki; Yoshida, Shosuke; Yano, Ayumu; Atomi, Haruyuki] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kusatsu, Shiga 5258577, Japan	Kyoto University; Kyoto University; Ritsumeikan University	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp	Nakamura, Akira/C-1658-2016; Nakamura, Akira/K-2982-2019	Nakamura, Akira/0000-0001-7733-4007; Nakamura, Akira/0000-0001-7733-4007; Atomi, Haruyuki/0000-0001-9687-6426; Aono, Riku/0000-0003-4235-0968	Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22750150] Funding Source: KAKEN	Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buman M, 2004, J BIOL CHEM, V279, P37087, DOI 10.1074/jbc.M404458200; COLLYER CA, 1990, J MOL BIOL, V212, P211, DOI 10.1016/0022-2836(90)90316-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hamada K, 2003, J BIOL CHEM, V278, P49183, DOI 10.1074/jbc.M309272200; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; Kakuta Y, 2004, BIOCHEM BIOPH RES CO, V319, P725, DOI 10.1016/j.bbrc.2004.05.045; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P3726, DOI 10.1073/pnas.95.7.3726; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Mueller-Cajar O, 2007, BIOESSAYS, V29, P722, DOI 10.1002/bies.20616; Naor MM, 2004, PROTEINS, V57, P799, DOI 10.1002/prot.20261; O'Donoghue AM, 2005, BIOCHEMISTRY-US, V44, P2610, DOI 10.1021/bi047954c; O'Donoghue AMC, 2005, BIOCHEMISTRY-US, V44, P2622, DOI 10.1021/bi047953k; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE N, 1994, BIOCHIMIE, V76, P748, DOI 10.1016/0300-9084(94)90079-5; RIEDER SV, 1959, J BIOL CHEM, V234, P1007; Saito Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2021, DOI 10.1271/bbb.70209; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; SCHRAY KJ, 1973, J BIOL CHEM, V248, P2219; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Tamura H, 2008, PROTEIN SCI, V17, P126, DOI 10.1110/ps.073169008; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TOPPER YJ, 1957, J BIOL CHEM, V225, P419; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; WHITLOW M, 1991, PROTEINS, V9, P153, DOI 10.1002/prot.340090302; WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001; Zhang RG, 2003, STRUCTURE, V11, P31, DOI 10.1016/S0969-2126(02)00933-4	41	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20784	20796		10.1074/jbc.M112.349423	http://dx.doi.org/10.1074/jbc.M112.349423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V32MR	22511789	Green Published, hybrid			2022-12-28	WOS:000208955800001
J	Aussignargues, C; Giuliani, MC; Infossi, P; Lojou, E; Guiral, M; Giudici-Orticoni, MT; Ilbert, M				Aussignargues, Clement; Giuliani, Marie-Cecile; Infossi, Pascale; Lojou, Elisabeth; Guiral, Marianne; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne			Rhodanese Functions as Sulfur Supplier for Key Enzymes in Sulfur Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM AQUIFEX-AEOLICUS; MOLYBDENUM COFACTOR; OXYGENASE-REDUCTASE; ELEMENTAL SULFUR; SUD PROTEIN; SULFURTRANSFERASE; BIOSYNTHESIS; MEMBRANE; IDENTIFICATION; LOCALIZATION	How microorganisms obtain energy is a challenging topic, and there have been numerous studies on the mechanisms involved. Here, we focus on the energy substrate traffic in the hyperthermophilic bacterium Aquifex aeolicus. This bacterium can use insoluble sulfur as an energy substrate and has an intricate sulfur energy metabolism involving several sulfur-reducing and -oxidizing supercomplexes and enzymes. We demonstrate that the cytoplasmic rhodanese SbdP participates in this sulfur energy metabolism. Rhodaneses are a widespread family of proteins known to transfer sulfur atoms. We show that SbdP has also some unusual characteristics compared with other rhodaneses; it can load a long sulfur chain, and it can interact with more than one partner. Its partners (sulfur reductase and sulfur oxygenase reductase) are key enzymes of the sulfur energy metabolism of A. aeolicus and share the capacity to use long sulfur chains as substrate. We demonstrate a positive effect of SbdP, once loaded with sulfur chains, on sulfur reductase activity, most likely by optimizing substrate uptake. Taken together, these results lead us to propose a physiological role for SbdP as a carrier and sulfur chain donor to these key enzymes, therefore enabling channeling of sulfur substrate in the cell as well as greater efficiency of the sulfur energy metabolism of A. aeolicus.	[Aussignargues, Clement; Giuliani, Marie-Cecile; Infossi, Pascale; Lojou, Elisabeth; Guiral, Marianne; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne] Aix Marseille Univ, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, CNRS, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ilbert, M (corresponding author), Aix Marseille Univ, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	milbert@imm.cnrs.fr	Ilbert, marianne/ABG-5015-2021	ilbert, marianne/0000-0002-9070-2334	Ministere de l'Enseignement Superieur et de la Recherche; Collectivite Territoriale Corse	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Collectivite Territoriale Corse(Region Corse)	Recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.; Supported by the "Collectivite Territoriale Corse." Present address: Laboratoire de Biochimie et Biologie Moleculaire du Vegetal, UMR-CNRS 6134 SPE, Universite de Corse, Campus Grimaldi, 20250 Corte, France.	Acosta M, 2005, OMICS, V9, P13, DOI 10.1089/omi.2005.9.13; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; Bonch-Osmolovskaya E., 2007, ELS, DOI [10.1002/9780470015902.a0000405.pub2, DOI 10.1002/9780470015902.A0000405.PUB2]; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; BUKAU B, 1993, J GEN MICROBIOL, V139, P95, DOI 10.1099/00221287-139-1-95; CANNELLA C, 1984, ANAL BIOCHEM, V142, P159, DOI 10.1016/0003-2697(84)90531-1; Chen ZW, 2005, APPL ENVIRON MICROB, V71, P621, DOI 10.1128/AEM.71.2.621-628.2005; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Frigaard Niels-Ulrik, 2008, V27, P337; George GN, 2008, J BACTERIOL, V190, P6376, DOI 10.1128/JB.00539-08; Giuliani MC, 2007, FEBS J, V274, P4572, DOI 10.1111/j.1742-4658.2007.05985.x; Giuliani MC, 2010, BIOCHIMIE, V92, P388, DOI 10.1016/j.biochi.2009.12.013; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R., 2002, ELS, DOI [10.1038/npg.els.0000442, DOI 10.1038/NPG.ELS.0000442]; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Klimmek O, 1998, EUR J BIOCHEM, V253, P263, DOI 10.1046/j.1432-1327.1998.2530263.x; Klimmek O, 1999, EUR J BIOCHEM, V263, P79, DOI 10.1046/j.1432-1327.1999.00461.x; Klimmek O, 2005, MET IONS BIOL SYST, V43, P105; Lin YJ, 2004, BIOCHEMISTRY-US, V43, P1418, DOI 10.1021/bi0356597; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Montegrossi G, 2001, ANAL CHEM, V73, P3709, DOI 10.1021/ac001429b; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Pelletier N, 2008, EXTREMOPHILES, V12, P205, DOI 10.1007/s00792-007-0119-5; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Remelli W, 2010, BIOL CHEM, V391, P777, DOI 10.1515/BC.2010.073; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Urich T, 2006, SCIENCE, V311, P996, DOI 10.1126/science.1120306; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307	48	21	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19936	19948		10.1074/jbc.M111.324863	http://dx.doi.org/10.1074/jbc.M111.324863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22496367	hybrid, Green Published			2022-12-28	WOS:000306414500016
J	Chong, HH; Yao, X; Qiu, ZL; Qin, B; Han, RY; Waltersperger, S; Wang, MT; Cui, S; He, YX				Chong, Huihui; Yao, Xue; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; Waltersperger, Sandro; Wang, Meitian; Cui, Sheng; He, Yuxian			Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621-652	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 GP41; SIMIAN IMMUNODEFICIENCY VIRUS; COILED-COIL DOMAIN; 44 KDA ECTODOMAIN; CORE STRUCTURE; INTERHELICAL INTERACTIONS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; RESISTANT	The core structure of HIV-1 gp41 is a stable six-helix bundle (6-HB) folded by its trimeric N- and C-terminal heptad repeats (NHR and CHR). We previously identified that the (621)QIWNNMT(627) motif located at the upstream region of gp41 CHR plays critical roles for the stabilization of the 6-HB core and peptide CP621-652 containing this motif is a potent HIV-1 fusion inhibitor, however, the molecular determinants underlying the stability and anti-HIV activity remained elusive. In this study, we determined the high-resolution crystal structure of CP621-652 complexed by T21. We find that the (621)QIWNNMT(627) motif does not maintain the alpha-helical conformation. Instead, residues Met(626) and Thr(627) form a unique hook-like structure (denoted as M-T hook), in which Thr(627) redirects the peptide chain to position Met(626) above the left side of the hydrophobic pocket on the NHR trimer. The side chain of Met(626) caps the hydrophobic pocket, stabilizing the interaction between the pocket and the pocket-binding domain. Our mutagenesis studies demonstrate that mutations of the M-T hook residues could completely abolish HIV-1 Env-mediated cell fusion and virus entry, and significantly destabilize the interaction of NHR and CHR peptides and reduce the anti-HIV activity of CP621-652. Our results identify an unusual structural feature that stabilizes the six-helix bundle, providing novel insights into the mechanisms of HIV-1 fusion and inhibition.	[Chong, Huihui; Yao, Xue; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Chong, Huihui; Yao, Xue; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Cui, S (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cuisheng2007@yahoo.com.cn; yhe@ipb.pumc.edu.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	Natural Science Foundation of China [30870123]; National 973 program of China [2010CB530100]; National Science and Technology Major Project [2009ZX10004-303]; National Outstanding Youth Award of NSFC [81025009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); National Science and Technology Major Project; National Outstanding Youth Award of NSFC	This work was supported by Natural Science Foundation of China Grant 30870123 and National Outstanding Youth Award of NSFC Grant 81025009, National 973 program of China Grant 2010CB530100, and National Science and Technology Major Project Grant 2009ZX10004-303.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Berkhout B, 2011, ANTIVIR RES, V92, P7, DOI 10.1016/j.antiviral.2011.04.002; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN SSL, 1993, J VIROL, V67, P3615, DOI 10.1128/JVI.67.6.3615-3619.1993; Chen SSL, 1998, J VIROL, V72, P4765, DOI 10.1128/JVI.72.6.4765-4774.1998; Chong HH, 2009, J CLIN VIROL, V45, P255, DOI 10.1016/j.jcv.2009.05.001; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ji H, 2000, BIOCHEMISTRY-US, V39, P676, DOI 10.1021/bi991893e; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Mo HM, 2004, VIROLOGY, V329, P319, DOI 10.1016/j.virol.2004.08.025; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang SL, 2002, BIOCHEMISTRY-US, V41, P7283, DOI 10.1021/bi025648y; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000; Wexler-Cohen Y, 2006, J BIOL CHEM, V281, P9005, DOI 10.1074/jbc.M512475200; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	43	43	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20281	20289		10.1074/jbc.M112.354126	http://dx.doi.org/10.1074/jbc.M112.354126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22511760	Green Published, hybrid			2022-12-28	WOS:000306414500048
J	El-Mashtoly, SF; Kubo, M; Gu, YZ; Sawai, H; Nakashima, S; Ogura, T; Aono, S; Kitagawa, T				El-Mashtoly, Samir F.; Kubo, Minoru; Gu, Yuzong; Sawai, Hitomi; Nakashima, Satoru; Ogura, Takashi; Aono, Shigetoshi; Kitagawa, Teizo			Site-specific Protein Dynamics in Communication Pathway from Sensor to Signaling Domain of Oxygen Sensor Protein, HemAT-Bs TIME-RESOLVED ULTRAVIOLET RESONANCE RAMAN STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; LIGAND-BINDING; STRUCTURAL DYNAMICS; SENSING MECHANISM; HYDROGEN-BOND; CHEMOTAXIS; TYROSINE; TRANSMISSION; TRANSDUCTION; INTENSITIES	HemAT-Bs is a heme-based signal transducer protein responsible for aerotaxis. Time-resolved ultraviolet resonance Raman (UVRR) studies of wild-type and Y70F mutant of the full-length HemAT-Bs and the truncated sensor domain were performed to determine the site-specific protein dynamics following carbon monoxide (CO) photodissociation. The UVRR spectra indicated two phases of intensity changes for Trp, Tyr, and Phe bands of both full-length and sensor domain proteins. The W16 and W3 Raman bands of Trp, the F8a band of Phe, and the Y8a band of Tyr increased in intensity at hundreds of nanoseconds after CO photodissociation, and this was followed by recovery in similar to 50 mu s. These changes were assigned to Trp-132 (G-helix), Tyr-70 (B-helix), and Phe-69 (B-helix) and/or Phe-137 (G-helix), suggesting that the change in the heme structure drives the displacement of B- and G-helices. The UVRR difference spectra of the sensor domain displayed a positive peak for amide I in hundreds of nanoseconds after photolysis, which was followed by recovery in similar to 50 mu s. This difference band was absent in the spectra of the full-length protein, suggesting that the isolated sensor domain undergoes conformational changes of the protein backbone upon CO photolysis and that the changes are restrained by the signaling domain. The time-resolved difference spectrum at 200 mu s exhibited a pattern similar to that of the static (reduced - CO) difference spectrum, although the peak intensities were much weaker. Thus, the rearrangements of the protein moiety toward the equilibrium ligand-free structure occur in a time range of hundreds of microseconds.	[El-Mashtoly, Samir F.] Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany; [Kubo, Minoru; Nakashima, Satoru; Ogura, Takashi; Kitagawa, Teizo] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Kobe, Hyogo 6781297, Japan; [Gu, Yuzong; Sawai, Hitomi; Aono, Shigetoshi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Ruhr University Bochum; University of Hyogo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	El-Mashtoly, SF (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany.	samir@bph.rub.de; teizo@sci.u-hyogo.ac.jp	Asano, Yasuhisa/K-5898-2016; Sawai, Hitomi/AAW-5541-2021; Sawai, Hitomi/AAU-2584-2020; El-Mashtoly, Samir/C-8761-2014; Gu, Yuzong/ABC-5639-2021; Aono, Shigetoshi/ABD-7618-2020	Asano, Yasuhisa/0000-0003-3645-3952; El-Mashtoly, Samir/0000-0001-6087-8817; Gu, Yuzong/0000-0002-7107-5187; Aono, Shigetoshi/0000-0002-2870-3694; Nakashima, Satoru/0000-0001-8378-1153; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [243600086, 21026033, 22018026, 23685040]; Grants-in-Aid for Scientific Research [23350084, 23685040] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science 243600086 (to T. K.) and 21026033 (to S. A.), Grant-in-aid 22018026 for Priority Area 477 (to T. O.), and 23685040 for Young Scientists (A) (to M. K.).	Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Aono S, 2008, DALTON T, P3137, DOI 10.1039/b802070c; AUSTIN JC, 1993, ADV SPECTROSC, V20, P55; Balakrishnan G, 2008, CURR OPIN STRUC BIOL, V18, P623, DOI 10.1016/j.sbi.2008.06.001; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P23, DOI 10.1111/j.1365-2958.1992.tb00833.x; Chi ZH, 1998, J PHYS CHEM B, V102, P9595, DOI 10.1021/jp9828336; El-Mashtoly SF, 2008, J BIOL CHEM, V283, P6942, DOI 10.1074/jbc.M709209200; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; El-Mashtoly SF, 2011, J PHYS CHEM LETT, V2, P2212, DOI 10.1021/jz201017y; El-Mashtoly SF, 2005, J PHYS CHEM B, V109, P23666, DOI 10.1021/jp054772z; Gao Y, 2006, J BIOL CHEM, V281, P24637, DOI 10.1074/jbc.M603198200; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kneipp J, 2004, J PHYS CHEM B, V108, P15919, DOI 10.1021/jp047848k; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Kubo M, 2008, APPL SPECTROSC, V62, P30, DOI 10.1366/000370208783412573; Matsuno M, 1998, B CHEM SOC JPN, V71, P851, DOI 10.1246/bcsj.71.851; Mokdad A, 2007, FEBS LETT, V581, P4512, DOI 10.1016/j.febslet.2007.08.031; Ohta T, 2005, INORG CHEM, V44, P758, DOI 10.1021/ic0486318; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Pinakoulaki E, 2006, P NATL ACAD SCI USA, V103, P14796, DOI 10.1073/pnas.0604248103; Pinakoulaki E, 2006, BIOCHEMISTRY-US, V45, P7763, DOI 10.1021/bi0604072; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; RODGERS KR, 1994, SCIENCE, V265, P1697, DOI 10.1126/science.8085153; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; SU C, 1990, J RAMAN SPECTROSC, V21, P435, DOI 10.1002/jrs.1250210709; SWEENEY JA, 1990, J PHYS CHEM-US, V94, P4784, DOI 10.1021/j100375a009; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAKEUCHI H, 1989, J RAMAN SPECTROSC, V20, P233, DOI 10.1002/jrs.1250200407; Takeuchi H., 1986, ADV SPECTROSCOPY SPE, V13, P113; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Unno M, 2010, BIOPHYS J, V98, P1949, DOI 10.1016/j.bpj.2010.01.007; Yoshimura H, 2007, BIOCHEM BIOPH RES CO, V357, P1053, DOI 10.1016/j.bbrc.2007.04.041; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	41	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19973	19984		10.1074/jbc.M112.357855	http://dx.doi.org/10.1074/jbc.M112.357855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22528495	Green Published, hybrid			2022-12-28	WOS:000306414500019
J	Rajagopal, V; Park, EH; Hinnebusch, AG; Lorsch, JR				Rajagopal, Vaishnavi; Park, Eun-Hee; Hinnebusch, Alan G.; Lorsch, Jon R.			Specific Domains in Yeast Translation Initiation Factor eIF4G Strongly Bias RNA Unwinding Activity of the eIF4F Complex toward Duplexes with 5 '-Overhangs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-INDEPENDENT TRANSLATION; HELICASE ACTIVITY; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; FACTOR EIF-4A; FACTOR 4A; BINDING	During eukaryotic translation initiation, the 43 S ribosomal pre-initiation complex is recruited to the 5'-end of an mRNA through its interaction with the 7-methylguanosine cap, and it subsequently scans along the mRNA to locate the start codon. Both mRNA recruitment and scanning require the removal of secondary structure within the mRNA. Eukaryotic translation initiation factor 4A is an essential component of the translational machinery thought to participate in the clearing of secondary structural elements in the 5'-untranslated regions of mRNAs. eIF4A is part of the 5'-7-methylguanosine cap-binding complex, eIF4F, along with eIF4E, the cap-binding protein, and the scaffolding protein eIF4G. Here, we show that Saccharomyces cerevisiae eIF4F has a strong preference for unwinding an RNA duplex with a single-stranded 5'-overhang versus the same duplex with a 3'-overhang or without an overhang. In contrast, eIF4A on its own has little RNA substrate specificity. Using a series of deletion constructs of eIF4G, we demonstrate that its three previously elucidated RNA binding domains work together to provide eIF4F with its 5'-end specificity, both by promoting unwinding of substrates with 5'-overhangs and inhibiting unwinding of substrates with 3'-overhangs. Our data suggest that the RNA binding domains of eIF4G provide the S. cerevisiae eIF4F complex with a second mechanism, in addition to the eIF4E-cap interaction, for directing the binding of pre-initiation complexes to the 5'-ends of mRNAs and for biasing scanning in the 5' to 3' direction.	[Rajagopal, Vaishnavi; Lorsch, Jon R.] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, Baltimore, MD 21205 USA; [Park, Eun-Hee; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lorsch, JR (corresponding author), Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu		Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health [GM62128]; Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62128 (to J. R. L.) and by the Intramural Research Program (to A. G. H.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Bi XP, 2000, J BIOL CHEM, V275, P17740, DOI 10.1074/jbc.M909464199; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; Borman AM, 1997, RNA, V3, P186; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hinton TM, 2007, J BIOL CHEM, V282, P1695, DOI 10.1074/jbc.M602780200; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaye NM, 2009, J BIOL CHEM, V284, P17742, DOI 10.1074/jbc.M109.009001; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; NIELSEN PJ, 1985, NUCLEIC ACIDS RES, V13, P6867, DOI 10.1093/nar/13.19.6867; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Ohlmann T, 1996, EMBO J, V15, P1371, DOI 10.1002/j.1460-2075.1996.tb00479.x; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Vassilenko KS, 2011, NUCLEIC ACIDS RES, V39, P5555, DOI 10.1093/nar/gkr147	43	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20301	20312		10.1074/jbc.M112.347278	http://dx.doi.org/10.1074/jbc.M112.347278			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22467875	hybrid, Green Published			2022-12-28	WOS:000306414500050
J	Zhong, Q; Congdon, EE; Nagaraja, HN; Kuret, J				Zhong, Qi; Congdon, Erin E.; Nagaraja, Haikady N.; Kuret, Jeff			Tau Isoform Composition Influences Rate and Extent of Filament Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; HAPLOTYPE-SPECIFIC EXPRESSION; MILD COGNITIVE IMPAIRMENT; CORTICOBASAL DEGENERATION; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; GENE-EXPRESSION; MESSENGER-RNAS; PICKS-DISEASE	The risk of developing tauopathic neurodegenerative disease depends in part on the levels and composition of six naturally occurring Tau isoforms in human brain. These proteins, which form filamentous aggregates in disease, vary only by the presence or absence of three inserts encoded by alternatively spliced exons 2, 3, and 10 of the Tau gene (MAPT). To determine the contribution of alternatively spliced segments to Tau aggregation propensity, the aggregation kinetics of six unmodified, recombinant human Tau isoforms were examined in vitro using electron microscopy assay methods. Aggregation propensity was then compared at the level of elementary rate constants for nucleation and extension phases. We found that all three alternatively spliced segments modulated Tau aggregation but through differing kinetic mechanisms that could synergize or compete depending on sequence context. Overall, segments encoded by exons 2 and 10 promoted aggregation, whereas the segment encoded by exon 3 depressed it with its efficacy dependent on the presence or absence of a fourth microtubule binding repeat. In general, aggregation propensity correlated with genetic risk reported for multiple tauopathies, implicating aggregation as one candidate mechanism rationalizing the correlation between Tau expression patterns and disease.	[Zhong, Qi; Congdon, Erin E.; Kuret, Jeff] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Nagaraja, Haikady N.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Congdon, Erin/0000-0001-8322-6176	National Institutes of Health [AG14452]; Alzheimer's Association [IIRG-05-14288]; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14452. This work was also supported by Alzheimer's Association Grant IIRG-05-14288.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Armstrong RA, 1999, ACTA NEUROPATHOL, V97, P456, DOI 10.1007/s004010051014; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Caffrey TM, 2008, NEUROBIOL AGING, V29, P1923, DOI 10.1016/j.neurobiolaging.2007.05.002; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Chang E, 2008, J NEUROCHEM, V107, P1113, DOI 10.1111/j.1471-4159.2008.05692.x; Chang E, 2011, BBA-PROTEINS PROTEOM, V1814, P388, DOI 10.1016/j.bbapap.2010.10.005; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; DEANCOS JG, 1993, J BIOL CHEM, V268, P7976; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; FEANY MB, 1995, ACTA NEUROPATHOL, V90, P37; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FESCE R, 1992, J BIOL CHEM, V267, P11289; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Ginsberg SD, 2006, J NEUROCHEM, V96, P1401, DOI 10.1111/j.1471-4159.2005.03641.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; HOF PR, 1994, ACTA NEUROPATHOL, V87, P115; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; KRISTOFFERSON D, 1980, J BIOL CHEM, V255, P8567; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Muller R, 1997, CELL TISSUE RES, V288, P239, DOI 10.1007/s004410050809; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rice J. A., 2007, MATH STAT DATA ANAL, P165; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Terada S, 2005, ACTA NEUROPATHOL, V110, P12, DOI 10.1007/s00401-005-1012-x; Voss K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-18; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	64	69	72	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20711	20719		10.1074/jbc.M112.364067	http://dx.doi.org/10.1074/jbc.M112.364067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22539343	Green Published, hybrid			2022-12-28	WOS:000306414500089
J	Debreuil, J; Tambutte, E; Zoccola, D; Deleury, E; Guigonis, JM; Samson, M; Allemand, D; Tambutte, S				Debreuil, Julien; Tambutte, Eric; Zoccola, Didier; Deleury, Emeline; Guigonis, Jean-Marie; Samson, Michel; Allemand, Denis; Tambutte, Sylvie			Molecular Cloning and Characterization of First Organic Matrix Protoein from Sclerites of Red Coral, Corallium rubrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRGULATA LAMARCK COELENTERATA; PROTEINACEOUS COMPONENTS; STYLOPHORA-PISTILLATA; CARBONIC-ANHYDRASE; SHELL MATRIX; SPICULES; LOCALIZATION; BIOMINERALIZATION; PHOSPHORYLATION; ALCYONARIAN	We report here for the first time the isolation and characterization of a protein from the organic matrix (OM) of the sclerites of the alcyonarian, Corallium rubrum. This protein named scleritin is one of the predominant proteins extracted from the EDTA-soluble fraction of the OM. The entire open reading frame (ORF) was obtained by comparing amino acid sequences from de novo mass spectrometry and Edman degradation with an expressed sequence tag library dataset of C. rubrum. Scleritin is a secreted basic phosphorylated protein which exhibits a short amino acid sequence of 135 amino acids and a signal peptide of 20 amino acids. From specific antibodies raised against peptide sequences of scleritin, we obtained immunolabeling of scleroblasts and OM of the sclerites which provides information on the biomineralization pathway in C. rubrum.	[Debreuil, Julien; Tambutte, Eric; Zoccola, Didier; Allemand, Denis; Tambutte, Sylvie] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Deleury, Emeline] CNRS 7254, Inst Sophia Agrobiotech ISA INRA 1355, F-06903 Sophia Antipolis, France; [Guigonis, Jean-Marie] Commissariata Energie Atom, Lab Transporteur Imagerie & Radiotherapie Oncol, F-06107 Nice, France; [Guigonis, Jean-Marie] Ctr Antoine Lacassagne, F-06107 Nice, France; [Samson, Michel] Univ Nice Sophia Antipolis, Fac Med, Equipe Reg, Inst Natl Sante & Rech Med 21,Equipe Associee 431, F-06107 Nice, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Tambutte, S (corresponding author), Ctr Sci Monaco, Ave St Martin, MC-98000 Monaco, Monaco.	stambutte@centrescientifique.mc	Zoccola, Didier/A-5997-2009	Zoccola, Didier/0000-0002-1524-8098	Government of the Principality of Monaco; Ministere Francais de l'Enseignement Superieur et de la Recherche; Ministere Francais de l'Enseignement Superieur et de la Recherche, Ecole Doctorale Diversit, du Vivant, Universite Pierre et Marie Curie [392]	Government of the Principality of Monaco; Ministere Francais de l'Enseignement Superieur et de la Recherche; Ministere Francais de l'Enseignement Superieur et de la Recherche, Ecole Doctorale Diversit, du Vivant, Universite Pierre et Marie Curie	This work was conducted as part of the Centre Scientifique de Monaco research program, supported by the Government of the Principality of Monaco.; Supported by the Ministere Francais de l'Enseignement Superieur et de la Recherche, Ecole Doctorale Diversit, du Vivant 392, Universite Pierre et Marie Curie.	Allemand D, 1998, J EXP BIOL, V201, P2001; Allemand D., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P129; Allemand D, 1996, J EXP ZOOL, V276, P270, DOI 10.1002/(SICI)1097-010X(19961101)276:4<270::AID-JEZ4>3.0.CO;2-L; ALLEMAND D, 1992, J EXP ZOOL, V262, P237, DOI 10.1002/jez.1402620302; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Allemand Denis, 1993, Precious Corals & Octocoral Research, V2, P19; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameye L, 2001, J STRUCT BIOL, V134, P56, DOI 10.1006/jsbi.2001.4361; Anitei M, 2011, CURR OPIN CELL BIOL, V23, P443, DOI 10.1016/j.ceb.2011.03.013; [Anonymous], 1961, SHALLOW WATER OCTOCO; BORBAS JE, 1991, J EXP ZOOL, V258, P1, DOI 10.1002/jez.1402580102; Borelli G, 2003, CALCIFIED TISSUE INT, V72, P717, DOI 10.1007/s00223-001-2115-6; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Cvejic J, 2007, MAR BIOL, V152, P855, DOI 10.1007/s00227-007-0738-5; Dauphin Y, 2006, COMP BIOCHEM PHYS A, V145, P54, DOI 10.1016/j.cbpa.2006.04.029; Debreuil J, 2011, MAR BIOL, V158, P2765, DOI 10.1007/s00227-011-1775-7; Debreuil J, 2011, COMP BIOCHEM PHYS B, V159, P40, DOI 10.1016/j.cbpb.2011.01.007; DUBOIS P, 1989, ECHINODERM STUDIES, P109; Ehrlich H, 2009, MICRON, V40, P169, DOI 10.1016/j.micron.2008.06.004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Estroff LA, 2008, CHEM REV, V108, P4329, DOI 10.1021/cr8004789; Floquet N, 2011, AM MINERAL, V96, P1228, DOI 10.2138/am.2011.3805; Fritsch E, 2008, MAR BIOL, V154, P929, DOI 10.1007/s00227-008-0964-5; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; GOLDBERG WM, 1988, HISTOCHEMISTRY, V89, P163, DOI 10.1007/BF00489919; GRILLO MC, 1993, MAR BIOL, V117, P119, DOI 10.1007/BF00346433; HARVELL CD, 1989, LIMNOL OCEANOGR, V34, P382, DOI 10.4319/lo.1989.34.2.0382; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; KINGSLEY RJ, 1982, T AM MICROSC SOC, V101, P325, DOI 10.2307/3225750; Kingsley RJ, 1996, INVERTEBR BIOL, V115, P89, DOI 10.2307/3227039; KINGSLEY RJ, 1990, BIOL BULL, V179, P207, DOI 10.2307/1541771; KINGSLEY RJ, 1983, COMP BIOCHEM PHYS B, V76, P443, DOI 10.1016/0305-0491(83)90273-0; KINGSLEY RJ, 1989, J EXP MAR BIOL ECOL, V133, P57, DOI 10.1016/0022-0981(89)90157-3; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lacaze-Duthiers H., 1864, HIST NATURELLE CORAI, P110; LEWIS JC, 1991, BIOL BULL, V181, P275, DOI 10.2307/1542099; Lowenstam H.A., 1989, BIOMINERALISATION, P7; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Mankad RV, 1998, BIOL BULL, V195, P251, DOI 10.2307/1543135; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann S., 2001, BIOMINERALIZATION PR, P6; Marie B, 2011, MAR BIOTECHNOL, V13, P1159, DOI 10.1007/s10126-011-9379-2; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marie B, 2011, MAR BIOTECHNOL, V13, P955, DOI 10.1007/s10126-010-9357-0; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; MATEU G, 1986, Boletin Instituto Espanol de Oceanografia, V3, P1; MERLIN JC, 1983, B SOC ZOOL FR, V108, P289; Morel J.-P., 2000, CORALLO IERI CORALLO; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Rahman MA, 2008, J CRYST GROWTH, V310, P3528, DOI 10.1016/j.jcrysgro.2008.04.056; Rahman MA, 2008, MAR BIOTECHNOL, V10, P31, DOI 10.1007/s10126-007-9030-4; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2011, J BIOL CHEM, V286, P31638, DOI 10.1074/jbc.M109.070185; Rahman MA, 2006, CALCIFIED TISSUE INT, V78, P178, DOI 10.1007/s00223-005-0253-y; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rahman MA, 2005, J EXP MAR BIOL ECOL, V321, P71, DOI 10.1016/j.jembe.2005.01.012; SAMATA T, 1989, COMP BIOCHEM PHYS B, V94, P651, DOI 10.1016/0305-0491(89)90144-2; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Segev N, 2009, MOL BIOL INTELL UNIT, P1, DOI 10.1007/978-0-387-93877-6; Sethmann I, 2007, CRYSTENGCOMM, V9, P1262, DOI 10.1039/b711068e; TAMBUTTE S, 2007, HDB BIOMINERALIZATIO, V1, P243; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tescione G., 1973, ITALIANS THEIR CORAL; Testeniere O, 2002, BIOCHEM J, V361, P327, DOI 10.1042/0264-6021:3610327; Treccani L., 2005, BIOPOLYMERS ONLINE, P289; Vargas S, 2010, MICRON, V41, P158, DOI 10.1016/j.micron.2009.08.009; Wainwright S.A., 1982, MECH DESIGN ORGANISM; WEINBERG S, 1976, Beaufortia, V24, P63; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S., 1983, BIOMINER BIOL MET AC, P205, DOI [10.1007/978-94-009-7944-4_18, DOI 10.1007/978-94-009-7944-4_18]; Zoccola D, 1999, GENE, V227, P157, DOI 10.1016/S0378-1119(98)00602-7	82	21	22	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19367	19376		10.1074/jbc.M112.352005	http://dx.doi.org/10.1074/jbc.M112.352005			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22505718	Green Published, hybrid			2022-12-28	WOS:000306411900051
J	Bae, EJ; Xu, JF; Oh, DY; Bandyopadhyay, G; Lagakos, WS; Keshwani, M; Olefsky, JM				Bae, Eun Ju; Xu, Jianfeng; Oh, Da Young; Bandyopadhyay, Gautam; Lagakos, William S.; Keshwani, Malik; Olefsky, Jerrold M.			Liver-specific p70 S6 Kinase Depletion Protects against Hepatic Steatosis and Systemic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MAMMALIAN TARGET; AMINO-ACIDS; RAPAMYCIN PATHWAY; RAT HEPATOCYTES; LIPOGENESIS; ACTIVATION; MICE; AKT; SENSITIVITY	Obesity-associated hepatic steatosis is a manifestation of selective insulin resistance whereby lipogenesis remains sensitive to insulin but the ability of insulin to suppress glucose production is impaired. We created a mouse model of liver-specific knockdown of p70 S6 kinase (S6K) (L-S6K-KD) by systemic delivery of an adeno-associated virus carrying a shRNA for S6K and examined the effects on steatosis and insulin resistance. High fat diet (HFD) fed L-S6K-KD mice showed improved glucose tolerance and systemic insulin sensitivity compared with controls, with no changes in food intake or body weight. The induction of lipogenic gene expression was attenuated in the L-S6K-KD mice with decreased sterol regulatory element-binding protein (SREBP)-1c expression and mature SREBP-1c protein, as well as decreased steatosis on HFD. Our results demonstrate the importance of S6K: 1) as a modulator of the hepatic response to fasting/refeeding, 2) in the development of steatosis, and 3) as a key node in selective hepatic insulin resistance in obese mice.	[Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Keshwani, Malik] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			National Institutes of Health [DK033651, DK074868, T32 DK 007494, DK063491]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, T32DK007494, P01DK074868, P30DK063491, R37DK033651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants DK033651, DK074868, T32 DK 007494, and DK063491 from the National Institutes of Health. This work was also supported by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	26	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18769	18780		10.1074/jbc.M112.365544	http://dx.doi.org/10.1074/jbc.M112.365544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493495	Green Published, hybrid			2022-12-28	WOS:000306411600085
J	Breloy, I; Pacharra, S; Ottis, P; Bonar, D; Grahn, A; Hanisch, FG				Breloy, Isabelle; Pacharra, Sandra; Ottis, Philipp; Bonar, David; Grahn, Ammi; Hanisch, Franz-Georg			O-Linked N,N '-Diacetyllactosamine (LacdiNAc)-modified Glycans in Extracellular Matrix Glycoproteins Are Specifically Phosphorylated at Subterminal N-Acetylglucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN; DIFFERENTIAL EXPRESSION; MASS-SPECTROMETRY; IN-VIVO; GLYCOSYLATION; OLIGOSACCHARIDES; PROTEIN; DOMAIN; MUCIN; PROOPIOMELANOCORTIN	The terminal modification of glycans by beta 4 addition of N-acetylgalactosamine to N-acetylglucosamine with formation of the N,N-diacetyllactosediamine (LacdiNAc) moiety has been well documented for a number of N-linked glycoproteins and peptides, like neurohormones. Much less is known about O-glycoproteins in this regard because only human zona pellucida glycoprotein 3 (ZP3) and bovine proopiomelanocortin were reported to be LacdiNAc-modified. In searching for mammalian proteins modified with O-linked LacdiNAc we identified six positive species among nine endogenous and recombinant O-glycoproteins, which were extracellular matrix, or matrix-related proteins. These are ZP3 and the five novel LacdiNAc-positive species ECM1, AMACO, nidogen-1, alpha-dystroglycan, and neurofascin. The mass spectrometric analyses revealed a core 2-based tetrasaccharide as the common structural basis of O-linked LacdiNAc that could be further modified, similar to the type 2 LacNAc termini, with fucose, sialic acid, or sulfate. Here, we provide structural evidence for a novel type of mucin-type O-glycans that is strictly specific for LacdiNAc termini: sugar phosphorylation with formation of GalNAc beta 1-4(phospho-)GlcNAc. The structural details of the phosphatase-labile compound were elucidated by MS2 analysis of tetralysine complexes and by MSn measurements of the permethylated glycan alditols. Phospho-LacdiNAc was detected in human HEK-293 as well as in mouse myo-blast cells and in bovine brain tissue.	[Breloy, Isabelle; Pacharra, Sandra; Ottis, Philipp; Bonar, David; Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Grahn, Ammi] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Biomed, S-41345 Gothenburg, Sweden	University of Cologne; University of Cologne; Sahlgrenska University Hospital	Breloy, I (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany.	isabelle.breloy@uni-koeln.de; franz.hanisch@uni-koeln.de	Breloy, Isabelle/E-3804-2012		Deutsche Forschungsgemeinschaft [HA 2092/21-1, BR 3979/1-1]; Swedish Research Council [8266]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants HA 2092/21-1 (to F.-G.H.) and BR 3979/1-1 (to I.B.) and by Swedish Research Council Grant 8266 (to A.G.).	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Benoff S, 1997, MOL HUM REPROD, V3, P599, DOI 10.1093/molehr/3.7.599; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Chapman NR, 1996, MOL HUM REPROD, V2, P767, DOI 10.1093/molehr/2.10.767; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Dell A, 2003, P NATL ACAD SCI USA, V100, P15631, DOI 10.1073/pnas.2635507100; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Florea D, 2006, GLYCOCONJUGATE J, V23, P377, DOI 10.1007/s10719-006-6126-4; Gebauer JM, 2008, J BIOL CHEM, V283, P17846, DOI 10.1074/jbc.M704820200; GREEN ED, 1985, J BIOL CHEM, V260, P5623; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Huang HH, 2001, GLYCOBIOLOGY, V11, P395, DOI 10.1093/glycob/11.5.395; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; van Remoortere A, 2000, GLYCOBIOLOGY, V10, P601, DOI 10.1093/glycob/10.6.601; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113; Zhang Y, 2006, J AM SOC MASS SPECTR, V17, P1282, DOI 10.1016/j.jasms.2006.05.013	29	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18275	18286		10.1074/jbc.M111.280297	http://dx.doi.org/10.1074/jbc.M111.280297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22474328	hybrid, Green Published			2022-12-28	WOS:000306411600034
J	Ma, CY; Wang, NH; Detre, C; Wang, GX; O'Keeffe, M; Terhorst, C				Ma, Chunyan; Wang, Ninghai; Detre, Cynthia; Wang, Guoxing; O'Keeffe, Michael; Terhorst, Cox			Receptor Signaling Lymphocyte-activation Molecule Family 1 (Slamf1) Regulates Membrane Fusion and NADPH Oxidase 2 (NOX2) Activity by Recruiting a Beclin-1/Vps34/Ultraviolet Radiation Resistance-associated Gene (UVRAG) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; INNATE IMMUNITY; AUTOPHAGY GENE; ROLES; MACROPHAGES; BECLIN-1; PATHWAY; SENSOR; VPS34; CELL	Phagocytosis is a pivotal process by which macrophages eliminate microorganisms upon recognition by pathogen sensors. Surprisingly, the self-ligand cell surface receptor Slamf1 functions not only as a co-stimulatory molecule but also as a microbial sensor of several Gram-negative bacteria. Upon entering the phagosome of macrophages Slamf1 induces production of phosphatidylinositol 3-phosphate, which positively regulates the activity of the NOX2 enzyme and phagolysosomal maturation. Here, we report that in Escherichia coli-containing phagosomes of mouse macrophages, Slamf1 interacts with the class III PI3K Vps34 in a complex with Beclin-1 and UVRAG. Upon phagocytosis of bacteria the NOX2 activity was reduced in macrophages isolated from Beclin-1(+/-) mice compared with wild-type mice. This Slamf1/Beclin-1/Vps34/UVRAG protein complex is formed in intracellular membrane compartments as it is found without inducing phagocytosis in macrophages, human chronic lymphocytic leukemia cells, and transfectant HEK293 cells. Elimination of its cytoplasmic tail abolished the interaction of Slamf1 with the complex, but deletion or mutation of the two ITAM motifs did not. Both the BD and CCD domains of Beclin-1 were required for efficient binding to Slamf1. Because Slamf1 did not interact with Atg14L or Rubicon, which can also form a complex with Vps34 and Beclin-1, we conclude that Slamf1 recruits a subset of Vps34-associated proteins, which is involved in membrane fusion and NOX2 regulation.	[Ma, Chunyan; Wang, Ninghai; Detre, Cynthia; Wang, Guoxing; O'Keeffe, Michael; Terhorst, Cox] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ma, CY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA.	cma@bidmc.harvard.edu; cterhors@bidmc.harvard.edu	Wang, Guoxing/G-6586-2013		National Institutes of Health [AI-15066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015066, R01AI015066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant AI-15066 (to C. T.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cheson B. D, 2001, CHRONIC LYMPHOCYTIC, P33; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	23	33	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18359	18365		10.1074/jbc.M112.367060	http://dx.doi.org/10.1074/jbc.M112.367060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493499	Green Published, hybrid			2022-12-28	WOS:000306411600042
J	Melo, FR; Grujic, M; Spirkoski, J; Calounova, G; Pejler, G				Melo, Fabio R.; Grujic, Mirjana; Spirkoski, Jane; Calounova, Gabriela; Pejler, Gunnar			Serglycin Proteoglycan Promotes Apoptotic versus Necrotic Cell Death in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANZYME-B; POLY(ADP-RIBOSE) POLYMERASE; SECRETORY GRANULE; T-LYMPHOCYTES; PROTEASES; ACTIVATION; EXPRESSION; MATURATION; INHIBITORS; CLEAVAGE	The mechanisms that govern whether a cell dies by apoptosis or necrosis are not fully understood. Here we show that serglycin, a secretory granule proteoglycan of hematopoietic cells, can have a major impact on this decision. Wild type and serglycin(-/-) mast cells were equally sensitive to a range of cell death-inducing regimens. However, whereas wild type mast cells underwent apoptotic cell death, serglycin(-/-) cells died predominantly by necrosis. Investigations of the underlying mechanism revealed that cell death was accompanied by leakage of secretory granule compounds into the cytosol and that the necrotic phenotype of serglycin(-/-) mast cells was linked to defective degradation of poly(ADP-ribose) polymerase-1. Cells lacking mouse mast cell protease 6, a major serglycin-associated protease, exhibited similar defects in apoptosis as observed in serglycin(-/-) cells, indicating that the pro-apoptotic function of serglycin is due to downstream effects of proteases that are complex-bound to serglycin. Together, these findings implicate serglycin in promoting apoptotic versus necrotic cell death.	[Melo, Fabio R.] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, S-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Melo, FR (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, S-75123 Uppsala, Sweden.	Fabio.Melo@slu.se; Gunnar.Pejler@slu.se	Melo, Fabio Rabelo/GQP-0844-2022		King Gustaf V's 80-year Anniversary Fund; Swedish Research Council; Swedish Cancer Foundation	King Gustaf V's 80-year Anniversary Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants from King Gustaf V's 80-year Anniversary Fund, The Swedish Research Council, and The Swedish Cancer Foundation.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Berent-Maoz B, 2011, ANN ALLERG ASTHMA IM, V106, P239, DOI 10.1016/j.anai.2010.12.001; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hartmann K, 1997, J IMMUNOL, V159, P4006; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Melo FR, 2011, J BIOL CHEM, V286, P5423, DOI 10.1074/jbc.M110.176461; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tran TM, 2009, APOPTOSIS, V14, P320, DOI 10.1007/s10495-009-0311-4; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zernichow L, 2006, FEBS J, V273, P536, DOI 10.1111/j.1742-4658.2005.05085.x	38	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18142	18152		10.1074/jbc.M112.344796	http://dx.doi.org/10.1074/jbc.M112.344796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22493512	hybrid, Green Published			2022-12-28	WOS:000306411600022
J	Utreras, E; Keller, J; Terse, A; Prochazkova, M; Iadarola, MJ; Kulkarni, AB				Utreras, Elias; Keller, Jason; Terse, Anita; Prochazkova, Michaela; Iadarola, Michael J.; Kulkarni, Ashok B.			Transforming Growth Factor-beta 1 Regulates Cdk5 Activity in Primary Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE-5 ACTIVITY; B104 NEUROBLASTOMA-CELLS; FACTOR-BETA FAMILY; PERIPHERAL INFLAMMATION; TARGETED DISRUPTION; GROWTH; MICE; PAIN; EXPRESSION; ALZHEIMERS	In addition to many important roles for Cdk5 in brain development and synaptic function, we reported previously that Cdk5 regulates inflammatory pain signaling, partly through phosphorylation of transient receptor potential vanilloid 1 (TRPV1), an important Na+/Ca2+ channel expressed in primary nociceptive afferent nerves. Because TGF-beta regulates inflammatory processes and its receptor is expressed in TRPV1-positive afferents, we studied the cross-talk between these two pathways in sensory neurons during experimental peripheral inflammation. We demonstrate that TGF-beta 1 increases transcription and protein levels of the Cdk5 co-activator p35 through ERK1/2, resulting in an increase in Cdk5 activity in rat B104 neuroblastoma cells. Additionally, TGF-beta 1 enhances the capsaicin-induced Ca2+ influx in cultured primary neurons from dorsal root ganglia (DRG). Importantly, Cdk5 activity was reduced in the trigeminal ganglia and DRG of 14-day-old TGF-beta 1 knock-out mice, resulting in reduced Cdk5-dependent phosphorylation of TRPV1. The decreased Cdk5 activity is associated with attenuated thermal hyperalgesia in TGF-beta 1 receptor conditional knock-out mice, where TGF-beta signaling is significantly reduced in trigeminal ganglia and DRG. Collectively, our results indicate that active cross-talk between the TGF-beta and Cdk5 pathways contributes to inflammatory pain signaling.	[Utreras, Elias; Terse, Anita; Prochazkova, Michaela; Kulkarni, Ashok B.] NIDCR, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Keller, Jason; Iadarola, Michael J.] NIDCR, Neurobiol & Pain Therapeut Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kulkarni, AB (corresponding author), NIDCR, LCDB, NIH, 30 Convent Dr,Rm 130,MSC 4395, Bethesda, MD 20892 USA.	ak40m@nih.gov	Utreras, Elias/I-1038-2013	Utreras, Elias/0000-0002-1004-0466	National Institutes of Health Division of Intramural Research, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664, ZIADE000688] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Division of Intramural Research, NIDCR.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Bo SH, 2009, CEPHALALGIA, V29, P365, DOI 10.1111/j.1468-2982.2008.01727.x; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Cuellar JM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-39; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; FAN RJ, 1995, PHYSIOL BEHAV, V57, P1131, DOI 10.1016/0031-9384(94)00372-C; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; Ishizaki K, 2005, HEADACHE, V45, P1224, DOI 10.1111/j.1526-4610.2005.00246.x; Ko J, 2001, J NEUROSCI, V21, P6758; KULKARNI AB, 1993, AM J PATHOL, V143, P3; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Kulkarni Ashok B., 2002, Current Molecular Medicine (Hilversum), V2, P303; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Luo J, 1999, J NEUROCHEM, V72, P2286, DOI 10.1046/j.1471-4159.1999.0722286.x; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Miller MW, 2006, J NEUROCHEM, V97, P1182, DOI 10.1111/j.1471-4159.2006.03858.x; Mitchell K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-94; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Ronaldson PT, 2011, J PHARMACOL EXP THER, V336, P827, DOI 10.1124/jpet.110.174151; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tramullas M, 2010, J NEUROSCI, V30, P1502, DOI 10.1523/JNEUROSCI.2584-09.2010; Utreras E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-49; Utreras Elias, 2009, Drug Discov Today Ther Strateg, V6, P105, DOI 10.1016/j.ddstr.2009.04.004; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Wahl SM, 2005, ARTHRITIS RES THER, V7, P62, DOI 10.1186/ar1504; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Xie WY, 2009, J NEUROSCI, V29, P3551, DOI 10.1523/JNEUROSCI.0415-09.2009; Xu P, 2005, J NEUROSCI, V25, P9227, DOI 10.1523/JNEUROSCI.3051-05.2005; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhu WG, 2007, J NEUROSCI, V27, P13770, DOI 10.1523/JNEUROSCI.3822-07.2007	50	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16917	16929		10.1074/jbc.M111.329979	http://dx.doi.org/10.1074/jbc.M111.329979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22451679	Green Published, hybrid			2022-12-28	WOS:000304030900077
